Citrus Sinensis ID: 037285
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1094 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.245 | 0.288 | 0.393 | 5e-48 | |
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.235 | 0.314 | 0.404 | 9e-47 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.234 | 0.158 | 0.382 | 7e-44 | |
| P18160 | 2410 | Dual specificity protein | yes | no | 0.239 | 0.108 | 0.389 | 8e-44 | |
| Q54RB7 | 527 | Dual specificity protein | no | no | 0.232 | 0.481 | 0.394 | 3e-43 | |
| Q54IP4 | 653 | Dual specificity protein | no | no | 0.227 | 0.381 | 0.396 | 3e-43 | |
| Q55GU0 | 916 | Probable serine/threonine | no | no | 0.234 | 0.279 | 0.382 | 5e-43 | |
| A7J1T2 | 961 | Mitogen-activated protein | N/A | no | 0.223 | 0.253 | 0.389 | 8e-43 | |
| A7J1T0 | 961 | Mitogen-activated protein | N/A | no | 0.223 | 0.253 | 0.378 | 2e-42 | |
| Q1HKZ5 | 959 | Mitogen-activated protein | yes | no | 0.225 | 0.257 | 0.380 | 2e-42 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 194 bits (492), Expect = 5e-48, Method: Compositional matrix adjust.
Identities = 113/287 (39%), Positives = 158/287 (55%), Gaps = 18/287 (6%)
Query: 796 LVDFDVSSVQVIKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQER 855
L D DV ++ N DL + +G G++G VYH W GT+VA+K+ F+G +
Sbjct: 654 LDDADVGECEIPWN-DLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAA----- 707
Query: 856 LTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDR 915
EF E I+ +L HPNVV F G V P L+ V E++ GSL +L R +D
Sbjct: 708 -LAEFRSEVRIMRRLRHPNVVFFLGAVTRPPN--LSIVTEFLPRGSLYRILHRPKSHIDE 764
Query: 916 RRRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT 973
RRR+ +A+D A GM LH+ IVH DLK NLLV+ + KVGDFGLS++K NT
Sbjct: 765 RRRIKMALDVAMGMNCLHTSTPTIVHRDLKTPNLLVD----NNWNVKVGDFGLSRLKHNT 820
Query: 974 LVSG-GVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGG 1032
+S GT WMAPE+L S +EK DV+SFG++LWE+ T P+ M+ ++G
Sbjct: 821 FLSSKSTAGTPEWMAPEVLRNEPS--NEKCDVYSFGVILWELATLRLPWRGMNPMQVVGA 878
Query: 1033 IVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079
+ R IP D ++ ECW +P RPSF ++ L+ L+
Sbjct: 879 VGFQNRRLEIPKELDPVVGRIILECWQTDPNLRPSFAQLTEVLKPLN 925
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 189 bits (480), Expect = 9e-47, Method: Compositional matrix adjust.
Identities = 112/277 (40%), Positives = 160/277 (57%), Gaps = 19/277 (6%)
Query: 811 DLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL 870
DL ++++G+G+FGTV+ +W G+DVA+K + + F ER+ EF +E I+ +L
Sbjct: 550 DLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDF-----HAERVN-EFLREVAIMKRL 603
Query: 871 HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD--RFLDRRRRLIIAMDAAFG 928
HPN+V F G V P L+ V EY+ GSL +L + LD RRRL +A D A G
Sbjct: 604 RHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 661
Query: 929 MEYLHSKN--IVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSG-GVRGTLPW 985
M YLH++N IVH DLK NLLV+ K KV DFGLS++K +T +S GT W
Sbjct: 662 MNYLHNRNPPIVHRDLKSPNLLVDKKY----TVKVCDFGLSRLKASTFLSSKSAAGTPEW 717
Query: 986 MAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSY 1045
MAPE+L S +EK DV+SFG++LWE+ T ++P+ N++ ++ + R IP
Sbjct: 718 MAPEVLRDEPS--NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRN 775
Query: 1046 CDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAA 1082
+ + ++E CW P RPSF I LR L +A
Sbjct: 776 LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 812
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 179 bits (455), Expect = 7e-44, Method: Compositional matrix adjust.
Identities = 106/277 (38%), Positives = 159/277 (57%), Gaps = 20/277 (7%)
Query: 806 VIKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAE 865
+I +++ K++G G++G V++GKW+G DVA+K+ K + SE + L EF E
Sbjct: 1358 IINYDEISIGKQIGLGSYGIVFNGKWKGVDVAVKKFVKQ----KLSETQLL--EFRAEMA 1411
Query: 866 ILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDA 925
LS+L H N+V F G P + V EYM G+LR VL D + +L + A
Sbjct: 1412 FLSELKHSNIVTFIGACIKKPN--ICIVTEYMRMGNLRDVLKNPDIKITFANKLKLLYGA 1469
Query: 926 AFGMEYLHSKN--IVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKR-NTLVSGGVRGT 982
A G++YLHS N IVH D+K N+LV+ K+ DFG ++IK NT ++ GT
Sbjct: 1470 AMGIDYLHSSNPMIVHRDIKPANILVD----EHFNVKIADFGFARIKEDNTTMTRC--GT 1523
Query: 983 LPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTI 1042
W APE++ G K EK DVFSFG+V+WE+LTG+EP+A ++ + I+ RP I
Sbjct: 1524 PCWTAPEVIRGE--KYCEKADVFSFGVVMWEVLTGKEPFAECNFMKVSLDILEGG-RPII 1580
Query: 1043 PSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079
PS C E+ L+++CW RP+ TE+ +L +++
Sbjct: 1581 PSDCPHEFAKLIKKCWHAKAHKRPTMTEVVQQLMLIT 1617
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P18160|SPLA_DICDI Dual specificity protein kinase splA OS=Dictyostelium discoideum GN=splA PE=1 SV=3 | Back alignment and function description |
|---|
Score = 179 bits (455), Expect = 8e-44, Method: Compositional matrix adjust.
Identities = 111/285 (38%), Positives = 157/285 (55%), Gaps = 23/285 (8%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEI 866
I +LE + +G G FG V G WR TDVAIK I + F +SS V F E I
Sbjct: 2110 IDFNELEFGQTIGKGFFGEVKRGYWRETDVAIKIIYRDQFKTKSS-----LVMFQNEVGI 2164
Query: 867 LSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRR--RLIIAMD 924
LSKL HPNVV F G G V E+M GSLR L L++ RL +A+D
Sbjct: 2165 LSKLRHPNVVQFLGACTAGGEDHHCIVTEWMGGGSLRQFLTDHFNLLEQNPHIRLKLALD 2224
Query: 925 AAFGMEYLH--SKNIVHFDLKCDNLLVNLK-DPSRPI--------CKVGDFGLSKIK--R 971
A GM YLH + I+H DL N+L++ DP P+ CK+ DFGLS++K +
Sbjct: 2225 IAKGMNYLHGWTPPILHRDLSSRNILLDHNIDPKNPVVSSRQDIKCKISDFGLSRLKMEQ 2284
Query: 972 NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIG 1031
+ ++ V G +P+MAPE+ G S+ SEK DV+S+G+VL+E+LT +EP +M +
Sbjct: 2285 ASQMTQSV-GCIPYMAPEVFKGDSN--SEKSDVYSYGMVLFELLTSDEPQQDMKPMKMAH 2341
Query: 1032 GIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076
+ RP IP ++W+ ++ +CW NP +RP+F +I L+
Sbjct: 2342 LAAYESYRPPIPLTTSSKWKEILTQCWDSNPDSRPTFKQIIVHLK 2386
|
Essential for spore differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q54RB7|SHKA_DICDI Dual specificity protein kinase shkA OS=Dictyostelium discoideum GN=shkA PE=2 SV=1 | Back alignment and function description |
|---|
Score = 178 bits (451), Expect = 3e-43, Method: Compositional matrix adjust.
Identities = 109/276 (39%), Positives = 154/276 (55%), Gaps = 22/276 (7%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEI 866
I ++ + LG G+FGTVY G+ R DVA+K + K +Q+ LT +F KE I
Sbjct: 40 ISETEITTESILGDGSFGTVYKGRCRLKDVAVKVMLKQV------DQKTLT-DFRKEVAI 92
Query: 867 LSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAA 926
+SK+ HPN+V F G PG + + ++ G+L +L+ L R+ +A DAA
Sbjct: 93 MSKIFHPNIVLFLGACTSTPGKLM--ICTELMKGNLESLLLDPMVKLPLITRMRMAKDAA 150
Query: 927 FGMEYLHSKN--IVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRN--TLVSG--GVR 980
G+ +LHS N +H DLK NLLV+ + KV DFGLS+IK+ L G G +
Sbjct: 151 LGVLWLHSSNPVFIHRDLKTSNLLVD----ANLTVKVCDFGLSQIKQRGENLKDGQDGAK 206
Query: 981 GTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANM-HYGAIIGGIVNNTLR 1039
GT WMAPE+L G +EK DV+SFG+VLW+I T +E + ++ + I LR
Sbjct: 207 GTPLWMAPEVLQGRL--FNEKADVYSFGLVLWQIFTRQELFPEFDNFFKFVAAICEKQLR 264
Query: 1040 PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
P+IP C + L+++CW PNP RPSF I S L
Sbjct: 265 PSIPDDCPKSLKELIQKCWDPNPEVRPSFEGIVSEL 300
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54IP4|SHKB_DICDI Dual specificity protein kinase shkB OS=Dictyostelium discoideum GN=shkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 177 bits (450), Expect = 3e-43, Method: Compositional matrix adjust.
Identities = 109/275 (39%), Positives = 157/275 (57%), Gaps = 26/275 (9%)
Query: 815 QKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPN 874
+ +LGSG FG+VY G RG +VAIK++ ++ F +E EF KE +++KL +P+
Sbjct: 177 EAKLGSGAFGSVYKGIVRGKEVAIKKLTQTVF------EENTMNEFKKEVSLMAKLRNPH 230
Query: 875 VVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDR---FLDRRRRLIIAMDAAFGMEY 931
++ F G P L+ V E M GS+ +L K+ F+ +R ++IA D GM +
Sbjct: 231 LLLFMGACT-APED-LSIVTELMPKGSVHSLLRAKEDTSDFITFKRAILIARDTVLGMTW 288
Query: 932 LHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI----KRNTLVSGGVRGTLPWMA 987
LH+ NI+H DLK NLLV+ + KV DFGLSK ++ L+ G G+ +MA
Sbjct: 289 LHASNILHLDLKPANLLVD----QNWVVKVADFGLSKYMKPDSKDKLL--GQAGSPLYMA 342
Query: 988 PELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH--YGAIIGGIVNNTLRPTIPSY 1045
PE+L KVDVFSF I+LWE+LT +EPY ++ Y ++ G+VN RP IP Y
Sbjct: 343 PEMLVNQP--YDGKVDVFSFSILLWELLTKQEPYNKLYSSYPQLVEGVVNKKNRPIIPDY 400
Query: 1046 CDAEWRTLMEECWAPNPAARPSFTEIASRLRVLST 1080
+ L+ CW P+ RPSF EI S+ R+L T
Sbjct: 401 FPTRLKDLLARCWDHYPSRRPSFAEI-SKQRILET 434
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 177 bits (448), Expect = 5e-43, Method: Compositional matrix adjust.
Identities = 103/269 (38%), Positives = 146/269 (54%), Gaps = 13/269 (4%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEI 866
I +L+ +LG GTFG VY G WRG+ VAIK+IK + ++ EF KE I
Sbjct: 657 ISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKIN-----EDVNNQVLEEFRKELTI 711
Query: 867 LSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAA 926
LS+L HPN+V P L + EY+ GSL L K ++ + +A+ A
Sbjct: 712 LSRLRHPNIVLLMAACTAPP--NLCFITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIA 769
Query: 927 FGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWM 986
GM YLH ++H D+K NLL++ K+ DFGLSK+K + G+ WM
Sbjct: 770 QGMNYLHLSGVIHRDIKSLNLLLD----EHMNVKICDFGLSKLKSKSTEMTKSIGSPIWM 825
Query: 987 APELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYC 1046
+PELL G +EKVDV++FGI+LWE+ TGE PY+ + + + +LRP IP+
Sbjct: 826 SPELLMGED--YTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIPNAW 883
Query: 1047 DAEWRTLMEECWAPNPAARPSFTEIASRL 1075
+ L++ CW +P RPSFTEI + L
Sbjct: 884 PYQLSHLIQACWHQDPLKRPSFTEILNLL 912
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A7J1T2|M313A_XENLA Mitogen-activated protein kinase kinase kinase 13-A OS=Xenopus laevis GN=map3k13-a PE=2 SV=1 | Back alignment and function description |
|---|
Score = 176 bits (447), Expect = 8e-43, Method: Compositional matrix adjust.
Identities = 106/272 (38%), Positives = 148/272 (54%), Gaps = 28/272 (10%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEI--L 867
E++ E + LGSG G V+ GK+RG +VAIK++++ KE +I L
Sbjct: 167 EEISELQWLGSGAQGAVFLGKFRGEEVAIKKVREQ-----------------KETDIKHL 209
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
KL HPN++AF GV P L + EY G L VL R R + R + + A
Sbjct: 210 RKLKHPNIIAFKGVCTQAPCYCL--IMEYCAHGQLYEVL-RAGRKVSPRLLVDWSNGIAS 266
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMA 987
GM YLH I+H DLK N+LV D K+ DFG SK + GT+ WMA
Sbjct: 267 GMNYLHLHKIIHRDLKSPNVLVTHTD----TVKISDFGTSKELSDKSTKMSFAGTVAWMA 322
Query: 988 PELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCD 1047
PE++ + VSEKVD++SFG++LWE+LTGE PY ++ AII G+ +N+L +PS C
Sbjct: 323 PEVIR--NEPVSEKVDIWSFGVLLWELLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCP 380
Query: 1048 AEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079
++ LM++ W P RPSF +I L + S
Sbjct: 381 DGFKILMKQTWHSKPRNRPSFRQILMHLDIAS 412
|
May have a role in the JNK signaling pathway. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|A7J1T0|M313B_XENLA Mitogen-activated protein kinase kinase kinase 13-B OS=Xenopus laevis GN=map3k13-b PE=2 SV=1 | Back alignment and function description |
|---|
Score = 175 bits (443), Expect = 2e-42, Method: Compositional matrix adjust.
Identities = 103/272 (37%), Positives = 147/272 (54%), Gaps = 28/272 (10%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEI--L 867
E++ E + LGSG G V+ GK+RG +VAIK++++ KE +I L
Sbjct: 169 EEISELQWLGSGAQGAVFLGKFRGEEVAIKKVREQ-----------------KETDIKHL 211
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
KL HPN++AF GV P + EY G L VL R R + + + + A
Sbjct: 212 RKLKHPNIIAFKGVCTQAP--CYCILMEYCAQGQLYEVL-RAGRKVTPKLLVEWSTGIAS 268
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMA 987
GM YLH I+H DLK N+LV D K+ DFG SK + GT+ WMA
Sbjct: 269 GMNYLHLHKIIHRDLKSPNVLVTHAD----TVKISDFGTSKELSDKSTKMSFAGTVAWMA 324
Query: 988 PELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCD 1047
PE++ + VSEKVD++SFG++LWE+LTGE PY ++ AII G+ +N+L +PS C
Sbjct: 325 PEVIR--NEPVSEKVDIWSFGVLLWELLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCP 382
Query: 1048 AEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079
++ LM++ W P RPSF +I L + +
Sbjct: 383 DGFKILMKQTWQSKPRNRPSFRQILMHLDIAA 414
|
May have a role in the JNK signaling pathway. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q1HKZ5|M3K13_MOUSE Mitogen-activated protein kinase kinase kinase 13 OS=Mus musculus GN=Map3k13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 174 bits (442), Expect = 2e-42, Method: Compositional matrix adjust.
Identities = 103/271 (38%), Positives = 144/271 (53%), Gaps = 24/271 (8%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSK 869
E++ E + LGSG G V+ GK+R +VAIK+++ EQ ++ L K
Sbjct: 165 EEISELQWLGSGAQGAVFLGKFRAEEVAIKKVR---------EQNETDIKH------LRK 209
Query: 870 LHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGM 929
L HPN++AF GV P + EY G L VL R R + R + + A GM
Sbjct: 210 LKHPNIIAFKGVCTQAP--CYCIIMEYCAHGQLYEVL-RAGRKITPRLLVDWSTGIASGM 266
Query: 930 EYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPE 989
YLH I+H DLK N+LV D K+ DFG SK + GT+ WMAPE
Sbjct: 267 NYLHLHKIIHRDLKSPNVLVTHTD----AVKISDFGTSKELSDKSTKMSFAGTVAWMAPE 322
Query: 990 LLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAE 1049
++ + VSEKVD++SFG+VLWE+LTGE PY ++ AII G+ +N+L +PS C
Sbjct: 323 VIR--NEPVSEKVDIWSFGVVLWELLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDG 380
Query: 1050 WRTLMEECWAPNPAARPSFTEIASRLRVLST 1080
++ LM++ W P RPSF + L + S
Sbjct: 381 FKILMKQTWQSKPRNRPSFRQTLMHLDIASA 411
|
Activates the JUN N-terminal pathway through activation of the MAP kinase kinase MAP2K7. Acts synergistically with PRDX3 to regulate the activation of NF-kappa-B in the cytosol. This activation is kinase-dependent and involves activating the IKK complex, the IKBKB-containing complex that phosphorylates inhibitors of NF-kappa-B. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1094 | ||||||
| 225462248 | 1207 | PREDICTED: uncharacterized protein LOC10 | 0.992 | 0.899 | 0.605 | 0.0 | |
| 255544604 | 1240 | serine/threonine protein kinase, putativ | 0.967 | 0.853 | 0.579 | 0.0 | |
| 255544602 | 1240 | serine/threonine protein kinase, putativ | 0.983 | 0.867 | 0.563 | 0.0 | |
| 356555219 | 1243 | PREDICTED: uncharacterized protein LOC10 | 0.983 | 0.865 | 0.556 | 0.0 | |
| 356555215 | 1222 | PREDICTED: uncharacterized protein LOC10 | 0.970 | 0.869 | 0.561 | 0.0 | |
| 356528667 | 1245 | PREDICTED: uncharacterized protein LOC10 | 0.981 | 0.862 | 0.550 | 0.0 | |
| 356554759 | 1199 | PREDICTED: uncharacterized protein LOC10 | 0.964 | 0.879 | 0.556 | 0.0 | |
| 356528669 | 1253 | PREDICTED: uncharacterized protein LOC10 | 0.964 | 0.841 | 0.556 | 0.0 | |
| 359472758 | 1338 | PREDICTED: uncharacterized protein LOC10 | 0.987 | 0.807 | 0.527 | 0.0 | |
| 297737995 | 1238 | unnamed protein product [Vitis vinifera] | 0.966 | 0.853 | 0.550 | 0.0 |
| >gi|225462248|ref|XP_002263264.1| PREDICTED: uncharacterized protein LOC100257013 [Vitis vinifera] gi|147772468|emb|CAN65102.1| hypothetical protein VITISV_021043 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1278 bits (3307), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 692/1143 (60%), Positives = 831/1143 (72%), Gaps = 57/1143 (4%)
Query: 1 DPGYATGYMELKGILGISHTGSESGSDISMLTIVERGQKEYERRNSSLHEERGNYGSIQS 60
DP Y Y ELKGILGI+HTGSESGSDISMLTIVERG KE+ER+NS+L+E+R YGS+Q
Sbjct: 73 DPHYVPKYTELKGILGINHTGSESGSDISMLTIVERGPKEFERKNSALYEDRSYYGSVQL 132
Query: 61 AP-----NDSNRGSIHGYTSSEASDSSATKMKVLCSFGGKILPRPSDGKLRYVGGETRII 115
P +DS+RG IHGY SS ASDSS+TKMKVLCSFGGKILPRPSDGKLRYVGGETRII
Sbjct: 133 VPRTSSGHDSSRGVIHGYASSGASDSSSTKMKVLCSFGGKILPRPSDGKLRYVGGETRII 192
Query: 116 RIRKDISWQILRQKALEVYNQVHVIKYQLPGEDLDALVSVSCDEDLQNMMEEYNELGDRE 175
RIRKDISWQ L QK L V+NQ H+IKYQLPGEDLDALVSVSCDEDLQNMMEE NEL D E
Sbjct: 193 RIRKDISWQELVQKTLMVFNQAHIIKYQLPGEDLDALVSVSCDEDLQNMMEECNELEDGE 252
Query: 176 GSQRIRMFLFSMSDLAEAQSCLSSMDGDSEIQFVVAVNGMDSGSRNSLNLHGLRSSSAND 235
GS+++RMFLFS SDL +A L S DGDSEIQ+VVAVNGMD GSR + LHGL SS+N+
Sbjct: 253 GSKKLRMFLFSTSDLDDAYFGLDSTDGDSEIQYVVAVNGMDMGSRKNSTLHGLVGSSSNN 312
Query: 236 LEELGGHNIERETSRVVVDSARVSTPPLTGNIAPSSTIHSSRVIIPSSSNAHETYPQFHH 295
L +L G NIER +RV DS +ST PLTG I P STI SS+ I+P+SS+A+E P F+H
Sbjct: 313 LADLDGQNIERNATRVATDSVGISTLPLTGTIVPPSTIQSSQPILPNSSSAYEADPPFYH 372
Query: 296 DQRLHRRETREYPLHHA--CDPSNYSPYGEIPYSMPLHEHSNQPGGLSGGYQYSVLQVQN 353
Q ++ ET ++ LH+ SN +PY E MP+H Q G + G Y LQVQ+
Sbjct: 373 GQMIYHGETSQHMLHYGYPSHQSNCTPYQESTNLMPVHGLMTQQEGYAEGQPYIGLQVQD 432
Query: 354 PQMTVKQGMALPDGSIQPDSDTEKVSPL--DKPVPSWPYDDKLMKHFAVEEAAVSVGIPR 411
P + VK+ D SIQ ++ E +SP D +PS P D ++M VEEA VS I
Sbjct: 433 PSVLVKEVTLKNDASIQQENIPENISPSKNDCLIPSQPSDGEVMDRIPVEEALVS--ISS 490
Query: 412 VDIPPLFPPKSEGKHQEPGKVSPPADTLNAASKFSND-DLCSMSSGALGPGHRDSEINPI 470
+D FP +++GKH +P ++S D +N A +D D SS P + D +
Sbjct: 491 LD---QFPSENKGKHHKPVEISSSVDAMNQAQVPKSDYDHHPASSSPFAPVYADPGSGLM 547
Query: 471 DSSYLEPPVPPQRIYRSEKIPREQLDLLNRLSKSDDSLGSQFIMSQSHSDVVQPDPVSEP 530
D SYLEPPV PQR+Y SE++PREQ +LLNRLSKSDDSLGSQF++S S SD+ + D V+E
Sbjct: 548 DLSYLEPPVLPQRVYYSERVPREQAELLNRLSKSDDSLGSQFLISHSRSDIEKQDSVAES 607
Query: 531 NEKVQ------KEDQTFENELTQLQKHKEFAD-AISQTNSKPSEEILD-VQEPRQGIP-- 580
+K++ + +Q+ ++ AD + T P + +L EP +P
Sbjct: 608 TDKLRNGNLAPQTEQSISTGEAMVEDMAVKADHGTTGTKDIPRKLLLHGTTEPGSELPAM 667
Query: 581 -DALANNETNDPVDYNKKPLVDDG-LPSESSINDVYQGI----------SSVGVSTQQRV 628
+ DP+ + P +D G + + ++ G+ SSVGVST ++
Sbjct: 668 NQVASVKHCQDPL--STPPELDQGEMSGKDFTSNNTLGVGDAQTFAWTGSSVGVSTPEQG 725
Query: 629 DISVDIDDRFPRDFLSDIYSKALISEDSSGIITLHKDGAGISVNMENHEPKRWSYFRNLA 688
DI +DI+DRFPRDFLSDI+SKA+ DS I KDGAG+S+NMEN EPK WSYF+ LA
Sbjct: 726 DILIDINDRFPRDFLSDIFSKAVHFADSPDISKPQKDGAGLSLNMENREPKHWSYFQKLA 785
Query: 689 QVDFGQKDVSLIDQEHLGLSSGVREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQ 748
Q F Q DVSL+DQ+HLG SS + +V EE + Y FTPL D G+++S+++FG+++Q
Sbjct: 786 QGGFVQNDVSLMDQDHLGFSSVLTKVEEEVSKPYQFTPLMADEVLIGQLESRISFGEENQ 845
Query: 749 KT------------FGVDPSVSE-----SMQFDAMMENLRTTESDYEEGNAGNRNIGLPS 791
K D S SE S+QFD M+ENLRT +S+ E+G +NIG P
Sbjct: 846 KESPPGRIAADSTDLHSDYSPSEIKESDSVQFDRMIENLRTPDSEGEDGKMETKNIGRPP 905
Query: 792 LNPSLVDFDVSSVQVIKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSS 851
L+PS+ DFD++++Q+IKNEDLEE KELGSGTFGTVYHGKWRG+DVAIKRIKK CFT RSS
Sbjct: 906 LDPSIGDFDINTLQIIKNEDLEELKELGSGTFGTVYHGKWRGSDVAIKRIKKICFTSRSS 965
Query: 852 EQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDR 911
EQERLT+EFW+EA+ILSKLHHPNVVAFYGVV DGPG TLATV EYMVDGSLRHVL+RKDR
Sbjct: 966 EQERLTIEFWREADILSKLHHPNVVAFYGVVHDGPGATLATVTEYMVDGSLRHVLLRKDR 1025
Query: 912 FLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKR 971
+LDRR+RL+IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP RPICKVGDFGLSKIKR
Sbjct: 1026 YLDRRKRLLIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPLRPICKVGDFGLSKIKR 1085
Query: 972 NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIG 1031
NTLVSGGVRGTLPWMAPELL+GSS+KVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIG
Sbjct: 1086 NTLVSGGVRGTLPWMAPELLNGSSNKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIG 1145
Query: 1032 GIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQTKGHGNK 1091
GIV+NTLRPT+PS CD EWRTLME+CWAPNPA RPSFTEI RLRV+S AA+QTK G+K
Sbjct: 1146 GIVSNTLRPTVPSSCDPEWRTLMEQCWAPNPAVRPSFTEITGRLRVMS-AAAQTKTPGHK 1204
Query: 1092 PSK 1094
SK
Sbjct: 1205 ASK 1207
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255544604|ref|XP_002513363.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223547271|gb|EEF48766.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1237 bits (3201), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 685/1182 (57%), Positives = 818/1182 (69%), Gaps = 124/1182 (10%)
Query: 1 DPGYATGYMELKGILGISHTGSESGSDISMLTIVERGQKEYERRNSSLHEERGNYGSIQS 60
DP YATGY+ELKGILGISHTGSESGSDISMLTIVE+GQK++ER NSS HEERGNY SIQS
Sbjct: 95 DPNYATGYLELKGILGISHTGSESGSDISMLTIVEKGQKDFERTNSSFHEERGNYESIQS 154
Query: 61 APNDS----NRGSIHGYTSSEASDSSATKMKVLCSFGGKILPRPSDGKLRYVGGETRIIR 116
P S +RG GYTSS SDS + KMKVLCSFGGKILPRPSDGKLRYVGG+TRIIR
Sbjct: 155 VPQSSAGYGSRGPPVGYTSSGTSDSLSQKMKVLCSFGGKILPRPSDGKLRYVGGDTRIIR 214
Query: 117 IRKDISWQILRQKALEVYNQVHVIKYQLPGEDLDALVSVSCDEDLQNMMEEYNELGDREG 176
I +DISW L+QK L +Y+Q H IKYQLPGEDLD+LVSVSCDEDL NMMEE+NE+ DR G
Sbjct: 215 ITRDISWMELKQKTLAIYDQAHAIKYQLPGEDLDSLVSVSCDEDLLNMMEEWNEVEDRGG 274
Query: 177 SQRIRMFLFSMSDLAEAQSCLSSMDGDSEIQFVVAVNGMDSGSRNSLNLHGLRSSSANDL 236
SQ++RMF+FSMSDL +AQ LSS++ DSEIQ+VVAVNGMD GSR + LHGL SSS N+L
Sbjct: 275 SQKLRMFIFSMSDLDDAQFGLSSVEADSEIQYVVAVNGMDIGSRRNSMLHGLASSSGNNL 334
Query: 237 EELGGHNIERETSRVVVDSARVSTPPLTGNIAPSSTIHSSRVIIPSSSNAHETYPQFHHD 296
+EL N+++ETSRV S VST P T ++ +I SSSNA+ET+ ++
Sbjct: 335 DELDRLNLDKETSRVATVSVGVSTLPST-----------AQPVIRSSSNAYETHTPYYQG 383
Query: 297 QRLHRRETREYPLHHACDPSNYSPYGEIPYSMPLHEHSNQPGGLSGGYQYSVLQVQNPQM 356
+ RET+++ L + D ++SP+ E P+S+ + NQ GGL+ G + QV N Q+
Sbjct: 384 HLMDHRETQQFLLRNHHDSFHHSPFEETPHSILM----NQQGGLNEGQPSTSFQVHNSQI 439
Query: 357 TVKQGMALPDGSIQPDSDTEKVSPLDK--PVPSWPYDDKLMKHFAVEEAAVSVGIPRVDI 414
K+ D S+Q + D E+ PL+K PVP V+EA+++VG+ + D+
Sbjct: 440 LKKEEKPKFDASMQQEIDPERSRPLEKVYPVP-------------VDEASLAVGL-QGDL 485
Query: 415 PPLFPPKSEGKHQEPGKVSPPADTLNAAS--KFSNDDLCSMSSGALGPGHRDSEINPIDS 472
L P K+EG QE KVS AD +N++ S D CS S G G G+ D N ID
Sbjct: 486 HSL-PSKNEGWDQETEKVSSSADAVNSSQVPNSSEDGPCSASDGTYGTGNADPVSNLIDL 544
Query: 473 SYLEPPVPPQRIYRSEKIPREQLDLLNRLSKSDDSLGSQFIMS-------QSHSDVVQPD 525
SYLEP VPPQR+Y SE+IPREQ +LLNRLSKSDDSLG Q + S S S++
Sbjct: 545 SYLEPSVPPQRVYYSERIPREQAELLNRLSKSDDSLGPQLLNSIAESTEKLSSSNLASHA 604
Query: 526 PVSEPNEKVQKEDQTFENELTQLQKHKEFADAISQTNSKP--SEEILD--VQEPRQGIPD 581
S K + +T + L QLQK KEFADA+S N KP SE++L+ + P G
Sbjct: 605 KDSTSTSKQSADTRTINDGLAQLQKFKEFADAVSLMNKKPSDSEDVLESGFKHPVSG--- 661
Query: 582 ALANNET---------NDPVDYNKKPLVDDGLPSESSINDV------------------- 613
LA+ ++ + DY + P+ + V
Sbjct: 662 NLADKDSVHRDGILRGDSDTDYTTGIKAESEHPAGGKVTSVMHQMDPASIHSESTRAEMT 721
Query: 614 ---------------YQGISSVGVSTQQRVDISVDIDDRFPRDFLSDI---YSKALISED 655
+ GI S Q + SV + D DI + + +SE
Sbjct: 722 GKDFTGNNNLGHSLPFSGIESSAKDISQGIP-SVGVPATKQADITVDINDRFPRDFLSEI 780
Query: 656 -SSGII-------TLHKDGAGISVNMENHEPKRWSYFRNLAQVDFGQKDVSLIDQEHLGL 707
SSG+ T+HKDG G+SV+M+NHEPK WSYF+ LAQ F Q+DVSLIDQ+ +G
Sbjct: 781 FSSGVFAEDPGVSTMHKDGVGVSVHMKNHEPKHWSYFQKLAQEGFVQRDVSLIDQDSVGT 840
Query: 708 SSGVREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQK----TFGVDPSV------ 757
S E D + YHF PLTD + SQLNFG+D++K G D +V
Sbjct: 841 PSAPANA-EGDQKSYHFEPLTDVMSISHEY-SQLNFGEDNKKDLPGVIGADSAVLPDFGH 898
Query: 758 -----SESMQFDAMMENLRTTESDYEEGNAGNRNIGLPSLNPSLVDFDVSSVQVIKNEDL 812
SESMQF AM+ENL++ +S YE NRN+GLP L+PSLVDFD++++QVIKN+DL
Sbjct: 899 SQVKDSESMQFGAMIENLKSPDSVYEGAKLENRNVGLPPLDPSLVDFDINTLQVIKNDDL 958
Query: 813 EEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHH 872
EE +ELGSGTFGTVYHGKWRG+DVAIKR+KK CF+GRSSEQERLT EFW+EAEILSKLHH
Sbjct: 959 EELRELGSGTFGTVYHGKWRGSDVAIKRLKKICFSGRSSEQERLTSEFWREAEILSKLHH 1018
Query: 873 PNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYL 932
PNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVL++KDR+LDRR+RL+IAMDAAFGMEYL
Sbjct: 1019 PNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLLKKDRYLDRRKRLLIAMDAAFGMEYL 1078
Query: 933 HSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLS 992
HSKNIVHFDLKCDNLLVNLKDP RPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELL+
Sbjct: 1079 HSKNIVHFDLKCDNLLVNLKDPQRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLN 1138
Query: 993 GSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRT 1052
GSS+KVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPS CDAEW+
Sbjct: 1139 GSSNKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSNCDAEWKM 1198
Query: 1053 LMEECWAPNPAARPSFTEIASRLRVLSTAASQTKGHGNKPSK 1094
LME+CWAPNPAARPSFTEIA RLRV+S AA QTKGH NK SK
Sbjct: 1199 LMEQCWAPNPAARPSFTEIAGRLRVMSIAAGQTKGHHNKTSK 1240
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255544602|ref|XP_002513362.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223547270|gb|EEF48765.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1217 bits (3150), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 661/1172 (56%), Positives = 798/1172 (68%), Gaps = 96/1172 (8%)
Query: 1 DPGYATGYMELKGILGISHTGSESGSDISMLTIVERGQKEYERRNSSLHEERGNYGSIQS 60
+P + T +MELKG+LG SH SE+GSDISML VE G ++ ER N SL+EE+ NY + S
Sbjct: 87 NPNHGTSFMELKGVLGTSHIESENGSDISMLHSVENGPRKGERTNLSLYEEKSNYELVHS 146
Query: 61 APNDS----NRGSIHGYTSSEASDSSATKMKVLCSFGGKILPRPSDGKLRYVGGETRIIR 116
P S +R + GY+SS AS SS+TK+KVLCSFGG ILPRPSDGKLRYVGG+TRIIR
Sbjct: 147 VPQTSAEYESRELLPGYSSSIASGSSSTKIKVLCSFGGTILPRPSDGKLRYVGGDTRIIR 206
Query: 117 IRKDISWQILRQKALEVYNQVHVIKYQLPGEDLDALVSVSCDEDLQNMMEEYNELGDREG 176
I +DISWQ L+QK + NQ HVIKYQLPGEDLDALVSVSCDEDL+NMMEE+ E+ DREG
Sbjct: 207 ISRDISWQELKQKTFAICNQPHVIKYQLPGEDLDALVSVSCDEDLRNMMEEWIEVDDREG 266
Query: 177 SQRIRMFLFSMSDLAEAQSCLSSMDGDSEIQFVVAVNGMDSGSRNSLNLHGLRSSSANDL 236
SQ++RMFLFSMSDL +AQ L SM+GDSE+Q+VVA+NGMD SR + LHGL SSS N+L
Sbjct: 267 SQKLRMFLFSMSDLEDAQFGLGSMEGDSEVQYVVAINGMDMRSRRNSILHGLGSSSGNNL 326
Query: 237 EELGGHNIERETSRVVVDSARVSTPPLTGNIAPSSTIHSSRVIIPSSSNAHETYPQFHHD 296
EL G NI+RETSR S ++T PLT ST S++ I+ +SS +HE++P F+H
Sbjct: 327 NELDGLNIDRETSRAATASVGINTSPLT------STFQSAQPILQNSSTSHESHPHFYHG 380
Query: 297 QRLHRRETREYPLHHACDPSNYSPYGEIPYSMPLHEHSNQPGGLSGGYQYSVLQVQNPQM 356
Q + RET+++ D SNYS EIP S LH +NQ GG++ G +S QVQN QM
Sbjct: 381 QMMDNRETQQFLADCRNDSSNYSAPKEIPQSTSLHSLTNQQGGMNAGQSHSNFQVQNSQM 440
Query: 357 TVKQGMALPDGSIQPDSDTEKVSPLDKPVPSWPYDDKLMKHFAVEEAAVSVGIPRVDIPP 416
K+ +PDGS+Q D K P+++ V + P D+ + A +E A+
Sbjct: 441 LEKEVRPIPDGSVQHGIDIGKSHPIER-VSAVPVDE-ISVAVAAQEGALHS--------- 489
Query: 417 LFPPKSEGKHQEPGKVSPPADTLNAAS--KFSNDDLCSMSSGALGPGHRDSEINPIDSSY 474
P K+EGK + +S D ++ DD S SS G DS N ID SY
Sbjct: 490 -MPSKNEGKQRGSESISFSVDAIDPVHVPNSCEDDQFSTSSSIFGFDCADSVSNLIDLSY 548
Query: 475 LEPPVPPQRIYRSEKIPREQLDLLNRLSKSDDSLGSQFIMSQSHSDVVQPDPVSEPNEKV 534
+EP PPQR+Y SE+IPREQ +L+NRLSKSDDSLGSQF++ S D+ + + EK+
Sbjct: 549 VEPSAPPQRVYYSERIPREQAELMNRLSKSDDSLGSQFLIPHSRPDIAEQKSTTASAEKL 608
Query: 535 -------QKEDQTFE-----------NELTQLQKHKEFA--------------------- 555
Q ED + N L Q QK+ E A
Sbjct: 609 IQSNLLPQTEDPSTTAEPLLIDPQPINGLAQPQKYIELAAPDDVNDNDSVNRNAVLKADH 668
Query: 556 DAISQTNSKPSEEILDVQEPRQGIPDALANNETNDPVD--------------YNKKPLVD 601
D + + KP EE + + P DPV + V
Sbjct: 669 DCAAGNHKKPVEETGEARFGNPAAPQTTPGMYHRDPVSDHPGHKLGEITGKVFASNENVG 728
Query: 602 DGLP---SESSINDVYQGISSVGVSTQQRVDISVDIDDRFPRDFLSDIYSKALISEDSSG 658
LP +ESS NDV Q + + VS + DIS+DI+DRFPRDFLS+I+S+ +++ED +G
Sbjct: 729 YSLPYSLTESSTNDVSQEVPPIFVSATKPGDISIDINDRFPRDFLSEIFSRGILTEDRAG 788
Query: 659 IITLHKDGAGISVNMENHEPKRWSYFRNLAQVDFGQKDVSLIDQEHLGLSSGVREVREED 718
+ LHKDGAG+SV MENHEPK WSYF+ LAQ +F QKD SL+DQ+HLG + + +E D
Sbjct: 789 VNPLHKDGAGMSVIMENHEPKHWSYFQKLAQEEFVQKDFSLMDQDHLGTPPLIAKFKEGD 848
Query: 719 GRLYHFTPLTDDGAPKGRVDSQLNF-------------GQDSQKTFGVDPSV---SESMQ 762
YHF L +G + S+ NF DS G D S SESMQ
Sbjct: 849 QNSYHFARLKTEGVSMDQKYSRPNFVEGTNQKVLAGLRAADSTILSGFDHSHVKGSESMQ 908
Query: 763 FDAMMENLRTTESDYEEGNAGNRNIGLPSLNPSLVDFDVSSVQVIKNEDLEEQKELGSGT 822
F +M+NL+T E E GN NRN GLP + S+VDFD+ ++Q+IKNEDLEE +ELGSGT
Sbjct: 909 FGVVMDNLKTPEPRAEGGNLDNRNSGLPPVGLSVVDFDIDTLQIIKNEDLEELRELGSGT 968
Query: 823 FGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVV 882
FGTVYHGKWRG+DVAIKR+KK CFTGRSSEQERLT+EFW EAEILSKLHHPNVVAFYGVV
Sbjct: 969 FGTVYHGKWRGSDVAIKRLKKICFTGRSSEQERLTIEFWHEAEILSKLHHPNVVAFYGVV 1028
Query: 883 QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDL 942
QDGPGGTLATV EYMVDGSLRHVL++KDR+LDRR+RL+IAMDAAFGMEYLHSKNIVHFDL
Sbjct: 1029 QDGPGGTLATVTEYMVDGSLRHVLLKKDRYLDRRKRLLIAMDAAFGMEYLHSKNIVHFDL 1088
Query: 943 KCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKV 1002
KCDNLLVNLKDP RPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELL+G S+KVSEKV
Sbjct: 1089 KCDNLLVNLKDPQRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLNGGSNKVSEKV 1148
Query: 1003 DVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNP 1062
DVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP IP++CD EW+ LME+CWAPNP
Sbjct: 1149 DVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPAIPNFCDPEWKRLMEQCWAPNP 1208
Query: 1063 AARPSFTEIASRLRVLSTAASQTKGHGNKPSK 1094
AARP+FTEIA RLR++STAASQ KG G+K SK
Sbjct: 1209 AARPAFTEIAGRLRIMSTAASQNKGQGHKASK 1240
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356555219|ref|XP_003545932.1| PREDICTED: uncharacterized protein LOC100802996 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1165 bits (3015), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 657/1181 (55%), Positives = 804/1181 (68%), Gaps = 105/1181 (8%)
Query: 1 DPGYATGYMELKGILGISHTGSESGSDISMLTIVERGQKEYERRNSSLHEERGNYGSIQS 60
DP Y+TGYMELKGILG H GSESGSDIS+LT VE+G KE++RRNSS H++R NYGS +S
Sbjct: 81 DPNYSTGYMELKGILG--HPGSESGSDISVLTKVEKGPKEFDRRNSSQHQDRSNYGSARS 138
Query: 61 AP-NDSNRGS---IHGYTSSEASDSSATKMKVLCSFGGKILPRPSDGKLRYVGGETRIIR 116
P SN+ S +HG SS S+S+ KMKVLCSFGG+ILPRP DGKLRYVGGETRII
Sbjct: 139 IPRTSSNQDSYRVLHGTASSSVSESTPMKMKVLCSFGGRILPRPGDGKLRYVGGETRIIS 198
Query: 117 IRKDISWQILRQKALEVYNQVHVIKYQLPGEDLDALVSVSCDEDLQNMMEEYNELGDREG 176
IR+DI + L K L +YN+ HVIKYQLPGEDLDALVSVS DEDL+NMMEE ++L G
Sbjct: 199 IRRDIRFHELMLKTLSIYNETHVIKYQLPGEDLDALVSVSSDEDLRNMMEECHDLQGGRG 258
Query: 177 SQRIRMFLFSMSDLAEAQSCLSSMDGDSEIQFVVAVNGMDSGSRNSLNLHGLRSSSANDL 236
S ++R+FLFS++DL + Q + SMDGDSEIQ+VVAVNGMD GSRN+ L G S S ++L
Sbjct: 259 SNKLRIFLFSLNDLDDTQFGIGSMDGDSEIQYVVAVNGMDMGSRNNSILCG-ESGSTHNL 317
Query: 237 EELGGHNIERETSRVVVDSARVSTPPLTGNIAPSSTIHSSRVIIPSSSNAHETYPQFHHD 296
EL N ERET+RV++D+ VS LT N+ PS TI SS+ ++P SSNA+ET+P F+ D
Sbjct: 318 HELNEQNNERETNRVLMDTFGVSGSSLTDNVKPSLTIQSSQPVLPISSNAYETHPLFYDD 377
Query: 297 QRLHRRETREYPLHHACDPSNYSPYG--EIPYSMPLHEHSNQPGGLSGGYQYSVLQVQ-- 352
+ E +YPL H PSN S + EIP SMP H H +Q G ++ G S LQVQ
Sbjct: 378 PVIRHGEASQYPLQHGLGPSNNSAHNIQEIPVSMPTHGHVDQ-GIMNDGQASSELQVQIS 436
Query: 353 -NPQMTVKQGMALPDGSIQPDSDTEKVSPLDK--PVPSWPYDDKLMKHFAVEEAAVSVGI 409
P+ VK+ D I D+D KV PL+ P+PS P++ L H + EA+ + I
Sbjct: 437 AMPETLVKRK---GDNFIHTDNDPGKVFPLEATYPIPSQPFEGNL--HANLSEASATTAI 491
Query: 410 PRVDIPPLFPPKSEGKHQEPGKVSPPADTLNAAS--KFSNDDLCSMSSGALGPGHRDSEI 467
+ P P K++GKHQ+ S ++N K DD + S+ A H D+E
Sbjct: 492 SE-GLHPALPSKNKGKHQQSEDASSLFSSMNPTQTPKSVEDDFFTTSNDAFSRAHVDAES 550
Query: 468 NPIDSSYLEPPVPPQRIYRSEKIPREQLDLLNRLSKSDDSLGSQFIMSQSHSDVVQPDPV 527
N ID SYLEPP P R+Y SE+IPREQ DLLNR +KSDD+ GS +MS SD Q + +
Sbjct: 551 NVIDFSYLEPPPLPNRVYYSERIPREQADLLNRSTKSDDAHGSHLLMSDLLSDFSQKNSI 610
Query: 528 SEPNEKVQKEDQTFENELTQL-----------------QKHKEFADAISQTNSK------ 564
+E ++ + + + N ++ Q +K+ D S+ NSK
Sbjct: 611 TESSDILHSGNMSNLNMMSSSAAKPLQADGHTINDVLPQTYKQLPDTTSKVNSKLLQHVN 670
Query: 565 -PSEEILDVQEPRQGIPDALAN-NETN--DPVDYNKKPLVDDG------LP----SESSI 610
S+++L+ + + L++ N T + + +++ P V+ LP SE S
Sbjct: 671 SESKQVLEDNKVSRNEDQVLSSENRTKGAEHLAFHRVPSVEHNQNLTSKLPDLNLSEVST 730
Query: 611 ---------------------NDVYQGISSVGVSTQQRVDISVDIDDRFPRDFLSDIYSK 649
DV Q S + DI +DI+DRFPRDFL D++SK
Sbjct: 731 RESDNDTKVQSQTFPLTGNTGQDVSQEFPPEAKSRPTQGDILIDIEDRFPRDFLYDMFSK 790
Query: 650 ALISEDSSGIITLHKDGAGISVNMENHEPKRWSYFRNLAQVDFGQKDVSLIDQEHLGLSS 709
A+ISEDSS I L D AG+S+NM NHEPKRWSYF+NLA+ F +VSLIDQ++LG SS
Sbjct: 791 AIISEDSSSIGPLPTDRAGLSLNMGNHEPKRWSYFQNLAKEGF--DNVSLIDQDNLGFSS 848
Query: 710 GVREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSV------------ 757
VR+V+E D + PL G G +S LN G++SQK V
Sbjct: 849 AVRKVQEGDSKSQPSAPLPAAGVLAGHTESHLNVGEESQKNVPVATKTEATIFHQKYEHS 908
Query: 758 ----SESMQFDAMMENLRTTESDYEEGNAGNRNIGLPSLNPSLVDFDVSSVQVIKNEDLE 813
+E+ DA+MEN++ ES+Y++G RN+ + +FD S+VQ IKNEDLE
Sbjct: 909 QLKGNENKNMDAVMENIQPQESEYQDGKDEPRNVVVAG------EFDTSTVQFIKNEDLE 962
Query: 814 EQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
E +ELGSGTFGTVYHGKWRG+DVAIKRIKKSCF GRSSEQERLT+EFW+EA+ILSKLHHP
Sbjct: 963 ELRELGSGTFGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTIEFWREADILSKLHHP 1022
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLH 933
NVVAFYGVVQDGPG TLATVAEYMVDGSLR+VL+RKDR+LDRR+RLIIAMDAAFGMEYLH
Sbjct: 1023 NVVAFYGVVQDGPGATLATVAEYMVDGSLRNVLLRKDRYLDRRKRLIIAMDAAFGMEYLH 1082
Query: 934 SKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSG 993
SKNIVHFDLKCDNLLVNLKDP RPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELL+G
Sbjct: 1083 SKNIVHFDLKCDNLLVNLKDPMRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLNG 1142
Query: 994 SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTL 1053
SS+KVSEKVDVFSFGIVLWEILTG+EPYANMHYGAIIGGIVNNTLRPTIPSYCD +W+TL
Sbjct: 1143 SSNKVSEKVDVFSFGIVLWEILTGDEPYANMHYGAIIGGIVNNTLRPTIPSYCDLDWKTL 1202
Query: 1054 MEECWAPNPAARPSFTEIASRLRVLSTAASQTKGHGNKPSK 1094
ME+CWAPNPA RPSFTEIA RLRV+S AASQ KG G+K SK
Sbjct: 1203 MEQCWAPNPAVRPSFTEIARRLRVMSAAASQIKGQGHKASK 1243
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356555215|ref|XP_003545930.1| PREDICTED: uncharacterized protein LOC100801946 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1164 bits (3010), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 673/1198 (56%), Positives = 781/1198 (65%), Gaps = 136/1198 (11%)
Query: 1 DPGYATGYMELKGILGISHTGSESGSDISMLTIVERGQKEYERRNSSLHEERGNYGSIQS 60
D Y GYMELKGILGISH GSESGSDISML+IV++ KE++R N+SL +R NYGSIQS
Sbjct: 57 DSNYTPGYMELKGILGISHAGSESGSDISMLSIVDKYPKEFDRMNTSLPGDRSNYGSIQS 116
Query: 61 AP----NDSNRGSIHGYTSSEASDSSATKMKVLCSFGGKILPRPSDGKLRYVGGETRIIR 116
P N NR + GY S D S MK LCSFGG+ILPRP DGKLRYVGG+TRI+R
Sbjct: 117 MPRTSLNQDNRQFVPGYGSFGVYDRSMM-MKFLCSFGGRILPRPCDGKLRYVGGQTRILR 175
Query: 117 IRKDISWQILRQKALEVYNQVHVIKYQLPGEDLDALVSVSCDEDLQNMMEEYNELGDREG 176
IRKDISWQ L QKAL++YNQVH IKYQLPGEDLDALVSVS DEDLQNMMEE N L DREG
Sbjct: 176 IRKDISWQELMQKALQIYNQVHAIKYQLPGEDLDALVSVSSDEDLQNMMEECNHLLDREG 235
Query: 177 SQRIRMFLFSMSDLAEAQSCLSSMDGDSEIQFVVAVNGMDSGSRNSLNLHGLRSSSANDL 236
SQ++RMFLFSMSDL +AQ LSS+ DSEIQ+V AVNGMD SR + + G+ S SAND+
Sbjct: 236 SQKLRMFLFSMSDLEDAQFGLSSIGDDSEIQYVAAVNGMDLESRKNTTMFGV-SFSANDI 294
Query: 237 EELGGHNIERETSRVVVDSARVSTPPLTGNIAPSSTIHSSRVIIPSSSNAHETYPQFHHD 296
EL +I+RETSRV V+S S PLT N S HSS ++P+SSN+++ YPQF+ D
Sbjct: 295 NELDRQSIDRETSRVGVESIAQSA-PLTNNFDSSLATHSSPPVLPTSSNSYDAYPQFYGD 353
Query: 297 QRLHRRE-TREYPLHHACDPSNYSPYGEIPYSMPLHEHSNQPGGLSGGYQYSVLQVQNPQ 355
Q +H E + +Y ++H +PS+ GE P MP H NQ G L Q +QVQN +
Sbjct: 354 QMMHHGEPSDQYTINHGLNPSHKPVIGETPIIMPPHMLFNQQGILGESLQPRGIQVQNSE 413
Query: 356 MTVKQGMALPDGSIQPDSDTEK--VSPLDKPVPSWPYDDKLMKHFAVEEAAVSVGIPRVD 413
+ L D SIQ SD K VS L P+ ++ MK+ EA+V V P
Sbjct: 414 IPGTLANNLVDSSIQQGSDPGKVLVSELPSTAPAQLLNNGYMKN-NFPEASVVVTAP--- 469
Query: 414 IPPLFPPKSEGKHQEPGKVSPPADTLNAASKFSNDDLCSMSSGALGPGHRDSEINPIDSS 473
EG P K+ D + S SS A G + DS N D S
Sbjct: 470 ---------EGHSLHPTKMDKLQDY---------EVTSSTSSSAFGAAYVDSRSNAADLS 511
Query: 474 YLEPPVPPQRIYRSEKIPREQLDLLNRLSKSDDSLGSQFIMSQSHSDVVQPDPVSEPNEK 533
L PP P+R+Y SE+IPREQL+LLNR SKSDD+ SQF +S SD+ PD V+E +K
Sbjct: 512 SLHPPPLPKRVYYSERIPREQLELLNRSSKSDDTHSSQFHVSDLLSDINPPDSVTESGDK 571
Query: 534 -------------------VQKEDQTFENELTQLQKHKEFADAISQTNSKPSE----EIL 570
+ +D +N Q +K+ DA SQ SK +E E+
Sbjct: 572 LHGGNLPNLSEELGIAENHLHADDYAVDNVAVNHQIYKQLPDASSQMKSKLTEHVNPELK 631
Query: 571 DVQEPRQGIPDAL--------------ANNETNDPVDYNK--KP------------LVDD 602
V G D L NN VD K KP L+DD
Sbjct: 632 QVLLDNGGCKDLLNKDDAVGLETEIYSKNNYIKPLVDETKASKPDLPNLRQVSSDKLLDD 691
Query: 603 ---GLP-----------SESSIN---------------DVYQGISSVGVSTQQRVDISVD 633
LP S IN D + S VS Q + DI +D
Sbjct: 692 PASNLPEVDWGDTSVKESNEDINVQALPVSINGNTTTEDYSEEFPSNVVSKQVQADILID 751
Query: 634 IDDRFPRDFLSDIYSKALISEDSSGIITLHKDGAGISVNMENHEPKRWSYFRNLAQVDFG 693
I+DRFPR+F +D++SKA++ ED S + L DG G+SVNMEN EP RWSYF+ LAQ G
Sbjct: 752 INDRFPREFFTDMFSKAVLEEDPSSLHPLTSDGVGLSVNMENREPIRWSYFQKLAQE--G 809
Query: 694 QKDVSLIDQEHLGLSSGVREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQ----DSQK 749
+VSL+DQ+HLG S G + V D R H TPLT D +S L+F + D
Sbjct: 810 IDNVSLMDQDHLGFSPG-KVVG--DNRAQHVTPLTTDEVSLNHAESHLDFVEENIRDLHG 866
Query: 750 TFGVDPSV------------SESMQFDAMMENLRTTESDYEEGNAGNRNIGLPSLNPSLV 797
G + +V +ESMQFD MMEN+R ES YE G N LP +PS
Sbjct: 867 RIGAETTVLKSNYDHSQVNDTESMQFDVMMENIRAQESGYEVGKFEKMNSNLPPPDPSFA 926
Query: 798 -DFDVSSVQVIKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERL 856
+FD S+ QVI N+DLEE KELGSGTFGTVYHGKWRGTDVAIKRIKK CFTGRSSEQERL
Sbjct: 927 GEFDPSTFQVIMNDDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKICFTGRSSEQERL 986
Query: 857 TVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRR 916
TVEFW+EAEILSKLHHPNVVAFYGVVQDGPGGT+ATVAEYMVDGSLRHVL+RKDR+LDRR
Sbjct: 987 TVEFWREAEILSKLHHPNVVAFYGVVQDGPGGTMATVAEYMVDGSLRHVLLRKDRYLDRR 1046
Query: 917 RRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVS 976
+RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP RPICKVGDFGLSKIKRNTLVS
Sbjct: 1047 KRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPMRPICKVGDFGLSKIKRNTLVS 1106
Query: 977 GGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN 1036
GGVRGTLPWMAPELL+GSS+KVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN
Sbjct: 1107 GGVRGTLPWMAPELLNGSSNKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN 1166
Query: 1037 TLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQTKGHGNKPSK 1094
TLRPTIP +CD+EWRTLME+CWAPNPAARPSFTEIASRLR++S AASQTK KP+K
Sbjct: 1167 TLRPTIPDHCDSEWRTLMEQCWAPNPAARPSFTEIASRLRLMSAAASQTKTL--KPTK 1222
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356528667|ref|XP_003532921.1| PREDICTED: uncharacterized protein LOC100799118 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1152 bits (2980), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 652/1185 (55%), Positives = 797/1185 (67%), Gaps = 111/1185 (9%)
Query: 1 DPGYATGYMELKGILGISHTGSESGSDISMLTIVERGQKEYERRNSSLHEERGNYGSIQS 60
DP Y+TGYMELKGILG H GSESGSDIS+LT VE+G KE++RRNSS H++R NYGS QS
Sbjct: 81 DPNYSTGYMELKGILG--HPGSESGSDISVLTKVEKGPKEFDRRNSSQHQDRSNYGSAQS 138
Query: 61 AP-NDSNRGS---IHGYTSSEASDSSATKMKVLCSFGGKILPRPSDGKLRYVGGETRIIR 116
P + SN+ S +HG +SS S+S++ KMKVLCSFGGKILPRPSDGKLRYVGGETRII
Sbjct: 139 IPRSSSNQDSYRVLHGTSSSSVSESASMKMKVLCSFGGKILPRPSDGKLRYVGGETRIIS 198
Query: 117 IRKDISWQILRQKALEVYNQVHVIKYQLPGEDLDALVSVSCDEDLQNMMEEYNELGDREG 176
IR+DI + L K +YN+ HVIKYQLPGEDLDALVSVS DEDL+NMMEE ++L
Sbjct: 199 IRRDIRFHELMLKTSSIYNETHVIKYQLPGEDLDALVSVSSDEDLRNMMEECHDLQGGRE 258
Query: 177 SQRIRMFLFSMSDLAEAQSCLSSMDGDSEIQFVVAVNGMDSGSRNSLNLHGLRSSSANDL 236
S ++R+FL SM+DL + Q + SMDGDSEIQ+VVAVNGM GSRN+ L G S S N+L
Sbjct: 259 SNKLRIFLLSMNDLDDTQFGIGSMDGDSEIQYVVAVNGMGMGSRNNSILRG-ESGSTNNL 317
Query: 237 EELGGHNIERETSRVVVDSARVSTPPLTGNIAPSSTIHSSRVIIPSSSNAHETYPQFHHD 296
EL GHN ERET+RV++D+ VS+ LT N+ PS I SS+ ++P SSNA+ET+P F+ +
Sbjct: 318 HELNGHNNERETNRVLMDTFGVSSSSLTDNVKPSLAIQSSQPVLPISSNAYETHPLFYDE 377
Query: 297 QRLHRRETREYPLHHACDPSNYSPYG--EIPYSMPLHEHSNQPGGLSGGYQYSVLQVQ-- 352
Q +H E YPL H PSN S + EIP SMP H NQ G ++ G S LQVQ
Sbjct: 378 QIIHHGEASHYPLQHGLGPSNNSAHNLEEIPVSMPTHGLVNQ-GIMNDGQASSQLQVQIS 436
Query: 353 -NPQMTVKQGMALPDGSIQPDSDTEKVSPLDKP--VPSWPYDDKLMKHFAVEEAAVSVGI 409
P+ VK+ D I +D KV PL+ P +P P++ L H + +A+ + I
Sbjct: 437 AMPETLVKRK---GDNFIHTGNDPGKVFPLEAPYPIPLQPFEGNL--HANISDASATAAI 491
Query: 410 PRVDIPPLFPPKSEGKHQEPGKVSPPADTLNAAS--KFSNDDLCSMSSGALGPGHRDSEI 467
+ P P K++GKHQ+ S ++N K DD + ++ A H D+E
Sbjct: 492 SE-GLHPALPSKNKGKHQQSEDASSLISSMNPTQTPKSVEDDFFTTATDAFSHAHVDAES 550
Query: 468 NPIDSSYLEPPVPPQRIYRSEKIPREQLDLLNRLSKSDDSLGSQFIMSQSHSDVVQPDPV 527
N ID SYLEPP P R+Y SE+IPREQ DLLNR +KSDD+ GS +MS SD Q + +
Sbjct: 551 NVIDFSYLEPPPLPNRVYYSERIPREQADLLNRSTKSDDAHGSHLLMSDLLSDFSQKNSI 610
Query: 528 SEPNEKV-------------------QKEDQTFENELTQLQKHKEFADAISQTNSKPSEE 568
+E + + Q + T ++ Q +K+ D + N K S+
Sbjct: 611 TESTDMLHNGNTSNLNMMSSSAGKPLQADGHTIDDGFAPPQTYKQLPDTTIKVNPKLSQH 670
Query: 569 ILDVQEPRQGIPD----------ALANNET--NDPVDYNKKPLVDDG------LP----- 605
+ E +Q + D + NET + + +++ P V+ LP
Sbjct: 671 V--NSESKQVLEDNKVSRNEDQVLSSENETKGTEHLAFHQVPSVEQNQNLASKLPDLNLA 728
Query: 606 --------------------SESSINDVYQGISSVGVSTQQRVDISVDIDDRFPRDFLSD 645
+ ++ DV Q S + DI +DI+DRFPRDFL D
Sbjct: 729 EVSTRESDNDTKVQSQTFPLTGNTGQDVSQDFPPEAKSRPTQGDILIDIEDRFPRDFLYD 788
Query: 646 IYSKALISEDSSGIITLHKDGAGISVNMENHEPKRWSYFRNLAQVDFGQKDVSLIDQEHL 705
++SKA+ISEDSS I L D AG+S+NM+NHEPKRWSYF+NLA F +VSLIDQ++L
Sbjct: 789 MFSKAIISEDSSSIGPLPTDRAGLSLNMDNHEPKRWSYFQNLALEGF--DNVSLIDQDNL 846
Query: 706 GLSSGVREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSV-------- 757
G SS VR+V+E D + P G GR DS LN G+++QK V
Sbjct: 847 GFSSAVRKVQEGDSKSQPSAPQPAGGVLAGRTDSHLNIGEENQKNVPVATKTEASIFHQK 906
Query: 758 --------SESMQFDAMMENLRTTESDYEEGNAGNRNIGLPSLNPSLVDFDVSSVQVIKN 809
+E+ DA+MEN+R ES+Y++ RN+ + +FD S+VQ IKN
Sbjct: 907 YEHSQLKGNENKNMDAIMENIRPQESEYQDDKNEPRNVVVAG------EFDTSTVQFIKN 960
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSK 869
EDLEE +ELGSGTFGTVYHGKWRG+DVAIKRIKKSCF GRSSEQERLT+EFW+EA+ILSK
Sbjct: 961 EDLEELRELGSGTFGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTIEFWREADILSK 1020
Query: 870 LHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGM 929
LHHPNVVAFYGVVQDGPG TLATV E+MVDGSLR+VL+RKDR+LDRR+RLIIAMDAAFGM
Sbjct: 1021 LHHPNVVAFYGVVQDGPGATLATVTEFMVDGSLRNVLLRKDRYLDRRKRLIIAMDAAFGM 1080
Query: 930 EYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPE 989
EYLHSKNIVHFDLKCDNLLVNLKDP RPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPE
Sbjct: 1081 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPE 1140
Query: 990 LLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAE 1049
LL+GSS+KVSEKVDVFSFGIVLWEILTG+EPYANMHYGAIIGGIVNNTLRPTIPSYCD E
Sbjct: 1141 LLNGSSNKVSEKVDVFSFGIVLWEILTGDEPYANMHYGAIIGGIVNNTLRPTIPSYCDLE 1200
Query: 1050 WRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQTKGHGNKPSK 1094
W+TLME+CWAPNPA RPSF EIA RLRV+S AASQ KG G+K SK
Sbjct: 1201 WKTLMEQCWAPNPAVRPSFAEIARRLRVMSAAASQIKGQGHKASK 1245
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356554759|ref|XP_003545710.1| PREDICTED: uncharacterized protein LOC100816522 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1148 bits (2970), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 657/1181 (55%), Positives = 784/1181 (66%), Gaps = 126/1181 (10%)
Query: 4 YATGYMELKGILGISHTGSESGSDISMLTIVERGQKEYERRNSSLHEERGNYGSIQSAP- 62
YATG MELKG+LGISH SESGSDISML+ E+G E+ R+++SLH E NYGSI+S P
Sbjct: 55 YATGCMELKGVLGISHAASESGSDISMLSKAEKGPTEFNRQSTSLHGEGSNYGSIRSIPR 114
Query: 63 ---NDSNRGSIHGYTSSEASDSSATKMKVLCSFGGKILPRPSDGKLRYVGGETRIIRIRK 119
N N + Y SS SDSS+T MK LCSFGG+ILPRPSDGKLRYVGG+TRI+R+RK
Sbjct: 115 TSLNQENSRFVCEYGSSVGSDSSSTMMKCLCSFGGRILPRPSDGKLRYVGGQTRILRLRK 174
Query: 120 DISWQILRQKALEVYNQVHVIKYQLPGEDLDALVSVSCDEDLQNMMEEYNELGDREGSQR 179
DISWQ L QKAL +YN VHV+KYQLPGEDLDALVSVS +EDLQNMMEE N L +RE SQ+
Sbjct: 175 DISWQELLQKALVMYNLVHVLKYQLPGEDLDALVSVSSEEDLQNMMEECNLLDNRERSQK 234
Query: 180 IRMFLFSMSDLAEAQSCLSSMDGDSEIQFVVAVNGMDSGSRNSLNLHGLRSSSANDLEEL 239
+R+FLFS+SDL +AQ LSS+ GDSEIQ+V+AVN MD GS NS G+ S SA+DL EL
Sbjct: 235 LRLFLFSLSDLEDAQFVLSSIGGDSEIQYVLAVNAMDFGSINSSTPLGV-SFSADDLNEL 293
Query: 240 GGHNIERETSRVVVDSARVSTPPLTGNIAPSSTIHSSRVIIPSSSNAHETYPQFHHDQRL 299
ERETSRV +S VS PLT S TIHSS+ ++P++SNA+E + DQ +
Sbjct: 294 ERQTAERETSRVAAESIGVSNAPLTNKSDSSLTIHSSQPVLPNASNAYEINQLSYGDQMM 353
Query: 300 HRRE-TREYPLHHACDPSNYSPYGEIPYSMPLHEHSNQPGGLSGGYQYSVLQVQNPQMTV 358
E +R+Y +HH + S+ GE M H ++Q G L+ S LQ+QN Q++
Sbjct: 354 QVWEYSRQYFIHHGLNSSHNPVVGETSIPMAPHLLNSQQGVLNEDNLSSGLQIQNSQLST 413
Query: 359 KQGMALPDGSIQPDSDTEKVSPLDKPVP--SWPYDDKLMKHFAVEEAAVSVGIPRVDIPP 416
Q ++ SD KV + P P S P D L +F EA V V +P +PP
Sbjct: 414 VQ--------VKQGSDPGKVLSSETPSPAISQPIDSYLKSNFP--EAPVVVSMPE-GLPP 462
Query: 417 LFPPKSEGKHQEPGKVSPPADTLNAASKFSNDDLCSMSSGALGPGHRDSEINPIDSSYLE 476
P + +H++ +VS S SS A P + DS N ID S L
Sbjct: 463 SLPSTKKVQHKDYEQVS------------------STSSSAFVPSYVDSHTNAIDLSCLH 504
Query: 477 PPVPPQRIYRSEKIPREQLDLLNRLSKSDDSLGSQFIMSQSHSDVVQPDPVSE------- 529
PP P+R+Y SE+ PREQ++LLNR SKSDD+ SQ +S SDV +PV+E
Sbjct: 505 PPPLPERVYYSERTPREQVELLNRSSKSDDTHNSQIHVSDLLSDVNPENPVTESGDNLHD 564
Query: 530 -----PNEK-------VQKEDQTFENELTQLQKHKEFADAISQTNSKPSE----EILDVQ 573
P E+ + + T +N ++ Q K D S SK SE E+ V
Sbjct: 565 GKMLNPTEELGTVAKPLLADGLTIDNGFSKNQMSKPLPDTNSLVKSKLSEHTDPELKSVL 624
Query: 574 EPRQGIPDALANNETNDPVDYNKK--------------------------PLVDDG---- 603
+G + +N T VD + P +D G
Sbjct: 625 PSNEGTENYRKDNHTKLLVDETETKGGKSDLPALHHVSSGKRLDDLASNLPEIDWGEASG 684
Query: 604 -----------LPSESSIN---DVYQGISSVGVSTQQRVDISVDIDDRFPRDFLSDIYSK 649
LP + N D+YQ VS Q + DI +DIDDRFPR+ LSD++SK
Sbjct: 685 KESNDGCMVQELPVSVTGNITKDIYQDFPPTVVSEQSQGDILIDIDDRFPREILSDMFSK 744
Query: 650 ALISEDSSGIITLHKDGAGISVNMENHEPKRWSYFRNLAQVDFGQKDVSLIDQEHLGLSS 709
A++ ED S + L DG G+S+NMENHEPKRWSYF LAQ G +VSLIDQ+H G S
Sbjct: 745 AILGEDPSSLHPLPGDGVGLSINMENHEPKRWSYFHKLAQE--GIDNVSLIDQDHAGFSP 802
Query: 710 GVREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQ----KTFGVDPSV-------- 757
+ + D R +H T LT+DG P DS L+F +++Q + G + +V
Sbjct: 803 VIG--KAGDNRTHHVTLLTNDGHPLHHEDSHLDFNEENQEDLHRRIGTETTVLKSNYNQS 860
Query: 758 ----SESMQFDAMMENLRTTESDYEEGNAGNRNIGLPSLNPSLVDFDVSSVQVIKNEDLE 813
+ESMQFDAMMENLR ES++E+G +N LP L+ S D+S+VQVIKNEDLE
Sbjct: 861 QLKENESMQFDAMMENLRMQESEFEDGKFDAKNSNLPPLDSSF--GDLSTVQVIKNEDLE 918
Query: 814 EQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
E +ELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFW+EA+ILS LHHP
Sbjct: 919 ELRELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWREADILSNLHHP 978
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLH 933
NVVAFYGVVQ GPGGT+ATVAEYMVDGSLRHVL+RKDR+LDRR+RLIIAMDAAFGMEYLH
Sbjct: 979 NVVAFYGVVQHGPGGTMATVAEYMVDGSLRHVLLRKDRYLDRRKRLIIAMDAAFGMEYLH 1038
Query: 934 SKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSG 993
SKNIVHFDLKCDNLLVNLKDP RPICKVGDFGLSKIKRNTLV+GGVRGTLPWMAPELL+G
Sbjct: 1039 SKNIVHFDLKCDNLLVNLKDPLRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNG 1098
Query: 994 SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTL 1053
SS+KVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPS CD EWRTL
Sbjct: 1099 SSNKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSNCDHEWRTL 1158
Query: 1054 MEECWAPNPAARPSFTEIASRLRVLSTAASQTKGHGNKPSK 1094
ME+CWAPNP ARPSFTEI SRLR++S AASQTK GNK SK
Sbjct: 1159 MEQCWAPNPGARPSFTEITSRLRIMSAAASQTKTQGNKASK 1199
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356528669|ref|XP_003532922.1| PREDICTED: uncharacterized protein LOC100799639 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1147 bits (2966), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 663/1192 (55%), Positives = 780/1192 (65%), Gaps = 137/1192 (11%)
Query: 1 DPGYATGYMELKGILGISHTGSESGSDISMLTIVERGQKEYERRNSSLHEERGNYGSIQS 60
D Y GYMELKGILGISH GSESGSDISML++V++ KE++R N+SL +R NYGSI+S
Sbjct: 87 DSNYTPGYMELKGILGISHAGSESGSDISMLSMVDKYPKEFDRMNTSLPGDRSNYGSIRS 146
Query: 61 AP----NDSNRGSIHGYTSSEASDSSATKMKVLCSFGGKILPRPSDGKLRYVGGETRIIR 116
P N NR + GY S D S MK LCSFGG+ILPRP DGKLRYVGG+TRI+R
Sbjct: 147 MPRTSLNQDNRQFVPGYGSFGVYDRSMM-MKFLCSFGGRILPRPCDGKLRYVGGQTRILR 205
Query: 117 IRKDISWQILRQKALEVYNQVHVIKYQLPGEDLDALVSVSCDEDLQNMMEEYNELGDREG 176
IRKDISWQ L QKAL++YNQVH IKYQLPGEDLDALVSVS DEDLQNMMEE N L DREG
Sbjct: 206 IRKDISWQELMQKALQIYNQVHAIKYQLPGEDLDALVSVSSDEDLQNMMEECNHLLDREG 265
Query: 177 SQRIRMFLFSMSDLAEAQSCLSSMDGDSEIQFVVAVNGMDSGSRNSLNLHGLRSSSANDL 236
SQ++RMFLFSMSDL +AQ LSS+ DSEIQ+VVAVNGMD SR + + G+ S SAND+
Sbjct: 266 SQKLRMFLFSMSDLEDAQFGLSSIGDDSEIQYVVAVNGMDLESRKNTTMFGV-SFSANDI 324
Query: 237 EELGGH-NIERETSRVVVDSARVSTPPLTGNIAPSSTIHSSRVIIPSSSNAHETYPQFHH 295
EL +I+RETSRV V+S PLT N S SS ++P+SSN+++ YPQF+
Sbjct: 325 NELDRQISIDRETSRVGVESI-AQGAPLTNNFNSSLATQSSPPVLPTSSNSYDAYPQFYG 383
Query: 296 DQRLHRRE-TREYPLHHACDPSNYSPYGEIPYSMPLHEHSNQPGGLSGGYQYSVLQVQNP 354
DQ + R E + +Y ++H PS+ GE P MP H NQ G LS G +QVQN
Sbjct: 384 DQMIRRGEPSDQYIINHGLIPSHKPVIGETPIIMPPHMLVNQQGILSEGLPPHGIQVQNS 443
Query: 355 QMTVKQGMALPDGSIQPDSDTEKV--SPLDKPVPSWPYDDKLMKHFAVEEAAVSVGIPRV 412
++ L D SIQ SD K+ S L P+ ++ MK+ EA+V V P
Sbjct: 444 EIAGTFASNLVDSSIQQGSDPGKIFASELPSTAPAQLLNNGYMKN-NFPEASVVVTAP-- 500
Query: 413 DIPPLFPPKSEGKHQEPGKVSPPADTLNAASKFSNDDLCSMSSGALGPGHRDSEINPIDS 472
EG P K+ D +S SS A GP + DS N D
Sbjct: 501 ----------EGHSLHPTKMDKLPDYEETSST---------SSSAFGPAYVDSHYNAADL 541
Query: 473 SYLEPPVPPQRIYRSEKIPREQLDLLNRLSKSDDSLGSQFIMSQSHSDVVQPDPVSEPNE 532
S L PP P+R+Y SE+I REQL+LLNR SKSDD+ SQF +S SDV PD V+E +
Sbjct: 542 SSLHPPPLPKRVYYSERISREQLELLNRSSKSDDTNSSQFHVSDLLSDVNPPDSVTESGD 601
Query: 533 KVQ-------------------KEDQTFENELTQLQKHKEFADAISQTNSKPSE----EI 569
K+ + +N Q +K+ DA SQ SK +E E+
Sbjct: 602 KLHGGNLPNLSEELGITGKPLHADGYAIDNGAVNHQIYKQLPDASSQMKSKLTEHVSPEL 661
Query: 570 LDVQEPRQGIPDALANN-------ETNDPVDYNKKPLVDDGLPSESSINDVYQ------- 615
V G D L + E +YNK PL+D+ S+ + ++Q
Sbjct: 662 KQVSLDNGGRKDLLNKDNVVGLETEIYSINNYNK-PLIDETKTSKPDLPILHQVSSDKHL 720
Query: 616 ------------GISSVG--------------------------------VSTQQRVDIS 631
G +SV VS Q + DI
Sbjct: 721 DDPASILPEVDWGDTSVKESNEDINVQALPVSINGNTTTDEDSEEFPSNVVSKQAQGDIL 780
Query: 632 VDIDDRFPRDFLSDIYSKALISEDSSGIITLHKDGAGISVNMENHEPKRWSYFRNLAQVD 691
+DI+DRFPR+F +D++SKA++ ED S + L DG G+SVNMEN EPKRWSYF+ LAQ
Sbjct: 781 IDINDRFPREFFTDMFSKAVLEEDPSSLHPLTSDGVGLSVNMENREPKRWSYFQKLAQE- 839
Query: 692 FGQKDVSLIDQEHLGLSSGVREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQ----DS 747
G +VSL+DQ+HL S G + V E R H PLT D +S L+F + D
Sbjct: 840 -GIDNVSLMDQDHLDFSPG-KVVGE--NRAQHVKPLTTDEVSLNHAESHLDFVEENIRDL 895
Query: 748 QKTFGVDPSV------------SESMQFDAMMENLRTTESDYEEGNAGNRNIGLPSLNPS 795
G + +V +ESMQFD MMEN+R ES+YE G RN LP +PS
Sbjct: 896 HGRIGAETTVLKSNYDHSQVNDTESMQFDVMMENIRAQESEYEVGKFEKRNSNLPPPDPS 955
Query: 796 LV-DFDVSSVQVIKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQE 854
LV +FD S+ QVI N+DLEE KELGSGTFGTVYHGKWRGTDVAIKRIKK CFTGRSSEQE
Sbjct: 956 LVGEFDPSTFQVIMNDDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKICFTGRSSEQE 1015
Query: 855 RLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLD 914
RLTVEFW+EAEILSKLHHPNVVAFYGVVQDGPGGT+ATVAEYMVDGSLRHVL+RKDR+LD
Sbjct: 1016 RLTVEFWREAEILSKLHHPNVVAFYGVVQDGPGGTMATVAEYMVDGSLRHVLLRKDRYLD 1075
Query: 915 RRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTL 974
RR+RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP RPICKVGDFGLSKIKRNTL
Sbjct: 1076 RRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPMRPICKVGDFGLSKIKRNTL 1135
Query: 975 VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV 1034
VSGGVRGTLPWMAPELL+GSS+KVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV
Sbjct: 1136 VSGGVRGTLPWMAPELLNGSSNKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV 1195
Query: 1035 NNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQTK 1086
NNTLRPTIP +CD+EWRTLME+CWAPNPAARPSFTEIASRLR+++ AASQTK
Sbjct: 1196 NNTLRPTIPDHCDSEWRTLMEQCWAPNPAARPSFTEIASRLRIMTAAASQTK 1247
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359472758|ref|XP_002276237.2| PREDICTED: uncharacterized protein LOC100242423 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1134 bits (2933), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 656/1244 (52%), Positives = 799/1244 (64%), Gaps = 164/1244 (13%)
Query: 1 DPGYATGYMELKGILGISHTGSESGSDISMLTIVERGQ-KEYERRNSSLHEERGNYGSIQ 59
DP AT Y LKG LG SHTGSESG DI MLT VE+ + +E+ER++SS+HE++G Y S++
Sbjct: 92 DPNSATNYAVLKGFLGASHTGSESGPDIPMLTSVEKSRVQEFERKSSSVHEDKGYYDSVR 151
Query: 60 SAP-----NDSNRGSIHGYTSSEASDSSATKMKVLCSFGGKILPRPSDGKLRYVGGETRI 114
S P NDS+RG +HGYTSS AS+ S+TK K LCSFGGKILPRPSDGKLRYVGGETRI
Sbjct: 152 SVPRISSRNDSSRG-LHGYTSSGASERSSTKFKFLCSFGGKILPRPSDGKLRYVGGETRI 210
Query: 115 IRIRKDISWQILRQKALEVYNQVHVIKYQLPGEDLDALVSVSCDEDLQNMMEEYNELGDR 174
IR+ KDISWQ L QK + +YNQ H IKYQLPGEDLDALVSVSCDEDLQNMMEE N L D
Sbjct: 211 IRMNKDISWQDLMQKTMTIYNQSHTIKYQLPGEDLDALVSVSCDEDLQNMMEECNVLEDG 270
Query: 175 EGSQRIRMFLFSMSDLAEAQSCLSSMDGDSEIQFVVAVNGMDSGSRNSLNLHGLRSSSAN 234
GSQ++R+FLFS SD + Q L SM+GDSEIQ+VVAVNGMD SR N GL S+S N
Sbjct: 271 -GSQKLRLFLFSSSDFDDGQFGLGSMEGDSEIQYVVAVNGMDLESRK--NSIGLASTSDN 327
Query: 235 DLEELGGHNIERETSRVVVDSARVSTPPLTGNIAPSSTIHSSRVIIPSSSNAHETYPQFH 294
+L+EL N+ERET RV + ST P T N+ SS + SS+ ++P+ S A+E+ + +
Sbjct: 328 NLDELLNLNVERETGRVATELPGPSTAPSTVNVH-SSAVQSSQPLVPNFSGAYESNSKPY 386
Query: 295 HDQRLHRRETRE---YPLHH-----------------------ACDPSNYSPYGEIPYSM 328
Q++ E + +P+HH P NY P+GE M
Sbjct: 387 QGQKMRHGEAEQHQVFPVHHLESVHDLDGRNSVPFSVQFPYGYGSQPFNYGPFGENLVHM 446
Query: 329 PLHEHSNQPGGLSGGYQYSVLQVQ-------------------------------NPQMT 357
PLH H + GG + YS + V + +
Sbjct: 447 PLHGHVTRQGGPAEDQMYSDVHVHVQGLEVSAKEDKLKRDNSSQKMNEPEKNRSLEKEAS 506
Query: 358 VKQGMALPDGSIQPDSDTEKVSPLDKP--VPSWPYDDKLMKHFAVEEAAVSVGIPRVDIP 415
VK+ D S+Q ++ EK+ L+ V S P+D + + +EA+V + +P
Sbjct: 507 VKEAKIKTDSSVQKMNELEKIRSLESEHNVSSHPHDGSVPNYIPRDEASVVNSTADIGVP 566
Query: 416 PLFPPKSEGKHQEPGKVSPPADTLNAA--SKFSNDDLCSMSSGALGPGHRDSEINPIDSS 473
L P K+ KH E ++S P + ++ + F+ D S GA PG+ DSE +P + S
Sbjct: 567 MLLP-KTSKKHLESVQISKPPEAVSDGKINTFNGDGHFHTSGGAFSPGYGDSEADPTEVS 625
Query: 474 YLEPPVPPQRIYRSEKIPREQLDLLNRLSKSDDSLGSQFIMSQSHSDVVQP-----DPVS 528
Y E + P R++ SE+IPREQ +L NRLSKSDDS GSQF+MS + SDV Q D +
Sbjct: 626 YPEQTLIPPRVFHSERIPREQAEL-NRLSKSDDSFGSQFLMSHTRSDVSQQVAESIDKLH 684
Query: 529 EPNEKVQKED------------QTFENELTQLQKHKEFADAISQTNSKPSEEILDVQ--- 573
N Q E +T E+ LTQ +K+K+ AD I + NS SE+ L +
Sbjct: 685 GGNVTSQSEQAASSTTALYTNPKTVEDGLTQFEKYKDVADDIKKLNSNISEDGLGPKLLK 744
Query: 574 -EPRQGIPDALANNETNDPVDYNKKPLVDD----GL-----------------PS----- 606
E + P ++ ++E D NK P V D GL PS
Sbjct: 745 SESKWPAPTSVDDHEIAGVRDGNKDPAVSDREAAGLNNLTASQGTSSKPHDDSPSKPTGF 804
Query: 607 -------------------------ESSINDVYQGISSVGVSTQQRVDISVDIDDRFPRD 641
E+ + V G SSVGV + DI +DI+DRFPRD
Sbjct: 805 HWDEMAVKKNNDDNTKGHAQPMAWTENPLRSVPGGESSVGVGAPEGGDILIDINDRFPRD 864
Query: 642 FLSDIYSKALISEDSSGIITLHKDGAGISVNMENHEPKRWSYFRNLAQVDFGQKDVSLID 701
FLSDI+SKA SE GI LH DG G+S+N+ENHEPK WS+F+ LAQ +F +K VSL+D
Sbjct: 865 FLSDIFSKARTSEGPPGISPLHGDGTGLSLNLENHEPKHWSFFQKLAQEEFIRKGVSLMD 924
Query: 702 QEHLGLSSGVREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFG--------- 752
Q+HLG S + + E Y F PL DG G +DS++NF ++ Q+
Sbjct: 925 QDHLGYPSSLMNIEEGTPIDYSFPPLKSDGVALGPMDSRINFEEEIQQESSSMVRPNTID 984
Query: 753 ----VDPS---VSESMQFDAMMENLRTTESDYEEGNAGNRNIGLPSLNPSLVDFDVSSVQ 805
DPS ES+Q D M N RT +SDYEE +N G P ++PSL D D+S++Q
Sbjct: 985 MHEDYDPSPVKRDESVQMDGMA-NPRTPDSDYEEVKFEIQNTGAPFVDPSLGDIDISTLQ 1043
Query: 806 VIKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAE 865
+IKNEDLEE +ELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFW+EA+
Sbjct: 1044 IIKNEDLEELRELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWREAD 1103
Query: 866 ILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDA 925
ILSKLHHPNVVAFYGVVQDGPGGTLATV E+MV+GSLRHVLV KDR LDRR+RLIIAMDA
Sbjct: 1104 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLVSKDRHLDRRKRLIIAMDA 1163
Query: 926 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPW 985
AFGMEYLHSKNIVHFDLKCDNLLVNLKDP RPICKVGDFGLSKIKRNTLV+GGVRGTLPW
Sbjct: 1164 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPLRPICKVGDFGLSKIKRNTLVTGGVRGTLPW 1223
Query: 986 MAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSY 1045
MAPELL+GSSS+VSEKVDVFSFGIVLWEILTGEEPYA+MHYGAIIGGIVNNTLRP +PSY
Sbjct: 1224 MAPELLNGSSSRVSEKVDVFSFGIVLWEILTGEEPYAHMHYGAIIGGIVNNTLRPPVPSY 1283
Query: 1046 CDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQTKGHG 1089
CD+EW+ LME+CWAP+P RPSFTEIA RLR +S AA QTK G
Sbjct: 1284 CDSEWKLLMEQCWAPDPIGRPSFTEIARRLRAMS-AACQTKPQG 1326
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297737995|emb|CBI27196.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1124 bits (2906), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 642/1167 (55%), Positives = 785/1167 (67%), Gaps = 110/1167 (9%)
Query: 1 DPGYATGYMELKGILGISHTGSESGSDISMLTIVERGQ-KEYERRNSSLHEERGNYGSIQ 59
DP AT Y LKG LG SHTGSESG DI MLT VE+ + +E+ER++SS+HE++G Y S++
Sbjct: 92 DPNSATNYAVLKGFLGASHTGSESGPDIPMLTSVEKSRVQEFERKSSSVHEDKGYYDSVR 151
Query: 60 SAP-----NDSNRGSIHGYTSSEASDSSATKMKVLCSFGGKILPRPSDGKLRYVGGETRI 114
S P NDS+RG +HGYTSS AS+ S+TK K LCSFGGKILPRPSDGKLRYVGGETRI
Sbjct: 152 SVPRISSRNDSSRG-LHGYTSSGASERSSTKFKFLCSFGGKILPRPSDGKLRYVGGETRI 210
Query: 115 IRIRKDISWQILRQKALEVYNQVHVIKYQLPGEDLDALVSVSCDEDLQNMMEEYNELGDR 174
IR+ KDISWQ L QK + +YNQ H IKYQLPGEDLDALVSVSCDEDLQNMMEE N L D
Sbjct: 211 IRMNKDISWQDLMQKTMTIYNQSHTIKYQLPGEDLDALVSVSCDEDLQNMMEECNVLEDG 270
Query: 175 EGSQRIRMFLFSMSDLAEAQSCLSSMDGDSEIQFVVAVNGMDSGSRNSLNLHGLRSSSAN 234
GSQ++R+FLFS SD + Q L SM+GDSEIQ+VVAVNGMD SR N GL S+S N
Sbjct: 271 -GSQKLRLFLFSSSDFDDGQFGLGSMEGDSEIQYVVAVNGMDLESRK--NSIGLASTSDN 327
Query: 235 DLEELGGHNIERETSRVVVDSARVSTPPLTGNIAPSSTIHSSRVIIPSSSNAHETYPQFH 294
+L+EL N+ERET RV + ST P T N+ SS + SS+ ++P+ S A+E+ + +
Sbjct: 328 NLDELLNLNVERETGRVATELPGPSTAPSTVNVH-SSAVQSSQPLVPNFSGAYESNSKPY 386
Query: 295 HDQRLHRRETREYPLHHACDPSNYSPYGEIPYSMPLHEHSNQPGGLSGGYQYSVLQVQNP 354
Q++ E + H +Y+ P+ M N+P +
Sbjct: 387 QGQKMRHGEAEQ----HQVKSGSYAS----PWKM------NEP---------EKNRSLEK 423
Query: 355 QMTVKQGMALPDGSIQPDSDTEKVSPLDKP--VPSWPYDDKLMKHFAVEEAAVSVGIPRV 412
+ +VK+ D S+Q ++ EK+ L+ V S P+D + + +EA+V +
Sbjct: 424 EASVKEAKIKTDSSVQKMNELEKIRSLESEHNVSSHPHDGSVPNYIPRDEASVVNSTADI 483
Query: 413 DIPPLFPPKSEGKHQEPGKVSPPADTLNAA--SKFSNDDLCSMSSGALGPGHRDSEINPI 470
+P L P K+ KH E ++S P + ++ + F+ D S GA PG+ DSE +P
Sbjct: 484 GVPMLLP-KTSKKHLESVQISKPPEAVSDGKINTFNGDGHFHTSGGAFSPGYGDSEADPT 542
Query: 471 DSSYLEPPVPPQRIYRSEKIPREQLDLLNRLSKSDDSLGSQFIMSQSHSDVVQP-----D 525
+ SY E + P R++ SE+IPREQ +L NRLSKSDDS GSQF+MS + SDV Q D
Sbjct: 543 EVSYPEQTLIPPRVFHSERIPREQAEL-NRLSKSDDSFGSQFLMSHTRSDVSQQVAESID 601
Query: 526 PVSEPNEKVQKED------------QTFENELTQLQKHKEFADAISQTNSKPSEEILDVQ 573
+ N Q E +T E+ LTQ +K+K+ AD I + NS SE+ L +
Sbjct: 602 KLHGGNVTSQSEQAASSTTALYTNPKTVEDGLTQFEKYKDVADDIKKLNSNISEDGLGPK 661
Query: 574 ----EPRQGIPDALANNETNDPVDYNKKPLVDD----GL-----------------PSES 608
E + P ++ ++E D NK P V D GL PS+
Sbjct: 662 LLKSESKWPAPTSVDDHEIAGVRDGNKDPAVSDREAAGLNNLTASQGTSSKPHDDSPSKP 721
Query: 609 S----------INDVYQGISSVGVSTQQRVDISVDIDDRFPRDFLSDIYSKALISEDSSG 658
+ + V G SSVGV + DI +DI+DRFPRDFLSDI+SKA SE G
Sbjct: 722 TGFHWDEMANPLRSVPGGESSVGVGAPEGGDILIDINDRFPRDFLSDIFSKARTSEGPPG 781
Query: 659 IITLHKDGAGISVNMENHEPKRWSYFRNLAQVDFGQKDVSLIDQEHLGLSSGVREVREED 718
I LH DG G+S+N+ENHEPK WS+F+ LAQ +F +K VSL+DQ+HLG S + + E
Sbjct: 782 ISPLHGDGTGLSLNLENHEPKHWSFFQKLAQEEFIRKGVSLMDQDHLGYPSSLMNIEEGT 841
Query: 719 GRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFG-------------VDPS---VSESMQ 762
Y F PL DG G +DS++NF ++ Q+ DPS ES+Q
Sbjct: 842 PIDYSFPPLKSDGVALGPMDSRINFEEEIQQESSSMVRPNTIDMHEDYDPSPVKRDESVQ 901
Query: 763 FDAMMENLRTTESDYEEGNAGNRNIGLPSLNPSLVDFDVSSVQVIKNEDLEEQKELGSGT 822
D M N RT +SDYEE +N G P ++PSL D D+S++Q+IKNEDLEE +ELGSGT
Sbjct: 902 MDGMA-NPRTPDSDYEEVKFEIQNTGAPFVDPSLGDIDISTLQIIKNEDLEELRELGSGT 960
Query: 823 FGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVV 882
FGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFW+EA+ILSKLHHPNVVAFYGVV
Sbjct: 961 FGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWREADILSKLHHPNVVAFYGVV 1020
Query: 883 QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDL 942
QDGPGGTLATV E+MV+GSLRHVLV KDR LDRR+RLIIAMDAAFGMEYLHSKNIVHFDL
Sbjct: 1021 QDGPGGTLATVTEFMVNGSLRHVLVSKDRHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDL 1080
Query: 943 KCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKV 1002
KCDNLLVNLKDP RPICKVGDFGLSKIKRNTLV+GGVRGTLPWMAPELL+GSSS+VSEKV
Sbjct: 1081 KCDNLLVNLKDPLRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSRVSEKV 1140
Query: 1003 DVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNP 1062
DVFSFGIVLWEILTGEEPYA+MHYGAIIGGIVNNTLRP +PSYCD+EW+ LME+CWAP+P
Sbjct: 1141 DVFSFGIVLWEILTGEEPYAHMHYGAIIGGIVNNTLRPPVPSYCDSEWKLLMEQCWAPDP 1200
Query: 1063 AARPSFTEIASRLRVLSTAASQTKGHG 1089
RPSFTEIA RLR +S AA QTK G
Sbjct: 1201 IGRPSFTEIARRLRAMS-AACQTKPQG 1226
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1094 | ||||||
| TAIR|locus:2032895 | 1147 | AT1G16270 [Arabidopsis thalian | 0.312 | 0.298 | 0.797 | 2.1e-246 | |
| TAIR|locus:2044702 | 1257 | AT2G35050 [Arabidopsis thalian | 0.505 | 0.439 | 0.559 | 4.1e-221 | |
| TAIR|locus:2206350 | 1248 | AT1G79570 [Arabidopsis thalian | 0.733 | 0.642 | 0.521 | 1.9e-202 | |
| TAIR|locus:2093146 | 1117 | AT3G24715 [Arabidopsis thalian | 0.389 | 0.381 | 0.556 | 2.6e-160 | |
| TAIR|locus:2197788 | 1042 | AT1G04700 [Arabidopsis thalian | 0.285 | 0.299 | 0.695 | 4.2e-156 | |
| TAIR|locus:2102787 | 1171 | AT3G46920 [Arabidopsis thalian | 0.318 | 0.297 | 0.601 | 5.5e-151 | |
| TAIR|locus:2174552 | 1054 | AT5G57610 [Arabidopsis thalian | 0.254 | 0.263 | 0.683 | 1.9e-140 | |
| TAIR|locus:2200296 | 765 | AT1G67890 [Arabidopsis thalian | 0.248 | 0.355 | 0.384 | 1.7e-41 | |
| DICTYBASE|DDB_G0283267 | 527 | shkA "SHK subfamily protein ki | 0.238 | 0.495 | 0.381 | 1.1e-40 | |
| TAIR|locus:2027794 | 1030 | AT1G73660 [Arabidopsis thalian | 0.263 | 0.279 | 0.367 | 2.9e-40 |
| TAIR|locus:2032895 AT1G16270 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1436 (510.6 bits), Expect = 2.1e-246, Sum P(2) = 2.1e-246
Identities = 276/346 (79%), Positives = 299/346 (86%)
Query: 753 VDPS--VSESMQFDAMMENLRTTESDYEEGNAGNRNIGLPSLNPSLVDFDVSSVQVIKNE 810
VDP V+ES +FDAM+ENLRT++ + E+ + RN GLP + PSL D+D S +Q+I N+
Sbjct: 802 VDPQMKVTESEEFDAMVENLRTSDCEQEDEKSETRNAGLPPVGPSLADYDTSGLQIIMND 861
Query: 811 DLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL 870
DLEE KELGSGTFGTVYHGKWRG+DVAIKRIKKSCF GRSSEQERLT EFW EAEILSKL
Sbjct: 862 DLEELKELGSGTFGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTGEFWGEAEILSKL 921
Query: 871 HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHXXXXXXXXXXXXXXXIIAMDAAFGME 930
HHPNVVAFYGVV+DGPG TLATV EYMVDGSLRH IIAMDAAFGME
Sbjct: 922 HHPNVVAFYGVVKDGPGATLATVTEYMVDGSLRHVLVRKDRHLDRRKRLIIAMDAAFGME 981
Query: 931 YLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPEL 990
YLH+KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPEL
Sbjct: 982 YLHAKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPEL 1041
Query: 991 LSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEW 1050
L+GSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCD++W
Sbjct: 1042 LNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDSDW 1101
Query: 1051 RTLMEECWAPNPAARPSFTEIASRLRVLSTAAS--QTKGHGNKPSK 1094
R LMEECWAPNP ARPSFTEIA RLRV+STAA+ Q+K +K SK
Sbjct: 1102 RILMEECWAPNPTARPSFTEIAGRLRVMSTAATSNQSKPPAHKASK 1147
|
|
| TAIR|locus:2044702 AT2G35050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1542 (547.9 bits), Expect = 4.1e-221, Sum P(2) = 4.1e-221
Identities = 326/583 (55%), Positives = 398/583 (68%)
Query: 518 HSDVVQPDPVSEPNEKVQKEDQTFENELTQLQKHKEFADAISQTNSKPSEEILDVQE--P 575
HS+ DP +E N ++ K D + ++ Q + IS+++ E ++ Q P
Sbjct: 685 HSERTVRDP-TETN-RLSKSDDSLASQFVMAQTTSDAFLPISESSETSHEANMESQNVHP 742
Query: 576 RQGI---PDALANNETNDPVDYNKKPLVDDGLPSESSINDVYQGISSVGVSTQQRVDISV 632
+ PD++ E + + ++K V+ P S + +V ++ DI V
Sbjct: 743 TAPVIPAPDSIWTAEGS--MSQSEKKNVETNTPEHVSQTET--SAKAVPQGHNEKGDIVV 798
Query: 633 DIDDRFPRDFLSDIYSKALISEDSSGIITLHKDGAGISVNMENHEPKRWSYFRNLAQVDF 692
DI+DRFPR+FL+DI K S + G+ LH DGAG+S+N++N++PK WSYFRNLAQ +F
Sbjct: 799 DINDRFPREFLADIL-KTKESLNFPGLGPLHADGAGVSLNIQNNDPKTWSYFRNLAQDEF 857
Query: 693 GQKDVSLIDQEHLGLSSGVREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFG 752
+KD+SL+DQ+H G + + Y + PL + ++ Q++F D
Sbjct: 858 ERKDLSLMDQDHPGFPTSMTNTNGVPID-YSYPPLQSEKVASSQIHPQIHF--DGN---- 910
Query: 753 VDPSVSESMQFDAMMENLRTTESDYE-------EGNAGNRNIGLPSLNPSLVDFDVSSVQ 805
+ P VS D N T+ DY E N G+P ++ D + S+Q
Sbjct: 911 IKPDVSTITIPDL---NTVDTQEDYSQSQIKGAESTDATLNAGVPLIDFMAADSGMRSLQ 967
Query: 806 VIKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAE 865
VIKN+DLEE KELGSGTFGTVYHGKWRGTDVAIKRIK+SCF GRSSEQERLT EFW EAE
Sbjct: 968 VIKNDDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKRSCFIGRSSEQERLTSEFWHEAE 1027
Query: 866 ILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHXXXXXXXXXXXXXXXIIAMDA 925
ILSKLHHPNV+AFYGVV+DGPGGTLATV EYMV+GSLRH IIAMDA
Sbjct: 1028 ILSKLHHPNVMAFYGVVKDGPGGTLATVTEYMVNGSLRHVLLSNRHLDRRKRL-IIAMDA 1086
Query: 926 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPW 985
AFGMEYLHSK+IVHFDLKCDNLLVNLKDP+RPICKVGDFGLSKIKRNTLV+GGVRGTLPW
Sbjct: 1087 AFGMEYLHSKSIVHFDLKCDNLLVNLKDPARPICKVGDFGLSKIKRNTLVTGGVRGTLPW 1146
Query: 986 MAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSY 1045
MAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT+P+Y
Sbjct: 1147 MAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTVPNY 1206
Query: 1046 CDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQTKGH 1088
CD EWR LME+CWAP+P RP+F EIA RLR +S++A TK H
Sbjct: 1207 CDPEWRMLMEQCWAPDPFVRPAFPEIARRLRTMSSSAVHTKPH 1249
|
|
| TAIR|locus:2206350 AT1G79570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1959 (694.7 bits), Expect = 1.9e-202, P = 1.9e-202
Identities = 445/853 (52%), Positives = 547/853 (64%)
Query: 266 NIAPSSTIHSSRVIIPSSSNAHETYPQFHHDQRLHRRETREYPLHHACDPSNYSPYGEIP 325
+I P S+ + IIP S++++ YPQ++ H R +PL+ SNYS GE
Sbjct: 416 SITPGSSYQYPQSIIPGSASSYGIYPQYYGHVVQHGERER-FPLYPD-HSSNYSAIGETT 473
Query: 326 YSMPLHEHSNQPGGLSGGYQYSVLQVQNPQMTVKQGMALPDGSIQPDSDTE--KVSPLDK 383
S+P+ H +Q GG + GY Y ++ Q ++ D I+ + + E K D
Sbjct: 474 SSIPIQGHVSQQGGWAEGYPYPGSTPKSTQALAEEQKVSSDMKIREEVEPENRKTPGNDH 533
Query: 384 PVPSWPYDDKLMKHFAVEEAAVSVGIPRVDIPPLFPPKSEGKHQEPGKVSPPADT-LNAA 442
P D ++ H V E AV+ P D L PP + + K + D +
Sbjct: 534 QNPPQIDDVEVRNHNQVREMAVATTPPSQDAH-LLPPSRDPRQNTTAKPATYRDAVITGQ 592
Query: 443 SKFSN-DDLCSMSSGALGPGHRDSEINPIDSSYLEPPVPPQRIYRSEKIPREQLDLLNRL 501
S +D S SS P H DSE N ID +Y EP QR+Y SE+IPREQL+LLNRL
Sbjct: 593 VPLSGIEDQLSTSSSTYAPVHSDSESNLIDLNYPEPEQSSQRVYCSERIPREQLELLNRL 652
Query: 502 SKSDDSLGSQFIMSQSHSDVVQPDPVSEPNEKVQKEDQTFENELTQLQKHKEFADAISQT 561
SKSD+SL SQF+ S+S ++ Q D E K E +T ++ HK+ +
Sbjct: 653 SKSDNSLSSQFVTSESPANTAQQDSGKEAVGKSHDEFKTVNDDANH-HTHKDVETIFEKV 711
Query: 562 NSKPSEEILDVQEPRQGIPDALANNETNDPVDYNKKPLVDDGLPSE---SSINDVYQGIS 618
S+E L+ EP I + P D NK +V+ G +E S+++ V +S
Sbjct: 712 GV--SDETLE-SEPLHKIVN---------PDDANKNRVVN-GADTEIGVSNLSHVNAAMS 758
Query: 619 SVGVSTQQRV--DISVDIDDRFPRDFLSDIYSKALISEDSSGIITLHKDGAGISVNMENH 676
V Q + DI +DI+DRFPRDFLS+I+S+A ISED+S + DGA +S+N++NH
Sbjct: 759 HVIPEEQASLQGDILIDINDRFPRDFLSEIFSQA-ISEDTSTVRPYPHDGAAVSMNVQNH 817
Query: 677 EPKRWSYFRNLAQVDFGQKDVSLIDQEHLGLSSGVREVREEDGRLYHFTPLTDDGAPKGR 736
+ K WSYF+ LA+ F Q+DV ++DQ + S R+ E RL + +PL+ DG
Sbjct: 818 DRKNWSYFQQLAEDQFIQRDV-VLDQADSRIPSD-RKDGGESSRLPYVSPLSRDGISTNL 875
Query: 737 VDSQLNFGQD-----SQKTFG----VDPS-------VSESMQFDAMMENLRTTESDYEEG 780
+ QL GQD S+K G + P+ V+ES +F AM+ENLRT +S+ ++
Sbjct: 876 ANPQLTLGQDYGGNFSEKDGGGTGSIPPALENEQMKVTESEEFGAMVENLRTPDSEPKDE 935
Query: 781 NAGNRNIGLPSLNPSLVDFDVSSVQVIKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKR 840
R+ LP L +FD S +Q+IKNEDLEE +ELGSGTFGTVYHGKWRG+DVAIKR
Sbjct: 936 KTETRHAALPPLGS---EFDYSGLQIIKNEDLEELRELGSGTFGTVYHGKWRGSDVAIKR 992
Query: 841 IKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDG 900
IKKSCF GRSSEQERLT EFW EAEILSKLHHPNVVAFYGVV+DGPGGTLATV EYMVDG
Sbjct: 993 IKKSCFAGRSSEQERLTGEFWGEAEILSKLHHPNVVAFYGVVKDGPGGTLATVTEYMVDG 1052
Query: 901 SLRHXXXXXXXXXXXXXXXIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICK 960
SLRH IIAMDAAFGMEYLHSKN VHFDLKCDNLLVNLKDPSRPICK
Sbjct: 1053 SLRHVLVRKDRHLDRRKRLIIAMDAAFGMEYLHSKNTVHFDLKCDNLLVNLKDPSRPICK 1112
Query: 961 VGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEP 1020
VGDFGLSKIKRNTLVSGGVRGTLPWMAPELL+GSSSKVSEKVDVFSFGIVLWEILTGEEP
Sbjct: 1113 VGDFGLSKIKRNTLVSGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 1172
Query: 1021 YANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLST 1080
YANMHYGAIIGGIVNNTLRPTIP +CD EWRTLMEECWAPNP ARPSFTEIA RLRV+S+
Sbjct: 1173 YANMHYGAIIGGIVNNTLRPTIPGFCDDEWRTLMEECWAPNPMARPSFTEIAGRLRVMSS 1232
Query: 1081 AASQTKGHGNKPS 1093
AA+ T+ +KPS
Sbjct: 1233 AATSTQ---SKPS 1242
|
|
| TAIR|locus:2093146 AT3G24715 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1145 (408.1 bits), Expect = 2.6e-160, Sum P(4) = 2.6e-160
Identities = 252/453 (55%), Positives = 303/453 (66%)
Query: 656 SSGIITLHKDGAGISVNMENHEPK-RWSYFRNLAQVD--FGQKDVSLIDQEHL-GLSSG- 710
S+ +I+L + GI+ N N EP+ R + RNL +V F K V + D+ L ++S
Sbjct: 676 SANLISLEE---GIAANTPNEEPESRAARERNL-EVSGIFISKRV-VSDENFLFSIASES 730
Query: 711 -----VREVR----EEDGRLYHFT-PLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSES 760
V E + E +G L H P+ D P S+ S KT D +S
Sbjct: 731 PNSKIVHETQKNRTEREGGLGHVRIPIMDLNQPAPATASETY----SLKTPREDSP--QS 784
Query: 761 MQFDAMMENLRTTESDYEEGNAGNRNIGLPSLNPSLVDFDVSSVQVIKNEDLEEQKELGS 820
+ + S+ E N G + ++ V +Q+IKN DLE+ ELGS
Sbjct: 785 IPHAKITSGDTIFLSEEAEANTGQKENSFKDTLFVEMEASVYGLQIIKNADLEDLTELGS 844
Query: 821 GTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYG 880
GT+GTVYHG WRGTDVAIKRI+ SCF GRSSEQERLT +FW+EA+ILS LHHPNVVAFYG
Sbjct: 845 GTYGTVYHGTWRGTDVAIKRIRNSCFAGRSSEQERLTKDFWREAQILSNLHHPNVVAFYG 904
Query: 881 VVQDGPGGTLATVAEYMVDGSLRHXXXXXXXXXXXXXXXIIAMDAAFGMEYLHSKNIVHF 940
+V DG GGTLATV E+MV+GSLRH IIAMDAAFGMEYLHSKNIVHF
Sbjct: 905 IVPDGTGGTLATVTEFMVNGSLRHALLKKDRLLDTRKKIIIAMDAAFGMEYLHSKNIVHF 964
Query: 941 DLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSE 1000
DLKC+NLLVNL+DP RPICKVGD GLS+IKRNTLVSGGVRGTLPWMAPELL+GSS++VSE
Sbjct: 965 DLKCENLLVNLRDPQRPICKVGDLGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSTRVSE 1024
Query: 1001 KVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAP 1060
KVDVFS+GI LWEILTGEEPYA+MH GAIIGGIV NTLRP IP C EW+ LME+CW+
Sbjct: 1025 KVDVFSYGISLWEILTGEEPYADMHCGAIIGGIVKNTLRPPIPKSCSPEWKKLMEQCWSV 1084
Query: 1061 NPAARPSFTEIASRLRVLST-AASQTKGHGNKP 1092
+P +RP FTEI RLR +S +++K NKP
Sbjct: 1085 DPDSRPPFTEITCRLRSMSMEVVTKSKRRENKP 1117
|
|
| TAIR|locus:2197788 AT1G04700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1150 (409.9 bits), Expect = 4.2e-156, Sum P(4) = 4.2e-156
Identities = 219/315 (69%), Positives = 252/315 (80%)
Query: 774 ESDYEEGNAGNRNIGLPSLNPSLVDFD--VSSVQVIKNEDLEEQKELGSGTFGTVYHGKW 831
ES+ EE +RN ++V+ + + +Q+IKN DLE+ ELGSGTFGTVY+GKW
Sbjct: 726 ESEMEEKYKKSRNTDDSFSEAAMVEIEAGIYGLQIIKNTDLEDLHELGSGTFGTVYYGKW 785
Query: 832 RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLA 891
RGTDVAIKRIK SCF+G SSEQ R T +FW+EA IL+ LHHPNVVAFYGVV DGPGGT+A
Sbjct: 786 RGTDVAIKRIKNSCFSGGSSEQARQTKDFWREARILANLHHPNVVAFYGVVPDGPGGTMA 845
Query: 892 TVAEYMVDGSLRHXXXXXXXXXXXXXXXIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNL 951
TV EYMV+GSLRH +I +D+AFGMEYLH KNIVHFDLKCDNLLVNL
Sbjct: 846 TVTEYMVNGSLRHVLQRKDRLLDRRKKLMITLDSAFGMEYLHMKNIVHFDLKCDNLLVNL 905
Query: 952 KDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVL 1011
+DP RPICKVGDFGLS+IKRNTLVSGGVRGTLPWMAPELL+GSS++VSEKVDVFSFGIV+
Sbjct: 906 RDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGIVM 965
Query: 1012 WEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
WEILTGEEPYAN+H GAIIGGIVNNTLRP +P C+AEWR LME+CW+ +P RPSFTEI
Sbjct: 966 WEILTGEEPYANLHCGAIIGGIVNNTLRPPVPERCEAEWRKLMEQCWSFDPGVRPSFTEI 1025
Query: 1072 ASRLRVLSTAASQTK 1086
RLR + T A Q K
Sbjct: 1026 VERLRSM-TVALQPK 1039
|
|
| TAIR|locus:2102787 AT3G46920 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1076 (383.8 bits), Expect = 5.5e-151, Sum P(3) = 5.5e-151
Identities = 211/351 (60%), Positives = 253/351 (72%)
Query: 745 QDSQKTFGVDPSVSESMQFDAMMENLRTTESDYEEGNAGN-RNIGLPSLNPSLVDFD-VS 802
Q S ++ P + F++ E R E + + + RN L LN D +
Sbjct: 819 QSSTPSYHEPPIKVDEYAFNSKGEVSRNDEMKQQSTHFKDIRNQLLERLNFGYSGSDSLD 878
Query: 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWK 862
+Q+IK+ DLEE +ELGSGTFGTVYHGKWRGTDVAIKRI CF G+ SEQER+ +FW
Sbjct: 879 QLQIIKDSDLEELRELGSGTFGTVYHGKWRGTDVAIKRINDRCFAGKPSEQERMIDDFWN 938
Query: 863 EAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHXXXXXXXXXXXXXXXIIA 922
EA+ L+ LHHPNVVAFYGVV D PGG++ATV EYMV+GSLR+ +IA
Sbjct: 939 EAQNLAGLHHPNVVAFYGVVLDSPGGSVATVTEYMVNGSLRNALQKNVRNFDRCKRQLIA 998
Query: 923 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGT 982
MD AFGMEYLH K IVHFDLK DNLLVNL+DP RPICKVGD GLSK+K TL+SGGVRGT
Sbjct: 999 MDIAFGMEYLHGKKIVHFDLKSDNLLVNLRDPHRPICKVGDLGLSKVKCQTLISGGVRGT 1058
Query: 983 LPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTI 1042
LPWMAPELL+G+SS VSEKVDVFSFGIVLWE+ TGEEPYA++HYGAIIGGIV+NTLRP I
Sbjct: 1059 LPWMAPELLNGTSSLVSEKVDVFSFGIVLWELFTGEEPYADLHYGAIIGGIVSNTLRPQI 1118
Query: 1043 PSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAA-SQTKGHGNKP 1092
P +CD +W+ LME CW+ P+ RPSFTEI + LR ++T S+ +G P
Sbjct: 1119 PDFCDMDWKLLMERCWSAEPSERPSFTEIVNELRTMATKLPSKEQGSTQGP 1169
|
|
| TAIR|locus:2174552 AT5G57610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1061 (378.5 bits), Expect = 1.9e-140, Sum P(2) = 1.9e-140
Identities = 190/278 (68%), Positives = 228/278 (82%)
Query: 804 VQVIKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKE 863
+Q I+N+DLEE +ELG GT+G+VYHGKW+G+DVAIKRIK SCF G+ SE+ERL +FWKE
Sbjct: 773 LQSIRNDDLEEIRELGHGTYGSVYHGKWKGSDVAIKRIKASCFAGKPSERERLIEDFWKE 832
Query: 864 AEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHXXXXXXXXXXXXXXXIIAM 923
A +LS LHHPNVV+FYG+V+DGP G+LATVAE+MV+GSL+ IIAM
Sbjct: 833 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVAEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 892
Query: 924 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTL 983
D AFGMEYLH KNIVHFDLKC+NLLVN++DP RPICK+GD GLSK+K+ TLVSGGVRGTL
Sbjct: 893 DTAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPICKIGDLGLSKVKQKTLVSGGVRGTL 952
Query: 984 PWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIP 1043
PWMAPELLSG S+ VSEK+DV+SFGIV+WE+LTGEEPYA+MH +IIGGIVNN LRP IP
Sbjct: 953 PWMAPELLSGKSNMVSEKIDVYSFGIVMWELLTGEEPYADMHCASIIGGIVNNALRPKIP 1012
Query: 1044 SYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081
+CD EW+ LME CW P RPSFTEI+ +LR ++ A
Sbjct: 1013 QWCDPEWKGLMESCWTSEPTERPSFTEISQKLRTMAAA 1050
|
|
| TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 465 (168.7 bits), Expect = 1.7e-41, Sum P(2) = 1.7e-41
Identities = 111/289 (38%), Positives = 156/289 (53%)
Query: 792 LNPSLVDFDVSSVQVIKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSS 851
+N +D D +++ EDL +++G G+ GTVYHG W G+DVA+K K ++
Sbjct: 468 MNKVDMDSDCLDYEILW-EDLTIGEQIGQGSCGTVYHGLWFGSDVAVKVFSKQEYS---- 522
Query: 852 EQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHXXXXXXX 911
E + F +E ++ +L HPNV+ F G V P L V E++ GSL
Sbjct: 523 --EEIITSFKQEVSLMKRLRHPNVLLFMGAVAS-PQ-RLCIVTEFLPRGSLFRLLQRNKS 578
Query: 912 XXXXXXXXIIAMDAAFGMEYLH--SKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI 969
+A D A GM YLH S I+H DLK NLLV D + + KV DFGLS+I
Sbjct: 579 KLDLRRRIHMASDIARGMNYLHHCSPPIIHRDLKSSNLLV---DRNWTV-KVADFGLSRI 634
Query: 970 KRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAI 1029
K T ++ RGT WMAPE+L ++ EK DV+SFG+VLWE++T + P+ N++ +
Sbjct: 635 KHETYLTTNGRGTPQWMAPEVLRNEAA--DEKSDVYSFGVVLWELVTEKIPWENLNAMQV 692
Query: 1030 IGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078
IG + R +P D +W LME CW P RPSF E+ +LR L
Sbjct: 693 IGAVGFMNQRLEVPKDVDPQWIALMESCWHSEPQCRPSFQELMDKLREL 741
|
|
| DICTYBASE|DDB_G0283267 shkA "SHK subfamily protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 432 (157.1 bits), Expect = 1.1e-40, Sum P(2) = 1.1e-40
Identities = 108/283 (38%), Positives = 151/283 (53%)
Query: 800 DVSSVQVIKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVE 859
D+ I ++ + LG G+FGTVY G+ R DVA+K + K +Q+ LT +
Sbjct: 33 DILGPPEISETEITTESILGDGSFGTVYKGRCRLKDVAVKVMLKQV------DQKTLT-D 85
Query: 860 FWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHXXXXXXXXXXXXXXX 919
F KE I+SK+ HPN+V F G PG + + ++ G+L
Sbjct: 86 FRKEVAIMSKIFHPNIVLFLGACTSTPGKLM--ICTELMKGNLESLLLDPMVKLPLITRM 143
Query: 920 IIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRN--TLV 975
+A DAA G+ +LHS N +H DLK NLLV D + + KV DFGLS+IK+ L
Sbjct: 144 RMAKDAALGVLWLHSSNPVFIHRDLKTSNLLV---DANLTV-KVCDFGLSQIKQRGENLK 199
Query: 976 SG--GVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANM-HYGAIIGG 1032
G G +GT WMAPE+L G +EK DV+SFG+VLW+I T +E + ++ +
Sbjct: 200 DGQDGAKGTPLWMAPEVLQGRL--FNEKADVYSFGLVLWQIFTRQELFPEFDNFFKFVAA 257
Query: 1033 IVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
I LRP+IP C + L+++CW PNP RPSF I S L
Sbjct: 258 ICEKQLRPSIPDDCPKSLKELIQKCWDPNPEVRPSFEGIVSEL 300
|
|
| TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 451 (163.8 bits), Expect = 2.9e-40, Sum P(2) = 2.9e-40
Identities = 114/310 (36%), Positives = 162/310 (52%)
Query: 776 DYEEG-NAGNRNIGLPSLN--PSLVDFD-VSSVQVIKNEDLEEQKELGSGTFGTVYHGKW 831
D G N+G I S+ S D D VS +++ E++ + +G G++G VY G W
Sbjct: 709 DSNHGPNSGGERISDKSIGNESSKSDCDDVSDCEILW-EEITVGERIGLGSYGEVYRGDW 767
Query: 832 RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLA 891
GT+VA+K+ TG + E EF E I+ KL HPN+V F G V P L+
Sbjct: 768 HGTEVAVKKFLDQDLTGEALE------EFRSEVRIMKKLRHPNIVLFMGAVTRPPN--LS 819
Query: 892 TVAEYMVDGSLRHXXXXXXXXXXXXXXXIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLV 949
V E++ GSL +A+DAA GM YLHS N IVH DLK NLLV
Sbjct: 820 IVTEFLPRGSLYRLIHRPNNQLDERRRLRMALDAARGMNYLHSCNPMIVHRDLKSPNLLV 879
Query: 950 NLKDPSRPICKVGDFGLSKIKRNTLVSG-GVRGTLPWMAPELLSGSSSKVSEKVDVFSFG 1008
+ + KV DFGLS++K +T +S GT WMAPE+L + EK DV+S+G
Sbjct: 880 D----KNWVVKVCDFGLSRMKHSTYLSSKSTAGTAEWMAPEVLRNEPA--DEKCDVYSYG 933
Query: 1009 IVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSF 1068
++LWE+ T ++P+ M+ ++G + R IP + D L+ +CW + RPSF
Sbjct: 934 VILWELFTLQQPWGKMNPMQVVGAVGFQHRRLDIPDFVDPAIADLISKCWQTDSKLRPSF 993
Query: 1069 TEIASRLRVL 1078
EI + L+ L
Sbjct: 994 AEIMASLKRL 1003
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1094 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-79 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-76 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-76 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-72 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-60 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-58 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-58 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-49 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-48 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-46 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-45 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-45 | |
| cd06410 | 97 | cd06410, PB1_UP2, Uncharacterized protein 2 | 2e-44 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-43 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-43 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-42 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-41 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-41 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-40 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-40 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-40 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-39 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-39 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-39 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-39 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-38 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-38 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-38 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-38 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-37 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-37 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-37 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-37 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-37 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-37 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-37 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-36 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-36 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-35 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-35 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-34 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-34 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-34 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-34 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-34 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-33 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-33 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-32 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-32 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-32 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-31 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-31 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-31 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-31 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-30 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-30 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-30 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-30 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-30 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-29 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-29 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-29 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-29 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-29 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-29 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-29 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 9e-29 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-29 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 9e-29 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-28 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-28 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-28 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-28 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-28 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-28 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-27 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-27 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-27 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-27 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-27 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-27 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-26 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-26 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-26 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-26 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-26 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-26 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-26 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 9e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-25 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-25 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-24 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-24 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-24 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-24 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-24 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-24 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-24 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-24 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-23 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-23 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-23 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-23 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-22 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-22 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-22 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-22 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-22 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-22 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 8e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-21 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-21 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-21 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-20 | |
| pfam00564 | 84 | pfam00564, PB1, PB1 domain | 3e-20 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-20 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-20 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-19 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-19 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-19 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-19 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-19 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-19 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 9e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-18 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-18 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-18 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-18 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-18 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-18 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-18 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-18 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-18 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-18 | |
| smart00666 | 81 | smart00666, PB1, PB1 domain | 1e-17 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-17 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-17 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-17 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-17 | |
| cd05992 | 81 | cd05992, PB1, The PB1 domain is a modular domain m | 3e-17 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-16 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-16 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-16 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-16 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-16 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-16 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 6e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-15 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-15 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-15 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-15 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-15 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-14 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-14 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-14 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-14 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-14 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 9e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-13 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-13 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-13 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-13 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-12 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 9e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-11 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-11 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-10 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 9e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 9e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 9e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-07 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 7e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-06 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-04 | |
| COG2112 | 201 | COG2112, COG2112, Predicted Ser/Thr protein kinase | 4e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.002 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 0.002 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.003 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 258 bits (662), Expect = 7e-79
Identities = 109/278 (39%), Positives = 139/278 (50%), Gaps = 34/278 (12%)
Query: 812 LEEQKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAE 865
LE K+LG G FG VY G +G T VA+K +K+ +SE+ER EF +EA
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEG-----ASEEERE--EFLEEAS 53
Query: 866 ILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDA 925
I+ KL HPN+V GV G L V EYM G L L + L + L +A+
Sbjct: 54 IMKKLSHPNIVRLLGVCTQG--EPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQI 111
Query: 926 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT---LVSGGVRGT 982
A GMEYL SKN VH DL N LV + K+ DFGLS+ GG +
Sbjct: 112 AKGMEYLESKNFVHRDLAARNCLVT----ENLVVKISDFGLSRDIYEDDYYRKRGGGKLP 167
Query: 983 LPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH----YGAIIGGIVNNT 1037
+ WMAPE L K + K DV+SFG++LWEI T GE+PY M + G
Sbjct: 168 IKWMAPESLKD--GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDG----- 220
Query: 1038 LRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
R P C E LM +CWA +P RP+F+E+ L
Sbjct: 221 YRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 252 bits (645), Expect = 1e-76
Identities = 104/274 (37%), Positives = 137/274 (50%), Gaps = 26/274 (9%)
Query: 812 LEEQKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAE 865
L K+LG G FG VY G +G +VA+K +K+ +SEQ+ EF +EA
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKED-----ASEQQIE--EFLREAR 53
Query: 866 ILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVL-VRKDRFLDRRRRLIIAMD 924
I+ KL HPN+V GV + + V EYM G L L + + L L A+
Sbjct: 54 IMRKLDHPNIVKLLGVCTEEEPLMI--VMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQ 111
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLP 984
A GMEYL SKN +H DL N LV + K+ DFGLS+ + G LP
Sbjct: 112 IARGMEYLESKNFIHRDLAARNCLVG----ENLVVKISDFGLSRDLYDDDYYKVKGGKLP 167
Query: 985 --WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPT 1041
WMAPE L K + K DV+SFG++LWEI T GEEPY M ++ + R
Sbjct: 168 IRWMAPESL--KEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKG-YRLP 224
Query: 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
P C E LM +CWA +P RP+F+E+ L
Sbjct: 225 KPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 251 bits (643), Expect = 3e-76
Identities = 108/274 (39%), Positives = 139/274 (50%), Gaps = 27/274 (9%)
Query: 812 LEEQKELGSGTFGTVYHGKWRGT------DVAIKRIKKSCFTGRSSEQERLTVEFWKEAE 865
L K+LG G FG VY GK +G +VA+K +K+ SEQ+ EF +EA
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA-----SEQQIE--EFLREAR 53
Query: 866 ILSKLHHPNVVAFYGVV-QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMD 924
I+ KL HPNVV GV ++ P L V EYM G L L + L L A+
Sbjct: 54 IMRKLDHPNVVKLLGVCTEEEP---LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQ 110
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLP 984
A GMEYL SKN +H DL N LV + K+ DFGLS+ + G LP
Sbjct: 111 IARGMEYLESKNFIHRDLAARNCLVG----ENLVVKISDFGLSRDLYDDDYYRKRGGKLP 166
Query: 985 --WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPT 1041
WMAPE L K + K DV+SFG++LWEI T GE+PY M ++ + N R
Sbjct: 167 IRWMAPESL--KEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNG-YRLP 223
Query: 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
P C E LM +CWA +P RP+F+E+ L
Sbjct: 224 QPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 239 bits (612), Expect = 7e-72
Identities = 107/282 (37%), Positives = 138/282 (48%), Gaps = 41/282 (14%)
Query: 816 KELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL 870
K+LG G FG VY GK +G T+VA+K +K+ +SE+ER +F KEA ++ KL
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKED-----ASEEER--KDFLKEARVMKKL 53
Query: 871 HHPNVVAFYGV-VQDGPGGTLATVAEYMVDGSLRHVLVRK--------DRFLDRRRRLII 921
HPNVV GV ++ P L V EYM G L L + L + L
Sbjct: 54 GHPNVVRLLGVCTEEEP---LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSF 110
Query: 922 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR- 980
A+ A GMEYL SK VH DL N LV + K+ DFGLS R+ R
Sbjct: 111 AIQIAKGMEYLASKKFVHRDLAARNCLVG----EDLVVKISDFGLS---RDVYDDDYYRK 163
Query: 981 ---GTLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIV 1034
G LP WMAPE L + K DV+SFG++LWEI T G PY + ++ +
Sbjct: 164 KTGGKLPIRWMAPESLK--DGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLE-YL 220
Query: 1035 NNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076
R P YC E LM CW +P RP+F+E+ RL
Sbjct: 221 RKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 206 bits (526), Expect = 3e-60
Identities = 80/260 (30%), Positives = 123/260 (47%), Gaps = 20/260 (7%)
Query: 816 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
++LG G+FG VY + + T VAIK IKK + ++ +E +IL KL HP
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKK-------KIKKDRERILREIKILKKLKHP 57
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLH 933
N+V Y V +D L V EY G L +L ++ R + R + +EYLH
Sbjct: 58 NIVRLYDVFEDE--DKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLR-QILSALEYLH 114
Query: 934 SKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSG 993
SK IVH DLK +N+L++ K+ DFGL++ GT +MAPE+L G
Sbjct: 115 SKGIVHRDLKPENILLD----EDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLG 170
Query: 994 SSSKVSEKVDVFSFGIVLWEILTGEEPYANM-HYGAIIGGIVNNTLRPTIPSY-CDAEWR 1051
+ VD++S G++L+E+LTG+ P+ + I P + E +
Sbjct: 171 --KGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAK 228
Query: 1052 TLMEECWAPNPAARPSFTEI 1071
L+ + +P R + E
Sbjct: 229 DLIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 2e-58
Identities = 86/270 (31%), Positives = 138/270 (51%), Gaps = 26/270 (9%)
Query: 812 LEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSK 869
E ++LGSG+FGTVY K +GT VA+K +KK S++++ +E IL +
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKR---SEKSKKDQ---TARREIRILRR 54
Query: 870 LHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGM 929
L HPN+V +D L V EY G L L R + + I G+
Sbjct: 55 LSHPNIVRLIDAFEDK--DHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILR-GL 111
Query: 930 EYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK-RNTLVSGGVRGTLPWMAP 988
EYLHS I+H DLK +N+L++ + K+ DFGL+K +++ GT +MAP
Sbjct: 112 EYLHSNGIIHRDLKPENILLD----ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAP 167
Query: 989 ELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDA 1048
E+L G + KVDV+S G++L+E+LTG+ P++ + + ++ L P +
Sbjct: 168 EVLLG-GNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQL-QLIRRILGPPLEFDEP- 224
Query: 1049 EWRT-------LMEECWAPNPAARPSFTEI 1071
+W + L+++C +P+ RP+ EI
Sbjct: 225 KWSSGSEEAKDLIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 199 bits (508), Expect = 3e-58
Identities = 87/257 (33%), Positives = 122/257 (47%), Gaps = 49/257 (19%)
Query: 818 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNV 875
LG G FGTVY + + T VAIK IKK + L E +E EIL KL+HPN+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKE-------DSSSLLEELLREIEILKKLNHPNI 53
Query: 876 VAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSK 935
V YGV +D L V EY GSL+ +L + L L I + G+EYLHS
Sbjct: 54 VKLYGVFEDENHLYL--VMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN 111
Query: 936 NIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-IKRNTLVSGGVRGTLPWMAPELLSGS 994
I+H DLK +N+L++ + K+ DFGLSK + + + + GT +MAPE+L G
Sbjct: 112 GIIHRDLKPENILLDSDN---GKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLG- 167
Query: 995 SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLM 1054
SEK D++S G++L+E+ E + L+
Sbjct: 168 KGYYSEKSDIWSLGVILYEL---------------------------------PELKDLI 194
Query: 1055 EECWAPNPAARPSFTEI 1071
+ +P RPS EI
Sbjct: 195 RKMLQKDPEKRPSAKEI 211
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 8e-49
Identities = 82/265 (30%), Positives = 130/265 (49%), Gaps = 27/265 (10%)
Query: 816 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
+ LG G+FG+VY + T +A+K ++ S + E +E ILS L HP
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALE------REIRILSSLQHP 59
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDR--RR--RLIIAMDAAFGM 929
N+V +YG +D TL EY+ GSL +L + + + R+ R I+ G+
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILE-----GL 114
Query: 930 EYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGG---VRGTLPWM 986
YLHS IVH D+K N+LV+ + K+ DFG +K + G VRGT WM
Sbjct: 115 AYLHSNGIVHRDIKGANILVDSDG----VVKLADFGCAKRLGDIETGEGTGSVRGTPYWM 170
Query: 987 APELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY-GAIIGGIVNNTLRPTIPSY 1045
APE++ G + D++S G + E+ TG+ P++ + A + I ++ P IP +
Sbjct: 171 APEVIRG--EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEH 228
Query: 1046 CDAEWRTLMEECWAPNPAARPSFTE 1070
E + + +C +P RP+ E
Sbjct: 229 LSEEAKDFLRKCLRRDPKKRPTADE 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 3e-48
Identities = 98/274 (35%), Positives = 136/274 (49%), Gaps = 26/274 (9%)
Query: 806 VIKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAE 865
I +++L+ +G G FG V G +RG VA+K +K ++ F EA
Sbjct: 2 AINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQA---------FLAEAS 52
Query: 866 ILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDR-FLDRRRRLIIAMD 924
+++ L HPN+V GVV G L V EYM GSL L + R + ++L A+D
Sbjct: 53 VMTTLRHPNLVQLLGVVLQGNP--LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALD 110
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLP 984
GMEYL KN VH DL N+LV+ + KV DFGL+K S G LP
Sbjct: 111 VCEGMEYLEEKNFVHRDLAARNVLVSEDL----VAKVSDFGLAKEASQGQDS----GKLP 162
Query: 985 --WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPT 1041
W APE L K S K DV+SFGI+LWEI + G PY + ++ + R
Sbjct: 163 VKWTAPEAL--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG-YRME 219
Query: 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
P C E +M++CW +PA RP+F ++ +L
Sbjct: 220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 1e-46
Identities = 95/270 (35%), Positives = 135/270 (50%), Gaps = 24/270 (8%)
Query: 811 DLEEQKELGSGTFGTVYHGKWRGT-DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSK 869
+L KELGSG FG V+ GKWRG DVAIK I++ G SE + F +EA+++ K
Sbjct: 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIRE----GAMSEDD-----FIEEAKVMMK 55
Query: 870 LHHPNVVAFYGVV-QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFG 928
L HPN+V YGV + P + V EYM +G L + L + L L + D
Sbjct: 56 LSHPNLVQLYGVCTKQRP---IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEA 112
Query: 929 MEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK--IKRNTLVSGGVRGTLPWM 986
MEYL S +H DL N LV + KV DFGL++ + S G + + W
Sbjct: 113 MEYLESNGFIHRDLAARNCLVG----EDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWA 168
Query: 987 APELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSY 1045
PE+ S+ S K DV+SFG+++WE+ + G+ PY ++ + R P
Sbjct: 169 PPEVF--DYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG-YRLYRPKL 225
Query: 1046 CDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
E T+M CW P RP+F ++ S+L
Sbjct: 226 APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 1e-45
Identities = 92/270 (34%), Positives = 137/270 (50%), Gaps = 25/270 (9%)
Query: 815 QKELGSGTFGTVYHGKWRGT-----DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSK 869
+K +G G FG V G+ + DVAIK +K S+++RL +F EA I+ +
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-----SDKQRL--DFLTEASIMGQ 61
Query: 870 LHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGM 929
HPN++ GVV + + EYM +GSL L D + + + A GM
Sbjct: 62 FDHPNIIRLEGVVTKSR--PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGM 119
Query: 930 EYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRN---TLVSGGVRGTLPWM 986
+YL N VH DL N+LVN S +CKV DFGLS+ + T + G + + W
Sbjct: 120 KYLSEMNYVHRDLAARNILVN----SNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT 175
Query: 987 APELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSY 1045
APE + + K + DV+SFGIV+WE+++ GE PY +M +I + + R P
Sbjct: 176 APEAI--AYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV-EDGYRLPPPMD 232
Query: 1046 CDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
C + LM +CW + RP+F++I S L
Sbjct: 233 CPSALYQLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 4e-45
Identities = 100/294 (34%), Positives = 136/294 (46%), Gaps = 46/294 (15%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTVE 859
+ E + +ELG G+FG VY G +G T VAIK + +S +ER+ E
Sbjct: 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTV-----NENASMRERI--E 55
Query: 860 FWKEAEILSKLHHPNVVAFYGVVQDG-PGGTLATVAEYMVDGSLRHVLVRKDR------- 911
F EA ++ + + +VV GVV G P TL V E M G L+ L R R
Sbjct: 56 FLNEASVMKEFNCHHVVRLLGVVSTGQP--TL-VVMELMAKGDLKSYL-RSRRPEAENNP 111
Query: 912 ---FLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968
++ + +A + A GM YL +K VH DL N +V K+GDFG+++
Sbjct: 112 GLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA----EDLTVKIGDFGMTR 167
Query: 969 -IKRNTLVSGGVRGTLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPY--- 1021
I G +G LP WMAPE L + K DV+SFG+VLWE+ T E+PY
Sbjct: 168 DIYETDYYRKGGKGLLPVRWMAPESLK--DGVFTTKSDVWSFGVVLWEMATLAEQPYQGL 225
Query: 1022 ANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
+N + L P C + LM CW NP RP+F EI S L
Sbjct: 226 SNEEVLKFVID--GGHLDL--PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|99731 cd06410, PB1_UP2, Uncharacterized protein 2 | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 2e-44
Identities = 58/99 (58%), Positives = 74/99 (74%), Gaps = 4/99 (4%)
Query: 89 LCSFGGKILPRPSDGKLRYVGGETRIIRIRKDISWQILRQKALEVYNQVH--VIKYQLPG 146
LCS+GG+ILPRP DG+LRYVGGETRI+ + + IS++ L K E++ +KYQLP
Sbjct: 1 LCSYGGRILPRPPDGQLRYVGGETRIVSVDRSISFKELVSKLSELFGAGVVVTLKYQLPD 60
Query: 147 EDLDALVSVSCDEDLQNMMEEYNELGDREGSQRIRMFLF 185
EDLDAL+SVS DEDL+NMMEEY+ L S R+R+FLF
Sbjct: 61 EDLDALISVSNDEDLKNMMEEYDRLSGG--SARLRVFLF 97
|
The PB1 domain is a modular domain mediating specific protein-protein interaction which play a role in many critical cell processes such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. Length = 97 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (400), Expect = 2e-43
Identities = 100/267 (37%), Positives = 143/267 (53%), Gaps = 25/267 (9%)
Query: 816 KELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPN 874
+++G G FG VY G + T+VA+K +C RS+ L +F +EAEIL + HPN
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVK----TC---RSTLPPDLKRKFLQEAEILKQYDHPN 53
Query: 875 VVAFYGV-VQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLH 933
+V GV VQ P + V E + GSL L +K L ++ L +++DAA GMEYL
Sbjct: 54 IVKLIGVCVQKQP---IYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE 110
Query: 934 SKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTL--VSGGVRGTLP--WMAPE 989
SKN +H DL N LV + + K+ DFG+S+ + + VS G +P W APE
Sbjct: 111 SKNCIHRDLAARNCLVGENN----VLKISDFGMSREEEGGIYTVSDG-LKQIPIKWTAPE 165
Query: 990 LLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDA 1048
L + + + + DV+S+GI+LWE + G+ PY M I + P P C
Sbjct: 166 AL--NYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPA-PQLCPE 222
Query: 1049 EWRTLMEECWAPNPAARPSFTEIASRL 1075
E LM +CWA +P RPSF+EI + L
Sbjct: 223 EIYRLMLQCWAYDPENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 9e-43
Identities = 93/276 (33%), Positives = 137/276 (49%), Gaps = 27/276 (9%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAE 865
I E L+ +++LG+G FG V+ G W G T VA+K +K + F +EA+
Sbjct: 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---------PEAFLQEAQ 53
Query: 866 ILSKLHHPNVVAFYGVVQDG-PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMD 924
I+ KL H +V Y V + P + V EYM GSL L + R ++ M
Sbjct: 54 IMKKLRHDKLVQLYAVCSEEEP---IYIVTEYMSKGSLLDFL-KSGEGKKLRLPQLVDMA 109
Query: 925 A--AFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-IKRNTLVS-GGVR 980
A A GM YL S+N +H DL N+LV +CK+ DFGL++ I+ + + G +
Sbjct: 110 AQIAEGMAYLESRNYIHRDLAARNILVG----ENLVCKIADFGLARLIEDDEYTAREGAK 165
Query: 981 GTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLR 1039
+ W APE + + + + K DV+SFGI+L EI+T G PY M ++ + R
Sbjct: 166 FPIKWTAPE--AANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG-YR 222
Query: 1040 PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
P C E LM +CW +P RP+F + S L
Sbjct: 223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFL 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 7e-42
Identities = 90/270 (33%), Positives = 131/270 (48%), Gaps = 21/270 (7%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGT-DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILS 868
E+ +++LGSG FG V+ G W+ VAIK +K S+ +F KE + L
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILK--------SDDLLKQQDFQKEVQALK 57
Query: 869 KLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAF 927
+L H ++++ + V G + + E M GSL L + + L + +A A
Sbjct: 58 RLRHKHLISLFAVCSVGE--PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAE 115
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-IKRNTLVSGGVRGTLPWM 986
GM YL +N +H DL N+LV +CKV DFGL++ IK + +S + W
Sbjct: 116 GMAYLEEQNSIHRDLAARNILVG----EDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT 171
Query: 987 APELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSY 1045
APE S S K DV+SFGI+L+E+ T G+ PY M+ + I P P+
Sbjct: 172 APEAAS--HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPC-PAK 228
Query: 1046 CDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
C E +M ECWA P RPSF + L
Sbjct: 229 CPQEIYKIMLECWAAEPEDRPSFKALREEL 258
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 3e-41
Identities = 84/284 (29%), Positives = 135/284 (47%), Gaps = 29/284 (10%)
Query: 806 VIKNEDLEEQKELGSGTFGTVYHGKWR------GTDVAIKRIKKSCFTGRSSEQERLTVE 859
++K +LE+ K LGSG FGTVY G W VAIK +++ T + +E L
Sbjct: 3 ILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE--TSPKANKEIL--- 57
Query: 860 FWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSL-RHVLVRKDRFLDRRRR 918
EA +++ + HP+VV G+ + + + M G L +V KD + +
Sbjct: 58 --DEAYVMASVDHPHVVRLLGIC---LSSQVQLITQLMPLGCLLDYVRNHKDN-IGSQYL 111
Query: 919 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI---KRNTLV 975
L + A GM YL K +VH DL N+LV K P K+ DFGL+K+
Sbjct: 112 LNWCVQIAKGMSYLEEKRLVHRDLAARNVLV--KTPQH--VKITDFGLAKLLDVDEKEYH 167
Query: 976 SGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIV 1034
+ G + + WMA E S + K DV+S+G+ +WE++T G +PY + I ++
Sbjct: 168 AEGGKVPIKWMALE--SILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP-AVEIPDLL 224
Query: 1035 NNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078
R P C + ++ +CW + +RP+F E+ + +
Sbjct: 225 EKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 5e-41
Identities = 95/272 (34%), Positives = 134/272 (49%), Gaps = 24/272 (8%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGT-DVAIKRIKKSCFTGRSSEQERLTVEFWKEAE 865
I +DL KELG+G FG V +GKWRG DVAIK IK+ G SE E F +EA+
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE----GSMSEDE-----FIEEAK 51
Query: 866 ILSKLHHPNVVAFYGV-VQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMD 924
++ KL H +V YGV + P + V EYM +G L + L + + L + D
Sbjct: 52 VMMKLSHEKLVQLYGVCTKQRP---IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKD 108
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLP 984
GM YL SK +H DL N LV+ + KV DFGLS+ + + V P
Sbjct: 109 VCEGMAYLESKQFIHRDLAARNCLVD----DQGCVKVSDFGLSRYVLDDEYTSSVGSKFP 164
Query: 985 --WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPT 1041
W PE+L SK S K DV++FG+++WE+ + G+ PY + + + LR
Sbjct: 165 VRWSPPEVL--LYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG-LRLY 221
Query: 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIAS 1073
P + +M CW RP+F ++ S
Sbjct: 222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLS 253
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 89/275 (32%), Positives = 132/275 (48%), Gaps = 25/275 (9%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAE 865
I ++ ++LG+G FG V+ G W T VA+K +K G ++ F EA+
Sbjct: 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLK----PGTMDPKD-----FLAEAQ 53
Query: 866 ILSKLHHPNVVAFYGV-VQDGPGGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAM 923
I+ KL HP ++ Y V + P + V E M GSL L R L + + +A
Sbjct: 54 IMKKLRHPKLIQLYAVCTLEEP---IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAA 110
Query: 924 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTL 983
A GM YL ++N +H DL N+LV ICKV DFGL+++ + +
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLVG----ENNICKVADFGLARVIKEDIYEAREGAKF 166
Query: 984 P--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 1040
P W APE + ++ S K DV+SFGI+L EI+T G PY M ++ + P
Sbjct: 167 PIKWTAPE--AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMP 224
Query: 1041 TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
P C E +M +CW +P RP+F + +L
Sbjct: 225 C-PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKL 258
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 91/273 (33%), Positives = 128/273 (46%), Gaps = 32/273 (11%)
Query: 816 KELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL 870
KELG G FG+V G + +VA+K +K+ EF +EA ++++L
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQE-------HIAAGKKEFLREASVMAQL 53
Query: 871 HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGME 930
HP +V GV + G L V E G L ++K R + +A A GM
Sbjct: 54 DHPCIVRLIGVCK-GEPLML--VMELAPLGPL-LKYLKKRREIPVSDLKELAHQVAMGMA 109
Query: 931 YLHSKNIVHFDLKCDN-LLVNLKDPSRPICKVGDFGLSKIKRN-----TLVSGGVRGTLP 984
YL SK+ VH DL N LLVN R K+ DFG+S+ + G R L
Sbjct: 110 YLESKHFVHRDLAARNVLLVN-----RHQAKISDFGMSRALGAGSDYYRATTAG-RWPLK 163
Query: 985 WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIP 1043
W APE + K S K DV+S+G+ LWE + G +PY M GA + ++ + R P
Sbjct: 164 WYAPE--CINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK-GAEVIAMLESGERLPRP 220
Query: 1044 SYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076
C E ++M CW P RP+F+E+ S R
Sbjct: 221 EECPQEIYSIMLSCWKYRPEDRPTFSELESTFR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 4e-40
Identities = 94/297 (31%), Positives = 140/297 (47%), Gaps = 46/297 (15%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTVE 859
++ + + ++ELG G FG V+ G+ VA+K +K++ S++ + +
Sbjct: 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA----SNDARK---D 54
Query: 860 FWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD---RFLDRR 916
F +EAE+L+ H N+V FYGV +G V EYM G L L FL
Sbjct: 55 FEREAELLTNFQHENIVKFYGVCTEG--DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSP 112
Query: 917 RR----------LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV--NLKDPSRPICKVGDF 964
L IA+ A GM YL S++ VH DL N LV +L + K+GDF
Sbjct: 113 DSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL------VVKIGDF 166
Query: 965 GLSK-IKRNTLVSGGVRGTLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEP 1020
G+S+ + G LP WM PE S K + + DV+SFG+VLWEI T G++P
Sbjct: 167 GMSRDVYTTDYYRVGGHTMLPIRWMPPE--SIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
Query: 1021 YANMHYGAIIGGIVNNT-LRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076
+ + +I I L+ P C +E +M CW +P R + +I RL+
Sbjct: 225 WYGLSNEEVIECITQGRLLQR--PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 84/270 (31%), Positives = 129/270 (47%), Gaps = 33/270 (12%)
Query: 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILS 868
E +++G G FG VY + + G +VAIK IK ++E++ E +IL
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLE----SKEKKEKII----NEIQILK 52
Query: 869 KLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFG 928
K HPN+V +YG L V E+ GSL+ +L ++ L + + + G
Sbjct: 53 KCKHPNIVKYYGSYLKK--DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKG 110
Query: 929 MEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK-----RNTLVSGGVRGTL 983
+EYLHS I+H D+K N+L+ S K+ DFGLS RNT+V GT
Sbjct: 111 LEYLHSNGIIHRDIKAANILLT----SDGEVKLIDFGLSAQLSDTKARNTMV-----GTP 161
Query: 984 PWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN---TLRP 1040
WMAPE+++G K D++S GI E+ G+ PY+ + + I N LR
Sbjct: 162 YWMAPEVING--KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLR- 218
Query: 1041 TIPSYCDAEWRTLMEECWAPNPAARPSFTE 1070
P E++ +++C NP RP+ +
Sbjct: 219 -NPEKWSDEFKDFLKKCLQKNPEKRPTAEQ 247
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 1e-39
Identities = 89/284 (31%), Positives = 128/284 (45%), Gaps = 37/284 (13%)
Query: 816 KELGSGTFGTVYHGKW------RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSK 869
K+LG G FG V ++ G VA+K + S S+ ER E EIL
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFER-------EIEILRT 62
Query: 870 LHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGM 929
L H N+V + GV + G +L + EY+ GSLR L R ++ +R L+ + GM
Sbjct: 63 LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGM 122
Query: 930 EYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI--KRNTLVSGGVRGTLP--W 985
+YL S+ +H DL N+LV S + K+ DFGL+K+ + G P W
Sbjct: 123 DYLGSQRYIHRDLAARNILVE----SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFW 178
Query: 986 MAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN--------- 1035
APE L +SK S DV+SFG+ L+E+ T G+ + + GI
Sbjct: 179 YAPECL--RTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236
Query: 1036 NTLRPTI----PSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
L+ P C E LM+ CW P RPSF ++ +
Sbjct: 237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 91/272 (33%), Positives = 126/272 (46%), Gaps = 29/272 (10%)
Query: 816 KELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL 870
K+LG G+FG V G+W + VA+K +K + + F KEA I+ L
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDD-------FLKEAAIMHSL 53
Query: 871 HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDR--FLDRRRRLIIAMDAAFG 928
H N++ YGVV P L V E GSL L RKD A+ A G
Sbjct: 54 DHENLIRLYGVVLTHP---LMMVTELAPLGSLLDRL-RKDALGHFLISTLCDYAVQIANG 109
Query: 929 MEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK----IKRNTLVSGGVRGTLP 984
M YL SK +H DL N+L+ S K+GDFGL + + + ++ ++
Sbjct: 110 MRYLESKRFIHRDLAARNILL----ASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFA 165
Query: 985 WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIP 1043
W APE L + S DV+ FG+ LWE+ T GEEP+A + I+ I R P
Sbjct: 166 WCAPESLR--TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERP 223
Query: 1044 SYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
C + +M +CWA NPA RP+F + L
Sbjct: 224 EACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 7e-39
Identities = 89/271 (32%), Positives = 130/271 (47%), Gaps = 24/271 (8%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEA 864
++ D+ + +LG G +G VY G W+ VA+K +K E EF KEA
Sbjct: 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---------EDTMEVEEFLKEA 53
Query: 865 EILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDR-FLDRRRRLIIAM 923
++ ++ HPN+V GV P + E+M G+L L +R ++ L +A
Sbjct: 54 AVMKEIKHPNLVQLLGVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 111
Query: 924 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSG--GVRG 981
+ MEYL KN +H DL N LV + KV DFGLS++ + G +
Sbjct: 112 QISSAMEYLEKKNFIHRDLAARNCLVG----ENHLVKVADFGLSRLMTGDTYTAHAGAKF 167
Query: 982 TLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 1040
+ W APE L+ +K S K DV++FG++LWEI T G PY + + ++ R
Sbjct: 168 PIKWTAPESLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKGYRM 224
Query: 1041 TIPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
P C + LM CW NP+ RPSF EI
Sbjct: 225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 105/297 (35%), Positives = 140/297 (47%), Gaps = 46/297 (15%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTVEFWK 862
+ +ELG G FG VY G+ G T VAIK +K++ + ++ EF +
Sbjct: 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN-------AEPKVQQEFRQ 57
Query: 863 EAEILSKLHHPNVVAFYGVV-QDGPGGTLATVAEYMVDGSLRHVLVRKD----------- 910
EAE++S L HPN+V GV ++ P + EY+ G L LVR
Sbjct: 58 EAELMSDLQHPNIVCLLGVCTKEQP---TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGD 114
Query: 911 ----RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966
LD L IA+ A GMEYL S + VH DL N LV + K+ DFGL
Sbjct: 115 ETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG---EGLTV-KISDFGL 170
Query: 967 SK-IKRNTLVSGGVRGTLP--WMAPE-LLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPY 1021
S+ I + LP WM PE +L G K + + D++SFG+VLWEI + G +PY
Sbjct: 171 SRDIYSADYYRVQSKSLLPVRWMPPEAILYG---KFTTESDIWSFGVVLWEIFSYGLQPY 227
Query: 1022 ANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078
+I I + L P P C A LM ECW PA RP F +I +RLR
Sbjct: 228 YGFSNQEVIEMIRSRQLLPC-PEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 2e-38
Identities = 95/272 (34%), Positives = 137/272 (50%), Gaps = 28/272 (10%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGT-DVAIKRIKKSCFTGRSSEQERLTVEFWKEAE 865
I +L KELGSG FG V+ GKWR VAIK I + G SE++ F +EA+
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINE----GAMSEED-----FIEEAK 51
Query: 866 ILSKLHHPNVVAFYGV-VQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMD 924
++ KL HP +V YGV Q P L V E+M +G L + L ++ L + L + D
Sbjct: 52 VMMKLSHPKLVQLYGVCTQQKP---LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQD 108
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK--IKRNTLVSGGVRGT 982
GMEYL + +H DL N LV+ S + KV DFG+++ + S G +
Sbjct: 109 VCEGMEYLERNSFIHRDLAARNCLVS----STGVVKVSDFGMTRYVLDDEYTSSSGAKFP 164
Query: 983 LPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIV--NNTLR 1039
+ W PE+ + SK S K DV+SFG+++WE+ T G+ P+ ++ I R
Sbjct: 165 VKWSPPEVF--NFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR 222
Query: 1040 PTIPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
P + S E +M CW P RP+F E+
Sbjct: 223 PKLASMTVYE---VMYSCWHEKPEGRPTFAEL 251
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 4e-38
Identities = 95/274 (34%), Positives = 137/274 (50%), Gaps = 26/274 (9%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEI 866
+ ++L+ + +G G FG V G +RG VA+K IK T ++ F EA +
Sbjct: 3 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-TAQA---------FLAEASV 52
Query: 867 LSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDR-FLDRRRRLIIAMDA 925
+++L H N+V GV+ + GG L V EYM GSL L + R L L ++D
Sbjct: 53 MTQLRHSNLVQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 111
Query: 926 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLP- 984
MEYL + N VH DL N+LV+ + + KV DFGL+K +T + G LP
Sbjct: 112 CEAMEYLEANNFVHRDLAARNVLVSEDN----VAKVSDFGLTKEASSTQDT----GKLPV 163
Query: 985 -WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTI 1042
W APE L K S K DV+SFGI+LWEI + G PY + ++ V +
Sbjct: 164 KWTAPEAL--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMDA 220
Query: 1043 PSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076
P C +M++CW + A RPSF ++ +L
Sbjct: 221 PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 7e-38
Identities = 98/288 (34%), Positives = 141/288 (48%), Gaps = 39/288 (13%)
Query: 816 KELGSGTFGTV----YH--GKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSK 869
++LG G FG+V Y G VA+K+++ S ++E R +F +E EIL
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-----TAEHLR---DFEREIEILKS 61
Query: 870 LHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGM 929
L H N+V + GV L V EY+ GSLR L + LD R+ L+ A GM
Sbjct: 62 LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGM 121
Query: 930 EYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI----KRNTLVSGGVRGTLPW 985
EYL SK VH DL N+LV S K+GDFGL+K+ K V + W
Sbjct: 122 EYLGSKRYVHRDLATRNILVE----SENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFW 177
Query: 986 MAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN--MHYGAIIGG----------- 1032
APE L + SK S DV+SFG+VL+E+ T + + + ++G
Sbjct: 178 YAPESL--TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235
Query: 1033 --IVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078
++ N R P C AE +M+ECW +P+ RPSF+E+A ++ +
Sbjct: 236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 1e-37
Identities = 80/266 (30%), Positives = 130/266 (48%), Gaps = 23/266 (8%)
Query: 813 EEQKELGSGTFGTVYHGKWRGTD---VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSK 869
E K++G G+FG VY + R +D +K I S SE+ER E +IL K
Sbjct: 3 EIIKQIGKGSFGKVYLVR-RKSDGKLYVLKEIDLS----NMSEKEREDAL--NEVKILKK 55
Query: 870 LHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVL---VRKDRFLDRRRRLIIAMDAA 926
L+HPN++ +Y ++ G L V EY G L + ++ + + L +
Sbjct: 56 LNHPNIIKYYESFEE--KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLC 113
Query: 927 FGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGG-VRGTLPW 985
++YLHS+ I+H D+K N+ + S + K+GDFG+SK+ +T+ V GT +
Sbjct: 114 LALKYLHSRKILHRDIKPQNIFLT----SNGLVKLGDFGISKVLSSTVDLAKTVVGTPYY 169
Query: 986 MAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSY 1045
++PEL + K D++S G VL+E+ T + P+ + + I+ P IPS
Sbjct: 170 LSPELCQN--KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP-IPSQ 226
Query: 1046 CDAEWRTLMEECWAPNPAARPSFTEI 1071
+E R L+ +P RPS +I
Sbjct: 227 YSSELRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 2e-37
Identities = 81/266 (30%), Positives = 127/266 (47%), Gaps = 33/266 (12%)
Query: 818 LGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNV 875
+G G G VY R T +VAIK+++ + + L + E I+ HPN+
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRK------QNKELII---NEILIMKDCKHPNI 77
Query: 876 VAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSK 935
V +Y G L V EYM GSL ++ + ++ + + + G+EYLHS+
Sbjct: 78 VDYYDSYLVG--DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ 135
Query: 936 NIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS------KIKRNTLVSGGVRGTLPWMAPE 989
N++H D+K DN+L++ KD S K+ DFG + K KRN++V GT WMAPE
Sbjct: 136 NVIHRDIKSDNILLS-KDGS---VKLADFGFAAQLTKEKSKRNSVV-----GTPYWMAPE 186
Query: 990 LLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTI--PSYCD 1047
++ KVD++S GI+ E+ GE PY + I + P + P
Sbjct: 187 VIKR--KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI-PPLKNPEKWS 243
Query: 1048 AEWRTLMEECWAPNPAARPSFTEIAS 1073
E++ + +C +P RPS E+
Sbjct: 244 PEFKDFLNKCLVKDPEKRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 77/260 (29%), Positives = 124/260 (47%), Gaps = 31/260 (11%)
Query: 817 ELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPN 874
+G G FG VY G G VAIK+I E + +E ++L L HPN
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISL---EKIKEEALK---SIMQEIDLLKNLKHPN 60
Query: 875 VVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF------G 928
+V + G ++ +L + EY +GSLR ++ + F L+ A + G
Sbjct: 61 IVKYIGSIETS--DSLYIILEYAENGSLRQIIKKFGPF---PESLV----AVYVYQVLQG 111
Query: 929 MEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS-KIKRNTLVSGGVRGTLPWMA 987
+ YLH + ++H D+K N+L KD K+ DFG++ K+ + V GT WMA
Sbjct: 112 LAYLHEQGVIHRDIKAANILTT-KDGV---VKLADFGVATKLNDVSKDDASVVGTPYWMA 167
Query: 988 PELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCD 1047
PE++ S S D++S G + E+LTG PY +++ A + IV + P +P
Sbjct: 168 PEVIEMSG--ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD-HPPLPEGIS 224
Query: 1048 AEWRTLMEECWAPNPAARPS 1067
E + + +C+ +P RP+
Sbjct: 225 PELKDFLMQCFQKDPNLRPT 244
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 2e-37
Identities = 97/278 (34%), Positives = 138/278 (49%), Gaps = 33/278 (11%)
Query: 818 LGSGTFGTVYHGKWRGTD--------VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSK 869
LGSG FG VY G VA+K ++K +++QE+ EF KEA ++S
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG-----ATDQEK--KEFLKEAHLMSN 55
Query: 870 LHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVL--VRKDRF----LDRRRRLIIAM 923
+HPN+V GV + + E M G L L R +RF L + L I +
Sbjct: 56 FNHPNIVKLLGVCLLNEPQYI--IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICL 113
Query: 924 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRP-ICKVGDFGLSK-IKRNTLVSGGVRG 981
D A G YL + +H DL N LV+ K + K+GDFGL++ I ++ G
Sbjct: 114 DVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG 173
Query: 982 TLP--WMAPE-LLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNT 1037
LP WMAPE LL G K + + DV+SFG+++WEILT G++PY ++ ++ V
Sbjct: 174 LLPVRWMAPESLLDG---KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL-QHVTAG 229
Query: 1038 LRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
R P C + LM CWA +P+ RP+F I L
Sbjct: 230 GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 4e-37
Identities = 89/278 (32%), Positives = 135/278 (48%), Gaps = 27/278 (9%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTVEFW 861
I+ ED+ + +G G FG VY G + VA+K K + +F
Sbjct: 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-------SPSVREKFL 55
Query: 862 KEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLII 921
+EA I+ + HP++V GV+ + P + +A G LR L LD ++
Sbjct: 56 QEAYIMRQFDHPHIVKLIGVITENPVWIVMELAPL---GELRSYLQVNKYSLDLASLILY 112
Query: 922 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC-KVGDFGLSKIKRNTLVSGGVR 980
+ + + YL SK VH D+ N+LV S P C K+GDFGLS+ + +
Sbjct: 113 SYQLSTALAYLESKRFVHRDIAARNVLV-----SSPDCVKLGDFGLSRYLEDESYYKASK 167
Query: 981 GTLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNT 1037
G LP WMAPE S + + + DV+ FG+ +WEIL G +P+ + +IG I N
Sbjct: 168 GKLPIKWMAPE--SINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE 225
Query: 1038 LRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
R +P C +LM +CWA +P+ RP FTE+ ++L
Sbjct: 226 -RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQL 262
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 6e-37
Identities = 91/274 (33%), Positives = 134/274 (48%), Gaps = 24/274 (8%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAE 865
I +L +E+GSG FG V+ G W VAIK I++ G SE++ F +EA+
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIRE----GAMSEED-----FIEEAQ 51
Query: 866 ILSKLHHPNVVAFYGVV-QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMD 924
++ KL HP +V YGV + P + V E+M G L L + + L + +D
Sbjct: 52 VMMKLSHPKLVQLYGVCTERSP---ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLD 108
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI--KRNTLVSGGVRGT 982
GM YL S N++H DL N LV + KV DFG+++ S G +
Sbjct: 109 VCEGMAYLESSNVIHRDLAARNCLVG----ENQVVKVSDFGMTRFVLDDQYTSSTGTKFP 164
Query: 983 LPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPT 1041
+ W +PE+ S SK S K DV+SFG+++WE+ + G+ PY N ++ I N R
Sbjct: 165 VKWSSPEVF--SFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI-NAGFRLY 221
Query: 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
P LM+ CW P RPSF+ + +L
Sbjct: 222 KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 8e-37
Identities = 91/262 (34%), Positives = 133/262 (50%), Gaps = 28/262 (10%)
Query: 818 LGSGTFGTVYHGKWRGTDVAIKRIKKSC-FTGRSSEQERLTVEFWKEAEILSKLHHPNVV 876
+G G FG V G++ G VA+K IK C T ++ F +E +++KLHH N+V
Sbjct: 14 IGEGEFGAVLQGEYTGQKVAVKNIK--CDVTAQA---------FLEETAVMTKLHHKNLV 62
Query: 877 AFYGVV-QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLI-IAMDAAFGMEYLHS 934
GV+ +G L V E M G+L + L + R L +L+ ++D A GMEYL S
Sbjct: 63 RLLGVILHNG----LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES 118
Query: 935 KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGS 994
K +VH DL N+LV+ + KV DFGL+++ + + + + W APE L
Sbjct: 119 KKLVHRDLAARNILVS----EDGVAKVSDFGLARVGSMGVDNS--KLPVKWTAPEAL--K 170
Query: 995 SSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTL 1053
K S K DV+S+G++LWE+ + G PY M + V R P C A+ L
Sbjct: 171 HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-VKECVEKGYRMEPPEGCPADVYVL 229
Query: 1054 MEECWAPNPAARPSFTEIASRL 1075
M CW P RPSF ++ +L
Sbjct: 230 MTSCWETEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 4e-36
Identities = 94/289 (32%), Positives = 136/289 (47%), Gaps = 36/289 (12%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTVE 859
+ + + + LG G FG VY G +RG D VA+K + +SC SEQ+ +
Sbjct: 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-----SEQDES--D 55
Query: 860 FWKEAEILSKLHHPNVVAFYGV-VQDGPGGTLATVAEYMVDGSLRHVLVRKDR------F 912
F EA I+SK +H N+V GV + P + E M G L+ L R++R
Sbjct: 56 FLMEALIMSKFNHQNIVRLIGVSFERLP---RFILLELMAGGDLKSFL-RENRPRPERPS 111
Query: 913 LDRRRRLI-IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-IK 970
+ L+ A D A G +YL + +H D+ N L+ K P R + K+ DFG+++ I
Sbjct: 112 SLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGR-VAKIADFGMARDIY 170
Query: 971 RNTLVSGGVRGTLP--WMAPE-LLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHY 1026
R + G R LP WM PE L G + K DV+SFG++LWEI + G PY
Sbjct: 171 RASYYRKGGRAMLPIKWMPPEAFLDGI---FTSKTDVWSFGVLLWEIFSLGYMPYPGRTN 227
Query: 1027 GAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
++ V R P C +M +CW P RP+F I R+
Sbjct: 228 QEVME-FVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 6e-36
Identities = 87/290 (30%), Positives = 133/290 (45%), Gaps = 45/290 (15%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTVEFWK 862
+L+E LG G FG V+ K +G + V +K ++K+ + E L EF +
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-------KDENLQSEFRR 57
Query: 863 EAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLV--------RKDRFLD 914
E ++ KL H NVV G+ ++ + + EY G L+ L K L
Sbjct: 58 ELDMFRKLSHKNVVRLLGLCREAEPHYM--ILEYTDLGDLKQFLRATKSKDEKLKPPPLS 115
Query: 915 RRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK---- 970
++++ + A GM++L + VH DL N LV+ S+ KV LSK
Sbjct: 116 TKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVS----SQREVKVSLLSLSKDVYNSE 171
Query: 971 ----RNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH 1025
RN L+ L W+APE + S K DV+SFG+++WE+ T GE P+ +
Sbjct: 172 YYKLRNALIP------LRWLAPEAVQ--EDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS 223
Query: 1026 YGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
++ + L +P C + LM CWA NP RPSF+E+ S L
Sbjct: 224 DEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 94/288 (32%), Positives = 142/288 (49%), Gaps = 36/288 (12%)
Query: 800 DVSSVQVIKNEDLEEQKELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQE 854
DVS V++ ++ +G+G FG V G+ R VAIK +K +G + +Q
Sbjct: 2 DVSCVKI--------EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLK----SGYTEKQR 49
Query: 855 RLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLD 914
R +F EA I+ + HPN++ GVV + + E+M +G+L L + D
Sbjct: 50 R---DFLSEASIMGQFDHPNIIHLEGVVTKSR--PVMIITEFMENGALDSFLRQNDGQFT 104
Query: 915 RRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI----K 970
+ + + A GM+YL N VH DL N+LVN S +CKV DFGLS+
Sbjct: 105 VIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVN----SNLVCKVSDFGLSRFLEDDT 160
Query: 971 RNTLVSGGVRGTLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYG 1027
+ + + G +P W APE ++ K + DV+S+GIV+WE+++ GE PY +M
Sbjct: 161 SDPTYTSSLGGKIPIRWTAPEAIA--YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 218
Query: 1028 AIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
+I I + P P C LM +CW + ARP F +I S L
Sbjct: 219 DVINAIEQDYRLPP-PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 7e-35
Identities = 90/275 (32%), Positives = 134/275 (48%), Gaps = 26/275 (9%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAE 865
+ E L+ K+LG+G FG V+ G + G T VAIK +K+ + + F EA
Sbjct: 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA---------FLAEAN 53
Query: 866 ILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDA 925
++ +L HP +V Y VV P + + EYM +GSL L + + +I M A
Sbjct: 54 LMKQLQHPRLVRLYAVVTQEP---IYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAA 109
Query: 926 --AFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT--LVSGGVRG 981
A GM ++ KN +H DL+ N+LV+ CK+ DFGL+++ + G +
Sbjct: 110 QIAEGMAFIERKNYIHRDLRAANILVS----ETLCCKIADFGLARLIEDNEYTAREGAKF 165
Query: 982 TLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 1040
+ W APE ++ + + K DV+SFGI+L EI+T G PY M +I + P
Sbjct: 166 PIKWTAPEAINYGTFTI--KSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP 223
Query: 1041 TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
P C E LM CW P RP+F + S L
Sbjct: 224 R-PDNCPEELYELMRLCWKEKPEERPTFEYLRSVL 257
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 92/271 (33%), Positives = 132/271 (48%), Gaps = 26/271 (9%)
Query: 815 QKELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSK 869
+K +G+G FG V G+ R VAIK +K G + +Q R +F EA I+ +
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLK----AGYTEKQRR---DFLSEASIMGQ 61
Query: 870 LHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGM 929
HPN++ GVV + V EYM +GSL L + D + + + A GM
Sbjct: 62 FDHPNIIHLEGVVTKSK--PVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGM 119
Query: 930 EYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRN----TLVSGGVRGTLPW 985
+YL VH DL N+LVN S +CKV DFGLS++ + + G + + W
Sbjct: 120 KYLSDMGYVHRDLAARNILVN----SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 175
Query: 986 MAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPS 1044
APE ++ K + DV+S+GIV+WE+++ GE PY M +I I P P
Sbjct: 176 TAPEAIA--YRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPA-PM 232
Query: 1045 YCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
C A LM +CW + RP F +I S L
Sbjct: 233 DCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 92/274 (33%), Positives = 135/274 (49%), Gaps = 24/274 (8%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAE 865
I E L+ K+LG+G FG V+ G W G T VA+K +K + S F +EA+
Sbjct: 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES---------FLEEAQ 53
Query: 866 ILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMD 924
I+ KL H +V Y VV + P + V EYM GSL L + R L + +A
Sbjct: 54 IMKKLRHDKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQ 110
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSG--GVRGT 982
A GM Y+ N +H DL+ N+LV +CK+ DFGL+++ + + G +
Sbjct: 111 VAAGMAYIERMNYIHRDLRSANILVG----DGLVCKIADFGLARLIEDNEYTARQGAKFP 166
Query: 983 LPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPT 1041
+ W APE + + + K DV+SFGI+L E++T G PY M+ ++ V R
Sbjct: 167 IKWTAPE--AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQ-VERGYRMP 223
Query: 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
P C LM +CW +P RP+F + S L
Sbjct: 224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFL 257
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 94/277 (33%), Positives = 139/277 (50%), Gaps = 26/277 (9%)
Query: 812 LEEQKELGSGTFGTVYHG--KWRG---TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEI 866
+ +QK +G+G FG V+ G K G VAIK +K +E++R +F EA I
Sbjct: 7 ITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG-----YTEKQR--QDFLSEASI 59
Query: 867 LSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAA 926
+ + H N++ GVV + T EYM +G+L L D + + + A
Sbjct: 60 MGQFSHHNIIRLEGVVTKFKPAMIIT--EYMENGALDKYLRDHDGEFSSYQLVGMLRGIA 117
Query: 927 FGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRN----TLVSGGVRGT 982
GM+YL N VH DL N+LVN S CKV DFGLS++ + T + G +
Sbjct: 118 AGMKYLSDMNYVHRDLAARNILVN----SNLECKVSDFGLSRVLEDDPEGTYTTSGGKIP 173
Query: 983 LPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPT 1041
+ W APE ++ K + DV+SFGIV+WE+++ GE PY +M ++ I N+ R
Sbjct: 174 IRWTAPEAIA--YRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI-NDGFRLP 230
Query: 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078
P C + LM +CW + A RP F +I + L L
Sbjct: 231 APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 3e-34
Identities = 89/274 (32%), Positives = 130/274 (47%), Gaps = 36/274 (13%)
Query: 818 LGSGTFGTVYHGKWRGTD-----VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHH 872
+G G FG VYHG +D A+K + R ++ E + +F KE I+ H
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLN------RITDLEEVE-QFLKEGIIMKDFSH 55
Query: 873 PNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLI-IAMDAAFGMEY 931
PNV++ G+ G L V YM G LR+ +R + + LI + A GMEY
Sbjct: 56 PNVLSLLGICLPSEGSPL-VVLPYMKHGDLRN-FIRSETHNPTVKDLIGFGLQVAKGMEY 113
Query: 932 LHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS---------KIKRNTLVSGGVRGT 982
L SK VH DL N +++ KV DFGL+ + +T G +
Sbjct: 114 LASKKFVHRDLAARNCMLD----ESFTVKVADFGLARDIYDKEYYSVHNHT----GAKLP 165
Query: 983 LPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPT 1041
+ WMA E L + K + K DV+SFG++LWE++T G PY ++ I ++ R
Sbjct: 166 VKWMALESLQ--TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR-RLL 222
Query: 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
P YC +M CW P P RP+F+E+ SR+
Sbjct: 223 QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRI 256
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 3e-34
Identities = 93/280 (33%), Positives = 133/280 (47%), Gaps = 30/280 (10%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTVEFWK 862
+L K LG+G FG V G VA+K +K T SSE+E L E
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKP---TAHSSEREALMSEL-- 89
Query: 863 EAEILSKL-HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRK-DRFLDRRRRLI 920
+I+S L +H N+V G G G + + EY G L + L RK + FL L
Sbjct: 90 --KIMSHLGNHENIVNLLGACTIG--GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLS 145
Query: 921 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-IKR--NTLVSG 977
+ A GM +L SKN +H DL N+L+ I K+ DFGL++ I N +V G
Sbjct: 146 FSYQVAKGMAFLASKNCIHRDLAARNVLLT----HGKIVKICDFGLARDIMNDSNYVVKG 201
Query: 978 GVRGTLPWMAPE-LLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 1035
R + WMAPE + + + S DV+S+GI+LWEI + G PY M + ++
Sbjct: 202 NARLPVKWMAPESIFNCVYTFES---DVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK 258
Query: 1036 NTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
R P + AE +M+ CW +P RP+F +I +
Sbjct: 259 EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 6e-33
Identities = 90/267 (33%), Positives = 133/267 (49%), Gaps = 24/267 (8%)
Query: 816 KELGSGTFGTVYHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
+ +G G FG V+ G+ R T VA+K SC R + L +F +EA IL + HP
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVK----SC---RETLPPDLKAKFLQEARILKQYSHP 53
Query: 874 NVVAFYGV-VQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYL 932
N+V GV Q P + V E + G L + L + + + +AA GMEYL
Sbjct: 54 NIVRLIGVCTQKQP---IYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYL 110
Query: 933 HSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTL--VSGGVRGT-LPWMAPE 989
SK+ +H DL N LV K+ + K+ DFG+S+ + + + +GG++ + W APE
Sbjct: 111 ESKHCIHRDLAARNCLVTEKN----VLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPE 166
Query: 990 LLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDA 1048
L + + S + DV+SFGI+LWE + G PYAN+ + +R P C
Sbjct: 167 AL--NYGRYSSESDVWSFGILLWEAFSLGAVPYANLS-NQQTREAIEQGVRLPCPELCPD 223
Query: 1049 EWRTLMEECWAPNPAARPSFTEIASRL 1075
LME CW +P RPSF+ + L
Sbjct: 224 AVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 8e-33
Identities = 92/269 (34%), Positives = 130/269 (48%), Gaps = 28/269 (10%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGT-DVAIKRIKKSCFTGRSSEQERLTVEFWKEAE 865
I E L + +LG G FG V+ G W GT VAIK +K + + F +EA+
Sbjct: 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---------FLQEAQ 53
Query: 866 ILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLI-IAMD 924
++ KL H +V Y VV + P + V EYM GSL L + R +L+ +A
Sbjct: 54 VMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQ 110
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLV--NLKDPSRPICKVGDFGLSKIKRNTLVSG--GVR 980
A GM Y+ N VH DL+ N+LV NL +CKV DFGL+++ + + G +
Sbjct: 111 IASGMAYVERMNYVHRDLRAANILVGENL------VCKVADFGLARLIEDNEYTARQGAK 164
Query: 981 GTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLR 1039
+ W APE + + + K DV+SFGI+L E+ T G PY M ++ V R
Sbjct: 165 FPIKWTAPE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYR 221
Query: 1040 PTIPSYCDAEWRTLMEECWAPNPAARPSF 1068
P C LM +CW P RP+F
Sbjct: 222 MPCPPECPESLHDLMCQCWRKEPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 93/276 (33%), Positives = 134/276 (48%), Gaps = 28/276 (10%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGT-DVAIKRIKKSCFTGRSSEQERLTVEFWKEAE 865
I E L +LG G FG V+ G W GT VAIK +K + F +EA+
Sbjct: 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA---------FLQEAQ 53
Query: 866 ILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMD 924
I+ KL H +V Y VV + P + V E+M GSL L D ++L + + +A
Sbjct: 54 IMKKLRHDKLVPLYAVVSEEP---IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQ 110
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLV--NLKDPSRPICKVGDFGLSKIKRNTLVSG--GVR 980
A GM Y+ N +H DL+ N+LV NL +CK+ DFGL+++ + + G +
Sbjct: 111 IADGMAYIERMNYIHRDLRAANILVGDNL------VCKIADFGLARLIEDNEYTARQGAK 164
Query: 981 GTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLR 1039
+ W APE + + + K DV+SFGI+L E++T G PY M ++ V R
Sbjct: 165 FPIKWTAPE--AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQ-VERGYR 221
Query: 1040 PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
P C LM+ CW +P RP+F I S L
Sbjct: 222 MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFL 257
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 74/258 (28%), Positives = 124/258 (48%), Gaps = 17/258 (6%)
Query: 818 LGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVA 877
LGSG+FG+VY G D +K+ + + +E +LSKL HPN+V
Sbjct: 8 LGSGSFGSVYEG-LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 878 FYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRL----IIAMDAAFGMEYLH 933
+ G ++ L E + GSL +L + F + RL I+ G+EYLH
Sbjct: 67 YLGTEREE--DNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-----GLEYLH 119
Query: 934 SKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSG 993
+N VH D+K N+LV D + + K+ DFG++K + +G+ WMAPE+++
Sbjct: 120 DRNTVHRDIKGANILV---DTNGVV-KLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIA- 174
Query: 994 SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTL 1053
D++S G + E+ TG+ P++ + A + I + P IP + E +
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDF 234
Query: 1054 MEECWAPNPAARPSFTEI 1071
+ +C +P+ RP+ E+
Sbjct: 235 ILKCLQRDPSLRPTAAEL 252
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 6e-32
Identities = 87/263 (33%), Positives = 126/263 (47%), Gaps = 22/263 (8%)
Query: 818 LGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVV 876
LG G FG V+ G + T VA+K K+ + L ++F EA IL + HPN+V
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDL-------PQELKIKFLSEARILKQYDHPNIV 55
Query: 877 AFYGV-VQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSK 935
GV Q P + V E + G L +K L ++ + A+DAA GM YL SK
Sbjct: 56 KLIGVCTQRQP---IYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK 112
Query: 936 NIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLP--WMAPELLSG 993
N +H DL N LV + + K+ DFG+S+ + + + S +P W APE L
Sbjct: 113 NCIHRDLAARNCLVGENN----VLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEAL-- 166
Query: 994 SSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRT 1052
+ + S + DV+S+GI+LWE + G PY M V R + P C +
Sbjct: 167 NYGRYSSESDVWSYGILLWETFSLGVCPYPGM-TNQQAREQVEKGYRMSCPQKCPDDVYK 225
Query: 1053 LMEECWAPNPAARPSFTEIASRL 1075
+M+ CW P RP F+E+ L
Sbjct: 226 VMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 81/265 (30%), Positives = 128/265 (48%), Gaps = 18/265 (6%)
Query: 818 LGSGTFGTVYHG--KWRGTDVAIKRIK-KSCFTGRSSEQERLTVEFWK-EAEILSKLHHP 873
+G GT+G VY G +A+K+++ + GR +++ V+ + E E L L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLH 933
N+V + G + L+ EY+ GS+ L RF ++ R G+ YLH
Sbjct: 69 NIVQYLGF-ETTEE-YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFF-TEQVLEGLAYLH 125
Query: 934 SKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGG---VRGTLPWMAPEL 990
SK I+H DLK DNLLV+ ICK+ DFG+SK + + ++G++ WMAPE+
Sbjct: 126 SKGILHRDLKADNLLVDADG----ICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 991 LSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIP----SYC 1046
+ S S KVD++S G V+ E+ G P+++ A + + N P IP
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241
Query: 1047 DAEWRTLMEECWAPNPAARPSFTEI 1071
+ C+ NP RP+ E+
Sbjct: 242 SPVALDFLNACFTINPDNRPTAREL 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 1e-31
Identities = 88/271 (32%), Positives = 127/271 (46%), Gaps = 30/271 (11%)
Query: 817 ELGSGTFGTVYHG----KWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHH 872
ELGSG FG V G + + DVAIK +K + ++ + E +EAEI+ +L +
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLK-------NENEKSVRDEMMREAEIMHQLDN 54
Query: 873 PNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYL 932
P +V GV + L V E G L L K + + + + GM+YL
Sbjct: 55 PYIVRMIGVCE---AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYL 111
Query: 933 HSKNIVHFDLKCDN-LLVNLKDPSRPICKVGDFGLSKI-----KRNTLVSGGVRGTLPWM 986
KN VH DL N LLVN + K+ DFGLSK S G + L W
Sbjct: 112 EGKNFVHRDLAARNVLLVN-----QHYAKISDFGLSKALGADDSYYKARSAG-KWPLKWY 165
Query: 987 APELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSY 1045
APE ++ K S + DV+S+GI +WE + G++PY M ++ I R P+
Sbjct: 166 APECIN--FRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK-RLDCPAE 222
Query: 1046 CDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076
C E LM++CW RP+F ++ R+R
Sbjct: 223 CPPEMYALMKDCWIYKWEDRPNFAKVEERMR 253
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 84/275 (30%), Positives = 125/275 (45%), Gaps = 37/275 (13%)
Query: 810 EDLEEQKELGSGTFGTVY---HGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEI 866
DLE K LG G+ G VY H K G A+K+I G +++L +E +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRH-KPTGKIYALKKIH---VDGDEEFRKQLL----RELKT 52
Query: 867 LSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAA 926
L P VV YG G ++ V EYM GSL L++K + IA
Sbjct: 53 LRSCESPYVVKCYGAFYKE--GEISIVLEYMDGGSL-ADLLKKVGKIPEPVLAYIARQIL 109
Query: 927 FGMEYLHSK-NIVHFDLKCDNLLVNLK-DPSRPICKVGDFGLSKI------KRNTLVSGG 978
G++YLH+K +I+H D+K NLL+N K + K+ DFG+SK+ + NT V
Sbjct: 110 KGLDYLHTKRHIIHRDIKPSNLLINSKGEV-----KIADFGISKVLENTLDQCNTFV--- 161
Query: 979 VRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYA---NMHYGAIIGGIVN 1035
GT+ +M+PE + G S S D++S G+ L E G+ P+ + ++ I +
Sbjct: 162 --GTVTYMSPERIQGESY--SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD 217
Query: 1036 NTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTE 1070
E+R + C +P RPS E
Sbjct: 218 GPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 80/272 (29%), Positives = 121/272 (44%), Gaps = 36/272 (13%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
E + ++LG G++G+VY + G VAIK + E E KE IL
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV----------PVEEDLQEIIKEISIL 52
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
+ P +V +YG L V EY GS+ ++ ++ L I
Sbjct: 53 KQCDSPYIVKYYGSYFKN--TDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLK 110
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI------KRNTLVSGGVRG 981
G+EYLHS +H D+K N+L+N K+ DFG+S KRNT++ G
Sbjct: 111 GLEYLHSNKKIHRDIKAGNILLN----EEGQAKLADFGVSGQLTDTMAKRNTVI-----G 161
Query: 982 TLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN---TL 1038
T WMAPE++ + K D++S GI E+ G+ PY+++H I I N TL
Sbjct: 162 TPFWMAPEVIQE--IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTL 219
Query: 1039 RPTIPSYCDAEWRTLMEECWAPNPAARPSFTE 1070
P E+ +++C +P RPS +
Sbjct: 220 S--DPEKWSPEFNDFVKKCLVKDPEERPSAIQ 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 94/284 (33%), Positives = 137/284 (48%), Gaps = 41/284 (14%)
Query: 818 LGSGTFGTVYHGKWRGTD-----VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHH 872
LG G FG+V + + D VA+K +K F+ SS+ E EF +EA + + H
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS--SSDIE----EFLREAACMKEFDH 60
Query: 873 PNVVAFYGV-VQDGPGGTLA---TVAEYMVDGSLRHVLVRKDRF------LDRRRRLIIA 922
PNV+ GV ++ G L + +M G L H + R L + +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDL-HTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 923 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS-KIKRNTLVSGGVRG 981
+D A GMEYL SKN +H DL N ++N + +C V DFGLS KI G
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLN---ENMTVC-VADFGLSKKIYSGDYYRQGCAS 175
Query: 982 TLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH----YGAIIGGIV 1034
LP W+A E L+ + DV++FG+ +WEI+T G+ PYA + Y +I G
Sbjct: 176 KLPVKWLALESLADNVYTTHS--DVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG-- 231
Query: 1035 NNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078
N L+ P C + LM +CW+P P RPSF + +L ++
Sbjct: 232 -NRLKQ--PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 86/282 (30%), Positives = 122/282 (43%), Gaps = 39/282 (13%)
Query: 816 KELGSGTFGTVYHGKWRGTD-----VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL 870
K LG G FG+V G+ D VA+K +K T E EF EA +
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIE------EFLSEAACMKDF 58
Query: 871 HHPNVVAFYGV-VQDGPGGTLAT---VAEYMVDGSLRHVLVRK-----DRFLDRRRRLII 921
HPNV+ GV + + + +M G L L+ L + L
Sbjct: 59 DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF 118
Query: 922 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSG---- 977
+D A GMEYL ++N +H DL N ++ +C V DFGLSK + SG
Sbjct: 119 MVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVC-VADFGLSK----KIYSGDYYR 170
Query: 978 -GVRGTLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGI 1033
G +P W+A E L + + K DV++FG+ +WEI T G+ PY + I +
Sbjct: 171 QGRIAKMPVKWIAIESL--ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL 228
Query: 1034 VNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
+ R P C E LM CW +P RP+FT++ L
Sbjct: 229 RHGN-RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 2e-30
Identities = 81/279 (29%), Positives = 135/279 (48%), Gaps = 46/279 (16%)
Query: 818 LGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTVE-FWKEAEILSKLHHPN 874
+GSG+FG+VY G G +A+K+++ + S +++R ++ +E +L +L H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 875 VVAFYGVVQDG----------PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMD 924
+V + G D PGG++A + G+ LVR F+ R I+
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRN--FV----RQILK-- 117
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLP 984
G+ YLH++ I+H D+K N+LV+ K K+ DFG+SK +S G P
Sbjct: 118 ---GLNYLHNRGIIHRDIKGANILVDNKGG----IKISDFGISKKLEANSLSTKTNGARP 170
Query: 985 -------WMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANM-HYGAI--IGGIV 1034
WMAPE++ +S + K D++S G ++ E+LTG+ P+ + AI IG
Sbjct: 171 SLQGSVFWMAPEVVKQTSY--TRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA 228
Query: 1035 NNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIAS 1073
P IPS +E +E+ + + RP+ E+
Sbjct: 229 ----SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 92/290 (31%), Positives = 132/290 (45%), Gaps = 41/290 (14%)
Query: 812 LEEQKELGSGTFGTV----YHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWK-EA 864
L++ + LG G FG V Y GT VA+K +K+ C +Q WK E
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-----GQQNT---SGWKKEI 57
Query: 865 EILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMD 924
IL L+H N+V + G + G L + EY+ GSLR L + L+ + L+ A
Sbjct: 58 NILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQ 115
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR--GT 982
GM YLHS++ +H DL N+L+ D R + K+GDFGL+K VR G
Sbjct: 116 ICEGMAYLHSQHYIHRDLAARNVLL---DNDR-LVKIGDFGLAKAVPEGHEYYRVREDGD 171
Query: 983 LP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN--MHYGAIIG---GIVN 1035
P W A E L +K S DV+SFG+ L+E+LT + + + +IG G +
Sbjct: 172 SPVFWYAVECL--KENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMT 229
Query: 1036 ---------NTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076
+R P C E LM+ CW RP+F + L+
Sbjct: 230 VVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 80/271 (29%), Positives = 122/271 (45%), Gaps = 34/271 (12%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
E + +G G+FG VY + T+ VAIK I +E E ++ +E + L
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE-----EAEDEIEDIQ--QEIQFL 53
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
S+ P + +YG G L + EY GS +L K LD I +
Sbjct: 54 SQCRSPYITKYYGSFLKG--SKLWIIMEYCGGGSCLDLL--KPGKLDETYIAFILREVLL 109
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS------KIKRNTLVSGGVRG 981
G+EYLH + +H D+K N+L++ K+ DFG+S KRNT V G
Sbjct: 110 GLEYLHEEGKIHRDIKAANILLS----EEGDVKLADFGVSGQLTSTMSKRNTFV-----G 160
Query: 982 TLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT 1041
T WMAPE++ S EK D++S GI E+ GE P +++H ++ I N P+
Sbjct: 161 TPFWMAPEVIKQSG--YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP-PS 217
Query: 1042 IP--SYCDAEWRTLMEECWAPNPAARPSFTE 1070
+ + ++ + C +P RPS E
Sbjct: 218 LEGNKFSK-PFKDFVSLCLNKDPKERPSAKE 247
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 98/295 (33%), Positives = 132/295 (44%), Gaps = 42/295 (14%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTVE 859
IK D+ + ELG G FG V+ + VA+K +K++ SE R +
Sbjct: 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA------SESARQ--D 53
Query: 860 FWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD---RFLDRR 916
F +EAE+L+ L H ++V FYGV +G L V EYM G L L + L
Sbjct: 54 FQREAELLTVLQHQHIVRFYGVCTEGR--PLLMVFEYMRHGDLNRFLRSHGPDAKILAGG 111
Query: 917 R-----------RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965
L IA A GM YL S + VH DL N LV + K+GDFG
Sbjct: 112 EDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG----QGLVVKIGDFG 167
Query: 966 LSK-IKRNTLVSGGVRGTLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPY 1021
+S+ I G R LP WM PE S K + + D++SFG+VLWEI T G++P+
Sbjct: 168 MSRDIYSTDYYRVGGRTMLPIRWMPPE--SILYRKFTTESDIWSFGVVLWEIFTYGKQPW 225
Query: 1022 ANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076
+ I I P C E +M+ CW P R +I SRL+
Sbjct: 226 YQLSNTEAIECITQGR-ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 96/317 (30%), Positives = 131/317 (41%), Gaps = 76/317 (23%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTVE 859
+ + L K LG G FG V + G D VA+K +K +E++ +
Sbjct: 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-----TEKDLS--D 61
Query: 860 FWKEAEILSKL-HHPNVVAFYGV-VQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRR 917
E E++ + H N++ GV Q+GP L V EY G+LR FL RR
Sbjct: 62 LVSEMEMMKMIGKHKNIINLLGVCTQEGP---LYVVVEYAAHGNLRD-------FLRARR 111
Query: 918 -----------RLII-----------AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPS 955
R A A GME+L SK +H DL N+LV
Sbjct: 112 PPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH-- 169
Query: 956 RPICKVGDFGLSK-IKRNTLVSGGVRGTLP--WMAPELLSGSSSKVSEKVDVFSFGIVLW 1012
+ K+ DFGL++ I G LP WMAPE L + + DV+SFG++LW
Sbjct: 170 --VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGVLLW 225
Query: 1013 EILT-GEEPYANMHYGAIIGGIVNNTL--------RPTIPSYCDAEWRTLMEECWAPNPA 1063
EI T G PY GI L R P C E LM +CW P+
Sbjct: 226 EIFTLGGSPYP---------GIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPS 276
Query: 1064 ARPSFTEIASRL-RVLS 1079
RP+F ++ L R+L+
Sbjct: 277 QRPTFKQLVEDLDRMLT 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 94/294 (31%), Positives = 135/294 (45%), Gaps = 56/294 (19%)
Query: 816 KELGSGTFGTVYHGKWR--GTD----VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSK 869
+ELG FG +Y G G D VAIK +K ++ Q+ EF +EA ++++
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI-----NNPQQ--WGEFQQEASLMAE 63
Query: 870 LHHPNVVAFYGVV-QDGPGGTLATVAEYMVDGSLRHVLVRKD----------------RF 912
LHHPN+V GVV Q+ P + + EY+ G L L+ +
Sbjct: 64 LHHPNIVCLLGVVTQEQP---VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 913 LDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK---- 968
LD L IA+ A GMEYL S VH DL N+L+ + K+ D GLS+
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG----EQLHVKISDLGLSREIYS 176
Query: 969 -----IKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYA 1022
++ +L+ + WM PE + K S D++SFG+VLWEI + G +PY
Sbjct: 177 ADYYRVQPKSLLP------IRWMPPEAIM--YGKFSSDSDIWSFGVVLWEIFSFGLQPYY 228
Query: 1023 NMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076
+I + L P C +LM ECW P+ RP F +I +RLR
Sbjct: 229 GFSNQEVIEMVRKRQLLPC-SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 85/277 (30%), Positives = 128/277 (46%), Gaps = 24/277 (8%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHG-----KWRGTDVAIKRIKKSCFTGRSSEQERLTVEFW 861
+ N+ ++ ++ LG+G FG + G R VAI ++ C S +Q R F
Sbjct: 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC----SDKQRR---GFL 54
Query: 862 KEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLII 921
EA L + H N+V GV+ G T+ V EYM +G+L L + + L + + +
Sbjct: 55 AEALTLGQFDHSNIVRLEGVITRG--NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGM 112
Query: 922 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRG 981
A GM+YL VH L +LVN S +CK+ F + ++ + + G
Sbjct: 113 LPGLASGMKYLSEMGYVHKGLAAHKVLVN----SDLVCKISGFRRLQEDKSEAIYTTMSG 168
Query: 982 TLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 1038
P W APE + S DV+SFGIV+WE+++ GE PY +M +I V +
Sbjct: 169 KSPVLWAAPEAIQ--YHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKA-VEDGF 225
Query: 1039 RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
R P C LM +CW RP F++I S L
Sbjct: 226 RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 87/275 (31%), Positives = 135/275 (49%), Gaps = 25/275 (9%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAE 865
I E ++ K+LG+G FG V+ G + T VA+K +K G S Q F +EA
Sbjct: 3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKP----GTMSVQA-----FLEEAN 53
Query: 866 ILSKLHHPNVVAFYGVV-QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLI-IAM 923
++ L H +V Y VV ++ P + + EYM GSL L + +LI +
Sbjct: 54 LMKTLQHDKLVRLYAVVTKEEP---IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA 110
Query: 924 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSG--GVRG 981
A GM Y+ KN +H DL+ N+LV+ +CK+ DFGL+++ + + G +
Sbjct: 111 QIAEGMAYIERKNYIHRDLRAANVLVS----ESLMCKIADFGLARVIEDNEYTAREGAKF 166
Query: 982 TLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 1040
+ W APE ++ S + K DV+SFGI+L+EI+T G+ PY M ++ + P
Sbjct: 167 PIKWTAPEAINFGSFTI--KSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMP 224
Query: 1041 TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
C E +M+ CW RP+F + S L
Sbjct: 225 R-MENCPDELYDIMKTCWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 96/286 (33%), Positives = 136/286 (47%), Gaps = 46/286 (16%)
Query: 816 KELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILS 868
+ELG G+FG VY G R T VA+K + +S +S +ER +EF EA ++
Sbjct: 12 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES-----ASLRER--IEFLNEASVMK 64
Query: 869 KLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVL--VRKD------RFLDRRRRLI 920
+VV GVV G TL V E M G L+ L +R + R + +I
Sbjct: 65 GFTCHHVVRLLGVVSKGQP-TL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 122
Query: 921 -IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-IKRNTLVSGG 978
+A + A GM YL++K VH DL N +V K+GDFG+++ I G
Sbjct: 123 QMAAEIADGMAYLNAKKFVHRDLAARNCMV----AHDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 979 VRGTLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAII----- 1030
+G LP WMAPE L + D++SFG+VLWEI + E+PY + ++
Sbjct: 179 GKGLLPVRWMAPESLKDGV--FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD 236
Query: 1031 GGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076
GG ++ P C LM CW NP RP+F EI + L+
Sbjct: 237 GGYLDQ------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 6e-29
Identities = 94/300 (31%), Positives = 126/300 (42%), Gaps = 64/300 (21%)
Query: 816 KELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTV--------------EFW 861
++LG G FG V+ + D +K+ +++ L +F
Sbjct: 11 EKLGEGQFGEVHLCE---ADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 862 KEAEILSKLHHPNVVAFYGV-VQDGPGGTLATVAEYMVDGSL-----RHVLVRKD----- 910
KE +ILS+L PN+ GV D P L + EYM +G L +HV
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPP---LCMIMEYMENGDLNQFLQKHVAETSGLACNS 124
Query: 911 RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK 970
+ L L +A A GM YL S N VH DL N LV + I K+ DFG+S
Sbjct: 125 KSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG---KNYTI-KIADFGMS--- 177
Query: 971 RNTLVSGG---VRGTLP----WMAPE-LLSGSSSKVSEKVDVFSFGIVLWEILT--GEEP 1020
L S V+G P WMA E +L G K + K DV++FG+ LWEILT E+P
Sbjct: 178 -RNLYSSDYYRVQGRAPLPIRWMAWESVLLG---KFTTKSDVWAFGVTLWEILTLCREQP 233
Query: 1021 YA---------NMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
Y N + G RP C + LM ECW + RP+F EI
Sbjct: 234 YEHLTDQQVIENAGHFFRDDGRQIYLPRPPN---CPKDIYELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 76/264 (28%), Positives = 122/264 (46%), Gaps = 21/264 (7%)
Query: 818 LGSGTFG--TVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNV 875
LG G FG T+Y + V K + + R SE+ER E ILS L HPN+
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLT----RLSEKERRDAL--NEIVILSLLQHPNI 61
Query: 876 VAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAM--DAAFGMEYLH 933
+A+Y D TL EY G+L +VR+ L +++ + Y+H
Sbjct: 62 IAYYNHFMD--DNTLLIEMEYANGGTLYDKIVRQKGQL-FEEEMVLWYLFQIVSAVSYIH 118
Query: 934 SKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI-KRNTLVSGGVRGTLPWMAPELLS 992
I+H D+K N+ + + K+GDFG+SKI ++ V GT +M+PEL
Sbjct: 119 KAGILHRDIKTLNIFLT----KAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQ 174
Query: 993 GSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRT 1052
G K + K D+++ G VL+E+LT + + + ++ IV P + S +E +
Sbjct: 175 G--VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP-VVSVYSSELIS 231
Query: 1053 LMEECWAPNPAARPSFTEIASRLR 1076
L+ +P RP+ E+ +
Sbjct: 232 LVHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 8e-29
Identities = 78/262 (29%), Positives = 120/262 (45%), Gaps = 31/262 (11%)
Query: 818 LGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNV 875
LG G+FG V + + T A+K +KK + + + E ILS+++HP +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKK-----KKIIKRKEVEHTLTERNILSRINHPFI 55
Query: 876 VAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSK 935
V + Q L V EY G L L ++ RF + R R A + +EYLHS
Sbjct: 56 VKLHYAFQTE--EKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAA-EIVLALEYLHSL 112
Query: 936 NIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR-----GTLPWMAPEL 990
I++ DLK +N+L++ + K+ DFGL+K L S G R GT ++APE+
Sbjct: 113 GIIYRDLKPENILLD----ADGHIKLTDFGLAKE----LSSEGSRTNTFCGTPEYLAPEV 164
Query: 991 LSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR--PTIPSYCDA 1048
L G + VD +S G++L+E+LTG+ P+ Y I L+ P +
Sbjct: 165 LLG--KGYGKAVDWWSLGVLLYEMLTGKPPF----YAEDRKEIYEKILKDPLRFPEFLSP 218
Query: 1049 EWRTLMEECWAPNPAARPSFTE 1070
E R L+ +P R
Sbjct: 219 EARDLISGLLQKDPTKRLGSGG 240
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 9e-29
Identities = 96/290 (33%), Positives = 141/290 (48%), Gaps = 36/290 (12%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTVE 859
+ E + +ELG G+FG VY G +G T VAIK + ++ +S +ER +E
Sbjct: 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA-----ASMRER--IE 55
Query: 860 FWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVL--VRKD------R 911
F EA ++ + + +VV GVV G TL + E M G L+ L +R + +
Sbjct: 56 FLNEASVMKEFNCHHVVRLLGVVSQGQP-TL-VIMELMTRGDLKSYLRSLRPEMENNPVQ 113
Query: 912 FLDRRRRLI-IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-I 969
+++I +A + A GM YL++ VH DL N +V K+GDFG+++ I
Sbjct: 114 APPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV----AEDFTVKIGDFGMTRDI 169
Query: 970 KRNTLVSGGVRGTLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHY 1026
G +G LP WM+PE L + DV+SFG+VLWEI T E+PY M
Sbjct: 170 YETDYYRKGGKGLLPVRWMSPESLK--DGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN 227
Query: 1027 GAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076
++ ++ L P C LM CW NP RPSF EI S ++
Sbjct: 228 EQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 9e-29
Identities = 97/303 (32%), Positives = 134/303 (44%), Gaps = 47/303 (15%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTVE 859
IK D+ ++ELG G FG V+ + VA+K +K R +
Sbjct: 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK--------D 53
Query: 860 FWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVL------------- 906
F +EAE+L+ L H ++V FYGV D G L V EYM G L L
Sbjct: 54 FQREAELLTNLQHEHIVKFYGVCGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDG 111
Query: 907 --VRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964
+ L + L IA A GM YL S++ VH DL N LV + + K+GDF
Sbjct: 112 QPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG----ANLLVKIGDF 167
Query: 965 GLSK-IKRNTLVSGGVRGTLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEP 1020
G+S+ + G LP WM PE S K + + DV+SFG++LWEI T G++P
Sbjct: 168 GMSRDVYSTDYYRVGGHTMLPIRWMPPE--SIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
Query: 1021 YANMHYGAIIGGIVNNTL--RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078
+ + +I I + RP + C E +M CW P R + EI L L
Sbjct: 226 WFQLSNTEVIECITQGRVLERPRV---CPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282
Query: 1079 STA 1081
A
Sbjct: 283 GKA 285
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 9e-29
Identities = 80/270 (29%), Positives = 124/270 (45%), Gaps = 26/270 (9%)
Query: 816 KELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH 871
ELGSG FGTV G ++ VA+K +K + L E +EA ++ +L
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKND------NNDPALKDELLREANVMQQLD 54
Query: 872 HPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEY 931
+P +V G+ + + V E G L + ++K++ + + + + GM+Y
Sbjct: 55 NPYIVRMIGICE---AESWMLVMELAELGPL-NKFLQKNKHVTEKNITELVHQVSMGMKY 110
Query: 932 LHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKR--NTLVSGGVRGTLP--WMA 987
L N VH DL N+L+ ++ K+ DFGLSK G P W A
Sbjct: 111 LEETNFVHRDLAARNVLL----VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYA 166
Query: 988 PELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSYC 1046
PE ++ K S K DV+SFG+++WE + G++PY M G + ++ + R P C
Sbjct: 167 PECMN--YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK-GNEVTQMIESGERMECPQRC 223
Query: 1047 DAEWRTLMEECWAPNPAARPSFTEIASRLR 1076
E LM+ CW RP F + RLR
Sbjct: 224 PPEMYDLMKLCWTYGVDERPGFAVVELRLR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 74/276 (26%), Positives = 117/276 (42%), Gaps = 35/276 (12%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
ED E + +GSGT+G VY + T VAIK IK + +E +L
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK-------LEPGDDFE-IIQQEISML 54
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
+ HPN+VA++G L V EY GSL+ + L + + +
Sbjct: 55 KECRHPNIVAYFGSYLRR--DKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLK 112
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI------KRNTLVSGGVRG 981
G+ YLH +H D+K N+L+ K+ DFG+S KR + + G
Sbjct: 113 GLAYLHETGKIHRDIKGANILLT----EDGDVKLADFGVSAQLTATIAKRKSFI-----G 163
Query: 982 TLPWMAPELLSGSS-SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 1040
T WMAPE+ + K D+++ GI E+ + P ++H + I + P
Sbjct: 164 TPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP 223
Query: 1041 TIPSYCDAE-WRTLM----EECWAPNPAARPSFTEI 1071
P D E W + ++C +P RP+ T++
Sbjct: 224 --PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKL 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 77/269 (28%), Positives = 125/269 (46%), Gaps = 26/269 (9%)
Query: 816 KELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
++LG+G F + Y + GT +A+K++ SSEQE + KE ++++L+HP
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYV--RNTSSEQEEVVEALRKEIRLMARLNHP 63
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIA--MDAAFGMEY 931
+++ G + E+M GS+ H+L + F + +II G+ Y
Sbjct: 64 HIIRMLGATCED--SHFNLFVEWMAGGSVSHLLSKYGAF---KEAVIINYTEQLLRGLSY 118
Query: 932 LHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL-----SKIKRNTLVSGGVRGTLPWM 986
LH I+H D+K NLL+ D + ++ DFG +K G + GT+ +M
Sbjct: 119 LHENQIIHRDVKGANLLI---DSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 987 APELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANM----HYGAIIGGIVNNTLRPTI 1042
APE+L G S DV+S G V+ E+ T + P+ H A+I I + T P+I
Sbjct: 176 APEVLRGEQYGRS--CDVWSVGCVIIEMATAKPPWNAEKHSNHL-ALIFKIASATTAPSI 232
Query: 1043 PSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
P + R + C P RP E+
Sbjct: 233 PEHLSPGLRDVTLRCLELQPEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 85/267 (31%), Positives = 128/267 (47%), Gaps = 28/267 (10%)
Query: 816 KELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWK-EAEILSKLHH 872
K LG G FG VY + G ++A+K++ S + + V + E ++L L H
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVP----FDPDSPETKKEVNALECEIQLLKNLQH 63
Query: 873 PNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVR----KDRFLDRRRRLIIAMDAAFG 928
+V +YG ++D TL+ EYM GS++ L + + R I+ G
Sbjct: 64 ERIVQYYGCLRDD--ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE-----G 116
Query: 929 MEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGG----VRGTLP 984
+EYLHS IVH D+K N+L +D + + K+GDFG SK + SG V GT
Sbjct: 117 VEYLHSNMIVHRDIKGANIL---RDSAGNV-KLGDFGASKRLQTICSSGTGMKSVTGTPY 172
Query: 985 WMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPS 1044
WM+PE++SG K DV+S G + E+LT + P+A A I I P +PS
Sbjct: 173 WMSPEVISGEGY--GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPS 230
Query: 1045 YCDAEWRTLMEECWAPNPAARPSFTEI 1071
+ + R + + N RPS E+
Sbjct: 231 HVSPDARNFLRRTFVENAKKRPSAEEL 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 118 bits (295), Expect = 2e-28
Identities = 77/218 (35%), Positives = 112/218 (51%), Gaps = 22/218 (10%)
Query: 815 QKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHP 873
++LG G+FG VY + VA+K + K +S E ER F +E +IL+ L H P
Sbjct: 5 LRKLGEGSFGEVYLAR-DRKLVALKVLAKK-LESKSKEVER----FLREIQILASLNHPP 58
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDR--FLDRRRRLIIAMDAAFGMEY 931
N+V Y QD L EY+ GSL +L + R L L I +EY
Sbjct: 59 NIVKLYDFFQDEGSLYLVM--EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116
Query: 932 LHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR-------GTLP 984
LHSK I+H D+K +N+L+ D + K+ DFGL+K+ + + + GT
Sbjct: 117 LHSKGIIHRDIKPENILL---DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173
Query: 985 WMAPELLSGSS-SKVSEKVDVFSFGIVLWEILTGEEPY 1021
+MAPE+L G S + S D++S GI L+E+LTG P+
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPF 211
|
Length = 384 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 84/288 (29%), Positives = 127/288 (44%), Gaps = 45/288 (15%)
Query: 812 LEEQKELGSGTFGTVY------HGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAE 865
L+ ++LG G FG V G G VA+K +K + KE E
Sbjct: 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-------PESGGNHIADLKKEIE 58
Query: 866 ILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDA 925
IL L+H N+V + G+ + G + + E++ GSL+ L R ++ +++L A+
Sbjct: 59 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQI 118
Query: 926 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-IKRNT---LVSGGVRG 981
GM+YL S+ VH DL N+LV S K+GDFGL+K I+ + V +
Sbjct: 119 CKGMDYLGSRQYVHRDLAARNVLVE----SEHQVKIGDFGLTKAIETDKEYYTVKDDLDS 174
Query: 982 TLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG------AIIG---- 1031
+ W APE L SK DV+SFG+ L+E+LT Y + +IG
Sbjct: 175 PVFWYAPECL--IQSKFYIASDVWSFGVTLYELLT----YCDSESSPMTLFLKMIGPTHG 228
Query: 1032 --------GIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
++ R P C E LM +CW P+ R +F +
Sbjct: 229 QMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 96/306 (31%), Positives = 134/306 (43%), Gaps = 68/306 (22%)
Query: 816 KELGSGTFGTV-----YHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILS 868
K LG G FG V + K R T VA+K +K++ SSE L EF +L
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN---ASSSELRDLLSEF----NLLK 58
Query: 869 KLHHPNVVAFYGVV-QDGPGGTLATVAEYMVDGSLRHVLVRKDR---------------- 911
+++HP+V+ YG QDGP L + EY GSLR L R+ R
Sbjct: 59 QVNHPHVIKLYGACSQDGP---LLLIVEYAKYGSLRSFL-RESRKVGPSYLGSDGNRNSS 114
Query: 912 --FLDRRRRLIIAMDAAF------GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGD 963
R L + +F GM+YL +VH DL N+LV K+ D
Sbjct: 115 YLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV----AEGRKMKISD 170
Query: 964 FGLSK--------IKRNTLVSGGVRGTLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWE 1013
FGLS+ +KR+ +G +P WMA E L + + DV+SFG++LWE
Sbjct: 171 FGLSRDVYEEDSYVKRS-------KGRIPVKWMAIESLF--DHIYTTQSDVWSFGVLLWE 221
Query: 1014 ILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIA 1072
I+T G PY + + ++ R P C E LM CW P RP+F +I+
Sbjct: 222 IVTLGGNPYPGIAPERLFN-LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADIS 280
Query: 1073 SRLRVL 1078
L +
Sbjct: 281 KELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 85/275 (30%), Positives = 133/275 (48%), Gaps = 26/275 (9%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSSEQERLTVE-FWKEA 864
I E L+ +K+LG+G FG V+ + + T VA+K +K ++VE F EA
Sbjct: 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS----------MSVEAFLAEA 52
Query: 865 EILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLI-IAM 923
++ L H +V + VV P + + E+M GSL L + +LI +
Sbjct: 53 NVMKTLQHDKLVKLHAVVTKEP---IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 109
Query: 924 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT--LVSGGVRG 981
A GM ++ +N +H DL+ N+LV+ + +CK+ DFGL+++ + G +
Sbjct: 110 QIAEGMAFIEQRNYIHRDLRAANILVS----ASLVCKIADFGLARVIEDNEYTAREGAKF 165
Query: 982 TLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 1040
+ W APE ++ S + K DV+SFGI+L EI+T G PY M +I + P
Sbjct: 166 PIKWTAPEAINFGSFTI--KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP 223
Query: 1041 TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
+ C E +M CW P RP+F I S L
Sbjct: 224 RPEN-CPEELYNIMMRCWKNRPEERPTFEYIQSVL 257
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 94/290 (32%), Positives = 135/290 (46%), Gaps = 43/290 (14%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRG----TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAE 865
ED++ + +G G FG V + + AIK +K+ +SE + +F E E
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-----ASENDHR--DFAGELE 54
Query: 866 ILSKL-HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLD---------- 914
+L KL HHPN++ G ++ G L EY G+L L RK R L+
Sbjct: 55 VLCKLGHHPNIINLLGACENR--GYLYIAIEYAPYGNLLDFL-RKSRVLETDPAFAKEHG 111
Query: 915 ------RRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV--NLKDPSRPICKVGDFGL 966
++ L A D A GM+YL K +H DL N+LV NL K+ DFGL
Sbjct: 112 TASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL------ASKIADFGL 165
Query: 967 SKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH 1025
S+ + + R + WMA E L+ S + K DV+SFG++LWEI++ G PY M
Sbjct: 166 SRGEEVYVKKTMGRLPVRWMAIESLN--YSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223
Query: 1026 YGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
+ + R P CD E LM +CW P RP F +I+ +L
Sbjct: 224 CAELYEKLPQG-YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQL 272
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 66/230 (28%), Positives = 106/230 (46%), Gaps = 19/230 (8%)
Query: 819 GSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVV 876
G G FG V + R T A+K + K + S + L E IL +L+HP +V
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVL-----NERRILQELNHPFLV 63
Query: 877 AFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKN 936
+ QD + V + ++ G LR+ L +K +F + + + I + +EYLHSK
Sbjct: 64 NLWYSFQDEE--NMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC-EIVLALEYLHSKG 120
Query: 937 IVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSS 996
I+H D+K DN+L++ + + DF ++ ++ GT +MAPE+L
Sbjct: 121 IIHRDIKPDNILLD----EQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGY 176
Query: 997 KVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN--TLRPTIPS 1044
V+ VD +S G+ +E L G+ PY H I I T P+
Sbjct: 177 SVA--VDWWSLGVTAYECLRGKRPY-RGHSRTIRDQIRAKQETADVLYPA 223
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 2e-27
Identities = 93/288 (32%), Positives = 133/288 (46%), Gaps = 39/288 (13%)
Query: 806 VIKNEDLEEQKELGSGTFGTVYHGKWRG----TDVAIKRIKKSCFTGRSSEQERLTVEFW 861
V++ D++ Q +G G FG V + + D AIKR+K+ S + R +F
Sbjct: 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDHR---DFA 55
Query: 862 KEAEILSKL-HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLD------ 914
E E+L KL HHPN++ G + G L EY G+L L RK R L+
Sbjct: 56 GELEVLCKLGHHPNIINLLGACEHR--GYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFA 112
Query: 915 ----------RRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964
++ L A D A GM+YL K +H DL N+LV + K+ DF
Sbjct: 113 IANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG----ENYVAKIADF 168
Query: 965 GLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYAN 1023
GLS+ + + R + WMA E L+ S + DV+S+G++LWEI++ G PY
Sbjct: 169 GLSRGQEVYVKKTMGRLPVRWMAIESLN--YSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 226
Query: 1024 MHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
M + + R P CD E LM +CW P RPSF +I
Sbjct: 227 MTCAELYEKLPQG-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 273
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 86/280 (30%), Positives = 133/280 (47%), Gaps = 29/280 (10%)
Query: 805 QVIKNEDLEEQKELGSGTFGTVYHGKW--RGTD----VAIKRIKKSCFTGRSSEQERLTV 858
+++K +L + K LGSG FGTV+ G W G VAIK I+ +GR + QE
Sbjct: 2 RILKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQE---- 55
Query: 859 EFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSL-RHVLVRKDRFLDRRR 917
+ L H +V G+ PG +L V + GSL HV +D LD +R
Sbjct: 56 -ITDHMLAMGSLDHAYIVRLLGIC---PGASLQLVTQLSPLGSLLDHVRQHRDS-LDPQR 110
Query: 918 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI---KRNTL 974
L + A GM YL +VH +L N+L LK S I ++ DFG++ +
Sbjct: 111 LLNWCVQIAKGMYYLEEHRMVHRNLAARNIL--LKSDS--IVQIADFGVADLLYPDDKKY 166
Query: 975 VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGI 1033
+ + WMA E S + + + DV+S+G+ +WE+++ G EPYA M + +
Sbjct: 167 FYSEHKTPIKWMALE--SILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-HEVPDL 223
Query: 1034 VNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIAS 1073
+ R P C + +M +CW + RP+F E+A+
Sbjct: 224 LEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 73/266 (27%), Positives = 121/266 (45%), Gaps = 29/266 (10%)
Query: 817 ELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVV 876
ELG G FG VY + + T + K E E +F E +ILS+ HPN+V
Sbjct: 12 ELGDGAFGKVYKAQHKETGL--FAAAKIIQIESEEELE----DFMVEIDILSECKHPNIV 65
Query: 877 AFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKN 936
Y L + E+ G+L +++ +R L + + + +LHS
Sbjct: 66 GLYEAYFYEN--KLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK 123
Query: 937 IVHFDLKCDNLLVNLKDPSRPICKVGDFGLS------KIKRNTLVSGGVRGTLPWMAPEL 990
++H DLK N+L+ L K+ DFG+S KR+T + GT WMAPE+
Sbjct: 124 VIHRDLKAGNILLTLDGD----VKLADFGVSAKNKSTLQKRDTFI-----GTPYWMAPEV 174
Query: 991 LSGSSSK---VSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTI--PSY 1045
++ + K K D++S GI L E+ E P+ ++ ++ I+ + PT+ PS
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE-PPTLDQPSK 233
Query: 1046 CDAEWRTLMEECWAPNPAARPSFTEI 1071
+ + ++ C +P RP+ E+
Sbjct: 234 WSSSFNDFLKSCLVKDPDDRPTAAEL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 91/279 (32%), Positives = 133/279 (47%), Gaps = 42/279 (15%)
Query: 810 EDLEEQKELGSGTFGTVY---HGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEI 866
+DLE ELG+G G V H + G +A+K I+ + Q+++ +E +I
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLH-RPTGKIMAVKTIR---LEINEAIQKQIL----RELDI 52
Query: 867 LSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLI------ 920
L K + P +V FYG + G ++ EYM GSL D+ L + I
Sbjct: 53 LHKCNSPYIVGFYGAFYNN--GDISICMEYMDGGSL-------DKILKEVQGRIPERILG 103
Query: 921 -IAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGG 978
IA+ G+ YLH K I+H D+K N+LVN SR K+ DFG+S N+L
Sbjct: 104 KIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN----SRGQIKLCDFGVSGQLVNSLAKTF 159
Query: 979 VRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYA--NMHYGAII---GGI 1033
V GT +MAPE + G+ V K D++S G+ L E+ TG PY N I I
Sbjct: 160 V-GTSSYMAPERIQGNDYSV--KSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI 216
Query: 1034 VNNTLRPTIPSYC-DAEWRTLMEECWAPNPAARPSFTEI 1071
VN P +PS +++ + C +P RPS+ E+
Sbjct: 217 VNEP-PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKEL 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 74/261 (28%), Positives = 118/261 (45%), Gaps = 36/261 (13%)
Query: 818 LGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNV 875
LG G FG V K + + A+K +KK ++ + E EIL + +HP +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEH-----IFSEKEILEECNHPFI 55
Query: 876 VAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSK 935
V Y +D + + EY + G L +L + F + R IA EYLH++
Sbjct: 56 VKLYRTFKDKK--YIYMLMEYCLGGELWTILRDRGLFDEYTARFYIAC-VVLAFEYLHNR 112
Query: 936 NIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR-----GTLPWMAPEL 990
I++ DLK +NLL++ S K+ DFG +K + G + GT ++APE+
Sbjct: 113 GIIYRDLKPENLLLD----SNGYVKLVDFGFAKK-----LKSGQKTWTFCGTPEYVAPEI 163
Query: 991 LSGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN------MHYGAIIGGIVNNTLRPTIPS 1044
+ S VD +S GI+L+E+LTG P+ Y I+ G + P+
Sbjct: 164 ILNKGYDFS--VDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG----KLEFPN 217
Query: 1045 YCDAEWRTLMEECWAPNPAAR 1065
Y D + L+++ NP R
Sbjct: 218 YIDKAAKDLIKQLLRRNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 90/280 (32%), Positives = 128/280 (45%), Gaps = 39/280 (13%)
Query: 818 LGSGTFGTVYHGKWRG----TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HH 872
+G G FG V + + D AIKR+K+ +S+ + +F E E+L KL HH
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-----ASKDDHR--DFAGELEVLCKLGHH 55
Query: 873 PNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLD----------------RR 916
PN++ G + G L EY G+L L RK R L+ +
Sbjct: 56 PNIINLLGACEHR--GYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQ 112
Query: 917 RRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVS 976
+ L A D A GM+YL K +H DL N+LV + K+ DFGLS+ + +
Sbjct: 113 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA----KIADFGLSRGQEVYVKK 168
Query: 977 GGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 1035
R + WMA E L+ S + DV+S+G++LWEI++ G PY M + +
Sbjct: 169 TMGRLPVRWMAIESLN--YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 226
Query: 1036 NTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
R P CD E LM +CW P RPSF +I L
Sbjct: 227 G-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 75/273 (27%), Positives = 138/273 (50%), Gaps = 35/273 (12%)
Query: 813 EEQKELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL 870
E+ + +G G FG V+ K V IK+I + ++ ERL + E ++L L
Sbjct: 3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIP----VEQMTKDERLAAQ--NECQVLKLL 56
Query: 871 HHPNVVAFYG----------VVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLI 920
HPN++ +Y V++ PGGTLA EY+ + L+ +D L +++
Sbjct: 57 SHPNIIEYYENFLEDKALMIVMEYAPGGTLA---EYIQKR--CNSLLDEDTILHFFVQIL 111
Query: 921 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR 980
+A+ ++H+K I+H DLK N+L++ + + K+GDFG+SKI + + V
Sbjct: 112 LAL------HHVHTKLILHRDLKTQNILLDKH---KMVVKIGDFGISKILSSKSKAYTVV 162
Query: 981 GTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 1040
GT +++PEL G ++K D+++ G VL+E+ + + + + A++ I++ T P
Sbjct: 163 GTPCYISPELCEGKP--YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP 220
Query: 1041 TIPSYCDAEWRTLMEECWAPNPAARPSFTEIAS 1073
Y + R L+ +P+ RP ++I +
Sbjct: 221 ISDRYSP-DLRQLILSMLNLDPSKRPQLSQIMA 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 65/221 (29%), Positives = 111/221 (50%), Gaps = 38/221 (17%)
Query: 813 EEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL 870
E+ ++G GT+G VY + + T VA+K+I+ +E+E + +E ++L KL
Sbjct: 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRME------NEKEGFPITAIREIKLLQKL 55
Query: 871 HHPNVVAFYGVVQDGPGGTLATVAEYM---VDGSLRHVLVR------KDRFLDRRRRLII 921
HPN+V +V G++ V EYM + G L V+ K ++L+
Sbjct: 56 RHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYM----KQLLE 111
Query: 922 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL----SKIKRNTLVSG 977
G++YLHS I+H D+K N+L+N + + K+ DFGL +K +
Sbjct: 112 ------GLQYLHSNGILHRDIKGSNILIN----NDGVLKLADFGLARPYTKRNSADYTNR 161
Query: 978 GVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
+ TL + PELL G +++ +VD++S G +L E+ G+
Sbjct: 162 VI--TLWYRPPELLLG-ATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 2e-26
Identities = 96/299 (32%), Positives = 137/299 (45%), Gaps = 40/299 (13%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTVE 859
IK ++ ++ELG G FG V+ + VA+K +K + R +
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARK--------D 53
Query: 860 FWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLV------------ 907
F +EAE+L+ L H ++V FYGV + G L V EYM G L L
Sbjct: 54 FHREAELLTNLQHEHIVKFYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEG 111
Query: 908 RKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967
+ L + + L IA A GM YL S++ VH DL N LV + K+GDFG+S
Sbjct: 112 NRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG----ENLLVKIGDFGMS 167
Query: 968 KIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYAN 1023
+ +T V G + WM PE S K + + DV+S G+VLWEI T G++P+
Sbjct: 168 RDVYSTDYYRVGGHTMLPIRWMPPE--SIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ 225
Query: 1024 MHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAA 1082
+ +I I + P C E LM CW P R + EI S L+ L+ A+
Sbjct: 226 LSNNEVIECITQGRVLQR-PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 5e-26
Identities = 85/298 (28%), Positives = 128/298 (42%), Gaps = 58/298 (19%)
Query: 811 DLEEQKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTVEFWKE 863
++E +++G G FG V+ + G T VA+K +K+ +S + +F +E
Sbjct: 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-----ASAD--MQADFQRE 58
Query: 864 AEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVR--------------K 909
A ++++ HPN+V GV G + + EYM G L L
Sbjct: 59 AALMAEFDHPNIVKLLGVCAVGK--PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSS 116
Query: 910 DRFLDRRR-------RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962
R +L IA A GM YL + VH DL N LV + K+
Sbjct: 117 ARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG----ENMVVKIA 172
Query: 963 DFGLS-KIKRNTLVSGGVRGTLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GE 1018
DFGLS I +P WM PE S ++ + + DV+++G+VLWEI + G
Sbjct: 173 DFGLSRNIYSADYYKASENDAIPIRWMPPE--SIFYNRYTTESDVWAYGVVLWEIFSYGM 230
Query: 1019 EPYANMHYGAII-----GGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
+PY M + +I G +++ P C E LM CW+ P+ RPSF I
Sbjct: 231 QPYYGMAHEEVIYYVRDGNVLS------CPDNCPLELYNLMRLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 97/294 (32%), Positives = 133/294 (45%), Gaps = 56/294 (19%)
Query: 816 KELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILS 868
+ELG FG VY G GT VAIK +K + L EF EA + S
Sbjct: 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-------EGPLREEFKHEAMMRS 63
Query: 869 KLHHPNVVAFYGVV-QDGPGGTLATVAEYMVDGSLRHVLVRK-----------DRF---- 912
+L HPN+V GVV ++ P L+ + Y L LV + D+
Sbjct: 64 RLQHPNIVCLLGVVTKEQP---LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 913 LDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL------ 966
L+ + I A GME+L S ++VH DL N+LV K K+ D GL
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN----VKISDLGLFREVYA 176
Query: 967 ---SKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYA 1022
K+ N+L+ + WM+PE + K S D++S+G+VLWE+ + G +PY
Sbjct: 177 ADYYKLMGNSLLP------IRWMSPEAIM--YGKFSIDSDIWSYGVVLWEVFSYGLQPYC 228
Query: 1023 NMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076
+I I N + P P C A TLM ECW P+ RP F +I SRLR
Sbjct: 229 GYSNQDVIEMIRNRQVLPC-PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 84/287 (29%), Positives = 127/287 (44%), Gaps = 51/287 (17%)
Query: 810 EDLEEQKELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFW-KEAEI 866
+D E + +G G VY VAIKRI E+ + +V+ KE +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRI--------DLEKCQTSVDELRKEVQA 52
Query: 867 LSKLHHPNVVAFYG--VVQDGPGGTLATVAEYMVDGSLRHVLVRKDR--FLDRRRRLIIA 922
+S+ +HPNVV +Y VV D L V Y+ GSL ++ LD +
Sbjct: 53 MSQCNHPNVVKYYTSFVVGD----ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL 108
Query: 923 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS----------KIKRN 972
+ G+EYLHS +H D+K N+L+ +D S K+ DFG+S + R
Sbjct: 109 KEVLKGLEYLHSNGQIHRDIKAGNILLG-EDGS---VKIADFGVSASLADGGDRTRKVRK 164
Query: 973 TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGG 1032
T V GT WMAPE++ K D++SFGI E+ TG PY+ Y +
Sbjct: 165 TFV-----GTPCWMAPEVME-QVHGYDFKADIWSFGITAIELATGAAPYS--KYPPM--K 214
Query: 1033 IVNNTLRPTIPSY--------CDAEWRTLMEECWAPNPAARPSFTEI 1071
++ TL+ PS +R ++ C +P+ RP+ E+
Sbjct: 215 VLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEEL 261
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 80/269 (29%), Positives = 121/269 (44%), Gaps = 33/269 (12%)
Query: 818 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNV 875
+ G +G V+ K + T AIK IKK+ ++ + LT E +ILS+ P V
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLT-----ERDILSQAQSPYV 55
Query: 876 VAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSK 935
V Y Q L V EY+ G L +L + R+ IA + +EYLHS
Sbjct: 56 VKLYYSFQGK--KNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIA-EIVLALEYLHSN 112
Query: 936 NIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK---IKRNTLVSGG------VRGTLPWM 986
I+H DLK DN+L++ S K+ DFGLSK ++R ++ + GT ++
Sbjct: 113 GIIHRDLKPDNILID----SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 987 APELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPY----ANMHYGAIIGGIVNNTLRPTI 1042
APE++ G S+ VD +S G +L+E L G P+ + I+ G + P
Sbjct: 169 APEVILGQGH--SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIE---WPED 223
Query: 1043 PSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
D E L+ + P+P R I
Sbjct: 224 VEVSD-EAIDLISKLLVPDPEKRLGAKSI 251
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 7e-25
Identities = 68/221 (30%), Positives = 105/221 (47%), Gaps = 41/221 (18%)
Query: 813 EEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL 870
E+ ++LG GT+G VY + + T VA+K+I+ +E+E + +E +L +L
Sbjct: 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLD------NEEEGIPSTALREISLLKEL 55
Query: 871 HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF--- 927
HPN+V V+ L V EY D L+ +LD+R +
Sbjct: 56 KHPNIVKLLDVIHTE--RKLYLVFEYC-DMDLKK-------YLDKRPG---PLSPNLIKS 102
Query: 928 -------GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK---IKRNTLVSG 977
G+ Y HS I+H DLK N+L+N + K+ DFGL++ I T
Sbjct: 103 IMYQLLRGLAYCHSHRILHRDLKPQNILIN----RDGVLKLADFGLARAFGIPLRTYTHE 158
Query: 978 GVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
V TL + APE+L G S S VD++S G + E++TG+
Sbjct: 159 VV--TLWYRAPEILLG-SKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 7e-25
Identities = 92/300 (30%), Positives = 134/300 (44%), Gaps = 48/300 (16%)
Query: 816 KELGSGTFGTVYHGKWRGTD---------VAIKRIKKSCFTGRSSEQERLTVEFWKEAEI 866
K LG G FG V + G D VA+K +K S E+ + E E+
Sbjct: 24 KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLK-------SDATEKDLSDLISEMEM 76
Query: 867 LSKL-HHPNVVAFYGV-VQDGPGGTLATVAEYMVDGSLRHVL-VRK-------------- 909
+ + H N++ G QDGP L + EY G+LR L R+
Sbjct: 77 MKMIGKHKNIINLLGACTQDGP---LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133
Query: 910 DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK- 968
+ L + + A A GMEYL SK +H DL N+LV + + K+ DFGL++
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN----VMKIADFGLARD 189
Query: 969 IKRNTLVSGGVRGTLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH 1025
I G LP WMAPE L + + DV+SFG++LWEI T G PY +
Sbjct: 190 IHHIDYYKKTTNGRLPVKWMAPEALF--DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247
Query: 1026 YGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL-RVLSTAASQ 1084
+ ++ R PS C E +M +CW P+ RP+F ++ L R+L+ ++Q
Sbjct: 248 VEELFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTSNQ 306
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 90/306 (29%), Positives = 133/306 (43%), Gaps = 49/306 (16%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD---------VAIKRIKKSCFTGRSSEQERLTVEF 860
+ L K LG G FG V + G D VA+K +K + ++ +
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLK-------DNATDKDLADL 64
Query: 861 WKEAEILSKL-HHPNVVAFYGV-VQDGPGGTLATVAEYMVDGSLRHVLVRK--------- 909
E E++ + H N++ GV Q+GP L + EY G+LR L +
Sbjct: 65 ISEMELMKLIGKHKNIINLLGVCTQEGP---LYVIVEYAAKGNLREFLRARRPPGPDYTF 121
Query: 910 ------DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGD 963
+ L + + A A GMEYL S+ +H DL N+LV + + K+ D
Sbjct: 122 DITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN----VMKIAD 177
Query: 964 FGLSK----IKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GE 1018
FGL++ I S G R + WMAPE L + + DV+SFGI++WEI T G
Sbjct: 178 FGLARGVHDIDYYKKTSNG-RLPVKWMAPEALF--DRVYTHQSDVWSFGILMWEIFTLGG 234
Query: 1019 EPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078
PY + + ++ R PS C E LM ECW P RP+F ++ L +
Sbjct: 235 SPYPGIPVEELFK-LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293
Query: 1079 STAASQ 1084
A S+
Sbjct: 294 LAAVSE 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 78/265 (29%), Positives = 124/265 (46%), Gaps = 29/265 (10%)
Query: 811 DLEEQKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILS 868
D E ++G G+FG V+ K A+K+I S R E E EA +L+
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRERE------EAIDEARVLA 54
Query: 869 KLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLI------IA 922
KL ++ +Y D G L V EY +G L H L++ R R L
Sbjct: 55 KLDSSYIIRYYESFLDK--GKLNIVMEYAENGDL-HKLLKMQR----GRPLPEDQVWRFF 107
Query: 923 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI-KRNTLVSGGVRG 981
+ G+ +LHSK I+H D+K NL ++ D K+GD G++K+ NT + + G
Sbjct: 108 IQILLGLAHLHSKKILHRDIKSLNLFLDAYDN----VKIGDLGVAKLLSDNTNFANTIVG 163
Query: 982 TLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT 1041
T +++PEL +EK DV++ G+VL+E TG+ P+ + GA+I I+ P
Sbjct: 164 TPYYLSPELCE--DKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPP- 220
Query: 1042 IPSYCDAEWRTLMEECWAPNPAARP 1066
+ + L+++C + RP
Sbjct: 221 VSQMYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 70/287 (24%), Positives = 129/287 (44%), Gaps = 35/287 (12%)
Query: 799 FDVSSVQVIKNEDLEEQKEL--GSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERL 856
++ ++ I+++D+++ + ++Y G + +V I+ KK + L
Sbjct: 7 SYINDIKCIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKF-----HKGHKVL 61
Query: 857 TVEFWKEAEILSKLHHPNVVAFYG----VVQDGPGGTLATVAEYMVDGSLRHVLVRKDRF 912
E + L ++ N++ YG +V D P +L + EY G LR VL K++
Sbjct: 62 IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSL--ILEYCTRGYLREVL-DKEKD 118
Query: 913 LDRRRRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI-- 969
L + +L +A+D G+ L+ N + +L + LV K+ GL KI
Sbjct: 119 LSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVT----ENYKLKIICHGLEKILS 174
Query: 970 -----KRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANM 1024
N +V + + ++L+ S+ + K D++S G+VLWEI TG+ P+ N+
Sbjct: 175 SPPFKNVNFMV---------YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225
Query: 1025 HYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
I I+N +P C E + ++E C + + RP+ EI
Sbjct: 226 TTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEI 272
|
Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-24
Identities = 80/276 (28%), Positives = 132/276 (47%), Gaps = 15/276 (5%)
Query: 804 VQVIKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKE 863
++++K +L+ K LGSG FGTVY G W +K I + + + VEF E
Sbjct: 1 LRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVK-IPVAIKILNETTGPKANVEFMDE 59
Query: 864 AEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAM 923
A I++ + HP++V GV T+ V + M G L + + + L +
Sbjct: 60 ALIMASMDHPHLVRLLGVCLS---PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCV 116
Query: 924 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI---KRNTLVSGGVR 980
A GM YL + +VH DL N+LV K P+ K+ DFGL+++ + G +
Sbjct: 117 QIAKGMMYLEERRLVHRDLAARNVLV--KSPNH--VKITDFGLARLLEGDEKEYNADGGK 172
Query: 981 GTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLR 1039
+ WMA E + K + + DV+S+G+ +WE++T G +PY + I ++ R
Sbjct: 173 MPIKWMALECI--HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-IPDLLEKGER 229
Query: 1040 PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
P C + +M +CW + +RP F E+A+
Sbjct: 230 LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEF 265
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-24
Identities = 92/303 (30%), Positives = 132/303 (43%), Gaps = 60/303 (19%)
Query: 815 QKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTV---------------E 859
+++LG G FG V+ + G +++ F+ S + + V +
Sbjct: 10 KEKLGEGQFGEVHLCEAEG----MEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARND 65
Query: 860 FWKEAEILSKLHHPNVVAFYGV-VQDGPGGTLATVAEYMVDGSLRHVLVRKD-------- 910
F KE +I+S+L PN++ V + P L + EYM +G L L R +
Sbjct: 66 FLKEIKIMSRLKDPNIIRLLAVCITSDP---LCMITEYMENGDLNQFLSRHEPQEAAEKA 122
Query: 911 --RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968
+ + +A A GM+YL S N VH DL N LV K+ DFG+S
Sbjct: 123 DVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG----KNYTIKIADFGMS- 177
Query: 969 IKRNTLVSGGV-----RGTLP--WMAPE-LLSGSSSKVSEKVDVFSFGIVLWEILT--GE 1018
RN L SG R LP WM+ E +L G + S DV++FG+ LWEILT E
Sbjct: 178 --RN-LYSGDYYRIQGRAVLPIRWMSWESILLGKFTTAS---DVWAFGVTLWEILTLCKE 231
Query: 1019 EPYANMHYGAII---GGIVNNTLRPTI---PSYCDAEWRTLMEECWAPNPAARPSFTEIA 1072
+PY+ + +I G + R P+ C LM CW N RPSF EI
Sbjct: 232 QPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIH 291
Query: 1073 SRL 1075
+ L
Sbjct: 292 ATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-24
Identities = 81/276 (29%), Positives = 132/276 (47%), Gaps = 23/276 (8%)
Query: 804 VQVIKNEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFW 861
++++K + ++ K LGSG FGTVY G W G V I K R + + E
Sbjct: 1 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL---REATSPKANKEIL 57
Query: 862 KEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGS-LRHVLVRKDRFLDRRRRLI 920
EA +++ + +P+V G+ T+ + + M G L +V KD + + L
Sbjct: 58 DEAYVMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDN-IGSQYLLN 113
Query: 921 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI----KRNTLVS 976
+ A GM YL + +VH DL N+LV K P K+ DFGL+K+ ++
Sbjct: 114 WCVQIAKGMNYLEERRLVHRDLAARNVLV--KTPQH--VKITDFGLAKLLGADEKEYHAE 169
Query: 977 GGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 1035
GG + + WMA E S + + DV+S+G+ +WE++T G +PY + + I I+
Sbjct: 170 GG-KVPIKWMALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-ASEISSILE 225
Query: 1036 NTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
R P C + +M +CW + +RP F E+
Sbjct: 226 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFREL 261
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 81/266 (30%), Positives = 125/266 (46%), Gaps = 25/266 (9%)
Query: 816 KELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
K LG G FG VY + G ++A+K+++ F S E + E ++L L H
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQ---FDPESPETSKEVNALECEIQLLKNLLHE 64
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVL----VRKDRFLDRRRRLIIAMDAAFGM 929
+V +YG ++D TL+ E+M GS++ L + + R I+ G+
Sbjct: 65 RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILE-----GV 119
Query: 930 EYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSG----GVRGTLPW 985
YLHS IVH D+K N+ L+D + K+GDFG SK + +SG V GT W
Sbjct: 120 SYLHSNMIVHRDIKGANI---LRDSVGNV-KLGDFGASKRLQTICLSGTGMKSVTGTPYW 175
Query: 986 MAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSY 1045
M+PE++SG K D++S G + E+LT + P+A A I I P +P +
Sbjct: 176 MSPEVISGEG--YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPH 233
Query: 1046 CDAEWRTLMEECWAPNPAARPSFTEI 1071
R ++ + RPS E+
Sbjct: 234 VSDHCRDFLKRIFV-EAKLRPSADEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 87/266 (32%), Positives = 126/266 (47%), Gaps = 25/266 (9%)
Query: 816 KELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
K LG G FG VY + G ++A K+++ F S E + E ++L L H
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQ---FDPESPETSKEVSALECEIQLLKNLQHE 64
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVL----VRKDRFLDRRRRLIIAMDAAFGM 929
+V +YG ++D TL EYM GS++ L + + R I+ GM
Sbjct: 65 RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILE-----GM 119
Query: 930 EYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSG-GVR---GTLPW 985
YLHS IVH D+K N+ L+D + + K+GDFG SK + +SG G+R GT W
Sbjct: 120 SYLHSNMIVHRDIKGANI---LRDSAGNV-KLGDFGASKRLQTICMSGTGIRSVTGTPYW 175
Query: 986 MAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSY 1045
M+PE++SG K DV+S G + E+LT + P+A A I I P +PS+
Sbjct: 176 MSPEVISGEG--YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSH 233
Query: 1046 CDAEWRTLMEECWAPNPAARPSFTEI 1071
R + C RPS E+
Sbjct: 234 ISEHARDFL-GCIFVEARHRPSAEEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 77/276 (27%), Positives = 131/276 (47%), Gaps = 41/276 (14%)
Query: 811 DLEEQKELGSGTFGTVYHGKWRGTD---VAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
D + K+LG G++G+VY K R +D A+K + G S++ER + E IL
Sbjct: 1 DFKVLKKLGKGSYGSVYKVK-RLSDNQFYALKEVD----LGSMSQKERE--DAVNEIRIL 53
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLI------- 920
+ ++HPN++++ DG L V EY G L + ++ + +R+LI
Sbjct: 54 ASVNHPNIISYKEAFLDG--NKLCIVMEYAPFGDLSKAISKRKK----KRKLIPEQEIWR 107
Query: 921 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR 980
I + G++ LH + I+H DLK N+L+ D + K+GD G+SK+ + + +
Sbjct: 108 IFIQLLRGLQALHEQKILHRDLKSANILLVAND----LVKIGDLGISKVLKKNMAKTQI- 162
Query: 981 GTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPY-----ANMHYGAIIGGIVN 1035
GT +MAPE+ G S K D++S G +L+E+ T P+ ++ Y + G
Sbjct: 163 GTPHYMAPEVWKGRP--YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY-KVQRGKY- 218
Query: 1036 NTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
P IP + + + P RP+ +I
Sbjct: 219 ----PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 8e-24
Identities = 78/273 (28%), Positives = 125/273 (45%), Gaps = 37/273 (13%)
Query: 816 KELGSGTFGTVYHGKWRGTDV------AIKRIKKSCFTGRSSEQERLTVEFWKEAEILSK 869
++G GTFG VY ++ A+K I+ + E E ++L
Sbjct: 6 NKIGGGTFGKVY----TAVNLDTGELMAVKEIRIQ------DNDPKTIKEIADEMKVLEL 55
Query: 870 LHHPNVVAFYGV-VQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRR--RRLIIAMDAA 926
L HPN+V +YGV V + EY G+L +L R LD R + +
Sbjct: 56 LKHPNLVKYYGVEVHRE---KVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTLQL--L 109
Query: 927 FGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-IKRNTLVSG----GVRG 981
G+ YLHS IVH D+K N+ ++ + K+GDFG + +K NT G + G
Sbjct: 110 EGLAYLHSHGIVHRDIKPANIFLD----HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAG 165
Query: 982 TLPWMAPELLSGSSSKVSEK-VDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 1040
T +MAPE+++G K + D++S G V+ E+ TG+ P++ + I V +P
Sbjct: 166 TPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKP 225
Query: 1041 TIPS--YCDAEWRTLMEECWAPNPAARPSFTEI 1071
IP E + ++ C +P RP+ +E+
Sbjct: 226 PIPDSLQLSPEGKDFLDRCLESDPKKRPTASEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 91/278 (32%), Positives = 123/278 (44%), Gaps = 32/278 (11%)
Query: 816 KELGSGTFGTVYHGKWRGTD----VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH 871
K LG G FG+V G+ D VA+K +K + T SE E +F EA + +
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICT--RSEME----DFLSEAVCMKEFD 58
Query: 872 HPNVVAFYGVVQDGPGG----TLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAM---- 923
HPNV+ GV + + +M G L H + R D + L M
Sbjct: 59 HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDL-HSFLLYSRLGDCPQYLPTQMLVKF 117
Query: 924 --DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS-KIKRNTLVSGGVR 980
D A GMEYL SK+ +H DL N ++N + +C V DFGLS KI G
Sbjct: 118 MTDIASGMEYLSSKSFIHRDLAARNCMLN---ENMNVC-VADFGLSKKIYNGDYYRQGRI 173
Query: 981 GTLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNT 1037
+P W+A E L + + K DV+SFG+ +WEI T G+ PY + I +
Sbjct: 174 AKMPVKWIAIESL--ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN 231
Query: 1038 LRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
R P C +LM CW NP RPSF + L
Sbjct: 232 -RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCEL 268
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 81/270 (30%), Positives = 120/270 (44%), Gaps = 22/270 (8%)
Query: 811 DLEEQKE---LGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTVEFWKEAE 865
+ +E E LG GT+G VY + T V AIK I + R S + E E
Sbjct: 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPE-----RDSRYVQPLHE---EIA 57
Query: 866 ILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDA 925
+ S L H N+V + G D G E + GSL +L K L + II
Sbjct: 58 LHSYLKHRNIVQYLG--SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK 115
Query: 926 AF--GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-IKRNTLVSGGVRGT 982
G++YLH IVH D+K DN+LVN + K+ DFG SK + + GT
Sbjct: 116 QILEGLKYLHDNQIVHRDIKGDNVLVNTYS---GVVKISDFGTSKRLAGINPCTETFTGT 172
Query: 983 LPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANM-HYGAIIGGIVNNTLRPT 1041
L +MAPE++ D++S G + E+ TG+ P+ + A + + + P
Sbjct: 173 LQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPE 232
Query: 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
IP AE + + C+ P+P R S ++
Sbjct: 233 IPESLSAEAKNFILRCFEPDPDKRASAHDL 262
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 81/279 (29%), Positives = 121/279 (43%), Gaps = 44/279 (15%)
Query: 816 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HH 872
+ +G GT+G VY + + T VAIK + E+E + E+ IL K +H
Sbjct: 12 EVIGEGTYGKVYKARHKKTGQLVAIKIMDI-----IEDEEEEIKEEY----NILRKYSNH 62
Query: 873 PNVVAFYGV----VQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRR--LI--IAMD 924
PN+ FYG G L V E GS+ LV+ R +R + I I +
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTD-LVKGLRKKGKRLKEEWIAYILRE 121
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK------IKRNTLVSGG 978
G+ YLH ++H D+K N+L L + K+ DFG+S +RNT +
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNIL--LTKNAE--VKLVDFGVSAQLDSTLGRRNTFI--- 174
Query: 979 VRGTLPWMAPELLSGSSS---KVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN 1035
GT WMAPE+++ + DV+S GI E+ G+ P +MH + I
Sbjct: 175 --GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR 232
Query: 1036 N---TLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
N TL+ P ++ + EC N RP E+
Sbjct: 233 NPPPTLKS--PENWSKKFNDFISECLIKNYEQRPFMEEL 269
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 82/288 (28%), Positives = 135/288 (46%), Gaps = 21/288 (7%)
Query: 804 VQVIKNEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFW 861
++++K +L++ K LGSG FGTVY G W G +V +I + R + + E
Sbjct: 1 MRILKETELKKVKVLGSGAFGTVYKGIWIPDGENV---KIPVAIKVLRENTSPKANKEIL 57
Query: 862 KEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGS-LRHVLVRKDRFLDRRRRLI 920
EA +++ + P V G+ T+ V + M G L +V KDR + + L
Sbjct: 58 DEAYVMAGVGSPYVCRLLGICLT---STVQLVTQLMPYGCLLDYVRENKDR-IGSQDLLN 113
Query: 921 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK---IKRNTLVSG 977
+ A GM YL +VH DL N+LV K P+ K+ DFGL++ I +
Sbjct: 114 WCVQIAKGMSYLEEVRLVHRDLAARNVLV--KSPNH--VKITDFGLARLLDIDETEYHAD 169
Query: 978 GVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 1036
G + + WMA E S + + + DV+S+G+ +WE++T G +PY + I ++
Sbjct: 170 GGKVPIKWMALE--SILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP-AREIPDLLEK 226
Query: 1037 TLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQ 1084
R P C + +M +CW + RP F E+ ++ S+
Sbjct: 227 GERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPSR 274
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 76/274 (27%), Positives = 125/274 (45%), Gaps = 48/274 (17%)
Query: 818 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHH--- 872
+G G +G VY GK T VA+K I + + + + +E +LS+L
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLD-----TPDDD--VSDIQREVALLSQLRQSQP 61
Query: 873 PNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYL 932
PN+ +YG GP L + EY GS+R ++ K + + +I + ++Y+
Sbjct: 62 PNITKYYGSYLKGP--RLWIIMEYAEGGSVRTLM--KAGPIAEKYISVIIREVLVALKYI 117
Query: 933 HSKNIVHFDLKCDNLLV----NLKDPSRPICKVGDFGLS------KIKRNTLVSGGVRGT 982
H ++H D+K N+LV N+K +C DFG++ KR+T V GT
Sbjct: 118 HKVGVIHRDIKAANILVTNTGNVK-----LC---DFGVAALLNQNSSKRSTFV-----GT 164
Query: 983 LPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTI 1042
WMAPE+++ K D++S GI ++E+ TG PY+++ + I + +P
Sbjct: 165 PYWMAPEVITEGKY-YDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KP-- 219
Query: 1043 PSYCDAEWRTLMEE----CWAPNPAARPSFTEIA 1072
P D + L+ E C P R S E+
Sbjct: 220 PRLEDNGYSKLLREFVAACLDEEPKERLSAEELL 253
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 1e-22
Identities = 95/311 (30%), Positives = 139/311 (44%), Gaps = 65/311 (20%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD----------------VAIKRIKKSCFTGRSSEQ 853
+ L +++LG G FG V+ + G VA+K + R+
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKML-------RADVT 57
Query: 854 ERLTVEFWKEAEILSKLHHPNVVAFYGV-VQDGPGGTLATVAEYMVDGSLRHVLVRKDRF 912
+ +F KE +I+S+L +PN++ GV V D P L + EYM +G L L +++
Sbjct: 58 KTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDP---LCMITEYMENGDLNQFLSQREIE 114
Query: 913 -----------LDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKV 961
+ L +A+ A GM+YL S N VH DL N LV I K+
Sbjct: 115 STFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV---GNHYTI-KI 170
Query: 962 GDFGLSKIKRNTLVSGGV-----RGTLP--WMAPE-LLSGSSSKVSEKVDVFSFGIVLWE 1013
DFG+S RN L SG R LP WMA E +L G + S DV++FG+ LWE
Sbjct: 171 ADFGMS---RN-LYSGDYYRIQGRAVLPIRWMAWESILLGKFTTAS---DVWAFGVTLWE 223
Query: 1014 I--LTGEEPYANMHYGAII---GGIVNNTLRP---TIPSYCDAEWRTLMEECWAPNPAAR 1065
+ L E+PY+ + +I G N R + C + LM CW+ + R
Sbjct: 224 MFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDR 283
Query: 1066 PSFTEIASRLR 1076
P+F +I LR
Sbjct: 284 PTFNKIHHFLR 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 76/277 (27%), Positives = 125/277 (45%), Gaps = 34/277 (12%)
Query: 811 DLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQER--LTVEFWKEAEILS 868
D E + +G G+FGTV + R +D I K+ + G +E+E+ L E IL
Sbjct: 1 DYEVLETIGKGSFGTVRKVR-RKSDGKILVWKEIDY-GNMTEKEKQQLVSEV----NILR 54
Query: 869 KLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVL--VRKDR-FLDRRRRLIIAMDA 925
+L HPN+V +Y + D TL V EY G L ++ +K+R +++ I
Sbjct: 55 ELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQL 114
Query: 926 AFGMEYLH-----SKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRN------TL 974
+ H ++H DLK N+ ++ + K+GDFGL+KI + T
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLD----ANNNVKLGDFGLAKILGHDSSFAKTY 170
Query: 975 VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV 1034
V GT +M+PE L+ S EK D++S G +++E+ P+ + + I
Sbjct: 171 V-----GTPYYMSPEQLNHMSY--DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK 223
Query: 1035 NNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
R IP +E +++ +P RPS E+
Sbjct: 224 EGKFRR-IPYRYSSELNEVIKSMLNVDPDKRPSTEEL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 2e-22
Identities = 84/275 (30%), Positives = 126/275 (45%), Gaps = 40/275 (14%)
Query: 809 NEDLEEQ----KELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFW--- 861
+D E+ +E+G G+FG VY + T+ + IKK ++G+ S E W
Sbjct: 10 KDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVA-IKKMSYSGKQS------NEKWQDI 62
Query: 862 -KEAEILSKLHHPNVVAFYGV-VQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRL 919
KE L +L HPN + + G +++ T V EY + GS +L + L
Sbjct: 63 IKEVRFLQQLRHPNTIEYKGCYLREH---TAWLVMEYCL-GSASDILEVHKKPLQEVEIA 118
Query: 920 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKR--NTLVSG 977
I A G+ YLHS +H D+K N+L L +P K+ DFG + + N+ V
Sbjct: 119 AICHGALQGLAYLHSHERIHRDIKAGNIL--LTEPG--TVKLADFGSASLVSPANSFV-- 172
Query: 978 GVRGTLPWMAPE-LLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN 1036
GT WMAPE +L+ + KVDV+S GI E+ + P NM+ + + I N
Sbjct: 173 ---GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 229
Query: 1037 TLRPTIPSYCDAEW----RTLMEECWAPNPAARPS 1067
PT+ S +W R ++ C P RPS
Sbjct: 230 D-SPTLSS---NDWSDYFRNFVDSCLQKIPQDRPS 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 3e-22
Identities = 71/216 (32%), Positives = 110/216 (50%), Gaps = 31/216 (14%)
Query: 813 EEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL 870
+ K+LG GTFG+VY + + G VAIK++KK F S +E + + +E + L KL
Sbjct: 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKK-FY---SWEECMNL---REVKSLRKL 54
Query: 871 -HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLV-RKDRFLDRRR-RLIIAMDAAF 927
HPN+V V ++ L V EYM +G+L ++ RK + R II
Sbjct: 55 NEHPNIVKLKEVFRE--NDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQ- 110
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRN-----TLVSGGVRGT 982
G+ ++H H DLK +NLLV+ + K+ DFGL++ R+ VS T
Sbjct: 111 GLAHIHKHGFFHRDLKPENLLVS----GPEVVKIADFGLAREIRSRPPYTDYVS-----T 161
Query: 983 LPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
+ APE+L S+S S VD+++ G ++ E+ T
Sbjct: 162 RWYRAPEILLRSTS-YSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 7e-22
Identities = 70/276 (25%), Positives = 118/276 (42%), Gaps = 38/276 (13%)
Query: 821 GTFGTVYHGKWRGTDVAIKR--IKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAF 878
GTFG +++G + K+ S Q L +E+ +L L H N++
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTL---LLQESCLLYGLSHQNILPI 73
Query: 879 YGVVQDGPGGTLATVAEYMVDGSL-------RHVLVRKDRFLDRRRRLIIAMDAAFGMEY 931
V + YM G+L R + L ++ + +A+ A GM Y
Sbjct: 74 LHVCIEDGEPPFVLYP-YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSY 132
Query: 932 LHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK----IKRNTLVSGGVRGTLPWMA 987
LH + ++H D+ N +++ + + K+ D LS+ + + L R + WMA
Sbjct: 133 LHKRGVIHKDIAARNCVID--EELQ--VKITDNALSRDLFPMDYHCLGDNENR-PVKWMA 187
Query: 988 PELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANM------HYGAIIGGIVNNTLRP 1040
E L + + S DV+SFG++LWE++T G+ PY + Y + + R
Sbjct: 188 LESLV--NKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAY-------LKDGYRL 238
Query: 1041 TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076
P C E +M CWA +P RPSF+++ L
Sbjct: 239 AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLT 274
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 7e-22
Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 27/210 (12%)
Query: 816 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
++G GT+G VY + + T VAIK+IK E E + +E ++L +L+HP
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIK------LRFESEGIPKTALREIKLLKELNHP 58
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLH 933
N++ V G L V E+M D L ++ + R L G+ + H
Sbjct: 59 NIIKLLDVF--RHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115
Query: 934 SKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR------GTLPWMA 987
S I+H DLK +NLL+N + + K+ DFGL++ VR T + A
Sbjct: 116 SHGILHRDLKPENLLINTEG----VLKLADFGLAR-----SFGSPVRPYTHYVVTRWYRA 166
Query: 988 PELLSGSSSKVSEKVDVFSFGIVLWEILTG 1017
PELL G S VD++S G + E+L+
Sbjct: 167 PELLLG-DKGYSTPVDIWSVGCIFAELLSR 195
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 8e-22
Identities = 70/269 (26%), Positives = 132/269 (49%), Gaps = 30/269 (11%)
Query: 816 KELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
K++G G+FG +Y K IK I + + E + KE +L+K+ HP
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK------KEVILLAKMKHP 59
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSL-------RHVLVRKDRFLDRRRRLIIAMDAA 926
N+V F+ Q+ G L V EY G L R VL +D+ L ++ +
Sbjct: 60 NIVTFFASFQE--NGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQI------S 111
Query: 927 FGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTL-VSGGVRGTLPW 985
G++++H + I+H D+K N+ ++ + + K+GDFG+++ +++ ++ GT +
Sbjct: 112 LGLKHIHDRKILHRDIKSQNIFLS---KNGMVAKLGDFGIARQLNDSMELAYTCVGTPYY 168
Query: 986 MAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSY 1045
++PE+ + + K D++S G VL+E+ T + P+ + ++ I P P++
Sbjct: 169 LSPEIC--QNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNF 226
Query: 1046 CDAEWRTLMEECWAPNPAARPSFTEIASR 1074
+ R+L+ + + +P RPS T I R
Sbjct: 227 -SRDLRSLISQLFKVSPRDRPSITSILKR 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 8e-22
Identities = 78/294 (26%), Positives = 118/294 (40%), Gaps = 74/294 (25%)
Query: 818 LGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQE------------RLTVEFWKEAE 865
LG GTF +Y G R +S QE R ++ F++ A
Sbjct: 3 LGQGTFTNIYKGVLR---------VQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETAS 53
Query: 866 ILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRR-------R 918
++S+L H ++V YGV + V EY+ G L D FL R + +
Sbjct: 54 LMSQLSHKHLVKLYGVCV-RDENIM--VEEYVKFGPL-------DVFLHREKNNVSLHWK 103
Query: 919 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSR---PICKVGDFG--LSKIKRNT 973
L +A A + YL K +VH ++ N+LV + P K+ D G ++ + R
Sbjct: 104 LDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREE 163
Query: 974 LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGG 1032
V +PW+APE + + ++ D +SFG L EI + GEEP
Sbjct: 164 RVE-----RIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPL----------- 207
Query: 1033 IVNNTLRPT-----------IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
+TL + +P AE L+ +CW +P RPSF I L
Sbjct: 208 ---STLSSSEKERFYQDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 1e-21
Identities = 64/238 (26%), Positives = 110/238 (46%), Gaps = 42/238 (17%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
+D + K +G G+F TV K + T+ AIK + K +E+ E E+L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI-----KEKKVKYVKIEKEVL 55
Query: 868 SKL-HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIA--MD 924
++L HP ++ Y QD L V EY +G L + + ++ R A +
Sbjct: 56 TRLNGHPGIIKLYYTFQDE--ENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILL 113
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR---- 980
A +EYLHSK I+H DLK +N+L++ KD K+ DFG +K+ +
Sbjct: 114 A---LEYLHSKGIIHRDLKPENILLD-KDMH---IKITDFGTAKVLDPNSSPESNKGDAT 166
Query: 981 -----------------GTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1021
GT +++PELL+ + + D+++ G +++++LTG+ P+
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA--GKSSDLWALGCIIYQMLTGKPPF 222
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 1e-21
Identities = 85/300 (28%), Positives = 130/300 (43%), Gaps = 48/300 (16%)
Query: 816 KELGSGTFGTVYHGKWRGTD---------VAIKRIKKSCFTGRSSEQERLTVEFWKEAEI 866
K LG G FG V + G D VA+K +K E+ + E E+
Sbjct: 21 KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-------TEKDLSDLVSEMEM 73
Query: 867 LSKL-HHPNVVAFYGV-VQDGPGGTLATVAEYMVDGSLRHVLVRK--------------- 909
+ + H N++ G QDGP L + EY G+LR L +
Sbjct: 74 MKMIGKHKNIINLLGACTQDGP---LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130
Query: 910 DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI 969
D + + + A GMEYL S+ +H DL N+LV + + K+ DFGL++
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENN----VMKIADFGLARD 186
Query: 970 KRNT-LVSGGVRGTLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH 1025
N G LP WMAPE L + + DV+SFG+++WEI T G PY +
Sbjct: 187 VNNIDYYKKTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244
Query: 1026 YGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL-RVLSTAASQ 1084
+ ++ R P+ C E +M +CW P+ RP+F ++ L R+L+ ++
Sbjct: 245 VEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTNE 303
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-21
Identities = 78/251 (31%), Positives = 118/251 (47%), Gaps = 24/251 (9%)
Query: 816 KELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
K LG G FG VY + G ++A+K++ F S E + E ++L L H
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVP---FDPDSQETSKEVNALECEIQLLKNLRHD 64
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVL----VRKDRFLDRRRRLIIAMDAAFGM 929
+V +YG ++D L+ EYM GS++ L + R R I+ G+
Sbjct: 65 RIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQ-----GV 119
Query: 930 EYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSG----GVRGTLPW 985
YLHS IVH D+K N+ L+D + + K+GDFG SK + +SG V GT W
Sbjct: 120 SYLHSNMIVHRDIKGANI---LRDSAGNV-KLGDFGASKRIQTICMSGTGIKSVTGTPYW 175
Query: 986 MAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSY 1045
M+PE++SG K DV+S + E+LT + P+A A I I +P +P
Sbjct: 176 MSPEVISGEG--YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDG 233
Query: 1046 CDAEWRTLMEE 1056
R +++
Sbjct: 234 VSDACRDFLKQ 244
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 4e-21
Identities = 67/213 (31%), Positives = 103/213 (48%), Gaps = 34/213 (15%)
Query: 816 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
K+LG GT+ VY + + T VAIK+IK R ++ + +E ++L +L HP
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLG---ERKEAKDGINFTALREIKLLQELKHP 62
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF------ 927
N++ V G + V E+M + L V+ KD+ + L A ++
Sbjct: 63 NIIGLLDVF--GHKSNINLVFEFM-ETDLEKVI--KDKSI----VLTPADIKSYMLMTLR 113
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGT----L 983
G+EYLHS I+H DLK +NLL+ S + K+ DFGL++ S + T
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIA----SDGVLKLADFGLARS----FGSPNRKMTHQVVT 165
Query: 984 PWM-APELLSGSSSKVSEKVDVFSFGIVLWEIL 1015
W APELL G+ VD++S G + E+L
Sbjct: 166 RWYRAPELLFGARH-YGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 4e-21
Identities = 89/299 (29%), Positives = 132/299 (44%), Gaps = 48/299 (16%)
Query: 816 KELGSGTFGTVYHGKWRGTD---------VAIKRIKKSCFTGRSSEQERLTVEFWKEAEI 866
K LG G FG V + G D VA+K +K ++ + E E+
Sbjct: 18 KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLK-------DDATDKDLSDLVSEMEM 70
Query: 867 LSKL-HHPNVVAFYGV-VQDGPGGTLATVAEYMVDGSLRHVL-VRKDRFLDR-------- 915
+ + H N++ G QDGP L + EY G+LR L R+ +D
Sbjct: 71 MKMIGKHKNIINLLGACTQDGP---LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLP 127
Query: 916 ------RRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI 969
+ + A A GMEYL S+ +H DL N+LV + + K+ DFGL++
Sbjct: 128 EEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDN----VMKIADFGLARD 183
Query: 970 KRNT-LVSGGVRGTLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH 1025
N G LP WMAPE L + + DV+SFG++LWEI T G PY +
Sbjct: 184 VHNIDYYKKTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241
Query: 1026 YGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL-RVLSTAAS 1083
+ ++ R P+ C E +M ECW P+ RP+F ++ L RVL+ ++
Sbjct: 242 VEELFK-LLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 2e-20
Identities = 77/265 (29%), Positives = 120/265 (45%), Gaps = 34/265 (12%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
+D E K LG+G+FG V + +G+ A+K + K+ +Q + E IL
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV--KLKQVEHVLN---EKRIL 55
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
+ HP +V YG QD L V EY+ G L L + RF + R A
Sbjct: 56 QSIRHPFLVNLYGSFQDD--SNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAA-QVVL 112
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRN---TLVSGGVRGTLP 984
+EYLHS +IV+ DLK +NLL++ S K+ DFG +K + TL GT
Sbjct: 113 ALEYLHSLDIVYRDLKPENLLLD----SDGYIKITDFGFAKRVKGRTYTLC-----GTPE 163
Query: 985 WMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYA----NMHYGAIIGGIVNNTLRP 1040
++APE++ + VD ++ GI+++E+L G P+ Y I+ G V
Sbjct: 164 YLAPEIILSKGYGKA--VDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKV------ 215
Query: 1041 TIPSYCDAEWRTLMEECWAPNPAAR 1065
PS+ + + L+ + R
Sbjct: 216 RFPSFFSPDAKDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|215996 pfam00564, PB1, PB1 domain | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 3e-20
Identities = 30/87 (34%), Positives = 45/87 (51%), Gaps = 6/87 (6%)
Query: 100 PSDGKLRYVGGETRIIRIRKDISWQILRQKALEVYNQ-VHVIKYQLPGEDLDALVSVSCD 158
KLRY GG R + + IS++ LR K + + K + P ED D LVS++ D
Sbjct: 1 TVRVKLRYGGGIRRFLSVSPGISFEELRSKVEQRFGLDRVDFKLKYPDEDGD-LVSITSD 59
Query: 159 EDLQNMMEEYNELGDREGSQRIRMFLF 185
EDL+ +EE GS+ +R+ +F
Sbjct: 60 EDLEEAIEEA----RSLGSKTLRLHVF 82
|
Length = 84 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 5e-20
Identities = 85/254 (33%), Positives = 116/254 (45%), Gaps = 53/254 (20%)
Query: 859 EFWKEAEILSKLHHPNVVAFYGV-VQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRR 917
+F KE +ILS+L PN++ GV V + P L + EYM +G L L LD +
Sbjct: 65 DFLKEVKILSRLKDPNIIRLLGVCVDEDP---LCMITEYMENGDLNQFL--SSHHLDDKE 119
Query: 918 R--------------------LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRP 957
L +A+ A GM+YL S N VH DL N LV +
Sbjct: 120 ENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVG---ENLT 176
Query: 958 ICKVGDFGLSKIKRNTLVSGGV-----RGTLP--WMAPE-LLSGSSSKVSEKVDVFSFGI 1009
I K+ DFG+S RN L +G R LP WMA E +L G + S DV++FG+
Sbjct: 177 I-KIADFGMS---RN-LYAGDYYRIQGRAVLPIRWMAWECILMGKFTTAS---DVWAFGV 228
Query: 1010 VLWEILT--GEEPYANMHYGAII---GGIVNNTLRPTI---PSYCDAEWRTLMEECWAPN 1061
LWEIL E+PY + +I G + R P C LM +CW+ +
Sbjct: 229 TLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRD 288
Query: 1062 PAARPSFTEIASRL 1075
RPSF++I + L
Sbjct: 289 CRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 7e-20
Identities = 75/260 (28%), Positives = 128/260 (49%), Gaps = 18/260 (6%)
Query: 816 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
+ +G G++G V + R G IK++ +S +ER E +EA++LS+L HP
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLR----NASRRERKAAE--QEAQLLSQLKHP 59
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLV-RKDRFLDRRRRLIIAMDAAFGMEYL 932
N+VA Y +G G L V + G L H L +K + L + + + A ++YL
Sbjct: 60 NIVA-YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYL 118
Query: 933 HSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTL-VSGGVRGTLPWMAPELL 991
H K+I+H DLK N+ + + I KVGD G++++ N ++ + GT +M+PEL
Sbjct: 119 HEKHILHRDLKTQNVFLTRTN----IIKVGDLGIARVLENQCDMASTLIGTPYYMSPELF 174
Query: 992 SGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWR 1051
S+ + K DV++ G ++E+ T + + +++ I+ L P +P E
Sbjct: 175 --SNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL-PPMPKDYSPELG 231
Query: 1052 TLMEECWAPNPAARPSFTEI 1071
L+ + P RPS I
Sbjct: 232 ELIATMLSKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 7e-20
Identities = 79/274 (28%), Positives = 128/274 (46%), Gaps = 29/274 (10%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEI 866
++NEDLE +LG+G G+V K T + KK G S + + +E +I
Sbjct: 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMA--KKVVHIGAKSSVRKQIL---RELQI 56
Query: 867 LSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAA 926
+ + P +V+FYG + + E+M GSL + +K + IA+
Sbjct: 57 MHECRSPYIVSFYGAFLNEN--NICMCMEFMDCGSLDRIY-KKGGPIPVEILGKIAVAVV 113
Query: 927 FGMEYLHSKN-IVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPW 985
G+ YL++ + I+H D+K N+LVN SR K+ DFG+S N++ V GT +
Sbjct: 114 EGLTYLYNVHRIMHRDIKPSNILVN----SRGQIKLCDFGVSGELINSIADTFV-GTSTY 168
Query: 986 MAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYA-----------NMHYGAIIGGIV 1034
M+PE + G K + K DV+S GI + E+ G+ P+A M ++ IV
Sbjct: 169 MSPERIQG--GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV 226
Query: 1035 NNTLRPTIPS-YCDAEWRTLMEECWAPNPAARPS 1067
P +PS + R ++ C +P RP+
Sbjct: 227 QEP-PPRLPSSDFPEDLRDFVDACLLKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 8e-20
Identities = 73/220 (33%), Positives = 102/220 (46%), Gaps = 53/220 (24%)
Query: 821 GTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAF 878
GT+G VY + + T VA+K++K E+E + +E IL KL HPN+V
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLK------MEKEKEGFPITSLREINILLKLQHPNIVTV 69
Query: 879 YGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF----------- 927
VV G L + YMV + H L K L+ M F
Sbjct: 70 KEVVV---GSNLDKI--YMVMEYVEHDL--KS--------LMETMKQPFLQSEVKCLMLQ 114
Query: 928 ---GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL-----SKIKRNT-LVSGG 978
G+ +LH I+H DLK NLL+N +R I K+ DFGL S +K T LV
Sbjct: 115 LLSGVAHLHDNWILHRDLKTSNLLLN----NRGILKICDFGLAREYGSPLKPYTQLVV-- 168
Query: 979 VRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
TL + APELL G + + S +D++S G + E+LT +
Sbjct: 169 ---TLWYRAPELLLG-AKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 8e-20
Identities = 84/270 (31%), Positives = 129/270 (47%), Gaps = 26/270 (9%)
Query: 816 KELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNV 875
+E+G G+FG VY + T+ + IKK ++G+ S ++ + KE + L ++ HPN
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVA-IKKMSYSGKQSNEK--WQDIIKEVKFLQRIKHPNS 87
Query: 876 VAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSK 935
+ + G L V EY + GS +L + L I A G+ YLHS
Sbjct: 88 IEYKGCYLREHTAWL--VMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 144
Query: 936 NIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKR--NTLVSGGVRGTLPWMAPE-LLS 992
N++H D+K N+L L +P + K+ DFG + I N+ V GT WMAPE +L+
Sbjct: 145 NMIHRDIKAGNIL--LTEPGQ--VKLADFGSASIASPANSFV-----GTPYWMAPEVILA 195
Query: 993 GSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEW-- 1050
+ KVDV+S GI E+ + P NM+ + + I N PT+ S EW
Sbjct: 196 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SPTLQS---NEWSD 251
Query: 1051 --RTLMEECWAPNPAARPSFTEIASRLRVL 1078
R ++ C P RP+ E+ + VL
Sbjct: 252 YFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 64/206 (31%), Positives = 98/206 (47%), Gaps = 22/206 (10%)
Query: 818 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNV 875
+G G G V+ K R T VA+K++ R E + + +E + L HP V
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKV-----ALRRLE-GGIPNQALREIKALQACQHPYV 61
Query: 876 VAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRR-RLIIAMDAAFGMEYLHS 934
V V G G V EYM L VL ++R L + + + M G+ Y+H+
Sbjct: 62 VKLLDVFPHGSG--FVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLK-GVAYMHA 117
Query: 935 KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI---KRNTLVSGGVRGTLPWMAPELL 991
I+H DLK NLL++ + + K+ DFGL+++ + L S V T + APELL
Sbjct: 118 NGIMHRDLKPANLLIS----ADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELL 172
Query: 992 SGSSSKVSEKVDVFSFGIVLWEILTG 1017
G + K VD+++ G + E+L G
Sbjct: 173 YG-ARKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 2e-19
Identities = 74/268 (27%), Positives = 129/268 (48%), Gaps = 30/268 (11%)
Query: 818 LGSGTFGTVYHG-KWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVV 876
LG G +GTVY G +G +A+K+++ ++E+E ++ +E ++L L H N+V
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQ--EEVDLLKSLKHVNIV 65
Query: 877 AFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLD----RRRRLIIAMDAAFGMEYL 932
+ G D T++ E++ GS+ +L R + + + I+ G+ YL
Sbjct: 66 QYLGTCLDD--NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD-----GVAYL 118
Query: 933 HSKNIVHFDLKCDNLL------VNLKD--PSRPICKVGDFGLSKIKRNTLVSGGVRGTLP 984
H+ +VH D+K +N++ + L D +R + V GL N L S + GT
Sbjct: 119 HNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV---GLHGTHSNMLKS--MHGTPY 173
Query: 985 WMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN-TLRPTIP 1043
WMAPE++ + S K D++S G ++E+ TG+ P A+M A + I + L P +P
Sbjct: 174 WMAPEVI--NESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLP 231
Query: 1044 SYCDAEWRTLMEECWAPNPAARPSFTEI 1071
A + C + RPS ++
Sbjct: 232 DSFSAAAIDFVTSCLTRDQHERPSALQL 259
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-19
Identities = 83/271 (30%), Positives = 124/271 (45%), Gaps = 23/271 (8%)
Query: 809 NEDLEEQKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTVEFWKEAEI 866
NE E ELG G FG VY K + T A K I+ T E E VE EI
Sbjct: 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIE----TKSEEELEDYMVEI----EI 62
Query: 867 LSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAA 926
L+ +HP +V G G L + E+ G++ +++ DR L + +I
Sbjct: 63 LATCNHPYIVKLLGAFYWD--GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML 120
Query: 927 FGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVS-GGVRGTLPW 985
++YLHS I+H DLK N+L+ L K+ DFG+S TL GT W
Sbjct: 121 EALQYLHSMKIIHRDLKAGNVLLTLDGD----IKLADFGVSAKNVKTLQRRDSFIGTPYW 176
Query: 986 MAPELLSGSSSKVSE---KVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTI 1042
MAPE++ + K + K D++S GI L E+ E P+ ++ ++ I + PT+
Sbjct: 177 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE-PPTL 235
Query: 1043 --PSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
PS E+R ++ +P RPS ++
Sbjct: 236 SQPSKWSMEFRDFLKTALDKHPETRPSAAQL 266
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-19
Identities = 79/262 (30%), Positives = 124/262 (47%), Gaps = 31/262 (11%)
Query: 818 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNV 875
+G G+FG VY G T VAIK I E E + +E +LS+ P +
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLE-------EAEDEIEDIQQEITVLSQCDSPYI 64
Query: 876 VAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSK 935
+YG G L + EY+ GS +L K L+ I + G++YLHS+
Sbjct: 65 TRYYGSYLKG--TKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHSE 120
Query: 936 NIVHFDLKCDNLLVNLKDPSRPICKVGDFGL------SKIKRNTLVSGGVRGTLPWMAPE 989
+H D+K N+L++ + K+ DFG+ ++IKRNT V GT WMAPE
Sbjct: 121 RKIHRDIKAANVLLSEQGD----VKLADFGVAGQLTDTQIKRNTFV-----GTPFWMAPE 171
Query: 990 LLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAE 1049
++ S+ K D++S GI E+ GE P +++H ++ I N+ PT+
Sbjct: 172 VIKQSAYDF--KADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS-PPTLEGQYSKP 228
Query: 1050 WRTLMEECWAPNPAARPSFTEI 1071
++ +E C +P RP+ E+
Sbjct: 229 FKEFVEACLNKDPRFRPTAKEL 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 3e-19
Identities = 79/256 (30%), Positives = 120/256 (46%), Gaps = 20/256 (7%)
Query: 816 KELGSGTFGTVYHGK-WRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPN 874
+E+G G+FG VY + R ++V IKK ++G+ S ++ + KE L KL HPN
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVA--IKKMSYSGKQSNEK--WQDIIKEVRFLQKLRHPN 76
Query: 875 VVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHS 934
+ + G L V EY + GS +L + L + A G+ YLHS
Sbjct: 77 TIQYRGCYLREHTAWL--VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 935 KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI--KRNTLVSGGVRGTLPWMAPE-LL 991
N++H D+K N+L L +P + K+GDFG + I N V GT WMAPE +L
Sbjct: 134 HNMIHRDVKAGNIL--LSEPG--LVKLGDFGSASIMAPANXFV-----GTPYWMAPEVIL 184
Query: 992 SGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWR 1051
+ + KVDV+S GI E+ + P NM+ + + I N + +R
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFR 244
Query: 1052 TLMEECWAPNPAARPS 1067
++ C P RP+
Sbjct: 245 NFVDSCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 3e-19
Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 34/226 (15%)
Query: 816 KELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLT----VEF--WKEAEIL 867
LG GT+G V G VAIK++K + ++ +L + F +E +I+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 868 SKLHHPNVVAFYGV-VQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAA 926
+++ H N++ V V+ G + V + M L+ V+ RK R + + + I+ +
Sbjct: 75 NEIKHENIMGLVDVYVE---GDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCIL-LQIL 129
Query: 927 FGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRG----- 981
G+ LH +H DL N+ +N S+ ICK+ DFGL++ S +
Sbjct: 130 NGLNVLHKWYFMHRDLSPANIFIN----SKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 982 ----------TLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTG 1017
TL + APELL G + K VD++S G + E+LTG
Sbjct: 186 RREEMTSKVVTLWYRAPELLMG-AEKYHFAVDMWSVGCIFAELLTG 230
|
Length = 335 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 4e-19
Identities = 83/292 (28%), Positives = 134/292 (45%), Gaps = 32/292 (10%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
+LE +GSG GTVY R T A+K I + ++ + + +E EIL
Sbjct: 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVI-------YGNHEDTVRRQICREIEIL 126
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
++HPNVV + + G + + E+M GSL + ++FL R I++
Sbjct: 127 RDVNHPNVVKCHDMFDHN--GEIQVLLEFMDGGSLEGTHIADEQFLADVARQILS----- 179
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTL--VSGGVRGTLPW 985
G+ YLH ++IVH D+K NLL+N S K+ DFG+S+I T+ + V GT+ +
Sbjct: 180 GIAYLHRRHIVHRDIKPSNLLIN----SAKNVKIADFGVSRILAQTMDPCNSSV-GTIAY 234
Query: 986 MAPE-----LLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG--AIIGGIVNNTL 1038
M+PE L G+ + D++S G+ + E G P+ G A + + +
Sbjct: 235 MSPERINTDLNHGAYDGYAG--DIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ 292
Query: 1039 RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQTKGHGN 1090
P P+ E+R + C PA R S ++ +L Q +G N
Sbjct: 293 PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQGQGGPN 344
|
Length = 353 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 5e-19
Identities = 70/254 (27%), Positives = 110/254 (43%), Gaps = 20/254 (7%)
Query: 816 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
K + G FG+VY K R T AIK +KKS ++ ++T + A ++ + P
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKN----QVTNVKAERAIMMIQGESP 57
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLH 933
V Y Q L V EY+ G L++ L + G+E LH
Sbjct: 58 YVAKLYYSFQSK--DYLYLVMEYLNGGDCA-SLIKTLGGLPEDWAKQYIAEVVLGVEDLH 114
Query: 934 SKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSG 993
+ I+H D+K +NLL++ K+ DFGLS RN L + GT ++APE + G
Sbjct: 115 QRGIIHRDIKPENLLID----QTGHLKLTDFGLS---RNGLENKKFVGTPDYLAPETILG 167
Query: 994 SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT--IPSYCDAEWR 1051
+ D +S G V++E L G P+ A+ I++ + + +C E
Sbjct: 168 VGD--DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAV 225
Query: 1052 TLMEECWAPNPAAR 1065
L+ +PA R
Sbjct: 226 DLINRLLCMDPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 5e-19
Identities = 72/265 (27%), Positives = 125/265 (47%), Gaps = 23/265 (8%)
Query: 815 QKELGSGTFGTVYHGKWRGTDVAIKRIK--KSCFTGRSSEQERLTVEFWKEAEILSKLHH 872
Q+ LG G+FGTVY K + A +R+K K G + E TV+ +EA++LSKL H
Sbjct: 5 QQRLGKGSFGTVYLVKDKKAV-AEERLKVLKEIPVGELNPNE--TVQANQEAQLLSKLDH 61
Query: 873 PNVVAFYG--VVQDGPGGTLATVAEYMVDGSLR---HVLVRKDRFLDRRRRLIIAMDAAF 927
P +V F+ + +D + EY L L + L + +
Sbjct: 62 PAIVKFHASFLERD----AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL 117
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTL-VSGGVRGTLPWM 986
G+ Y+H + I+H DLK N+ + + K+GDFG+S++ + ++ GT +M
Sbjct: 118 GVHYMHQRRILHRDLKAKNIFLK-----NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYM 172
Query: 987 APELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYC 1046
+PE L K D++S G +L+E+ + ++ +++ IV P++P
Sbjct: 173 SPEALKHQG--YDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGP-TPSLPETY 229
Query: 1047 DAEWRTLMEECWAPNPAARPSFTEI 1071
+ ++M+ +P+ RPS EI
Sbjct: 230 SRQLNSIMQSMLNKDPSLRPSAAEI 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 6e-19
Identities = 79/262 (30%), Positives = 125/262 (47%), Gaps = 31/262 (11%)
Query: 818 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNV 875
+G G+FG V+ G T VAIK I E E + +E +LS+ P V
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIID-------LEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 876 VAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSK 935
+YG G L + EY+ GS +L R F D + + + G++YLHS+
Sbjct: 65 TKYYGSYLKG--TKLWIIMEYLGGGSALDLL-RAGPF-DEFQIATMLKEILKGLDYLHSE 120
Query: 936 NIVHFDLKCDNLLVNLKDPSRPICKVGDFGL------SKIKRNTLVSGGVRGTLPWMAPE 989
+H D+K N+L++ + K+ DFG+ ++IKRNT V GT WMAPE
Sbjct: 121 KKIHRDIKAANVLLS----EQGDVKLADFGVAGQLTDTQIKRNTFV-----GTPFWMAPE 171
Query: 990 LLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAE 1049
++ S+ K D++S GI E+ GE P ++MH ++ I N PT+
Sbjct: 172 VIQQSA--YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN-PPTLTGEFSKP 228
Query: 1050 WRTLMEECWAPNPAARPSFTEI 1071
++ ++ C +P+ RP+ E+
Sbjct: 229 FKEFIDACLNKDPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 6e-19
Identities = 78/254 (30%), Positives = 123/254 (48%), Gaps = 20/254 (7%)
Query: 816 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
K LG G+FG V + +GT+ AIK +KK + E VE + L+ HP
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL-EDDDVECTMVE--RRVLALAW-EHP 56
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLH 933
+ + Q L V EY+ G L + RF + R R A + G+++LH
Sbjct: 57 FLTHLFCTFQTKE--HLFFVMEYLNGGDLMFHIQSSGRFDEARARFY-AAEIICGLQFLH 113
Query: 934 SKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK--IKRNTLVSGGVRGTLPWMAPELL 991
K I++ DLK DN+L++ KD K+ DFG+ K + S GT ++APE+L
Sbjct: 114 KKGIIYRDLKLDNVLLD-KDGH---IKIADFGMCKENMNGEGKASTFC-GTPDYIAPEIL 168
Query: 992 SGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWR 1051
G K +E VD +SFG++L+E+L G+ P+ + I+N+ RP P + E +
Sbjct: 169 KG--QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND--RPHFPRWISKEAK 224
Query: 1052 TLMEECWAPNPAAR 1065
+ + + +P R
Sbjct: 225 DCLSKLFERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 9e-19
Identities = 56/167 (33%), Positives = 83/167 (49%), Gaps = 10/167 (5%)
Query: 913 LDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKR- 971
LD L + A GM +L SKN +H DL N+L+ I K+ DFGL++ R
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT----HGRITKICDFGLARDIRN 266
Query: 972 --NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGA 1028
N +V G R + WMAPE S + + + DV+S+GI+LWEI + G PY M +
Sbjct: 267 DSNYVVKGNARLPVKWMAPE--SIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS 324
Query: 1029 IIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
++ R P +E +M+ CW +P RP+F +I +
Sbjct: 325 KFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 65/265 (24%), Positives = 117/265 (44%), Gaps = 21/265 (7%)
Query: 815 QKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHH 872
+K++G G F VY G VA+K+++ + Q+ L KE ++L +L H
Sbjct: 7 EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCL-----KEIDLLKQLDH 61
Query: 873 PNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVL---VRKDRFLDRRRRLIIAMDAAFGM 929
PNV+ + + L V E G L ++ ++ R + R + +
Sbjct: 62 PNVIKYLASFIEN--NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 930 EYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI-KRNTLVSGGVRGTLPWMAP 988
E++HSK I+H D+K N+ + + K+GD GL + T + + GT +M+P
Sbjct: 120 EHMHSKRIMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 989 ELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPY--ANMHYGAIIGGIVNNTLRPTIPSYC 1046
E + + K D++S G +L+E+ + P+ M+ ++ I P +
Sbjct: 176 ERIHENGYNF--KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHY 233
Query: 1047 DAEWRTLMEECWAPNPAARPSFTEI 1071
E R L+ C P+P RP + +
Sbjct: 234 SEELRDLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 1e-18
Identities = 80/262 (30%), Positives = 123/262 (46%), Gaps = 26/262 (9%)
Query: 817 ELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVV 876
E+G G+FG VY T+ + +KK ++G+ + ++ + KE + L +L HPN +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVA-VKKMSYSGKQTNEK--WQDIIKEVKFLQQLKHPNTI 84
Query: 877 AFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKN 936
+ G L V EY + GS +L + L I A G+ YLHS N
Sbjct: 85 EYKGCYLKEHTAWL--VMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN 141
Query: 937 IVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKR--NTLVSGGVRGTLPWMAPE-LLSG 993
++H D+K N+L L +P + K+ DFG + N+ V GT WMAPE +L+
Sbjct: 142 MIHRDIKAGNIL--LTEPGQ--VKLADFGSASKSSPANSFV-----GTPYWMAPEVILAM 192
Query: 994 SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEW--- 1050
+ KVDV+S GI E+ + P NM+ + + I N PT+ S EW
Sbjct: 193 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-SPTLQS---NEWTDS 248
Query: 1051 -RTLMEECWAPNPAARPSFTEI 1071
R ++ C P RP+ E+
Sbjct: 249 FRGFVDYCLQKIPQERPASAEL 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 82/274 (29%), Positives = 125/274 (45%), Gaps = 39/274 (14%)
Query: 818 LGSGTFGTVYH--GKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPN 874
+G GT+G VY K G+ A+K + S E + E+ IL L +HPN
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPI-----SDVDEEIEAEY----NILQSLPNHPN 80
Query: 875 VVAFYGVVQDGP---GGTLATVAEYMVDGSLRHV---LVRKDRFLDRRRRLIIAMDAAFG 928
VV FYG+ GG L V E GS+ + L+ + LD I A G
Sbjct: 81 VVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLG 140
Query: 929 MEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS------KIKRNTLVSGGVRGT 982
+++LH+ I+H D+K +N+L+ + K+ DFG+S +++RNT V GT
Sbjct: 141 LQHLHNNRIIHRDVKGNNILLTTEGG----VKLVDFGVSAQLTSTRLRRNTSV-----GT 191
Query: 983 LPWMAPELLSGSS---SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 1039
WMAPE+++ + DV+S GI E+ G+ P +MH + I N
Sbjct: 192 PFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP-P 250
Query: 1040 PTI--PSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
PT+ P + + +C + ARPS T +
Sbjct: 251 PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHL 284
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 70/266 (26%), Positives = 131/266 (49%), Gaps = 31/266 (11%)
Query: 816 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
K++G G+FG K + G IK I S + + E+ R KE +LS + HP
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESR------KEVAVLSNMKHP 59
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSL-------RHVLVRKDRFLDRRRRLIIAMDAA 926
N+V + ++ G L V +Y G L R VL +D+ LD ++ +A
Sbjct: 60 NIVQYQESFEE--NGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA---- 113
Query: 927 FGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTL-VSGGVRGTLPW 985
++++H + I+H D+K N+ + KD K+GDFG++++ +T+ ++ GT +
Sbjct: 114 --LKHVHDRKILHRDIKSQNIFLT-KD---GTIKLGDFGIARVLNSTVELARTCIGTPYY 167
Query: 986 MAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSY 1045
++PE+ + + K D+++ G VL+E+ T + + + ++ I+ + P + S+
Sbjct: 168 LSPEIC--ENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY-PPVSSH 224
Query: 1046 CDAEWRTLMEECWAPNPAARPSFTEI 1071
+ R L+ + + NP RPS I
Sbjct: 225 YSYDLRNLVSQLFKRNPRDRPSVNSI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 3e-18
Identities = 76/271 (28%), Positives = 131/271 (48%), Gaps = 22/271 (8%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEI- 866
+DLE +ELG G +G V + GT +A+KRI+ + S EQ+RL ++ +I
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATV---NSQEQKRLLMDL----DIS 53
Query: 867 LSKLHHPNVVAFYGVV-QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDA 925
+ + P V FYG + ++G V + +D + V K + IA+
Sbjct: 54 MRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVY-DKGLTIPEDILGKIAVSI 112
Query: 926 AFGMEYLHSK-NIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLP 984
+EYLHSK +++H D+K N+L+N ++ +C DFG+S +++ G P
Sbjct: 113 VKALEYLHSKLSVIHRDVKPSNVLIN-RNGQVKLC---DFGISGYLVDSVAKTIDAGCKP 168
Query: 985 WMAPELLS--GSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-AIIGGIVNNTLRPT 1041
+MAPE ++ + K DV+S GI + E+ TG PY + + +V P
Sbjct: 169 YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP-SPQ 227
Query: 1042 IPS-YCDAEWRTLMEECWAPNPAARPSFTEI 1071
+P+ E++ + +C N RP++ E+
Sbjct: 228 LPAEKFSPEFQDFVNKCLKKNYKERPNYPEL 258
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 3e-18
Identities = 78/260 (30%), Positives = 116/260 (44%), Gaps = 35/260 (13%)
Query: 818 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVE---FWKEAEILSKLHH 872
LG G FG V +++ T AIK +KK R E E L E F E + H
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARD-EVESLMCEKRIF----ETANSERH 61
Query: 873 PNVVAFYGVVQDGPGGTLATVAEYMVDGSL-RHVLVRKDRFLDRRRRLIIAMDAAFGMEY 931
P +V + Q + V EY G L H+ D F R + A G++Y
Sbjct: 62 PFLVNLFACFQTE--DHVCFVMEYAAGGDLMMHI--HTDVF-SEPRAVFYAACVVLGLQY 116
Query: 932 LHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK------IKRNTLVSGGVRGTLPW 985
LH IV+ DLK DNLL++ + K+ DFGL K + +T GT +
Sbjct: 117 LHENKIVYRDLKLDNLLLDTEG----FVKIADFGLCKEGMGFGDRTSTFC-----GTPEF 167
Query: 986 MAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSY 1045
+APE+L+ +S + VD + G++++E+L GE P+ + IVN+ +R P +
Sbjct: 168 LAPEVLTETS--YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR--YPRF 223
Query: 1046 CDAEWRTLMEECWAPNPAAR 1065
E ++M NP R
Sbjct: 224 LSREAISIMRRLLRRNPERR 243
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 3e-18
Identities = 53/155 (34%), Positives = 82/155 (52%), Gaps = 12/155 (7%)
Query: 926 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-IKRNT--LVSGGVRGT 982
A GME+L S+ +H DL N+L++ + + K+ DFGL++ I ++ + G R
Sbjct: 183 ARGMEFLASRKCIHRDLAARNILLSENN----VVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 983 LPWMAPELLSGSSSKV-SEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 1040
L WMAPE + KV + + DV+SFG++LWEI + G PY + + R
Sbjct: 239 LKWMAPESIF---DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM 295
Query: 1041 TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
P Y E ++M +CW NP RP+F+E+ L
Sbjct: 296 RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 3e-18
Identities = 68/279 (24%), Positives = 128/279 (45%), Gaps = 39/279 (13%)
Query: 816 KELGSGTFGTVYHGK-WRGTDVA---IKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH 871
E+G+G FG V G+ RG A +K ++ S ++ E+L F +E + +L+
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-----ATPDEQLL--FLQEVQPYRELN 53
Query: 872 HPNVVAFYG-VVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFL-----DRRRRLIIAMDA 925
HPNV+ G ++ P V E+ G L++ L R +R + + +A +
Sbjct: 54 HPNVLQCLGQCIESIP---YLLVLEFCPLGDLKNYL-RSNRGMVAQMAQKDVLQRMACEV 109
Query: 926 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL--SKIKRNTLVSGGVRGT- 982
A G+ +LH + +H DL N + + K+GD+GL + + ++
Sbjct: 110 ASGLLWLHQADFIHSDLALRNCQLT----ADLSVKIGDYGLALEQYPEDYYITKDCHAVP 165
Query: 983 LPWMAPELLSGSSS-----KVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 1036
L W+APEL+ ++K +++S G+ +WE+ T ++PY ++ ++ +V
Sbjct: 166 LRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE 225
Query: 1037 TL----RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
+P + W +M+ CW +P RP+ E+
Sbjct: 226 QDIKLPKPQLDLKYSDRWYEVMQFCWL-DPETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 4e-18
Identities = 49/151 (32%), Positives = 80/151 (52%), Gaps = 10/151 (6%)
Query: 926 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI---KRNTLVSGGVRGT 982
A GM++L SKN +H D+ N+L+ + K+ DFGL++ N +V G R
Sbjct: 222 AQGMDFLASKNCIHRDVAARNVLLT----DGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 983 LPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPT 1041
+ WMAPE + V DV+S+GI+LWEI + G+ PY + + +V + +
Sbjct: 278 VKWMAPESIFDCVYTVQS--DVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMS 335
Query: 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIA 1072
P + E ++M+ CW P RP+F++I+
Sbjct: 336 RPDFAPPEIYSIMKMCWNLEPTERPTFSQIS 366
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 4e-18
Identities = 80/257 (31%), Positives = 124/257 (48%), Gaps = 29/257 (11%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTD---VAIKRIKKSCFTGRSSEQERLTVEFWKE 863
+K ED + LG+G+FG V ++ D VAIKR +KS +++ + E
Sbjct: 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-----KQKQVDHVFSE 81
Query: 864 AEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAM 923
+IL+ ++HP V YG +D L V E+++ G L R RF + A
Sbjct: 82 RKILNYINHPFCVNLYGSFKDE--SYLYLVLEFVIGGEFFTFLRRNKRFPNDVG-CFYAA 138
Query: 924 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTL 983
EYL S NIV+ DLK +NLL++ KD K+ DFG +K+ + + GT
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLD-KD---GFIKMTDFGFAKVVDTRTYT--LCGTP 192
Query: 984 PWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEP-YAN---MHYGAIIGGIVNNTLR 1039
++APE+L + D ++ GI ++EIL G P YAN + Y I+ GI+
Sbjct: 193 EYIAPEILLNVGH--GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII----- 245
Query: 1040 PTIPSYCDAEWRTLMEE 1056
P + D + LM++
Sbjct: 246 -YFPKFLDNNCKHLMKK 261
|
Length = 340 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 5e-18
Identities = 86/342 (25%), Positives = 130/342 (38%), Gaps = 87/342 (25%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTVE 859
+ L K LG G FG V G D VA+K +K+ +SE + L E
Sbjct: 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG---ATASEHKALMSE 60
Query: 860 FWKEAEILSKL-HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRF------ 912
+IL + +H NVV G P G L + E+ G+L + L K F
Sbjct: 61 L----KILIHIGNHLNVVNLLGACTK-PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYRE 115
Query: 913 -----------------LDRRRR------------------------------------- 918
+DRR
Sbjct: 116 KSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMED 175
Query: 919 -LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-IKRNT--L 974
+ + A GME+L S+ +H DL N+L++ + + K+ DFGL++ I ++ +
Sbjct: 176 LICYSFQVARGMEFLASRKCIHRDLAARNILLSENN----VVKICDFGLARDIYKDPDYV 231
Query: 975 VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGI 1033
G R L WMAPE S + + DV+SFG++LWEI + G PY +
Sbjct: 232 RKGSARLPLKWMAPE--SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR 289
Query: 1034 VNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
+ + R P E +M CW +P RP+F+ + L
Sbjct: 290 LKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-18
Identities = 80/275 (29%), Positives = 129/275 (46%), Gaps = 33/275 (12%)
Query: 816 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
+++G G+FG V+ G T VAIK I E E + +E +LS+ P
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIID-------LEEAEDEIEDIQQEITVLSQCDSP 62
Query: 874 NVVAFYG-VVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYL 932
V +YG ++D L + EY+ GS +L + LD + I + G++YL
Sbjct: 63 YVTKYYGSYLKDT---KLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYL 117
Query: 933 HSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL------SKIKRNTLVSGGVRGTLPWM 986
HS+ +H D+K N+L++ K+ DFG+ ++IKRNT V GT WM
Sbjct: 118 HSEKKIHRDIKAANVLLS----EHGEVKLADFGVAGQLTDTQIKRNTFV-----GTPFWM 168
Query: 987 APELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYC 1046
APE++ S+ K D++S GI E+ GE P++ +H ++ I N PT+
Sbjct: 169 APEVIKQSA--YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN-PPTLEGNY 225
Query: 1047 DAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081
+ +E C P+ RP+ E+ ++ A
Sbjct: 226 SKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFA 260
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 6e-18
Identities = 66/226 (29%), Positives = 111/226 (49%), Gaps = 39/226 (17%)
Query: 810 EDLEEQKELGSGTFGTV--YHGKWRGTDVAIKR--IKKSCFTGRSSEQERLTVEFWKEAE 865
L+ ++G G+ G V K G VA+K+ ++K Q+R + F E
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---------QQRRELLF-NEVV 68
Query: 866 ILSKLHHPNVVAFYG--VVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAM 923
I+ HPN+V Y +V D L V E++ G+L + V R ++ + + +
Sbjct: 69 IMRDYQHPNIVEMYSSYLVGD----ELWVVMEFLEGGALTDI-VTHTR-MNEEQIATVCL 122
Query: 924 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG----LSK--IKRNTLVSG 977
+ +LH++ ++H D+K D++L+ S K+ DFG +SK +R +LV
Sbjct: 123 AVLKALSFLHAQGVIHRDIKSDSILLT----SDGRVKLSDFGFCAQVSKEVPRRKSLV-- 176
Query: 978 GVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN 1023
GT WMAPE++S +VD++S GI++ E++ GE PY N
Sbjct: 177 ---GTPYWMAPEVIS--RLPYGTEVDIWSLGIMVIEMVDGEPPYFN 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 6e-18
Identities = 68/216 (31%), Positives = 104/216 (48%), Gaps = 38/216 (17%)
Query: 816 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
++LG GT+ TVY G+ R T VA+K I G S R E ++ +L H
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-------EISLMKELKHE 58
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLD---RRRRLIIAMDAAF--- 927
N+V + V+ L V EYM D L+ +++D R L +F
Sbjct: 59 NIVRLHDVIH--TENKLMLVFEYM-DKDLK-------KYMDTHGVRGALDPNTVKSFTYQ 108
Query: 928 ---GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK---IKRNTLVSGGVRG 981
G+ + H ++H DLK NLL+N R K+ DFGL++ I NT + V
Sbjct: 109 LLKGIAFCHENRVLHRDLKPQNLLIN----KRGELKLADFGLARAFGIPVNTFSNEVV-- 162
Query: 982 TLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTG 1017
TL + AP++L GS + S +D++S G ++ E++TG
Sbjct: 163 TLWYRAPDVLLGSRT-YSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|214770 smart00666, PB1, PB1 domain | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 1e-17
Identities = 39/89 (43%), Positives = 56/89 (62%), Gaps = 11/89 (12%)
Query: 100 PSDGKLRYVGGETRIIRIRKDISWQILRQKALEVY---NQVHVIKYQLPGEDLDALVSVS 156
D KLRY GGETR + + +DIS++ LR K + + NQ +KYQ ED D LVS++
Sbjct: 1 TVDVKLRY-GGETRRLSVPRDISFEDLRSKVAKRFGLDNQSFTLKYQ--DEDGD-LVSLT 56
Query: 157 CDEDLQNMMEEYNELGDREGSQRIRMFLF 185
DEDL+ +EEY D GS+++R+ +F
Sbjct: 57 SDEDLEEAIEEY----DSLGSKKLRLHVF 81
|
Phox and Bem1p domain, present in many eukaryotic cytoplasmic signalling proteins. The domain adopts a beta-grasp fold, similar to that found in ubiquitin and Ras-binding domains. A motif, variously termed OPR, PC and AID, represents the most conserved region of the majority of PB1 domains, and is necessary for PB1 domain function. This function is the formation of PB1 domain heterodimers, although not all PB1 domain pairs associate. Length = 81 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 1e-17
Identities = 80/273 (29%), Positives = 130/273 (47%), Gaps = 33/273 (12%)
Query: 800 DVSSVQVIKNEDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLT 857
D SS ++ D E + LG+G+FG V K +GT AIK +KK + + + +
Sbjct: 11 DTSSWKL---SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL-KMKQVQHVA 66
Query: 858 VEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRR 917
+E IL +L HP +V QD + + E++V G L L + RF +
Sbjct: 67 ----QEKSILMELSHPFIVNMMCSFQDE--NRVYFLLEFVVGGELFTHLRKAGRFPNDVA 120
Query: 918 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSG 977
+ A + EYLHSK+I++ DLK +NLL++ K KV DFG + K+ +
Sbjct: 121 KFYHA-ELVLAFEYLHSKDIIYRDLKPENLLLDNKGH----VKVTDFGFA--KKVPDRTF 173
Query: 978 GVRGTLPWMAPELLSGSSSKVSEK-VDVFSFGIVLWEILTGEEPYANMH----YGAIIGG 1032
+ GT ++APE++ SK K VD ++ G++L+E + G P+ + Y I+ G
Sbjct: 174 TLCGTPEYLAPEVI---QSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG 230
Query: 1033 IVNNTLRPTIPSYCDAEWRTLMEECWAPNPAAR 1065
R P++ D R L++ + R
Sbjct: 231 ------RLKFPNWFDGRARDLVKGLLQTDHTKR 257
|
Length = 329 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-17
Identities = 50/154 (32%), Positives = 77/154 (50%), Gaps = 10/154 (6%)
Query: 926 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-IKRNT--LVSGGVRGT 982
A GME+L S+ +H DL N+L++ + + K+ DFGL++ I ++ + G R
Sbjct: 189 AKGMEFLASRKCIHRDLAARNILLSENN----VVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 983 LPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPT 1041
L WMAPE + + DV+SFG++LWEI + G PY + + R
Sbjct: 245 LKWMAPETIFDRVYTIQS--DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 302
Query: 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
P Y E M +CW P+ RP+F+E+ L
Sbjct: 303 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 61/217 (28%), Positives = 112/217 (51%), Gaps = 15/217 (6%)
Query: 862 KEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSL-RHVLVRKDRFLDRRRRLI 920
KEA +L+K+ HPN+VAF + G L V EY G L + + +++ + L
Sbjct: 47 KEAVLLAKMKHPNIVAFKESFE--ADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQ 104
Query: 921 IAMDAAFGMEYLHSKNIVHFDLKCDNLLV--NLKDPSRPICKVGDFGLSKIKRNTLVSGG 978
+ G++++H K ++H D+K N+ + N K K+GDFG +++ +
Sbjct: 105 WFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGK------VKLGDFGSARLLTSPGAYAC 158
Query: 979 VR-GTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 1037
GT ++ PE+ + + K D++S G +L+E+ T + P+ + +I + +
Sbjct: 159 TYVGTPYYVPPEIW--ENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGS 216
Query: 1038 LRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074
+P +PS+ E R+L+++ + NP +RPS T I SR
Sbjct: 217 YKP-LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 29/222 (13%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTDVAIKRI--KKSCFTGRSSEQERLTVEFWKEAEIL 867
E + E LG G G+V + + T I K+ T + + ++ + +E EI
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNT----GMIFALKTITTDPNPDLQK---QILRELEIN 53
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVL--VRK------DRFLDRRRRL 919
P +V +YG D ++ EY GSL + V+K ++ L +
Sbjct: 54 KSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGK---- 109
Query: 920 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGV 979
IA G+ YLHS+ I+H D+K N+L+ K K+ DFG+S N+L +G
Sbjct: 110 -IAESVLKGLSYLHSRKIIHRDIKPSNILLTRKG----QVKLCDFGVSGELVNSL-AGTF 163
Query: 980 RGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1021
GT +MAPE + G ++ DV+S G+ L E+ P+
Sbjct: 164 TGTSFYMAPERIQGKPYSITS--DVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 2e-17
Identities = 77/259 (29%), Positives = 117/259 (45%), Gaps = 30/259 (11%)
Query: 816 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILS-KLHH 872
K LG G+FG V+ + +GT+ AIK +KK + E VE +LS H
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL-MDDDVECTMVE----KRVLSLAWEH 55
Query: 873 PNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYL 932
P + Y Q L V EY+ G L + +F D R A + G+++L
Sbjct: 56 PFLTHLYCTFQTKE--NLFFVMEYLNGGDLMFHIQSCHKF-DLPRATFYAAEIICGLQFL 112
Query: 933 HSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK------IKRNTLVSGGVRGTLPWM 986
HSK IV+ DLK DN+L++ K+ DFG+ K K T GT ++
Sbjct: 113 HSKGIVYRDLKLDNILLDTDGH----IKIADFGMCKENMLGDAKTCTFC-----GTPDYI 163
Query: 987 APELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYC 1046
APE+L G K + VD +SFG++L+E+L G+ P+ + I P P +
Sbjct: 164 APEILLG--QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI--RMDNPCYPRWL 219
Query: 1047 DAEWRTLMEECWAPNPAAR 1065
E + ++ + + P R
Sbjct: 220 TREAKDILVKLFVREPERR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|99716 cd05992, PB1, The PB1 domain is a modular domain mediating specific protein-protein interactions which play a role in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 3e-17
Identities = 30/85 (35%), Positives = 48/85 (56%), Gaps = 6/85 (7%)
Query: 102 DGKLRYVGGETRIIRIRKDISWQILRQKALEVYN-QVHVIKYQLPGEDLDALVSVSCDED 160
K++Y G R + + + IS++ LR K E + K + P ED D LV++S DED
Sbjct: 2 RVKVKYGGEIRRFVVVSRSISFEDLRSKIAEKFGLDAVSFKLKYPDEDGD-LVTISSDED 60
Query: 161 LQNMMEEYNELGDREGSQRIRMFLF 185
L+ +EE R GS+++R+F+F
Sbjct: 61 LEEAIEEA----RRSGSKKLRLFVF 81
|
A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as a noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, fungi, animals, and plants. Length = 81 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-17
Identities = 81/267 (30%), Positives = 122/267 (45%), Gaps = 31/267 (11%)
Query: 817 ELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPN 874
ELG G FG VY + + T V A K I T E E VE +IL+ HPN
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVID----TKSEEELEDYMVEI----DILASCDHPN 63
Query: 875 VV----AFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGME 930
+V AFY L + E+ G++ V++ +R L + ++ +
Sbjct: 64 IVKLLDAFY------YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALN 117
Query: 931 YLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS-KIKRNTLVSGGVRGTLPWMAPE 989
YLH I+H DLK N+L L K+ DFG+S K R GT WMAPE
Sbjct: 118 YLHENKIIHRDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE 173
Query: 990 LLSGSSSK---VSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTI--PS 1044
++ +SK K DV+S GI L E+ E P+ ++ ++ I + PT+ PS
Sbjct: 174 VVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE-PPTLAQPS 232
Query: 1045 YCDAEWRTLMEECWAPNPAARPSFTEI 1071
+E++ +++C N AR + T++
Sbjct: 233 RWSSEFKDFLKKCLEKNVDARWTTTQL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 6e-17
Identities = 68/219 (31%), Positives = 109/219 (49%), Gaps = 37/219 (16%)
Query: 816 KELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
+++G G GTVY G +VAIK++ ++ L + E ++ + HP
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQ-----QQPKKELII---NEILVMRENKHP 76
Query: 874 NVVAF---YGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGME 930
N+V + Y V G L V EY+ GSL V+ + +D + + + +E
Sbjct: 77 NIVNYLDSYLV-----GDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALE 129
Query: 931 YLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL------SKIKRNTLVSGGVRGTLP 984
+LHS ++H D+K DN+L+ + D S K+ DFG + KR+T+V GT
Sbjct: 130 FLHSNQVIHRDIKSDNILLGM-DGS---VKLTDFGFCAQITPEQSKRSTMV-----GTPY 180
Query: 985 WMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN 1023
WMAPE++ + KVD++S GI+ E++ GE PY N
Sbjct: 181 WMAPEVV--TRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 8e-17
Identities = 69/270 (25%), Positives = 122/270 (45%), Gaps = 22/270 (8%)
Query: 818 LGSGTFGTVYHGKWR---GTDVAIKRI--KKSCFTGRSSEQERLTVEFWKEAEILSK-LH 871
LGSG FG VY + + +A+K I F E+++ + E I+ + L
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 872 HPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLV----RKDRFLDRRR-RLIIAMDAA 926
HPN+V +Y + L V + + L +K RF + R + + M A
Sbjct: 68 HPNIVRYYKTFLEN--DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 927 FGMEYLH-SKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPW 985
+ YLH K IVH DL +N+++ D + DFGL+K K+ V GT+ +
Sbjct: 126 --LRYLHKEKRIVHRDLTPNNIMLGEDDK----VTITDFGLAKQKQPESKLTSVVGTILY 179
Query: 986 MAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSY 1045
PE++ + EK DV++FG +L+++ T + P+ + + ++ IV P
Sbjct: 180 SCPEIVK--NEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237
Query: 1046 CDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
+ ++ C P+ ARP ++++ +
Sbjct: 238 YSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 8e-17
Identities = 66/217 (30%), Positives = 100/217 (46%), Gaps = 34/217 (15%)
Query: 813 EEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL 870
EE E+G G +GTVY + G VA+K+++ +E + + +E +L +L
Sbjct: 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVP------LSEEGIPLSTLREIALLKQL 55
Query: 871 ---HHPNVVAFYGV---VQDGPGGTLATVAEYMVDGSLRHVLVR-------KDRFLDRRR 917
HPN+V V + L V E+ VD L L + + D R
Sbjct: 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEH-VDQDLATYLSKCPKPGLPPETIKDLMR 114
Query: 918 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSG 977
+L+ G+++LHS IVH DLK N+LV S K+ DFGL++I +
Sbjct: 115 QLLR------GVDFLHSHRIVHRDLKPQNILVT----SDGQVKIADFGLARIYSFEMALT 164
Query: 978 GVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEI 1014
V TL + APE+L SS VD++S G + E+
Sbjct: 165 SVVVTLWYRAPEVLLQSSYATP--VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 1e-16
Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 816 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HH 872
K LG G+FG V + +GTD A+K +KK + +T E +L+ H
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMT-----EKRVLALAGKH 55
Query: 873 PNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYL 932
P + + Q L V EY+ G L + R RF D R A + G+++L
Sbjct: 56 PFLTQLHSCFQTKD--RLFFVMEYVNGGDLMFHIQRSGRF-DEPRARFYAAEIVLGLQFL 112
Query: 933 HSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR-----GTLPWMA 987
H + I++ DLK DN+L++ S K+ DFG+ K + GGV GT ++A
Sbjct: 113 HERGIIYRDLKLDNVLLD----SEGHIKIADFGMCKEG----ILGGVTTSTFCGTPDYIA 164
Query: 988 PELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1021
PE+LS + VD ++ G++L+E+L G+ P+
Sbjct: 165 PEILSYQPYGPA--VDWWALGVLLYEMLAGQSPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 65/272 (23%), Positives = 123/272 (45%), Gaps = 31/272 (11%)
Query: 815 QKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHH 872
+K++G G F VY G VA+K+++ + + + KE ++L +L+H
Sbjct: 7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCI-----KEIDLLKQLNH 61
Query: 873 PNVVAFYG-VVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLI-------IAMD 924
PNV+ +Y ++D L V E G L ++ + +++RLI +
Sbjct: 62 PNVIKYYASFIED---NELNIVLELADAGDLSRMI----KHFKKQKRLIPEKTVWKYFVQ 114
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-IKRNTLVSGGVRGTL 983
+E++HS+ ++H D+K N+ + + + K+GD GL + T + + GT
Sbjct: 115 LCSALEHMHSRRVMHRDIKPANVFIT----ATGVVKLGDLGLGRFFSSKTTAAHSLVGTP 170
Query: 984 PWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPY--ANMHYGAIIGGIVNNTLRPT 1041
+M+PE + + K D++S G +L+E+ + P+ M+ ++ I P
Sbjct: 171 YYMSPERIHENGYNF--KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL 228
Query: 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIAS 1073
+ E R L+ C P+P RP T +
Sbjct: 229 PSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-16
Identities = 76/257 (29%), Positives = 126/257 (49%), Gaps = 23/257 (8%)
Query: 816 KELGSGTFGTVY-----HGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL 870
K LG G +G V+ G G A+K +KK+ R+ + T E IL +
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV-RNQKD---TAHTKAERNILEAV 57
Query: 871 HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGME 930
HP +V Q G G L + EY+ G L L R+ F++ ++ + + +E
Sbjct: 58 KHPFIVDLIYAFQTG--GKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS-EISLALE 114
Query: 931 YLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK--IKRNTLVSGGVRGTLPWMAP 988
+LH + I++ DLK +N+L++ ++ K+ DFGL K I T V+ GT+ +MAP
Sbjct: 115 HLHQQGIIYRDLKPENILLD----AQGHVKLTDFGLCKESIHEGT-VTHTFCGTIEYMAP 169
Query: 989 ELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDA 1048
E+L S + VD +S G +++++LTG P+ + I I+ L +P Y
Sbjct: 170 EILMRSGH--GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL--NLPPYLTP 225
Query: 1049 EWRTLMEECWAPNPAAR 1065
E R L+++ NP++R
Sbjct: 226 EARDLLKKLLKRNPSSR 242
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 2e-16
Identities = 71/251 (28%), Positives = 121/251 (48%), Gaps = 19/251 (7%)
Query: 818 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNV 875
+G G+FG V + R T A+K I+K+ RS L E +L++++ P +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLA-----ERTVLAQVNCPFI 55
Query: 876 VAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSK 935
V Q L V ++ G L H L R+ RF R R A + +E LH
Sbjct: 56 VPLKFSFQSP--EKLYLVLAFINGGELFHHLQREGRFDLSRARFYTA-ELLCALENLHKF 112
Query: 936 NIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK-RNTLVSGGVRGTLPWMAPELLSGS 994
N+++ DLK +N+L++ + +C DFGL K+ ++ + GT ++APELL G
Sbjct: 113 NVIYRDLKPENILLDYQG-HIALC---DFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGH 168
Query: 995 SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLM 1054
++ VD ++ G++L+E+LTG P+ + + + I+ LR P D + + L+
Sbjct: 169 G--YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLR--FPDGFDRDAKDLL 224
Query: 1055 EECWAPNPAAR 1065
+ +P R
Sbjct: 225 IGLLSRDPTRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 77/274 (28%), Positives = 124/274 (45%), Gaps = 39/274 (14%)
Query: 818 LGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HPN 874
+G GT+G V+ K G+ A+K + + E E IL L HPN
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPI---------HDIDEEIEAEYNILKALSDHPN 76
Query: 875 VVAFYGVVQDGP---GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAM---DAAFG 928
VV FYG+ G L V E GS+ ++ + +R IIA +A G
Sbjct: 77 VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMG 136
Query: 929 MEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS------KIKRNTLVSGGVRGT 982
+++LH +H D+K +N+L+ + K+ DFG+S +++RNT V GT
Sbjct: 137 LQHLHVNKTIHRDVKGNNILLTTEGG----VKLVDFGVSAQLTSTRLRRNTSV-----GT 187
Query: 983 LPWMAPELLSGSS---SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 1039
WMAPE+++ S + DV+S GI E+ G+ P A++H + I N
Sbjct: 188 PFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP-P 246
Query: 1040 PTI--PSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
PT+ P E+ + +C + RP+ +++
Sbjct: 247 PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDL 280
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 59/226 (26%), Positives = 96/226 (42%), Gaps = 59/226 (26%)
Query: 818 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQER--LTVEFWKEAEILSKLHHP 873
+G GT+G VY + + VA+K+++ + ER + + +E +L L HP
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVR--------MDNERDGIPISSLREITLLLNLRHP 66
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF------ 927
N+V VV G L ++ ++V L L+ M F
Sbjct: 67 NIVELKEVVV---GKHLDSI--FLVMEYCEQDLAS----------LLDNMPTPFSESQVK 111
Query: 928 --------GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRN------- 972
G++YLH I+H DLK NLL+ K K+ DFGL++
Sbjct: 112 CLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG----CLKIADFGLARTYGLPAKPMTP 167
Query: 973 TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
+V TL + APELL G + + +D+++ G +L E+L +
Sbjct: 168 KVV------TLWYRAPELLLG-CTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 3e-16
Identities = 65/219 (29%), Positives = 110/219 (50%), Gaps = 37/219 (16%)
Query: 816 KELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
+++G G GTV+ G +VAIK+I + ++ L + E ++ +L +P
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINL-----QKQPKKELII---NEILVMKELKNP 76
Query: 874 NVVAF---YGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGME 930
N+V F + V G L V EY+ GSL V+ + +D + + + +E
Sbjct: 77 NIVNFLDSFLV-----GDELFVVMEYLAGGSLTDVVT--ETCMDEAQIAAVCRECLQALE 129
Query: 931 YLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL------SKIKRNTLVSGGVRGTLP 984
+LH+ ++H D+K DN+L+ + K+ DFG + KR+T+V GT
Sbjct: 130 FLHANQVIHRDIKSDNVLLGMDGS----VKLTDFGFCAQITPEQSKRSTMV-----GTPY 180
Query: 985 WMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN 1023
WMAPE+++ + KVD++S GI+ E++ GE PY N
Sbjct: 181 WMAPEVVTRKA--YGPKVDIWSLGIMAIEMVEGEPPYLN 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 27/220 (12%)
Query: 813 EEQKELGSGTFGTVYHGKW----RGTDVAIKRIK--KSCFTGRSSEQERLTVEFWKEAEI 866
E + +G GT+G VY K G + AIK+ K K +TG S R E +
Sbjct: 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR-------EIAL 55
Query: 867 LSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAA 926
L +L H NVV+ V + ++ + +Y + L ++ K +R + +M +
Sbjct: 56 LRELKHENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQII--KFHRQAKRVSIPPSMVKS 112
Query: 927 F------GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVS---- 976
G+ YLHS ++H DLK N+LV + P R + K+GD GL+++ L
Sbjct: 113 LLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL 172
Query: 977 GGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT 1016
V T+ + APELL G + ++ +D+++ G + E+LT
Sbjct: 173 DPVVVTIWYRAPELLLG-ARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 4e-16
Identities = 70/258 (27%), Positives = 111/258 (43%), Gaps = 44/258 (17%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTDVAIKR------IKKSCFTGRSSEQERLTVEFWKE 863
+D E+ ELG+G G V R + + + R IK + + +E
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRN-----------QIIRE 49
Query: 864 AEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDR----FLDRRRRL 919
++L + + P +V FYG G ++ E+M GSL VL + R L +
Sbjct: 50 LKVLHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAGRIPENILGK---- 103
Query: 920 IIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGG 978
I++ G+ YL K I+H D+K N+LVN SR K+ DFG+S +++ +
Sbjct: 104 -ISIAVLRGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLCDFGVSGQLIDSMANSF 158
Query: 979 VRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEP--------YANMHYGAII 1030
V GT +M+PE L G+ V D++S G+ L E+ G P M +
Sbjct: 159 V-GTRSYMSPERLQGTHYTVQS--DIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVS 215
Query: 1031 GGIVNNTLRPTIPSYCDA 1048
G + RP D+
Sbjct: 216 EGEAKESHRPVSGHPPDS 233
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 6e-16
Identities = 66/240 (27%), Positives = 107/240 (44%), Gaps = 50/240 (20%)
Query: 818 LGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNV 875
+G G G VY + VA+K+I++ SE L F +EA+I + L HP +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDL-----SENPLLKKRFLREAKIAADLIHPGI 64
Query: 876 VAFYGVVQDGPGGTLATVAEYM--VDG-SLRHVL--VRKDRFLDRRRR--------LIIA 922
V Y + DG V M ++G +L+ +L V + L + L I
Sbjct: 65 VPVYSICSDGD-----PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 923 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKR----------- 971
+EY+HSK ++H DLK DN+L+ L + D+G + K+
Sbjct: 120 HKICATIEYVHSKGVLHRDLKPDNILLGLFGE----VVILDWGAAIFKKLEEEDLLDIDV 175
Query: 972 --------NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN 1023
+ + G + GT +MAPE L G + SE D+++ G++L+++LT PY
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPA--SESTDIYALGVILYQMLTLSFPYRR 233
|
Length = 932 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 6e-16
Identities = 69/270 (25%), Positives = 122/270 (45%), Gaps = 35/270 (12%)
Query: 818 LGSGTFGTVYHG---------KWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILS 868
LG GTF ++ G + T+V +K + KS + F++ A ++S
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--------HRNYSESFFEAASMMS 54
Query: 869 KLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFG 928
+L H ++V YGV G + V EY+ GSL L + ++ +L +A A+
Sbjct: 55 QLSHKHLVLNYGVCVCGDESIM--VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWA 112
Query: 929 MEYLHSKNIVHFDLKCDNLLV----NLKDPSRPICKVGDFGLSK--IKRNTLVSGGVRGT 982
+ +L K + H ++ N+L+ + K + P K+ D G+S + + L+
Sbjct: 113 LHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLE-----R 167
Query: 983 LPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTG-EEPYANMHYGAIIGGIVNNTLRPT 1041
+PW+ PE + + +S D +SFG LWEI +G ++P + + + + R
Sbjct: 168 IPWVPPECIENPQN-LSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED---RHQ 223
Query: 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
+P+ E L+ +C P RPSF I
Sbjct: 224 LPAPKWTELANLINQCMDYEPDFRPSFRAI 253
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-15
Identities = 71/260 (27%), Positives = 129/260 (49%), Gaps = 31/260 (11%)
Query: 816 KELGSGTFGTVY-----HGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL 870
K LG G+FG V+ G G A+K +KK+ R + ++ E +IL+++
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM------ERDILAEV 55
Query: 871 HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGME 930
+HP +V + Q G L + +++ G L L ++ F + + +A + A ++
Sbjct: 56 NHPFIVKLHYAFQTE--GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALALD 112
Query: 931 YLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR-----GTLPW 985
+LHS I++ DLK +N+L+ D I K+ DFGLSK + + GT+ +
Sbjct: 113 HLHSLGIIYRDLKPENILL---DEEGHI-KLTDFGLSK----ESIDHEKKAYSFCGTVEY 164
Query: 986 MAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSY 1045
MAPE+++ ++ D +SFG++++E+LTG P+ + I+ L +P +
Sbjct: 165 MAPEVVNRRGH--TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL--GMPQF 220
Query: 1046 CDAEWRTLMEECWAPNPAAR 1065
E ++L+ + NPA R
Sbjct: 221 LSPEAQSLLRALFKRNPANR 240
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 77/318 (24%), Positives = 124/318 (38%), Gaps = 70/318 (22%)
Query: 811 DLEEQKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTVEFWKEAEILS 868
++ K LG G G V+ + +GT A+K + K R+ + LT E EIL+
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLT-----EQEILA 56
Query: 869 KLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAA-F 927
L HP + Y Q L V +Y G L R L R+ ++ + A F
Sbjct: 57 TLDHPFLPTLYASFQTET--YLCLVMDYCPGGELF-------RLLQRQPGKCLSEEVARF 107
Query: 928 -------GMEYLHSKNIVHFDLKCDNLLV---------------NLKDPSRPICKVGDFG 965
+EYLH IV+ DLK +N+L+ P+ K G
Sbjct: 108 YAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKG 167
Query: 966 LSKIKRNTLV------SGGVR-----GTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEI 1014
+ N++ R GT ++APE++SG VD ++ GI+L+E+
Sbjct: 168 SRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH--GSAVDWWTLGILLYEM 225
Query: 1015 LTGEEPYA----NMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTE 1070
L G P+ + + I+ V P + S R L+ + +P+ R
Sbjct: 226 LYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSA----RDLIRKLLVKDPSKR----- 276
Query: 1071 IASRLRVLSTAASQTKGH 1088
+ S+ A++ K H
Sbjct: 277 LGSK-----RGAAEIKQH 289
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 62/212 (29%), Positives = 95/212 (44%), Gaps = 37/212 (17%)
Query: 818 LGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPN 874
+G GTF V + R G AIK +KK +S EQ V +E + L +L HPN
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHF---KSLEQ----VNNLREIQALRRLSPHPN 59
Query: 875 VVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHS 934
++ V+ D G LA V E M D +L ++ + R L +R ++++H
Sbjct: 60 ILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR 118
Query: 935 KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLP--------WM 986
I H D+K +N+L+ I K+ DFG + G+ P W
Sbjct: 119 NGIFHRDIKPENILIKDD-----ILKLADFGSCR---------GIYSKPPYTEYISTRWY 164
Query: 987 -APE-LLSGSSSKVSEKVDVFSFGIVLWEILT 1016
APE LL+ K+D+++ G V +EIL+
Sbjct: 165 RAPECLLTDGY--YGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 73/285 (25%), Positives = 118/285 (41%), Gaps = 80/285 (28%)
Query: 817 ELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPN 874
++G GT+G VY + + T VA+K+++ +E+E + +E +IL +L+H N
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVR------LDNEKEGFPITAIREIKILRQLNHRN 67
Query: 875 VVAFYGVVQDGPG--------GTLATVAEYM------------VDGSLRHVLVRKDRFLD 914
+V +V D G V EYM V S H+ + L+
Sbjct: 68 IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLE 127
Query: 915 RRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI----- 969
G+ Y H KN +H D+KC N+L+N K K+ DFGL+++
Sbjct: 128 -------------GLNYCHKKNFLHRDIKCSNILLNNKGQ----IKLADFGLARLYNSEE 170
Query: 970 KR---NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY 1026
R N ++ TL + PELL G + +DV+S G +L E+ T ++P
Sbjct: 171 SRPYTNKVI------TLWYRPPELLLG-EERYGPAIDVWSCGCILGELFT-KKPIFQ--- 219
Query: 1027 GAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
N L A+ + C +P PA P ++
Sbjct: 220 -------ANQEL---------AQLELISRLCGSPCPAVWPDVIKL 248
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 61/217 (28%), Positives = 109/217 (50%), Gaps = 31/217 (14%)
Query: 811 DLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILS 868
D + +++G GT+G VY G+ + T VA+K+I+ SE+E + +E +L
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIR------LESEEEGVPSTAIREISLLK 54
Query: 869 KLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVL--VRKDRFLDRRRRLIIAMDAA 926
+L HPN+V V+ L + E++ L+ L + K +++D
Sbjct: 55 ELQHPNIVCLQDVLMQES--RLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQIL 111
Query: 927 FGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS-------KIKRNTLVSGGV 979
G+ + HS+ ++H DLK NLL++ ++ + K+ DFGL+ ++ + +V
Sbjct: 112 QGILFCHSRRVLHRDLKPQNLLID----NKGVIKLADFGLARAFGIPVRVYTHEVV---- 163
Query: 980 RGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT 1016
TL + APE+L G S + S VD++S G + E+ T
Sbjct: 164 --TLWYRAPEVLLG-SPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-15
Identities = 53/150 (35%), Positives = 76/150 (50%), Gaps = 10/150 (6%)
Query: 926 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-IKR--NTLVSGGVRGT 982
A GME+L SKN VH DL N+L+ + K+ DFGL++ I R N + G
Sbjct: 249 ANGMEFLASKNCVHRDLAARNVLIC----EGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 983 LPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPT 1041
L WMAPE S ++ + DV+SFGI+LWEI T G PY + + R
Sbjct: 305 LKWMAPE--SIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMA 362
Query: 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
P++ E +M++CW RP F+++
Sbjct: 363 KPAHASDEIYEIMQKCWEEKFEIRPDFSQL 392
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 4e-15
Identities = 74/227 (32%), Positives = 103/227 (45%), Gaps = 49/227 (21%)
Query: 810 EDLEEQKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWK----E 863
+D++ Q+ LG G GTVY +A+K I +TVE K E
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLD-----------ITVELQKQIMSE 49
Query: 864 AEILSKLHHPNVVAFYGV--VQDGPGGTLATVAEYMVDGSL-------RHVLVRKDRFLD 914
EIL K P ++ FYG V++ ++ E+M GSL HVL R
Sbjct: 50 LEILYKCDSPYIIGFYGAFFVEN----RISICTEFMDGGSLDVYRKIPEHVLGR------ 99
Query: 915 RRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTL 974
IA+ G+ YL S I+H D+K N+LVN +R K+ DFG+S N++
Sbjct: 100 ------IAVAVVKGLTYLWSLKILHRDVKPSNMLVN----TRGQVKLCDFGVSTQLVNSI 149
Query: 975 VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1021
V GT +MAPE +SG + DV+S GI E+ G PY
Sbjct: 150 AKTYV-GTNAYMAPERISGEQYGIHS--DVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 5e-15
Identities = 59/223 (26%), Positives = 109/223 (48%), Gaps = 27/223 (12%)
Query: 811 DLEEQKELGSGTFGTVY-----HGKWRGTDVAIKRIKKSCF-----TGRSSEQERLTVEF 860
+ E K LG+G +G V+ G G A+K +KK+ T + ER +E
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 861 WKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLI 920
+++ L LH+ AF + L + +Y+ G L L +++RF ++ ++
Sbjct: 61 IRQSPFLVTLHY----AFQTDTK------LHLILDYINGGELFTHLSQRERFKEQEVQIY 110
Query: 921 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK--IKRNTLVSGG 978
+ +E+LH I++ D+K +N+L++ S + DFGLSK + +
Sbjct: 111 SG-EIVLALEHLHKLGIIYRDIKLENILLD----SNGHVVLTDFGLSKEFHEDEVERAYS 165
Query: 979 VRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1021
GT+ +MAP+++ G + VD +S G++++E+LTG P+
Sbjct: 166 FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 5e-15
Identities = 77/257 (29%), Positives = 122/257 (47%), Gaps = 26/257 (10%)
Query: 816 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
K LG G+FG V + +G A+K +KK + E VE K L+ +P
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL-IDDDVECTMVE--KRVLALA-WENP 56
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLH 933
+ Y Q L V E++ G L + K RF D R A + G+++LH
Sbjct: 57 FLTHLYCTFQTKE--HLFFVMEFLNGGDLMFHIQDKGRF-DLYRATFYAAEIVCGLQFLH 113
Query: 934 SKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR-----GTLPWMAP 988
SK I++ DLK DN++++ +D K+ DFG+ K V G R GT ++AP
Sbjct: 114 SKGIIYRDLKLDNVMLD-RDGH---IKIADFGMCKEN----VFGDNRASTFCGTPDYIAP 165
Query: 989 ELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDA 1048
E+L G K + VD +SFG++L+E+L G+ P+ + I +T P P +
Sbjct: 166 EILQG--LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT--PHYPRWITK 221
Query: 1049 EWRTLMEECWAPNPAAR 1065
E + ++E+ + +P R
Sbjct: 222 ESKDILEKLFERDPTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 6e-15
Identities = 64/215 (29%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 813 EEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL 870
E +G G +G V + + T VAIK+ K+S E + T +E ++L +L
Sbjct: 4 EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKES----EDDEDVKKTAL--REVKVLRQL 57
Query: 871 HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRR--RRLIIAMDAAFG 928
H N+V + G L V EY V+ +L +L L R I + A
Sbjct: 58 RHENIVNLKEAFRRK--GRLYLVFEY-VERTLLELLEASPGGLPPDAVRSYIWQLLQAIA 114
Query: 929 MEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGT----LP 984
Y HS NI+H D+K +N+LV+ + K+ DFG + R T
Sbjct: 115 --YCHSHNIIHRDIKPENILVSESG----VLKLCDFGFA---RALRARPASPLTDYVATR 165
Query: 985 WM-APELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
W APELL G ++ + VDV++ G ++ E+L GE
Sbjct: 166 WYRAPELLVGDTN-YGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 9e-15
Identities = 63/227 (27%), Positives = 107/227 (47%), Gaps = 33/227 (14%)
Query: 811 DLEEQKELGSGTFGTVY-----HGKWRGTDVAIKRIKKSCF-----TGRSSEQERLTVEF 860
+ E + LG+G +G V+ G G A+K +KK+ T + ER +E
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 861 WKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLI 920
+ L LH+ AF + L + +Y+ G L L +++ F + R+
Sbjct: 61 VRRCPFLVTLHY----AFQTDTK------LHLILDYVNGGELFTHLYQREHFTESEVRVY 110
Query: 921 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR 980
IA + +++LH I++ D+K +N+L++ S + DFGLSK L R
Sbjct: 111 IA-EIVLALDHLHQLGIIYRDIKLENILLD----SEGHVVLTDFGLSKE---FLAEEEER 162
Query: 981 -----GTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYA 1022
GT+ +MAPE++ G S + VD +S G++ +E+LTG P+
Sbjct: 163 AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT 209
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 1e-14
Identities = 67/230 (29%), Positives = 101/230 (43%), Gaps = 36/230 (15%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
D E +LG GTFG VY + G VA+K+I +E++ + +E +IL
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMH------NEKDGFPITALREIKIL 61
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAE-YMVDGSLRHVLVRKDRFLDRRR-RLIIA--- 922
KL HPNVV + + P + YMV + H L L+ +L +
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSG---LLENPSVKLTESQIK 118
Query: 923 --MDAAF-GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRN---TLVS 976
M G+ YLH +I+H D+K N+L++ ++ I K+ DFGL++
Sbjct: 119 CYMLQLLEGINYLHENHILHRDIKAANILID----NQGILKIADFGLARPYDGPPPNPKG 174
Query: 977 GGVRGTLP--------WM-APELLSGSSSKVSEKVDVFSFGIVLWEILTG 1017
GG GT W PELL G + + VD++ G V E+ T
Sbjct: 175 GGGGGTRKYTNLVVTRWYRPPELLLG-ERRYTTAVDIWGIGCVFAEMFTR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 1e-14
Identities = 77/279 (27%), Positives = 119/279 (42%), Gaps = 35/279 (12%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
+++E ELG G +G+VY R T V A+K I R E + E +IL
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEI-------RLELDESKFNQIIMELDIL 53
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHV------LVRKDRFLDRRRRLII 921
K P +V FYG G + EYM GSL + + RR I
Sbjct: 54 HKAVSPYIVDFYGAFFIE--GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRR----I 107
Query: 922 AMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR 980
G+++L + NI+H D+K N+LVN K+ DFG+S +L +
Sbjct: 108 TYAVVKGLKFLKEEHNIIHRDVKPTNVLVN----GNGQVKLCDFGVSGNLVASLAKTNI- 162
Query: 981 GTLPWMAPELLSGSSSK----VSEKVDVFSFGIVLWEILTGEEPYANMHYGAI---IGGI 1033
G +MAPE + + + DV+S G+ + E+ G PY Y I + I
Sbjct: 163 GCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAI 222
Query: 1034 VNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIA 1072
V+ PT+PS + + + +C P RP++ ++
Sbjct: 223 VDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLL 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-14
Identities = 55/152 (36%), Positives = 77/152 (50%), Gaps = 12/152 (7%)
Query: 926 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK--IKRNTLVSGGVRGTL 983
A GME+L SKN VH DL N+L+ I K+ DFGL++ + + VS G L
Sbjct: 247 ARGMEFLASKNCVHRDLAARNVLLA----QGKIVKICDFGLARDIMHDSNYVSKG-STFL 301
Query: 984 P--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 1040
P WMAPE S + + DV+S+GI+LWEI + G PY M + + + R
Sbjct: 302 PVKWMAPE--SIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRM 359
Query: 1041 TIPSYCDAEWRTLMEECWAPNPAARPSFTEIA 1072
P + E +M +CW P RPSF ++
Sbjct: 360 AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLS 391
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 64/212 (30%), Positives = 94/212 (44%), Gaps = 26/212 (12%)
Query: 818 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNV 875
LG G FG V + + T A K++ K R EQ L E +IL K+ +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALN-----EKKILEKVSSRFI 55
Query: 876 V----AFYGVVQDGPGGTLATVAEYMVDGSLR-HVLVRKDRFLDRRRRLIIAMDAAFGME 930
V AF L V M G L+ H+ + R + A G+E
Sbjct: 56 VSLAYAFETKDD------LCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLE 109
Query: 931 YLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS-KIKRNTLVSGGVRGTLPWMAPE 989
+LH + IV+ DLK +N+L L D ++ D GL+ ++K + G GT +MAPE
Sbjct: 110 HLHQRRIVYRDLKPENVL--LDDHGN--VRISDLGLAVELKGGKKIKGRA-GTPGYMAPE 164
Query: 990 LLSGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1021
+L G S VD F+ G L+E++ G P+
Sbjct: 165 VLQGEVYDFS--VDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 23/221 (10%)
Query: 810 EDLEEQKELGSGTFGTVY---HGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEI 866
EDL++ E+G G FGTV H GT +A+KRI+ S + ++ + ++ +
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKP-SGTIMAVKRIR-STVDEKEQKRLLMDLDVVMRSS- 60
Query: 867 LSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSL----RHVLVRKDRFLDRRRRLIIA 922
P +V FYG + G E M D SL ++V + IA
Sbjct: 61 ----DCPYIVKFYGALFRE--GDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIA 113
Query: 923 MDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRG 981
+ + YL + I+H D+K N+L++ K+ DFG+S +++ G
Sbjct: 114 VATVKALNYLKEELKIIHRDVKPSNILLDR----NGNIKLCDFGISGQLVDSIAKTRDAG 169
Query: 982 TLPWMAPE-LLSGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1021
P+MAPE + + + DV+S GI L+E+ TG+ PY
Sbjct: 170 CRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY 210
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-14
Identities = 74/266 (27%), Positives = 125/266 (46%), Gaps = 20/266 (7%)
Query: 816 KELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
K +G G+FG V + + + A+K ++K + E+ ++ + +L + HP
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMS----ERNVLLKNVKHP 56
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLH 933
+V + Q L V +Y+ G L + L R+ FL+ R R A + A + YLH
Sbjct: 57 FLVGLHFSFQTA--DKLYFVLDYINGGELFYHLQRERCFLEPRARFY-AAEIASALGYLH 113
Query: 934 SKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK--IKRNTLVSGGVRGTLPWMAPELL 991
S NIV+ DLK +N+L++ S+ + DFGL K I+ N S GT ++APE+L
Sbjct: 114 SLNIVYRDLKPENILLD----SQGHIVLTDFGLCKENIEHNGTTSTFC-GTPEYLAPEVL 168
Query: 992 SGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN--TLRPTIPSYCDAE 1049
VD + G VL+E+L G P+ + + + I+N L+P I +
Sbjct: 169 --HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHL 226
Query: 1050 WRTLMEECWAPNPAARPSFTEIASRL 1075
L+++ A+ F EI + +
Sbjct: 227 LEGLLQKDRTKRLGAKDDFMEIKNHI 252
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 30/210 (14%)
Query: 817 ELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPN 874
+LG GT+ TV+ G+ + T+ VA+K I R +E +E +L L H N
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEI-------RLEHEEGAPCTAIREVSLLKNLKHAN 64
Query: 875 VVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHS 934
+V + ++ TL V EY+ D L+ L + I G+ Y H
Sbjct: 65 IVTLHDIIHTERCLTL--VFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK 121
Query: 935 KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK-------RNTLVSGGVRGTLPWMA 987
+ I+H DLK NLL+N + K+ DFGL++ K N +V TL +
Sbjct: 122 RKILHRDLKPQNLLIN----EKGELKLADFGLARAKSVPTKTYSNEVV------TLWYRP 171
Query: 988 PELLSGSSSKVSEKVDVFSFGIVLWEILTG 1017
P++L G S++ S +D++ G +L+E+ TG
Sbjct: 172 PDVLLG-STEYSTPIDMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-14
Identities = 74/268 (27%), Positives = 125/268 (46%), Gaps = 38/268 (14%)
Query: 816 KELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
+++G G GTVY G +VAIK++ + ++ L + E ++ + +P
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNL-----QQQPKKELII---NEILVMRENKNP 76
Query: 874 NVVAF---YGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGME 930
N+V + Y V G L V EY+ GSL V+ + +D + + + ++
Sbjct: 77 NIVNYLDSYLV-----GDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALD 129
Query: 931 YLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL------SKIKRNTLVSGGVRGTLP 984
+LHS ++H D+K DN+L+ + K+ DFG + KR+T+V GT
Sbjct: 130 FLHSNQVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMV-----GTPY 180
Query: 985 WMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH-YGAIIGGIVNNTLRPTIP 1043
WMAPE+++ + KVD++S GI+ E++ GE PY N + A+ N T P
Sbjct: 181 WMAPEVVTRKA--YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP 238
Query: 1044 SYCDAEWRTLMEECWAPNPAARPSFTEI 1071
A +R + C + R S E+
Sbjct: 239 ERLSAVFRDFLNRCLEMDVDRRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 72/256 (28%), Positives = 114/256 (44%), Gaps = 25/256 (9%)
Query: 816 KELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
K LG GTFG V K G A+K ++K + +T E+ +L HP
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT-----ESRVLQNTRHP 55
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLH 933
+ A Q L V EY G L L R+ F + R R A + +EYLH
Sbjct: 56 FLTALKYAFQTH--DRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIVSALEYLH 112
Query: 934 SKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR----GTLPWMAPE 989
S+++V+ D+K +NL+++ KD K+ DFGL K + G GT ++APE
Sbjct: 113 SRDVVYRDIKLENLMLD-KDGH---IKITDFGLCK---EGISDGATMKTFCGTPEYLAPE 165
Query: 990 LLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAE 1049
+L + VD + G+V++E++ G P+ N + + I+ +R P E
Sbjct: 166 VL--EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPE 221
Query: 1050 WRTLMEECWAPNPAAR 1065
++L+ +P R
Sbjct: 222 AKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 18/204 (8%)
Query: 817 ELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPN 874
+LG GT+ TVY G+ + TD VA+K I R +E +E +L L H N
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEI-------RLEHEEGAPCTAIREVSLLKDLKHAN 65
Query: 875 VVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHS 934
+V + ++ +L V EY+ D L+ L ++ + G+ Y H
Sbjct: 66 IVTLHDIIHTEK--SLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR 122
Query: 935 KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKR-NTLVSGGVRGTLPWMAPELLSG 993
+ ++H DLK NLL+N R K+ DFGL++ K T TL + P++L G
Sbjct: 123 RKVLHRDLKPQNLLIN----ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLG 178
Query: 994 SSSKVSEKVDVFSFGIVLWEILTG 1017
S+ S ++D++ G + +E+ TG
Sbjct: 179 -STDYSTQIDMWGVGCIFYEMSTG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 4e-14
Identities = 73/254 (28%), Positives = 113/254 (44%), Gaps = 21/254 (8%)
Query: 816 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
K LG GTFG V + + T A+K +KK + LT E+ +L HP
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLT-----ESRVLQNTRHP 55
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLH 933
+ A Q L V EY G L L R+ F + R R A + + YLH
Sbjct: 56 FLTALKYSFQTH--DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALGYLH 112
Query: 934 SKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK--IKRNTLVSGGVRGTLPWMAPELL 991
S ++V+ DLK +NL+++ KD K+ DFGL K I + GT ++APE+L
Sbjct: 113 SCDVVYRDLKLENLMLD-KDGH---IKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVL 167
Query: 992 SGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWR 1051
+ VD + G+V++E++ G P+ N + + I+ +R P E +
Sbjct: 168 --EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLSPEAK 223
Query: 1052 TLMEECWAPNPAAR 1065
+L+ +P R
Sbjct: 224 SLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 66/217 (30%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
+DLE K +G+GTFG V+ + R A+K + EQ E +L
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQH-----VHNEKRVL 55
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
++ HP ++ + D L + EY+ G L L RF L A +
Sbjct: 56 KEVSHPFIIRLFWTEHDQ--RFLYMLMEYVPGGELFSYLRNSGRF-SNSTGLFYASEIVC 112
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRN---TLVSGGVRGTLP 984
+EYLHSK IV+ DLK +N+L++ K+ K+ DFG +K R+ TL GT
Sbjct: 113 ALEYLHSKEIVYRDLKPENILLD-KEGH---IKLTDFGFAKKLRDRTWTLC-----GTPE 163
Query: 985 WMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1021
++APE++ S ++ VD ++ GI+++E+L G P+
Sbjct: 164 YLAPEVI--QSKGHNKAVDWWALGILIYEMLVGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 4e-14
Identities = 74/268 (27%), Positives = 125/268 (46%), Gaps = 38/268 (14%)
Query: 816 KELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
+++G G GTVY G +VAI+++ + ++ L + E ++ + +P
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNL-----QQQPKKELII---NEILVMRENKNP 77
Query: 874 NVVAF---YGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGME 930
N+V + Y V G L V EY+ GSL V+ + +D + + + +E
Sbjct: 78 NIVNYLDSYLV-----GDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALE 130
Query: 931 YLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL------SKIKRNTLVSGGVRGTLP 984
+LHS ++H D+K DN+L+ + K+ DFG + KR+T+V GT
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMV-----GTPY 181
Query: 985 WMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH-YGAIIGGIVNNTLRPTIP 1043
WMAPE+++ + KVD++S GI+ E++ GE PY N + A+ N T P
Sbjct: 182 WMAPEVVTRKA--YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP 239
Query: 1044 SYCDAEWRTLMEECWAPNPAARPSFTEI 1071
A +R + C + R S E+
Sbjct: 240 EKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 5e-14
Identities = 64/220 (29%), Positives = 105/220 (47%), Gaps = 38/220 (17%)
Query: 815 QKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHH 872
K +GSG +G V K G VAIK+I F + R+ +E ++L L H
Sbjct: 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKISN-VFDDLIDAK-RI----LREIKLLRHLRH 58
Query: 873 PNVVAFYGVVQDGPG---GTLATVAEYMVDGSLRHVLVRKDRFL--DRRRRLIIAMDAAF 927
N++ +++ + V E M + L H +++ + L D + + +
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELM-ETDL-HKVIKSPQPLTDDHIQYFLYQI--LR 114
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC--KVGDFGLSKI-----KRNTLVSGGV- 979
G++YLHS N++H DLK N+LVN + C K+ DFGL++ ++ V
Sbjct: 115 GLKYLHSANVIHRDLKPSNILVN-SN-----CDLKICDFGLARGVDPDEDEKGFLTEYVV 168
Query: 980 -RGTLPWM-APELLSGSSSKVSEKVDVFSFGIVLWEILTG 1017
R W APELL SSS+ ++ +D++S G + E+LT
Sbjct: 169 TR----WYRAPELL-LSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 6e-14
Identities = 61/208 (29%), Positives = 94/208 (45%), Gaps = 28/208 (13%)
Query: 818 LGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNV 875
+G GT+G VY + + G VA+K+I+ +E E + +E +L +L+HPN+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIR------LETEDEGVPSTAIREISLLKELNHPNI 60
Query: 876 VAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRF-LDRRRRLIIAMDAAFGMEYLHS 934
V VV L V E+ +D L+ + LD G+ Y HS
Sbjct: 61 VRLLDVVHSE--NKLYLVFEF-LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 935 KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRG------TLPWMAP 988
++H DLK NLL++ K+ DFGL++ VR TL + AP
Sbjct: 118 HRVLHRDLKPQNLLID----REGALKLADFGLARA-----FGVPVRTYTHEVVTLWYRAP 168
Query: 989 ELLSGSSSKVSEKVDVFSFGIVLWEILT 1016
E+L GS S VD++S G + E++
Sbjct: 169 EILLGSRQ-YSTPVDIWSIGCIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 6e-14
Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 21/213 (9%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
+ E+ +++G GT+G VY + R T+ +A+K+I+ E E + +E +L
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIR------LEQEDEGVPSTAIREISLL 55
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
++ H N+V VV L V EY+ D L+ + F R + +
Sbjct: 56 KEMQHGNIVRLQDVVHSEK--RLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQIL 112
Query: 928 -GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK---IKRNTLVSGGVRGTL 983
G+ Y HS ++H DLK NLL+ D K+ DFGL++ I T V TL
Sbjct: 113 RGIAYCHSHRVLHRDLKPQNLLI---DRRTNALKLADFGLARAFGIPVRTFTHEVV--TL 167
Query: 984 PWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT 1016
+ APE+L GS S VD++S G + E++
Sbjct: 168 WYRAPEILLGSRH-YSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 6e-14
Identities = 69/230 (30%), Positives = 103/230 (44%), Gaps = 32/230 (13%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
ED E K + +G +G VY + + T A+K+I K R+ Q+ E +IL
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFV-----ERDIL 55
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
+ +P VV+ + + L V EY+ G +L R+ A +
Sbjct: 56 TFAENPFVVSMFCSFETKR--HLCMVMEYVEGGDCATLLKNIGALPVDMARMYFA-ETVL 112
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI---KRNTLVSGG------ 978
+EYLH+ IVH DLK DNLL+ S K+ DFGLSKI T + G
Sbjct: 113 ALEYLHNYGIVHRDLKPDNLLIT----SMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDT 168
Query: 979 -------VRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1021
V GT ++APE++ + VD ++ GI+L+E L G P+
Sbjct: 169 REFLDKQVCGTPEYIAPEVI--LRQGYGKPVDWWAMGIILYEFLVGCVPF 216
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 8e-14
Identities = 72/269 (26%), Positives = 117/269 (43%), Gaps = 31/269 (11%)
Query: 818 LGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVV 876
+G+GT+G VY G+ T + IK TG E E +E +L K HH N+
Sbjct: 14 VGNGTYGQVYKGRHVKTG-QLAAIKVMDVTGDEEE------EIKQEINMLKKYSHHRNIA 66
Query: 877 AFYGV-VQDGPGGT---LATVAEYMVDGSLRHVLVR-KDRFLDRRRRLIIAMDAAFGMEY 931
+YG ++ P G L V E+ GS+ ++ K L I + G+ +
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126
Query: 932 LHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI------KRNTLVSGGVRGTLPW 985
LH ++H D+K N+L+ K+ DFG+S +RNT + GT W
Sbjct: 127 LHQHKVIHRDIKGQNVLLT----ENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPYW 177
Query: 986 MAPELLS---GSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTI 1042
MAPE+++ + K D++S GI E+ G P +MH + I N
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLK 237
Query: 1043 PSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
++++ +E C N + RP+ ++
Sbjct: 238 SKKWSKKFQSFIESCLVKNHSQRPTTEQL 266
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 9e-14
Identities = 73/292 (25%), Positives = 127/292 (43%), Gaps = 39/292 (13%)
Query: 811 DLEEQKELGSGTFGTVY-----HGKWRGTDVAIKRIKKSCFTGRSSEQE-----RLTVEF 860
+ E K LG+G +G V+ G G A+K ++K+ ++ E R +E
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 861 WKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLI 920
+++ L LH+ AF + L + +Y+ G + L ++D F + R
Sbjct: 61 VRQSPFLVTLHY----AFQTEAK------LHLILDYVSGGEMFTHLYQRDNFSEDEVRFY 110
Query: 921 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK--IKRNTLVSGG 978
+ +E+LH IV+ D+K +N+L++ S + DFGLSK + +
Sbjct: 111 SG-EIILALEHLHKLGIVYRDIKLENILLD----SEGHVVLTDFGLSKEFLSEEKERTYS 165
Query: 979 VRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 1038
GT+ +MAPE++ G + VD +S GI+++E+LTG P+ + L
Sbjct: 166 FCGTIEYMAPEIIRGKGGH-GKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL 224
Query: 1039 R--PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQTKGH 1088
+ P PS+ E + L+ + +P RL AS+ K H
Sbjct: 225 KCDPPFPSFIGPEAQDLLHKLLRKDP---------KKRLGAGPQGASEIKEH 267
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 1e-13
Identities = 68/253 (26%), Positives = 114/253 (45%), Gaps = 22/253 (8%)
Query: 818 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HPN 874
LG G+FG V + + + A+K +KK + +T E ILS HP
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMT-----EKRILSLARNHPF 57
Query: 875 VVAFYGVVQDGPGGTLATVAEYMVDGSLR-HVLVRKDRFLDRRRRLIIAMDAAFGMEYLH 933
+ Y Q L V E++ G L H+ +K R D R A + + +LH
Sbjct: 58 LTQLYCCFQTPD--RLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEITSALMFLH 113
Query: 934 SKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK-RNTLVSGGVRGTLPWMAPELLS 992
K I++ DLK DN+L++ + CK+ DFG+ K N + GT ++APE+L
Sbjct: 114 DKGIIYRDLKLDNVLLDHEGH----CKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQ 169
Query: 993 GSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRT 1052
S VD ++ G++L+E+L G P+ + + I+N+ + P++ +
Sbjct: 170 EMLYGPS--VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV--VYPTWLSQDAVD 225
Query: 1053 LMEECWAPNPAAR 1065
+++ NP R
Sbjct: 226 ILKAFMTKNPTMR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-13
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 816 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILS-KLHH 872
K LG G+FG V + +GTD AIK +KK +T E IL+ H
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMT-----EKRILALAAKH 55
Query: 873 PNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYL 932
P + A + Q L V EY+ G L + R +F + R R A + + +L
Sbjct: 56 PFLTALHCCFQTKD--RLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFY-AAEVTLALMFL 112
Query: 933 HSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK--IKRNTLVSGGVRGTLPWMAPEL 990
H +++ DLK DN+L++ + CK+ DFG+ K I + GT ++APE+
Sbjct: 113 HRHGVIYRDLKLDNILLD----AEGHCKLADFGMCKEGILNGVTTTTFC-GTPDYIAPEI 167
Query: 991 LSGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1021
L S VD ++ G++++E++ G+ P+
Sbjct: 168 LQELEYGPS--VDWWALGVLMYEMMAGQPPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 18/213 (8%)
Query: 808 KNEDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAE 865
K E + ++LG GT+ TV+ G+ + T+ VA+K I R +E +E
Sbjct: 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEI-------RLEHEEGAPCTAIREVS 56
Query: 866 ILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDA 925
+L L H N+V + +V TL V EY+ D L+ + + I
Sbjct: 57 LLKDLKHANIVTLHDIVHTDKSLTL--VFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQI 113
Query: 926 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKR-NTLVSGGVRGTLP 984
G+ Y H + ++H DLK NLL+N R K+ DFGL++ K T TL
Sbjct: 114 LRGLAYCHRRKVLHRDLKPQNLLIN----ERGELKLADFGLARAKSVPTKTYSNEVVTLW 169
Query: 985 WMAPELLSGSSSKVSEKVDVFSFGIVLWEILTG 1017
+ P++L G SS+ S ++D++ G + +E+ +G
Sbjct: 170 YRPPDVLLG-SSEYSTQIDMWGVGCIFFEMASG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 65/274 (23%), Positives = 124/274 (45%), Gaps = 30/274 (10%)
Query: 816 KELGSGTFGTVYHGK-WRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPN 874
+E+G+G FG V + + T VA +K+ S EQ EF ++ + L HPN
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQN----EFLQQGDPYRILQHPN 56
Query: 875 VVAFYG-VVQDGPGGTLATVAEYMVDGSLR-HVLVRKDRFLDRRRRLI--IAMDAAFGME 930
++ G V+ P V EY G L+ ++ + + + L+ +A + A G+
Sbjct: 57 ILQCLGQCVEAIP---YLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVT 113
Query: 931 YLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL--SKIKRNTLVS-GGVRGTLPWMA 987
++H N +H DL N + S KVGD+G+ S+ K + + + L W+A
Sbjct: 114 HMHKHNFLHSDLALRNCFLT----SDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLA 169
Query: 988 PELLSGSSSKV-----SEKVDVFSFGIVLWEIL-TGEEPYANMHYGAIIGGIVNNT---- 1037
PEL+ + ++ +V++ G+ LWE+ +PY+++ ++ ++ +
Sbjct: 170 PELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKL 229
Query: 1038 LRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
+P + W +++ CW P R + E+
Sbjct: 230 FKPQLELPYSERWYEVLQFCWLS-PEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 2e-13
Identities = 71/247 (28%), Positives = 108/247 (43%), Gaps = 48/247 (19%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
+D E K +G G FG V+ + + T A+K ++KS R Q E +IL
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKR--NQIAH---VRAERDIL 55
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIA-MDAA 926
+ P +V Y QD L V EYM G L ++L+RKD F + R IA + A
Sbjct: 56 ADADSPWIVKLYYSFQDE--EHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLA 113
Query: 927 FGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK---------------IKR 971
++ +H +H D+K DN+L+ D I K+ DFGL K
Sbjct: 114 --LDSVHKLGFIHRDIKPDNILI---DADGHI-KLADFGLCKKMNKAKDREYYLNDSHNL 167
Query: 972 NTLVSGGVR---------------GTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT 1016
+ VR GT ++APE+L G+ + D +S G++L+E+L
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP--YGLECDWWSLGVILYEMLY 225
Query: 1017 GEEPYAN 1023
G P+ +
Sbjct: 226 GFPPFYS 232
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 3e-13
Identities = 68/232 (29%), Positives = 112/232 (48%), Gaps = 41/232 (17%)
Query: 816 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
+ LG G+ G V+ D VA+K+I T S + L +E +I+ +L H
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKI---VLTDPQSVKHAL-----REIKIIRRLDHD 62
Query: 874 NVVAFYGVVQDGPGG--------------TLATVAEYMVDGSLRHVLVRKDRFLDRRRRL 919
N+V Y V+ GP G ++ V EYM + L +VL + + RL
Sbjct: 63 NIVKVYEVL--GPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVL-EQGPLSEEHARL 118
Query: 920 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI------KRNT 973
G++Y+HS N++H DLK N+ +N +D + K+GDFGL++I +
Sbjct: 119 F-MYQLLRGLKYIHSANVLHRDLKPANVFINTED---LVLKIGDFGLARIVDPHYSHKGY 174
Query: 974 LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH 1025
L G V T + +P LL S + ++ +D+++ G + E+LTG+ +A H
Sbjct: 175 LSEGLV--TKWYRSPRLLL-SPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH 223
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 3e-13
Identities = 77/255 (30%), Positives = 115/255 (45%), Gaps = 22/255 (8%)
Query: 816 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
K LG GTFG V K + T A+K +KK + LT E +L HP
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT-----ENRVLQNSRHP 55
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLH 933
+ A Q L V EY G L L R+ F + R R A + ++YLH
Sbjct: 56 FLTALKYSFQTH--DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDYLH 112
Query: 934 S-KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK--IKRNTLVSGGVRGTLPWMAPEL 990
S KN+V+ DLK +NL+++ KD K+ DFGL K IK + GT ++APE+
Sbjct: 113 SEKNVVYRDLKLENLMLD-KDGH---IKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEV 167
Query: 991 LSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEW 1050
L + VD + G+V++E++ G P+ N + + I+ +R P E
Sbjct: 168 L--EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLSPEA 223
Query: 1051 RTLMEECWAPNPAAR 1065
++L+ +P R
Sbjct: 224 KSLLSGLLKKDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 73/265 (27%), Positives = 113/265 (42%), Gaps = 53/265 (20%)
Query: 818 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNV 875
LG G++ TVY G+ + T VA+K I R +E +EA +L L H N+
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEI-------RLEHEEGAPFTAIREASLLKDLKHANI 65
Query: 876 VAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSK 935
V + ++ TL V EY+ D L+ + L + G+ Y H +
Sbjct: 66 VTLHDIIHTKK--TLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR 122
Query: 936 NIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKR---NTLVSGGVRGTLPWMAPELLS 992
++H DLK NLL++ R K+ DFGL++ K T + V TL + P++L
Sbjct: 123 RVLHRDLKPQNLLIS----ERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPDVLL 176
Query: 993 GSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAE--- 1049
G S++ S +D++ G + +E+ TG RP P D E
Sbjct: 177 G-STEYSTSLDMWGVGCIFYEMATG---------------------RPLFPGSTDVEDQL 214
Query: 1050 ---WRTL---MEECWAPNPAARPSF 1068
+R L EE W P ++ P F
Sbjct: 215 HKIFRVLGTPTEETW-PGVSSNPEF 238
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 73/277 (26%), Positives = 124/277 (44%), Gaps = 35/277 (12%)
Query: 816 KELGSGTFGTVYHGK----WRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH 871
KE+G+G FG V G+ + V +K ++ S +S QE++ +F +EA+ L
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVS-----ASVQEQM--KFLEEAQPYRSLQ 53
Query: 872 HPNVVAFYGVVQDGPGGTLATVAEYM----VDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
H N++ G + L V E+ + G LR + D +A + A
Sbjct: 54 HSNLLQCLGQCTEVTPYLL--VMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIAL 111
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS--KIKRNTLVSGGVRGT-LP 984
G+ +LH N +H DL N L+ + K+GD+GLS K K + V+ L
Sbjct: 112 GLLHLHKNNFIHSDLALRNCLLT----ADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR 167
Query: 985 WMAPELLSGSSSKV-----SEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 1038
W+APEL+ + +++ +V+S G+ +WE+ G +PY ++ ++ V
Sbjct: 168 WIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ 227
Query: 1039 ----RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
+P + W +M+ CW P RPS E+
Sbjct: 228 LKLPKPRLKLPLSDRWYEVMQFCWLQ-PEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 4e-13
Identities = 63/225 (28%), Positives = 102/225 (45%), Gaps = 31/225 (13%)
Query: 860 FWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRF-LDRRRR 918
F++ A ++S++ H ++ +GV G + V E++ G L V +RK++ + +
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIM--VEEFVEHGPL-DVCLRKEKGRVPVAWK 119
Query: 919 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV---NLKDPSRPICKVGDFGLS--KIKRNT 973
+ +A A + YL KN+VH ++ N+L+ L + + P K+ D G+S + R
Sbjct: 120 ITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREE 179
Query: 974 LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEI-------LTGEEPYANMHY 1026
V +PW+APE + G +S +S D +SFG L EI L P +
Sbjct: 180 RVE-----RIPWIAPECVPGGNS-LSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF 233
Query: 1027 GAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
R PS C E TL+ +C P RPSF I
Sbjct: 234 -------YEKKHRLPEPS-C-KELATLISQCLTYEPTQRPSFRTI 269
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-13
Identities = 61/196 (31%), Positives = 96/196 (48%), Gaps = 22/196 (11%)
Query: 833 GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLAT 892
G +VAIK ++ + E+E F +E + ++L+HPN+VA + P G L
Sbjct: 3 GHEVAIKLLRTD-----APEEEHQRARFRRETALCARLYHPNIVALLDSGEAPP-GLLFA 56
Query: 893 VAEYMVDGSLRHVLVRKDRF--LDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVN 950
V EY+ +LR VL + R ++ +DA + H++ IVH DLK N++V+
Sbjct: 57 VFEYVPGRTLREVLAADGALPAGETGRLMLQVLDA---LACAHNQGIVHRDLKPQNIMVS 113
Query: 951 LKDPSRPICKVGDFGLS-------KIKRNTLV-SGGVRGTLPWMAPELLSGSSSKVSEKV 1002
RP KV DFG+ TL + V GT + APE L G V+
Sbjct: 114 QTG-VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEP--VTPNS 170
Query: 1003 DVFSFGIVLWEILTGE 1018
D++++G++ E LTG+
Sbjct: 171 DLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 21/217 (9%)
Query: 810 EDLEEQKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
E L+ ++G G+ G V K G VA+K++ +Q+R + F E I+
Sbjct: 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR-------KQQRRELLF-NEVVIM 73
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
HH NVV Y G L V E++ G+L ++ ++ + + +
Sbjct: 74 RDYHHENVVDMYNSYL--VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLR 129
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL-SKIKRNTLVSGGVRGTLPWM 986
+ YLH++ ++H D+K D++L+ S K+ DFG +++ + + GT WM
Sbjct: 130 ALSYLHNQGVIHRDIKSDSILLT----SDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWM 185
Query: 987 APELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN 1023
APE++S +VD++S GI++ E++ GE PY N
Sbjct: 186 APEVIS--RLPYGTEVDIWSLGIMVIEMIDGEPPYFN 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 5e-13
Identities = 67/228 (29%), Positives = 106/228 (46%), Gaps = 18/228 (7%)
Query: 816 KELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
K +G G+FG V K + A+K ++K + EQ+ + E +L + HP
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKK-EQKHIMAE---RNVLLKNVKHP 56
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLH 933
+V + Q L V +Y+ G L L R+ F + R R A + A + YLH
Sbjct: 57 FLVGLHYSFQTAD--KLYFVLDYVNGGELFFHLQRERSFPEPRARFY-AAEIASALGYLH 113
Query: 934 SKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK--IKRNTLVSGGVRGTLPWMAPELL 991
S NI++ DLK +N+L++ + + DFGL K I+ + S GT ++APE+L
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVV----LTDFGLCKEGIEHSKTTSTFC-GTPEYLAPEVL 168
Query: 992 SGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 1039
VD + G VL+E+L G P+ + + I+N LR
Sbjct: 169 --RKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLR 214
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 5e-13
Identities = 53/175 (30%), Positives = 85/175 (48%), Gaps = 21/175 (12%)
Query: 863 EAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIA 922
EA +L ++HP+V+ + G T + Y D L L ++ R L + LII
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAI-TCMVLPHYSSD--LYTYLTKRSRPLPIDQALIIE 163
Query: 923 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGT 982
G+ YLH++ I+H D+K +N+ +N D +C +GD G ++ G+ GT
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDVD---QVC-IGDLGAAQFPVVAPAFLGLAGT 219
Query: 983 LPWMAPELLSGSSSKVSEKVDVFSFGIVLWEIL------------TGEEPYANMH 1025
+ APE+L + K + K D++S GIVL+E+L T EE + H
Sbjct: 220 VETNAPEVL--ARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCH 272
|
Length = 357 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-13
Identities = 68/246 (27%), Positives = 113/246 (45%), Gaps = 32/246 (13%)
Query: 795 SLVDFDVSSVQVIKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQE 854
SL D D+S+++ E + +G+GT+G VY G+ T + IK T E+
Sbjct: 2 SLDDIDLSALRDPAG-IFELVEVVGNGTYGQVYKGRHVKTG-QLAAIKVMDVTEDEEEEI 59
Query: 855 RLTVEFWKEAEILSKLHHPNVVAFYGV-VQDGPGG---TLATVAEYMVDGSLRHVLVRKD 910
+L + K+ HH N+ +YG ++ P G L V E+ GS+ LV+
Sbjct: 60 KLEINMLKKYS-----HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTD-LVKNT 113
Query: 911 RFLDRRRRLI--IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968
+ + I I + G+ +LH+ ++H D+K N+L+ K+ DFG+S
Sbjct: 114 KGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT----ENAEVKLVDFGVSA 169
Query: 969 I------KRNTLVSGGVRGTLPWMAPELLS---GSSSKVSEKVDVFSFGIVLWEILTGEE 1019
+RNT + GT WMAPE+++ + + D++S GI E+ G
Sbjct: 170 QLDRTVGRRNTFI-----GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
Query: 1020 PYANMH 1025
P +MH
Sbjct: 225 PLCDMH 230
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-13
Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 22/210 (10%)
Query: 818 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNV 875
LG G FG V + R T A K+++K R E L E +IL K++ V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN-----EKQILEKVNSRFV 62
Query: 876 V--AFYGVVQDGPGGTLATVAEYMVDGSLR-HVLVRKDRFLDRRRRLIIAMDAAFGMEYL 932
V A+ +D L V M G L+ H+ + D R + A + G+E L
Sbjct: 63 VSLAYAYETKDA----LCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDL 118
Query: 933 HSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS-KIKRNTLVSGGVRGTLPWMAPELL 991
H + IV+ DLK +N+L++ ++ D GL+ +I + G V GT+ +MAPE++
Sbjct: 119 HRERIVYRDLKPENILLD----DYGHIRISDLGLAVEIPEGETIRGRV-GTVGYMAPEVV 173
Query: 992 SGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1021
+ + + D + G +++E++ G+ P+
Sbjct: 174 --KNERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 8e-13
Identities = 68/212 (32%), Positives = 100/212 (47%), Gaps = 26/212 (12%)
Query: 817 ELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPN 874
++G G +G V+ K + T VA+KR+KKS + + LT E +IL+
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLT-----ERDILTTTKSEW 62
Query: 875 VVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIA-MDAAFGMEYLH 933
+V QD LA EY+ G R +L + R +A M A ++ LH
Sbjct: 63 LVKLLYAFQDDEYLYLAM--EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEA--VDALH 118
Query: 934 SKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK---IKRNTLVSGGVRGTLPWMAPEL 990
+H DLK +N L+ D S I K+ DFGLSK N++V G+ +MAPE+
Sbjct: 119 ELGYIHRDLKPENFLI---DASGHI-KLTDFGLSKGIVTYANSVV-----GSPDYMAPEV 169
Query: 991 LSGSSSKVSEKVDVFSFGIVLWEILTGEEPYA 1022
L G VD +S G +L+E L G P++
Sbjct: 170 LRGK--GYDFTVDYWSLGCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 8e-13
Identities = 65/225 (28%), Positives = 107/225 (47%), Gaps = 49/225 (21%)
Query: 815 QKELGSGTFGTVYHGKWRGTD------VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILS 868
++LG G +G V W+ D VA+K+I + F + Q ++E L
Sbjct: 12 LQKLGKGAYGIV----WKAIDRRTKEVVALKKIFDA-FRNATDAQRT-----FREIMFLQ 61
Query: 869 KL-HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLII-----A 922
+L HPN+V V++ + V EYM + L H ++R + D +R I+ A
Sbjct: 62 ELGDHPNIVKLLNVIKAENDKDIYLVFEYM-ETDL-HAVIRANILEDVHKRYIMYQLLKA 119
Query: 923 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGT 982
+ +Y+HS N++H DLK N+L+N S K+ DFGL++ +L
Sbjct: 120 L------KYIHSGNVIHRDLKPSNILLN----SDCRVKLADFGLAR----SLSELEENPE 165
Query: 983 LPWM----------APELLSGSSSKVSEKVDVFSFGIVLWEILTG 1017
P + APE+L G S++ ++ VD++S G +L E+L G
Sbjct: 166 NPVLTDYVATRWYRAPEILLG-STRYTKGVDMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-12
Identities = 72/253 (28%), Positives = 113/253 (44%), Gaps = 19/253 (7%)
Query: 816 KELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
K LG GTFG V K G A+K +KK + LT E+ +L HP
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLT-----ESRVLKNTRHP 55
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLH 933
+ + Q L V EY+ G L L R+ F + R R A + ++YLH
Sbjct: 56 FLTSLKYSFQTK--DRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGA-EIVSALDYLH 112
Query: 934 SKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK-RNTLVSGGVRGTLPWMAPELLS 992
S IV+ DLK +NL+++ KD K+ DFGL K + GT ++APE+L
Sbjct: 113 SGKIVYRDLKLENLMLD-KDGH---IKITDFGLCKEGITDAATMKTFCGTPEYLAPEVL- 167
Query: 993 GSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRT 1052
+ VD + G+V++E++ G P+ N + + I+ ++ P A+ ++
Sbjct: 168 -EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK--FPRTLSADAKS 224
Query: 1053 LMEECWAPNPAAR 1065
L+ +P R
Sbjct: 225 LLSGLLIKDPNKR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 21/213 (9%)
Query: 812 LEEQKELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSK 869
LE ++G G+ G V K G VA+K + +Q+R + F E I+
Sbjct: 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMD-------LRKQQRRELLF-NEVVIMRD 74
Query: 870 LHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGM 929
H NVV Y G L + E++ G+L + V + R L+ + + +
Sbjct: 75 YQHQNVVEMYKSYLVGE--ELWVLMEFLQGGALTDI-VSQTR-LNEEQIATVCESVLQAL 130
Query: 930 EYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL-SKIKRNTLVSGGVRGTLPWMAP 988
YLHS+ ++H D+K D++L+ L K+ DFG ++I ++ + GT WMAP
Sbjct: 131 CYLHSQGVIHRDIKSDSILLTLDGR----VKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 186
Query: 989 ELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1021
E++ S + +VD++S GI++ E++ GE PY
Sbjct: 187 EVI--SRTPYGTEVDIWSLGIMVIEMVDGEPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-12
Identities = 66/241 (27%), Positives = 111/241 (46%), Gaps = 31/241 (12%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEA 864
+K ED + K +G G FG V + + + A+K + K RS + FW+E
Sbjct: 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSD-----SAFFWEER 94
Query: 865 EILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD------RFLDRRRR 918
+I++ + +V + QD L V EYM G L +++ D RF
Sbjct: 95 DIMAHANSEWIVQLHYAFQDDK--YLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAE-- 150
Query: 919 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS-KIKRNTLV-S 976
+++A+DA +HS +H D+K DN+L+ D S + K+ DFG K+ N +V
Sbjct: 151 VVLALDA------IHSMGFIHRDVKPDNMLL---DKSGHL-KLADFGTCMKMDANGMVRC 200
Query: 977 GGVRGTLPWMAPELL--SGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV 1034
GT +++PE+L G + D +S G+ L+E+L G+ P+ I+
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260
Query: 1035 N 1035
+
Sbjct: 261 D 261
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-12
Identities = 68/228 (29%), Positives = 108/228 (47%), Gaps = 18/228 (7%)
Query: 816 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
K +G G+FG V K + G+ A+K ++K + EQ + E +L L HP
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL-KKKEQNHIMAE---RNVLLKNLKHP 56
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLH 933
+V + Q L V +Y+ G L L R+ FL+ R R A + A + YLH
Sbjct: 57 FLVGLHYSFQTAE--KLYFVLDYVNGGELFFHLQRERCFLEPRARFY-AAEVASAIGYLH 113
Query: 934 SKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK--IKRNTLVSGGVRGTLPWMAPELL 991
S NI++ DLK +N+L++ S+ + DFGL K ++ S GT ++APE+L
Sbjct: 114 SLNIIYRDLKPENILLD----SQGHVVLTDFGLCKEGVEPEETTSTFC-GTPEYLAPEVL 168
Query: 992 SGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 1039
VD + G VL+E+L G P+ + + I++ L+
Sbjct: 169 --RKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQ 214
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 60/210 (28%), Positives = 92/210 (43%), Gaps = 19/210 (9%)
Query: 818 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNV 875
LG G FG V + R T A K++ K R + + E IL+K+H +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMV-----EKRILAKVHSRFI 55
Query: 876 VAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDR---FLDRRRRLIIAMDAAFGMEYL 932
V+ Q L V M G LR+ + D R G+E+L
Sbjct: 56 VSLAYAFQTKT--DLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHL 113
Query: 933 HSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS-KIKRNTLVSGGVRGTLPWMAPELL 991
H + I++ DLK +N+L++ R + D GL+ ++K + G GT +MAPELL
Sbjct: 114 HQRRIIYRDLKPENVLLDNDGNVR----ISDLGLAVELKDGQSKTKGYAGTPGFMAPELL 169
Query: 992 SGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1021
G S VD F+ G+ L+E++ P+
Sbjct: 170 QGEEYDFS--VDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-12
Identities = 62/221 (28%), Positives = 108/221 (48%), Gaps = 28/221 (12%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKR------IKKSCFTGRSSEQERLTVEF 860
+K++D E ELG+G G V + + + + + R IK + + +
Sbjct: 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPA-----------IRNQI 50
Query: 861 WKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLI 920
+E ++L + + P +V FYG G ++ E+M GSL VL ++ + +
Sbjct: 51 IRELQVLHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVL-KEAKRIPEEILGK 107
Query: 921 IAMDAAFGMEYLHSKN-IVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGV 979
+++ G+ YL K+ I+H D+K N+LVN SR K+ DFG+S +++ + V
Sbjct: 108 VSIAVLRGLAYLREKHQIMHRDVKPSNILVN----SRGEIKLCDFGVSGQLIDSMANSFV 163
Query: 980 RGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEP 1020
GT +M+PE L G+ V D++S G+ L E+ G P
Sbjct: 164 -GTRSYMSPERLQGTHYSVQS--DIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 5e-12
Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 34/226 (15%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
+ E+ +++G GT+G VY + + T VA+K+ T ++E + +E +L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKK------TRLEMDEEGIPPTALREISLL 54
Query: 868 SKLHH-PNVVAFYGVV---QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAM 923
L +V V + +L V EY+ D L+ + R R
Sbjct: 55 QMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIK 113
Query: 924 DAAF----GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-----IKRNT- 973
+ G+ + H ++H DLK NLLV D + + K+ D GL + +K T
Sbjct: 114 SFMYQLLKGVAHCHKHGVMHRDLKPQNLLV---DKQKGLLKIADLGLGRAFSIPVKSYTH 170
Query: 974 -LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
+V TL + APE+L GS+ S VD++S G + E+ +
Sbjct: 171 EIV------TLWYRAPEVLLGSTH-YSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 5e-12
Identities = 54/226 (23%), Positives = 92/226 (40%), Gaps = 35/226 (15%)
Query: 816 KELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNV 875
K + K T VA+K+I S +E L + +E +L HPN+
Sbjct: 8 KCFEDLMIVHLAKHKPTNTLVAVKKINLD-----SCSKEDLKLLQ-QEIITSRQLQHPNI 61
Query: 876 VAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAM---DAAFGMEYL 932
+ + L V+ M GS +L K F + L IA D ++Y+
Sbjct: 62 LPYVTSFIVD--SELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLNALDYI 117
Query: 933 HSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRN-TLVSGGVRGT--------- 982
HSK +H +K ++L+ + LS ++ + +++ G R
Sbjct: 118 HSKGFIHRSVKASHILL---SGDGKVV------LSGLRYSVSMIKHGKRQRVVHDFPKSS 168
Query: 983 ---LPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH 1025
LPW++PE+L + +EK D++S GI E+ G P+ +M
Sbjct: 169 VKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMP 214
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 65/283 (22%), Positives = 129/283 (45%), Gaps = 34/283 (12%)
Query: 811 DLEEQKELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILS 868
+ + +K++G G F VY VA+K+++ + Q+ + KE ++L
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCV-----KEIDLLK 57
Query: 869 KLHHPNVVAFY-GVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLI------- 920
+L+HPNV+ + ++D L V E G L ++ ++ +++RLI
Sbjct: 58 QLNHPNVIKYLDSFIED---NELNIVLELADAGDLSQMI----KYFKKQKRLIPERTVWK 110
Query: 921 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-IKRNTLVSGGV 979
+ +E++HS+ ++H D+K N+ + + + K+GD GL + T + +
Sbjct: 111 YFVQLCSAVEHMHSRRVMHRDIKPANVFIT----ATGVVKLGDLGLGRFFSSKTTAAHSL 166
Query: 980 RGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN--MHYGAIIGGIVNNT 1037
GT +M+PE + + K D++S G +L+E+ + P+ M+ ++ I
Sbjct: 167 VGTPYYMSPERIHENGYNF--KSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD 224
Query: 1038 LRPTIPSYCDAEWRTLMEECWAPNPAARPSFT---EIASRLRV 1077
P + + R L+ C P+P RP +IA ++ V
Sbjct: 225 YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMHV 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 6e-12
Identities = 66/253 (26%), Positives = 107/253 (42%), Gaps = 63/253 (24%)
Query: 799 FDVSSVQVIKNEDLEEQKELGSGTFGTV---YHGKWRGTDVAIKRIKKSCFTGRSSEQER 855
FDV + +G G +G V H K G VAIK+I S F E +
Sbjct: 1 FDVGP-------RYQNLSYIGEGAYGMVCSATH-KPTGVKVAIKKI--SPF-----EHQT 45
Query: 856 LTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLAT------VAEYMVDGSLRHVLVRK 909
+E +IL + H N++ +++ + + V E M + L + L++
Sbjct: 46 FCQRTLREIKILRRFKHENIIGILDIIR---PPSFESFNDVYIVQELM-ETDL-YKLIKT 100
Query: 910 DR--------FLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVN----LKDPSRP 957
FL + R G++Y+HS N++H DLK NLL+N LK
Sbjct: 101 QHLSNDHIQYFLYQILR---------GLKYIHSANVLHRDLKPSNLLLNTNCDLK----- 146
Query: 958 ICKVGDFGLSKIKRNTLVSGGVR----GTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWE 1013
IC DFGL++I G T + APE++ +S ++ +D++S G +L E
Sbjct: 147 IC---DFGLARIADPEHDHTGFLTEYVATRWYRAPEIML-NSKGYTKAIDIWSVGCILAE 202
Query: 1014 ILTGEEPYANMHY 1026
+L+ + Y
Sbjct: 203 MLSNRPLFPGKDY 215
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 7e-12
Identities = 60/240 (25%), Positives = 103/240 (42%), Gaps = 50/240 (20%)
Query: 805 QVIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWK 862
DLE E+GSGT G VY +++ G +A+K++++ TG E +R+ ++
Sbjct: 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRR---TGNKEENKRILMDL-- 64
Query: 863 EAEILSKLHH-PNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLI- 920
+++ K H P +V YG ++ D + + LD+ + I
Sbjct: 65 --DVVLKSHDCPYIVKCYGY--------------FITDSDVFICMELMSTCLDKLLKRIQ 108
Query: 921 ----------IAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI 969
+ + + YL K ++H D+K N+L++ + K+ DFG+S
Sbjct: 109 GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLD----ASGNVKLCDFGIS-- 162
Query: 970 KRNTLVSGGVR----GTLPWMAPELLSGSSSKVSEKV--DVFSFGIVLWEILTGEEPYAN 1023
LV + G +MAPE + + DV+S GI L E+ TG+ PY N
Sbjct: 163 --GRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 9e-12
Identities = 68/227 (29%), Positives = 109/227 (48%), Gaps = 31/227 (13%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEA 864
+K ED E K +G G FG V + + T A+K + K RS + FW+E
Sbjct: 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSD-----SAFFWEER 94
Query: 865 EILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD------RFLDRRRR 918
+I++ + P VV + QD L V EYM G L +++ D RF
Sbjct: 95 DIMAFANSPWVVQLFYAFQDDR--YLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAE-- 150
Query: 919 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS-KIKRNTLVSG 977
+++A+DA +HS +H D+K DN+L+ D S + K+ DFG K+ + +V
Sbjct: 151 VVLALDA------IHSMGFIHRDVKPDNMLL---DKSGHL-KLADFGTCMKMNKEGMVRC 200
Query: 978 GVR-GTLPWMAPELL--SGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1021
GT +++PE+L G + D +S G+ L+E+L G+ P+
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 9e-12
Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 21/210 (10%)
Query: 817 ELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPN 874
++G G+ G V K G VA+K++ +Q+R + F E I+ H N
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLR-------KQQRRELLF-NEVVIMRDYQHEN 78
Query: 875 VVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHS 934
VV Y G L V E++ G+L ++ ++ + + + + LH+
Sbjct: 79 VVEMYNSYL--VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLKALSVLHA 134
Query: 935 KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL-SKIKRNTLVSGGVRGTLPWMAPELLSG 993
+ ++H D+K D++L L R K+ DFG +++ + + GT WMAPEL+S
Sbjct: 135 QGVIHRDIKSDSIL--LTHDGR--VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELIS- 189
Query: 994 SSSKVSEKVDVFSFGIVLWEILTGEEPYAN 1023
+VD++S GI++ E++ GE PY N
Sbjct: 190 -RLPYGPEVDIWSLGIMVIEMVDGEPPYFN 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 9e-12
Identities = 65/210 (30%), Positives = 100/210 (47%), Gaps = 22/210 (10%)
Query: 818 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNV 875
LG G FG V + R T A KR++K R E L E +IL K++ V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALN-----EKQILEKVNSQFV 62
Query: 876 V--AFYGVVQDGPGGTLATVAEYMVDGSLR-HVLVRKDRFLDRRRRLIIAMDAAFGMEYL 932
V A+ +D L V M G L+ H+ + + R L A + G+E L
Sbjct: 63 VNLAYAYETKDA----LCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDL 118
Query: 933 HSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS-KIKRNTLVSGGVRGTLPWMAPELL 991
H +N V+ DLK +N+L L D ++ D GL+ KI + G V GT+ +MAPE+L
Sbjct: 119 HRENTVYRDLKPENIL--LDDYGH--IRISDLGLAVKIPEGESIRGRV-GTVGYMAPEVL 173
Query: 992 SGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1021
+ +S D + G +++E++ G+ P+
Sbjct: 174 NNQRYTLSP--DYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 1e-11
Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 40/216 (18%)
Query: 818 LGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNV 875
+GSG +G V G VAIK+I + + L +E +IL H N+
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKI------PHAFDVPTLAKRTLRELKILRHFKHDNI 66
Query: 876 VAFYGVVQ--DGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF------ 927
+A +++ + V + M + L H++ + R F
Sbjct: 67 IAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIR-------YFLYQLLR 118
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC--KVGDFGLSK------IKRNTLVSGGV 979
G++Y+HS N++H DLK NLLVN +D C ++GDFG+++ + ++ V
Sbjct: 119 GLKYIHSANVIHRDLKPSNLLVN-ED-----CELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 980 RGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEIL 1015
T + APELL S + + +D++S G + E+L
Sbjct: 173 -ATRWYRAPELLL-SLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 65/222 (29%), Positives = 111/222 (50%), Gaps = 30/222 (13%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKR------IKKSCFTGRSSEQERLTVEF 860
+K++D E+ ELG+G G V+ + + + + R IK + + +
Sbjct: 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPA-----------IRNQI 50
Query: 861 WKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDR-RRRL 919
+E ++L + + P +V FYG G ++ E+M GSL VL + R ++ ++
Sbjct: 51 IRELQVLHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKV 108
Query: 920 IIAMDAAFGMEYLHSKN-IVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGG 978
IA+ G+ YL K+ I+H D+K N+LVN SR K+ DFG+S +++ +
Sbjct: 109 SIAVIK--GLTYLREKHKIMHRDVKPSNILVN----SRGEIKLCDFGVSGQLIDSMANSF 162
Query: 979 VRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEP 1020
V GT +M+PE L G+ V D++S G+ L E+ G P
Sbjct: 163 V-GTRSYMSPERLQGTHYSVQS--DIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 66/243 (27%), Positives = 111/243 (45%), Gaps = 20/243 (8%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
ED E K +G G FG V K + D A+K + K R+ T F +E ++L
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAE-----TACFREERDVL 55
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVR-KDRFLDRRRRLIIAMDAA 926
+ + + QD L V +Y V G L +L + +DR + R +A +
Sbjct: 56 VNGDNQWITTLHYAFQDE--NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA-EMV 112
Query: 927 FGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG--LSKIKRNTLVSGGVRGTLP 984
++ +H + VH D+K DN+L+++ R + DFG L ++ T+ S GT
Sbjct: 113 IAIDSVHQLHYVHRDIKPDNILMDMNGHIR----LADFGSCLKLMEDGTVQSSVAVGTPD 168
Query: 985 WMAPELLSG---SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT 1041
+++PE+L K + D +S G+ ++E+L GE P+ G I+N+ R
Sbjct: 169 YISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ 228
Query: 1042 IPS 1044
P+
Sbjct: 229 FPA 231
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 27/216 (12%)
Query: 813 EEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL 870
E+ +++G GT+GTV+ K R T VA+KR++ + E + +E +L +L
Sbjct: 3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLLKEL 56
Query: 871 HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGME 930
H N+V Y V+ TL V EY D L+ + +D G+
Sbjct: 57 KHKNIVRLYDVLHSDKKLTL--VFEY-CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLA 113
Query: 931 YLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRG------TLP 984
+ HS N++H DLK NLL+N K+ DFGL+ R + VR TL
Sbjct: 114 FCHSHNVLHRDLKPQNLLIN----KNGELKLADFGLA---RAFGIP--VRCYSAEVVTLW 164
Query: 985 WMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEP 1020
+ P++L G+ S +D++S G + E+ P
Sbjct: 165 YRPPDVLFGAKL-YSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-11
Identities = 52/188 (27%), Positives = 93/188 (49%), Gaps = 21/188 (11%)
Query: 890 LATVAEYMVDGSLRHVL---VRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDN 946
+A V +Y G LR + + +R ++ + + ++HSK+++H D+K N
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSAN 173
Query: 947 LLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR----GTLPWMAPELLSGSSSKVSEKV 1002
+L+ S + K+GDFG SK+ T VS V GT ++APE+ S+K
Sbjct: 174 ILLC----SNGLVKLGDFGFSKMYAAT-VSDDVGRTFCGTPYYVAPEIWR--RKPYSKKA 226
Query: 1003 DVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR---PTIPSYCDAEWRTLMEECWA 1059
D+FS G++L+E+LT + P+ G + +++ TL +P E + ++ +
Sbjct: 227 DMFSLGVLLYELLTLKRPFD----GENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLS 282
Query: 1060 PNPAARPS 1067
+P RPS
Sbjct: 283 SDPKRRPS 290
|
Length = 496 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 32/217 (14%)
Query: 813 EEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL 870
E E+G G +GTVY + G VA+K ++ + ++ L + +E +L +L
Sbjct: 3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQ------TNEDGLPLSTVREVALLKRL 56
Query: 871 H---HPNVVAFYGVVQDGPGG--TLATVAEYMVDGSLRHVLVRK-------DRFLDRRRR 918
HPN+V V T T+ VD LR L + + D R+
Sbjct: 57 EAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQ 116
Query: 919 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGG 978
+ G+++LH+ IVH DLK +N+LV S K+ DFGL++I +
Sbjct: 117 FLR------GLDFLHANCIVHRDLKPENILVT----SGGQVKLADFGLARIYSCQMALTP 166
Query: 979 VRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEIL 1015
V TL + APE+L S+ + VD++S G + E+
Sbjct: 167 VVVTLWYRAPEVLLQST--YATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 72/280 (25%), Positives = 111/280 (39%), Gaps = 47/280 (16%)
Query: 816 KELGSGTFGTVYHGKWR----------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAE 865
+ LG GT +Y G + IK I K +++ F++ A
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVL----DPSHRDISLAFFETAS 56
Query: 866 ILSKLHHPNVVAFYGV-VQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMD 924
++ ++ H ++V YGV V+D V E++ G L + RK L + +A
Sbjct: 57 MMRQVSHKHIVLLYGVCVRDVEN---IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQ 113
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLV---NLKDPSRPICKVGDFG--LSKIKRNTLVSGGV 979
A + YL K++VH ++ N+L+ + P K+ D G ++ + R V
Sbjct: 114 LASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE--- 170
Query: 980 RGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEI-LTGEEPYANM-------HYGAIIG 1031
+PW+APE + S +S D +SFG LWEI GE P + Y
Sbjct: 171 --RIPWIAPECVE-DSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEG--- 224
Query: 1032 GIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
PS C E LM C +P RP F I
Sbjct: 225 -----QCMLVTPS-CK-ELADLMTHCMNYDPNQRPFFRAI 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-11
Identities = 60/211 (28%), Positives = 105/211 (49%), Gaps = 24/211 (11%)
Query: 818 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQ----ERLTVEFWKEAEILSKLH 871
LG G+FG V + +GTD AIK +KK + E+ + + L++LH
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67
Query: 872 HPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEY 931
F + + L V EY+ G L + + + RF + A + A G+ +
Sbjct: 68 S----CFQTMDR------LYFVMEYVNGGDLMYQIQQVGRF-KEPHAVFYAAEIAIGLFF 116
Query: 932 LHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKR-NTLVSGGVRGTLPWMAPEL 990
LHSK I++ DLK DN++++ S K+ DFG+ K + + + GT ++APE+
Sbjct: 117 LHSKGIIYRDLKLDNVMLD----SEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEI 172
Query: 991 LSGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1021
+ + + VD ++FG++L+E+L G+ P+
Sbjct: 173 I--AYQPYGKSVDWWAFGVLLYEMLAGQAPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-11
Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 816 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
++LG G++ TVY G R G VA+K I +E + +EA +L L H
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKT-------EEGVPFTAIREASLLKGLKHA 63
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLH 933
N+V + ++ TL V EYM L +++ L + G+ Y+H
Sbjct: 64 NIVLLHDIIHTKE--TLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH 120
Query: 934 SKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKR---NTLVSGGVRGTLPWMAPEL 990
++I+H DLK NLL++ K+ DFGL++ K T S V TL + P++
Sbjct: 121 GQHILHRDLKPQNLLISYLGE----LKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDV 174
Query: 991 LSGSSSKVSEKVDVFSFGIVLWEILTGEEPYA 1022
L G++ S +D++ G + E+L G+ +
Sbjct: 175 LLGATDYSSA-LDIWGAGCIFIEMLQGQPAFP 205
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 4e-11
Identities = 65/226 (28%), Positives = 105/226 (46%), Gaps = 30/226 (13%)
Query: 808 KNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAE 865
K + E+ ++LG G++ TVY GK + G VA+K I R E+E +EA
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVI-------RLQEEEGTPFTAIREAS 55
Query: 866 ILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDA 925
+L L H N+V + ++ TL V EY V L + + L +
Sbjct: 56 LLKGLKHANIVLLHDIIHTKE--TLTLVFEY-VHTDLCQYMDKHPGGLHPENVKLFLFQL 112
Query: 926 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK-------RNTLVSGG 978
G+ Y+H + I+H DLK NLL++ D K+ DFGL++ K N +V
Sbjct: 113 LRGLSYIHQRYILHRDLKPQNLLIS--DTGE--LKLADFGLARAKSVPSHTYSNEVV--- 165
Query: 979 VRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANM 1024
TL + P++L G S++ S +D++ G + E++ G + M
Sbjct: 166 ---TLWYRPPDVLLG-STEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 5e-11
Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 19/221 (8%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEA 864
+K ED + K +G G FG V + + + A+K + K RS + FW+E
Sbjct: 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSD-----SAFFWEER 94
Query: 865 EILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMD 924
+I++ + P VV + QD L V EYM G L +++ D + + +
Sbjct: 95 DIMAFANSPWVVQLFCAFQDDK--YLYMVMEYMPGGDLVNLMSNYD--VPEKWAKFYTAE 150
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS-KIKRNTLVSGGVR-GT 982
++ +HS ++H D+K DN+L++ K+ DFG K+ +V GT
Sbjct: 151 VVLALDAIHSMGLIHRDVKPDNMLLD----KHGHLKLADFGTCMKMDETGMVRCDTAVGT 206
Query: 983 LPWMAPELL--SGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1021
+++PE+L G + D +S G+ L+E+L G+ P+
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 6e-11
Identities = 75/264 (28%), Positives = 119/264 (45%), Gaps = 24/264 (9%)
Query: 816 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
K +G G+FG V K + G A+K ++K R EQ+ + E +L + HP
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRK-EQKHIMAE---RNVLLKNVKHP 56
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIA-MDAAFGMEYL 932
+V + Q L V +++ G L L R+ F + R R A + +A G YL
Sbjct: 57 FLVGLHYSFQTTE--KLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALG--YL 112
Query: 933 HSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK---IKRNTLVSGGVRGTLPWMAPE 989
HS NIV+ DLK +N+L++ S+ + DFGL K + +T + GT ++APE
Sbjct: 113 HSINIVYRDLKPENILLD----SQGHVVLTDFGLCKEGIAQSDTTTT--FCGTPEYLAPE 166
Query: 990 LLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN--TLRPTIPSYCD 1047
++ VD + G VL+E+L G P+ + I++ LRP
Sbjct: 167 VI--RKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAW 224
Query: 1048 AEWRTLMEECWAPNPAARPSFTEI 1071
+ L+E+ A+ F EI
Sbjct: 225 SILEELLEKDRQRRLGAKEDFLEI 248
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-11
Identities = 67/244 (27%), Positives = 109/244 (44%), Gaps = 20/244 (8%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
+D E K +G G FG V K + T+ A+K + K R+ T F +E +L
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAE-----TACFREERNVL 55
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVR-KDRFLDRRRRLIIAMDAA 926
+ + QD L V +Y V G L +L + +DR + R IA +
Sbjct: 56 VNGDCQWITTLHYAFQDE--NYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIA-EMV 112
Query: 927 FGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG--LSKIKRNTLVSGGVRGTLP 984
+ +H + VH D+K DN+L+++ R + DFG L + T+ S GT
Sbjct: 113 LAIHSIHQLHYVHRDIKPDNVLLDMNGHIR----LADFGSCLKMNQDGTVQSSVAVGTPD 168
Query: 985 WMAPELLSGSSS---KVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT 1041
+++PE+L K + D +S G+ ++E+L GE P+ G I+N+ R
Sbjct: 169 YISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ 228
Query: 1042 IPSY 1045
PS+
Sbjct: 229 FPSH 232
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 6e-11
Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 30/228 (13%)
Query: 818 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL---SKLHH 872
+G GTFG VY + + T A+K + K + + E IL
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTI-----GERNILVRTLLDES 55
Query: 873 PNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYL 932
P +V Q L V +YM G L L ++ RF + R + IA + +E+L
Sbjct: 56 PFIVGLKFSFQT--DSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHL 112
Query: 933 HSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK--IKRNTLVSGGVRGTLPWMAPEL 990
H +IV+ DLK +N+L++ +C DFGLSK + N + GT ++APE+
Sbjct: 113 HKYDIVYRDLKPENILLD-ATGHIALC---DFGLSKANLTDNKT-TNTFCGTTEYLAPEV 167
Query: 991 LSGSSSKVSEKVDVFSFGIVLWEILTGEEP---------YANMHYGAI 1029
L ++ VD +S G++++E+ G P Y N+ +G +
Sbjct: 168 LL-DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV 214
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 27/217 (12%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEF-WKEAEI 866
E E+ ++G G++G V+ + R G VAIK+ F SE + + + +E +
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKK-----FV--ESEDDPVIKKIALREIRM 53
Query: 867 LSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAA 926
L +L HPN+V V + L V EY D ++ + L + R + I
Sbjct: 54 LKQLKHPNLVNLIEVFRRKR--KLHLVFEY-CDHTVLNELEKNPRGVPEHLIKKIIWQTL 110
Query: 927 FGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR-----G 981
+ + H N +H D+K +N+L+ + K+ DFG ++I L G
Sbjct: 111 QAVNFCHKHNCIHRDVKPENILITKQG----QIKLCDFGFARI----LTGPGDDYTDYVA 162
Query: 982 TLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
T + APELL G ++ VDV++ G V E+LTG+
Sbjct: 163 TRWYRAPELLVG-DTQYGPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 8e-11
Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 25/208 (12%)
Query: 818 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNV 875
+G G++G V K + T VAIK+ +S + + + +E +L +L H N+
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLES------EDDKMVKKIAMREIRMLKQLRHENL 62
Query: 876 VAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSK 935
V V + L V E+ VD ++ L + LD R G+E+ HS
Sbjct: 63 VNLIEVFRRKK--RLYLVFEF-VDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH 119
Query: 936 NIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGG-----VRGTLPWMAPEL 990
NI+H D+K +N+LV+ + K+ DFG ++ TL + G T + APEL
Sbjct: 120 NIIHRDIKPENILVSQSG----VVKLCDFGFAR----TLAAPGEVYTDYVATRWYRAPEL 171
Query: 991 LSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
L G +K VD+++ G ++ E+LTGE
Sbjct: 172 LVG-DTKYGRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 36/217 (16%)
Query: 813 EEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL 870
++ +++G GT+G VY + + G VA+K+I+ +E E + +E +L +L
Sbjct: 3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLLKEL 56
Query: 871 HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAA---- 926
+HPN+V V+ L V E++ L+ +F+D I +
Sbjct: 57 NHPNIVKLLDVIHTE--NKLYLVFEFL-HQDLK-------KFMDASPLSGIPLPLIKSYL 106
Query: 927 ----FGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK---IKRNTLVSGGV 979
G+ + HS ++H DLK NLL+N + K+ DFGL++ + T V
Sbjct: 107 FQLLQGLAFCHSHRVLHRDLKPQNLLIN----TEGAIKLADFGLARAFGVPVRTYTHEVV 162
Query: 980 RGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT 1016
TL + APE+L G S VD++S G + E++T
Sbjct: 163 --TLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 19/205 (9%)
Query: 816 KELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
+ +G G FG V + G +VAIK+I K T +++ ++E ++L L H
Sbjct: 16 QPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRT------YRELKLLKHLRHE 69
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLH 933
N+++ + P + V E + G+ H L+ R L+++ G++Y+H
Sbjct: 70 NIISLSDIFIS-PLEDIYFVTELL--GTDLHRLL-TSRPLEKQFIQYFLYQILRGLKYVH 125
Query: 934 SKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSG 993
S +VH DLK N+L+N ++ IC DFGL++I+ + G T + APE++
Sbjct: 126 SAGVVHRDLKPSNILIN-ENCDLKIC---DFGLARIQDPQMT--GYVSTRYYRAPEIML- 178
Query: 994 SSSKVSEKVDVFSFGIVLWEILTGE 1018
+ K +VD++S G + E+L G+
Sbjct: 179 TWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-10
Identities = 51/154 (33%), Positives = 81/154 (52%), Gaps = 12/154 (7%)
Query: 863 EAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIA 922
EA +L +L HP V+A V G G T + +Y D L L + R L + +A
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVG-GLTCLVLPKYRSD--LYTYLGARLRPLGLAQVTAVA 266
Query: 923 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG---LSKIKRNTLVSGGV 979
++Y+H + I+H D+K +N+LVN + IC +GDFG ++ +T G+
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPE---DIC-LGDFGAACFARGSWSTPFHYGI 322
Query: 980 RGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWE 1013
GT+ APE+L+G S VD++S G+V++E
Sbjct: 323 AGTVDTNAPEVLAGDPYTPS--VDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 37/218 (16%)
Query: 816 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
K +G G +G V K T+ VAIK+I + F R + L +E ++L L H
Sbjct: 11 KPIGRGAYGIVCSAKNSETNEKVAIKKIANA-FDNRIDAKRTL-----REIKLLRHLDHE 64
Query: 874 NVVAFYGVVQDGPGGTLA-----TVAEYMVDGSLRHVLVRKDRFL--DRRRRLIIAMDAA 926
NV+A ++ P A V E M D L H ++R + L D + + +
Sbjct: 65 NVIAIKDIMP--PPHREAFNDVYIVYELM-DTDL-HQIIRSSQTLSDDHCQYFLYQL--L 118
Query: 927 FGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC--KVGDFGLSKIKRNTLVSGGVRG--- 981
G++Y+HS N++H DLK NLL+N C K+ DFGL+ R T G
Sbjct: 119 RGLKYIHSANVLHRDLKPSNLLLNAN------CDLKICDFGLA---RTTSEKGDFMTEYV 169
Query: 982 -TLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
T + APELL + S+ + +DV+S G + E+L +
Sbjct: 170 VTRWYRAPELLL-NCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 59/214 (27%), Positives = 105/214 (49%), Gaps = 30/214 (14%)
Query: 818 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQ----ERLTVEFWKEAEILSKLH 871
LG G+FG V + +GTD AIK +KK + E+ + + L++LH
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 872 HPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEY 931
F V + L V EY+ G L + + + +F + + A + + G+ +
Sbjct: 68 S----CFQTVDR------LYFVMEYVNGGDLMYHIQQVGKF-KEPQAVFYAAEISVGLFF 116
Query: 932 LHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR----GTLPWMA 987
LH + I++ DLK DN++++ S K+ DFG+ K +V G GT ++A
Sbjct: 117 LHRRGIIYRDLKLDNVMLD----SEGHIKIADFGMCK---EHMVDGVTTRTFCGTPDYIA 169
Query: 988 PELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1021
PE+++ S VD +++G++L+E+L G+ P+
Sbjct: 170 PEIIAYQPYGKS--VDWWAYGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-10
Identities = 73/300 (24%), Positives = 124/300 (41%), Gaps = 54/300 (18%)
Query: 812 LEEQKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTVEFWKEAEILSK 869
L+E+ + G G Y GK + +K I +S + K
Sbjct: 692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDV-----NSIPSSEIADM-------GK 739
Query: 870 LHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGM 929
L HPN+V G+ + G L + EY+ +L VL R L RR IA+ A +
Sbjct: 740 LQHPNIVKLIGLCRSEKGAYL--IHEYIEGKNLSEVL----RNLSWERRRKIAIGIAKAL 793
Query: 930 EYLH---SKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWM 986
+LH S +V +L + ++++ KD P ++ GL +S ++
Sbjct: 794 RFLHCRCSPAVVVGNLSPEKIIIDGKD--EPHLRLSLPGLLCTDTKCFISSA------YV 845
Query: 987 APELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN----------- 1035
APE + + ++EK D++ FG++L E+LTG+ P A+ +G + G IV
Sbjct: 846 APE--TRETKDITEKSDIYGFGLILIELLTGKSP-ADAEFG-VHGSIVEWARYCYSDCHL 901
Query: 1036 -NTLRPTIPSYCDAEWRTLME------ECWAPNPAARPSFTEIASRLR-VLSTAASQTKG 1087
+ P+I ++E C A +P ARP ++ L +++S G
Sbjct: 902 DMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSSCVTG 961
|
Length = 968 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 18/208 (8%)
Query: 818 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNV 875
LG G FG V + R T A K+++K R E L E IL K++ V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN-----EKRILEKVNSRFV 62
Query: 876 VAFYGVVQDGPGGTLATVAEYMVDGSLR-HVLVRKDRFLDRRRRLIIAMDAAFGMEYLHS 934
V+ + L V M G L+ H+ + D +R + A + G+E L
Sbjct: 63 VSLAYAYETKDA--LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 935 KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS-KIKRNTLVSGGVRGTLPWMAPELLSG 993
+ IV+ DLK +N+L++ R ++ D GL+ +I V G V GT+ +MAPE+++
Sbjct: 121 ERIVYRDLKPENILLD----DRGHIRISDLGLAVQIPEGETVRGRV-GTVGYMAPEVINN 175
Query: 994 SSSKVSEKVDVFSFGIVLWEILTGEEPY 1021
S D + G +++E++ G+ P+
Sbjct: 176 EKYTFSP--DWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 22/210 (10%)
Query: 818 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPN- 874
LG G+FG V + +GTD AIK +KK + + E +L+ P
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMV-----EKRVLALPGKPPF 62
Query: 875 VVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHS 934
+ + Q L V EY+ G L + + + +F + + A + A G+ +LHS
Sbjct: 63 LTQLHSCFQTM--DRLYFVMEYVNGGDLMYHIQQVGKFKEPHA-VFYAAEIAIGLFFLHS 119
Query: 935 KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR---GTLPWMAPELL 991
K I++ DLK DN++++ + K+ DFG+ K N R GT ++APE++
Sbjct: 120 KGIIYRDLKLDNVMLD----AEGHIKIADFGMC--KENIFGGKTTRTFCGTPDYIAPEII 173
Query: 992 SGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1021
+ S VD ++FG++L+E+L G+ P+
Sbjct: 174 AYQPYGKS--VDWWAFGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 3e-10
Identities = 66/226 (29%), Positives = 94/226 (41%), Gaps = 49/226 (21%)
Query: 816 KELGSGTFGTV----YHGKWRGTDVAIKRI----KKSCFTGRSSEQERLTVEFWKEAEIL 867
KELG G +G V VAIK+I K R+ + +L F
Sbjct: 6 KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHF------- 58
Query: 868 SKLHHPNVVAFYG--VVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDA 925
H N+ Y +V G L E M + L H ++R + L DA
Sbjct: 59 --RGHKNITCLYDMDIVFPGNFNELYLYEELM-EADL-HQIIRSGQPLT---------DA 105
Query: 926 AF---------GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-IKRNTLV 975
F G++Y+HS N++H DLK NLLVN D IC DFGL++ N
Sbjct: 106 HFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNA-DCELKIC---DFGLARGFSENPGE 161
Query: 976 SGGVR----GTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTG 1017
+ G T + APE++ S ++ +DV+S G +L E+L
Sbjct: 162 NAGFMTEYVATRWYRAPEIML-SFQSYTKAIDVWSVGCILAELLGR 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 4e-10
Identities = 63/233 (27%), Positives = 99/233 (42%), Gaps = 40/233 (17%)
Query: 795 SLVDFDVSSVQVIKNEDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSE 852
LV F + + +++K L + K FG V K + T K IK F
Sbjct: 8 ELVQF-LKNCEIVKKLKLIDGK------FGKVSVLKHKPTQKLFVQKIIKAKNFNA---- 56
Query: 853 QERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVA---EYMVDGSLRHVLVRK 909
+E L K +PN + Y V TL +Y+ DG L L++K
Sbjct: 57 -----IEPM--VHQLMK-DNPNFIKLYYSV-----TTLKGHVLIMDYIKDGDLFD-LLKK 102
Query: 910 DRFLDRRR-RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968
+ L + II + LH NI+H D+K +N+L + +C D+GL K
Sbjct: 103 EGKLSEAEVKKII-RQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLC---DYGLCK 158
Query: 969 IKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1021
I GTL + +PE + G + VS D ++ G++ +E+LTG+ P+
Sbjct: 159 IIGTPSCY---DGTLDYFSPEKIKGHNYDVS--FDWWAVGVLTYELLTGKHPF 206
|
Length = 267 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 818 LGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNV 875
LG G FG V K G A K++ K +S E+ L E EIL K++ P +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALL-----EKEILEKVNSPFI 55
Query: 876 VAFYGVVQDGPGGTLATVAEYMVDGSLR-HVLVRKDRFLDRRRRLIIAMDAAFGMEYLHS 934
V + L V M G L+ H+ +R L+ R + + G+ +LHS
Sbjct: 56 VNLAYAFESKT--HLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS 113
Query: 935 KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS---KIKRNTLVSGGVRGTLPWMAPELL 991
+IV+ D+K +N+L L D C++ D GL+ K + G G +MAPE+L
Sbjct: 114 MDIVYRDMKPENVL--LDDQGN--CRLSDLGLAVELKDGKTITQRAGTNG---YMAPEIL 166
Query: 992 SGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN 1023
VD F+ G ++E++ G P+ +
Sbjct: 167 KEEPYSYP--VDWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 64/218 (29%), Positives = 95/218 (43%), Gaps = 41/218 (18%)
Query: 817 ELGSGTFGTVYHG---KWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-- 871
E+G G +G V+ K G VA+KR++ + +E + + +E +L L
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQ------TGEEGMPLSTIREVAVLRHLETF 61
Query: 872 -HPNVVAFYGV--VQDGPGGTLATVAEYMVDGSLRHVLVR-----------KDRFLDRRR 917
HPNVV + V V T T+ VD L L + KD R
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 121
Query: 918 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSG 977
G+++LHS +VH DLK N+LV S K+ DFGL++I +
Sbjct: 122 ----------GLDFLHSHRVVHRDLKPQNILVT----SSGQIKLADFGLARIYSFQMALT 167
Query: 978 GVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEIL 1015
V TL + APE+L SS + VD++S G + E+
Sbjct: 168 SVVVTLWYRAPEVLLQSS--YATPVDLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 818 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNV 875
LG G FG V + R T A K+++K R E L E +IL K++ V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALN-----EKQILEKVNSRFV 62
Query: 876 V--AFYGVVQDGPGGTLATVAEYMVDGSLR-HVLVRKDRFLDRRRRLIIAMDAAFGMEYL 932
V A+ +D L V M G L+ H+ + + R + A + G+E L
Sbjct: 63 VSLAYAYETKDA----LCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDL 118
Query: 933 HSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS-KIKRNTLVSGGVRGTLPWMAPELL 991
H + IV+ DLK +N+L L D ++ D GL+ + + G V GT+ +MAPE++
Sbjct: 119 HQERIVYRDLKPENIL--LDDHGH--IRISDLGLAVHVPEGQTIKGRV-GTVGYMAPEVV 173
Query: 992 SGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1021
S D ++ G +L+E++ G+ P+
Sbjct: 174 KNERYTFSP--DWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 7e-10
Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 32/217 (14%)
Query: 813 EEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL 870
+ +GSG +G V T VAIK++ + S+ + T ++E +L +
Sbjct: 18 QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ---SAIHAKRT---YRELRLLKHM 71
Query: 871 HHPNVVAFYGVVQDGPGGTLATVAE-YMV----DGSLRHVLVRKDRFLDRRRRLIIAMDA 925
H NV+ V P +L + Y+V L +++ + + D + ++
Sbjct: 72 DHENVIGLLDVFT--PASSLEDFQDVYLVTHLMGADLNNIV-KCQKLSDDHIQFLV-YQI 127
Query: 926 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC--KVGDFGLSKIKRNTLVSGGVRGTL 983
G++Y+HS I+H DLK N+ VN +D C K+ DFGL++ + ++G V T
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNIAVN-ED-----CELKILDFGLAR-HTDDEMTGYV-ATR 179
Query: 984 PWMAPE--LLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
+ APE L ++ VD++S G ++ E+LTG+
Sbjct: 180 WYRAPEIMLNWMHYNQT---VDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 9e-10
Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 33/221 (14%)
Query: 813 EEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL 870
E+ ++G GTFG V+ + + T VA+K++ +E+E + +E +IL L
Sbjct: 15 EKLAKIGQGTFGEVFKARHKKTKQIVALKKVL------MENEKEGFPITALREIKILQLL 68
Query: 871 HHPNVVAFYGVV------QDGPGGTLATV---AEYMVDGSLRHVLVRKDRFLDRRRRLII 921
H NVV + + G+ V E+ + G L + V+ L ++++
Sbjct: 69 KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFT--LSEIKKVMK 126
Query: 922 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL------SKIKRNTLV 975
+ G+ Y+H I+H D+K N+L+ KD I K+ DFGL SK +
Sbjct: 127 MLLN--GLYYIHRNKILHRDMKAANILIT-KD---GILKLADFGLARAFSLSKNSKPNRY 180
Query: 976 SGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT 1016
+ V TL + PELL G +D++ G ++ E+ T
Sbjct: 181 TNRVV-TLWYRPPELLLGERD-YGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 9e-10
Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 28/221 (12%)
Query: 814 EQKELGSGTFGTVYHGKWRG----TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSK 869
E ++G GT+G VY K + D A+K+I E +++ +E +L +
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQI----------EGTGISMSACREIALLRE 54
Query: 870 LHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLV--RKDRFLDRRRRLIIAMDAAF 927
L HPNV++ V + + +Y + L H++ R + + +L M +
Sbjct: 55 LKHPNVISLQKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLPRGMVKSL 113
Query: 928 ------GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVS----G 977
G+ YLH+ ++H DLK N+LV + P R K+ D G +++ + L
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 978 GVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
V T + APELL G + ++ +D+++ G + E+LT E
Sbjct: 174 PVVVTFWYRAPELLLG-ARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 1e-09
Identities = 59/218 (27%), Positives = 104/218 (47%), Gaps = 22/218 (10%)
Query: 814 EQKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHH 872
E ++G GT+G VY K + G D +K+ TG +++ +E +L +L H
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-------ISMSACREIALLRELKH 57
Query: 873 PNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLV--RKDRFLDRRRRLIIAMDAAF--- 927
PNV+A V + + +Y + L H++ R + + +L +M +
Sbjct: 58 PNVIALQKVFLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQ 116
Query: 928 ---GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVS----GGVR 980
G+ YLH+ ++H DLK N+LV + P R K+ D G +++ + L V
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 981 GTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
T + APELL G + ++ +D+++ G + E+LT E
Sbjct: 177 VTFWYRAPELLLG-ARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-09
Identities = 64/224 (28%), Positives = 97/224 (43%), Gaps = 40/224 (17%)
Query: 811 DLEEQKELGSGTFGTVYHGKWRGTD------VAIKRIKKSCFTGRSSEQERLTVEFWKEA 864
D+E + +G G FG V W TD VA+K++ F S + +E
Sbjct: 1 DVEPDRPIGYGAFGVV----WSVTDPRDGKRVALKKMPN-VFQNLVSCKRVF-----REL 50
Query: 865 EILSKLHHPNVVAFYGVVQD---GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLII 921
++L H NV++ ++Q P + V E M L ++V ++ +
Sbjct: 51 KMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELM-QSDLHKIIVSPQPLSSDHVKVFL 109
Query: 922 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL--------SKIKRNT 973
G++YLHS I+H D+K NLLVN S + K+ DFGL SK
Sbjct: 110 -YQILRGLKYLHSAGILHRDIKPGNLLVN----SNCVLKICDFGLARVEEPDESKHMTQE 164
Query: 974 LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTG 1017
+V+ R APE+L GS S VD++S G + E+L
Sbjct: 165 VVTQYYR------APEILMGSRHYTS-AVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-09
Identities = 42/148 (28%), Positives = 78/148 (52%), Gaps = 10/148 (6%)
Query: 927 FGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTL---VSGGVRGTL 983
++ +HS+ ++H DLK N+ + P+ I K+GDFG SK +++ V+ GT
Sbjct: 180 LALDEVHSRKMMHRDLKSANIFLM---PT-GIIKLGDFGFSKQYSDSVSLDVASSFCGTP 235
Query: 984 PWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIP 1043
++APEL + S+K D++S G++L+E+LT P+ I+ ++ P P
Sbjct: 236 YYLAPELWE--RKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP-FP 292
Query: 1044 SYCDAEWRTLMEECWAPNPAARPSFTEI 1071
+ + L++ + NPA RP+ ++
Sbjct: 293 CPVSSGMKALLDPLLSKNPALRPTTQQL 320
|
Length = 478 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 70/274 (25%), Positives = 118/274 (43%), Gaps = 40/274 (14%)
Query: 810 EDLEEQKELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
ED E + +GSGT+G VY + G AIK IK + Q+ + ++
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEII--------MM 60
Query: 868 SKLHHPNVVAFYG--VVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDA 925
H N+VA++G + +D L E+ GSL+ + L + ++ +
Sbjct: 61 KDCKHSNIVAYFGSYLRRD----KLWICMEFCGGGSLQDIY-HVTGPLSESQIAYVSRET 115
Query: 926 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK------IKRNTLVSGGV 979
G+ YLHSK +H D+K N+L L D K+ DFG+S KR + +
Sbjct: 116 LQGLYYLHSKGKMHRDIKGANIL--LTDNGH--VKLADFGVSAQITATIAKRKSFI---- 167
Query: 980 RGTLPWMAPELLS-GSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 1038
GT WMAPE+ + ++ D+++ GI E+ + P ++H + + +
Sbjct: 168 -GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNF 226
Query: 1039 RPTIPSYCD-AEWRT----LMEECWAPNPAARPS 1067
+P P D +W ++ NP RP+
Sbjct: 227 QP--PKLKDKMKWSNSFHHFVKMALTKNPKKRPT 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-09
Identities = 63/233 (27%), Positives = 102/233 (43%), Gaps = 32/233 (13%)
Query: 798 DFDVSSVQVIKNEDLEEQKELGSGTFGTVYHGKWRGT-DV-AIKRIKKSCFTGRSSEQER 855
DFDV S+ +G G FG V + + T D+ A+K +KKS +
Sbjct: 2 DFDVKSL-------------VGRGHFGEVQVVREKATGDIYAMKVMKKS-----VLLAQE 43
Query: 856 LTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDR 915
F +E +ILS + P + QD L V EY G L +L R + D
Sbjct: 44 TVSFFEEERDILSISNSPWIPQLQYAFQDK--DNLYLVMEYQPGGDLLSLLNRYEDQFDE 101
Query: 916 RRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS-KIKRN-T 973
+ + +H VH D+K +N+L+ D + I K+ DFG + ++ N
Sbjct: 102 DMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI---DRTGHI-KLADFGSAARLTANKM 157
Query: 974 LVSGGVRGTLPWMAPELLSG--SSSKVSEKV--DVFSFGIVLWEILTGEEPYA 1022
+ S GT ++APE+L+ K + V D +S G++ +E++ G P+
Sbjct: 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 9e-09
Identities = 49/161 (30%), Positives = 78/161 (48%), Gaps = 14/161 (8%)
Query: 810 EDLEEQKELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
+D E K +G G FG V K G A+K+++KS + EQ E +IL
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEK--EQ---VAHVRAERDIL 55
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
++ +P VV Y QD L + EY+ G + +L++KD F + R IA +
Sbjct: 56 AEADNPWVVKLYYSFQDE--NYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA-ETIL 112
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968
++ +H +H D+K DNLL++ ++ K+ DFGL
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLD----AKGHIKLSDFGLCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 63/214 (29%), Positives = 110/214 (51%), Gaps = 28/214 (13%)
Query: 814 EQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH 871
+ K++GSG +GTV R G VAIK++ R + E ++E +L +
Sbjct: 19 DLKQVGSGAYGTVCSALDRRTGAKVAIKKLY------RPFQSELFAKRAYRELRLLKHMK 72
Query: 872 HPNVVAFYGVVQDGPGGTLATVAE-YMVD---GSLRHVLVRKDRFL-DRRRRLIIAMDAA 926
H NV+ V P +L + Y+V G+ L++ ++ DR + L+ M
Sbjct: 73 HENVIGLLDVFT--PDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQM--L 128
Query: 927 FGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC--KVGDFGLSKIKRNTLVSGGVRGTLP 984
G++Y+H+ I+H DLK NL VN C K+ DFGL++ + ++ ++G V T
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVNED------CELKILDFGLAR-QTDSEMTGYVV-TRW 180
Query: 985 WMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
+ APE++ + ++ VD++S G ++ E+LTG+
Sbjct: 181 YRAPEVIL-NWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 54/210 (25%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 818 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAE---ILSKLHH 872
+G G++ V + + T+ A+K +KK ++ E + W + E +H
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELV----NDDEDID---WVQTEKHVFEQASNH 55
Query: 873 PNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYL 932
P +V + Q L V EY+ G L + R+ + + R A + + + YL
Sbjct: 56 PFLVGLHSCFQTE--SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYL 112
Query: 933 HSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK-RNTLVSGGVRGTLPWMAPELL 991
H + I++ DLK DN+L++ S K+ D+G+ K R + GT ++APE+L
Sbjct: 113 HERGIIYRDLKLDNVLLD----SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 168
Query: 992 SGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1021
G S VD ++ G++++E++ G P+
Sbjct: 169 RGEDYGFS--VDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 52/211 (24%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 818 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAE---ILSKLHH 872
+G G++ V + + T A+K IKK + E + W + E + +H
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVN----DDEDID---WVQTEKHVFETASNH 55
Query: 873 PNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYL 932
P +V + Q L V E++ G L + R+ + + R + + + + +L
Sbjct: 56 PFLVGLHSCFQTE--SRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFY-SAEISLALNFL 112
Query: 933 HSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK--IKRNTLVSGGVRGTLPWMAPEL 990
H + I++ DLK DN+L++ + K+ D+G+ K I+ S GT ++APE+
Sbjct: 113 HERGIIYRDLKLDNVLLD----AEGHIKLTDYGMCKEGIRPGDTTSTFC-GTPNYIAPEI 167
Query: 991 LSGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1021
L G S VD ++ G++++E++ G P+
Sbjct: 168 LRGEDYGFS--VDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 4e-08
Identities = 50/165 (30%), Positives = 80/165 (48%), Gaps = 14/165 (8%)
Query: 810 EDLEEQKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
E+ K + G FG VY G K A+K +KK+ ++ + V+ ++A L
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQ---VQAERDALAL 60
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
SK P +V Y +Q L V EY++ G ++ +L F + I+ + A
Sbjct: 61 SK--SPFIVHLYYSLQSANNVYL--VMEYLIGGDVKSLLHIYGYFDEEMAVKYIS-EVAL 115
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRN 972
++YLH I+H DLK DN+L++ + K+ DFGLSK+ N
Sbjct: 116 ALDYLHRHGIIHRDLKPDNMLIS----NEGHIKLTDFGLSKVTLN 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 5e-08
Identities = 60/234 (25%), Positives = 98/234 (41%), Gaps = 41/234 (17%)
Query: 813 EEQKELGSG--TFGTVYHGKWR--GTDVAIKRIK-KSCFTGRSSEQERLTVEFWKEAEIL 867
E Q E+G G +VY + GT V ++ ++C +E L + +L
Sbjct: 1 ELQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC------TEEHLKA--LQNEVVL 52
Query: 868 SKL-HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIA---M 923
S HPN++ + V G L ++ +M GS +L K F + +I
Sbjct: 53 SHFFRHPNIMTSWTVFT--TGSWLWVISPFMAYGSANSLL--KTYFPEGMSEALIGNILF 108
Query: 924 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR--- 980
A G+ YLH +H ++K ++L++ V GLS + +LV G +
Sbjct: 109 GALRGLNYLHQNGYIHRNIKASHILISGDG------LVSLSGLSHL--YSLVRNGQKAKV 160
Query: 981 ---------GTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH 1025
LPW++PELL + K D++S GI E+ TG P+ +M
Sbjct: 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML 214
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 6e-08
Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 26/210 (12%)
Query: 816 KELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HH 872
K +GSG G V + G +VAIK++ + F + + R E +L KL +H
Sbjct: 22 KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRP-FQNVTHAK-RAYREL-----VLMKLVNH 74
Query: 873 PNVVAFYGVVQDGPGGTLATVAE-YMV----DGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
N++ V P +L + Y+V D +L V+ LD R +
Sbjct: 75 KNIIGLLNVFT--PQKSLEEFQDVYLVMELMDANLCQVI---QMDLDHERMSYLLYQMLC 129
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMA 987
G+++LHS I+H DLK N++V S K+ DFGL++ + + T + A
Sbjct: 130 GIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 185
Query: 988 PELLSGSSSKVSEKVDVFSFGIVLWEILTG 1017
PE++ G K E VD++S G ++ E++ G
Sbjct: 186 PEVILGMGYK--ENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 9e-08
Identities = 65/252 (25%), Positives = 107/252 (42%), Gaps = 38/252 (15%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTDVA-----------IKRIKKSCFTGRSSEQERLTV 858
+D E K +G G FG V K + T +KR + +CF +E V
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACF------REERDV 54
Query: 859 EFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVR-KDRFLDRRR 917
+ ++ LH+ AF QD L V +Y V G L +L + +DR +
Sbjct: 55 LVNGDRRWITNLHY----AF----QDE--NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMA 104
Query: 918 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG--LSKIKRNTLV 975
R +A + ++ +H VH D+K DN+L++ R + DFG L + T+
Sbjct: 105 RFYLA-EMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIR----LADFGSCLRLLADGTVQ 159
Query: 976 SGGVRGTLPWMAPELL---SGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGG 1032
S GT +++PE+L + + D +S G+ ++E+L GE P+ G
Sbjct: 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 219
Query: 1033 IVNNTLRPTIPS 1044
I+N+ P
Sbjct: 220 IMNHKEHFQFPP 231
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-07
Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 31/218 (14%)
Query: 815 QKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHH 872
Q+ +G G++G V G VAIK+I F S L +E ++L L H
Sbjct: 5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIN-DVFEHVSDATRIL-----REIKLLRLLRH 58
Query: 873 PNVVAFYGVV--------QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMD 924
P++V ++ +D + V E M S H +++ + L
Sbjct: 59 PDIVEIKHIMLPPSRREFKD-----IYVVFELM--ESDLHQVIKANDDLTPEHHQFFLYQ 111
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRN----TLVSGGVR 980
++Y+H+ N+ H DLK N+L N D IC DFGL+++ N +
Sbjct: 112 LLRALKYIHTANVFHRDLKPKNILAN-ADCKLKIC---DFGLARVAFNDTPTAIFWTDYV 167
Query: 981 GTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
T + APEL SK + +D++S G + E+LTG+
Sbjct: 168 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-07
Identities = 48/167 (28%), Positives = 78/167 (46%), Gaps = 28/167 (16%)
Query: 863 EAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRL--- 919
EA IL ++HP+++ G T + Y D +L +R +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYN-KFTCLILPRYKTDLYC---------YLAAKRNIAIC 182
Query: 920 -IIAMDAAF--GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS----KIKRN 972
I+A++ + ++YLH I+H D+K +N+ +N P +C +GDFG + I N
Sbjct: 183 DILAIERSVLRAIQYLHENRIIHRDIKAENIFIN--HPG-DVC-LGDFGAACFPVDINAN 238
Query: 973 TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEE 1019
G GT+ APELL + VD++S GIVL+E+ T +
Sbjct: 239 KYY--GWAGTIATNAPELL--ARDPYGPAVDIWSAGIVLFEMATCHD 281
|
Length = 391 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 26/223 (11%)
Query: 802 SSVQVIKNEDLEEQKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTVE 859
S+ V+K ++ K +GSG G V G +VA+K++ R + +
Sbjct: 15 STFTVLKR--YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKL------SRPFQNQTHAKR 66
Query: 860 FWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAE-YMV----DGSLRHVLVRKDRFLD 914
++E +L ++H N+++ V P +L + Y+V D +L V+ + LD
Sbjct: 67 AYRELVLLKCVNHKNIISLLNVFT--PQKSLEEFQDVYLVMELMDANLCQVIHME---LD 121
Query: 915 RRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTL 974
R + G+++LHS I+H DLK N++V S K+ DFGL++
Sbjct: 122 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILDFGLARTACTNF 177
Query: 975 VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTG 1017
+ T + APE++ G K E VD++S G ++ E++ G
Sbjct: 178 MMTPYVVTRYYRAPEVILGMGYK--ENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 39/230 (16%)
Query: 810 EDLEEQKELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
D E + +GSGT+G VY + G A+K IK S Q+ E ++
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ--------EIFMV 60
Query: 868 SKLHHPNVVAFYG----------VVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRR 917
+ H N+VA++G ++ GG+L + Y V G L + +
Sbjct: 61 KECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDI--YHVTGPLSELQIA--------- 109
Query: 918 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL-SKIKRNTLVS 976
+ + G+ YLHSK +H D+K N+L L D K+ DFG+ +KI
Sbjct: 110 --YVCRETLQGLAYLHSKGKMHRDIKGANIL--LTDNGD--VKLADFGVAAKITATIAKR 163
Query: 977 GGVRGTLPWMAPELLS-GSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH 1025
GT WMAPE+ + + ++ D+++ GI E+ + P ++H
Sbjct: 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLH 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 58/224 (25%), Positives = 106/224 (47%), Gaps = 24/224 (10%)
Query: 810 EDLEEQKELGSGTFGTV---YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEI 866
E + +GSG +G+V Y + R VA+K++ + +S R T ++E +
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLR-QKVAVKKLSRPF---QSLIHARRT---YRELRL 67
Query: 867 LSKLHHPNVVAFYGVVQDGPGGTLATVAE-YMVD---GSLRHVLVRKDRFLDRRRRLIIA 922
L + H NV+ V P ++ E Y+V G+ + +V+ + D + +I
Sbjct: 68 LKHMKHENVIGLLDVFT--PATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLI- 124
Query: 923 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGT 982
G++Y+HS I+H DLK N+ VN R + DFGL++ + + G T
Sbjct: 125 YQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELR----ILDFGLARQADDEMT--GYVAT 178
Query: 983 LPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY 1026
+ APE++ + ++ VD++S G ++ E+L G+ + Y
Sbjct: 179 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY 221
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 4e-07
Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 816 KELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
K +GSG G V + +VAIK++ R + + ++E ++ ++H
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLS------RPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 874 NVVAFYGVVQDGPGGTLATVAE-YMV----DGSLRHVLVRKDRFLDRRRRLIIAMDAAFG 928
N+++ V P +L + Y+V D +L V+ + LD R + G
Sbjct: 77 NIISLLNVFT--PQKSLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCG 131
Query: 929 MEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAP 988
+++LHS I+H DLK N++V S K+ DFGL++ + + T + AP
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVK----SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187
Query: 989 ELLSGSSSKVSEKVDVFSFGIVLWEIL 1015
E++ G K E VD++S G ++ E++
Sbjct: 188 EVILGMGYK--ENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 7e-07
Identities = 50/201 (24%), Positives = 89/201 (44%), Gaps = 37/201 (18%)
Query: 867 LSKL-HHPNVVAFYGV-VQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIA-- 922
+SKL +HPN+V + + D L V +M GS + ++ F+D L IA
Sbjct: 52 VSKLFNHPNIVPYRATFIADN---ELWVVTSFMAYGSAKDLIC--THFMDGMSELAIAYI 106
Query: 923 -MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRN-TLVSGGVR 980
++Y+H VH +K ++L+++ G LS ++ N ++++ G R
Sbjct: 107 LQGVLKALDYIHHMGYVHRSVKASHILISVD---------GKVYLSGLRSNLSMINHGQR 157
Query: 981 G------------TLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA 1028
LPW++PE+L + K D++S GI E+ G P+ +M
Sbjct: 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ 217
Query: 1029 IIGGIVNNTL-----RPTIPS 1044
++ +N T+ TIP+
Sbjct: 218 MLLEKLNGTVPCLLDTTTIPA 238
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 7e-07
Identities = 59/219 (26%), Positives = 102/219 (46%), Gaps = 27/219 (12%)
Query: 816 KELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
K++GSG +G+V K G VAIK++ R + E ++E +L + H
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKLS------RPFQSEIFAKRAYRELTLLKHMQHE 74
Query: 874 NVVAFYGVVQDGPGG----TLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGM 929
NV+ V G V YM + + + + + ++ G+
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQK---IMGHPLSEDKVQYLV-YQMLCGL 130
Query: 930 EYLHSKNIVHFDLKCDNLLVNLKDPSRPIC--KVGDFGLSKIKRNTLVSGGVRGTLPWMA 987
+Y+HS I+H DLK NL VN +D C K+ DFGL++ + ++G V T + A
Sbjct: 131 KYIHSAGIIHRDLKPGNLAVN-ED-----CELKILDFGLAR-HADAEMTGYVV-TRWYRA 182
Query: 988 PELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY 1026
PE++ + ++ VD++S G ++ E+LTG+ + Y
Sbjct: 183 PEVIL-NWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY 220
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 9e-07
Identities = 58/207 (28%), Positives = 105/207 (50%), Gaps = 24/207 (11%)
Query: 818 LGSGTFGTV---YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPN 874
+GSG +G+V + K G VA+K++ + +S + T ++E +L + H N
Sbjct: 25 VGSGAYGSVCAAFDTK-TGLRVAVKKLSRPF---QSIIHAKRT---YRELRLLKHMKHEN 77
Query: 875 VVAFYGVVQDGPGGTLATVAE-YMVD---GSLRHVLVRKDRFLDRRRRLIIAMDAAFGME 930
V+ V P +L + Y+V G+ + +V+ + D + +I G++
Sbjct: 78 VIGLLDVFT--PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK 134
Query: 931 YLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPEL 990
Y+HS +I+H DLK NL VN +D K+ DFGL++ + + G T + APE+
Sbjct: 135 YIHSADIIHRDLKPSNLAVN-EDCE---LKILDFGLARHTDDEMT--GYVATRWYRAPEI 188
Query: 991 LSGSSSKVSEKVDVFSFGIVLWEILTG 1017
+ + ++ VD++S G ++ E+LTG
Sbjct: 189 ML-NWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-06
Identities = 58/232 (25%), Positives = 105/232 (45%), Gaps = 26/232 (11%)
Query: 793 NPSLVDFDVSSVQVIKNEDLEEQKELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRS 850
N V+ S+ V+K + K +GSG G V + +VAIK++ R
Sbjct: 9 NFYSVEIGDSTFTVLKR--YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS------RP 60
Query: 851 SEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEY-----MVDGSLRHV 905
+ + ++E ++ ++H N++ V P +L + ++D +L V
Sbjct: 61 FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT--PQKSLEEFQDVYIVMELMDANLCQV 118
Query: 906 LVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965
+ + LD R + G+++LHS I+H DLK N++V S K+ DFG
Sbjct: 119 IQME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILDFG 171
Query: 966 LSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTG 1017
L++ + + T + APE++ G K E VD++S G ++ E++ G
Sbjct: 172 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYK--ENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 41/136 (30%), Positives = 69/136 (50%), Gaps = 15/136 (11%)
Query: 890 LATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV 949
L + + M G L + L + F ++ R A + G+E++H++ +V+ DLK N+L+
Sbjct: 72 LCFILDLMNGGDLHYHLSQHGVFSEKEMRFY-ATEIILGLEHMHNRFVVYRDLKPANILL 130
Query: 950 NLKDPSRPICKVGDFGL----SKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVF 1005
+ R + D GL SK K + V GT +MAPE+L ++ S D F
Sbjct: 131 DEHGHVR----ISDLGLACDFSKKKPHASV-----GTHGYMAPEVLQKGTAYDSS-ADWF 180
Query: 1006 SFGIVLWEILTGEEPY 1021
S G +L+++L G P+
Sbjct: 181 SLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-06
Identities = 55/233 (23%), Positives = 104/233 (44%), Gaps = 35/233 (15%)
Query: 816 KELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSE--QERLTVEFWKEAEILSKLHHP 873
K++G+G FG V+ K + T + C+ S +ER + E ++ +L H
Sbjct: 19 KKIGNGRFGEVFLVKHKRTQ------EFFCWKAISYRGLKEREKSQLVIEVNVMRELKHK 72
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVL---------VRKDRFLDRRRRLIIAMD 924
N+V + + L + E+ G L + + + +D R+L+ A+
Sbjct: 73 NIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALA 132
Query: 925 AAFGM-EYLHSKNIVHFDLKCDNLLV---------------NLKDPSRPICKVGDFGLSK 968
+ + + + ++H DLK N+ + NL RPI K+GDFGLSK
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLN--GRPIAKIGDFGLSK 190
Query: 969 IKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1021
++ GT + +PELL + +K D+++ G +++E+ +G+ P+
Sbjct: 191 NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-06
Identities = 36/133 (27%), Positives = 66/133 (49%), Gaps = 8/133 (6%)
Query: 890 LATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV 949
L V EY+ G L + R+ + + R A + + +LH + I++ DLK DN+L+
Sbjct: 71 LFLVIEYVNGGDLMFHMQRQRKLPEEHARFY-AAEICIALNFLHERGIIYRDLKLDNVLL 129
Query: 950 NLKDPSRPICKVGDFGLSKIK-RNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFG 1008
+ K+ D+G+ K + GT ++APE+L G S VD ++ G
Sbjct: 130 DADGH----IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFS--VDWWALG 183
Query: 1009 IVLWEILTGEEPY 1021
++++E++ G P+
Sbjct: 184 VLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 61/252 (24%), Positives = 107/252 (42%), Gaps = 52/252 (20%)
Query: 810 EDLEEQKELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
ED E K +G G FG V K G A+K ++K+ E+E++ E +IL
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML----EKEQVG-HIRAERDIL 55
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
+ VV + QD L + E++ G + +L++KD + + IA +
Sbjct: 56 VEADSLWVVKMFYSFQDKL--NLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVL 112
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL--------------------- 966
++ +H +H D+K DNLL++ S+ K+ DFGL
Sbjct: 113 AIDSIHQLGFIHRDIKPDNLLLD----SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLP 168
Query: 967 ---------SKIKRNTL------VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVL 1011
SK K T ++ GT ++APE+ + ++ D +S G+++
Sbjct: 169 SDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVF--MQTGYNKLCDWWSLGVIM 226
Query: 1012 WEILTGEEPYAN 1023
+E+L G P+ +
Sbjct: 227 YEMLIGYPPFCS 238
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-06
Identities = 60/254 (23%), Positives = 101/254 (39%), Gaps = 64/254 (25%)
Query: 816 KELGSGTFGTVYHGKWRGTDV----AIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH 871
K +G G FG V R D A+K ++K+ R + V+ E +IL++
Sbjct: 7 KTIGIGAFGEVCLV--RKVDTNALYAMKTLRKADVLMR---NQAAHVK--AERDILAEAD 59
Query: 872 HPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEY 931
+ VV Y QD L V +Y+ G + +L+R F + R IA + +E
Sbjct: 60 NEWVVKLYYSFQDK--DNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA-ELTCAIES 116
Query: 932 LHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL------------------------- 966
+H +H D+K DN+L++ K+ DFGL
Sbjct: 117 VHKMGFIHRDIKPDNILIDRDGH----IKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSME 172
Query: 967 --------SKIKRNTLVSGGVR-----------GTLPWMAPELLSGSSSKVSEKVDVFSF 1007
+ + L R GT ++APE+L + ++ D +S
Sbjct: 173 PSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVL--LRTGYTQLCDWWSV 230
Query: 1008 GIVLWEILTGEEPY 1021
G++L+E+L G+ P+
Sbjct: 231 GVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 15/136 (11%)
Query: 890 LATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV 949
L+ + + M G L + L + F + R A + G+E++H++ +V+ DLK N+L+
Sbjct: 72 LSFILDLMNGGDLHYHLSQHGVFSEAEMRFY-AAEIILGLEHMHNRFVVYRDLKPANILL 130
Query: 950 NLKDPSRPICKVGDFGL----SKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVF 1005
+ R + D GL SK K + V GT +MAPE+L + S D F
Sbjct: 131 DEHGHVR----ISDLGLACDFSKKKPHASV-----GTHGYMAPEVLQKGVAYDSS-ADWF 180
Query: 1006 SFGIVLWEILTGEEPY 1021
S G +L+++L G P+
Sbjct: 181 SLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 8e-06
Identities = 66/264 (25%), Positives = 115/264 (43%), Gaps = 43/264 (16%)
Query: 771 RTTESDYEEGNAGNRNIGLPSLNPSLVDFDVSSVQVIKNEDLEEQKELGSGTFGTVYHGK 830
+ EE + N N G ++D D++ N+ + +G+G+FG VY
Sbjct: 30 MNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRS---PNKSYKLGNIIGNGSFGVVYEAI 86
Query: 831 WRGTD--VAIKRI-KKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVV---AFY---GV 881
T VAIK++ + + R E I+ L+H N++ +Y
Sbjct: 87 CIDTSEKVAIKKVLQDPQYKNR-------------ELLIMKNLNHINIIFLKDYYYTECF 133
Query: 882 VQDGPGGTLATVAEYM---VDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIV 938
++ L V E++ V ++H R + L + + + Y+HSK I
Sbjct: 134 KKNEKNIFLNVVMEFIPQTVHKYMKH-YARNNHALPLFLVKLYSYQLCRALAYIHSKFIC 192
Query: 939 HFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRG-----TLPWMAPELLSG 993
H DLK NLL+ DP+ K+ DFG +K N L G R + + APEL+ G
Sbjct: 193 HRDLKPQNLLI---DPNTHTLKLCDFGSAK---NLL--AGQRSVSYICSRFYRAPELMLG 244
Query: 994 SSSKVSEKVDVFSFGIVLWEILTG 1017
+++ + +D++S G ++ E++ G
Sbjct: 245 ATNYTTH-IDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-05
Identities = 41/173 (23%), Positives = 81/173 (46%), Gaps = 21/173 (12%)
Query: 855 RLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLAT------VAEYMVDGSLRHVLVR 908
R ++ E L +L+H N++ +++ + T + +M D +
Sbjct: 205 RAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDW---- 260
Query: 909 KDR-FLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967
KDR L + R ++ + A +EY+H K ++H D+K +N+ +N +GDFG +
Sbjct: 261 KDRPLLKQTRAIMKQLLCA--VEYIHDKKLIHRDIKLENIFLNCDGKI----VLGDFGTA 314
Query: 968 KIKRNTLVSG--GVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
+ G GT+ +PE+L+G E D++S G++L ++L+ +
Sbjct: 315 MPFEKEREAFDYGWVGTVATNSPEILAGDG--YCEITDIWSCGLILLDMLSHD 365
|
Length = 501 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 60/256 (23%), Positives = 104/256 (40%), Gaps = 64/256 (25%)
Query: 816 KELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
K LG G FG V T A+K ++K R+ E +IL++ +
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQ-----VAHVKAERDILAEADNE 61
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLH 933
VV Y QD L V +Y+ G + +L+R + F + R IA + +E +H
Sbjct: 62 WVVKLYYSFQDKD--NLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVH 118
Query: 934 SKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL----------------SKIKRNTL--- 974
+H D+K DN+L++L K+ DFGL S I+++++
Sbjct: 119 KMGFIHRDIKPDNILIDLDGH----IKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPS 174
Query: 975 -----------------------------VSGGVRGTLPWMAPELLSGSSSKVSEKVDVF 1005
++ + GT ++APE+L ++ D +
Sbjct: 175 DLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL--LRKGYTQLCDWW 232
Query: 1006 SFGIVLWEILTGEEPY 1021
S G++L+E+L G+ P+
Sbjct: 233 SVGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-05
Identities = 59/253 (23%), Positives = 105/253 (41%), Gaps = 54/253 (21%)
Query: 810 EDLEEQKELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
+D E K +G G FG V K G A+K ++K+ E+E++ E +IL
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML----EKEQVA-HIRAERDIL 55
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
+ VV + QD L + E++ G + +L++KD + + IA +
Sbjct: 56 VEADGAWVVKMFYSFQDKR--NLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVL 112
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS-------------------- 967
++ +H +H D+K DNLL++ ++ K+ DFGL
Sbjct: 113 AIDAIHQLGFIHRDIKPDNLLLD----AKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPP 168
Query: 968 -----------------KIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIV 1010
K R L V GT ++APE+ + ++ D +S G++
Sbjct: 169 SDFSFQNMNSKRKAETWKKNRRQLAYSTV-GTPDYIAPEVF--MQTGYNKLCDWWSLGVI 225
Query: 1011 LWEILTGEEPYAN 1023
++E+L G P+ +
Sbjct: 226 MYEMLIGYPPFCS 238
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 29/210 (13%)
Query: 818 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNV 875
+G G +G V + + T VAIK+ K S E E + +E ++L L N+
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDS------EENEEVKETTLRELKMLRTLKQENI 62
Query: 876 VAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFL-DRRRRLIIAMDAAFGMEYLHS 934
V + G L V EY+ L + + ++ R I + A + + H
Sbjct: 63 VELKEAFRRR--GKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKA--IHWCHK 118
Query: 935 KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMA------P 988
+IVH D+K +NLL++ D + K+ DFG ++ L G ++A P
Sbjct: 119 NDIVHRDIKPENLLISHND----VLKLCDFGFAR----NLSEGSNANYTEYVATRWYRSP 170
Query: 989 ELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
ELL G+ + VD++S G +L E+ G+
Sbjct: 171 ELLLGAP--YGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 9e-05
Identities = 47/169 (27%), Positives = 73/169 (43%), Gaps = 32/169 (18%)
Query: 810 EDLEEQKELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWK----- 862
ED K +G G FG V K G A+K + KS E +K
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKS--------------EMFKKDQLA 46
Query: 863 ----EAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRR 918
E ++L++ P VV+ Y QD L + E++ G L +L++ D F + R
Sbjct: 47 HVKAERDVLAESDSPWVVSLYYSFQDA--QYLYLIMEFLPGGDLMTMLIKYDTFSEDVTR 104
Query: 919 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967
+A + +E +H +H D+K DN+L++ K+ DFGLS
Sbjct: 105 FYMA-ECVLAIEAVHKLGFIHRDIKPDNILIDRGGH----IKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 32/126 (25%), Positives = 48/126 (38%), Gaps = 18/126 (14%)
Query: 900 GSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC 959
SL +L + R L+ + + + LH + L + L+ L
Sbjct: 1 VSLADILEVRGRPLNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKL-------- 52
Query: 960 KVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEE 1019
G K T R +MAPE++ G S +EK D++S GI L+E L E
Sbjct: 53 ----DGSVAFK--TPEQS--RPDPYFMAPEVIQGQS--YTEKADIYSLGITLYEALDYEL 102
Query: 1020 PYANMH 1025
PY
Sbjct: 103 PYNEER 108
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|225023 COG2112, COG2112, Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 29/72 (40%), Positives = 36/72 (50%), Gaps = 13/72 (18%)
Query: 812 LEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH 871
L +KEL GT VY G+WRG +VA+K R + R +E KEA+IL L
Sbjct: 24 LRVEKELAKGTTSVVYLGEWRGGEVALKV--------RRRDSPRRNLE--KEAKILEILA 73
Query: 872 HPNV---VAFYG 880
V V FYG
Sbjct: 74 GEGVTPEVYFYG 85
|
Length = 201 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 59/259 (22%), Positives = 103/259 (39%), Gaps = 62/259 (23%)
Query: 812 LEEQKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTVEFWKEAEILSK 869
+ K LG G FG V + T A+K ++K R+ E +IL++
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQ-----VAHVKAERDILAE 57
Query: 870 LHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGM 929
+ VV Y QD L V +Y+ G + +L+R F + R IA + +
Sbjct: 58 ADNEWVVRLYYSFQDK--DNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA-ELTCAV 114
Query: 930 EYLHSKNIVHFDLKCDNLLVN--------------------------------------- 950
E +H +H D+K DN+L++
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFS 174
Query: 951 --LKDPSRPICKVGDFGLSKIKRNT------LVSGGVRGTLPWMAPELLSGSSSKVSEKV 1002
DP+ C+ GD L ++R ++ + GT ++APE+L + ++
Sbjct: 175 NEWGDPAN--CRCGD-RLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL--LRTGYTQLC 229
Query: 1003 DVFSFGIVLWEILTGEEPY 1021
D +S G++L+E+L G+ P+
Sbjct: 230 DWWSVGVILYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 33/102 (32%), Positives = 54/102 (52%), Gaps = 15/102 (14%)
Query: 917 RRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS---KIKRNT 973
RRL+ A+ YLH + I+H D+K +N+ ++ +P + +GDFG + +T
Sbjct: 192 RRLLEAL------AYLHGRGIIHRDVKTENIFLD--EPENAV--LGDFGAACKLDAHPDT 241
Query: 974 LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEIL 1015
G GTL +PELL + K D++S G+VL+E+
Sbjct: 242 PQCYGWSGTLETNSPELL--ALDPYCAKTDIWSAGLVLFEMS 281
|
Length = 392 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.003
Identities = 47/174 (27%), Positives = 70/174 (40%), Gaps = 33/174 (18%)
Query: 816 KELGSGTFGTVYHGKWRGTDVAIK-RIKKSCFTGRSSE------QERLTVEFWKEAEILS 868
K + G +Y G + G IK RI K R E +ER T +EA I+S
Sbjct: 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRY---RHPELDERIRRER-TR---REARIMS 54
Query: 869 KLHHP--NVVAFYGVVQDGPGGTLATVAEYMVDG-SLRHVLVRKDRFLDRRRRLIIAMDA 925
+ NV A Y V D + V EY ++G L+ ++ + L +
Sbjct: 55 RARKAGVNVPAVYFV--DPENFII--VMEY-IEGEPLKDLI---NSNGMEELELSREIGR 106
Query: 926 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGV 979
G LHS I+H DL N++++ I + DFGL++ L V
Sbjct: 107 LVGK--LHSAGIIHGDLTTSNMILS----GGKIYLI-DFGLAEFS-KDLEDRAV 152
|
Length = 211 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1094 | |||
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06410 | 97 | PB1_UP2 Uncharacterized protein 2. The PB1 domain | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.78 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.76 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.75 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.73 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.72 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.7 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.7 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.63 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.6 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.56 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.52 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.51 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.48 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.4 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.21 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.17 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.15 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.11 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.06 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.04 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.02 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.99 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.98 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.97 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.91 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.85 | |
| smart00666 | 81 | PB1 PB1 domain. Phox and Bem1p domain, present in | 98.75 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.67 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.62 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.59 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.54 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.53 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.29 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.21 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.18 | |
| PF00564 | 84 | PB1: PB1 domain; InterPro: IPR000270 The Phox and | 98.17 | |
| cd05992 | 81 | PB1 The PB1 domain is a modular domain mediating s | 98.07 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.97 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.92 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.9 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.8 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.74 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.72 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.67 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.64 | |
| cd06407 | 82 | PB1_NLP A PB1 domain is present in NIN like protei | 97.59 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.52 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.51 | |
| PF00017 | 77 | SH2: SH2 domain; InterPro: IPR000980 The Src homol | 97.49 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.46 | |
| smart00252 | 84 | SH2 Src homology 2 domains. Src homology 2 domains | 97.39 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.37 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.36 | |
| cd06408 | 86 | PB1_NoxR The PB1 domain is present in the Epichloe | 97.26 | |
| cd00173 | 94 | SH2 Src homology 2 domains; Signal transduction, i | 97.15 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.1 | |
| cd06405 | 79 | PB1_Mekk2_3 The PB1 domain is present in the two m | 97.08 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.04 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.98 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.84 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.48 | |
| cd06401 | 81 | PB1_TFG The PB1 domain found in TFG protein, an on | 96.43 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.36 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.24 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.1 | |
| cd06398 | 91 | PB1_Joka2 The PB1 domain is present in the Nicotia | 96.04 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 95.94 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.86 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.7 | |
| cd06404 | 83 | PB1_aPKC PB1 domain is an essential modular domain | 95.58 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.54 | |
| cd06396 | 81 | PB1_NBR1 The PB1 domain is an essential part of NB | 95.51 | |
| KOG4792 | 293 | consensus Crk family adapters [Signal transduction | 95.19 | |
| PLN02236 | 344 | choline kinase | 94.87 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.79 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.77 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 94.62 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.6 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 93.55 |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-60 Score=543.33 Aligned_cols=384 Identities=32% Similarity=0.507 Sum_probs=332.7
Q ss_pred cccccCCCCchhhh-------ccccccccccCCCChhHHHHcCCchh-------hhhhhhcCCceeEEeeeccC-CCCCC
Q 037285 671 VNMENHEPKRWSYF-------RNLAQVDFGQKDVSLIDQEHLGLSSG-------VREVREEDGRLYHFTPLTDD-GAPKG 735 (1094)
Q Consensus 671 ~~~~~~~~~~~~~~-------~~Le~~~Wy~~~IsR~~AE~ll~a~g-------VR~s~~~~G~~y~~S~l~~~-ga~~g 735 (1094)
++.++++|+|+++- .+|+.++||+++|+|.+||+++.+.+ ||++....| .|++|+.+.. +.+..
T Consensus 55 ~~~~g~ip~N~v~~~~~~~~~~~l~~~~Wf~~~isR~~ae~~ll~p~~~~G~flvR~se~~~g-~yslsv~~~~~~~~~~ 133 (468)
T KOG0197|consen 55 LGQEGYIPSNYVARNRGSPAFIKLSDEPWFFGKISREEAERQLLAPENKEGAFLVRESESDKG-DYSLSVREGDSGGLGA 133 (468)
T ss_pred cCCCCcCcCceeeccccCCCccccccCCchhccccHHHHHHhhcCCCCCccceeeecccCCcC-CeeEEEEeccccCCcc
Confidence 77888999999964 89999999999999999997777766 899988788 9999999975 33445
Q ss_pred cccccccccccCCCccccCCCcccccchHHHHHhhhcccccccccCCCCCc--CCCCCCC---CCCcccCC-Ccceeecc
Q 037285 736 RVDSQLNFGQDSQKTFGVDPSVSESMQFDAMMENLRTTESDYEEGNAGNRN--IGLPSLN---PSLVDFDV-SSVQVIKN 809 (1094)
Q Consensus 736 ~v~shy~I~~dsq~r~~vtp~isE~~qFdsL~ElLrt~eSdyee~nagn~~--l~~P~ln---psl~~~dl-ssv~eIs~ 809 (1094)
.|+ ||+|++...+.++ +.++++..|+.+.+++ .|+..++.+.. +..|+.. ...+..+. ...|+|..
T Consensus 134 ~v~-hyri~~~~~~~~~--~~~~~~~~F~~l~~lv-----~~~~~~~~gl~~~l~~p~~~~~~~~p~~~~~~~d~wei~r 205 (468)
T KOG0197|consen 134 KVK-HYRIRQLDGGGLY--PYIDERELFSSLQQLV-----NYYSKNADGLCTRLRDPCSKQGHTKPQTPDLARDPWEIPR 205 (468)
T ss_pred cee-eeeeeEcCCCCee--cCCCHHHhhhhHHHHH-----hhhhccCcchhhcccCchhccCCCCCCCCccccCCeeecH
Confidence 777 9999987766555 3489999999999999 45555544332 2333322 12233333 57899999
Q ss_pred CCeeEEEEecccCceEEEEeeecCc-eEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWRGT-DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~rGt-~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
+.+++.+.||+|.||+||+|.|++. .||+|.++...+.. ..|.+|+++|++|+|+|||+++++|..+.
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~---------~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-- 274 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP---------EAFLREAQIMKKLRHEKLVKLYGVCTKQE-- 274 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh---------hHHHHHHHHHHhCcccCeEEEEEEEecCC--
Confidence 9999999999999999999999986 89999999875442 57889999999999999999999999865
Q ss_pred ceEEEeeecccchhHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 889 TLATVAEYMVDGSLRHVLVR-KDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k-~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.++||||||..|+|.++|.. .+..+...+.+.|+.|||+||+||+++++|||||.++||||+ ++..|||+|||||
T Consensus 275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~----~~~~vKIsDFGLA 350 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVD----EDLVVKISDFGLA 350 (468)
T ss_pred ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeec----cCceEEEcccccc
Confidence 89999999999999999987 556799999999999999999999999999999999999999 8889999999999
Q ss_pred ccc--cCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCCCCC
Q 037285 968 KIK--RNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPS 1044 (1094)
Q Consensus 968 rl~--~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~iPe 1044 (1094)
+.. +.+........+..|.|||.+. ..+|+.|||||||||+||||+| |+.||..+.+.++++.+ ..++|++.|.
T Consensus 351 r~~~d~~Y~~~~~~kfPIkWtAPEa~~--~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~l-e~GyRlp~P~ 427 (468)
T KOG0197|consen 351 RLIGDDEYTASEGGKFPIKWTAPEALN--YGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELL-ERGYRLPRPE 427 (468)
T ss_pred cccCCCceeecCCCCCCceecCHHHHh--hCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHH-hccCcCCCCC
Confidence 953 3455666777899999999999 7889999999999999999999 99999999999999876 8899999999
Q ss_pred cCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1045 YCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1045 ~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
.||+++++||..||+.+|++||||..+...|+++...
T Consensus 428 ~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 428 GCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 9999999999999999999999999999999998754
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-52 Score=476.43 Aligned_cols=377 Identities=29% Similarity=0.489 Sum_probs=323.5
Q ss_pred cccccCCCCchh-hhccccccccccCCCChhHHHHcCCchh-----hhhhhhcCCceeEEeeeccCCCCCCccccccccc
Q 037285 671 VNMENHEPKRWS-YFRNLAQVDFGQKDVSLIDQEHLGLSSG-----VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFG 744 (1094)
Q Consensus 671 ~~~~~~~~~~~~-~~~~Le~~~Wy~~~IsR~~AE~ll~a~g-----VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~ 744 (1094)
-|-++-.|+||- -+++||+|.||||.|||..||..|-..- ||++....| -|..++.+. |||. ||.|.
T Consensus 132 KNGqGWVPSNyItPvNSLeKhsWYHGpvSRsaaEy~LsSgInGSFLVRESEsSpg-Q~sISlRye-----GRVy-HYRIN 204 (1157)
T KOG4278|consen 132 KNGQGWVPSNYITPVNSLEKHSWYHGPVSRSAAEYILSSGINGSFLVRESESSPG-QYSISLRYE-----GRVY-HYRIN 204 (1157)
T ss_pred cCCCccccccccccccchhhcccccCccccchhhhhhhcCcccceEEeeccCCCc-ceeEEEEec-----ceEE-EEEee
Confidence 566788999988 8999999999999999999999987654 999999999 888888886 9999 99999
Q ss_pred ccCCCccccCCCcccccchHHHHHhhhcccccccccCCCCCcCC----CCCCCCCCcccC---CCcceeeccCCeeEEEE
Q 037285 745 QDSQKTFGVDPSVSESMQFDAMMENLRTTESDYEEGNAGNRNIG----LPSLNPSLVDFD---VSSVQVIKNEDLEEQKE 817 (1094)
Q Consensus 745 ~dsq~r~~vtp~isE~~qFdsL~ElLrt~eSdyee~nagn~~l~----~P~lnpsl~~~d---lssv~eIs~edYei~kk 817 (1094)
.+..++.| +.....|.++.|++- -+...+.+..+. .|..+.. .-+. ..+.|++...++++..+
T Consensus 205 t~~dgK~y----vt~EsrF~TLaELVH-----HHStvADGLittLhYPApK~nKp-tvygvSPn~DkWEmeRtdItMkhK 274 (1157)
T KOG4278|consen 205 TDNDGKMY----VTQESRFRTLAELVH-----HHSTVADGLITTLHYPAPKKNKP-TVYGVSPNADKWEMERTDITMKHK 274 (1157)
T ss_pred ccCCccEE----EeehhhhhHHHHHHh-----hccccccceeEeeeccCccCCCC-ceeeecCCcchhhccchheeeeec
Confidence 99999999 778889999999983 222233333211 1111111 1111 12579999999999999
Q ss_pred ecccCceEEEEeeecC--ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEEEee
Q 037285 818 LGSGTFGTVYHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAE 895 (1094)
Q Consensus 818 LGsG~FGtVYKAk~rG--t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~IVmE 895 (1094)
||.|.||.||.|.|+. -.||||.++...| .+++|++|+.+|+.++|||+|+++|+|+.+. .+|||+|
T Consensus 275 LGGGQYGeVYeGvWKkyslTvAVKtLKEDtM---------eveEFLkEAAvMKeikHpNLVqLLGVCT~Ep--PFYIiTE 343 (1157)
T KOG4278|consen 275 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---------EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP--PFYIITE 343 (1157)
T ss_pred cCCCcccceeeeeeeccceeeehhhhhhcch---------hHHHHHHHHHHHHhhcCccHHHHhhhhccCC--CeEEEEe
Confidence 9999999999999975 4599999987543 3578999999999999999999999999877 9999999
Q ss_pred ecccchhHHHHhhccc-ccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCccccc--C
Q 037285 896 YMVDGSLRHVLVRKDR-FLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKR--N 972 (1094)
Q Consensus 896 YmegGSL~d~L~k~~~-~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~--~ 972 (1094)
||..|+|.+||.+..+ .++.-.++.|+.||..||+||..+++|||||.++||||. ++..|||+||||++++. .
T Consensus 344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVg----EnhiVKvADFGLsRlMtgDT 419 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG----ENHIVKVADFGLSRLMTGDT 419 (1157)
T ss_pred cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccc----ccceEEeeccchhhhhcCCc
Confidence 9999999999987653 466667889999999999999999999999999999999 89999999999999754 3
Q ss_pred ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHH
Q 037285 973 TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWR 1051 (1094)
Q Consensus 973 ~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~ 1051 (1094)
++...+.+++..|.|||-+. ++.|+.|+|||+|||+|||+.| |..||.+.+..+++. ++..++++.-|+.|++.++
T Consensus 420 YTAHAGAKFPIKWTAPEsLA--yNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~-LLEkgyRM~~PeGCPpkVY 496 (1157)
T KOG4278|consen 420 YTAHAGAKFPIKWTAPESLA--YNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYG-LLEKGYRMDGPEGCPPKVY 496 (1157)
T ss_pred eecccCccCcccccCccccc--ccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHH-HHhccccccCCCCCCHHHH
Confidence 44555677899999999998 8899999999999999999999 999999998877765 5588999999999999999
Q ss_pred HHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 037285 1052 TLMEECWAPNPAARPSFTEIASRLRVLSTAA 1082 (1094)
Q Consensus 1052 dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~ 1082 (1094)
+||+.||++.|.+||+|.++-+.++.+....
T Consensus 497 eLMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 497 ELMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred HHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 9999999999999999999999998876443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=429.41 Aligned_cols=270 Identities=48% Similarity=0.812 Sum_probs=241.1
Q ss_pred cceeeccCCeeEEEEecccCceEEEEeeecCce-EEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeE
Q 037285 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKWRGTD-VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGV 881 (1094)
Q Consensus 803 sv~eIs~edYei~kkLGsG~FGtVYKAk~rGt~-VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv 881 (1094)
..+.|...++.+.+.||.|+||+||+|.|+|+. ||||++....... +. ..+|.+|+.+|.+|+|||||+++|+
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~-----~~-~~~f~~E~~il~~l~HpNIV~f~G~ 107 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDD-----ES-RKAFRREASLLSRLRHPNIVQFYGA 107 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcCh-----HH-HHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 457788888888899999999999999999988 9999998754332 11 5789999999999999999999999
Q ss_pred eecCCCCceEEEeeecccchhHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCceEeccCCCCCC-c
Q 037285 882 VQDGPGGTLATVAEYMVDGSLRHVLVR-KDRFLDRRRRLIIAMDAAFGMEYLHSKN-IVHFDLKCDNLLVNLKDPSRP-I 958 (1094)
Q Consensus 882 ~~d~~~~~L~IVmEYmegGSL~d~L~k-~~~~Lse~~~l~Ia~QIaeGLaYLHs~G-IIHRDLKPeNILLD~~~~e~g-~ 958 (1094)
|.+... .++||||||++|+|.+++.. ....+++..++.|+.||++||+|||+++ |||||||++|||++ ... +
T Consensus 108 ~~~~~~-~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~----~~~~~ 182 (362)
T KOG0192|consen 108 CTSPPG-SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVD----LKGKT 182 (362)
T ss_pred EcCCCC-ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEc----CCCCE
Confidence 998642 68999999999999999988 3677999999999999999999999999 99999999999999 675 9
Q ss_pred EEEEecCCcccccCc-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhcc
Q 037285 959 CKVGDFGLSKIKRNT-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 1037 (1094)
Q Consensus 959 VKLsDFGLSrl~~~~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~ 1037 (1094)
+||+|||+++..... .......||+.|||||++.+....|+.|+||||||++||||+||+.||.......+...++...
T Consensus 183 ~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~ 262 (362)
T KOG0192|consen 183 LKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGG 262 (362)
T ss_pred EEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcC
Confidence 999999999976553 3333467999999999998433479999999999999999999999999999988888888999
Q ss_pred CCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 037285 1038 LRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAAS 1083 (1094)
Q Consensus 1038 lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s 1083 (1094)
.++.+|..+++.+..||.+||+.||..||+|.+++..|+.+.....
T Consensus 263 ~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 263 LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 9999999999999999999999999999999999999999986544
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-47 Score=435.30 Aligned_cols=368 Identities=31% Similarity=0.475 Sum_probs=298.9
Q ss_pred ccccccccccCCCChhHHHHcCCchh---hhhhhhcCCcee---EEeeeccCCCCCCcccccccccccCCCccccCCCcc
Q 037285 685 RNLAQVDFGQKDVSLIDQEHLGLSSG---VREVREEDGRLY---HFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVS 758 (1094)
Q Consensus 685 ~~Le~~~Wy~~~IsR~~AE~ll~a~g---VR~s~~~~G~~y---~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~is 758 (1094)
..|..++||||-+.|.+++.+|+-.| ||.+...+|... -+|+... ....+. ||.|..+.. .+. ..
T Consensus 44 ~~~~~~~~yHG~l~red~~~lL~~~GDfLvR~s~~~~~~~~~~~vlSv~~~---~~~~~~-h~vi~~~~~-~~~----~~ 114 (474)
T KOG0194|consen 44 KDLRELPYYHGLLPREDAEKLLKNDGDFLVRASEPKEGEKREFVVLSVKWS---VFKKIK-HYVIKRNGN-LFF----FE 114 (474)
T ss_pred hHhhcCccccccccHhHHHHHhCCCCceEEEeecccCCcceeEEEEEEEee---cCCcee-EEEEEEcCC-eeE----Ee
Confidence 34555899999999999999999999 999988777533 3444431 112344 888887655 233 45
Q ss_pred cccchHHHHHhhhcccccccccCCCCCcCCCCCCCCCCcccCCCcceeeccCCeeEEEEecccCceEEEEeeec--C---
Q 037285 759 ESMQFDAMMENLRTTESDYEEGNAGNRNIGLPSLNPSLVDFDVSSVQVIKNEDLEEQKELGSGTFGTVYHGKWR--G--- 833 (1094)
Q Consensus 759 E~~qFdsL~ElLrt~eSdyee~nagn~~l~~P~lnpsl~~~dlssv~eIs~edYei~kkLGsG~FGtVYKAk~r--G--- 833 (1094)
...+|.++.+++................+..|. ..+.|++..++..+.++||+|+||+||+|+++ +
T Consensus 115 ~~~~F~si~~li~~~~~~~~~~~~~~~~L~~PI---------~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~ 185 (474)
T KOG0194|consen 115 GLRKFPTISELVNYYKFSKLEITGKNFFLKRPI---------PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFK 185 (474)
T ss_pred ccccCCcHHHHHHHHHhcccceeccceeecccc---------cccccEEeccCccccceeecccccEEEEEEEEecCCce
Confidence 557899999998432222211111111111111 13569999999999999999999999999874 2
Q ss_pred ce-EEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEEEeeecccchhHHHHhhcccc
Q 037285 834 TD-VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRF 912 (1094)
Q Consensus 834 t~-VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~ 912 (1094)
.. ||||..+... ...+..+.+|++|+++|++++|||||++||++.... ++++|||+|.||+|.++|.+....
T Consensus 186 ~~~VAvK~~k~~~-----~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~--Pl~ivmEl~~gGsL~~~L~k~~~~ 258 (474)
T KOG0194|consen 186 VVPVAVKTTKGSS-----ELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE--PLMLVMELCNGGSLDDYLKKNKKS 258 (474)
T ss_pred eeeeEEEeecccc-----cccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC--ccEEEEEecCCCcHHHHHHhCCCC
Confidence 13 8999887522 123455689999999999999999999999999877 999999999999999999988777
Q ss_pred cCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccCccccC-CccCCCcccCcccc
Q 037285 913 LDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSG-GVRGTLPWMAPELL 991 (1094)
Q Consensus 913 Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~~~ss-~~~GT~~YmAPEvL 991 (1094)
++..+.+.++.+.+.||+|||++++|||||.++|||++ .+..+||+|||+++......... ...-+.+|+|||.+
T Consensus 259 v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~----~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl 334 (474)
T KOG0194|consen 259 LPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYS----KKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETL 334 (474)
T ss_pred CCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheec----CCCeEEeCccccccCCcceeeccccccCcceecChhhh
Confidence 99999999999999999999999999999999999999 67779999999998655333333 23467899999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHH
Q 037285 992 SGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTE 1070 (1094)
Q Consensus 992 ~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eE 1070 (1094)
. ...|++++|||||||++||+++ |..||.+....++...+...+++...+...+.++..++.+||..+|+.||+|.+
T Consensus 335 ~--~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~ 412 (474)
T KOG0194|consen 335 N--TGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMST 412 (474)
T ss_pred c--cCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHH
Confidence 8 5589999999999999999999 899999999999999998999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHhh
Q 037285 1071 IASRLRVLSTAAS 1083 (1094)
Q Consensus 1071 LLq~L~~L~ta~s 1083 (1094)
+.+.|..+.....
T Consensus 413 i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 413 IKKKLEALEKKKE 425 (474)
T ss_pred HHHHHHHHHhccc
Confidence 9999999875543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=405.98 Aligned_cols=266 Identities=29% Similarity=0.380 Sum_probs=226.4
Q ss_pred ccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~ 885 (1094)
..+.|.+.+.||+|+||.|-+|..+ |+.||||++.+........ .........+|+++|++|+|||||+++++|...
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~-~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSR-AIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccc-cccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 4567889999999999999999774 7889999998875544222 111223456899999999999999999999987
Q ss_pred CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecC
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFG 965 (1094)
. ..||||||++||+|.+.+...+ .+.+.....+++||+.|+.|||++||+||||||+|||+..+. +...+||+|||
T Consensus 249 d--s~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~-e~~llKItDFG 324 (475)
T KOG0615|consen 249 D--SSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDA-EDCLLKITDFG 324 (475)
T ss_pred C--ceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCC-cceEEEecccc
Confidence 6 7899999999999999998765 488888999999999999999999999999999999998433 56899999999
Q ss_pred CcccccCccccCCccCCCcccCccccccCCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCChHH-HHHhHhhccCC--CC
Q 037285 966 LSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVS-EKVDVFSFGIVLWEILTGEEPYANMHYGA-IIGGIVNNTLR--PT 1041 (1094)
Q Consensus 966 LSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS-~KSDVWSLGVLLyELLTGk~PF~~~~~~e-ile~Iv~~~lr--p~ 1041 (1094)
+|+.........+.|||+.|.|||++......+. .++|+|||||+||-+++|.+||....... ..+++..+.+. +.
T Consensus 325 lAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~ 404 (475)
T KOG0615|consen 325 LAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPL 404 (475)
T ss_pred hhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccCh
Confidence 9999888778888999999999999985444444 49999999999999999999998876555 66777766654 33
Q ss_pred CCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1042 iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
....++++..+||.+||..||++|||+.+++++-|--
T Consensus 405 ~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~ 441 (475)
T KOG0615|consen 405 QWDRISEEALDLINWMLVVDPENRPSADEALNHPWFK 441 (475)
T ss_pred hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence 4456889999999999999999999999999988865
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=406.80 Aligned_cols=252 Identities=31% Similarity=0.469 Sum_probs=227.3
Q ss_pred CCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
..|...+.||+|+|+.||+++. +|..||+|++.+..+.. ....+...+||++.++|+|||||+++++|++..
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k-----~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~- 91 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKK-----PKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN- 91 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcC-----cchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC-
Confidence 5799999999999999999987 58899999998876544 233466789999999999999999999999976
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
++|||.|+|..++|..++++ .+.+++.++..+++||+.||.|||+++|||||||..|+|++ ++.+|||+|||||
T Consensus 92 -nVYivLELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~----~~~~VKIgDFGLA 165 (592)
T KOG0575|consen 92 -NVYIVLELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLN----ENMNVKIGDFGLA 165 (592)
T ss_pred -ceEEEEEecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeec----CcCcEEeccccee
Confidence 99999999999999999984 45699999999999999999999999999999999999999 8899999999999
Q ss_pred cccc-CccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcC
Q 037285 968 KIKR-NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYC 1046 (1094)
Q Consensus 968 rl~~-~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~ 1046 (1094)
.... ......+.|||+.|.|||++. ....++.+||||+||+||-|++|++||+.....+.+..+....+. +|..+
T Consensus 166 t~le~~~Erk~TlCGTPNYIAPEVl~--k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~--~P~~l 241 (592)
T KOG0575|consen 166 TQLEYDGERKKTLCGTPNYIAPEVLN--KSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYS--MPSHL 241 (592)
T ss_pred eeecCcccccceecCCCcccChhHhc--cCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcc--ccccc
Confidence 8654 445667789999999999998 556789999999999999999999999999999999988777664 67799
Q ss_pred cHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1047 DAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1047 S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
+.++++||.++|+.||.+|||+.+|+.+-.-
T Consensus 242 s~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 242 SAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 9999999999999999999999999987544
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=387.94 Aligned_cols=257 Identities=33% Similarity=0.485 Sum_probs=224.4
Q ss_pred eeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEee
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQ 883 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~ 883 (1094)
.++.++++.++.||+|..|+|||++++ +.-+|+|.+... .++....++.+|+++++..+||+||.+||+|.
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-------~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~ 147 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-------IDPALQKQILRELEILRSCQSPYIVGFYGAFY 147 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-------CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence 366678999999999999999999986 667999999532 23455678899999999999999999999999
Q ss_pred cCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs-~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
.... .+.|+||||++|+|..++...+ .+++..+..|+.+|++||.|||+ ++||||||||+|||++ ..+.||||
T Consensus 148 ~~~~-~isI~mEYMDgGSLd~~~k~~g-~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvN----skGeVKic 221 (364)
T KOG0581|consen 148 SNGE-EISICMEYMDGGSLDDILKRVG-RIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVN----SKGEVKIC 221 (364)
T ss_pred eCCc-eEEeehhhcCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeec----cCCCEEec
Confidence 8642 5999999999999999997764 49999999999999999999995 9999999999999999 89999999
Q ss_pred ecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-----ChHHHHHhHhhcc
Q 037285 963 DFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANM-----HYGAIIGGIVNNT 1037 (1094)
Q Consensus 963 DFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~-----~~~eile~Iv~~~ 1037 (1094)
|||.++..... ...++.||..|||||.+. ...|+.++||||||+.++||++|+.||... ...+++..++.+
T Consensus 222 DFGVS~~lvnS-~a~tfvGT~~YMsPERi~--g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~- 297 (364)
T KOG0581|consen 222 DFGVSGILVNS-IANTFVGTSAYMSPERIS--GESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE- 297 (364)
T ss_pred cccccHHhhhh-hcccccccccccChhhhc--CCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC-
Confidence 99999965544 556788999999999999 568899999999999999999999999874 556677766554
Q ss_pred CCCCCCCc-CcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1038 LRPTIPSY-CDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1038 lrp~iPe~-~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
..|.+|.. +++++++||..||++||.+||++.+|++|-+-.+
T Consensus 298 ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~ 340 (364)
T KOG0581|consen 298 PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKK 340 (364)
T ss_pred CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhh
Confidence 45667776 9999999999999999999999999999877654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=386.28 Aligned_cols=254 Identities=30% Similarity=0.526 Sum_probs=220.8
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
.+|.+.++||.|+|++||+|+++ +..||||.+.+... ..+..+-...|+.+|+.++|||||++++++.+..
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l------~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~- 82 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL------NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD- 82 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc------CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC-
Confidence 57888899999999999999885 67899999976532 2344566789999999999999999999999866
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCC--CcEEEEecC
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSR--PICKVGDFG 965 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~--g~VKLsDFG 965 (1094)
.+|+|||||.||+|.+|+.+++. +++..+..++.||+.||++||+++||||||||+|||++...... ..+||+|||
T Consensus 83 -~i~lVMEyC~gGDLs~yi~~~~~-l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 83 -FIYLVMEYCNGGDLSDYIRRRGR-LPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred -eEEEEEEeCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 99999999999999999988764 99999999999999999999999999999999999998542222 689999999
Q ss_pred CcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhcc-CCCCCCC
Q 037285 966 LSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-LRPTIPS 1044 (1094)
Q Consensus 966 LSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~-lrp~iPe 1044 (1094)
+|+.........+.||++.|||||++. ..+|+.|+|+||+|+|+|+|++|+.||...+..++...+.... ..+..+.
T Consensus 161 fAR~L~~~~~a~tlcGSplYMAPEV~~--~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~ 238 (429)
T KOG0595|consen 161 FARFLQPGSMAETLCGSPLYMAPEVIM--SQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPA 238 (429)
T ss_pred hhhhCCchhHHHHhhCCccccCHHHHH--hccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhh
Confidence 999888888888899999999999998 7789999999999999999999999999999988887654433 3345566
Q ss_pred cCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1045 YCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1045 ~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
.++..+.+|+...++.++..|-++.+-..+
T Consensus 239 ~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 239 ELSNPLRELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred hccCchhhhhhHHHhcCccccCchHHhhhh
Confidence 677788899999999999999887765543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=378.91 Aligned_cols=254 Identities=30% Similarity=0.462 Sum_probs=222.9
Q ss_pred eeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEee
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQ 883 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~ 883 (1094)
.+..++|++++.||+|+||.||.++.+ ++-+|+|++++..+... .......+|..+|.+++||+||+++..|+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~-----~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ 95 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK-----KEVRHTKAERNILSKIKHPFIVKLIYSFQ 95 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh-----hhHHHHHHHHHHHHhCCCCcEeeeEEecc
Confidence 466789999999999999999999775 56799999998766543 23456778999999999999999999999
Q ss_pred cCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEe
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGD 963 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsD 963 (1094)
+.. .+|+|+||+.||.|...|.+++. +++..+..++.+|+.||.|||++|||||||||+|||++ .+|+|+|+|
T Consensus 96 t~~--kLylVld~~~GGeLf~hL~~eg~-F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd----~~GHi~LtD 168 (357)
T KOG0598|consen 96 TEE--KLYLVLDYLNGGELFYHLQREGR-FSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLD----EQGHIKLTD 168 (357)
T ss_pred cCC--eEEEEEeccCCccHHHHHHhcCC-cchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeec----CCCcEEEec
Confidence 866 99999999999999999987664 88888888899999999999999999999999999999 899999999
Q ss_pred cCCccc-ccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCC
Q 037285 964 FGLSKI-KRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTI 1042 (1094)
Q Consensus 964 FGLSrl-~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~i 1042 (1094)
||+|+. ......+.++|||+.|||||++. ...|+..+|+||||++||||++|.+||...+.....+.+.... .+..
T Consensus 169 FgL~k~~~~~~~~t~tfcGT~eYmAPEil~--~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-~~~~ 245 (357)
T KOG0598|consen 169 FGLCKEDLKDGDATRTFCGTPEYMAPEILL--GKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-LPLP 245 (357)
T ss_pred cccchhcccCCCccccccCCccccChHHHh--cCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-CCCC
Confidence 999994 44455667789999999999999 5588999999999999999999999999999999988887665 3455
Q ss_pred CCcCcHHHHHHHHHhccCCCCCCC----CHHHHHHH
Q 037285 1043 PSYCDAEWRTLMEECWAPNPAARP----SFTEIASR 1074 (1094)
Q Consensus 1043 Pe~~S~eL~dLI~kCLq~DPeeRP----S~eELLq~ 1074 (1094)
|..++.+.+++++++|..||++|. ++.+|..+
T Consensus 246 p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 246 PGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred CccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 677999999999999999999995 55555443
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=369.49 Aligned_cols=262 Identities=29% Similarity=0.490 Sum_probs=215.4
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeec-------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCcee
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVV 876 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~r-------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIV 876 (1094)
|.+..++|++.++||+|+||.||+|.+. +..||||+++.... ......+.+|+.+|.++ +||||+
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~niv 74 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT-------ASEHKALMSELKILIHIGNHLNVV 74 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc-------hHHHHHHHHHHHHHHHhccCccee
Confidence 6778889999999999999999999752 35699999864311 12235688999999999 899999
Q ss_pred EEEeEeecCCCCceEEEeeecccchhHHHHhhcc----------------------------------------------
Q 037285 877 AFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD---------------------------------------------- 910 (1094)
Q Consensus 877 qL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~---------------------------------------------- 910 (1094)
+++++|... ...+++||||+++|+|.+++....
T Consensus 75 ~~~~~~~~~-~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (338)
T cd05102 75 NLLGACTKP-NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPST 153 (338)
T ss_pred eEEeEecCC-CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCcccccccccc
Confidence 999988754 346899999999999999986532
Q ss_pred ---------------cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccCc--
Q 037285 911 ---------------RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT-- 973 (1094)
Q Consensus 911 ---------------~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~-- 973 (1094)
..+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+|||+++.....
T Consensus 154 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~----~~~~~kl~DfG~a~~~~~~~~ 229 (338)
T cd05102 154 SGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLS----ENNVVKICDFGLARDIYKDPD 229 (338)
T ss_pred CcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEc----CCCcEEEeecccccccccCcc
Confidence 2377888899999999999999999999999999999998 6788999999999743211
Q ss_pred -cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHH
Q 037285 974 -LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWR 1051 (1094)
Q Consensus 974 -~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~ 1051 (1094)
.......++..|+|||++. ...++.++|||||||++|||++ |..||......+..............+..+++.+.
T Consensus 230 ~~~~~~~~~~~~y~aPE~~~--~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 307 (338)
T cd05102 230 YVRKGSARLPLKWMAPESIF--DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIY 307 (338)
T ss_pred hhcccCCCCCccccCcHHhh--cCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 1222334567899999987 4568899999999999999997 99999876654444444455555566778899999
Q ss_pred HHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 037285 1052 TLMEECWAPNPAARPSFTEIASRLRVLST 1080 (1094)
Q Consensus 1052 dLI~kCLq~DPeeRPS~eELLq~L~~L~t 1080 (1094)
+||.+||+.||.+|||+.+|++.|+.+..
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=360.25 Aligned_cols=265 Identities=25% Similarity=0.373 Sum_probs=226.4
Q ss_pred cceeeccCCeeEE--EEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEe
Q 037285 803 SVQVIKNEDLEEQ--KELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYG 880 (1094)
Q Consensus 803 sv~eIs~edYei~--kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~G 880 (1094)
+++.|..++++.. ..||+|+++.||+|+++|..||||+++.... ........|.+|+.+|++++||||+++++
T Consensus 11 ~~~~i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~h~nIv~~~g 85 (283)
T PHA02988 11 DIKCIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHK-----GHKVLIDITENEIKNLRRIDSNNILKIYG 85 (283)
T ss_pred cceecCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEecccccc-----ccHHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence 4556666666665 7899999999999999999999999875421 12334567889999999999999999999
Q ss_pred Eeec--CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeccCCCCCC
Q 037285 881 VVQD--GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPSRP 957 (1094)
Q Consensus 881 v~~d--~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~-GIIHRDLKPeNILLD~~~~e~g 957 (1094)
++.+ .....+++||||+.+|+|.+++.... .+++...+.++.|++.||.|||+. +++||||||+|||++ .++
T Consensus 86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~----~~~ 160 (283)
T PHA02988 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVT----ENY 160 (283)
T ss_pred eEEecccCCCceEEEEEeCCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEEC----CCC
Confidence 9876 33347899999999999999997654 588999999999999999999984 899999999999999 788
Q ss_pred cEEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhcc
Q 037285 958 ICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 1037 (1094)
Q Consensus 958 ~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~ 1037 (1094)
.+||+|||+++...... ....++..|+|||++.+....++.++|||||||++|||++|+.||......+....+....
T Consensus 161 ~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~ 238 (283)
T PHA02988 161 KLKIICHGLEKILSSPP--FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKN 238 (283)
T ss_pred cEEEcccchHhhhcccc--ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcC
Confidence 99999999988543322 2345789999999997544678999999999999999999999999988888777777777
Q ss_pred CCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1038 LRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1038 lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
.++..+..++..+.+||.+||+.||++|||+.+|++.|..+.
T Consensus 239 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 239 NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 777777789999999999999999999999999999999876
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=406.44 Aligned_cols=263 Identities=39% Similarity=0.645 Sum_probs=232.3
Q ss_pred cceeeccCCeeEEEEecccCceEEEEeeecC-------ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCce
Q 037285 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNV 875 (1094)
Q Consensus 803 sv~eIs~edYei~kkLGsG~FGtVYKAk~rG-------t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNI 875 (1094)
.+.+|+..+..+.+.||+|+||+||+|+..+ ..||||.++... ......+|.+|+.+|..|+||||
T Consensus 479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-------~~~~~~dF~REaeLla~l~H~nI 551 (774)
T KOG1026|consen 479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-------ENQARQDFRREAELLAELQHPNI 551 (774)
T ss_pred ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-------cHHHHHHHHHHHHHHHhccCCCe
Confidence 4678899999999999999999999998642 349999998642 23345799999999999999999
Q ss_pred eEEEeEeecCCCCceEEEeeecccchhHHHHhhcc---------c----ccCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 037285 876 VAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD---------R----FLDRRRRLIIAMDAAFGMEYLHSKNIVHFDL 942 (1094)
Q Consensus 876 VqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~---------~----~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDL 942 (1094)
|+|+|+|..++ ++++|+|||..|+|.++|.... . .|+..+.+.||.|||.||.||-++.+|||||
T Consensus 552 VrLlGVC~~~~--P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDL 629 (774)
T KOG1026|consen 552 VRLLGVCREGD--PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDL 629 (774)
T ss_pred EEEEEEEccCC--eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccch
Confidence 99999999876 9999999999999999996532 2 2888999999999999999999999999999
Q ss_pred CCCceEeccCCCCCCcEEEEecCCccccc---CccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CC
Q 037285 943 KCDNLLVNLKDPSRPICKVGDFGLSKIKR---NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GE 1018 (1094)
Q Consensus 943 KPeNILLD~~~~e~g~VKLsDFGLSrl~~---~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk 1018 (1094)
..+|+||. ++..|||+||||++..- -+.......-+.+|||||.+. +.+|+++||||||||+|||+++ |+
T Consensus 630 ATRNCLVg----e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIl--y~kFTteSDVWs~GVvLWEIFsyG~ 703 (774)
T KOG1026|consen 630 ATRNCLVG----ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESIL--YGKFTTESDVWSFGVVLWEIFSYGK 703 (774)
T ss_pred hhhhceec----cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhh--cCcccchhhhhhhhhhhhhhhcccc
Confidence 99999999 89999999999999432 122222344678999999999 8899999999999999999998 99
Q ss_pred CCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1019 EPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1019 ~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
.||.+..+.++++-+.++.. ...|+.||.++++||..||+.+|.+||+|++|-..|.....+
T Consensus 704 QPy~glSn~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 704 QPYYGLSNQEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred CcccccchHHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 99999999999998866666 889999999999999999999999999999999999987644
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=395.03 Aligned_cols=257 Identities=36% Similarity=0.631 Sum_probs=232.8
Q ss_pred CcceeeccCCeeEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeE
Q 037285 802 SSVQVIKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGV 881 (1094)
Q Consensus 802 ssv~eIs~edYei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv 881 (1094)
.+.|+|..+....++.||.|+.|.||+|+.+++.||||.++.- -..+|+-|++|+||||+.|.|+
T Consensus 116 ~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~el---------------kETdIKHLRkLkH~NII~FkGV 180 (904)
T KOG4721|consen 116 EELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVREL---------------KETDIKHLRKLKHPNIITFKGV 180 (904)
T ss_pred hhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhh---------------hhhhHHHHHhccCcceeeEeee
Confidence 3568899899999999999999999999999999999987532 0136788999999999999999
Q ss_pred eecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEE
Q 037285 882 VQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKV 961 (1094)
Q Consensus 882 ~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKL 961 (1094)
|++.+ ++|||||||..|-|...|+... .++......|.++|+.||.|||.+.|||||||.-||||. .+..|||
T Consensus 181 CtqsP--cyCIiMEfCa~GqL~~VLka~~-~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs----~~d~VKI 253 (904)
T KOG4721|consen 181 CTQSP--CYCIIMEFCAQGQLYEVLKAGR-PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILIS----YDDVVKI 253 (904)
T ss_pred ecCCc--eeEEeeeccccccHHHHHhccC-ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEee----ccceEEe
Confidence 99987 9999999999999999997665 589999999999999999999999999999999999999 6678999
Q ss_pred EecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCC
Q 037285 962 GDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT 1041 (1094)
Q Consensus 962 sDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~ 1041 (1094)
+|||.++..........++||+.|||||++. +...+.|+|||||||+||||+||..||.+.....++..+-...+...
T Consensus 254 sDFGTS~e~~~~STkMSFaGTVaWMAPEvIr--nePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~Lp 331 (904)
T KOG4721|consen 254 SDFGTSKELSDKSTKMSFAGTVAWMAPEVIR--NEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLP 331 (904)
T ss_pred ccccchHhhhhhhhhhhhhhhHhhhCHHHhh--cCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCccccc
Confidence 9999999655544455788999999999999 77889999999999999999999999999888888888878888899
Q ss_pred CCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 037285 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAA 1082 (1094)
Q Consensus 1042 iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~ 1082 (1094)
.|..|++.++-||++||+..|..||+|.+|+.||+-..+..
T Consensus 332 vPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pel 372 (904)
T KOG4721|consen 332 VPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL 372 (904)
T ss_pred CcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence 99999999999999999999999999999999998876553
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=373.47 Aligned_cols=256 Identities=25% Similarity=0.439 Sum_probs=219.0
Q ss_pred ccCCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~ 885 (1094)
+..+|+++++||+|+||+||++.. +|..||.|.+.-..+ +.+...+...|+.+|++|+|||||+++++-..+
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m------d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~ 90 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM------DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIE 90 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc------cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhc
Confidence 456899999999999999999865 588899999874322 234457788999999999999999999955444
Q ss_pred CCCceEEEeeecccchhHHHHh---hcccccCHHHHHHHHHHHHHHHHHHHH--CC--ceeccCCCCceEeccCCCCCCc
Q 037285 886 PGGTLATVAEYMVDGSLRHVLV---RKDRFLDRRRRLIIAMDAAFGMEYLHS--KN--IVHFDLKCDNLLVNLKDPSRPI 958 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~---k~~~~Lse~~~l~Ia~QIaeGLaYLHs--~G--IIHRDLKPeNILLD~~~~e~g~ 958 (1094)
....++||||||..|+|.++++ +.++.+++..+|+++.|+|.||..+|+ .. |+||||||.||+++ .+|.
T Consensus 91 ~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~----~~gv 166 (375)
T KOG0591|consen 91 DNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT----ANGV 166 (375)
T ss_pred cchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc----CCCc
Confidence 4446999999999999999885 345679999999999999999999998 44 99999999999999 8899
Q ss_pred EEEEecCCccccc-CccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhcc
Q 037285 959 CKVGDFGLSKIKR-NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 1037 (1094)
Q Consensus 959 VKLsDFGLSrl~~-~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~ 1037 (1094)
|||+|||++++.. ..+.....+|||.||+||++. ...|++||||||+||++|||+.-+.||.+.+..++..++.+..
T Consensus 167 vKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~--~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd 244 (375)
T KOG0591|consen 167 VKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIH--ESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGD 244 (375)
T ss_pred eeeccchhHhHhcchhHHHHhhcCCCcccCHHHHh--cCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCC
Confidence 9999999999654 445566788999999999999 6789999999999999999999999999998888888887665
Q ss_pred CCCCCC-CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1038 LRPTIP-SYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1038 lrp~iP-e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
+ +++| ..++.++..||..|+..||+.||+...++..+.
T Consensus 245 ~-~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 245 Y-PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred C-CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 5 4455 788999999999999999999998544544443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=370.88 Aligned_cols=261 Identities=30% Similarity=0.470 Sum_probs=223.6
Q ss_pred eccCCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-CCceeEEEeEee
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HPNVVAFYGVVQ 883 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-HPNIVqL~Gv~~ 883 (1094)
.....|.+.+.||+|+||.|++|+. ++..||||++.+....... ......+.+|+.++++++ ||||++++.++.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~---~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~ 90 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS---QKLDELIKREISILRRLRSHPNIIRLLEVFA 90 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccc---cccchhhHHHHHHHHHhccCCCEeEEEEEEe
Confidence 3456899999999999999999987 4788999987765322111 122334558999999999 999999999999
Q ss_pred cCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCC-CcEEEE
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSR-PICKVG 962 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~-g~VKLs 962 (1094)
... .+++||||+.+|+|.+++.+ .+.+.+..+..++.||+.|++|||++||+||||||+|||++ .+ +++||+
T Consensus 91 t~~--~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld----~~~~~~Kl~ 163 (370)
T KOG0583|consen 91 TPT--KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLD----GNEGNLKLS 163 (370)
T ss_pred cCC--eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEec----CCCCCEEEe
Confidence 876 69999999999999999988 55699999999999999999999999999999999999999 56 899999
Q ss_pred ecCCcccc-cCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCC
Q 037285 963 DFGLSKIK-RNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT 1041 (1094)
Q Consensus 963 DFGLSrl~-~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~ 1041 (1094)
|||++... .........+||+.|+|||++.+....-..++||||+||+||-|++|+.||.......+...+....+ .
T Consensus 164 DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~--~ 241 (370)
T KOG0583|consen 164 DFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEF--K 241 (370)
T ss_pred ccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCc--c
Confidence 99999977 45566678899999999999996331225899999999999999999999999887777777655544 4
Q ss_pred CCCcC-cHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1042 IPSYC-DAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1042 iPe~~-S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
+|..+ +.+++.|+++||..||.+|+++.+|+.+-|-..
T Consensus 242 ~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 242 IPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 77788 999999999999999999999999997777654
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=342.36 Aligned_cols=256 Identities=30% Similarity=0.568 Sum_probs=215.2
Q ss_pred eccCCeeEEEEecccCceEEEEeeec-----CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeE
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGV 881 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r-----Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv 881 (1094)
|...+|++.+.||+|+||.||+|+++ +..||+|.++.... ......|.+|+.++++++||||++++++
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 74 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-------DKQRRGFLAEALTLGQFDHSNIVRLEGV 74 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-------HHHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence 45678999999999999999999763 45799999875421 1223578899999999999999999999
Q ss_pred eecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEE
Q 037285 882 VQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKV 961 (1094)
Q Consensus 882 ~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKL 961 (1094)
+.... .+++||||+.+|+|.+++......+++..++.++.||+.||+|||+++++||||||+|||++ .++.+|+
T Consensus 75 ~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~----~~~~~~l 148 (266)
T cd05064 75 ITRGN--TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVN----SDLVCKI 148 (266)
T ss_pred EecCC--CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEc----CCCcEEE
Confidence 98754 89999999999999999987656689999999999999999999999999999999999998 7789999
Q ss_pred EecCCcccccCcc--ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccC
Q 037285 962 GDFGLSKIKRNTL--VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 1038 (1094)
Q Consensus 962 sDFGLSrl~~~~~--~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~l 1038 (1094)
+|||.+....... ......++..|+|||++. ...++.++|||||||++|||++ |+.||......+....+ ....
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~-~~~~ 225 (266)
T cd05064 149 SGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQ--YHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV-EDGF 225 (266)
T ss_pred CCCcccccccccchhcccCCCCceeecCHHHHh--hCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-HCCC
Confidence 9999876432211 111223567899999987 4578899999999999999885 99999988777766655 4445
Q ss_pred CCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1039 RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1039 rp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
....+..++..+.+++.+||+.+|.+||++.+|++.|.++
T Consensus 226 ~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 5567788999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=403.00 Aligned_cols=264 Identities=36% Similarity=0.636 Sum_probs=230.6
Q ss_pred ceeeccCCeeEEEEecccCceEEEEeeec---Cc----eEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCcee
Q 037285 804 VQVIKNEDLEEQKELGSGTFGTVYHGKWR---GT----DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVV 876 (1094)
Q Consensus 804 v~eIs~edYei~kkLGsG~FGtVYKAk~r---Gt----~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIV 876 (1094)
+..+.....++.+.||+|.||.||.|... +. .||||.+++.. .+....+|++|..+|++++|||||
T Consensus 686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-------~~~~~~~Fl~Ea~~m~~f~HpNiv 758 (1025)
T KOG1095|consen 686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-------SEQEVSDFLKEALLMSKFDHPNIV 758 (1025)
T ss_pred cccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-------CHHHHHHHHHHHHHHhcCCCccee
Confidence 34466788999999999999999999874 32 38898887642 233457899999999999999999
Q ss_pred EEEeEeecCCCCceEEEeeecccchhHHHHhhc------ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEec
Q 037285 877 AFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRK------DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVN 950 (1094)
Q Consensus 877 qL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~------~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD 950 (1094)
+++|+|.+. +..+|++|||++|+|..+|++. ...++...++.|+.|||+|++||+++++|||||.++|||++
T Consensus 759 ~liGv~l~~--~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~ 836 (1025)
T KOG1095|consen 759 SLIGVCLDS--GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLD 836 (1025)
T ss_pred eEEEeecCC--CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeec
Confidence 999999984 4899999999999999999887 56799999999999999999999999999999999999999
Q ss_pred cCCCCCCcEEEEecCCccc-cc-Cccc-cCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCh
Q 037285 951 LKDPSRPICKVGDFGLSKI-KR-NTLV-SGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHY 1026 (1094)
Q Consensus 951 ~~~~e~g~VKLsDFGLSrl-~~-~~~~-ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~ 1026 (1094)
....|||+|||||+. .+ +... .....-+.+|||||.+. ...|+.|+|||||||+|||++| |..||....+
T Consensus 837 ----~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~--d~iFtskSDvWsFGVllWEifslG~~PY~~~~n 910 (1025)
T KOG1095|consen 837 ----ERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLK--DGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN 910 (1025)
T ss_pred ----ccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHh--hcccccccchhhhHHHHHHHHhCCCCCCCCcch
Confidence 779999999999993 22 1111 12223568999999999 5789999999999999999999 9999999999
Q ss_pred HHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 037285 1027 GAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAAS 1083 (1094)
Q Consensus 1027 ~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s 1083 (1094)
.+++..++.++ |+..|..|+..++++|.+||+.+|++||+|..|++.+..+.....
T Consensus 911 ~~v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 911 FEVLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred HHHHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 99998787777 899999999999999999999999999999999999999876543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=378.90 Aligned_cols=254 Identities=28% Similarity=0.429 Sum_probs=223.8
Q ss_pred eeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEe
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVV 882 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~ 882 (1094)
.....+|.+++.||.|+|++|++|+.+ +..+|||++.+..+. .+..+..+..|-.+|.+| .||.|++||..|
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Ii-----ke~KvkYV~~Ek~~l~~L~~hPgivkLy~TF 143 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYII-----KEKKVKYVTREKEALTQLSGHPGIVKLYFTF 143 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHH-----hhcccchhhHHHHHHHHhhCCCCeEEEEEEe
Confidence 346689999999999999999999874 678999999876443 345566777899999999 799999999999
Q ss_pred ecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 883 QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 883 ~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
++.. .+|+|+||+++|+|.++|.+.+ .+++..+..++.+|+.||+|||++|||||||||+|||++ .++++||+
T Consensus 144 QD~~--sLYFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd----~dmhikIT 216 (604)
T KOG0592|consen 144 QDEE--SLYFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLD----KDGHIKIT 216 (604)
T ss_pred eccc--ceEEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEc----CCCcEEEe
Confidence 9976 9999999999999999998775 499999999999999999999999999999999999999 89999999
Q ss_pred ecCCcccccCc------------ccc--CCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH
Q 037285 963 DFGLSKIKRNT------------LVS--GGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA 1028 (1094)
Q Consensus 963 DFGLSrl~~~~------------~~s--s~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~e 1028 (1094)
|||.|+..... ... ..++||..|.+||++. ....+..+|+|+||||+|+|+.|++||...+..-
T Consensus 217 DFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~--~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl 294 (604)
T KOG0592|consen 217 DFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLN--DSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL 294 (604)
T ss_pred eccccccCChhhccccCccCcccccCcccceeeeecccCHHHhc--CCCCCcccchHHHHHHHHHHhcCCCCCccccHHH
Confidence 99999853211 112 4588999999999998 5667889999999999999999999999999888
Q ss_pred HHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037285 1029 IIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1029 ile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L 1075 (1094)
+.++++.-.+ .+|...++.+.+||+++|..||.+|+|+.+|.+|.
T Consensus 295 iFqkI~~l~y--~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 295 IFQKIQALDY--EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HHHHHHHhcc--cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 8888876544 58899999999999999999999999999998763
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=392.17 Aligned_cols=263 Identities=35% Similarity=0.621 Sum_probs=237.6
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeec--C---ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEE
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWR--G---TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFY 879 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~r--G---t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~ 879 (1094)
.+|+.+...+.++||.|.||+||+|+.+ | ..||||.++... .++...+|+.|+.||-++.||||++|.
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-------tekqrrdFL~EAsIMGQFdHPNIIrLE 696 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-------TEKQRRDFLSEASIMGQFDHPNIIRLE 696 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-------cHHHHhhhhhhhhhcccCCCCcEEEEE
Confidence 5788889999999999999999999875 3 359999998652 345567999999999999999999999
Q ss_pred eEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcE
Q 037285 880 GVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC 959 (1094)
Q Consensus 880 Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~V 959 (1094)
|+++... +++||+|||++|+|..+|.++.+.++..++..|++.|+.||+||-+.++|||||.++||||+ .+..+
T Consensus 697 GVVTks~--PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVN----snLvC 770 (996)
T KOG0196|consen 697 GVVTKSK--PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVN----SNLVC 770 (996)
T ss_pred EEEecCc--eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeec----cceEE
Confidence 9999876 99999999999999999999888899999999999999999999999999999999999999 89999
Q ss_pred EEEecCCcccccC----ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHh
Q 037285 960 KVGDFGLSKIKRN----TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIV 1034 (1094)
Q Consensus 960 KLsDFGLSrl~~~----~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv 1034 (1094)
|++||||++...+ ...+.+-+-+.+|.|||.+. ..+|+.+|||||||++|||+++ |..||-++.+.+++..+
T Consensus 771 KVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa--~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaI- 847 (996)
T KOG0196|consen 771 KVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIA--YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI- 847 (996)
T ss_pred EeccccceeecccCCCccccccCCccceeecChhHhh--hcccCchhhccccceEEEEecccCCCcccccchHHHHHHH-
Confidence 9999999996532 22333445678999999998 8899999999999999999997 99999999999999877
Q ss_pred hccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 037285 1035 NNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAAS 1083 (1094)
Q Consensus 1035 ~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s 1083 (1094)
.++++.+-|-.|+..+++||..||++|-.+||.|.+|+..|+++...-.
T Consensus 848 e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 848 EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 7789988999999999999999999999999999999999999975533
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=348.93 Aligned_cols=250 Identities=26% Similarity=0.376 Sum_probs=213.1
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||+|+||.||+|+++ ++.||||++..... ...+....+.+|+.++++++||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 74 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEV-----IRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR- 74 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHH-----hhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC-
Confidence 47899999999999999999885 78899999875321 11223456788999999999999999999988754
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++||||+.+|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 75 -~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~----~~~~~kl~Dfg~~ 148 (291)
T cd05612 75 -FLYMLMEYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLD----KEGHIKLTDFGFA 148 (291)
T ss_pred -eEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC----CCCCEEEEecCcc
Confidence 8999999999999999997654 489999999999999999999999999999999999998 7789999999999
Q ss_pred ccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCc
Q 037285 968 KIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCD 1047 (1094)
Q Consensus 968 rl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S 1047 (1094)
+...... ....||+.|+|||++. ...++.++|||||||++|+|++|+.||......+....+.... ..++..++
T Consensus 149 ~~~~~~~--~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~ 222 (291)
T cd05612 149 KKLRDRT--WTLCGTPEYLAPEVIQ--SKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK--LEFPRHLD 222 (291)
T ss_pred hhccCCc--ccccCChhhcCHHHHc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--cCCCccCC
Confidence 8543322 2346899999999997 4567899999999999999999999999888777777665543 34667789
Q ss_pred HHHHHHHHHhccCCCCCCCC-----HHHHHHHHHH
Q 037285 1048 AEWRTLMEECWAPNPAARPS-----FTEIASRLRV 1077 (1094)
Q Consensus 1048 ~eL~dLI~kCLq~DPeeRPS-----~eELLq~L~~ 1077 (1094)
..+++||++||..||.+||+ +.+++++.+-
T Consensus 223 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~ 257 (291)
T cd05612 223 LYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWF 257 (291)
T ss_pred HHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccc
Confidence 99999999999999999995 9999988654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=334.03 Aligned_cols=250 Identities=35% Similarity=0.620 Sum_probs=211.0
Q ss_pred ccCCeeEEEEecccCceEEEEeeecC-ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~rG-t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
+.++|++.+.||+|+||.||++.++. ..+|+|.+..... ....|.+|+.+|++++||||+++++++....
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM---------SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK 72 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc---------cHHHHHHHHHHHHHCCCCCceeEEEEEccCC
Confidence 45679999999999999999999864 5799998764321 1246788999999999999999999998754
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+++||||+++|+|.+++......+++..++.++.|++.||+|||+++|+||||||+||+++ .++.+||+|||+
T Consensus 73 --~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~----~~~~~kl~d~g~ 146 (256)
T cd05114 73 --PLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVS----STGVVKVSDFGM 146 (256)
T ss_pred --CEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEc----CCCeEEECCCCC
Confidence 89999999999999999976555689999999999999999999999999999999999998 778899999999
Q ss_pred cccccCcc--ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCCCC
Q 037285 967 SKIKRNTL--VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIP 1043 (1094)
Q Consensus 967 Srl~~~~~--~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~iP 1043 (1094)
++...... ......++..|+|||++. ...++.++||||||+++|+|++ |+.||......+....+.. ..+...+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~-~~~~~~~ 223 (256)
T cd05114 147 TRYVLDDEYTSSSGAKFPVKWSPPEVFN--FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR-GFRLYRP 223 (256)
T ss_pred ccccCCCceeccCCCCCchhhCChhhcc--cCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCCCCCC
Confidence 87432211 112233567899999987 4467889999999999999999 9999998887777766644 3445566
Q ss_pred CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037285 1044 SYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1044 e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L 1075 (1094)
...+..+.++|.+||+.+|.+||++.+|++.|
T Consensus 224 ~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 224 KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 77889999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=363.20 Aligned_cols=260 Identities=28% Similarity=0.457 Sum_probs=218.0
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
..++...+.||+|+||.||++... |...|||.+.... ... .+.+.+|+.+|.+|+|||||+++|......
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~-----~~~---~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~ 87 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED-----SPT---SESLEREIRILSRLNHPNIVQYYGSSSSRE 87 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc-----chh---HHHHHHHHHHHHhCCCCCEEeeCCcccccc
Confidence 346788899999999999999885 6889999886541 011 456789999999999999999999754433
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCC-CCcEEEEecC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPS-RPICKVGDFG 965 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e-~g~VKLsDFG 965 (1094)
...++|+|||+.+|+|.+++.+.+..+++..+..++.||++||+|||++|||||||||+|||++ . ++.+||+|||
T Consensus 88 ~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~----~~~~~~KlaDFG 163 (313)
T KOG0198|consen 88 NDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLD----PSNGDVKLADFG 163 (313)
T ss_pred CeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEe----CCCCeEEeccCc
Confidence 2368999999999999999988765699999999999999999999999999999999999999 5 6899999999
Q ss_pred CcccccC----ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC-CChHHHHHhHhhccCCC
Q 037285 966 LSKIKRN----TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN-MHYGAIIGGIVNNTLRP 1040 (1094)
Q Consensus 966 LSrl~~~----~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~-~~~~eile~Iv~~~lrp 1040 (1094)
+++.... ........||+.|||||++.. ......++|||||||++.||+||+.||.. ....+.+..+......|
T Consensus 164 ~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~-g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P 242 (313)
T KOG0198|consen 164 LAKKLESKGTKSDSELSVQGTPNYMAPEVIRN-GEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP 242 (313)
T ss_pred cccccccccccccccccccCCccccCchhhcC-CCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC
Confidence 9985542 122345679999999999984 22233589999999999999999999998 45555555566666667
Q ss_pred CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1041 TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1041 ~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
.+|..++.+.++||.+|+..+|++|||+.+++++.......
T Consensus 243 ~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 243 EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 89999999999999999999999999999999998775533
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=379.33 Aligned_cols=264 Identities=35% Similarity=0.589 Sum_probs=226.1
Q ss_pred cceeeccCCeeEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEe
Q 037285 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVV 882 (1094)
Q Consensus 803 sv~eIs~edYei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~ 882 (1094)
..|+|..+++.+...||+|.||+||+|+|.| .||||++...... ....+.|.+|+.+|++-+|.||+-|.|+|
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt------~~qlqaFKnEVa~lkkTRH~NIlLFMG~~ 457 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPT------PEQLQAFKNEVAVLKKTRHENILLFMGAC 457 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCC------HHHHHHHHHHHHHHhhcchhhheeeehhh
Confidence 5799999999999999999999999999977 5999999876432 22568999999999999999999999999
Q ss_pred ecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 883 QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 883 ~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
.... +.||+.+|+|.+|..+++-....++..+.+.|+.||++||.|||.++|||||||..|||+. +++.|||+
T Consensus 458 ~~p~---~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~----~~~kVkIg 530 (678)
T KOG0193|consen 458 MNPP---LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLH----EDLKVKIG 530 (678)
T ss_pred cCCc---eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEc----cCCcEEEe
Confidence 9764 6999999999999999987777799999999999999999999999999999999999998 77999999
Q ss_pred ecCCcccccCc---cccCCccCCCcccCccccc-cCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccC
Q 037285 963 DFGLSKIKRNT---LVSGGVRGTLPWMAPELLS-GSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 1038 (1094)
Q Consensus 963 DFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~-g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~l 1038 (1094)
|||++...... .......|...|||||+++ .....|++.+||||||+++|||+||..||.......++..+-.+.+
T Consensus 531 DFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l 610 (678)
T KOG0193|consen 531 DFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYL 610 (678)
T ss_pred cccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccccc
Confidence 99998743221 1122345788999999986 3456799999999999999999999999996655666655544433
Q ss_pred CCC---CCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 037285 1039 RPT---IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLST 1080 (1094)
Q Consensus 1039 rp~---iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~t 1080 (1094)
.+. ....|++++++|+..||..++++||.|.+|+..|..+..
T Consensus 611 ~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 611 MPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred CccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 332 335788999999999999999999999999998888765
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=354.68 Aligned_cols=251 Identities=27% Similarity=0.405 Sum_probs=214.0
Q ss_pred ccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~ 885 (1094)
..++|++.+.||+|+||.||+|+++ ++.||||++...... .......+.+|+.+|++++||||+++++++...
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 90 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL-----KMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE 90 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-----hhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC
Confidence 4568999999999999999999885 678999999754211 122345688999999999999999999999876
Q ss_pred CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecC
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFG 965 (1094)
. .+++||||+.+|+|.+++.... .+++..+..++.||+.||+|||+++|+||||||+|||++ .++.+||+|||
T Consensus 91 ~--~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~----~~~~~kl~Dfg 163 (329)
T PTZ00263 91 N--RVYFLLEFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLD----NKGHVKVTDFG 163 (329)
T ss_pred C--EEEEEEcCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEC----CCCCEEEeecc
Confidence 5 8999999999999999997654 488999999999999999999999999999999999998 78899999999
Q ss_pred CcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCc
Q 037285 966 LSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSY 1045 (1094)
Q Consensus 966 LSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~ 1045 (1094)
+++...... ....||+.|+|||++. ...++.++|||||||++|+|++|+.||......+....+.... ..++..
T Consensus 164 ~~~~~~~~~--~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~--~~~p~~ 237 (329)
T PTZ00263 164 FAKKVPDRT--FTLCGTPEYLAPEVIQ--SKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR--LKFPNW 237 (329)
T ss_pred CceEcCCCc--ceecCChhhcCHHHHc--CCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--cCCCCC
Confidence 998654322 2356899999999998 4567889999999999999999999999887777776665543 446777
Q ss_pred CcHHHHHHHHHhccCCCCCCCC-----HHHHHHHHH
Q 037285 1046 CDAEWRTLMEECWAPNPAARPS-----FTEIASRLR 1076 (1094)
Q Consensus 1046 ~S~eL~dLI~kCLq~DPeeRPS-----~eELLq~L~ 1076 (1094)
++..+++||.+||+.||.+|++ +.+|+.+-+
T Consensus 238 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~ 273 (329)
T PTZ00263 238 FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPY 273 (329)
T ss_pred CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCc
Confidence 8999999999999999999986 789987743
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=340.64 Aligned_cols=247 Identities=38% Similarity=0.662 Sum_probs=204.9
Q ss_pred eEEEEecccCceEEEEeeec------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 813 EEQKELGSGTFGTVYHGKWR------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 813 ei~kkLGsG~FGtVYKAk~r------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
++.+.||.|.||.||+|.++ +..|+||+++... .......|.+|++++++++||||++++|++....
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~-------~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~ 74 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS-------SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE 74 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS-------SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc-------ccccceeeeecccccccccccccccccccccccc
Confidence 46789999999999999997 4679999995421 1223568899999999999999999999999544
Q ss_pred CCceEEEeeecccchhHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRK-DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~-~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFG 965 (1094)
.+++||||+.+|+|.++|... ...+++..++.|+.||+.||.|||+++++|++|+++|||++ .++.+||+|||
T Consensus 75 --~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~----~~~~~Kl~~f~ 148 (259)
T PF07714_consen 75 --PLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLD----SNGQVKLSDFG 148 (259)
T ss_dssp --SEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEE----TTTEEEEESTT
T ss_pred --ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----ccccccccccc
Confidence 699999999999999999887 55699999999999999999999999999999999999999 78899999999
Q ss_pred CcccccC---ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCC
Q 037285 966 LSKIKRN---TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPT 1041 (1094)
Q Consensus 966 LSrl~~~---~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~ 1041 (1094)
++..... ............|+|||.+. ...++.++||||||+++|||++ |+.||......+....+ ....++.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~ 225 (259)
T PF07714_consen 149 LSRPISEKSKYKNDSSQQLPLRYLAPEVLK--DGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLP 225 (259)
T ss_dssp TGEETTTSSSEEESTTSESGGGGS-HHHHH--HSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETT
T ss_pred cccccccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccc-cccccce
Confidence 9985521 12223344678899999997 3458999999999999999999 78999999888877776 5556667
Q ss_pred CCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037285 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1042 iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L 1075 (1094)
.+..++..+.++|.+||..+|.+||++.+|++.|
T Consensus 226 ~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 7888999999999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=375.03 Aligned_cols=259 Identities=32% Similarity=0.583 Sum_probs=228.5
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeec----Cc--eEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEE
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWR----GT--DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAF 878 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~r----Gt--~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL 878 (1094)
.++..+..++.++||.|.||.||+|.+. |. .||||..+..+..+ ..+.|+.|..+|++++|||||++
T Consensus 384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d-------~tekflqEa~iMrnfdHphIikL 456 (974)
T KOG4257|consen 384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPD-------DTEKFLQEASIMRNFDHPHIIKL 456 (974)
T ss_pred ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChh-------hHHHHHHHHHHHHhCCCcchhhe
Confidence 3566667777889999999999999874 32 39999988765332 24679999999999999999999
Q ss_pred EeEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCc
Q 037285 879 YGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPI 958 (1094)
Q Consensus 879 ~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~ 958 (1094)
+|+|.+. +++||||.++.|.|..||..+...++...+..+|.||+.||+|||+..+|||||..+|||+. +...
T Consensus 457 IGv~~e~---P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVs----Sp~C 529 (974)
T KOG4257|consen 457 IGVCVEQ---PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVS----SPQC 529 (974)
T ss_pred eeeeecc---ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeec----Ccce
Confidence 9999976 69999999999999999998888899999999999999999999999999999999999999 7789
Q ss_pred EEEEecCCcccccCc--cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhh
Q 037285 959 CKVGDFGLSKIKRNT--LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 1035 (1094)
Q Consensus 959 VKLsDFGLSrl~~~~--~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~ 1035 (1094)
|||+|||+++..... ...+...-+..|||||.++ ...|+.++|||.|||+|||++. |..||.+..+.+++..+ .
T Consensus 530 VKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESIN--fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i-E 606 (974)
T KOG4257|consen 530 VKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESIN--FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI-E 606 (974)
T ss_pred eeecccchhhhccccchhhccccccceeecCccccc--hhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe-c
Confidence 999999999965432 2233445678899999998 8899999999999999999997 99999999988887765 6
Q ss_pred ccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 037285 1036 NTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLST 1080 (1094)
Q Consensus 1036 ~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~t 1080 (1094)
.+-|+++|.+|++.++.||.+||..+|.+||.|.+|...|.++..
T Consensus 607 nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 607 NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 788899999999999999999999999999999999999998875
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=341.60 Aligned_cols=253 Identities=22% Similarity=0.320 Sum_probs=206.0
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
.|+..+.||+|+||.||++.+. +..||||.+.+.... .......+.+|+.++.+++|+||+++++++.+..
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~-- 73 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-----KRKGEAMALNEKRILEKVNSRFVVSLAYAYETKD-- 73 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhh-----hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCC--
Confidence 3778899999999999999874 788999998764321 1122345778999999999999999999998755
Q ss_pred ceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 889 TLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++||||+.+|+|..++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~----~~~~~kl~Dfg~~ 149 (285)
T cd05631 74 ALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLD----DRGHIRISDLGLA 149 (285)
T ss_pred eEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC----CCCCEEEeeCCCc
Confidence 8999999999999998876433 3589999999999999999999999999999999999998 7788999999999
Q ss_pred ccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhh--ccCCCCCCCc
Q 037285 968 KIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN--NTLRPTIPSY 1045 (1094)
Q Consensus 968 rl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~--~~lrp~iPe~ 1045 (1094)
.............||..|+|||++. ...++.++|||||||++|+|++|+.||...........+.. ......++..
T Consensus 150 ~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
T cd05631 150 VQIPEGETVRGRVGTVGYMAPEVIN--NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEK 227 (285)
T ss_pred EEcCCCCeecCCCCCCCccCHhhhc--CCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCcc
Confidence 8654333333456899999999998 45788999999999999999999999987554322221111 1222345667
Q ss_pred CcHHHHHHHHHhccCCCCCCCC-----HHHHHHHHH
Q 037285 1046 CDAEWRTLMEECWAPNPAARPS-----FTEIASRLR 1076 (1094)
Q Consensus 1046 ~S~eL~dLI~kCLq~DPeeRPS-----~eELLq~L~ 1076 (1094)
++..+.+||++||+.||.+||+ +.+++++-+
T Consensus 228 ~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~ 263 (285)
T cd05631 228 FSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPI 263 (285)
T ss_pred CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHh
Confidence 8899999999999999999997 899998743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=333.13 Aligned_cols=256 Identities=34% Similarity=0.621 Sum_probs=216.3
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEe
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVV 882 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~ 882 (1094)
|++...+|++.+.||.|+||.||+|.++ ++.||+|.+.... ....++.+|+.++++++|+||+++++++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 71 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---------MEVEEFLKEAAVMKEIKHPNLVQLLGVC 71 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---------hHHHHHHHHHHHHHhCCCCChhheEEEE
Confidence 4567788999999999999999999885 6779999886431 1135688999999999999999999999
Q ss_pred ecCCCCceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEE
Q 037285 883 QDGPGGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKV 961 (1094)
Q Consensus 883 ~d~~~~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKL 961 (1094)
.... .+++||||+.+++|.+++.... ..+++..++.++.|+++||+|||+++++||||||+|||++ +++.+||
T Consensus 72 ~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~----~~~~~kl 145 (263)
T cd05052 72 TREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG----ENHLVKV 145 (263)
T ss_pred cCCC--CcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc----CCCcEEe
Confidence 8754 8899999999999999986543 4588999999999999999999999999999999999998 7789999
Q ss_pred EecCCcccccCccc--cCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccC
Q 037285 962 GDFGLSKIKRNTLV--SGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 1038 (1094)
Q Consensus 962 sDFGLSrl~~~~~~--ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~l 1038 (1094)
+|||++........ .....++..|+|||.+. ...++.++|||||||++|||++ |..||......+....+ ....
T Consensus 146 ~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~ 222 (263)
T cd05052 146 ADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKGY 222 (263)
T ss_pred CCCccccccccceeeccCCCCCccccCCHHHhc--cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCC
Confidence 99999985433221 11223467899999987 4567889999999999999998 99999887766655544 4455
Q ss_pred CCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1039 RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1039 rp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
....+..++..+.++|.+||+.+|++||++.++++.|+.+
T Consensus 223 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 223 RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 6677888999999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=358.84 Aligned_cols=261 Identities=32% Similarity=0.514 Sum_probs=215.4
Q ss_pred cceeeccCCeeEEEEecccCceEEEEeeec-------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCc
Q 037285 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPN 874 (1094)
Q Consensus 803 sv~eIs~edYei~kkLGsG~FGtVYKAk~r-------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPN 874 (1094)
..|.+..++|++.+.||+|+||.||+|++. +..||||+++.... ......+.+|+.+|..+ +|||
T Consensus 28 ~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-------~~~~~~~~~Ei~il~~l~~Hpn 100 (375)
T cd05104 28 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-------LTEREALMSELKVLSYLGNHIN 100 (375)
T ss_pred cccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-------cHHHHHHHHHHHHHHHhcCCcc
Confidence 356777889999999999999999999752 34699999864321 11235678899999999 8999
Q ss_pred eeEEEeEeecCCCCceEEEeeecccchhHHHHhhcc--------------------------------------------
Q 037285 875 VVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD-------------------------------------------- 910 (1094)
Q Consensus 875 IVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~-------------------------------------------- 910 (1094)
|++++++|.... ..++||||+.+|+|.+++....
T Consensus 101 Iv~l~~~~~~~~--~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 178 (375)
T cd05104 101 IVNLLGACTVGG--PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYV 178 (375)
T ss_pred eeeeeeeeccCC--cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccc
Confidence 999999998765 8999999999999999986432
Q ss_pred ------------------------------cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEE
Q 037285 911 ------------------------------RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICK 960 (1094)
Q Consensus 911 ------------------------------~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VK 960 (1094)
..+++..++.++.||+.||+|||+++|+||||||+|||++ .+..+|
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~----~~~~~k 254 (375)
T cd05104 179 VPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT----HGRITK 254 (375)
T ss_pred cccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEE----CCCcEE
Confidence 1367888999999999999999999999999999999998 677899
Q ss_pred EEecCCcccccCcc---ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhc
Q 037285 961 VGDFGLSKIKRNTL---VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 1036 (1094)
Q Consensus 961 LsDFGLSrl~~~~~---~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~ 1036 (1094)
|+|||+++...... ......++..|+|||++. ...++.++|||||||++|||++ |..||..........+.+..
T Consensus 255 l~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~ 332 (375)
T cd05104 255 ICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIF--NCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKE 332 (375)
T ss_pred EecCccceeccCcccccccCCCCCCcceeChhHhc--CCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHh
Confidence 99999997543211 112233567799999997 4568899999999999999998 99999887665555555566
Q ss_pred cCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1037 TLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1037 ~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
..+...+...+.++++||.+||+.||++||++.+|++.|++.
T Consensus 333 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 333 GYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 666666777889999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=342.12 Aligned_cols=254 Identities=32% Similarity=0.513 Sum_probs=205.1
Q ss_pred ccCCeeEEEEecccCceEEEEeeec------------------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhh
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWR------------------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSK 869 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~r------------------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkr 869 (1094)
...+|++.++||+|+||.||+|.+. +..||||.+.... ......+|.+|+.+|.+
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~ 75 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-------NKNARNDFLKEVKILSR 75 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-------CHHHHHHHHHHHHHHhh
Confidence 4568999999999999999999753 2359999887532 12234578899999999
Q ss_pred CCCCceeEEEeEeecCCCCceEEEeeecccchhHHHHhhcc------------------cccCHHHHHHHHHHHHHHHHH
Q 037285 870 LHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD------------------RFLDRRRRLIIAMDAAFGMEY 931 (1094)
Q Consensus 870 L~HPNIVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~------------------~~Lse~~~l~Ia~QIaeGLaY 931 (1094)
++||||+++++++.+.. ..++||||+.+++|.+++.... ..+++..++.++.||+.||.|
T Consensus 76 l~h~niv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~ 153 (304)
T cd05096 76 LKDPNIIRLLGVCVDED--PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKY 153 (304)
T ss_pred cCCCCeeEEEEEEecCC--ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 99999999999998755 7999999999999999985432 236778899999999999999
Q ss_pred HHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHH
Q 037285 932 LHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFG 1008 (1094)
Q Consensus 932 LHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLG 1008 (1094)
||+++|+||||||+|||++ .++.+||+|||+++..... .......++..|+|||++. ...++.++||||||
T Consensus 154 lH~~~ivH~dlkp~Nill~----~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG 227 (304)
T cd05096 154 LSSLNFVHRDLATRNCLVG----ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECIL--MGKFTTASDVWAFG 227 (304)
T ss_pred HHHCCccccCcchhheEEc----CCccEEECCCccceecccCceeEecCcCCCCccccCHHHHh--cCCCCchhhhHHHH
Confidence 9999999999999999999 7789999999999743221 1222334578899999987 45688999999999
Q ss_pred HHHHHHHc--CCCCCCCCChHHHHHhHhh------ccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1009 IVLWEILT--GEEPYANMHYGAIIGGIVN------NTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1009 VLLyELLT--Gk~PF~~~~~~eile~Iv~------~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
|++|+|++ +..||......+....+.. .......+..++..+.+||.+||+.+|.+|||+.+|.+.|+
T Consensus 228 ~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 228 VTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 99999986 6788987766655443321 11122345578899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=352.54 Aligned_cols=243 Identities=27% Similarity=0.394 Sum_probs=205.7
Q ss_pred EEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEEE
Q 037285 816 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATV 893 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~IV 893 (1094)
+.||+|+||.||+++.+ |..||||++++.... .......+.+|+.++++++||||+++++++.... .+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~--~~~lv 73 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVII-----AKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD--RLCFV 73 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC--EEEEE
Confidence 46999999999999874 678999999764221 1223456778999999999999999999998765 89999
Q ss_pred eeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccc-cC
Q 037285 894 AEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK-RN 972 (1094)
Q Consensus 894 mEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~-~~ 972 (1094)
|||+.+++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++.. ..
T Consensus 74 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~----~~~~~kl~DfG~a~~~~~~ 148 (323)
T cd05571 74 MEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLD----KDGHIKITDFGLCKEGISD 148 (323)
T ss_pred EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC----CCCCEEEeeCCCCcccccC
Confidence 99999999999987654 589999999999999999999999999999999999998 7788999999998743 22
Q ss_pred ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHH
Q 037285 973 TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRT 1052 (1094)
Q Consensus 973 ~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~d 1052 (1094)
.......+||+.|+|||++. ...++.++|||||||++|||++|+.||...........+.... ..++..++.++.+
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~ 224 (323)
T cd05571 149 GATMKTFCGTPEYLAPEVLE--DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--IRFPRTLSPEAKS 224 (323)
T ss_pred CCcccceecCccccChhhhc--CCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHH
Confidence 22233456999999999997 4567899999999999999999999998877776666554443 3567788999999
Q ss_pred HHHHhccCCCCCCC-----CHHHHHHH
Q 037285 1053 LMEECWAPNPAARP-----SFTEIASR 1074 (1094)
Q Consensus 1053 LI~kCLq~DPeeRP-----S~eELLq~ 1074 (1094)
||.+||..||++|| ++.+++++
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 225 LLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 99999999999999 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=331.94 Aligned_cols=255 Identities=35% Similarity=0.637 Sum_probs=215.4
Q ss_pred ccCCeeEEEEecccCceEEEEeeec-----CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEe
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVV 882 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~r-----Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~ 882 (1094)
..++|++.+.||+|+||.||+|+++ ...||||.++... ......+|.+|+.++++++||||+++++++
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 74 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-------SDKQRLDFLTEASIMGQFDHPNIIRLEGVV 74 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-------ChHHHHHHHHHHHHHHhCCCCCcceEeEEE
Confidence 4578999999999999999999884 2369999886532 122345788999999999999999999999
Q ss_pred ecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 883 QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 883 ~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
.... ..++||||+.+++|.+++......+++..++.++.|++.||.|||+++|+|+||||+|||++ +++.+||+
T Consensus 75 ~~~~--~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~----~~~~~~l~ 148 (266)
T cd05033 75 TKSR--PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVN----SNLVCKVS 148 (266)
T ss_pred ecCC--ceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc----CCCCEEEC
Confidence 8754 89999999999999999987666789999999999999999999999999999999999998 78899999
Q ss_pred ecCCcccccC---ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccC
Q 037285 963 DFGLSKIKRN---TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 1038 (1094)
Q Consensus 963 DFGLSrl~~~---~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~l 1038 (1094)
|||+++.... ........++..|+|||.+. ...++.++||||||+++|+|++ |..||......+....+. ...
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~--~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~ 225 (266)
T cd05033 149 DFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIA--YRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE-DGY 225 (266)
T ss_pred ccchhhcccccccceeccCCCCCccccChhhhc--cCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH-cCC
Confidence 9999985431 11122233567899999987 4568899999999999999998 999998887777666553 344
Q ss_pred CCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1039 RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1039 rp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
....+..++..+.+++.+||+.+|++||++.+|+++|.++
T Consensus 226 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 5556678899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=336.77 Aligned_cols=254 Identities=39% Similarity=0.634 Sum_probs=212.6
Q ss_pred ccCCeeEEEEecccCceEEEEeeecC-------ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEe
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYG 880 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~rG-------t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~G 880 (1094)
..++|++.+.||+|+||.||+|.+.+ ..||+|.++... .......|.+|+.++.+++||||+++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-------~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 75 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-------EPKVQQEFRQEAELMSDLQHPNIVCLLG 75 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-------CHHHHHHHHHHHHHHHhcCCcccceEEE
Confidence 34678999999999999999998743 359999886431 1223456889999999999999999999
Q ss_pred EeecCCCCceEEEeeecccchhHHHHhhcc---------------cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 037285 881 VVQDGPGGTLATVAEYMVDGSLRHVLVRKD---------------RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCD 945 (1094)
Q Consensus 881 v~~d~~~~~L~IVmEYmegGSL~d~L~k~~---------------~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPe 945 (1094)
++.... ..+++|||+.+++|.+++.... ..+++..++.++.||+.||.|||+++++|+||||+
T Consensus 76 ~~~~~~--~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~ 153 (283)
T cd05048 76 VCTKEQ--PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAAR 153 (283)
T ss_pred EEcCCC--ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccc
Confidence 998754 7899999999999999996542 34788899999999999999999999999999999
Q ss_pred ceEeccCCCCCCcEEEEecCCcccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCC
Q 037285 946 NLLVNLKDPSRPICKVGDFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPY 1021 (1094)
Q Consensus 946 NILLD~~~~e~g~VKLsDFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF 1021 (1094)
|||++ .++.+||+|||+++..... .......+++.|+|||.+. ...++.++|||||||++|||++ |..||
T Consensus 154 Nil~~----~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~sDv~slG~il~el~~~g~~p~ 227 (283)
T cd05048 154 NCLVG----EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAIL--YGKFTTESDIWSFGVVLWEIFSYGLQPY 227 (283)
T ss_pred eEEEc----CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhc--cCcCchhhhHHHHHHHHHHHHcCCCCCC
Confidence 99998 6788999999998743221 1222334678899999987 4568899999999999999998 99999
Q ss_pred CCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1022 ANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1022 ~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
......+....+. .......+..++.++.+|+.+||+.||.+||++.+|+++|..
T Consensus 228 ~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 228 YGFSNQEVIEMIR-SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred CCCCHHHHHHHHH-cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 9888777766554 344455678899999999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=349.73 Aligned_cols=251 Identities=25% Similarity=0.327 Sum_probs=210.2
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
.+|++.+.||+|+||.||+|++. +..||||++++.... .......+.+|+.++.+++||||+++++++....
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~- 74 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF-----KLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE- 74 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHh-----hhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC-
Confidence 36899999999999999999885 678999999764221 1223456788999999999999999999998765
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++||||+++++|.+++.... .+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 75 -~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~----~~~~~kL~Dfg~a 148 (333)
T cd05600 75 -YLYLAMEYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLID----ASGHIKLTDFGLS 148 (333)
T ss_pred -EEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC----CCCCEEEEeCcCC
Confidence 8999999999999999997654 589999999999999999999999999999999999998 7789999999999
Q ss_pred ccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCC----
Q 037285 968 KIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIP---- 1043 (1094)
Q Consensus 968 rl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iP---- 1043 (1094)
+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+.........+
T Consensus 149 ~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 224 (333)
T cd05600 149 KGIVT--YANSVVGSPDYMAPEVLRG--KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDD 224 (333)
T ss_pred ccccc--ccCCcccCccccChhHhcC--CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCc
Confidence 85433 2234568999999999984 478899999999999999999999999887766655554322211112
Q ss_pred --CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1044 --SYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1044 --e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
..++.++.++|.+||..+|.+||++.+++++.+
T Consensus 225 ~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~ 259 (333)
T cd05600 225 PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPF 259 (333)
T ss_pred cccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcc
Confidence 145889999999999999999999999998743
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=331.16 Aligned_cols=256 Identities=31% Similarity=0.574 Sum_probs=214.7
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeec-CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEee
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQ 883 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~r-Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~ 883 (1094)
|.|..++|++.++||+|+||.||+|... +..||+|.+..... ....+.+|+.++++++|+||+++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---------SVQAFLEEANLMKTLQHDKLVRLYAVVT 71 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch---------hHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 5677889999999999999999999875 46799998764311 1356889999999999999999999988
Q ss_pred cCCCCceEEEeeecccchhHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLVRK-DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~k~-~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
... ..+++|||+.+++|.+++... ...+++..++.++.|++.||+|||+++++||||||+||+++ .++.+||+
T Consensus 72 ~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~----~~~~~~l~ 145 (261)
T cd05072 72 KEE--PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS----ESLMCKIA 145 (261)
T ss_pred CCC--CcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEec----CCCcEEEC
Confidence 754 789999999999999998654 34588899999999999999999999999999999999999 77899999
Q ss_pred ecCCcccccCcc--ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCC
Q 037285 963 DFGLSKIKRNTL--VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLR 1039 (1094)
Q Consensus 963 DFGLSrl~~~~~--~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lr 1039 (1094)
|||+++...... ......++..|+|||++. ...++.++|||||||++|+|+| |+.||...........+ ....+
T Consensus 146 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-~~~~~ 222 (261)
T cd05072 146 DFGLARVIEDNEYTAREGAKFPIKWTAPEAIN--FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL-QRGYR 222 (261)
T ss_pred CCccceecCCCceeccCCCccceecCCHHHhc--cCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHH-HcCCC
Confidence 999998543321 122234567899999987 4567889999999999999998 99999887776666555 33445
Q ss_pred CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1040 PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1040 p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
......++..+.+++.+||..+|++||++.++++.|+++
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 223 MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 555567889999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=358.20 Aligned_cols=263 Identities=30% Similarity=0.516 Sum_probs=217.6
Q ss_pred CcceeeccCCeeEEEEecccCceEEEEeeec-------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCC
Q 037285 802 SSVQVIKNEDLEEQKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHP 873 (1094)
Q Consensus 802 ssv~eIs~edYei~kkLGsG~FGtVYKAk~r-------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HP 873 (1094)
...|.+..++|++.+.||+|+||.||+|++. +..||||+++.... ......+.+|+.+++.+ +|+
T Consensus 30 ~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~il~~l~~h~ 102 (374)
T cd05106 30 NEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-------TDEREALMSELKILSHLGQHK 102 (374)
T ss_pred cccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-------HHHHHHHHHHHHHHHhhccCC
Confidence 3456777889999999999999999998863 23699999875421 11235678999999999 899
Q ss_pred ceeEEEeEeecCCCCceEEEeeecccchhHHHHhhcc-------------------------------------------
Q 037285 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD------------------------------------------- 910 (1094)
Q Consensus 874 NIVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~------------------------------------------- 910 (1094)
||++++++|.... .+++||||+.+|+|.+++....
T Consensus 103 nIv~~~~~~~~~~--~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (374)
T cd05106 103 NIVNLLGACTHGG--PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDT 180 (374)
T ss_pred ceeeEeeEecCCC--CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccccccccc
Confidence 9999999998765 8999999999999999985431
Q ss_pred --------------------------cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 911 --------------------------RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 911 --------------------------~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
..+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+||
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~----~~~~~kL~Df 256 (374)
T cd05106 181 YVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT----DGRVAKICDF 256 (374)
T ss_pred ccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEe----CCCeEEEeec
Confidence 2367888999999999999999999999999999999998 6788999999
Q ss_pred CCcccccCcc---ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCC
Q 037285 965 GLSKIKRNTL---VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 1040 (1094)
Q Consensus 965 GLSrl~~~~~---~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp 1040 (1094)
|+++...... ......++..|+|||++. ...++.++|||||||++|+|++ |+.||..................+
T Consensus 257 Gla~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~ 334 (374)
T cd05106 257 GLARDIMNDSNYVVKGNARLPVKWMAPESIF--DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM 334 (374)
T ss_pred eeeeeccCCcceeeccCCCCccceeCHHHhc--CCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc
Confidence 9997533211 112233567899999987 4568899999999999999997 999998876655555555666666
Q ss_pred CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1041 TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1041 ~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
..+..++.++.++|.+||+.||.+|||+.+|++.|.++.
T Consensus 335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 677778999999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=371.46 Aligned_cols=257 Identities=27% Similarity=0.387 Sum_probs=217.2
Q ss_pred ccCCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-CCceeEEEeEeec
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HPNVVAFYGVVQD 884 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-HPNIVqL~Gv~~d 884 (1094)
.-++|+++++||.|+||.||+|+. .|..||||.+++.... .++ ..-+||++.|++|+ |||||++++++.+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s----~ee---~~nLREvksL~kln~hpniikL~Evi~d 80 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS----WEE---CMNLREVKSLRKLNPHPNIIKLKEVIRD 80 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc----HHH---HHHHHHHHHHHhcCCCCcchhhHHHhhc
Confidence 346899999999999999999986 4788999999876432 222 23468999999999 9999999999988
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
.. +.+++||||| ..+|.++++.+++.+++..+..|+.||++||+|+|++|+.||||||+|||+. .+..|||+||
T Consensus 81 ~~-~~L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~----~~~~iKiaDF 154 (538)
T KOG0661|consen 81 ND-RILYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILIS----GNDVIKIADF 154 (538)
T ss_pred cC-ceEeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEec----ccceeEeccc
Confidence 64 3899999999 6899999999999999999999999999999999999999999999999998 6889999999
Q ss_pred CCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhc--------
Q 037285 965 GLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN-------- 1036 (1094)
Q Consensus 965 GLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~-------- 1036 (1094)
|+||..........++.|.+|.|||++.. ...|+.+.||||+||||+|+++-++.|.+....+.+.+++.-
T Consensus 155 GLARev~SkpPYTeYVSTRWYRAPEvLLr-s~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~ 233 (538)
T KOG0661|consen 155 GLAREVRSKPPYTEYVSTRWYRAPEVLLR-SGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDS 233 (538)
T ss_pred ccccccccCCCcchhhhcccccchHHhhh-ccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCcccc
Confidence 99997766666667789999999999985 567899999999999999999999999988776655444321
Q ss_pred -----------cCC-CC--------CCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1037 -----------TLR-PT--------IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1037 -----------~lr-p~--------iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
+++ +. +-..++.++.++|.+|+.+||++|||+.+.+++-=-.
T Consensus 234 ~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq 295 (538)
T KOG0661|consen 234 WPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQ 295 (538)
T ss_pred chhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccc
Confidence 011 00 1123788999999999999999999999999875443
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=342.37 Aligned_cols=258 Identities=29% Similarity=0.552 Sum_probs=214.9
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--Cc----eEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEe
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GT----DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYG 880 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt----~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~G 880 (1094)
+...+|++.+.||+|+||.||+|++. +. .||||+++... ......++.+|+.+++.++||||+++++
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~niv~~~g 76 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-------SPKANKEILDEAYVMASVDNPHVCRLLG 76 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-------CHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 45678999999999999999999873 33 38999886431 1223456888999999999999999999
Q ss_pred EeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEE
Q 037285 881 VVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICK 960 (1094)
Q Consensus 881 v~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VK 960 (1094)
+|... ..++|+||+.+|+|.+++......+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+|
T Consensus 77 ~~~~~---~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~----~~~~~k 149 (316)
T cd05108 77 ICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVK----TPQHVK 149 (316)
T ss_pred EEcCC---CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEec----CCCcEE
Confidence 99764 47789999999999999987666689999999999999999999999999999999999998 678899
Q ss_pred EEecCCcccccCccc---cCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhc
Q 037285 961 VGDFGLSKIKRNTLV---SGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 1036 (1094)
Q Consensus 961 LsDFGLSrl~~~~~~---ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~ 1036 (1094)
|+|||+++....... .....++..|+|||++. ...++.++|||||||++|||++ |+.||......+.. .+...
T Consensus 150 l~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~--~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~ 226 (316)
T cd05108 150 ITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEK 226 (316)
T ss_pred EccccccccccCCCcceeccCCccceeecChHHhc--cCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhC
Confidence 999999985432211 12233467899999987 4578899999999999999998 99999887665543 34455
Q ss_pred cCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1037 TLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1037 ~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
......+..++..+.++|.+||..+|.+||++.+++..|..+...
T Consensus 227 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 227 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 556666778899999999999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=375.04 Aligned_cols=255 Identities=28% Similarity=0.411 Sum_probs=227.1
Q ss_pred CCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
.-|++++-||.|+-|.|-+|++ +|+.+|||++.+.. ...+.....+.+||-+|+-|.|||++++|++|.+..
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~-----~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~- 85 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRS-----ELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ- 85 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeecccc-----ccccccccchhhhhHHHHHhcCCCeeeeeeeeccCc-
Confidence 3477889999999999999988 58999999997652 111223355678999999999999999999999866
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+|+|.||+++|.|.+++..++. +.+..+.++++||+.|+.|||..+|+||||||+|+|++ ..++|||+|||+|
T Consensus 86 -~lylvlEyv~gGELFdylv~kG~-l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd----~~~nIKIADFGMA 159 (786)
T KOG0588|consen 86 -HLYLVLEYVPGGELFDYLVRKGP-LPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLD----VKNNIKIADFGMA 159 (786)
T ss_pred -eEEEEEEecCCchhHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhh----cccCEeeecccee
Confidence 99999999999999999988775 88899999999999999999999999999999999999 5666999999999
Q ss_pred ccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCc
Q 037285 968 KIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCD 1047 (1094)
Q Consensus 968 rl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S 1047 (1094)
.+........+.||++.|.|||++.|..+. +.++||||.|||||.|+||+.||++.+-..++.++..+.+. +|..++
T Consensus 160 sLe~~gklLeTSCGSPHYA~PEIV~G~pYd-G~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~--MPs~Is 236 (786)
T KOG0588|consen 160 SLEVPGKLLETSCGSPHYAAPEIVSGRPYD-GRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFE--MPSNIS 236 (786)
T ss_pred ecccCCccccccCCCcccCCchhhcCCCCC-CCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCccc--CCCcCC
Confidence 988888888889999999999999975444 78999999999999999999999998888888888777665 678999
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1048 AEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1048 ~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
.++++||++|+..||++|.|+++|++|.+-..
T Consensus 237 ~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g 268 (786)
T KOG0588|consen 237 SEAQDLLRRMLDVDPSTRITTEEILKHPFLSG 268 (786)
T ss_pred HHHHHHHHHHhccCccccccHHHHhhCchhhc
Confidence 99999999999999999999999999988765
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=331.28 Aligned_cols=250 Identities=36% Similarity=0.625 Sum_probs=210.7
Q ss_pred ccCCeeEEEEecccCceEEEEeeecC-ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~rG-t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
...+|++.+.||+|+||.||++++.+ ..+|||.+...... ...|.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---------EDEFIEEAKVMMKLSHEKLVQLYGVCTKQR 72 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc---------HHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 45689999999999999999999875 45999988754221 246889999999999999999999997754
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+++||||+.+++|.+++......+++..++.++.||+.||.|||+.+++|+||||+|||++ .++.+||+|||+
T Consensus 73 --~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~----~~~~~kl~d~g~ 146 (256)
T cd05113 73 --PIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVD----DQGCVKVSDFGL 146 (256)
T ss_pred --CcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc----CCCCEEECCCcc
Confidence 78999999999999999976555689999999999999999999999999999999999998 678899999999
Q ss_pred cccccCcc--ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCCCC
Q 037285 967 SKIKRNTL--VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIP 1043 (1094)
Q Consensus 967 Srl~~~~~--~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~iP 1043 (1094)
++...... ......++..|+|||++. ...++.++|||||||++|+|++ |+.||...........+.. ..+...+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~--~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~ 223 (256)
T cd05113 147 SRYVLDDEYTSSVGSKFPVRWSPPEVLL--YSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ-GLRLYRP 223 (256)
T ss_pred ceecCCCceeecCCCccChhhCCHHHHh--cCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhc-CCCCCCC
Confidence 87432221 112233567899999997 3467889999999999999999 9999988877766666544 3445556
Q ss_pred CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037285 1044 SYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1044 e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L 1075 (1094)
...+..+++++.+||+.+|.+||++.+|+..|
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 224 HLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 67889999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=337.71 Aligned_cols=251 Identities=24% Similarity=0.340 Sum_probs=202.8
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.++||.|+||.||+|+.+ +..||+|.++..... .....+.+|+.++++++||||+++++++....
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 76 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-------GAPCTAIREVSLLKNLKHANIVTLHDIIHTER 76 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-------CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 467999999999999999999874 678999998754211 11235678999999999999999999998754
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
..++||||+. ++|.+++......+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+
T Consensus 77 --~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~----~~~~~kl~DfG~ 149 (288)
T cd07871 77 --CLTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLIN----EKGELKLADFGL 149 (288)
T ss_pred --eEEEEEeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC----CCCCEEECcCcc
Confidence 8999999997 589998877666689999999999999999999999999999999999998 778899999999
Q ss_pred cccccCc-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCC------
Q 037285 967 SKIKRNT-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR------ 1039 (1094)
Q Consensus 967 Srl~~~~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lr------ 1039 (1094)
++..... .......++..|+|||++.+ ...++.++|||||||++|+|+||+.||......+.+..+......
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07871 150 ARAKSVPTKTYSNEVVTLWYRPPDVLLG-STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETW 228 (288)
T ss_pred eeeccCCCccccCceecccccChHHhcC-CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHh
Confidence 9754322 12233457899999999874 346789999999999999999999999887665544333211000
Q ss_pred -----------CCC-----------CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1040 -----------PTI-----------PSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1040 -----------p~i-----------Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
..+ ...++.++.+||.+||..||.+|||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 229 PGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 001 12357789999999999999999999999876
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=350.93 Aligned_cols=252 Identities=28% Similarity=0.424 Sum_probs=211.9
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||+|+||.||+|++. +..||||++++.... .......+.+|+.++..++|+||+++++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI-----KRNQIAHVRAERDILADADSPWIVKLYYSFQDEE- 74 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHh-----hccHHHHHHHHHHHHHhcCCCCccchhhheecCC-
Confidence 47899999999999999999986 788999999764321 1123456788999999999999999999998755
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++||||+.+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 75 -~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~----~~~~~kL~Dfg~~ 148 (350)
T cd05573 75 -HLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILID----ADGHIKLADFGLC 148 (350)
T ss_pred -eEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC----CCCCEEeecCCCC
Confidence 899999999999999999776 4589999999999999999999999999999999999998 7889999999998
Q ss_pred ccccCcc------------------------------ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcC
Q 037285 968 KIKRNTL------------------------------VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTG 1017 (1094)
Q Consensus 968 rl~~~~~------------------------------~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTG 1017 (1094)
+...... ......||+.|+|||++. ...++.++|||||||++|+|++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~ell~g 226 (350)
T cd05573 149 KKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR--GTPYGLECDWWSLGVILYEMLYG 226 (350)
T ss_pred ccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHc--CCCCCCceeeEecchhhhhhccC
Confidence 7543222 223456899999999998 44788999999999999999999
Q ss_pred CCCCCCCChHHHHHhHhh--ccCCCCCCCcCcHHHHHHHHHhccCCCCCCCC-HHHHHHHHH
Q 037285 1018 EEPYANMHYGAIIGGIVN--NTLRPTIPSYCDAEWRTLMEECWAPNPAARPS-FTEIASRLR 1076 (1094)
Q Consensus 1018 k~PF~~~~~~eile~Iv~--~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS-~eELLq~L~ 1076 (1094)
+.||...........+.. ..........+++++.+||.+||. +|.+||+ +.+++++.+
T Consensus 227 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~ 287 (350)
T cd05573 227 FPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287 (350)
T ss_pred CCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCC
Confidence 999998887777666655 222222223369999999999997 9999999 999998754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=328.70 Aligned_cols=256 Identities=34% Similarity=0.607 Sum_probs=214.9
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeec-CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEee
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQ 883 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~r-Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~ 883 (1094)
|++..++|++.+.||+|+||.||+|.+. +..||||.++.... ....+.+|+.++++++|+||+++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM---------DPKDFLAEAQIMKKLRHPKLIQLYAVCT 71 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc---------cHHHHHHHHHHHHHCCCCCccceeEEEe
Confidence 4567788999999999999999999875 46799999875421 1245788999999999999999999988
Q ss_pred cCCCCceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
... .+++||||+.+++|.+++.... ..+++..+..++.|++.||.|||+++|+|+||||+||+++ .++.+||+
T Consensus 72 ~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~~l~ 145 (261)
T cd05068 72 LEE--PIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVG----ENNICKVA 145 (261)
T ss_pred cCC--CeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEc----CCCCEEEC
Confidence 755 7899999999999999997643 4589999999999999999999999999999999999999 77889999
Q ss_pred ecCCcccccCccc--cCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCC
Q 037285 963 DFGLSKIKRNTLV--SGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLR 1039 (1094)
Q Consensus 963 DFGLSrl~~~~~~--ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lr 1039 (1094)
|||+++....... ......+..|+|||++. ...++.++||||||+++|+|++ |+.||...........+ .....
T Consensus 146 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~ 222 (261)
T cd05068 146 DFGLARVIKEDIYEAREGAKFPIKWTAPEAAL--YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV-DQGYR 222 (261)
T ss_pred CcceEEEccCCcccccCCCcCceeccCccccc--cCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-HcCCC
Confidence 9999985432211 11222345799999987 4568899999999999999999 99999988777666555 34445
Q ss_pred CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1040 PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1040 p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
...+..++..+.+++.+||+.+|.+||++.+|++.|+.+
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 556677899999999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=329.74 Aligned_cols=250 Identities=36% Similarity=0.658 Sum_probs=210.6
Q ss_pred ccCCeeEEEEecccCceEEEEeeecC-ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~rG-t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
...+|++.+.||+|+||.||++++++ ..+|+|++...... ...|.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~---------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS---------EDDFIEEAKVMMKLSHPNLVQLYGVCTKQR 72 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC---------HHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 34578899999999999999998864 56999998654221 246778999999999999999999987754
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
..++||||+++++|.+++......+++..++.++.||+.||+|||+++|+||||||+||+++ .++.+||+|||+
T Consensus 73 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~----~~~~~kl~dfg~ 146 (256)
T cd05059 73 --PIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVG----EDNVVKVSDFGL 146 (256)
T ss_pred --ceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEEC----CCCcEEECCccc
Confidence 89999999999999999977655789999999999999999999999999999999999998 778899999999
Q ss_pred cccccCccc--cCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCCCC
Q 037285 967 SKIKRNTLV--SGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIP 1043 (1094)
Q Consensus 967 Srl~~~~~~--ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~iP 1043 (1094)
++....... .....++..|+|||.+. ...++.++||||||+++|+|++ |+.||......+....+ ....+...+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~--~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~ 223 (256)
T cd05059 147 ARYVLDDQYTSSQGTKFPVKWAPPEVFD--YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV-SAGYRLYRP 223 (256)
T ss_pred ceecccccccccCCCCCCccccCHHHhc--cCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH-HcCCcCCCC
Confidence 875432211 11222456799999987 4567889999999999999999 89999887777666555 445566677
Q ss_pred CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037285 1044 SYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1044 e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L 1075 (1094)
..++..+.+++.+||..+|++|||+.++++.|
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 78899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=351.10 Aligned_cols=251 Identities=25% Similarity=0.337 Sum_probs=206.3
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
+.|+.+.++|+|+||+||+++.+ |+-||||+|... +++.....-.++|+++|++|+|+|+|.++.+|....
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es------edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkr- 74 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES------EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKR- 74 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC------CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcc-
Confidence 45788889999999999999875 778999999764 233444566789999999999999999999998755
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++|+|||+..-| +-|......++.+.+.++++|++.|+.|+|++++|||||||+|||++ .++.+||||||+|
T Consensus 75 -klhLVFE~~dhTvL-~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit----~~gvvKLCDFGFA 148 (396)
T KOG0593|consen 75 -KLHLVFEYCDHTVL-HELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILIT----QNGVVKLCDFGFA 148 (396)
T ss_pred -eeEEEeeecchHHH-HHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEe----cCCcEEeccchhh
Confidence 89999999976555 44555555689999999999999999999999999999999999999 8999999999999
Q ss_pred cccc-CccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhc----------
Q 037285 968 KIKR-NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN---------- 1036 (1094)
Q Consensus 968 rl~~-~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~---------- 1036 (1094)
+... .......++.|.+|.|||.+.| ...|+..+||||+||++.||++|.+.|.+....+.+-.+...
T Consensus 149 R~L~~pgd~YTDYVATRWYRaPELLvG-DtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~ 227 (396)
T KOG0593|consen 149 RTLSAPGDNYTDYVATRWYRAPELLVG-DTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQS 227 (396)
T ss_pred HhhcCCcchhhhhhhhhhccChhhhcc-cCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHH
Confidence 9654 4445556778999999999996 567899999999999999999999999988766544333221
Q ss_pred ---------cCCCCCC----------CcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1037 ---------TLRPTIP----------SYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1037 ---------~lrp~iP----------e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
+.+.+-+ ..++..+.+|++.||+.||++|++.++++.+
T Consensus 228 iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 228 IFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred HhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 1111111 1245568899999999999999999999854
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=345.23 Aligned_cols=241 Identities=28% Similarity=0.469 Sum_probs=217.6
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
...++|++++.||.|+||.|.+++.+ |..+|+|++.+.... .-+.++...+|..+|+.+.||+++++++.|.+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vV-----klKQveH~~nEk~vL~~v~~PFlv~l~~t~~d 115 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVV-----KLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD 115 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHH-----HHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence 44578999999999999999999875 677999999876433 34455677789999999999999999999988
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
.. .+++||||++||.|..++++.++ +++..+..++.||+.||+|||+++|++|||||+|||+| .+|.+||+||
T Consensus 116 ~~--~lymvmeyv~GGElFS~Lrk~~r-F~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD----~~G~iKitDF 188 (355)
T KOG0616|consen 116 NS--NLYMVMEYVPGGELFSYLRKSGR-FSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLD----QNGHIKITDF 188 (355)
T ss_pred CC--eEEEEEeccCCccHHHHHHhcCC-CCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeec----cCCcEEEEec
Confidence 66 99999999999999999987765 89999999999999999999999999999999999999 8999999999
Q ss_pred CCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCC
Q 037285 965 GLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPS 1044 (1094)
Q Consensus 965 GLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe 1044 (1094)
|+|+..... +.+.|||+.|+|||++. ...+..++|+|||||++|||+.|.+||...+...+.++++...+. +|.
T Consensus 189 GFAK~v~~r--T~TlCGTPeYLAPEii~--sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~--fP~ 262 (355)
T KOG0616|consen 189 GFAKRVSGR--TWTLCGTPEYLAPEIIQ--SKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVK--FPS 262 (355)
T ss_pred cceEEecCc--EEEecCCccccChHHhh--cCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCccc--CCc
Confidence 999966554 45689999999999998 567888999999999999999999999999999999999988765 888
Q ss_pred cCcHHHHHHHHHhccCCCCCC
Q 037285 1045 YCDAEWRTLMEECWAPNPAAR 1065 (1094)
Q Consensus 1045 ~~S~eL~dLI~kCLq~DPeeR 1065 (1094)
..+.++++||+++|+.|-.+|
T Consensus 263 ~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 263 YFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ccCHHHHHHHHHHHhhhhHhh
Confidence 999999999999999999999
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=347.25 Aligned_cols=244 Identities=26% Similarity=0.405 Sum_probs=205.8
Q ss_pred EEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEEE
Q 037285 816 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATV 893 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~IV 893 (1094)
+.||+|+||.||+++.+ |..||+|+++..... .......+.+|+.++++++||||+++++++.... .+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~--~~~lv 73 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVII-----AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD--RLCFV 73 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC--EEEEE
Confidence 46999999999999874 678999999764221 1223456778999999999999999999998755 89999
Q ss_pred eeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccc-cC
Q 037285 894 AEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK-RN 972 (1094)
Q Consensus 894 mEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~-~~ 972 (1094)
|||+.+|+|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.. ..
T Consensus 74 ~E~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~~kL~Dfg~~~~~~~~ 148 (323)
T cd05595 74 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD----KDGHIKITDFGLCKEGISD 148 (323)
T ss_pred EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEc----CCCCEEecccHHhccccCC
Confidence 99999999998886654 589999999999999999999999999999999999998 7789999999998742 22
Q ss_pred ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHH
Q 037285 973 TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRT 1052 (1094)
Q Consensus 973 ~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~d 1052 (1094)
........||+.|+|||++. ...++.++|||||||++|+|++|+.||...........+..... .++..+++++.+
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~ 224 (323)
T cd05595 149 GATMKTFCGTPEYLAPEVLE--DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI--RFPRTLSPEAKS 224 (323)
T ss_pred CCccccccCCcCcCCccccc--CCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCHHHHH
Confidence 22223456899999999997 45678999999999999999999999998877776666654433 466788999999
Q ss_pred HHHHhccCCCCCCC-----CHHHHHHHH
Q 037285 1053 LMEECWAPNPAARP-----SFTEIASRL 1075 (1094)
Q Consensus 1053 LI~kCLq~DPeeRP-----S~eELLq~L 1075 (1094)
+|.+||..||.+|+ ++.+++++-
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~~l~h~ 252 (323)
T cd05595 225 LLAGLLKKDPKQRLGGGPSDAKEVMEHR 252 (323)
T ss_pred HHHHHccCCHHHhCCCCCCCHHHHHcCC
Confidence 99999999999998 899998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=335.79 Aligned_cols=250 Identities=22% Similarity=0.265 Sum_probs=199.9
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||+|+||.||+++++ +..||||+++..... +.....+.+|+.++++++||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 73 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN------EEVKETTLRELKMLRTLKQENIVELKEAFRRRG- 73 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc------ccchhhHHHHHHHHHhCCCccccchhhhEecCC-
Confidence 36899999999999999999985 567999998754211 122356778999999999999999999998754
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++||||+.++.+..+.. ....+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||++
T Consensus 74 -~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~----~~~~~kl~Dfg~~ 147 (287)
T cd07848 74 -KLYLVFEYVEKNMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLIS----HNDVLKLCDFGFA 147 (287)
T ss_pred -EEEEEEecCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCcEEEeeccCc
Confidence 8999999999887765543 344589999999999999999999999999999999999998 7789999999999
Q ss_pred ccccCc--cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhc---------
Q 037285 968 KIKRNT--LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN--------- 1036 (1094)
Q Consensus 968 rl~~~~--~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~--------- 1036 (1094)
+..... .......+|..|+|||++. ...++.++|||||||++|+|++|+.||...........+...
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (287)
T cd07848 148 RNLSEGSNANYTEYVATRWYRSPELLL--GAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQM 225 (287)
T ss_pred ccccccccccccccccccccCCcHHHc--CCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHH
Confidence 854322 1223356899999999997 446789999999999999999999999876554432221110
Q ss_pred ----------cCC-C----------CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1037 ----------TLR-P----------TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1037 ----------~lr-p----------~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
... + .....++..+.+||.+||+.||++|||+++++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 226 KLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred HhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000 0 0112367889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=342.69 Aligned_cols=256 Identities=26% Similarity=0.405 Sum_probs=208.1
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
+..++|++.+.||+|+||.||++++. +..+|+|++.... .......+.+|+.+|++++||||+++++++..
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-------KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-------CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 45678999999999999999999885 6779999987531 12334678899999999999999999999987
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeccCCCCCCcEEEEe
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPSRPICKVGD 963 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~-GIIHRDLKPeNILLD~~~~e~g~VKLsD 963 (1094)
.. .+++||||+++++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++ .++.+||+|
T Consensus 75 ~~--~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~----~~~~~kl~D 147 (331)
T cd06649 75 DG--EISICMEHMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVN----SRGEIKLCD 147 (331)
T ss_pred CC--EEEEEeecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEc----CCCcEEEcc
Confidence 54 8999999999999999997654 489999999999999999999986 699999999999998 778899999
Q ss_pred cCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHh---------
Q 037285 964 FGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV--------- 1034 (1094)
Q Consensus 964 FGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv--------- 1034 (1094)
||+++...... .....||..|+|||++. ...++.++|||||||++|+|++|+.||......+....+.
T Consensus 148 fg~~~~~~~~~-~~~~~g~~~y~aPE~~~--~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (331)
T cd06649 148 FGVSGQLIDSM-ANSFVGTRSYMSPERLQ--GTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEG 224 (331)
T ss_pred Ccccccccccc-cccCCCCcCcCCHhHhc--CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccC
Confidence 99987543322 23456899999999998 4568899999999999999999999997655433221110
Q ss_pred ------------------------------------hccCCCCC-CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1035 ------------------------------------NNTLRPTI-PSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1035 ------------------------------------~~~lrp~i-Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
....++.. ...++.++++||.+||..||++|||+.+|+++.+-
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 225 EPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred CccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 00011111 12467889999999999999999999999999865
Q ss_pred HH
Q 037285 1078 LS 1079 (1094)
Q Consensus 1078 L~ 1079 (1094)
..
T Consensus 305 ~~ 306 (331)
T cd06649 305 KR 306 (331)
T ss_pred hh
Confidence 43
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=327.17 Aligned_cols=254 Identities=35% Similarity=0.616 Sum_probs=214.2
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
|.+...+|++.+.||+|+||.||++..++..||+|.++... ....|.+|+.++++++|+|++++++++..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 70 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----------TAQAFLAEASVMTQLRHSNLVQLLGVIVE 70 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc----------hHHHHHHHHHHHHhCCCCCeeeEEEEEEc
Confidence 34566789999999999999999999999999999886431 13468899999999999999999998654
Q ss_pred CCCCceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEe
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGD 963 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsD 963 (1094)
. ....++||||+++++|.+++.... ..+++..++.++.||+.||+|||++|++||||||+||+++ .++.+||+|
T Consensus 71 ~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~----~~~~~kl~d 145 (256)
T cd05082 71 E-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVS----EDNVAKVSD 145 (256)
T ss_pred C-CCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEc----CCCcEEecC
Confidence 3 247899999999999999997654 3478999999999999999999999999999999999998 788999999
Q ss_pred cCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCCC
Q 037285 964 FGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTI 1042 (1094)
Q Consensus 964 FGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~i 1042 (1094)
||+++...... .....+..|+|||++. ...++.++|||||||++|+|++ |+.||......+....+ .....+..
T Consensus 146 fg~~~~~~~~~--~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~-~~~~~~~~ 220 (256)
T cd05082 146 FGLTKEASSTQ--DTGKLPVKWTAPEALR--EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMDA 220 (256)
T ss_pred CccceeccccC--CCCccceeecCHHHHc--cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-hcCCCCCC
Confidence 99987543222 2233567899999987 4567889999999999999997 99999887766665554 34455667
Q ss_pred CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1043 PSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1043 Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
+..++..+.++|.+||+.+|++|||+.++++.|+.+
T Consensus 221 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 221 PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 778899999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=350.44 Aligned_cols=252 Identities=25% Similarity=0.408 Sum_probs=209.4
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||+|+||.||+|+++ ++.||||++...... .......+.+|+.+|+.++||||+++++++.+..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~- 74 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-----EKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN- 74 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC-
Confidence 47899999999999999999884 678999999764221 1233456778999999999999999999998865
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++||||+.+|+|.+++.... .+++..+..++.||+.||+|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 75 -~~~lv~E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~----~~~~~kl~Dfg~~ 148 (364)
T cd05599 75 -YLYLIMEYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLD----AKGHIKLSDFGLC 148 (364)
T ss_pred -eEEEEECCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC----CCCCEEEeecccc
Confidence 8999999999999999997654 589999999999999999999999999999999999998 7889999999998
Q ss_pred ccccCcc---------------------------------------ccCCccCCCcccCccccccCCCCCCchhhHHHHH
Q 037285 968 KIKRNTL---------------------------------------VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFG 1008 (1094)
Q Consensus 968 rl~~~~~---------------------------------------~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLG 1008 (1094)
+...... .....+||+.|+|||++. ...++.++||||||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG 226 (364)
T cd05599 149 TGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL--QTGYNKECDWWSLG 226 (364)
T ss_pred eeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHc--CCCCCCeeeeecch
Confidence 6422110 011245899999999997 45688999999999
Q ss_pred HHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCC--cCcHHHHHHHHHhccCCCCCCCC---HHHHHHHHH
Q 037285 1009 IVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPS--YCDAEWRTLMEECWAPNPAARPS---FTEIASRLR 1076 (1094)
Q Consensus 1009 VLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe--~~S~eL~dLI~kCLq~DPeeRPS---~eELLq~L~ 1076 (1094)
|++|||++|..||......+....+........++. .+++++.++|.+|+. +|.+|++ +.+++++-+
T Consensus 227 ~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~ 298 (364)
T cd05599 227 VIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPF 298 (364)
T ss_pred hHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCC
Confidence 999999999999998887776666655433333333 468999999999997 9999997 999988643
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=351.42 Aligned_cols=254 Identities=28% Similarity=0.440 Sum_probs=215.2
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeecC---ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeE
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWRG---TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGV 881 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~rG---t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv 881 (1094)
..+..++|++.+.||+|+||.||+|++++ ..||+|.+...... .......+.+|+.+++.++||||++++++
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~ 99 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-----KQKQVDHVFSERKILNYINHPFCVNLYGS 99 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh-----hhhhHHHHHHHHHHHHhCCCCCCcceEEE
Confidence 34566789999999999999999998743 46999998754221 12234567889999999999999999999
Q ss_pred eecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEE
Q 037285 882 VQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKV 961 (1094)
Q Consensus 882 ~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKL 961 (1094)
+.+.. .+++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||
T Consensus 100 ~~~~~--~~~lv~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~----~~~~ikL 172 (340)
T PTZ00426 100 FKDES--YLYLVLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD----KDGFIKM 172 (340)
T ss_pred EEeCC--EEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC----CCCCEEE
Confidence 98865 8999999999999999997654 489999999999999999999999999999999999998 7889999
Q ss_pred EecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCC
Q 037285 962 GDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT 1041 (1094)
Q Consensus 962 sDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~ 1041 (1094)
+|||+++..... .....||+.|+|||++. ...++.++|||||||++|||++|+.||...........+..... .
T Consensus 173 ~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~--~ 246 (340)
T PTZ00426 173 TDFGFAKVVDTR--TYTLCGTPEYIAPEILL--NVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII--Y 246 (340)
T ss_pred ecCCCCeecCCC--cceecCChhhcCHHHHh--CCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC--C
Confidence 999999865432 23456899999999997 45678899999999999999999999998877766666655433 4
Q ss_pred CCCcCcHHHHHHHHHhccCCCCCCC-----CHHHHHHHHH
Q 037285 1042 IPSYCDAEWRTLMEECWAPNPAARP-----SFTEIASRLR 1076 (1094)
Q Consensus 1042 iPe~~S~eL~dLI~kCLq~DPeeRP-----S~eELLq~L~ 1076 (1094)
+|..++..+.++|++||+.||.+|+ ++++++++.+
T Consensus 247 ~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~ 286 (340)
T PTZ00426 247 FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPW 286 (340)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCC
Confidence 5777899999999999999999995 8999998744
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=343.92 Aligned_cols=241 Identities=26% Similarity=0.391 Sum_probs=203.4
Q ss_pred ecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEEEee
Q 037285 818 LGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAE 895 (1094)
Q Consensus 818 LGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~IVmE 895 (1094)
||+|+||.||+|++. +..||+|++++.... .......+.+|+.++++++||||+++++++.... .+++|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e 73 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIV-----SRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPE--KLYLVLA 73 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCC--eEEEEEc
Confidence 799999999999885 577999999754221 1223456788999999999999999999998755 8999999
Q ss_pred ecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCccccc-Ccc
Q 037285 896 YMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKR-NTL 974 (1094)
Q Consensus 896 YmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~-~~~ 974 (1094)
|+.+|+|.+++.... .+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++... ...
T Consensus 74 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~----~~~~~kl~Dfg~~~~~~~~~~ 148 (312)
T cd05585 74 FINGGELFHHLQREG-RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLD----YQGHIALCDFGLCKLNMKDDD 148 (312)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEEC----CCCcEEEEECcccccCccCCC
Confidence 999999999997654 489999999999999999999999999999999999998 77899999999998432 222
Q ss_pred ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHH
Q 037285 975 VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLM 1054 (1094)
Q Consensus 975 ~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI 1054 (1094)
......||+.|+|||++. ...++.++|||||||++|+|++|+.||......+....+... ...++..++..+.++|
T Consensus 149 ~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li 224 (312)
T cd05585 149 KTNTFCGTPEYLAPELLL--GHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE--PLRFPDGFDRDAKDLL 224 (312)
T ss_pred ccccccCCcccCCHHHHc--CCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--CCCCCCcCCHHHHHHH
Confidence 234456999999999998 456889999999999999999999999988777776666544 3346778899999999
Q ss_pred HHhccCCCCCCC---CHHHHHHH
Q 037285 1055 EECWAPNPAARP---SFTEIASR 1074 (1094)
Q Consensus 1055 ~kCLq~DPeeRP---S~eELLq~ 1074 (1094)
.+||..||.+|| ++.+++.+
T Consensus 225 ~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 225 IGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred HHHcCCCHHHcCCCCCHHHHHcC
Confidence 999999999997 46777765
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=348.10 Aligned_cols=251 Identities=24% Similarity=0.374 Sum_probs=205.9
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||+|+||+||+++.+ ++.||||++++... ........+.+|+.++.+++|+||+++++++.+..
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~- 74 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM-----LEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL- 74 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHH-----HHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC-
Confidence 47899999999999999999874 67899999976421 12233456778999999999999999999998765
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++||||+++|+|.+++.+.. .+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 75 -~~~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~----~~~~vkL~DFGla 148 (363)
T cd05628 75 -NLYLIMEFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLD----SKGHVKLSDFGLC 148 (363)
T ss_pred -eEEEEEcCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC----CCCCEEEeeccCc
Confidence 8999999999999999997654 589999999999999999999999999999999999998 6789999999998
Q ss_pred ccccCcc------------------------------------ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHH
Q 037285 968 KIKRNTL------------------------------------VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVL 1011 (1094)
Q Consensus 968 rl~~~~~------------------------------------~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLL 1011 (1094)
+...... .....+||+.|+|||++. ...++.++|||||||++
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~--~~~~~~~~DvwSlGvil 226 (363)
T cd05628 149 TGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM--QTGYNKLCDWWSLGVIM 226 (363)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHc--CCCCCCchhhhhhHHHH
Confidence 7432110 012356999999999998 45688999999999999
Q ss_pred HHHHcCCCCCCCCChHHHHHhHhhccCCCCCCC--cCcHHHHHHHHHhcc--CCCCCCCCHHHHHHH
Q 037285 1012 WEILTGEEPYANMHYGAIIGGIVNNTLRPTIPS--YCDAEWRTLMEECWA--PNPAARPSFTEIASR 1074 (1094)
Q Consensus 1012 yELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe--~~S~eL~dLI~kCLq--~DPeeRPS~eELLq~ 1074 (1094)
|||++|+.||......+....+........+|. .++.+++++|.+|+. .++..||++.+|+++
T Consensus 227 ~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 227 YEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 999999999998887777777665433333443 367899999998654 233456899999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=336.99 Aligned_cols=253 Identities=25% Similarity=0.334 Sum_probs=199.4
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||.|+||.||+|+.+ +..||||++...... .....+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 76 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-------GTPFTAIREASLLKGLKHANIVLLHDIIHTKE 76 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-------ccchhHHHHHHHHhhCCCCCcCeEEEEEecCC
Confidence 468999999999999999999884 678999998753211 11235678999999999999999999998765
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+++||||+. ++|.+++......+++..+..++.||+.||+|||+++|+||||||+|||++ .++.+||+|||+
T Consensus 77 --~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~----~~~~~kl~Dfg~ 149 (303)
T cd07869 77 --TLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS----DTGELKLADFGL 149 (303)
T ss_pred --eEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEECCCCc
Confidence 8999999995 678888776666689999999999999999999999999999999999998 778899999999
Q ss_pred cccccC-ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH-HHHHhHhhc--------
Q 037285 967 SKIKRN-TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-AIIGGIVNN-------- 1036 (1094)
Q Consensus 967 Srl~~~-~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~-eile~Iv~~-------- 1036 (1094)
++.... ........+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||...... ..+..+...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 228 (303)
T cd07869 150 ARAKSVPSHTYSNEVVTLWYRPPDVLLG-STEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDT 228 (303)
T ss_pred ceeccCCCccCCCCcccCCCCChHHHcC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhh
Confidence 874322 122233458899999999864 345788999999999999999999999875432 222211110
Q ss_pred -------------cCCCCCC---------CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1037 -------------TLRPTIP---------SYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1037 -------------~lrp~iP---------e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
.+....+ ...+..+.+||.+||+.||.+|||+.+++++-+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~ 290 (303)
T cd07869 229 WPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEY 290 (303)
T ss_pred ccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcc
Confidence 0000000 023467889999999999999999999998654
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=325.09 Aligned_cols=257 Identities=22% Similarity=0.407 Sum_probs=209.1
Q ss_pred CCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||+|+||.||+|++ .+..||||.++..... .......+.+|+.++++++||||+++++++.+..
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 75 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMM-----DAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN- 75 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccC-----CHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC-
Confidence 5799999999999999999987 4688999988653221 1233456889999999999999999999988754
Q ss_pred CceEEEeeecccchhHHHHhh---cccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 888 GTLATVAEYMVDGSLRHVLVR---KDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k---~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
..++||||+.+++|.+++.. ....+++..++.++.||+.||.|||+++++|+||||+|||++ .++.++|+||
T Consensus 76 -~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~----~~~~~~l~d~ 150 (267)
T cd08228 76 -ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFIT----ATGVVKLGDL 150 (267)
T ss_pred -eEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEc----CCCCEEECcc
Confidence 88999999999999988753 234578899999999999999999999999999999999998 6778999999
Q ss_pred CCcccccCcc-ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh--HHHHHhHhhccCCCC
Q 037285 965 GLSKIKRNTL-VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY--GAIIGGIVNNTLRPT 1041 (1094)
Q Consensus 965 GLSrl~~~~~-~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~--~eile~Iv~~~lrp~ 1041 (1094)
|++....... ......++..|+|||.+. ...++.++||||||+++|+|++|+.||..... ......+......+.
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 228 (267)
T cd08228 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIH--ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPL 228 (267)
T ss_pred ccceeccchhHHHhcCCCCccccChhhhc--cCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCC
Confidence 9988543221 122345888999999987 45678899999999999999999999865432 333333333333333
Q ss_pred CCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1042 iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
.+..++..+.++|.+||..+|.+||++.++++.|+.++
T Consensus 229 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 229 PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 34567789999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=323.40 Aligned_cols=254 Identities=32% Similarity=0.478 Sum_probs=213.4
Q ss_pred CCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||+|+||.||++.. .+..||+|.+...... .........+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 77 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDS---PETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE- 77 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccc---hhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC-
Confidence 4688999999999999999976 4688999998754221 122223457889999999999999999999998765
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++|+||+.+++|.+++.... .+++..+..++.|++.||.|||+.+|+|+||+|+||+++ .++.++|+|||++
T Consensus 78 -~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~----~~~~~~l~dfg~~ 151 (263)
T cd06625 78 -TLSIFMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRD----SAGNVKLGDFGAS 151 (263)
T ss_pred -eEEEEEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEEEeecccc
Confidence 8999999999999999987654 488999999999999999999999999999999999998 6788999999998
Q ss_pred ccccCcccc----CCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCC
Q 037285 968 KIKRNTLVS----GGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIP 1043 (1094)
Q Consensus 968 rl~~~~~~s----s~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iP 1043 (1094)
+........ ....++..|+|||++.+ ..++.++||||||+++|+|++|+.||....................++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 229 (263)
T cd06625 152 KRLQTICSSGTGMKSVTGTPYWMSPEVISG--EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLP 229 (263)
T ss_pred eeccccccccccccCCCcCccccCcceecc--CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCC
Confidence 744321111 23457889999999984 458899999999999999999999998877666655555555666778
Q ss_pred CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037285 1044 SYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1044 e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L 1075 (1094)
..++..+.++|.+||..+|.+|||+.+++++.
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 230 SHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred ccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 88999999999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=346.57 Aligned_cols=244 Identities=27% Similarity=0.398 Sum_probs=205.6
Q ss_pred EEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEEE
Q 037285 816 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATV 893 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~IV 893 (1094)
+.||+|+||.||+++.+ +..||||++.+.... .......+.+|+.++++++||||+++++++.... .+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv 73 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVII-----AKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD--RLCFV 73 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC--EEEEE
Confidence 46999999999999874 678999999764321 1223456788999999999999999999998765 89999
Q ss_pred eeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCccccc-C
Q 037285 894 AEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKR-N 972 (1094)
Q Consensus 894 mEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~-~ 972 (1094)
|||+.+|+|..++.... .+++..+..++.||+.||+|||+++|+||||||+|||++ .++.+||+|||+++... .
T Consensus 74 ~Ey~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~----~~~~~kL~DfG~~~~~~~~ 148 (328)
T cd05593 74 MEYVNGGELFFHLSRER-VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLD----KDGHIKITDFGLCKEGITD 148 (328)
T ss_pred EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEEC----CCCcEEEecCcCCccCCCc
Confidence 99999999998886654 589999999999999999999999999999999999998 78899999999987432 2
Q ss_pred ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHH
Q 037285 973 TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRT 1052 (1094)
Q Consensus 973 ~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~d 1052 (1094)
........||+.|+|||++. ...++.++|||||||++|+|++|+.||......+....+.... ..++..++.++.+
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~ 224 (328)
T cd05593 149 AATMKTFCGTPEYLAPEVLE--DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED--IKFPRTLSADAKS 224 (328)
T ss_pred ccccccccCCcCccChhhhc--CCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC--ccCCCCCCHHHHH
Confidence 22233456999999999997 4567899999999999999999999998877766666554332 3467788999999
Q ss_pred HHHHhccCCCCCCC-----CHHHHHHHH
Q 037285 1053 LMEECWAPNPAARP-----SFTEIASRL 1075 (1094)
Q Consensus 1053 LI~kCLq~DPeeRP-----S~eELLq~L 1075 (1094)
+|.+||..||.+|+ ++.+++++.
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~il~h~ 252 (328)
T cd05593 225 LLSGLLIKDPNKRLGGGPDDAKEIMRHS 252 (328)
T ss_pred HHHHHcCCCHHHcCCCCCCCHHHHhcCC
Confidence 99999999999997 899999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=362.78 Aligned_cols=254 Identities=28% Similarity=0.408 Sum_probs=217.6
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
+..++|++++.||+|+||.||+|+-+ |..+|+|++++..+.. ...+.....|-.+|....+|+||++|..|++
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~-----~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD 212 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLK-----KNQVEHVRAERDILAEVDSPWVVKLYYSFQD 212 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHh-----hhhHHHHHHHHHHhhhcCCCcEEEEEEEecC
Confidence 46689999999999999999999764 7889999999876643 3345677889999999999999999999999
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
.. ++|+||||++||++..+|.+.+ .|++..+..++.+++.|+..||+.|+|||||||+|+||| ..|++||+||
T Consensus 213 ~~--~LYLiMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD----~~GHiKLSDF 285 (550)
T KOG0605|consen 213 KE--YLYLIMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLID----AKGHIKLSDF 285 (550)
T ss_pred CC--eeEEEEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeec----CCCCEeeccc
Confidence 77 9999999999999999998766 599999999999999999999999999999999999999 8999999999
Q ss_pred CCcccccC-------------------------cc-----------------------ccCCccCCCcccCccccccCCC
Q 037285 965 GLSKIKRN-------------------------TL-----------------------VSGGVRGTLPWMAPELLSGSSS 996 (1094)
Q Consensus 965 GLSrl~~~-------------------------~~-----------------------~ss~~~GT~~YmAPEvL~g~~~ 996 (1094)
|||.-... .. .....+|||.|||||++.+ .
T Consensus 286 GLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~--k 363 (550)
T KOG0605|consen 286 GLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG--K 363 (550)
T ss_pred cccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc--C
Confidence 99862100 00 0012469999999999994 5
Q ss_pred CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCC--CcCcHHHHHHHHHhccCCCCCCC---CHHHH
Q 037285 997 KVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIP--SYCDAEWRTLMEECWAPNPAARP---SFTEI 1071 (1094)
Q Consensus 997 kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iP--e~~S~eL~dLI~kCLq~DPeeRP---S~eEL 1071 (1094)
.|+..+|+||||||||||+.|.+||...+..+++.+++.......+| ..++.++.+||.+|+. ||++|. .+.||
T Consensus 364 gY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EI 442 (550)
T KOG0605|consen 364 GYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEI 442 (550)
T ss_pred CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHH
Confidence 68899999999999999999999999999999999998766444444 4578999999999999 999997 57777
Q ss_pred HHHH
Q 037285 1072 ASRL 1075 (1094)
Q Consensus 1072 Lq~L 1075 (1094)
.+|-
T Consensus 443 K~HP 446 (550)
T KOG0605|consen 443 KKHP 446 (550)
T ss_pred hcCC
Confidence 7654
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=338.89 Aligned_cols=255 Identities=25% Similarity=0.329 Sum_probs=199.6
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC-
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG- 887 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~- 887 (1094)
+|++.+.||+|+||.||+|+.+ +..||||++...... ......+.+|+.++++++||||+++++++.....
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 74 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH------VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 74 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc------chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCC
Confidence 5889999999999999999874 678999998643211 1122467899999999999999999998864321
Q ss_pred --CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecC
Q 037285 888 --GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965 (1094)
Q Consensus 888 --~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFG 965 (1094)
..+++||||+. ++|.+++.... .+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||
T Consensus 75 ~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~----~~~~~kL~Dfg 148 (338)
T cd07859 75 EFKDIYVVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILAN----ADCKLKICDFG 148 (338)
T ss_pred CCceEEEEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----CCCcEEEccCc
Confidence 25899999995 68888886554 489999999999999999999999999999999999998 78899999999
Q ss_pred CcccccCc----cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhh------
Q 037285 966 LSKIKRNT----LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN------ 1035 (1094)
Q Consensus 966 LSrl~~~~----~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~------ 1035 (1094)
+++..... .......+|..|+|||++.+....++.++|||||||++|+|+||+.||...........+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 228 (338)
T cd07859 149 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPS 228 (338)
T ss_pred cccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 99743211 11233568999999999875345788999999999999999999999977654322211100
Q ss_pred --------------------ccCCCCC---CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1036 --------------------NTLRPTI---PSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1036 --------------------~~lrp~i---Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
......+ -..++..+.++|.+||..||++|||+.+++++-+-
T Consensus 229 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f 293 (338)
T cd07859 229 PETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYF 293 (338)
T ss_pred HHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchh
Confidence 0000000 12356788999999999999999999999988554
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=322.90 Aligned_cols=252 Identities=37% Similarity=0.656 Sum_probs=215.4
Q ss_pred eeccCCeeEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~ 885 (1094)
.+..++|++.+.||.|+||.||+|...++.||||.++.... ....+.+|+.++++++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 72 (256)
T cd05039 2 AINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---------AAQAFLAEASVMTTLRHPNLVQLLGVVLQG 72 (256)
T ss_pred ccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---------HHHHHHHHHHHHHhcCCcceeeeEEEEcCC
Confidence 35567899999999999999999999999999999875421 245788999999999999999999999874
Q ss_pred CCCceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
. ..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+++++|+||||+||+++ .++.+||+||
T Consensus 73 ~--~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~----~~~~~~l~d~ 146 (256)
T cd05039 73 N--PLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVS----EDLVAKVSDF 146 (256)
T ss_pred C--CeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEe----CCCCEEEccc
Confidence 4 8999999999999999997654 3589999999999999999999999999999999999998 7889999999
Q ss_pred CCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCCCC
Q 037285 965 GLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIP 1043 (1094)
Q Consensus 965 GLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~iP 1043 (1094)
|+++....... ....+..|+|||.+. ...++.++||||||+++|+|++ |..||...........+ ....+...+
T Consensus 147 g~~~~~~~~~~--~~~~~~~~~ape~~~--~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~ 221 (256)
T cd05039 147 GLAKEASQGQD--SGKLPVKWTAPEALR--EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHV-EKGYRMEAP 221 (256)
T ss_pred ccccccccccc--cCCCcccccCchhhc--CCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-hcCCCCCCc
Confidence 99985532222 233567899999987 4567889999999999999997 99999888766655544 444555667
Q ss_pred CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1044 SYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1044 e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
..+++.+.++|.+||..+|.+||++.+|++.|+.
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 222 EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 7789999999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=350.58 Aligned_cols=252 Identities=25% Similarity=0.332 Sum_probs=205.4
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
.|++++.||+|+||+||+|++. +..||||++.+.... .......+.+|+.++++++|+||+++++++.+..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~-- 74 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVL-----NRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD-- 74 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCC--
Confidence 6889999999999999999874 577999999764321 1233457889999999999999999999998765
Q ss_pred ceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 889 TLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
.+++||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~----~~~~~kL~DFGl~~ 149 (381)
T cd05626 75 NLYFVMDYIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILID----LDGHIKLTDFGLCT 149 (381)
T ss_pred EEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEEC----CCCCEEEeeCcCCc
Confidence 8999999999999999987654 488889999999999999999999999999999999998 77899999999975
Q ss_pred cccCc------------------------------------------------cccCCccCCCcccCccccccCCCCCCc
Q 037285 969 IKRNT------------------------------------------------LVSGGVRGTLPWMAPELLSGSSSKVSE 1000 (1094)
Q Consensus 969 l~~~~------------------------------------------------~~ss~~~GT~~YmAPEvL~g~~~kyS~ 1000 (1094)
..... .......||+.|+|||++. ...++.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~~~ 227 (381)
T cd05626 150 GFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL--RKGYTQ 227 (381)
T ss_pred ccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHc--CCCCCC
Confidence 22100 0012346999999999997 456789
Q ss_pred hhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCC--CcCcHHHHHHHHH--hccCCCCCCCCHHHHHHHHH
Q 037285 1001 KVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIP--SYCDAEWRTLMEE--CWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1001 KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iP--e~~S~eL~dLI~k--CLq~DPeeRPS~eELLq~L~ 1076 (1094)
++|||||||++|||+||+.||......+....+........++ ..+++++.+||.+ |+..++..|+++.+|+.+-+
T Consensus 228 ~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~ 307 (381)
T cd05626 228 LCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPF 307 (381)
T ss_pred ccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcc
Confidence 9999999999999999999998877666555554433223333 3578999999998 44566667999999998754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=327.42 Aligned_cols=256 Identities=34% Similarity=0.584 Sum_probs=213.5
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeecC-------ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeE
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVA 877 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~rG-------t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVq 877 (1094)
|++..++|++.+.||+|+||.||+|.+++ ..||+|.+.... .......+.+|+.+++.++|+||++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~ 73 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-------SMRERIEFLNEASVMKEFNCHHVVR 73 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-------CHHHHHHHHHHHHHHHhCCCCceeE
Confidence 46778899999999999999999998753 469999975431 1122356889999999999999999
Q ss_pred EEeEeecCCCCceEEEeeecccchhHHHHhhcc---------cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceE
Q 037285 878 FYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD---------RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLL 948 (1094)
Q Consensus 878 L~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~---------~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNIL 948 (1094)
+++++.... ..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||
T Consensus 74 ~~~~~~~~~--~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nil 151 (277)
T cd05032 74 LLGVVSTGQ--PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCM 151 (277)
T ss_pred EEEEEcCCC--CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEE
Confidence 999998764 8999999999999999986432 23678899999999999999999999999999999999
Q ss_pred eccCCCCCCcEEEEecCCcccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 037285 949 VNLKDPSRPICKVGDFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANM 1024 (1094)
Q Consensus 949 LD~~~~e~g~VKLsDFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~ 1024 (1094)
++ .++.+||+|||+++..... .......++..|+|||.+. ...++.++|||||||++|||+| |+.||...
T Consensus 152 l~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 225 (277)
T cd05032 152 VA----EDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK--DGVFTTKSDVWSFGVVLWEMATLAEQPYQGL 225 (277)
T ss_pred Ec----CCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHh--cCCCCcccchHHHHHHHHHhhccCCCCCccC
Confidence 99 7889999999998743221 1122334678899999987 4567889999999999999998 99999888
Q ss_pred ChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1025 HYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1025 ~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
...+....+. .......+..++..+.++|.+||+.+|++|||+.+|++.|.
T Consensus 226 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 226 SNEEVLKFVI-DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 7777666554 44455677788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=354.48 Aligned_cols=262 Identities=31% Similarity=0.485 Sum_probs=217.0
Q ss_pred cceeeccCCeeEEEEecccCceEEEEeeecC-------ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-CCc
Q 037285 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HPN 874 (1094)
Q Consensus 803 sv~eIs~edYei~kkLGsG~FGtVYKAk~rG-------t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-HPN 874 (1094)
+.|++..++|+++++||+|+||.||+|++.+ ..||||+++.... ......|.+|+.+|+++. |||
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-------~~~~~~~~~Ei~~l~~l~~Hpn 102 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR-------SSEKQALMSELKIMTHLGPHLN 102 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC-------hHHHHHHHHHHHHHHhcCCCCC
Confidence 4678888999999999999999999998642 3599999865321 122357889999999996 999
Q ss_pred eeEEEeEeecCCCCceEEEeeecccchhHHHHhhcc--------------------------------------------
Q 037285 875 VVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD-------------------------------------------- 910 (1094)
Q Consensus 875 IVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~-------------------------------------------- 910 (1094)
|++++++|.... .+++|||||.+|+|.+++....
T Consensus 103 Iv~l~~~~~~~~--~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (400)
T cd05105 103 IVNLLGACTKSG--PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDM 180 (400)
T ss_pred eeeEEEEEccCC--ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccc
Confidence 999999998754 8999999999999999886431
Q ss_pred ---------------------------------------------------cccCHHHHHHHHHHHHHHHHHHHHCCcee
Q 037285 911 ---------------------------------------------------RFLDRRRRLIIAMDAAFGMEYLHSKNIVH 939 (1094)
Q Consensus 911 ---------------------------------------------------~~Lse~~~l~Ia~QIaeGLaYLHs~GIIH 939 (1094)
..+++..++.++.||+.||+|||+++|+|
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH 260 (400)
T cd05105 181 KQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVH 260 (400)
T ss_pred ccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence 23677888999999999999999999999
Q ss_pred ccCCCCceEeccCCCCCCcEEEEecCCcccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc
Q 037285 940 FDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT 1016 (1094)
Q Consensus 940 RDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT 1016 (1094)
|||||+|||++ .++.+||+|||+++..... .......++..|+|||++. ...++.++|||||||++|+|++
T Consensus 261 ~dikp~Nill~----~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwSlGvil~ellt 334 (400)
T cd05105 261 RDLAARNVLLA----QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIF--DNLYTTLSDVWSYGILLWEIFS 334 (400)
T ss_pred CCCChHhEEEe----CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhc--CCCCCchhhHHHHHHHHHHHHH
Confidence 99999999998 6788999999999843221 1222334678899999987 4567899999999999999997
Q ss_pred -CCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1017 -GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1017 -Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
|..||............+....++..+..++..+.++|.+||+.+|++||++.+|.+.|..+.
T Consensus 335 ~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 335 LGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred CCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 999998766555444455556666677788999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=329.07 Aligned_cols=256 Identities=34% Similarity=0.562 Sum_probs=209.8
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeecC-------ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeE
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVA 877 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~rG-------t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVq 877 (1094)
|.+..++|++.+.||+|+||.||+|.+++ ..||||.+.... . .....+|.+|+.++++++|+||++
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-----~--~~~~~~~~~e~~~l~~l~~~~iv~ 73 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-----S--MRERIEFLNEASVMKEFNCHHVVR 73 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-----C--HHHHHHHHHHHHHHHhCCCCCeee
Confidence 45667889999999999999999987643 459999875421 1 122356889999999999999999
Q ss_pred EEeEeecCCCCceEEEeeecccchhHHHHhhcc---------cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceE
Q 037285 878 FYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD---------RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLL 948 (1094)
Q Consensus 878 L~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~---------~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNIL 948 (1094)
+++++.... ..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+++++|+||||+|||
T Consensus 74 ~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil 151 (277)
T cd05062 74 LLGVVSQGQ--PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCM 151 (277)
T ss_pred EEEEEcCCC--CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEE
Confidence 999997654 8999999999999999986532 23577888999999999999999999999999999999
Q ss_pred eccCCCCCCcEEEEecCCcccccCcc---ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 037285 949 VNLKDPSRPICKVGDFGLSKIKRNTL---VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANM 1024 (1094)
Q Consensus 949 LD~~~~e~g~VKLsDFGLSrl~~~~~---~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~ 1024 (1094)
++ +++.+||+|||+++...... ......++..|+|||++. ...++.++|||||||++|||++ |..||...
T Consensus 152 ~~----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~~~~~~p~~~~ 225 (277)
T cd05062 152 VA----EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK--DGVFTTYSDVWSFGVVLWEIATLAEQPYQGM 225 (277)
T ss_pred Ec----CCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhh--cCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99 77889999999987432211 111223577899999987 4567899999999999999999 79999888
Q ss_pred ChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1025 HYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1025 ~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
........+.... ....+..++..+.++|.+||+.+|.+|||+.++++.|.
T Consensus 226 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 226 SNEQVLRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CHHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 7766665554433 34566778999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=326.68 Aligned_cols=255 Identities=34% Similarity=0.603 Sum_probs=215.3
Q ss_pred eccCCeeEEEEecccCceEEEEeeec-CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r-Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~ 885 (1094)
....+|++.++||.|+||.||+|.+. +..+|+|.+.... ......+.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 74 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD--------LLKQQDFQKEVQALKRLRHKHLISLFAVCSVG 74 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc--------hhhHHHHHHHHHHHhcCCCcchhheeeeEecC
Confidence 34568999999999999999999886 4779999986542 11234677899999999999999999999876
Q ss_pred CCCceEEEeeecccchhHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRK-DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~-~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
. .+++||||+++++|.+++... ...+++..++.++.||+.||.|||++|++|+||||+|||++ .++.+||+||
T Consensus 75 ~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~----~~~~~kl~d~ 148 (261)
T cd05148 75 E--PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVG----EDLVCKVADF 148 (261)
T ss_pred C--CeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEc----CCceEEEccc
Confidence 5 899999999999999999764 34589999999999999999999999999999999999998 7789999999
Q ss_pred CCcccccCcc-ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCCC
Q 037285 965 GLSKIKRNTL-VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTI 1042 (1094)
Q Consensus 965 GLSrl~~~~~-~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~i 1042 (1094)
|++....... ......++..|+|||++. ...++.++||||||+++|+|++ |+.||......+....+. ...+...
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~~~PE~~~--~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~ 225 (261)
T cd05148 149 GLARLIKEDVYLSSDKKIPYKWTAPEAAS--HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPC 225 (261)
T ss_pred cchhhcCCccccccCCCCceEecCHHHHc--cCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-hCCcCCC
Confidence 9997543221 122334567899999987 4567889999999999999998 899998887777666654 4456667
Q ss_pred CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1043 PSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1043 Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
+..++..+.++|.+||+.+|.+|||+.+|++.|+.+
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 226 PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 788999999999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=332.60 Aligned_cols=252 Identities=27% Similarity=0.362 Sum_probs=199.2
Q ss_pred CCeeEEEEecccCceEEEEeeec---CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC---CCCceeEEEeEee
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR---GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL---HHPNVVAFYGVVQ 883 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r---Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL---~HPNIVqL~Gv~~ 883 (1094)
.+|++.+.||+|+||.||+|++. +..||||.++...... .....+.+|+.+++++ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~ 74 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE------GMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 74 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC------CchHHHHHHHHHHHhhcccCCCCcceEEEEEe
Confidence 36899999999999999999873 4679999987543221 1123445666666655 6999999999986
Q ss_pred c---CCCCceEEEeeecccchhHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcE
Q 037285 884 D---GPGGTLATVAEYMVDGSLRHVLVRK-DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC 959 (1094)
Q Consensus 884 d---~~~~~L~IVmEYmegGSL~d~L~k~-~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~V 959 (1094)
. .....+++||||+. ++|.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+
T Consensus 75 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~----~~~~~ 149 (290)
T cd07862 75 VSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT----SSGQI 149 (290)
T ss_pred cccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEc----CCCCE
Confidence 3 22346899999996 6888888653 24589999999999999999999999999999999999998 77899
Q ss_pred EEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCC
Q 037285 960 KVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 1039 (1094)
Q Consensus 960 KLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lr 1039 (1094)
||+|||+++............+|..|+|||++. ...++.++|||||||++|||++|+.||......+.+..+......
T Consensus 150 kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~ 227 (290)
T cd07862 150 KLADFGLARIYSFQMALTSVVVTLWYRAPEVLL--QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 227 (290)
T ss_pred EEccccceEeccCCcccccccccccccChHHHh--CCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCC
Confidence 999999998654444444566899999999997 456788999999999999999999999987766655554332100
Q ss_pred C-------------------------CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1040 P-------------------------TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1040 p-------------------------~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
+ .+...++..+.++|.+||+.||++|||+.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0 0112457788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=343.60 Aligned_cols=252 Identities=25% Similarity=0.404 Sum_probs=204.1
Q ss_pred CeeEEEEecccCceEEEEeee-----cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEeec
Q 037285 811 DLEEQKELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQD 884 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~-----rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~~d 884 (1094)
+|++.+.||+|+||.||+++. .+..||+|++.+.... ........+.+|+.+++++ +|+||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALV----QKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHh----hhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec
Confidence 588999999999999999875 3677999999764221 1122345677899999999 49999999999887
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
.. .+++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+||
T Consensus 77 ~~--~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~----~~~~~kl~Df 149 (332)
T cd05614 77 EA--KLHLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLD----SEGHVVLTDF 149 (332)
T ss_pred CC--EEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEEC----CCCCEEEeeC
Confidence 54 8999999999999999987654 489999999999999999999999999999999999998 6789999999
Q ss_pred CCcccccC--ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh----HHHHHhHhhccC
Q 037285 965 GLSKIKRN--TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY----GAIIGGIVNNTL 1038 (1094)
Q Consensus 965 GLSrl~~~--~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~----~eile~Iv~~~l 1038 (1094)
|+++.... ........||..|+|||++.+ ...++.++|||||||++|||+||+.||..... ......+. ..
T Consensus 150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~--~~ 226 (332)
T cd05614 150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRG-KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL--KC 226 (332)
T ss_pred cCCccccccCCCccccccCCccccCHHHhcC-CCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh--cC
Confidence 99874322 222234569999999999874 33467899999999999999999999964322 22222222 23
Q ss_pred CCCCCCcCcHHHHHHHHHhccCCCCCCC-----CHHHHHHHHH
Q 037285 1039 RPTIPSYCDAEWRTLMEECWAPNPAARP-----SFTEIASRLR 1076 (1094)
Q Consensus 1039 rp~iPe~~S~eL~dLI~kCLq~DPeeRP-----S~eELLq~L~ 1076 (1094)
.+.++..++..+.++|.+||+.||++|| ++.+++++-+
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 269 (332)
T cd05614 227 DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF 269 (332)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCC
Confidence 4556778899999999999999999999 7889987643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=341.60 Aligned_cols=247 Identities=27% Similarity=0.444 Sum_probs=204.5
Q ss_pred eeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHH---hhCCCCceeEEEeEeecCC
Q 037285 812 LEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL---SKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 812 Yei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkIL---krL~HPNIVqL~Gv~~d~~ 886 (1094)
|++.+.||+|+||.||+|.++ ++.||||++++..... ......+.+|+.++ ++++||||+++++++....
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIA-----RDEVESLMCEKRIFETANSERHPFLVNLFACFQTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh-----hhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC
Confidence 678899999999999999875 6789999997643211 12233455565554 5678999999999998765
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+|+||||+.+++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 76 --~~~lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~----~~~~~kL~Dfg~ 147 (324)
T cd05589 76 --HVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD----TEGFVKIADFGL 147 (324)
T ss_pred --EEEEEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC----CCCcEEeCcccC
Confidence 89999999999999988754 3589999999999999999999999999999999999999 778999999999
Q ss_pred ccccc-CccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCc
Q 037285 967 SKIKR-NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSY 1045 (1094)
Q Consensus 967 Srl~~-~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~ 1045 (1094)
++... .........|++.|+|||++. ...++.++|||||||++|+|++|+.||......+....+.... ..++..
T Consensus 148 ~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--~~~p~~ 223 (324)
T cd05589 148 CKEGMGFGDRTSTFCGTPEFLAPEVLT--ETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE--VRYPRF 223 (324)
T ss_pred CccCCCCCCcccccccCccccCHhHhc--CCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCC
Confidence 87432 222234467899999999998 4567889999999999999999999999888777776665543 346678
Q ss_pred CcHHHHHHHHHhccCCCCCCC-----CHHHHHHHH
Q 037285 1046 CDAEWRTLMEECWAPNPAARP-----SFTEIASRL 1075 (1094)
Q Consensus 1046 ~S~eL~dLI~kCLq~DPeeRP-----S~eELLq~L 1075 (1094)
++..+.++|.+||+.||.+|| ++.+++++.
T Consensus 224 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~ 258 (324)
T cd05589 224 LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP 258 (324)
T ss_pred CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence 899999999999999999999 688888764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=324.82 Aligned_cols=245 Identities=32% Similarity=0.558 Sum_probs=204.6
Q ss_pred EecccCceEEEEeeec----CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEE
Q 037285 817 ELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLAT 892 (1094)
Q Consensus 817 kLGsG~FGtVYKAk~r----Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~I 892 (1094)
+||+|+||.||+|.++ +..+|+|+++... .......++.+|+.+++++.|+||+++++++... .+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~l 72 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN------NDPALKDELLREANVMQQLDNPYIVRMIGICEAE---SWML 72 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC------CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC---CcEE
Confidence 5899999999999763 5679999886432 1123456788999999999999999999998643 5789
Q ss_pred EeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccC
Q 037285 893 VAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRN 972 (1094)
Q Consensus 893 VmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~ 972 (1094)
||||+.+++|.+++.... .+++..++.++.|++.||+|||++||+||||||.|||++ .++.+||+|||+++....
T Consensus 73 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~----~~~~~kl~Dfg~~~~~~~ 147 (257)
T cd05116 73 VMELAELGPLNKFLQKNK-HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLV----TQHYAKISDFGLSKALGA 147 (257)
T ss_pred EEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEc----CCCeEEECCCccccccCC
Confidence 999999999999997554 589999999999999999999999999999999999998 678899999999975432
Q ss_pred ccc----cCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCCCCCcCc
Q 037285 973 TLV----SGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCD 1047 (1094)
Q Consensus 973 ~~~----ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S 1047 (1094)
... .....++..|+|||.+. ...++.++|||||||++|||++ |+.||......+....+ .....+..+..++
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i-~~~~~~~~~~~~~ 224 (257)
T cd05116 148 DENYYKAKTHGKWPVKWYAPECMN--YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI-ESGERMECPQRCP 224 (257)
T ss_pred CCCeeeecCCCCCCccccCHhHhc--cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HCCCCCCCCCCCC
Confidence 211 11223457899999987 4567889999999999999998 99999987776665555 4445567788899
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1048 AEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1048 ~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
.++.++|.+||+.||++||++.+|.+.|+..
T Consensus 225 ~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 225 PEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 9999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=342.74 Aligned_cols=245 Identities=29% Similarity=0.461 Sum_probs=205.1
Q ss_pred EEecccCceEEEEeee-----cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCce
Q 037285 816 KELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTL 890 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~-----rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L 890 (1094)
+.||+|+||.||+++. .++.||||+++..... ........+.+|+.+|++++||||+++++++.... .+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~--~~ 75 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV----RNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGG--KL 75 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHH----hhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCC--eE
Confidence 6799999999999875 3577999999764221 11222345678999999999999999999998754 89
Q ss_pred EEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccc
Q 037285 891 ATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK 970 (1094)
Q Consensus 891 ~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~ 970 (1094)
++||||+.+++|.+++.... .+.+..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++..
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~----~~~~~kl~Dfg~~~~~ 150 (323)
T cd05584 76 YLILEYLSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLD----AQGHVKLTDFGLCKES 150 (323)
T ss_pred EEEEeCCCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----CCCCEEEeeCcCCeec
Confidence 99999999999999987654 478888999999999999999999999999999999998 7889999999998743
Q ss_pred -cCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCcHH
Q 037285 971 -RNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAE 1049 (1094)
Q Consensus 971 -~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~e 1049 (1094)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||...........+.... ..++..++..
T Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~ 226 (323)
T cd05584 151 IHEGTVTHTFCGTIEYMAPEILM--RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK--LNLPPYLTPE 226 (323)
T ss_pred ccCCCcccccCCCccccChhhcc--CCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHH
Confidence 2222333456899999999997 4457889999999999999999999999888777766665543 3567788999
Q ss_pred HHHHHHHhccCCCCCCC-----CHHHHHHHH
Q 037285 1050 WRTLMEECWAPNPAARP-----SFTEIASRL 1075 (1094)
Q Consensus 1050 L~dLI~kCLq~DPeeRP-----S~eELLq~L 1075 (1094)
+.++|.+||+.+|++|| ++.+++++-
T Consensus 227 ~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~ 257 (323)
T cd05584 227 ARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP 257 (323)
T ss_pred HHHHHHHHcccCHhHcCCCCCCCHHHHhcCC
Confidence 99999999999999999 899988864
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=327.03 Aligned_cols=257 Identities=29% Similarity=0.540 Sum_probs=212.5
Q ss_pred eeccCCeeEEEEecccCceEEEEeeec--Cc----eEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEE
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWR--GT----DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFY 879 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~r--Gt----~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~ 879 (1094)
.+...+|++.+.||+|+||+||+|++. +. .||+|+++.... ......+.+|+.+++.++|+||++++
T Consensus 3 ~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~-------~~~~~~~~~e~~~l~~~~~~~i~~~~ 75 (279)
T cd05109 3 ILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS-------PKANKEILDEAYVMAGVGSPYVCRLL 75 (279)
T ss_pred ccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC-------HHHHHHHHHHHHHHHhcCCCCCceEE
Confidence 356678999999999999999999873 43 489998865321 22335688899999999999999999
Q ss_pred eEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcE
Q 037285 880 GVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC 959 (1094)
Q Consensus 880 Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~V 959 (1094)
+++... ..++++||+++|+|.+++......+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+
T Consensus 76 ~~~~~~---~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~----~~~~~ 148 (279)
T cd05109 76 GICLTS---TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVK----SPNHV 148 (279)
T ss_pred EEEcCC---CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc----CCCcE
Confidence 999753 57889999999999999977666689999999999999999999999999999999999998 67789
Q ss_pred EEEecCCcccccCccc---cCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhh
Q 037285 960 KVGDFGLSKIKRNTLV---SGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 1035 (1094)
Q Consensus 960 KLsDFGLSrl~~~~~~---ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~ 1035 (1094)
||+|||+++....... .....++..|+|||.+. ...++.++|||||||++|||++ |..||........... ..
T Consensus 149 kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~-~~ 225 (279)
T cd05109 149 KITDFGLARLLDIDETEYHADGGKVPIKWMALESIL--HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDL-LE 225 (279)
T ss_pred EECCCCceeecccccceeecCCCccchhhCCHHHhc--cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HH
Confidence 9999999985432211 12223567899999987 4568899999999999999998 9999987766555443 34
Q ss_pred ccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1036 NTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1036 ~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
.......+..++..+.++|.+||..||++||++.++++.|..+.
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 226 KGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred CCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 44445556778999999999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=345.32 Aligned_cols=262 Identities=31% Similarity=0.526 Sum_probs=215.2
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeec-------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCcee
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVV 876 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~r-------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIV 876 (1094)
|.+..++|++.+.||+|+||.||+|.+. ++.||+|+++.... ......+.+|+.++.++ +|+||+
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~-------~~~~~~~~~E~~~~~~l~~h~niv 74 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT-------ASEYKALMTELKILIHIGHHLNVV 74 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC-------HHHHHHHHHHHHHHHhhccCcchh
Confidence 6777889999999999999999999753 25699999864311 11234677899999999 899999
Q ss_pred EEEeEeecCCCCceEEEeeecccchhHHHHhhcc----------------------------------------------
Q 037285 877 AFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD---------------------------------------------- 910 (1094)
Q Consensus 877 qL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~---------------------------------------------- 910 (1094)
+++++|... ...++++|||+.+++|.+++....
T Consensus 75 ~~~~~~~~~-~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (337)
T cd05054 75 NLLGACTKP-GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSL 153 (337)
T ss_pred heeeeEecC-CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcch
Confidence 999988653 347899999999999999985421
Q ss_pred --------------cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccCc---
Q 037285 911 --------------RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT--- 973 (1094)
Q Consensus 911 --------------~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~--- 973 (1094)
..+++..+..++.||+.||+|||+++|+||||||+|||++ .++.+||+|||+++.....
T Consensus 154 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~----~~~~vkL~DfG~a~~~~~~~~~ 229 (337)
T cd05054 154 SDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS----ENNVVKICDFGLARDIYKDPDY 229 (337)
T ss_pred hhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEe----CCCcEEEeccccchhcccCcch
Confidence 2578899999999999999999999999999999999999 6788999999999853221
Q ss_pred cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHH
Q 037285 974 LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRT 1052 (1094)
Q Consensus 974 ~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~d 1052 (1094)
.......++..|+|||++. ...++.++|||||||++|||++ |..||......+..........++..+..++.++.+
T Consensus 230 ~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (337)
T cd05054 230 VRKGDARLPLKWMAPESIF--DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYS 307 (337)
T ss_pred hhccCCCCCccccCcHHhc--CCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHH
Confidence 1122334567899999987 4578899999999999999998 999998765545444455555666667788899999
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 037285 1053 LMEECWAPNPAARPSFTEIASRLRVLST 1080 (1094)
Q Consensus 1053 LI~kCLq~DPeeRPS~eELLq~L~~L~t 1080 (1094)
++.+||+.+|++||++.+|+++|..+..
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=324.74 Aligned_cols=254 Identities=34% Similarity=0.607 Sum_probs=213.7
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeec-CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEee
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQ 883 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~r-Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~ 883 (1094)
|+|..++|++.++||+|+||.||+|... +..||+|.+...... ...+.+|+.++++++|+||+++++++.
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~~ 71 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---------PEAFLAEANLMKQLQHPRLVRLYAVVT 71 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc---------HHHHHHHHHHHHhcCCcCeeeEEEEEc
Confidence 4677789999999999999999999875 578999998754221 246788999999999999999999875
Q ss_pred cCCCCceEEEeeecccchhHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLVRK-DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~k~-~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
.. ..+++|||+.+++|.+++... ...+++..++.++.|++.||+|||+.+++|+||||+||+++ .++.++|+
T Consensus 72 ~~---~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~----~~~~~~l~ 144 (260)
T cd05067 72 QE---PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVS----ETLCCKIA 144 (260)
T ss_pred cC---CcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEc----CCCCEEEc
Confidence 43 689999999999999998653 34588999999999999999999999999999999999999 77889999
Q ss_pred ecCCcccccCc--cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCC
Q 037285 963 DFGLSKIKRNT--LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLR 1039 (1094)
Q Consensus 963 DFGLSrl~~~~--~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lr 1039 (1094)
|||++...... .......++..|+|||++. ...++.++||||||+++|+|++ |+.||......+....+ .....
T Consensus 145 dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~--~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~ 221 (260)
T cd05067 145 DFGLARLIEDNEYTAREGAKFPIKWTAPEAIN--YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL-ERGYR 221 (260)
T ss_pred cCcceeecCCCCcccccCCcccccccCHHHhc--cCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-HcCCC
Confidence 99998754321 1122334567899999987 4567889999999999999999 99999988776666554 44555
Q ss_pred CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1040 PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1040 p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
...+..++.++.++|.+||..+|++||++++|+..|+.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 56777888999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=320.90 Aligned_cols=250 Identities=34% Similarity=0.646 Sum_probs=210.9
Q ss_pred ccCCeeEEEEecccCceEEEEeeec-CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~r-Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
...+|++.+.||+|+||.||++.+. +..+|+|.+...... ...|.+|++++++++||||+++++++....
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~---------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---------EEDFIEEAQVMMKLSHPKLVQLYGVCTERS 72 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC---------HHHHHHHHHHHHhCCCCCeeeEEEEEccCC
Confidence 3468999999999999999999886 678999988654221 246788999999999999999999988755
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
..++||||+.+++|.+++......++++.++.++.|++.+|+|||+++++|+||||+||+++ .++.+||+|||+
T Consensus 73 --~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~----~~~~~~l~d~g~ 146 (256)
T cd05112 73 --PICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVG----ENQVVKVSDFGM 146 (256)
T ss_pred --ceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEc----CCCeEEECCCcc
Confidence 88999999999999999977666689999999999999999999999999999999999998 678899999999
Q ss_pred cccccCcc--ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCCCC
Q 037285 967 SKIKRNTL--VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIP 1043 (1094)
Q Consensus 967 Srl~~~~~--~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~iP 1043 (1094)
++...... ......++..|+|||.+. ...++.++||||||+++|+|++ |+.||...........+ ....+...+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~aPe~~~--~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~ 223 (256)
T cd05112 147 TRFVLDDQYTSSTGTKFPVKWSSPEVFS--FSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI-NAGFRLYKP 223 (256)
T ss_pred eeecccCcccccCCCccchhhcCHhHhc--cCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH-hCCCCCCCC
Confidence 87443221 112233567899999987 4567889999999999999998 99999887776666655 334455556
Q ss_pred CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037285 1044 SYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1044 e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L 1075 (1094)
...+..+.+|+.+||+.+|++||++.+++++|
T Consensus 224 ~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 224 RLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 67889999999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=324.62 Aligned_cols=254 Identities=35% Similarity=0.620 Sum_probs=212.7
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeec-CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEee
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQ 883 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~r-Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~ 883 (1094)
|++..++|++.++||+|+||.||+|.+. +..+|+|.+...... ...|.+|+.++++++|+||+++++++.
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---------~~~~~~E~~~l~~l~~~~i~~~~~~~~ 71 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---------PESFLEEAQIMKKLRHDKLVQLYAVVS 71 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC---------HHHHHHHHHHHHhcCCCceEEEEeEEC
Confidence 4566789999999999999999999875 467999998754221 245889999999999999999999885
Q ss_pred cCCCCceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
.. ..+++|||+.+++|.+++.... ..+++..++.++.|++.||+|||+++++||||||+||+++ +++.+||+
T Consensus 72 ~~---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~----~~~~~~l~ 144 (260)
T cd05070 72 EE---PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG----DGLVCKIA 144 (260)
T ss_pred CC---CcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEe----CCceEEeC
Confidence 43 5889999999999999987543 4589999999999999999999999999999999999998 77899999
Q ss_pred ecCCcccccCcc--ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCC
Q 037285 963 DFGLSKIKRNTL--VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLR 1039 (1094)
Q Consensus 963 DFGLSrl~~~~~--~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lr 1039 (1094)
|||++....... ......++..|+|||++. ...++.++||||||+++|+|++ |..||......+....+. ....
T Consensus 145 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~ 221 (260)
T cd05070 145 DFGLARLIEDNEYTARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYR 221 (260)
T ss_pred CceeeeeccCcccccccCCCCCccccChHHHh--cCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCC
Confidence 999998543221 112233567899999987 4567889999999999999999 999998887776666553 3455
Q ss_pred CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1040 PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1040 p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
...+..++..+.+|+.+||..+|.+|||+.++.+.|+.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 56677889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=349.38 Aligned_cols=252 Identities=25% Similarity=0.351 Sum_probs=206.1
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||+|+||.||+++.+ +..||||++.+... ........+.+|+.++++++||||+++++++.+..
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~- 74 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM-----FKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ- 74 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHH-----HHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-
Confidence 47899999999999999999874 67899999865321 12233456788999999999999999999998765
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+|+||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 75 -~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~----~~~~~kl~DfGla 148 (377)
T cd05629 75 -YLYLIMEFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILID----RGGHIKLSDFGLS 148 (377)
T ss_pred -eeEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC----CCCCEEEeecccc
Confidence 8999999999999999987654 588999999999999999999999999999999999998 7789999999998
Q ss_pred ccccCcc------------------------------------------------ccCCccCCCcccCccccccCCCCCC
Q 037285 968 KIKRNTL------------------------------------------------VSGGVRGTLPWMAPELLSGSSSKVS 999 (1094)
Q Consensus 968 rl~~~~~------------------------------------------------~ss~~~GT~~YmAPEvL~g~~~kyS 999 (1094)
+...... .....+||+.|+|||++. ...++
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~ 226 (377)
T cd05629 149 TGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL--QQGYG 226 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHc--cCCCC
Confidence 6211000 001246899999999997 45688
Q ss_pred chhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCC--cCcHHHHHHHHHhccCCCCCC---CCHHHHHHH
Q 037285 1000 EKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPS--YCDAEWRTLMEECWAPNPAAR---PSFTEIASR 1074 (1094)
Q Consensus 1000 ~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe--~~S~eL~dLI~kCLq~DPeeR---PS~eELLq~ 1074 (1094)
.++|||||||++|||++|+.||......+....+........++. .++.++.+||.+||. +|.+| +++.+++.+
T Consensus 227 ~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 227 QECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred CceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 999999999999999999999988777666666554333333443 478899999999997 67765 599999988
Q ss_pred HH
Q 037285 1075 LR 1076 (1094)
Q Consensus 1075 L~ 1076 (1094)
.+
T Consensus 306 p~ 307 (377)
T cd05629 306 PF 307 (377)
T ss_pred CC
Confidence 54
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=340.18 Aligned_cols=248 Identities=25% Similarity=0.378 Sum_probs=206.3
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCC-ceeEEEeEeecCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP-NVVAFYGVVQDGPG 887 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HP-NIVqL~Gv~~d~~~ 887 (1094)
+|++.+.||+|+||.||+|+++ +..||||++.+.... .......+..|+.++..+.|+ +|+++++++....
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~- 74 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVII-----QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD- 74 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC-
Confidence 5889999999999999999886 467999999764321 122335677899999999765 5888988888755
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++||||+.+|+|..++.... .+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 75 -~~~lv~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~----~~~~~kL~Dfg~~ 148 (324)
T cd05587 75 -RLYFVMEYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD----AEGHIKIADFGMC 148 (324)
T ss_pred -EEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEc----CCCCEEEeecCcc
Confidence 8999999999999999987654 488999999999999999999999999999999999998 7789999999998
Q ss_pred cccc-CccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcC
Q 037285 968 KIKR-NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYC 1046 (1094)
Q Consensus 968 rl~~-~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~ 1046 (1094)
+... .........||+.|+|||++. ...++.++|||||||++|+|+||+.||......+....+... ...++..+
T Consensus 149 ~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~--~~~~~~~~ 224 (324)
T cd05587 149 KENIFGGKTTRTFCGTPDYIAPEIIA--YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH--NVSYPKSL 224 (324)
T ss_pred eecCCCCCceeeecCCccccChhhhc--CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCCC
Confidence 7421 222233456899999999998 456788999999999999999999999988877777766543 34567788
Q ss_pred cHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 037285 1047 DAEWRTLMEECWAPNPAARPSF-----TEIASR 1074 (1094)
Q Consensus 1047 S~eL~dLI~kCLq~DPeeRPS~-----eELLq~ 1074 (1094)
+.++.++|.+||..||.+|++. .+++++
T Consensus 225 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 225 SKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 9999999999999999999976 677765
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=368.81 Aligned_cols=246 Identities=28% Similarity=0.455 Sum_probs=215.7
Q ss_pred eeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEe
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVV 882 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~ 882 (1094)
.+..++|.++++||+|.||+|+++..+ ++.+|||++++..+-.+. .++....|.+|+... +||.+++++.+|
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d-----~Ve~~~~EkrI~~la~~HPFL~~L~~~f 438 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRD-----EVESLMCEKRIFELANRHPFLVNLFSCF 438 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccc-----cHHHHHHHHHHHHHhccCCeEeeccccc
Confidence 467789999999999999999999886 466999999998765433 234556677777766 499999999999
Q ss_pred ecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 883 QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 883 ~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
++.. ++|+||||+.||++..+. ....+++..+..++..|+.||.|||++||||||||.+|||+| ..|++||+
T Consensus 439 QT~~--~l~fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD----~eGh~kiA 510 (694)
T KOG0694|consen 439 QTKE--HLFFVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLD----TEGHVKIA 510 (694)
T ss_pred ccCC--eEEEEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEc----ccCcEEec
Confidence 9876 999999999999955444 334589999999999999999999999999999999999999 88999999
Q ss_pred ecCCccc-ccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCC
Q 037285 963 DFGLSKI-KRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT 1041 (1094)
Q Consensus 963 DFGLSrl-~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~ 1041 (1094)
|||+++. ......++++|||+.|||||++. ...|+..+|+|||||+||||+.|..||.+.+.+++...++.... .
T Consensus 511 DFGlcKe~m~~g~~TsTfCGTpey~aPEil~--e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~--~ 586 (694)
T KOG0694|consen 511 DFGLCKEGMGQGDRTSTFCGTPEFLAPEVLT--EQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEV--R 586 (694)
T ss_pred ccccccccCCCCCccccccCChhhcChhhhc--cCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC--C
Confidence 9999994 33555778899999999999999 56899999999999999999999999999999999999987654 5
Q ss_pred CCCcCcHHHHHHHHHhccCCCCCCCCH
Q 037285 1042 IPSYCDAEWRTLMEECWAPNPAARPSF 1068 (1094)
Q Consensus 1042 iPe~~S~eL~dLI~kCLq~DPeeRPS~ 1068 (1094)
+|..++.+..+||+++|..+|++|.-+
T Consensus 587 yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 587 YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCcccHHHHHHHHHHhccCcccccCC
Confidence 888999999999999999999999743
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=319.39 Aligned_cols=249 Identities=28% Similarity=0.478 Sum_probs=210.7
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
+|++.+.||+|+||.||++++. +..|++|.+...... ......+.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 72 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN------RREREEAIDEARVLAKLDSSYIIRYYESFLDKG-- 72 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC------HHHHHHHHHHHHHHHhcCCCCeehheeeeccCC--
Confidence 5788999999999999999884 678999998754221 233467889999999999999999999998754
Q ss_pred ceEEEeeecccchhHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 889 TLATVAEYMVDGSLRHVLVRK-DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~-~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
..++||||+.+++|.+++... ...+++..++.++.||+.||.|||+++++|+||||+||+++ .++.+||+|||++
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~----~~~~~~l~df~~~ 148 (256)
T cd08529 73 KLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD----AYDNVKIGDLGVA 148 (256)
T ss_pred EEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEe----CCCCEEEcccccc
Confidence 899999999999999999764 45689999999999999999999999999999999999999 7789999999998
Q ss_pred ccccCc-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcC
Q 037285 968 KIKRNT-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYC 1046 (1094)
Q Consensus 968 rl~~~~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~ 1046 (1094)
+..... .......+++.|+|||++. ...++.++|||||||++|+|++|+.||...........+.. ...+.++..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~ 225 (256)
T cd08529 149 KLLSDNTNFANTIVGTPYYLSPELCE--DKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR-GVFPPVSQMY 225 (256)
T ss_pred eeccCccchhhccccCccccCHHHhc--CCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-CCCCCCcccc
Confidence 854332 2223345888999999998 44578899999999999999999999988876666655543 3345566678
Q ss_pred cHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1047 DAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1047 S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
+..+.++|.+||+.+|++||++.+++++
T Consensus 226 ~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 226 SQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 8999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=329.61 Aligned_cols=260 Identities=31% Similarity=0.556 Sum_probs=216.4
Q ss_pred ceeeccCCeeEEEEecccCceEEEEeeecC-------ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCce
Q 037285 804 VQVIKNEDLEEQKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNV 875 (1094)
Q Consensus 804 v~eIs~edYei~kkLGsG~FGtVYKAk~rG-------t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNI 875 (1094)
.+.+..++|++.+.||+|+||.||++.+.+ ..+|+|.+.... . .....++.+|+.+++++ +|+||
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-----~--~~~~~~~~~E~~~l~~l~~h~~i 78 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-----T--EKDLSDLVSEMEMMKMIGKHKNI 78 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-----C--HHHHHHHHHHHHHHHhhcCCCCe
Confidence 467788899999999999999999998742 458999886531 1 12235688999999999 79999
Q ss_pred eEEEeEeecCCCCceEEEeeecccchhHHHHhhc---------------ccccCHHHHHHHHHHHHHHHHHHHHCCceec
Q 037285 876 VAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRK---------------DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHF 940 (1094)
Q Consensus 876 VqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~---------------~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHR 940 (1094)
+++++++.... .++++|||+.+|+|..++... ...+++..++.++.||+.||+|||+++|+||
T Consensus 79 ~~~~~~~~~~~--~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~ 156 (293)
T cd05053 79 INLLGVCTQEG--PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHR 156 (293)
T ss_pred eeEEEEEcCCC--CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 99999998754 899999999999999998642 2458899999999999999999999999999
Q ss_pred cCCCCceEeccCCCCCCcEEEEecCCcccccCcc---ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-
Q 037285 941 DLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTL---VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT- 1016 (1094)
Q Consensus 941 DLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~~---~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT- 1016 (1094)
||||+|||++ .++.+||+|||+++...... ......++..|+|||++. ...++.++|||||||++|||++
T Consensus 157 dlkp~Nil~~----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~~ 230 (293)
T cd05053 157 DLAARNVLVT----EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLLWEIFTL 230 (293)
T ss_pred ccceeeEEEc----CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhc--cCCcCcccceeehhhHHHHHhcC
Confidence 9999999998 77899999999998543221 112223567899999987 4567899999999999999998
Q ss_pred CCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1017 GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1017 Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
|..||......+....+ ........+..++..+.+|+.+||..+|.+|||+.++++.|.++.
T Consensus 231 g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 231 GGSPYPGIPVEELFKLL-KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CCCCCCCCCHHHHHHHH-HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 99999887776666554 444555667788999999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=353.86 Aligned_cols=253 Identities=27% Similarity=0.455 Sum_probs=227.2
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
..+|++.+.||+|+||.|-+|... |+.||||.|++..+.+ +...-.+.+||.||..|+||||+++|.+|....
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkd-----eqDlvhIRREIeIMSsLNHPhII~IyEVFENkd 126 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKD-----EQDLVHIRREIEIMSSLNHPHIIQIYEVFENKD 126 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhccc-----HHHHHHHHHHHHHHhhcCCCceeehhhhhcCCc
Confidence 358999999999999999999763 8899999999875432 333457889999999999999999999998765
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+.|||||..+|.|.+|+..++. +++..+..+++||..|+.|+|.++++|||||.+|||+| .++++||+|||+
T Consensus 127 --KIvivMEYaS~GeLYDYiSer~~-LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD----~N~NiKIADFGL 199 (668)
T KOG0611|consen 127 --KIVIVMEYASGGELYDYISERGS-LSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLD----QNNNIKIADFGL 199 (668)
T ss_pred --eEEEEEEecCCccHHHHHHHhcc-ccHHHHHHHHHHHHHHHHHHhhccceecccchhheeec----CCCCeeeeccch
Confidence 89999999999999999987765 99999999999999999999999999999999999999 899999999999
Q ss_pred cccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcC
Q 037285 967 SKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYC 1046 (1094)
Q Consensus 967 Srl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~ 1046 (1094)
+.+........++||++-|.+||+++|..++ .+.+|.|||||+||-|+.|.+||++.+...++.++..+.++.+ .-
T Consensus 200 SNly~~~kfLqTFCGSPLYASPEIvNG~PY~-GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP---~~ 275 (668)
T KOG0611|consen 200 SNLYADKKFLQTFCGSPLYASPEIVNGTPYK-GPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP---ET 275 (668)
T ss_pred hhhhccccHHHHhcCCcccCCccccCCCCCC-CCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC---CC
Confidence 9988888888889999999999999975544 7889999999999999999999999999999999988887643 33
Q ss_pred cHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1047 DAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1047 S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
+....-||++||..+|++|.|+.+|..+-|.
T Consensus 276 PSdA~gLIRwmLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 276 PSDASGLIRWMLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred CchHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence 5567889999999999999999999998764
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=343.25 Aligned_cols=255 Identities=23% Similarity=0.321 Sum_probs=211.1
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||+|+||.||+++.+ +..||||+++..... .......+.+|+.+++.++|+||+++++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~- 74 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL-----AQETVSFFEEERDILSISNSPWIPQLQYAFQDKD- 74 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC-
Confidence 36899999999999999999874 678999999864221 1223456778999999999999999999998754
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++||||+++|+|.+++.+....+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 75 -~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~----~~~~~kL~Dfg~a 149 (330)
T cd05601 75 -NLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLID----RTGHIKLADFGSA 149 (330)
T ss_pred -eEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEEC----CCCCEEeccCCCC
Confidence 89999999999999999987756799999999999999999999999999999999999999 7889999999999
Q ss_pred ccccCcc--ccCCccCCCcccCccccccC----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCC
Q 037285 968 KIKRNTL--VSGGVRGTLPWMAPELLSGS----SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT 1041 (1094)
Q Consensus 968 rl~~~~~--~ss~~~GT~~YmAPEvL~g~----~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~ 1041 (1094)
....... ......||+.|+|||++... ...++.++|||||||++|+|++|+.||...........+........
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~ 229 (330)
T cd05601 150 ARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLK 229 (330)
T ss_pred eECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccC
Confidence 7543221 22234689999999998631 34577899999999999999999999998877776666654432223
Q ss_pred CC--CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1042 IP--SYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1042 iP--e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
++ ..++..+.+||.+||. +|.+||++.+++.+-+
T Consensus 230 ~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~ 265 (330)
T cd05601 230 FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPF 265 (330)
T ss_pred CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCC
Confidence 33 3578999999999998 9999999999997643
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=327.41 Aligned_cols=254 Identities=34% Similarity=0.579 Sum_probs=208.8
Q ss_pred ccCCeeEEEEecccCceEEEEeee------cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeE
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKW------RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGV 881 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~------rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv 881 (1094)
..++|++.+.||+|+||.||+|++ .+..||+|.+.... .......|.+|+.++++++||||++++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 75 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-------NPQQWGEFQQEASLMAELHHPNIVCLLGV 75 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-------CHHHHHHHHHHHHHHhhCCCCCeeeEEEE
Confidence 346789999999999999999985 23569999886431 11223568889999999999999999999
Q ss_pred eecCCCCceEEEeeecccchhHHHHhhcc----------------cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 037285 882 VQDGPGGTLATVAEYMVDGSLRHVLVRKD----------------RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCD 945 (1094)
Q Consensus 882 ~~d~~~~~L~IVmEYmegGSL~d~L~k~~----------------~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPe 945 (1094)
+.... ..++||||+.+++|.+++.... ..+++..++.++.||+.||+|||+++++||||||+
T Consensus 76 ~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~ 153 (283)
T cd05090 76 VTQEQ--PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAAR 153 (283)
T ss_pred EecCC--ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccc
Confidence 88755 8999999999999999985321 24788889999999999999999999999999999
Q ss_pred ceEeccCCCCCCcEEEEecCCcccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCC
Q 037285 946 NLLVNLKDPSRPICKVGDFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPY 1021 (1094)
Q Consensus 946 NILLD~~~~e~g~VKLsDFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF 1021 (1094)
|||++ ..+.+||+|||+++..... .......++..|+|||++. ...++.++|||||||++|||++ |..||
T Consensus 154 nili~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~il~el~~~g~~p~ 227 (283)
T cd05090 154 NILIG----EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIM--YGKFSSDSDIWSFGVVLWEIFSFGLQPY 227 (283)
T ss_pred eEEEc----CCCcEEeccccccccccCCcceecccCCCccceecChHHhc--cCCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence 99998 6778999999999753221 1122334567899999987 4567899999999999999998 99999
Q ss_pred CCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1022 ANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1022 ~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
...........+. ....+..+..++..+.++|.+||+.+|++||++.+|+++|..
T Consensus 228 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 228 YGFSNQEVIEMVR-KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred CCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 8877666555543 334455677889999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=324.83 Aligned_cols=255 Identities=35% Similarity=0.612 Sum_probs=212.1
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeecC-ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEee
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQ 883 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~rG-t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~ 883 (1094)
|++..++|++.++||+|+||.||+|++.+ ..||+|++..... ....|.+|+.++++++|+||+++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~---------~~~~~~~E~~~l~~l~~~~i~~~~~~~~ 71 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---------SPEAFLQEAQVMKKLRHEKLVQLYAVVS 71 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc---------CHHHHHHHHHHHHhCCCCCcceEEEEEC
Confidence 45667889999999999999999998864 4699999875321 1246788999999999999999999875
Q ss_pred cCCCCceEEEeeecccchhHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLVRK-DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~k~-~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
.. ..++||||+.+++|.+++... ...+++..++.++.|++.||+|||+++++|+||||+||+++ .++.+||+
T Consensus 72 ~~---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~----~~~~~~L~ 144 (262)
T cd05071 72 EE---PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG----ENLVCKVA 144 (262)
T ss_pred CC---CcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEc----CCCcEEec
Confidence 43 578999999999999999754 34578999999999999999999999999999999999998 67889999
Q ss_pred ecCCcccccCcc--ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCC
Q 037285 963 DFGLSKIKRNTL--VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLR 1039 (1094)
Q Consensus 963 DFGLSrl~~~~~--~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lr 1039 (1094)
|||+++...... ......++..|+|||+.. ...++.++|||||||++|+|+| |..||......+....+. ....
T Consensus 145 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~-~~~~ 221 (262)
T cd05071 145 DFGLARLIEDNEYTARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYR 221 (262)
T ss_pred cCCceeeccccccccccCCcccceecCHhHhc--cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh-cCCC
Confidence 999997543221 122334667899999987 4567899999999999999999 899998877766665543 3334
Q ss_pred CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1040 PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1040 p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
...+..++..+.++|.+||+.+|++||++.++++.|+..
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 445667889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=328.46 Aligned_cols=258 Identities=36% Similarity=0.598 Sum_probs=214.5
Q ss_pred eccCCeeEEEEecccCceEEEEeeec-------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEE
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFY 879 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r-------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~ 879 (1094)
|...+|.+.+.||+|+||.||++... +..+|+|.+.... ......+.+|+.++++++||||++++
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~ 73 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--------DNARKDFHREAELLTNLQHEHIVKFY 73 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--------HHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 45578999999999999999998742 2458999876431 22345788999999999999999999
Q ss_pred eEeecCCCCceEEEeeecccchhHHHHhhcc------------cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCce
Q 037285 880 GVVQDGPGGTLATVAEYMVDGSLRHVLVRKD------------RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNL 947 (1094)
Q Consensus 880 Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~------------~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNI 947 (1094)
+++.... .+++||||+.+++|.+++.... ..+++..++.++.||+.||+|||++|++||||||+||
T Consensus 74 ~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Ni 151 (288)
T cd05093 74 GVCVEGD--PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNC 151 (288)
T ss_pred EEEecCC--ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceE
Confidence 9998754 8999999999999999986443 2489999999999999999999999999999999999
Q ss_pred EeccCCCCCCcEEEEecCCcccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 037285 948 LVNLKDPSRPICKVGDFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYAN 1023 (1094)
Q Consensus 948 LLD~~~~e~g~VKLsDFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~ 1023 (1094)
|++ .++.+||+|||+++..... .......++..|+|||++. ...++.++|||||||++|+|++ |..||..
T Consensus 152 li~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~sDiwslG~il~~l~t~g~~p~~~ 225 (288)
T cd05093 152 LVG----ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM--YRKFTTESDVWSLGVVLWEIFTYGKQPWYQ 225 (288)
T ss_pred EEc----cCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 998 7889999999998743221 1122233577899999987 4568899999999999999998 9999988
Q ss_pred CChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1024 MHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1024 ~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
.........+... .....+..++.++.+|+.+||+.||.+|||+.++++.|+++...
T Consensus 226 ~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 226 LSNNEVIECITQG-RVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred CCHHHHHHHHHcC-CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 8777766666443 33445667889999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=344.00 Aligned_cols=245 Identities=28% Similarity=0.390 Sum_probs=204.9
Q ss_pred EEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEEE
Q 037285 816 KELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATV 893 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~IV 893 (1094)
+.||+|+||.||+++. ++..||+|++.+.... .......+.+|+.+++.++||||+++++++.... .+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~-----~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~--~~~lv 73 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-----AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD--RLCFV 73 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCC--EEEEE
Confidence 4699999999999987 4678999999764322 1223456778999999999999999999998765 89999
Q ss_pred eeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeccCCCCCCcEEEEecCCccccc-
Q 037285 894 AEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKR- 971 (1094)
Q Consensus 894 mEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs-~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~- 971 (1094)
|||+.+|+|..++.... .+++..+..++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++...
T Consensus 74 ~E~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~----~~~~~kL~Dfg~~~~~~~ 148 (325)
T cd05594 74 MEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD----KDGHIKITDFGLCKEGIK 148 (325)
T ss_pred EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEEC----CCCCEEEecCCCCeecCC
Confidence 99999999998886554 58999999999999999999997 7999999999999998 77899999999987422
Q ss_pred CccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHH
Q 037285 972 NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWR 1051 (1094)
Q Consensus 972 ~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~ 1051 (1094)
.........||+.|+|||++. ...++.++|||||||++|+|++|+.||...........+.... ..++..+++++.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~ 224 (325)
T cd05594 149 DGATMKTFCGTPEYLAPEVLE--DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--IRFPRTLSPEAK 224 (325)
T ss_pred CCcccccccCCcccCCHHHHc--cCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHH
Confidence 222233456999999999997 4567899999999999999999999998877766666554433 346778899999
Q ss_pred HHHHHhccCCCCCCC-----CHHHHHHHHH
Q 037285 1052 TLMEECWAPNPAARP-----SFTEIASRLR 1076 (1094)
Q Consensus 1052 dLI~kCLq~DPeeRP-----S~eELLq~L~ 1076 (1094)
++|.+||+.||++|+ ++.+++++.+
T Consensus 225 ~li~~~L~~dP~~R~~~~~~~~~~il~h~~ 254 (325)
T cd05594 225 SLLSGLLKKDPKQRLGGGPDDAKEIMQHKF 254 (325)
T ss_pred HHHHHHhhcCHHHhCCCCCCCHHHHhcCCC
Confidence 999999999999996 8999998743
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=327.25 Aligned_cols=253 Identities=35% Similarity=0.594 Sum_probs=210.7
Q ss_pred ccCCeeEEEEecccCceEEEEeeec-------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEe
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYG 880 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~r-------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~G 880 (1094)
...+|.+.+.||+|+||.||+|++. +..||||.++.... ......|.+|+++|++++|+||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~ 75 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-------NDARKDFEREAELLTNFQHENIVKFYG 75 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-------HHHHHHHHHHHHHHHhcCCCCchheee
Confidence 3467888999999999999999763 25699999865311 123467889999999999999999999
Q ss_pred EeecCCCCceEEEeeecccchhHHHHhhcc-------------cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCce
Q 037285 881 VVQDGPGGTLATVAEYMVDGSLRHVLVRKD-------------RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNL 947 (1094)
Q Consensus 881 v~~d~~~~~L~IVmEYmegGSL~d~L~k~~-------------~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNI 947 (1094)
++.... ..++||||+.+++|.+++...+ ..+++..++.++.||+.||.|||+++++||||||+||
T Consensus 76 ~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~ni 153 (280)
T cd05049 76 VCTEGD--PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNC 153 (280)
T ss_pred EEecCC--CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceE
Confidence 998764 8999999999999999996542 3478889999999999999999999999999999999
Q ss_pred EeccCCCCCCcEEEEecCCcccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 037285 948 LVNLKDPSRPICKVGDFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYAN 1023 (1094)
Q Consensus 948 LLD~~~~e~g~VKLsDFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~ 1023 (1094)
|++ .++.+||+|||+++..... .......++..|+|||++. ...++.++|||||||++|||++ |+.||..
T Consensus 154 li~----~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~e~~~~g~~p~~~ 227 (280)
T cd05049 154 LVG----YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIM--YRKFTTESDVWSFGVVLWEIFTYGKQPWYG 227 (280)
T ss_pred EEc----CCCeEEECCcccceecccCcceecCCCCcccceecChhhhc--cCCcchhhhHHHHHHHHHHHHhcCCCCCCC
Confidence 998 7789999999998743221 1122334578899999997 4568899999999999999998 9999988
Q ss_pred CChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1024 MHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1024 ~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
....+....+.. +.....+..++..++++|.+||..||++||++.++++.|.
T Consensus 228 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 228 LSNEEVIECITQ-GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred CCHHHHHHHHHc-CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 877776666543 3334456678999999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=321.06 Aligned_cols=255 Identities=35% Similarity=0.628 Sum_probs=214.9
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeecC-ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEee
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQ 883 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~rG-t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~ 883 (1094)
|++..++|++.++||.|+||.||+|.+++ ..||||.+..... ...++.+|+.++++++|+||+++++++.
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM---------SPEAFLQEAQIMKKLRHDKLVQLYAVCS 71 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc---------CHHHHHHHHHHHhhCCCCCEeeeeeeee
Confidence 45778899999999999999999998754 6699998875322 1246788999999999999999999988
Q ss_pred cCCCCceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
... .+++||||+.+++|.+++.... ..+++..+..++.||+.||.|||+++++|+||||+||+++ .++.+||+
T Consensus 72 ~~~--~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~----~~~~~~l~ 145 (261)
T cd05034 72 EEE--PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVG----ENLVCKIA 145 (261)
T ss_pred cCC--ceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEc----CCCCEEEC
Confidence 754 7999999999999999997643 4689999999999999999999999999999999999998 77899999
Q ss_pred ecCCcccccCcc--ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCC
Q 037285 963 DFGLSKIKRNTL--VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLR 1039 (1094)
Q Consensus 963 DFGLSrl~~~~~--~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lr 1039 (1094)
|||+++...... .......+..|+|||.+. ...++.++|||||||++|+|++ |+.||...........+. ....
T Consensus 146 d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~ 222 (261)
T cd05034 146 DFGLARLIEDDEYTAREGAKFPIKWTAPEAAN--YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYR 222 (261)
T ss_pred ccccceeccchhhhhhhccCCCccccCHHHhc--cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCC
Confidence 999987543211 112233567899999987 4567889999999999999998 999998887776666553 4445
Q ss_pred CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1040 PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1040 p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
...+..++..+.+++.+||..+|.+||++.++.+.|+.
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 55667789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=332.00 Aligned_cols=252 Identities=22% Similarity=0.324 Sum_probs=206.4
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
.|++.+.||+|+||.||++.+. ++.||||.+...... .......+.+|+.++++++||||+++++++....
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 73 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-----KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD-- 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh-----hhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC--
Confidence 4788999999999999999874 678999998754221 1222345678999999999999999999998765
Q ss_pred ceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 889 TLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++||||+.+|+|..++.... ..+++..+..++.||+.||.|||+++|+||||||+||+++ +++.++|+|||++
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~----~~~~~~l~Dfg~~ 149 (285)
T cd05605 74 ALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLD----DYGHIRISDLGLA 149 (285)
T ss_pred eEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEEC----CCCCEEEeeCCCc
Confidence 8999999999999998886543 4589999999999999999999999999999999999998 7789999999999
Q ss_pred ccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhh--ccCCCCCCCc
Q 037285 968 KIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN--NTLRPTIPSY 1045 (1094)
Q Consensus 968 rl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~--~~lrp~iPe~ 1045 (1094)
.............|+..|+|||++. ...++.++|||||||++|+|++|+.||...........+.. ......++..
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
T cd05605 150 VEIPEGETIRGRVGTVGYMAPEVVK--NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEK 227 (285)
T ss_pred eecCCCCccccccCCCCccCcHHhc--CCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcc
Confidence 8654333333456899999999997 45678899999999999999999999987654333222211 1223345567
Q ss_pred CcHHHHHHHHHhccCCCCCCC-----CHHHHHHHH
Q 037285 1046 CDAEWRTLMEECWAPNPAARP-----SFTEIASRL 1075 (1094)
Q Consensus 1046 ~S~eL~dLI~kCLq~DPeeRP-----S~eELLq~L 1075 (1094)
++..+++||.+||..||.+|| ++.+++++-
T Consensus 228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~ 262 (285)
T cd05605 228 FSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHP 262 (285)
T ss_pred cCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCc
Confidence 889999999999999999999 899998873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=354.14 Aligned_cols=265 Identities=34% Similarity=0.555 Sum_probs=208.5
Q ss_pred cCCCcceeeccCCeeEEEEecccCceEEEEeeecC-ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeE
Q 037285 799 FDVSSVQVIKNEDLEEQKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVA 877 (1094)
Q Consensus 799 ~dlssv~eIs~edYei~kkLGsG~FGtVYKAk~rG-t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVq 877 (1094)
|...++...+ ++|.....||+|+||.||+|...+ ..||||++...... . ..+|.+|+.+|.+++|||||+
T Consensus 65 fs~~el~~AT-~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~------~--~~eF~~Ei~~ls~l~H~Nlv~ 135 (361)
T KOG1187|consen 65 FSYDELRKAT-NNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQ------G--EREFLNEVEILSRLRHPNLVK 135 (361)
T ss_pred eeHHHHHHHH-hCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCc------c--hhHHHHHHHHHhcCCCcCccc
Confidence 3333333333 578888999999999999999875 88999977654211 1 245999999999999999999
Q ss_pred EEeEeecCCCCceEEEeeecccchhHHHHhhccc-ccCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCceEeccCC
Q 037285 878 FYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDR-FLDRRRRLIIAMDAAFGMEYLHSKN---IVHFDLKCDNLLVNLKD 953 (1094)
Q Consensus 878 L~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~-~Lse~~~l~Ia~QIaeGLaYLHs~G---IIHRDLKPeNILLD~~~ 953 (1094)
++|||.+... ..++|+|||.+|+|.++|..... .++|..+++||.++|+||+|||... |||||||++|||+|
T Consensus 136 LlGyC~e~~~-~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD--- 211 (361)
T KOG1187|consen 136 LLGYCLEGGE-HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD--- 211 (361)
T ss_pred EEEEEecCCc-eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC---
Confidence 9999998642 48999999999999999987765 7999999999999999999999854 99999999999999
Q ss_pred CCCCcEEEEecCCcccccC-ccccCCc-cCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---hHH
Q 037285 954 PSRPICKVGDFGLSKIKRN-TLVSGGV-RGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH---YGA 1028 (1094)
Q Consensus 954 ~e~g~VKLsDFGLSrl~~~-~~~ss~~-~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~---~~e 1028 (1094)
+++.+||+|||+|+.... ....... .||.+|+|||++. ....+.|+|||||||+|+||+||+.+.+... ...
T Consensus 212 -~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~--~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~ 288 (361)
T KOG1187|consen 212 -EDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYAS--TGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELS 288 (361)
T ss_pred -CCCCEEccCccCcccCCccccceeeecCCCCccCChhhhc--cCCcCcccccccchHHHHHHHhCCcccCCCCCccccc
Confidence 899999999999986554 3322222 7999999999997 4678999999999999999999998877532 111
Q ss_pred HHH---hH-----hhccCCCCCC-CcCc-----HHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1029 IIG---GI-----VNNTLRPTIP-SYCD-----AEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1029 ile---~I-----v~~~lrp~iP-e~~S-----~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
... .. +.....+.+. ...+ ..+..+..+|++.+|.+||++.+|++.|..+.
T Consensus 289 l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 289 LVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 111 11 1122233332 2222 23567788999999999999999999996654
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=321.93 Aligned_cols=254 Identities=35% Similarity=0.630 Sum_probs=211.6
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeecC-ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEee
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQ 883 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~rG-t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~ 883 (1094)
|++..++|++.++||+|+||.||++.+.+ ..+|+|.+..... ....+.+|+.++++++|+||+++++++.
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~---------~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 71 (260)
T cd05069 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM---------MPEAFLQEAQIMKKLRHDKLVPLYAVVS 71 (260)
T ss_pred CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc---------cHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 45566789999999999999999998864 4699998764321 1246788999999999999999999885
Q ss_pred cCCCCceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
.. ..++||||+.+++|.+++.... ..+++..+..++.||+.||.|||+.+++|+||||+||+++ +++.+||+
T Consensus 72 ~~---~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~----~~~~~~l~ 144 (260)
T cd05069 72 EE---PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVG----DNLVCKIA 144 (260)
T ss_pred CC---CcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc----CCCeEEEC
Confidence 43 5789999999999999997543 3578999999999999999999999999999999999998 78899999
Q ss_pred ecCCcccccCcc--ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCC
Q 037285 963 DFGLSKIKRNTL--VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLR 1039 (1094)
Q Consensus 963 DFGLSrl~~~~~--~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lr 1039 (1094)
|||+++...... ......++..|+|||... ...++.++||||||+++|+|+| |+.||......+....+ .....
T Consensus 145 dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~--~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~ 221 (260)
T cd05069 145 DFGLARLIEDNEYTARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV-ERGYR 221 (260)
T ss_pred CCccceEccCCcccccCCCccchhhCCHHHhc--cCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCC
Confidence 999997543221 112234567899999987 4568899999999999999999 99999987776666554 34455
Q ss_pred CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1040 PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1040 p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
...+...+..+.+++.+||..+|.+||++++|++.|++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 55667788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=338.74 Aligned_cols=248 Identities=25% Similarity=0.385 Sum_probs=206.6
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEeecCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~~d~~~ 887 (1094)
+|++.+.||+|+||.||+|+.+ +..||||++.+.... .+.....+..|..++..+ +|++|+++++++....
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~- 74 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-----QDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD- 74 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC-
Confidence 5889999999999999999885 467999999864321 122234566788888777 5899999999998755
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++||||+.+|+|.+++.... .+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 75 -~~~lv~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~----~~~~~kL~DfG~~ 148 (323)
T cd05616 75 -RLYFVMEYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD----SEGHIKIADFGMC 148 (323)
T ss_pred -EEEEEEcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEEC----CCCcEEEccCCCc
Confidence 8999999999999999986654 489999999999999999999999999999999999999 7889999999998
Q ss_pred cccc-CccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcC
Q 037285 968 KIKR-NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYC 1046 (1094)
Q Consensus 968 rl~~-~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~ 1046 (1094)
+... .........||+.|+|||++. ...++.++|||||||++|||+||+.||...........+.... ..+|..+
T Consensus 149 ~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~p~~~ 224 (323)
T cd05616 149 KENMWDGVTTKTFCGTPDYIAPEIIA--YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--VAYPKSM 224 (323)
T ss_pred eecCCCCCccccCCCChhhcCHHHhc--CCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCcC
Confidence 7432 222333456899999999998 4568899999999999999999999999988877777766543 3466788
Q ss_pred cHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 037285 1047 DAEWRTLMEECWAPNPAARPSF-----TEIASR 1074 (1094)
Q Consensus 1047 S~eL~dLI~kCLq~DPeeRPS~-----eELLq~ 1074 (1094)
+.++.++|.+||+.+|.+|+++ .+++++
T Consensus 225 s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 225 SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred CHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 9999999999999999999974 666654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=320.05 Aligned_cols=245 Identities=34% Similarity=0.620 Sum_probs=203.1
Q ss_pred EEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEEE
Q 037285 816 KELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATV 893 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~IV 893 (1094)
+.||+|+||.||+|++ .++.||+|.+.... .......|.+|+.++++++||||+++++++.... .+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 71 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-------PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ--PIYIV 71 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC--CeEEE
Confidence 3699999999999987 47789999876431 1223457889999999999999999999998755 89999
Q ss_pred eeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccCc
Q 037285 894 AEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT 973 (1094)
Q Consensus 894 mEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~ 973 (1094)
|||+.+++|.+++......+++..++.++.|++.||.|||+++|+||||||+|||++ .++.+||+|||++......
T Consensus 72 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~----~~~~~kl~dfg~~~~~~~~ 147 (252)
T cd05084 72 MELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVT----EKNVLKISDFGMSREEEDG 147 (252)
T ss_pred EeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEc----CCCcEEECccccCcccccc
Confidence 999999999999976665689999999999999999999999999999999999998 6778999999998753322
Q ss_pred ccc---CCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCCCCCcCcHH
Q 037285 974 LVS---GGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAE 1049 (1094)
Q Consensus 974 ~~s---s~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~e 1049 (1094)
... .....+..|+|||.+. ...++.++|||||||++|+|++ |..||...........+ ........+..++..
T Consensus 148 ~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 224 (252)
T cd05084 148 VYASTGGMKQIPVKWTAPEALN--YGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI-EQGVRLPCPELCPDA 224 (252)
T ss_pred cccccCCCCCCceeecCchhhc--CCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHH-HcCCCCCCcccCCHH
Confidence 111 1112345699999987 4457889999999999999998 99999877765554443 344555677788999
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1050 WRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1050 L~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
+.+++.+||+.+|++|||+.+|++.|.
T Consensus 225 ~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 225 VYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=340.36 Aligned_cols=245 Identities=26% Similarity=0.424 Sum_probs=205.1
Q ss_pred EEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEeecCCCCceEE
Q 037285 816 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQDGPGGTLAT 892 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~~d~~~~~L~I 892 (1094)
+.||+|+||.||+|++. ++.||||++++.... .......+..|..++..+ +||||+++++++.... .+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~--~~~l 73 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL-----QDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKD--RLFF 73 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhh-----hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC--eEEE
Confidence 36999999999999885 568999999764221 122334567788888865 7999999999998765 8999
Q ss_pred EeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccc-c
Q 037285 893 VAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK-R 971 (1094)
Q Consensus 893 VmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~-~ 971 (1094)
||||+++++|..++.... .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.. .
T Consensus 74 v~E~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~----~~~~~kL~Dfg~~~~~~~ 148 (321)
T cd05591 74 VMEYVNGGDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLD----AEGHCKLADFGMCKEGIL 148 (321)
T ss_pred EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC----CCCCEEEeecccceeccc
Confidence 999999999999887654 489999999999999999999999999999999999998 7889999999998743 2
Q ss_pred CccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHH
Q 037285 972 NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWR 1051 (1094)
Q Consensus 972 ~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~ 1051 (1094)
.........||+.|+|||++. ...++.++|||||||++|+|++|+.||...........+..... ..+..++.++.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~--~~p~~~~~~~~ 224 (321)
T cd05591 149 NGVTTTTFCGTPDYIAPEILQ--ELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV--LYPVWLSKEAV 224 (321)
T ss_pred CCccccccccCccccCHHHHc--CCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCHHHH
Confidence 222233456899999999987 45678999999999999999999999999888877777665433 45667899999
Q ss_pred HHHHHhccCCCCCCC-------CHHHHHHHHH
Q 037285 1052 TLMEECWAPNPAARP-------SFTEIASRLR 1076 (1094)
Q Consensus 1052 dLI~kCLq~DPeeRP-------S~eELLq~L~ 1076 (1094)
++|.+||..||.+|+ ++.+++++-+
T Consensus 225 ~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~ 256 (321)
T cd05591 225 SILKAFMTKNPNKRLGCVASQGGEDAIKQHPF 256 (321)
T ss_pred HHHHHHhccCHHHcCCCCCCCCCHHHHhcCCc
Confidence 999999999999999 8888887743
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=326.41 Aligned_cols=256 Identities=29% Similarity=0.533 Sum_probs=210.6
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--Cc----eEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEe
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GT----DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYG 880 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt----~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~G 880 (1094)
+...+|++.+.||+|+||+||+|++. +. .+++|.+... .......++..|+.++.++.||||+++++
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-------~~~~~~~~~~~~~~~l~~l~h~~iv~~~~ 76 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-------SGRQTFQEITDHMLAMGSLDHAYIVRLLG 76 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-------cchHHHHHHHHHHHHHhcCCCCCcceEEE
Confidence 44568899999999999999999983 44 3666665421 11223356778888999999999999999
Q ss_pred EeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEE
Q 037285 881 VVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICK 960 (1094)
Q Consensus 881 v~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VK 960 (1094)
++... ..++++||+.+|+|.+++......+++..++.++.||+.||.|||+++++||||||+|||++ .++.+|
T Consensus 77 ~~~~~---~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~----~~~~~k 149 (279)
T cd05111 77 ICPGA---SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLK----SDSIVQ 149 (279)
T ss_pred EECCC---ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc----CCCcEE
Confidence 88543 57889999999999999987666789999999999999999999999999999999999998 788999
Q ss_pred EEecCCcccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhc
Q 037285 961 VGDFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 1036 (1094)
Q Consensus 961 LsDFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~ 1036 (1094)
|+|||+++..... .......++..|+|||.+. ...++.++|||||||++|||++ |+.||.......... +...
T Consensus 150 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~--~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~-~~~~ 226 (279)
T cd05111 150 IADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL--FGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD-LLEK 226 (279)
T ss_pred EcCCccceeccCCCcccccCCCCCcccccCHHHhc--cCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHC
Confidence 9999999853221 1122344677899999987 4568899999999999999998 999998876655433 3455
Q ss_pred cCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1037 TLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1037 ~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
+..+..+..++..+.+++.+||..+|++|||+.++++.|..+.
T Consensus 227 ~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 227 GERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 5566667778899999999999999999999999999988865
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=322.54 Aligned_cols=259 Identities=32% Similarity=0.589 Sum_probs=215.2
Q ss_pred eeccCCeeEEEEecccCceEEEEeeecC-----ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEe
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYG 880 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~rG-----t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~G 880 (1094)
++...+|++.++||+|+||.||+|.+.. ..||||.+.... .......+.+|+.+++++.||||+++++
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-------~~~~~~~~~~e~~~l~~~~h~~i~~~~~ 74 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-------SPSVREKFLQEAYIMRQFDHPHIVKLIG 74 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-------CHHHHHHHHHHHHHHHhCCCCchhceeE
Confidence 3566789999999999999999998742 358999876431 1223457889999999999999999999
Q ss_pred EeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEE
Q 037285 881 VVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICK 960 (1094)
Q Consensus 881 v~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VK 960 (1094)
++.+. ..++||||+.+++|.+++......+++..++.++.||+.||+|||+++++|+||||+|||++ ..+.+|
T Consensus 75 ~~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~----~~~~~~ 147 (270)
T cd05056 75 VITEN---PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVS----SPDCVK 147 (270)
T ss_pred EEcCC---CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEe----cCCCeE
Confidence 98764 57899999999999999977665689999999999999999999999999999999999998 678999
Q ss_pred EEecCCcccccCcc--ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhcc
Q 037285 961 VGDFGLSKIKRNTL--VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNT 1037 (1094)
Q Consensus 961 LsDFGLSrl~~~~~--~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~ 1037 (1094)
|+|||+++...... ......++..|+|||.+. ...++.++|||||||++|+|++ |..||......+....+ ...
T Consensus 148 l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~-~~~ 224 (270)
T cd05056 148 LGDFGLSRYLEDESYYKASKGKLPIKWMAPESIN--FRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI-ENG 224 (270)
T ss_pred EccCceeeecccccceecCCCCccccccChhhhc--cCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-HcC
Confidence 99999987543221 111223456899999987 4567899999999999999996 99999888777666554 344
Q ss_pred CCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1038 LRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1038 lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
.+...+..++..+.++|.+||..+|.+|||+.++++.|..+..+
T Consensus 225 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 225 ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 45566778899999999999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=359.57 Aligned_cols=255 Identities=25% Similarity=0.388 Sum_probs=214.9
Q ss_pred ccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~ 885 (1094)
..+.|+.+++||+|+||.||+|+.. |..||+|.++... .++.+.....+||.||++|+||||+++.++++..
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~------~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~ 188 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN------EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK 188 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc------CCCcchHHHHHHHHHHHhcCCCcccceeeEEEec
Confidence 4567899999999999999999984 6779999998653 2234556778999999999999999999999987
Q ss_pred CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecC
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFG 965 (1094)
..+.+|+|+|||+ -+|.-++....-.+++.++..+++||+.||+|||++||+|||||..||||+ .++.+||+|||
T Consensus 189 ~~~siYlVFeYMd-hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLid----n~G~LKiaDFG 263 (560)
T KOG0600|consen 189 LSGSIYLVFEYMD-HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILID----NNGVLKIADFG 263 (560)
T ss_pred CCceEEEEEeccc-chhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEc----CCCCEEecccc
Confidence 6679999999994 678888877777799999999999999999999999999999999999999 89999999999
Q ss_pred CcccccCcc--ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhcc------
Q 037285 966 LSKIKRNTL--VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT------ 1037 (1094)
Q Consensus 966 LSrl~~~~~--~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~------ 1037 (1094)
||++..... .....+.|.+|.|||++.| ...|+.++|+||.||||.||++|++.|.+.+..+.+..|.+-.
T Consensus 264 LAr~y~~~~~~~~T~rVvTLWYRpPELLLG-~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~ 342 (560)
T KOG0600|consen 264 LARFYTPSGSAPYTSRVVTLWYRPPELLLG-ATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTED 342 (560)
T ss_pred ceeeccCCCCcccccceEEeeccChHHhcC-CcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChh
Confidence 999654322 2334457999999999997 5689999999999999999999999999998888776664421
Q ss_pred -CC-CCCC-------------------CcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1038 -LR-PTIP-------------------SYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1038 -lr-p~iP-------------------e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
|. ..+| ..++....+|+..+|..||.+|.|+.+.+..
T Consensus 343 ~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 343 YWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 11 0111 2356678899999999999999999988864
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=330.52 Aligned_cols=263 Identities=31% Similarity=0.527 Sum_probs=216.3
Q ss_pred ceeeccCCeeEEEEecccCceEEEEeeecC---------ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCC
Q 037285 804 VQVIKNEDLEEQKELGSGTFGTVYHGKWRG---------TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHP 873 (1094)
Q Consensus 804 v~eIs~edYei~kkLGsG~FGtVYKAk~rG---------t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HP 873 (1094)
.|++..++|.+.+.||+|+||.||++++.+ ..+|+|.++... .+....++.+|+.+++++ +|+
T Consensus 12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~e~~~l~~l~~h~ 84 (307)
T cd05098 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-------TEKDLSDLISEMEMMKMIGKHK 84 (307)
T ss_pred cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-------ChHHHHHHHHHHHHHHHhcCCC
Confidence 456667899999999999999999998632 359999886531 112235678899999999 799
Q ss_pred ceeEEEeEeecCCCCceEEEeeecccchhHHHHhhcc---------------cccCHHHHHHHHHHHHHHHHHHHHCCce
Q 037285 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD---------------RFLDRRRRLIIAMDAAFGMEYLHSKNIV 938 (1094)
Q Consensus 874 NIVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~---------------~~Lse~~~l~Ia~QIaeGLaYLHs~GII 938 (1094)
||+++++++.... .+++||||+.+++|.+++.... ..+++..++.++.||+.||+|||++|++
T Consensus 85 ~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~ 162 (307)
T cd05098 85 NIINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCI 162 (307)
T ss_pred CEeeEEEEEecCC--ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999998754 8999999999999999997542 2478899999999999999999999999
Q ss_pred eccCCCCceEeccCCCCCCcEEEEecCCcccccCcc---ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHH
Q 037285 939 HFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTL---VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEIL 1015 (1094)
Q Consensus 939 HRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~~---~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELL 1015 (1094)
||||||+|||++ .++.+||+|||+++...... ......++..|+|||++. ...++.++|||||||++|+|+
T Consensus 163 H~dlkp~Nill~----~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslG~~l~el~ 236 (307)
T cd05098 163 HRDLAARNVLVT----EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF--DRIYTHQSDVWSFGVLLWEIF 236 (307)
T ss_pred cccccHHheEEc----CCCcEEECCCcccccccccchhhccccCCCccceeChHHhc--cCCCCcHHHHHHHHHHHHHHH
Confidence 999999999998 67889999999987443211 111222456899999987 456789999999999999999
Q ss_pred c-CCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 037285 1016 T-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAA 1082 (1094)
Q Consensus 1016 T-Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~ 1082 (1094)
+ |..||......+....+ ........+..++.++.+||.+||..+|.+||++.++++.|.++.+..
T Consensus 237 ~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 237 TLGGSPYPGVPVEELFKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred cCCCCCCCcCCHHHHHHHH-HcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 8 89999877665555443 455556677788999999999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=323.09 Aligned_cols=245 Identities=34% Similarity=0.590 Sum_probs=204.6
Q ss_pred EecccCceEEEEeeec----CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEE
Q 037285 817 ELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLAT 892 (1094)
Q Consensus 817 kLGsG~FGtVYKAk~r----Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~I 892 (1094)
.||+|+||.||+|.++ +..||+|++.... .......|.+|+.++++++|+||+++++++... ..++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~---~~~l 71 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-------EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE---ALML 71 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-------ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCC---CeEE
Confidence 4899999999999874 3459999886531 123345788999999999999999999988543 6899
Q ss_pred EeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccC
Q 037285 893 VAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRN 972 (1094)
Q Consensus 893 VmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~ 972 (1094)
||||+++++|.+++......+++..++.++.||+.||.|||+++++||||||+|||++ .++.+||+|||++.....
T Consensus 72 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~----~~~~~kl~dfg~~~~~~~ 147 (257)
T cd05115 72 VMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLV----NQHYAKISDFGLSKALGA 147 (257)
T ss_pred EEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEc----CCCcEEeccCCccccccC
Confidence 9999999999999976666789999999999999999999999999999999999998 778899999999874322
Q ss_pred cc----ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCCCCCcCc
Q 037285 973 TL----VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCD 1047 (1094)
Q Consensus 973 ~~----~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S 1047 (1094)
.. ......++..|+|||++. ...++.++|||||||++|+|++ |..||...........+ ..+.++..+..++
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~ 224 (257)
T cd05115 148 DDSYYKARSAGKWPLKWYAPECIN--FRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI-EQGKRLDCPAECP 224 (257)
T ss_pred CccceeccCCCCCCcccCCHHHHc--cCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-HCCCCCCCCCCCC
Confidence 11 111122357899999987 4567889999999999999996 99999988776665544 4455667788899
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1048 AEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1048 ~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
.++.++|.+||..+|++||++.+|.+.|+.+
T Consensus 225 ~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 225 PEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 9999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=340.90 Aligned_cols=244 Identities=27% Similarity=0.433 Sum_probs=203.8
Q ss_pred EEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEeecCCCCceEE
Q 037285 816 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQDGPGGTLAT 892 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~~d~~~~~L~I 892 (1094)
+.||+|+||.||+|+.+ ++.||||++++.... .+.....+..|+.++..+ +||||+++++++.... .+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~--~~~i 73 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL-----QDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPD--RLFF 73 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-----hccHHHHHHHHHHHHHhccCCCchhceeeEEEcCC--EEEE
Confidence 46999999999999875 678999999764221 122335667888888876 6999999999998765 8999
Q ss_pred EeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccc-c
Q 037285 893 VAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK-R 971 (1094)
Q Consensus 893 VmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~-~ 971 (1094)
||||+.+|+|..++.... .+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++.. .
T Consensus 74 v~Ey~~~g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~----~~~~~kL~DfG~~~~~~~ 148 (320)
T cd05590 74 VMEFVNGGDLMFHIQKSR-RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLD----HEGHCKLADFGMCKEGIF 148 (320)
T ss_pred EEcCCCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC----CCCcEEEeeCCCCeecCc
Confidence 999999999999887654 589999999999999999999999999999999999998 7789999999998743 2
Q ss_pred CccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHH
Q 037285 972 NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWR 1051 (1094)
Q Consensus 972 ~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~ 1051 (1094)
.........||+.|+|||++. ...++.++|||||||++|+|++|+.||......+....+.... ...+..++.++.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~ 224 (320)
T cd05590 149 NGKTTSTFCGTPDYIAPEILQ--EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE--VVYPTWLSQDAV 224 (320)
T ss_pred CCCcccccccCccccCHHHHc--CCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHH
Confidence 222334456999999999997 4567889999999999999999999999888877777665543 345677899999
Q ss_pred HHHHHhccCCCCCCCCH------HHHHHHH
Q 037285 1052 TLMEECWAPNPAARPSF------TEIASRL 1075 (1094)
Q Consensus 1052 dLI~kCLq~DPeeRPS~------eELLq~L 1075 (1094)
++|.+||+.||.+||++ ++++.+-
T Consensus 225 ~li~~~L~~dP~~R~~~~~~~~~~~~~~h~ 254 (320)
T cd05590 225 DILKAFMTKNPTMRLGSLTLGGEEAILRHP 254 (320)
T ss_pred HHHHHHcccCHHHCCCCCCCCCHHHHHcCC
Confidence 99999999999999998 7777653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=321.24 Aligned_cols=256 Identities=35% Similarity=0.619 Sum_probs=212.2
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--C---ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeE
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--G---TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGV 881 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--G---t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv 881 (1094)
|..++|+..+.||+|+||.||+|+.. + ..+|+|.++... .......+..|+.++++++|+||++++++
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 74 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-------TEKQRQDFLSEASIMGQFSHHNIIRLEGV 74 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-------CHHHHHHHHHHHHHHhcCCCCCeeEEEEE
Confidence 45678999999999999999999874 2 258999886431 12224568899999999999999999999
Q ss_pred eecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEE
Q 037285 882 VQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKV 961 (1094)
Q Consensus 882 ~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKL 961 (1094)
+.... ..++||||+.+++|.+++......+++..+..++.|++.||+|||+.+++|+||||+||+++ .++.+||
T Consensus 75 ~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~----~~~~~kl 148 (268)
T cd05063 75 VTKFK--PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVN----SNLECKV 148 (268)
T ss_pred EccCC--CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEc----CCCcEEE
Confidence 98754 88999999999999999977666789999999999999999999999999999999999998 6788999
Q ss_pred EecCCcccccCccc----cCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhc
Q 037285 962 GDFGLSKIKRNTLV----SGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 1036 (1094)
Q Consensus 962 sDFGLSrl~~~~~~----ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~ 1036 (1094)
+|||++........ ......+..|+|||++. ...++.++|||||||++|||++ |+.||......+....+..
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~- 225 (268)
T cd05063 149 SDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA--YRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND- 225 (268)
T ss_pred CCCccceecccccccceeccCCCcCceecCHHHhh--cCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc-
Confidence 99999874422111 11122345799999987 4567899999999999999998 9999988777666665543
Q ss_pred cCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1037 TLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1037 ~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
......+..++..+.+++.+||+.+|.+||++.+|++.|.++
T Consensus 226 ~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 226 GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 344455667889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=329.23 Aligned_cols=256 Identities=34% Similarity=0.562 Sum_probs=210.1
Q ss_pred CCeeEEEEecccCceEEEEeeecC--c--eEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEeec
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWRG--T--DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQD 884 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~rG--t--~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~~d 884 (1094)
++|++.+.||+|+||.||+|+++. . .+++|.++... .......|.+|+.++.++ +||||+++++++..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 74 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-------SENDHRDFAGELEVLCKLGHHPNIINLLGACEN 74 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-------CHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc
Confidence 578999999999999999998742 2 47888776321 112235688999999999 79999999999877
Q ss_pred CCCCceEEEeeecccchhHHHHhhcc---------------cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEe
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKD---------------RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV 949 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~---------------~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILL 949 (1094)
.. .+++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||+
T Consensus 75 ~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill 152 (297)
T cd05089 75 RG--YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV 152 (297)
T ss_pred CC--cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE
Confidence 54 7999999999999999996532 247889999999999999999999999999999999999
Q ss_pred ccCCCCCCcEEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHH
Q 037285 950 NLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGA 1028 (1094)
Q Consensus 950 D~~~~e~g~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~e 1028 (1094)
+ .++.+||+|||++..............+..|+|||++. ...++.++|||||||++|||++ |..||......+
T Consensus 153 ~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~ 226 (297)
T cd05089 153 G----ENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLN--YSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE 226 (297)
T ss_pred C----CCCeEEECCcCCCccccceeccCCCCcCccccCchhhc--cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 8 67889999999987433222222222356799999987 4567899999999999999997 999999887777
Q ss_pred HHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1029 IIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1029 ile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
....+. .......+..++..+++||.+||+.+|.+||++.++++.|..+...
T Consensus 227 ~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 227 LYEKLP-QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred HHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 666553 3455566778899999999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=329.02 Aligned_cols=254 Identities=35% Similarity=0.559 Sum_probs=209.8
Q ss_pred ccCCeeEEEEecccCceEEEEeeec-------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEe
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYG 880 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~r-------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~G 880 (1094)
...+|++.++||+|+||.||+|++. +..||||+++... .......|.+|+.++.+++||||+++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~h~~iv~~~~ 75 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-------EGPLREEFKHEAMMRSRLQHPNIVCLLG 75 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-------CHHHHHHHHHHHHHHhcCCCCCcCeEEE
Confidence 4456888899999999999999874 2569999987431 1223456889999999999999999999
Q ss_pred EeecCCCCceEEEeeecccchhHHHHhhc---------------ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 037285 881 VVQDGPGGTLATVAEYMVDGSLRHVLVRK---------------DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCD 945 (1094)
Q Consensus 881 v~~d~~~~~L~IVmEYmegGSL~d~L~k~---------------~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPe 945 (1094)
++.... .+++++||+.+++|.+++... ...+++..++.++.|++.||.|||++||+||||||+
T Consensus 76 ~~~~~~--~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~ 153 (283)
T cd05091 76 VVTKEQ--PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATR 153 (283)
T ss_pred EEcCCC--ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence 998765 789999999999999998532 124788889999999999999999999999999999
Q ss_pred ceEeccCCCCCCcEEEEecCCcccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCC
Q 037285 946 NLLVNLKDPSRPICKVGDFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPY 1021 (1094)
Q Consensus 946 NILLD~~~~e~g~VKLsDFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF 1021 (1094)
|||++ .++.+||+|||+++..... .......+++.|+|||.+. ...++.++|||||||++|||++ |..||
T Consensus 154 Nil~~----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~~l~el~~~g~~p~ 227 (283)
T cd05091 154 NVLVF----DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIM--YGKFSIDSDIWSYGVVLWEVFSYGLQPY 227 (283)
T ss_pred heEec----CCCceEecccccccccccchheeeccCccCCccccCHHHHh--cCCCCcchhHHHHHHHHHHHHcCCCCCC
Confidence 99998 6778999999998743221 1122334578899999987 4567889999999999999998 89999
Q ss_pred CCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1022 ANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1022 ~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
......+....+... .....+..++..+.+|+.+||+.+|.+||++.+|+..|+.
T Consensus 228 ~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 228 CGYSNQDVIEMIRNR-QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred CCCCHHHHHHHHHcC-CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 888777766665443 3445677899999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=327.41 Aligned_cols=257 Identities=36% Similarity=0.583 Sum_probs=213.3
Q ss_pred ccCCeeEEEEecccCceEEEEeeec-------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEe
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYG 880 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~r-------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~G 880 (1094)
+..+|.+.+.||+|+||.||+|++. +..+++|.+.... ......+.+|+.++++++|+||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 74 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--------LAARKDFQREAELLTNLQHEHIVKFYG 74 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--------HHHHHHHHHHHHHHhcCCCCCcceEEE
Confidence 4567899999999999999999753 2348888875431 122356889999999999999999999
Q ss_pred EeecCCCCceEEEeeecccchhHHHHhhcc---------------cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 037285 881 VVQDGPGGTLATVAEYMVDGSLRHVLVRKD---------------RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCD 945 (1094)
Q Consensus 881 v~~d~~~~~L~IVmEYmegGSL~d~L~k~~---------------~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPe 945 (1094)
++.... ..++||||+.+++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+
T Consensus 75 ~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~ 152 (291)
T cd05094 75 VCGDGD--PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATR 152 (291)
T ss_pred EEccCC--ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcc
Confidence 998754 8999999999999999996532 24788999999999999999999999999999999
Q ss_pred ceEeccCCCCCCcEEEEecCCcccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCC
Q 037285 946 NLLVNLKDPSRPICKVGDFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPY 1021 (1094)
Q Consensus 946 NILLD~~~~e~g~VKLsDFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF 1021 (1094)
|||++ .++.+||+|||+++..... .......++..|+|||++. ...++.++|||||||++|+|+| |+.||
T Consensus 153 Nil~~----~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~t~g~~p~ 226 (291)
T cd05094 153 NCLVG----ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM--YRKFTTESDVWSFGVILWEIFTYGKQPW 226 (291)
T ss_pred eEEEc----cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhc--cCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999 7789999999999743221 1122344678899999987 4568889999999999999999 99999
Q ss_pred CCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1022 ANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1022 ~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
......+....+ ........+..++..+.+++.+||+.+|.+||++.+|++.|.++...
T Consensus 227 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 227 FQLSNTEVIECI-TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred CCCCHHHHHHHH-hCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 888777766655 33444455667889999999999999999999999999999999643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=321.38 Aligned_cols=254 Identities=32% Similarity=0.505 Sum_probs=205.0
Q ss_pred eeEEEEecccCceEEEEeeecC--c--eEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC-
Q 037285 812 LEEQKELGSGTFGTVYHGKWRG--T--DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP- 886 (1094)
Q Consensus 812 Yei~kkLGsG~FGtVYKAk~rG--t--~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~- 886 (1094)
|.+.+.||+|+||.||+|+++. . .+|+|.++.... .......+.+|+.++++++|+||+++++++....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC------TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVE 74 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCc
Confidence 3467889999999999998853 2 589998865321 1223467888999999999999999999875422
Q ss_pred ---CCceEEEeeecccchhHHHHhhc-----ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCc
Q 037285 887 ---GGTLATVAEYMVDGSLRHVLVRK-----DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPI 958 (1094)
Q Consensus 887 ---~~~L~IVmEYmegGSL~d~L~k~-----~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~ 958 (1094)
....+++|||+.+|+|..++... ...+++..++.++.||+.||+|||+++|+||||||+|||++ .++.
T Consensus 75 ~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~ 150 (272)
T cd05075 75 SEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLN----ENMN 150 (272)
T ss_pred ccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEc----CCCC
Confidence 12568999999999999887432 23478999999999999999999999999999999999998 7788
Q ss_pred EEEEecCCcccccCcc---ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHh
Q 037285 959 CKVGDFGLSKIKRNTL---VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIV 1034 (1094)
Q Consensus 959 VKLsDFGLSrl~~~~~---~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv 1034 (1094)
+||+|||+++...... ......++..|+|||++. ...++.++|||||||++|+|++ |+.||......+....+.
T Consensus 151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 228 (272)
T cd05075 151 VCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLA--DRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR 228 (272)
T ss_pred EEECCCCcccccCcccceecCCcccCCcccCCHHHcc--CCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999998543221 112234567899999987 4568899999999999999999 899998877766665554
Q ss_pred hccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1035 NNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1035 ~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
. ......+..++..+.++|.+||+.+|++|||+.+|++.|+.+
T Consensus 229 ~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 229 Q-GNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred c-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 3 333445667889999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=363.50 Aligned_cols=247 Identities=29% Similarity=0.461 Sum_probs=211.5
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
..|+..++||+|+-|.||.++.. +..||||++....-.. .+-+++|+.+|+.++|+|||.+++.|....
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--------keLilnEi~Vm~~~~H~NiVnfl~Sylv~d- 343 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--------KELLLNEILVMRDLHHPNIVNFLDSYLVGD- 343 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--------hhhhHHHHHHHHhccchHHHHHHHHhcccc-
Confidence 35677789999999999999874 5779999997654321 234678999999999999999999887654
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++|||||++|+|.+.+.... +++.++..||+++++||+|||.+||+|||||.+|||++ .++.+||+|||+|
T Consensus 344 -eLWVVMEym~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~----~~g~vKltDFGFc 416 (550)
T KOG0578|consen 344 -ELWVVMEYMEGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLT----MDGSVKLTDFGFC 416 (550)
T ss_pred -eeEEEEeecCCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEec----cCCcEEEeeeeee
Confidence 8999999999999999986553 89999999999999999999999999999999999999 7778999999999
Q ss_pred ccccC-ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhc-cCCCCCCCc
Q 037285 968 KIKRN-TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN-TLRPTIPSY 1045 (1094)
Q Consensus 968 rl~~~-~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~-~lrp~iPe~ 1045 (1094)
..... .....+.+||+.|||||++. ...|++|+||||||++++||+.|.+||-..+.-..+..+... ......+..
T Consensus 417 aqi~~~~~KR~TmVGTPYWMAPEVvt--rk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~k 494 (550)
T KOG0578|consen 417 AQISEEQSKRSTMVGTPYWMAPEVVT--RKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEK 494 (550)
T ss_pred eccccccCccccccCCCCccchhhhh--hcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccc
Confidence 85433 33556678999999999998 678999999999999999999999999876655555444333 334456788
Q ss_pred CcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1046 CDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1046 ~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
+++.+++|+.+||..|+++|+++.+||+|
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 99999999999999999999999999986
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=347.57 Aligned_cols=252 Identities=23% Similarity=0.307 Sum_probs=205.5
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||+|+||.||+++.. +..||||++.+... ........+.+|+.+|++++|+||+++++.+.+..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~-----~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~- 74 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADV-----LMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD- 74 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHH-----HhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-
Confidence 46899999999999999999874 67899999865321 11223456778999999999999999999998755
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++||||+++|+|.+++...+ .+++..+..++.||+.||+|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 75 -~~~lv~E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~----~~~~ikL~DFG~a 148 (376)
T cd05598 75 -NLYFVMDYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID----RDGHIKLTDFGLC 148 (376)
T ss_pred -EEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEEC----CCCCEEEEeCCCC
Confidence 8999999999999999997654 588899999999999999999999999999999999998 7789999999997
Q ss_pred ccccC--------------------------------------------ccccCCccCCCcccCccccccCCCCCCchhh
Q 037285 968 KIKRN--------------------------------------------TLVSGGVRGTLPWMAPELLSGSSSKVSEKVD 1003 (1094)
Q Consensus 968 rl~~~--------------------------------------------~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSD 1003 (1094)
..... ........||+.|+|||++. ...++.++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~D 226 (376)
T cd05598 149 TGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL--RTGYTQLCD 226 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHc--CCCCCccee
Confidence 42110 00012346999999999998 456789999
Q ss_pred HHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCC--CCcCcHHHHHHHHHhccCCCCCCC---CHHHHHHHHH
Q 037285 1004 VFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTI--PSYCDAEWRTLMEECWAPNPAARP---SFTEIASRLR 1076 (1094)
Q Consensus 1004 VWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~i--Pe~~S~eL~dLI~kCLq~DPeeRP---S~eELLq~L~ 1076 (1094)
||||||++|||++|+.||......+....+........+ ...++.++.++|.+|+ .+|.+|+ ++.+++++-+
T Consensus 227 iwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~ 303 (376)
T cd05598 227 WWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPF 303 (376)
T ss_pred eeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCC
Confidence 999999999999999999988776665555433222222 2357889999999987 4999999 9999998844
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=340.78 Aligned_cols=262 Identities=31% Similarity=0.524 Sum_probs=213.4
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeec-------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCcee
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVV 876 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~r-------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIV 876 (1094)
|.+..++|++.+.||+|+||.||+|++. ++.||||+++.... ......+.+|+.+|.++ +|+||+
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~niv 74 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-------HSEHRALMSELKILIHIGHHLNVV 74 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-------hHHHHHHHHHHHHHHhccCCccHh
Confidence 5677889999999999999999999752 46799999875321 12235678899999999 689999
Q ss_pred EEEeEeecCCCCceEEEeeecccchhHHHHhhcc----------------------------------------------
Q 037285 877 AFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD---------------------------------------------- 910 (1094)
Q Consensus 877 qL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~---------------------------------------------- 910 (1094)
++++++... +..+++||||+.+|+|.+++....
T Consensus 75 ~~~~~~~~~-~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (343)
T cd05103 75 NLLGACTKP-GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFV 153 (343)
T ss_pred hhcceeecC-CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhcccccccccccccccc
Confidence 999988654 347899999999999999986421
Q ss_pred --------------------cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccc
Q 037285 911 --------------------RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK 970 (1094)
Q Consensus 911 --------------------~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~ 970 (1094)
..+++..+..++.||+.||+|||+++|+||||||+|||++ .++.+||+|||+++..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~----~~~~~kl~dfg~~~~~ 229 (343)
T cd05103 154 EEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----ENNVVKICDFGLARDI 229 (343)
T ss_pred CCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEc----CCCcEEEEeccccccc
Confidence 2367788899999999999999999999999999999998 6789999999998753
Q ss_pred cCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCCCCCcC
Q 037285 971 RNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSYC 1046 (1094)
Q Consensus 971 ~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~ 1046 (1094)
... .......++..|+|||++. ...++.++||||||+++|+|++ |..||.................+...+..+
T Consensus 230 ~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (343)
T cd05103 230 YKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYT 307 (343)
T ss_pred ccCcchhhcCCCCCCcceECcHHhc--CCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCC
Confidence 211 1122233567899999987 4567899999999999999997 999998765544444444555566667778
Q ss_pred cHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 037285 1047 DAEWRTLMEECWAPNPAARPSFTEIASRLRVLST 1080 (1094)
Q Consensus 1047 S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~t 1080 (1094)
++++.++|.+||+.+|.+||++.+|+++|..+..
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 8999999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=338.92 Aligned_cols=243 Identities=28% Similarity=0.471 Sum_probs=199.8
Q ss_pred EEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhh-CCCCceeEEEeEeecCCCCceEE
Q 037285 816 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSK-LHHPNVVAFYGVVQDGPGGTLAT 892 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkr-L~HPNIVqL~Gv~~d~~~~~L~I 892 (1094)
+.||+|+||.||+|+++ +..||||+++...... ......+..|..++.. ++||||+++++++.... .+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~--~~~l 73 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLE-----DDDVECTMVERRVLALAWEHPFLTHLFCTFQTKE--HLFF 73 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-----hhhHHHHHHHHHHHHhccCCCCccceeeEEEcCC--EEEE
Confidence 46999999999999885 5679999998643211 1223344566666664 48999999999998755 8999
Q ss_pred EeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCccccc-
Q 037285 893 VAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKR- 971 (1094)
Q Consensus 893 VmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~- 971 (1094)
||||+.+|+|..++.... .+++..+..++.||+.||+|||+++|+||||||+|||++ .++.+||+|||+++...
T Consensus 74 v~e~~~gg~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~----~~~~~kL~Dfg~a~~~~~ 148 (316)
T cd05592 74 VMEYLNGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLD----KDGHIKIADFGMCKENMN 148 (316)
T ss_pred EEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEEC----CCCCEEEccCcCCeECCC
Confidence 999999999999987654 589999999999999999999999999999999999998 77899999999997432
Q ss_pred CccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHH
Q 037285 972 NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWR 1051 (1094)
Q Consensus 972 ~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~ 1051 (1094)
.........||+.|+|||++. ...++.++|||||||++|+|++|+.||......+....+... .+.++..++.++.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~ 224 (316)
T cd05592 149 GEGKASTFCGTPDYIAPEILK--GQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND--RPHFPRWISKEAK 224 (316)
T ss_pred CCCccccccCCccccCHHHHc--CCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHH
Confidence 222334456899999999998 456789999999999999999999999988877776665433 4556778899999
Q ss_pred HHHHHhccCCCCCCCCHH-HHHHH
Q 037285 1052 TLMEECWAPNPAARPSFT-EIASR 1074 (1094)
Q Consensus 1052 dLI~kCLq~DPeeRPS~e-ELLq~ 1074 (1094)
++|.+||+.||.+||++. +++++
T Consensus 225 ~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 225 DCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred HHHHHHccCCHHHcCCChHHHHcC
Confidence 999999999999999865 66554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=344.11 Aligned_cols=254 Identities=29% Similarity=0.442 Sum_probs=204.1
Q ss_pred ccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~ 885 (1094)
..++|++.++||+|+||.||+|++. ++.||||++.... .......+.+|+.++++++|+||+++++++...
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 144 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-------EDTVRRQICREIEILRDVNHPNVVKCHDMFDHN 144 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-------cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC
Confidence 3467888999999999999999875 6889999986431 123346788999999999999999999999875
Q ss_pred CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecC
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFG 965 (1094)
. .+++||||+.+++|.... ...+..+..++.||+.||+|||+++|+||||||+|||++ .++.+||+|||
T Consensus 145 ~--~~~lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~----~~~~~kL~DfG 213 (353)
T PLN00034 145 G--EIQVLLEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLIN----SAKNVKIADFG 213 (353)
T ss_pred C--eEEEEEecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc----CCCCEEEcccc
Confidence 4 899999999999986532 356777889999999999999999999999999999998 77899999999
Q ss_pred CcccccCc-cccCCccCCCcccCccccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH---HHHhHhhccC
Q 037285 966 LSKIKRNT-LVSGGVRGTLPWMAPELLSGS---SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA---IIGGIVNNTL 1038 (1094)
Q Consensus 966 LSrl~~~~-~~ss~~~GT~~YmAPEvL~g~---~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~e---ile~Iv~~~l 1038 (1094)
+++..... .......||..|+|||++... ....+.++|||||||++|||++|+.||....... ....+ ....
T Consensus 214 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~-~~~~ 292 (353)
T PLN00034 214 VSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI-CMSQ 292 (353)
T ss_pred cceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH-hccC
Confidence 99854332 122345689999999998521 2234568999999999999999999997433222 22222 2233
Q ss_pred CCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 037285 1039 RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLST 1080 (1094)
Q Consensus 1039 rp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~t 1080 (1094)
.+..+..++.++++||.+||+.||++||++.+|+++-+-..+
T Consensus 293 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 293 PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 445567789999999999999999999999999999776553
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=324.90 Aligned_cols=253 Identities=32% Similarity=0.512 Sum_probs=203.8
Q ss_pred eeEEEEecccCceEEEEeee------cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC
Q 037285 812 LEEQKELGSGTFGTVYHGKW------RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 812 Yei~kkLGsG~FGtVYKAk~------rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~ 885 (1094)
|++.+.||+|+||+||++.+ .+..||+|.++.... ......|.+|+.+|++++||||+++++++...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-------QQNTSGWKKEINILKTLYHENIVKYKGCCSEQ 78 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-------hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 38899999999999988654 256799999875421 11235678899999999999999999998765
Q ss_pred CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecC
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFG 965 (1094)
....+++||||+.+++|.+++... .+++..++.++.|++.||.|||+++|+||||||+|||++ .++.+||+|||
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~~l~dfg 152 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLD----NDRLVKIGDFG 152 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEc----CCCcEEEeecc
Confidence 555789999999999999998654 489999999999999999999999999999999999998 67889999999
Q ss_pred CcccccCccc----cCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH--------------
Q 037285 966 LSKIKRNTLV----SGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-------------- 1027 (1094)
Q Consensus 966 LSrl~~~~~~----ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~-------------- 1027 (1094)
+++....... .....++..|+|||.+. ...++.++||||||+++|+|+||+.||......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~--~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05080 153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLK--ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTV 230 (283)
T ss_pred cccccCCcchhhccCCCCCCCceeeCHhHhc--ccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccch
Confidence 9885432211 12223566799999987 456789999999999999999999998653211
Q ss_pred HHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1028 AIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1028 eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
...............+..++..+.+++.+||+.+|.+|||+.+|++.|.++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 231 VRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1111122233344556778899999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=347.70 Aligned_cols=257 Identities=23% Similarity=0.351 Sum_probs=213.3
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
+..++|++.+.||+|+||.||+++.+ +..||||++.+..... ......+.+|+.+++.++||||+++++++.+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~ 114 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIK-----RSDSAFFWEERDIMAHANSEWIVQLHYAFQD 114 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-----hhhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 45678999999999999999999874 6789999997532211 1223457789999999999999999999987
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
.. .+++||||+.+|+|.+++... .+++..+..++.||+.||+|||+++|+||||||+|||++ .++.+||+||
T Consensus 115 ~~--~~~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~----~~~~~kL~Df 186 (370)
T cd05596 115 DK--YLYMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD----KSGHLKLADF 186 (370)
T ss_pred CC--EEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEc----CCCCEEEEec
Confidence 65 899999999999999988654 478889999999999999999999999999999999998 7889999999
Q ss_pred CCcccccCc--cccCCccCCCcccCccccccC--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCC
Q 037285 965 GLSKIKRNT--LVSGGVRGTLPWMAPELLSGS--SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 1040 (1094)
Q Consensus 965 GLSrl~~~~--~~ss~~~GT~~YmAPEvL~g~--~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp 1040 (1094)
|++...... .......||+.|+|||++.+. ...++.++|||||||++|||++|+.||...........+.......
T Consensus 187 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~ 266 (370)
T cd05596 187 GTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSL 266 (370)
T ss_pred cceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcC
Confidence 999754322 122345699999999998642 2347889999999999999999999999888777777776544344
Q ss_pred CCCC--cCcHHHHHHHHHhccCCCCC--CCCHHHHHHHHH
Q 037285 1041 TIPS--YCDAEWRTLMEECWAPNPAA--RPSFTEIASRLR 1076 (1094)
Q Consensus 1041 ~iPe--~~S~eL~dLI~kCLq~DPee--RPS~eELLq~L~ 1076 (1094)
.++. .++.++.+||.+||..+|.+ |+++.+++++.+
T Consensus 267 ~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~ 306 (370)
T cd05596 267 TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPF 306 (370)
T ss_pred CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcc
Confidence 4444 47899999999999999988 999999998754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=346.43 Aligned_cols=250 Identities=24% Similarity=0.333 Sum_probs=204.9
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
.|+++++||+|+||.||+|+.. +..||||++.+... ........+.+|+.++++++|+||+++++++.+..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~-----~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~-- 74 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDV-----LLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-- 74 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHh-----hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC--
Confidence 6889999999999999999874 57799999875321 12334467888999999999999999999998765
Q ss_pred ceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 889 TLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
.+++||||+++|+|.+++.+.+ .+++..+..++.||+.||+|||+++|+||||||+|||++ .++.+||+|||+++
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~----~~g~~kL~DFGla~ 149 (382)
T cd05625 75 NLYFVMDYIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILID----RDGHIKLTDFGLCT 149 (382)
T ss_pred EEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCCEEEeECCCCc
Confidence 8999999999999999987654 588899999999999999999999999999999999998 78899999999975
Q ss_pred cccC------------------------------------------------ccccCCccCCCcccCccccccCCCCCCc
Q 037285 969 IKRN------------------------------------------------TLVSGGVRGTLPWMAPELLSGSSSKVSE 1000 (1094)
Q Consensus 969 l~~~------------------------------------------------~~~ss~~~GT~~YmAPEvL~g~~~kyS~ 1000 (1094)
.... .......+||+.|+|||++. ...++.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~~~ 227 (382)
T cd05625 150 GFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL--RTGYTQ 227 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhc--CCCCCC
Confidence 2110 00112346899999999997 456889
Q ss_pred hhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCC--CcCcHHHHHHHHHhccCCCCCCCC---HHHHHHHH
Q 037285 1001 KVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIP--SYCDAEWRTLMEECWAPNPAARPS---FTEIASRL 1075 (1094)
Q Consensus 1001 KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iP--e~~S~eL~dLI~kCLq~DPeeRPS---~eELLq~L 1075 (1094)
++|||||||+||||++|+.||......+....+........+| ..+++++.++|.+|+ .+|.+|++ +.+++++-
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp 306 (382)
T cd05625 228 LCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHP 306 (382)
T ss_pred eeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCC
Confidence 9999999999999999999999887766666655433333333 357889999998876 59999987 88888763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=322.49 Aligned_cols=255 Identities=36% Similarity=0.627 Sum_probs=211.9
Q ss_pred ccCCeeEEEEecccCceEEEEeeec--C---ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEe
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWR--G---TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVV 882 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~r--G---t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~ 882 (1094)
...+|++.+.||+|+||.||+|+++ + ..+|+|.++.... ......|.+|+.++++++||||+++++++
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 74 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-------EKQRRDFLSEASIMGQFDHPNIIHLEGVV 74 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-------HHHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 4568999999999999999999873 2 3689998864311 12245788999999999999999999999
Q ss_pred ecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 883 QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 883 ~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
.... ..++||||+++++|.+++......+++..++.++.|++.||+|||+++++||||||+|||++ .++.+||+
T Consensus 75 ~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~----~~~~~~l~ 148 (267)
T cd05066 75 TKSK--PVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVN----SNLVCKVS 148 (267)
T ss_pred ecCC--ccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEEC----CCCeEEeC
Confidence 8754 89999999999999999987666689999999999999999999999999999999999998 77899999
Q ss_pred ecCCcccccCccc----cCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhcc
Q 037285 963 DFGLSKIKRNTLV----SGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNT 1037 (1094)
Q Consensus 963 DFGLSrl~~~~~~----ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~ 1037 (1094)
|||++........ .....++..|+|||++. ...++.++|||||||++|++++ |..||......+....+. ..
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~--~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-~~ 225 (267)
T cd05066 149 DFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA--YRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE-EG 225 (267)
T ss_pred CCCcccccccccceeeecCCCccceeecCHhHhc--cCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHh-CC
Confidence 9999985432111 11122356899999997 4568899999999999999887 999998877666655553 34
Q ss_pred CCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1038 LRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1038 lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
.+...+..++..+.+++.+||+.+|.+||++.++++.|.++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 55556667889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=340.91 Aligned_cols=242 Identities=28% Similarity=0.429 Sum_probs=202.8
Q ss_pred EEecccCceEEEEeee-----cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCce
Q 037285 816 KELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTL 890 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~-----rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L 890 (1094)
+.||+|+||.||+++. .++.||+|++...... ......+.+|+.+|++++||||+++++++.... .+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~ 73 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK------VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEG--KL 73 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCC--EE
Confidence 5799999999999865 3678999999764211 122345678999999999999999999998754 89
Q ss_pred EEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccc
Q 037285 891 ATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK 970 (1094)
Q Consensus 891 ~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~ 970 (1094)
|+||||+.+|+|.+++.+.. .+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++..
T Consensus 74 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~kL~Dfg~~~~~ 148 (318)
T cd05582 74 YLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD----EEGHIKLTDFGLSKES 148 (318)
T ss_pred EEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEEC----CCCcEEEeeccCCccc
Confidence 99999999999999986554 589999999999999999999999999999999999998 7788999999998754
Q ss_pred cCc-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCcHH
Q 037285 971 RNT-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAE 1049 (1094)
Q Consensus 971 ~~~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~e 1049 (1094)
... .......||+.|+|||++. ...++.++|||||||++|+|++|+.||......+....+.... ..++..++..
T Consensus 149 ~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~--~~~p~~~~~~ 224 (318)
T cd05582 149 IDHEKKAYSFCGTVEYMAPEVVN--RRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK--LGMPQFLSPE 224 (318)
T ss_pred CCCCCceecccCChhhcCHHHHc--CCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHH
Confidence 322 2233456899999999997 4567889999999999999999999999888777776665443 3466778999
Q ss_pred HHHHHHHhccCCCCCCCC-----HHHHHHH
Q 037285 1050 WRTLMEECWAPNPAARPS-----FTEIASR 1074 (1094)
Q Consensus 1050 L~dLI~kCLq~DPeeRPS-----~eELLq~ 1074 (1094)
+.+||.+||+.||.+||+ +.+++.+
T Consensus 225 ~~~li~~~l~~~P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 225 AQSLLRALFKRNPANRLGAGPDGVEEIKRH 254 (318)
T ss_pred HHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence 999999999999999999 5666654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=320.10 Aligned_cols=254 Identities=31% Similarity=0.509 Sum_probs=208.4
Q ss_pred eeEEEEecccCceEEEEeeec-----CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 812 LEEQKELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 812 Yei~kkLGsG~FGtVYKAk~r-----Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
|++.+.||+|+||.||+|++. +..||||+++..... ......+.+|+.+++.++|+||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT------YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC------HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCC
Confidence 567889999999999999864 256999998753211 223457889999999999999999999886543
Q ss_pred C----CceEEEeeecccchhHHHHhhc-----ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCC
Q 037285 887 G----GTLATVAEYMVDGSLRHVLVRK-----DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRP 957 (1094)
Q Consensus 887 ~----~~L~IVmEYmegGSL~d~L~k~-----~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g 957 (1094)
. ...++||||+.+++|..++... ...+++..++.++.|++.||.|||+++++||||||+||+++ +++
T Consensus 75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~----~~~ 150 (273)
T cd05035 75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLR----EDM 150 (273)
T ss_pred ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEEC----CCC
Confidence 1 2478999999999999988543 23588999999999999999999999999999999999998 778
Q ss_pred cEEEEecCCcccccCcc---ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhH
Q 037285 958 ICKVGDFGLSKIKRNTL---VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGI 1033 (1094)
Q Consensus 958 ~VKLsDFGLSrl~~~~~---~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~I 1033 (1094)
.+||+|||+++...... ......++..|+|||.+. ...++.++|||||||++|||++ |..||......+....+
T Consensus 151 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~ 228 (273)
T cd05035 151 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA--DRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL 228 (273)
T ss_pred eEEECCccceeeccccccccccccccCCccccCHhhcc--cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99999999998543211 111223567899999986 4567899999999999999999 99999888777766655
Q ss_pred hhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1034 VNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1034 v~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
.. ......+..++..+.++|.+||+.||.+||++.++++.|..+
T Consensus 229 ~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 229 RH-GNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred Hc-CCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 43 344556778999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=324.50 Aligned_cols=257 Identities=31% Similarity=0.568 Sum_probs=209.3
Q ss_pred eccCCeeEEEEecccCceEEEEeeecC-------ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEE
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFY 879 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~rG-------t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~ 879 (1094)
+..++|++.+.||+|+||.||+|.+.+ ..||+|.+.... .......|.+|+.++++++|+||++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~ 75 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-------SEQDESDFLMEALIMSKFNHQNIVRLI 75 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-------CHHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 345789999999999999999998854 458888775421 122235688999999999999999999
Q ss_pred eEeecCCCCceEEEeeecccchhHHHHhhcc------cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCC
Q 037285 880 GVVQDGPGGTLATVAEYMVDGSLRHVLVRKD------RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKD 953 (1094)
Q Consensus 880 Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~------~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~ 953 (1094)
+++.+.. ..++||||+.+++|.+++.... ..+++..++.++.||+.||+|||+++++||||||+|||++..+
T Consensus 76 ~~~~~~~--~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~ 153 (277)
T cd05036 76 GVSFERL--PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKG 153 (277)
T ss_pred EEEccCC--CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccC
Confidence 9988754 7899999999999999987643 2488999999999999999999999999999999999998322
Q ss_pred CCCCcEEEEecCCcccccCccc---cCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 037285 954 PSRPICKVGDFGLSKIKRNTLV---SGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAI 1029 (1094)
Q Consensus 954 ~e~g~VKLsDFGLSrl~~~~~~---ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ei 1029 (1094)
....+||+|||+++....... ......+..|+|||++. ...++.++|||||||++|+|++ |..||........
T Consensus 154 -~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~ 230 (277)
T cd05036 154 -PGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFL--DGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV 230 (277)
T ss_pred -CCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHh--cCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 245799999999985422111 11222356799999987 4568999999999999999997 9999998777766
Q ss_pred HHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1030 IGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1030 le~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
...+ ....+...+..++..+.++|.+||+.+|++||++.+|+++|.
T Consensus 231 ~~~~-~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 231 MEFV-TGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHH-HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 5544 334445567788999999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=355.64 Aligned_cols=267 Identities=28% Similarity=0.400 Sum_probs=220.5
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCc------hhHHHHHHHHHHHHHHHhhCCCCceeEE
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRS------SEQERLTVEFWKEAEILSKLHHPNVVAF 878 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~------~eqe~~~~eFlrEIkILkrL~HPNIVqL 878 (1094)
...++|++++.||+|.||.|-+|+.. ++.||||++.+..+.... .....-.+...+||.+|++|+|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34578999999999999999999884 678999999765432111 1111123577899999999999999999
Q ss_pred EeEeecCCCCceEEEeeecccchhHHHHhhcccc-cCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCC
Q 037285 879 YGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRF-LDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRP 957 (1094)
Q Consensus 879 ~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~-Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g 957 (1094)
+.+..+.....+|||+|||..|.+...= .... +++.++++++.+++.||+|||.+|||||||||.|+|++ +.+
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~----~~g 247 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLS----SDG 247 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEc----CCC
Confidence 9999998888999999999988875422 2233 89999999999999999999999999999999999999 789
Q ss_pred cEEEEecCCccccc------CccccCCccCCCcccCccccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 037285 958 ICKVGDFGLSKIKR------NTLVSGGVRGTLPWMAPELLSGSS--SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAI 1029 (1094)
Q Consensus 958 ~VKLsDFGLSrl~~------~~~~ss~~~GT~~YmAPEvL~g~~--~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~ei 1029 (1094)
+|||+|||.+.... .........||+.|+|||.+.+.. ...+++.||||+||+||.|+.|+.||-+....++
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l 327 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL 327 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence 99999999987441 222223367999999999998522 2356789999999999999999999999988899
Q ss_pred HHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1030 IGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1030 le~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
..+++...+.-+....+..++++||.+||.+||+.|.++.+|..|.|...
T Consensus 328 ~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 328 FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 99988775543333347899999999999999999999999999998765
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=347.56 Aligned_cols=258 Identities=25% Similarity=0.364 Sum_probs=218.7
Q ss_pred eeeccCCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEe
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVV 882 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~ 882 (1094)
|.+..++|++..+||.|.-++||+|+. +++.||||++..+... ...+.+.+|+..|+.++||||+.++..|
T Consensus 21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~-------~~ld~l~kE~~~msl~~HPNIv~~~~sF 93 (516)
T KOG0582|consen 21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN-------NDLDALRKEVQTMSLIDHPNIVTYHCSF 93 (516)
T ss_pred CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh-------hhHHHHHHHHHHhhhcCCCCcceEEEEE
Confidence 456778999999999999999999987 4788999999765321 1256788999999999999999999999
Q ss_pred ecCCCCceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEE
Q 037285 883 QDGPGGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKV 961 (1094)
Q Consensus 883 ~d~~~~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKL 961 (1094)
..+. .+|+||.||.+|++.++++..- ..+++..+..|++++++||.|||++|.||||||+.||||+ .+|.|||
T Consensus 94 vv~~--~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~----~dG~VkL 167 (516)
T KOG0582|consen 94 VVDS--ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILID----SDGTVKL 167 (516)
T ss_pred Eecc--eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEc----CCCcEEE
Confidence 9865 8999999999999999997643 3489999999999999999999999999999999999999 8999999
Q ss_pred EecCCcccccC-----ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhc
Q 037285 962 GDFGLSKIKRN-----TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN 1036 (1094)
Q Consensus 962 sDFGLSrl~~~-----~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~ 1036 (1094)
+|||.+..... ......+.||++|||||++...-..|++|+||||||++..||.+|..||..+....++...+++
T Consensus 168 adFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn 247 (516)
T KOG0582|consen 168 ADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQN 247 (516)
T ss_pred cCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence 99998763211 1112567899999999997766778999999999999999999999999999988877666555
Q ss_pred cCCCCC--------CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037285 1037 TLRPTI--------PSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1037 ~lrp~i--------Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L 1075 (1094)
...... ....+..++++|..||..||.+|||+.+++++-
T Consensus 248 ~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~ 294 (516)
T KOG0582|consen 248 DPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHA 294 (516)
T ss_pred CCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccH
Confidence 432111 123566799999999999999999999999764
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=330.63 Aligned_cols=264 Identities=31% Similarity=0.527 Sum_probs=216.3
Q ss_pred ceeeccCCeeEEEEecccCceEEEEeeec---------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCC
Q 037285 804 VQVIKNEDLEEQKELGSGTFGTVYHGKWR---------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHP 873 (1094)
Q Consensus 804 v~eIs~edYei~kkLGsG~FGtVYKAk~r---------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HP 873 (1094)
.|.+..++|.+.+.||+|+||.||+++.. ...+|+|.++.... .....++.+|+.+++++ +||
T Consensus 6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~ 78 (314)
T cd05099 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-------DKDLADLISEMELMKLIGKHK 78 (314)
T ss_pred cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC-------hHHHHHHHHHHHHHHhccCCC
Confidence 45677789999999999999999999752 23589998764311 12245688899999999 699
Q ss_pred ceeEEEeEeecCCCCceEEEeeecccchhHHHHhhcc---------------cccCHHHHHHHHHHHHHHHHHHHHCCce
Q 037285 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD---------------RFLDRRRRLIIAMDAAFGMEYLHSKNIV 938 (1094)
Q Consensus 874 NIVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~---------------~~Lse~~~l~Ia~QIaeGLaYLHs~GII 938 (1094)
||+++++++.... .+++||||+.+|+|.+++.... ..+++..+..++.||+.||.|||++|++
T Consensus 79 ~iv~~~~~~~~~~--~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~ 156 (314)
T cd05099 79 NIINLLGVCTQEG--PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCI 156 (314)
T ss_pred CeeeEEEEEccCC--ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 9999999998754 8999999999999999996532 3478889999999999999999999999
Q ss_pred eccCCCCceEeccCCCCCCcEEEEecCCcccccCcc---ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHH
Q 037285 939 HFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTL---VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEIL 1015 (1094)
Q Consensus 939 HRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~~---~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELL 1015 (1094)
||||||+|||++ .++.+||+|||+++...... ......++..|+|||++. ...++.++|||||||++|+|+
T Consensus 157 H~dlkp~Nill~----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~~l~el~ 230 (314)
T cd05099 157 HRDLAARNVLVT----EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALF--DRVYTHQSDVWSFGILMWEIF 230 (314)
T ss_pred eccccceeEEEc----CCCcEEEccccccccccccccccccccCCCCccccCHHHHc--cCCcCccchhhHHHHHHHHHH
Confidence 999999999998 67889999999998543211 111122456799999987 456788999999999999999
Q ss_pred c-CCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 037285 1016 T-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAAS 1083 (1094)
Q Consensus 1016 T-Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s 1083 (1094)
+ |..||......+....+ ........+..++..+.++|.+||..+|++||++.++++.|..+.....
T Consensus 231 ~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 298 (314)
T cd05099 231 TLGGSPYPGIPVEELFKLL-REGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS 298 (314)
T ss_pred hCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhc
Confidence 9 99999887766666554 3444556677889999999999999999999999999999999875543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=362.04 Aligned_cols=248 Identities=29% Similarity=0.483 Sum_probs=218.5
Q ss_pred CCeeEEEEecccCceEEEEeeecC--ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~rG--t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|.+.+.||+|.||.||||+.++ +.||||.+.+... .++....+.+|+++++.|+|||||.++++|....
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr------~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~- 74 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR------NEKELKNLRQEVRILRSLKHPNIVEMLESFETSA- 74 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC------chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccc-
Confidence 578888999999999999998764 5699999977532 2344567889999999999999999999998866
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++|+||+.| +|..+|...+ .++++.+..++.|++.||.|||+++|+|||+||+|||+. .++.+|+||||+|
T Consensus 75 -~~~vVte~a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~----~~~~~KlcdFg~A 147 (808)
T KOG0597|consen 75 -HLWVVTEYAVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLE----KGGTLKLCDFGLA 147 (808)
T ss_pred -eEEEEehhhhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeec----CCCceeechhhhh
Confidence 89999999976 9999997665 499999999999999999999999999999999999999 8899999999999
Q ss_pred ccccC-ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcC
Q 037285 968 KIKRN-TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYC 1046 (1094)
Q Consensus 968 rl~~~-~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~ 1046 (1094)
+.... .......+||+-|||||++. ...|+..+|+||||||+|||++|++||......+++..+...... .|...
T Consensus 148 r~m~~~t~vltsikGtPlYmAPElv~--e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~--~p~~~ 223 (808)
T KOG0597|consen 148 RAMSTNTSVLTSIKGTPLYMAPELVE--EQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVK--PPSTA 223 (808)
T ss_pred hhcccCceeeeeccCcccccCHHHHc--CCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCC--Ccccc
Confidence 96543 34455678999999999999 567899999999999999999999999998888888888776554 45588
Q ss_pred cHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037285 1047 DAEWRTLMEECWAPNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1047 S~eL~dLI~kCLq~DPeeRPS~eELLq~L 1075 (1094)
+..+..|+..+|.+||..|.+..+++.|-
T Consensus 224 S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 224 SSSFVNFLQGLLIKDPAQRLTWTDLLGHP 252 (808)
T ss_pred cHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence 99999999999999999999999999763
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=315.50 Aligned_cols=245 Identities=40% Similarity=0.674 Sum_probs=210.0
Q ss_pred EEecccCceEEEEeeec-----CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCce
Q 037285 816 KELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTL 890 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~r-----Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L 890 (1094)
+.||+|+||.||+|.+. +..||+|.+...... .....+.+|+.+++.++|+||+++++++.... .+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~ 71 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE-------EERKDFLKEARVMKKLGHPNVVRLLGVCTEEE--PL 71 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccch-------hHHHHHHHHHHHHhhcCCCChheeeeeecCCC--ce
Confidence 46999999999999886 667999998764211 13467889999999999999999999998744 89
Q ss_pred EEEeeecccchhHHHHhhc--------ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 891 ATVAEYMVDGSLRHVLVRK--------DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 891 ~IVmEYmegGSL~d~L~k~--------~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
++||||+.+++|.+++... ...+++..++.++.|++.||+|||+++++|+||||+||+++ .++.+||+
T Consensus 72 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~----~~~~~~l~ 147 (262)
T cd00192 72 YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVG----EDLVVKIS 147 (262)
T ss_pred EEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEEC----CCCcEEEc
Confidence 9999999999999999876 46689999999999999999999999999999999999999 77899999
Q ss_pred ecCCcccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccC
Q 037285 963 DFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 1038 (1094)
Q Consensus 963 DFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~l 1038 (1094)
|||.+...... .......++..|+|||.+.. ..++.++|||||||++|+|++ |..||......+....+.. ..
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~ 224 (262)
T cd00192 148 DFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKD--GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GY 224 (262)
T ss_pred ccccccccccccccccccCCCcCccccCHHHhcc--CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CC
Confidence 99999854432 22334457889999999873 478899999999999999999 6999999887777666644 55
Q ss_pred CCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1039 RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1039 rp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
+...+..++.++.+++.+||+.+|.+||++.+++++|+
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 66677888999999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=321.21 Aligned_cols=254 Identities=34% Similarity=0.628 Sum_probs=211.0
Q ss_pred cCCeeEEEEecccCceEEEEeeec--C---ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEee
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--G---TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQ 883 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--G---t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~ 883 (1094)
..+|++.+.||+|+||.||+|.++ + ..||||.+.... .+....+|..|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 75 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-------TEKQRRDFLSEASIMGQFDHPNIIHLEGVVT 75 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-------CHHHHHHHHHHHHHHHhCCCcCcceEEEEEC
Confidence 456889999999999999999874 2 259999986531 1233467889999999999999999999997
Q ss_pred cCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEe
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGD 963 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsD 963 (1094)
... .+++||||+.+++|.+++......+++..++.++.|++.||+|||++|++|+||||+|||++ .++.+||+|
T Consensus 76 ~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~----~~~~~kl~d 149 (269)
T cd05065 76 KSR--PVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVN----SNLVCKVSD 149 (269)
T ss_pred CCC--ceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEc----CCCcEEECC
Confidence 754 89999999999999999987666689999999999999999999999999999999999998 778999999
Q ss_pred cCCcccccCccc----cCCc--cCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhc
Q 037285 964 FGLSKIKRNTLV----SGGV--RGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 1036 (1094)
Q Consensus 964 FGLSrl~~~~~~----ss~~--~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~ 1036 (1094)
||++........ .... ..+..|+|||.+. ...++.++|||||||++|||++ |..||...........+ ..
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i-~~ 226 (269)
T cd05065 150 FGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA--YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI-EQ 226 (269)
T ss_pred CccccccccCccccccccccCCCcceeecCHhHhc--cCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH-Hc
Confidence 999875432111 1111 1245799999987 4567889999999999999987 99999887777666655 34
Q ss_pred cCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1037 TLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1037 ~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
......+..++..+.+++.+||..+|.+||++.+|+..|+.+
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 227 DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 445555667899999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=316.68 Aligned_cols=256 Identities=24% Similarity=0.444 Sum_probs=209.6
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||+|+||.||+|... +..||+|.++...... ......+.+|+.++++++|+||+++++++....
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~- 75 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMD-----AKARQDCLKEIDLLKQLDHPNVIKYLASFIENN- 75 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccc-----hhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC-
Confidence 47999999999999999999885 7889999987533221 222456889999999999999999999998754
Q ss_pred CceEEEeeecccchhHHHHhh---cccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 888 GTLATVAEYMVDGSLRHVLVR---KDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k---~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
..++||||+++++|..++.. ....+++..++.++.+|+.||.|||+.||+|+||+|+||+++ .++.++|+||
T Consensus 76 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~----~~~~~~l~d~ 150 (267)
T cd08224 76 -ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFIT----ATGVVKLGDL 150 (267)
T ss_pred -eEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEEC----CCCcEEEecc
Confidence 89999999999999998864 234588999999999999999999999999999999999998 7788999999
Q ss_pred CCcccccCcc-ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--hHHHHHhHhhccCCCC
Q 037285 965 GLSKIKRNTL-VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH--YGAIIGGIVNNTLRPT 1041 (1094)
Q Consensus 965 GLSrl~~~~~-~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~--~~eile~Iv~~~lrp~ 1041 (1094)
|++....... ......++..|+|||.+. ...++.++|||||||++|+|++|+.||.... .......+.. ...+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~ 227 (267)
T cd08224 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIH--ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK-CDYPP 227 (267)
T ss_pred ceeeeccCCCcccceecCCccccCHHHhc--cCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc-CCCCC
Confidence 9987543221 222345788999999987 4567889999999999999999999996543 2233333322 23333
Q ss_pred CCC-cCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1042 IPS-YCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1042 iPe-~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
.+. .++..+.++|.+||..+|.+||++.+|++.|+.++
T Consensus 228 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 228 LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 443 67889999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.23 Aligned_cols=254 Identities=31% Similarity=0.566 Sum_probs=212.7
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeec-CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEee
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQ 883 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~r-Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~ 883 (1094)
|++..++|++.++||+|+||.||++.+. +..+|+|.+.... .....|.+|+.++++++|+||+++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~---------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 71 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---------MSVEAFLAEANVMKTLQHDKLVKLHAVVT 71 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh---------hHHHHHHHHHHHHHhcCCCCcceEEEEEc
Confidence 5678899999999999999999999875 4679999876431 12356888999999999999999999987
Q ss_pred cCCCCceEEEeeecccchhHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLVRK-DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~k~-~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
. ...+++|||+.+++|.+++... ...+++..++.++.||+.||.|||+++++|+||||+||+++ ..+.+||+
T Consensus 72 ~---~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~----~~~~~~l~ 144 (260)
T cd05073 72 K---EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS----ASLVCKIA 144 (260)
T ss_pred C---CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc----CCCcEEEC
Confidence 6 2689999999999999999763 34578889999999999999999999999999999999998 78899999
Q ss_pred ecCCcccccCc--cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCC
Q 037285 963 DFGLSKIKRNT--LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLR 1039 (1094)
Q Consensus 963 DFGLSrl~~~~--~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lr 1039 (1094)
|||++...... .......++..|+|||++. ...++.++|||||||++|+|+| |+.||...........+ .....
T Consensus 145 d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-~~~~~ 221 (260)
T cd05073 145 DFGLARVIEDNEYTAREGAKFPIKWTAPEAIN--FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-ERGYR 221 (260)
T ss_pred CCcceeeccCCCcccccCCcccccccCHhHhc--cCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-hCCCC
Confidence 99998754321 1122233567799999987 4567889999999999999999 99999987766665544 44455
Q ss_pred CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1040 PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1040 p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
...+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 222 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 55667788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=336.58 Aligned_cols=254 Identities=28% Similarity=0.443 Sum_probs=204.4
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
+..++|++.++||+|+||.||++.+. +..+|+|++.... .......+.+|++++++++|+||++++++|..
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-------KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-------CHHHHHHHHHHHHHHHHCCCCcccceeEEEEE
Confidence 45678999999999999999999885 5679999886531 12234568899999999999999999999988
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeccCCCCCCcEEEEe
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPSRPICKVGD 963 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~-GIIHRDLKPeNILLD~~~~e~g~VKLsD 963 (1094)
.. .+++||||+.+++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++ .++.+||+|
T Consensus 75 ~~--~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~----~~~~~kL~D 147 (333)
T cd06650 75 DG--EISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLCD 147 (333)
T ss_pred CC--EEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEc----CCCCEEEee
Confidence 54 8999999999999999997654 488999999999999999999975 799999999999998 678899999
Q ss_pred cCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhH----------
Q 037285 964 FGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI---------- 1033 (1094)
Q Consensus 964 FGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~I---------- 1033 (1094)
||++...... ......++..|+|||++. ...++.++|||||||++|+|++|+.||...........+
T Consensus 148 fg~~~~~~~~-~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (333)
T cd06650 148 FGVSGQLIDS-MANSFVGTRSYMSPERLQ--GTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAE 224 (333)
T ss_pred CCcchhhhhh-ccccCCCCccccCHHHhc--CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccc
Confidence 9998754322 123356899999999997 456889999999999999999999999765432221100
Q ss_pred ---------------------------------hhccCCCCCC-CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1034 ---------------------------------VNNTLRPTIP-SYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1034 ---------------------------------v~~~lrp~iP-e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
......+..+ ...+.++++||.+||+.||++|||+.+++.+-+-
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~ 302 (333)
T cd06650 225 SETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFI 302 (333)
T ss_pred cccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHH
Confidence 0011111111 2356789999999999999999999999987654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=321.91 Aligned_cols=255 Identities=36% Similarity=0.569 Sum_probs=204.4
Q ss_pred CCeeEEEEecccCceEEEEeee------cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEee
Q 037285 810 EDLEEQKELGSGTFGTVYHGKW------RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQ 883 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~------rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~ 883 (1094)
.+|++.+.||+|+||.||++.+ .+..||||.+.... ......|.+|+.++++++||||+++++++.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 75 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--------AEHLRDFEREIEILKSLQHDNIVKYKGVCY 75 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--------HHHHHHHHHHHHHHHhCCCCCeeEEEEEEc
Confidence 4788999999999999999874 25679999986431 223457889999999999999999999886
Q ss_pred cCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEe
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGD 963 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsD 963 (1094)
......+++||||+++++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~----~~~~~~l~d 151 (284)
T cd05081 76 SAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVE----SENRVKIGD 151 (284)
T ss_pred cCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEEC----CCCeEEECC
Confidence 5544578999999999999999976655689999999999999999999999999999999999998 778899999
Q ss_pred cCCcccccCccc----cCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH-----------
Q 037285 964 FGLSKIKRNTLV----SGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA----------- 1028 (1094)
Q Consensus 964 FGLSrl~~~~~~----ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~e----------- 1028 (1094)
||+++....... .....++..|+|||++. ...++.++|||||||++|||++|..++.......
T Consensus 152 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd05081 152 FGLTKVLPQDKEYYKVREPGESPIFWYAPESLT--ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQ 229 (284)
T ss_pred CcccccccCCCcceeecCCCCCceEeeCHHHhc--cCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccc
Confidence 999985432211 11122345699999987 4567889999999999999999877654322110
Q ss_pred ----HHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1029 ----IIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1029 ----ile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
.+...+........+..++..+.+||.+||..+|++|||+.+|++.|..+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 230 MIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 01122333344455667889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=331.25 Aligned_cols=259 Identities=34% Similarity=0.575 Sum_probs=210.4
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--Cc--eEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeE
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GT--DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGV 881 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt--~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv 881 (1094)
+..++|++.+.||+|+||.||+|.++ +. .+|+|.++... .......+.+|+.++.++ +|+||++++++
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~ 76 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-------SKDDHRDFAGELEVLCKLGHHPNIINLLGA 76 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC-------CHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence 44568999999999999999999874 33 35777665321 122345788899999999 89999999999
Q ss_pred eecCCCCceEEEeeecccchhHHHHhhcc---------------cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 037285 882 VQDGPGGTLATVAEYMVDGSLRHVLVRKD---------------RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDN 946 (1094)
Q Consensus 882 ~~d~~~~~L~IVmEYmegGSL~d~L~k~~---------------~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeN 946 (1094)
+.... .+++||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|
T Consensus 77 ~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~N 154 (303)
T cd05088 77 CEHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN 154 (303)
T ss_pred ECCCC--CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchhe
Confidence 98754 8999999999999999996542 247899999999999999999999999999999999
Q ss_pred eEeccCCCCCCcEEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 037285 947 LLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH 1025 (1094)
Q Consensus 947 ILLD~~~~e~g~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~ 1025 (1094)
||++ .++.+||+|||++.............++..|+|||++. ...++.++|||||||++|+|+| |..||....
T Consensus 155 ili~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 228 (303)
T cd05088 155 ILVG----ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN--YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228 (303)
T ss_pred EEec----CCCcEEeCccccCcccchhhhcccCCCcccccCHHHHh--ccCCcccccchhhhhHHHHHHhcCCCCcccCC
Confidence 9998 67889999999987432222222223467799999987 4457889999999999999998 999998777
Q ss_pred hHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1026 YGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1026 ~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
..+....+ ....+...+..++..+.+||.+||+.+|.+||++.+++..|..+...
T Consensus 229 ~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 229 CAELYEKL-PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred hHHHHHHH-hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 66655544 34445556667889999999999999999999999999999887533
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=337.34 Aligned_cols=243 Identities=27% Similarity=0.447 Sum_probs=203.6
Q ss_pred EEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEeecCCCCceEE
Q 037285 816 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQDGPGGTLAT 892 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~~d~~~~~L~I 892 (1094)
+.||+|+||.||+++++ +..||||++++.... .......+..|+.+++.+ +||||+++++++.... .+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~--~~~l 73 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVIL-----QDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD--RLFF 73 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh-----hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC--EEEE
Confidence 46999999999999885 567999999864321 122335567888888887 6999999999998755 8999
Q ss_pred EeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccc-c
Q 037285 893 VAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK-R 971 (1094)
Q Consensus 893 VmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~-~ 971 (1094)
||||+.+|+|..++.... .+++..+..++.||+.||+|||+++|+||||||+|||++ .++.+||+|||+++.. .
T Consensus 74 v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~----~~~~~kl~Dfg~~~~~~~ 148 (318)
T cd05570 74 VMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLD----SEGHIKIADFGMCKEGIL 148 (318)
T ss_pred EEcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEEC----CCCcEEecccCCCeecCc
Confidence 999999999999887654 589999999999999999999999999999999999998 7789999999998742 2
Q ss_pred CccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHH
Q 037285 972 NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWR 1051 (1094)
Q Consensus 972 ~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~ 1051 (1094)
........+||..|+|||++. ...++.++|||||||++|+|++|+.||...........+.... ..++..++..+.
T Consensus 149 ~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~ 224 (318)
T cd05570 149 GGVTTSTFCGTPDYIAPEILS--YQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE--VRYPRWLSKEAK 224 (318)
T ss_pred CCCcccceecCccccCHHHhc--CCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--CCCCCcCCHHHH
Confidence 222233456899999999998 4567899999999999999999999999887777666654443 346677899999
Q ss_pred HHHHHhccCCCCCCCCH-----HHHHHH
Q 037285 1052 TLMEECWAPNPAARPSF-----TEIASR 1074 (1094)
Q Consensus 1052 dLI~kCLq~DPeeRPS~-----eELLq~ 1074 (1094)
+||.+||..||.+||++ .+++++
T Consensus 225 ~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 225 SILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 99999999999999999 888876
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=327.53 Aligned_cols=261 Identities=29% Similarity=0.520 Sum_probs=216.0
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeec---------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCc
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWR---------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPN 874 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~r---------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPN 874 (1094)
|.+...+|++.+.||+|+||.||+|++. +..||+|.+.... .......+.+|+.+++.+ +|||
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~ 82 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-------TEKDLSDLVSEMEMMKMIGKHKN 82 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-------chHHHHHHHHHHHHHHhhccCCC
Confidence 4567789999999999999999999752 2358999876431 112235688999999999 8999
Q ss_pred eeEEEeEeecCCCCceEEEeeecccchhHHHHhhcc---------------cccCHHHHHHHHHHHHHHHHHHHHCCcee
Q 037285 875 VVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD---------------RFLDRRRRLIIAMDAAFGMEYLHSKNIVH 939 (1094)
Q Consensus 875 IVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~---------------~~Lse~~~l~Ia~QIaeGLaYLHs~GIIH 939 (1094)
|+++++++.... ..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+|
T Consensus 83 i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH 160 (304)
T cd05101 83 IINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIH 160 (304)
T ss_pred chheeEEEecCC--ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeee
Confidence 999999998754 8899999999999999997532 24778889999999999999999999999
Q ss_pred ccCCCCceEeccCCCCCCcEEEEecCCcccccCcc---ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc
Q 037285 940 FDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTL---VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT 1016 (1094)
Q Consensus 940 RDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~~---~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT 1016 (1094)
|||||+|||++ .++.+||+|||+++...... ......++..|+|||++. ...++.++||||||+++|+|++
T Consensus 161 ~dlkp~Nili~----~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~~ 234 (304)
T cd05101 161 RDLAARNVLVT----ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFT 234 (304)
T ss_pred cccccceEEEc----CCCcEEECCCccceecccccccccccCCCCCceeeCchhhc--cCCCCchhhHHHHHHHHHHHHc
Confidence 99999999998 77899999999998543211 122234567899999987 4567899999999999999998
Q ss_pred -CCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1017 -GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1017 -Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
|..||......+....+ ....+...+..++..+++||.+||+.+|.+||++.+|++.|.++.+-
T Consensus 235 ~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 235 LGGSPYPGIPVEELFKLL-KEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred CCCCCcccCCHHHHHHHH-HcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 88999888777766655 44455566778899999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=325.17 Aligned_cols=254 Identities=32% Similarity=0.526 Sum_probs=209.6
Q ss_pred CeeEEEEecccCceEEEEeeecC-------ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEee
Q 037285 811 DLEEQKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQ 883 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~rG-------t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~ 883 (1094)
+|++.+.||+|+||.||+|+... ..+|+|.+..... ......+.+|+.++++++||||+++++.+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 73 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-------SSELRDLLSEFNLLKQVNHPHVIKLYGACS 73 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-------HHHHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 47788999999999999998642 4588888764321 122356889999999999999999999988
Q ss_pred cCCCCceEEEeeecccchhHHHHhhcc-----------------------cccCHHHHHHHHHHHHHHHHHHHHCCceec
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLVRKD-----------------------RFLDRRRRLIIAMDAAFGMEYLHSKNIVHF 940 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~k~~-----------------------~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHR 940 (1094)
... ..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+++++||
T Consensus 74 ~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~ 151 (290)
T cd05045 74 QDG--PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHR 151 (290)
T ss_pred cCC--CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehh
Confidence 754 7899999999999999986421 247888999999999999999999999999
Q ss_pred cCCCCceEeccCCCCCCcEEEEecCCcccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-
Q 037285 941 DLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT- 1016 (1094)
Q Consensus 941 DLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT- 1016 (1094)
||||+|||++ +++.+||+|||+++..... .......++..|+|||.+. ...++.++||||||+++|+|++
T Consensus 152 dikp~nill~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~--~~~~~~~~Di~slG~~l~el~t~ 225 (290)
T cd05045 152 DLAARNVLVA----EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLF--DHIYTTQSDVWSFGVLLWEIVTL 225 (290)
T ss_pred hhhhheEEEc----CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHc--cCCcchHhHHHHHHHHHHHHHhc
Confidence 9999999998 6789999999998743211 1122234567899999986 4568899999999999999998
Q ss_pred CCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 037285 1017 GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLST 1080 (1094)
Q Consensus 1017 Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~t 1080 (1094)
|..||.......+... .........+..++.++.++|.+||+.+|.+||++.++++.|+++..
T Consensus 226 g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 226 GGNPYPGIAPERLFNL-LKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred CCCCCCCCCHHHHHHH-HhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 9999988776665544 35555666778889999999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=330.13 Aligned_cols=260 Identities=32% Similarity=0.530 Sum_probs=215.6
Q ss_pred ceeeccCCeeEEEEecccCceEEEEeeec-------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCce
Q 037285 804 VQVIKNEDLEEQKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNV 875 (1094)
Q Consensus 804 v~eIs~edYei~kkLGsG~FGtVYKAk~r-------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNI 875 (1094)
.+.+..++|.+.+.||+|+||.||++.+. +..||||+++.... ......+.+|+.+++++ +|+||
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~~i 101 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-------SSEREALMSELKIMSHLGNHENI 101 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-------hHHHHHHHHHHHHHHhccCCCCc
Confidence 35567789999999999999999998752 23699998865321 12235788999999999 79999
Q ss_pred eEEEeEeecCCCCceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCC
Q 037285 876 VAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP 954 (1094)
Q Consensus 876 VqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~ 954 (1094)
+++++++.... .+++||||+.+++|.+++.... ..+++..++.++.||+.||+|||+++|+|+||||+|||++
T Consensus 102 v~~~~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~---- 175 (302)
T cd05055 102 VNLLGACTIGG--PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT---- 175 (302)
T ss_pred ceEEEEEecCC--ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEc----
Confidence 99999998754 8999999999999999997543 3489999999999999999999999999999999999998
Q ss_pred CCCcEEEEecCCcccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 037285 955 SRPICKVGDFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAII 1030 (1094)
Q Consensus 955 e~g~VKLsDFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eil 1030 (1094)
.++.+||+|||+++..... .......++..|+|||.+. ...++.++|||||||++|+|++ |..||......+..
T Consensus 176 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~ 253 (302)
T cd05055 176 HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIF--NCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF 253 (302)
T ss_pred CCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhc--cCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH
Confidence 6788999999998843221 1122234577899999987 4467889999999999999998 99999887766555
Q ss_pred HhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1031 GGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1031 e~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
........+...+...+..+.++|.+||..+|++|||+.+|++.|.++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 254 YKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 555555666666677889999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=321.72 Aligned_cols=259 Identities=27% Similarity=0.469 Sum_probs=213.9
Q ss_pred eccCCeeEEEEecccCceEEEEeeecC------ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEe
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYG 880 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~rG------t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~G 880 (1094)
+..++|++.+.||+|+||.||+|.+.. ..|++|++.... .......+.+|+.++++++|+||+++++
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~-------~~~~~~~~~~e~~~l~~l~h~ni~~~~~ 75 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-------SEIQVTLLLQESCLLYGLSHQNILPILH 75 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC-------CHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 456789999999999999999998753 668999876321 1233466889999999999999999999
Q ss_pred EeecCCCCceEEEeeecccchhHHHHhhcc-------cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCC
Q 037285 881 VVQDGPGGTLATVAEYMVDGSLRHVLVRKD-------RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKD 953 (1094)
Q Consensus 881 v~~d~~~~~L~IVmEYmegGSL~d~L~k~~-------~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~ 953 (1094)
++... ....+++++|+.+++|.+++.... ..+++..++.++.||+.||+|||+++++|+||||+|||++
T Consensus 76 ~~~~~-~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~--- 151 (280)
T cd05043 76 VCIED-GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVID--- 151 (280)
T ss_pred EEecC-CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEc---
Confidence 88764 247889999999999999986542 3588999999999999999999999999999999999998
Q ss_pred CCCCcEEEEecCCcccccCcc---ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 037285 954 PSRPICKVGDFGLSKIKRNTL---VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAI 1029 (1094)
Q Consensus 954 ~e~g~VKLsDFGLSrl~~~~~---~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ei 1029 (1094)
..+.+||+|||+++...... ......++..|+|||++. ...++.++|||||||++|++++ |+.||......+.
T Consensus 152 -~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~--~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 228 (280)
T cd05043 152 -EELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLV--NKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM 228 (280)
T ss_pred -CCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHh--cCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHH
Confidence 67899999999997432111 112234567899999987 4567899999999999999999 9999988766555
Q ss_pred HHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 037285 1030 IGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLST 1080 (1094)
Q Consensus 1030 le~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~t 1080 (1094)
...+ ........+..++.++.++|.+||..+|++|||+.++++.|..+..
T Consensus 229 ~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 229 AAYL-KDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred HHHH-HcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 4433 4455555566789999999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=348.42 Aligned_cols=262 Identities=31% Similarity=0.489 Sum_probs=219.0
Q ss_pred cceeeccCCeeEEEEecccCceEEEEeeecC-------ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-CCc
Q 037285 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HPN 874 (1094)
Q Consensus 803 sv~eIs~edYei~kkLGsG~FGtVYKAk~rG-------t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-HPN 874 (1094)
..|++..++|.+.++||+|+||.||+|++++ ..||||+++.... ......+.+|+.+|.++. |||
T Consensus 30 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-------~~~~~~~~~E~~~l~~l~~H~n 102 (401)
T cd05107 30 SAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-------SSEKQALMSELKIMSHLGPHLN 102 (401)
T ss_pred CcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-------hhHHHHHHHHHHHHHhcCCCCC
Confidence 4578889999999999999999999998753 4699999975321 112346889999999997 999
Q ss_pred eeEEEeEeecCCCCceEEEeeecccchhHHHHhhcc--------------------------------------------
Q 037285 875 VVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD-------------------------------------------- 910 (1094)
Q Consensus 875 IVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~-------------------------------------------- 910 (1094)
|++++++|.... .+++||||+.+|+|.+++....
T Consensus 103 iv~~~~~~~~~~--~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (401)
T cd05107 103 IVNLLGACTKGG--PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMD 180 (401)
T ss_pred eEEEEEEEccCC--CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccc
Confidence 999999998754 8999999999999999986432
Q ss_pred -----------------------------------------------------cccCHHHHHHHHHHHHHHHHHHHHCCc
Q 037285 911 -----------------------------------------------------RFLDRRRRLIIAMDAAFGMEYLHSKNI 937 (1094)
Q Consensus 911 -----------------------------------------------------~~Lse~~~l~Ia~QIaeGLaYLHs~GI 937 (1094)
..+++..++.++.||+.||+|||+++|
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~i 260 (401)
T cd05107 181 MSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNC 260 (401)
T ss_pred cCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCc
Confidence 135677788999999999999999999
Q ss_pred eeccCCCCceEeccCCCCCCcEEEEecCCcccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHH
Q 037285 938 VHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEI 1014 (1094)
Q Consensus 938 IHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyEL 1014 (1094)
+||||||+|||++ ..+.+||+|||+++..... .......++..|+|||++. ...++.++|||||||++|||
T Consensus 261 vHrdlkp~NiLl~----~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslGvil~e~ 334 (401)
T cd05107 261 VHRDLAARNVLIC----EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIF--NNLYTTLSDVWSFGILLWEI 334 (401)
T ss_pred CcccCCcceEEEe----CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhc--CCCCCcHhHHHHHHHHHHHH
Confidence 9999999999998 6788999999999853221 1122345678899999997 45678999999999999999
Q ss_pred Hc-CCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1015 LT-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1015 LT-Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
++ |..||......+..........++..+..++.++.+||.+||..+|.+||++.+|+..|..+.
T Consensus 335 l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 335 FTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 98 899998776666555555666777778889999999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=321.27 Aligned_cols=257 Identities=23% Similarity=0.440 Sum_probs=209.5
Q ss_pred CCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||+|+||.||++.+ .+..+|||.+..... .......++.+|+.+++.++|+||+++++++....
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~- 75 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL-----MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN- 75 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh-----hhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC-
Confidence 4688889999999999999986 478899998865322 12233467889999999999999999999998754
Q ss_pred CceEEEeeecccchhHHHHhh---cccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 888 GTLATVAEYMVDGSLRHVLVR---KDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k---~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
..+++|||+.+++|.+++.. ....+++..++.++.||+.||.|||++|++|+||||+||+++ .++.++|+||
T Consensus 76 -~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~----~~~~~~l~df 150 (267)
T cd08229 76 -ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT----ATGVVKLGDL 150 (267)
T ss_pred -eEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCCEEECcc
Confidence 89999999999999998864 234589999999999999999999999999999999999998 6788999999
Q ss_pred CCcccccCcc-ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh--HHHHHhHhhccCCCC
Q 037285 965 GLSKIKRNTL-VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY--GAIIGGIVNNTLRPT 1041 (1094)
Q Consensus 965 GLSrl~~~~~-~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~--~eile~Iv~~~lrp~ 1041 (1094)
|++....... ......++..|+|||++. ...++.++||||||+++|+|++|..||..... ......+......+.
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~ape~~~--~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 228 (267)
T cd08229 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIH--ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL 228 (267)
T ss_pred hhhhccccCCcccccccCCcCccCHHHhc--CCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCC
Confidence 9987543322 223346889999999987 45678899999999999999999999975433 233333322233333
Q ss_pred CCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1042 iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
.+..++..+.++|.+||..+|.+|||+.+|++.+.++.
T Consensus 229 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 229 PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 34567889999999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=329.06 Aligned_cols=255 Identities=25% Similarity=0.354 Sum_probs=204.1
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.++||+|+||.||+|+++ +..||||.++...... ....+.+|+.++++++||||+++++++....
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 77 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-------APCTAIREVSLLKDLKHANIVTLHDIVHTDK 77 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC-------cchhHHHHHHHHHhCCCCCcceEEEEEeeCC
Confidence 367999999999999999999874 5779999987542211 1235678999999999999999999998755
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+++||||+.+ +|.+++......+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 78 --~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~----~~~~~kl~Dfg~ 150 (309)
T cd07872 78 --SLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLIN----ERGELKLADFGL 150 (309)
T ss_pred --eEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEECcccc
Confidence 89999999974 78888876666689999999999999999999999999999999999998 778899999999
Q ss_pred cccccCc-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhcc--------
Q 037285 967 SKIKRNT-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-------- 1037 (1094)
Q Consensus 967 Srl~~~~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~-------- 1037 (1094)
++..... .......+|..|+|||++.+ ...++.++|||||||++|+|+||+.||......+....+....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 229 (309)
T cd07872 151 ARAKSVPTKTYSNEVVTLWYRPPDVLLG-SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETW 229 (309)
T ss_pred ceecCCCccccccccccccccCCHHHhC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 8753322 22223457899999999864 3467889999999999999999999998776544433322110
Q ss_pred -------------CCC-------CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1038 -------------LRP-------TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1038 -------------lrp-------~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
... .....++.++.+||.+||+.||.+|||+.+++++-+--
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 290 (309)
T cd07872 230 PGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFR 290 (309)
T ss_pred hhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhh
Confidence 000 01124678899999999999999999999999976553
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=352.82 Aligned_cols=254 Identities=21% Similarity=0.266 Sum_probs=199.8
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
....+|++.+.||+|+||.||+|.+. +..||||.+.... ....+|+.+|++++||||+++++++..
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------------~~~~~Ei~il~~l~h~niv~l~~~~~~ 130 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------------QYKNRELLIMKNLNHINIIFLKDYYYT 130 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------------chHHHHHHHHHhcCCCCCcceeeeEee
Confidence 34568999999999999999999874 6789999885431 123469999999999999999887643
Q ss_pred C------CCCceEEEeeecccchhHHHHhh---cccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCC
Q 037285 885 G------PGGTLATVAEYMVDGSLRHVLVR---KDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPS 955 (1094)
Q Consensus 885 ~------~~~~L~IVmEYmegGSL~d~L~k---~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e 955 (1094)
. ....+++||||+++ +|.+++.. ....+++..++.++.||+.||+|||+++|+||||||+|||++. .
T Consensus 131 ~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~---~ 206 (440)
T PTZ00036 131 ECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDP---N 206 (440)
T ss_pred cccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcC---C
Confidence 2 11257799999975 66666542 3456899999999999999999999999999999999999981 2
Q ss_pred CCcEEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhh
Q 037285 956 RPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN 1035 (1094)
Q Consensus 956 ~g~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~ 1035 (1094)
.+.+||+|||+++............+|+.|+|||++.+ ...++.++|||||||+||||++|..||.+....+.+..+..
T Consensus 207 ~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 285 (440)
T PTZ00036 207 THTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLG-ATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQ 285 (440)
T ss_pred CCceeeeccccchhccCCCCcccCCCCcCccCHHHhcC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 34799999999985543333344568999999999864 34688999999999999999999999988766554443322
Q ss_pred c---------------------------cCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1036 N---------------------------TLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1036 ~---------------------------~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
. .+...+|...+.++.+||.+||..||.+|||+.+++++-+-
T Consensus 286 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f 354 (440)
T PTZ00036 286 VLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFF 354 (440)
T ss_pred HhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhH
Confidence 1 01112344577899999999999999999999999987654
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=337.39 Aligned_cols=254 Identities=23% Similarity=0.311 Sum_probs=199.8
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
..+|++.+.||+|+||.||+++.+ +..||||++...... ......+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN------QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQK 93 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccc------hhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC
Confidence 468999999999999999999874 678999998754211 122356778999999999999999999986432
Q ss_pred C----CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 887 G----GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 887 ~----~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
. ..+++||||+.+ +|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~----~~~~~kl~ 165 (359)
T cd07876 94 SLEEFQDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKIL 165 (359)
T ss_pred CccccceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC----CCCCEEEe
Confidence 1 257999999965 56555532 378889999999999999999999999999999999998 78899999
Q ss_pred ecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccC----
Q 037285 963 DFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL---- 1038 (1094)
Q Consensus 963 DFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~l---- 1038 (1094)
|||+++............+|..|+|||++. ...++.++|||||||++|+|++|+.||...+.......+.....
T Consensus 166 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 243 (359)
T cd07876 166 DFGLARTACTNFMMTPYVVTRYYRAPEVIL--GMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSA 243 (359)
T ss_pred cCCCccccccCccCCCCcccCCCCCchhcc--CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcH
Confidence 999998544333334456899999999997 45678899999999999999999999987654332221111000
Q ss_pred ----------------CC--------------------CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1039 ----------------RP--------------------TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1039 ----------------rp--------------------~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
.+ ......+..+++||.+||..||++|||+.+++++-+-.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 319 (359)
T cd07876 244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT 319 (359)
T ss_pred HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhh
Confidence 00 01122457789999999999999999999999987643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=323.68 Aligned_cols=253 Identities=37% Similarity=0.600 Sum_probs=209.4
Q ss_pred eccCCeeEEEEecccCceEEEEeeec-------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEE
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFY 879 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r-------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~ 879 (1094)
|...+|.+.++||+|+||.||++... +..+|+|.++... ......|.+|+.++++++|+||++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~ 73 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--------ESARQDFQREAELLTVLQHQHIVRFY 73 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC--------HHHHHHHHHHHHHHhcCCCCCCceEE
Confidence 34568889999999999999998642 3468899876431 23345788999999999999999999
Q ss_pred eEeecCCCCceEEEeeecccchhHHHHhhcc--------------cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 037285 880 GVVQDGPGGTLATVAEYMVDGSLRHVLVRKD--------------RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCD 945 (1094)
Q Consensus 880 Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~--------------~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPe 945 (1094)
+++.... ..+++|||+.+++|.+++.... ..+++..++.++.||+.||+|||+++++||||||+
T Consensus 74 ~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~ 151 (280)
T cd05092 74 GVCTEGR--PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATR 151 (280)
T ss_pred EEEecCC--ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHh
Confidence 9998754 7899999999999999987543 24788999999999999999999999999999999
Q ss_pred ceEeccCCCCCCcEEEEecCCcccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCC
Q 037285 946 NLLVNLKDPSRPICKVGDFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPY 1021 (1094)
Q Consensus 946 NILLD~~~~e~g~VKLsDFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF 1021 (1094)
|||++ +++.+||+|||+++..... .......+++.|+|||++. ...++.++|||||||++|+|++ |+.||
T Consensus 152 nil~~----~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~~g~~p~ 225 (280)
T cd05092 152 NCLVG----QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL--YRKFTTESDIWSFGVVLWEIFTYGKQPW 225 (280)
T ss_pred hEEEc----CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhc--cCCcCchhhHHHHHHHHHHHHcCCCCCC
Confidence 99998 6789999999998743221 1122233567899999987 4568899999999999999998 99999
Q ss_pred CCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1022 ANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1022 ~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
......+....+.. ......+..++..+.+||.+||+.||.+||++.+|++.|.
T Consensus 226 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 226 YQLSNTEAIECITQ-GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ccCCHHHHHHHHHc-CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 88777666655533 3344566788999999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=316.55 Aligned_cols=248 Identities=26% Similarity=0.424 Sum_probs=208.2
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
+|++.+.||.|+||.||++++. +..+|+|.++.... ......+.+|+.++++++|+||+++++.+.+..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 71 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-------SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG-- 71 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-------hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC--
Confidence 5788999999999999999874 67899999864321 122356778999999999999999999998765
Q ss_pred ceEEEeeecccchhHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 889 TLATVAEYMVDGSLRHVLVRK-DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~-~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++||||+++++|.+++... ...+++..++.++.||+.||.|||+++|+|+||||+||+++ .++.++|+|||++
T Consensus 72 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~----~~~~~~l~dfg~~ 147 (255)
T cd08219 72 HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLT----QNGKVKLGDFGSA 147 (255)
T ss_pred EEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEC----CCCcEEEcccCcc
Confidence 899999999999999988653 34578999999999999999999999999999999999998 7788999999998
Q ss_pred ccccC-ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcC
Q 037285 968 KIKRN-TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYC 1046 (1094)
Q Consensus 968 rl~~~-~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~ 1046 (1094)
+.... ........++..|+|||++. ...++.++||||||+++|+|++|+.||...........+... .....+..+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~ 224 (255)
T cd08219 148 RLLTSPGAYACTYVGTPYYVPPEIWE--NMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQG-SYKPLPSHY 224 (255)
T ss_pred eeecccccccccccCCccccCHHHHc--cCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcC-CCCCCCccc
Confidence 75432 22223456888999999987 456788999999999999999999999987776666655443 334466778
Q ss_pred cHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1047 DAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1047 S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
+..+.++|.+||+.||++||++.+|+..
T Consensus 225 ~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 225 SYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 8999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=338.03 Aligned_cols=243 Identities=22% Similarity=0.383 Sum_probs=198.2
Q ss_pred EEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEeecCCCCceEE
Q 037285 816 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQDGPGGTLAT 892 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~~d~~~~~L~I 892 (1094)
+.||+|+||.||++++. +..||||++++..... ......+.+|+.++.++ +||||+++++++.+.. .+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~-----~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~--~~~l 73 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVND-----DEDIDWVQTEKHVFETASNHPFLVGLHSCFQTES--RLFF 73 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-----hhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCC--EEEE
Confidence 46999999999999875 6789999998643221 22345677899999988 6999999999998765 8999
Q ss_pred EeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccc-c
Q 037285 893 VAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK-R 971 (1094)
Q Consensus 893 VmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~-~ 971 (1094)
||||+++|+|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.. .
T Consensus 74 v~e~~~~g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~----~~~~~kL~Dfg~~~~~~~ 148 (329)
T cd05588 74 VIEFVSGGDLMFHMQRQR-KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLD----AEGHIKLTDYGMCKEGIR 148 (329)
T ss_pred EEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC----CCCCEEECcCcccccccc
Confidence 999999999998886554 589999999999999999999999999999999999998 7789999999998742 2
Q ss_pred CccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--------hHH-HHHhHhhccCCCCC
Q 037285 972 NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH--------YGA-IIGGIVNNTLRPTI 1042 (1094)
Q Consensus 972 ~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~--------~~e-ile~Iv~~~lrp~i 1042 (1094)
.........||+.|+|||++. ...++.++|||||||++|+|++|+.||.... ... ....+... ...+
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 224 (329)
T cd05588 149 PGDTTSTFCGTPNYIAPEILR--GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK--QIRI 224 (329)
T ss_pred CCCccccccCCccccCHHHHc--CCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC--CCCC
Confidence 222334467899999999998 4567889999999999999999999996321 111 22223222 2346
Q ss_pred CCcCcHHHHHHHHHhccCCCCCCCC------HHHHHHH
Q 037285 1043 PSYCDAEWRTLMEECWAPNPAARPS------FTEIASR 1074 (1094)
Q Consensus 1043 Pe~~S~eL~dLI~kCLq~DPeeRPS------~eELLq~ 1074 (1094)
|..++..+.++|.+||+.||.+|++ +.+++++
T Consensus 225 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 225 PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 7788999999999999999999987 6788766
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=312.59 Aligned_cols=251 Identities=27% Similarity=0.429 Sum_probs=211.0
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
+|++.+.||.|+||.||++.+. +..||+|++...... ......+..|+.++++++|+||+++++++......
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT------EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ 74 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC------HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCC
Confidence 4788999999999999999874 678999998754221 22235678899999999999999999988765556
Q ss_pred ceEEEeeecccchhHHHHhhc---ccccCHHHHHHHHHHHHHHHHHHH-----HCCceeccCCCCceEeccCCCCCCcEE
Q 037285 889 TLATVAEYMVDGSLRHVLVRK---DRFLDRRRRLIIAMDAAFGMEYLH-----SKNIVHFDLKCDNLLVNLKDPSRPICK 960 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~---~~~Lse~~~l~Ia~QIaeGLaYLH-----s~GIIHRDLKPeNILLD~~~~e~g~VK 960 (1094)
.++++|||+.+++|.+++... ...+++..++.++.||+.||.||| +.+++|+||+|+||+++ .++.+|
T Consensus 75 ~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~----~~~~~k 150 (265)
T cd08217 75 TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLD----ANNNVK 150 (265)
T ss_pred EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEe----cCCCEE
Confidence 789999999999999998653 456899999999999999999999 88999999999999999 778999
Q ss_pred EEecCCcccccCccc-cCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCC
Q 037285 961 VGDFGLSKIKRNTLV-SGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 1039 (1094)
Q Consensus 961 LsDFGLSrl~~~~~~-ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lr 1039 (1094)
|+|||++........ .....++..|+|||++. ...++.++||||||+++|+|++|+.||...........+ .....
T Consensus 151 l~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~--~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~ 227 (265)
T cd08217 151 LGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLN--HMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI-KEGKF 227 (265)
T ss_pred EecccccccccCCcccccccccCCCccChhhhc--CCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHH-hcCCC
Confidence 999999986543322 33456899999999987 445788999999999999999999999988765555544 44444
Q ss_pred CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1040 PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1040 p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
+.++..++..+.+++.+||..+|.+||++.+|+++
T Consensus 228 ~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 56677889999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=335.77 Aligned_cols=243 Identities=29% Similarity=0.450 Sum_probs=199.9
Q ss_pred EEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhh-CCCCceeEEEeEeecCCCCceEE
Q 037285 816 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSK-LHHPNVVAFYGVVQDGPGGTLAT 892 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkr-L~HPNIVqL~Gv~~d~~~~~L~I 892 (1094)
+.||+|+||.||+|+++ +..||||+++...... +.....+..|..++.. ++||||+++++++.+.. .+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~--~~~l 73 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLM-----DDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKE--NLFF 73 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-----cchHHHHHHHHHHHHhccCCCcCcceEEEEEeCC--EEEE
Confidence 46999999999999885 5679999998643211 1122445667777775 58999999999998765 8999
Q ss_pred EeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCccccc-
Q 037285 893 VAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKR- 971 (1094)
Q Consensus 893 VmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~- 971 (1094)
||||+.+|+|..++.... .+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++...
T Consensus 74 v~ey~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~----~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05619 74 VMEYLNGGDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLD----TDGHIKIADFGMCKENML 148 (316)
T ss_pred EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC----CCCCEEEccCCcceECCC
Confidence 999999999999987643 488999999999999999999999999999999999998 77889999999987421
Q ss_pred CccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHH
Q 037285 972 NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWR 1051 (1094)
Q Consensus 972 ~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~ 1051 (1094)
.........||..|+|||++. ...++.++|||||||++|+|++|+.||......+....+... .+.++..++.++.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~ 224 (316)
T cd05619 149 GDAKTCTFCGTPDYIAPEILL--GQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--NPCYPRWLTREAK 224 (316)
T ss_pred CCCceeeecCCccccCHHHHc--CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHHH
Confidence 122233456899999999997 456889999999999999999999999988777766655433 2446677899999
Q ss_pred HHHHHhccCCCCCCCCHH-HHHHH
Q 037285 1052 TLMEECWAPNPAARPSFT-EIASR 1074 (1094)
Q Consensus 1052 dLI~kCLq~DPeeRPS~e-ELLq~ 1074 (1094)
++|.+||+.||.+||++. +++++
T Consensus 225 ~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 225 DILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred HHHHHHhccCHhhcCCChHHHHcC
Confidence 999999999999999997 66653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=317.90 Aligned_cols=250 Identities=34% Similarity=0.639 Sum_probs=211.3
Q ss_pred eeccCCeeEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~ 885 (1094)
.+...+|++.+.||+|+||.||++...+..||+|.++... ....+.+|+.++++++||||+++++++...
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~----------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (254)
T cd05083 2 LLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----------TAQAFLEETAVMTKLHHKNLVRLLGVILHN 71 (254)
T ss_pred cccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc----------hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC
Confidence 3455789999999999999999999989999999986431 124678899999999999999999998753
Q ss_pred CCCceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+|||++ .++.+||+||
T Consensus 72 ---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~----~~~~~kl~Df 144 (254)
T cd05083 72 ---GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVS----EDGVAKVSDF 144 (254)
T ss_pred ---CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc----CCCcEEECCC
Confidence 4789999999999999997653 3578999999999999999999999999999999999998 6789999999
Q ss_pred CCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCCCC
Q 037285 965 GLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIP 1043 (1094)
Q Consensus 965 GLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~iP 1043 (1094)
|++....... .....+..|+|||.+. ...++.++|||||||++|+|++ |+.||......+....+ ....++..+
T Consensus 145 g~~~~~~~~~--~~~~~~~~y~~pe~~~--~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~ 219 (254)
T cd05083 145 GLARVGSMGV--DNSKLPVKWTAPEALK--HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV-EKGYRMEPP 219 (254)
T ss_pred ccceeccccC--CCCCCCceecCHHHhc--cCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH-hCCCCCCCC
Confidence 9987543221 2233467899999987 4567889999999999999997 99999988776665554 444555666
Q ss_pred CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1044 SYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1044 e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
..++..+.+++.+||+.+|++||++.+|+..|++
T Consensus 220 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 220 EGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 7789999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=351.81 Aligned_cols=248 Identities=22% Similarity=0.352 Sum_probs=208.2
Q ss_pred CCeeEEEEecccCceEEEEeeec---CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR---GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r---Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
..|.+.+.||+|+||.||+|... +..||+|.+... .......+.+|+.+|+.++|||||++++++....
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--------~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~ 138 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--------DERQAAYARSELHCLAACDHFGIVKHFDDFKSDD 138 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--------CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC
Confidence 34899999999999999999763 456888876432 1222346778999999999999999999998765
Q ss_pred CCceEEEeeecccchhHHHHhhc---ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEe
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRK---DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGD 963 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~---~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsD 963 (1094)
.+++||||+.+|+|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|
T Consensus 139 --~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~----~~~~~kL~D 212 (478)
T PTZ00267 139 --KLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLM----PTGIIKLGD 212 (478)
T ss_pred --EEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEEC----CCCcEEEEe
Confidence 899999999999999887542 34588999999999999999999999999999999999999 788999999
Q ss_pred cCCcccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCC
Q 037285 964 FGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 1040 (1094)
Q Consensus 964 FGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp 1040 (1094)
||+++..... ......+||+.|+|||++. ...++.++|||||||++|+|++|+.||......+.+..+..... .
T Consensus 213 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~-~ 289 (478)
T PTZ00267 213 FGFSKQYSDSVSLDVASSFCGTPYYLAPELWE--RKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY-D 289 (478)
T ss_pred CcCceecCCccccccccccCCCccccCHhHhC--CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-C
Confidence 9999854322 1234456999999999997 45788999999999999999999999998887777776655443 3
Q ss_pred CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1041 TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1041 ~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
..+..++.+++++|.+||..||++||++.+++.+
T Consensus 290 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 4566788999999999999999999999998754
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=335.90 Aligned_cols=243 Identities=28% Similarity=0.444 Sum_probs=199.5
Q ss_pred EEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhh-CCCCceeEEEeEeecCCCCceEE
Q 037285 816 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSK-LHHPNVVAFYGVVQDGPGGTLAT 892 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkr-L~HPNIVqL~Gv~~d~~~~~L~I 892 (1094)
+.||+|+||.||+|+++ +..||||.+++..... +.....+..|..++.. ++||||+++++++.+.. .+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~--~~~l 73 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLI-----DDDVECTMVEKRVLALAWENPFLTHLYCTFQTKE--HLFF 73 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-----cchHHHHHHHHHHHHhccCCCCccCeeEEEEeCC--EEEE
Confidence 46999999999999885 6789999997642211 1122345667777765 48999999999998755 8999
Q ss_pred EeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCccccc-
Q 037285 893 VAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKR- 971 (1094)
Q Consensus 893 VmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~- 971 (1094)
||||+.+|+|..++.... .+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 74 v~E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~----~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05620 74 VMEFLNGGDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLD----RDGHIKIADFGMCKENVF 148 (316)
T ss_pred EECCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC----CCCCEEeCccCCCeeccc
Confidence 999999999999987654 489999999999999999999999999999999999998 77899999999987421
Q ss_pred CccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHH
Q 037285 972 NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWR 1051 (1094)
Q Consensus 972 ~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~ 1051 (1094)
.........||..|+|||++. ...++.++|||||||++|+|++|+.||......+....+... .+.++..++.+++
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 224 (316)
T cd05620 149 GDNRASTFCGTPDYIAPEILQ--GLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--TPHYPRWITKESK 224 (316)
T ss_pred CCCceeccCCCcCccCHHHHc--CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHH
Confidence 112223456899999999998 456889999999999999999999999988777666655433 3456778899999
Q ss_pred HHHHHhccCCCCCCCCHH-HHHHH
Q 037285 1052 TLMEECWAPNPAARPSFT-EIASR 1074 (1094)
Q Consensus 1052 dLI~kCLq~DPeeRPS~e-ELLq~ 1074 (1094)
++|.+||+.||.+||++. +++++
T Consensus 225 ~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 225 DILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred HHHHHHccCCHHHcCCChHHHHcC
Confidence 999999999999999974 66644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=321.17 Aligned_cols=253 Identities=25% Similarity=0.353 Sum_probs=203.8
Q ss_pred ccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~ 885 (1094)
...+|++.+.||+|+||.||+|++. +..||+|++..... .....+.+|+.++++++||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--------~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~ 78 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--------DDFSLIQQEIFMVKECKHCNIVAYFGSYLSR 78 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--------chHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Confidence 4568999999999999999999874 67799999864311 1123567899999999999999999999875
Q ss_pred CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecC
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFG 965 (1094)
. .+++||||+.+++|.+++.... .+++..+..++.|++.||.|||+.+|+||||+|+||+++ .++.+||+|||
T Consensus 79 ~--~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~----~~~~~~l~dfg 151 (267)
T cd06646 79 E--KLWICMEYCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLT----DNGDVKLADFG 151 (267)
T ss_pred C--EEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC----CCCCEEECcCc
Confidence 5 8999999999999999986554 589999999999999999999999999999999999998 67789999999
Q ss_pred CcccccCc-cccCCccCCCcccCcccccc-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCC-
Q 037285 966 LSKIKRNT-LVSGGVRGTLPWMAPELLSG-SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTI- 1042 (1094)
Q Consensus 966 LSrl~~~~-~~ss~~~GT~~YmAPEvL~g-~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~i- 1042 (1094)
++...... .......++..|+|||.+.+ ....++.++|||||||++|+|++|+.||...........+....+.+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (267)
T cd06646 152 VAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKL 231 (267)
T ss_pred cceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCC
Confidence 99854322 12234568889999998752 1344778999999999999999999999765544333222222222221
Q ss_pred --CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037285 1043 --PSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1043 --Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L 1075 (1094)
...++..+.++|.+||..+|++||++.+|+++|
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 234678999999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=323.19 Aligned_cols=259 Identities=33% Similarity=0.537 Sum_probs=211.0
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeec-------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeE
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVA 877 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~r-------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVq 877 (1094)
|++..++|++.+.||+|+||.||+|..+ +..||+|.+.... . ......+.+|+.++++++||||++
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~--~~~~~~~~~e~~~l~~l~~~~i~~ 73 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-----S--LRERIEFLNEASVMKGFTCHHVVR 73 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-----C--HHHHHHHHHHHHHHHhCCCCCeee
Confidence 5677889999999999999999998753 2369999876431 1 112346788999999999999999
Q ss_pred EEeEeecCCCCceEEEeeecccchhHHHHhhcc---------cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceE
Q 037285 878 FYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD---------RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLL 948 (1094)
Q Consensus 878 L~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~---------~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNIL 948 (1094)
+++++.... ..++||||+.+|+|.+++.... ..++...+..++.||+.||.|||+++|+||||||+|||
T Consensus 74 ~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nil 151 (288)
T cd05061 74 LLGVVSKGQ--PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCM 151 (288)
T ss_pred EEEEEcCCC--CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEE
Confidence 999988754 7899999999999999996532 23466788899999999999999999999999999999
Q ss_pred eccCCCCCCcEEEEecCCcccccCcc---ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 037285 949 VNLKDPSRPICKVGDFGLSKIKRNTL---VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANM 1024 (1094)
Q Consensus 949 LD~~~~e~g~VKLsDFGLSrl~~~~~---~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~ 1024 (1094)
++ .++.+||+|||+++...... ......++..|+|||.+. ...++.++|||||||++|||++ |..||...
T Consensus 152 i~----~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~--~~~~~~~~DvwslG~~l~el~~~~~~p~~~~ 225 (288)
T cd05061 152 VA----HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK--DGVFTTSSDMWSFGVVLWEITSLAEQPYQGL 225 (288)
T ss_pred Ec----CCCcEEECcCCccccccccccccccCCCcccccccCHHHhc--cCCCChHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 98 77899999999987432211 111223567899999987 4567899999999999999998 89999887
Q ss_pred ChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1025 HYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1025 ~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
...+....+.... ....+..++..+.+++.+||+.+|.+|||+.++++.|.+..
T Consensus 226 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 226 SNEQVLKFVMDGG-YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 7776665554433 33456678899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=347.45 Aligned_cols=258 Identities=28% Similarity=0.392 Sum_probs=226.8
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-CCceeEEEeEeecC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HPNVVAFYGVVQDG 885 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-HPNIVqL~Gv~~d~ 885 (1094)
...|++.+.||+|.||.||+++.+ |..+|+|.+.+....... ....+.+|+.+|++|. |||||+++++|.+.
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~-----~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~ 108 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKE-----DREDVRREVAILQQLSGHPNIVQLKDAFEDP 108 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccc-----cHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence 457899999999999999999875 678999999887554321 3357789999999998 99999999999987
Q ss_pred CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecC
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFG 965 (1094)
. .+++|||++.||.|.+.+... .+++..+..++.||+.+++|||+.||+||||||+|+|+......++.+|++|||
T Consensus 109 ~--~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 109 D--SVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred C--eEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 6 899999999999999999877 399999999999999999999999999999999999998655445689999999
Q ss_pred CcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCC--CCC
Q 037285 966 LSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP--TIP 1043 (1094)
Q Consensus 966 LSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp--~iP 1043 (1094)
++............+||+.|+|||++. ...|+..+||||+||++|.|++|..||...........+....+.- ...
T Consensus 185 la~~~~~~~~~~~~~Gtp~y~APEvl~--~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w 262 (382)
T KOG0032|consen 185 LAKFIKPGERLHTIVGTPEYVAPEVLG--GRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPW 262 (382)
T ss_pred CceEccCCceEeeecCCccccCchhhc--CCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCc
Confidence 999776666667789999999999998 5678999999999999999999999999999888888887776632 223
Q ss_pred CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1044 SYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1044 e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
..++..++++|++|+..||.+|+|+.++++|.|-
T Consensus 263 ~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi 296 (382)
T KOG0032|consen 263 DDISESAKDFIRKLLEFDPRKRLTAAQALQHPWI 296 (382)
T ss_pred cccCHHHHHHHHHhcccCcccCCCHHHHhcCccc
Confidence 4578999999999999999999999999998773
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=336.22 Aligned_cols=243 Identities=28% Similarity=0.409 Sum_probs=199.0
Q ss_pred EEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHH-HHhhCCCCceeEEEeEeecCCCCceEE
Q 037285 816 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAE-ILSKLHHPNVVAFYGVVQDGPGGTLAT 892 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIk-ILkrL~HPNIVqL~Gv~~d~~~~~L~I 892 (1094)
+.||+|+||+||+|+++ +..||||++.+..... ......+..|.. +++.++||||+++++++.... .+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~--~~~l 73 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK-----KKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTAD--KLYF 73 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-----hhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCC--EEEE
Confidence 46999999999999884 6889999997642211 112234445554 567899999999999998755 8999
Q ss_pred EeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccc-c
Q 037285 893 VAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK-R 971 (1094)
Q Consensus 893 VmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~-~ 971 (1094)
||||+.+|+|..++.... .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.. .
T Consensus 74 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~----~~~~~kl~Dfg~~~~~~~ 148 (323)
T cd05575 74 VLDYVNGGELFFHLQRER-SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLD----SQGHVVLTDFGLCKEGIE 148 (323)
T ss_pred EEcCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC----CCCcEEEeccCCCccccc
Confidence 999999999999987654 589999999999999999999999999999999999998 7789999999998743 2
Q ss_pred CccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHH
Q 037285 972 NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWR 1051 (1094)
Q Consensus 972 ~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~ 1051 (1094)
.........||+.|+|||++. ...++.++|||||||++|+|++|+.||......+....+..... .++..++..+.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~ 224 (323)
T cd05575 149 HSKTTSTFCGTPEYLAPEVLR--KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL--RLKPNISVSAR 224 (323)
T ss_pred CCCccccccCChhhcChhhhc--CCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCHHHH
Confidence 222233456899999999998 45688899999999999999999999998887777766655433 34556799999
Q ss_pred HHHHHhccCCCCCCCCH----HHHHHH
Q 037285 1052 TLMEECWAPNPAARPSF----TEIASR 1074 (1094)
Q Consensus 1052 dLI~kCLq~DPeeRPS~----eELLq~ 1074 (1094)
++|.+||+.||.+||++ .+++++
T Consensus 225 ~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 225 HLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred HHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 99999999999999987 466654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=313.15 Aligned_cols=245 Identities=34% Similarity=0.619 Sum_probs=204.9
Q ss_pred EEecccCceEEEEeeec-CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEEEe
Q 037285 816 KELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVA 894 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~r-Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~IVm 894 (1094)
+.||+|+||.||+|... +..+|+|.+.... .......|.+|+.++++++||||+++++++.... ..++||
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~ 71 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-------PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ--PIYIVM 71 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC-------CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCC--ccEEEE
Confidence 36899999999999865 5679999886532 1223356889999999999999999999998754 899999
Q ss_pred eecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccCcc
Q 037285 895 EYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTL 974 (1094)
Q Consensus 895 EYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~~ 974 (1094)
||+.+++|.+++......+++..++.++.|++.+|.|||+++++|+||||+||+++ .++.+||+|||++.......
T Consensus 72 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~----~~~~~~l~d~g~~~~~~~~~ 147 (250)
T cd05085 72 ELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVG----ENNVLKISDFGMSRQEDDGI 147 (250)
T ss_pred ECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEc----CCCeEEECCCccceeccccc
Confidence 99999999999976666689999999999999999999999999999999999998 77889999999987533221
Q ss_pred c--cCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHH
Q 037285 975 V--SGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWR 1051 (1094)
Q Consensus 975 ~--ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~ 1051 (1094)
. .....++..|+|||++. ...++.++||||||+++|+|++ |..||...........+ ....+...+..++..+.
T Consensus 148 ~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 224 (250)
T cd05085 148 YSSSGLKQIPIKWTAPEALN--YGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV-EKGYRMSCPQKCPDDVY 224 (250)
T ss_pred cccCCCCCCcccccCHHHhc--cCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHH
Confidence 1 11123456799999987 4567889999999999999998 99999888776665554 44555666778899999
Q ss_pred HHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1052 TLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1052 dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
+++.+||..+|++||++.++++.|.
T Consensus 225 ~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 225 KVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHcccCcccCCCHHHHHHHhc
Confidence 9999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=340.76 Aligned_cols=252 Identities=23% Similarity=0.372 Sum_probs=206.6
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||+|+||.||+++.+ +..||||++...... .......+.+|+.++.+++|+||+++++++.+..
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~- 74 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML-----EKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR- 74 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh-----hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-
Confidence 46899999999999999999874 678999999753211 1223456778999999999999999999998765
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++||||+++|+|.+++.+.. .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 75 -~~~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~----~~~~vkL~DfG~~ 148 (360)
T cd05627 75 -NLYLIMEFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLD----AKGHVKLSDFGLC 148 (360)
T ss_pred -EEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC----CCCCEEEeeccCC
Confidence 8999999999999999997654 489999999999999999999999999999999999998 7889999999998
Q ss_pred ccccCc------------------------------------cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHH
Q 037285 968 KIKRNT------------------------------------LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVL 1011 (1094)
Q Consensus 968 rl~~~~------------------------------------~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLL 1011 (1094)
+..... ......+||+.|+|||++. ...++.++|||||||++
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~--~~~~~~~~DiwSlGvil 226 (360)
T cd05627 149 TGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM--QTGYNKLCDWWSLGVIM 226 (360)
T ss_pred cccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHc--CCCCCCcceecccccee
Confidence 632211 0112346999999999998 45688999999999999
Q ss_pred HHHHcCCCCCCCCChHHHHHhHhhccCCCCCCC--cCcHHHHHHHHHhccCCCCCCC---CHHHHHHHHH
Q 037285 1012 WEILTGEEPYANMHYGAIIGGIVNNTLRPTIPS--YCDAEWRTLMEECWAPNPAARP---SFTEIASRLR 1076 (1094)
Q Consensus 1012 yELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe--~~S~eL~dLI~kCLq~DPeeRP---S~eELLq~L~ 1076 (1094)
|||++|+.||...........+........++. .++.+++++|.+|+. +|.+|+ ++.+++++-+
T Consensus 227 yel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~ 295 (360)
T cd05627 227 YEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPF 295 (360)
T ss_pred eecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCC
Confidence 999999999998887777666654333333333 368899999999774 999998 4788887743
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=324.93 Aligned_cols=246 Identities=24% Similarity=0.336 Sum_probs=197.4
Q ss_pred ecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEEEee
Q 037285 818 LGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAE 895 (1094)
Q Consensus 818 LGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~IVmE 895 (1094)
||+|+||+||++.++ +..||||.+...... .......+..|+.++++++|+||+++++++.... .+++|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~--~~~lv~e 73 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK-----KRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKT--DLCLVMT 73 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHh-----hhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCC--eEEEEEe
Confidence 799999999999874 678999998754221 1222356778999999999999999999988754 7999999
Q ss_pred ecccchhHHHHhh---cccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccC
Q 037285 896 YMVDGSLRHVLVR---KDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRN 972 (1094)
Q Consensus 896 YmegGSL~d~L~k---~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~ 972 (1094)
|+++|+|..++.. ....+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++.....
T Consensus 74 ~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~~l~dfg~~~~~~~ 149 (280)
T cd05608 74 IMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLD----NDGNVRISDLGLAVELKD 149 (280)
T ss_pred CCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEEeeCccceecCC
Confidence 9999999888743 234589999999999999999999999999999999999998 678899999999875432
Q ss_pred c-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhcc--CCCCCCCcCcHH
Q 037285 973 T-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT--LRPTIPSYCDAE 1049 (1094)
Q Consensus 973 ~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~--lrp~iPe~~S~e 1049 (1094)
. .......||+.|+|||++. ...++.++|||||||++|+|++|+.||...........+.... ....++..++..
T Consensus 150 ~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (280)
T cd05608 150 GQSKTKGYAGTPGFMAPELLQ--GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPA 227 (280)
T ss_pred CCccccccCCCcCccCHHHhc--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHH
Confidence 2 2233456899999999998 4567889999999999999999999998654322111111111 123455678999
Q ss_pred HHHHHHHhccCCCCCCC-----CHHHHHHHHH
Q 037285 1050 WRTLMEECWAPNPAARP-----SFTEIASRLR 1076 (1094)
Q Consensus 1050 L~dLI~kCLq~DPeeRP-----S~eELLq~L~ 1076 (1094)
+.+++.+||+.||++|| ++++++++-+
T Consensus 228 ~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~ 259 (280)
T cd05608 228 SKSFCEALLAKDPEKRLGFRDGNCDGLRTHPL 259 (280)
T ss_pred HHHHHHHHhcCCHHHhcCCCCCCHHHHhcChh
Confidence 99999999999999999 7788888744
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=315.78 Aligned_cols=245 Identities=36% Similarity=0.603 Sum_probs=206.8
Q ss_pred EEecccCceEEEEeeecC---c--eEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCce
Q 037285 816 KELGSGTFGTVYHGKWRG---T--DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTL 890 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~rG---t--~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L 890 (1094)
++||+|+||.||+|.+.. + .||||.+...... .....+.+|+.++++++||||+++++++.. ..+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~ 70 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-------DIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPL 70 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-------HHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeE
Confidence 368999999999998742 2 5899998764321 445678899999999999999999999887 389
Q ss_pred EEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCccc
Q 037285 891 ATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI 969 (1094)
Q Consensus 891 ~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl 969 (1094)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++++|+||||+||+++ .++.+||+|||+++.
T Consensus 71 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~----~~~~~kl~dfg~~~~ 146 (257)
T cd05040 71 MMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLA----SDDKVKIGDFGLMRA 146 (257)
T ss_pred EEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEe----cCCEEEecccccccc
Confidence 99999999999999997755 5689999999999999999999999999999999999999 678999999999885
Q ss_pred ccCc----cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCCCCC
Q 037285 970 KRNT----LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPS 1044 (1094)
Q Consensus 970 ~~~~----~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~iPe 1044 (1094)
.... .......++..|+|||.+. ...++.++|||||||++|+|++ |+.||......+....+.........+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~~pE~~~--~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 224 (257)
T cd05040 147 LPQNEDHYVMEEHLKVPFAWCAPESLR--TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPE 224 (257)
T ss_pred ccccccceecccCCCCCceecCHHHhc--ccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCc
Confidence 4321 1112234678899999987 4568889999999999999998 9999988877776666655455555667
Q ss_pred cCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1045 YCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1045 ~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
.++..+.+++.+||+.+|++||++.+|++.|.
T Consensus 225 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 225 ACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 78899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=334.16 Aligned_cols=256 Identities=23% Similarity=0.331 Sum_probs=207.3
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||+|+||.||+++.. +..||||++.+... ........+.+|+.+++.++|+||+++++++.+..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM-----LKRAETACFREERDVLVNGDRRWITNLHYAFQDEN- 74 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH-----hhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC-
Confidence 47999999999999999999875 67899999875321 11223456788999999999999999999998765
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++||||+.+|+|.+++.+....+++..+..++.||+.||+|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 75 -~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~----~~~~~kl~Dfg~~ 149 (331)
T cd05597 75 -NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD----KNGHIRLADFGSC 149 (331)
T ss_pred -eEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEEC----CCCCEEEEECCce
Confidence 89999999999999999977566689999999999999999999999999999999999998 7789999999998
Q ss_pred ccccCc--cccCCccCCCcccCccccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCC
Q 037285 968 KIKRNT--LVSGGVRGTLPWMAPELLSGS---SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTI 1042 (1094)
Q Consensus 968 rl~~~~--~~ss~~~GT~~YmAPEvL~g~---~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~i 1042 (1094)
...... .......||+.|+|||++.+. ...++.++|||||||++|+|++|+.||......+....+........+
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 229 (331)
T cd05597 150 LRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQF 229 (331)
T ss_pred eecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccC
Confidence 743221 122234589999999998631 245778999999999999999999999887776666665543322222
Q ss_pred C---CcCcHHHHHHHHHhccCCCC--CCCCHHHHHHHHH
Q 037285 1043 P---SYCDAEWRTLMEECWAPNPA--ARPSFTEIASRLR 1076 (1094)
Q Consensus 1043 P---e~~S~eL~dLI~kCLq~DPe--eRPS~eELLq~L~ 1076 (1094)
+ ..++..++++|.+|+..++. .|+++.+++++-+
T Consensus 230 ~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~ 268 (331)
T cd05597 230 PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPF 268 (331)
T ss_pred CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCC
Confidence 2 34789999999998865444 3789999999854
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=315.67 Aligned_cols=254 Identities=27% Similarity=0.463 Sum_probs=209.2
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCC-chhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGR-SSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~-~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
+|.+.+.||.|+||.||+|... +..+|+|.+........ ..........+.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD- 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-
Confidence 3677889999999999999874 67899998876533221 1223344567889999999999999999999988754
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
..++||||+++++|.+++.... .+++..+..++.|++.||+|||+++++||||+|+||+++ .++.+||+|||++
T Consensus 80 -~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~----~~~~~~l~dfg~~ 153 (267)
T cd06628 80 -HLNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVD----NKGGIKISDFGIS 153 (267)
T ss_pred -ccEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEc----CCCCEEecccCCC
Confidence 8899999999999999997653 488899999999999999999999999999999999998 7889999999998
Q ss_pred ccccCcc-------ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCC
Q 037285 968 KIKRNTL-------VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 1040 (1094)
Q Consensus 968 rl~~~~~-------~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp 1040 (1094)
+...... ......++..|+|||.+. ...++.++|||||||++|+|++|+.||...........+.. ...+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~--~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~ 230 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVK--QTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE-NASP 230 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhc--cCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-cCCC
Confidence 7543111 112245788999999987 45678899999999999999999999988766555444323 4455
Q ss_pred CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1041 TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1041 ~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
..+..++..+.++|.+||+.||.+||++.+|+++
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 231 EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 6777889999999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=315.38 Aligned_cols=246 Identities=34% Similarity=0.575 Sum_probs=204.5
Q ss_pred EEecccCceEEEEeeecC-----ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCce
Q 037285 816 KELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTL 890 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~rG-----t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L 890 (1094)
++||+|+||.||+|++.. ..+|+|.+...... .....+.+|+.+++++.|+||+++++++... ..
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~ 70 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-------AGKKEFLREASVMAQLDHPCIVRLIGVCKGE---PL 70 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-------HHHHHHHHHHHHHHhcCCCCeeeEEEEEcCC---ce
Confidence 469999999999998742 56999998754221 2345788999999999999999999987643 58
Q ss_pred EEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccc
Q 037285 891 ATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK 970 (1094)
Q Consensus 891 ~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~ 970 (1094)
++||||+.+++|.+++.... .+++..++.++.|++.||+|||+++++|+||||+|||++ .++.+||+|||+++..
T Consensus 71 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~----~~~~~kl~df~~~~~~ 145 (257)
T cd05060 71 MLVMELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLV----NRHQAKISDFGMSRAL 145 (257)
T ss_pred EEEEEeCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEc----CCCcEEecccccccee
Confidence 99999999999999997655 589999999999999999999999999999999999998 7789999999998844
Q ss_pred cCccc----cCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCCCCCc
Q 037285 971 RNTLV----SGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSY 1045 (1094)
Q Consensus 971 ~~~~~----ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~iPe~ 1045 (1094)
..... .....++..|+|||.+. ...++.++|||||||++|+|++ |..||......+....+ ........+..
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~ 222 (257)
T cd05060 146 GAGSDYYRATTAGRWPLKWYAPECIN--YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML-ESGERLPRPEE 222 (257)
T ss_pred ecCCcccccccCccccccccCHHHhc--CCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH-HcCCcCCCCCC
Confidence 22211 11122346799999987 4568889999999999999998 99999888776655544 44445567778
Q ss_pred CcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1046 CDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1046 ~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
++..++++|.+||..+|.+||++.+|++.|..+.
T Consensus 223 ~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 223 CPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 8999999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=343.45 Aligned_cols=258 Identities=23% Similarity=0.368 Sum_probs=211.9
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
+..++|++.+.||+|+||.||+++++ +..+|+|++.+.... .......+.+|+.+++.++||||+++++++.+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI-----KRSDSAFFWEERDIMAFANSPWVVQLFCAFQD 114 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 34578999999999999999999885 577999998753221 11223457789999999999999999999987
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
.. .+++||||+.+|+|.+++... .+++..+..++.||+.||+|||+++|+||||||+|||++ .++.+||+||
T Consensus 115 ~~--~~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~----~~~~~kL~DF 186 (370)
T cd05621 115 DK--YLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD----KHGHLKLADF 186 (370)
T ss_pred CC--EEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC----CCCCEEEEec
Confidence 65 899999999999999998654 478899999999999999999999999999999999998 7889999999
Q ss_pred CCcccccCc--cccCCccCCCcccCccccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCC
Q 037285 965 GLSKIKRNT--LVSGGVRGTLPWMAPELLSGSS--SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 1040 (1094)
Q Consensus 965 GLSrl~~~~--~~ss~~~GT~~YmAPEvL~g~~--~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp 1040 (1094)
|++...... .......||+.|+|||++.+.. ..++.++|||||||++|+|++|+.||...........+.......
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~ 266 (370)
T cd05621 187 GTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL 266 (370)
T ss_pred ccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccc
Confidence 999854322 1223567999999999987422 247889999999999999999999999888777777776554444
Q ss_pred CCCC--cCcHHHHHHHHHhccCCCCC--CCCHHHHHHHHHH
Q 037285 1041 TIPS--YCDAEWRTLMEECWAPNPAA--RPSFTEIASRLRV 1077 (1094)
Q Consensus 1041 ~iPe--~~S~eL~dLI~kCLq~DPee--RPS~eELLq~L~~ 1077 (1094)
.++. .++..++++|.+||..++.+ |+++.+++++-+-
T Consensus 267 ~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~ 307 (370)
T cd05621 267 NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFF 307 (370)
T ss_pred CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCccc
Confidence 4444 46889999999999855543 8899999998654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=321.87 Aligned_cols=254 Identities=34% Similarity=0.541 Sum_probs=207.1
Q ss_pred ccCCeeEEEEecccCceEEEEeeecC------------------ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhh
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWRG------------------TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSK 869 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~rG------------------t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkr 869 (1094)
...+|++.+.||+|+||.||++++.. ..||+|.+..... ......+.+|+.++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-------~~~~~~~~~e~~~l~~ 75 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-------DNAREDFLKEVKILSR 75 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-------HHHHHHHHHHHHHHHh
Confidence 34688999999999999999987642 3489998875421 1334678899999999
Q ss_pred CCCCceeEEEeEeecCCCCceEEEeeecccchhHHHHhhcc----------cccCHHHHHHHHHHHHHHHHHHHHCCcee
Q 037285 870 LHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD----------RFLDRRRRLIIAMDAAFGMEYLHSKNIVH 939 (1094)
Q Consensus 870 L~HPNIVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~----------~~Lse~~~l~Ia~QIaeGLaYLHs~GIIH 939 (1094)
++||||+++++++.... .+++||||+.+++|.+++.... ..+++..++.++.|++.||+|||+++|+|
T Consensus 76 l~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H 153 (296)
T cd05051 76 LSDPNIARLLGVCTVDP--PLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVH 153 (296)
T ss_pred cCCCCEeEEEEEEecCC--CcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Confidence 99999999999998754 8999999999999999986644 25899999999999999999999999999
Q ss_pred ccCCCCceEeccCCCCCCcEEEEecCCcccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc
Q 037285 940 FDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT 1016 (1094)
Q Consensus 940 RDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT 1016 (1094)
+||||+||+++ ..+.++|+|||+++..... .......++..|+|||++. ...++.++|||||||++|+|++
T Consensus 154 ~dlkp~Nili~----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~~l~el~~ 227 (296)
T cd05051 154 RDLATRNCLVG----KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVL--LGKFTTKSDVWAFGVTLWEILT 227 (296)
T ss_pred cccchhceeec----CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhh--cCCCCccchhhhhHHHHHHHHh
Confidence 99999999998 6789999999998753221 1222344677899999987 4468899999999999999998
Q ss_pred --CCCCCCCCChHHHHHhHhhc------cCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1017 --GEEPYANMHYGAIIGGIVNN------TLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1017 --Gk~PF~~~~~~eile~Iv~~------~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
+..||......+.+...... ......+..++.++.++|.+||+.||.+|||+.+|++.|.
T Consensus 228 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 228 LCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred cCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 78899877766655544322 1112334567889999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=324.49 Aligned_cols=241 Identities=24% Similarity=0.336 Sum_probs=191.9
Q ss_pred ecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEEEee
Q 037285 818 LGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAE 895 (1094)
Q Consensus 818 LGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~IVmE 895 (1094)
||+|+||.||+++.+ |..+|+|.+....... ......+..|+.++++++||||+++++++.... .+++|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-----~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~--~~~lv~e 73 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK-----KSGEKMALLEKEILEKVNSPFIVNLAYAFESKT--HLCLVMS 73 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc-----chhhHHHHHHHHHHHhcCCCcEEEEEEEEecCC--eEEEEEe
Confidence 799999999999874 7889999986532211 111234556999999999999999999998755 8999999
Q ss_pred ecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccCcc
Q 037285 896 YMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTL 974 (1094)
Q Consensus 896 YmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~~ 974 (1094)
|+.+++|..++.... ..+++..++.++.||+.||+|||+.+|+||||||+|||++ .++.+||+|||++.......
T Consensus 74 ~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~----~~~~~~l~Dfg~~~~~~~~~ 149 (277)
T cd05607 74 LMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLD----DQGNCRLSDLGLAVELKDGK 149 (277)
T ss_pred cCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEc----CCCCEEEeeceeeeecCCCc
Confidence 999999998875543 3588999999999999999999999999999999999998 77889999999987654433
Q ss_pred ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH----HHHHhHhhccCCCCCCCcCcHHH
Q 037285 975 VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG----AIIGGIVNNTLRPTIPSYCDAEW 1050 (1094)
Q Consensus 975 ~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~----eile~Iv~~~lrp~iPe~~S~eL 1050 (1094)
......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...... +.......... ......++.++
T Consensus 150 ~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 226 (277)
T cd05607 150 TITQRAGTNGYMAPEILKE--EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV-KFEHQNFTEES 226 (277)
T ss_pred eeeccCCCCCccCHHHHcc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccc-ccccccCCHHH
Confidence 3334568999999999973 45889999999999999999999999764332 22222222221 11224678999
Q ss_pred HHHHHHhccCCCCCCCCHHHHH
Q 037285 1051 RTLMEECWAPNPAARPSFTEIA 1072 (1094)
Q Consensus 1051 ~dLI~kCLq~DPeeRPS~eELL 1072 (1094)
.+||.+||+.||.+||++.+++
T Consensus 227 ~~li~~~L~~~P~~R~~~~~~~ 248 (277)
T cd05607 227 KDICRLFLAKKPEDRLGSREKN 248 (277)
T ss_pred HHHHHHHhccCHhhCCCCccch
Confidence 9999999999999999995544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=318.41 Aligned_cols=252 Identities=26% Similarity=0.393 Sum_probs=204.5
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEeecCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~~d~~ 886 (1094)
+.|++.+.||+|+||.||+|.+. ++.||+|.+..... ....+.+|+.+++++ +|+||+++++++....
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 76 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---------EEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 76 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---------cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecC
Confidence 46888899999999999999874 57899999865311 124567899999998 6999999999987532
Q ss_pred ----CCceEEEeeecccchhHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEE
Q 037285 887 ----GGTLATVAEYMVDGSLRHVLVRK-DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKV 961 (1094)
Q Consensus 887 ----~~~L~IVmEYmegGSL~d~L~k~-~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKL 961 (1094)
...+++||||+.+++|.+++... ...+++..++.++.|++.||+|||+++|+|+||||+||+++ .++.+||
T Consensus 77 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~----~~~~~~l 152 (272)
T cd06637 77 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT----ENAEVKL 152 (272)
T ss_pred CCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEEC----CCCCEEE
Confidence 23689999999999999998764 34589999999999999999999999999999999999998 7788999
Q ss_pred EecCCcccccCc-cccCCccCCCcccCccccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhcc
Q 037285 962 GDFGLSKIKRNT-LVSGGVRGTLPWMAPELLSGS---SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 1037 (1094)
Q Consensus 962 sDFGLSrl~~~~-~~ss~~~GT~~YmAPEvL~g~---~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~ 1037 (1094)
+|||++...... .......|+..|+|||++.+. ...++.++|||||||++|+|++|+.||................
T Consensus 153 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~ 232 (272)
T cd06637 153 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 232 (272)
T ss_pred ccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC
Confidence 999998854322 222345688999999998632 2357889999999999999999999998766555444443333
Q ss_pred CCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1038 LRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1038 lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
.+...+..++..+.+||.+||..+|.+|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 233 APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 3334445678999999999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=329.61 Aligned_cols=263 Identities=30% Similarity=0.524 Sum_probs=217.0
Q ss_pred ceeeccCCeeEEEEecccCceEEEEeeecC---------ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCC
Q 037285 804 VQVIKNEDLEEQKELGSGTFGTVYHGKWRG---------TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHP 873 (1094)
Q Consensus 804 v~eIs~edYei~kkLGsG~FGtVYKAk~rG---------t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HP 873 (1094)
.|++...+|++.+.||+|+||.||++++.+ ..||+|.++... ......++.+|+.+++++ +||
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~ 78 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-------TDKDLSDLVSEMEMMKMIGKHK 78 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-------CHHHHHHHHHHHHHHHhhcCCC
Confidence 467777899999999999999999997531 258999876431 122345788999999999 799
Q ss_pred ceeEEEeEeecCCCCceEEEeeecccchhHHHHhhcc---------------cccCHHHHHHHHHHHHHHHHHHHHCCce
Q 037285 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD---------------RFLDRRRRLIIAMDAAFGMEYLHSKNIV 938 (1094)
Q Consensus 874 NIVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~---------------~~Lse~~~l~Ia~QIaeGLaYLHs~GII 938 (1094)
||+++++++.... .++++|||+.+|+|.+++.... ..+++..++.++.||+.||+|||++||+
T Consensus 79 ~iv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~giv 156 (334)
T cd05100 79 NIINLLGACTQDG--PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCI 156 (334)
T ss_pred CeeeeeEEEccCC--ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 9999999998754 8999999999999999986532 2477888999999999999999999999
Q ss_pred eccCCCCceEeccCCCCCCcEEEEecCCcccccCcc---ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHH
Q 037285 939 HFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTL---VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEIL 1015 (1094)
Q Consensus 939 HRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~~---~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELL 1015 (1094)
||||||+|||++ .++.+||+|||+++...... ......++..|+|||++. ...++.++|||||||++|||+
T Consensus 157 H~dlkp~Nill~----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~ 230 (334)
T cd05100 157 HRDLAARNVLVT----EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLLWEIF 230 (334)
T ss_pred ccccccceEEEc----CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhc--cCCcCchhhhHHHHHHHHHHH
Confidence 999999999998 67889999999987543221 112223456799999997 456788999999999999999
Q ss_pred c-CCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 037285 1016 T-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAA 1082 (1094)
Q Consensus 1016 T-Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~ 1082 (1094)
+ |..||......+....+ ........+..++..+.++|.+||+.+|.+||++.+|++.|..+.+..
T Consensus 231 ~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 231 TLGGSPYPGIPVEELFKLL-KEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred hcCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 8 89999888776666554 344455667788899999999999999999999999999999998554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=315.86 Aligned_cols=249 Identities=37% Similarity=0.513 Sum_probs=201.0
Q ss_pred eeEEEEecccCceEEEEeeecC--ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCc
Q 037285 812 LEEQKELGSGTFGTVYHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGT 889 (1094)
Q Consensus 812 Yei~kkLGsG~FGtVYKAk~rG--t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~ 889 (1094)
|++.+.||+|+||+||+++..+ ..+|+|++.... ..........+|+.++++++||||+++++++.... .
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~------~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--~ 72 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSE------IEEEEREENIREIKILRRLRHPNIVQILDVFQDDN--Y 72 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTT------HHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS--E
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccc------ccccccchhhhhhhccccccccccccccccccccc--c
Confidence 7889999999999999999864 569999998652 22222334456999999999999999999998854 8
Q ss_pred eEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCccc
Q 037285 890 LATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI 969 (1094)
Q Consensus 890 L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl 969 (1094)
+++||||+.+++|.+++... ..+++..++.++.||++||.+||+++|+|+||||+|||++ .++.++|+|||.+..
T Consensus 73 ~~~v~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~----~~~~~~l~Dfg~~~~ 147 (260)
T PF00069_consen 73 LYIVMEYCPGGSLQDYLQKN-KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLD----ENGEVKLIDFGSSVK 147 (260)
T ss_dssp EEEEEEEETTEBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEES----TTSEEEESSGTTTEE
T ss_pred cccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccc----ccccccccccccccc
Confidence 99999999999999999833 4589999999999999999999999999999999999999 788999999999874
Q ss_pred -ccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH---HHHhHhhccCCCCCC--
Q 037285 970 -KRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA---IIGGIVNNTLRPTIP-- 1043 (1094)
Q Consensus 970 -~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~e---ile~Iv~~~lrp~iP-- 1043 (1094)
...........++..|+|||++.. ...++.++||||||+++|+|++|..||....... ...............
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (260)
T PF00069_consen 148 LSENNENFNPFVGTPEYMAPEVLQQ-GKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQS 226 (260)
T ss_dssp STSTTSEBSSSSSSGGGSCHHHHTT-TSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSH
T ss_pred ccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccchhhhhhhhhccccccccccccc
Confidence 233334445668999999999862 3467889999999999999999999999873322 222222111111111
Q ss_pred CcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1044 SYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1044 e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
...+..+.++|.+||+.||.+||++.+++++
T Consensus 227 ~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 227 REKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp TTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred chhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1224889999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=352.51 Aligned_cols=254 Identities=24% Similarity=0.372 Sum_probs=212.6
Q ss_pred ccCCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~ 885 (1094)
...+|++.+.||+|+||+||+|++ .+..||||++...... +.....+.+|+.++..++|+||++++..+...
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~------~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS------EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK 103 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC------HHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence 346999999999999999999987 4788999999765322 22345678899999999999999998877543
Q ss_pred CC------CceEEEeeecccchhHHHHhhc---ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCC
Q 037285 886 PG------GTLATVAEYMVDGSLRHVLVRK---DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSR 956 (1094)
Q Consensus 886 ~~------~~L~IVmEYmegGSL~d~L~k~---~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~ 956 (1094)
.. ..+++||||+.+|+|.+++... ...+++..+..++.|++.||.|||+++|+||||||+|||++ .+
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~----~~ 179 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLC----SN 179 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEe----CC
Confidence 21 1378999999999999998653 24688999999999999999999999999999999999999 78
Q ss_pred CcEEEEecCCcccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhH
Q 037285 957 PICKVGDFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI 1033 (1094)
Q Consensus 957 g~VKLsDFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~I 1033 (1094)
+.+||+|||+++..... .......||+.|+|||++. ...++.++|||||||++|||++|+.||......+.+..+
T Consensus 180 ~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~--~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~ 257 (496)
T PTZ00283 180 GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWR--RKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT 257 (496)
T ss_pred CCEEEEecccCeeccccccccccccccCCcceeCHHHhC--CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 89999999999754321 2233457999999999998 456889999999999999999999999988877777766
Q ss_pred hhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1034 VNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1034 v~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
..... ..++..+++++.++|.+||+.||.+||++.+++.+
T Consensus 258 ~~~~~-~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 258 LAGRY-DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred hcCCC-CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 55433 34677889999999999999999999999999876
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=317.85 Aligned_cols=256 Identities=30% Similarity=0.547 Sum_probs=214.3
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--Cc----eEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEe
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GT----DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYG 880 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt----~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~G 880 (1094)
+...+|++.+.||+|+||.||+|.++ +. .+|+|.+..... .....++.+|+.++++++|+||+++++
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 76 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-------PKANKEILDEAYVMASVDHPHVVRLLG 76 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-------HHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 45678999999999999999999874 32 489998765421 223457889999999999999999999
Q ss_pred EeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEE
Q 037285 881 VVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICK 960 (1094)
Q Consensus 881 v~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VK 960 (1094)
++.. ...++||||+.+|+|.+++......+++..++.++.||+.||+|||+++++||||||+|||++ .++.+|
T Consensus 77 ~~~~---~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~----~~~~~k 149 (279)
T cd05057 77 ICLS---SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVK----TPQHVK 149 (279)
T ss_pred EEec---CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEc----CCCeEE
Confidence 9986 378999999999999999987666699999999999999999999999999999999999998 677899
Q ss_pred EEecCCcccccCccc---cCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhc
Q 037285 961 VGDFGLSKIKRNTLV---SGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 1036 (1094)
Q Consensus 961 LsDFGLSrl~~~~~~---ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~ 1036 (1094)
|+|||+++....... .....++..|+|||.+. ...++.++|||||||++|||++ |+.||......+....+. .
T Consensus 150 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~ 226 (279)
T cd05057 150 ITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL--HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-K 226 (279)
T ss_pred ECCCcccccccCcccceecCCCcccccccCHHHhh--cCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-C
Confidence 999999985432211 11222456899999986 4567889999999999999999 999999887766655554 3
Q ss_pred cCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1037 TLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1037 ~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
......+..++..+.+++.+||..+|.+||++.++++.|..+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 227 GERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 4445566778899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=333.66 Aligned_cols=255 Identities=24% Similarity=0.338 Sum_probs=208.9
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.++||+|+||.||+++++ +..+|+|++.+... ........+.+|+.++..++|+||+++++++.+..
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM-----LKRAETACFREERDVLVNGDNQWITTLHYAFQDEN- 74 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHH-----HHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC-
Confidence 47899999999999999999885 46799999865311 11223345778999999999999999999998765
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++||||+.+|+|.+++.+....+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 75 -~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~----~~~~~kL~DfG~a 149 (332)
T cd05623 75 -NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD----MNGHIRLADFGSC 149 (332)
T ss_pred -EEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC----CCCCEEEeecchh
Confidence 89999999999999999987656689999999999999999999999999999999999998 7789999999998
Q ss_pred ccccC--ccccCCccCCCcccCcccccc---CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCC
Q 037285 968 KIKRN--TLVSGGVRGTLPWMAPELLSG---SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTI 1042 (1094)
Q Consensus 968 rl~~~--~~~ss~~~GT~~YmAPEvL~g---~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~i 1042 (1094)
..... ........||+.|+|||++.+ ....++.++|||||||++|||++|+.||......+....+.....+..+
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 229 (332)
T cd05623 150 LKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF 229 (332)
T ss_pred eecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccC
Confidence 74321 222234569999999999863 1345788999999999999999999999988877777777655443333
Q ss_pred C---CcCcHHHHHHHHHhccCCCCC--CCCHHHHHHHH
Q 037285 1043 P---SYCDAEWRTLMEECWAPNPAA--RPSFTEIASRL 1075 (1094)
Q Consensus 1043 P---e~~S~eL~dLI~kCLq~DPee--RPS~eELLq~L 1075 (1094)
+ ..++.++++||.+|+..++.+ |+++.+++++-
T Consensus 230 p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~ 267 (332)
T cd05623 230 PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHP 267 (332)
T ss_pred CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCC
Confidence 3 357899999999999664444 68999999883
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=321.95 Aligned_cols=251 Identities=23% Similarity=0.331 Sum_probs=204.7
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
.|+..+.||+|+||+||++.+. ++.+|+|.+...... .......+.+|+.+|++++|+||+.+++++....
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-- 73 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIK-----KRKGESMALNEKQILEKVNSQFVVNLAYAYETKD-- 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhh-----hhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCC--
Confidence 3678899999999999999884 678999998754221 1222345678999999999999999999988765
Q ss_pred ceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 889 TLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++||||+.+++|..++.... ..+++..+..++.|++.||.|||+++|+||||||+||+++ .++.+||+|||++
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~----~~~~~kl~Dfg~~ 149 (285)
T cd05632 74 ALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD----DYGHIRISDLGLA 149 (285)
T ss_pred EEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEC----CCCCEEEecCCcc
Confidence 8999999999999998886543 3589999999999999999999999999999999999998 6778999999998
Q ss_pred ccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhc--cCCCCCCCc
Q 037285 968 KIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN--TLRPTIPSY 1045 (1094)
Q Consensus 968 rl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~--~lrp~iPe~ 1045 (1094)
.............|+..|+|||++. ...++.++|+|||||++|+|++|+.||...........+... .....++..
T Consensus 150 ~~~~~~~~~~~~~g~~~~~aPE~~~--~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
T cd05632 150 VKIPEGESIRGRVGTVGYMAPEVLN--NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAK 227 (285)
T ss_pred eecCCCCcccCCCCCcCccChHHhc--CCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCcc
Confidence 7543322223456899999999997 456889999999999999999999999876654433332221 112345567
Q ss_pred CcHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 037285 1046 CDAEWRTLMEECWAPNPAARPS-----FTEIASR 1074 (1094)
Q Consensus 1046 ~S~eL~dLI~kCLq~DPeeRPS-----~eELLq~ 1074 (1094)
++..+.+|+.+||+.||++||+ +.+++.+
T Consensus 228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 228 FSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred CCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 8889999999999999999999 7888886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=335.22 Aligned_cols=238 Identities=27% Similarity=0.389 Sum_probs=194.6
Q ss_pred EEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHH-HHhhCCCCceeEEEeEeecCCCCceEE
Q 037285 816 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAE-ILSKLHHPNVVAFYGVVQDGPGGTLAT 892 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIk-ILkrL~HPNIVqL~Gv~~d~~~~~L~I 892 (1094)
+.||+|+||+||+|++. +..||+|++.+..... ......+..|.. +++.++||||+++++++.... .+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~--~~~l 73 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILK-----KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD--KLYF 73 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHh-----hhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCC--eEEE
Confidence 46999999999999885 5679999997542211 111233444444 567899999999999998765 8999
Q ss_pred EeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccc-c
Q 037285 893 VAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK-R 971 (1094)
Q Consensus 893 VmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~-~ 971 (1094)
||||+.+++|.+++.... .+.+..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.. .
T Consensus 74 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~----~~~~~kl~DfG~a~~~~~ 148 (325)
T cd05602 74 VLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD----SQGHIVLTDFGLCKENIE 148 (325)
T ss_pred EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC----CCCCEEEccCCCCccccc
Confidence 999999999999987654 478888889999999999999999999999999999998 6789999999998743 2
Q ss_pred CccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHH
Q 037285 972 NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWR 1051 (1094)
Q Consensus 972 ~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~ 1051 (1094)
.........||+.|+|||++. ...++.++|||||||++|+|++|+.||......+....+..... .++..++..+.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~ 224 (325)
T cd05602 149 HNGTTSTFCGTPEYLAPEVLH--KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL--QLKPNITNSAR 224 (325)
T ss_pred CCCCcccccCCccccCHHHHc--CCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc--CCCCCCCHHHH
Confidence 222334456999999999998 45678899999999999999999999998887777666654432 34557889999
Q ss_pred HHHHHhccCCCCCCCCHH
Q 037285 1052 TLMEECWAPNPAARPSFT 1069 (1094)
Q Consensus 1052 dLI~kCLq~DPeeRPS~e 1069 (1094)
++|.+||+.||.+|+++.
T Consensus 225 ~li~~~l~~~p~~R~~~~ 242 (325)
T cd05602 225 HLLEGLLQKDRTKRLGAK 242 (325)
T ss_pred HHHHHHcccCHHHCCCCC
Confidence 999999999999999876
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=360.97 Aligned_cols=256 Identities=36% Similarity=0.604 Sum_probs=224.0
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeec---C--ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEE
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWR---G--TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFY 879 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~r---G--t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~ 879 (1094)
-.|..+++++.++||+|.||.|++|.|+ | -.||||.++..... ....+|++|+.+|.+|+|||++++|
T Consensus 105 clIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~-------~~mddflrEas~M~~L~H~hliRLy 177 (1039)
T KOG0199|consen 105 CLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN-------AIMDDFLREASHMLKLQHPHLIRLY 177 (1039)
T ss_pred eeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc-------hhHHHHHHHHHHHHhccCcceeEEe
Confidence 3566778888999999999999999996 3 24999999765322 1457899999999999999999999
Q ss_pred eEeecCCCCceEEEeeecccchhHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCc
Q 037285 880 GVVQDGPGGTLATVAEYMVDGSLRHVLVR-KDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPI 958 (1094)
Q Consensus 880 Gv~~d~~~~~L~IVmEYmegGSL~d~L~k-~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~ 958 (1094)
|++.+. .+.+|||.++.|+|.+.|.+ ....+-...+..++.||+.||.||.++++|||||..+|||+. ....
T Consensus 178 GvVl~q---p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNllla----sprt 250 (1039)
T KOG0199|consen 178 GVVLDQ---PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLA----SPRT 250 (1039)
T ss_pred eeeccc---hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheec----ccce
Confidence 999974 69999999999999999987 455688888999999999999999999999999999999998 6778
Q ss_pred EEEEecCCccccc----CccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhH
Q 037285 959 CKVGDFGLSKIKR----NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGI 1033 (1094)
Q Consensus 959 VKLsDFGLSrl~~----~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~I 1033 (1094)
|||+||||.+... .+.+....+-...|||||.++ ..+|+.++|||+|||++|||+| |..||.+.....+++.+
T Consensus 251 VKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLr--h~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~i 328 (1039)
T KOG0199|consen 251 VKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLR--HRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNI 328 (1039)
T ss_pred eeeecccceeccCCCCcceEecCCCcCcccccCHhHhc--cccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhc
Confidence 9999999999543 233344455678899999999 7899999999999999999999 99999999999988877
Q ss_pred hhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1034 VNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1034 v~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
+.+-+...|+.|+++++++|+.||..+|++||||..|.+.+-.
T Consensus 329 -D~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 329 -DAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred -cccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 4788889999999999999999999999999999999855444
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=316.81 Aligned_cols=254 Identities=31% Similarity=0.442 Sum_probs=209.6
Q ss_pred CCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
.+|+..+.||+|+||.||+|.. ++..||+|.+...... .........+.+|+.++++++||||+++++++.....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPES---PETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCC---chhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCC
Confidence 4688899999999999999986 4678999988754321 1122344578899999999999999999999876545
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
..+++++||+.+++|.+++.... .+++...+.++.||+.||+|||+++|+|+||||+||+++ .++.+||+|||++
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~----~~~~~~l~dfg~~ 153 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRD----SAGNVKLGDFGAS 153 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC----CCCCEEEccCCCc
Confidence 57899999999999999997654 488999999999999999999999999999999999998 6788999999998
Q ss_pred ccccCc----cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCC
Q 037285 968 KIKRNT----LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIP 1043 (1094)
Q Consensus 968 rl~~~~----~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iP 1043 (1094)
+..... .......++..|+|||++. ...++.++|||||||++|+|++|+.||..................+.++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 231 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVIS--GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLP 231 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhC--CCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCc
Confidence 743221 1112245788999999987 4567899999999999999999999998876665555554555556677
Q ss_pred CcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1044 SYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1044 e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
..++..++++| +||..+|++||++.+|+++
T Consensus 232 ~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 232 SHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred hhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 77889999999 6888899999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=312.12 Aligned_cols=250 Identities=28% Similarity=0.436 Sum_probs=210.5
Q ss_pred CeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
+|+..+.||.|+||.||.++. .+..+++|.+...... ......+.+|+.++++++|+||+++++++.+..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-- 72 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS------EKERRDALNEIVILSLLQHPNIIAYYNHFMDDN-- 72 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc------hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCC--
Confidence 588999999999999988776 4678999998654221 223456789999999999999999999998755
Q ss_pred ceEEEeeecccchhHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 889 TLATVAEYMVDGSLRHVLVRK-DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~-~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.++++|||+.+++|.+++... ...+++..+..++.|++.||.|||+.+++|+||+|+||+++ .++.+||+|||++
T Consensus 73 ~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~----~~~~~kl~d~~~~ 148 (256)
T cd08221 73 TLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT----KAGLIKLGDFGIS 148 (256)
T ss_pred eEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEe----CCCCEEECcCcce
Confidence 899999999999999999765 34589999999999999999999999999999999999998 6788999999998
Q ss_pred ccccCcc-ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcC
Q 037285 968 KIKRNTL-VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYC 1046 (1094)
Q Consensus 968 rl~~~~~-~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~ 1046 (1094)
....... ......++..|+|||++.+ ..++.++||||||+++|+|++|..||......+....+....+. ..+..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~ape~~~~--~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 225 (256)
T cd08221 149 KILGSEYSMAETVVGTPYYMSPELCQG--VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT-PVVSVY 225 (256)
T ss_pred EEcccccccccccCCCccccCHhhcCC--CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC-CCcccc
Confidence 8543322 2234568999999999873 45778999999999999999999999887777777666554443 344677
Q ss_pred cHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037285 1047 DAEWRTLMEECWAPNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1047 S~eL~dLI~kCLq~DPeeRPS~eELLq~L 1075 (1094)
+.++.++|.+||..+|.+||++.++++++
T Consensus 226 ~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 226 SSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 89999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=340.95 Aligned_cols=259 Identities=25% Similarity=0.374 Sum_probs=210.7
Q ss_pred eeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEee
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQ 883 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~ 883 (1094)
.+..++|++.+.||+|+||.||+++++ +..+|+|++.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-----KRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 113 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 345689999999999999999999885 577999998753211 1222345778999999999999999999998
Q ss_pred cCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEe
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGD 963 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsD 963 (1094)
+.. .+++||||+++|+|.+++... .+++..+..++.||+.||+|||+++|+||||||+|||++ .++.+||+|
T Consensus 114 ~~~--~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~----~~~~ikL~D 185 (371)
T cd05622 114 DDR--YLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD----KSGHLKLAD 185 (371)
T ss_pred cCC--EEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEC----CCCCEEEEe
Confidence 755 899999999999999998654 378889999999999999999999999999999999998 778999999
Q ss_pred cCCcccccCc--cccCCccCCCcccCccccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCC
Q 037285 964 FGLSKIKRNT--LVSGGVRGTLPWMAPELLSGSS--SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 1039 (1094)
Q Consensus 964 FGLSrl~~~~--~~ss~~~GT~~YmAPEvL~g~~--~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lr 1039 (1094)
||+++..... .......||+.|+|||++.+.. ..++.++|||||||++|||++|+.||...........+......
T Consensus 186 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~ 265 (371)
T cd05622 186 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS 265 (371)
T ss_pred CCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCc
Confidence 9999854322 1223456999999999987422 23788999999999999999999999988877777766654433
Q ss_pred CCCC--CcCcHHHHHHHHHhccCCCCC--CCCHHHHHHHHHH
Q 037285 1040 PTIP--SYCDAEWRTLMEECWAPNPAA--RPSFTEIASRLRV 1077 (1094)
Q Consensus 1040 p~iP--e~~S~eL~dLI~kCLq~DPee--RPS~eELLq~L~~ 1077 (1094)
..++ ..++..++++|.+||...+.+ |+++.+|+++.+-
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~ 307 (371)
T cd05622 266 LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 307 (371)
T ss_pred ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCccc
Confidence 3333 357899999999999844433 7899999998643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=310.89 Aligned_cols=250 Identities=27% Similarity=0.449 Sum_probs=207.3
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
.|++.+.||.|+||.||+++.+ +..||+|.+...... ......+.+|+.++++++|+|++++++.+... ..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~ 73 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS------RRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-DG 73 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC------HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-CC
Confidence 4889999999999999999874 577999998653221 22345678899999999999999999887543 33
Q ss_pred ceEEEeeecccchhHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 889 TLATVAEYMVDGSLRHVLVRK-DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~-~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++||||+.+++|.+++... ...+++.+++.++.+++.||.|||++|++|+||||+||+++ .++.++|+|||++
T Consensus 74 ~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~----~~~~~~l~df~~~ 149 (257)
T cd08223 74 LLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLT----RTNIIKVGDLGIA 149 (257)
T ss_pred EEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEe----cCCcEEEecccce
Confidence 689999999999999998764 34589999999999999999999999999999999999998 7889999999998
Q ss_pred ccccC-ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcC
Q 037285 968 KIKRN-TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYC 1046 (1094)
Q Consensus 968 rl~~~-~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~ 1046 (1094)
..... ........+++.|+|||++. ...++.++|||||||++|+|++|+.||...........+.. ...+..+...
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 226 (257)
T cd08223 150 RVLENQCDMASTLIGTPYYMSPELFS--NKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE-GKLPPMPKDY 226 (257)
T ss_pred EEecccCCccccccCCcCccChhHhc--CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh-cCCCCCcccc
Confidence 75432 22223445889999999987 45678899999999999999999999988776665555433 3334566778
Q ss_pred cHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1047 DAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1047 S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
+..+.++|.+||+.+|.+||++.+++.+
T Consensus 227 ~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 227 SPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 8999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=331.84 Aligned_cols=248 Identities=23% Similarity=0.378 Sum_probs=204.9
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-CCceeEEEeEeecCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-HPNIVqL~Gv~~d~~~ 887 (1094)
+|++.+.||+|+||.||+|+.+ +..||||++.+.... .......+..|+.++..+. |++|+++++++....
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~- 74 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-----QDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD- 74 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC-
Confidence 4778899999999999999875 678999998764221 1222345677888888876 577888999888755
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++||||+.+|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 75 -~~~lv~Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~----~~~~ikL~Dfg~~ 148 (323)
T cd05615 75 -RLYFVMEYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLD----SEGHIKIADFGMC 148 (323)
T ss_pred -EEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC----CCCCEEEeccccc
Confidence 8999999999999999986654 489999999999999999999999999999999999999 7788999999998
Q ss_pred cccc-CccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcC
Q 037285 968 KIKR-NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYC 1046 (1094)
Q Consensus 968 rl~~-~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~ 1046 (1094)
+... .........||+.|+|||++. ...++.++|||||||++|+|++|+.||...........+.... ..+|..+
T Consensus 149 ~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~--~~~p~~~ 224 (323)
T cd05615 149 KEHMVDGVTTRTFCGTPDYIAPEIIA--YQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN--VSYPKSL 224 (323)
T ss_pred cccCCCCccccCccCCccccCHHHHc--CCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCccC
Confidence 7432 222233456899999999997 4567899999999999999999999999888777777766543 3466788
Q ss_pred cHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 037285 1047 DAEWRTLMEECWAPNPAARPSF-----TEIASR 1074 (1094)
Q Consensus 1047 S~eL~dLI~kCLq~DPeeRPS~-----eELLq~ 1074 (1094)
+.++.+++.+||+.+|.+|++. .+++++
T Consensus 225 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 225 SKEAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred CHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 9999999999999999999974 556554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=318.11 Aligned_cols=247 Identities=34% Similarity=0.581 Sum_probs=201.8
Q ss_pred EecccCceEEEEeeecC--c--eEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEeecCCCCceE
Q 037285 817 ELGSGTFGTVYHGKWRG--T--DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQDGPGGTLA 891 (1094)
Q Consensus 817 kLGsG~FGtVYKAk~rG--t--~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~~d~~~~~L~ 891 (1094)
.||+|+||.||+|++.+ . .+|+|.++... .......+.+|+.++.++ +||||+++++++.... .++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~--~~~ 72 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-------SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG--YLY 72 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-------CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCC--Cce
Confidence 58999999999998753 2 46888776421 112335678899999999 7999999999998754 799
Q ss_pred EEeeecccchhHHHHhhcc---------------cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCC
Q 037285 892 TVAEYMVDGSLRHVLVRKD---------------RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSR 956 (1094)
Q Consensus 892 IVmEYmegGSL~d~L~k~~---------------~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~ 956 (1094)
+||||+.+++|.+++.... ..+++..++.++.|++.||+|||+++++||||||+|||++ .+
T Consensus 73 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~----~~ 148 (270)
T cd05047 73 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG----EN 148 (270)
T ss_pred EEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEc----CC
Confidence 9999999999999986532 2478899999999999999999999999999999999998 78
Q ss_pred CcEEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhh
Q 037285 957 PICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 1035 (1094)
Q Consensus 957 g~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~ 1035 (1094)
+.+||+|||++..............+..|+|||++. ...++.++|||||||++|||++ |..||......+....+ .
T Consensus 149 ~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~--~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~-~ 225 (270)
T cd05047 149 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN--YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-P 225 (270)
T ss_pred CeEEECCCCCccccchhhhccCCCCccccCChHHHc--cCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHH-h
Confidence 899999999986432221112223456799999987 4568899999999999999997 99999887776665554 3
Q ss_pred ccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1036 NTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1036 ~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
.......+..++.++.+++.+||..+|.+|||+.+++..|..+.
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 226 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 34455566678899999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=314.90 Aligned_cols=253 Identities=27% Similarity=0.427 Sum_probs=208.1
Q ss_pred CeeEEEEecccCceEEEEeee-cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCc
Q 037285 811 DLEEQKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGT 889 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~-rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~ 889 (1094)
+|++.+.||+|+||.||+|.. .+..+|||.+...... .....+....+.+|+.++++++|+||+++++++.+.. .
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~--~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~ 76 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSN--VLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDN--T 76 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccc--hhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCC--e
Confidence 477889999999999999987 4678999998754221 1222334467889999999999999999999998764 8
Q ss_pred eEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCccc
Q 037285 890 LATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI 969 (1094)
Q Consensus 890 L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl 969 (1094)
+++||||+.+++|.+++.+.. .+++..+..++.|++.||+|||+.+|+|+||+|+||+++ .++.+||+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~----~~~~~~l~dfg~~~~ 151 (265)
T cd06631 77 ISIFMEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLM----PNGIIKLIDFGCARR 151 (265)
T ss_pred EEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEEC----CCCeEEeccchhhHh
Confidence 999999999999999997654 478999999999999999999999999999999999998 778999999999874
Q ss_pred ccC-------ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhc-cCCCC
Q 037285 970 KRN-------TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN-TLRPT 1041 (1094)
Q Consensus 970 ~~~-------~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~-~lrp~ 1041 (1094)
... ........++..|+|||++. ...++.++|||||||++|+|++|+.||...........+... ...+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 229 (265)
T cd06631 152 LAWVGLHGTHSNMLKSMHGTPYWMAPEVIN--ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPR 229 (265)
T ss_pred hhhccccccccccccccCCCccccChhhhc--CCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCC
Confidence 311 11122345888999999987 456788999999999999999999999877655444333322 34455
Q ss_pred CCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1042 iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
.+..++.++.++|.+||+.+|.+||++.+++++
T Consensus 230 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 230 LPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 677889999999999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=314.86 Aligned_cols=255 Identities=29% Similarity=0.419 Sum_probs=208.7
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
.+|++.+.||+|+||.||+|++. +..||||.+...... .........+.+|+.++++++||||+++++++.+...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPES---PETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCC---cccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCC
Confidence 57999999999999999999874 678999988643211 1112234578889999999999999999999876544
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
..+++||||+++++|.+++.... .+++..++.++.|++.||+|||+++|+|+||||+|||++ .++.+||+|||++
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~----~~~~~~l~Dfg~~ 153 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRD----SVGNVKLGDFGAS 153 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEec----CCCCEEECcCccc
Confidence 57889999999999999987654 478889999999999999999999999999999999998 7789999999998
Q ss_pred ccccCc----cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCC
Q 037285 968 KIKRNT----LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIP 1043 (1094)
Q Consensus 968 rl~~~~----~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iP 1043 (1094)
+..... .......++..|+|||++. ...++.++|||||||++|+|++|+.||..................+..+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVIS--GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLP 231 (265)
T ss_pred cccccccccccccccCCCCccccChhhhc--CCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCc
Confidence 743221 1122345788999999987 4567899999999999999999999998776655555554444455667
Q ss_pred CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037285 1044 SYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1044 e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L 1075 (1094)
...+..+.++|.+||. +|++||++.+|+++.
T Consensus 232 ~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~ 262 (265)
T cd06652 232 PHVSDHCRDFLKRIFV-EAKLRPSADELLRHT 262 (265)
T ss_pred hhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCc
Confidence 7778889999999995 899999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=311.17 Aligned_cols=250 Identities=26% Similarity=0.445 Sum_probs=210.1
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
+|++.+.||+|+||.||++... +..+|||.+....+. ......+.+|+.++++++||||+++++.+....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-- 72 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT------KDERLAAQNECQVLKLLSHPNIIEYYENFLEDK-- 72 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc------cHHHHHHHHHHHHHhhCCCCchhheeeeEecCC--
Confidence 5889999999999999998774 677999998764332 122457889999999999999999999987654
Q ss_pred ceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 889 TLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++||||+++++|.+++.... ..+++..++.++.+++.+|+|||+++++|+||+|+||+++. .+..+||+|||++
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~---~~~~~~l~d~~~~ 149 (256)
T cd08220 73 ALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDK---HKMVVKIGDFGIS 149 (256)
T ss_pred EEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC---CCCEEEEccCCCc
Confidence 8999999999999999997653 45899999999999999999999999999999999999971 3457899999999
Q ss_pred ccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCc
Q 037285 968 KIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCD 1047 (1094)
Q Consensus 968 rl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S 1047 (1094)
.............++..|+|||.+. ...++.++||||||+++|+|++|+.||...........+.... ...++..++
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 226 (256)
T cd08220 150 KILSSKSKAYTVVGTPCYISPELCE--GKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGT-FAPISDRYS 226 (256)
T ss_pred eecCCCccccccccCCcccCchhcc--CCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcC-CCCCCCCcC
Confidence 8655443334456889999999997 4567889999999999999999999998877766665554433 345666789
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1048 AEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1048 ~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
..+.+++.+||..+|.+|||+.+++++
T Consensus 227 ~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 227 PDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=313.92 Aligned_cols=249 Identities=33% Similarity=0.581 Sum_probs=201.4
Q ss_pred EEecccCceEEEEeeec-----CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCce
Q 037285 816 KELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTL 890 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~r-----Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L 890 (1094)
+.||+|+||.||+|++. ...||||.+.... .......+.+|+.+++.++||||+++++++... ++..
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~ 72 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-------DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS-EGSP 72 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-------CHHHHHHHHHHHHHHccCCCCCcceEEEEeecC-CCCc
Confidence 36899999999999863 2459999875321 122345788899999999999999999987643 2367
Q ss_pred EEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccc
Q 037285 891 ATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK 970 (1094)
Q Consensus 891 ~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~ 970 (1094)
++||||+.+++|.+++......+++..++.++.||+.||.|||+++++||||||+|||++ ..+.+||+|||+++..
T Consensus 73 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~----~~~~~kl~dfg~~~~~ 148 (262)
T cd05058 73 LVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLD----ESFTVKVADFGLARDI 148 (262)
T ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc----CCCcEEECCccccccc
Confidence 899999999999999977655578888899999999999999999999999999999998 6788999999998743
Q ss_pred cCc-----cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCCCCC
Q 037285 971 RNT-----LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPS 1044 (1094)
Q Consensus 971 ~~~-----~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~iPe 1044 (1094)
... .......++..|+|||.+. ...++.++|||||||++|||++ |..||......+....+ .....+..+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 225 (262)
T cd05058 149 YDKEYYSVHNHTGAKLPVKWMALESLQ--TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL-LQGRRLLQPE 225 (262)
T ss_pred cCCcceeecccccCcCCccccChhHhc--cCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-hcCCCCCCCC
Confidence 221 1112334577899999987 4568899999999999999999 56778776666655544 3334445566
Q ss_pred cCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1045 YCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1045 ~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
.++..+.++|.+||..+|++||++.+|++.|..+.
T Consensus 226 ~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 226 YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 78899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=321.37 Aligned_cols=251 Identities=27% Similarity=0.354 Sum_probs=195.9
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC---CCCceeEEEeEeecC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL---HHPNVVAFYGVVQDG 885 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL---~HPNIVqL~Gv~~d~ 885 (1094)
+|++.+.||+|+||+||+|+++ ++.||+|.++....... ....+.+|+.+++.+ +||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~ 74 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG------LPLSTVREVALLKRLEAFDHPNIVRLMDVCATS 74 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC------CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccc
Confidence 5889999999999999999875 67899999875422111 112344566666554 799999999988643
Q ss_pred ---CCCceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEE
Q 037285 886 ---PGGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKV 961 (1094)
Q Consensus 886 ---~~~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKL 961 (1094)
....+++||||+. ++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 75 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~----~~~~~kl 149 (288)
T cd07863 75 RTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT----SGGQVKL 149 (288)
T ss_pred cCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCCEEE
Confidence 2236899999997 58888886543 3489999999999999999999999999999999999998 7788999
Q ss_pred EecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhcc----
Q 037285 962 GDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT---- 1037 (1094)
Q Consensus 962 sDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~---- 1037 (1094)
+|||+++............+|..|+|||++. ...++.++|||||||++|+|++|+.||........+..+....
T Consensus 150 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07863 150 ADFGLARIYSCQMALTPVVVTLWYRAPEVLL--QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 227 (288)
T ss_pred CccCccccccCcccCCCccccccccCchHhh--CCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCC
Confidence 9999998654433334456899999999997 4568899999999999999999999998776555444332210
Q ss_pred ---C-----------CC-------CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1038 ---L-----------RP-------TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1038 ---l-----------rp-------~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
+ .. .+...++..+.++|.+||+.||.+|||+.+++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 228 EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred hhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 00 0112457788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=312.69 Aligned_cols=252 Identities=27% Similarity=0.400 Sum_probs=207.1
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||.|+||.||+|++. +..+++|.+..... .....+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 73 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--------DDFEIIQQEISMLKECRHPNIVAYFGSYLRRD 73 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--------hhHHHHHHHHHHHHhCCCCChhceEEEEEeCC
Confidence 367999999999999999999874 57799999875321 12357789999999999999999999998755
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.++++|||+.+++|.+++......+++..++.++.|++.||.|||+++++|+||+|+||+++ .++.+||+|||+
T Consensus 74 --~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~----~~~~~~l~d~g~ 147 (262)
T cd06613 74 --KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLT----EDGDVKLADFGV 147 (262)
T ss_pred --EEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEEC----CCCCEEECcccc
Confidence 89999999999999999977655699999999999999999999999999999999999999 678899999999
Q ss_pred cccccCcc-ccCCccCCCcccCccccccC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCC---
Q 037285 967 SKIKRNTL-VSGGVRGTLPWMAPELLSGS-SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT--- 1041 (1094)
Q Consensus 967 Srl~~~~~-~ss~~~GT~~YmAPEvL~g~-~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~--- 1041 (1094)
+....... ......++..|+|||.+.+. ...++.++|||||||++|+|++|+.||...........+....+.+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 227 (262)
T cd06613 148 SAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLK 227 (262)
T ss_pred chhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCcccc
Confidence 87543321 22334578899999998732 12678899999999999999999999988776555444433322221
Q ss_pred CCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1042 iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
.+...+.++.++|.+||..+|.+|||+.+|+.+
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred chhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 233456789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=352.79 Aligned_cols=262 Identities=30% Similarity=0.496 Sum_probs=224.1
Q ss_pred cceeeccCCeeEEEEecccCceEEEEeeecC-ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeE
Q 037285 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGV 881 (1094)
Q Consensus 803 sv~eIs~edYei~kkLGsG~FGtVYKAk~rG-t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv 881 (1094)
.+.++..+.+.+.++||+|.||+|.++...+ ..||||+++... ......+|.+|+++|.+|+|||||+++|+
T Consensus 531 al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a-------~~~~r~~F~kEIkiLsqLkhPNIveLvGV 603 (807)
T KOG1094|consen 531 ALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA-------TKNARNDFLKEIKILSRLKHPNIVELLGV 603 (807)
T ss_pred chhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCccc-------chhHHHHHHHHHHHHhccCCCCeeEEEee
Confidence 4567788899999999999999999999886 889999998652 23345789999999999999999999999
Q ss_pred eecCCCCceEEEeeecccchhHHHHhhccccc-CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEE
Q 037285 882 VQDGPGGTLATVAEYMVDGSLRHVLVRKDRFL-DRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICK 960 (1094)
Q Consensus 882 ~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~L-se~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VK 960 (1094)
|..++ .+++|+|||++|+|.+++.+...+. .-.....||.||+.||+||.+.++|||||.++|||++ .++++|
T Consensus 604 C~~De--PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~----~e~~iK 677 (807)
T KOG1094|consen 604 CVQDD--PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVD----GEFTIK 677 (807)
T ss_pred eecCC--chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeec----CcccEE
Confidence 99866 9999999999999999998775333 5556778999999999999999999999999999999 899999
Q ss_pred EEecCCcccc---cCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCChHHHHHhHhh
Q 037285 961 VGDFGLSKIK---RNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT--GEEPYANMHYGAIIGGIVN 1035 (1094)
Q Consensus 961 LsDFGLSrl~---~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT--Gk~PF~~~~~~eile~Iv~ 1035 (1094)
|+|||+++.. +.+.......-+.+|||+|.+. ..+++.++|||+||++|||+++ ...||...+++++++....
T Consensus 678 iadfgmsR~lysg~yy~vqgr~vlpiRwmawEsil--lgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~ 755 (807)
T KOG1094|consen 678 IADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESIL--LGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGE 755 (807)
T ss_pred ecCcccccccccCCceeeecceeeeeeehhHHHHH--hccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhh
Confidence 9999999932 1223333455678999999998 6799999999999999999886 8889999998887765422
Q ss_pred c------cCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1036 N------TLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1036 ~------~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
- ..-+..|..|+..++++|.+||..+-.+||+|++|..+|.+..
T Consensus 756 ~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 756 FFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred hcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 1 1124567889999999999999999999999999999998753
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=335.09 Aligned_cols=243 Identities=23% Similarity=0.391 Sum_probs=196.6
Q ss_pred EEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEeecCCCCceEE
Q 037285 816 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQDGPGGTLAT 892 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~~d~~~~~L~I 892 (1094)
+.||+|+||.||+++.+ +..||+|++++..... ......+..|+.++.++ +||||+++++++.... .+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~--~~~l 73 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVND-----DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES--RLFF 73 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcc-----hhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCC--EEEE
Confidence 46999999999999875 5779999998653221 12234567888888776 7999999999998765 8999
Q ss_pred EeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccc-c
Q 037285 893 VAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK-R 971 (1094)
Q Consensus 893 VmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~-~ 971 (1094)
||||+.+|+|..++.... .+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++.. .
T Consensus 74 v~E~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~----~~~~~kL~DfG~~~~~~~ 148 (329)
T cd05618 74 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD----SEGHIKLTDYGMCKEGLR 148 (329)
T ss_pred EEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC----CCCCEEEeeCCccccccC
Confidence 999999999998886554 589999999999999999999999999999999999998 7789999999998743 2
Q ss_pred CccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--------h-HHHHHhHhhccCCCCC
Q 037285 972 NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH--------Y-GAIIGGIVNNTLRPTI 1042 (1094)
Q Consensus 972 ~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~--------~-~eile~Iv~~~lrp~i 1042 (1094)
.........||..|+|||++. ...++.++|||||||++|+|++|+.||.... . ......+... ...+
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~~ 224 (329)
T cd05618 149 PGDTTSTFCGTPNYIAPEILR--GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRI 224 (329)
T ss_pred CCCccccccCCccccCHHHHc--CCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC--CCCC
Confidence 222233467899999999998 4567889999999999999999999995311 1 1122222222 3456
Q ss_pred CCcCcHHHHHHHHHhccCCCCCCCC------HHHHHHH
Q 037285 1043 PSYCDAEWRTLMEECWAPNPAARPS------FTEIASR 1074 (1094)
Q Consensus 1043 Pe~~S~eL~dLI~kCLq~DPeeRPS------~eELLq~ 1074 (1094)
|..++..+.++|.+||+.||.+||+ +.+++++
T Consensus 225 p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 225 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 7788999999999999999999998 5677766
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=333.50 Aligned_cols=243 Identities=27% Similarity=0.381 Sum_probs=197.8
Q ss_pred EEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHH-HHhhCCCCceeEEEeEeecCCCCceEE
Q 037285 816 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAE-ILSKLHHPNVVAFYGVVQDGPGGTLAT 892 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIk-ILkrL~HPNIVqL~Gv~~d~~~~~L~I 892 (1094)
+.||+|+||.||+|++. +..||+|++.+.... .......+.+|.. +++.++||||+++++++.+.. .+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~--~~~l 73 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL-----KKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAE--KLYF 73 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-----HhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCC--EEEE
Confidence 36999999999999884 678999999764221 1122334555554 578899999999999998765 8999
Q ss_pred EeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccc-c
Q 037285 893 VAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK-R 971 (1094)
Q Consensus 893 VmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~-~ 971 (1094)
||||+++++|..++.... .+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++.. .
T Consensus 74 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~----~~~~~kl~Dfg~~~~~~~ 148 (321)
T cd05603 74 VLDYVNGGELFFHLQRER-CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLD----SQGHVVLTDFGLCKEGVE 148 (321)
T ss_pred EEcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC----CCCCEEEccCCCCccCCC
Confidence 999999999998886543 588889999999999999999999999999999999998 7789999999998743 2
Q ss_pred CccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHH
Q 037285 972 NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWR 1051 (1094)
Q Consensus 972 ~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~ 1051 (1094)
.........||+.|+|||++. ...++.++|||||||++|||++|+.||...+.......+... ...++...+..+.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~ 224 (321)
T cd05603 149 PEETTSTFCGTPEYLAPEVLR--KEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK--PLQLPGGKTVAAC 224 (321)
T ss_pred CCCccccccCCcccCCHHHhc--CCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHH
Confidence 222334456899999999997 456888999999999999999999999988776666665543 2346667889999
Q ss_pred HHHHHhccCCCCCCCCH----HHHHHH
Q 037285 1052 TLMEECWAPNPAARPSF----TEIASR 1074 (1094)
Q Consensus 1052 dLI~kCLq~DPeeRPS~----eELLq~ 1074 (1094)
++|.+||+.||.+|+++ .+++++
T Consensus 225 ~li~~~l~~~p~~R~~~~~~~~~~~~~ 251 (321)
T cd05603 225 DLLVGLLHKDQRRRLGAKADFLEIKNH 251 (321)
T ss_pred HHHHHHccCCHhhcCCCCCCHHHHhCC
Confidence 99999999999999865 355544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=320.94 Aligned_cols=256 Identities=29% Similarity=0.402 Sum_probs=208.7
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
...+.|++.++||.|+||.||+|+.. +..+|+|.+.... ......+.+|+.++++++|+||+++++++..
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS--------EEELEDYMVEIEILATCNHPYIVKLLGAFYW 80 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC--------HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe
Confidence 34567999999999999999999875 5779999986431 2234668889999999999999999999887
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
.. .+++||||+.+++|..++.+....+++..++.++.|++.+|.|||+++++||||||+||+++ .++.+||+||
T Consensus 81 ~~--~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~kl~df 154 (292)
T cd06644 81 DG--KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLT----LDGDIKLADF 154 (292)
T ss_pred CC--eEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEc----CCCCEEEccC
Confidence 54 89999999999999988876666789999999999999999999999999999999999998 6788999999
Q ss_pred CCcccccC-ccccCCccCCCcccCcccccc---CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccC-C
Q 037285 965 GLSKIKRN-TLVSGGVRGTLPWMAPELLSG---SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL-R 1039 (1094)
Q Consensus 965 GLSrl~~~-~~~ss~~~GT~~YmAPEvL~g---~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~l-r 1039 (1094)
|++..... ........++..|+|||++.+ ....++.++|||||||++|+|++|+.||...........+..... .
T Consensus 155 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 234 (292)
T cd06644 155 GVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT 234 (292)
T ss_pred ccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCcc
Confidence 99874322 122233457889999999853 133467899999999999999999999987765554444433222 1
Q ss_pred CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1040 PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1040 p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
...+..++.++.++|.+||..+|++||++.+++++-+
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 271 (292)
T cd06644 235 LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPF 271 (292)
T ss_pred CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 2334567889999999999999999999999987644
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=333.77 Aligned_cols=253 Identities=23% Similarity=0.292 Sum_probs=199.9
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||+|+||.||++... +..||||.+..... .......+.+|+.+++.++||||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 89 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ------NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 89 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc------ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccc
Confidence 468999999999999999999864 67899999865421 1223356778999999999999999999886432
Q ss_pred ----CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 887 ----GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 887 ----~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
...+++||||+.+ +|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 90 ~~~~~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~----~~~~~kl~ 161 (355)
T cd07874 90 SLEEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKIL 161 (355)
T ss_pred cccccceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEC----CCCCEEEe
Confidence 1357999999965 56666643 378889999999999999999999999999999999998 77899999
Q ss_pred ecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccC----
Q 037285 963 DFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL---- 1038 (1094)
Q Consensus 963 DFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~l---- 1038 (1094)
|||+++............+|..|+|||++. ...++.++|||||||++|+|++|+.||...........+.....
T Consensus 162 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (355)
T cd07874 162 DFGLARTAGTSFMMTPYVVTRYYRAPEVIL--GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239 (355)
T ss_pred eCcccccCCCccccCCccccCCccCHHHHc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 999998655444444567899999999997 45688999999999999999999999987664433222211000
Q ss_pred ------------------------------------CCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1039 ------------------------------------RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1039 ------------------------------------rp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
....+...+..+++||.+||..||.+|||+.+++++-+-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~ 314 (355)
T cd07874 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYI 314 (355)
T ss_pred HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcch
Confidence 000112235678999999999999999999999998543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=333.58 Aligned_cols=255 Identities=24% Similarity=0.317 Sum_probs=208.1
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||+|+||.||+++.+ +..||+|++.+... ........+.+|+.++..++|+||+++++++.+..
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~- 74 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEM-----LKRAETACFREERNVLVNGDCQWITTLHYAFQDEN- 74 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHH-----HhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-
Confidence 47999999999999999999875 56799999875311 11223445778999999999999999999998765
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+|+||||+.+|+|.+++......+++..+..++.||+.||+|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 75 -~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~----~~~~~kl~DfG~a 149 (331)
T cd05624 75 -YLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLD----MNGHIRLADFGSC 149 (331)
T ss_pred -EEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEc----CCCCEEEEeccce
Confidence 89999999999999999987556689999999999999999999999999999999999998 6788999999998
Q ss_pred ccccCcc--ccCCccCCCcccCccccccCC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCC
Q 037285 968 KIKRNTL--VSGGVRGTLPWMAPELLSGSS---SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTI 1042 (1094)
Q Consensus 968 rl~~~~~--~ss~~~GT~~YmAPEvL~g~~---~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~i 1042 (1094)
+...... ......||+.|+|||++.+.. ..++.++|||||||++|+|++|+.||......+....+.....+..+
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 229 (331)
T cd05624 150 LKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQF 229 (331)
T ss_pred eeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccC
Confidence 7543221 223356999999999986421 35788999999999999999999999988777777666554443333
Q ss_pred CC---cCcHHHHHHHHHhccCCCCC--CCCHHHHHHHH
Q 037285 1043 PS---YCDAEWRTLMEECWAPNPAA--RPSFTEIASRL 1075 (1094)
Q Consensus 1043 Pe---~~S~eL~dLI~kCLq~DPee--RPS~eELLq~L 1075 (1094)
+. .++.+++++|.+||...+.+ |+++.+++++.
T Consensus 230 p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~ 267 (331)
T cd05624 230 PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHA 267 (331)
T ss_pred CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCC
Confidence 33 46889999999999876544 46899998774
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=320.58 Aligned_cols=254 Identities=32% Similarity=0.571 Sum_probs=208.7
Q ss_pred eccCCeeEEEEecccCceEEEEeeec-------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEE
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFY 879 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r-------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~ 879 (1094)
+..++|++.+.||+|+||.||++++. +..||+|++.... ......+|.+|+.++++++||||++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~ei~~l~~l~h~~iv~~~ 74 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-------SADMQADFQREAALMAEFDHPNIVKLL 74 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-------CHHHHHHHHHHHHHHHhcCCCchheEE
Confidence 34568999999999999999999863 4569999886432 122335688999999999999999999
Q ss_pred eEeecCCCCceEEEeeecccchhHHHHhhcc---------------------cccCHHHHHHHHHHHHHHHHHHHHCCce
Q 037285 880 GVVQDGPGGTLATVAEYMVDGSLRHVLVRKD---------------------RFLDRRRRLIIAMDAAFGMEYLHSKNIV 938 (1094)
Q Consensus 880 Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~---------------------~~Lse~~~l~Ia~QIaeGLaYLHs~GII 938 (1094)
+++.... ..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++++
T Consensus 75 ~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~ 152 (288)
T cd05050 75 GVCAVGK--PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV 152 (288)
T ss_pred EEEcCCC--ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 9998755 7899999999999999996432 2367888999999999999999999999
Q ss_pred eccCCCCceEeccCCCCCCcEEEEecCCcccccCcc---ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHH
Q 037285 939 HFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTL---VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEIL 1015 (1094)
Q Consensus 939 HRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~~---~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELL 1015 (1094)
||||||+|||++ .++.+||+|||++....... .......+..|+|||.+. ...++.++|||||||++|+|+
T Consensus 153 H~dl~p~nil~~----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~il~el~ 226 (288)
T cd05050 153 HRDLATRNCLVG----ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIF--YNRYTTESDVWAYGVVLWEIF 226 (288)
T ss_pred cccccHhheEec----CCCceEECccccceecccCccccccCCCccChhhcCHHHHh--cCCCCchhHHHHHHHHHHHHH
Confidence 999999999998 77899999999987432211 112223467799999987 456889999999999999999
Q ss_pred c-CCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1016 T-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1016 T-Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
+ |..||......+....+.... ....+..++.++.+||.+||+.+|.+|||+.+|++.|+
T Consensus 227 ~~~~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 227 SYGMQPYYGMAHEEVIYYVRDGN-VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred hCCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 8 889998877777666554333 33456678899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=320.17 Aligned_cols=254 Identities=27% Similarity=0.426 Sum_probs=211.3
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||.|+||.||+++++ +..+|+|.+.... ......|.+|+.++++++|+||+++++++....
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 75 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES--------EEELEDFMVEIDILSECKHPNIVGLYEAYFYEN- 75 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC--------HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC-
Confidence 57899999999999999999885 6789999986431 223457889999999999999999999998755
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++||||+.+++|..++......+++..++.++.|++.||.|||+++|+|+||||+||+++ .++.++|+|||++
T Consensus 76 -~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~----~~~~~~l~d~g~~ 150 (280)
T cd06611 76 -KLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLT----LDGDVKLADFGVS 150 (280)
T ss_pred -eEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEC----CCCCEEEccCccc
Confidence 89999999999999999987666799999999999999999999999999999999999998 7789999999998
Q ss_pred ccccC-ccccCCccCCCcccCcccccc---CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccC-CCCC
Q 037285 968 KIKRN-TLVSGGVRGTLPWMAPELLSG---SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL-RPTI 1042 (1094)
Q Consensus 968 rl~~~-~~~ss~~~GT~~YmAPEvL~g---~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~l-rp~i 1042 (1094)
..... ........++..|+|||++.. ....++.++|||||||++|+|++|+.||...........+..... ....
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 230 (280)
T cd06611 151 AKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQ 230 (280)
T ss_pred hhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCC
Confidence 74322 222234468899999999752 133467899999999999999999999988876665555533222 1233
Q ss_pred CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1043 PSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1043 Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
+..++.++.++|.+||+.+|.+||++.+++++-+-
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 265 (280)
T cd06611 231 PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFV 265 (280)
T ss_pred cccCCHHHHHHHHHHhccChhhCcCHHHHhcChhh
Confidence 55788999999999999999999999999988654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=319.99 Aligned_cols=256 Identities=31% Similarity=0.525 Sum_probs=204.7
Q ss_pred CCeeEEEEecccCceEEEEeee------cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEee
Q 037285 810 EDLEEQKELGSGTFGTVYHGKW------RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQ 883 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~------rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~ 883 (1094)
.-|++.++||+|+||.||++++ .+..||+|.++... .......+.+|+.++++++||||+++++++.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-------GGNHIADLKKEIEILRNLYHENIVKYKGICT 76 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-------cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 3578899999999999999874 25679999986431 1223457889999999999999999999988
Q ss_pred cCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEe
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGD 963 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsD 963 (1094)
......+++||||+++++|.+++.+....+++..++.++.||+.||+|||++|++||||||+|||++ .++.+||+|
T Consensus 77 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~----~~~~~~l~d 152 (284)
T cd05079 77 EDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE----SEHQVKIGD 152 (284)
T ss_pred cCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEc----CCCCEEECC
Confidence 7544578999999999999999976655689999999999999999999999999999999999998 678899999
Q ss_pred cCCcccccCcc----ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--------------
Q 037285 964 FGLSKIKRNTL----VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH-------------- 1025 (1094)
Q Consensus 964 FGLSrl~~~~~----~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~-------------- 1025 (1094)
||+++...... ......++..|+|||++. ...++.++|||||||++|+|+|++.|+....
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~--~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd05079 153 FGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI--QSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQM 230 (284)
T ss_pred CccccccccCccceeecCCCCCCccccCHHHhc--cCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccc
Confidence 99998543221 122344677899999987 4567889999999999999999876643211
Q ss_pred hHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1026 YGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1026 ~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
.............+...+..++..+.+||.+||+.+|.+||++.++++.|+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 231 TVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 01111112233334445667899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=322.55 Aligned_cols=255 Identities=31% Similarity=0.526 Sum_probs=204.2
Q ss_pred eccCCeeEEEEecccCceEEEEeeecC----------------ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWRG----------------TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL 870 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~rG----------------t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL 870 (1094)
+...+|++.+.||+|+||.||+++..+ ..||||.+..... ......|.+|+++++++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~ei~~l~~l 74 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT-------KTARNDFLKEIKIMSRL 74 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC-------HHHHHHHHHHHHHHHhC
Confidence 345689999999999999999987632 2489998865311 22345688999999999
Q ss_pred CCCceeEEEeEeecCCCCceEEEeeecccchhHHHHhhcc-----------cccCHHHHHHHHHHHHHHHHHHHHCCcee
Q 037285 871 HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD-----------RFLDRRRRLIIAMDAAFGMEYLHSKNIVH 939 (1094)
Q Consensus 871 ~HPNIVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~-----------~~Lse~~~l~Ia~QIaeGLaYLHs~GIIH 939 (1094)
+|+||+++++++.... .+++||||+.+++|.+++.... ..+++..++.++.|++.||+|||+++++|
T Consensus 75 ~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H 152 (295)
T cd05097 75 KNPNIIRLLGVCVSDD--PLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVH 152 (295)
T ss_pred CCCCcCeEEEEEcCCC--ccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeec
Confidence 9999999999998754 8999999999999999986532 13678889999999999999999999999
Q ss_pred ccCCCCceEeccCCCCCCcEEEEecCCcccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc
Q 037285 940 FDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT 1016 (1094)
Q Consensus 940 RDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT 1016 (1094)
+||||+|||++ .++.+||+|||++...... .......++..|+|||++. ...++.++|||||||++|+|++
T Consensus 153 ~dlkp~Nill~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwSlG~~l~el~~ 226 (295)
T cd05097 153 RDLATRNCLVG----NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESIL--LGKFTTASDVWAFGVTLWEMFT 226 (295)
T ss_pred cccChhhEEEc----CCCcEEecccccccccccCcceeccCcCcCceeecChhhhc--cCCcCchhhHHHHHHHHHHHHH
Confidence 99999999998 6778999999998743221 1122233567899999987 4568899999999999999998
Q ss_pred --CCCCCCCCChHHHHHhHhh------ccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1017 --GEEPYANMHYGAIIGGIVN------NTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1017 --Gk~PF~~~~~~eile~Iv~------~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
+..||......+....+.. .......+..++..+.+||.+||..+|.+||++.+|++.|.
T Consensus 227 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 227 LCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred cCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 6788988776665544322 11112335567899999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=310.51 Aligned_cols=253 Identities=28% Similarity=0.464 Sum_probs=210.0
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
+|+..+.||+|+||.||+|... +..|++|.+....... ........+.+|+.++++++|+||+++++++....
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-- 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQ---TGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREED-- 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccc---cchHHHHHHHHHHHHHHhcCCCCchheeeeEecCC--
Confidence 4677889999999999999874 6889999986542211 11233457889999999999999999999998754
Q ss_pred ceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 889 TLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
.+++|+||+++++|.+++.+.. .+++..++.++.||+.||+|||+++|+|+||+|+||+++ .++.+||+|||++.
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~----~~~~~kl~d~~~~~ 150 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVD----TNGVVKLADFGMAK 150 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEEccCccce
Confidence 8999999999999999997654 488999999999999999999999999999999999998 67899999999988
Q ss_pred cccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCcH
Q 037285 969 IKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDA 1048 (1094)
Q Consensus 969 l~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~ 1048 (1094)
............++..|+|||.+.... .++.++|+|||||++|+|++|+.||...........+......+.++..++.
T Consensus 151 ~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (258)
T cd06632 151 QVVEFSFAKSFKGSPYWMAPEVIAQQG-GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSD 229 (258)
T ss_pred eccccccccccCCCcceeCHHHhcCCC-CCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCH
Confidence 544333334456889999999987322 3789999999999999999999999887655555444443445566778899
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1049 EWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1049 eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
.+.++|.+||+.+|.+||++.+++.+
T Consensus 230 ~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 230 EAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 99999999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=316.31 Aligned_cols=254 Identities=33% Similarity=0.563 Sum_probs=210.0
Q ss_pred ccCCeeEEEEecccCceEEEEeeec-------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEe
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYG 880 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~r-------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~G 880 (1094)
..++|++.+.||.|+||.||+|+++ ...|++|.+... ..+.....+.+|+.++++++|+||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 75 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-------KDENLQSEFRRELDMFRKLSHKNVVRLLG 75 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc-------cchHHHHHHHHHHHHHHhcCCcceeeeEE
Confidence 4578999999999999999999874 245888877542 11234467889999999999999999999
Q ss_pred EeecCCCCceEEEeeecccchhHHHHhhcc--------cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccC
Q 037285 881 VVQDGPGGTLATVAEYMVDGSLRHVLVRKD--------RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLK 952 (1094)
Q Consensus 881 v~~d~~~~~L~IVmEYmegGSL~d~L~k~~--------~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~ 952 (1094)
++.+.. ..++||||+++++|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++
T Consensus 76 ~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~-- 151 (275)
T cd05046 76 LCREAE--PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVS-- 151 (275)
T ss_pred EECCCC--cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEe--
Confidence 997754 8899999999999999997544 1489999999999999999999999999999999999998
Q ss_pred CCCCCcEEEEecCCcccccC--ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 037285 953 DPSRPICKVGDFGLSKIKRN--TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAI 1029 (1094)
Q Consensus 953 ~~e~g~VKLsDFGLSrl~~~--~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ei 1029 (1094)
..+.++|+|||++..... ........++..|+|||.+. ...++.++||||||+++|+|++ |..||........
T Consensus 152 --~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~ 227 (275)
T cd05046 152 --SQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQ--EDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV 227 (275)
T ss_pred --CCCcEEEcccccccccCcccccccCCceeEEeecChhhhc--cCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH
Confidence 678899999999874321 11222334677899999987 3456789999999999999998 8899987777666
Q ss_pred HHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1030 IGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1030 le~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
+..+.........+..++..+.++|.+||+.+|.+||++.++++.|+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 228 LNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 66665455444556678999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=318.84 Aligned_cols=253 Identities=27% Similarity=0.396 Sum_probs=207.4
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
.|++.+.||.|+||.||+|.+. +..+++|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~-- 75 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--------EEELEDYMVEIDILASCDHPNIVKLLDAFYYEN-- 75 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--------HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC--
Confidence 3678899999999999999885 4668888875431 223456888999999999999999999998754
Q ss_pred ceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 889 TLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
..++||||+.+++|..++.+....+++..+..++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||++.
T Consensus 76 ~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~----~~~~~kl~dfg~~~ 151 (282)
T cd06643 76 NLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFT----LDGDIKLADFGVSA 151 (282)
T ss_pred EEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc----cCCCEEEccccccc
Confidence 89999999999999998876556789999999999999999999999999999999999998 77889999999987
Q ss_pred cccC-ccccCCccCCCcccCcccccc---CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhcc-CCCCCC
Q 037285 969 IKRN-TLVSGGVRGTLPWMAPELLSG---SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-LRPTIP 1043 (1094)
Q Consensus 969 l~~~-~~~ss~~~GT~~YmAPEvL~g---~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~-lrp~iP 1043 (1094)
.... ........++..|+|||++.. ....++.++|||||||++|+|++|+.||......+....+.... .....+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd06643 152 KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQP 231 (282)
T ss_pred cccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCc
Confidence 4322 122234568899999999842 13356789999999999999999999998877665555443322 123345
Q ss_pred CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1044 SYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1044 e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
..++..+.++|.+||+.+|.+||++.+++++.+-
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 265 (282)
T cd06643 232 SRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFV 265 (282)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcCCCE
Confidence 6688999999999999999999999999887653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=322.35 Aligned_cols=253 Identities=23% Similarity=0.346 Sum_probs=205.4
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
.|++.+.||+|+||.||++.+. ++.||||.+....... ......+.+|+.++++++|++|+.+++.+.+..
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-- 73 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-----RKGESMALNEKQILEKVNSRFVVSLAYAYETKD-- 73 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccc-----hHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC--
Confidence 3678899999999999999885 6789999987543221 122345678999999999999999999998755
Q ss_pred ceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 889 TLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.+|+||||||+||+++ .++.++|+|||++
T Consensus 74 ~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~----~~~~~~l~Dfg~~ 149 (285)
T cd05630 74 ALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLD----DHGHIRISDLGLA 149 (285)
T ss_pred EEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC----CCCCEEEeeccce
Confidence 8999999999999999885433 3589999999999999999999999999999999999998 6788999999998
Q ss_pred ccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH---HHHHhHhhccCCCCCCC
Q 037285 968 KIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG---AIIGGIVNNTLRPTIPS 1044 (1094)
Q Consensus 968 rl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~---eile~Iv~~~lrp~iPe 1044 (1094)
.............|+..|+|||++. ...++.++|||||||++|+|++|+.||...... ........ ......+.
T Consensus 150 ~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~ 226 (285)
T cd05630 150 VHVPEGQTIKGRVGTVGYMAPEVVK--NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK-EVQEEYSE 226 (285)
T ss_pred eecCCCccccCCCCCccccChHHHc--CCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh-hhhhhcCc
Confidence 7543333323456899999999997 456889999999999999999999999865432 22222211 22334566
Q ss_pred cCcHHHHHHHHHhccCCCCCCCC-----HHHHHHHHHH
Q 037285 1045 YCDAEWRTLMEECWAPNPAARPS-----FTEIASRLRV 1077 (1094)
Q Consensus 1045 ~~S~eL~dLI~kCLq~DPeeRPS-----~eELLq~L~~ 1077 (1094)
.++.++++||.+||+.||++||| +.+++++-+-
T Consensus 227 ~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~ 264 (285)
T cd05630 227 KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLF 264 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhh
Confidence 78899999999999999999999 8999986554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=334.02 Aligned_cols=253 Identities=23% Similarity=0.294 Sum_probs=201.3
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||+|+||.||++... +..||||++...... ......+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~ 96 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN------QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK 96 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccC------chhHHHHHHHHHHHHhcCCCCccccceeecccc
Confidence 468999999999999999999874 678999998754211 122356778999999999999999999876432
Q ss_pred ----CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 887 ----GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 887 ----~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
...+++||||+.+ +|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 97 ~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~~kL~ 168 (364)
T cd07875 97 SLEEFQDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKIL 168 (364)
T ss_pred cccccCeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEEC----CCCcEEEE
Confidence 2357999999965 66666643 378889999999999999999999999999999999998 77899999
Q ss_pred ecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccC----
Q 037285 963 DFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL---- 1038 (1094)
Q Consensus 963 DFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~l---- 1038 (1094)
|||+++............+|..|+|||++. ...++.++|||||||++|+|++|+.||...+..+.+..+.....
T Consensus 169 DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (364)
T cd07875 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVIL--GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 246 (364)
T ss_pred eCCCccccCCCCcccCCcccCCcCCHHHHh--CCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 999998655444444556899999999998 45688999999999999999999999988766554443322100
Q ss_pred ----------------CC--------------------CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1039 ----------------RP--------------------TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1039 ----------------rp--------------------~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
++ ......+..+++||.+||+.||.+|||+.+++++-+-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~ 321 (364)
T cd07875 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321 (364)
T ss_pred HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence 00 0011234578999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=326.84 Aligned_cols=255 Identities=27% Similarity=0.355 Sum_probs=213.0
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
.+|...++||+|+||.||+|++. |+.||||.++.....+ ......++|++.|+.++|+||+.++++|-...
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd------Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~- 74 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD------GINRTALREIKLLQELKHPNIIELIDVFPHKS- 74 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc------CccHHHHHHHHHHHHccCcchhhhhhhccCCC-
Confidence 46888899999999999999984 7889999998764322 22346789999999999999999999998765
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+.+|+||| ..+|+..++.+...++...+..++.++++||+|||++.|+||||||.|+|++ +++.+||+|||++
T Consensus 75 -~l~lVfEfm-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis----~~g~lKiADFGLA 148 (318)
T KOG0659|consen 75 -NLSLVFEFM-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLIS----SDGQLKIADFGLA 148 (318)
T ss_pred -ceEEEEEec-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEc----CCCcEEeecccch
Confidence 899999999 5789999998888999999999999999999999999999999999999999 8999999999999
Q ss_pred ccccCcc-ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCC-------
Q 037285 968 KIKRNTL-VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR------- 1039 (1094)
Q Consensus 968 rl~~~~~-~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lr------- 1039 (1094)
+...... .....+.|.+|.|||.+.| ...|+..+||||.|||+.||+-|.+-|.+.+.-+.+..+...--.
T Consensus 149 r~f~~p~~~~~~~V~TRWYRAPELLfG-sr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP 227 (318)
T KOG0659|consen 149 RFFGSPNRIQTHQVVTRWYRAPELLFG-SRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWP 227 (318)
T ss_pred hccCCCCcccccceeeeeccChHHhcc-chhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCc
Confidence 9654322 2222368999999999987 668999999999999999999999999888776665554332100
Q ss_pred --------------CC-----CCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1040 --------------PT-----IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1040 --------------p~-----iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
+. +-..++.++.+|+.+||..||.+|+++.+.+++-.--
T Consensus 228 ~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~ 285 (318)
T KOG0659|consen 228 EMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFK 285 (318)
T ss_pred cccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhh
Confidence 00 1123567789999999999999999999999885543
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=331.20 Aligned_cols=245 Identities=21% Similarity=0.367 Sum_probs=198.0
Q ss_pred EEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEeecCCCCceEE
Q 037285 816 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQDGPGGTLAT 892 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~~d~~~~~L~I 892 (1094)
+.||+|+||.||+|+.+ +..||||++++.... .......+.+|+.++.++ +||||+++++++.... .+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~l 73 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVH-----DDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTS--RLFL 73 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCC--EEEE
Confidence 46999999999999874 577999999864321 123345677899999888 6999999999998765 8999
Q ss_pred EeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccc-c
Q 037285 893 VAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK-R 971 (1094)
Q Consensus 893 VmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~-~ 971 (1094)
||||+.+|+|..++.... .+++..+..++.||+.||+|||+++|+||||||+|||++ .++.+||+|||+++.. .
T Consensus 74 v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~----~~~~~kl~Dfg~~~~~~~ 148 (327)
T cd05617 74 VIEYVNGGDLMFHMQRQR-KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD----ADGHIKLTDYGMCKEGLG 148 (327)
T ss_pred EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEe----CCCCEEEeccccceeccC
Confidence 999999999998886554 589999999999999999999999999999999999998 7788999999998742 2
Q ss_pred CccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC------ChHHHHHhHhhccCCCCCCCc
Q 037285 972 NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANM------HYGAIIGGIVNNTLRPTIPSY 1045 (1094)
Q Consensus 972 ~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~------~~~eile~Iv~~~lrp~iPe~ 1045 (1094)
........+||+.|+|||++. ...++.++|||||||++|+|++|+.||... ...+........ ....+|..
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~p~~ 225 (327)
T cd05617 149 PGDTTSTFCGTPNYIAPEILR--GEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE-KPIRIPRF 225 (327)
T ss_pred CCCceecccCCcccCCHHHHC--CCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh-CCCCCCCC
Confidence 222334467999999999997 456789999999999999999999999642 122222222222 23346778
Q ss_pred CcHHHHHHHHHhccCCCCCCCC------HHHHHHHH
Q 037285 1046 CDAEWRTLMEECWAPNPAARPS------FTEIASRL 1075 (1094)
Q Consensus 1046 ~S~eL~dLI~kCLq~DPeeRPS------~eELLq~L 1075 (1094)
++..+.++|.+||..||.+|++ +.+++++-
T Consensus 226 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~ 261 (327)
T cd05617 226 LSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHT 261 (327)
T ss_pred CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCC
Confidence 8999999999999999999997 56777653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=316.28 Aligned_cols=250 Identities=26% Similarity=0.367 Sum_probs=197.5
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
+|++.+.||.|+||.||+|+.+ +..||||.++..... +.....+.+|+.++++++||||+++++++..+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 72 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE------EGVPSTAIREISLLKELQHPNIVCLQDVLMQES-- 72 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc------CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCC--
Confidence 5888999999999999999874 678999998653211 122346778999999999999999999998754
Q ss_pred ceEEEeeecccchhHHHHhhcc--cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 889 TLATVAEYMVDGSLRHVLVRKD--RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~--~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||+++++|+||||+|||++ .++.+||+|||+
T Consensus 73 ~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~----~~~~~~l~dfg~ 147 (285)
T cd07861 73 RLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLID----NKGVIKLADFGL 147 (285)
T ss_pred eEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEc----CCCcEEECcccc
Confidence 8999999997 68888875432 4689999999999999999999999999999999999998 788999999999
Q ss_pred cccccCc-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhcc--------
Q 037285 967 SKIKRNT-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-------- 1037 (1094)
Q Consensus 967 Srl~~~~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~-------- 1037 (1094)
+...... .......+++.|+|||++.+ ...++.++|||||||++|+|+||+.||................
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (285)
T cd07861 148 ARAFGIPVRVYTHEVVTLWYRAPEVLLG-SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVW 226 (285)
T ss_pred eeecCCCcccccCCcccccccChHHhcC-CCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Confidence 8743322 11222346889999999864 3456889999999999999999999998765433222211100
Q ss_pred -------------------CCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1038 -------------------LRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1038 -------------------lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
........++.++.++|.+||..||.+|||+.+|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 227 PGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0001123468899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=321.13 Aligned_cols=255 Identities=24% Similarity=0.352 Sum_probs=203.9
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||.|+||.||+|+++ +..||+|.+...... .....+.+|+.++++++||||+++++++....
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~ 77 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-------GAPCTAIREVSLLKDLKHANIVTLHDIIHTEK 77 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-------CchhHHHHHHHHHHhcCCCCcceEEEEEecCC
Confidence 468999999999999999999875 678999998754211 11235668999999999999999999998755
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+++||||+. ++|.+++......+++..+..++.||+.||.|||+++|+|+||||+|||++ .++.+||+|||+
T Consensus 78 --~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~----~~~~~kl~dfg~ 150 (301)
T cd07873 78 --SLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLIN----ERGELKLADFGL 150 (301)
T ss_pred --eEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEEC----CCCcEEECcCcc
Confidence 8999999996 689888877666689999999999999999999999999999999999998 778899999999
Q ss_pred cccccCc-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhcc--------
Q 037285 967 SKIKRNT-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-------- 1037 (1094)
Q Consensus 967 Srl~~~~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~-------- 1037 (1094)
+...... .......++..|+|||++.+ ...++.++|||||||++|+|+||+.||...+..+....+....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 229 (301)
T cd07873 151 ARAKSIPTKTYSNEVVTLWYRPPDILLG-STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETW 229 (301)
T ss_pred hhccCCCCCcccccceeecccCcHHHhC-CCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhc
Confidence 8753221 12223456889999999874 3457889999999999999999999998776544333221100
Q ss_pred --------C-C---C--------CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1038 --------L-R---P--------TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1038 --------l-r---p--------~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
+ . + .....++..+++||.+||+.||.+|||+.+++++-+-.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~ 290 (301)
T cd07873 230 PGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH 290 (301)
T ss_pred hhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 0 0 0 01134678899999999999999999999999865543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=350.61 Aligned_cols=255 Identities=29% Similarity=0.473 Sum_probs=225.0
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|..++++|+|+||.+++++.+ +..+++|.+......+ +......+|+.++++++|||||.+.+.|....
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~------~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~- 76 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTE------PERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG- 76 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCc------hhhHHHHHHHHHHHhccCCCeeeeccchhcCC-
Confidence 57889999999999999998776 4679999998764433 22236789999999999999999999998753
Q ss_pred CceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
..++|||+||+||+|.+.+.+.+ ..++++.++.|+.||+.|+.|||++.|+|||||+.|||++ .+..|||+|||+
T Consensus 77 ~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Niflt----k~~~VkLgDfGl 152 (426)
T KOG0589|consen 77 QLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLT----KDKKVKLGDFGL 152 (426)
T ss_pred ceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcc----ccCceeecchhh
Confidence 23999999999999999997765 6789999999999999999999999999999999999999 677889999999
Q ss_pred cccccCcc-ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCc
Q 037285 967 SKIKRNTL-VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSY 1045 (1094)
Q Consensus 967 Srl~~~~~-~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~ 1045 (1094)
|+...... ...+..||+.||.||++. .-.|..|+|||||||++|||++-+.+|...+...++.++....+ .++|..
T Consensus 153 aK~l~~~~~~a~tvvGTp~YmcPEil~--d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~-~Plp~~ 229 (426)
T KOG0589|consen 153 AKILNPEDSLASTVVGTPYYMCPEILS--DIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLY-SPLPSM 229 (426)
T ss_pred hhhcCCchhhhheecCCCcccCHHHhC--CCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccC-CCCCcc
Confidence 99776655 666788999999999999 56788999999999999999999999999999999998877664 567889
Q ss_pred CcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1046 CDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1046 ~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
++.+++.+|+.||..+|..||++.+|+.+.-.+
T Consensus 230 ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 230 YSSELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred ccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 999999999999999999999999999874443
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=322.31 Aligned_cols=258 Identities=32% Similarity=0.588 Sum_probs=211.3
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--Cc----eEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEe
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GT----DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYG 880 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt----~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~G 880 (1094)
+..++|+..+.||+|+||.||+|.+. +. .||+|.+.... ......++.+|+.++++++||||+++++
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~h~niv~~~~ 76 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-------GPKANVEFMDEALIMASMDHPHLVRLLG 76 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-------CHHHHHHHHHHHHHHHhCCCCCcccEEE
Confidence 45678899999999999999999873 43 47888775431 1222346889999999999999999999
Q ss_pred EeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEE
Q 037285 881 VVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICK 960 (1094)
Q Consensus 881 v~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VK 960 (1094)
++... ..++++||+.+|+|.+++......+++..++.++.||+.||.|||+++|+|+||||+|||++ .++.+|
T Consensus 77 ~~~~~---~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~----~~~~~k 149 (303)
T cd05110 77 VCLSP---TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVK----SPNHVK 149 (303)
T ss_pred EEcCC---CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeec----CCCceE
Confidence 98754 46789999999999999987666689999999999999999999999999999999999998 677899
Q ss_pred EEecCCcccccCcc---ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhc
Q 037285 961 VGDFGLSKIKRNTL---VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 1036 (1094)
Q Consensus 961 LsDFGLSrl~~~~~---~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~ 1036 (1094)
|+|||+++...... ......++..|+|||++. ...++.++|||||||++|||++ |..||.......... +...
T Consensus 150 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~-~~~~ 226 (303)
T cd05110 150 ITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH--YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD-LLEK 226 (303)
T ss_pred EccccccccccCcccccccCCCccccccCCHHHhc--cCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHC
Confidence 99999998543211 122234567899999987 4568899999999999999997 999998766544433 3444
Q ss_pred cCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1037 TLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1037 ~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
......+..++..+.++|.+||..+|++||++.+|++.|.++...
T Consensus 227 ~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 227 GERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 455555667889999999999999999999999999999987533
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=351.99 Aligned_cols=248 Identities=29% Similarity=0.459 Sum_probs=215.4
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
..|+..++||+|.||.||+|.+. ++.||||++.... .+..+.++.+|+.+|.+++++||.++|+.+..+.
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~-------~~deIediqqei~~Ls~~~~~~it~yygsyl~g~- 84 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE-------AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT- 84 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhh-------cchhhHHHHHHHHHHHhcCcchHHhhhhheeecc-
Confidence 46777799999999999999885 6779999997643 2334567889999999999999999999999876
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.++++||||.||++.+.|.... .+.+..+..++++++.||.|||.++.+|||||+.|||+. ..+.+||+|||.+
T Consensus 85 -~LwiiMey~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s----~~g~vkl~DfgVa 158 (467)
T KOG0201|consen 85 -KLWIIMEYCGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS----ESGDVKLADFGVA 158 (467)
T ss_pred -cHHHHHHHhcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhhhcceecccccccceeEe----ccCcEEEEeccee
Confidence 8999999999999999997654 358888888999999999999999999999999999999 6789999999999
Q ss_pred ccccCcc-ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcC
Q 037285 968 KIKRNTL-VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYC 1046 (1094)
Q Consensus 968 rl~~~~~-~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~ 1046 (1094)
....... ...+++||+.|||||++. ...|+.|+||||||++++||++|.+||...+...++..+ .+...|.+...+
T Consensus 159 ~ql~~~~~rr~tfvGTPfwMAPEVI~--~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI-pk~~PP~L~~~~ 235 (467)
T KOG0201|consen 159 GQLTNTVKRRKTFVGTPFWMAPEVIK--QSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI-PKSAPPRLDGDF 235 (467)
T ss_pred eeeechhhccccccccccccchhhhc--cccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec-cCCCCCcccccc
Confidence 8654433 336788999999999999 567899999999999999999999999999886655544 444556667789
Q ss_pred cHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1047 DAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1047 S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
++.+++||..||+.||+.||++.+|+++
T Consensus 236 S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 236 SPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 9999999999999999999999999976
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=315.12 Aligned_cols=257 Identities=34% Similarity=0.557 Sum_probs=209.4
Q ss_pred cCCeeEEEEecccCceEEEEeeec------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEe
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVV 882 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~ 882 (1094)
...|++.+.||+|+||.||++++. +..+|||.+..... ......|.+|+.+++++.|+||+++++++
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~~ei~~l~~l~~~~i~~~~~~~ 75 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE-------EQHRSDFEREIEILRTLDHENIVKYKGVC 75 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc-------hHHHHHHHHHHHHHHhCCCCChheEEeee
Confidence 356888899999999999999864 46799999875421 12346788999999999999999999998
Q ss_pred ecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 883 QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 883 ~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
........++||||+++++|.+++......+++..++.++.||+.||+|||+++++|+||||+|||++ .++.+||+
T Consensus 76 ~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~----~~~~~~l~ 151 (284)
T cd05038 76 EKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVE----SEDLVKIS 151 (284)
T ss_pred ecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc----CCCCEEEc
Confidence 77444579999999999999999987665689999999999999999999999999999999999998 67899999
Q ss_pred ecCCcccccCcc----ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH----------
Q 037285 963 DFGLSKIKRNTL----VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA---------- 1028 (1094)
Q Consensus 963 DFGLSrl~~~~~----~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~e---------- 1028 (1094)
|||++....... ......++..|+|||.+. ...++.++||||||+++|||+||+.||.......
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~--~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 229 (284)
T cd05038 152 DFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR--TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQ 229 (284)
T ss_pred ccccccccccCCcceeccCCCCCcccccCcHHHc--cCCCCcccchHHHhhhhheeeccCCCcccccchhcccccccccc
Confidence 999998543211 111223456799999987 4567889999999999999999999986542211
Q ss_pred ----HHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1029 ----IIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1029 ----ile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
..........+...+..++.++.++|.+||+.+|.+||++.+|+++|..+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 230 MIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred ccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 12223334444455667889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=309.51 Aligned_cols=247 Identities=30% Similarity=0.489 Sum_probs=206.6
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||.|+||.||+|+++ +..+++|.+.... ....+.+|+.++++++|+||+++++++....
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~- 71 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----------DLQEIIKEISILKQCDSPYIVKYYGSYFKNT- 71 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----------HHHHHHHHHHHHHhCCCCcEeeeeeeeecCC-
Confidence 57899999999999999999986 5789999986431 1467889999999999999999999998764
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++++||+.+++|.+++......+++..++.++.|++.||.|||+.+++|+||+|+||+++ .++.+||+|||++
T Consensus 72 -~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~----~~~~~~l~dfg~~ 146 (256)
T cd06612 72 -DLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLN----EEGQAKLADFGVS 146 (256)
T ss_pred -cEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEC----CCCcEEEcccccc
Confidence 89999999999999999977667789999999999999999999999999999999999998 6788999999998
Q ss_pred ccccCcc-ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccC-CCCCCCc
Q 037285 968 KIKRNTL-VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL-RPTIPSY 1045 (1094)
Q Consensus 968 rl~~~~~-~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~l-rp~iPe~ 1045 (1094)
....... ......++..|+|||++. ...++.++||||||+++|+|++|+.||...........+..... ....+..
T Consensus 147 ~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (256)
T cd06612 147 GQLTDTMAKRNTVIGTPFWMAPEVIQ--EIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEK 224 (256)
T ss_pred hhcccCccccccccCCccccCHHHHh--cCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhh
Confidence 8543322 223345788999999987 44688999999999999999999999987665544433322111 1123445
Q ss_pred CcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1046 CDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1046 ~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
++..+.++|.+||+.+|.+|||+.+|+++
T Consensus 225 ~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 225 WSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred cCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 77899999999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=331.93 Aligned_cols=243 Identities=27% Similarity=0.384 Sum_probs=197.9
Q ss_pred EEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHH-HHhhCCCCceeEEEeEeecCCCCceEE
Q 037285 816 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAE-ILSKLHHPNVVAFYGVVQDGPGGTLAT 892 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIk-ILkrL~HPNIVqL~Gv~~d~~~~~L~I 892 (1094)
+.||+|+||.||+|+.+ |+.||||++.+.... .......+..|.. +++.++||||+++++++.... .+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~--~~~l 73 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL-----NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTE--KLYF 73 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCC--EEEE
Confidence 46999999999999874 688999999764221 1122234555554 467799999999999998755 8999
Q ss_pred EeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccc-c
Q 037285 893 VAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK-R 971 (1094)
Q Consensus 893 VmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~-~ 971 (1094)
||||+.+|+|..++.... .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.. .
T Consensus 74 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~----~~~~~kL~DfG~~~~~~~ 148 (325)
T cd05604 74 VLDFVNGGELFFHLQRER-SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLD----SQGHVVLTDFGLCKEGIA 148 (325)
T ss_pred EEcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC----CCCCEEEeecCCcccCCC
Confidence 999999999998886544 589999999999999999999999999999999999998 7789999999998743 2
Q ss_pred CccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHH
Q 037285 972 NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWR 1051 (1094)
Q Consensus 972 ~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~ 1051 (1094)
.........||..|+|||++. ...++.++|||||||++|+|++|+.||......+....+..... .++...+..+.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 224 (325)
T cd05604 149 QSDTTTTFCGTPEYLAPEVIR--KQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL--VLRPGASLTAW 224 (325)
T ss_pred CCCCcccccCChhhCCHHHHc--CCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc--cCCCCCCHHHH
Confidence 222233456899999999998 45678899999999999999999999998877777666655432 34456789999
Q ss_pred HHHHHhccCCCCCCCCHH----HHHHH
Q 037285 1052 TLMEECWAPNPAARPSFT----EIASR 1074 (1094)
Q Consensus 1052 dLI~kCLq~DPeeRPS~e----ELLq~ 1074 (1094)
++|.+||..+|.+||++. +++++
T Consensus 225 ~ll~~ll~~~p~~R~~~~~~~~~i~~h 251 (325)
T cd05604 225 SILEELLEKDRQRRLGAKEDFLEIQEH 251 (325)
T ss_pred HHHHHHhccCHHhcCCCCCCHHHHhcC
Confidence 999999999999999774 55543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=319.36 Aligned_cols=254 Identities=32% Similarity=0.538 Sum_probs=203.2
Q ss_pred ccCCeeEEEEecccCceEEEEeeecC------------------ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhh
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWRG------------------TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSK 869 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~rG------------------t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkr 869 (1094)
..++|++.+.||+|+||.||++.+.+ ..||+|++.... .......|.+|+.+|++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-------~~~~~~~~~~E~~~l~~ 75 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-------NKNARNDFLKEIKIMSR 75 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-------CHHHHHHHHHHHHHHHh
Confidence 34679999999999999999986432 248999886431 12234578899999999
Q ss_pred CCCCceeEEEeEeecCCCCceEEEeeecccchhHHHHhhcc----------cccCHHHHHHHHHHHHHHHHHHHHCCcee
Q 037285 870 LHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD----------RFLDRRRRLIIAMDAAFGMEYLHSKNIVH 939 (1094)
Q Consensus 870 L~HPNIVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~----------~~Lse~~~l~Ia~QIaeGLaYLHs~GIIH 939 (1094)
++|+||+++++++.... ..++||||+.+++|.+++.... ..+++..++.++.||+.||+|||+++++|
T Consensus 76 l~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H 153 (296)
T cd05095 76 LKDPNIIRLLAVCITSD--PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVH 153 (296)
T ss_pred CCCCCcceEEEEEecCC--ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 99999999999998755 7999999999999999986542 23677889999999999999999999999
Q ss_pred ccCCCCceEeccCCCCCCcEEEEecCCcccccCcc---ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc
Q 037285 940 FDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTL---VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT 1016 (1094)
Q Consensus 940 RDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~~---~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT 1016 (1094)
+||||+|||++ .++.+||+|||+++...... ......++..|+|||+.. ...++.++|||||||++|||++
T Consensus 154 ~dlkp~Nili~----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~~DiwSlG~~l~el~~ 227 (296)
T cd05095 154 RDLATRNCLVG----KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESIL--LGKFTTASDVWAFGVTLWEILT 227 (296)
T ss_pred ccCChheEEEc----CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHh--cCCccchhhhhHHHHHHHHHHH
Confidence 99999999998 67889999999987432211 122233467899999876 4568899999999999999998
Q ss_pred --CCCCCCCCChHHHHHhHhh------ccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1017 --GEEPYANMHYGAIIGGIVN------NTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1017 --Gk~PF~~~~~~eile~Iv~------~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
|..||......+....... .......+..++..+.+||.+||+.||.+||++.+|++.|.
T Consensus 228 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 228 LCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred hCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 7889987666554433211 11112334568899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=318.37 Aligned_cols=249 Identities=29% Similarity=0.448 Sum_probs=210.6
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||+|+||.||++.+. +..||+|.+...... .......+.+|+++|++++||||+++++++....
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 74 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV-----KLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS- 74 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC-
Confidence 47899999999999999999884 678999998754221 1223466889999999999999999999998765
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++||||+.+++|.+++.... .+++..+..++.||+.||.|||++|++|+||+|+|||++ .++.+||+|||++
T Consensus 75 -~~~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~----~~~~~kl~dfg~~ 148 (290)
T cd05580 75 -NLYLVMEYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLD----SDGYIKITDFGFA 148 (290)
T ss_pred -eEEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC----CCCCEEEeeCCCc
Confidence 8999999999999999997664 589999999999999999999999999999999999998 7788999999999
Q ss_pred ccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCc
Q 037285 968 KIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCD 1047 (1094)
Q Consensus 968 rl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S 1047 (1094)
+..... .....+++.|+|||.+. ....+.++||||||+++|+|++|+.||...........+... ...++...+
T Consensus 149 ~~~~~~--~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~ 222 (290)
T cd05580 149 KRVKGR--TYTLCGTPEYLAPEIIL--SKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--KVRFPSFFS 222 (290)
T ss_pred cccCCC--CCCCCCCccccChhhhc--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CccCCccCC
Confidence 865433 23456889999999987 346788999999999999999999999887766555555433 345677789
Q ss_pred HHHHHHHHHhccCCCCCCC-----CHHHHHHHHH
Q 037285 1048 AEWRTLMEECWAPNPAARP-----SFTEIASRLR 1076 (1094)
Q Consensus 1048 ~eL~dLI~kCLq~DPeeRP-----S~eELLq~L~ 1076 (1094)
..++++|.+||..||.+|+ ++.+++.+-+
T Consensus 223 ~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~ 256 (290)
T cd05580 223 PDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPW 256 (290)
T ss_pred HHHHHHHHHHccCCHHHccCcccCCHHHHHcCcc
Confidence 9999999999999999999 8888886653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=332.75 Aligned_cols=245 Identities=25% Similarity=0.358 Sum_probs=198.7
Q ss_pred ecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC---CCCceeEEEeEeecCCCCceEE
Q 037285 818 LGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL---HHPNVVAFYGVVQDGPGGTLAT 892 (1094)
Q Consensus 818 LGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL---~HPNIVqL~Gv~~d~~~~~L~I 892 (1094)
||+|+||+||+|+++ +..||||++.+.... .+.....+..|..++.++ .||||+++++++.... .+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~--~~~l 73 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIV-----AKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDS--DLYL 73 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHh-----hhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCC--eEEE
Confidence 799999999999874 688999998753221 122234455677777665 6999999999998765 8999
Q ss_pred EeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccc-c
Q 037285 893 VAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK-R 971 (1094)
Q Consensus 893 VmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~-~ 971 (1094)
||||+.+|+|..++.... .+++..+..++.||+.||+|||+++|+||||||+|||++ .++.+||+|||+++.. .
T Consensus 74 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~----~~~~~kl~Dfg~a~~~~~ 148 (330)
T cd05586 74 VTDYMSGGELFWHLQKEG-RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD----ATGHIALCDFGLSKANLT 148 (330)
T ss_pred EEcCCCCChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC----CCCCEEEecCCcCcCCCC
Confidence 999999999999887654 589999999999999999999999999999999999998 7788999999998743 2
Q ss_pred CccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHH
Q 037285 972 NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWR 1051 (1094)
Q Consensus 972 ~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~ 1051 (1094)
.........||..|+|||++.+ ...++.++|||||||++|+|++|+.||......+....+.....+.. ...++.++.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~ 226 (330)
T cd05586 149 DNKTTNTFCGTTEYLAPEVLLD-EKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFP-KNVLSDEGR 226 (330)
T ss_pred CCCCccCccCCccccCHHHHcC-CCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCC-CccCCHHHH
Confidence 2223345679999999999874 33478899999999999999999999998877776666654433321 235789999
Q ss_pred HHHHHhccCCCCCCC----CHHHHHHHHH
Q 037285 1052 TLMEECWAPNPAARP----SFTEIASRLR 1076 (1094)
Q Consensus 1052 dLI~kCLq~DPeeRP----S~eELLq~L~ 1076 (1094)
++|.+||..||.+|| ++.+++++-+
T Consensus 227 ~li~~~L~~~P~~R~~~~~~~~~ll~h~~ 255 (330)
T cd05586 227 QFVKGLLNRNPQHRLGAHRDAVELKEHPF 255 (330)
T ss_pred HHHHHHcCCCHHHCCCCCCCHHHHhcCcc
Confidence 999999999999998 6788877643
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=312.90 Aligned_cols=258 Identities=25% Similarity=0.440 Sum_probs=210.6
Q ss_pred CeeEEEEecccCceEEEEeeecC---ceEEEEEeecCccCCC--chhHHHHHHHHHHHHHHHhh-CCCCceeEEEeEeec
Q 037285 811 DLEEQKELGSGTFGTVYHGKWRG---TDVAIKRIKKSCFTGR--SSEQERLTVEFWKEAEILSK-LHHPNVVAFYGVVQD 884 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~rG---t~VAVKiIkk~~~se~--~~eqe~~~~eFlrEIkILkr-L~HPNIVqL~Gv~~d 884 (1094)
.|++.+.||+|+||.||+|.+++ ..+|+|.+........ .........++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999854 6799998865432111 11223344567789988865 799999999999987
Q ss_pred CCCCceEEEeeecccchhHHHHhh---cccccCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeccCCCCCCcEE
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVR---KDRFLDRRRRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPSRPICK 960 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k---~~~~Lse~~~l~Ia~QIaeGLaYLHs-~GIIHRDLKPeNILLD~~~~e~g~VK 960 (1094)
.. ..++||||+.+++|.+++.. ....+++..++.++.|++.||.|||+ .+++|+||+|+|||++ .++.+|
T Consensus 81 ~~--~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~----~~~~~~ 154 (269)
T cd08528 81 ND--RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLG----EDDKVT 154 (269)
T ss_pred CC--eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEEC----CCCcEE
Confidence 54 89999999999999988743 34468999999999999999999996 7899999999999998 778999
Q ss_pred EEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCC
Q 037285 961 VGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 1040 (1094)
Q Consensus 961 LsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp 1040 (1094)
|+|||++.............++..|+|||++. ...++.++||||||+++|+|++|+.||...........+......+
T Consensus 155 l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~--~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 232 (269)
T cd08528 155 ITDFGLAKQKQPESKLTSVVGTILYSCPEIVK--NEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP 232 (269)
T ss_pred EecccceeecccccccccccCcccCcChhhhc--CCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc
Confidence 99999998654433334456889999999998 4567899999999999999999999998877766666665555444
Q ss_pred CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1041 TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1041 ~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
.....++..+.++|.+||+.||++||++.++..+|.
T Consensus 233 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 233 LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 444467899999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=323.25 Aligned_cols=248 Identities=25% Similarity=0.360 Sum_probs=189.1
Q ss_pred EEEecccCceEEEEeeec----CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCce
Q 037285 815 QKELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTL 890 (1094)
Q Consensus 815 ~kkLGsG~FGtVYKAk~r----Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L 890 (1094)
.++||+|+||+||+|+++ +..||+|.+..... ...+.+|+.+|++++||||+++++++.......+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 75 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----------SMSACREIALLRELKHPNVISLQKVFLSHADRKV 75 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEE
Confidence 468999999999999864 36699998865321 1346689999999999999999999876655679
Q ss_pred EEEeeecccchhHHHHhhc--------ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 891 ATVAEYMVDGSLRHVLVRK--------DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 891 ~IVmEYmegGSL~d~L~k~--------~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
++||||+. ++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++..+...+.+||+
T Consensus 76 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~ 154 (317)
T cd07868 76 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 154 (317)
T ss_pred EEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEe
Confidence 99999985 5787776432 12488899999999999999999999999999999999996444467789999
Q ss_pred ecCCcccccCc----cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH---------HH
Q 037285 963 DFGLSKIKRNT----LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG---------AI 1029 (1094)
Q Consensus 963 DFGLSrl~~~~----~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~---------ei 1029 (1094)
|||+++..... .......+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||...... ..
T Consensus 155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~ 233 (317)
T cd07868 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG-ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 233 (317)
T ss_pred ecCceeccCCCCccccccCCccccccccCCHHHcC-CCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHH
Confidence 99999854322 12234568999999999874 345788999999999999999999999643321 11
Q ss_pred HHhHhhc-----------------------cCCC-------------CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037285 1030 IGGIVNN-----------------------TLRP-------------TIPSYCDAEWRTLMEECWAPNPAARPSFTEIAS 1073 (1094)
Q Consensus 1030 le~Iv~~-----------------------~lrp-------------~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq 1073 (1094)
+..+... .+.. ......+..+.+||.+||+.||.+|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 234 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred HHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1111000 0000 000112456889999999999999999999987
Q ss_pred H
Q 037285 1074 R 1074 (1094)
Q Consensus 1074 ~ 1074 (1094)
+
T Consensus 314 h 314 (317)
T cd07868 314 D 314 (317)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=307.54 Aligned_cols=248 Identities=40% Similarity=0.679 Sum_probs=207.8
Q ss_pred eeEEEEecccCceEEEEeeecC------ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC
Q 037285 812 LEEQKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 812 Yei~kkLGsG~FGtVYKAk~rG------t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~ 885 (1094)
+++.+.||.|+||.||++++.. ..||+|.+..... ......+..|+.++++++|+||+++++++.+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 73 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-------EQQIEEFLREARIMRKLDHPNIVKLLGVCTEE 73 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-------hHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 3567899999999999998864 6799999865421 11345788999999999999999999999876
Q ss_pred CCCceEEEeeecccchhHHHHhhcccc-cCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKDRF-LDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~~~-Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
. ..+++|||+.+++|.+++...... +++..++.++.||+.||+|||+.+++|+||||+||+++ .++.++|+||
T Consensus 74 ~--~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~----~~~~~~l~df 147 (258)
T smart00219 74 E--PLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVG----ENLVVKISDF 147 (258)
T ss_pred C--eeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEc----cCCeEEEccc
Confidence 4 899999999999999999765544 89999999999999999999999999999999999999 7779999999
Q ss_pred CCcccccCccc--cCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCC
Q 037285 965 GLSKIKRNTLV--SGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPT 1041 (1094)
Q Consensus 965 GLSrl~~~~~~--ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~ 1041 (1094)
|+++....... .....++..|+|||.+. ...++.++||||||+++|+|++ |+.||...........+.. .....
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~--~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~ 224 (258)
T smart00219 148 GLSRDLYDDDYYKKKGGKLPIRWMAPESLK--DGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK-GYRLP 224 (258)
T ss_pred CCceecccccccccccCCCcccccChHHhc--cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCC
Confidence 99985433211 11233678999999986 4567899999999999999998 8999988777766665543 44556
Q ss_pred CCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037285 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1042 iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L 1075 (1094)
.+..++.++.+++.+||..+|.+|||+.++++.|
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 6777899999999999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=314.32 Aligned_cols=251 Identities=25% Similarity=0.332 Sum_probs=200.5
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||+|+||.||+|+++ +..||+|++...... ......+.+|+.++++++|+||+++++++....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~- 73 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD------PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKR- 73 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC------ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC-
Confidence 46899999999999999999885 678999998653211 111245678999999999999999999998765
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++||||++++.|..++.... .+++..++.++.||+.||+|||+++++|+||||+||+++ .++.+||+|||++
T Consensus 74 -~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~----~~~~~~l~dfg~~ 147 (286)
T cd07847 74 -KLHLVFEYCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILIT----KQGQIKLCDFGFA 147 (286)
T ss_pred -EEEEEEeccCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEc----CCCcEEECccccc
Confidence 8999999999988888765443 489999999999999999999999999999999999998 7789999999999
Q ss_pred ccccCcc-ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhcc---------
Q 037285 968 KIKRNTL-VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT--------- 1037 (1094)
Q Consensus 968 rl~~~~~-~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~--------- 1037 (1094)
....... ......++..|+|||++.+ ...++.++|||||||++|+|++|+.||......+....+....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07847 148 RILTGPGDDYTDYVATRWYRAPELLVG-DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 226 (286)
T ss_pred eecCCCcccccCcccccccCCHHHHhC-CCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 8543322 2233457889999999864 3457889999999999999999999998776554433221100
Q ss_pred ----------C-CCC---------CCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1038 ----------L-RPT---------IPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1038 ----------l-rp~---------iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
. .+. .-...+..+.+||.+||+.+|++||++.+++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 227 IFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred hcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0 000 012357789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=334.10 Aligned_cols=254 Identities=26% Similarity=0.349 Sum_probs=200.6
Q ss_pred CeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC-
Q 037285 811 DLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG- 887 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~- 887 (1094)
+|++.+.||+|+||.||++.. .++.||||.+..... .......+.+|+.+|+.++|+||+++++++.....
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 74 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ------NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHID 74 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc------chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCcc
Confidence 477889999999999999986 478899998864311 11223567899999999999999999999876421
Q ss_pred --CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecC
Q 037285 888 --GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965 (1094)
Q Consensus 888 --~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFG 965 (1094)
..+++||||+. ++|.+++.... .+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||
T Consensus 75 ~~~~~~lv~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~----~~~~~kL~Dfg 148 (372)
T cd07853 75 PFEEIYVVTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVN----SNCVLKICDFG 148 (372)
T ss_pred ccceEEEEeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEEC----CCCCEEecccc
Confidence 26899999996 57777775543 589999999999999999999999999999999999999 78899999999
Q ss_pred CcccccCc--cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhh--------
Q 037285 966 LSKIKRNT--LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN-------- 1035 (1094)
Q Consensus 966 LSrl~~~~--~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~-------- 1035 (1094)
+++..... .......++..|+|||++.+ ...++.++|||||||++|||++|+.||........+..+..
T Consensus 149 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~ 227 (372)
T cd07853 149 LARVEEPDESKHMTQEVVTQYYRAPEILMG-SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLE 227 (372)
T ss_pred ceeecccCccccCCCCCcCCCcCCHHHHcC-CCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 99854321 12223457899999999875 34578899999999999999999999987765544333221
Q ss_pred ---------------ccCCC-------CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1036 ---------------NTLRP-------TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1036 ---------------~~lrp-------~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
....+ .+....+.++.+||.+||+.||.+|||+.+++++-+-
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~ 291 (372)
T cd07853 228 AMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYL 291 (372)
T ss_pred HHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhh
Confidence 01111 1223457889999999999999999999999988654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=307.23 Aligned_cols=245 Identities=37% Similarity=0.653 Sum_probs=204.6
Q ss_pred EEecccCceEEEEeeec-CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEEEe
Q 037285 816 KELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVA 894 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~r-Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~IVm 894 (1094)
++||.|+||.||++.+. +..||+|.+..... ......+.+|+.++++++|+||+++++++.... ..++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~v~ 71 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP-------PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQ--PIYIVM 71 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCC-------HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCC--CeEEEE
Confidence 36999999999999876 78899998875421 123457889999999999999999999998765 899999
Q ss_pred eecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccCcc
Q 037285 895 EYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTL 974 (1094)
Q Consensus 895 EYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~~ 974 (1094)
||+.+++|.+++......+++..++.++.+++.+|.|||+++++||||||+|||++ .++.+||+|||++.......
T Consensus 72 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~----~~~~~~l~d~g~~~~~~~~~ 147 (251)
T cd05041 72 ELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVG----ENNVLKISDFGMSREEEGGI 147 (251)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEc----CCCcEEEeeccccccccCCc
Confidence 99999999999977655689999999999999999999999999999999999998 77899999999987543211
Q ss_pred cc---CCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHH
Q 037285 975 VS---GGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEW 1050 (1094)
Q Consensus 975 ~s---s~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL 1050 (1094)
.. ....++..|+|||.+. ...++.++|||||||++|+|+| |..||...........+ ........+..++..+
T Consensus 148 ~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 224 (251)
T cd05041 148 YTVSDGLKQIPIKWTAPEALN--YGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI-ESGYRMPAPQLCPEEI 224 (251)
T ss_pred ceeccccCcceeccCChHhhc--cCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH-hcCCCCCCCccCCHHH
Confidence 11 1122356799999987 3467899999999999999999 89999887765555444 3344555677889999
Q ss_pred HHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1051 RTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1051 ~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
.++|.+||..+|.+||++.+|++.|+
T Consensus 225 ~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 225 YRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHhccChhhCcCHHHHHHHhh
Confidence 99999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.59 Aligned_cols=247 Identities=26% Similarity=0.510 Sum_probs=194.3
Q ss_pred EEecccCceEEEEeeec-C---ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceE
Q 037285 816 KELGSGTFGTVYHGKWR-G---TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLA 891 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~r-G---t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~ 891 (1094)
++||+|+||.||+|... + ..+|+|.+.... .......|.+|+.+++.++|+||+++++.+.... .++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~--~~~ 71 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-------TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI--PYL 71 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-------ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCC--ceE
Confidence 36999999999999753 2 357888765321 1223356889999999999999999999998754 899
Q ss_pred EEeeecccchhHHHHhhcc----cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 892 TVAEYMVDGSLRHVLVRKD----RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 892 IVmEYmegGSL~d~L~k~~----~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
+||||+.+|+|.+++.... ...++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 72 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~----~~~~~kl~dfg~~ 147 (269)
T cd05042 72 LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLT----ADLSVKIGDYGLA 147 (269)
T ss_pred EEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEec----CCCcEEEeccccc
Confidence 9999999999999997643 2246778889999999999999999999999999999999 7789999999998
Q ss_pred ccccCc---cccCCccCCCcccCccccccC-----CCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccC
Q 037285 968 KIKRNT---LVSGGVRGTLPWMAPELLSGS-----SSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 1038 (1094)
Q Consensus 968 rl~~~~---~~ss~~~GT~~YmAPEvL~g~-----~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~l 1038 (1094)
...... .......++..|+|||++... ...++.++|||||||++|||++ |..||......+..........
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 227 (269)
T cd05042 148 LEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQD 227 (269)
T ss_pred cccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccC
Confidence 743211 112233456789999997521 2356889999999999999999 8899988776665555433322
Q ss_pred ----CCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1039 ----RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1039 ----rp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
.+..+..++..+.+++..|| .||++|||+.+|++.|.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 228 IKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred ccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 22344567889999999999 59999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=312.75 Aligned_cols=247 Identities=28% Similarity=0.497 Sum_probs=192.9
Q ss_pred EEecccCceEEEEeeecC----ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceE
Q 037285 816 KELGSGTFGTVYHGKWRG----TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLA 891 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~rG----t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~ 891 (1094)
+.||+|+||.||+|++.+ ..+|+|.++.... ......+.+|+.++++++||||+++++++.+.. .++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~ 71 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-------VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVT--PYL 71 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-------hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC--CcE
Confidence 368999999999998642 4589998765321 112246888999999999999999999998754 789
Q ss_pred EEeeecccchhHHHHhhcc----cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 892 TVAEYMVDGSLRHVLVRKD----RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 892 IVmEYmegGSL~d~L~k~~----~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
+||||+++|+|.+++.... ...++..+..++.|++.||+|||+++++|+||||+||+++ ..+.+||+|||++
T Consensus 72 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~----~~~~~kL~dfg~~ 147 (269)
T cd05087 72 LVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLT----ADLTVKIGDYGLS 147 (269)
T ss_pred EEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc----CCCcEEECCcccc
Confidence 9999999999999986532 2356777888999999999999999999999999999998 6788999999998
Q ss_pred ccccCc---cccCCccCCCcccCccccccCC-----CCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhc-c
Q 037285 968 KIKRNT---LVSGGVRGTLPWMAPELLSGSS-----SKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN-T 1037 (1094)
Q Consensus 968 rl~~~~---~~ss~~~GT~~YmAPEvL~g~~-----~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~-~ 1037 (1094)
+..... .......++..|+|||++.+.. ..++.++||||||+++|||++ |+.||......+........ .
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 227 (269)
T cd05087 148 HNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ 227 (269)
T ss_pred ccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhccc
Confidence 743221 1122345778899999986321 135789999999999999996 99999877665544332222 1
Q ss_pred CC---CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1038 LR---PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1038 lr---p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
.. +.....++..+.++|.+|| .+|++|||+.+|+..|.
T Consensus 228 ~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 228 LKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11 2223356788999999999 58999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=313.98 Aligned_cols=251 Identities=25% Similarity=0.370 Sum_probs=202.2
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||+|+||.||+|++. +..||+|.++.... .....+.+|+.+++.++||||+++++++....
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~ 79 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--------EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD 79 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--------hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Confidence 458889999999999999999874 67899999875321 11245678999999999999999999998755
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+++||||+++++|.+++...+ .+++..++.++.|++.||.|||++|++|+||||+||+++ .++.+||+|||+
T Consensus 80 --~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~----~~~~~~l~dfg~ 152 (267)
T cd06645 80 --KLWICMEFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLT----DNGHVKLADFGV 152 (267)
T ss_pred --EEEEEEeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEECccee
Confidence 8999999999999999987654 589999999999999999999999999999999999998 678899999999
Q ss_pred cccccCc-cccCCccCCCcccCcccccc-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCC-C-
Q 037285 967 SKIKRNT-LVSGGVRGTLPWMAPELLSG-SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT-I- 1042 (1094)
Q Consensus 967 Srl~~~~-~~ss~~~GT~~YmAPEvL~g-~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~-i- 1042 (1094)
+...... .......|+..|+|||++.. ....++.++|||||||++|+|++|+.||..................+. .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 232 (267)
T cd06645 153 SAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLK 232 (267)
T ss_pred eeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCccc
Confidence 8743322 22234468999999999742 134578899999999999999999999876554433333322222221 1
Q ss_pred -CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1043 -PSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1043 -Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
...++..+.++|.+||..+|++||++.+|+++
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 233 DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 12467889999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=311.26 Aligned_cols=258 Identities=30% Similarity=0.489 Sum_probs=207.0
Q ss_pred CeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCC--CchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTG--RSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se--~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
+|.+.+.||.|+||.||+|.. .+..+|||.++...... .........+.+.+|+.++++++|+||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477889999999999999976 46789999886432211 11122334567888999999999999999999988754
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+++||||+.+++|.+++.... .+++..+..++.||+.||.|||+++++|+||+|+||+++ .++.++|+|||+
T Consensus 82 --~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~----~~~~~~l~d~~~ 154 (272)
T cd06629 82 --YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVD----ADGICKISDFGI 154 (272)
T ss_pred --ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEc----CCCeEEEeeccc
Confidence 8999999999999999997664 589999999999999999999999999999999999998 788999999999
Q ss_pred cccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCC
Q 037285 967 SKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIP 1043 (1094)
Q Consensus 967 Srl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iP 1043 (1094)
++..... .......++..|+|||++......++.++||||||+++|+|++|..||......+....+........++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIP 234 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCC
Confidence 8753321 1122345788999999987433457889999999999999999999998766554444433333333333
Q ss_pred ----CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037285 1044 ----SYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1044 ----e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L 1075 (1094)
..++..+.++|.+||..+|.+||++.+|+++.
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 270 (272)
T cd06629 235 PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHP 270 (272)
T ss_pred ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCC
Confidence 34588999999999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=314.21 Aligned_cols=256 Identities=27% Similarity=0.436 Sum_probs=202.8
Q ss_pred ccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEeec
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQD 884 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~~d 884 (1094)
..++|++.+.||+|+||.||+++.. ++.+|+|++.... .....+.+|+.+++++ +||||+++++++..
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---------DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---------chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 3468999999999999999999874 6789999875421 1124567899999999 69999999998753
Q ss_pred C---CCCceEEEeeecccchhHHHHhh---cccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCc
Q 037285 885 G---PGGTLATVAEYMVDGSLRHVLVR---KDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPI 958 (1094)
Q Consensus 885 ~---~~~~L~IVmEYmegGSL~d~L~k---~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~ 958 (1094)
. .+..+++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++|+||||||+||+++ .++.
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~----~~~~ 162 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT----TEGG 162 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEEC----CCCC
Confidence 2 23478999999999999988753 234588899999999999999999999999999999999998 6778
Q ss_pred EEEEecCCcccccCc-cccCCccCCCcccCccccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHh
Q 037285 959 CKVGDFGLSKIKRNT-LVSGGVRGTLPWMAPELLSGS---SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV 1034 (1094)
Q Consensus 959 VKLsDFGLSrl~~~~-~~ss~~~GT~~YmAPEvL~g~---~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv 1034 (1094)
+||+|||+++..... .......++..|+|||++... ...++.++|||||||++|+|++|+.||.............
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~ 242 (286)
T cd06638 163 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP 242 (286)
T ss_pred EEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc
Confidence 999999998754322 222334588999999998521 2347889999999999999999999998776544433322
Q ss_pred hcc-CCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1035 NNT-LRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1035 ~~~-lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
... .....+..++..+.++|.+||+.+|++|||+.+|+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~ 285 (286)
T cd06638 243 RNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285 (286)
T ss_pred ccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence 211 112234557889999999999999999999999998763
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=310.48 Aligned_cols=252 Identities=28% Similarity=0.444 Sum_probs=202.0
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
+++.....||+|+||.||+|+++ +..||+|.+.... ......+.+|+.++++++|+||+++++++....
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~- 78 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--------SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG- 78 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--------HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC-
Confidence 34445568999999999999875 4679999876431 112356889999999999999999999998765
Q ss_pred CceEEEeeecccchhHHHHhhccccc--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecC
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFL--DRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~L--se~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFG 965 (1094)
..++|+||+.+++|.+++......+ ++..+..++.||+.||+|||+++|+||||||+||+++. ..+.+||+|||
T Consensus 79 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~---~~~~~~l~dfg 154 (268)
T cd06624 79 -FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT---YSGVVKISDFG 154 (268)
T ss_pred -EEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC---CCCeEEEecch
Confidence 8999999999999999997654445 78888999999999999999999999999999999972 35689999999
Q ss_pred CcccccC-ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH-HHHhHhhccCCCCCC
Q 037285 966 LSKIKRN-TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA-IIGGIVNNTLRPTIP 1043 (1094)
Q Consensus 966 LSrl~~~-~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~e-ile~Iv~~~lrp~iP 1043 (1094)
++..... ........++..|+|||++......++.++||||||+++|+|++|+.||....... ...........+.++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (268)
T cd06624 155 TSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIP 234 (268)
T ss_pred hheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCC
Confidence 9874322 12222345789999999987544557899999999999999999999997654322 122221223345567
Q ss_pred CcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1044 SYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1044 e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
..++.++.+++.+||+.+|.+|||+.+++.+
T Consensus 235 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 235 ESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred cccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 7889999999999999999999999999876
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=309.60 Aligned_cols=253 Identities=28% Similarity=0.421 Sum_probs=204.3
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEeecC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQDG 885 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~~d~ 885 (1094)
.++|++.+.||+|+||.||+|+++ +..+++|++.... .....+.+|+.+++++ .|+||+++++++...
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 75 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---------DEEEEIKEEYNILRKYSNHPNIATFYGAFIKK 75 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---------hhHHHHHHHHHHHHHhcCCCChheEEEEEEec
Confidence 468999999999999999999985 5679999886531 1235678999999999 699999999998764
Q ss_pred C----CCceEEEeeecccchhHHHHhhc---ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCc
Q 037285 886 P----GGTLATVAEYMVDGSLRHVLVRK---DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPI 958 (1094)
Q Consensus 886 ~----~~~L~IVmEYmegGSL~d~L~k~---~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~ 958 (1094)
. ...+++||||+.+++|.+++... ...+++..++.++.|++.||.|||+++++|+||+|+||+++ .++.
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~----~~~~ 151 (275)
T cd06608 76 NPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT----KNAE 151 (275)
T ss_pred CCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEc----cCCe
Confidence 3 33589999999999999988653 35689999999999999999999999999999999999998 6788
Q ss_pred EEEEecCCcccccCc-cccCCccCCCcccCccccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHh
Q 037285 959 CKVGDFGLSKIKRNT-LVSGGVRGTLPWMAPELLSGS---SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV 1034 (1094)
Q Consensus 959 VKLsDFGLSrl~~~~-~~ss~~~GT~~YmAPEvL~g~---~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv 1034 (1094)
+||+|||++...... .......++..|+|||++... ...++.++|||||||+||+|++|+.||...........+.
T Consensus 152 ~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 231 (275)
T cd06608 152 VKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIP 231 (275)
T ss_pred EEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhh
Confidence 999999998754322 222334588899999997532 2357789999999999999999999998766555554443
Q ss_pred hccCC-CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1035 NNTLR-PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1035 ~~~lr-p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
..... ...+..++.++++||.+||..||.+|||+.+|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 232 RNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred ccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 33221 11223467899999999999999999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=336.89 Aligned_cols=247 Identities=23% Similarity=0.285 Sum_probs=194.9
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
+....|++.+.||+|+||.||++... +..||||.... ..+.+|+.+|++|+||||+++++++..
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------------~~~~~E~~il~~l~HpnIv~~~~~~~~ 154 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------------GGTATEAHILRAINHPSIIQLKGTFTY 154 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------------hhhHHHHHHHHhCCCCCCCCEeEEEEE
Confidence 45578999999999999999999874 67899996432 245689999999999999999999987
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
.. ..++|+|++. ++|..++.... .+++..++.++.||+.||.|||+++|+||||||+|||++ ..+.+||+||
T Consensus 155 ~~--~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~----~~~~vkL~DF 226 (391)
T PHA03212 155 NK--FTCLILPRYK-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN----HPGDVCLGDF 226 (391)
T ss_pred CC--eeEEEEecCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEc----CCCCEEEEeC
Confidence 54 8999999985 78888886554 488999999999999999999999999999999999998 6788999999
Q ss_pred CCcccccC--ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-------hHHHHHhHhh
Q 037285 965 GLSKIKRN--TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH-------YGAIIGGIVN 1035 (1094)
Q Consensus 965 GLSrl~~~--~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~-------~~eile~Iv~ 1035 (1094)
|+++.... ........||+.|+|||++. ...++.++|||||||++|||++|+.||-... ....+..+..
T Consensus 227 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~ 304 (391)
T PHA03212 227 GAACFPVDINANKYYGWAGTIATNAPELLA--RDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIR 304 (391)
T ss_pred CcccccccccccccccccCccCCCChhhhc--CCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHH
Confidence 99974322 11223456999999999997 4568899999999999999999998764321 1111111100
Q ss_pred --------------------------ccCC-C-CCC-----CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1036 --------------------------NTLR-P-TIP-----SYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1036 --------------------------~~lr-p-~iP-----e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
.... + ..+ ..++.++.+||.+||+.||.+|||+.+++++-+-
T Consensus 305 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f 379 (391)
T PHA03212 305 RSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAF 379 (391)
T ss_pred HhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhh
Confidence 0000 0 000 1245678999999999999999999999987664
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=317.80 Aligned_cols=251 Identities=26% Similarity=0.347 Sum_probs=196.8
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
+|++.+.||+|+||.||+|++. |..||+|.++..... +.....+.+|+.++++++|+||+++++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~------~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~-- 72 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD------EGVPSSALREICLLKELKHKNIVRLYDVLHSDK-- 72 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc------ccCccchhHHHHHHHhcCCCCeeeHHHHhccCC--
Confidence 4888999999999999999884 788999998754221 112245678999999999999999999998755
Q ss_pred ceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 889 TLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
.+++|+||+. ++|.+++......+++..++.++.||++||.|||+++|+||||||+||+++ .++.+||+|||+++
T Consensus 73 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~----~~~~~~l~dfg~~~ 147 (284)
T cd07839 73 KLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLIN----KNGELKLADFGLAR 147 (284)
T ss_pred ceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEc----CCCcEEECccchhh
Confidence 8999999996 578887766556689999999999999999999999999999999999998 67889999999987
Q ss_pred cccCc-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCC-CCChHHHHHhHhhc----------
Q 037285 969 IKRNT-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYA-NMHYGAIIGGIVNN---------- 1036 (1094)
Q Consensus 969 l~~~~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~-~~~~~eile~Iv~~---------- 1036 (1094)
..... .......++..|+|||++.+ ...++.++|||||||++|+|+||..||. .....+.+..+...
T Consensus 148 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07839 148 AFGIPVRCYSAEVVTLWYRPPDVLFG-AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWP 226 (284)
T ss_pred ccCCCCCCcCCCccccCCcChHHHhC-CcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhH
Confidence 54322 11223457889999999874 3456889999999999999999888853 33333322221110
Q ss_pred --------cCCC---------CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037285 1037 --------TLRP---------TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1037 --------~lrp---------~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L 1075 (1094)
...+ .....++.++.++|.+||+.||.+|||+.+++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~ 282 (284)
T cd07839 227 GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHP 282 (284)
T ss_pred HhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCC
Confidence 0000 01124678899999999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=307.15 Aligned_cols=249 Identities=24% Similarity=0.438 Sum_probs=208.9
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
+|++.+.||+|+||.||+++.. +..||+|.+...... .....++.+|+.++++++||||+++++++....
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS------PKEREESRKEVAVLSNMKHPNIVQYQESFEENG-- 72 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC------hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCC--
Confidence 5889999999999999998874 678999998753221 122357789999999999999999999998754
Q ss_pred ceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 889 TLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+++++|+||+|+|||++ .++.++|+|||++
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~----~~~~~~l~d~~~~ 148 (256)
T cd08218 73 NLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT----KDGTIKLGDFGIA 148 (256)
T ss_pred eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc----CCCCEEEeeccce
Confidence 8999999999999999987643 3578999999999999999999999999999999999998 6778999999998
Q ss_pred ccccCcc-ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcC
Q 037285 968 KIKRNTL-VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYC 1046 (1094)
Q Consensus 968 rl~~~~~-~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~ 1046 (1094)
....... ......++..|+|||++. ...++.++|||||||++|+|++|+.||......+....+... ..+..+..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 225 (256)
T cd08218 149 RVLNSTVELARTCIGTPYYLSPEICE--NRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG-SYPPVSSHY 225 (256)
T ss_pred eecCcchhhhhhccCCccccCHHHhC--CCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcC-CCCCCcccC
Confidence 7543321 112335788899999987 456788999999999999999999999887777766666443 344566778
Q ss_pred cHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1047 DAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1047 S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
+..+.++|.+||+.+|.+||++.+|+++
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 226 SYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=316.49 Aligned_cols=256 Identities=27% Similarity=0.449 Sum_probs=207.8
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||+|+||.||++++. +..||+|.++... .......+.+|+.++++++|+||+++++++....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 72 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-------DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEG- 72 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-------CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCC-
Confidence 46889999999999999999985 6889999886431 1222357889999999999999999999988754
Q ss_pred CceEEEeeecccchhHHHHhhc--ccccCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 888 GTLATVAEYMVDGSLRHVLVRK--DRFLDRRRRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~--~~~Lse~~~l~Ia~QIaeGLaYLHs-~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
.+++||||+.+++|..++... ...+++..+..++.||+.||.|||+ .+|+|+||||+||+++ .++.+||+||
T Consensus 73 -~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~----~~~~~~l~df 147 (286)
T cd06622 73 -AVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN----GNGQVKLCDF 147 (286)
T ss_pred -eEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC----CCCCEEEeec
Confidence 899999999999999988654 2358999999999999999999997 5999999999999998 6788999999
Q ss_pred CCcccccCccccCCccCCCcccCccccccC----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhH--hhccC
Q 037285 965 GLSKIKRNTLVSGGVRGTLPWMAPELLSGS----SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI--VNNTL 1038 (1094)
Q Consensus 965 GLSrl~~~~~~ss~~~GT~~YmAPEvL~g~----~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~I--v~~~l 1038 (1094)
|++....... .....++..|+|||++.+. ...++.++|||||||++|+|++|+.||...........+ .....
T Consensus 148 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd06622 148 GVSGNLVASL-AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD 226 (286)
T ss_pred CCcccccCCc-cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC
Confidence 9987543222 2234578899999998632 224578999999999999999999999765544433222 12233
Q ss_pred CCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1039 RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1039 rp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
.+.++..++.++.++|.+||..+|.+||++.+++.+-+-..
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~ 267 (286)
T cd06622 227 PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVK 267 (286)
T ss_pred CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhh
Confidence 44566678999999999999999999999999999766443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=308.53 Aligned_cols=243 Identities=29% Similarity=0.473 Sum_probs=191.9
Q ss_pred EEecccCceEEEEeeecCc------------eEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEee
Q 037285 816 KELGSGTFGTVYHGKWRGT------------DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQ 883 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~rGt------------~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~ 883 (1094)
+.||+|+||.||+|.+... .+++|.+.... .....|.+|+.++++++||||+++++++.
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---------RDSLAFFETASLMSQLSHKHLVKLYGVCV 71 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---------hhHHHHHHHHHHHHcCCCcchhheeeEEe
Confidence 3689999999999988643 37777765431 11467889999999999999999999987
Q ss_pred cCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCC---CCCcEE
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP---SRPICK 960 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~---e~g~VK 960 (1094)
. . ..++||||+.+|+|.+++......+++..++.++.||+.||+|||+++|+||||||+|||++..+. ....+|
T Consensus 72 ~-~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~k 148 (259)
T cd05037 72 R-D--ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIK 148 (259)
T ss_pred c-C--CcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEE
Confidence 7 3 578999999999999999876656899999999999999999999999999999999999983220 112799
Q ss_pred EEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCC
Q 037285 961 VGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLR 1039 (1094)
Q Consensus 961 LsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lr 1039 (1094)
|+|||++..... .....++..|+|||++.+....++.++|||||||++|+|++ |..||......+...... ...
T Consensus 149 l~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~- 223 (259)
T cd05037 149 LSDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQH- 223 (259)
T ss_pred eCCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCC-
Confidence 999999885433 22334677899999988533478899999999999999999 688887765433332222 111
Q ss_pred CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1040 PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1040 p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
..+......+.++|.+||..+|.+||++.+|++.|+
T Consensus 224 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 224 -RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 122223478999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=313.03 Aligned_cols=250 Identities=29% Similarity=0.439 Sum_probs=208.6
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||.|+||.||+|++. ++.||+|++..... ......+.+|+.+++.++|+||+++++++.+..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 72 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA-------EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS- 72 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc-------chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECC-
Confidence 36888899999999999999874 67899999865321 122356778999999999999999999998764
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++|+||+.+++|.+++... .+++..++.++.|++.||.|||+.+++|+||+|+||+++ +++.++|+|||++
T Consensus 73 -~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~----~~~~~~l~d~g~~ 145 (274)
T cd06609 73 -KLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLS----EEGDVKLADFGVS 145 (274)
T ss_pred -eEEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC----CCCCEEEcccccc
Confidence 899999999999999998765 589999999999999999999999999999999999999 7889999999999
Q ss_pred ccccCc-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCc-
Q 037285 968 KIKRNT-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSY- 1045 (1094)
Q Consensus 968 rl~~~~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~- 1045 (1094)
+..... .......++..|+|||++.+ ..++.++|||||||++|+|+||+.||...........+. ....+..+..
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 222 (274)
T cd06609 146 GQLTSTMSKRNTFVGTPFWMAPEVIKQ--SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP-KNNPPSLEGNK 222 (274)
T ss_pred eeecccccccccccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhh-hcCCCCCcccc
Confidence 855433 22234457889999999984 458899999999999999999999998776555444433 3334444444
Q ss_pred CcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1046 CDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1046 ~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
++..+.+++.+||..+|++||++.+++++-+-
T Consensus 223 ~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~ 254 (274)
T cd06609 223 FSKPFKDFVSLCLNKDPKERPSAKELLKHKFI 254 (274)
T ss_pred cCHHHHHHHHHHhhCChhhCcCHHHHhhChhh
Confidence 78899999999999999999999999987544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=322.66 Aligned_cols=258 Identities=27% Similarity=0.408 Sum_probs=226.2
Q ss_pred eeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEee
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQ 883 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~ 883 (1094)
.++.++|++++.||+|-||.||.|+.+ +.-||+|++.+..+ ........+.+|+.|-..|+||||+++|++|.
T Consensus 18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi-----~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh 92 (281)
T KOG0580|consen 18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQI-----LKTQVEHQLRREIEIQSHLRHPNILRLYGYFH 92 (281)
T ss_pred ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHH-----HHhcchhhhhheeEeecccCCccHHhhhhhee
Confidence 456679999999999999999999886 35599999987643 23344567889999999999999999999999
Q ss_pred cCCCCceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
+.. .+|+++||..+|+|...|.... ..+++...+.++.|++.||.|+|..+||||||||+|+|++ ..+.+||+
T Consensus 93 d~~--riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg----~~~~lkiA 166 (281)
T KOG0580|consen 93 DSK--RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLG----SAGELKIA 166 (281)
T ss_pred ccc--eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccC----CCCCeecc
Confidence 976 9999999999999999997433 4589999999999999999999999999999999999999 78889999
Q ss_pred ecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCC
Q 037285 963 DFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTI 1042 (1094)
Q Consensus 963 DFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~i 1042 (1094)
|||-+...+ .....+.|||..|++||+.. +...+.++|+|++|++.||++.|.+||......+....+.+- +..+
T Consensus 167 dfGwsV~~p-~~kR~tlcgt~dyl~pEmv~--~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~--~~~~ 241 (281)
T KOG0580|consen 167 DFGWSVHAP-SNKRKTLCGTLDYLPPEMVE--GRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV--DLKF 241 (281)
T ss_pred CCCceeecC-CCCceeeecccccCCHhhcC--CCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc--cccC
Confidence 999987655 33445688999999999998 567789999999999999999999999999988888887654 3457
Q ss_pred CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1043 PSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1043 Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
|..++.+++++|.+|+..+|.+|.+..+++.+-|-..
T Consensus 242 p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 242 PSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred CcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 7899999999999999999999999999999987643
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=314.69 Aligned_cols=247 Identities=28% Similarity=0.406 Sum_probs=198.5
Q ss_pred CCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||+|+||.||+|++ .+..||+|++..... ......+.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 72 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-------VELQKQIMSELEILYKCDSPYIIGFYGAFFVEN- 72 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-------hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC-
Confidence 3678889999999999999987 467799999865311 122356889999999999999999999998865
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
..++||||+++++|..+. .+++..+..++.|++.||.|||+++|+|+||||+|||++ .++.+||+|||++
T Consensus 73 -~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~----~~~~~~l~dfg~~ 142 (279)
T cd06619 73 -RISICTEFMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVN----TRGQVKLCDFGVS 142 (279)
T ss_pred -EEEEEEecCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEEC----CCCCEEEeeCCcc
Confidence 889999999999996553 367888999999999999999999999999999999998 7889999999999
Q ss_pred ccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH-------HHHHhHhhccCCC
Q 037285 968 KIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-------AIIGGIVNNTLRP 1040 (1094)
Q Consensus 968 rl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~-------eile~Iv~~~lrp 1040 (1094)
....... .....+|..|+|||++. ...++.++|||||||++|+|++|+.||...... .....+.......
T Consensus 143 ~~~~~~~-~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (279)
T cd06619 143 TQLVNSI-AKTYVGTNAYMAPERIS--GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV 219 (279)
T ss_pred eeccccc-ccCCCCChhhcCceeec--CCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCC
Confidence 7543322 23356899999999997 456789999999999999999999999653221 1112221111111
Q ss_pred CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1041 TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1041 ~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
......+.++.++|.+||+.+|++||++.+++++.+-
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~ 256 (279)
T cd06619 220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFI 256 (279)
T ss_pred CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccc
Confidence 1223467899999999999999999999999988654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=313.62 Aligned_cols=253 Identities=26% Similarity=0.380 Sum_probs=202.7
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEeecC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQDG 885 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~~d~ 885 (1094)
.+.|++.+.||.|+||.||+|++. +..+|+|++.... ....++..|+.+++++ +|+||+++++++...
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---------DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---------HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 367888999999999999999884 5789999875431 1224577899999998 699999999998642
Q ss_pred ----CCCceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEE
Q 037285 886 ----PGGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICK 960 (1094)
Q Consensus 886 ----~~~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VK 960 (1094)
....++++|||+.+|+|.+++.... ..+++..++.++.||+.||.|||+++|+|+||+|+||+++ .++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~----~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT----ENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEE
Confidence 2347899999999999999986533 4578888999999999999999999999999999999998 678899
Q ss_pred EEecCCcccccCc-cccCCccCCCcccCccccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhc
Q 037285 961 VGDFGLSKIKRNT-LVSGGVRGTLPWMAPELLSGS---SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN 1036 (1094)
Q Consensus 961 LsDFGLSrl~~~~-~~ss~~~GT~~YmAPEvL~g~---~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~ 1036 (1094)
|+|||++...... .......++..|+|||++... ...++.++|||||||++|+|++|+.||...........+...
T Consensus 162 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 241 (282)
T cd06636 162 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 241 (282)
T ss_pred EeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC
Confidence 9999998754321 122345688999999997521 345788999999999999999999999876654444433333
Q ss_pred cCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1037 TLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1037 ~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
.........++..+.+||.+||+.||.+||++.+|+++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 242 PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 22223344678999999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=311.50 Aligned_cols=251 Identities=26% Similarity=0.361 Sum_probs=204.2
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
+|++.+.||.|+||.||+|++. +..||||++...... ......+.+|+.++++++||||+++++++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-- 72 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE------GGIPNQALREIKALQACQHPYVVKLLDVFPHGS-- 72 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc------chhhHHHHHHHHHHHhCCCCCCcceeeEEecCC--
Confidence 5889999999999999999874 678999998764321 123356889999999999999999999998754
Q ss_pred ceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 889 TLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
.+++||||+ +++|.+++......+++..++.++.||+.||+|||+.+++|+||||+||+++ .++.++|+|||++.
T Consensus 73 ~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~----~~~~~~l~dfg~~~ 147 (286)
T cd07832 73 GFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLIS----ADGVLKIADFGLAR 147 (286)
T ss_pred eeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEc----CCCcEEEeeeeecc
Confidence 899999999 9999999977666799999999999999999999999999999999999999 67889999999988
Q ss_pred cccCcc--ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCC------
Q 037285 969 IKRNTL--VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP------ 1040 (1094)
Q Consensus 969 l~~~~~--~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp------ 1040 (1094)
...... ......++..|+|||++.+ ...++.++|||||||++|+|++|..+|...........+......+
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07832 148 LFSEEEPRLYSHQVATRWYRAPELLYG-ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWP 226 (286)
T ss_pred cccCCCCCccccccCcccccCceeeec-cccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHh
Confidence 543322 1233458899999999864 3456889999999999999999998887766544433332210000
Q ss_pred ----------------------CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037285 1041 ----------------------TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1041 ----------------------~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L 1075 (1094)
......+..+.++|.+||..+|.+||++++++.+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~ 283 (286)
T cd07832 227 GLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHP 283 (286)
T ss_pred hccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 01124568899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=311.76 Aligned_cols=248 Identities=35% Similarity=0.594 Sum_probs=199.7
Q ss_pred EecccCceEEEEeeecC--------ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 817 ELGSGTFGTVYHGKWRG--------TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 817 kLGsG~FGtVYKAk~rG--------t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
.||+|+||.||+|++.. ..+|||.+..... ......+.+|+.++++++||||+++++++....
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 72 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-------DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE-- 72 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccc-------hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC--
Confidence 58999999999998742 4589998754311 122356889999999999999999999998754
Q ss_pred ceEEEeeecccchhHHHHhhc------ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCC-CCCCcEEE
Q 037285 889 TLATVAEYMVDGSLRHVLVRK------DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKD-PSRPICKV 961 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~------~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~-~e~g~VKL 961 (1094)
..++||||+++++|.+++... ...+++..++.++.||+.||+|||+.+++|+||||+|||++..+ .....+||
T Consensus 73 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l 152 (269)
T cd05044 73 PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKI 152 (269)
T ss_pred CeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEE
Confidence 799999999999999998653 23478899999999999999999999999999999999998221 11238999
Q ss_pred EecCCcccccCcc---ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhcc
Q 037285 962 GDFGLSKIKRNTL---VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNT 1037 (1094)
Q Consensus 962 sDFGLSrl~~~~~---~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~ 1037 (1094)
+|||+++...... ......++..|+|||++. ...++.++|||||||++|+|+| |+.||......+....+ ...
T Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~-~~~ 229 (269)
T cd05044 153 GDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLL--DGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV-TAG 229 (269)
T ss_pred CCcccccccccccccccCcccCCCccccCHHHHc--cCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHH-hcC
Confidence 9999987432211 112234567899999987 4567899999999999999998 99999887766655544 333
Q ss_pred CCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1038 LRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1038 lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
.....+..++..+.++|.+||..+|.+||++.+|++.|.
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 230 GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 445566778899999999999999999999999999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=308.17 Aligned_cols=254 Identities=29% Similarity=0.414 Sum_probs=211.3
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||+|+||.||+|+.. +..||+|.+...... .........+.+|+.++++++|+||+++++++.+...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDS---QETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCccc---chhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCC
Confidence 57999999999999999999874 678999987542111 1122334678899999999999999999999877655
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
..+++||||+.+++|.+++.... .+++..+..++.||+.||.|||+++++|+||||+||+++ .++.++|+|||++
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~----~~~~~~l~dfg~~ 153 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRD----SAGNVKLGDFGAS 153 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc----CCCCEEECccccc
Confidence 67899999999999999987654 478899999999999999999999999999999999998 6778999999999
Q ss_pred ccccCc----cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCC
Q 037285 968 KIKRNT----LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIP 1043 (1094)
Q Consensus 968 rl~~~~----~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iP 1043 (1094)
+..... .......++..|+|||++. ...++.++|||||||++|+|++|+.||..........++.....++.+|
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p 231 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVIS--GEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLP 231 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhc--CCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCC
Confidence 743221 1112345888999999997 4567889999999999999999999998877666666665555667788
Q ss_pred CcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1044 SYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1044 e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
..++..+.++|.+||. ++..||++.+++.+
T Consensus 232 ~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 232 DGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred cccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 8899999999999999 57999999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=312.08 Aligned_cols=248 Identities=25% Similarity=0.377 Sum_probs=207.0
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
+|++.+.||.|+||.||+|++. +..||+|.+.+.... .......+.+|+.++++++||||+++++++....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 73 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV-----EKGSVRNVLNERRILQELNHPFLVNLWYSFQDEE-- 73 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhc-----chhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCC--
Confidence 5889999999999999999885 688999999764321 1234567889999999999999999999987755
Q ss_pred ceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 889 TLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
.+++|+||+.+++|..++... ..+++..++.++.||++||.|||+++++|+||+|+||+++ +++.++|+|||++.
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~----~~~~~~l~d~~~~~ 148 (258)
T cd05578 74 NMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLD----EQGHVHITDFNIAT 148 (258)
T ss_pred eEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEc----CCCCEEEeeccccc
Confidence 899999999999999999766 4589999999999999999999999999999999999998 77899999999988
Q ss_pred cccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh--HHHHHhHhhccCCCCCCCcC
Q 037285 969 IKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY--GAIIGGIVNNTLRPTIPSYC 1046 (1094)
Q Consensus 969 l~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~--~eile~Iv~~~lrp~iPe~~ 1046 (1094)
............++..|+|||++. ...++.++|+||||+++|+|++|+.||..... .......... .....+..+
T Consensus 149 ~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 225 (258)
T cd05578 149 KVTPDTLTTSTSGTPGYMAPEVLC--RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-ADVLYPATW 225 (258)
T ss_pred ccCCCccccccCCChhhcCHHHHc--ccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-ccccCcccC
Confidence 554433334456888999999987 44578999999999999999999999987764 2222222221 445667788
Q ss_pred cHHHHHHHHHhccCCCCCCCCH--HHHHH
Q 037285 1047 DAEWRTLMEECWAPNPAARPSF--TEIAS 1073 (1094)
Q Consensus 1047 S~eL~dLI~kCLq~DPeeRPS~--eELLq 1073 (1094)
+..+.++|.+||..||.+||++ +++++
T Consensus 226 ~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 226 STEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred cHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 9999999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=312.69 Aligned_cols=244 Identities=26% Similarity=0.438 Sum_probs=191.2
Q ss_pred EEecccCceEEEEeeecC--------------ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeE
Q 037285 816 KELGSGTFGTVYHGKWRG--------------TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGV 881 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~rG--------------t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv 881 (1094)
+.||+|+||.||+|++.. ..|++|.+... .......|.+|+.++.+++||||++++++
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--------~~~~~~~~~~~~~~l~~l~hp~iv~~~~~ 72 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--------HRDISLAFFETASMMRQVSHKHIVLLYGV 72 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--------hhhHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 368999999999998531 24788876542 12334578889999999999999999999
Q ss_pred eecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCC---CCCc
Q 037285 882 VQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP---SRPI 958 (1094)
Q Consensus 882 ~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~---e~g~ 958 (1094)
+.... ..++||||+.+++|..++......+++..++.++.||+.||+|||+++|+||||||+|||++..+. ....
T Consensus 73 ~~~~~--~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~ 150 (262)
T cd05077 73 CVRDV--ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPF 150 (262)
T ss_pred EecCC--CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCce
Confidence 98754 788999999999999998776667899999999999999999999999999999999999973221 1224
Q ss_pred EEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHH-cCCCCCCCCChHHHHHhHhhcc
Q 037285 959 CKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEIL-TGEEPYANMHYGAIIGGIVNNT 1037 (1094)
Q Consensus 959 VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELL-TGk~PF~~~~~~eile~Iv~~~ 1037 (1094)
+|++|||++...... ....++..|+|||++.. ...++.++|||||||++|+|+ +|..||......+... .....
T Consensus 151 ~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~ 225 (262)
T cd05077 151 IKLSDPGIPITVLSR---QECVERIPWIAPECVED-SKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQ 225 (262)
T ss_pred eEeCCCCCCccccCc---ccccccccccChhhhcC-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcC
Confidence 899999998743221 22347888999998863 356788999999999999998 5899987665443322 22222
Q ss_pred CCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1038 LRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1038 lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
.. .....+.++.+||.+||+.||.+||++.+|++.|+
T Consensus 226 ~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 226 CM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred cc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 21 22234578999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=364.82 Aligned_cols=263 Identities=22% Similarity=0.315 Sum_probs=211.2
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
....+|+++++||+|+||+||++++. +..||+|++...... ......|..|+.+|++|+|||||+++++|..
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~------e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d 83 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK------EREKSQLVIEVNVMRELKHKNIVRYIDRFLN 83 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC------HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence 44568999999999999999999885 467999998754322 2234578899999999999999999999876
Q ss_pred CCCCceEEEeeecccchhHHHHhhc---ccccCHHHHHHHHHHHHHHHHHHHHC-------CceeccCCCCceEeccCC-
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRK---DRFLDRRRRLIIAMDAAFGMEYLHSK-------NIVHFDLKCDNLLVNLKD- 953 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~---~~~Lse~~~l~Ia~QIaeGLaYLHs~-------GIIHRDLKPeNILLD~~~- 953 (1094)
.....+||||||+.+++|.++|... ...+++..++.|+.||+.||.|||+. +||||||||+||||+...
T Consensus 84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 5556899999999999999998653 24689999999999999999999984 499999999999996311
Q ss_pred ------------CCCCcEEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 037285 954 ------------PSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1021 (1094)
Q Consensus 954 ------------~e~g~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF 1021 (1094)
.....+||+|||++.............||+.|+|||++.+....++.++||||||||||+|+||+.||
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred ccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 12346999999999865443334455799999999998754556889999999999999999999999
Q ss_pred CCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1022 ANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1022 ~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
........+...+....... ...++.++.+||.+||..+|.+||++.+++.+-+
T Consensus 244 ~~~~~~~qli~~lk~~p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ 297 (1021)
T PTZ00266 244 HKANNFSQLISELKRGPDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLGYQI 297 (1021)
T ss_pred CcCCcHHHHHHHHhcCCCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHH
Confidence 87655444433333332222 2346889999999999999999999999996533
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=319.07 Aligned_cols=248 Identities=25% Similarity=0.365 Sum_probs=188.0
Q ss_pred EEEecccCceEEEEeeec----CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCce
Q 037285 815 QKELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTL 890 (1094)
Q Consensus 815 ~kkLGsG~FGtVYKAk~r----Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L 890 (1094)
..+||+|+||.||+|+.+ +..||+|.+..... ...+.+|+.+|++++||||+++++++.......+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 75 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----------SMSACREIALLRELKHPNVIALQKVFLSHSDRKV 75 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeE
Confidence 468999999999999864 35699998865321 1346789999999999999999999876555689
Q ss_pred EEEeeecccchhHHHHhhc--------ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 891 ATVAEYMVDGSLRHVLVRK--------DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 891 ~IVmEYmegGSL~d~L~k~--------~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
++||||+. ++|.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||+...+..++.+||+
T Consensus 76 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~ 154 (317)
T cd07867 76 WLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 154 (317)
T ss_pred EEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEe
Confidence 99999986 5777776421 12478889999999999999999999999999999999996444467899999
Q ss_pred ecCCcccccCcc----ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH---------HH
Q 037285 963 DFGLSKIKRNTL----VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG---------AI 1029 (1094)
Q Consensus 963 DFGLSrl~~~~~----~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~---------ei 1029 (1094)
|||+++...... ......+|..|+|||++.+ ...++.++|||||||++|||+||+.||...... ..
T Consensus 155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~ 233 (317)
T cd07867 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG-ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQ 233 (317)
T ss_pred eccceeccCCCcccccccCcceecccccCcHHhcC-CCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHH
Confidence 999998543221 1233468899999999874 345789999999999999999999999753221 00
Q ss_pred HHhHhhc-----------------------cC-C------------CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037285 1030 IGGIVNN-----------------------TL-R------------PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIAS 1073 (1094)
Q Consensus 1030 le~Iv~~-----------------------~l-r------------p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq 1073 (1094)
...+... .. . .......+..+.+||.+||..||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 234 LDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred HHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 0000000 00 0 0001123456889999999999999999999987
Q ss_pred H
Q 037285 1074 R 1074 (1094)
Q Consensus 1074 ~ 1074 (1094)
+
T Consensus 314 h 314 (317)
T cd07867 314 D 314 (317)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=308.22 Aligned_cols=245 Identities=28% Similarity=0.448 Sum_probs=206.7
Q ss_pred ecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEEEee
Q 037285 818 LGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAE 895 (1094)
Q Consensus 818 LGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~IVmE 895 (1094)
||.|+||.||+++.+ +..||+|++.+.... .......+.+|+.++++++||||+++++++.+.. .+++|||
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e 73 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIV-----ETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKK--YIYMLME 73 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcch-----hhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCC--ccEEEEe
Confidence 699999999999986 788999999764321 1223467889999999999999999999988765 8999999
Q ss_pred ecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccCccc
Q 037285 896 YMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLV 975 (1094)
Q Consensus 896 YmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~~~ 975 (1094)
|+.+++|.+++.+.. .+++..+..++.||+.||+|||+++++|+||+|+||+++ .++.+||+|||++........
T Consensus 74 ~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~----~~~~~~l~df~~~~~~~~~~~ 148 (262)
T cd05572 74 YCLGGELWTILRDRG-LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLD----SNGYVKLVDFGFAKKLKSGQK 148 (262)
T ss_pred cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEc----CCCCEEEeeCCcccccCcccc
Confidence 999999999997654 489999999999999999999999999999999999998 678899999999986544323
Q ss_pred cCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--hHHHHHhHhhccCCCCCCCcCcHHHHHH
Q 037285 976 SGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH--YGAIIGGIVNNTLRPTIPSYCDAEWRTL 1053 (1094)
Q Consensus 976 ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~--~~eile~Iv~~~lrp~iPe~~S~eL~dL 1053 (1094)
.....++..|+|||.+. ...++.++|+||||+++|+|++|..||.... .......+........++..++.++.++
T Consensus 149 ~~~~~~~~~~~~PE~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (262)
T cd05572 149 TWTFCGTPEYVAPEIIL--NKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDL 226 (262)
T ss_pred cccccCCcCccChhHhc--CCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHH
Confidence 33346788999999987 4567889999999999999999999998776 5555555554455566777779999999
Q ss_pred HHHhccCCCCCCCC-----HHHHHHHHH
Q 037285 1054 MEECWAPNPAARPS-----FTEIASRLR 1076 (1094)
Q Consensus 1054 I~kCLq~DPeeRPS-----~eELLq~L~ 1076 (1094)
|.+||..+|.+||+ +.+++++-+
T Consensus 227 i~~~l~~~p~~R~~~~~~~~~~l~~~~~ 254 (262)
T cd05572 227 IKQLLRRNPEERLGNLKGGIKDIKKHKW 254 (262)
T ss_pred HHHHccCChhhCcCCcccCHHHHhcChh
Confidence 99999999999999 888888654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=331.28 Aligned_cols=258 Identities=27% Similarity=0.347 Sum_probs=215.5
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
-++|+.+..|++|+||.||+|+++ ++-||+|+++... +.+-+....++||.+|.+++|||||.+-.++.-..
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek------ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~ 148 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK------EKEGFPITSLREINILLKARHPNIVEVKEVVVGSN 148 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc------ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence 368999999999999999999985 5679999998652 23344566789999999999999999999988766
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
-..+|||||||+ -+|..++.+..+.+...++.-+..|+++|++|||.+.|+|||||++|+|++ ..|.+||+|||+
T Consensus 149 ~d~iy~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~----~~G~lKiaDFGL 223 (419)
T KOG0663|consen 149 MDKIYIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLS----HKGILKIADFGL 223 (419)
T ss_pred cceeeeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeec----cCCcEEecccch
Confidence 668999999995 678888888877899999999999999999999999999999999999999 788999999999
Q ss_pred cccccCcc-ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhc---------
Q 037285 967 SKIKRNTL-VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN--------- 1036 (1094)
Q Consensus 967 Srl~~~~~-~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~--------- 1036 (1094)
|+...... .....+-|.+|.|||.+.| ...|++..|+||+||||.||+++++.|.+......+..+...
T Consensus 224 AR~ygsp~k~~T~lVVTLWYRaPELLLG-~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iw 302 (419)
T KOG0663|consen 224 AREYGSPLKPYTPLVVTLWYRAPELLLG-AKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIW 302 (419)
T ss_pred hhhhcCCcccCcceEEEeeecCHHHhcC-CcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccC
Confidence 99765542 2334567999999999997 567899999999999999999999999988776665554331
Q ss_pred --------------------cCCCCCCCc-CcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1037 --------------------TLRPTIPSY-CDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1037 --------------------~lrp~iPe~-~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
.++..++.. ++..-.+|+..+|..||.+|.|+.+.+++=+-.
T Consensus 303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~ 365 (419)
T KOG0663|consen 303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFR 365 (419)
T ss_pred CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccc
Confidence 001111111 457788999999999999999999999875543
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=314.69 Aligned_cols=242 Identities=27% Similarity=0.454 Sum_probs=192.8
Q ss_pred EecccCceEEEEeeec--------------------------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC
Q 037285 817 ELGSGTFGTVYHGKWR--------------------------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL 870 (1094)
Q Consensus 817 kLGsG~FGtVYKAk~r--------------------------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL 870 (1094)
.||+|+||.||+|.+. ...||+|++... .......|.+|+.+++++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--------~~~~~~~~~~~~~~~~~l 73 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--------HRDIALAFFETASLMSQV 73 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--------HHHHHHHHHHHHHHHhcC
Confidence 5999999999998752 124888887542 122345788899999999
Q ss_pred CCCceeEEEeEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEec
Q 037285 871 HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVN 950 (1094)
Q Consensus 871 ~HPNIVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD 950 (1094)
+||||+++++++.+.. ..++||||+++|+|..++......+++..++.++.||+.||+|||+++|+||||||+|||++
T Consensus 74 ~h~niv~~~~~~~~~~--~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~ 151 (274)
T cd05076 74 SHIHLAFVHGVCVRGS--ENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLA 151 (274)
T ss_pred CCCCeeeEEEEEEeCC--ceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEe
Confidence 9999999999998765 88999999999999999977666789999999999999999999999999999999999997
Q ss_pred cCC---CCCCcEEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHH-cCCCCCCCCCh
Q 037285 951 LKD---PSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEIL-TGEEPYANMHY 1026 (1094)
Q Consensus 951 ~~~---~e~g~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELL-TGk~PF~~~~~ 1026 (1094)
..+ .....+||+|||++...... ....++..|+|||.+.+ ...++.++|||||||++|||+ +|+.||.....
T Consensus 152 ~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~-~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 152 RLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPG-GNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred ccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcC-CCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 322 12345899999987643221 12346788999999874 356789999999999999995 69999987665
Q ss_pred HHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037285 1027 GAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1027 ~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L 1075 (1094)
.+... ..... ...+...+..+.++|.+||+.+|++|||+.+|++.|
T Consensus 228 ~~~~~-~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 228 SEKER-FYEKK--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHH-HHHhc--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 44322 22222 234445567899999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=318.66 Aligned_cols=253 Identities=27% Similarity=0.416 Sum_probs=203.3
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||+|+||.||++++. +..+|+|.+.... .......+.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 72 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-------KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG- 72 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-
Confidence 36899999999999999999885 5678999876431 1223456889999999999999999999998755
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs-~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+ .+++|+||||+|||++ .++.+||+|||+
T Consensus 73 -~~~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~----~~~~~~l~dfg~ 146 (308)
T cd06615 73 -EISICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLCDFGV 146 (308)
T ss_pred -EEEEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEe----cCCcEEEccCCC
Confidence 899999999999999999765 458999999999999999999997 5899999999999998 678899999999
Q ss_pred cccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhh-----------
Q 037285 967 SKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN----------- 1035 (1094)
Q Consensus 967 Srl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~----------- 1035 (1094)
+....... .....++..|+|||++. ...++.++|||||||++|+|++|+.||..............
T Consensus 147 ~~~~~~~~-~~~~~~~~~~~aPE~~~--~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (308)
T cd06615 147 SGQLIDSM-ANSFVGTRSYMSPERLQ--GTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESH 223 (308)
T ss_pred cccccccc-cccCCCCcCccChhHhc--CCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCc
Confidence 87543222 23456889999999987 34578899999999999999999999965443222111100
Q ss_pred ------------------------ccCCCCCC-CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1036 ------------------------NTLRPTIP-SYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1036 ------------------------~~lrp~iP-e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
....+..+ ..++.++++||.+||..+|++||++.+|+++.+-..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 224 RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred ccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 00111122 136778999999999999999999999999987654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=323.31 Aligned_cols=252 Identities=20% Similarity=0.333 Sum_probs=195.4
Q ss_pred EEEEeccc--CceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCc
Q 037285 814 EQKELGSG--TFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGT 889 (1094)
Q Consensus 814 i~kkLGsG--~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~ 889 (1094)
++++||+| +|++||+++.+ |..||||++..... .......+.+|+.+++.++||||+++++++.... .
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~--~ 73 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC------TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN--E 73 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc------cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC--E
Confidence 45789999 78999999875 67899999875421 1223345667999999999999999999998865 8
Q ss_pred eEEEeeecccchhHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 890 LATVAEYMVDGSLRHVLVRK-DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 890 L~IVmEYmegGSL~d~L~k~-~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
+++||||+++|+|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++ .++.++++||+.+.
T Consensus 74 ~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~----~~~~~~l~~~~~~~ 149 (327)
T cd08227 74 LWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS----VDGKVYLSGLRSNL 149 (327)
T ss_pred EEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEe----cCCcEEEcccchhh
Confidence 99999999999999999654 34589999999999999999999999999999999999998 67789999998654
Q ss_pred cccCc--------cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCC-
Q 037285 969 IKRNT--------LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR- 1039 (1094)
Q Consensus 969 l~~~~--------~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lr- 1039 (1094)
..... .......++..|+|||++.+....++.++|||||||++|+|++|+.||..................
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 229 (327)
T cd08227 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 229 (327)
T ss_pred ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccc
Confidence 21110 011123467789999999753356889999999999999999999999876544333222111100
Q ss_pred -------------------------------------------CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1040 -------------------------------------------PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1040 -------------------------------------------p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
......+++.+.+||.+||+.||++|||+.+|+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~ 309 (327)
T cd08227 230 LLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 309 (327)
T ss_pred cccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChh
Confidence 0011234678999999999999999999999998644
Q ss_pred H
Q 037285 1077 V 1077 (1094)
Q Consensus 1077 ~ 1077 (1094)
-
T Consensus 310 f 310 (327)
T cd08227 310 F 310 (327)
T ss_pred h
Confidence 3
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=317.04 Aligned_cols=254 Identities=26% Similarity=0.394 Sum_probs=209.3
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
.+|++.+.||+|+||.||+|... +..||||.+...... .......+..|+.++++++|+||+++++.+....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 74 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-----KRNKVKRVLTEQEILATLDHPFLPTLYASFQTET- 74 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccc-----hHHHHHHHHHHHHHHHhCCCCCchhheeeeecCC-
Confidence 36899999999999999999885 578999999764321 1233457889999999999999999999998755
Q ss_pred CceEEEeeecccchhHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 888 GTLATVAEYMVDGSLRHVLVRK-DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~-~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
..++||||+.+++|.+++... ...+++..++.++.||+.||+|||+++++|+||||+||+++ .++.++|+|||+
T Consensus 75 -~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~~l~dfg~ 149 (316)
T cd05574 75 -YLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLH----ESGHIMLSDFDL 149 (316)
T ss_pred -EEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEc----CCCCEEEeecch
Confidence 899999999999999998754 34689999999999999999999999999999999999998 678899999999
Q ss_pred cccccCcc------------------------------ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc
Q 037285 967 SKIKRNTL------------------------------VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT 1016 (1094)
Q Consensus 967 Srl~~~~~------------------------------~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT 1016 (1094)
+....... ......||..|+|||++. ...++.++||||||+++|+|++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~Di~slG~ll~~l~~ 227 (316)
T cd05574 150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVIS--GDGHGSAVDWWTLGILLYEMLY 227 (316)
T ss_pred hhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHc--CCCCCchHHHHHHHHHHHHHhh
Confidence 86432110 111235788999999997 4567889999999999999999
Q ss_pred CCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCC----HHHHHHHHH
Q 037285 1017 GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPS----FTEIASRLR 1076 (1094)
Q Consensus 1017 Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS----~eELLq~L~ 1076 (1094)
|+.||...........+.............+..++++|.+||..+|++||+ +.+++.+-+
T Consensus 228 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~ 291 (316)
T cd05574 228 GTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF 291 (316)
T ss_pred CCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCch
Confidence 999998887776666655444332223336899999999999999999999 888888643
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=326.72 Aligned_cols=254 Identities=22% Similarity=0.311 Sum_probs=200.4
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||.|+||.||+|... +..||||.+.... ........+.+|+.+|++++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF------QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPAT 87 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh------hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccc
Confidence 468999999999999999999874 5779999986532 11122345778999999999999999999886432
Q ss_pred ----CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 887 ----GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 887 ----~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
...++++++++ +++|.+++.. ..+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+
T Consensus 88 ~~~~~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~----~~~~~kl~ 160 (343)
T cd07878 88 SIENFNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN----EDCELRIL 160 (343)
T ss_pred cccccCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEEC----CCCCEEEc
Confidence 12578999987 7888887753 3489999999999999999999999999999999999998 78899999
Q ss_pred ecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccC----
Q 037285 963 DFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL---- 1038 (1094)
Q Consensus 963 DFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~l---- 1038 (1094)
|||+++..... .....+|..|+|||++.+ ...++.++|||||||++|+|++|+.||........+..+.....
T Consensus 161 Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07878 161 DFGLARQADDE--MTGYVATRWYRAPEIMLN-WMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP 237 (343)
T ss_pred CCccceecCCC--cCCccccccccCchHhcC-CccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99999865432 234568999999999874 34678899999999999999999999987655443333221100
Q ss_pred -----------------CCCC--------CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1039 -----------------RPTI--------PSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1039 -----------------rp~i--------Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
.+.. ...+++.+.+||.+||..||.+|||+.+++.+-+-.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~ 302 (343)
T cd07878 238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFS 302 (343)
T ss_pred HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchh
Confidence 0001 123456788999999999999999999999886554
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=304.52 Aligned_cols=251 Identities=29% Similarity=0.503 Sum_probs=204.5
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
+|++.+.||+|+||.||+|... +..||+|.++..... +.....+..|+.++++++|+||+++++++....
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-- 72 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND------PKTIKEIADEMKVLELLKHPNLVKYYGVEVHRE-- 72 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc------hHHHHHHHHHHHHHHhCCCCChhheeeeEecCC--
Confidence 5888999999999999999874 678999998764211 334577889999999999999999999987754
Q ss_pred ceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 889 TLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
.+++|+||+.+++|.+++.... .+++..+..++.+++.||.|||+++|+|+||+|+||+++ .++.+||+|||++.
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~----~~~~~kl~d~g~~~ 147 (264)
T cd06626 73 KVYIFMEYCSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLD----HNGVIKLGDFGCAV 147 (264)
T ss_pred EEEEEEecCCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEEccccccc
Confidence 8999999999999999997653 478999999999999999999999999999999999999 68899999999987
Q ss_pred cccCccc-----cCCccCCCcccCccccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCC
Q 037285 969 IKRNTLV-----SGGVRGTLPWMAPELLSGSS-SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTI 1042 (1094)
Q Consensus 969 l~~~~~~-----ss~~~GT~~YmAPEvL~g~~-~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~i 1042 (1094)
....... .....++..|+|||++.+.. ..++.++||||||+++|+|++|+.||..................+.+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 227 (264)
T cd06626 148 KLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPI 227 (264)
T ss_pred ccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCC
Confidence 5432211 11245788999999987432 33788999999999999999999999766433222222223344445
Q ss_pred CCcC--cHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1043 PSYC--DAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1043 Pe~~--S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
+... +..+.++|.+||+.+|.+||++.+++.+
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 228 PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred CcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 5444 8899999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=298.34 Aligned_cols=251 Identities=32% Similarity=0.502 Sum_probs=211.0
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
+|+..+.||+|++|.||+|..+ +..|++|++...... ......+.+|+.++++++|+||+++++++......
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS------EEELEALEREIRILSSLQHPNIVRYYGSERDEEKN 74 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc------hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCC
Confidence 4778899999999999999986 778999998764321 23346788999999999999999999999876334
Q ss_pred ceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 889 TLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
.+++|+||+.+++|.+++.... .+++..++.++.|++.||+|||+.+++|+||+|+||+++ .++.+||+|||.+.
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~----~~~~~~l~d~~~~~ 149 (260)
T cd06606 75 TLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVD----SDGVVKLADFGCAK 149 (260)
T ss_pred eEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc----CCCCEEEcccccEE
Confidence 8999999999999999997665 689999999999999999999999999999999999999 67899999999998
Q ss_pred cccCccc---cCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-hHHHHHhHhhccCCCCCCC
Q 037285 969 IKRNTLV---SGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH-YGAIIGGIVNNTLRPTIPS 1044 (1094)
Q Consensus 969 l~~~~~~---ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~-~~eile~Iv~~~lrp~iPe 1044 (1094)
....... .....++..|+|||.+. ...++.++||||||+++|+|++|..||.... .......+........++.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~pE~~~--~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (260)
T cd06606 150 RLGDIETGEGTGSVRGTPYWMAPEVIR--GEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPE 227 (260)
T ss_pred ecccccccccccCCCCCccccCHhhhc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCc
Confidence 6544332 33456889999999987 3457899999999999999999999998776 2333333333344556777
Q ss_pred cCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1045 YCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1045 ~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
.++..+.++|.+||..+|.+||++.+++.+
T Consensus 228 ~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 228 HLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred ccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 889999999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=315.90 Aligned_cols=250 Identities=26% Similarity=0.410 Sum_probs=204.5
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
.+|++.+.||+|+||.||+|+.. +..||+|.+...... ....+.+|+.+++.+.|+||+++++.+....
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--------~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~- 90 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--------KKELIINEILVMRENKNPNIVNYLDSYLVGD- 90 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--------hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC-
Confidence 57999999999999999999864 678999988754211 1246778999999999999999999998755
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
..++||||+.+++|.+++... .+++..++.++.|++.||.|||+.||+||||||+|||++ .++.+||+|||++
T Consensus 91 -~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~----~~~~~kl~dfg~~ 163 (296)
T cd06654 91 -ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG----MDGSVKLTDFGFC 163 (296)
T ss_pred -EEEEeecccCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc----CCCCEEECccccc
Confidence 899999999999999998643 478999999999999999999999999999999999998 6788999999998
Q ss_pred ccccCcc-ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhcc-CCCCCCCc
Q 037285 968 KIKRNTL-VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-LRPTIPSY 1045 (1094)
Q Consensus 968 rl~~~~~-~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~-lrp~iPe~ 1045 (1094)
....... ......+++.|+|||.+. ...++.++|||||||++|+|++|+.||................ .....+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T cd06654 164 AQITPEQSKRSTMVGTPYWMAPEVVT--RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241 (296)
T ss_pred hhccccccccCcccCCccccCHHHHc--CCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccc
Confidence 7433221 122345888999999987 4567889999999999999999999998766543332222222 12234556
Q ss_pred CcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1046 CDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1046 ~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
++..+.++|.+||..+|++||++.+|+++-+-
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~ 273 (296)
T cd06654 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273 (296)
T ss_pred cCHHHHHHHHHHCcCCcccCcCHHHHhhChhh
Confidence 78899999999999999999999999987443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=308.78 Aligned_cols=249 Identities=25% Similarity=0.301 Sum_probs=197.1
Q ss_pred eeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-CCceeEEEeEeecCCCC
Q 037285 812 LEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 812 Yei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-HPNIVqL~Gv~~d~~~~ 888 (1094)
|++.++||+|+||.||+|+.. +..||+|.++...... . .....+|+.++.++. |+||+++++++.+...+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~----~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 73 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL----E---QVNNLREIQALRRLSPHPNILRLIEVLFDRKTG 73 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc----h---hhhHHHHHHHHhhcCCCCCccceEEEEecCCCC
Confidence 678899999999999999874 6789999887542111 1 123457888898885 99999999999886446
Q ss_pred ceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 889 TLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
.+++||||+. ++|.+++......+++..++.++.||+.||+|||+.+++||||+|+||+++ . +.+||+|||+++
T Consensus 74 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~----~-~~~kl~dfg~~~ 147 (282)
T cd07831 74 RLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK----D-DILKLADFGSCR 147 (282)
T ss_pred cEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc----C-CCeEEEeccccc
Confidence 8999999996 578787776555689999999999999999999999999999999999998 5 899999999998
Q ss_pred cccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhcc-----------
Q 037285 969 IKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT----------- 1037 (1094)
Q Consensus 969 l~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~----------- 1037 (1094)
............++..|+|||++.. ...++.++|||||||++|||++|+.||...+..+.+..+....
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07831 148 GIYSKPPYTEYISTRWYRAPECLLT-DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKF 226 (282)
T ss_pred ccccCCCcCCCCCCcccCChhHhhc-CCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence 5543333334457889999998753 3456889999999999999999999998766544333221100
Q ss_pred -----CCCCC-----------CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1038 -----LRPTI-----------PSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1038 -----lrp~i-----------Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
....+ ...++..+.++|.+||..+|++||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00001 12467899999999999999999999999876
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=305.10 Aligned_cols=250 Identities=30% Similarity=0.448 Sum_probs=205.6
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||.|+||+||+|.+. +..+|+|++...... . ....+.+|+.+++.++|+||+++++.+....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 72 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ------T-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGD- 72 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc------h-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCC-
Confidence 47899999999999999999874 577999998653221 1 3457889999999999999999999988755
Q ss_pred CceEEEeeecccchhHHHHhhcc--cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecC
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKD--RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~--~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFG 965 (1094)
..++||||+.+++|.+++.... ..+++..+..++.|++.||+|||++|++|+||+|+||+++ +++.+||+|||
T Consensus 73 -~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~----~~~~~~l~df~ 147 (267)
T cd06610 73 -ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG----EDGSVKIADFG 147 (267)
T ss_pred -EEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc----CCCCEEEcccc
Confidence 8999999999999999997642 4589999999999999999999999999999999999999 67889999999
Q ss_pred CcccccCcc-----ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCC
Q 037285 966 LSKIKRNTL-----VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 1040 (1094)
Q Consensus 966 LSrl~~~~~-----~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp 1040 (1094)
++....... ......++..|+|||++... ..++.++|+|||||++|+|++|+.||................. +
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~ 225 (267)
T cd06610 148 VSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDP-P 225 (267)
T ss_pred hHHHhccCccccccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCC-C
Confidence 987433221 12334588999999998742 3678899999999999999999999988766655555443322 1
Q ss_pred CCC-----CcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1041 TIP-----SYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1041 ~iP-----e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
.++ ..++..+.+++.+||..||++||++.+|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 121 2567889999999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=312.94 Aligned_cols=244 Identities=28% Similarity=0.512 Sum_probs=194.7
Q ss_pred EEecccCceEEEEeeecC---------ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 816 KELGSGTFGTVYHGKWRG---------TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~rG---------t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
+.||.|+||.||+|.++. ..+|+|.+... .......+.+|+.++++++||||+++++++....
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~ 72 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--------HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD 72 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--------hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC
Confidence 368999999999998742 23777776432 1233457888999999999999999999998755
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCC----CCCCcEEEE
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKD----PSRPICKVG 962 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~----~e~g~VKLs 962 (1094)
..++||||+.+|+|..++......+++..++.++.||+.||+|||+++|+||||||+|||++.++ .....++++
T Consensus 73 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~ 150 (258)
T cd05078 73 --ESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLS 150 (258)
T ss_pred --CcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEec
Confidence 78999999999999999987666689999999999999999999999999999999999997322 112348999
Q ss_pred ecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCChHHHHHhHhhccCCCC
Q 037285 963 DFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTG-EEPYANMHYGAIIGGIVNNTLRPT 1041 (1094)
Q Consensus 963 DFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTG-k~PF~~~~~~eile~Iv~~~lrp~ 1041 (1094)
|||++...... ....++..|+|||++.+ ...++.++|||||||++|+|++| ..||.......... .... +..
T Consensus 151 d~g~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~--~~~ 223 (258)
T cd05078 151 DPGISITVLPK---EILLERIPWVPPECIEN-PQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYED--RHQ 223 (258)
T ss_pred ccccccccCCc---hhccccCCccCchhccC-CCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHc--ccc
Confidence 99998744322 23457889999999874 34578899999999999999998 56776655544332 2222 334
Q ss_pred CCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1042 iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
++...+..+.++|.+||+.+|++|||+.+|++.|+
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 224 LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 56667789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=314.94 Aligned_cols=253 Identities=28% Similarity=0.380 Sum_probs=203.8
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||.|+||.||+|+++ ++.+|||.++..... +.....+.+|+.++++++||||+++++++.....
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 78 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK------EGFPITSLREINILLKLQHPNIVTVKEVVVGSNL 78 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc------ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCC
Confidence 57889999999999999999985 678999999754322 2223456789999999999999999999887644
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
..+++||||+. ++|.+++......+++..++.++.||+.||+|||+++++|+||||+|||++ .++.+||+|||++
T Consensus 79 ~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~----~~~~~~l~d~g~~ 153 (293)
T cd07843 79 DKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLN----NRGILKICDFGLA 153 (293)
T ss_pred CcEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC----CCCcEEEeecCce
Confidence 58999999997 589888876655689999999999999999999999999999999999999 7789999999998
Q ss_pred ccccCc-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhc----------
Q 037285 968 KIKRNT-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN---------- 1036 (1094)
Q Consensus 968 rl~~~~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~---------- 1036 (1094)
...... .......++..|+|||.+.+ ...++.++||||||+++|+|++|+.||...........+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (293)
T cd07843 154 REYGSPLKPYTQLVVTLWYRAPELLLG-AKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP 232 (293)
T ss_pred eeccCCccccccccccccccCchhhcC-CccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHH
Confidence 854332 22233457889999999874 334688999999999999999999999876654443332211
Q ss_pred -------------------cCCCCCCCc-CcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1037 -------------------TLRPTIPSY-CDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1037 -------------------~lrp~iPe~-~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
.+...++.. +++.+.++|.+||+.+|++|||+.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred HhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 011122333 57889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=314.71 Aligned_cols=252 Identities=28% Similarity=0.426 Sum_probs=205.1
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||+|+||.||++... +..||||.+..... ........+.+|+.+++.++||||+++++.+....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL-----ILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR- 74 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh-----hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC-
Confidence 36899999999999999999875 57799998875421 11223456788999999999999999999998754
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++||||+.+++|.+++.... .+++..+..++.|++.||+|||+++++||||||+||+++ ..+.+||+|||++
T Consensus 75 -~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~----~~~~~~l~dfg~~ 148 (305)
T cd05609 75 -HLCMVMEYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLIT----SMGHIKLTDFGLS 148 (305)
T ss_pred -EEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEEC----CCCCEEEeeCCCc
Confidence 8999999999999999997654 589999999999999999999999999999999999998 7889999999998
Q ss_pred ccccCc----------------cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 037285 968 KIKRNT----------------LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIG 1031 (1094)
Q Consensus 968 rl~~~~----------------~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile 1031 (1094)
+..... .......++..|+|||.+. ...++.++|||||||++|+|++|+.||.+....+...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~ 226 (305)
T cd05609 149 KIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVIL--RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG 226 (305)
T ss_pred cccCcCccccccccccccchhhccccCCccCccccCchhcc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 631100 0111235788899999987 4567899999999999999999999998877777666
Q ss_pred hHhhccCC-CCCCCcCcHHHHHHHHHhccCCCCCCCC---HHHHHHHH
Q 037285 1032 GIVNNTLR-PTIPSYCDAEWRTLMEECWAPNPAARPS---FTEIASRL 1075 (1094)
Q Consensus 1032 ~Iv~~~lr-p~iPe~~S~eL~dLI~kCLq~DPeeRPS---~eELLq~L 1075 (1094)
........ +.....++.++.++|.+||+.+|++||+ +.+++++-
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 227 QVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred HHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 65544322 2223367899999999999999999998 45555553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=311.55 Aligned_cols=252 Identities=28% Similarity=0.445 Sum_probs=209.1
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
+.|+..+.||.|+||.||+|.+. +..||||.+..... ......+.+|+.+++++.|+||+++++++.+..
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 75 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-------EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT- 75 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-
Confidence 35777889999999999999874 67899999875321 123467889999999999999999999998865
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
..++||||+.+++|.+++... .+++..+..++.|++.||+|||+++++|+||+|+||+++ .++.++|+|||++
T Consensus 76 -~~~lv~e~~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~----~~~~~~l~dfg~~ 148 (277)
T cd06640 76 -KLWIIMEYLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS----EQGDVKLADFGVA 148 (277)
T ss_pred -EEEEEEecCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEc----CCCCEEEcccccc
Confidence 899999999999999998643 488899999999999999999999999999999999998 6788999999998
Q ss_pred ccccCcc-ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcC
Q 037285 968 KIKRNTL-VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYC 1046 (1094)
Q Consensus 968 rl~~~~~-~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~ 1046 (1094)
....... ......++..|+|||++. ...++.++|||||||++|+|+||+.||...........+ .....+..+..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~apE~~~--~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~ 225 (277)
T cd06640 149 GQLTDTQIKRNTFVGTPFWMAPEVIQ--QSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-PKNNPPTLTGEF 225 (277)
T ss_pred eeccCCccccccccCcccccCHhHhc--cCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-hcCCCCCCchhh
Confidence 7543221 222345788899999987 446789999999999999999999999887765554433 333445566678
Q ss_pred cHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1047 DAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1047 S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
+..+.++|.+||+.+|++||++.+++++.+-..
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06640 226 SKPFKEFIDACLNKDPSFRPTAKELLKHKFIVK 258 (277)
T ss_pred hHHHHHHHHHHcccCcccCcCHHHHHhChHhhh
Confidence 889999999999999999999999998865443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=334.62 Aligned_cols=257 Identities=27% Similarity=0.393 Sum_probs=219.1
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeecC--ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEe
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVV 882 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~rG--t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~ 882 (1094)
..+....|++++.||+|.-|+||+++.++ ..+|+|++.+..+.. +....+...|..||+.++||.++.+|..|
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~-----rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f 146 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLAS-----RKKLKRAQTEREILSLLDHPFLPTLYASF 146 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhh-----hhHHHHHHHHHHHHHhcCCCccchhhhee
Confidence 34566789999999999999999999986 569999998876543 33445667799999999999999999999
Q ss_pred ecCCCCceEEEeeecccchhHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEE
Q 037285 883 QDGPGGTLATVAEYMVDGSLRHVLVRK-DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKV 961 (1094)
Q Consensus 883 ~d~~~~~L~IVmEYmegGSL~d~L~k~-~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKL 961 (1094)
+... .+|+|||||.||+|..++.++ ++.+++..+..++.+|+.||+|||-.|||+|||||+||||. ++|+|.|
T Consensus 147 et~~--~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvr----edGHIML 220 (459)
T KOG0610|consen 147 ETDK--YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVR----EDGHIML 220 (459)
T ss_pred eccc--eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEe----cCCcEEe
Confidence 9866 999999999999999988765 46799999999999999999999999999999999999999 8999999
Q ss_pred EecCCcccc-------c---------------------------C-c----------------------cccCCccCCCc
Q 037285 962 GDFGLSKIK-------R---------------------------N-T----------------------LVSGGVRGTLP 984 (1094)
Q Consensus 962 sDFGLSrl~-------~---------------------------~-~----------------------~~ss~~~GT~~ 984 (1094)
+||.|+... . . . ..+..++||-.
T Consensus 221 sDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThE 300 (459)
T KOG0610|consen 221 SDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHE 300 (459)
T ss_pred eeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccc
Confidence 999987410 0 0 0 11234579999
Q ss_pred ccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCC
Q 037285 985 WMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAA 1064 (1094)
Q Consensus 985 YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPee 1064 (1094)
|+|||++.| ..-+.++|+|+|||++|||+.|+.||.+.++.+.+..++.+.+.-.-...++..+++||+++|.+||.+
T Consensus 301 YlAPEvI~G--~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~k 378 (459)
T KOG0610|consen 301 YLAPEVIRG--EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSK 378 (459)
T ss_pred cccceeeec--CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhh
Confidence 999999995 455789999999999999999999999999999999998876653333367789999999999999999
Q ss_pred CCC----HHHHHHH
Q 037285 1065 RPS----FTEIASR 1074 (1094)
Q Consensus 1065 RPS----~eELLq~ 1074 (1094)
|.. +.||.+|
T Consensus 379 Rlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 379 RLGSKRGAAEIKRH 392 (459)
T ss_pred hhccccchHHhhcC
Confidence 987 8888765
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=329.46 Aligned_cols=247 Identities=25% Similarity=0.341 Sum_probs=193.4
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
+....|++.+.||+|+||.||+|++. +..||+|+.... ....|+.++++++|+||+++++++..
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------------~~~~E~~~l~~l~h~~iv~~~~~~~~ 128 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------------TTLIEAMLLQNVNHPSVIRMKDTLVS 128 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------------ccHHHHHHHHhCCCCCCcChhheEEe
Confidence 44567999999999999999999986 457999975432 23468999999999999999999987
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
.. ..++||||+ .++|..++......+++..++.|+.||+.||.|||+++|+||||||+|||++ ..+.+||+||
T Consensus 129 ~~--~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~----~~~~~kl~Df 201 (357)
T PHA03209 129 GA--ITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN----DVDQVCIGDL 201 (357)
T ss_pred CC--eeEEEEEcc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEEecC
Confidence 65 789999999 5688888877666799999999999999999999999999999999999998 7788999999
Q ss_pred CCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCC-CCCCCCChH---------HHHHhHh
Q 037285 965 GLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGE-EPYANMHYG---------AIIGGIV 1034 (1094)
Q Consensus 965 GLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk-~PF~~~~~~---------eile~Iv 1034 (1094)
|+++............||..|+|||++. ...++.++|||||||++|||+++. .+|...... ..+..+.
T Consensus 202 G~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~ 279 (357)
T PHA03209 202 GAAQFPVVAPAFLGLAGTVETNAPEVLA--RDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKII 279 (357)
T ss_pred ccccccccCcccccccccccccCCeecC--CCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHH
Confidence 9998543333334456899999999998 456889999999999999999854 444432111 0111111
Q ss_pred hc-cC-CCCCC------------------------------CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1035 NN-TL-RPTIP------------------------------SYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1035 ~~-~l-rp~iP------------------------------e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
.. +. ...++ ..++.++.+||.+||+.||.+|||+.+++++-+
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~ 353 (357)
T PHA03209 280 STLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPM 353 (357)
T ss_pred HHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCch
Confidence 10 00 00000 134566778999999999999999999998744
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=314.64 Aligned_cols=254 Identities=29% Similarity=0.428 Sum_probs=205.8
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
..|++.+.||+|+||.||+|++. +..||+|.+...... .......+.+|+.+++.++||||+++++++....
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~- 88 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ-----SNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH- 88 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccC-----cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC-
Confidence 45888899999999999999874 688999988643211 1223356889999999999999999999998755
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
..++||||+. |+|.+++......+++..+..++.||+.||.|||+++|+|+||+|+||+++ .++.+||+|||++
T Consensus 89 -~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~----~~~~~kL~dfg~~ 162 (307)
T cd06607 89 -TAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLT----EPGTVKLADFGSA 162 (307)
T ss_pred -eEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEC----CCCCEEEeecCcc
Confidence 7899999996 677777765555689999999999999999999999999999999999998 7789999999998
Q ss_pred ccccCccccCCccCCCcccCcccccc-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcC
Q 037285 968 KIKRNTLVSGGVRGTLPWMAPELLSG-SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYC 1046 (1094)
Q Consensus 968 rl~~~~~~ss~~~GT~~YmAPEvL~g-~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~ 1046 (1094)
...... ....++..|+|||++.+ ....++.++||||||+++|+|+||+.||...........+.........+..+
T Consensus 163 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (307)
T cd06607 163 SLVSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDW 239 (307)
T ss_pred eecCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhh
Confidence 754322 23457889999999742 13457889999999999999999999998877655544443322222223457
Q ss_pred cHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1047 DAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1047 S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
+..+.++|.+||..+|.+||++.+|+.+.+..
T Consensus 240 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 271 (307)
T cd06607 240 SDYFRNFVDSCLQKIPQDRPSSEELLKHRFVL 271 (307)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence 88999999999999999999999999876643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=306.57 Aligned_cols=254 Identities=28% Similarity=0.474 Sum_probs=206.2
Q ss_pred CeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
+|+..+.||+|+||.||+++. .+..||+|.+...... ...+++....+.+|+.++++++|+||+++++++.+..
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 76 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNT--SSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS-- 76 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCC--chhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC--
Confidence 477889999999999999986 4678999998754211 2233445678899999999999999999999998755
Q ss_pred ceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 889 TLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
.+++||||+.+++|.+++.+.. .+++..++.++.||+.||.|||++|++|+||+|+||+++. .+..+||+|||++.
T Consensus 77 ~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~---~~~~~~l~dfg~~~ 152 (268)
T cd06630 77 HFNLFVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDS---TGQRLRIADFGAAA 152 (268)
T ss_pred eEEEEEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC---CCCEEEEccccccc
Confidence 8999999999999999987654 5889999999999999999999999999999999999971 23469999999987
Q ss_pred cccCcc-----ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH---HHHHhHhhccCCC
Q 037285 969 IKRNTL-----VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG---AIIGGIVNNTLRP 1040 (1094)
Q Consensus 969 l~~~~~-----~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~---eile~Iv~~~lrp 1040 (1094)
...... ......++..|+|||.+. ...++.++||||||+++|+|++|..||...... ............+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~--~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 230 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLR--GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAP 230 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhc--cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCC
Confidence 543221 122345788999999987 456788999999999999999999999754432 2222232334455
Q ss_pred CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1041 TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1041 ~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
..+..++.++.+++.+||..+|.+||++.+++++
T Consensus 231 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 231 SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 6677788999999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=296.58 Aligned_cols=247 Identities=31% Similarity=0.523 Sum_probs=206.6
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
+|+..+.||+|+||.||++.++ +..+++|++..... .....+.+|+.++++++|+||+++++++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 70 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--------EKKEKIINEIQILKKCKHPNIVKYYGSYLKKD-- 70 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--------hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC--
Confidence 4788899999999999999985 67899999875421 23457889999999999999999999998764
Q ss_pred ceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 889 TLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
..++++||+.+++|.+++......+++..++.++.|++.+|.|||+++++|+||+|+||+++ .++.++|+|||.+.
T Consensus 71 ~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~----~~~~~~l~d~~~~~ 146 (253)
T cd05122 71 ELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLT----SDGEVKLIDFGLSA 146 (253)
T ss_pred eEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEc----cCCeEEEeeccccc
Confidence 89999999999999999977655689999999999999999999999999999999999998 67899999999988
Q ss_pred cccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCC--cC
Q 037285 969 IKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPS--YC 1046 (1094)
Q Consensus 969 l~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe--~~ 1046 (1094)
............++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.............. ...+..+. .+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 223 (253)
T cd05122 147 QLSDTKARNTMVGTPYWMAPEVING--KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKW 223 (253)
T ss_pred cccccccccceecCCcccCHHHHcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCccccc
Confidence 6544332334568899999999873 4578899999999999999999999988755554444333 22222332 23
Q ss_pred cHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1047 DAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1047 S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
+..+.++|.+||+.||.+|||+.+++++
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 224 SDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 7899999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=313.30 Aligned_cols=251 Identities=28% Similarity=0.438 Sum_probs=206.1
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
+.|+..+.||+|+||.||+|.+. +..||+|.+..... ......+.+|+.++++++||||+++++++....
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 75 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-------EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT- 75 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-------hHHHHHHHHHHHHHHcCCCCccHhhhcccccCC-
Confidence 34667788999999999999874 67899998864311 223457889999999999999999999998755
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
..++||||+.+++|.+++.. ..+++..+..++.||++||.|||+++++|+||+|+||+++ .++.+||+|||++
T Consensus 76 -~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~----~~~~~~l~dfg~~ 148 (277)
T cd06642 76 -KLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS----EQGDVKLADFGVA 148 (277)
T ss_pred -ceEEEEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEe----CCCCEEEcccccc
Confidence 89999999999999998854 3588999999999999999999999999999999999998 6788999999998
Q ss_pred ccccCcc-ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcC
Q 037285 968 KIKRNTL-VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYC 1046 (1094)
Q Consensus 968 rl~~~~~-~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~ 1046 (1094)
....... ......++..|+|||.+. ...++.++|||||||++|+|++|+.||...........+ .....+..+..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~ 225 (277)
T cd06642 149 GQLTDTQIKRNTFVGTPFWMAPEVIK--QSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI-PKNSPPTLEGQY 225 (277)
T ss_pred ccccCcchhhhcccCcccccCHHHhC--cCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh-hcCCCCCCCccc
Confidence 7543221 222345788999999987 446788999999999999999999999876554444333 333344555667
Q ss_pred cHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1047 DAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1047 S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
+..+.++|.+||+.+|++||++.+++++-+-.
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 257 (277)
T cd06642 226 SKPFKEFVEACLNKDPRFRPTAKELLKHKFIT 257 (277)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHhHHHH
Confidence 88999999999999999999999999976543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=339.72 Aligned_cols=253 Identities=26% Similarity=0.414 Sum_probs=225.3
Q ss_pred CeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
=|.+.+-||+|-|.+|-+|++ +|..||||++.+..+. +.....+++|++.|+..+|||||++|.+.....
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD------~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQT-- 90 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD------TLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQT-- 90 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccc------hhhhhHHHHHHHHHHHhcCcCeeeeeehhcccc--
Confidence 467778899999999999875 7999999999886543 233456789999999999999999999998766
Q ss_pred ceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 889 TLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
.+|+|+|.-.+|+|.+|+-+....+.+..+.+++.||+.|+.|+|+..+|||||||+||.+.. .-|.|||+|||++.
T Consensus 91 KlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFE---KlGlVKLTDFGFSN 167 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFE---KLGLVKLTDFGFSN 167 (864)
T ss_pred eEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEee---ecCceEeeeccccc
Confidence 899999999999999999988888999999999999999999999999999999999998872 56899999999998
Q ss_pred cccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCcH
Q 037285 969 IKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDA 1048 (1094)
Q Consensus 969 l~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~ 1048 (1094)
.........+.||+..|.|||++.|..+. .+++||||||||||.|++|+.||...+..+.+..++.-.+ .+|..++.
T Consensus 168 kf~PG~kL~TsCGSLAYSAPEILLGDsYD-APAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY--tvPshvS~ 244 (864)
T KOG4717|consen 168 KFQPGKKLTTSCGSLAYSAPEILLGDSYD-APAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY--TVPSHVSK 244 (864)
T ss_pred cCCCcchhhcccchhhccCchhhhcCccC-CcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc--cCchhhhH
Confidence 76666666788999999999999975444 5789999999999999999999999999999888887766 47889999
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1049 EWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1049 eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
++++||..||..||.+|.+.++|...-|-
T Consensus 245 eCrdLI~sMLvRdPkkRAslEeI~s~~Wl 273 (864)
T KOG4717|consen 245 ECRDLIQSMLVRDPKKRASLEEIVSTSWL 273 (864)
T ss_pred HHHHHHHHHHhcCchhhccHHHHhccccc
Confidence 99999999999999999999999887664
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.46 Aligned_cols=254 Identities=29% Similarity=0.467 Sum_probs=206.9
Q ss_pred ccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~ 885 (1094)
..++|++.+.||+|+||+||++.+. +..||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-------KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE 75 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-------cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC
Confidence 4568899999999999999999885 7789999886531 122346788999999999999999999999886
Q ss_pred CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs-~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
. .+++||||+++++|..++...+ .+++..+..++.+++.+|.|||+ .+++||||||+||+++ .++.++|+||
T Consensus 76 ~--~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~----~~~~~~l~d~ 148 (284)
T cd06620 76 N--NICMCMEFMDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVN----SRGQIKLCDF 148 (284)
T ss_pred C--EEEEEEecCCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEEC----CCCcEEEccC
Confidence 4 8999999999999999886643 58999999999999999999997 5899999999999998 6788999999
Q ss_pred CCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH-----------HHHHhH
Q 037285 965 GLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-----------AIIGGI 1033 (1094)
Q Consensus 965 GLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~-----------eile~I 1033 (1094)
|++...... ......++..|+|||++. ...++.++|||||||++|+|++|+.||...... +....+
T Consensus 149 gl~~~~~~~-~~~~~~~~~~~~aPE~~~--~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd06620 149 GVSGELINS-IADTFVGTSTYMSPERIQ--GGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI 225 (284)
T ss_pred Ccccchhhh-ccCccccCcccCCHHHHc--cCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHH
Confidence 998743221 122456899999999987 347788999999999999999999999865432 222222
Q ss_pred hhccCCCCCCC-cCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1034 VNNTLRPTIPS-YCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1034 v~~~lrp~iPe-~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
.... .+.++. .++..+.+||.+||+.||++||++.++++++.-+.
T Consensus 226 ~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 226 VQEP-PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred hhcc-CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 2221 222222 37788999999999999999999999999876655
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=308.38 Aligned_cols=255 Identities=28% Similarity=0.422 Sum_probs=199.0
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHH-HhhCCCCceeEEEeEeecCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEI-LSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkI-LkrL~HPNIVqL~Gv~~d~~ 886 (1094)
++|++.+.||+|+||.||++++. |..||||.++..... . ....+..|+.+ ++.++||||+++++++....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~----~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~ 73 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS---Q----EQKRLLMDLDISMRSVDCPYTVTFYGALFREG 73 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc---H----HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCC
Confidence 37899999999999999999885 688999998754211 1 11344456554 56678999999999998754
Q ss_pred CCceEEEeeecccchhHHHHhh---cccccCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeccCCCCCCcEEEE
Q 037285 887 GGTLATVAEYMVDGSLRHVLVR---KDRFLDRRRRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k---~~~~Lse~~~l~Ia~QIaeGLaYLHs~-GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
.+++||||++ ++|.+++.. ....+++..++.++.||+.||.|||++ +++||||||+|||++ .++.+||+
T Consensus 74 --~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~----~~~~~kl~ 146 (283)
T cd06617 74 --DVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLIN----RNGQVKLC 146 (283)
T ss_pred --cEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEEC----CCCCEEEe
Confidence 8999999996 677777654 234689999999999999999999997 999999999999998 77899999
Q ss_pred ecCCcccccCccccCCccCCCcccCccccccC--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh-HHHHHhHhhccCC
Q 037285 963 DFGLSKIKRNTLVSGGVRGTLPWMAPELLSGS--SSKVSEKVDVFSFGIVLWEILTGEEPYANMHY-GAIIGGIVNNTLR 1039 (1094)
Q Consensus 963 DFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~--~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~-~eile~Iv~~~lr 1039 (1094)
|||+++............++..|+|||++.+. ...++.++|+|||||++|+|++|+.||..... .+.+..... ...
T Consensus 147 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~ 225 (283)
T cd06617 147 DFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE-EPS 225 (283)
T ss_pred ecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh-cCC
Confidence 99998854333322334578899999998631 14568899999999999999999999975432 233333333 222
Q ss_pred CCCC-CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1040 PTIP-SYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1040 p~iP-e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
+.++ ..++.++.++|.+||..+|.+||++.+|+++-+-..
T Consensus 226 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 266 (283)
T cd06617 226 PQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266 (283)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhh
Confidence 3333 457899999999999999999999999998655544
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=306.08 Aligned_cols=254 Identities=31% Similarity=0.539 Sum_probs=203.4
Q ss_pred eeEEEEecccCceEEEEeeec-----CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 812 LEEQKELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 812 Yei~kkLGsG~FGtVYKAk~r-----Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
|++.+.||+|+||.||+|.++ +..||||++...... .....++.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS------SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC------hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 567789999999999999863 467999998754211 222456889999999999999999999886532
Q ss_pred C----CceEEEeeecccchhHHHHhhcc-----cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCC
Q 037285 887 G----GTLATVAEYMVDGSLRHVLVRKD-----RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRP 957 (1094)
Q Consensus 887 ~----~~L~IVmEYmegGSL~d~L~k~~-----~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g 957 (1094)
. ...+++++|+.+|+|..++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++ .++
T Consensus 75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~----~~~ 150 (273)
T cd05074 75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN----ENM 150 (273)
T ss_pred CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEc----CCC
Confidence 1 13478899999999988874321 2478889999999999999999999999999999999998 678
Q ss_pred cEEEEecCCcccccCcc---ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhH
Q 037285 958 ICKVGDFGLSKIKRNTL---VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGI 1033 (1094)
Q Consensus 958 ~VKLsDFGLSrl~~~~~---~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~I 1033 (1094)
.+||+|||+++...... ......++..|++||.+. ...++.++|||||||++|+|++ |+.||......+....+
T Consensus 151 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~ 228 (273)
T cd05074 151 TVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLA--DNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL 228 (273)
T ss_pred CEEECcccccccccCCcceecCCCccCchhhcCHhHHh--cCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Confidence 89999999988542211 112233567899999987 4567889999999999999999 99999887766655544
Q ss_pred hhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1034 VNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1034 v~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
... .....+..++..+.+++.+||+.+|.+||++.++++.|..+
T Consensus 229 ~~~-~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 229 IKG-NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HcC-CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 332 23344556789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=312.23 Aligned_cols=251 Identities=27% Similarity=0.352 Sum_probs=199.9
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.++||+|+||.||+|.++ +..||+|++...... ......+.+|+.++++++||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 73 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD------KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKK- 73 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc------chhhHHHHHHHHHHHhcCCcchhhHHHhcccCC-
Confidence 47899999999999999999985 678999988654211 122346778999999999999999999998754
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++||||+.+++|..+..... .+++..++.++.||+.||+|||+.+++|+||+|+||+++ +++.++|+|||++
T Consensus 74 -~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~----~~~~~~l~dfg~~ 147 (286)
T cd07846 74 -RLYLVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVS----QSGVVKLCDFGFA 147 (286)
T ss_pred -eEEEEEecCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC----CCCcEEEEeeeee
Confidence 8999999999998888765443 489999999999999999999999999999999999998 7889999999998
Q ss_pred ccccC-ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhc----------
Q 037285 968 KIKRN-TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN---------- 1036 (1094)
Q Consensus 968 rl~~~-~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~---------- 1036 (1094)
..... ........++..|+|||++.+ ...++.++|||||||++|+|++|+.||......+....+...
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07846 148 RTLAAPGEVYTDYVATRWYRAPELLVG-DTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQE 226 (286)
T ss_pred eeccCCccccCcccceeeccCcHHhcc-ccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHH
Confidence 75422 222233457889999999874 345678999999999999999999999765543332222110
Q ss_pred ----------cCCCC---------CCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1037 ----------TLRPT---------IPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1037 ----------~lrp~---------iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
...+. ....++..+.++|.+||..+|++||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 227 IFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00000 123467889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=308.96 Aligned_cols=250 Identities=34% Similarity=0.515 Sum_probs=206.0
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
+|++.+.||.|+||.||++.++ +..+|+|.+..... ......+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-- 72 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-------EAIQKQILRELDILHKCNSPYIVGFYGAFYNNG-- 72 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-------hHHHHHHHHHHHHHHHCCCCchhhhheeeecCC--
Confidence 6778889999999999999886 67899999876421 123457889999999999999999999998764
Q ss_pred ceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 889 TLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs-~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++++||+.+++|.+++......+++..+..++.|++.||+|||+ .+++|+||||+||+++ .++.+||+|||++
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~----~~~~~~l~d~g~~ 148 (265)
T cd06605 73 DISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN----SRGQIKLCDFGVS 148 (265)
T ss_pred EEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC----CCCCEEEeecccc
Confidence 8999999999999999998765668999999999999999999999 9999999999999999 6788999999998
Q ss_pred ccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-----hHHHHHhHhhccCCCCC
Q 037285 968 KIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH-----YGAIIGGIVNNTLRPTI 1042 (1094)
Q Consensus 968 rl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~-----~~eile~Iv~~~lrp~i 1042 (1094)
......... ...++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.... ..+....+.. ...+..
T Consensus 149 ~~~~~~~~~-~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~ 224 (265)
T cd06605 149 GQLVNSLAK-TFVGTSSYMAPERIQG--NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN-EPPPRL 224 (265)
T ss_pred hhhHHHHhh-cccCChhccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc-CCCCCC
Confidence 754322211 2568889999999874 478899999999999999999999997652 2233333322 233344
Q ss_pred CCc-CcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1043 PSY-CDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1043 Pe~-~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
+.. ++..+.++|.+||..+|.+|||+.+++.+-+-
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 260 (265)
T cd06605 225 PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260 (265)
T ss_pred ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchh
Confidence 444 78899999999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=313.42 Aligned_cols=252 Identities=27% Similarity=0.409 Sum_probs=207.7
Q ss_pred CCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
.+|++.+.||.|+||.||+|.. .+..||||.+..... .....+.+|+.++++++||||+++++++....
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~- 89 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--------PKKELIINEILVMKELKNPNIVNFLDSFLVGD- 89 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--------chHHHHHHHHHHHHhcCCCceeeeeeeEecCc-
Confidence 4699999999999999999986 468899998864321 11346778999999999999999999998755
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++|+||+.+++|..++... .+++..++.++.|++.||.|||+++++|+||||+||+++ .++.+||+|||++
T Consensus 90 -~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~----~~~~~kl~dfg~~ 162 (296)
T cd06655 90 -ELFVVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLG----MDGSVKLTDFGFC 162 (296)
T ss_pred -eEEEEEEecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEEccCccc
Confidence 899999999999999988643 489999999999999999999999999999999999998 6788999999998
Q ss_pred ccccCcc-ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhcc-CCCCCCCc
Q 037285 968 KIKRNTL-VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-LRPTIPSY 1045 (1094)
Q Consensus 968 rl~~~~~-~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~-lrp~iPe~ 1045 (1094)
....... ......++..|+|||.+. ...++.++|||||||++|+|++|+.||...........+.... .....+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T cd06655 163 AQITPEQSKRSTMVGTPYWMAPEVVT--RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEK 240 (296)
T ss_pred hhcccccccCCCcCCCccccCcchhc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCccc
Confidence 7433221 122345888999999987 4567889999999999999999999998876655444333222 12234566
Q ss_pred CcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1046 CDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1046 ~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
++..+.++|.+||..+|.+||++.+|+++-+--.
T Consensus 241 ~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 241 LSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred CCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhh
Confidence 8899999999999999999999999998766543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=316.18 Aligned_cols=260 Identities=24% Similarity=0.321 Sum_probs=206.9
Q ss_pred ccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~ 885 (1094)
..++|++.+.||+|+||.||+|+++ |+.||+|.++...... .....+.+|+.++++++|+||+++++++...
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD------GIPISSLREITLLLNLRHPNIVELKEVVVGK 78 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC------CCcchhhHHHHHHHhCCCCCCcceEEEEecC
Confidence 3468999999999999999999874 7889999987542211 1123456799999999999999999999765
Q ss_pred CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecC
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFG 965 (1094)
....+++||||+. ++|.+++......+++..++.++.||+.||.|||+++++||||||+||+++ .++.+||+|||
T Consensus 79 ~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~----~~~~~kL~dfg 153 (309)
T cd07845 79 HLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT----DKGCLKIADFG 153 (309)
T ss_pred CCCeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCCEEECccc
Confidence 5457899999996 578888876556689999999999999999999999999999999999998 77899999999
Q ss_pred CcccccCc-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCC----
Q 037285 966 LSKIKRNT-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP---- 1040 (1094)
Q Consensus 966 LSrl~~~~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp---- 1040 (1094)
++...... .......++..|+|||++.+ ...++.++|||||||++|+|++|+.||...+..+.+..+......+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07845 154 LARTYGLPAKPMTPKVVTLWYRAPELLLG-CTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESI 232 (309)
T ss_pred eeeecCCccCCCCcccccccccChhhhcC-CCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 99854332 11122335788999999864 3457889999999999999999999998877666555443311000
Q ss_pred -------------CC-----------CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1041 -------------TI-----------PSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1041 -------------~i-----------Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
.. ....++.+.++|.+||+.||.+|||+.+++.+-+-..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~ 295 (309)
T cd07845 233 WPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295 (309)
T ss_pred chhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 00 0124788899999999999999999999999877643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=337.81 Aligned_cols=255 Identities=19% Similarity=0.247 Sum_probs=192.6
Q ss_pred ccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC------CCceeEEE
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH------HPNVVAFY 879 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~------HPNIVqL~ 879 (1094)
...+|++.++||+|+||+||+|++. +..||||+++... ....++..|+.+++.++ |.+|++++
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---------~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~ 197 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---------KYTRDAKIEIQFMEKVRQADPADRFPLMKIQ 197 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---------hhHHHHHHHHHHHHHHhhcCcccCcceeeeE
Confidence 4578999999999999999999874 6779999986421 11223445666666554 45689999
Q ss_pred eEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeccCCC----
Q 037285 880 GVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDP---- 954 (1094)
Q Consensus 880 Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs-~GIIHRDLKPeNILLD~~~~---- 954 (1094)
+++... ...+|+||+++ +++|.+++.+.. .+++..+..++.||+.||.|||+ .|||||||||+|||++..+.
T Consensus 198 ~~~~~~-~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 198 RYFQNE-TGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred EEEEcC-CceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccc
Confidence 988764 34789999988 778888886654 58999999999999999999998 59999999999999973321
Q ss_pred --------CCCcEEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh
Q 037285 955 --------SRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY 1026 (1094)
Q Consensus 955 --------e~g~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~ 1026 (1094)
+...+||+|||++..... ......||+.|+|||++. ...++.++|||||||++|||++|+.||.....
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~--~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 350 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVL--GLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN 350 (467)
T ss_pred ccccccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhh--cCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 123599999998864322 223467999999999998 45688999999999999999999999987765
Q ss_pred HHHHHhHhhccC-------------------------CCCC---------------CCcCcHHHHHHHHHhccCCCCCCC
Q 037285 1027 GAIIGGIVNNTL-------------------------RPTI---------------PSYCDAEWRTLMEECWAPNPAARP 1066 (1094)
Q Consensus 1027 ~eile~Iv~~~l-------------------------rp~i---------------Pe~~S~eL~dLI~kCLq~DPeeRP 1066 (1094)
.+.+..+..... ++.. .......+.+||.+||+.||.+||
T Consensus 351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ 430 (467)
T PTZ00284 351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL 430 (467)
T ss_pred HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence 543332211100 0000 001134577999999999999999
Q ss_pred CHHHHHHHHHHH
Q 037285 1067 SFTEIASRLRVL 1078 (1094)
Q Consensus 1067 S~eELLq~L~~L 1078 (1094)
|+.++++|-+-.
T Consensus 431 ta~e~L~Hp~~~ 442 (467)
T PTZ00284 431 NARQMTTHPYVL 442 (467)
T ss_pred CHHHHhcCcccc
Confidence 999999976554
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=298.91 Aligned_cols=249 Identities=30% Similarity=0.522 Sum_probs=211.7
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
+|++.+.||.|+||.||++.+. +..+|+|.+...... ......+.+|++++++++|+|++++++.+....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~-- 72 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS------EKEREDALNEVKILKKLNHPNIIKYYESFEEKG-- 72 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC------hHHHHHHHHHHHHHHhcCCCChhheEEEEecCC--
Confidence 5888999999999999999986 788999998754221 223456788999999999999999999998764
Q ss_pred ceEEEeeecccchhHHHHhhc---ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecC
Q 037285 889 TLATVAEYMVDGSLRHVLVRK---DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~---~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFG 965 (1094)
..++|+||+++++|.+++... ...+++..++.++.+++.||.|||+++++|+||+|+||+++ .++.++|+|||
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~----~~~~~~l~d~~ 148 (258)
T cd08215 73 KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT----SNGLVKLGDFG 148 (258)
T ss_pred EEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEc----CCCcEEECCcc
Confidence 899999999999999999765 36689999999999999999999999999999999999998 67899999999
Q ss_pred CcccccCcc-ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCC
Q 037285 966 LSKIKRNTL-VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPS 1044 (1094)
Q Consensus 966 LSrl~~~~~-~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe 1044 (1094)
++....... ......+++.|+|||.+. ...++.++||||||+++|+|++|+.||................ ...++.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~--~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~ 225 (258)
T cd08215 149 ISKVLSSTVDLAKTVVGTPYYLSPELCQ--NKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ-YPPIPS 225 (258)
T ss_pred ceeecccCcceecceeeeecccChhHhc--cCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-CCCCCC
Confidence 988543332 233346888999999987 4567889999999999999999999998887766666654433 455677
Q ss_pred cCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1045 YCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1045 ~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
.++..+.++|.+||..+|.+||++.+++++
T Consensus 226 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 226 QYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 889999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=301.28 Aligned_cols=250 Identities=31% Similarity=0.503 Sum_probs=209.4
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||.|+||.||+|+.. +..|+||++...... .....+.+|+.++.+++|+||+++++++....
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 72 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-------EFRKQLLRELKTLRSCESPYVVKCYGAFYKEG- 72 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-------HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCC-
Confidence 36889999999999999999885 678999998754211 23467889999999999999999999998764
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs-~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+++||||+.+++|.+++... ..+++..++.++.||++||.|||+ .+++|+||+|+||+++ .++.++|+|||+
T Consensus 73 -~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~----~~~~~~l~df~~ 146 (264)
T cd06623 73 -EISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLIN----SKGEVKIADFGI 146 (264)
T ss_pred -eEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEEC----CCCCEEEccCcc
Confidence 899999999999999999765 458999999999999999999999 9999999999999998 788999999999
Q ss_pred cccccCcccc-CCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---hHHHHHhHhhccCCCCC
Q 037285 967 SKIKRNTLVS-GGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH---YGAIIGGIVNNTLRPTI 1042 (1094)
Q Consensus 967 Srl~~~~~~s-s~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~---~~eile~Iv~~~lrp~i 1042 (1094)
+......... ....++..|+|||.+. ...++.++||||||+++|+|+||+.||.... ..+....+. ....+..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~~pE~~~--~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~ 223 (264)
T cd06623 147 SKVLENTLDQCNTFVGTVTYMSPERIQ--GESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-DGPPPSL 223 (264)
T ss_pred ceecccCCCcccceeecccccCHhhhC--CCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-cCCCCCC
Confidence 8854332222 2345788999999987 4477889999999999999999999998773 344444443 3333445
Q ss_pred CCc-CcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1043 PSY-CDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1043 Pe~-~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
+.. ++..+.++|.+||..+|.+||++.+++++-+
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~ 258 (264)
T cd06623 224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPF 258 (264)
T ss_pred CcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHH
Confidence 555 8899999999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=308.99 Aligned_cols=253 Identities=30% Similarity=0.432 Sum_probs=202.7
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEeecC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQDG 885 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~~d~ 885 (1094)
.++|++.+.||+|+||.||++... +..+|+|.+.... .....+.+|+.+++++ +||||+++++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---------~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---------DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---------cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 468999999999999999999874 6789999886431 1124566889999998 799999999998753
Q ss_pred C---CCceEEEeeecccchhHHHHhh---cccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcE
Q 037285 886 P---GGTLATVAEYMVDGSLRHVLVR---KDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC 959 (1094)
Q Consensus 886 ~---~~~L~IVmEYmegGSL~d~L~k---~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~V 959 (1094)
. ...+++||||+.+++|.+++.. ....+++..++.++.|++.||+|||+.+++|+||||+||+++ .++.+
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~----~~~~~ 167 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLT----TEGGV 167 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc----CCCCE
Confidence 2 2468999999999999998753 334689999999999999999999999999999999999998 67789
Q ss_pred EEEecCCcccccCcc-ccCCccCCCcccCccccccCC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhh
Q 037285 960 KVGDFGLSKIKRNTL-VSGGVRGTLPWMAPELLSGSS---SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN 1035 (1094)
Q Consensus 960 KLsDFGLSrl~~~~~-~ss~~~GT~~YmAPEvL~g~~---~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~ 1035 (1094)
||+|||++....... ......++..|+|||++.... ..++.++|||||||++|+|++|+.||........+..+..
T Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~ 247 (291)
T cd06639 168 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR 247 (291)
T ss_pred EEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc
Confidence 999999987543221 223345788999999986321 2367899999999999999999999988766555444432
Q ss_pred ccC-CCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1036 NTL-RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1036 ~~l-rp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
... ....+...+..+.++|.+||+.+|++||++.+|+++
T Consensus 248 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 248 NPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 211 122344567889999999999999999999999976
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=307.93 Aligned_cols=246 Identities=24% Similarity=0.480 Sum_probs=192.9
Q ss_pred EecccCceEEEEeeec-Cc---eEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEE
Q 037285 817 ELGSGTFGTVYHGKWR-GT---DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLAT 892 (1094)
Q Consensus 817 kLGsG~FGtVYKAk~r-Gt---~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~I 892 (1094)
.||+|+||.||++++. +. .+++|.+.... .......|.+|+.+++.++||||+++++.+.+.. ..++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~--~~~l 72 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-------SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAI--PYLL 72 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-------ChHHHHHHHHHHHHHhccCCcchhheEEEecCCC--ccEE
Confidence 5999999999999763 22 35566554321 1122467889999999999999999999998755 8999
Q ss_pred EeeecccchhHHHHhhcc---cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCccc
Q 037285 893 VAEYMVDGSLRHVLVRKD---RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI 969 (1094)
Q Consensus 893 VmEYmegGSL~d~L~k~~---~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl 969 (1094)
||||+.+|+|.+++.+.. ...++..++.++.||+.||+|||+.+++||||||+|||++ .++.+||+|||++..
T Consensus 73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~----~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 73 VFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLT----SDLTVKVGDYGIGPS 148 (268)
T ss_pred EEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEc----CCccEEecccccccc
Confidence 999999999999997542 2356677889999999999999999999999999999998 678899999999863
Q ss_pred ccC---ccccCCccCCCcccCccccccC-----CCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhcc---
Q 037285 970 KRN---TLVSGGVRGTLPWMAPELLSGS-----SSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNT--- 1037 (1094)
Q Consensus 970 ~~~---~~~ss~~~GT~~YmAPEvL~g~-----~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~--- 1037 (1094)
... ........++..|+|||++... ...++.++|||||||++|||++ |..||......+....+....
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~ 228 (268)
T cd05086 149 RYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK 228 (268)
T ss_pred cCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc
Confidence 211 1122344578899999997521 2245789999999999999997 678998777766655544332
Q ss_pred -CCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1038 -LRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1038 -lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
.++..+..++..+++++..|| .+|++||++.+|++.|.
T Consensus 229 ~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 229 LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 234445567889999999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=308.70 Aligned_cols=251 Identities=25% Similarity=0.327 Sum_probs=200.6
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||+|+||.||+|.++ +..||||.++.... .......+.+|++++++++|+||+++++++....
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 73 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED------DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKG- 73 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc------cccchhHHHHHHHHHHhcCCCCeeehhheEEECC-
Confidence 36899999999999999999885 67899998865321 1223457889999999999999999999998754
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++||||+.++.+..++.. ...+++..++.++.||+.||.|||+++++|+||+|+||+++ .++.+||+|||++
T Consensus 74 -~~~iv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~----~~~~~kl~d~g~~ 147 (288)
T cd07833 74 -RLYLVFEYVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVS----ESGVLKLCDFGFA 147 (288)
T ss_pred -EEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----CCCCEEEEeeecc
Confidence 89999999998777665544 34589999999999999999999999999999999999999 7889999999998
Q ss_pred ccccCcc--ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhc---------
Q 037285 968 KIKRNTL--VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN--------- 1036 (1094)
Q Consensus 968 rl~~~~~--~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~--------- 1036 (1094)
....... ......++..|+|||++.+ ...++.++||||||+++|+|++|+.||......+.+..+...
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (288)
T cd07833 148 RALRARPASPLTDYVATRWYRAPELLVG-DTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQ 226 (288)
T ss_pred cccCCCccccccCcccccCCcCCchhcC-CCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHh
Confidence 8543322 2334557889999999974 226788999999999999999999999876544332221110
Q ss_pred -------cC--------------CCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1037 -------TL--------------RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1037 -------~l--------------rp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
.+ ....+..++.++.+||.+||..+|++||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 227 ELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred hhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00 001233458889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=308.18 Aligned_cols=250 Identities=26% Similarity=0.467 Sum_probs=203.2
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC---CCceeEEEeEeecC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH---HPNVVAFYGVVQDG 885 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~---HPNIVqL~Gv~~d~ 885 (1094)
.|++.+.||+|+||.||+|.+. +..||+|.+..... ......+.+|+.++++++ |||++++++++...
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~ 74 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-------DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG 74 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-------chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC
Confidence 4777889999999999999974 67899999865321 122346778999999986 99999999999875
Q ss_pred CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecC
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFG 965 (1094)
. ..++||||+.+++|.+++... .+++..++.++.|++.||.|||+.+|+|+||+|+||+++ ..+.++|+|||
T Consensus 75 ~--~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~----~~~~~~l~dfg 146 (277)
T cd06917 75 P--RLWIIMEYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVT----NTGNVKLCDFG 146 (277)
T ss_pred C--EEEEEEecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEc----CCCCEEEccCC
Confidence 4 899999999999999998653 589999999999999999999999999999999999999 67899999999
Q ss_pred CcccccCcc-ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCC
Q 037285 966 LSKIKRNTL-VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPS 1044 (1094)
Q Consensus 966 LSrl~~~~~-~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe 1044 (1094)
++....... ......|+..|+|||.+.+ ...++.++|||||||++|+|++|+.||...........+.. ...+.++.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~-~~~~~~~~ 224 (277)
T cd06917 147 VAALLNQNSSKRSTFVGTPYWMAPEVITE-GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK-SKPPRLED 224 (277)
T ss_pred ceeecCCCccccccccCCcceeCHHHhcc-CCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc-CCCCCCCc
Confidence 987543322 2233458889999999863 34568899999999999999999999987765544433222 22233333
Q ss_pred -cCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1045 -YCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1045 -~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
.++.++.++|.+||+.||.+||++.+++.+-+-
T Consensus 225 ~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~ 258 (277)
T cd06917 225 NGYSKLLREFVAACLDEEPKERLSAEELLKSKWI 258 (277)
T ss_pred ccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHh
Confidence 378899999999999999999999999986554
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=327.87 Aligned_cols=253 Identities=26% Similarity=0.351 Sum_probs=207.1
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec---
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD--- 884 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d--- 884 (1094)
..|...+.||.|+||.|+.+..+ |..||||.+... ........+..+|+++|+.++|+||+.+++++..
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~------F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP------FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh------hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 45666899999999999999874 788999988643 2234455677899999999999999999999876
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
..-..+|+|+|+| +.+|.+.++.+. .++...+..+++||+.||+|+|+.+|+||||||.|+|++ .+..+||+||
T Consensus 96 ~~f~DvYiV~elM-etDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n----~~c~lKI~DF 169 (359)
T KOG0660|consen 96 DKFNDVYLVFELM-ETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLN----ADCDLKICDF 169 (359)
T ss_pred cccceeEEehhHH-hhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhhcccccccccchhheeec----cCCCEEeccc
Confidence 3345799999999 678888886554 499999999999999999999999999999999999999 8889999999
Q ss_pred CCcccccC---ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhc-----
Q 037285 965 GLSKIKRN---TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN----- 1036 (1094)
Q Consensus 965 GLSrl~~~---~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~----- 1036 (1094)
|+|+.... .......+.|.+|.|||++.. ...|+.+.||||+||||.||++|++.|.+.+....+..+..-
T Consensus 170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~-~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~ 248 (359)
T KOG0660|consen 170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLN-SSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS 248 (359)
T ss_pred cceeeccccCcccchhcceeeeeecCHHHHhc-cccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence 99996642 223345668999999999974 678999999999999999999999999987765443332111
Q ss_pred -------------------cCCCCCC-----CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037285 1037 -------------------TLRPTIP-----SYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1037 -------------------~lrp~iP-----e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L 1075 (1094)
...+..+ ..+++.+.+|+.+||..||.+|+|+++.+.+.
T Consensus 249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 1111111 35778899999999999999999999999874
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=324.28 Aligned_cols=257 Identities=25% Similarity=0.361 Sum_probs=225.5
Q ss_pred cCCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||+|.|+.||++.. +|+.+|+|++....+... -.+++.+|+.|-+.|+|||||++++.+...
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~------~~e~l~rEarIC~~LqHP~IvrL~~ti~~~- 82 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR------DFQKLEREARICRKLQHPNIVRLHDSIQEE- 82 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc------cHHHHHHHHHHHHhcCCCcEeehhhhhccc-
Confidence 46788899999999999999866 478899999887665543 235677899999999999999999988764
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
+..|+|+|+|.|++|..-+..+. ..++..+-..+.||+++|.|+|.++|||||+||.|+|+-.+. ...-+||+|||+
T Consensus 83 -~~~ylvFe~m~G~dl~~eIV~R~-~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~-~~A~vKL~~FGv 159 (355)
T KOG0033|consen 83 -SFHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKA-KGAAVKLADFGL 159 (355)
T ss_pred -ceeEEEEecccchHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeecc-CCCceeecccce
Confidence 48999999999999987776653 578889999999999999999999999999999999997544 456799999999
Q ss_pred cccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCC--CCC
Q 037285 967 SKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT--IPS 1044 (1094)
Q Consensus 967 Srl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~--iPe 1044 (1094)
+..........+..||+.|||||++. ...|+..+|||+.|||||-|+.|++||.+.+...+.+++....+... ...
T Consensus 160 Ai~l~~g~~~~G~~GtP~fmaPEvvr--kdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~ 237 (355)
T KOG0033|consen 160 AIEVNDGEAWHGFAGTPGYLSPEVLK--KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWD 237 (355)
T ss_pred EEEeCCccccccccCCCcccCHHHhh--cCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccC
Confidence 99877777788889999999999998 67899999999999999999999999999999999999988877643 345
Q ss_pred cCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1045 YCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1045 ~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
.++++.++|+++||..||.+|.|+.|.+++-|-
T Consensus 238 ~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi 270 (355)
T KOG0033|consen 238 TVTPEAKSLIRRMLTVNPKKRITADEALKHPWI 270 (355)
T ss_pred cCCHHHHHHHHHHhccChhhhccHHHHhCCchh
Confidence 789999999999999999999999999987664
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.35 Aligned_cols=251 Identities=25% Similarity=0.370 Sum_probs=196.3
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||.|+||.||+|+.+ ++.||||.+....... ....+.+|+.++++++|+||+++++++.+..
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 76 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-------APFTAIREASLLKDLKHANIVTLHDIIHTKK 76 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-------CchhHHHHHHHHhhCCCcceeeEEEEEecCC
Confidence 368999999999999999999874 6889999987542111 1134568999999999999999999998755
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
..++||||+. ++|.+++......+++..+..++.||++||.|||+++|+||||||+|||++ .++.+||+|||+
T Consensus 77 --~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~----~~~~~kl~dfg~ 149 (291)
T cd07844 77 --TLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLIS----ERGELKLADFGL 149 (291)
T ss_pred --eEEEEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEc----CCCCEEECcccc
Confidence 8999999997 489998877666789999999999999999999999999999999999998 778899999999
Q ss_pred cccccCcc-ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-hHHHHHhHhhcc-------
Q 037285 967 SKIKRNTL-VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH-YGAIIGGIVNNT------- 1037 (1094)
Q Consensus 967 Srl~~~~~-~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~-~~eile~Iv~~~------- 1037 (1094)
++...... ......++..|+|||++.+ ...++.++|||||||++|+|++|+.||.... ..+.+..+....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (291)
T cd07844 150 ARAKSVPSKTYSNEVVTLWYRPPDVLLG-STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEET 228 (291)
T ss_pred ccccCCCCccccccccccccCCcHHhhc-CcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhh
Confidence 87432211 1122346788999999864 3457889999999999999999999997655 222221111000
Q ss_pred --------------CCC-------CCCCcCc--HHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1038 --------------LRP-------TIPSYCD--AEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1038 --------------lrp-------~iPe~~S--~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
... ......+ ..+.++|.+||+.+|.+||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 229 WPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 000 0001223 778899999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=310.89 Aligned_cols=256 Identities=27% Similarity=0.351 Sum_probs=203.6
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
+|++.+.||.|+||.||+|.++ ++.||||.++...... ........+..|+.++++++|+||+++++++.+..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-- 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKE---AKDGINFTALREIKLLQELKHPNIIGLLDVFGHKS-- 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEecccccc---ccchhhHHHHHHHHHHhhcCCCCChhhhheeecCC--
Confidence 4788899999999999999874 6789999997654321 11223345678999999999999999999998854
Q ss_pred ceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 889 TLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
.+++||||+ +++|.+++......+++..++.++.||++||.|||+++|+|+||+|+|||++ .++.+||+|||+++
T Consensus 76 ~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~----~~~~~~l~dfg~~~ 150 (298)
T cd07841 76 NINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIA----SDGVLKLADFGLAR 150 (298)
T ss_pred EEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEc----CCCCEEEccceeee
Confidence 899999999 9999999976654689999999999999999999999999999999999999 77899999999998
Q ss_pred cccCc-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCC--------
Q 037285 969 IKRNT-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR-------- 1039 (1094)
Q Consensus 969 l~~~~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lr-------- 1039 (1094)
..... .......++..|+|||.+.+ ...++.++|||||||++|+|++|..+|...........+......
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 151 SFGSPNRKMTHQVVTRWYRAPELLFG-ARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229 (298)
T ss_pred eccCCCccccccccceeeeCHHHHhC-CCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhh
Confidence 54332 12223346788999999863 345788999999999999999998888776654444333221000
Q ss_pred -------------C-----CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1040 -------------P-----TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1040 -------------p-----~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
+ ......+..+.++|.+||+.+|.+|||+.+++.+-+-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~ 285 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYF 285 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccc
Confidence 0 0113346789999999999999999999999996443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=349.44 Aligned_cols=263 Identities=22% Similarity=0.311 Sum_probs=214.1
Q ss_pred CCcceeeccCCeeEEEEecccCceEEEEeeec-C-ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-CCceeE
Q 037285 801 VSSVQVIKNEDLEEQKELGSGTFGTVYHGKWR-G-TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HPNVVA 877 (1094)
Q Consensus 801 lssv~eIs~edYei~kkLGsG~FGtVYKAk~r-G-t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-HPNIVq 877 (1094)
...+-++...++++.+.|-+|||+.||+|... + ..+|+|++... ++.....+.+||.+|++|+ |+|||.
T Consensus 28 ~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--------de~~L~~v~~EI~~MK~L~gh~nIV~ 99 (738)
T KOG1989|consen 28 VGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--------DEEALNAVKREIDIMKLLSGHKNIVS 99 (738)
T ss_pred CceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--------CHHHHHHHHHHHHHHHHhcCCCceee
Confidence 34556778889999999999999999999985 3 78999988643 2445677889999999998 999999
Q ss_pred EEeE-eecC--C--CCceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEe
Q 037285 878 FYGV-VQDG--P--GGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLV 949 (1094)
Q Consensus 878 L~Gv-~~d~--~--~~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~G--IIHRDLKPeNILL 949 (1094)
+++. .... . ...++|+||||.+|.|.++|..+. ..|++.++++|+.|+|+|+++||... |||||||-+||||
T Consensus 100 yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl 179 (738)
T KOG1989|consen 100 YIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL 179 (738)
T ss_pred EeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE
Confidence 9993 2221 1 125789999999999999997542 34999999999999999999999988 9999999999999
Q ss_pred ccCCCCCCcEEEEecCCcccccCcc-ccC---------CccCCCcccCccccc-cCCCCCCchhhHHHHHHHHHHHHcCC
Q 037285 950 NLKDPSRPICKVGDFGLSKIKRNTL-VSG---------GVRGTLPWMAPELLS-GSSSKVSEKVDVFSFGIVLWEILTGE 1018 (1094)
Q Consensus 950 D~~~~e~g~VKLsDFGLSrl~~~~~-~ss---------~~~GT~~YmAPEvL~-g~~~kyS~KSDVWSLGVLLyELLTGk 1018 (1094)
. .++.+||||||.++..-... ... ...-|+.|.|||++. .....++.|+|||+|||+||-||...
T Consensus 180 s----~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t 255 (738)
T KOG1989|consen 180 S----ADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFT 255 (738)
T ss_pred c----CCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhC
Confidence 9 78899999999987321111 100 112589999999986 22456899999999999999999999
Q ss_pred CCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1019 EPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1019 ~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
.||+....- .|+...+..+-...++..+.+||+.||+.||++||++-+++.++.++.
T Consensus 256 ~PFe~sg~l----aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 256 TPFEESGKL----AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA 312 (738)
T ss_pred CCcCcCcce----eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence 999976432 355555654444578999999999999999999999999999999886
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=313.73 Aligned_cols=250 Identities=26% Similarity=0.408 Sum_probs=204.2
Q ss_pred CCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
.+|++.+.||+|+||.||+++. .+..||+|.+..... .....+.+|+.+++.++|+||+++++++....
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~- 89 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--------PKKELIINEILVMRENKNPNIVNYLDSYLVGD- 89 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--------chHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-
Confidence 5899999999999999999986 478899999865321 11245778999999999999999999998755
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
..++||||+++++|.+++.+. .+++..+..++.|++.||.|||+.+++||||||+|||++ .++.+||+|||++
T Consensus 90 -~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~----~~~~~~l~Dfg~~ 162 (297)
T cd06656 90 -ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLG----MDGSVKLTDFGFC 162 (297)
T ss_pred -EEEEeecccCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEECcCccc
Confidence 899999999999999998643 478899999999999999999999999999999999998 7789999999998
Q ss_pred ccccCcc-ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhcc-CCCCCCCc
Q 037285 968 KIKRNTL-VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-LRPTIPSY 1045 (1094)
Q Consensus 968 rl~~~~~-~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~-lrp~iPe~ 1045 (1094)
....... ......+++.|+|||.+. ...++.++|||||||++|+|++|+.||................ .....+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (297)
T cd06656 163 AQITPEQSKRSTMVGTPYWMAPEVVT--RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPER 240 (297)
T ss_pred eEccCCccCcCcccCCccccCHHHHc--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccc
Confidence 7543221 122345788999999987 4567889999999999999999999997655433222222211 12234566
Q ss_pred CcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1046 CDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1046 ~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
++..++++|.+||..+|++||++.+|+++-+-
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (297)
T cd06656 241 LSAVFRDFLNRCLEMDVDRRGSAKELLQHPFL 272 (297)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCchh
Confidence 78889999999999999999999999996543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=328.69 Aligned_cols=250 Identities=22% Similarity=0.268 Sum_probs=197.4
Q ss_pred eccCCeeEEEEecccCceEEEEeeec----CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEe
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVV 882 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r----Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~ 882 (1094)
+...+|++.+.||.|+||.||++... +..||+|.+... ..+.+|+.+|++++||||+++++++
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------------~~~~~E~~il~~l~h~~iv~~~~~~ 155 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------------KTPGREIDILKTISHRAIINLIHAY 155 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------------ccHHHHHHHHHhcCCCCccceeeeE
Confidence 44568999999999999999998764 356899987543 1245799999999999999999999
Q ss_pred ecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 883 QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 883 ~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
.... .+++|||++. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ..+.+||+
T Consensus 156 ~~~~--~~~lv~e~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~----~~~~~~l~ 227 (392)
T PHA03207 156 RWKS--TVCMVMPKYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLD----EPENAVLG 227 (392)
T ss_pred eeCC--EEEEEehhcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc----CCCCEEEc
Confidence 8754 8999999985 678888843 34589999999999999999999999999999999999998 77899999
Q ss_pred ecCCcccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH---HHHHhHhh-
Q 037285 963 DFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG---AIIGGIVN- 1035 (1094)
Q Consensus 963 DFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~---eile~Iv~- 1035 (1094)
|||+++..... .......||..|+|||++. ...++.++|||||||++|||++|+.||...... ..+..+..
T Consensus 228 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~ 305 (392)
T PHA03207 228 DFGAACKLDAHPDTPQCYGWSGTLETNSPELLA--LDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC 305 (392)
T ss_pred cCccccccCcccccccccccccccCccCHhHhc--CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHH
Confidence 99998743322 1223456899999999997 456889999999999999999999999764321 11111111
Q ss_pred ------------------------ccCCCCC--C-----CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1036 ------------------------NTLRPTI--P-----SYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1036 ------------------------~~lrp~i--P-----e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
...++.. + ..++.++.++|.+||..||.+||++.+++.+-+-..
T Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 306 MQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred hccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 0011111 1 234667899999999999999999999999876543
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=305.40 Aligned_cols=250 Identities=28% Similarity=0.437 Sum_probs=207.2
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
-|++.+.||.|+||.||+|.+. +..||||.+.... .......+.+|+.++.+++||||+++++++....
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 75 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-------AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT-- 75 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-------chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC--
Confidence 4678889999999999999874 6789999875431 1223457889999999999999999999998765
Q ss_pred ceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 889 TLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
..++||||+.+++|..++... .+++..+..++.|++.+|.|||+++++|+||+|+||+++ .++.++|+|||++.
T Consensus 76 ~~~lv~e~~~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~----~~~~~~l~dfg~~~ 149 (277)
T cd06641 76 KLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS----EHGEVKLADFGVAG 149 (277)
T ss_pred eEEEEEEeCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEEC----CCCCEEEeecccce
Confidence 899999999999999998643 489999999999999999999999999999999999998 67889999999987
Q ss_pred cccCcc-ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCc
Q 037285 969 IKRNTL-VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCD 1047 (1094)
Q Consensus 969 l~~~~~-~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S 1047 (1094)
...... ......++..|+|||.+. ...++.++|||||||++|+|++|..||...........+ .....+.++..++
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~ 226 (277)
T cd06641 150 QLTDTQIKRNTFVGTPFWMAPEVIK--QSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI-PKNNPPTLEGNYS 226 (277)
T ss_pred ecccchhhhccccCCccccChhhhc--cCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHH-hcCCCCCCCcccC
Confidence 543221 122345788999999987 456788999999999999999999999877655555443 3334455666788
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1048 AEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1048 ~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
.++.++|.+||+.+|.+||++.+++++-.-.
T Consensus 227 ~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~ 257 (277)
T cd06641 227 KPLKEFVEACLNKEPSFRPTAKELLKHKFIV 257 (277)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHhCHHHh
Confidence 9999999999999999999999999974443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=300.81 Aligned_cols=249 Identities=26% Similarity=0.482 Sum_probs=205.4
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
+|++.+.||.|+||.||++.++ +..+|+|.+....... .....+.+|+.++++++|+||+++++++....
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~-- 72 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV------KEKEASKKEVILLAKMKHPNIVTFFASFQENG-- 72 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc------hhhHHHHHHHHHHHhCCCCChhhhhheeccCC--
Confidence 4788999999999999999885 6789999986542211 12346778999999999999999999988754
Q ss_pred ceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCC-CcEEEEecCC
Q 037285 889 TLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSR-PICKVGDFGL 966 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~-g~VKLsDFGL 966 (1094)
..++|+||+.+++|.+++.... ..+++..+..++.||+.||.|||+++++|+||||+||+++ ++ ..+||+|||.
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~----~~~~~~~l~d~~~ 148 (257)
T cd08225 73 RLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLS----KNGMVAKLGDFGI 148 (257)
T ss_pred eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEc----CCCCeEEeccccc
Confidence 8999999999999999986643 3478999999999999999999999999999999999998 34 4679999999
Q ss_pred cccccCcc-ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCc
Q 037285 967 SKIKRNTL-VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSY 1045 (1094)
Q Consensus 967 Srl~~~~~-~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~ 1045 (1094)
+....... ......++..|+|||++. ...++.++||||||+++|+|++|..||......+....+..... ......
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~ape~~~--~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~ 225 (257)
T cd08225 149 ARQLNDSMELAYTCVGTPYYLSPEICQ--NRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF-APISPN 225 (257)
T ss_pred chhccCCcccccccCCCccccCHHHHc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccC-CCCCCC
Confidence 87543322 122235788999999987 45678999999999999999999999988776666655544333 334556
Q ss_pred CcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1046 CDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1046 ~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
++..+.++|.+||..+|++|||+.+|+++
T Consensus 226 ~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 226 FSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 78899999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=312.28 Aligned_cols=255 Identities=29% Similarity=0.441 Sum_probs=210.3
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
..|+..+.||+|+||.||++++. +..||+|.+...... .......+.+|+.++++++|+|++++++++....
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~- 98 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ-----SNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH- 98 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCC-----chHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC-
Confidence 34778899999999999999874 678999988653211 1233457889999999999999999999998765
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
..++||||+. |+|.+++......+++..+..++.||+.||.|||+++|+||||+|+||+++ .++.+||+|||++
T Consensus 99 -~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~----~~~~~kl~dfg~~ 172 (317)
T cd06635 99 -TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT----EPGQVKLADFGSA 172 (317)
T ss_pred -eEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEEC----CCCCEEEecCCCc
Confidence 7899999996 577777766666789999999999999999999999999999999999998 6788999999998
Q ss_pred ccccCccccCCccCCCcccCcccccc-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcC
Q 037285 968 KIKRNTLVSGGVRGTLPWMAPELLSG-SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYC 1046 (1094)
Q Consensus 968 rl~~~~~~ss~~~GT~~YmAPEvL~g-~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~ 1046 (1094)
...... ....++..|+|||++.. ....++.++|||||||++|+|++|+.||...........+............+
T Consensus 173 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (317)
T cd06635 173 SIASPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW 249 (317)
T ss_pred cccCCc---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccc
Confidence 754322 23458889999999742 13457889999999999999999999998877666666555554444445567
Q ss_pred cHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1047 DAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1047 S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
+..+.++|.+||+.+|.+||++.++++++..+.
T Consensus 250 ~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 250 SDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred cHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 889999999999999999999999999877654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=305.71 Aligned_cols=253 Identities=27% Similarity=0.433 Sum_probs=202.7
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||.|++|.||++... +..+|+|.+..... ......+.+|++++++++||||++++++|.....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 73 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-------PDLQKQILRELEINKSCKSPYIVKYYGAFLDESS 73 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-------hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCC
Confidence 36889999999999999999884 57799999875321 1234568899999999999999999999877655
Q ss_pred CceEEEeeecccchhHHHHhh---cccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 888 GTLATVAEYMVDGSLRHVLVR---KDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k---~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
..+++||||+++++|.+++.. ....+++..+..++.||+.||.|||+.+++|+||+|+||+++ .++.++|+||
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~----~~~~~~l~df 149 (287)
T cd06621 74 SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT----RKGQVKLCDF 149 (287)
T ss_pred CeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe----cCCeEEEeec
Confidence 679999999999999888653 334588999999999999999999999999999999999998 6778999999
Q ss_pred CCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-----hHHHHHhHhhccCC
Q 037285 965 GLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH-----YGAIIGGIVNNTLR 1039 (1094)
Q Consensus 965 GLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~-----~~eile~Iv~~~lr 1039 (1094)
|++........ ....++..|+|||.+. ...++.++|||||||++|+|++|+.||.... ..+....+.. ...
T Consensus 150 g~~~~~~~~~~-~~~~~~~~y~~pE~~~--~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~ 225 (287)
T cd06621 150 GVSGELVNSLA-GTFTGTSFYMAPERIQ--GKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-MPN 225 (287)
T ss_pred ccccccccccc-ccccCCccccCHHHhc--CCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-CCc
Confidence 99874432221 2345788899999987 4567889999999999999999999998652 1222222221 111
Q ss_pred CCCC------CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1040 PTIP------SYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1040 p~iP------e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
+.++ ...++.+.++|.+||..+|.+|||+.+|+++-+-
T Consensus 226 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~ 269 (287)
T cd06621 226 PELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269 (287)
T ss_pred hhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccc
Confidence 1111 2345789999999999999999999999997664
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=298.67 Aligned_cols=248 Identities=26% Similarity=0.461 Sum_probs=208.6
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
+|++.++||.|+||.||++++. +..+|+|.+...... ......+.+|+.++++++|+||+++++++....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS------QKEREDAVNEIRILASVNHPNIISYKEAFLDGN-- 72 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc------HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCC--
Confidence 4888999999999999999874 577999998764321 122356778999999999999999999988754
Q ss_pred ceEEEeeecccchhHHHHhhc---ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecC
Q 037285 889 TLATVAEYMVDGSLRHVLVRK---DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~---~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFG 965 (1094)
..++||||+++++|..++... ...+++..++.++.|++.||+|||+.|++|+||+|.||+++ .++.+||+|||
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~----~~~~~kl~d~g 148 (256)
T cd08530 73 KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV----ANDLVKIGDLG 148 (256)
T ss_pred EEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe----cCCcEEEeecc
Confidence 899999999999999998652 24589999999999999999999999999999999999999 67889999999
Q ss_pred CcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCc
Q 037285 966 LSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSY 1045 (1094)
Q Consensus 966 LSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~ 1045 (1094)
++...... ......++..|+|||.+. ...++.++|+||||+++|+|++|+.||......+....+.. ...+..+..
T Consensus 149 ~~~~~~~~-~~~~~~~~~~~~~Pe~~~--~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~ 224 (256)
T cd08530 149 ISKVLKKN-MAKTQIGTPHYMAPEVWK--GRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR-GKYPPIPPI 224 (256)
T ss_pred chhhhccC-CcccccCCccccCHHHHC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-CCCCCCchh
Confidence 99865443 223345788999999997 45678899999999999999999999998877666555533 334455567
Q ss_pred CcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1046 CDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1046 ~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
++.++.++|.+||..+|++||++.+++++
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 225 YSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred hCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 88999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=305.13 Aligned_cols=250 Identities=26% Similarity=0.369 Sum_probs=193.7
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
.+|++.+.||+|+||.||+|..+ +..||||++....... ....+.+|+.++++++|+||+++++++....
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~- 76 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG-------VPFTAIREASLLKGLKHANIVLLHDIIHTKE- 76 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC-------CcHHHHHHHHHHHhcCCCCEeEEEEEEecCC-
Confidence 57999999999999999999874 7889999986542211 1235668999999999999999999998754
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
..++||||+. ++|.+++......+.+..+..++.||+.||.|||+++|+|+||||+|||++ .++.+||+|||++
T Consensus 77 -~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~----~~~~~~l~Dfg~~ 150 (291)
T cd07870 77 -TLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLIS----YLGELKLADFGLA 150 (291)
T ss_pred -eEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEc----CCCcEEEeccccc
Confidence 8999999995 677777665545578888999999999999999999999999999999998 6788999999998
Q ss_pred ccccCc-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH-HHHHhHhhc---------
Q 037285 968 KIKRNT-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-AIIGGIVNN--------- 1036 (1094)
Q Consensus 968 rl~~~~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~-eile~Iv~~--------- 1036 (1094)
+..... .......++..|+|||++.+ ...++.++|||||||++|+|++|+.||...... +.+..+...
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (291)
T cd07870 151 RAKSIPSQTYSSEVVTLWYRPPDVLLG-ATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTW 229 (291)
T ss_pred cccCCCCCCCCCccccccccCCceeec-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhh
Confidence 743221 11223447889999999864 234678999999999999999999999765432 211111100
Q ss_pred -------cCCCC-----CC---------CcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1037 -------TLRPT-----IP---------SYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1037 -------~lrp~-----iP---------e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
.+... .+ ...+..+.+++.+||..||.+|||+.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 230 PGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00000 00 0125678999999999999999999999865
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=306.14 Aligned_cols=250 Identities=25% Similarity=0.351 Sum_probs=197.5
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
+|++.+.||.|+||.||+|++. +..||||.+...... ......+.+|+.++++++||||+++++++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 72 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET------EGVPSTAIREISLLKELNHPNIVKLLDVIHTEN-- 72 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc------cccchHHHHHHHHHHhcCCCCCcchhhhcccCC--
Confidence 4888999999999999999874 678999988654211 112246788999999999999999999988754
Q ss_pred ceEEEeeecccchhHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 889 TLATVAEYMVDGSLRHVLVRK-DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~-~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
..++||||+. ++|..++... ...+++..++.++.||+.||+|||+++++|+||+|+||+++ .++.+||+|||++
T Consensus 73 ~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~----~~~~~~l~dfg~~ 147 (284)
T cd07860 73 KLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN----TEGAIKLADFGLA 147 (284)
T ss_pred cEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEEeeccch
Confidence 8999999995 6788887653 34589999999999999999999999999999999999999 7788999999998
Q ss_pred ccccCc-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCC------
Q 037285 968 KIKRNT-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP------ 1040 (1094)
Q Consensus 968 rl~~~~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp------ 1040 (1094)
...... .......++..|+|||++.+ ...++.++|||||||++|+|+||+.||...........+......+
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07860 148 RAFGVPVRTYTHEVVTLWYRAPEILLG-CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 226 (284)
T ss_pred hhcccCccccccccccccccCCeEEec-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Confidence 754322 11223346788999999874 3346889999999999999999999998765544333222110000
Q ss_pred ---------------------CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1041 ---------------------TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1041 ---------------------~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
.....++.+++++|.+||+.||.+||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 227 GVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0112467888999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=303.35 Aligned_cols=249 Identities=27% Similarity=0.383 Sum_probs=199.0
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
+|++.++||.|++|.||+|++. +..||||.++..... .....+.+|+.++++++|+||+++++++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 71 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-------GTPSTAIREISLMKELKHENIVRLHDVIHTEN-- 71 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-------cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC--
Confidence 5889999999999999999984 678999998754221 11245668999999999999999999998765
Q ss_pred ceEEEeeecccchhHHHHhhcc--cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 889 TLATVAEYMVDGSLRHVLVRKD--RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~--~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+++||||+.+ +|.+++.... ..+++..+..++.||+.||.|||+.+++||||||+||+++ +++.+||+|||+
T Consensus 72 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~----~~~~~~l~d~g~ 146 (284)
T cd07836 72 KLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLIN----KRGELKLADFGL 146 (284)
T ss_pred cEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC----CCCcEEEeecch
Confidence 88999999974 8888876543 4589999999999999999999999999999999999998 778899999999
Q ss_pred cccccCcc-ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhcc--------
Q 037285 967 SKIKRNTL-VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-------- 1037 (1094)
Q Consensus 967 Srl~~~~~-~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~-------- 1037 (1094)
++...... ......++..|++||++.+ ...++.++|||||||++|+|++|+.||......+....+....
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07836 147 ARAFGIPVNTFSNEVVTLWYRAPDVLLG-SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTW 225 (284)
T ss_pred hhhhcCCccccccccccccccChHHhcC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhH
Confidence 97443221 1123346889999999864 3457889999999999999999999998776555444332210
Q ss_pred --------CCCCC-----------CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1038 --------LRPTI-----------PSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1038 --------lrp~i-----------Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
+...+ ...++..+.++|.+||+.||.+||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 226 PGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred HHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00011 12356788999999999999999999999865
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=306.81 Aligned_cols=253 Identities=24% Similarity=0.282 Sum_probs=196.5
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-CCceeEEEeEeecCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HPNVVAFYGVVQDGP 886 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-HPNIVqL~Gv~~d~~ 886 (1094)
++|++.+.||+|+||.||+|.+. ++.||||.+...... +.....+.+|+.+++++. |+||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~------~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 74 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE------EGIPPTALREISLLQMLSESIYIVRLLDVEHVEE 74 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc------cCCchHHHHHHHHHHHccCCCCccceeeeEeecC
Confidence 46899999999999999999874 678999987653211 112346778999999995 699999999987643
Q ss_pred C---CceEEEeeecccchhHHHHhhcc----cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCC-CCc
Q 037285 887 G---GTLATVAEYMVDGSLRHVLVRKD----RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPS-RPI 958 (1094)
Q Consensus 887 ~---~~L~IVmEYmegGSL~d~L~k~~----~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e-~g~ 958 (1094)
. ..+++||||+.+ +|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+||+++ . ++.
T Consensus 75 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~----~~~~~ 149 (295)
T cd07837 75 KNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD----KQKGL 149 (295)
T ss_pred CCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEe----cCCCe
Confidence 1 137999999985 7888875432 3579999999999999999999999999999999999998 4 778
Q ss_pred EEEEecCCcccccCc-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhcc
Q 037285 959 CKVGDFGLSKIKRNT-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 1037 (1094)
Q Consensus 959 VKLsDFGLSrl~~~~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~ 1037 (1094)
+||+|||+++..... .......+++.|+|||++.+ ...++.++||||||+++|+|++|..||...........+....
T Consensus 150 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~ 228 (295)
T cd07837 150 LKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLG-STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLL 228 (295)
T ss_pred EEEeecccceecCCCccccCCcccccCCCChHHhhC-CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 999999998743221 11122346788999999864 3457889999999999999999999998766554443332210
Q ss_pred CC------------------C--------CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1038 LR------------------P--------TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1038 lr------------------p--------~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
.. + .....++.++.++|.+||..||.+||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 0 0012467889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=305.91 Aligned_cols=247 Identities=25% Similarity=0.336 Sum_probs=198.1
Q ss_pred ecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEEEee
Q 037285 818 LGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAE 895 (1094)
Q Consensus 818 LGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~IVmE 895 (1094)
||+|+||+||++.++ +..||+|.+....... ......+..|+.+|++++||||+++++++.... .+|+|||
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~e 73 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKK-----RKGEQMALNEKKILEKVSSRFIVSLAYAFETKD--DLCLVMT 73 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhh-----hhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCC--eEEEEEe
Confidence 699999999999774 6889999987542211 112345678999999999999999999998754 8999999
Q ss_pred ecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccCcc
Q 037285 896 YMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTL 974 (1094)
Q Consensus 896 YmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~~ 974 (1094)
|+++++|.+++.... ..+++..++.++.|++.||.|||+++++|+||+|+||+++ .++.+||+|||++.......
T Consensus 74 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~----~~~~~~l~dfg~~~~~~~~~ 149 (277)
T cd05577 74 LMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLD----DHGNVRISDLGLAVELKGGK 149 (277)
T ss_pred cCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC----CCCCEEEccCcchhhhccCC
Confidence 999999999987654 3589999999999999999999999999999999999998 77899999999987544333
Q ss_pred ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhh--ccCCCCCCCcCcHHHHH
Q 037285 975 VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN--NTLRPTIPSYCDAEWRT 1052 (1094)
Q Consensus 975 ~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~--~~lrp~iPe~~S~eL~d 1052 (1094)
......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.. .......+..+++.+.+
T Consensus 150 ~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQG--EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKD 227 (277)
T ss_pred ccccccCCCCcCCHHHhcC--CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHH
Confidence 3334557889999999874 4478899999999999999999999977543211111111 11233455677899999
Q ss_pred HHHHhccCCCCCCC-----CHHHHHHHHHH
Q 037285 1053 LMEECWAPNPAARP-----SFTEIASRLRV 1077 (1094)
Q Consensus 1053 LI~kCLq~DPeeRP-----S~eELLq~L~~ 1077 (1094)
+|.+||+.+|.+|| ++.+++.+-+-
T Consensus 228 li~~~l~~~p~~R~~~~~~~~~~ll~h~~~ 257 (277)
T cd05577 228 LCEALLQKDPEKRLGCRGGSADEVREHPLF 257 (277)
T ss_pred HHHHHccCChhHccCCCcccHHHHHhChhh
Confidence 99999999999999 77778876443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=308.54 Aligned_cols=261 Identities=23% Similarity=0.364 Sum_probs=205.1
Q ss_pred ceeeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-CCceeEEEe
Q 037285 804 VQVIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HPNVVAFYG 880 (1094)
Q Consensus 804 v~eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-HPNIVqL~G 880 (1094)
.+.+..++|++.+.||+|+||.||+|++. +..||||.++..... .....+.+|+.++.++. |+||+++++
T Consensus 9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-------~~~~~~~~e~~~~~~~~~~~~i~~~~~ 81 (296)
T cd06618 9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-------EENKRILMDLDVVLKSHDCPYIVKCYG 81 (296)
T ss_pred eccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-------HHHHHHHHHHHHHHhccCCCchHhhhe
Confidence 34566788999999999999999999986 788999998754211 11245566777676665 999999999
Q ss_pred EeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeccCCCCCCcE
Q 037285 881 VVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPSRPIC 959 (1094)
Q Consensus 881 v~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs-~GIIHRDLKPeNILLD~~~~e~g~V 959 (1094)
++.+.. .+++||||+. ++|..++......+++..+..++.||+.||.|||+ .+|+||||+|+||+++ .++.+
T Consensus 82 ~~~~~~--~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~----~~~~~ 154 (296)
T cd06618 82 YFITDS--DVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLD----ASGNV 154 (296)
T ss_pred eeecCC--eEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEc----CCCCE
Confidence 998765 8999999984 57777776655578999999999999999999997 5999999999999998 77899
Q ss_pred EEEecCCcccccCccccCCccCCCcccCccccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCh-HHHHHhHhhc
Q 037285 960 KVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSS--SKVSEKVDVFSFGIVLWEILTGEEPYANMHY-GAIIGGIVNN 1036 (1094)
Q Consensus 960 KLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~--~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~-~eile~Iv~~ 1036 (1094)
||+|||++.............++..|+|||.+.+.. ..++.++||||||+++|+|++|+.||..... .+.+..+...
T Consensus 155 kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 234 (296)
T cd06618 155 KLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE 234 (296)
T ss_pred EECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC
Confidence 999999987543332223345788999999987432 3478899999999999999999999976433 2333333333
Q ss_pred cCC-CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1037 TLR-PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1037 ~lr-p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
... ......++.++.+||.+||..||.+||++.+++.+.+..
T Consensus 235 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~ 277 (296)
T cd06618 235 EPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277 (296)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhh
Confidence 211 112234788999999999999999999999999887643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=301.42 Aligned_cols=251 Identities=26% Similarity=0.380 Sum_probs=201.2
Q ss_pred eeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCc
Q 037285 812 LEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGT 889 (1094)
Q Consensus 812 Yei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~ 889 (1094)
|++.++||.|+||.||+|++. +..+|+|.+..... .......+.+|+.++++++|+||+++++++.....+.
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 74 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENE------KEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGS 74 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccc------cccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCc
Confidence 678899999999999999885 57899999986531 1222356778999999999999999999998763358
Q ss_pred eEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCccc
Q 037285 890 LATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI 969 (1094)
Q Consensus 890 L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl 969 (1094)
+++||||+. ++|..++......+++..++.++.||+.||+|||+.+++|+||+|+|||++ +++.+||+|||++..
T Consensus 75 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~----~~~~~~l~d~g~~~~ 149 (287)
T cd07840 75 IYMVFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILIN----NDGVLKLADFGLARP 149 (287)
T ss_pred EEEEecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEc----CCCCEEEccccceee
Confidence 999999997 488888876655689999999999999999999999999999999999999 788999999999985
Q ss_pred ccCcc--ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCC--------
Q 037285 970 KRNTL--VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR-------- 1039 (1094)
Q Consensus 970 ~~~~~--~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lr-------- 1039 (1094)
..... ......++..|+|||.+.+ ...++.++||||||+++|+|++|+.||........+..+......
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07840 150 YTKRNSADYTNRVITLWYRPPELLLG-ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPG 228 (287)
T ss_pred ccCCCcccccccccccccCCceeeEc-cccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccc
Confidence 43322 1223346788999998764 345788999999999999999999999877655444433221000
Q ss_pred ---------------------CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1040 ---------------------PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1040 ---------------------p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
..+...++..+.++|.+||+.+|.+||++.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred cccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00112247889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=346.19 Aligned_cols=247 Identities=31% Similarity=0.483 Sum_probs=212.4
Q ss_pred EEEecccCceEEEEeeecCc--eEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEE
Q 037285 815 QKELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLAT 892 (1094)
Q Consensus 815 ~kkLGsG~FGtVYKAk~rGt--~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~I 892 (1094)
.-+||+|+||+||-|++..+ .+|||.+.... .+...-...||.+.++|+|.|||+++|.|.+ ++++-|
T Consensus 580 rvVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--------sr~~QPLhEEIaLH~~LrHkNIVrYLGs~se--nGf~kI 649 (1226)
T KOG4279|consen 580 RVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--------SREVQPLHEEIALHSTLRHKNIVRYLGSVSE--NGFFKI 649 (1226)
T ss_pred eEEeecCceeEEEeeccccceeEEEeeeccccc--------chhhccHHHHHHHHHHHhhHhHHHHhhccCC--CCeEEE
Confidence 35799999999999998754 47888875431 2233456689999999999999999999876 459999
Q ss_pred EeeecccchhHHHHhhccccc--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCccc-
Q 037285 893 VAEYMVDGSLRHVLVRKDRFL--DRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI- 969 (1094)
Q Consensus 893 VmEYmegGSL~d~L~k~~~~L--se~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl- 969 (1094)
+||-.+||+|..+|..+-+++ .+.+...+.+||++||+|||++.|||||||-+||||+. -.|.+||+|||.++.
T Consensus 650 FMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNT---ySGvlKISDFGTsKRL 726 (1226)
T KOG4279|consen 650 FMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNT---YSGVLKISDFGTSKRL 726 (1226)
T ss_pred EeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEee---ccceEEecccccchhh
Confidence 999999999999998877667 78888999999999999999999999999999999973 578999999999984
Q ss_pred ccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHH-HHhHhhccCCCCCCCcCcH
Q 037285 970 KRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAI-IGGIVNNTLRPTIPSYCDA 1048 (1094)
Q Consensus 970 ~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~ei-le~Iv~~~lrp~iPe~~S~ 1048 (1094)
..-...+.++.||..|||||++..+...|+.++|||||||++.||.||++||........ +.++---+..|.+|..++.
T Consensus 727 AginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsa 806 (1226)
T KOG4279|consen 727 AGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSA 806 (1226)
T ss_pred ccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHH
Confidence 444556677889999999999997788999999999999999999999999988776543 3333334556889999999
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1049 EWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1049 eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
+++.+|.+|+.++|.+||++.+++..
T Consensus 807 eak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 807 EAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHHHHcCCCcccCccHHHhccC
Confidence 99999999999999999999999864
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=315.53 Aligned_cols=268 Identities=24% Similarity=0.328 Sum_probs=229.8
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEeecCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~~d~~ 886 (1094)
..|...+.||.|..++|-++..+ |..+|+|++.........+...+..++-.+|+.+|+++ .||+|+++.+++....
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 35677788999999999988664 67899999987665555555677778888999999998 5999999999998865
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+++|+|.|+.|.|.++|...- .++++....|++|+.+|++|||.++||||||||+|||++ ++.++||+|||+
T Consensus 97 --F~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILld----dn~~i~isDFGF 169 (411)
T KOG0599|consen 97 --FVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLD----DNMNIKISDFGF 169 (411)
T ss_pred --hhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeec----cccceEEeccce
Confidence 8999999999999999997654 489999999999999999999999999999999999999 889999999999
Q ss_pred cccccCccccCCccCCCcccCccccc----cCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCC
Q 037285 967 SKIKRNTLVSGGVRGTLPWMAPELLS----GSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTI 1042 (1094)
Q Consensus 967 Srl~~~~~~ss~~~GT~~YmAPEvL~----g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~i 1042 (1094)
++...........|||++|+|||.+. .....|+..+|+|++|||||-|+.|.+||.-....-.+..++.+.+.-.-
T Consensus 170 a~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~s 249 (411)
T KOG0599|consen 170 ACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRS 249 (411)
T ss_pred eeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCC
Confidence 99877776666789999999999985 23457899999999999999999999999876666666677777665444
Q ss_pred C--CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhc
Q 037285 1043 P--SYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQ 1084 (1094)
Q Consensus 1043 P--e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s~ 1084 (1094)
| ..++...++||.+||+.||.+|.|+++.+.|-+.+.-...+
T Consensus 250 peWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~ 293 (411)
T KOG0599|consen 250 PEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQ 293 (411)
T ss_pred cchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhc
Confidence 4 35678899999999999999999999999998887655443
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=306.66 Aligned_cols=253 Identities=23% Similarity=0.328 Sum_probs=195.8
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC-
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP- 886 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~- 886 (1094)
++|++.++||+|+||.||+|+.+ +..||||.+...... +.....+.+|+.++++++||||+++++++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK------EGFPITALREIKILQLLKHENVVNLIEICRTKAT 85 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc------CCchhHHHHHHHHHHhCCCCCccceEEEEecccc
Confidence 57999999999999999999874 678999988653211 112234567999999999999999999987543
Q ss_pred -----CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEE
Q 037285 887 -----GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKV 961 (1094)
Q Consensus 887 -----~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKL 961 (1094)
....++||||+. ++|.+++......+++..++.++.||+.||+|||+++++|+||||+||+++ .++.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~----~~~~~kl 160 (310)
T cd07865 86 PYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILIT----KDGILKL 160 (310)
T ss_pred cccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC----CCCcEEE
Confidence 135699999996 578888876655689999999999999999999999999999999999998 7889999
Q ss_pred EecCCcccccCcc-----ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhh-
Q 037285 962 GDFGLSKIKRNTL-----VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN- 1035 (1094)
Q Consensus 962 sDFGLSrl~~~~~-----~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~- 1035 (1094)
+|||++....... ......++..|+|||++.+ ...++.++||||||+++|+|++|+.||...........+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~ 239 (310)
T cd07865 161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLG-ERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQL 239 (310)
T ss_pred CcCCCcccccCCcccCCCCccCcccCccccCcHHhcC-CcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 9999997442211 1123457788999999864 34467899999999999999999999987654433221111
Q ss_pred -ccCCC---------------CC-------------CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1036 -NTLRP---------------TI-------------PSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1036 -~~lrp---------------~i-------------Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
....+ .+ +...+..+.+||.+||..||.+|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00000 00 11235677899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=292.81 Aligned_cols=248 Identities=29% Similarity=0.518 Sum_probs=208.5
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
+|++.+.||+|+||.||++++. +..|++|.+...... +.....+.+|++++++++|+|++++++++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK------EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSD-- 72 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC------HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCC--
Confidence 4788999999999999999874 578999998765321 234467889999999999999999999988754
Q ss_pred ceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 889 TLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
..++||||+.+++|.+++... ..+++..++.++.|++.||.|||++||+|+||+|+||+++ .++.++|+|||++.
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~----~~~~~~l~d~~~~~ 147 (254)
T cd06627 73 SLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTT----KDGVVKLADFGVAT 147 (254)
T ss_pred EEEEEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEC----CCCCEEEeccccce
Confidence 899999999999999998765 4589999999999999999999999999999999999998 67899999999998
Q ss_pred cccCccc-cCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCc
Q 037285 969 IKRNTLV-SGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCD 1047 (1094)
Q Consensus 969 l~~~~~~-ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S 1047 (1094)
....... .....++..|+|||.+.+ ..++.++|||+||+++|+|++|+.||............. ....+..+..++
T Consensus 148 ~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 224 (254)
T cd06627 148 KLNDVSKDDASVVGTPYWMAPEVIEM--SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGIS 224 (254)
T ss_pred ecCCCcccccccccchhhcCHhhhcC--CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-ccCCCCCCCCCC
Confidence 5433222 223457889999999874 347889999999999999999999998776555554443 334455677889
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1048 AEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1048 ~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
..+.++|.+||..+|++||++.+++.+
T Consensus 225 ~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 225 PELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred HHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 999999999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=298.89 Aligned_cols=241 Identities=32% Similarity=0.470 Sum_probs=199.5
Q ss_pred ecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEEEee
Q 037285 818 LGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAE 895 (1094)
Q Consensus 818 LGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~IVmE 895 (1094)
||.|+||.||++++. +..+|+|.+...... .......+.+|+.++++++|+||+++++.+.... .+++|||
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~lv~e 73 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMI-----RKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK--NLYLVME 73 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhh-----hhhHHHHHHHHHHHHHhCCCcchhHHHHheecCc--EEEEEEe
Confidence 689999999999985 788999998654221 1234567888999999999999999999988754 8999999
Q ss_pred ecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccCc--
Q 037285 896 YMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT-- 973 (1094)
Q Consensus 896 YmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~-- 973 (1094)
|+.+++|.+++.+.. .+++..++.++.||++||+|||+++++|+||+|+||+++ .++.+||+|||++......
T Consensus 74 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~----~~~~~~l~dfg~~~~~~~~~~ 148 (265)
T cd05579 74 YLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILID----SNGHLKLTDFGLSKVGLVRRQ 148 (265)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEc----CCCCEEEEecccchhcccCcc
Confidence 999999999997655 589999999999999999999999999999999999999 7789999999998743221
Q ss_pred -------cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcC
Q 037285 974 -------LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYC 1046 (1094)
Q Consensus 974 -------~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~ 1046 (1094)
.......++..|+|||.+. ....+.++||||||+++|+|++|+.||......+....+...... .+..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~Pe~~~--~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~ 224 (265)
T cd05579 149 INLNDDEKEDKRIVGTPDYIAPEVIL--GQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIE--WPEDV 224 (265)
T ss_pred cccccccccccCcccCccccCHHHhc--CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcC--CCccc
Confidence 1223345788999999987 345788999999999999999999999988877776666553333 33344
Q ss_pred --cHHHHHHHHHhccCCCCCCCCH---HHHHHH
Q 037285 1047 --DAEWRTLMEECWAPNPAARPSF---TEIASR 1074 (1094)
Q Consensus 1047 --S~eL~dLI~kCLq~DPeeRPS~---eELLq~ 1074 (1094)
+..+.++|.+||+.+|.+|||+ .+++++
T Consensus 225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 225 EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 8999999999999999999999 555543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=304.33 Aligned_cols=253 Identities=29% Similarity=0.478 Sum_probs=209.2
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
..|++.+.||+|+||.||+|.+. +..|++|.+..... ....+.+|+.++++++|+||+++++++....
T Consensus 19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 88 (286)
T cd06614 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---------NKELIINEILIMKDCKHPNIVDYYDSYLVGD- 88 (286)
T ss_pred ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---------hHHHHHHHHHHHHHCCCCCeeEEEEEEEECC-
Confidence 45788889999999999999986 78899999875321 2356788999999999999999999998765
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
..++|+||+.+++|.+++......+++..++.++.|++.||.|||+.|++|+||+|+||+++ .++.++|+|||++
T Consensus 89 -~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~----~~~~~~l~d~~~~ 163 (286)
T cd06614 89 -ELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLS----KDGSVKLADFGFA 163 (286)
T ss_pred -EEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEc----CCCCEEECccchh
Confidence 89999999999999999987654689999999999999999999999999999999999998 7788999999988
Q ss_pred ccccCc-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCC-CCCCc
Q 037285 968 KIKRNT-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP-TIPSY 1045 (1094)
Q Consensus 968 rl~~~~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp-~iPe~ 1045 (1094)
...... .......++..|+|||++. ...++.++|||||||++|+|++|+.||...........+....... ..+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (286)
T cd06614 164 AQLTKEKSKRNSVVGTPYWMAPEVIK--RKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEK 241 (286)
T ss_pred hhhccchhhhccccCCcccCCHhHhc--CCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhh
Confidence 643221 1222345788999999987 4467899999999999999999999998877665555443333222 12234
Q ss_pred CcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1046 CDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1046 ~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
++..+.++|.+||+.+|.+||++.+|+.+..-..
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 242 WSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 7889999999999999999999999998765543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=345.71 Aligned_cols=261 Identities=33% Similarity=0.532 Sum_probs=224.0
Q ss_pred cceeeccCCeeEEEEecccCceEEEEeeec---------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CC
Q 037285 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKWR---------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HH 872 (1094)
Q Consensus 803 sv~eIs~edYei~kkLGsG~FGtVYKAk~r---------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~H 872 (1094)
..|++..+++.+.+.||.|.||.|++|... ...||||+++..... .....+..|+++|+.+ +|
T Consensus 289 ~~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-------~~~~~~~~El~~m~~~g~H 361 (609)
T KOG0200|consen 289 PKWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-------SEKKDLMSELNVLKELGKH 361 (609)
T ss_pred CceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-------HHHHHHHHHHHHHHHhcCC
Confidence 378999999999999999999999998753 235999998865321 2346788999999988 59
Q ss_pred CceeEEEeEeecCCCCceEEEeeecccchhHHHHhhcc---------------cccCHHHHHHHHHHHHHHHHHHHHCCc
Q 037285 873 PNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD---------------RFLDRRRRLIIAMDAAFGMEYLHSKNI 937 (1094)
Q Consensus 873 PNIVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~---------------~~Lse~~~l~Ia~QIaeGLaYLHs~GI 937 (1094)
+||+.++|+|++ .+.+++|+||+..|+|.++|...+ ..++...++.++.||+.||+||++..+
T Consensus 362 ~niv~llG~~t~--~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~ 439 (609)
T KOG0200|consen 362 PNIVNLLGACTQ--DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPC 439 (609)
T ss_pred cchhhheeeecc--CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCc
Confidence 999999999998 458999999999999999998776 348899999999999999999999999
Q ss_pred eeccCCCCceEeccCCCCCCcEEEEecCCcccccC--ccccCCcc--CCCcccCccccccCCCCCCchhhHHHHHHHHHH
Q 037285 938 VHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRN--TLVSGGVR--GTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWE 1013 (1094)
Q Consensus 938 IHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~--~~~ss~~~--GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyE 1013 (1094)
|||||.++|||+. .+..+||+|||+++.... ........ -+..|||||.+. ...|+.|+|||||||+|||
T Consensus 440 vHRDLAaRNVLi~----~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~--~~~ft~kSDVWSfGI~L~E 513 (609)
T KOG0200|consen 440 VHRDLAARNVLIT----KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLF--DRVFTSKSDVWSFGILLWE 513 (609)
T ss_pred cchhhhhhhEEec----CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhc--cCcccccchhhHHHHHHHH
Confidence 9999999999999 788999999999984222 11111111 356799999998 5789999999999999999
Q ss_pred HHc-CCCCCCCCC-hHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1014 ILT-GEEPYANMH-YGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1014 LLT-Gk~PF~~~~-~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
|+| |..||.+.. ..++ ...+..+.++..|..|+.+++++|+.||+.+|++||+|.++.+.|....
T Consensus 514 ifsLG~~PYp~~~~~~~l-~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 514 IFTLGGTPYPGIPPTEEL-LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred HhhCCCCCCCCCCcHHHH-HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 999 999999876 5555 4477899999999999999999999999999999999999999999853
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=316.55 Aligned_cols=253 Identities=23% Similarity=0.311 Sum_probs=199.8
Q ss_pred cCCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
..+|++.+.||+|+||.||+|+. .+..||||.+...... ......+.+|+.++++++|+||+++++++....
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQN------VTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQK 88 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccC------hhHHHHHHHHHHHHHhcCCCCCcceeeeeccCC
Confidence 46899999999999999999987 4788999998643211 122345678999999999999999999886432
Q ss_pred ----CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 887 ----GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 887 ----~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
....++||||+. ++|.+++... ++...+..++.||+.||+|||++||+||||||+|||++ .++.+||+
T Consensus 89 ~~~~~~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~----~~~~~kL~ 160 (353)
T cd07850 89 SLEEFQDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKIL 160 (353)
T ss_pred CccccCcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC----CCCCEEEc
Confidence 125799999995 5788877543 78899999999999999999999999999999999998 77889999
Q ss_pred ecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCC---
Q 037285 963 DFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR--- 1039 (1094)
Q Consensus 963 DFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lr--- 1039 (1094)
|||+++............++..|+|||++. ...++.++|||||||++|+|++|+.||...+.......+......
T Consensus 161 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 238 (353)
T cd07850 161 DFGLARTAGTSFMMTPYVVTRYYRAPEVIL--GMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSD 238 (353)
T ss_pred cCccceeCCCCCCCCCCcccccccCHHHHh--CCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 999998655443334456889999999997 456889999999999999999999999876544333222110000
Q ss_pred -----------------C---------CC------------CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1040 -----------------P---------TI------------PSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1040 -----------------p---------~i------------Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
+ .+ +...+..+.++|.+||+.||.+|||+.+++.+-+-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~ 314 (353)
T cd07850 239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYI 314 (353)
T ss_pred HHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhH
Confidence 0 00 11345678999999999999999999999988654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=303.64 Aligned_cols=249 Identities=26% Similarity=0.338 Sum_probs=197.4
Q ss_pred eeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCc
Q 037285 812 LEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGT 889 (1094)
Q Consensus 812 Yei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~ 889 (1094)
|++.+.||.|++|.||+|.++ |..||||++...... +.....+.+|+.++++++||||+++++++.+.. .
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~--~ 72 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED------EGVPSTAIREISLLKELNHPNIVRLLDVVHSEN--K 72 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc------ccchhHHHHHHHHHHhcCCCCccCHhheeccCC--e
Confidence 567889999999999999874 788999998754221 112245778999999999999999999998764 8
Q ss_pred eEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 890 LATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 890 L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
.+++|||+. ++|.+++.... ..+++..++.++.|+++||+|||+++++|+||+|+||+++ .++.++|+|||++.
T Consensus 73 ~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~----~~~~~~l~df~~~~ 147 (283)
T cd07835 73 LYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLID----REGALKLADFGLAR 147 (283)
T ss_pred EEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc----CCCcEEEeeccccc
Confidence 999999995 68999886654 3589999999999999999999999999999999999998 67899999999987
Q ss_pred cccCcc-ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCC--------
Q 037285 969 IKRNTL-VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR-------- 1039 (1094)
Q Consensus 969 l~~~~~-~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lr-------- 1039 (1094)
...... ......++..|+|||++.+ ...++.++||||||+++|+|++|+.||...........+......
T Consensus 148 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd07835 148 AFGVPVRTYTHEVVTLWYRAPEILLG-SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPG 226 (283)
T ss_pred ccCCCccccCccccccCCCCCceeec-CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhh
Confidence 543221 1122346888999998864 334688999999999999999999999876654433322221000
Q ss_pred -------------------CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1040 -------------------PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1040 -------------------p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
......++..+.++|.+||+.+|.+|||+.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 227 VTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 01123466889999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=306.71 Aligned_cols=255 Identities=26% Similarity=0.364 Sum_probs=200.5
Q ss_pred ccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~ 885 (1094)
..++|++.+.||.|+||.||+|.++ ++.||||.++..... ......+.+|+.++++++||||+++++++.+.
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~------~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~ 78 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK------EGFPITAIREIKILRQLNHRNIVNLKEIVTDK 78 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc------cCchHHHHHHHHHHHhCCCCCeeeeeheecCc
Confidence 3468999999999999999999984 678999998754211 11224567899999999999999999998764
Q ss_pred C--------CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCC
Q 037285 886 P--------GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRP 957 (1094)
Q Consensus 886 ~--------~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g 957 (1094)
. ...+++|+||+.+ +|..++......+++..++.++.||+.||+|||+++|+|+||||+||+++ +++
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~----~~~ 153 (302)
T cd07864 79 QDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLN----NKG 153 (302)
T ss_pred chhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCC
Confidence 3 2378999999975 67777766555689999999999999999999999999999999999998 788
Q ss_pred cEEEEecCCcccccCcc--ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhh
Q 037285 958 ICKVGDFGLSKIKRNTL--VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN 1035 (1094)
Q Consensus 958 ~VKLsDFGLSrl~~~~~--~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~ 1035 (1094)
.+||+|||++....... ......++..|+|||.+.+ ...++.++|||||||++|+|++|+.||......+.+..+..
T Consensus 154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~ 232 (302)
T cd07864 154 QIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLG-EERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR 232 (302)
T ss_pred cEEeCcccccccccCCcccccccceeccCccChHHhcC-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 99999999988543221 1122345778999998864 33568899999999999999999999987665544433322
Q ss_pred ccCCC----------------------------CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1036 NTLRP----------------------------TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1036 ~~lrp----------------------------~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
....+ .....++..+.++|.+||+.+|.+||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 10000 0112467899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=307.01 Aligned_cols=257 Identities=25% Similarity=0.359 Sum_probs=196.5
Q ss_pred CeeEEEEecccCceEEEEeeec----CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r----Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.|++.++||+|+||.||+|++. +..||||.+...... .......+.+|+.++++++||||+++++++.+..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQ-----YTGISQSACREIALLRELKHENVVSLVEVFLEHA 75 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEecccccc-----ccCccHHHHHHHHHHHhcCCCCccceEEEEeCCC
Confidence 4788999999999999999883 578999999864211 1112345678999999999999999999998874
Q ss_pred CCceEEEeeecccchhHHHHhhc----ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRK----DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~----~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
...+++||||+++ +|.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||++.++...+.+||+
T Consensus 76 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~ 154 (316)
T cd07842 76 DKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIG 154 (316)
T ss_pred CceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEEC
Confidence 4589999999975 566665432 22588999999999999999999999999999999999999433348899999
Q ss_pred ecCCcccccCcc----ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH---------H
Q 037285 963 DFGLSKIKRNTL----VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA---------I 1029 (1094)
Q Consensus 963 DFGLSrl~~~~~----~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~e---------i 1029 (1094)
|||+++...... ......++..|+|||++.+ ...++.++|||||||++|+|++|+.||....... .
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 233 (316)
T cd07842 155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLG-ARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ 233 (316)
T ss_pred CCccccccCCCcccccccCCccccccccCHHHHhC-CCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHH
Confidence 999988543221 1233457889999998864 3457889999999999999999999997654321 1
Q ss_pred HHhHhh------------------------ccCCCCCC-----------CcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1030 IGGIVN------------------------NTLRPTIP-----------SYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1030 le~Iv~------------------------~~lrp~iP-----------e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
+..++. ......++ ...+..+.++|.+||+.||++|||+.+++++
T Consensus 234 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 234 LERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 111000 00011111 1456788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=305.53 Aligned_cols=254 Identities=25% Similarity=0.393 Sum_probs=195.6
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-CCceeEEEeEeecCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HPNVVAFYGVVQDGP 886 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-HPNIVqL~Gv~~d~~ 886 (1094)
++|+..+.||+|+||.||+++++ +..||||.+...... .....+.+|+.++.++. |+||+++++++....
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~ 76 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-------KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG 76 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-------HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC
Confidence 46777789999999999999885 678999998753211 22356788999999996 999999999988754
Q ss_pred CCceEEEeeecccchhHH---HHhh-cccccCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeccCCCCCCcEEE
Q 037285 887 GGTLATVAEYMVDGSLRH---VLVR-KDRFLDRRRRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPSRPICKV 961 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d---~L~k-~~~~Lse~~~l~Ia~QIaeGLaYLHs~-GIIHRDLKPeNILLD~~~~e~g~VKL 961 (1094)
..+++|||+.. +|.+ ++.. ....+++..+..++.+++.||+|||+. +|+||||||+|||++ .++.+||
T Consensus 77 --~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~----~~~~~kl 149 (288)
T cd06616 77 --DCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLD----RNGNIKL 149 (288)
T ss_pred --cEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEc----cCCcEEE
Confidence 78899999854 4433 3322 235689999999999999999999975 999999999999998 6788999
Q ss_pred EecCCcccccCccccCCccCCCcccCccccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChH-HHHHhHhhccC-
Q 037285 962 GDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSS-SKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-AIIGGIVNNTL- 1038 (1094)
Q Consensus 962 sDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~-~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~-eile~Iv~~~l- 1038 (1094)
+|||+++............++..|+|||++.+.. ..++.++|||||||++|+|++|+.||...... +.+..+.....
T Consensus 150 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd06616 150 CDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPP 229 (288)
T ss_pred eecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCC
Confidence 9999987543332223345888999999987421 36889999999999999999999999765421 22222211111
Q ss_pred --CCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1039 --RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1039 --rp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
....+..++..+.+||.+||+.+|++|||+.+|+.+-+-
T Consensus 230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~ 270 (288)
T cd06616 230 ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFI 270 (288)
T ss_pred cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 111223478899999999999999999999999987544
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=303.13 Aligned_cols=254 Identities=24% Similarity=0.297 Sum_probs=198.3
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||.|.||.||+|+++ ++.||||.+...... +.....+.+|+.++++++|+||+++++++....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 74 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED------EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK- 74 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc------ccchHHHHHHHHHHHhccCCCEeeEEEEEecCC-
Confidence 57999999999999999999875 678999988654221 122346778999999999999999999998765
Q ss_pred CceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
..++||||+. ++|.+++.... ..+++..++.++.||+.||+|||+++++|+||+|+||+++. .++.+||+|||+
T Consensus 75 -~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~---~~~~~kl~dfg~ 149 (294)
T PLN00009 75 -RLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR---RTNALKLADFGL 149 (294)
T ss_pred -eEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEEC---CCCEEEEccccc
Confidence 8999999996 57777775443 23678888999999999999999999999999999999972 345799999999
Q ss_pred cccccCc-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCC------
Q 037285 967 SKIKRNT-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR------ 1039 (1094)
Q Consensus 967 Srl~~~~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lr------ 1039 (1094)
+...... .......++..|+|||++.+ ...++.++|||||||++|+|+||+.||......+....+......
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 228 (294)
T PLN00009 150 ARAFGIPVRTFTHEVVTLWYRAPEILLG-SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETW 228 (294)
T ss_pred ccccCCCccccccCceeecccCHHHHhC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 9754322 11223346889999999864 345788999999999999999999999876655444333211000
Q ss_pred -------------CC--------CCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1040 -------------PT--------IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1040 -------------p~--------iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
+. .....+..+.+++.+||+.+|++||++.+++++-+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~ 286 (294)
T PLN00009 229 PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEY 286 (294)
T ss_pred cccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence 00 11245788999999999999999999999997643
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=304.32 Aligned_cols=251 Identities=25% Similarity=0.406 Sum_probs=201.3
Q ss_pred CeeEEEEecccCceEEEEeee-----cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEeec
Q 037285 811 DLEEQKELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQD 884 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~-----rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~~d 884 (1094)
+|++.+.||.|+||.||+++. +|..||+|+++..... ........+.+|+.+++++ +|+||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~----~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIV----QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhh----hcchHHHHHHHHHHHHHhcccCCChhceeeEeec
Confidence 478899999999999999876 4678999998754221 1122235677899999999 59999999999887
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
.. .+++||||+++++|.+++.... .+++..+..++.||+.||.|||+++++||||+|+|||++ .++.+||+||
T Consensus 77 ~~--~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~----~~~~~kl~df 149 (290)
T cd05613 77 DT--KLHLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLD----SNGHVVLTDF 149 (290)
T ss_pred CC--eEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEC----CCCCEEEeeC
Confidence 54 8899999999999999997654 488999999999999999999999999999999999998 6789999999
Q ss_pred CCcccccCc--cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh----HHHHHhHhhccC
Q 037285 965 GLSKIKRNT--LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY----GAIIGGIVNNTL 1038 (1094)
Q Consensus 965 GLSrl~~~~--~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~----~eile~Iv~~~l 1038 (1094)
|+++..... .......++..|+|||.+.+....++.++||||||+++|+|++|+.||..... ......+.. .
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~--~ 227 (290)
T cd05613 150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK--S 227 (290)
T ss_pred ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc--c
Confidence 998754321 12223458899999999875344567899999999999999999999974322 222222222 2
Q ss_pred CCCCCCcCcHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 037285 1039 RPTIPSYCDAEWRTLMEECWAPNPAARP-----SFTEIASR 1074 (1094)
Q Consensus 1039 rp~iPe~~S~eL~dLI~kCLq~DPeeRP-----S~eELLq~ 1074 (1094)
.+.++..++..+.+++.+||..+|++|| ++.+++.+
T Consensus 228 ~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 228 EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 2345667889999999999999999997 78888876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=300.48 Aligned_cols=249 Identities=27% Similarity=0.450 Sum_probs=207.7
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-CCceeEEEeEeecCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HPNVVAFYGVVQDGP 886 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-HPNIVqL~Gv~~d~~ 886 (1094)
++|++.+.||+|+||.||+++.+ +..||+|++.+.... .+.....+.+|+.+++++. |+||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI-----KEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc-----chHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCc
Confidence 47899999999999999999884 688999998764321 1222356788999999998 999999999987754
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+++||||+.+++|.+++.+.. .+++..++.++.|++.||.|||+++++|+||+|+||+++ .++.++|+|||+
T Consensus 76 --~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~----~~~~~~l~df~~ 148 (280)
T cd05581 76 --NLYFVLEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD----KDMHIKITDFGT 148 (280)
T ss_pred --eEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC----CCCCEEecCCcc
Confidence 8999999999999999997654 599999999999999999999999999999999999998 778899999999
Q ss_pred cccccCc---------------------cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 037285 967 SKIKRNT---------------------LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH 1025 (1094)
Q Consensus 967 Srl~~~~---------------------~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~ 1025 (1094)
+...... .......++..|+|||++. ...++.++||||||+++|+|++|+.||....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~--~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 149 AKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLN--EKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred ccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhC--CCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 8743221 1122345788999999987 3457889999999999999999999999877
Q ss_pred hHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCH----HHHHHH
Q 037285 1026 YGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSF----TEIASR 1074 (1094)
Q Consensus 1026 ~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~----eELLq~ 1074 (1094)
.......+... ...++..+++.+.++|.+||+.+|.+||++ .+++++
T Consensus 227 ~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 227 EYLTFQKILKL--EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHHHHHHHHhc--CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 65555555432 334566778999999999999999999999 888765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=322.49 Aligned_cols=252 Identities=27% Similarity=0.366 Sum_probs=203.0
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
.|+..+++|+|+||.||+|+.. +..||||......- .--+|+.+|+.+.|||||++..+|......
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------------~knrEl~im~~l~HpNIV~L~~~f~~~~~~ 92 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------------YKNRELQIMRKLDHPNIVRLLYFFSSSTES 92 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------------cCcHHHHHHHhcCCcCeeeEEEEEEecCCC
Confidence 4777899999999999999885 57799998765321 112699999999999999999888754433
Q ss_pred ---ceEEEeeecccchhHHHHhh---cccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 889 ---TLATVAEYMVDGSLRHVLVR---KDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 889 ---~L~IVmEYmegGSL~d~L~k---~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
++.+|||||+ .+|..+++. .+..++.-.+.-+.+||++||+|||+.||+||||||+|||+| ++.+.+|||
T Consensus 93 d~~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD---~~tg~LKic 168 (364)
T KOG0658|consen 93 DEVYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD---PDTGVLKIC 168 (364)
T ss_pred chhHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc---CCCCeEEec
Confidence 6779999996 677777753 244577778888999999999999999999999999999999 467999999
Q ss_pred ecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhc------
Q 037285 963 DFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN------ 1036 (1094)
Q Consensus 963 DFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~------ 1036 (1094)
|||.|+..........+..|..|.|||.+.| ...|+.+.||||.||+|.||+-|++-|.+......+..+++-
T Consensus 169 DFGSAK~L~~~epniSYicSRyYRaPELifg-a~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~ 247 (364)
T KOG0658|consen 169 DFGSAKVLVKGEPNISYICSRYYRAPELIFG-ATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTR 247 (364)
T ss_pred cCCcceeeccCCCceeEEEeccccCHHHHcC-ccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCH
Confidence 9999997665555556678999999999987 567899999999999999999999999987766555443221
Q ss_pred ---------------------cCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHHH
Q 037285 1037 ---------------------TLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR--LRVLS 1079 (1094)
Q Consensus 1037 ---------------------~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~--L~~L~ 1079 (1094)
.+...+....++++.+|+.++|..+|.+|.++.+++.+ ++.+.
T Consensus 248 e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 248 EDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR 313 (364)
T ss_pred HHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence 00011234568899999999999999999999999854 44444
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=303.09 Aligned_cols=247 Identities=25% Similarity=0.449 Sum_probs=201.6
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
.|...+.||+|+||.||++.+. +..+++|.+.... ......+.+|+.++++++||||+++++++....
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--------~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~-- 89 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--------QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGD-- 89 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--------hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCC--
Confidence 4555679999999999999874 5779999875421 112345778999999999999999999988754
Q ss_pred ceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 889 TLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
..++|+||+.+++|.+++.. ..+++..++.++.|++.||+|||+++++||||+|+||+++ .++.++|+|||++.
T Consensus 90 ~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~~l~d~g~~~ 163 (285)
T cd06648 90 ELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLT----SDGRVKLSDFGFCA 163 (285)
T ss_pred eEEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEc----CCCcEEEcccccch
Confidence 89999999999999999876 3589999999999999999999999999999999999998 77899999999887
Q ss_pred cccCc-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCC--CCc
Q 037285 969 IKRNT-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTI--PSY 1045 (1094)
Q Consensus 969 l~~~~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~i--Pe~ 1045 (1094)
..... .......++..|+|||++. ...++.++|||||||++|+|++|+.||...........+... ..+.. +..
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~ 240 (285)
T cd06648 164 QVSKEVPRRKSLVGTPYWMAPEVIS--RLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPPKLKNLHK 240 (285)
T ss_pred hhccCCcccccccCCccccCHHHhc--CCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCCCCccccc
Confidence 43322 1222345889999999987 345788999999999999999999999877665555544333 22222 233
Q ss_pred CcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1046 CDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1046 ~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
++..+.++|.+||+.+|.+||++.+++++-.
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 271 (285)
T cd06648 241 VSPRLRSFLDRMLVRDPAQRATAAELLNHPF 271 (285)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHccCcc
Confidence 7889999999999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=296.64 Aligned_cols=243 Identities=28% Similarity=0.408 Sum_probs=193.6
Q ss_pred EEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHH-HhhCCCCceeEEEeEeecCCCCceEE
Q 037285 816 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEI-LSKLHHPNVVAFYGVVQDGPGGTLAT 892 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkI-LkrL~HPNIVqL~Gv~~d~~~~~L~I 892 (1094)
+.||.|+||.||+|... ++.||||++.+.... .......+..|..+ ...++|+||+++++++.... .+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~l 74 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMI-----AKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKD--YLYL 74 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhh-----HHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCC--eEEE
Confidence 56999999999999874 678999998654221 11112234445444 44568999999999998754 8999
Q ss_pred EeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccC
Q 037285 893 VAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRN 972 (1094)
Q Consensus 893 VmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~ 972 (1094)
||||+.+++|..++.... .+++..+..++.||+.||.|||+.+++|+||+|+||+++ .++.+||+|||+++....
T Consensus 75 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~----~~~~~~l~dfg~~~~~~~ 149 (260)
T cd05611 75 VMEYLNGGDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID----QTGHLKLTDFGLSRNGLE 149 (260)
T ss_pred EEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----CCCcEEEeecccceeccc
Confidence 999999999999987654 589999999999999999999999999999999999998 678899999999875332
Q ss_pred ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccC--CCCCCCcCcHHH
Q 037285 973 TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL--RPTIPSYCDAEW 1050 (1094)
Q Consensus 973 ~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~l--rp~iPe~~S~eL 1050 (1094)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|..||...........+..... .......++..+
T Consensus 150 ---~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (260)
T cd05611 150 ---NKKFVGTPDYLAPETILG--VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEA 224 (260)
T ss_pred ---cccCCCCcCccChhhhcC--CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHH
Confidence 223457889999999874 3478999999999999999999999988777665555433322 223444678999
Q ss_pred HHHHHHhccCCCCCCCCH---HHHHHHH
Q 037285 1051 RTLMEECWAPNPAARPSF---TEIASRL 1075 (1094)
Q Consensus 1051 ~dLI~kCLq~DPeeRPS~---eELLq~L 1075 (1094)
.++|.+||..+|++||++ .+++.+-
T Consensus 225 ~~~i~~~l~~~p~~R~~~~~~~~~l~~~ 252 (260)
T cd05611 225 VDLINRLLCMDPAKRLGANGYQEIKSHP 252 (260)
T ss_pred HHHHHHHccCCHHHccCCCcHHHHHcCh
Confidence 999999999999999955 5666553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=331.21 Aligned_cols=245 Identities=25% Similarity=0.307 Sum_probs=192.3
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
...|.+.+.||+|+||.||++.+. +..||||.... ..+.+|+.+|++|+|+|||++++++....
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~ 233 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------------ASSVHEARLLRRLSHPAVLALLDVRVVGG 233 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------------cCHHHHHHHHHHCCCCCCCcEEEEEEECC
Confidence 457999999999999999999985 56799995321 23567999999999999999999988754
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
..++|||++. ++|..++......+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 234 --~~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~----~~~~vkL~DFGl 306 (461)
T PHA03211 234 --LTCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVN----GPEDICLGDFGA 306 (461)
T ss_pred --EEEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEEC----CCCCEEEcccCC
Confidence 8899999994 788888876656799999999999999999999999999999999999998 678899999999
Q ss_pred cccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--------hHHHHHhHhh
Q 037285 967 SKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH--------YGAIIGGIVN 1035 (1094)
Q Consensus 967 Srl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~--------~~eile~Iv~ 1035 (1094)
++..... .......||..|+|||++. ...++.++|||||||+||||++|..++-... ...+...+..
T Consensus 307 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~--~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~ 384 (461)
T PHA03211 307 ACFARGSWSTPFHYGIAGTVDTNAPEVLA--GDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQ 384 (461)
T ss_pred ceecccccccccccccCCCcCCcCHHHHc--CCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHh
Confidence 9854322 1122456999999999998 4568899999999999999999776542211 1122211111
Q ss_pred ccC-------------------------CCCCC-------CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1036 NTL-------------------------RPTIP-------SYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1036 ~~l-------------------------rp~iP-------e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
... ++... ...+..+.+||.+||+.||.+|||+.+|+++-+
T Consensus 385 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~ 457 (461)
T PHA03211 385 AQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPL 457 (461)
T ss_pred hccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcc
Confidence 110 00000 023457899999999999999999999998743
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=302.44 Aligned_cols=246 Identities=23% Similarity=0.339 Sum_probs=192.5
Q ss_pred EecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHH---HHhhCCCCceeEEEeEeecCCCCceE
Q 037285 817 ELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAE---ILSKLHHPNVVAFYGVVQDGPGGTLA 891 (1094)
Q Consensus 817 kLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIk---ILkrL~HPNIVqL~Gv~~d~~~~~L~ 891 (1094)
.||+|+||.||++... ++.+|||.+.+....... .+ ..+.+|.. ++...+||||+.+++++.... ..+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~ 73 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--GE---TLALNERIMLSLVSTGDCPFIVCMTYAFHTPD--KLC 73 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccch--HH---HHHHHHHHHHHHHhhCCCCcEeEEEEEEecCC--eEE
Confidence 3899999999999874 678999998765332111 11 12233433 344457999999999998754 899
Q ss_pred EEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCccccc
Q 037285 892 TVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKR 971 (1094)
Q Consensus 892 IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~ 971 (1094)
+||||+.+++|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|||++ .++.+||+|||++....
T Consensus 74 lv~e~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~----~~~~~~l~dfg~~~~~~ 148 (279)
T cd05633 74 FILDLMNGGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLD----EHGHVRISDLGLACDFS 148 (279)
T ss_pred EEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEEC----CCCCEEEccCCcceecc
Confidence 9999999999999887654 489999999999999999999999999999999999998 77899999999987443
Q ss_pred CccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH--HHHHhHhhccCCCCCCCcCcHH
Q 037285 972 NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG--AIIGGIVNNTLRPTIPSYCDAE 1049 (1094)
Q Consensus 972 ~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~--eile~Iv~~~lrp~iPe~~S~e 1049 (1094)
... .....++..|+|||.+.. ...++.++|||||||++|+|++|..||...... ...... .......++..++.+
T Consensus 149 ~~~-~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 225 (279)
T cd05633 149 KKK-PHASVGTHGYMAPEVLQK-GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTVNVELPDSFSPE 225 (279)
T ss_pred ccC-ccCcCCCcCccCHHHhcC-CCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH-hhcCCcCCccccCHH
Confidence 222 223458999999999863 345788999999999999999999999754321 122211 223344567778999
Q ss_pred HHHHHHHhccCCCCCCC-----CHHHHHHHHHH
Q 037285 1050 WRTLMEECWAPNPAARP-----SFTEIASRLRV 1077 (1094)
Q Consensus 1050 L~dLI~kCLq~DPeeRP-----S~eELLq~L~~ 1077 (1094)
+.++|.+||..||.+|| ++++++++.+.
T Consensus 226 ~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~ 258 (279)
T cd05633 226 LKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFF 258 (279)
T ss_pred HHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccc
Confidence 99999999999999999 69999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=346.95 Aligned_cols=258 Identities=26% Similarity=0.351 Sum_probs=204.4
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.++||+|+||.||+|++. ++.||||++..... ..+....+|.+|+.++++++||||+++++++.+..
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~-----~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~- 75 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS-----ENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD- 75 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccc-----cCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC-
Confidence 57999999999999999999874 67899999875421 12334567889999999999999999999998754
Q ss_pred CceEEEeeecccchhHHHHhhc----------ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCC
Q 037285 888 GTLATVAEYMVDGSLRHVLVRK----------DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRP 957 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~----------~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g 957 (1094)
..++||||+++++|.+++... ...++...++.++.||+.||+|||++||+||||||+|||++ ..+
T Consensus 76 -~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd----~dg 150 (932)
T PRK13184 76 -PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLG----LFG 150 (932)
T ss_pred -EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEc----CCC
Confidence 899999999999999998642 12355677889999999999999999999999999999998 778
Q ss_pred cEEEEecCCcccccC-------------------ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCC
Q 037285 958 ICKVGDFGLSKIKRN-------------------TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018 (1094)
Q Consensus 958 ~VKLsDFGLSrl~~~-------------------~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk 1018 (1094)
.+||+|||+++.... ........||+.|+|||++. ...++.++|||||||++|||+||+
T Consensus 151 ~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~--g~~~S~kSDIWSLGVILyELLTG~ 228 (932)
T PRK13184 151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLL--GVPASESTDIYALGVILYQMLTLS 228 (932)
T ss_pred CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhc--CCCCCcHhHHHHHHHHHHHHHHCC
Confidence 899999999975410 01112246899999999987 456789999999999999999999
Q ss_pred CCCCCCChHHHHHhH-hhccCCCCCCCcCcHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHHH
Q 037285 1019 EPYANMHYGAIIGGI-VNNTLRPTIPSYCDAEWRTLMEECWAPNPAARP-SFTEIASRLRVLST 1080 (1094)
Q Consensus 1019 ~PF~~~~~~eile~I-v~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRP-S~eELLq~L~~L~t 1080 (1094)
.||............ ............++..+.+++.+||..||.+|+ +++++++.|..+..
T Consensus 229 ~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 229 FPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred CCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 999875543332211 111001111235788899999999999999996 67778888887754
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=306.27 Aligned_cols=250 Identities=27% Similarity=0.421 Sum_probs=202.6
Q ss_pred CCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
.+|++.+.||+|+||.||++.. .+..||+|.+.... ......+.+|+.++++++||||+++++++....
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~- 89 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--------QPKKELIINEILVMRENKHPNIVNYLDSYLVGD- 89 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--------chHHHHHHHHHHHHhhcCCCCeeehhheeeeCC-
Confidence 5889999999999999999976 46789999885421 112356788999999999999999999998755
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
..++|+||+.+++|.+++.+. .+++..+..++.|++.||.|||+++++|+||+|+||+++ .++.+||+|||++
T Consensus 90 -~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~----~~~~~kL~dfg~~ 162 (293)
T cd06647 90 -ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG----MDGSVKLTDFGFC 162 (293)
T ss_pred -cEEEEEecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEc----CCCCEEEccCcce
Confidence 899999999999999998654 478889999999999999999999999999999999998 6778999999988
Q ss_pred ccccC-ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccC-CCCCCCc
Q 037285 968 KIKRN-TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL-RPTIPSY 1045 (1094)
Q Consensus 968 rl~~~-~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~l-rp~iPe~ 1045 (1094)
..... ........+++.|+|||.+. ...++.++|||||||++|+|++|+.||...........+..... ....+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T cd06647 163 AQITPEQSKRSTMVGTPYWMAPEVVT--RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEK 240 (293)
T ss_pred ecccccccccccccCChhhcCchhhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccc
Confidence 74322 12223345888999999987 34678899999999999999999999987655443322221111 1122345
Q ss_pred CcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1046 CDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1046 ~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
++..++++|.+||..+|.+||++.+++.+-+-
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~ 272 (293)
T cd06647 241 LSAIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272 (293)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCHHH
Confidence 67889999999999999999999999988544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=308.63 Aligned_cols=249 Identities=25% Similarity=0.417 Sum_probs=201.8
Q ss_pred CeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
.|.....||+|+||.||++.. ++..||||.+.... ......+.+|+.++++++|+||+++++.+....
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~-- 92 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--------QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD-- 92 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--------HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC--
Confidence 444557799999999999986 46789999885431 122356789999999999999999999988755
Q ss_pred ceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 889 TLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
..++||||+.+++|.+++... .+++..++.++.||+.||.|||+++|+||||||+||+++ .++.+||+|||++.
T Consensus 93 ~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~----~~~~~kL~dfg~~~ 166 (292)
T cd06658 93 ELWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLT----SDGRIKLSDFGFCA 166 (292)
T ss_pred eEEEEEeCCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc----CCCCEEEccCcchh
Confidence 899999999999999988543 488999999999999999999999999999999999998 67889999999987
Q ss_pred cccCc-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCC--CCCc
Q 037285 969 IKRNT-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT--IPSY 1045 (1094)
Q Consensus 969 l~~~~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~--iPe~ 1045 (1094)
..... .......++..|+|||++. ...++.++||||||+++|||++|+.||...........+.. ..... ....
T Consensus 167 ~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~ 243 (292)
T cd06658 167 QVSKEVPKRKSLVGTPYWMAPEVIS--RLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD-NLPPRVKDSHK 243 (292)
T ss_pred hcccccccCceeecCccccCHHHHc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-cCCCccccccc
Confidence 43221 1222345889999999987 45678899999999999999999999987766554443322 22222 2235
Q ss_pred CcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1046 CDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1046 ~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
++..+.++|.+||..||.+|||+.+++++-+-.
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~ 276 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQHPFLK 276 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhChhhh
Confidence 678899999999999999999999999875543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=312.57 Aligned_cols=255 Identities=24% Similarity=0.369 Sum_probs=197.4
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC-
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP- 886 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~- 886 (1094)
++|++.+.||+|+||.||+|++. ++.||||.+.... .......+.+|+.++++++|+||+++++++....
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 77 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-------HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSF 77 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-------cchhHHHHHHHHHHHHhCCCCCcCchhheeecccc
Confidence 58999999999999999999874 6889999986421 1123356778999999999999999999876432
Q ss_pred --CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 887 --GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 887 --~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
...+++|+||+. ++|..++.. ..+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+||
T Consensus 78 ~~~~~~~lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~----~~~~~kl~df 150 (336)
T cd07849 78 ESFNDVYIVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN----TNCDLKICDF 150 (336)
T ss_pred cccceEEEEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC----CCCCEEECcc
Confidence 135799999996 577777744 3589999999999999999999999999999999999998 7889999999
Q ss_pred CCcccccCcc----ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhh-----
Q 037285 965 GLSKIKRNTL----VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN----- 1035 (1094)
Q Consensus 965 GLSrl~~~~~----~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~----- 1035 (1094)
|+++...... ......++..|+|||.+.+ ...++.++|||||||++|+|++|+.||...........+..
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~ 229 (336)
T cd07849 151 GLARIADPEHDHTGFLTEYVATRWYRAPEIMLN-SKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTP 229 (336)
T ss_pred cceeeccccccccCCcCCcCcCCCccChHHhhC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 9987532211 1123457899999998753 34578899999999999999999999976554332211110
Q ss_pred ----------cc---------CCCC-----CCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHHH
Q 037285 1036 ----------NT---------LRPT-----IPSYCDAEWRTLMEECWAPNPAARPSFTEIASR--LRVLS 1079 (1094)
Q Consensus 1036 ----------~~---------lrp~-----iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~--L~~L~ 1079 (1094)
.. .... .....+.++.++|.+||+.+|++|||+.+++++ ++.+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred CHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 00 0000 012356789999999999999999999999998 44443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=318.48 Aligned_cols=259 Identities=28% Similarity=0.363 Sum_probs=208.5
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCc-eeEEEeEeecC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPN-VVAFYGVVQDG 885 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPN-IVqL~Gv~~d~ 885 (1094)
...|+..++||+|+||+||+|+.+ |..||+|.++..... |......++|+.+|+.|+|+| ||.+++++.+.
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~------EG~P~taiREisllk~L~~~~~iv~L~dv~~~~ 83 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE------EGVPSTAIREISLLKRLSHANHIVRLHDVIHTS 83 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc------cCCCchhhHHHHHHHHhCCCcceEEEEeeeeec
Confidence 356777888999999999999874 778999999865321 223356679999999999999 99999999875
Q ss_pred C----CCceEEEeeecccchhHHHHhhcc---cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCc
Q 037285 886 P----GGTLATVAEYMVDGSLRHVLVRKD---RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPI 958 (1094)
Q Consensus 886 ~----~~~L~IVmEYmegGSL~d~L~k~~---~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~ 958 (1094)
. .+.+++|+||+ .-+|..++.... ..++...+..+..||+.||+|||+++|+||||||+||||+ +.+.
T Consensus 84 ~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~----~~G~ 158 (323)
T KOG0594|consen 84 NNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLIS----SSGV 158 (323)
T ss_pred ccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEEC----CCCc
Confidence 3 24789999998 688999997765 3578889999999999999999999999999999999999 7899
Q ss_pred EEEEecCCcccccCc-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhc-
Q 037285 959 CKVGDFGLSKIKRNT-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN- 1036 (1094)
Q Consensus 959 VKLsDFGLSrl~~~~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~- 1036 (1094)
+||+|||+|+...-. .......+|.+|.|||++.|. ..|+...||||+|||++||++++..|.+....+.+..+...
T Consensus 159 lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs-~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~l 237 (323)
T KOG0594|consen 159 LKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGS-TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLL 237 (323)
T ss_pred EeeeccchHHHhcCCcccccccEEEeeccCHHHhcCC-CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHc
Confidence 999999999955422 223345689999999999974 45899999999999999999999999988876665554331
Q ss_pred ---------------cCCCCCCC------------cCcHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHHH
Q 037285 1037 ---------------TLRPTIPS------------YCDAEWRTLMEECWAPNPAARPSFTEIASR--LRVLS 1079 (1094)
Q Consensus 1037 ---------------~lrp~iPe------------~~S~eL~dLI~kCLq~DPeeRPS~eELLq~--L~~L~ 1079 (1094)
.+...++. ....+..+++.+||+.+|.+|.|++..+.+ +..+.
T Consensus 238 GtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 238 GTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred CCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 01111111 122467899999999999999999999988 55543
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=307.22 Aligned_cols=255 Identities=29% Similarity=0.440 Sum_probs=206.8
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
..|+..+.||+|+||.||+|+++ +..+|||.+...... ......++.+|+.+++.++|+|++++++++....
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 88 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-----SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH- 88 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccccc-----ChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC-
Confidence 45777889999999999999874 577999988643211 1223456788999999999999999999998754
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
..++||||+. |+|.+++......+++..++.++.|++.||.|||+++++||||+|+|||++ .++.+||+|||++
T Consensus 89 -~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~----~~~~~kl~dfg~~ 162 (308)
T cd06634 89 -TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS----EPGLVKLGDFGSA 162 (308)
T ss_pred -eeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEEC----CCCcEEECCcccc
Confidence 8899999996 678887766556689999999999999999999999999999999999998 6788999999998
Q ss_pred ccccCccccCCccCCCcccCcccccc-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcC
Q 037285 968 KIKRNTLVSGGVRGTLPWMAPELLSG-SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYC 1046 (1094)
Q Consensus 968 rl~~~~~~ss~~~GT~~YmAPEvL~g-~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~ 1046 (1094)
...... ....++..|+|||.+.+ ....++.++|||||||++|+|++|+.||......+....+............+
T Consensus 163 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (308)
T cd06634 163 SIMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW 239 (308)
T ss_pred eeecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccc
Confidence 754332 23457889999999752 13457889999999999999999999998776655555444433333334567
Q ss_pred cHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1047 DAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1047 S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
+..+.+||.+||..+|.+||++.+++.+.+...
T Consensus 240 ~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 240 SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred cHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 889999999999999999999999998877544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=301.57 Aligned_cols=253 Identities=24% Similarity=0.383 Sum_probs=200.5
Q ss_pred CeeEEEEecccCceEEEEeeec-----CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEeec
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQD 884 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r-----Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~~d 884 (1094)
+|++.+.||+|+||.||++++. +..||||.+++... .........+.+|+.++.++ +||||+++++++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~----~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~ 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI----VQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHH----HhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec
Confidence 4788999999999999998753 46799999875421 11223345678899999999 59999999999877
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
.. .+++||||+.+++|.+++.... .+++..+..++.|++++|.|||+.+++|+||+|+||+++ .++.++|+||
T Consensus 77 ~~--~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~----~~~~~~l~df 149 (288)
T cd05583 77 DT--KLHLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLD----SEGHVVLTDF 149 (288)
T ss_pred CC--EEEEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC----CCCCEEEEEC
Confidence 54 8999999999999999987653 488999999999999999999999999999999999998 6788999999
Q ss_pred CCcccccCc--cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh----HHHHHhHhhccC
Q 037285 965 GLSKIKRNT--LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY----GAIIGGIVNNTL 1038 (1094)
Q Consensus 965 GLSrl~~~~--~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~----~eile~Iv~~~l 1038 (1094)
|+++..... .......++..|+|||.+.+.....+.++||||||+++|+|++|..||..... .+....+.. .
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--~ 227 (288)
T cd05583 150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK--S 227 (288)
T ss_pred ccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc--c
Confidence 998743221 11223457889999999875333468899999999999999999999964322 222222222 2
Q ss_pred CCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1039 RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1039 rp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
....+..++..++++|.+||+.+|++|||+.++.+.|.
T Consensus 228 ~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 228 KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 24456678899999999999999999999766654443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=296.76 Aligned_cols=251 Identities=27% Similarity=0.444 Sum_probs=202.5
Q ss_pred CeeEEEEecccCceEEEEeeecC--ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~rG--t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
+|.+.++||+|+||.||++++.. ..+++|+++........ ......+..|+.++++++||||+++++++.+..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELN---PNETVQANQEAQLLSKLDHPAIVKFHASFLERD-- 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccC---cchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC--
Confidence 58889999999999999998853 44667766543221111 112235667899999999999999999988755
Q ss_pred ceEEEeeecccchhHHHHhh---cccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecC
Q 037285 889 TLATVAEYMVDGSLRHVLVR---KDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k---~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFG 965 (1094)
..++||||+.+++|..++.. ....+++..++.++.|++.||.|||+++++|+||+|+||+++ .+.+||+|||
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~-----~~~~~l~d~g 150 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK-----NNLLKIGDFG 150 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee-----cCCEeecccC
Confidence 78999999999999988864 234689999999999999999999999999999999999997 2469999999
Q ss_pred Cccccc-CccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCC
Q 037285 966 LSKIKR-NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPS 1044 (1094)
Q Consensus 966 LSrl~~-~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe 1044 (1094)
+++... .........++..|+|||.+. ...++.++|+||||+++|+|++|..||...........+.. ...+..+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 227 (260)
T cd08222 151 VSRLLMGSCDLATTFTGTPYYMSPEALK--HQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE-GPTPSLPE 227 (260)
T ss_pred ceeecCCCcccccCCCCCcCccCHHHHc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc-CCCCCCcc
Confidence 987542 222233455788999999986 45678899999999999999999999987766655555433 44455677
Q ss_pred cCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1045 YCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1045 ~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
.++.++.++|.+||..+|++||++.+++++
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 228 TYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred hhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 788999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=297.18 Aligned_cols=250 Identities=28% Similarity=0.335 Sum_probs=195.6
Q ss_pred eeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC---CCCceeEEEeEeecCC
Q 037285 812 LEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL---HHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 812 Yei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL---~HPNIVqL~Gv~~d~~ 886 (1094)
|++.+.||+|+||.||+|+++ +..+|+|+++..... ......+.+|+.+++++ +|+||+++++++....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 74 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE------EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPR 74 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc------chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence 678899999999999999985 688999999754221 11123455677766655 6999999999998654
Q ss_pred C---CceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 887 G---GTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 887 ~---~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
. ..++++|||+. ++|.+++.... ..+++..++.++.||+.||.|||+.+++|+||+|+||+++ .++.+||+
T Consensus 75 ~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~----~~~~~~l~ 149 (287)
T cd07838 75 TDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT----SDGQVKIA 149 (287)
T ss_pred CCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEc----cCCCEEEe
Confidence 1 13899999996 57888886643 3589999999999999999999999999999999999999 67899999
Q ss_pred ecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCC---
Q 037285 963 DFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR--- 1039 (1094)
Q Consensus 963 DFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lr--- 1039 (1094)
|||++.............++..|+|||++. ...++.++|||||||++|+|++|+.||......+....+......
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~--~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07838 150 DFGLARIYSFEMALTSVVVTLWYRAPEVLL--QSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSE 227 (287)
T ss_pred ccCcceeccCCcccccccccccccChHHhc--cCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCCh
Confidence 999988654333333345788999999997 446788999999999999999999999887766555444331100
Q ss_pred ---------------C-------CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1040 ---------------P-------TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1040 ---------------p-------~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
. ......+..+.++|.+||+.||.+||++.+++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 228 EEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred HhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0 0001235678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=304.14 Aligned_cols=248 Identities=28% Similarity=0.431 Sum_probs=202.8
Q ss_pred eeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCc
Q 037285 812 LEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGT 889 (1094)
Q Consensus 812 Yei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~ 889 (1094)
|...++||+|+||+||+|++ .+..||+|.+...... .......+.+|+.++++++|||++++++++.+.. .
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~ 95 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQ-----TNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEH--T 95 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccC-----chHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC--E
Confidence 56678899999999999987 4678999998654221 1223456788999999999999999999998865 8
Q ss_pred eEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCccc
Q 037285 890 LATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI 969 (1094)
Q Consensus 890 L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl 969 (1094)
.++||||+. ++|.+++......+++..++.++.||+.+|.|||++|++|+||+|+||+++ .++.+||+|||++..
T Consensus 96 ~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~----~~~~~kL~dfg~~~~ 170 (313)
T cd06633 96 AWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT----EPGQVKLADFGSASK 170 (313)
T ss_pred EEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEEC----CCCCEEEeecCCCcc
Confidence 999999995 678788776666789999999999999999999999999999999999998 678899999999864
Q ss_pred ccCccccCCccCCCcccCcccccc-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCcH
Q 037285 970 KRNTLVSGGVRGTLPWMAPELLSG-SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDA 1048 (1094)
Q Consensus 970 ~~~~~~ss~~~GT~~YmAPEvL~g-~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~ 1048 (1094)
... .....++..|+|||++.. ....++.++|||||||++|+|++|..||...........+............++.
T Consensus 171 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (313)
T cd06633 171 SSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTD 247 (313)
T ss_pred cCC---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCH
Confidence 322 224568889999999842 1345788999999999999999999999887765555554443333333345678
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1049 EWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1049 eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
.+.+||.+||+.+|.+||++.+++.+
T Consensus 248 ~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 248 SFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 89999999999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=309.94 Aligned_cols=252 Identities=27% Similarity=0.366 Sum_probs=199.3
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEeecCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~~d~~ 886 (1094)
++|++.+.||+|+||.||+|.+. +..+|||.+...... ......+.+|+.+++++ +||||++++++|....
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~------~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~ 80 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN------ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN 80 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCc------chhhhhhhHHHHHHHHhcCCCCccceeeeeccCC
Confidence 57889999999999999999874 678999988643111 11224567899999999 9999999999987654
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
...+++||||+. ++|..++... .+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~----~~~~~kl~d~g~ 153 (337)
T cd07852 81 DKDIYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLN----SDCRVKLADFGL 153 (337)
T ss_pred CceEEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCcEEEeeccc
Confidence 457899999997 5898888654 578889999999999999999999999999999999999 788999999999
Q ss_pred cccccCc------cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccC--
Q 037285 967 SKIKRNT------LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL-- 1038 (1094)
Q Consensus 967 Srl~~~~------~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~l-- 1038 (1094)
++..... .......++..|+|||.+.+ ...++.++||||||+++|+|+||+.||...........+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 232 (337)
T cd07852 154 ARSLSELEENPENPVLTDYVATRWYRAPEILLG-STRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPP 232 (337)
T ss_pred hhccccccccccCcchhcccccccccCceeeec-cccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 8743221 12223458889999998864 34578899999999999999999999986654433322211100
Q ss_pred ------------------------C---CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037285 1039 ------------------------R---PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1039 ------------------------r---p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L 1075 (1094)
. ......++.++.++|.+||+.+|.+|||+.+++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~ 296 (337)
T cd07852 233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHP 296 (337)
T ss_pred CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhCh
Confidence 0 011123678899999999999999999999999873
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=298.30 Aligned_cols=249 Identities=26% Similarity=0.356 Sum_probs=200.2
Q ss_pred eeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCc
Q 037285 812 LEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGT 889 (1094)
Q Consensus 812 Yei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~ 889 (1094)
|++.+.||.|++|.||+++.. +..+++|.+...... ......+.+|+.++++++|+||+++++++.... .
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~ 72 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES------EGIPKTALREIKLLKELNHPNIIKLLDVFRHKG--D 72 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc------chhHHHHHHHHHHHHHhcCCCcchHHHhhccCC--C
Confidence 566789999999999999874 678999998754321 123356778999999999999999999988764 8
Q ss_pred eEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCccc
Q 037285 890 LATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI 969 (1094)
Q Consensus 890 L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl 969 (1094)
+++|+||+.+ +|.+++......+++..++.++.||+.||.|||+++|+|+||||+||+++ .++.+||+|||.+..
T Consensus 73 ~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~----~~~~~~l~df~~~~~ 147 (283)
T cd05118 73 LYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLIN----TEGVLKLADFGLARS 147 (283)
T ss_pred EEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEEC----CCCcEEEeeeeeeEe
Confidence 9999999975 88888877656789999999999999999999999999999999999998 678899999999875
Q ss_pred ccCcc-ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCC---------
Q 037285 970 KRNTL-VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR--------- 1039 (1094)
Q Consensus 970 ~~~~~-~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lr--------- 1039 (1094)
..... ......++..|+|||.+.+ ...++.++||||||+++|+|+||+.||...+..+....+......
T Consensus 148 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd05118 148 FGSPVRPYTHYVVTRWYRAPELLLG-DKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKF 226 (283)
T ss_pred cCCCcccccCccCcccccCcHHHhc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccc
Confidence 44332 2223457888999999874 336789999999999999999999999877665443333221000
Q ss_pred -------------------CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1040 -------------------PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1040 -------------------p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
......++..+.++|.+||+.||.+||++.+++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 227 TSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00112367889999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=304.22 Aligned_cols=257 Identities=17% Similarity=0.202 Sum_probs=187.5
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeecCc-----eEEEEEeecCccCCCchhHHHH------HHHHHHHHHHHhhCCCC
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWRGT-----DVAIKRIKKSCFTGRSSEQERL------TVEFWKEAEILSKLHHP 873 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~rGt-----~VAVKiIkk~~~se~~~eqe~~------~~eFlrEIkILkrL~HP 873 (1094)
..+...+|++.++||+|+||.||+|.+.+. .+|+|+..... .....+.. ......+...+..+.|+
T Consensus 7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~---~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~ 83 (294)
T PHA02882 7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLEN---ETIVMETLVYNNIYDIDKIALWKNIHNIDHL 83 (294)
T ss_pred eccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccC---CchhhHHHHHHhhhhHHHHHHHHHhccCCCC
Confidence 345667999999999999999999988643 46666543221 11111110 11233445566778999
Q ss_pred ceeEEEeEeecCCCC--ceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEecc
Q 037285 874 NVVAFYGVVQDGPGG--TLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNL 951 (1094)
Q Consensus 874 NIVqL~Gv~~d~~~~--~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~ 951 (1094)
||+++++++...... ..+++++++. .++.+.+.... ..++..++.++.|++.||.|||+++|+||||||+|||++
T Consensus 84 ~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~- 160 (294)
T PHA02882 84 GIPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVD- 160 (294)
T ss_pred CCCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc-
Confidence 999999976543221 3466777763 35555554432 357888899999999999999999999999999999998
Q ss_pred CCCCCCcEEEEecCCcccccCc--------cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 037285 952 KDPSRPICKVGDFGLSKIKRNT--------LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN 1023 (1094)
Q Consensus 952 ~~~e~g~VKLsDFGLSrl~~~~--------~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~ 1023 (1094)
.++.+||+|||+++..... .......||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 161 ---~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~--~~~~~~~~DiwSlG~~l~el~~g~~P~~~ 235 (294)
T PHA02882 161 ---GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHN--GACVTRRGDLESLGYCMLKWAGIKLPWKG 235 (294)
T ss_pred ---CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhC--CCCCCcHHHHHHHHHHHHHHHhCCCCCCc
Confidence 6778999999999743211 1122346999999999987 45689999999999999999999999987
Q ss_pred CCh-HHHH--------HhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037285 1024 MHY-GAII--------GGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1024 ~~~-~eil--------e~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L 1075 (1094)
... .... ..+.... .....++..+.+++..||..+|++||++.+|++.|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 236 FGHNGNLIHAAKCDFIKRLHEGK---IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred cccchHHHHHhHHHHHHHhhhhh---hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 732 2221 1111111 12346789999999999999999999999999876
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=306.67 Aligned_cols=250 Identities=24% Similarity=0.390 Sum_probs=202.1
Q ss_pred eeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCc
Q 037285 812 LEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGT 889 (1094)
Q Consensus 812 Yei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~ 889 (1094)
|.....||.|+||.||++.. .+..||||.+..... .....+.+|+.++..+.||||+++++++.... .
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--------~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~--~ 92 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--------QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGE--E 92 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--------chHHHHHHHHHHHHhCCCCchhhhhhheeeCC--e
Confidence 33445799999999999977 478899999864321 11245778999999999999999999988755 8
Q ss_pred eEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCccc
Q 037285 890 LATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI 969 (1094)
Q Consensus 890 L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl 969 (1094)
.++||||+++++|..++.. ..+++..++.++.||+.||.|||+++++||||||+|||++ .++.+||+|||++..
T Consensus 93 ~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~----~~~~~kL~dfg~~~~ 166 (297)
T cd06659 93 LWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLT----LDGRVKLSDFGFCAQ 166 (297)
T ss_pred EEEEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEc----cCCcEEEeechhHhh
Confidence 9999999999999987754 3489999999999999999999999999999999999998 778999999999874
Q ss_pred ccCc-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccC-CCCCCCcCc
Q 037285 970 KRNT-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL-RPTIPSYCD 1047 (1094)
Q Consensus 970 ~~~~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~l-rp~iPe~~S 1047 (1094)
.... .......++..|+|||++. ...++.++|||||||++|+|++|+.||......+....+..... .......++
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (297)
T cd06659 167 ISKDVPKRKSLVGTPYWMAPEVIS--RTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKIS 244 (297)
T ss_pred cccccccccceecCccccCHHHHc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCC
Confidence 3222 1223355889999999997 34678899999999999999999999987766555544322211 112234567
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1048 AEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1048 ~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
..+.++|.+||+.+|.+||++.+|+++-.-+.
T Consensus 245 ~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~ 276 (297)
T cd06659 245 PVLRDFLERMLTREPQERATAQELLDHPFLLQ 276 (297)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhhChhhcc
Confidence 88999999999999999999999999765544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=302.18 Aligned_cols=254 Identities=26% Similarity=0.365 Sum_probs=196.8
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.++||.|+||.||+|+++ ++.+|||++....... .....+.+|+.++++++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD------GFPITALREIKILKKLKHPNVVPLIDMAVERP 80 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC------CcchhHHHHHHHHHhcCCCCccchhhheeccc
Confidence 368999999999999999999885 6789999987543221 11234568999999999999999999876533
Q ss_pred ------CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEE
Q 037285 887 ------GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICK 960 (1094)
Q Consensus 887 ------~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VK 960 (1094)
...+++||||+.+ +|...+......+++..+..++.||++||.|||++||+|+||||+|||++ +++.+|
T Consensus 81 ~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~----~~~~~~ 155 (311)
T cd07866 81 DKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILID----NQGILK 155 (311)
T ss_pred ccccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCCEE
Confidence 2257999999864 67676665555699999999999999999999999999999999999999 788999
Q ss_pred EEecCCcccccCccc------------cCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH
Q 037285 961 VGDFGLSKIKRNTLV------------SGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA 1028 (1094)
Q Consensus 961 LsDFGLSrl~~~~~~------------ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~e 1028 (1094)
|+|||+++....... .....++..|+|||++.+ ...++.++|||||||++|+|++|+.||.......
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~ 234 (311)
T cd07866 156 IADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG-ERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID 234 (311)
T ss_pred ECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhC-CCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999999874322111 112346788999999864 3457889999999999999999999998766544
Q ss_pred HHHhHhhccCC---------------------CCCC-------CcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1029 IIGGIVNNTLR---------------------PTIP-------SYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1029 ile~Iv~~~lr---------------------p~iP-------e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
....+...... ...+ ..+...+.++|.+||..+|.+|||+.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 235 QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 43332221000 0000 1234678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=319.22 Aligned_cols=254 Identities=29% Similarity=0.408 Sum_probs=221.2
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEe
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVV 882 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~ 882 (1094)
..++-++|.++++||+|+||.|-+++-+ ++.+|||++++..+..+. .+..-+.|-++|+..+||.+..+...|
T Consensus 163 ~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakd-----EVAHTlTE~RVL~~~~HPFLt~LKYsF 237 (516)
T KOG0690|consen 163 NKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKD-----EVAHTLTENRVLQNCRHPFLTSLKYSF 237 (516)
T ss_pred ceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehH-----HhhhhhhHHHHHHhccCcHHHHhhhhh
Confidence 4567789999999999999999998775 678999999988665432 234456789999999999999998888
Q ss_pred ecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 883 QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 883 ~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
+... .+|+||||..||.|.-.|.+.. .+++.....+..+|+.||.|||+++||+||||.+|+|+| .+|++||+
T Consensus 238 Qt~d--rlCFVMeyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLD----kDGHIKit 310 (516)
T KOG0690|consen 238 QTQD--RLCFVMEYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLD----KDGHIKIT 310 (516)
T ss_pred ccCc--eEEEEEEEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheec----cCCceEee
Confidence 8765 9999999999999998887654 488888888999999999999999999999999999999 88999999
Q ss_pred ecCCccc-ccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCC
Q 037285 963 DFGLSKI-KRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT 1041 (1094)
Q Consensus 963 DFGLSrl-~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~ 1041 (1094)
|||+++. ......+.++|||+.|+|||++. ...|..++|+|.+||+||||++|+.||...++..+.+.++...+ .
T Consensus 311 DFGLCKE~I~~g~t~kTFCGTPEYLAPEVle--DnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~--k 386 (516)
T KOG0690|consen 311 DFGLCKEEIKYGDTTKTFCGTPEYLAPEVLE--DNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL--K 386 (516)
T ss_pred ecccchhcccccceeccccCChhhcCchhhc--cccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc--c
Confidence 9999984 34445567899999999999998 67899999999999999999999999999999888887776655 4
Q ss_pred CCCcCcHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 037285 1042 IPSYCDAEWRTLMEECWAPNPAARP-----SFTEIASR 1074 (1094)
Q Consensus 1042 iPe~~S~eL~dLI~kCLq~DPeeRP-----S~eELLq~ 1074 (1094)
+|..++++.+.|+..+|.+||.+|. ++.+|.++
T Consensus 387 FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 387 FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 8889999999999999999999995 56666544
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=308.42 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=195.9
Q ss_pred EEeccc--CceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceE
Q 037285 816 KELGSG--TFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLA 891 (1094)
Q Consensus 816 kkLGsG--~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~ 891 (1094)
..||+| +||+||++++ .++.||||++...... ....+.+.+|+.+++.++||||++++++|.... .++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~--~~~ 75 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT------EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS--WLW 75 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC------HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCC--ceE
Confidence 356666 9999999987 4789999998653211 123467888999999999999999999998865 899
Q ss_pred EEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccc
Q 037285 892 TVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK 970 (1094)
Q Consensus 892 IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~ 970 (1094)
+||||+.+++|.+++.+.. ..+++..+..++.||+.||+|||+++|+||||||+|||++ ..+.+|++||+.+...
T Consensus 76 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~----~~~~~~~~~~~~~~~~ 151 (328)
T cd08226 76 VISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS----GDGLVSLSGLSHLYSL 151 (328)
T ss_pred EEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEe----CCCcEEEechHHHhhh
Confidence 9999999999999987643 3588999999999999999999999999999999999998 6788999999865321
Q ss_pred cCc--------cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhcc-----
Q 037285 971 RNT--------LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT----- 1037 (1094)
Q Consensus 971 ~~~--------~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~----- 1037 (1094)
... .......++..|+|||++.+....++.++|||||||++|+|++|+.||................
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd08226 152 VRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPL 231 (328)
T ss_pred hccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCc
Confidence 110 0011123456799999997544567899999999999999999999998766544332222110
Q ss_pred ----------------------------------------CCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1038 ----------------------------------------LRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1038 ----------------------------------------lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
.+...+..++..+.+||++||..||++|||+.+++++-+-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~ 311 (328)
T cd08226 232 DITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFF 311 (328)
T ss_pred cccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHH
Confidence 0111123356788999999999999999999999988775
Q ss_pred HH
Q 037285 1078 LS 1079 (1094)
Q Consensus 1078 L~ 1079 (1094)
..
T Consensus 312 ~~ 313 (328)
T cd08226 312 KQ 313 (328)
T ss_pred HH
Confidence 44
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=296.80 Aligned_cols=248 Identities=27% Similarity=0.385 Sum_probs=197.1
Q ss_pred eeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-CCceeEEEeEeecCCCC
Q 037285 812 LEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 812 Yei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-HPNIVqL~Gv~~d~~~~ 888 (1094)
|++.+.||+|+||+||+|+.. +..||||.+...... . ......+|+..+++++ |+||+++++++....
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~----~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~-- 71 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS----W---EECMNLREVKSLRKLNEHPNIVKLKEVFREND-- 71 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc----h---hHHHHHHHHHHHHhccCCCCchhHHHHhhcCC--
Confidence 677899999999999999984 577999998654211 1 1123456889999999 999999999998744
Q ss_pred ceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 889 TLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
..++||||+ +++|.+++.... ..+++..++.++.|++.+|.|||+++++|+||+|+||+++ .++.++|+|||++
T Consensus 72 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~----~~~~~~l~d~~~~ 146 (283)
T cd07830 72 ELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVS----GPEVVKIADFGLA 146 (283)
T ss_pred cEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc----CCCCEEEeecccc
Confidence 899999999 889988887654 4689999999999999999999999999999999999999 7889999999999
Q ss_pred ccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhc-----------
Q 037285 968 KIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN----------- 1036 (1094)
Q Consensus 968 rl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~----------- 1036 (1094)
+............++..|+|||++.. ...++.++|+||||+++|+|++|+.||...........+...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd07830 147 REIRSRPPYTDYVSTRWYRAPEILLR-STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPE 225 (283)
T ss_pred eeccCCCCcCCCCCcccccCceeeec-CcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhh
Confidence 86544333334557889999998863 345788999999999999999999999776554433322110
Q ss_pred ------cCCC-----------CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1037 ------TLRP-----------TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1037 ------~lrp-----------~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
.... ......+..+.++|.+||+.+|.+||++.+++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 226 GYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred HhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000 0011235789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=298.31 Aligned_cols=248 Identities=23% Similarity=0.317 Sum_probs=193.2
Q ss_pred EecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEEEe
Q 037285 817 ELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVA 894 (1094)
Q Consensus 817 kLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~IVm 894 (1094)
.||+|+||.||+++.. ++.||||.+.+....... .+.........+.+++...||+|+++++++.... .+++||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~~v~ 76 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--GETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD--KLSFIL 76 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccch--hHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC--EEEEEE
Confidence 3899999999998874 678999998765332111 1111111122334455568999999999998765 899999
Q ss_pred eecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccCcc
Q 037285 895 EYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTL 974 (1094)
Q Consensus 895 EYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~~ 974 (1094)
||+.+++|..++.... .+++..+..++.|++.||.|||+.+|+||||||+||+++ .++.+||+|||++.......
T Consensus 77 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~----~~~~~kl~dfg~~~~~~~~~ 151 (278)
T cd05606 77 DLMNGGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD----EHGHVRISDLGLACDFSKKK 151 (278)
T ss_pred ecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEEC----CCCCEEEccCcCccccCccC
Confidence 9999999999886543 589999999999999999999999999999999999998 67889999999987443221
Q ss_pred ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh---HHHHHhHhhccCCCCCCCcCcHHHH
Q 037285 975 VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY---GAIIGGIVNNTLRPTIPSYCDAEWR 1051 (1094)
Q Consensus 975 ~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~---~eile~Iv~~~lrp~iPe~~S~eL~ 1051 (1094)
.....|+..|+|||++.+ ...++.++|||||||++|+|++|+.||..... ...... .......++..++..+.
T Consensus 152 -~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~s~~~~ 227 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQK-GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM--TLTMAVELPDSFSPELR 227 (278)
T ss_pred -CcCcCCCcCCcCcHHhcC-CCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH--hhccCCCCCCcCCHHHH
Confidence 223468999999999863 23578899999999999999999999987632 222211 22234556677899999
Q ss_pred HHHHHhccCCCCCCC-----CHHHHHHHHHH
Q 037285 1052 TLMEECWAPNPAARP-----SFTEIASRLRV 1077 (1094)
Q Consensus 1052 dLI~kCLq~DPeeRP-----S~eELLq~L~~ 1077 (1094)
+++.+||..+|.+|| ++.+++++-+-
T Consensus 228 ~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~ 258 (278)
T cd05606 228 SLLEGLLQRDVNRRLGCLGRGAQEVKEHPFF 258 (278)
T ss_pred HHHHHHhhcCHHhccCCCCCCHHHHHhCccc
Confidence 999999999999999 99999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=309.72 Aligned_cols=257 Identities=25% Similarity=0.319 Sum_probs=200.4
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
.+|.+.+.||+|+||.||+++.. +..||||.+...... ......+.+|+.+++.++|+||+++++++.....
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~ 78 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDN------RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHR 78 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccc------cchhHHHHHHHHHHHhcCCCCccchHHheecccc
Confidence 47999999999999999999874 688999998753211 1122456689999999999999999998865321
Q ss_pred ---CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 888 ---GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 888 ---~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
..+++|+||+. ++|.+++.... .+++..++.++.||+.||.|||+++++||||||+||+++ .++.+||+||
T Consensus 79 ~~~~~~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~----~~~~~kL~Df 152 (337)
T cd07858 79 EAFNDVYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN----ANCDLKICDF 152 (337)
T ss_pred cccCcEEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc----CCCCEEECcC
Confidence 35899999995 78888886554 589999999999999999999999999999999999998 6788999999
Q ss_pred CCcccccCc-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhh--------
Q 037285 965 GLSKIKRNT-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN-------- 1035 (1094)
Q Consensus 965 GLSrl~~~~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~-------- 1035 (1094)
|+++..... .......++..|+|||.+.. ...++.++|||||||++|+|++|+.||...........+..
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 231 (337)
T cd07858 153 GLARTTSEKGDFMTEYVVTRWYRAPELLLN-CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEE 231 (337)
T ss_pred ccccccCCCcccccccccccCccChHHHhc-CCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChH
Confidence 999854332 22233457889999999863 23478899999999999999999999976543322211110
Q ss_pred ---------------c---cCCC---CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHHH
Q 037285 1036 ---------------N---TLRP---TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR--LRVLS 1079 (1094)
Q Consensus 1036 ---------------~---~lrp---~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~--L~~L~ 1079 (1094)
. ..+. .....++.++.++|.+||+.+|++|||+.+++++ +..+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 0 0000 1123578889999999999999999999999998 54443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=330.64 Aligned_cols=254 Identities=26% Similarity=0.302 Sum_probs=207.1
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-C-----CceeEEEeEe
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-H-----PNVVAFYGVV 882 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-H-----PNIVqL~Gv~ 882 (1094)
+|++.+.||+|+||.|-+|.+. ++.||||+++.. ..+..+...|+.+|..|+ | -|||+++++|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---------k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F 257 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---------KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF 257 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---------hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence 8999999999999999999885 677999999875 334456667999999997 3 5899999999
Q ss_pred ecCCCCceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEE
Q 037285 883 QDGPGGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKV 961 (1094)
Q Consensus 883 ~d~~~~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKL 961 (1094)
.... ++|||+|.+ ..+|.++|+... ..++...+..|+.||+.||.+||+.+|||+||||+||||... ....|||
T Consensus 258 ~fr~--HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~--~r~~vKV 332 (586)
T KOG0667|consen 258 YFRN--HLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDP--KRSRIKV 332 (586)
T ss_pred cccc--ceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccC--CcCceeE
Confidence 9866 999999987 789999997654 569999999999999999999999999999999999999743 4558999
Q ss_pred EecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhc-----
Q 037285 962 GDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN----- 1036 (1094)
Q Consensus 962 sDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~----- 1036 (1094)
+|||.|+....... .+..+..|.|||++. ...|+.+.||||||||++||++|.+.|.+.+..+.+..++.-
T Consensus 333 IDFGSSc~~~q~vy--tYiQSRfYRAPEVIL--GlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp 408 (586)
T KOG0667|consen 333 IDFGSSCFESQRVY--TYIQSRFYRAPEVIL--GLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPP 408 (586)
T ss_pred EecccccccCCcce--eeeeccccccchhhc--cCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCC
Confidence 99999997766544 567889999999999 467899999999999999999999999887765544322110
Q ss_pred -----------------c----------------------------CCCCCC-----------CcCcHHHHHHHHHhccC
Q 037285 1037 -----------------T----------------------------LRPTIP-----------SYCDAEWRTLMEECWAP 1060 (1094)
Q Consensus 1037 -----------------~----------------------------lrp~iP-----------e~~S~eL~dLI~kCLq~ 1060 (1094)
. .....| ......+.++|++||..
T Consensus 409 ~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~ 488 (586)
T KOG0667|consen 409 PKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEW 488 (586)
T ss_pred HHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhcc
Confidence 0 000011 01124578999999999
Q ss_pred CCCCCCCHHHHHHHHHHHHHHh
Q 037285 1061 NPAARPSFTEIASRLRVLSTAA 1082 (1094)
Q Consensus 1061 DPeeRPS~eELLq~L~~L~ta~ 1082 (1094)
||.+|+|..+.++|-+--....
T Consensus 489 dP~~R~tp~qal~Hpfl~~~~~ 510 (586)
T KOG0667|consen 489 DPAERITPAQALNHPFLTGTSL 510 (586)
T ss_pred CchhcCCHHHHhcCcccccccc
Confidence 9999999999999877654333
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=289.15 Aligned_cols=241 Identities=29% Similarity=0.427 Sum_probs=202.1
Q ss_pred ecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEEEee
Q 037285 818 LGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAE 895 (1094)
Q Consensus 818 LGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~IVmE 895 (1094)
||+|+||.||++.+. +..+|+|++....... ......+..|+.++++++|+||+++++.+.... .+++|||
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v~e 73 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIK-----RKEVEHTLTERNILSRINHPFIVKLHYAFQTEE--KLYLVLE 73 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcc-----hHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCC--eeEEEEe
Confidence 699999999999885 6889999987653221 223457888999999999999999999988755 8999999
Q ss_pred ecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccCc-c
Q 037285 896 YMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT-L 974 (1094)
Q Consensus 896 YmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~-~ 974 (1094)
|+.+++|.+++.... .+++..++.++.|++.||.|||+.+++|+||+|+||+++ .++.++|+|||++...... .
T Consensus 74 ~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~----~~~~~~l~d~~~~~~~~~~~~ 148 (250)
T cd05123 74 YAPGGELFSHLSKEG-RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLD----ADGHIKLTDFGLAKELSSEGS 148 (250)
T ss_pred cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEc----CCCcEEEeecCcceecccCCC
Confidence 999999999997654 489999999999999999999999999999999999998 6788999999998854332 2
Q ss_pred ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHH
Q 037285 975 VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLM 1054 (1094)
Q Consensus 975 ~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI 1054 (1094)
......++..|+|||.+. ....+.++|+||||+++|+|++|+.||...........+.. ....++...+..+.++|
T Consensus 149 ~~~~~~~~~~~~~Pe~~~--~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i 224 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLL--GKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFLSPEARDLI 224 (250)
T ss_pred cccCCcCCccccChHHhC--CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHH
Confidence 233456788999999987 34578899999999999999999999988776665555544 33457777899999999
Q ss_pred HHhccCCCCCCCCH---HHHHHH
Q 037285 1055 EECWAPNPAARPSF---TEIASR 1074 (1094)
Q Consensus 1055 ~kCLq~DPeeRPS~---eELLq~ 1074 (1094)
.+||..||++||++ .+++++
T Consensus 225 ~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 225 SGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred HHHhcCCHhhCCCcccHHHHHhC
Confidence 99999999999999 566543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=305.74 Aligned_cols=260 Identities=27% Similarity=0.348 Sum_probs=200.6
Q ss_pred CCee-EEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhH------HHHHHHHHHHHHHHhhCCCCceeEEEe
Q 037285 810 EDLE-EQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQ------ERLTVEFWKEAEILSKLHHPNVVAFYG 880 (1094)
Q Consensus 810 edYe-i~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eq------e~~~~eFlrEIkILkrL~HPNIVqL~G 880 (1094)
++|. +.+.||.|+||+||+|.+. ++.||||.++........... ......+.+|+.++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3454 4577999999999999864 678999998764322100000 001225678999999999999999999
Q ss_pred EeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEE
Q 037285 881 VVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICK 960 (1094)
Q Consensus 881 v~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VK 960 (1094)
++.... .+++||||+. ++|.+++.... .+++..++.++.||+.||.|||+.+|+|+||+|+|||++ .++.+|
T Consensus 88 ~~~~~~--~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~----~~~~~k 159 (335)
T PTZ00024 88 VYVEGD--FINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFIN----SKGICK 159 (335)
T ss_pred EEecCC--cEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEEC----CCCCEE
Confidence 998755 8999999996 68988886544 489999999999999999999999999999999999998 778999
Q ss_pred EEecCCcccccC---------------ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 037285 961 VGDFGLSKIKRN---------------TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH 1025 (1094)
Q Consensus 961 LsDFGLSrl~~~---------------~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~ 1025 (1094)
|+|||+++.... ........++..|+|||++.+ ...++.++|||||||++|+|++|+.||....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG-AEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhccc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999874330 111112346788999999874 3457889999999999999999999998877
Q ss_pred hHHHHHhHhhccCCC--------------------------CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1026 YGAIIGGIVNNTLRP--------------------------TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1026 ~~eile~Iv~~~lrp--------------------------~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
..+.+..+......+ .....++..+.++|.+||+.+|++||++.+++.+.+--
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~ 317 (335)
T PTZ00024 239 EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFK 317 (335)
T ss_pred HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccC
Confidence 655544332211000 01124577899999999999999999999999877653
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=303.61 Aligned_cols=254 Identities=21% Similarity=0.280 Sum_probs=197.2
Q ss_pred eEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEE
Q 037285 813 EEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLAT 892 (1094)
Q Consensus 813 ei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~I 892 (1094)
.+.+.+|.|+++.||+++.++..||||++...... ......+.+|+.++++++|+||+++++++.... ..++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~--~~~~ 76 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCS------KEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS--ELYV 76 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccc------hhHHHHHHHHHHHHHhcCCcchhhhhheeecCC--eEEE
Confidence 44556677777777787778899999998754211 223457889999999999999999999998755 8999
Q ss_pred EeeecccchhHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCccccc
Q 037285 893 VAEYMVDGSLRHVLVRK-DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKR 971 (1094)
Q Consensus 893 VmEYmegGSL~d~L~k~-~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~ 971 (1094)
+|||+.+++|.+++... ...+++..+..++.||+.||+|||+++|+||||||+|||++ .++.+||+|||.+....
T Consensus 77 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~----~~~~~kl~d~~~~~~~~ 152 (314)
T cd08216 77 VSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLS----GDGKVVLSGLRYSVSMI 152 (314)
T ss_pred EEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEe----cCCceEEecCccceeec
Confidence 99999999999999764 34588899999999999999999999999999999999998 67889999999886321
Q ss_pred Cc--------cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCC----
Q 037285 972 NT--------LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR---- 1039 (1094)
Q Consensus 972 ~~--------~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lr---- 1039 (1094)
.. .......++..|+|||++......++.++|||||||++|+|++|+.||..................
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (314)
T cd08216 153 KHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLD 232 (314)
T ss_pred cccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccc
Confidence 11 111233467789999998753346788999999999999999999999876544332221111100
Q ss_pred ----------------------------CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1040 ----------------------------PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1040 ----------------------------p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
.......+.++.+||.+||..||++|||+.+++++.+-.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~ 299 (314)
T cd08216 233 KSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFK 299 (314)
T ss_pred cCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHh
Confidence 001112346788999999999999999999999886643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=308.49 Aligned_cols=259 Identities=22% Similarity=0.319 Sum_probs=202.4
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC--
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG-- 885 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~-- 885 (1094)
.+|++.+.||.|+||.||+|+.. +..||+|++...... ......+.+|+.+|++++||||+++++++...
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 78 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV------PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGA 78 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc------ccchHHHHHHHHHHHhcCCCCccCHHHhccccCC
Confidence 67999999999999999999874 788999998753211 12235667899999999999999999987643
Q ss_pred CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecC
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFG 965 (1094)
....+++||||+. ++|.+++.... .+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||
T Consensus 79 ~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~----~~~~~kl~dfg 152 (334)
T cd07855 79 DFKDVYVVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVN----EDCELRIGDFG 152 (334)
T ss_pred CCceEEEEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCcEEecccc
Confidence 2246899999995 68888886554 489999999999999999999999999999999999999 78899999999
Q ss_pred CcccccCcc-----ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhc----
Q 037285 966 LSKIKRNTL-----VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN---- 1036 (1094)
Q Consensus 966 LSrl~~~~~-----~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~---- 1036 (1094)
++....... ......++..|+|||++.+ ...++.++|||||||++|+|++|+.||........+..+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~ 231 (334)
T cd07855 153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLS-LPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSP 231 (334)
T ss_pred cceeecccCcCCCcccccccccccccChHHhcC-CcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCC
Confidence 987432211 1123468889999999864 245788999999999999999999999876543322211110
Q ss_pred --------------------cCCCCC-----CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1037 --------------------TLRPTI-----PSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1037 --------------------~lrp~i-----Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
...... ....+.++.++|.+||+.+|.+||++.+++.+.+--...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 232 SEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred hhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 000011 134578899999999999999999999999987765433
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06410 PB1_UP2 Uncharacterized protein 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=272.35 Aligned_cols=95 Identities=62% Similarity=1.070 Sum_probs=91.0
Q ss_pred EeecCCccccCCCCCCceeecCceEEEEecCCCChHHHHHHHHHHcCCce--EEEEeCCCCCCCceeeccChhhHHHHHH
Q 037285 89 LCSFGGKILPRPSDGKLRYVGGETRIIRIRKDISWQILRQKALEVYNQVH--VIKYQLPGEDLDALVSVSCDEDLQNMME 166 (1094)
Q Consensus 89 mcSyGG~i~pr~~d~~l~YvGG~triv~v~r~~~~~~l~~kl~~~~~~~~--~lkyqLp~edld~LisV~~deDl~~m~~ 166 (1094)
||||||+|+|||+||+|+|+||+|||++|+|++||+||+.||+++++... +||||||+||||+||||++||||+|||+
T Consensus 1 ~cs~GG~i~pr~~dg~l~Y~GG~tr~i~V~r~~s~~el~~kl~~~~~~~~~~~lky~Lp~edld~Lisv~~DeDl~~M~~ 80 (97)
T cd06410 1 LCSYGGRILPRPPDGQLRYVGGETRIVSVDRSISFKELVSKLSELFGAGVVVTLKYQLPDEDLDALISVSNDEDLKNMME 80 (97)
T ss_pred CcccCCEEeCcCCCCCEEEcCCceEEEEEcCCCCHHHHHHHHHHHhCCCCceEEEEEcCCCCcceeEEecCcHHHHHHHH
Confidence 89999999999999999999999999999999999999999999998554 8999999999999999999999999999
Q ss_pred HHhhcCCCCCCCeEEEEEe
Q 037285 167 EYNELGDREGSQRIRMFLF 185 (1094)
Q Consensus 167 eydr~~~~~~~~r~R~FlF 185 (1094)
||+|+ ...++|+|+|||
T Consensus 81 e~~~~--~~~~~rirvflf 97 (97)
T cd06410 81 EYDRL--SGGSARLRVFLF 97 (97)
T ss_pred hhccc--cCCCceEEEEEC
Confidence 99998 566789999998
|
The PB1 domain is a modular domain mediating specific protein-protein interaction which play a role in many critical cell processes such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=330.85 Aligned_cols=251 Identities=29% Similarity=0.434 Sum_probs=212.2
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
-|+-++.||.|+||.||-|++. ...||||.+.-.. . .....+.++++|+..|.+|+|||+|.+-|||..+.
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySG---K--Qs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~-- 99 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG---K--QSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH-- 99 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccc---c--ccHHHHHHHHHHHHHHHhccCCCcccccceeeccc--
Confidence 3566788999999999999874 5679999875332 1 22334678999999999999999999999998865
Q ss_pred ceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 889 TLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
..++||||| -|+-.+++.-..+++-+..+..|+.+.+.||+|||+.+.||||||+-|||++ +.+.|||+|||.+.
T Consensus 100 TaWLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs----e~g~VKLaDFGSAs 174 (948)
T KOG0577|consen 100 TAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS----EPGLVKLADFGSAS 174 (948)
T ss_pred hHHHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec----CCCeeeeccccchh
Confidence 899999999 5778888877777899999999999999999999999999999999999999 89999999999987
Q ss_pred cccCccccCCccCCCcccCcccccc-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCc
Q 037285 969 IKRNTLVSGGVRGTLPWMAPELLSG-SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCD 1047 (1094)
Q Consensus 969 l~~~~~~ss~~~GT~~YmAPEvL~g-~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S 1047 (1094)
..... ..++|||.|||||++.. ..+.|+-|+||||||++..||...++|+-.++....+-.+....-...-...++
T Consensus 175 i~~PA---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS 251 (948)
T KOG0577|consen 175 IMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWS 251 (948)
T ss_pred hcCch---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhH
Confidence 65443 45789999999999863 245788999999999999999999999998888777766655443333345678
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1048 AEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1048 ~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
..++.|+..||++-|.+|||..+++.+--
T Consensus 252 ~~F~~Fvd~CLqKipqeRptse~ll~H~f 280 (948)
T KOG0577|consen 252 DYFRNFVDSCLQKIPQERPTSEELLKHRF 280 (948)
T ss_pred HHHHHHHHHHHhhCcccCCcHHHHhhcch
Confidence 88999999999999999999999987743
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=303.32 Aligned_cols=253 Identities=27% Similarity=0.325 Sum_probs=203.2
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC--
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP-- 886 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~-- 886 (1094)
+|++.+.||.|+||.||+|+.. +..||||.+..... .......+.+|+.++++++|+||+++++++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD------DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPE 74 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc------cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcc
Confidence 5889999999999999999875 67899999875421 1222356888999999999999999999987642
Q ss_pred -CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecC
Q 037285 887 -GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965 (1094)
Q Consensus 887 -~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFG 965 (1094)
...+++||||+. ++|.+++.... .+++..++.++.||+.||+|||++||+|+||||+|||++ .++.++|+|||
T Consensus 75 ~~~~~~lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~----~~~~~~L~dfg 148 (330)
T cd07834 75 DFNDVYIVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVN----SNCDLKICDFG 148 (330)
T ss_pred cccceEEEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEEEcccC
Confidence 236899999997 58888886554 689999999999999999999999999999999999999 77899999999
Q ss_pred CcccccCcc----ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCC-
Q 037285 966 LSKIKRNTL----VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP- 1040 (1094)
Q Consensus 966 LSrl~~~~~----~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp- 1040 (1094)
++....... ......++..|+|||++.+. ..++.++||||||+++|+|++|+.||......+....+....-.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 227 (330)
T cd07834 149 LARGVDPDEDEKGFLTEYVVTRWYRAPELLLSS-SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPS 227 (330)
T ss_pred ceEeecccccccccccccccccCcCCceeeecc-cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCC
Confidence 998544332 22334578899999999852 267899999999999999999999998877655444332211000
Q ss_pred ----------------------------CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1041 ----------------------------TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1041 ----------------------------~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
.....++..+.++|.+||+.+|.+||++.+++.+.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 291 (330)
T cd07834 228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPY 291 (330)
T ss_pred hhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCcc
Confidence 011235788999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=332.81 Aligned_cols=252 Identities=27% Similarity=0.403 Sum_probs=213.2
Q ss_pred eeEEEEecccCceEEEEeeecCce--EEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCc
Q 037285 812 LEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGT 889 (1094)
Q Consensus 812 Yei~kkLGsG~FGtVYKAk~rGt~--VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~ 889 (1094)
|.++..||.|+||.||+|..+.+. .|-|+|... .+....+|+-||.||....||+||++++.|.... .
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--------seEELEDylVEIeILa~CdHP~ivkLl~ayy~en--k 103 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--------SEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN--K 103 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--------chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC--c
Confidence 455678999999999999876433 466776432 1334578899999999999999999999877644 8
Q ss_pred eEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcc-
Q 037285 890 LATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK- 968 (1094)
Q Consensus 890 L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr- 968 (1094)
++|+.|||.||-....+..-++.|++.++..+|+|++.||.|||+++|||||||+-|||++ -+|.|+|+|||.+.
T Consensus 104 LwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~T----ldGdirLADFGVSAK 179 (1187)
T KOG0579|consen 104 LWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLT----LDGDIRLADFGVSAK 179 (1187)
T ss_pred eEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEE----ecCcEeeeccccccc
Confidence 9999999999999999988888899999999999999999999999999999999999999 78899999999875
Q ss_pred cccCccccCCccCCCcccCcccccc---CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCC-CCCCC
Q 037285 969 IKRNTLVSGGVRGTLPWMAPELLSG---SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR-PTIPS 1044 (1094)
Q Consensus 969 l~~~~~~ss~~~GT~~YmAPEvL~g---~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lr-p~iPe 1044 (1094)
..........+.||+.|||||+..- ....|+.++||||||++|.||..+.+|....+...++.++...... ..-|.
T Consensus 180 n~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS 259 (1187)
T KOG0579|consen 180 NKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPS 259 (1187)
T ss_pred chhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcc
Confidence 3333344567889999999999752 2456899999999999999999999999998888888777554433 34567
Q ss_pred cCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1045 YCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1045 ~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
.++..+.+|+.+||.+||..||++.+|++|-+.
T Consensus 260 ~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv 292 (1187)
T KOG0579|consen 260 HWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFV 292 (1187)
T ss_pred hhhhHHHHHHHHHHhcCCccCCCHHHHhhCccc
Confidence 889999999999999999999999999987543
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=330.15 Aligned_cols=255 Identities=29% Similarity=0.475 Sum_probs=224.8
Q ss_pred cCCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
...|.+.+.||+|.|+.|.+++. ++..||||+|.+.... ......+.+|+++|+.|+|||||+++.+.....
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln------~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~ 128 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLN------PSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA 128 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccC------hHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence 35788999999999999999987 4788999999876432 122344789999999999999999999998765
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+|+||||+.+|.+.+|+.+.++ +.+..+..++.|+..|++|||+++|+|||||++|||++ .+.++||+|||+
T Consensus 129 --~lylV~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~----~~mnikIaDfgf 201 (596)
T KOG0586|consen 129 --TLYLVMEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLD----ENMNIKIADFGF 201 (596)
T ss_pred --eeEEEEEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccc----cccceeeecccc
Confidence 89999999999999999998876 56688899999999999999999999999999999999 788899999999
Q ss_pred cccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcC
Q 037285 967 SKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYC 1046 (1094)
Q Consensus 967 Srl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~ 1046 (1094)
+.+........+++|++.|.|||++.+.. ...+.+|+||+|+++|-|++|..||++....+.-..++...++ +|..+
T Consensus 202 S~~~~~~~~lqt~cgsppyAaPEl~~g~~-y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~r--Ip~~m 278 (596)
T KOG0586|consen 202 STFFDYGLMLQTFCGSPPYAAPELFNGKK-YDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYR--IPFYM 278 (596)
T ss_pred ceeecccccccccCCCCCccChHhhcCcc-cCCcceehhhhhhhheeeeecccccCCcccccccchheeeeec--cccee
Confidence 99887777788899999999999999754 5578999999999999999999999998887777777777666 55567
Q ss_pred cHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1047 DAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1047 S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
+.++.++|+++|-.+|.+|++++++.++-|.-.
T Consensus 279 s~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~ 311 (596)
T KOG0586|consen 279 SCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRND 311 (596)
T ss_pred echhHHHHHHhhccCccccCCHHHhhhhcccch
Confidence 889999999999999999999999998877543
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=326.28 Aligned_cols=258 Identities=25% Similarity=0.367 Sum_probs=208.0
Q ss_pred cceeeccCCeeEEEEecccCceEEEEeeecC-ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-CCceeEEEe
Q 037285 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HPNVVAFYG 880 (1094)
Q Consensus 803 sv~eIs~edYei~kkLGsG~FGtVYKAk~rG-t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-HPNIVqL~G 880 (1094)
.+-.+...+|+++++||+||-+.||++...+ +.+|+|.+... ..+.....-|..|+..|.+|+ |.+||++++
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~------~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~D 427 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLL------EADNQTLDGYRNEIALLNKLKGHDKIIQLYD 427 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHh------hcCHHHHHHHHHHHHHHHHhcCCceEEEEee
Confidence 3556788899999999999999999998754 55788766543 223556788999999999996 899999999
Q ss_pred EeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEE
Q 037285 881 VVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICK 960 (1094)
Q Consensus 881 v~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VK 960 (1094)
+-..+ +.+|+|||| ...+|.++|.++...+..-.+..+..||+.++.++|+.||||.||||.|+|+- .|.+|
T Consensus 428 YEv~d--~~lYmvmE~-Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-----kG~LK 499 (677)
T KOG0596|consen 428 YEVTD--GYLYMVMEC-GDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-----KGRLK 499 (677)
T ss_pred eeccC--ceEEEEeec-ccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-----eeeEE
Confidence 98764 499999996 47899999988766555447788899999999999999999999999999996 68999
Q ss_pred EEecCCcccccCcc---ccCCccCCCcccCccccccCC---------CCCCchhhHHHHHHHHHHHHcCCCCCCCCChH-
Q 037285 961 VGDFGLSKIKRNTL---VSGGVRGTLPWMAPELLSGSS---------SKVSEKVDVFSFGIVLWEILTGEEPYANMHYG- 1027 (1094)
Q Consensus 961 LsDFGLSrl~~~~~---~ss~~~GT~~YmAPEvL~g~~---------~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~- 1027 (1094)
|+|||.|......+ ....-+||+.||+||.+.... -+.+.++||||||||||+|+.|+.||....+.
T Consensus 500 LIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~ 579 (677)
T KOG0596|consen 500 LIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI 579 (677)
T ss_pred eeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH
Confidence 99999998654432 234567999999999986322 23778999999999999999999999887643
Q ss_pred HHHHhHhhccCCCCCCCcCcHH-HHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1028 AIIGGIVNNTLRPTIPSYCDAE-WRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1028 eile~Iv~~~lrp~iPe~~S~e-L~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
..+..+..-+...++|..-+.. +.++|+.||..||.+||++.+||++
T Consensus 580 aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 580 AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 3334444433434555544433 9999999999999999999999975
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=333.61 Aligned_cols=249 Identities=31% Similarity=0.499 Sum_probs=210.2
Q ss_pred eEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCce
Q 037285 813 EEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTL 890 (1094)
Q Consensus 813 ei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L 890 (1094)
++..+||+|+|-+||+|.+. |-.||.-.++...+.. ......+|..|+.+|+.|+||||+++|..|.+.....+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q----~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i 118 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQ----SPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI 118 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhc----ChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence 45678999999999999885 5567765444332221 13335789999999999999999999999998877789
Q ss_pred EEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 891 ATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 891 ~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~G--IIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
.+|+|.+..|+|..|+++.++ ++...+..||+||++||.|||++. |||||||-+||||+ ...|.|||+|+|||+
T Consensus 119 n~iTEL~TSGtLr~Y~kk~~~-vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin---G~~G~VKIGDLGLAt 194 (632)
T KOG0584|consen 119 NFITELFTSGTLREYRKKHRR-VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN---GNLGEVKIGDLGLAT 194 (632)
T ss_pred eeeeecccCCcHHHHHHHhcc-CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc---CCcCceeecchhHHH
Confidence 999999999999999987765 899999999999999999999885 99999999999998 367899999999999
Q ss_pred cccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH-HHHHhHhhccCCCCCCCcCc
Q 037285 969 IKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-AIIGGIVNNTLRPTIPSYCD 1047 (1094)
Q Consensus 969 l~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~-eile~Iv~~~lrp~iPe~~S 1047 (1094)
......... ..|||.|||||++. ..|...+||||||++|+||+|+..||..+.+. ++++++..+...-.+...-.
T Consensus 195 l~r~s~aks-vIGTPEFMAPEmYE---E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~d 270 (632)
T KOG0584|consen 195 LLRKSHAKS-VIGTPEFMAPEMYE---ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKD 270 (632)
T ss_pred Hhhccccce-eccCccccChHHHh---hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCC
Confidence 877666555 67999999999997 57889999999999999999999999887665 55566655554444555567
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1048 AEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1048 ~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
+++++||.+|+.. ..+|||+.+||.+
T Consensus 271 Pevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 271 PEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 8999999999999 9999999999975
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=334.16 Aligned_cols=255 Identities=33% Similarity=0.577 Sum_probs=221.7
Q ss_pred ccCCeeEEEEecccCceEEEEeee--cC----ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeE
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKW--RG----TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGV 881 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~--rG----t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv 881 (1094)
+..++...++||+|+||+||+|.| +| -+||||++...... ....+++.|+-+|.+|.|||+++++++
T Consensus 694 kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~-------~~s~e~LdeAl~masldHpnl~RLLgv 766 (1177)
T KOG1025|consen 694 KETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP-------KASIELLDEALRMASLDHPNLLRLLGV 766 (1177)
T ss_pred hhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc-------hhhHHHHHHHHHHhcCCCchHHHHhhh
Confidence 334566788999999999999998 33 46999998765322 223678899999999999999999999
Q ss_pred eecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEE
Q 037285 882 VQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKV 961 (1094)
Q Consensus 882 ~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKL 961 (1094)
|... .+.||++||+.|+|.+|++..+..+-.+..+.|+.||++||.|||.++++||||.++||||. +-.++||
T Consensus 767 c~~s---~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVk----sP~hvki 839 (1177)
T KOG1025|consen 767 CMLS---TLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVK----SPNHVKI 839 (1177)
T ss_pred cccc---hHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeec----CCCeEEE
Confidence 9865 48999999999999999998888899999999999999999999999999999999999998 6779999
Q ss_pred EecCCcccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhcc
Q 037285 962 GDFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNT 1037 (1094)
Q Consensus 962 sDFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~ 1037 (1094)
+|||+++..... ......+-.+.|||-|.+. ...|+.++|||||||++||++| |..||.+....++-. .++.+
T Consensus 840 tdfgla~ll~~d~~ey~~~~gK~pikwmale~i~--~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~d-lle~g 916 (1177)
T KOG1025|consen 840 TDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIR--IRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPD-LLEKG 916 (1177)
T ss_pred EecchhhccCcccccccccccccCcHHHHHHHhh--ccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhH-HHhcc
Confidence 999999965332 2233445678899999998 7789999999999999999999 999999988776554 55777
Q ss_pred CCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1038 LRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1038 lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
.|...|..|+.+++.+|.+||..|+..||+|+++...+.++.
T Consensus 917 eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 917 ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 788999999999999999999999999999999999988765
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=301.45 Aligned_cols=263 Identities=25% Similarity=0.353 Sum_probs=210.0
Q ss_pred eeeccCCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEe
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVV 882 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~ 882 (1094)
-.|..++|++.+.||.|+|+-||+++. ++.-+|+|++.-.. .+..+...+|+...++++|||+++++++.
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--------~~~~e~~~rEid~~rkf~s~~vl~l~dh~ 87 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--------QEDIEEALREIDNHRKFNSPNVLRLVDHQ 87 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--------hHHHHHHHHHHHHHHhhCCcchHHHHHHH
Confidence 357889999999999999999999874 56779999987542 12245678999999999999999999876
Q ss_pred ecCC---CCceEEEeeecccchhHHHHhhc---ccccCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeccCCC
Q 037285 883 QDGP---GGTLATVAEYMVDGSLRHVLVRK---DRFLDRRRRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNLKDP 954 (1094)
Q Consensus 883 ~d~~---~~~L~IVmEYmegGSL~d~L~k~---~~~Lse~~~l~Ia~QIaeGLaYLHs~G--IIHRDLKPeNILLD~~~~ 954 (1094)
..+. ....||++.|...|+|.+.+... +..+++.+++.|+.+|++||++||+.. ++||||||.|||+.
T Consensus 88 l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls---- 163 (302)
T KOG2345|consen 88 LREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS---- 163 (302)
T ss_pred HHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec----
Confidence 5432 23699999999999999998653 457999999999999999999999998 99999999999998
Q ss_pred CCCcEEEEecCCcccccCccc----------cCCccCCCcccCccccc-cCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 037285 955 SRPICKVGDFGLSKIKRNTLV----------SGGVRGTLPWMAPELLS-GSSSKVSEKVDVFSFGIVLWEILTGEEPYAN 1023 (1094)
Q Consensus 955 e~g~VKLsDFGLSrl~~~~~~----------ss~~~GT~~YmAPEvL~-g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~ 1023 (1094)
+.+.++|.|||.++...-... ......|..|.|||.+. ......+.++|||||||+||.|+.|..||+.
T Consensus 164 ~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~ 243 (302)
T KOG2345|consen 164 DSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER 243 (302)
T ss_pred CCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence 678999999999874321111 11123688999999986 2355788999999999999999999999974
Q ss_pred CCh--HHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1024 MHY--GAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1024 ~~~--~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
.-. ..+...+....+.-+....++..+.++|+.||+.||.+||++.+|+.++.++.
T Consensus 244 ~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 244 IYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred HhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 321 11222222322222233448899999999999999999999999999998874
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=292.58 Aligned_cols=239 Identities=23% Similarity=0.320 Sum_probs=187.5
Q ss_pred CeeEEEE--ecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhh-CCCCceeEEEeEeecC
Q 037285 811 DLEEQKE--LGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSK-LHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 811 dYei~kk--LGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkr-L~HPNIVqL~Gv~~d~ 885 (1094)
+|++.+. ||.|+||.||+++.+ +..+|+|.+....... .|+.+... .+|+||+++++++...
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------------~e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------------IEPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------------hhHHHHHHhhcCCCEEEEEEEEecC
Confidence 4455444 599999999999864 6779999987542211 01222221 2799999999999876
Q ss_pred CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCC-cEEEEec
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRP-ICKVGDF 964 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g-~VKLsDF 964 (1094)
. .+++||||+++++|.+++.... .+++..++.++.||+.||.|||+.+++||||||+||+++ .++ .++|+||
T Consensus 82 ~--~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~----~~~~~~~l~df 154 (267)
T PHA03390 82 K--GHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD----RAKDRIYLCDY 154 (267)
T ss_pred C--eeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe----CCCCeEEEecC
Confidence 5 8999999999999999997664 689999999999999999999999999999999999998 555 8999999
Q ss_pred CCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHH-HhHhh-ccCCCCC
Q 037285 965 GLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAII-GGIVN-NTLRPTI 1042 (1094)
Q Consensus 965 GLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eil-e~Iv~-~~lrp~i 1042 (1094)
|+++..... ....++..|+|||++. ...++.++||||||+++|+|++|+.||......... ..... .......
T Consensus 155 g~~~~~~~~---~~~~~~~~y~aPE~~~--~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 229 (267)
T PHA03390 155 GLCKIIGTP---SCYDGTLDYFSPEKIK--GHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPF 229 (267)
T ss_pred ccceecCCC---ccCCCCCcccChhhhc--CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCc
Confidence 998754332 2345889999999997 456788999999999999999999999865433211 11111 1222344
Q ss_pred CCcCcHHHHHHHHHhccCCCCCCCC-HHHHHHH
Q 037285 1043 PSYCDAEWRTLMEECWAPNPAARPS-FTEIASR 1074 (1094)
Q Consensus 1043 Pe~~S~eL~dLI~kCLq~DPeeRPS-~eELLq~ 1074 (1094)
+..++..++++|.+||+.+|.+||+ +++++++
T Consensus 230 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 230 IKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred ccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 5578999999999999999999995 6999865
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=297.92 Aligned_cols=246 Identities=24% Similarity=0.408 Sum_probs=199.4
Q ss_pred eEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCce
Q 037285 813 EEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTL 890 (1094)
Q Consensus 813 ei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L 890 (1094)
....+||+|+||.||++... +..||||.+.... ......+.+|+.++++++|+||+++++++.... ..
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~ 92 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--------QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD--EL 92 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--------hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCC--EE
Confidence 33467999999999999874 6789999875321 122356888999999999999999999998765 89
Q ss_pred EEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccc
Q 037285 891 ATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK 970 (1094)
Q Consensus 891 ~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~ 970 (1094)
++||||+.+++|.+++... .+++..++.++.|++.||+|||++|++|+||+|+||+++ .++.++|+|||++...
T Consensus 93 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~----~~~~~~l~dfg~~~~~ 166 (292)
T cd06657 93 WVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLT----HDGRVKLSDFGFCAQV 166 (292)
T ss_pred EEEEecCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEEcccccceec
Confidence 9999999999999987543 478999999999999999999999999999999999998 6788999999998743
Q ss_pred cCc-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCC--CCCcCc
Q 037285 971 RNT-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT--IPSYCD 1047 (1094)
Q Consensus 971 ~~~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~--iPe~~S 1047 (1094)
... .......++..|+|||.+. ...++.++||||||+++|+|++|..||...........+ ....... ....++
T Consensus 167 ~~~~~~~~~~~~~~~y~~pE~~~--~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 243 (292)
T cd06657 167 SKEVPRRKSLVGTPYWMAPELIS--RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-RDNLPPKLKNLHKVS 243 (292)
T ss_pred ccccccccccccCccccCHHHhc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhhCCcccCCcccCC
Confidence 321 1223345788999999987 456788999999999999999999999876655544433 2222222 234578
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1048 AEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1048 ~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
..+.++|.+||+.+|.+||++.+++.+=+-
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~~~~~ 273 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLKHPFL 273 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhcChHH
Confidence 899999999999999999999999986443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=290.94 Aligned_cols=249 Identities=31% Similarity=0.400 Sum_probs=199.0
Q ss_pred eeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCc
Q 037285 812 LEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGT 889 (1094)
Q Consensus 812 Yei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~ 889 (1094)
|++.+.||+|.||.||+|+.. ++.+|+|.+..... .+.....+..|+.++++++|+||+++++++.... .
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~ 72 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE------EEGIPSTALREISLLKELKHPNIVKLLDVIHTER--K 72 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc------cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC--c
Confidence 567788999999999999885 68899999876431 1223356778999999999999999999998754 8
Q ss_pred eEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCccc
Q 037285 890 LATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI 969 (1094)
Q Consensus 890 L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl 969 (1094)
+++||||+. ++|.+++.+....+++..++.++.|++.||+|||+++|+|+||+|+||+++ .++.+||+|||+++.
T Consensus 73 ~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~----~~~~~~l~d~g~~~~ 147 (282)
T cd07829 73 LYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILIN----RDGVLKLADFGLARA 147 (282)
T ss_pred eEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEc----CCCCEEEecCCcccc
Confidence 999999997 589999987645689999999999999999999999999999999999999 688999999999885
Q ss_pred ccCcc-ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhcc-----------
Q 037285 970 KRNTL-VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT----------- 1037 (1094)
Q Consensus 970 ~~~~~-~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~----------- 1037 (1094)
..... ......++..|+|||.+.+ ...++.++|||||||++|+|++|+.||........+..+....
T Consensus 148 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07829 148 FGIPLRTYTHEVVTLWYRAPEILLG-SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV 226 (282)
T ss_pred cCCCccccCccccCcCcCChHHhcC-CcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhh
Confidence 43322 2223345778999999874 3367889999999999999999999998766544433322100
Q ss_pred -----CCCCC-----------CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1038 -----LRPTI-----------PSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1038 -----lrp~i-----------Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
....+ -...+..+.++|.+||..+|.+||++.+++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00000 01236789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=301.98 Aligned_cols=257 Identities=23% Similarity=0.336 Sum_probs=202.3
Q ss_pred ceeeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeE
Q 037285 804 VQVIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGV 881 (1094)
Q Consensus 804 v~eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv 881 (1094)
+|.+ .++|++.+.||+|+||.||++... +..||||++..... .......+.+|+.+|++++||||++++++
T Consensus 10 ~~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 82 (343)
T cd07880 10 IWEV-PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ------SELFAKRAYRELRLLKHMKHENVIGLLDV 82 (343)
T ss_pred hhcc-ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc------chHHHHHHHHHHHHHHhcCCCCccceeee
Confidence 4554 357999999999999999999874 68899999864321 12233567789999999999999999999
Q ss_pred eecCCC----CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCC
Q 037285 882 VQDGPG----GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRP 957 (1094)
Q Consensus 882 ~~d~~~----~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g 957 (1094)
+..... ..+++||||+ +++|..++.. ..+++..++.++.||+.||+|||++||+||||||+||+++ .++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~----~~~ 155 (343)
T cd07880 83 FTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN----EDC 155 (343)
T ss_pred ecCCccccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCC
Confidence 875431 2468999998 7788888754 3589999999999999999999999999999999999998 678
Q ss_pred cEEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhcc
Q 037285 958 ICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 1037 (1094)
Q Consensus 958 ~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~ 1037 (1094)
.+||+|||++...... .....++..|+|||++.+ ...++.++|||||||++|+|++|+.||...........+....
T Consensus 156 ~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~ 232 (343)
T cd07880 156 ELKILDFGLARQTDSE--MTGYVVTRWYRAPEVILN-WMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVT 232 (343)
T ss_pred CEEEeecccccccccC--ccccccCCcccCHHHHhC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 8999999998854332 223457889999999874 2357889999999999999999999998766543333222110
Q ss_pred CC-----------------------------CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1038 LR-----------------------------PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1038 lr-----------------------------p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
.. ......++..+.++|.+||+.||.+|||+.+++.+-+-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~ 301 (343)
T cd07880 233 GTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYF 301 (343)
T ss_pred CCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccH
Confidence 00 01123567789999999999999999999999966443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=303.64 Aligned_cols=258 Identities=25% Similarity=0.366 Sum_probs=200.3
Q ss_pred ceeeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeE
Q 037285 804 VQVIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGV 881 (1094)
Q Consensus 804 v~eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv 881 (1094)
.|.+. .+|.+.+.||+|+||.||+|++. ++.||||.+...... +.....+.+|+.++++++||||++++++
T Consensus 10 ~~~~~-~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~ 82 (342)
T cd07879 10 VWELP-ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS------EIFAKRAYRELTLLKHMQHENVIGLLDV 82 (342)
T ss_pred hhccc-cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc------ccchhHHHHHHHHHHhcCCCCccchhhe
Confidence 45554 58999999999999999999874 788999998754211 1223457789999999999999999999
Q ss_pred eecCCC----CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCC
Q 037285 882 VQDGPG----GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRP 957 (1094)
Q Consensus 882 ~~d~~~----~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g 957 (1094)
+..... ..+++|+||+. .+|..++ ...+++..+..++.|++.||+|||+++++||||||+|||++ .++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~----~~~ 154 (342)
T cd07879 83 FTSAVSGDEFQDFYLVMPYMQ-TDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN----EDC 154 (342)
T ss_pred ecccccCCCCceEEEEecccc-cCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCC
Confidence 865421 24689999985 4666654 23488999999999999999999999999999999999998 778
Q ss_pred cEEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhcc
Q 037285 958 ICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 1037 (1094)
Q Consensus 958 ~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~ 1037 (1094)
.+||+|||+++..... .....++..|+|||++.+ ...++.++|||||||++|||++|+.||........+..+....
T Consensus 155 ~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 231 (342)
T cd07879 155 ELKILDFGLARHADAE--MTGYVVTRWYRAPEVILN-WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 231 (342)
T ss_pred CEEEeeCCCCcCCCCC--CCCceeeecccChhhhcC-ccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999998754322 223457889999999863 2457889999999999999999999998766544333222100
Q ss_pred C---------------------CCCC--------CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHHH
Q 037285 1038 L---------------------RPTI--------PSYCDAEWRTLMEECWAPNPAARPSFTEIASR--LRVLS 1079 (1094)
Q Consensus 1038 l---------------------rp~i--------Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~--L~~L~ 1079 (1094)
- .+.. ...++..+.+||.+||+.||.+||++.+++.+ ++.+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 232 GVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred CCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 0 0000 12356788999999999999999999999966 65554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=302.56 Aligned_cols=253 Identities=25% Similarity=0.351 Sum_probs=196.6
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
.+|++.+.||.|+||.||+|..+ +..||+|.+..... .....+.+|+.++++++||||+++++++.....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--------~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~ 76 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--------QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGS 76 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--------chHHHHHHHHHHHHhcCCCcchhhHhhhccccc
Confidence 68999999999999999999874 67899999865421 123457789999999999999999987664321
Q ss_pred ------------CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCC
Q 037285 888 ------------GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPS 955 (1094)
Q Consensus 888 ------------~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e 955 (1094)
..+++||||+. ++|.+++... .+++..++.++.||++||.|||++||+||||||+|||++. .
T Consensus 77 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~---~ 150 (342)
T cd07854 77 DLTEDVGSLTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT---E 150 (342)
T ss_pred ccccccccccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC---C
Confidence 25789999996 5888887543 4889999999999999999999999999999999999972 4
Q ss_pred CCcEEEEecCCcccccCccc----cCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 037285 956 RPICKVGDFGLSKIKRNTLV----SGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIG 1031 (1094)
Q Consensus 956 ~g~VKLsDFGLSrl~~~~~~----ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile 1031 (1094)
+..+||+|||+++....... .....++..|+|||++.. ...++.++|||||||++|+|++|+.||......+...
T Consensus 151 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~ 229 (342)
T cd07854 151 DLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ 229 (342)
T ss_pred CceEEECCcccceecCCccccccccccccccccccCHHHHhC-ccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 56799999999875432211 122347888999998753 3457889999999999999999999998766544333
Q ss_pred hHhhcc-----------------------CCCC-----CCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1032 GIVNNT-----------------------LRPT-----IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1032 ~Iv~~~-----------------------lrp~-----iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
.+.... .... +...++.++.+||.+||..||.+|||+.+++.+-+-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~ 303 (342)
T cd07854 230 LILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYM 303 (342)
T ss_pred HHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcc
Confidence 322110 0000 112467889999999999999999999999966443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=353.69 Aligned_cols=251 Identities=29% Similarity=0.445 Sum_probs=210.4
Q ss_pred CeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
+++...+||.|.||.||.|.. +|.-.|+|.++-.... .+....+.+|.++|..|+|||+|++||+-...+
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~------~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe-- 1307 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD------HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE-- 1307 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc------cccCcchHHHHHHHHhccCccccccCceeecHH--
Confidence 566778999999999999876 5777999988754221 333456678999999999999999999988766
Q ss_pred ceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 889 TLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
.++|.||||.+|+|.+.+...+ ..++.....+..|++.|++|||+.|||||||||+|||++ .++.+|++|||.|.
T Consensus 1308 kv~IFMEyC~~GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld----~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLD----FNGLIKYGDFGSAV 1382 (1509)
T ss_pred HHHHHHHHhccCcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeee----cCCcEEeeccccee
Confidence 7899999999999999986543 356666667889999999999999999999999999999 78899999999998
Q ss_pred cccCcc-----ccCCccCCCcccCccccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCC
Q 037285 969 IKRNTL-----VSGGVRGTLPWMAPELLSGSS-SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTI 1042 (1094)
Q Consensus 969 l~~~~~-----~ss~~~GT~~YmAPEvL~g~~-~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~i 1042 (1094)
...... ......||+.|||||++.+.. ..-.-+.|||||||++.||+||+.||..+++.-.+.-.+..+..|.+
T Consensus 1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~ 1462 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQI 1462 (1509)
T ss_pred EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCC
Confidence 543322 223457999999999998644 23345899999999999999999999998877665555677888999
Q ss_pred CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1043 PSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1043 Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
|+.++.+-+++|.+||..||..|.++.+|+++
T Consensus 1463 P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1463 PERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred chhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 99999999999999999999999999888765
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=298.43 Aligned_cols=254 Identities=25% Similarity=0.307 Sum_probs=195.4
Q ss_pred CeeEEEEecccCceEEEEeeec----CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEeecC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQDG 885 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r----Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~~d~ 885 (1094)
+|++.+.||+|+||.||++++. +..||||.+..... .......+.+|+.+++++ +||||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 74 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS------KKILAKRALRELKLLRHFRGHKNITCLYDMDIVF 74 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc------cchhHHHHHHHHHHHHHhcCCCChheeeeeeeec
Confidence 4788999999999999999985 45799999864311 111234677899999999 599999999875432
Q ss_pred --CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEe
Q 037285 886 --PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGD 963 (1094)
Q Consensus 886 --~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsD 963 (1094)
....++++++|+. ++|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 75 ~~~~~~~~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~----~~~~~kl~D 148 (332)
T cd07857 75 PGNFNELYLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVN----ADCELKICD 148 (332)
T ss_pred cccCCcEEEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEc----CCCCEEeCc
Confidence 2235788899885 68888886543 589999999999999999999999999999999999998 678899999
Q ss_pred cCCcccccCcc-----ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhc--
Q 037285 964 FGLSKIKRNTL-----VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN-- 1036 (1094)
Q Consensus 964 FGLSrl~~~~~-----~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~-- 1036 (1094)
||+++...... ......+|..|+|||++.+ ...++.++|||||||++|+|++|+.||...........+...
T Consensus 149 fg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 227 (332)
T cd07857 149 FGLARGFSENPGENAGFMTEYVATRWYRAPEIMLS-FQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG 227 (332)
T ss_pred CCCceecccccccccccccCcccCccccCcHHHhC-CCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhC
Confidence 99997432211 1223468999999998763 346789999999999999999999999876543332221110
Q ss_pred ------------------------cCCC---CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1037 ------------------------TLRP---TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1037 ------------------------~lrp---~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
.... .....++..+.++|.+||+.||.+|||+.+++.+-+-
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~ 295 (332)
T cd07857 228 TPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYL 295 (332)
T ss_pred CCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhh
Confidence 0000 0112357889999999999999999999999987553
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=300.07 Aligned_cols=258 Identities=22% Similarity=0.296 Sum_probs=200.3
Q ss_pred ceeeccCCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeE
Q 037285 804 VQVIKNEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGV 881 (1094)
Q Consensus 804 v~eIs~edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv 881 (1094)
+|.+. ++|++.+.||+|+||.||+|.. .+..||+|++..... .......+.+|+.++++++||||++++++
T Consensus 12 ~~~~~-~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~ 84 (345)
T cd07877 12 IWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ------SIIHAKRTYRELRLLKHMKHENVIGLLDV 84 (345)
T ss_pred Hhhcc-CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch------hhHHHHHHHHHHHHHHHcCCCcccceeee
Confidence 34443 6899999999999999999976 467899998865311 11223457789999999999999999998
Q ss_pred eecCC----CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCC
Q 037285 882 VQDGP----GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRP 957 (1094)
Q Consensus 882 ~~d~~----~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g 957 (1094)
+.... ...++++++++ +++|.+++... .+++..++.++.||+.||+|||+++|+||||||+||+++ .++
T Consensus 85 ~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~----~~~ 157 (345)
T cd07877 85 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN----EDC 157 (345)
T ss_pred eeecccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEc----CCC
Confidence 86432 12477888876 78898877543 489999999999999999999999999999999999998 778
Q ss_pred cEEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhcc
Q 037285 958 ICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 1037 (1094)
Q Consensus 958 ~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~ 1037 (1094)
.+||+|||+++..... .....++..|+|||++.+ ...++.++|||||||++|+|++|+.||...........+....
T Consensus 158 ~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 234 (345)
T cd07877 158 ELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLN-WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 234 (345)
T ss_pred CEEEeccccccccccc--ccccccCCCccCHHHHhC-ccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 8999999998854332 233467889999999863 3457889999999999999999999997665443322221100
Q ss_pred C------------------------CC-----CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1038 L------------------------RP-----TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1038 l------------------------rp-----~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
. .+ ......+..+.++|.+||+.||.+||++.+++.+-+-.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~ 304 (345)
T cd07877 235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 304 (345)
T ss_pred CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhh
Confidence 0 00 00113577899999999999999999999999887643
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=315.00 Aligned_cols=246 Identities=28% Similarity=0.461 Sum_probs=211.2
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
+-|.++++||+|+||.||++.++ |+.+|||.+... ....++++|+.+|++.+.|++|++||.+....
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~s- 101 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----------TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHS- 101 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----------chHHHHHHHHHHHHHcCCchhhhhhhhhccCC-
Confidence 34678899999999999999875 788999987543 12467889999999999999999999887755
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.++||||||..|+..+.+..+++.+++..+..++++.+.||+|||...-||||||+-|||++ ..+..||+|||.+
T Consensus 102 -DLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLN----T~G~AKLADFGVA 176 (502)
T KOG0574|consen 102 -DLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLN----TDGIAKLADFGVA 176 (502)
T ss_pred -ceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEc----ccchhhhhhcccc
Confidence 89999999999999999999999999999999999999999999999999999999999999 7889999999999
Q ss_pred ccccCc-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCC--CCC
Q 037285 968 KIKRNT-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT--IPS 1044 (1094)
Q Consensus 968 rl~~~~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~--iPe 1044 (1094)
...... ....+..||+.|||||++. .-.|..++||||||++..||..|++||...+....+..+ .....+. .|+
T Consensus 177 GQLTDTMAKRNTVIGTPFWMAPEVI~--EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI-PT~PPPTF~KPE 253 (502)
T KOG0574|consen 177 GQLTDTMAKRNTVIGTPFWMAPEVIE--EIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI-PTKPPPTFKKPE 253 (502)
T ss_pred chhhhhHHhhCccccCcccccHHHHH--HhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec-cCCCCCCCCChH
Confidence 854332 3445678999999999998 446789999999999999999999999988765544332 2222232 356
Q ss_pred cCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1045 YCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1045 ~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
..+.++.+++++||-++|++|.|+..|+++
T Consensus 254 ~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 254 EWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 788899999999999999999999998876
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=302.63 Aligned_cols=256 Identities=23% Similarity=0.321 Sum_probs=202.0
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEe
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVV 882 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~ 882 (1094)
|++ .++|++.+.||+|+||.||+|++. +..||||++..... .......+.+|+.++++++|+||+++++++
T Consensus 11 ~~~-~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07851 11 WEV-PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ------SAIHAKRTYRELRLLKHMDHENVIGLLDVF 83 (343)
T ss_pred ecc-cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc------hhhHHHHHHHHHHHHHhccCCCHHHHHHHh
Confidence 344 457999999999999999999885 67899998864311 112234567899999999999999999877
Q ss_pred ecCCC----CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCc
Q 037285 883 QDGPG----GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPI 958 (1094)
Q Consensus 883 ~d~~~----~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~ 958 (1094)
..... ..+++|+||+ +++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++ .++.
T Consensus 84 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~----~~~~ 156 (343)
T cd07851 84 TPASSLEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN----EDCE 156 (343)
T ss_pred hccccccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----CCCC
Confidence 65431 2489999998 6799988865 3589999999999999999999999999999999999998 6788
Q ss_pred EEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccC
Q 037285 959 CKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 1038 (1094)
Q Consensus 959 VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~l 1038 (1094)
+||+|||++...... .....++..|+|||.+.+ ...++.++|||||||++|+|++|+.||........+..+.....
T Consensus 157 ~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~ 233 (343)
T cd07851 157 LKILDFGLARHTDDE--MTGYVATRWYRAPEIMLN-WMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVG 233 (343)
T ss_pred EEEcccccccccccc--ccCCcccccccCHHHHhC-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Confidence 999999998854332 233457889999999863 23678899999999999999999999987665544443322110
Q ss_pred C--------------------------C---CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1039 R--------------------------P---TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1039 r--------------------------p---~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
. . .....++..+.++|.+||+.+|.+|||+.+|+++-+-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~ 301 (343)
T cd07851 234 TPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL 301 (343)
T ss_pred CCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCc
Confidence 0 0 0012357889999999999999999999999986443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=321.65 Aligned_cols=259 Identities=18% Similarity=0.274 Sum_probs=184.8
Q ss_pred cCCeeEEEEecccCceEEEEeeecC---ceEEEEEeecCc---------cCCCchhHHHHHHHHHHHHHHHhhCCCCcee
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWRG---TDVAIKRIKKSC---------FTGRSSEQERLTVEFWKEAEILSKLHHPNVV 876 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~rG---t~VAVKiIkk~~---------~se~~~eqe~~~~eFlrEIkILkrL~HPNIV 876 (1094)
.++|++.++||+|+||+||++.++. ..+++|.+.... ..............+.+|+.+|++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 3689999999999999999987642 222222111000 0000001122345678999999999999999
Q ss_pred EEEeEeecCCCCceEEEeeecccchhHHHHhhcc----cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccC
Q 037285 877 AFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD----RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLK 952 (1094)
Q Consensus 877 qL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~----~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~ 952 (1094)
++++++.... ..++|++++. ++|..++.... .......+..++.||+.||.|||++||+||||||+|||++
T Consensus 227 ~l~~~~~~~~--~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~-- 301 (501)
T PHA03210 227 KIEEILRSEA--NTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN-- 301 (501)
T ss_pred cEeEEEEECC--eeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC--
Confidence 9999998765 7899999984 56666664321 1234566778999999999999999999999999999998
Q ss_pred CCCCCcEEEEecCCcccccCc--cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCC-CCCCCC--hH
Q 037285 953 DPSRPICKVGDFGLSKIKRNT--LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEE-PYANMH--YG 1027 (1094)
Q Consensus 953 ~~e~g~VKLsDFGLSrl~~~~--~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~-PF~~~~--~~ 1027 (1094)
.++.+||+|||+++..... .......||..|+|||++. ...++.++|||||||+||||++|.. ||.... ..
T Consensus 302 --~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 302 --CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILA--GDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred --CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhc--CCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 7789999999999854322 2223456999999999998 4568899999999999999999775 444322 11
Q ss_pred HHHHhHhhc------cCC-------------------CCC-----CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1028 AIIGGIVNN------TLR-------------------PTI-----PSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1028 eile~Iv~~------~lr-------------------p~i-----Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
..+..++.. .+. ..+ ...++.++.++|.+||+.||.+|||+.+++.+-+
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~ 456 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL 456 (501)
T ss_pred HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence 111111110 000 000 0124567788899999999999999999998755
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-32 Score=296.02 Aligned_cols=251 Identities=25% Similarity=0.355 Sum_probs=196.4
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||.|+||.||++... +..||||.+.+.... ......+.+|+.++++++||||+++++++...
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~- 81 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST------PVLAKRTYRELKLLKHLRHENIISLSDIFISP- 81 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc------cchhHHHHHHHHHHHhcCCCCeeeEeeeEecC-
Confidence 457999999999999999999764 678999988654211 11234567899999999999999999998653
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
....++||||+ +++|..++... .+++..+..++.||++||+|||+++|+||||+|+|||++ .++.+||+|||+
T Consensus 82 ~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~----~~~~~~l~dfg~ 154 (328)
T cd07856 82 LEDIYFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN----ENCDLKICDFGL 154 (328)
T ss_pred CCcEEEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeEC----CCCCEEeCcccc
Confidence 23688999998 56888887543 478888889999999999999999999999999999998 778999999999
Q ss_pred cccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhh-----------
Q 037285 967 SKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN----------- 1035 (1094)
Q Consensus 967 Srl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~----------- 1035 (1094)
+....... ....++..|+|||.+.+ ...++.++|||||||++|+|++|+.||...........+.+
T Consensus 155 ~~~~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 155 ARIQDPQM--TGYVSTRYYRAPEIMLT-WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN 231 (328)
T ss_pred ccccCCCc--CCCcccccccCceeeec-cCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 87543221 23457889999998763 34678999999999999999999999977654322111100
Q ss_pred -------------ccCCCC-----CCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1036 -------------NTLRPT-----IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1036 -------------~~lrp~-----iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
...... ....++..++++|.+||+.+|++||++.+++.+-+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~ 290 (328)
T cd07856 232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPY 290 (328)
T ss_pred hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCc
Confidence 000001 11246788999999999999999999999998743
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=297.35 Aligned_cols=254 Identities=24% Similarity=0.420 Sum_probs=209.6
Q ss_pred eeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-CCceeEEEeEe
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HPNVVAFYGVV 882 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-HPNIVqL~Gv~ 882 (1094)
....++++.+..||.|+.|.|++++++ |.-.|||.+....- .....+++..+.++.+-+ +|+||+++|+|
T Consensus 88 ~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N-------kee~kRILmDldvv~~s~dcpyIV~c~GyF 160 (391)
T KOG0983|consen 88 QADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN-------KEENKRILMDLDVVLKSHDCPYIVQCFGYF 160 (391)
T ss_pred ccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC-------HHHHHHHHHhhhHHhhccCCCeeeeeeeEE
Confidence 344567788889999999999999886 57799999876421 112245667777766554 89999999999
Q ss_pred ecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeccCCCCCCcEEE
Q 037285 883 QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPSRPICKV 961 (1094)
Q Consensus 883 ~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs-~GIIHRDLKPeNILLD~~~~e~g~VKL 961 (1094)
.... .++|.||.| ..++..++.+-.+++++..+-+|..-++.||.||.+ ++|||||+||+|||+| +.|++||
T Consensus 161 i~n~--dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlD----e~GniKl 233 (391)
T KOG0983|consen 161 ITNT--DVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD----ERGNIKL 233 (391)
T ss_pred eeCc--hHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEc----cCCCEEe
Confidence 8866 788999988 678888888877889999999999999999999985 5899999999999999 8999999
Q ss_pred EecCCcccccCccccCCccCCCcccCccccccC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh-HHHHHhHhhccCC
Q 037285 962 GDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGS-SSKVSEKVDVFSFGIVLWEILTGEEPYANMHY-GAIIGGIVNNTLR 1039 (1094)
Q Consensus 962 sDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~-~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~-~eile~Iv~~~lr 1039 (1094)
||||.+.............|-+.|||||.+... ..+|+.++||||||++++||.||+.||.+... .+++..+++ ...
T Consensus 234 CDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~eP 312 (391)
T KOG0983|consen 234 CDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEP 312 (391)
T ss_pred ecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCC
Confidence 999999866555555556688999999999743 56799999999999999999999999998654 455555655 444
Q ss_pred CCCCC--cCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1040 PTIPS--YCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1040 p~iPe--~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
+.++. ..++.+.+++..||.+|+.+||.+.+|+++
T Consensus 313 P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 313 PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 55553 379999999999999999999999998865
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=306.51 Aligned_cols=254 Identities=25% Similarity=0.327 Sum_probs=206.8
Q ss_pred CCeeEE-EEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEeecC
Q 037285 810 EDLEEQ-KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQDG 885 (1094)
Q Consensus 810 edYei~-kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~~d~ 885 (1094)
++|++. ++||-|-.|.|..+..+ ++.+|+|++... ....+|+++.-.. .|||||++++++...
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------------~KARrEVeLHw~~s~h~~iV~IidVyeNs 127 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------------PKARREVELHWMASGHPHIVSIIDVYENS 127 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------------HHHHhHhhhhhhhcCCCceEEeehhhhhh
Confidence 466653 68999999999998764 678999988643 2345777765444 599999999998643
Q ss_pred C--CCceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 886 P--GGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 886 ~--~~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
. ..++.+|||.|+||.|...+..++ ..+++.++..|.+||+.|+.|||+.+|.||||||+|+|..... .+..+||+
T Consensus 128 ~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~-~na~lKLt 206 (400)
T KOG0604|consen 128 YQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTS-PNAPLKLT 206 (400)
T ss_pred ccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCC-CCcceEec
Confidence 2 347889999999999999997765 5699999999999999999999999999999999999998555 67899999
Q ss_pred ecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHH----HHhHhhccC
Q 037285 963 DFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAI----IGGIVNNTL 1038 (1094)
Q Consensus 963 DFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~ei----le~Iv~~~l 1038 (1094)
|||+|+.........+.+.|+.|.|||++. ..+|+..+|+||+||+||-|++|.+||...+...+ ...+....+
T Consensus 207 DfGFAK~t~~~~~L~TPc~TPyYvaPevlg--~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy 284 (400)
T KOG0604|consen 207 DFGFAKETQEPGDLMTPCFTPYYVAPEVLG--PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQY 284 (400)
T ss_pred ccccccccCCCccccCCcccccccCHHHhC--chhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCc
Confidence 999999766555556778999999999998 67899999999999999999999999988765322 222322222
Q ss_pred CCCCC--CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1039 RPTIP--SYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1039 rp~iP--e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
.-+-+ ..+++..+++|+++|..+|.+|.|+.+++.+-|-..
T Consensus 285 ~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~ 327 (400)
T KOG0604|consen 285 EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ 327 (400)
T ss_pred cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence 21112 346888999999999999999999999999877644
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=324.30 Aligned_cols=147 Identities=29% Similarity=0.498 Sum_probs=129.4
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.++||+|+||.||+|.+. ++.||||+++..... .......+.+|+.++..++|+||+++++++....
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~- 77 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMI-----NKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN- 77 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhcc-----CHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC-
Confidence 57999999999999999999986 788999999764322 1334467888999999999999999999988755
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+|+||||+.+++|.+++.... .+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 78 -~~~lVmEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~----~~g~vkL~DFGls 151 (669)
T cd05610 78 -NVYLVMEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS----NEGHIKLTDFGLS 151 (669)
T ss_pred -EEEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEc----CCCCEEEEeCCCC
Confidence 8999999999999999986544 588999999999999999999999999999999999998 6789999999987
Q ss_pred c
Q 037285 968 K 968 (1094)
Q Consensus 968 r 968 (1094)
+
T Consensus 152 ~ 152 (669)
T cd05610 152 K 152 (669)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=342.78 Aligned_cols=258 Identities=26% Similarity=0.358 Sum_probs=223.6
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
+..++|.++++||+|+||.|.+++.+ ++.+|+|++.+-.|..+. ...-|+.|-.+|..-+.+-|++++..|++
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~-----~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRA-----ETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhch-----hHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 46789999999999999999999886 466999999875443322 23568889999999999999999999999
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
.. ++|+|||||+||+|..+|.+.. .+++..+..++..|..||..||+.|+|||||||+|||+| ..|+|||+||
T Consensus 147 ~~--~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld----~~GHikLADF 219 (1317)
T KOG0612|consen 147 ER--YLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLD----KSGHIKLADF 219 (1317)
T ss_pred cc--ceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEec----ccCcEeeccc
Confidence 76 9999999999999999998877 699999999999999999999999999999999999999 8999999999
Q ss_pred CCccccc--CccccCCccCCCcccCcccccc--CC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCC
Q 037285 965 GLSKIKR--NTLVSGGVRGTLPWMAPELLSG--SS-SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 1039 (1094)
Q Consensus 965 GLSrl~~--~~~~ss~~~GT~~YmAPEvL~g--~~-~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lr 1039 (1094)
|.|-... -...+...+|||.|.+||++.. .. +.|+..+|+||+||++|||+.|..||......+.+.+|+...-.
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~ 299 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKES 299 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhh
Confidence 9886433 2344566789999999999862 23 67899999999999999999999999999999999999888666
Q ss_pred CCCC--CcCcHHHHHHHHHhccCCCCCCCC---HHHHHHHHHH
Q 037285 1040 PTIP--SYCDAEWRTLMEECWAPNPAARPS---FTEIASRLRV 1077 (1094)
Q Consensus 1040 p~iP--e~~S~eL~dLI~kCLq~DPeeRPS---~eELLq~L~~ 1077 (1094)
..+| ..+|.++++||.+++. +|+.|.. +.++..|..-
T Consensus 300 l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF 341 (1317)
T KOG0612|consen 300 LSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFF 341 (1317)
T ss_pred cCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccc
Confidence 6677 4589999999999998 6888987 9998877643
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=306.96 Aligned_cols=246 Identities=26% Similarity=0.403 Sum_probs=211.4
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeecCc--eEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeE
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGV 881 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~rGt--~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv 881 (1094)
..|...+|.++.+||+|+||.|.+|..+|+ .+|||++++..+...... +--..|-++|... +-|.+++++.+
T Consensus 344 d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDv-----ectm~EKrvLAL~~kppFL~qlHSc 418 (683)
T KOG0696|consen 344 DRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDV-----ECTMVEKRVLALPGKPPFLVQLHSC 418 (683)
T ss_pred cceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcc-----cceehhhhheecCCCCchHHHHHHH
Confidence 357778999999999999999999998875 499999998765432211 1122455666544 57899999999
Q ss_pred eecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEE
Q 037285 882 VQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKV 961 (1094)
Q Consensus 882 ~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKL 961 (1094)
|+.-. .+|+||||+.||+|--.+.+-++ +.+..+..++.+|+-||-|||++|||+||||.+|||++ ..++|||
T Consensus 419 FQTmD--RLyFVMEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd----~eGHiKi 491 (683)
T KOG0696|consen 419 FQTMD--RLYFVMEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD----SEGHIKI 491 (683)
T ss_pred hhhhh--heeeEEEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEec----cCCceEe
Confidence 98755 89999999999999888876654 78888899999999999999999999999999999999 8899999
Q ss_pred EecCCccc-ccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCC
Q 037285 962 GDFGLSKI-KRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 1040 (1094)
Q Consensus 962 sDFGLSrl-~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp 1040 (1094)
+|||+++. .-....+.+++||+.|+|||++. +..|+..+|+|||||+||||+.|+.||++.+..++.+.+.....
T Consensus 492 ~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~--YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv-- 567 (683)
T KOG0696|consen 492 ADFGMCKENIFDGVTTKTFCGTPDYIAPEIIA--YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV-- 567 (683)
T ss_pred eecccccccccCCcceeeecCCCcccccceEE--ecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC--
Confidence 99999984 23344556789999999999999 77899999999999999999999999999999999999988765
Q ss_pred CCCCcCcHHHHHHHHHhccCCCCCCC
Q 037285 1041 TIPSYCDAEWRTLMEECWAPNPAARP 1066 (1094)
Q Consensus 1041 ~iPe~~S~eL~dLI~kCLq~DPeeRP 1066 (1094)
.+|..++.+..++++..|.+.|.+|.
T Consensus 568 syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 568 SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred cCcccccHHHHHHHHHHhhcCCcccc
Confidence 58889999999999999999999995
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-33 Score=317.29 Aligned_cols=258 Identities=24% Similarity=0.350 Sum_probs=230.9
Q ss_pred eccCCeeEEEEecccCceEEEEeeecCce--EEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~rGt~--VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
+..++++.+.-||-|+||.|-+++.+++. +|+|++++..+.+ .+..+.+..|-++|...+.|.||++|..|.+
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVd-----tkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd 491 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVD-----TKQQEHVFSERNIMMECRSDFIVRLYRTFRD 491 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccc-----hhHHHHHHhHHHHHHhcCchHHHHHHHHhcc
Confidence 45567788889999999999999887655 8999999877654 2334567789999999999999999999998
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
.. ++|++||-|.||.|+..|..++. ++..++..++.-+++|++|||++|||+|||||+|++++ .+|.+||.||
T Consensus 492 ~k--yvYmLmEaClGGElWTiLrdRg~-Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd----~~Gy~KLVDF 564 (732)
T KOG0614|consen 492 SK--YVYMLMEACLGGELWTILRDRGS-FDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLD----NRGYLKLVDF 564 (732)
T ss_pred ch--hhhhhHHhhcCchhhhhhhhcCC-cccchhhhhHHHHHHHHHHHHhcCceeccCChhheeec----cCCceEEeeh
Confidence 66 99999999999999999987765 78888888889999999999999999999999999999 8899999999
Q ss_pred CCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCC
Q 037285 965 GLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPS 1044 (1094)
Q Consensus 965 GLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe 1044 (1094)
|+|+.......+.++|||+.|.|||++. +..-+.++|.||||+++|||++|.+||.+.+.......++++.-...+|.
T Consensus 565 GFAKki~~g~KTwTFcGTpEYVAPEIIL--nKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr 642 (732)
T KOG0614|consen 565 GFAKKIGSGRKTWTFCGTPEYVAPEIIL--NKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPR 642 (732)
T ss_pred hhHHHhccCCceeeecCCcccccchhhh--ccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhccc
Confidence 9999988888889999999999999998 45567899999999999999999999999999999988888877788999
Q ss_pred cCcHHHHHHHHHhccCCCCCCCC-----HHHHHHHHHHH
Q 037285 1045 YCDAEWRTLMEECWAPNPAARPS-----FTEIASRLRVL 1078 (1094)
Q Consensus 1045 ~~S~eL~dLI~kCLq~DPeeRPS-----~eELLq~L~~L 1078 (1094)
.++....+||+++...+|.+|.. +.+|.+|-|-.
T Consensus 643 ~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~ 681 (732)
T KOG0614|consen 643 RITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFE 681 (732)
T ss_pred ccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhh
Confidence 99999999999999999999975 78888887754
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=279.33 Aligned_cols=218 Identities=22% Similarity=0.262 Sum_probs=177.3
Q ss_pred cCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEEEeeecc
Q 037285 821 GTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMV 898 (1094)
Q Consensus 821 G~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~IVmEYme 898 (1094)
|.||.||+++++ ++.+|+|.++... .+.+|...+....||||+++++++.... ..++||||+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------------~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv~e~~~ 68 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------------EYSRERLTIIPHCVPNMVCLHKYIVSED--SVFLVLQHAE 68 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------------hhhhHHHHHHhcCCCceeehhhheecCC--eEEEEEecCC
Confidence 899999999884 6789999987541 2234455556667999999999998755 8999999999
Q ss_pred cchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccCccccCC
Q 037285 899 DGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGG 978 (1094)
Q Consensus 899 gGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~~~ss~ 978 (1094)
+|+|.+++.... .+++..+..++.|++.||.|||+++|+||||||+||+++ .++.++|+|||++....... ..
T Consensus 69 ~~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~~l~df~~~~~~~~~~--~~ 141 (237)
T cd05576 69 GGKLWSHISKFL-NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD----DRGHIQLTYFSRWSEVEDSC--DG 141 (237)
T ss_pred CCCHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc----CCCCEEEecccchhcccccc--cc
Confidence 999999987654 489999999999999999999999999999999999999 77889999999876443321 22
Q ss_pred ccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhc
Q 037285 979 VRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECW 1058 (1094)
Q Consensus 979 ~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCL 1058 (1094)
..++..|+|||.+. ...++.++||||||+++|+|++|+.||...... ........++..++..++++|.+||
T Consensus 142 ~~~~~~y~aPE~~~--~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l 213 (237)
T cd05576 142 EAVENMYCAPEVGG--ISEETEACDWWSLGAILFELLTGKTLVECHPSG------INTHTTLNIPEWVSEEARSLLQQLL 213 (237)
T ss_pred CCcCccccCCcccC--CCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------cccccccCCcccCCHHHHHHHHHHc
Confidence 34577899999986 456788999999999999999999887643221 1112223456778899999999999
Q ss_pred cCCCCCCCCH
Q 037285 1059 APNPAARPSF 1068 (1094)
Q Consensus 1059 q~DPeeRPS~ 1068 (1094)
+.||.+||++
T Consensus 214 ~~dp~~R~~~ 223 (237)
T cd05576 214 QFNPTERLGA 223 (237)
T ss_pred cCCHHHhcCC
Confidence 9999999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=266.15 Aligned_cols=237 Identities=32% Similarity=0.470 Sum_probs=194.6
Q ss_pred CceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEEEeeeccc
Q 037285 822 TFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVD 899 (1094)
Q Consensus 822 ~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~IVmEYmeg 899 (1094)
+||.||+|++. +..+|+|++....... ....+.+|+.++++++|+||+++++++.... ..++++||+.+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--~~~l~~e~~~~ 71 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKK-------KRERILREISILKKLKHPNIVRLYDVFEDED--KLYLVMEYCDG 71 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEeccccccc-------HHHHHHHHHHHHHhCCCCcHHHHHhheeeCC--EEEEEEeCCCC
Confidence 58999999985 5889999987643211 0467889999999999999999999998754 89999999999
Q ss_pred chhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccCccccCCc
Q 037285 900 GSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGV 979 (1094)
Q Consensus 900 GSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~~~ss~~ 979 (1094)
++|..++..... +++..++.++.+++.+|.|||+.+++|+||+|+||+++ .++.++|+|||++............
T Consensus 72 ~~L~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~----~~~~~~l~d~~~~~~~~~~~~~~~~ 146 (244)
T smart00220 72 GDLFDLLKKRGR-LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLD----EDGHVKLADFGLARQLDPGGLLTTF 146 (244)
T ss_pred CCHHHHHHhccC-CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEEC----CCCcEEEccccceeeeccccccccc
Confidence 999999876554 88999999999999999999999999999999999998 6789999999999865544334455
Q ss_pred cCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCc--CcHHHHHHHHHh
Q 037285 980 RGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSY--CDAEWRTLMEEC 1057 (1094)
Q Consensus 980 ~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~--~S~eL~dLI~kC 1057 (1094)
.++..|++||.+. ...++.++|||+||+++|+|++|..||........................ ++..+.+++.+|
T Consensus 147 ~~~~~~~~pE~~~--~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 224 (244)
T smart00220 147 VGTPEYMAPEVLL--GKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKL 224 (244)
T ss_pred cCCcCCCCHHHHc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHH
Confidence 6888999999987 456788999999999999999999999874333333333333322222222 788999999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 037285 1058 WAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1058 Lq~DPeeRPS~eELLq~ 1074 (1094)
|..+|.+||++.+++++
T Consensus 225 l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 225 LVKDPEKRLTAEEALQH 241 (244)
T ss_pred ccCCchhccCHHHHhhC
Confidence 99999999999999874
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=310.28 Aligned_cols=249 Identities=31% Similarity=0.438 Sum_probs=209.2
Q ss_pred EEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEEE
Q 037285 816 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATV 893 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~IV 893 (1094)
+.||.|.||+||-|+++ |+.||||+|.+..+....+ ..+.+|+.||+++.||.||.+...|.+.+ .++.|
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe------sqlR~EVaILq~l~HPGiV~le~M~ET~e--rvFVV 641 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE------SQLRNEVAILQNLHHPGIVNLECMFETPE--RVFVV 641 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchH------HHHHHHHHHHHhcCCCCeeEEEEeecCCc--eEEEE
Confidence 67999999999999875 7899999999876654322 45678999999999999999999998876 89999
Q ss_pred eeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccCc
Q 037285 894 AEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT 973 (1094)
Q Consensus 894 mEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~ 973 (1094)
||-+.|.-|+-.|..+.+.+++..-..++.||+.||+|||-++|+|+||||+|||+... ..-.++||||||+|+...+.
T Consensus 642 MEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~-~~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 642 MEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASA-SPFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred ehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccC-CCCCceeeccccceeecchh
Confidence 99996666666666677789999999999999999999999999999999999999743 24568999999999998887
Q ss_pred cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhc--cCCCCCCCcCcHHHH
Q 037285 974 LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN--TLRPTIPSYCDAEWR 1051 (1094)
Q Consensus 974 ~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~--~lrp~iPe~~S~eL~ 1051 (1094)
.......||+.|+|||++. +..|...-|+||+|||+|--++|..||..... +-.++-+. .+.+.-...++++..
T Consensus 721 sFRrsVVGTPAYLaPEVLr--nkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNAaFMyPp~PW~eis~~Ai 796 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLR--NKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNAAFMYPPNPWSEISPEAI 796 (888)
T ss_pred hhhhhhcCCccccCHHHHh--hccccccccceeeeEEEEEEecccccCCCccc--hhHHhhccccccCCCchhhcCHHHH
Confidence 7777788999999999998 56788889999999999999999999976543 22233222 233333456889999
Q ss_pred HHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1052 TLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1052 dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
+||..+|+..-.+|-+...-+.+.|.
T Consensus 797 dlIn~LLqVkm~kRysvdk~lsh~Wl 822 (888)
T KOG4236|consen 797 DLINNLLQVKMRKRYSVDKSLSHPWL 822 (888)
T ss_pred HHHHHHHHHHHHHhcchHhhccchhh
Confidence 99999999999999999988876654
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=308.17 Aligned_cols=252 Identities=24% Similarity=0.340 Sum_probs=208.8
Q ss_pred cceeeccCCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEe
Q 037285 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYG 880 (1094)
Q Consensus 803 sv~eIs~edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~G 880 (1094)
+.+.++.+.|+.-++||+|+||.||-++. +|..+|+|.+.+..+.. +.-..-.+.|-.+|++++.+.||.+-.
T Consensus 178 E~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKk-----r~ge~maLnEk~iL~kV~s~FiVslaY 252 (591)
T KOG0986|consen 178 ELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKK-----RKGETMALNEKQILEKVSSPFIVSLAY 252 (591)
T ss_pred HhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHH-----hhhhHHhhHHHHHHHHhccCcEEEEee
Confidence 34567788899999999999999998765 57889999886653322 111234567999999999999999988
Q ss_pred EeecCCCCceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcE
Q 037285 881 VVQDGPGGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC 959 (1094)
Q Consensus 881 v~~d~~~~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~V 959 (1094)
.|.+.. .+|+|+..|.||+|.-+|-+.+ ..+++..+..++.+|+.||++||+.+||+|||||+|||+| +.|+|
T Consensus 253 AfeTkd--~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLD----d~Ghv 326 (591)
T KOG0986|consen 253 AFETKD--ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLD----DHGHV 326 (591)
T ss_pred eecCCC--ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeec----cCCCe
Confidence 888765 8999999999999988886654 4589999999999999999999999999999999999999 89999
Q ss_pred EEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH----HHHHhHhh
Q 037285 960 KVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG----AIIGGIVN 1035 (1094)
Q Consensus 960 KLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~----eile~Iv~ 1035 (1094)
+|+|+|||.............||.+|||||++. +..|+...|+|||||++|||+.|+.||...... ++-..+..
T Consensus 327 RISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~--ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~ 404 (591)
T KOG0986|consen 327 RISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQ--NEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE 404 (591)
T ss_pred EeeccceEEecCCCCccccccCcccccCHHHHc--CCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc
Confidence 999999999766655555557999999999999 566999999999999999999999999765432 22222222
Q ss_pred ccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHH
Q 037285 1036 NTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFT 1069 (1094)
Q Consensus 1036 ~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~e 1069 (1094)
....++...++++++|++.+|..||.+|....
T Consensus 405 --~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 405 --DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred --chhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 23456788999999999999999999997443
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-32 Score=316.00 Aligned_cols=260 Identities=28% Similarity=0.422 Sum_probs=203.1
Q ss_pred eeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC---
Q 037285 812 LEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP--- 886 (1094)
Q Consensus 812 Yei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~--- 886 (1094)
|...+.||+|+||.||+|+.+ |+.||||.+++... .+..+...+|+++|++|+|+|||+++++-.+..
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~-------~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~ 87 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS-------LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGL 87 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcc-------cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCc
Confidence 344578999999999999864 88999999987542 223456789999999999999999999876554
Q ss_pred -CCceEEEeeecccchhHHHHhhcc--cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEe
Q 037285 887 -GGTLATVAEYMVDGSLRHVLVRKD--RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGD 963 (1094)
Q Consensus 887 -~~~L~IVmEYmegGSL~d~L~k~~--~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsD 963 (1094)
...-.+|||||.+|+|...|.+.. ..|++.+.+.++.+++.||.|||++||+||||||.||++-...+.....||+|
T Consensus 88 ~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 88 VTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred ccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeec
Confidence 345678999999999999997543 45999999999999999999999999999999999999964444566799999
Q ss_pred cCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH----HHHHhHhhccC-
Q 037285 964 FGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG----AIIGGIVNNTL- 1038 (1094)
Q Consensus 964 FGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~----eile~Iv~~~l- 1038 (1094)
||.|+...+......+.||..|++||++.. ...|+..+|.|||||++|+++||..||...... +++..+..+..
T Consensus 168 fG~Arel~d~s~~~S~vGT~~YLhPel~E~-q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~ 246 (732)
T KOG4250|consen 168 FGAARELDDNSLFTSLVGTEEYLHPELYER-QKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS 246 (732)
T ss_pred ccccccCCCCCeeeeecCchhhcChHHHhh-ccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence 999998777777778889999999999973 367888999999999999999999999764433 23322211111
Q ss_pred ------------------CCCCCCcCcHHH----HHHHHHhccCCCCCCC--CHHHHHHHHHHHH
Q 037285 1039 ------------------RPTIPSYCDAEW----RTLMEECWAPNPAARP--SFTEIASRLRVLS 1079 (1094)
Q Consensus 1039 ------------------rp~iPe~~S~eL----~dLI~kCLq~DPeeRP--S~eELLq~L~~L~ 1079 (1094)
..++|..++..+ -..+..+|..+|.+|. .+.+....+.++.
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 112233344443 3456678888888888 6666666666554
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=329.40 Aligned_cols=242 Identities=26% Similarity=0.396 Sum_probs=185.8
Q ss_pred CeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
.+...+.||+|+||.||+|++ .+..||||.+..... ....|+.++++++|||||+++++|.+..
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------~~~~~~~~l~~l~HpnIv~~~~~~~~~~-- 756 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------------IPSSEIADMGKLQHPNIVKLIGLCRSEK-- 756 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------------ccHHHHHHHhhCCCCCcceEEEEEEcCC--
Confidence 466778999999999999986 478899998864311 1123578899999999999999998765
Q ss_pred ceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HCCceeccCCCCceEeccCCCCCCcEEEEecC
Q 037285 889 TLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLH---SKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLH---s~GIIHRDLKPeNILLD~~~~e~g~VKLsDFG 965 (1094)
..++||||+++|+|.+++.. +++..+..|+.||+.||+||| +.+|+||||||+||+++ .+...++. |+
T Consensus 757 ~~~lv~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~----~~~~~~~~-~~ 827 (968)
T PLN00113 757 GAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID----GKDEPHLR-LS 827 (968)
T ss_pred CCEEEEeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEEC----CCCceEEE-ec
Confidence 78999999999999999952 789999999999999999999 66999999999999998 55556664 66
Q ss_pred CcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh--HHHHH---hHh-----h
Q 037285 966 LSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY--GAIIG---GIV-----N 1035 (1094)
Q Consensus 966 LSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~--~eile---~Iv-----~ 1035 (1094)
........ ....+|..|+|||++. ...++.++|||||||++|||+||+.||..... ..... ... .
T Consensus 828 ~~~~~~~~---~~~~~t~~y~aPE~~~--~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 902 (968)
T PLN00113 828 LPGLLCTD---TKCFISSAYVAPETRE--TKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLD 902 (968)
T ss_pred cccccccC---CCccccccccCccccc--CCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchh
Confidence 55432211 1235789999999987 45689999999999999999999999854211 11110 000 0
Q ss_pred ccCCCCC------CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 037285 1036 NTLRPTI------PSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLST 1080 (1094)
Q Consensus 1036 ~~lrp~i------Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~t 1080 (1094)
...++.. +.....++.+++.+||+.+|++||++.++++.|+++..
T Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 903 MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred heeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 0011111 11122357789999999999999999999999999864
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=294.94 Aligned_cols=254 Identities=33% Similarity=0.582 Sum_probs=203.4
Q ss_pred CCeeEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhh--CCCCceeEEEeEeecC--
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSK--LHHPNVVAFYGVVQDG-- 885 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkr--L~HPNIVqL~Gv~~d~-- 885 (1094)
.+.++.+.||+|.||+||+|+|+|+.||||+|... + ...+.+|.++++. |+|+||+.|++.-...
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~sr--------d---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g 279 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSR--------D---ERSWFRETEIYQTVMLRHENILGFIAADNKDNG 279 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEeccc--------c---hhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence 46788999999999999999999999999999653 1 1456677777765 6999999999864432
Q ss_pred CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCceEeccCCCCCC
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSK--------NIVHFDLKCDNLLVNLKDPSRP 957 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~--------GIIHRDLKPeNILLD~~~~e~g 957 (1094)
....+++|++|.+.|+|.+||.+. .++.+..++++..++.||++||-. .|+|||||..||||. .++
T Consensus 280 s~TQLwLvTdYHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK----kn~ 353 (513)
T KOG2052|consen 280 SWTQLWLVTDYHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK----KNG 353 (513)
T ss_pred ceEEEEEeeecccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc----cCC
Confidence 223699999999999999999774 589999999999999999999942 399999999999999 899
Q ss_pred cEEEEecCCcccccCc-----cccCCccCCCcccCccccccCCCC--C--CchhhHHHHHHHHHHHHc----C------C
Q 037285 958 ICKVGDFGLSKIKRNT-----LVSGGVRGTLPWMAPELLSGSSSK--V--SEKVDVFSFGIVLWEILT----G------E 1018 (1094)
Q Consensus 958 ~VKLsDFGLSrl~~~~-----~~ss~~~GT~~YmAPEvL~g~~~k--y--S~KSDVWSLGVLLyELLT----G------k 1018 (1094)
.+.|+|+|||...... ......+||.+|||||++...-+. | -..+||||||++|||++. | +
T Consensus 354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~ 433 (513)
T KOG2052|consen 354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ 433 (513)
T ss_pred cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence 9999999999743322 223445799999999998742111 1 135899999999999975 2 4
Q ss_pred CCCCCC-----ChHHHHHhHhhccCCCCCCCcCc-----HHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 037285 1019 EPYANM-----HYGAIIGGIVNNTLRPTIPSYCD-----AEWRTLMEECWAPNPAARPSFTEIASRLRVLST 1080 (1094)
Q Consensus 1019 ~PF~~~-----~~~eile~Iv~~~lrp~iPe~~S-----~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~t 1080 (1094)
.||.+. ..++..+.+..+.++|.+|.... ..+..||+-||..+|..|.|+--|.+.|.++..
T Consensus 434 ~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 434 LPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 577543 34555666677888888886543 346788999999999999999999999999874
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=322.64 Aligned_cols=250 Identities=31% Similarity=0.500 Sum_probs=191.7
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec---
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD--- 884 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d--- 884 (1094)
++|++++.||+|+||.||+++.+ |+.+|||+|.... ....-..+.+|+.+|.+|+|||||++|..|.+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-------s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~ 551 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-------SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTA 551 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-------HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCC
Confidence 57888999999999999999874 8999999997542 23445678899999999999999999732110
Q ss_pred --------------------------------------------------------------C-----------------
Q 037285 885 --------------------------------------------------------------G----------------- 885 (1094)
Q Consensus 885 --------------------------------------------------------------~----------------- 885 (1094)
.
T Consensus 552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S 631 (1351)
T KOG1035|consen 552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS 631 (1351)
T ss_pred ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence 0
Q ss_pred -----------------------------------CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHH
Q 037285 886 -----------------------------------PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGME 930 (1094)
Q Consensus 886 -----------------------------------~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLa 930 (1094)
....+||=||||+..+|.+++..+...-....+|+++.+|++||.
T Consensus 632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLA 711 (1351)
T ss_pred cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHH
Confidence 003578999999999998888765432246789999999999999
Q ss_pred HHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCccccc-------------------CccccCCccCCCcccCcccc
Q 037285 931 YLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKR-------------------NTLVSGGVRGTLPWMAPELL 991 (1094)
Q Consensus 931 YLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~-------------------~~~~ss~~~GT~~YmAPEvL 991 (1094)
|+|++|||||||||.||+++ +...|||+|||+++... .........||.-|+|||++
T Consensus 712 YIH~~giIHRDLKP~NIFLd----~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 712 YIHDQGIIHRDLKPRNIFLD----SRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred HHHhCceeeccCCcceeEEc----CCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 99999999999999999999 78899999999998510 01122345699999999999
Q ss_pred ccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCC-CChHHHHHhHhhccCCCC--CCCcCcHHHHHHHHHhccCCCCCCCC
Q 037285 992 SGSS-SKVSEKVDVFSFGIVLWEILTGEEPYAN-MHYGAIIGGIVNNTLRPT--IPSYCDAEWRTLMEECWAPNPAARPS 1067 (1094)
Q Consensus 992 ~g~~-~kyS~KSDVWSLGVLLyELLTGk~PF~~-~~~~eile~Iv~~~lrp~--iPe~~S~eL~dLI~kCLq~DPeeRPS 1067 (1094)
.+.. .+|+.|+|+||||++|+||+. ||.. +....++..+........ +...--+.-..+|++|++.||.+|||
T Consensus 788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPt 864 (1351)
T KOG1035|consen 788 SDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPT 864 (1351)
T ss_pred cccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCC
Confidence 8533 279999999999999999985 4654 334444544433222211 01112234578999999999999999
Q ss_pred HHHHHH
Q 037285 1068 FTEIAS 1073 (1094)
Q Consensus 1068 ~eELLq 1073 (1094)
+.+||.
T Consensus 865 A~eLL~ 870 (1351)
T KOG1035|consen 865 ATELLN 870 (1351)
T ss_pred HHHHhh
Confidence 999985
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=289.88 Aligned_cols=262 Identities=27% Similarity=0.452 Sum_probs=219.7
Q ss_pred eccCCeeEEEEecccCceEEEEeeecCc-------eEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEE
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWRGT-------DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFY 879 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~rGt-------~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~ 879 (1094)
+...+++....+-+|+||.||.|.|+.+ .|.+|.++.. ..+.....++.|..+|..+.|||+.++.
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-------AS~iQv~~~L~es~lly~~sH~nll~V~ 353 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-------ASQIQVNLLLQESMLLYGASHPNLLSVL 353 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-------ccHHHHHHHHHHHHHHhcCcCCCcccee
Confidence 4556788888999999999999988632 3666766543 1234456788999999999999999999
Q ss_pred eEeecCCCCceEEEeeecccchhHHHHhhc-------ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccC
Q 037285 880 GVVQDGPGGTLATVAEYMVDGSLRHVLVRK-------DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLK 952 (1094)
Q Consensus 880 Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~-------~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~ 952 (1094)
+++.+.. ...+.++.++.-|+|..+|... .+.++..+...|+.|++.||+|||+++|||.||.++|++++
T Consensus 354 ~V~ie~~-~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvId-- 430 (563)
T KOG1024|consen 354 GVSIEDY-ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVID-- 430 (563)
T ss_pred EEEeecc-CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceeh--
Confidence 9987643 3567788999999999999732 24577778889999999999999999999999999999999
Q ss_pred CCCCCcEEEEecCCcccc--cC-ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHH
Q 037285 953 DPSRPICKVGDFGLSKIK--RN-TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGA 1028 (1094)
Q Consensus 953 ~~e~g~VKLsDFGLSrl~--~~-~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~e 1028 (1094)
+..+|||+|=.+++.. .+ .........+..||+||.+. +..|+.++|||||||+||||+| |+.||...+..+
T Consensus 431 --d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~--n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE 506 (563)
T KOG1024|consen 431 --DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQ--NSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE 506 (563)
T ss_pred --hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHh--hhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH
Confidence 8899999999999832 11 22222333578999999998 7789999999999999999999 999999998877
Q ss_pred HHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 037285 1029 IIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAAS 1083 (1094)
Q Consensus 1029 ile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s 1083 (1094)
... .++.++|...|-+|++++..+|..||...|++||+|+++...|.++.++..
T Consensus 507 m~~-ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt 560 (563)
T KOG1024|consen 507 MEH-YLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT 560 (563)
T ss_pred HHH-HHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence 654 568899999999999999999999999999999999999999999987653
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=293.42 Aligned_cols=259 Identities=29% Similarity=0.435 Sum_probs=206.0
Q ss_pred ccCCeeEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHh--hCCCCceeEEEeEeecC
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILS--KLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILk--rL~HPNIVqL~Gv~~d~ 885 (1094)
....+++.++||+|.||.||||+..++.||||++... ....|..|-.|++ .|+|+||++|++.-...
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~-----------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~ 276 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQ-----------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRG 276 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhccCceeEEEecCHH-----------HHHHHHhHHHHHhccCccchhHHHhhchhccC
Confidence 3456788899999999999999999999999998642 2356777777766 46899999999876533
Q ss_pred C--CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHC---------CceeccCCCCceEeccCCC
Q 037285 886 P--GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSK---------NIVHFDLKCDNLLVNLKDP 954 (1094)
Q Consensus 886 ~--~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~---------GIIHRDLKPeNILLD~~~~ 954 (1094)
. ...+++|++|.+.|+|.+||... .++|....+|+..|++||+|||+. .|+|||||.+||||.
T Consensus 277 t~~~~eywLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK---- 350 (534)
T KOG3653|consen 277 TADRMEYWLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK---- 350 (534)
T ss_pred CccccceeEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc----
Confidence 2 33688999999999999999776 489999999999999999999953 499999999999998
Q ss_pred CCCcEEEEecCCcccccCc---cccCCccCCCcccCccccccCCC----CCCchhhHHHHHHHHHHHHcCCC--------
Q 037285 955 SRPICKVGDFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSS----KVSEKVDVFSFGIVLWEILTGEE-------- 1019 (1094)
Q Consensus 955 e~g~VKLsDFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~----kyS~KSDVWSLGVLLyELLTGk~-------- 1019 (1094)
+++.+.|+|||+|...... ..+..-+||.+|||||++.+.-+ ..-.+.||||+|++||||++...
T Consensus 351 ~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp 430 (534)
T KOG3653|consen 351 NDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVP 430 (534)
T ss_pred cCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCC
Confidence 8899999999999854322 22233579999999999975221 11146899999999999997432
Q ss_pred ----CCCC-----CChHHHHHhHhhccCCCCCCCcC-----cHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 037285 1020 ----PYAN-----MHYGAIIGGIVNNTLRPTIPSYC-----DAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAAS 1083 (1094)
Q Consensus 1020 ----PF~~-----~~~~eile~Iv~~~lrp~iPe~~-----S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s 1083 (1094)
||+. ...++....++.++.||.+|... ...+++.|..||+.|++.|.|+.-+.++++.+.....
T Consensus 431 ~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 431 EYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred cccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 3331 12345556677788888887543 3567899999999999999999999999999876554
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=304.12 Aligned_cols=243 Identities=27% Similarity=0.356 Sum_probs=201.1
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHH-hhCCCCceeEEEeEeecC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL-SKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkIL-krL~HPNIVqL~Gv~~d~ 885 (1094)
.++|.+...||.|+|+.|-.+... +...++|++.+... +-.+|+.++ ..-+||||+++++++.+.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------------~~~~e~~~~~~~~~h~niv~~~~v~~~~ 388 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------------DNQDEIPISLLVRDHPNIVKSHDVYEDG 388 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc------------ccccccchhhhhcCCCcceeecceecCC
Confidence 467888889999999999998774 67799999976521 112355444 344799999999999986
Q ss_pred CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecC
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFG 965 (1094)
. ..++|||.+.++.|.+.+..... .. ..+..|+.+|+.|+.|||++|||||||||+|||++ .+.++++|+|||
T Consensus 389 ~--~~~~v~e~l~g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~---~~~g~lrltyFG 461 (612)
T KOG0603|consen 389 K--EIYLVMELLDGGELLRRIRSKPE-FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD---GSAGHLRLTYFG 461 (612)
T ss_pred c--eeeeeehhccccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec---CCCCcEEEEEec
Confidence 6 89999999999999888866543 23 67778999999999999999999999999999994 167899999999
Q ss_pred CcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCc
Q 037285 966 LSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSY 1045 (1094)
Q Consensus 966 LSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~ 1045 (1094)
.++..... ....+.|..|.|||++. ...|+.++||||||++||+|++|+.||........ +......+.+...
T Consensus 462 ~a~~~~~~--~~tp~~t~~y~APEvl~--~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e---i~~~i~~~~~s~~ 534 (612)
T KOG0603|consen 462 FWSELERS--CDTPALTLQYVAPEVLA--IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE---IHTRIQMPKFSEC 534 (612)
T ss_pred hhhhCchh--hcccchhhcccChhhhc--cCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH---HHHhhcCCccccc
Confidence 99876555 23345789999999998 67899999999999999999999999998776622 2233334445588
Q ss_pred CcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1046 CDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1046 ~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
+|..+++||.+||+.||.+|+++.++..+-|.
T Consensus 535 vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 535 VSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred cCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 99999999999999999999999999999887
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=294.90 Aligned_cols=263 Identities=25% Similarity=0.371 Sum_probs=207.9
Q ss_pred ccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~ 885 (1094)
.+++|-++.+||+|+|++||+|.+- .+.||||+-...... +.+..+.......+|..|.+.|.||.||++|++|.-+
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~W-rdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNW-RDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccch-hhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 4578889999999999999999873 567999986543211 1233455667778999999999999999999999755
Q ss_pred CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeccCCCCCCcEEEEe
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNLKDPSRPICKVGD 963 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~G--IIHRDLKPeNILLD~~~~e~g~VKLsD 963 (1094)
. ..+|-|+|||+|.+|..||+... .+++..+..|+.||+.||.||.+.. |||-||||.|||+- .+..-|.+||+|
T Consensus 540 t-dsFCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv-~GtacGeIKITD 616 (775)
T KOG1151|consen 540 T-DSFCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLV-NGTACGEIKITD 616 (775)
T ss_pred c-ccceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEe-cCcccceeEeee
Confidence 3 47899999999999999997664 5999999999999999999999764 99999999999996 334678999999
Q ss_pred cCCcccccCc--------cccCCccCCCcccCccccccC--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHh-
Q 037285 964 FGLSKIKRNT--------LVSGGVRGTLPWMAPELLSGS--SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGG- 1032 (1094)
Q Consensus 964 FGLSrl~~~~--------~~ss~~~GT~~YmAPEvL~g~--~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~- 1032 (1094)
|||++..... ..++...||.+|++||++.-. ..+++.|+||||+|||+|.++.|+.||........+.+
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe 696 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE 696 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh
Confidence 9999954321 234556799999999998632 56789999999999999999999999987654432211
Q ss_pred --Hhh-ccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1033 --IVN-NTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1033 --Iv~-~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
+++ ....-+....++.+.+++|++||..--++|.+..+|...
T Consensus 697 NTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 697 NTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred hchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 111 111111224678999999999999999999988887654
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=282.79 Aligned_cols=259 Identities=25% Similarity=0.353 Sum_probs=200.2
Q ss_pred CCeeEEEEecccCceEEEEeeecC------ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEee
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQ 883 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~rG------t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~ 883 (1094)
..|+..++||+|+||.||+|..++ ..+|||.|+...... -......+|+.+++.|+||||+.+..+|.
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t------GiS~SAcREiaL~REl~h~nvi~Lv~Vfl 97 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT------GISMSACREIALLRELKHPNVISLVKVFL 97 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC------CcCHHHHHHHHHHHHhcCCcchhHHHHHh
Confidence 578899999999999999996532 258999987652211 12245678999999999999999999988
Q ss_pred cCCCCceEEEeeecccchhHHHHhhc----ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcE
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLVRK----DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC 959 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~k~----~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~V 959 (1094)
.. +..+++++||.+ -+|++.++-. .+.++...+..|+.||+.|+.|||++-|+||||||.||||..++++.|.|
T Consensus 98 ~~-d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~V 175 (438)
T KOG0666|consen 98 SH-DKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRV 175 (438)
T ss_pred cc-CceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCee
Confidence 74 458999999985 5777777532 24688899999999999999999999999999999999999888889999
Q ss_pred EEEecCCcccccCcc----ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh---------
Q 037285 960 KVGDFGLSKIKRNTL----VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY--------- 1026 (1094)
Q Consensus 960 KLsDFGLSrl~~~~~----~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~--------- 1026 (1094)
||+|||+++...... .....+-|.+|.|||.+.| ..+|+.+.|||+.|||+.||+|-++.|.+...
T Consensus 176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLG-a~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq 254 (438)
T KOG0666|consen 176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLG-ARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQ 254 (438)
T ss_pred EeecccHHHHhhccccccccCCceEEEEEecChHHhcc-cccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCch
Confidence 999999999654432 3345567999999999997 67899999999999999999998887764321
Q ss_pred HHHHHhHhhc-------cCC--CCCC--------------------------CcCcHHHHHHHHHhccCCCCCCCCHHHH
Q 037285 1027 GAIIGGIVNN-------TLR--PTIP--------------------------SYCDAEWRTLMEECWAPNPAARPSFTEI 1071 (1094)
Q Consensus 1027 ~eile~Iv~~-------~lr--p~iP--------------------------e~~S~eL~dLI~kCLq~DPeeRPS~eEL 1071 (1094)
...+..+..- .|. ..+| ..-++...+|+.+||..||.+|.|+++.
T Consensus 255 ~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qA 334 (438)
T KOG0666|consen 255 HDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQA 334 (438)
T ss_pred HHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHH
Confidence 1111111110 000 0000 1123447799999999999999999999
Q ss_pred HHHHHH
Q 037285 1072 ASRLRV 1077 (1094)
Q Consensus 1072 Lq~L~~ 1077 (1094)
+++.--
T Consensus 335 leh~yF 340 (438)
T KOG0666|consen 335 LEHPYF 340 (438)
T ss_pred hccccc
Confidence 887543
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=285.42 Aligned_cols=258 Identities=24% Similarity=0.387 Sum_probs=203.2
Q ss_pred cceeeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhh-CCCCceeEEE
Q 037285 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSK-LHHPNVVAFY 879 (1094)
Q Consensus 803 sv~eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkr-L~HPNIVqL~ 879 (1094)
..++++.++++-+..||.|+||+|+|-.++ |...|||+|+.... ++...+++.|..+.++ -+.||||++|
T Consensus 57 ~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-------~keq~rll~e~d~~mks~~cp~IVkfy 129 (361)
T KOG1006|consen 57 HLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-------EKEQKRLLMEHDTVMKSSNCPNIVKFY 129 (361)
T ss_pred cccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-------hHHHHHHHHHHHHHHhhcCCcHHHHHh
Confidence 356677788888999999999999998775 78899999986432 3344677788876554 4799999999
Q ss_pred eEeecCCCCceEEEeeecccchhHHHHh----hcccccCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeccCCC
Q 037285 880 GVVQDGPGGTLATVAEYMVDGSLRHVLV----RKDRFLDRRRRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDP 954 (1094)
Q Consensus 880 Gv~~d~~~~~L~IVmEYmegGSL~d~L~----k~~~~Lse~~~l~Ia~QIaeGLaYLHs-~GIIHRDLKPeNILLD~~~~ 954 (1094)
|++..+ +..+|.||.| ..+|..+.+ .+...+++..+-.|..-...||.||-. ..|||||+||+|||++
T Consensus 130 Ga~F~E--GdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILld---- 202 (361)
T KOG1006|consen 130 GALFSE--GDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLD---- 202 (361)
T ss_pred hhhhcC--CceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEe----
Confidence 998763 4789999998 456655432 133458888888898889999999985 5799999999999999
Q ss_pred CCCcEEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh-HHHHHhH
Q 037285 955 SRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY-GAIIGGI 1033 (1094)
Q Consensus 955 e~g~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~-~eile~I 1033 (1094)
..|.|||||||.+.............|-..|||||.+......|+.+|||||||++|||+.||+.||..... .+.+.++
T Consensus 203 r~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~V 282 (361)
T KOG1006|consen 203 RHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQV 282 (361)
T ss_pred cCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHH
Confidence 788999999999986544444444568889999999986555699999999999999999999999987654 3334444
Q ss_pred hhccCCC-CCCC---cCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1034 VNNTLRP-TIPS---YCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1034 v~~~lrp-~iPe---~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
+.+.... ..+. ..+..+..+|..||.+|-..||.+.+|+++
T Consensus 283 v~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 283 VIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 4433321 1222 367889999999999999999999999875
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=280.90 Aligned_cols=248 Identities=21% Similarity=0.344 Sum_probs=204.8
Q ss_pred cceeeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEE
Q 037285 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFY 879 (1094)
Q Consensus 803 sv~eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~ 879 (1094)
..|.+...+|.++++||+|+|+.|.+++.+ .+-+|+|+++++.+.+.... +-...|-.++.+- +||.+|.++
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedi-----dwvqtek~vfe~asn~pflvglh 317 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDI-----DWVQTEKHVFEQASNNPFLVGLH 317 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccc-----hhHHhhHHHHHhccCCCeEEehh
Confidence 346677789999999999999999999875 45699999998866543222 2233466666654 799999999
Q ss_pred eEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcE
Q 037285 880 GVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC 959 (1094)
Q Consensus 880 Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~V 959 (1094)
.+|+.+. .+++|.||.+||+|...+.+.. .++++.+..+..+|+.||.|||++|||+||||.+|||++ ..+++
T Consensus 318 scfqtes--rlffvieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh~rgiiyrdlkldnvlld----aeghi 390 (593)
T KOG0695|consen 318 SCFQTES--RLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLD----AEGHI 390 (593)
T ss_pred hhhcccc--eEEEEEEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEc----cCCce
Confidence 9999866 9999999999999988887665 489999999999999999999999999999999999999 88999
Q ss_pred EEEecCCccc-ccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC--C-----ChHHHHH
Q 037285 960 KVGDFGLSKI-KRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN--M-----HYGAIIG 1031 (1094)
Q Consensus 960 KLsDFGLSrl-~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~--~-----~~~eile 1031 (1094)
||+|+|+++. ......+++++||+.|.|||++. ...|.+.+|+|+|||+|+||+.|+.||+- + +.+..+.
T Consensus 391 kltdygmcke~l~~gd~tstfcgtpnyiapeilr--geeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylf 468 (593)
T KOG0695|consen 391 KLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILR--GEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLF 468 (593)
T ss_pred eecccchhhcCCCCCcccccccCCCcccchhhhc--ccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHH
Confidence 9999999984 45556678899999999999999 45678889999999999999999999963 2 2223333
Q ss_pred h-HhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCC
Q 037285 1032 G-IVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARP 1066 (1094)
Q Consensus 1032 ~-Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRP 1066 (1094)
+ ++... ..+|..++.....+++..|++||.+|.
T Consensus 469 qvilekq--iriprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 469 QVILEKQ--IRIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred HHHhhhc--ccccceeehhhHHHHHHhhcCCcHHhc
Confidence 3 33332 346778888889999999999999995
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=281.27 Aligned_cols=248 Identities=23% Similarity=0.367 Sum_probs=199.1
Q ss_pred EEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-CCceeEEEeEeecCCCCceEE
Q 037285 816 KELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HPNVVAFYGVVQDGPGGTLAT 892 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-HPNIVqL~Gv~~d~~~~~L~I 892 (1094)
+.||+|+|+.|-.++. +|..+|||++.+.. .....+..+|++++.+.+ |+||++++++|.++. .+|+
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--------gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~--~FYL 153 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--------GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT--RFYL 153 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCC--------chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc--eEEE
Confidence 6799999999998764 68889999997752 233467889999999986 999999999999876 8999
Q ss_pred EeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccC
Q 037285 893 VAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRN 972 (1094)
Q Consensus 893 VmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~ 972 (1094)
|||-|.||.|...+.++. .+++.++..++++|+.||.|||.+||.||||||+|||....+ .-.-||||||.+......
T Consensus 154 VfEKm~GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn-~vsPvKiCDfDLgSg~k~ 231 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHIQKRK-HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPN-KVSPVKICDFDLGSGIKL 231 (463)
T ss_pred EEecccCchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCC-CcCceeeecccccccccc
Confidence 999999999999997665 589999999999999999999999999999999999997433 344699999999763211
Q ss_pred --------ccccCCccCCCcccCccccc---cCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh-------H---H---
Q 037285 973 --------TLVSGGVRGTLPWMAPELLS---GSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY-------G---A--- 1028 (1094)
Q Consensus 973 --------~~~ss~~~GT~~YmAPEvL~---g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~-------~---e--- 1028 (1094)
.....+.+|+..|||||+.. +....|+.++|.||||||+|-|++|.+||.+.=. . .
T Consensus 232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ 311 (463)
T KOG0607|consen 232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ 311 (463)
T ss_pred CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHH
Confidence 11122456889999999964 4445689999999999999999999999975321 1 1
Q ss_pred --HHHhHhhccCCCCCC----CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1029 --IIGGIVNNTLRPTIP----SYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1029 --ile~Iv~~~lrp~iP----e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
+.+.+-.+.+ .+| ..++.+.+++|..++..|+..|.++.+++.+.+.
T Consensus 312 ~~LFesIQEGkY--eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~ 364 (463)
T KOG0607|consen 312 NKLFESIQEGKY--EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWV 364 (463)
T ss_pred HHHHHHHhccCC--cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccc
Confidence 2222322222 344 3578899999999999999999999999986554
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=299.50 Aligned_cols=252 Identities=28% Similarity=0.421 Sum_probs=207.5
Q ss_pred CCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEeec--
Q 037285 810 EDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQD-- 884 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~~d-- 884 (1094)
.-|++.+.||.|.+|.||+++. .++.+|+|+....... .+++..|.++|+.+ .|||++.+||++..
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~---------deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE---------EEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc---------cHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 3577889999999999999876 4788999987654211 13455688888887 59999999999863
Q ss_pred -CCCCceEEEeeecccchhHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 885 -GPGGTLATVAEYMVDGSLRHVLVRK-DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 885 -~~~~~L~IVmEYmegGSL~d~L~k~-~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
..++.+++|||||.+|+.-+++++- +..+.|+.+..|++.++.||.+||.+.++|||||-.|||++ .++.|||+
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT----~e~~VKLv 165 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLT----ENAEVKLV 165 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEe----ccCcEEEe
Confidence 2345799999999999999988653 45699999999999999999999999999999999999999 88999999
Q ss_pred ecCCcccccC-ccccCCccCCCcccCcccccc---CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccC
Q 037285 963 DFGLSKIKRN-TLVSGGVRGTLPWMAPELLSG---SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 1038 (1094)
Q Consensus 963 DFGLSrl~~~-~~~ss~~~GT~~YmAPEvL~g---~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~l 1038 (1094)
|||.+..... .....+..||+.|||||++.. ....|+..+|+||||++..||.-|.+|+-.++....+..+...-.
T Consensus 166 DFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPP 245 (953)
T KOG0587|consen 166 DFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP 245 (953)
T ss_pred eeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCC
Confidence 9999885443 334566789999999999862 234578899999999999999999999999998877766533222
Q ss_pred C-CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1039 R-PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1039 r-p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
. ...|...++.+-++|..||.+|.++||+..+++++
T Consensus 246 PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 246 PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 1 12356778899999999999999999999998865
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=291.84 Aligned_cols=245 Identities=23% Similarity=0.356 Sum_probs=196.5
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
.+.+-|..++-||-|+||+|+++... ...+|+|.+++... ..+..+.....|-.||..-..+-||+||..|++
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDV-----l~rnQvaHVKAERDILAEADn~WVVrLyySFQD 700 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADV-----LMRNQVAHVKAERDILAEADNEWVVRLYYSFQD 700 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHH-----HhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc
Confidence 34566888899999999999998653 45599999887532 223344567789999999999999999999998
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
.. .+|+||+|++||++-.+|.+.+ .+.+..+..++.++..|+++.|..|+|||||||+||||| .+|+|||+||
T Consensus 701 kd--nLYFVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILID----rdGHIKLTDF 773 (1034)
T KOG0608|consen 701 KD--NLYFVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID----RDGHIKLTDF 773 (1034)
T ss_pred CC--ceEEEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEc----cCCceeeeec
Confidence 66 9999999999999999998766 478888888889999999999999999999999999999 8899999999
Q ss_pred CCccccc-----------C--------------------------------ccccCCccCCCcccCccccccCCCCCCch
Q 037285 965 GLSKIKR-----------N--------------------------------TLVSGGVRGTLPWMAPELLSGSSSKVSEK 1001 (1094)
Q Consensus 965 GLSrl~~-----------~--------------------------------~~~ss~~~GT~~YmAPEvL~g~~~kyS~K 1001 (1094)
|||+-.. . .......+||+.|+|||++. ...|+..
T Consensus 774 GLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~--r~g~~q~ 851 (1034)
T KOG0608|consen 774 GLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLA--RTGYTQL 851 (1034)
T ss_pred cccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhc--ccCcccc
Confidence 9986210 0 00111346999999999998 5678889
Q ss_pred hhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhc--cCCCCCCCcCcHHHHHHHHHhccCCCCCCC
Q 037285 1002 VDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN--TLRPTIPSYCDAEWRTLMEECWAPNPAARP 1066 (1094)
Q Consensus 1002 SDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~--~lrp~iPe~~S~eL~dLI~kCLq~DPeeRP 1066 (1094)
+|+||.|||||||+.|+.||-.....+...++.+- .+.......++.++.++|.++.. +++.|.
T Consensus 852 cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RL 917 (1034)
T KOG0608|consen 852 CDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRL 917 (1034)
T ss_pred chhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhhh
Confidence 99999999999999999999888776665554432 22333446789999999887554 455664
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-30 Score=285.38 Aligned_cols=253 Identities=25% Similarity=0.276 Sum_probs=199.6
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-C-----CceeEE
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-H-----PNVVAF 878 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-H-----PNIVqL 878 (1094)
+...+|.+...+|+|+||.|..+.++ +..||||+++.- .+..+...-|+.+|++|. + --+|++
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---------~kYreAa~iEi~vLqki~~~DP~g~~rcv~m 156 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---------DKYREAALIEIEVLQKINESDPNGKFRCVQM 156 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---------HHHhhHHHHHHHHHHHHHhcCCCCceEEEee
Confidence 34679999999999999999999875 567999999753 334456677999999994 2 237788
Q ss_pred EeEeecCCCCceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCC----
Q 037285 879 YGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKD---- 953 (1094)
Q Consensus 879 ~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~---- 953 (1094)
.+||.- .+.+|||+|.+ |-++.++|.+++ ..++...+..|+.|++++|+|||+++++|.||||+|||+....
T Consensus 157 ~~wFdy--rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 157 RDWFDY--RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred ehhhhc--cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEE
Confidence 888866 44999999987 668999997643 5688999999999999999999999999999999999985211
Q ss_pred ------------CCCCcEEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 037285 954 ------------PSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1021 (1094)
Q Consensus 954 ------------~e~g~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF 1021 (1094)
..+..|||+|||.|+...+.. ...+.|..|.|||++.+ -.++.++||||+||||+|++||...|
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLg--LGwS~pCDvWSiGCIL~ElytG~~LF 309 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILG--LGWSQPCDVWSIGCILVELYTGETLF 309 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheec--cCcCCccCceeeeeEEEEeeccceec
Confidence 225679999999999876665 45678999999999994 57889999999999999999999999
Q ss_pred CCCChHHHH---HhHhhc--------c--------CCCCCCC-------------------------cCcHHHHHHHHHh
Q 037285 1022 ANMHYGAII---GGIVNN--------T--------LRPTIPS-------------------------YCDAEWRTLMEEC 1057 (1094)
Q Consensus 1022 ~~~~~~eil---e~Iv~~--------~--------lrp~iPe-------------------------~~S~eL~dLI~kC 1057 (1094)
....+.+.+ +.++.. . -+...++ ....++.+||++|
T Consensus 310 qtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m 389 (415)
T KOG0671|consen 310 QTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM 389 (415)
T ss_pred ccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence 988766633 222110 0 0000000 0123578999999
Q ss_pred ccCCCCCCCCHHHHHHHH
Q 037285 1058 WAPNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1058 Lq~DPeeRPS~eELLq~L 1075 (1094)
|..||.+|+|+.|++.+-
T Consensus 390 L~fDP~~RiTl~EAL~Hp 407 (415)
T KOG0671|consen 390 LEFDPARRITLREALSHP 407 (415)
T ss_pred HccCccccccHHHHhcCH
Confidence 999999999999999874
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=256.75 Aligned_cols=250 Identities=26% Similarity=0.365 Sum_probs=203.8
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
+|...++||+|+||+||+|+.+ ++-||+|+++.... ++......++|+.+|+.|+|.|||+++++...+.
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd------degvpssalreicllkelkhknivrl~dvlhsdk-- 74 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD------DEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-- 74 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC------CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCc--
Confidence 4566789999999999999875 46699999986532 2333456789999999999999999999987755
Q ss_pred ceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 889 TLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
.+.+|+||| ..+|..++...++.++.+.+..++.|+++||.|+|++++.||||||+|+|++ .++.+||+|||+++
T Consensus 75 kltlvfe~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin----~ngelkladfglar 149 (292)
T KOG0662|consen 75 KLTLVFEFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLIN----RNGELKLADFGLAR 149 (292)
T ss_pred eeEEeHHHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEec----cCCcEEecccchhh
Confidence 899999999 5789999988888899999999999999999999999999999999999999 89999999999999
Q ss_pred cccCcc-ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhcc-------CC
Q 037285 969 IKRNTL-VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNT-------LR 1039 (1094)
Q Consensus 969 l~~~~~-~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~-------lr 1039 (1094)
...-.. ..+...-|.+|.+|.++.| ..-|++..|+||-|||+.|+.. |++.|.+.+....+..+...- +.
T Consensus 150 afgipvrcysaevvtlwyrppdvlfg-akly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wp 228 (292)
T KOG0662|consen 150 AFGIPVRCYSAEVVTLWYRPPDVLFG-AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWP 228 (292)
T ss_pred hcCCceEeeeceeeeeeccCcceeee-eehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCC
Confidence 654432 2233457899999999986 4467889999999999999996 999999988877766654321 10
Q ss_pred -----------CCCCC---------cCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1040 -----------PTIPS---------YCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1040 -----------p~iPe---------~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
+.+|. .++..-++++.+++.-+|..|.++++.+++
T Consensus 229 s~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 229 SMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred ccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 11111 122334789999999999999999988765
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=293.28 Aligned_cols=256 Identities=18% Similarity=0.192 Sum_probs=169.4
Q ss_pred eeccCCeeEEEEecccCceEEEEeeec------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEE
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWR------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFY 879 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~r------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~ 879 (1094)
.+..++|++.+.||+|+||.||+|++. +..||||.+.... ..+. +..+ .+....+.+++.+.
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~------~~e~----~~~e--~l~~~~~~~~~~~~ 195 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG------AVEI----WMNE--RVRRACPNSCADFV 195 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc------hhHH----HHHH--HHHhhchhhHHHHH
Confidence 346679999999999999999999884 4679999876421 1111 1111 11222222222222
Q ss_pred eE----eecCCCCceEEEeeecccchhHHHHhhcccc-------------------cCHHHHHHHHHHHHHHHHHHHHCC
Q 037285 880 GV----VQDGPGGTLATVAEYMVDGSLRHVLVRKDRF-------------------LDRRRRLIIAMDAAFGMEYLHSKN 936 (1094)
Q Consensus 880 Gv----~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~-------------------Lse~~~l~Ia~QIaeGLaYLHs~G 936 (1094)
.. ........+++||||+.+++|.+++...... .....+..++.||+.||.|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g 275 (566)
T PLN03225 196 YGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG 275 (566)
T ss_pred HhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC
Confidence 11 1112234799999999999999988654211 123345679999999999999999
Q ss_pred ceeccCCCCceEeccCCCCCCcEEEEecCCcccccC--ccccCCccCCCcccCccccccCCC------------------
Q 037285 937 IVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRN--TLVSGGVRGTLPWMAPELLSGSSS------------------ 996 (1094)
Q Consensus 937 IIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~--~~~ss~~~GT~~YmAPEvL~g~~~------------------ 996 (1094)
|+||||||+|||++. ..+.+||+|||+++.... ........+|+.|+|||.+.....
T Consensus 276 IiHRDLKP~NILl~~---~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~ 352 (566)
T PLN03225 276 IVHRDVKPQNIIFSE---GSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLW 352 (566)
T ss_pred EEeCcCCHHHEEEeC---CCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhc
Confidence 999999999999982 356899999999984322 222345678999999997642111
Q ss_pred --CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhh-------------ccCCCC------CCCcCcHHHHHHHH
Q 037285 997 --KVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN-------------NTLRPT------IPSYCDAEWRTLME 1055 (1094)
Q Consensus 997 --kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~-------------~~lrp~------iPe~~S~eL~dLI~ 1055 (1094)
.+..++|||||||+||||+++..++..... .....+.. ....+. ..........+||.
T Consensus 353 ~~~~~~k~DVwSlGviL~el~~~~~~~~~~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~ 431 (566)
T PLN03225 353 QLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLI-QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLK 431 (566)
T ss_pred cccCCCCcccHHHHHHHHHHHhCcCCCchHHH-HHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHH
Confidence 234567999999999999997776543211 11111100 000000 00112234568999
Q ss_pred HhccCCCCCCCCHHHHHHHHHH
Q 037285 1056 ECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1056 kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
+||+.||.+|||+.++++|-+-
T Consensus 432 ~mL~~dP~kR~ta~e~L~Hpff 453 (566)
T PLN03225 432 SMMRFKGRQRISAKAALAHPYF 453 (566)
T ss_pred HHccCCcccCCCHHHHhCCcCc
Confidence 9999999999999999998554
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=286.07 Aligned_cols=267 Identities=19% Similarity=0.173 Sum_probs=185.7
Q ss_pred eccCCeeEEEEecccCceEEEEeee------------------cCceEEEEEeecCccCCCch-hH-----HHHHHHHHH
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKW------------------RGTDVAIKRIKKSCFTGRSS-EQ-----ERLTVEFWK 862 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~------------------rGt~VAVKiIkk~~~se~~~-eq-----e~~~~eFlr 862 (1094)
+..++|++.++||+|+||+||+|.+ .++.||||.+.......... .. ....+.+..
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 4678999999999999999999864 23569999986431100000 00 001123445
Q ss_pred HHHHHhhCCCCce-----eEEEeEeecC------CCCceEEEeeecccchhHHHHhhcc---------------------
Q 037285 863 EAEILSKLHHPNV-----VAFYGVVQDG------PGGTLATVAEYMVDGSLRHVLVRKD--------------------- 910 (1094)
Q Consensus 863 EIkILkrL~HPNI-----VqL~Gv~~d~------~~~~L~IVmEYmegGSL~d~L~k~~--------------------- 910 (1094)
|+.++.+++|.++ ++++++|... ..+..++||||+.+++|.+++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777788876654 6677776532 1236899999999999999886421
Q ss_pred --cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccCccccC--CccCCCccc
Q 037285 911 --RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSG--GVRGTLPWM 986 (1094)
Q Consensus 911 --~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~~~ss--~~~GT~~Ym 986 (1094)
..+++..+..++.|++.+|.|||+++|+||||||+|||++ .++.+||+|||+++......... ...+|+.|+
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~----~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~ 377 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVT----VDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYS 377 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEEC----CCCcEEEEeCcCccccccCCccCccccCCCccee
Confidence 1235677888999999999999999999999999999998 67789999999997543222111 223478999
Q ss_pred CccccccCC--------------------CCCCchhhHHHHHHHHHHHHcCCC-CCCCCChHHH-----------HHhHh
Q 037285 987 APELLSGSS--------------------SKVSEKVDVFSFGIVLWEILTGEE-PYANMHYGAI-----------IGGIV 1034 (1094)
Q Consensus 987 APEvL~g~~--------------------~kyS~KSDVWSLGVLLyELLTGk~-PF~~~~~~ei-----------le~Iv 1034 (1094)
|||.+.... +....+.||||+||++|+|++|.. ||........ +....
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~ 457 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK 457 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc
Confidence 999975311 111235799999999999999875 7754321111 11111
Q ss_pred hccCCCCCCCcCcHHHHHHHHHhccCCC---CCCCCHHHHHHHHHH
Q 037285 1035 NNTLRPTIPSYCDAEWRTLMEECWAPNP---AARPSFTEIASRLRV 1077 (1094)
Q Consensus 1035 ~~~lrp~iPe~~S~eL~dLI~kCLq~DP---eeRPS~eELLq~L~~ 1077 (1094)
...+.......++...++|+.+||..+| .+|+|+.++++|-+-
T Consensus 458 ~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f 503 (507)
T PLN03224 458 GQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFF 503 (507)
T ss_pred ccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCc
Confidence 1222222334578889999999999766 689999999988653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-27 Score=233.87 Aligned_cols=211 Identities=42% Similarity=0.655 Sum_probs=180.3
Q ss_pred ecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEEEee
Q 037285 818 LGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAE 895 (1094)
Q Consensus 818 LGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~IVmE 895 (1094)
||.|.+|.||++... +..+++|++....... ....+.+|+.+++.+.|++|+++++++.... ..++++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--~~~~~~e 71 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-------LLEELLREIEILKKLNHPNIVKLYGVFEDEN--HLYLVME 71 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-------HHHHHHHHHHHHHhcCCCCeeeEeeeeecCC--eEEEEEe
Confidence 689999999999987 7889999987642210 3457889999999999999999999998754 8999999
Q ss_pred ecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCC-CCcEEEEecCCcccccCcc
Q 037285 896 YMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPS-RPICKVGDFGLSKIKRNTL 974 (1094)
Q Consensus 896 YmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e-~g~VKLsDFGLSrl~~~~~ 974 (1094)
|+.+++|.+++......+++..++.++.+++.+|.+||+.+++|+||+|.||+++ . .+.++|+|||.+.......
T Consensus 72 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~----~~~~~~~l~d~~~~~~~~~~~ 147 (215)
T cd00180 72 YCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLD----SDNGKVKLADFGLSKLLTSDK 147 (215)
T ss_pred cCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEe----CCCCcEEEecCCceEEccCCc
Confidence 9999999999976644589999999999999999999999999999999999998 5 6789999999998554332
Q ss_pred -ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHH
Q 037285 975 -VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTL 1053 (1094)
Q Consensus 975 -~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dL 1053 (1094)
......+...|++||.+... ..++.++|+|+||+++++| ..+.++
T Consensus 148 ~~~~~~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~ 193 (215)
T cd00180 148 SLLKTIVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL---------------------------------PELKDL 193 (215)
T ss_pred chhhcccCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH---------------------------------HHHHHH
Confidence 12234578889999998742 3678899999999999999 678999
Q ss_pred HHHhccCCCCCCCCHHHHHHHH
Q 037285 1054 MEECWAPNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1054 I~kCLq~DPeeRPS~eELLq~L 1075 (1094)
+.+||+.+|.+||++.+++++|
T Consensus 194 l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 194 IRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHhhCCcccCcCHHHHhhCC
Confidence 9999999999999999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-30 Score=273.26 Aligned_cols=263 Identities=22% Similarity=0.319 Sum_probs=205.0
Q ss_pred ccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~ 885 (1094)
..+.|+...+||+|.||+||+|+.+ |+.||+|++..+ .+.+.+-...++|+++|..|+|+|++.++.+|...
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlme------neKeGfpitalreikiL~~lkHenv~nliEic~tk 88 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLME------NEKEGFPITALREIKILQLLKHENVVNLIEICRTK 88 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHh------ccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhc
Confidence 3456777889999999999999875 566898866432 22344556778999999999999999999887532
Q ss_pred ------CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcE
Q 037285 886 ------PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC 959 (1094)
Q Consensus 886 ------~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~V 959 (1094)
....+|+||.+|+ -+|..+|.+....++..++.++..+++.||.|+|++.|+|||+||+|+||+ .++.+
T Consensus 89 ~Tp~~r~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt----~dgil 163 (376)
T KOG0669|consen 89 ATPTNRDRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLIT----KDGIL 163 (376)
T ss_pred cCCcccccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEc----CCceE
Confidence 2345899999995 678888877767799999999999999999999999999999999999999 78899
Q ss_pred EEEecCCcccccCccc-----cCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHh
Q 037285 960 KVGDFGLSKIKRNTLV-----SGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV 1034 (1094)
Q Consensus 960 KLsDFGLSrl~~~~~~-----ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv 1034 (1094)
||+|||+++....... ....+-|.+|.+||.+.| ...|+.+.|||.-||||.||+|+.+-|.+......+..+.
T Consensus 164 klADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG-~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is 242 (376)
T KOG0669|consen 164 KLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLG-DREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLIS 242 (376)
T ss_pred EeeccccccceecccccCCCCcccceeeeecCCHHHhhc-ccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHH
Confidence 9999999974322111 122346899999999997 6788999999999999999999999998877665443321
Q ss_pred h-------ccCC-------------CCCC-------------CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1035 N-------NTLR-------------PTIP-------------SYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1035 ~-------~~lr-------------p~iP-------------e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
. +.|. ++++ -.-.++..+||.++|..||.+|+++.+++.+-.-...+
T Consensus 243 ~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 243 QLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP 322 (376)
T ss_pred HHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence 1 0000 0011 11234678999999999999999999999887665544
Q ss_pred h
Q 037285 1082 A 1082 (1094)
Q Consensus 1082 ~ 1082 (1094)
.
T Consensus 323 ~ 323 (376)
T KOG0669|consen 323 M 323 (376)
T ss_pred c
Confidence 3
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-29 Score=294.31 Aligned_cols=243 Identities=30% Similarity=0.455 Sum_probs=184.8
Q ss_pred EEEEecccCce-EEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEeecCCCCceE
Q 037285 814 EQKELGSGTFG-TVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQDGPGGTLA 891 (1094)
Q Consensus 814 i~kkLGsG~FG-tVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~~d~~~~~L~ 891 (1094)
-.+.+|.|+-| .||+|.+.|+.||||++...+ ..-..+|+..|+.- .|||||++|+.-.+.. .+|
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~-----------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~q--F~Y 579 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF-----------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQ--FLY 579 (903)
T ss_pred cHHHcccCCCCcEEEEEeeCCceehHHHHhhHh-----------HHHHHHHHHHHHhccCCCceEEEEeeccCCc--eEE
Confidence 34678999987 579999999999999986543 23456899999877 5999999998877755 999
Q ss_pred EEeeecccchhHHHHhhccc---ccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCC-CCCcEEEEecCCc
Q 037285 892 TVAEYMVDGSLRHVLVRKDR---FLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP-SRPICKVGDFGLS 967 (1094)
Q Consensus 892 IVmEYmegGSL~d~L~k~~~---~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~-e~g~VKLsDFGLS 967 (1094)
|+.|.| ..+|.+++..... .......+.+..|+++||++||+.+||||||||+||||+..+. ....++|+|||++
T Consensus 580 IalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls 658 (903)
T KOG1027|consen 580 IALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLS 658 (903)
T ss_pred EEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccc
Confidence 999999 6899999977411 1111345678899999999999999999999999999985332 3478999999999
Q ss_pred ccccC----ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCCC
Q 037285 968 KIKRN----TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTI 1042 (1094)
Q Consensus 968 rl~~~----~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~i 1042 (1094)
+.... -....+..||-+|+|||++.. ..-+.++|||||||++|++++ |..||...-..+ ..++........
T Consensus 659 Kkl~~~~sS~~r~s~~sGt~GW~APE~L~~--~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L~~ 734 (903)
T KOG1027|consen 659 KKLAGGKSSFSRLSGGSGTSGWQAPEQLRE--DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTLVH 734 (903)
T ss_pred cccCCCcchhhcccCCCCcccccCHHHHhc--cccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccceee
Confidence 84322 122445679999999999984 344568999999999999999 699998754432 123333222111
Q ss_pred -CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1043 -PSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1043 -Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
......+..+||.+|++++|..||++.+|+.|
T Consensus 735 L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 735 LEPLPDCEAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred eccCchHHHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 11111188999999999999999999999843
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-26 Score=232.15 Aligned_cols=212 Identities=36% Similarity=0.571 Sum_probs=174.3
Q ss_pred eeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCc
Q 037285 812 LEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGT 889 (1094)
Q Consensus 812 Yei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~ 889 (1094)
|.+.+.||.|++|.||++... +..+|+|.+...... .....+.+|+.++++++|+|++++++++.... .
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~--~ 71 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-------KQREEFLREIRILKKLKHPNIVKLYGVFEDPE--P 71 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-------HHHHHHHHHHHHHHhCCCCChhhheeeeecCC--c
Confidence 567789999999999999885 578999998764321 23467889999999999999999999988754 8
Q ss_pred eEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCccc
Q 037285 890 LATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI 969 (1094)
Q Consensus 890 L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl 969 (1094)
.++++||+.+++|.+++......+++..++.++.+++.+|.+||+.+++|+||+|.||+++ .++.++|+|||++..
T Consensus 72 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~----~~~~~~l~d~g~~~~ 147 (225)
T smart00221 72 LYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLG----MDGLVKLADFGLARF 147 (225)
T ss_pred eEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEEEeeCceeeE
Confidence 9999999999999999976543378999999999999999999999999999999999998 668999999999886
Q ss_pred ccCcc--ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC-CChHHHHHhHhhcc
Q 037285 970 KRNTL--VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN-MHYGAIIGGIVNNT 1037 (1094)
Q Consensus 970 ~~~~~--~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~-~~~~eile~Iv~~~ 1037 (1094)
..... ......++..|++||.+. ....++.++|||+||+++|+|++|+.||.. ..+...+.+.+..+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~ 217 (225)
T smart00221 148 IHRDLAALLKTVKGTPFYLAPEVLL-GGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFG 217 (225)
T ss_pred ecCcccccccceeccCCcCCHhHhc-CCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcC
Confidence 54332 223445788899999984 356777899999999999999999999977 45553444333433
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=250.80 Aligned_cols=251 Identities=19% Similarity=0.270 Sum_probs=202.8
Q ss_pred ccCCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-CCceeEEEeEeec
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HPNVVAFYGVVQD 884 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-HPNIVqL~Gv~~d 884 (1094)
..++|++.+++|+|.|++||.|.. +++.++||++++-. ...+.+|+++|+.|. ||||+++++++.+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----------kkKIkREikIL~nL~gg~NIi~L~DiV~D 104 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----------KKKIKREIKILQNLRGGPNIIKLLDIVKD 104 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----------HHHHHHHHHHHHhccCCCCeeehhhhhcC
Confidence 457899999999999999999974 57889999997631 256789999999998 9999999999998
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
.......+|+||+.+.+...+.. .++...+...+.+++.||.|||++||+|||+||.|++++. +...++|+|+
T Consensus 105 p~SktpaLiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh---~~rkLrlIDW 177 (338)
T KOG0668|consen 105 PESKTPSLIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDH---ELRKLRLIDW 177 (338)
T ss_pred ccccCchhHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeech---hhceeeeeec
Confidence 87778889999999988877653 3677778889999999999999999999999999999984 5668999999
Q ss_pred CCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCC-CCCChHHHHHhHhh--------
Q 037285 965 GLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPY-ANMHYGAIIGGIVN-------- 1035 (1094)
Q Consensus 965 GLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF-~~~~~~eile~Iv~-------- 1035 (1094)
|+|.+............+..|--||.+.. ...|+..-|+|||||++..|+..+.|| .+.++.+.+.++..
T Consensus 178 GLAEFYHp~~eYnVRVASRyfKGPELLVd-y~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~ 256 (338)
T KOG0668|consen 178 GLAEFYHPGKEYNVRVASRYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELY 256 (338)
T ss_pred chHhhcCCCceeeeeeehhhcCCchheee-chhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHH
Confidence 99998776655555567778899999875 567888899999999999999988886 44444433222111
Q ss_pred -------ccCC--------------------CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1036 -------NTLR--------------------PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1036 -------~~lr--------------------p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
-.+. .......++++.+|+.++|..|..+|+|++|.+.+-.-
T Consensus 257 ~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF 325 (338)
T KOG0668|consen 257 AYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYF 325 (338)
T ss_pred HHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchH
Confidence 0011 11112356899999999999999999999999877543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-27 Score=269.78 Aligned_cols=252 Identities=25% Similarity=0.323 Sum_probs=201.4
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC------CCcee
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH------HPNVV 876 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~------HPNIV 876 (1094)
-++...+|.+....|+|-|++|.+|.+. |..||||+|+.. +.+...-++|+.+|++|+ --|++
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---------E~M~KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---------EVMHKTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc---------hHHhhhhhHHHHHHHHhhccCchhhhHHH
Confidence 3456689999999999999999999884 778999999864 344566778999999995 35788
Q ss_pred EEEeEeecCCCCceEEEeeecccchhHHHHhhccc--ccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCC
Q 037285 877 AFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDR--FLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP 954 (1094)
Q Consensus 877 qL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~--~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~ 954 (1094)
+++..|...+ ++|+|+|-+ ..+|.+.|++-+. .|....+..++.|+.-||..|-..||+|.||||+||||+.
T Consensus 498 rl~r~F~hkn--HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE--- 571 (752)
T KOG0670|consen 498 RLFRHFKHKN--HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNE--- 571 (752)
T ss_pred HHHHHhhhcc--eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEecc---
Confidence 8888887755 999999977 6889999987553 4788899999999999999999999999999999999982
Q ss_pred CCCcEEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHh
Q 037285 955 SRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV 1034 (1094)
Q Consensus 955 e~g~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv 1034 (1094)
....+||||||.|........+.. .-+..|.|||++.| -.|+...|+||+||+||||+||+..|.+.++...+.-.+
T Consensus 572 ~k~iLKLCDfGSA~~~~eneitPY-LVSRFYRaPEIiLG--~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~m 648 (752)
T KOG0670|consen 572 SKNILKLCDFGSASFASENEITPY-LVSRFYRAPEIILG--LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFM 648 (752)
T ss_pred CcceeeeccCccccccccccccHH-HHHHhccCcceeec--CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHH
Confidence 567899999999987666555433 34667999999995 457778999999999999999999999988766543221
Q ss_pred hc--cCC---------------C-----------------------CCC-----------CcCc-------HHHHHHHHH
Q 037285 1035 NN--TLR---------------P-----------------------TIP-----------SYCD-------AEWRTLMEE 1056 (1094)
Q Consensus 1035 ~~--~lr---------------p-----------------------~iP-----------e~~S-------~eL~dLI~k 1056 (1094)
.- .+. . ..| +.++ ..+++|+.+
T Consensus 649 e~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdk 728 (752)
T KOG0670|consen 649 ELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDK 728 (752)
T ss_pred HhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHH
Confidence 10 000 0 000 0011 357899999
Q ss_pred hccCCCCCCCCHHHHHHH
Q 037285 1057 CWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1057 CLq~DPeeRPS~eELLq~ 1074 (1094)
||..||++|.|..+.|.|
T Consensus 729 ml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 729 MLILDPEKRITVNQALKH 746 (752)
T ss_pred HhccChhhcCCHHHHhcC
Confidence 999999999999998876
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=241.37 Aligned_cols=216 Identities=29% Similarity=0.420 Sum_probs=168.9
Q ss_pred eccCCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEee
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQ 883 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~~ 883 (1094)
+..+.+..+..||+|++|.|-+-++ .|+-.|+|.++.... .+...+.++|+.+..+. .+|.+|.+||...
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-------~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~ 115 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-------SQEQKRLLMDLDIIMRTVDCPFTVHFYGALF 115 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-------hHHHHHHHHhhhhhccCCCCCeEEEeehhhh
Confidence 4445566678899999998877665 588899999976421 12234567788876654 6999999999876
Q ss_pred cCCCCceEEEeeecccchhHHHHh---hcccccCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeccCCCCCCcE
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLV---RKDRFLDRRRRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPSRPIC 959 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~---k~~~~Lse~~~l~Ia~QIaeGLaYLHs~-GIIHRDLKPeNILLD~~~~e~g~V 959 (1094)
.. +.++|.||.| ..+|..+.. .++..+++..+-+|+..|..||.|||++ .+||||+||.|||++ ..|+|
T Consensus 116 re--gdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn----~~GqV 188 (282)
T KOG0984|consen 116 RE--GDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILIN----YDGQV 188 (282)
T ss_pred cc--ccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEc----cCCcE
Confidence 64 4899999998 466665543 3456789999999999999999999976 799999999999999 78899
Q ss_pred EEEecCCcccccCccccCCccCCCcccCccccccC--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-hHHHHHhHhhc
Q 037285 960 KVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGS--SSKVSEKVDVFSFGIVLWEILTGEEPYANMH-YGAIIGGIVNN 1036 (1094)
Q Consensus 960 KLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~--~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~-~~eile~Iv~~ 1036 (1094)
|+||||.+....+........|-..|||||.+... ...|+.|+||||||+++.||.+++.||.... ..+.+.+++.+
T Consensus 189 KiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 189 KICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred EEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 99999999855444333334577889999998732 2368999999999999999999999998754 45555655543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.1e-26 Score=257.23 Aligned_cols=260 Identities=22% Similarity=0.275 Sum_probs=196.5
Q ss_pred eeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC--------CCce
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH--------HPNV 875 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~--------HPNI 875 (1094)
.+...+|.+.++||+|.|++||++.++ .+.||+|+.+.. +.+.+..+.||++|++++ -.+|
T Consensus 74 ~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---------qhYtEaAlDEIklL~~v~~~Dp~~~~~~~V 144 (590)
T KOG1290|consen 74 VFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---------QHYTEAALDEIKLLQQVREGDPNDPGKKCV 144 (590)
T ss_pred cccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---------hHHHHHHHHHHHHHHHHHhcCCCCCCCcee
Confidence 355689999999999999999999885 467999998753 566678889999999984 3579
Q ss_pred eEEEeEeecC--CCCceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEecc
Q 037285 876 VAFYGVVQDG--PGGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNL 951 (1094)
Q Consensus 876 VqL~Gv~~d~--~~~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs-~GIIHRDLKPeNILLD~ 951 (1094)
|+|++.|... .+.++|+|+|++ |-+|..+|.... +.++...+.+||+||+.||.|||. .||||.||||+|||+..
T Consensus 145 V~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~ 223 (590)
T KOG1290|consen 145 VQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCS 223 (590)
T ss_pred eeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeec
Confidence 9999998632 344899999998 778888886543 569999999999999999999995 58999999999999853
Q ss_pred CC------------------------------------------------------------------------------
Q 037285 952 KD------------------------------------------------------------------------------ 953 (1094)
Q Consensus 952 ~~------------------------------------------------------------------------------ 953 (1094)
..
T Consensus 224 ~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~ 303 (590)
T KOG1290|consen 224 TEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESY 303 (590)
T ss_pred cccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccccc
Confidence 10
Q ss_pred ---------------------------------CC---------------------------------------------
Q 037285 954 ---------------------------------PS--------------------------------------------- 955 (1094)
Q Consensus 954 ---------------------------------~e--------------------------------------------- 955 (1094)
..
T Consensus 304 n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~ 383 (590)
T KOG1290|consen 304 NNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPD 383 (590)
T ss_pred ccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCC
Confidence 00
Q ss_pred ------CCcEEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh---
Q 037285 956 ------RPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY--- 1026 (1094)
Q Consensus 956 ------~g~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~--- 1026 (1094)
...|||+|||-|+....... ....|..|.|||++. ...|++.+||||++|++|||+||...|+....
T Consensus 384 ~~~~~~di~vKIaDlGNACW~~khFT--~DIQTRQYRapEVll--GsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y 459 (590)
T KOG1290|consen 384 IPLPECDIRVKIADLGNACWVHKHFT--EDIQTRQYRAPEVLL--GSGYSTSADIWSTACMAFELATGDYLFEPHSGENY 459 (590)
T ss_pred CCCCccceeEEEeeccchhhhhhhhc--hhhhhhhccCcceee--cCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCC
Confidence 01378888888876443321 234789999999999 46788999999999999999999999864321
Q ss_pred ---HHHHHhHhh------------cc-----------CC----C-------------CCCCcCcHHHHHHHHHhccCCCC
Q 037285 1027 ---GAIIGGIVN------------NT-----------LR----P-------------TIPSYCDAEWRTLMEECWAPNPA 1063 (1094)
Q Consensus 1027 ---~eile~Iv~------------~~-----------lr----p-------------~iPe~~S~eL~dLI~kCLq~DPe 1063 (1094)
+..+..++. +. ++ . .++.....++.+|+.-||+.+|+
T Consensus 460 ~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~Pe 539 (590)
T KOG1290|consen 460 SRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPE 539 (590)
T ss_pred CccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcc
Confidence 111111111 00 00 0 01112234678999999999999
Q ss_pred CCCCHHHHHHHHHHHH
Q 037285 1064 ARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1064 eRPS~eELLq~L~~L~ 1079 (1094)
+|||+.+.+++-|-..
T Consensus 540 KR~tA~~cl~hPwLn~ 555 (590)
T KOG1290|consen 540 KRPTAAQCLKHPWLNP 555 (590)
T ss_pred ccccHHHHhcCccccC
Confidence 9999999999877653
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.3e-27 Score=269.65 Aligned_cols=206 Identities=27% Similarity=0.388 Sum_probs=171.8
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC---CCceeEEEeEee
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH---HPNVVAFYGVVQ 883 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~---HPNIVqL~Gv~~ 883 (1094)
..+|+.++.||.|+||.|++|.++ ...|+||+|+++.+-.......+..-..-.||+||..|+ |+||++++++|.
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 357999999999999999999886 466999999886543322222222334456999999998 999999999999
Q ss_pred cCCCCceEEEeeecc-cchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 884 DGPGGTLATVAEYMV-DGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 884 d~~~~~L~IVmEYme-gGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
+.. ++||+||-.. +-+|.+++..+.. +++..+..|++||+.|+++||+.||||||||-+||.++ .+|.+||+
T Consensus 640 ddd--~yyl~te~hg~gIDLFd~IE~kp~-m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd----~~g~~kli 712 (772)
T KOG1152|consen 640 DDD--YYYLETEVHGEGIDLFDFIEFKPR-MDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVD----SNGFVKLI 712 (772)
T ss_pred cCC--eeEEEecCCCCCcchhhhhhccCc-cchHHHHHHHHHHHhccccccccCceecccccccEEEe----cCCeEEEe
Confidence 865 9999999864 4589999977654 99999999999999999999999999999999999999 89999999
Q ss_pred ecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 037285 963 DFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN 1023 (1094)
Q Consensus 963 DFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~ 1023 (1094)
|||.+...... ....+.||..|.|||++.|. ......-|||+||++||-++....||..
T Consensus 713 dfgsaa~~ksg-pfd~f~gtv~~aapevl~g~-~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 713 DFGSAAYTKSG-PFDVFVGTVDYAAPEVLGGE-KYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred eccchhhhcCC-CcceeeeeccccchhhhCCC-ccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99998755443 33567899999999999863 3447788999999999999988888864
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-27 Score=253.87 Aligned_cols=249 Identities=27% Similarity=0.372 Sum_probs=190.7
Q ss_pred EEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC---Cc
Q 037285 815 QKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG---GT 889 (1094)
Q Consensus 815 ~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~---~~ 889 (1094)
-+-||-|+||.||.+.+ .|+.||+|.+..- ...-.....+.+|+++|.-++|.|++..+++..-..- ..
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv------fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV------FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchH------HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 46799999999999887 3788999987543 1222335678899999999999999999887654321 13
Q ss_pred eEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCccc
Q 037285 890 LATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI 969 (1094)
Q Consensus 890 L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl 969 (1094)
+|.++|.| ..+|...+... +.++...+.-+++||++||+|||+.+|.||||||.|+|++ ++..+||||||+++.
T Consensus 132 iYV~TELm-QSDLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVN----SNCvLKICDFGLARv 205 (449)
T KOG0664|consen 132 LYVLTELM-QSDLHKIIVSP-QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVN----SNCILKICDFGLART 205 (449)
T ss_pred HHHHHHHH-HhhhhheeccC-CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEec----cCceEEecccccccc
Confidence 67788877 46677766544 4589999999999999999999999999999999999999 899999999999995
Q ss_pred ccCcc--ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhh------------
Q 037285 970 KRNTL--VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN------------ 1035 (1094)
Q Consensus 970 ~~~~~--~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~------------ 1035 (1094)
..... ......-|..|.|||++.| ..+|+.+.||||+|||+.||+..+..|..-...+.++.+.+
T Consensus 206 ee~d~~~hMTqEVVTQYYRAPEiLMG-aRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 206 WDQRDRLNMTHEVVTQYYRAPELLMG-ARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred cchhhhhhhHHHHHHHHhccHHHhhc-chhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence 43321 1122336788999999997 67899999999999999999999999987665544333211
Q ss_pred -----------ccCC-CCCC--------CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1036 -----------NTLR-PTIP--------SYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1036 -----------~~lr-p~iP--------e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
...+ +.++ ..-..+...++.+++..||.+|.+..+.+.++.
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 1111 1111 122346678889999999999999888877654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.4e-27 Score=271.87 Aligned_cols=250 Identities=24% Similarity=0.381 Sum_probs=208.1
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|+.+..+|.|+||.|||+++. ++..|+|+++...-.+ ..-..+|+-+++..+|||||.++|.+....
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd--------~~~iqqei~~~~dc~h~nivay~gsylr~d 85 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD--------FSGIQQEIGMLRDCRHPNIVAYFGSYLRRD 85 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc--------ccccccceeeeecCCCcChHHHHhhhhhhc
Confidence 468999999999999999999884 7889999998753222 123456888999999999999999988765
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.++|+||||.+|+|++.-.-. +.+++.++..++++.++||+|||+.|-+|||||-.|||++ +.+.+|++|||.
T Consensus 86 --klwicMEycgggslQdiy~~T-gplselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt----d~gDvklaDfgv 158 (829)
T KOG0576|consen 86 --KLWICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT----DEGDVKLADFGV 158 (829)
T ss_pred --CcEEEEEecCCCcccceeeec-ccchhHHHHHHHhhhhccchhhhcCCcccccccccceeec----ccCceeecccCc
Confidence 899999999999999876544 4599999999999999999999999999999999999999 889999999999
Q ss_pred cccccC-ccccCCccCCCcccCccccc-cCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCC--
Q 037285 967 SKIKRN-TLVSGGVRGTLPWMAPELLS-GSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTI-- 1042 (1094)
Q Consensus 967 Srl~~~-~~~ss~~~GT~~YmAPEvL~-g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~i-- 1042 (1094)
+..... ......+.||+.|||||+.. +....|..++|||++|++..|+-.-+.|.-.......+.-..+.++.+.-
T Consensus 159 saqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lk 238 (829)
T KOG0576|consen 159 SAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLK 238 (829)
T ss_pred hhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCccc
Confidence 874432 23345678999999999964 34567889999999999999999888887666666666555555555432
Q ss_pred -CCcCcHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037285 1043 -PSYCDAEWRTLMEECWAPNPAARPSFTEIAS 1073 (1094)
Q Consensus 1043 -Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq 1073 (1094)
+...++.+.+|++.|+.++|.+||+++.++.
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 3456788999999999999999999988765
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=244.68 Aligned_cols=250 Identities=24% Similarity=0.335 Sum_probs=195.2
Q ss_pred cCCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
..+|.-++.+|.|.- .|..+.+ .+++||+|....+ +.. .....+..+|..++..++|+||++++.+|+-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n-----~~~akra~rel~l~~~v~~~nii~l~n~ftP~~ 88 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQN-----QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQK 88 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-ccc-----CccchhhhhhhhhhhhhcccceeeeeeccCccc
Confidence 457777888999988 6666655 4789999987665 222 122345678999999999999999999997542
Q ss_pred ----CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 887 ----GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 887 ----~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
....|+|||+| ..+|.+.+..+ ++-+.+..|+.|++.|++|||+.||+||||||+||++. ....+||.
T Consensus 89 ~l~~~~e~y~v~e~m-~~nl~~vi~~e---lDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~----~~~~lKi~ 160 (369)
T KOG0665|consen 89 TLEEFQEVYLVMELM-DANLCQVILME---LDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVN----SDCTLKIL 160 (369)
T ss_pred cHHHHHhHHHHHHhh-hhHHHHHHHHh---cchHHHHHHHHHHHHHHHHHHhcceeecccCcccceec----chhheeec
Confidence 12578999999 67888877632 67778889999999999999999999999999999998 88899999
Q ss_pred ecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhcc-----
Q 037285 963 DFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT----- 1037 (1094)
Q Consensus 963 DFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~----- 1037 (1094)
|||+|+........+.+..|..|.|||++.+. .+...+||||+||++.||++|+..|.+.+.-..+.++...-
T Consensus 161 dfg~ar~e~~~~~mtpyVvtRyyrapevil~~--~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~ 238 (369)
T KOG0665|consen 161 DFGLARTEDTDFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDP 238 (369)
T ss_pred cchhhcccCcccccCchhheeeccCchheecc--CCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCH
Confidence 99999977666555567789999999999964 38899999999999999999999998765544332221110
Q ss_pred ------------------------CCCCCC-----------CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037285 1038 ------------------------LRPTIP-----------SYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1038 ------------------------lrp~iP-----------e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L 1075 (1094)
+...+| ..-...+++++.+||-.||++|.+++++|.|-
T Consensus 239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence 000011 11234578999999999999999999999873
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.5e-25 Score=218.09 Aligned_cols=164 Identities=24% Similarity=0.320 Sum_probs=130.5
Q ss_pred chhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccCccccCCc
Q 037285 900 GSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGV 979 (1094)
Q Consensus 900 GSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~~~ss~~ 979 (1094)
|+|.+++...+..+++..++.++.||+.||.|||+++ ||+|||++ .++.+|+ ||+++...... .
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~----~~~~~~~--fG~~~~~~~~~----~ 64 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLT----WDGLLKL--DGSVAFKTPEQ----S 64 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEc----Cccceee--ccceEeecccc----C
Confidence 6899999876667999999999999999999999998 99999998 7788998 99988654322 2
Q ss_pred cCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH-HHHHhHhhccCCC-----CCCCcCcH--HHH
Q 037285 980 RGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-AIIGGIVNNTLRP-----TIPSYCDA--EWR 1051 (1094)
Q Consensus 980 ~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~-eile~Iv~~~lrp-----~iPe~~S~--eL~ 1051 (1094)
.||+.|+|||++. ...++.++|||||||++|||+||+.||...... .....+....... ..+...+. .+.
T Consensus 65 ~g~~~y~aPE~~~--~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (176)
T smart00750 65 RVDPYFMAPEVIQ--GQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFA 142 (176)
T ss_pred CCcccccChHHhc--CCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHH
Confidence 5889999999998 456789999999999999999999999765432 2222222221111 01122333 689
Q ss_pred HHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1052 TLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1052 dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
++|.+||..+|.+||++.++++++..+...
T Consensus 143 ~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 143 DFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred HHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 999999999999999999999999988654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-25 Score=271.45 Aligned_cols=203 Identities=19% Similarity=0.218 Sum_probs=146.8
Q ss_pred hCCC-CceeEEEeEeecC-----CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 037285 869 KLHH-PNVVAFYGVVQDG-----PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDL 942 (1094)
Q Consensus 869 rL~H-PNIVqL~Gv~~d~-----~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDL 942 (1094)
.++| +||++++++|... ....++.++||+ +++|.++|......+++..++.++.||++||.|||++||+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 4455 5788888877211 123677788887 67999999766666999999999999999999999999999999
Q ss_pred CCCceEeccCC---------------CCCCcEEEEecCCcccccCc-----------------cccCCccCCCcccCccc
Q 037285 943 KCDNLLVNLKD---------------PSRPICKVGDFGLSKIKRNT-----------------LVSGGVRGTLPWMAPEL 990 (1094)
Q Consensus 943 KPeNILLD~~~---------------~e~g~VKLsDFGLSrl~~~~-----------------~~ss~~~GT~~YmAPEv 990 (1094)
||+||||+..+ ...+.+||+|||+++..... .......||+.|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 99999996210 13456778888877632110 00112357889999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHH
Q 037285 991 LSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTE 1070 (1094)
Q Consensus 991 L~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eE 1070 (1094)
+. ...++.++|||||||+||||++|..|+.... .....+......+.. ........+++.+||+.+|.+||++.+
T Consensus 187 ~~--~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~L~~~P~~Rps~~e 261 (793)
T PLN00181 187 DN--GSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQI-LLNWPKEASFCLWLLHPEPSCRPSMSE 261 (793)
T ss_pred hc--cCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChhh-hhcCHHHHHHHHHhCCCChhhCcChHH
Confidence 88 4567899999999999999999998876422 122222122111111 122455678999999999999999999
Q ss_pred HHHHHHH
Q 037285 1071 IASRLRV 1077 (1094)
Q Consensus 1071 LLq~L~~ 1077 (1094)
|+++.+-
T Consensus 262 il~h~~~ 268 (793)
T PLN00181 262 LLQSEFI 268 (793)
T ss_pred Hhhchhh
Confidence 9987654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-22 Score=204.88 Aligned_cols=251 Identities=32% Similarity=0.473 Sum_probs=198.5
Q ss_pred eeEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCC-ceeEEEeEeecCCCCce
Q 037285 812 LEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP-NVVAFYGVVQDGPGGTL 890 (1094)
Q Consensus 812 Yei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HP-NIVqL~Gv~~d~~~~~L 890 (1094)
|.+.+.||.|+|+.||++.+. ..+++|.+....... ......|.+|+.++..+.|+ +|+++++.+.... ..
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~-----~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESK-----SKEVERFLREIQILASLNHPPNIVKLYDFFQDEG--SL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccc-----hhHHHHHHHHHHHHHHccCCcceeeEEEEEecCC--EE
Confidence 678899999999999999987 778999987653321 12456788999999999988 7999999996543 57
Q ss_pred EEEeeecccchhHHHHhhcc--cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCC-cEEEEecCCc
Q 037285 891 ATVAEYMVDGSLRHVLVRKD--RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRP-ICKVGDFGLS 967 (1094)
Q Consensus 891 ~IVmEYmegGSL~d~L~k~~--~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g-~VKLsDFGLS 967 (1094)
+++++++.++++.+++.... ..+.......++.|++.++.|+|+.+++||||||+||+++ ... .++++|||++
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~----~~~~~~~l~dfg~~ 149 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD----RDGRVVKLIDFGLA 149 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec----CCCCeEEEeccCcc
Confidence 99999999999997776554 2588999999999999999999999999999999999998 555 7999999998
Q ss_pred ccccCcc-------ccCCccCCCcccCccccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCh----HHHHHhHhh
Q 037285 968 KIKRNTL-------VSGGVRGTLPWMAPELLSGSS-SKVSEKVDVFSFGIVLWEILTGEEPYANMHY----GAIIGGIVN 1035 (1094)
Q Consensus 968 rl~~~~~-------~ss~~~GT~~YmAPEvL~g~~-~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~----~eile~Iv~ 1035 (1094)
+...... ......+|..|+|||.+.+.. ..++...|+|++|++++++++|..||..... ......+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 229 (384)
T COG0515 150 KLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE 229 (384)
T ss_pred eecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHh
Confidence 7433221 235667999999999998532 5678899999999999999999999887763 333333323
Q ss_pred ccCC---CCCCCcC----cHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1036 NTLR---PTIPSYC----DAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1036 ~~lr---p~iPe~~----S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
.... ....... ...+.+++..|+..+|..|.+.......
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 230 LPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 2221 1111111 2578999999999999999988887765
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-24 Score=230.46 Aligned_cols=251 Identities=23% Similarity=0.309 Sum_probs=188.5
Q ss_pred CCeeEEEEecccCceEEEEeeecC--ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEeecCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~rG--t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~~d~~ 886 (1094)
+.|.+.+.||+|.||.+.++.+++ +.+++|.+..+. ....+|.+|..---.| .|.||+.-|++..+.
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---------tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt- 93 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---------TTQADFVREFHYSFFLSPHQHIIDTYEVAFQT- 93 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---------hhHHHHHHHhccceeeccchhhhHHHHHHhhc-
Confidence 578999999999999999999975 569999886642 2346888888654445 489999888764433
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+.+.+++||++.|+|..-+... .+.+.....++.|+++||.|+|+.++||||||.+||||... +...|||||||+
T Consensus 94 ~d~YvF~qE~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~--df~rvKlcDFG~ 169 (378)
T KOG1345|consen 94 SDAYVFVQEFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDA--DFYRVKLCDFGL 169 (378)
T ss_pred CceEEEeeccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecC--CccEEEeeeccc
Confidence 23788899999999999887553 37888899999999999999999999999999999999743 345899999999
Q ss_pred cccccCccccCCccCCCcccCcccccc---CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh----HHHHHhHhhccCC
Q 037285 967 SKIKRNTLVSGGVRGTLPWMAPELLSG---SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY----GAIIGGIVNNTLR 1039 (1094)
Q Consensus 967 Srl~~~~~~ss~~~GT~~YmAPEvL~g---~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~----~eile~Iv~~~lr 1039 (1094)
++....... ....+..|.+||++.. ......+.+|||.||+++|.++||+.||..... .-...+. .++..
T Consensus 170 t~k~g~tV~--~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w-~~rk~ 246 (378)
T KOG1345|consen 170 TRKVGTTVK--YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQW-LKRKN 246 (378)
T ss_pred ccccCceeh--hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHH-hcccC
Confidence 875443322 2234667999998752 233456789999999999999999999974221 1111222 23333
Q ss_pred CCCCC---cCcHHHHHHHHHhccCCCCCC---CCHHHHHHHHHH
Q 037285 1040 PTIPS---YCDAEWRTLMEECWAPNPAAR---PSFTEIASRLRV 1077 (1094)
Q Consensus 1040 p~iPe---~~S~eL~dLI~kCLq~DPeeR---PS~eELLq~L~~ 1077 (1094)
+..|. ..++.+..+.++-|..++++| .+.+.....+|.
T Consensus 247 ~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 247 PALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred ccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 44443 457788889999999999999 455555555544
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.5e-22 Score=219.15 Aligned_cols=260 Identities=21% Similarity=0.253 Sum_probs=198.6
Q ss_pred CeeEEEEecccCceEEEEeeecCc---eEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC----CCceeEEEeEee
Q 037285 811 DLEEQKELGSGTFGTVYHGKWRGT---DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH----HPNVVAFYGVVQ 883 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~rGt---~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~----HPNIVqL~Gv~~ 883 (1094)
+|.+.++||+|+||.||++..... .+|+|.......... ..+..|+.+|..+. ..++..+++...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--------~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--------SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR 90 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--------ccchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence 799999999999999999987543 589998765422110 13556788888876 268888888884
Q ss_pred cCCCCceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCC-CCCCcEEE
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKD-PSRPICKV 961 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~-~e~g~VKL 961 (1094)
.....-+|||+.+ |.+|.++..... +.++..+++.|+.|++.+|++||+.|++||||||.|+++.... .....+.|
T Consensus 91 -~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~l 168 (322)
T KOG1164|consen 91 -STEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYL 168 (322)
T ss_pred -CCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEE
Confidence 1233788999976 899999886554 6799999999999999999999999999999999999998443 22367999
Q ss_pred EecCCcc--cc--cC------c-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 037285 962 GDFGLSK--IK--RN------T-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAII 1030 (1094)
Q Consensus 962 sDFGLSr--l~--~~------~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eil 1030 (1094)
.|||+++ .. .. . .....+.||.+|+++.+.. ....+.+.|+||++.++.+|+.|..||.........
T Consensus 169 lDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~--~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~ 246 (322)
T KOG1164|consen 169 LDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHL--GIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK 246 (322)
T ss_pred EecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhC--CCccCCchhhhhHHHHHHHHhcCCCCCccccccchH
Confidence 9999998 21 01 1 1123456999999999887 456788999999999999999999999776543222
Q ss_pred HhHhh---ccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 037285 1031 GGIVN---NTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAA 1082 (1094)
Q Consensus 1031 e~Iv~---~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~ 1082 (1094)
..+.. ...........+.++.+++..+-..+...+|....+...|.......
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 247 SKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 22212 11111133445678888888888899999999999999998887654
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-22 Score=227.21 Aligned_cols=245 Identities=23% Similarity=0.330 Sum_probs=186.1
Q ss_pred CCeeEEEEecccCceEEEEeeec-----CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-CCceeEEEeEee
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HPNVVAFYGVVQ 883 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r-----Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-HPNIVqL~Gv~~ 883 (1094)
+.|...++||.|.|++||++... ...||+|.+..... ...+..|+++|..+. +.||+++.+++.
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----------p~ri~~El~~L~~~gG~~ni~~~~~~~r 105 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----------PSRILNELEMLYRLGGSDNIIKLNGCFR 105 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----------chHHHHHHHHHHHhccchhhhcchhhhc
Confidence 56888999999999999998763 35699998865422 245778999999985 899999999998
Q ss_pred cCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEe
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGD 963 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsD 963 (1094)
... ...+|+||++.....+++.. ++...+..+++.++.||+++|.+|||||||||.|+|.+. ..+.-.|+|
T Consensus 106 nnd--~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~---~t~rg~LvD 176 (418)
T KOG1167|consen 106 NND--QVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNR---RTQRGVLVD 176 (418)
T ss_pred cCC--eeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccccc---ccCCceEEe
Confidence 755 89999999999988888753 677888999999999999999999999999999999973 556779999
Q ss_pred cCCccccc---------C-----ccc-------------------------------cCCccCCCcccCccccccCCCCC
Q 037285 964 FGLSKIKR---------N-----TLV-------------------------------SGGVRGTLPWMAPELLSGSSSKV 998 (1094)
Q Consensus 964 FGLSrl~~---------~-----~~~-------------------------------ss~~~GT~~YmAPEvL~g~~~ky 998 (1094)
||++.... . ... .-...||++|.|||++... ..-
T Consensus 177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~-~~Q 255 (418)
T KOG1167|consen 177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC-PRQ 255 (418)
T ss_pred chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-cCc
Confidence 99986100 0 000 0012489999999999863 455
Q ss_pred CchhhHHHHHHHHHHHHcCCCCCCCCChH-----HHH--------Hh---------Hhh--------------ccC----
Q 037285 999 SEKVDVFSFGIVLWEILTGEEPYANMHYG-----AII--------GG---------IVN--------------NTL---- 1038 (1094)
Q Consensus 999 S~KSDVWSLGVLLyELLTGk~PF~~~~~~-----eil--------e~---------Iv~--------------~~l---- 1038 (1094)
++++||||.|||++.+++++.||-..... +++ .+ +.. ...
T Consensus 256 ttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~ 335 (418)
T KOG1167|consen 256 TTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIES 335 (418)
T ss_pred CCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhh
Confidence 78999999999999999999998533211 000 00 000 000
Q ss_pred ----------CCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1039 ----------RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1039 ----------rp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
+....+..+..+.+|+.+|+..||.+|.|+++.|++
T Consensus 336 ~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 336 IYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 000011234578999999999999999999999875
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.6e-22 Score=211.79 Aligned_cols=259 Identities=28% Similarity=0.470 Sum_probs=211.1
Q ss_pred cceeeccCCeeEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEe
Q 037285 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVV 882 (1094)
Q Consensus 803 sv~eIs~edYei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~ 882 (1094)
...-|+..++.+..+|.....|+.|+|+|.|..++.|++...... .+...+|..|.-.|+-+.||||+.+++.|
T Consensus 183 r~~gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t------~risrdfneefp~lrifshpnilpvlgac 256 (448)
T KOG0195|consen 183 RYTGIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVT------ARISRDFNEEFPALRIFSHPNILPVLGAC 256 (448)
T ss_pred cccCcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcc------hhhcchhhhhCcceeeecCCchhhhhhhc
Confidence 334456667777889999999999999999999999998765433 23345788888888888999999999999
Q ss_pred ecCCCCceEEEeeecccchhHHHHhhccc-ccCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeccCCCCCCcE
Q 037285 883 QDGPGGTLATVAEYMVDGSLRHVLVRKDR-FLDRRRRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNLKDPSRPIC 959 (1094)
Q Consensus 883 ~d~~~~~L~IVmEYmegGSL~d~L~k~~~-~Lse~~~l~Ia~QIaeGLaYLHs~G--IIHRDLKPeNILLD~~~~e~g~V 959 (1094)
...+ .+.++..||+.|+|...|..... ..+..++.+++.+|++||+|||+.. |.---|....|+++ ++...
T Consensus 257 nspp--nlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmid----edlta 330 (448)
T KOG0195|consen 257 NSPP--NLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMID----EDLTA 330 (448)
T ss_pred cCCC--CceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEec----chhhh
Confidence 9876 89999999999999999987643 4677889999999999999999875 44456888899998 55554
Q ss_pred EE--EecCCcccccCccccCCccCCCcccCccccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhc
Q 037285 960 KV--GDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKV-SEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN 1036 (1094)
Q Consensus 960 KL--sDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~ky-S~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~ 1036 (1094)
+| +|--++-. ..+....+.||+||.+....... -.++|+|||++++|||.|...||....+.+.-.++.-+
T Consensus 331 rismad~kfsfq------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkiale 404 (448)
T KOG0195|consen 331 RISMADTKFSFQ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALE 404 (448)
T ss_pred heecccceeeee------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhc
Confidence 44 33222211 11223578899999997433322 34789999999999999999999999999988888889
Q ss_pred cCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1037 TLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1037 ~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
+++..+|..++..+..||.-|++.||.+||.|..|+-.|+++.
T Consensus 405 glrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 405 GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 9999999999999999999999999999999999999888763
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.3e-20 Score=205.42 Aligned_cols=263 Identities=19% Similarity=0.256 Sum_probs=207.6
Q ss_pred eccCCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-CCceeEEEeEee
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HPNVVAFYGVVQ 883 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-HPNIVqL~Gv~~ 883 (1094)
+-.-.|.++++||+|.||+.+.|+. ++++||||.-.... +. -.+..|...++.|. .++|.+.|.+-.
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS------~A----PQLrdEYr~YKlL~g~~GIP~vYYFGq 94 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS------EA----PQLRDEYRTYKLLGGTEGIPQVYYFGQ 94 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccC------Cc----chHHHHHHHHHHHcCCCCCCceeeecc
Confidence 4456899999999999999999976 68999999754331 11 23445666777764 789999988877
Q ss_pred cCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCC-CCCCcEEEE
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKD-PSRPICKVG 962 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~-~e~g~VKLs 962 (1094)
++. +-.+|+|.+ |.+|++++.-+++.++.++++.++.|++.-|+|+|++.+|+|||||+|+||...+ .....|.|+
T Consensus 95 eG~--~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~Ihii 171 (449)
T KOG1165|consen 95 EGK--YNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHII 171 (449)
T ss_pred ccc--hhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEE
Confidence 654 667899977 8999999999999999999999999999999999999999999999999997543 245689999
Q ss_pred ecCCcccccCc--------cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---hHHHHH
Q 037285 963 DFGLSKIKRNT--------LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH---YGAIIG 1031 (1094)
Q Consensus 963 DFGLSrl~~~~--------~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~---~~eile 1031 (1094)
|||+|+..... .......||.+||+--... ...-+.+-|+-|||-++++.+.|..||.+.. +.+..+
T Consensus 172 DFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHl--GrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYe 249 (449)
T KOG1165|consen 172 DFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHL--GREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYE 249 (449)
T ss_pred eccchhhhcCccccccCccccccccccceeeeEeeccc--cchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHH
Confidence 99999854321 2234567999999987776 3456889999999999999999999998864 344455
Q ss_pred hHhhccCCCC---CCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhc
Q 037285 1032 GIVNNTLRPT---IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQ 1084 (1094)
Q Consensus 1032 ~Iv~~~lrp~---iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s~ 1084 (1094)
+|-....... +-..+|.++..-|+-.-..+-.+-|+.+.+...+.++......
T Consensus 250 KIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~ 305 (449)
T KOG1165|consen 250 KIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGE 305 (449)
T ss_pred HhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCC
Confidence 5533332222 2245688899999988888999999999999988888765443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.3e-20 Score=195.98 Aligned_cols=258 Identities=22% Similarity=0.293 Sum_probs=201.0
Q ss_pred eeccCCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCC-CceeEEEeEe
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHH-PNVVAFYGVV 882 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~H-PNIVqL~Gv~ 882 (1094)
.|-...|.++++||+|+||.+|.|.. .|..||||+-....-. .....|.+++..|++ ..|..+..+.
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----------pqL~yEskvY~iL~~g~GiP~i~~y~ 80 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----------PQLLYESKVYRILQGGVGIPHIRHYG 80 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----------cchhHHHHHHHHhccCCCCchhhhhc
Confidence 45667899999999999999999976 5899999987654221 245578888888874 6777777777
Q ss_pred ecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 883 QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 883 ~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
.+.. +-.+||+.+ |.+|++++.-+.+.++..+++-++-|++.-++|+|.+++|||||||+|.|+...- ....+.|+
T Consensus 81 ~e~~--ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgr-h~~kl~LI 156 (341)
T KOG1163|consen 81 TEKD--YNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGR-HCNKLYLI 156 (341)
T ss_pred cccc--cceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeecccc-ccceEEEE
Confidence 6654 778899987 8999999988888899999999999999999999999999999999999997332 45679999
Q ss_pred ecCCcccccC--------ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH---HHH
Q 037285 963 DFGLSKIKRN--------TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA---IIG 1031 (1094)
Q Consensus 963 DFGLSrl~~~--------~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~e---ile 1031 (1094)
|||+|+...+ ........||.+|.+--...+ -.-+.+-|+-|+|.+|.++..|..||.+..... ..+
T Consensus 157 DFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g--~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE 234 (341)
T KOG1163|consen 157 DFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLG--IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE 234 (341)
T ss_pred eccchhhhccccccccCccccCCccceeeeehhhhhhhh--hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH
Confidence 9999984321 112234569999988665542 334678999999999999999999999876433 334
Q ss_pred hHhhccCCCC---CCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1032 GIVNNTLRPT---IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1032 ~Iv~~~lrp~---iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
++.+...... +-...|.++.-.+.-|-..--++-|+...|.+.++.+.
T Consensus 235 kI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 235 KISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred HHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 4444333322 23456889999999999999999999988888777664
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.2e-20 Score=209.91 Aligned_cols=166 Identities=21% Similarity=0.135 Sum_probs=124.5
Q ss_pred eccCCeeEEEEecccCceEEEEeeec---CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeE-EEeEe
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR---GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVA-FYGVV 882 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r---Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVq-L~Gv~ 882 (1094)
.....|++.+.||+|+||+||+|+++ ++.||||++....... ........|.+|+++|++|+|+|++. ++.+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~---~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWW---SKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEeccccccc---ccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 34568999999999999999999873 5668999875321100 01123456889999999999999985 4432
Q ss_pred ecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCceEeccCCCCCCcEEE
Q 037285 883 QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDL-KCDNLLVNLKDPSRPICKV 961 (1094)
Q Consensus 883 ~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDL-KPeNILLD~~~~e~g~VKL 961 (1094)
+..++||||+++++|.. +. . .. ...++.+++++|.|||++||+|||| ||+|||++ .++.+||
T Consensus 91 -----~~~~LVmE~~~G~~L~~-~~-~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~----~~~~ikL 153 (365)
T PRK09188 91 -----GKDGLVRGWTEGVPLHL-AR-P---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMG----PDGEAAV 153 (365)
T ss_pred -----CCcEEEEEccCCCCHHH-hC-c---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEc----CCCCEEE
Confidence 25799999999999963 21 1 11 1457889999999999999999999 99999998 5678999
Q ss_pred EecCCcccccCcc---------ccCCccCCCcccCcccccc
Q 037285 962 GDFGLSKIKRNTL---------VSGGVRGTLPWMAPELLSG 993 (1094)
Q Consensus 962 sDFGLSrl~~~~~---------~ss~~~GT~~YmAPEvL~g 993 (1094)
+|||+|+...... .-....++..|+|||.+..
T Consensus 154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9999998432211 1124557888999999864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.3e-21 Score=228.00 Aligned_cols=255 Identities=26% Similarity=0.347 Sum_probs=187.3
Q ss_pred eEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCce
Q 037285 813 EEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTL 890 (1094)
Q Consensus 813 ei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L 890 (1094)
.....+|.|++|.|+..... ...++.|.++.. .. .....+.....+..|+.+-..|+|+|++..+..+.+.. ..
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~-~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~--~~ 396 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VK-PTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID--GI 396 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcc-cC-CcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc--cc
Confidence 34578999999987776553 333555544321 10 11222333334777888888999999988887776643 33
Q ss_pred EEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccc
Q 037285 891 ATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK 970 (1094)
Q Consensus 891 ~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~ 970 (1094)
.-+||||++ +|..++.... .++...+..+++|++.|++|+|+.||.|||||++|+++. .++.+||+|||.+...
T Consensus 397 ~~~mE~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~----~~g~lki~Dfg~~~vf 470 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVT----ENGILKIIDFGAASVF 470 (601)
T ss_pred hhhhhcccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEe----cCCceEEeecCcceee
Confidence 344999999 9999987653 488889999999999999999999999999999999999 7889999999998743
Q ss_pred c-----CccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHH-HhHhhccCC-----
Q 037285 971 R-----NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAII-GGIVNNTLR----- 1039 (1094)
Q Consensus 971 ~-----~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eil-e~Iv~~~lr----- 1039 (1094)
. ......+.+|+..|+|||++.+..+. ....||||.|+++..|++|+.||......+.. ........+
T Consensus 471 ~~~~e~~~~~~~g~~gS~pY~apE~~~~~~yd-pr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~ 549 (601)
T KOG0590|consen 471 RYPWEKNIHESSGIVGSDPYLAPEVLTGKEYD-PRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEG 549 (601)
T ss_pred ccCcchhhhhhcCcccCCcCcCcccccccccC-cchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccC
Confidence 2 22455678899999999999853332 45789999999999999999999764433221 111011110
Q ss_pred -CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1040 -PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1040 -p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
..+...++.+.+.+|.+||+.+|.+|.|+.+|++.=|.-
T Consensus 550 ~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~ 589 (601)
T KOG0590|consen 550 PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIR 589 (601)
T ss_pred hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhh
Confidence 011234677889999999999999999999999865543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.3e-20 Score=205.20 Aligned_cols=261 Identities=24% Similarity=0.287 Sum_probs=187.4
Q ss_pred eeccCCeeEEEEecccCceEEEEeeecC--c-----------------------------------eEEEEEeecCccCC
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWRG--T-----------------------------------DVAIKRIKKSCFTG 848 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~rG--t-----------------------------------~VAVKiIkk~~~se 848 (1094)
.++.++|++++.||+|.-..||.+.... . +.|||++..-...
T Consensus 153 kFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~- 231 (598)
T KOG4158|consen 153 KFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHD- 231 (598)
T ss_pred ccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccC-
Confidence 3566799999999999999999875421 0 2577776654322
Q ss_pred CchhHHHHHHHHHHHHH------H--------Hhh--------CCCCceeEEEeEeecC---------------------
Q 037285 849 RSSEQERLTVEFWKEAE------I--------LSK--------LHHPNVVAFYGVVQDG--------------------- 885 (1094)
Q Consensus 849 ~~~eqe~~~~eFlrEIk------I--------Lkr--------L~HPNIVqL~Gv~~d~--------------------- 885 (1094)
+........+.+|.- . .+. -+|||||+++++|.+.
T Consensus 232 --s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p 309 (598)
T KOG4158|consen 232 --SGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYP 309 (598)
T ss_pred --CchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecc
Confidence 223334444444331 1 111 1599999999877641
Q ss_pred ----CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEE
Q 037285 886 ----PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKV 961 (1094)
Q Consensus 886 ----~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKL 961 (1094)
....+|+||... ..+|.+|+..+. .+.....-|+.|+++|+.|||++||.|||||.+|||+..++++-..+.|
T Consensus 310 ~g~g~~~tlylvMkrY-~~tLr~yl~~~~--~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVv 386 (598)
T KOG4158|consen 310 SGAGEPKTLYLVMKRY-RQTLREYLWTRH--RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVV 386 (598)
T ss_pred cccCCCceEEEehhcc-hhhHHHHHhcCC--CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEE
Confidence 234688999876 578999997654 5777788899999999999999999999999999999887777789999
Q ss_pred EecCCcccccCc------cccC-CccCCCcccCccccccCCCCC----CchhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 037285 962 GDFGLSKIKRNT------LVSG-GVRGTLPWMAPELLSGSSSKV----SEKVDVFSFGIVLWEILTGEEPYANMHYGAII 1030 (1094)
Q Consensus 962 sDFGLSrl~~~~------~~ss-~~~GT~~YmAPEvL~g~~~ky----S~KSDVWSLGVLLyELLTGk~PF~~~~~~eil 1030 (1094)
+|||.+-..... .... ..-|...-||||+...-.... -.|+|.|+.|.+.||+++...||.......+-
T Consensus 387 aDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~ 466 (598)
T KOG4158|consen 387 ADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD 466 (598)
T ss_pred cccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec
Confidence 999987532221 1111 112566789999986422221 13899999999999999999999874332222
Q ss_pred HhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHH
Q 037285 1031 GGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIA 1072 (1094)
Q Consensus 1031 e~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELL 1072 (1094)
.....+...+.+|+.+++.+++++..+|+.||.+|++..-..
T Consensus 467 ~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAA 508 (598)
T KOG4158|consen 467 TRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAA 508 (598)
T ss_pred hhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHH
Confidence 222345556788999999999999999999999998765433
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.2e-19 Score=188.89 Aligned_cols=177 Identities=11% Similarity=0.052 Sum_probs=134.3
Q ss_pred eccCCeeEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHH------HHHHHHHHhhCCCCceeEEEe
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVE------FWKEAEILSKLHHPNVVAFYG 880 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~e------FlrEIkILkrL~HPNIVqL~G 880 (1094)
+...+|+..+.||.|+||.||+....+..+|||++...... .+..... +.+|+..+.++.|++|..+..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~-----~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d 102 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKR-----TERFLKSFVKGDYYENLIVQTDRVRSEGLASLND 102 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCc-----hHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceE
Confidence 45689999999999999999998777778999999765322 1222233 578999999999999999988
Q ss_pred EeecCC------CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCC
Q 037285 881 VVQDGP------GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP 954 (1094)
Q Consensus 881 v~~d~~------~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~ 954 (1094)
++.... .+..++||||++|.+|.++.. +++ ....+|+.+|..||+.|++||||||.||+++
T Consensus 103 ~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~---- 169 (232)
T PRK10359 103 FYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVS---- 169 (232)
T ss_pred eeeecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEe----
Confidence 865332 235889999999999988742 232 2455899999999999999999999999998
Q ss_pred CCCcEEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHH
Q 037285 955 SRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEIL 1015 (1094)
Q Consensus 955 e~g~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELL 1015 (1094)
.++ ++|+|||..+.......... ++. ...|..++|+|+||+++..+.
T Consensus 170 ~~g-i~liDfg~~~~~~e~~a~d~-----------~vl--er~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRKAKDR-----------IDL--ERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCC-EEEEECCCcccccchhhHHH-----------HHH--HhHhcccccccceeEeehHHH
Confidence 556 99999998764422211110 222 234567899999999887554
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=9.5e-20 Score=213.39 Aligned_cols=225 Identities=28% Similarity=0.405 Sum_probs=182.9
Q ss_pred ecccCceEEEEee-----ecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-CCceeEEEeEeecCCCCceE
Q 037285 818 LGSGTFGTVYHGK-----WRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HPNVVAFYGVVQDGPGGTLA 891 (1094)
Q Consensus 818 LGsG~FGtVYKAk-----~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-HPNIVqL~Gv~~d~~~~~L~ 891 (1094)
+|+|+||.|++++ ..+.-+|+|+.++.....+... ....|..++...+ ||.+|+++..++... .++
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~------~t~~er~il~~~~~~~f~v~lhyafqt~~--kl~ 73 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT------HTKQERIILAFVHNTPFLVKLHYAFQTDG--KLY 73 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc------ccccHHHHHhhccCCCceeeeeeeecccc--chh
Confidence 7999999999753 2356689999887654432211 3345777788887 999999999998755 899
Q ss_pred EEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCccccc
Q 037285 892 TVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKR 971 (1094)
Q Consensus 892 IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~ 971 (1094)
++++|..+|.|...+.+... +++.........++-+++++|+.+++|||+|++||+++ .+|++|+.|||+++..-
T Consensus 74 l~ld~~rgg~lft~l~~~~~-f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld----~~Ghi~~tdfglske~v 148 (612)
T KOG0603|consen 74 LILDFLRGGDLFTRLSKEVM-FDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLL----LEGHIKLTDFGLSKEAV 148 (612)
T ss_pred HhhhhcccchhhhccccCCc-hHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeec----ccCccccCCchhhhHhH
Confidence 99999999999988876654 56666666777899999999999999999999999999 89999999999998543
Q ss_pred CccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHH
Q 037285 972 NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWR 1051 (1094)
Q Consensus 972 ~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~ 1051 (1094)
..... |||..|||||++++ ....+|+||||++++||+||..||.. +++..+.... +.+|...+..++
T Consensus 149 ~~~~~---cgt~eymApEI~~g----h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~--~~~p~~l~~~a~ 215 (612)
T KOG0603|consen 149 KEKIA---CGTYEYRAPEIING----HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE--LEMPRELSAEAR 215 (612)
T ss_pred hhhhc---ccchhhhhhHhhhc----cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc--cCCchhhhHHHH
Confidence 33322 79999999999982 35689999999999999999999987 5555555433 357788899999
Q ss_pred HHHHHhccCCCCCCCCH
Q 037285 1052 TLMEECWAPNPAARPSF 1068 (1094)
Q Consensus 1052 dLI~kCLq~DPeeRPS~ 1068 (1094)
+++..++..+|.+|.-.
T Consensus 216 ~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 216 SLFRQLFKRNPENRLGA 232 (612)
T ss_pred HHHHHHHhhCHHHHhcc
Confidence 99999999999999744
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.3e-18 Score=177.48 Aligned_cols=146 Identities=20% Similarity=0.165 Sum_probs=108.0
Q ss_pred EEEecccCceEEEEeee-cCceEEEEEeecCccCCCch------------------hHHHHHHHHHHHHHHHhhCCCCce
Q 037285 815 QKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSS------------------EQERLTVEFWKEAEILSKLHHPNV 875 (1094)
Q Consensus 815 ~kkLGsG~FGtVYKAk~-rGt~VAVKiIkk~~~se~~~------------------eqe~~~~eFlrEIkILkrL~HPNI 875 (1094)
...||+|+||.||+|.. +|+.||||+++......... ..........+|+.+|.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35799999999999987 48899999998653211110 000011223459999999987776
Q ss_pred eEEEeEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCceEeccCCC
Q 037285 876 VAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYL-HSKNIVHFDLKCDNLLVNLKDP 954 (1094)
Q Consensus 876 VqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYL-Hs~GIIHRDLKPeNILLD~~~~ 954 (1094)
.....+... ..+|||||+++++|...+... ..++...++.++.|++.+|.+| |+.||+||||||+|||++
T Consensus 82 ~~p~~~~~~----~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~---- 152 (190)
T cd05147 82 PCPEPILLK----SHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH---- 152 (190)
T ss_pred CCCcEEEec----CCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE----
Confidence 443322222 237999999988776554333 4588999999999999999999 799999999999999997
Q ss_pred CCCcEEEEecCCcccc
Q 037285 955 SRPICKVGDFGLSKIK 970 (1094)
Q Consensus 955 e~g~VKLsDFGLSrl~ 970 (1094)
++.++|+|||+|...
T Consensus 153 -~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 -DGKLYIIDVSQSVEH 167 (190)
T ss_pred -CCcEEEEEccccccC
Confidence 257999999998743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.1e-19 Score=216.06 Aligned_cols=243 Identities=21% Similarity=0.223 Sum_probs=177.5
Q ss_pred CeeEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCce
Q 037285 811 DLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTL 890 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L 890 (1094)
++...+.||.+.|=.|.+|+++.-.|+||++.+....- ..+.+ .+-+.|++ ...+++||.+.+-.+..... ..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~---sL~~~-~qrL~~ik-~~l~~~pn~lPfqk~~~t~k--AA 96 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTI---SLRPF-KQRLEEIK-FALMKAPNCLPFQKVLVTDK--AA 96 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCC---CchHH-HHHHHHHH-HHhhcCCcccchHHHHHhhH--HH
Confidence 67888999999999999999976669999997754211 11112 22334555 56678999999877755543 67
Q ss_pred EEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCccc-
Q 037285 891 ATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI- 969 (1094)
Q Consensus 891 ~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl- 969 (1094)
|+|-+|. .-+|.+.+..+. ++...+...|+.|++.||.-+|..||+|+|||.+||||+ +-+.+.|+||..-+-
T Consensus 97 ylvRqyv-khnLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiT----SWNW~~LtDFAsFKPt 170 (1431)
T KOG1240|consen 97 YLVRQYV-KHNLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILIT----SWNWLYLTDFASFKPT 170 (1431)
T ss_pred HHHHHHH-hhhhhhhhccch-HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEe----eechhhhhcccccCCc
Confidence 7787877 568888886554 578888888999999999999999999999999999999 788999999986551
Q ss_pred ---ccCccccCCcc----CCCcccCccccccCC--------C-CCCchhhHHHHHHHHHHHHc-CCCCCCCCCh------
Q 037285 970 ---KRNTLVSGGVR----GTLPWMAPELLSGSS--------S-KVSEKVDVFSFGIVLWEILT-GEEPYANMHY------ 1026 (1094)
Q Consensus 970 ---~~~~~~ss~~~----GT~~YmAPEvL~g~~--------~-kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~------ 1026 (1094)
.++......+. .-.+|+|||.+.... . ..+++-||||+||+++||++ |+++|.-...
T Consensus 171 YLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~ 250 (1431)
T KOG1240|consen 171 YLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSG 250 (1431)
T ss_pred cCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhcc
Confidence 11221111122 235699999986311 1 26778999999999999998 8999863211
Q ss_pred -HHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1027 -GAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1027 -~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
....+++++ ..-+..++.+|..|++.||.+|.++++.|+.
T Consensus 251 ~~~~~e~~Le--------~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 251 NADDPEQLLE--------KIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CccCHHHHHH--------hCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 111111111 1123468999999999999999999999876
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.5e-17 Score=183.73 Aligned_cols=237 Identities=19% Similarity=0.209 Sum_probs=151.3
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC----------CCceeEE
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH----------HPNVVAF 878 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~----------HPNIVqL 878 (1094)
.+...+.||.|+|+.||.+++. ++.+|+|++..... ......+.+.+|.-....+. |-.++-.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~-----~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P 87 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPAD-----ASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVP 87 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESST-----THTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccc-----cchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEee
Confidence 4567889999999999999985 68899999876542 12223455555554444432 2223322
Q ss_pred EeEeec---------CCCC------ceEEEeeecccchhHHHHhh---cc---cccCHHHHHHHHHHHHHHHHHHHHCCc
Q 037285 879 YGVVQD---------GPGG------TLATVAEYMVDGSLRHVLVR---KD---RFLDRRRRLIIAMDAAFGMEYLHSKNI 937 (1094)
Q Consensus 879 ~Gv~~d---------~~~~------~L~IVmEYmegGSL~d~L~k---~~---~~Lse~~~l~Ia~QIaeGLaYLHs~GI 937 (1094)
++...- ..+. ..+++|+-+ .++|.+++.. .. ..+....++.+..|+++.+++||..|+
T Consensus 88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~Gl 166 (288)
T PF14531_consen 88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGL 166 (288)
T ss_dssp SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred eEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcce
Confidence 332221 1111 235566655 6777777532 21 124455567788999999999999999
Q ss_pred eeccCCCCceEeccCCCCCCcEEEEecCCcccccCccccCCccCCCcccCccccccC------CCCCCchhhHHHHHHHH
Q 037285 938 VHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGS------SSKVSEKVDVFSFGIVL 1011 (1094)
Q Consensus 938 IHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~------~~kyS~KSDVWSLGVLL 1011 (1094)
+|+||+|+|+|++ .+|.++|+||+........... ...+..|.+||..... .-.++.+.|.|+||+++
T Consensus 167 VHgdi~~~nfll~----~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~l 240 (288)
T PF14531_consen 167 VHGDIKPENFLLD----QDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITL 240 (288)
T ss_dssp EEST-SGGGEEE-----TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHH
T ss_pred EecccceeeEEEc----CCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHH
Confidence 9999999999999 8899999999987655443332 3356789999987521 23578899999999999
Q ss_pred HHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCC
Q 037285 1012 WEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAAR 1065 (1094)
Q Consensus 1012 yELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeR 1065 (1094)
|.|+|+..||............ ...+. .+++.++.||..+|+.+|.+|
T Consensus 241 y~lWC~~lPf~~~~~~~~~~~~-----f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 241 YSLWCGRLPFGLSSPEADPEWD-----FSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHSS-STCCCGGGSTSGGG-----GTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHccCCCCCCCcccccccc-----chhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999999999876543322111 12344 778999999999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.5e-17 Score=171.29 Aligned_cols=147 Identities=18% Similarity=0.128 Sum_probs=110.0
Q ss_pred EEEecccCceEEEEeeec-CceEEEEEeecCccCCCc------------------hhHHHHHHHHHHHHHHHhhCCCCce
Q 037285 815 QKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRS------------------SEQERLTVEFWKEAEILSKLHHPNV 875 (1094)
Q Consensus 815 ~kkLGsG~FGtVYKAk~r-Gt~VAVKiIkk~~~se~~------------------~eqe~~~~eFlrEIkILkrL~HPNI 875 (1094)
.+.||+|+||.||+|+.. |+.||||+++........ .........+.+|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 467999999999999875 899999999875321000 0111112234579999999999987
Q ss_pred eEEEeEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeccCCC
Q 037285 876 VAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDP 954 (1094)
Q Consensus 876 VqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs-~GIIHRDLKPeNILLD~~~~ 954 (1094)
.....+... ..++||||++++++....... ..++...+..++.|++.+|.+||+ .||+||||||+|||++
T Consensus 82 ~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~-~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~---- 152 (190)
T cd05145 82 PVPEPILLK----KNVLVMEFIGDDGSPAPRLKD-VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH---- 152 (190)
T ss_pred CCceEEEec----CCEEEEEEecCCCchhhhhhh-ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE----
Confidence 544443332 247999999988654432222 347888999999999999999999 9999999999999997
Q ss_pred CCCcEEEEecCCccccc
Q 037285 955 SRPICKVGDFGLSKIKR 971 (1094)
Q Consensus 955 e~g~VKLsDFGLSrl~~ 971 (1094)
++.++|+|||+++...
T Consensus 153 -~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 -DGKPYIIDVSQAVELD 168 (190)
T ss_pred -CCCEEEEEcccceecC
Confidence 3579999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.8e-17 Score=167.26 Aligned_cols=142 Identities=21% Similarity=0.272 Sum_probs=113.6
Q ss_pred EEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEEEee
Q 037285 816 KELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAE 895 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~IVmE 895 (1094)
+.||+|++|.||+|.+.|..|++|+...................+.+|+.++..+.|++|+....++.... ..++|||
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE--NFIIVME 79 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC--CCEEEEE
Confidence 57999999999999999999999987654332211122223356788999999999998876666655443 6789999
Q ss_pred ecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCccc
Q 037285 896 YMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI 969 (1094)
Q Consensus 896 YmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl 969 (1094)
|++|++|.+++.... . .+..++.+++.+|.+||+.+++|+|++|.|||++ .+.++|+|||+++.
T Consensus 80 ~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-----~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-----GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-----CCCEEEEECCcccC
Confidence 999999999886432 2 7888999999999999999999999999999997 45799999998764
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.1e-17 Score=195.00 Aligned_cols=208 Identities=36% Similarity=0.561 Sum_probs=165.8
Q ss_pred HhhCCCCceeEEEeEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCc-eeccCCCC
Q 037285 867 LSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNI-VHFDLKCD 945 (1094)
Q Consensus 867 LkrL~HPNIVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GI-IHRDLKPe 945 (1094)
|+.+.|.|+.+++|.+.++. .+++|.+||..|+|.+.+......+++.....++++|+.||.|||...| .|+.|+..
T Consensus 1 l~~l~h~n~~~f~g~~~~~~--~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGP--EMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCC--ceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 46789999999999999875 8999999999999999999877779999999999999999999998876 99999999
Q ss_pred ceEeccCCCCCCcEEEEecCCcccccC---ccccCCccCCCcccCccccccC--CCC---CCchhhHHHHHHHHHHHHcC
Q 037285 946 NLLVNLKDPSRPICKVGDFGLSKIKRN---TLVSGGVRGTLPWMAPELLSGS--SSK---VSEKVDVFSFGIVLWEILTG 1017 (1094)
Q Consensus 946 NILLD~~~~e~g~VKLsDFGLSrl~~~---~~~ss~~~GT~~YmAPEvL~g~--~~k---yS~KSDVWSLGVLLyELLTG 1017 (1094)
|++++ ..+.+||+|||+...... ........-..-|.|||.+.+. ... .+.+.||||||++++|+++.
T Consensus 79 nClvd----~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 79 NCLVD----SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred cceee----eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 99999 899999999999875532 1111111233569999999852 111 47789999999999999999
Q ss_pred CCCCCCCC----hHHHHHhHhhcc---CCCCCCC--cCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 037285 1018 EEPYANMH----YGAIIGGIVNNT---LRPTIPS--YCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLST 1080 (1094)
Q Consensus 1018 k~PF~~~~----~~eile~Iv~~~---lrp~iPe--~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~t 1080 (1094)
+.||.... ..+++..+.... ++|.+.. ..++++..++..||..+|.+||++..+-..+..+..
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 99997632 234555543312 3333321 345578999999999999999999999998888764
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.3e-17 Score=172.64 Aligned_cols=188 Identities=16% Similarity=0.039 Sum_probs=137.9
Q ss_pred EEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-CCceeEEEeEeecCCCCceEE
Q 037285 814 EQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HPNVVAFYGVVQDGPGGTLAT 892 (1094)
Q Consensus 814 i~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-HPNIVqL~Gv~~d~~~~~L~I 892 (1094)
+...|++|+||+||.+...+.+++.+.+....+.. .......|.+|+++|++|. |++|++++++. ..++
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~----~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~------~~~l 75 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWL----RGVAWWLARREALALRQLDGLPRTPRLLHWD------GRHL 75 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhhh----hhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc------CEEE
Confidence 45679999999999887777888877765443211 1111224778999999995 58899998861 4689
Q ss_pred EeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCceEeccCCCCCCcEEEEecCCccccc
Q 037285 893 VAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDL-KCDNLLVNLKDPSRPICKVGDFGLSKIKR 971 (1094)
Q Consensus 893 VmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDL-KPeNILLD~~~~e~g~VKLsDFGLSrl~~ 971 (1094)
+|||+.|.+|.+.+.. ....++.|++.+|.++|++||+|||| ||.|||++ .++.++|+|||++....
T Consensus 76 vmeyI~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~----~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 76 DRSYLAGAAMYQRPPR--------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQ----EDGSPAVIDFQLAVRGN 143 (218)
T ss_pred EEeeecCccHHhhhhh--------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEc----CCCCEEEEECCCceecC
Confidence 9999999998754321 11346789999999999999999999 79999998 67789999999998443
Q ss_pred Cccc--------------cCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 037285 972 NTLV--------------SGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN 1023 (1094)
Q Consensus 972 ~~~~--------------ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~ 1023 (1094)
.... ..-...++.|++|+...-....--...++++.|+-+|.++|+..++-.
T Consensus 144 ~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 144 PRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred CcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 2211 011225778888887542222222567999999999999998887543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2e-17 Score=201.68 Aligned_cols=205 Identities=31% Similarity=0.460 Sum_probs=152.5
Q ss_pred ccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~ 885 (1094)
..++|..++.|..|+||.||.++++ .+++|+|+-+... +.+- ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l--------------ilRn--ilt~a~npfvv--------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL--------------ILRN--ILTFAGNPFVV--------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcccccch--------------hhhc--cccccCCccee---------
Confidence 3468899999999999999999876 6778985433221 0010 12222222222
Q ss_pred CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecC
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFG 965 (1094)
|+-...++.-+. ++. +++.+++|||+.||+|||+||+|.||+ .-+++|++|||
T Consensus 136 --------------gDc~tllk~~g~-lPv--------dmvla~Eylh~ygivhrdlkpdnllIT----~mGhiKlTDfg 188 (1205)
T KOG0606|consen 136 --------------GDCATLLKNIGP-LPV--------DMVLAVEYLHSYGIVHRDLKPDNLLIT----SMGHIKLTDFG 188 (1205)
T ss_pred --------------chhhhhcccCCC-Ccc--------hhhHHhHhhccCCeecCCCCCCcceee----ecccccccchh
Confidence 333344433222 322 237789999999999999999999999 88999999999
Q ss_pred Ccccc--c--------------CccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 037285 966 LSKIK--R--------------NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAI 1029 (1094)
Q Consensus 966 LSrl~--~--------------~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~ei 1029 (1094)
+++.. . ........+||+.|.|||++. .+.|...+|+|++|+|+||.+.|+.||.+.+.+++
T Consensus 189 Lsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVil--rqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel 266 (1205)
T KOG0606|consen 189 LSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVIL--RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL 266 (1205)
T ss_pred hhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhh--hhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH
Confidence 98731 0 011233568999999999998 67789999999999999999999999999999998
Q ss_pred HHhHhhcc-CCCCCCCcCcHHHHHHHHHhccCCCCCCC
Q 037285 1030 IGGIVNNT-LRPTIPSYCDAEWRTLMEECWAPNPAARP 1066 (1094)
Q Consensus 1030 le~Iv~~~-lrp~iPe~~S~eL~dLI~kCLq~DPeeRP 1066 (1094)
+.+++... ..++-...++++++++|.++|+.+|..|.
T Consensus 267 fg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 267 FGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred HhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 88776542 22333566789999999999999999995
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.4e-16 Score=168.66 Aligned_cols=141 Identities=21% Similarity=0.222 Sum_probs=105.5
Q ss_pred EEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-----CCCceeEEEeEeecCCC-
Q 037285 814 EQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-----HHPNVVAFYGVVQDGPG- 887 (1094)
Q Consensus 814 i~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-----~HPNIVqL~Gv~~d~~~- 887 (1094)
-.+.||+|+||.||.-...+. .+||++...... ....+.+|+.+++++ .||||+++++++.+..+
T Consensus 6 ~~~~LG~G~~~~Vy~hp~~~~-k~IKv~~~~~~~--------~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~ 76 (210)
T PRK10345 6 EQSPLGTGRHRKCYAHPEDAQ-RCIKIVYHRGDG--------GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGT 76 (210)
T ss_pred CcceecCCCceEEEECCCCcC-eEEEEEeccccc--------hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCC
Confidence 357899999999996222233 478887653211 124678999999999 57999999999987642
Q ss_pred CceE-EEeee--cccchhHHHHhhcccccCHHHHHHHHHHHHHHH-HHHHHCCceeccCCCCceEeccCCCCCCcEEEEe
Q 037285 888 GTLA-TVAEY--MVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGM-EYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGD 963 (1094)
Q Consensus 888 ~~L~-IVmEY--megGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGL-aYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsD 963 (1094)
+.++ +|+|| +.+++|.+++.+. .+++. ..++.+++.++ +|||+++|+||||||+|||++..+..+..++|+|
T Consensus 77 g~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 77 GYVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred eEEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 3434 78999 5589999999653 25555 34567777777 9999999999999999999985443456899999
Q ss_pred cCCc
Q 037285 964 FGLS 967 (1094)
Q Consensus 964 FGLS 967 (1094)
|+.+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5544
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.2e-16 Score=197.52 Aligned_cols=249 Identities=21% Similarity=0.292 Sum_probs=183.1
Q ss_pred eeeccCCeeEEEEecccCceEEEEeee-cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC---CCceeEEEe
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH---HPNVVAFYG 880 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~-rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~---HPNIVqL~G 880 (1094)
-++..+.|.+.+.||+|+||.||+|.. +|+.||+|+-+.....+ |.-=.+++.+|+ -+.|..+..
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE-----------fYI~~q~~~RLk~~~~~~~~~~~~ 761 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE-----------FYICLQVMERLKPQMLPSIMHISS 761 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee-----------eeehHHHHHhhchhhhcchHHHHH
Confidence 456778999999999999999999987 47889999987764322 222234555665 223333333
Q ss_pred EeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEecc---CCCCCC
Q 037285 881 VVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNL---KDPSRP 957 (1094)
Q Consensus 881 v~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~---~~~e~g 957 (1094)
+..-.. .-++|+||.+.|+|.+++. ..+.+++..+..++.||+..++.||..+|||+||||+|+||.. .+....
T Consensus 762 a~~~~~--~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~ 838 (974)
T KOG1166|consen 762 AHVFQN--ASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSK 838 (974)
T ss_pred HHccCC--cceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCccc
Confidence 332222 4678999999999999997 4456999999999999999999999999999999999999953 223456
Q ss_pred cEEEEecCCcc---cccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHh
Q 037285 958 ICKVGDFGLSK---IKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV 1034 (1094)
Q Consensus 958 ~VKLsDFGLSr---l~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv 1034 (1094)
.++|+|||.+. +....+.....++|-.+-.+|+.. +..++...|.|.|+.+++-|+.|+.-- ..
T Consensus 839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~--grpWtYq~DyfGlAa~~h~mLFG~y~q-----------~~ 905 (974)
T KOG1166|consen 839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMRE--GRPWTYQIDYFGLAATVHVMLFGKYME-----------VK 905 (974)
T ss_pred ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhc--CCCCchhhhhHHHHHHHHHHHHHHHHH-----------hc
Confidence 79999999986 334445556677899999999998 567888999999999999999886531 11
Q ss_pred hccC---CCCCCCcCc-HHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 037285 1035 NNTL---RPTIPSYCD-AEWRTLMEECWAPNPAARPSFTEIASRLRVLST 1080 (1094)
Q Consensus 1035 ~~~l---rp~iPe~~S-~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~t 1080 (1094)
.+.. ...++.... .-|.+|...+|+.|-..=|...+|...|..+..
T Consensus 906 ~g~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 906 NGSSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred CCcceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 1111 111222222 346788889999666666888888877776653
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.7e-16 Score=162.09 Aligned_cols=138 Identities=22% Similarity=0.262 Sum_probs=106.8
Q ss_pred EecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEEEeee
Q 037285 817 ELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEY 896 (1094)
Q Consensus 817 kLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~IVmEY 896 (1094)
.||+|+||.||+|.+.+..|++|...................++.+|+.++..+.|+++.....++.... ..++||||
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD--NKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC--CCEEEEEE
Confidence 3899999999999999999999987654322111112223456788999999998876544333333332 57899999
Q ss_pred cccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCccc
Q 037285 897 MVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI 969 (1094)
Q Consensus 897 megGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl 969 (1094)
++|++|.+++..... .++.+++.+|.+||+.+++|+|++|.||+++ .+.++++|||+++.
T Consensus 79 ~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-----~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND--------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-----DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH--------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-----CCcEEEEECCCCcC
Confidence 999999988754321 7889999999999999999999999999997 46799999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.1e-16 Score=184.67 Aligned_cols=142 Identities=24% Similarity=0.239 Sum_probs=113.3
Q ss_pred eeEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceE
Q 037285 812 LEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLA 891 (1094)
Q Consensus 812 Yei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~ 891 (1094)
|...++||+|+||+||+|.+.+..+++|+...................+.+|+.++++++|++++....++.... ..+
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~ 412 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE--EKT 412 (535)
T ss_pred cCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC--CCE
Confidence 455789999999999999998877777765433222111122223456889999999999999988777666543 678
Q ss_pred EEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCccc
Q 037285 892 TVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI 969 (1094)
Q Consensus 892 IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl 969 (1094)
+||||+++++|.+++. ....++.+++.+|.+||+.+++||||||+|||++ ++.++|+|||+++.
T Consensus 413 lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-----~~~~~liDFGla~~ 476 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-----DDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-----CCcEEEEeCccccc
Confidence 9999999999999885 3467889999999999999999999999999995 45799999999874
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.4e-15 Score=163.31 Aligned_cols=148 Identities=18% Similarity=0.097 Sum_probs=110.0
Q ss_pred CeeEEEEecccCceEEEEee---ecCceEEEEEeecCccCCCc----------------hhHHHHHHHHHHHHHHHhhCC
Q 037285 811 DLEEQKELGSGTFGTVYHGK---WRGTDVAIKRIKKSCFTGRS----------------SEQERLTVEFWKEAEILSKLH 871 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk---~rGt~VAVKiIkk~~~se~~----------------~eqe~~~~eFlrEIkILkrL~ 871 (1094)
-|.+.+.||+|+||.||+|. ..|+.||||+++........ .........+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46778899999999999998 35889999999864321100 001112234568999999997
Q ss_pred CC--ceeEEEeEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCceE
Q 037285 872 HP--NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKN-IVHFDLKCDNLL 948 (1094)
Q Consensus 872 HP--NIVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~G-IIHRDLKPeNIL 948 (1094)
+. .+.+++++ . ..++||||+.+.+|..++.... .+....+..++.||+.+|.+||+.| |+||||||+||+
T Consensus 109 ~~~i~~p~~~~~---~---~~~lV~E~~~g~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl 181 (237)
T smart00090 109 EAGVPVPKPIAW---R---RNVLVMEFIGGDGLPAPRLKDV-EPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL 181 (237)
T ss_pred hcCCCCCeeeEe---c---CceEEEEEecCCcccccccccC-CcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence 53 34455443 1 3479999999988876653332 3566677889999999999999999 999999999999
Q ss_pred eccCCCCCCcEEEEecCCcccc
Q 037285 949 VNLKDPSRPICKVGDFGLSKIK 970 (1094)
Q Consensus 949 LD~~~~e~g~VKLsDFGLSrl~ 970 (1094)
++ .+.++|+|||++...
T Consensus 182 i~-----~~~i~LiDFg~a~~~ 198 (237)
T smart00090 182 VH-----DGKVVIIDVSQSVEL 198 (237)
T ss_pred EE-----CCCEEEEEChhhhcc
Confidence 97 357999999998743
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.5e-15 Score=153.86 Aligned_cols=141 Identities=21% Similarity=0.079 Sum_probs=106.0
Q ss_pred eeEEEEecccCceEEEEeee-cCceEEEEEeecCccCCCchh--------------HHHHHHHHHHHHHHHhhCCCCc--
Q 037285 812 LEEQKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSSE--------------QERLTVEFWKEAEILSKLHHPN-- 874 (1094)
Q Consensus 812 Yei~kkLGsG~FGtVYKAk~-rGt~VAVKiIkk~~~se~~~e--------------qe~~~~eFlrEIkILkrL~HPN-- 874 (1094)
|.+.+.||+|+||.||++.+ .|+.||||++........... .......+..|+.++.++.|.+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 66678899999999999988 478999999875421100000 0011234667899999998774
Q ss_pred eeEEEeEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCC
Q 037285 875 VVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP 954 (1094)
Q Consensus 875 IVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~ 954 (1094)
++..++. ...++||||+++++|...... .....++.+++.++.++|+.||+||||||.||+++
T Consensus 97 v~~~~~~------~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~---- 159 (198)
T cd05144 97 VPKPIDW------NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVD---- 159 (198)
T ss_pred CCceeec------CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEc----
Confidence 4444432 146899999999998765421 33567888999999999999999999999999998
Q ss_pred CCCcEEEEecCCccc
Q 037285 955 SRPICKVGDFGLSKI 969 (1094)
Q Consensus 955 e~g~VKLsDFGLSrl 969 (1094)
.++.++|+|||++..
T Consensus 160 ~~~~~~liDfg~~~~ 174 (198)
T cd05144 160 DDEKIYIIDWPQMVS 174 (198)
T ss_pred CCCcEEEEECCcccc
Confidence 678999999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.5e-15 Score=175.77 Aligned_cols=170 Identities=28% Similarity=0.397 Sum_probs=129.1
Q ss_pred ceEEEeeecccchhHHHHhhcc--cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 889 TLATVAEYMVDGSLRHVLVRKD--RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~--~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
+++|.|++|...+|.+||..+. ...++...+.++.|++.|++| ++.+|+|+||.||++. .+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~----~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS----DDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc----cchhhhhhhhhh
Confidence 6899999999999999996443 346778889999999999999 9999999999999997 566899999999
Q ss_pred cccccCc-------cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccC
Q 037285 967 SKIKRNT-------LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 1038 (1094)
Q Consensus 967 Srl~~~~-------~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~l 1038 (1094)
....... .......||..||+||.+. ...|+.|+||||||+||+||++ =...|..... ...+....+
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~--g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t---~~d~r~g~i 477 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIR--GQQYSEKVDIYALGLILAELLIQFSTQFERIAT---LTDIRDGII 477 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHh--hhhhhhhcchhhHHHHHHHHHHHhccHHHHHHh---hhhhhcCCC
Confidence 8743322 2344567999999999999 5789999999999999999997 3333332211 122222333
Q ss_pred CCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHH
Q 037285 1039 RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071 (1094)
Q Consensus 1039 rp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eEL 1071 (1094)
.+.+.... +.-++|+.+++.+.|.+||++.+.
T Consensus 478 p~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 478 PPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred ChHHhhcC-cHHHHHHHHhcCCCcccCchHHHH
Confidence 22332333 345689999999999999955443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.52 E-value=8.6e-14 Score=131.31 Aligned_cols=132 Identities=22% Similarity=0.160 Sum_probs=109.1
Q ss_pred EEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCC--CceeEEEeEeecCCCCceE
Q 037285 814 EQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHH--PNVVAFYGVVQDGPGGTLA 891 (1094)
Q Consensus 814 i~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~H--PNIVqL~Gv~~d~~~~~L~ 891 (1094)
+.+.||.|.++.||++...+..+++|.+..... ...+.+|+.+++.+.+ .++++++.+.... +..+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~--~~~~ 69 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----------GADREREVAILQLLARKGLPVPKVLASGESD--GWSY 69 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc----------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CccE
Confidence 357899999999999999888899998865421 2467789999999976 5889998887764 3789
Q ss_pred EEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 892 TVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSK---NIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 892 IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~---GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
++|||+.++.+..+ +......++.+++++|++||.. +++|+||+|.||+++ ..+.++++|||.++
T Consensus 70 ~v~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~----~~~~~~l~Df~~~~ 137 (155)
T cd05120 70 LLMEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD----DGKILGIIDWEYAG 137 (155)
T ss_pred EEEEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE----CCcEEEEEeccccc
Confidence 99999988877654 4455667889999999999985 699999999999998 56789999999876
Q ss_pred c
Q 037285 969 I 969 (1094)
Q Consensus 969 l 969 (1094)
.
T Consensus 138 ~ 138 (155)
T cd05120 138 Y 138 (155)
T ss_pred C
Confidence 3
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.3e-13 Score=148.25 Aligned_cols=144 Identities=15% Similarity=0.154 Sum_probs=105.7
Q ss_pred EEec-ccCceEEEEeeecCceEEEEEeecCccCCC-----chhHHHHHHHHHHHHHHHhhCCCCce--eEEEeEeecCCC
Q 037285 816 KELG-SGTFGTVYHGKWRGTDVAIKRIKKSCFTGR-----SSEQERLTVEFWKEAEILSKLHHPNV--VAFYGVVQDGPG 887 (1094)
Q Consensus 816 kkLG-sG~FGtVYKAk~rGt~VAVKiIkk~~~se~-----~~eqe~~~~eFlrEIkILkrL~HPNI--VqL~Gv~~d~~~ 887 (1094)
..|| .|+.|+||++...+..++||.+........ ..........+.+|+.++.+|.|++| +..+++......
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4577 888889998888888999999865432110 00011223567889999999998875 677776543321
Q ss_pred C--ceEEEeeeccc-chhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 888 G--TLATVAEYMVD-GSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 888 ~--~L~IVmEYmeg-GSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
. ..++|||++++ .+|.+++... .++.. .+.+|+.+|.+||++||+||||||.|||++ .++.++|+||
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~----~~~~v~LIDf 186 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLD----PDGKFWLIDF 186 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEc----CCCCEEEEEC
Confidence 1 23599999997 6888887543 34543 356899999999999999999999999998 5668999999
Q ss_pred CCccc
Q 037285 965 GLSKI 969 (1094)
Q Consensus 965 GLSrl 969 (1094)
|.++.
T Consensus 187 g~~~~ 191 (239)
T PRK01723 187 DRGEL 191 (239)
T ss_pred CCccc
Confidence 98764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.6e-13 Score=138.68 Aligned_cols=142 Identities=20% Similarity=0.085 Sum_probs=96.2
Q ss_pred EEEecccCceEEEEeeec-CceEEEEEeecCccCCCchhHHH----------------HHHHHHHHHHHHhhCCCCc--e
Q 037285 815 QKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQER----------------LTVEFWKEAEILSKLHHPN--V 875 (1094)
Q Consensus 815 ~kkLGsG~FGtVYKAk~r-Gt~VAVKiIkk~~~se~~~eqe~----------------~~~eFlrEIkILkrL~HPN--I 875 (1094)
.+.||+|+||.||+|... ++.||||+++............. .......|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999886 78899999876432111100000 0001134566666664432 4
Q ss_pred eEEEeEeecCCCCceEEEeeecccchhHHH-HhhcccccCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeccCC
Q 037285 876 VAFYGVVQDGPGGTLATVAEYMVDGSLRHV-LVRKDRFLDRRRRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKD 953 (1094)
Q Consensus 876 VqL~Gv~~d~~~~~L~IVmEYmegGSL~d~-L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs-~GIIHRDLKPeNILLD~~~ 953 (1094)
.+.+++. ..++||||+.++.+... +.... .. ..+..++.+++.++.++|. .+|+|+||||+||+++
T Consensus 82 ~~~~~~~------~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~--- 149 (187)
T cd05119 82 PKPIDLN------RHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD--- 149 (187)
T ss_pred CceEecC------CCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE---
Confidence 4444431 35899999998543221 11111 11 5677899999999999999 9999999999999997
Q ss_pred CCCCcEEEEecCCcccc
Q 037285 954 PSRPICKVGDFGLSKIK 970 (1094)
Q Consensus 954 ~e~g~VKLsDFGLSrl~ 970 (1094)
++.++|+|||.+...
T Consensus 150 --~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 --DGKVYIIDVPQAVEI 164 (187)
T ss_pred --CCcEEEEECcccccc
Confidence 467999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.8e-14 Score=173.46 Aligned_cols=258 Identities=25% Similarity=0.262 Sum_probs=190.6
Q ss_pred cCCeeEEEEecccCceEEEEeeecC---ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-CCceeEEEeEeec
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWRG---TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HPNVVAFYGVVQD 884 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~rG---t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-HPNIVqL~Gv~~d 884 (1094)
...|.+.+.||+|+|+.|-.....+ ..+|+|.+..... ..........|..+-+.+. |.|++++++....
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~------~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~ 92 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPK------SEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS 92 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCC------ccchhhhcCccccccccccccccccccCCccCC
Confidence 4567777889999999998876532 3366666654321 1222234445777767776 9999999999887
Q ss_pred CCCCceEEEeeecccchhHHHH-hhcccccCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCceEeccCCCCCC-cEEE
Q 037285 885 GPGGTLATVAEYMVDGSLRHVL-VRKDRFLDRRRRLIIAMDAAFGMEYLH-SKNIVHFDLKCDNLLVNLKDPSRP-ICKV 961 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L-~k~~~~Lse~~~l~Ia~QIaeGLaYLH-s~GIIHRDLKPeNILLD~~~~e~g-~VKL 961 (1094)
.. ..+++++|..++++...+ .......+...+...+.|+..++.|+| ..++.|+||||+|.+++ ..+ .+|+
T Consensus 93 ~~--~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~----~s~~~l~~ 166 (601)
T KOG0590|consen 93 PR--SYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLD----ESGSALKI 166 (601)
T ss_pred Cc--ccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhc----cCCCcccC
Confidence 65 788999999999998888 444324677778889999999999999 99999999999999998 566 8999
Q ss_pred EecCCcccccC----ccccCCccC-CCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHH-HhHhh
Q 037285 962 GDFGLSKIKRN----TLVSGGVRG-TLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAII-GGIVN 1035 (1094)
Q Consensus 962 sDFGLSrl~~~----~~~ss~~~G-T~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eil-e~Iv~ 1035 (1094)
+|||+|..... .......+| ++.|+|||...+. .......|+||.|+++.-+++|..||......... .....
T Consensus 167 ~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~ 245 (601)
T KOG0590|consen 167 ADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKS 245 (601)
T ss_pred CCchhhccccccCCcceeeecccCCCCCCCCcccccch-hhcCCCcccccccccccccccCCCCccccccccccceeecc
Confidence 99999985433 222334567 9999999998852 34467899999999999999999998765433211 11111
Q ss_pred ccC--CCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1036 NTL--RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1036 ~~l--rp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
... ........+....+++.+++..+|..|.+.+++...-+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 246 NKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 111 12334556778899999999999999999998876544433
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.21 E-value=8.3e-12 Score=146.92 Aligned_cols=248 Identities=22% Similarity=0.228 Sum_probs=179.3
Q ss_pred cCCeeEEEEecc--cCceEEEEeee----cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-CCceeEEEeE
Q 037285 809 NEDLEEQKELGS--GTFGTVYHGKW----RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HPNVVAFYGV 881 (1094)
Q Consensus 809 ~edYei~kkLGs--G~FGtVYKAk~----rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-HPNIVqL~Gv 881 (1094)
...+.+.+.+|. |.+|.||.+.. .+..+|+|.-+... ..... ...=.+|+...++++ |+|.++.+..
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~-s~p~~-----~~~k~~~~~s~~~i~~~~~~v~~~~~ 186 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF-SPPLD-----SKRKLREFLSHHKIDSHENPVRDSPA 186 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCC-CCccc-----cccccchhhcccccCccccccccCcc
Confidence 345667788999 99999999776 25668888743321 10000 011224555555664 9999998888
Q ss_pred eecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHH----HHHHHHHCCceeccCCCCceEeccCCCCC-
Q 037285 882 VQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF----GMEYLHSKNIVHFDLKCDNLLVNLKDPSR- 956 (1094)
Q Consensus 882 ~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIae----GLaYLHs~GIIHRDLKPeNILLD~~~~e~- 956 (1094)
+.... .+++-+|++ +.+|..+.......++...++..+.+..+ ||.++|+.+++|-|+||.||++. .+
T Consensus 187 ~e~~~--~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~----~~~ 259 (524)
T KOG0601|consen 187 WEGSG--ILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTT----SDW 259 (524)
T ss_pred cccCC--cceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecc----ccc
Confidence 87654 888888888 58899998887777899999999999999 99999999999999999999998 55
Q ss_pred CcEEEEecCCcccccCcccc------CCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 037285 957 PICKVGDFGLSKIKRNTLVS------GGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAII 1030 (1094)
Q Consensus 957 g~VKLsDFGLSrl~~~~~~s------s~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eil 1030 (1094)
..++++|||+.......... ....+...|++||...+ -++.+.|+|+||.++.+..++..+.....+. .+
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~---l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-~W 335 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG---LATFASDIFSLGEVILEAILGSHLPSVGKNS-SW 335 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc---ccchHhhhcchhhhhHhhHhhcccccCCCCC-Cc
Confidence 78999999998855433321 12247788999999874 5678999999999999999877664432110 01
Q ss_pred HhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037285 1031 GGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIAS 1073 (1094)
Q Consensus 1031 e~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq 1073 (1094)
.++........+-...+.++...+.+|++.++..|++++.+..
T Consensus 336 ~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 336 SQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 1111111222333445667778999999999999998876553
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.1e-10 Score=115.74 Aligned_cols=127 Identities=17% Similarity=0.093 Sum_probs=94.0
Q ss_pred EEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCce-eEEEeEeecCCCCceEEE
Q 037285 815 QKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNV-VAFYGVVQDGPGGTLATV 893 (1094)
Q Consensus 815 ~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNI-VqL~Gv~~d~~~~~L~IV 893 (1094)
.+.|+.|.++.||+++..+..+++|+...... ....+.+|+.+++.+.+.++ .+++.+... ..++|
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~---------~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~----~~~lv 69 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE---------LLINRENEAENSKLAAEAGIGPKLYYFDPE----TGVLI 69 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcc---------cccCHHHHHHHHHHHHHhCCCCceEEEeCC----CCeEE
Confidence 46789999999999998889999998754321 01235578888888765444 455554432 34789
Q ss_pred eeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCc-----eeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 894 AEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNI-----VHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 894 mEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GI-----IHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
|||+++.++.... .. ...++.+++++|+.||+.++ +|+|++|.||+++ ++.++|+||+.+.
T Consensus 70 ~e~i~G~~l~~~~------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-----~~~~~liDf~~a~ 135 (170)
T cd05151 70 TEFIEGSELLTED------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-----DGRLWLIDWEYAG 135 (170)
T ss_pred EEecCCCcccccc------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-----CCeEEEEeccccc
Confidence 9999998886530 11 12346789999999999885 9999999999997 3468999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.5e-10 Score=135.15 Aligned_cols=148 Identities=20% Similarity=0.183 Sum_probs=98.7
Q ss_pred EEecccCceEEEEeee-cCceEEEEEeecCccCCCc--------------------------hhHHHH------HHHHHH
Q 037285 816 KELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRS--------------------------SEQERL------TVEFWK 862 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~-rGt~VAVKiIkk~~~se~~--------------------------~eqe~~------~~eFlr 862 (1094)
+.||.|++|.||+|+. .|+.||||+.++.....-. ...+.+ ..+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5699999999999988 4899999998764210000 000000 113556
Q ss_pred HHHHHhhCC----CCceeEEEeEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHH-HHHHHHHCCc
Q 037285 863 EAEILSKLH----HPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF-GMEYLHSKNI 937 (1094)
Q Consensus 863 EIkILkrL~----HPNIVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIae-GLaYLHs~GI 937 (1094)
|+..+.++. +.+-+.+-.++.+. ....++||||++|++|.++........+ ...++..++. .+..+|..|+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 666666653 33333333333321 1246899999999999887653322222 3345556655 4788999999
Q ss_pred eeccCCCCceEeccCCCCCCcEEEEecCCccccc
Q 037285 938 VHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKR 971 (1094)
Q Consensus 938 IHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~ 971 (1094)
+|+|++|.||+++ .++.++|+|||++....
T Consensus 279 ~H~D~hPgNilv~----~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVL----KDGKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEEC----CCCcEEEEeCCCeeECC
Confidence 9999999999998 67889999999987543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=7e-10 Score=116.33 Aligned_cols=137 Identities=22% Similarity=0.254 Sum_probs=103.1
Q ss_pred EEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCc--eeEEEeEeecCCCCceEEE
Q 037285 816 KELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPN--VVAFYGVVQDGPGGTLATV 893 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPN--IVqL~Gv~~d~~~~~L~IV 893 (1094)
..+++|+-+.+|.+.|.|.++++|.=.++......-.+......-.+|+.++.+++--. ...++++.. . ...|+
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~--~--~~~I~ 77 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDP--D--NGLIV 77 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcC--C--CCEEE
Confidence 35789999999999998888888865444443333333334456678999999886433 344444433 2 56789
Q ss_pred eeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCccc
Q 037285 894 AEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI 969 (1094)
Q Consensus 894 mEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl 969 (1094)
|||++|..|.+++... ...++..|-.-+.-||..||+|+||.++||++. +..+.++||||+..
T Consensus 78 me~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~-----~~~i~~IDfGLg~~ 140 (204)
T COG3642 78 MEYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILS-----GGRIYFIDFGLGEF 140 (204)
T ss_pred EEEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEe-----CCcEEEEECCcccc
Confidence 9999999999988654 245777888888999999999999999999997 44599999999874
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.7e-10 Score=128.37 Aligned_cols=200 Identities=22% Similarity=0.299 Sum_probs=139.6
Q ss_pred HHhhCCCCceeEEEeEeecCC---CCceEEEeeecccchhHHHHhhcc---cccCHHHHHHHHHHHHHHHHHHHHCC--c
Q 037285 866 ILSKLHHPNVVAFYGVVQDGP---GGTLATVAEYMVDGSLRHVLVRKD---RFLDRRRRLIIAMDAAFGMEYLHSKN--I 937 (1094)
Q Consensus 866 ILkrL~HPNIVqL~Gv~~d~~---~~~L~IVmEYmegGSL~d~L~k~~---~~Lse~~~l~Ia~QIaeGLaYLHs~G--I 937 (1094)
-|-++-|-|||+++.+|.+.. .....+++|||..|+|..+|++.. ..+......+|+.||+.||.|||+.. |
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 345667999999999997643 235778999999999999997543 45777888899999999999999875 9
Q ss_pred eeccCCCCceEeccCCCCCCcEEEEecCCcccc-----cCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHH
Q 037285 938 VHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK-----RNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLW 1012 (1094)
Q Consensus 938 IHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~-----~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLy 1012 (1094)
+|+++..+-|++. .++.+|+.---..... ..........+-++|.|||.-. ....+-++|||+||....
T Consensus 200 ihgnlTc~tifiq----~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~--~tn~~~a~dIy~fgmcAl 273 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQ----HNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGT--TTNTTGASDIYKFGMCAL 273 (458)
T ss_pred ccCCcchhheeec----CCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCc--ccccccchhhhhhhHHHH
Confidence 9999999999998 6788887543222111 0111122334668899999854 345567899999999999
Q ss_pred HHHcCCCCCCCCC-hHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1013 EILTGEEPYANMH-YGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1013 ELLTGk~PF~~~~-~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
+|..+..--.... ..+.-..+... +-..-...-+++|.+|++..|..||++.+++-|..
T Consensus 274 emailEiq~tnseS~~~~ee~ia~~-----i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpl 333 (458)
T KOG1266|consen 274 EMAILEIQSTNSESKVEVEENIANV-----IIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPL 333 (458)
T ss_pred HHHHheeccCCCcceeehhhhhhhh-----eeeccCccccCcCcccccCCCCCCcchhhhhcCce
Confidence 9988765322111 11111111111 01111223367899999999999999999886643
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.5e-09 Score=112.22 Aligned_cols=153 Identities=18% Similarity=0.173 Sum_probs=111.2
Q ss_pred EEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEEE
Q 037285 814 EQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATV 893 (1094)
Q Consensus 814 i~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~IV 893 (1094)
....|-+|+-+.|+++.+.|+...||.-....+.-..-.+.-...+..+|+++|.++.--.|.-.-=++.+.. .-.|+
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~--~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY--GGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC--CCeEE
Confidence 4567889999999999999999888865444443333344445566778999999886444433222344433 45678
Q ss_pred eeeccc-chhHHHHhhcccccCHHH-HHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCccc
Q 037285 894 AEYMVD-GSLRHVLVRKDRFLDRRR-RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI 969 (1094)
Q Consensus 894 mEYmeg-GSL~d~L~k~~~~Lse~~-~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl 969 (1094)
|||+++ .++.+++......-.... ...++..|-+.+.-||.++|||+||..+||++..++ ....+.|+|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~-~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDG-NQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCC-CcCceEEEeecchhc
Confidence 999976 478888765543233333 378899999999999999999999999999997444 556679999999864
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.02 E-value=3.3e-09 Score=112.23 Aligned_cols=142 Identities=19% Similarity=0.110 Sum_probs=99.0
Q ss_pred EEecccCceEEEEeeec--------CceEEEEEeecCccC--CCc----------------hhHHHHHHHHHHHHHHHhh
Q 037285 816 KELGSGTFGTVYHGKWR--------GTDVAIKRIKKSCFT--GRS----------------SEQERLTVEFWKEAEILSK 869 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~r--------Gt~VAVKiIkk~~~s--e~~----------------~eqe~~~~eFlrEIkILkr 869 (1094)
..||.|--+.||.|... +..+|||+++..... ... ........-..+|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999754 368999999854211 100 0011111223379999999
Q ss_pred CCC--CceeEEEeEeecCCCCceEEEeeecccchhHH-HHhhcccccCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCC
Q 037285 870 LHH--PNVVAFYGVVQDGPGGTLATVAEYMVDGSLRH-VLVRKDRFLDRRRRLIIAMDAAFGMEYL-HSKNIVHFDLKCD 945 (1094)
Q Consensus 870 L~H--PNIVqL~Gv~~d~~~~~L~IVmEYmegGSL~d-~L~k~~~~Lse~~~l~Ia~QIaeGLaYL-Hs~GIIHRDLKPe 945 (1094)
+.. -++.+.+++ . .-++||||+.+..+.. .+.. ..++......+..+++.+|..| |+.|+||+||++.
T Consensus 83 l~~~Gv~vP~pi~~--~----~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~ 154 (197)
T cd05146 83 MQKAGIPCPEVVVL--K----KHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEY 154 (197)
T ss_pred HHHcCCCCCeEEEe--c----CCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 853 456666654 1 4678999997654422 2221 2355566677889999999998 8999999999999
Q ss_pred ceEeccCCCCCCcEEEEecCCcccc
Q 037285 946 NLLVNLKDPSRPICKVGDFGLSKIK 970 (1094)
Q Consensus 946 NILLD~~~~e~g~VKLsDFGLSrl~ 970 (1094)
|||+. ++.+.|+|||.+...
T Consensus 155 NIL~~-----~~~v~iIDF~qav~~ 174 (197)
T cd05146 155 NMLWH-----DGKVWFIDVSQSVEP 174 (197)
T ss_pred HEEEE-----CCcEEEEECCCceeC
Confidence 99997 357999999988644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.99 E-value=8.4e-10 Score=131.81 Aligned_cols=151 Identities=20% Similarity=0.278 Sum_probs=94.3
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccC---------------------C-C----chhHHHHH-----
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFT---------------------G-R----SSEQERLT----- 857 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~s---------------------e-~----~~eqe~~~----- 857 (1094)
+|.. +.||+|++|.||+|+.+ |+.||||++++.... . . ...-+.+.
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4554 67999999999999884 789999999865210 0 0 00000111
Q ss_pred -HHHHHHHHHHhhCC----CCceeEEEeEeecCCCCceEEEeeecccchhHHHH--hhccc---ccCHHHHHHHHHHHHH
Q 037285 858 -VEFWKEAEILSKLH----HPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVL--VRKDR---FLDRRRRLIIAMDAAF 927 (1094)
Q Consensus 858 -~eFlrEIkILkrL~----HPNIVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L--~k~~~---~Lse~~~l~Ia~QIae 927 (1094)
.+|.+|+..+.++. +.+.+.+-.++.+- ....++||||+.|+.+.++- ...+. .+....+..++.||
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 23455665555553 44444444444321 22578999999999997753 22221 12333333334443
Q ss_pred HHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccc
Q 037285 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK 970 (1094)
Q Consensus 928 GLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~ 970 (1094)
...|++|+|+||.||+++.+++..+.++++|||++...
T Consensus 277 -----f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 277 -----FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred -----HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 46899999999999999844434459999999998743
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.4e-10 Score=140.89 Aligned_cols=250 Identities=23% Similarity=0.257 Sum_probs=180.3
Q ss_pred eeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEee
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQ 883 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~ 883 (1094)
..+.+.+.+.+-+-+|.|+.++.++-. |.-.++|+.....+..... ......+-.++-.-++|.++....-+.
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~-----~~s~r~~s~~~i~p~~P~v~~~~~s~~ 874 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTND-----YESIRSKSNILITPRSPAVVRSFPSFP 874 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhcccc-----ccccCCccCccccCCCCceecccCCCC
Confidence 346677888888999999999987765 3334555443322111100 111222333333334677776655544
Q ss_pred cCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEe
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGD 963 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsD 963 (1094)
... .++++++|+.+++|...|.+.+ ..+.+.+...+..+..+++|||...+.|+|++|.|+|.. ..++.+++|
T Consensus 875 ~rs--P~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~----~~gh~~l~~ 947 (1205)
T KOG0606|consen 875 CRS--PLPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIA----YDGHRPLTD 947 (1205)
T ss_pred CCC--CcchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccchhhcccccccchhhc----ccCCcccCc
Confidence 433 8999999999999999987765 356666666777888999999999999999999999998 788999999
Q ss_pred cCCccc---c----cC-------------------------ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHH
Q 037285 964 FGLSKI---K----RN-------------------------TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVL 1011 (1094)
Q Consensus 964 FGLSrl---~----~~-------------------------~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLL 1011 (1094)
||+... . .. ........+|+.|.+||.+.+ ..-...+|+|++|+++
T Consensus 948 ~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg--~~hgs~ad~~~~g~~l 1025 (1205)
T KOG0606|consen 948 FGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG--RRHGSAADWWSSGVCL 1025 (1205)
T ss_pred cccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc--ccCCCcchhhhhhhhh
Confidence 984321 0 00 011223568999999999985 3345689999999999
Q ss_pred HHHHcCCCCCCCCChHHHHHhHhhccCC-CCCCCcCcHHHHHHHHHhccCCCCCCCCHH
Q 037285 1012 WEILTGEEPYANMHYGAIIGGIVNNTLR-PTIPSYCDAEWRTLMEECWAPNPAARPSFT 1069 (1094)
Q Consensus 1012 yELLTGk~PF~~~~~~eile~Iv~~~lr-p~iPe~~S~eL~dLI~kCLq~DPeeRPS~e 1069 (1094)
+|.++|..||.......+.+.+...... +.-+...+.+.++++...+..++.+|..+.
T Consensus 1026 ~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1026 FEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9999999999999988888777654433 334566788999999999999999997665
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.6e-10 Score=133.39 Aligned_cols=255 Identities=22% Similarity=0.217 Sum_probs=177.8
Q ss_pred eccCCeeEEEEecccCceEEEEeeec---CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEe
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR---GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVV 882 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r---Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~ 882 (1094)
....+|.++..||.|.|+.|+....+ +..+++|...+..... ..+ ..-..|+.+...+ .|.+++..+..|
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~--~~d----i~sl~ev~l~~~l~~~~~~~g~~~~W 335 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATF--ASD----IFSLGEVILEAILGSHLPSVGKNSSW 335 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccch--Hhh----hcchhhhhHhhHhhcccccCCCCCCc
Confidence 44568899999999999999987654 4668888877653321 111 1223456555555 488888877766
Q ss_pred ecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 883 QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 883 ~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
..-. ..+|=.|||.++++...+. -...+++...+.+..|++.++.++|+..++|+|+||.||++..+ .+..++.
T Consensus 336 ~~~r--~~~ip~e~~~~~s~~l~~~-~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~---~~~~~~~ 409 (524)
T KOG0601|consen 336 SQLR--QGYIPLEFCEGGSSSLRSV-TSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISND---GFFSKLG 409 (524)
T ss_pred cccc--cccCchhhhcCcchhhhhH-HHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccc---hhhhhcc
Confidence 6544 6778999999998877663 23347888899999999999999999999999999999999721 2789999
Q ss_pred ecCCcccccCccccCCccCCCccc-CccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCC
Q 037285 963 DFGLSKIKRNTLVSGGVRGTLPWM-APELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT 1041 (1094)
Q Consensus 963 DFGLSrl~~~~~~ss~~~GT~~Ym-APEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~ 1041 (1094)
|||..+...- ........-++. ..|++.. ...+-.+.|++|||..+.+.+++...=..... ...+ ..+.-+.
T Consensus 410 ~~~~~t~~~~--~~~~~~~~~r~~p~~~~~~e-~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i-~~~~~p~ 482 (524)
T KOG0601|consen 410 DFGCWTRLAF--SSGVFHHIDRLYPIAEILLE-DYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTI-RSGDTPN 482 (524)
T ss_pred ccccccccce--ecccccccccccccchhhcc-ccccccccccccccccccccccCcccCccccc---ceee-ecccccC
Confidence 9999863111 111122333444 3555553 45667799999999999999997663221111 1111 2222223
Q ss_pred CCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1042 iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
.+. ....+..+.+.+...++..||.+.++..+.....+.
T Consensus 483 ~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~~ 521 (524)
T KOG0601|consen 483 LPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRDS 521 (524)
T ss_pred CCc-hHHhhhhhhhhhcCCccccchhhhhhcccchhhhhc
Confidence 333 337788899999999999999999988877766543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=2.3e-08 Score=119.74 Aligned_cols=161 Identities=21% Similarity=0.293 Sum_probs=116.5
Q ss_pred CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEEEeeecccchhHHHHhhcccc
Q 037285 833 GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRF 912 (1094)
Q Consensus 833 Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~ 912 (1094)
+.+|.|..++... . .......+-++-|+.|+||||++++..+.... .+|+|+|-+ ..|..++++..
T Consensus 37 ~~~vsVF~~~~~~-----~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~--~~ylvTErV--~Pl~~~lk~l~-- 102 (690)
T KOG1243|consen 37 GGPVSVFVYKRSN-----G---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEG--TLYLVTERV--RPLETVLKELG-- 102 (690)
T ss_pred CCceEEEEEeCCC-----c---hhhHHHHHHHHHhhhccCchhhhhhhhhcccC--ceEEEeecc--ccHHHHHHHhH--
Confidence 5677777776532 1 11233456678899999999999999987754 899999987 35666665533
Q ss_pred cCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccCccc-cCCccCCCcccCccc
Q 037285 913 LDRRRRLIIAMDAAFGMEYLH-SKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLV-SGGVRGTLPWMAPEL 990 (1094)
Q Consensus 913 Lse~~~l~Ia~QIaeGLaYLH-s~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~~~-ss~~~GT~~YmAPEv 990 (1094)
...+...+.||+.||.||| +.+++|++|.-..|+|+ ..|..||++|.++........ .....--..|..|+.
T Consensus 103 --~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn----~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~ 176 (690)
T KOG1243|consen 103 --KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVN----ESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEE 176 (690)
T ss_pred --HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEc----CCCcEEEeeeEEEeccccCCcccccchhhhcccChhh
Confidence 5566667889999999998 56799999999999999 889999999998763322111 111111223566665
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcC
Q 037285 991 LSGSSSKVSEKVDVFSFGIVLWEILTG 1017 (1094)
Q Consensus 991 L~g~~~kyS~KSDVWSLGVLLyELLTG 1017 (1094)
+. ... -..|.|.|||++|+++.|
T Consensus 177 ~~--~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 177 ID--PSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cC--ccc--cchhhhhHHHHHHHHhCc
Confidence 54 122 346999999999999998
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.85 E-value=2e-08 Score=103.11 Aligned_cols=143 Identities=23% Similarity=0.249 Sum_probs=101.7
Q ss_pred EEecccCceEEEEeeecC-ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCC--CceeEEEeEeecCC-CCceE
Q 037285 816 KELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHH--PNVVAFYGVVQDGP-GGTLA 891 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~rG-t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~H--PNIVqL~Gv~~d~~-~~~L~ 891 (1094)
+.|+.|.++.||++...+ ..+++|+....... .....+.+|+.+++.+.+ ..+.+++.+..... .+..+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-------~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~ 76 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-------PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPF 76 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-------cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCce
Confidence 568999999999998765 78999987653211 012456788999999875 34566777665421 12568
Q ss_pred EEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 037285 892 TVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHS------------------------------------- 934 (1094)
Q Consensus 892 IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs------------------------------------- 934 (1094)
+||||+++.++...+.. ..++......++.+++++|..||+
T Consensus 77 ~v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (223)
T cd05154 77 YVMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEP 154 (223)
T ss_pred EEEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccccc
Confidence 99999999988765532 235666666677777777777763
Q ss_pred -------------------CCceeccCCCCceEeccCCCCCCcEEEEecCCccc
Q 037285 935 -------------------KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI 969 (1094)
Q Consensus 935 -------------------~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl 969 (1094)
..++|+|+++.||+++.. ..+.+.|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~--~~~~~~iID~e~~~~ 206 (223)
T cd05154 155 PAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD--EPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCC--CCcEEEEEecccccc
Confidence 236999999999999821 145789999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >smart00666 PB1 PB1 domain | Back alignment and domain information |
|---|
Probab=98.75 E-value=4.7e-08 Score=88.42 Aligned_cols=75 Identities=48% Similarity=0.817 Sum_probs=65.2
Q ss_pred CCceeecCceEEEEecCCCChHHHHHHHHHHcCC---ceEEEEeCCCCCCCceeeccChhhHHHHHHHHhhcCCCCCCCe
Q 037285 103 GKLRYVGGETRIIRIRKDISWQILRQKALEVYNQ---VHVIKYQLPGEDLDALVSVSCDEDLQNMMEEYNELGDREGSQR 179 (1094)
Q Consensus 103 ~~l~YvGG~triv~v~r~~~~~~l~~kl~~~~~~---~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~r 179 (1094)
.+++| ||++|.+.|+++++|.+|+.++...++. .+.|||+ .||-| +|++++|+||..|++.+.+.. ...
T Consensus 4 vK~~~-~~~~~~~~~~~~~s~~dL~~~i~~~~~~~~~~~~l~Y~--Dedgd-~v~l~sd~Dl~~a~~~~~~~~----~~~ 75 (81)
T smart00666 4 VKLRY-GGETRRLSVPRDISFEDLRSKVAKRFGLDNQSFTLKYQ--DEDGD-LVSLTSDEDLEEAIEEYDSLG----SKK 75 (81)
T ss_pred EEEEE-CCEEEEEEECCCCCHHHHHHHHHHHhCCCCCCeEEEEE--CCCCC-EEEecCHHHHHHHHHHHHHcC----Cce
Confidence 35677 8999999999999999999999999985 6889999 67766 999999999999999996642 457
Q ss_pred EEEEEe
Q 037285 180 IRMFLF 185 (1094)
Q Consensus 180 ~R~FlF 185 (1094)
+|+++|
T Consensus 76 l~l~v~ 81 (81)
T smart00666 76 LRLHVF 81 (81)
T ss_pred EEEEeC
Confidence 888886
|
Phox and Bem1p domain, present in many eukaryotic cytoplasmic signalling proteins. The domain adopts a beta-grasp fold, similar to that found in ubiquitin and Ras-binding domains. A motif, variously termed OPR, PC and AID, represents the most conserved region of the majority of PB1 domains, and is necessary for PB1 domain function. This function is the formation of PB1 domain heterodimers, although not all PB1 domain pairs associate. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.67 E-value=4.8e-07 Score=99.94 Aligned_cols=143 Identities=15% Similarity=0.074 Sum_probs=95.0
Q ss_pred EEEeeecCceEEEEEeecCccCCC-chh--HHHHHHHHHHHHHHHhhCCCCc--eeEEEeEeecCC---CCceEEEeeec
Q 037285 826 VYHGKWRGTDVAIKRIKKSCFTGR-SSE--QERLTVEFWKEAEILSKLHHPN--VVAFYGVVQDGP---GGTLATVAEYM 897 (1094)
Q Consensus 826 VYKAk~rGt~VAVKiIkk~~~se~-~~e--qe~~~~eFlrEIkILkrL~HPN--IVqL~Gv~~d~~---~~~L~IVmEYm 897 (1094)
|++..+.|+.+.||......+... ... ...-...+.+|...+.+|..-+ .+..+++..... ...-++|||++
T Consensus 38 vvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l 117 (268)
T PRK15123 38 TLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDL 117 (268)
T ss_pred EEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeC
Confidence 556777788899997754321100 000 0000113678888887774322 223333333211 12467999999
Q ss_pred ccc-hhHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccC---CCCCCcEEEEecCCcc
Q 037285 898 VDG-SLRHVLVRK-DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLK---DPSRPICKVGDFGLSK 968 (1094)
Q Consensus 898 egG-SL~d~L~k~-~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~---~~e~g~VKLsDFGLSr 968 (1094)
++. +|.+++... ....+...+..++.+++..+.-||..||+|+||++.|||++.+ +.+...+.|+||+.++
T Consensus 118 ~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 118 APTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred CCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 886 788887532 2335566777899999999999999999999999999999831 1245789999999875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.62 E-value=3.4e-07 Score=96.41 Aligned_cols=132 Identities=26% Similarity=0.181 Sum_probs=82.1
Q ss_pred EEEEeee-cCceEEEEEeecCccC-----------CC-------chhHHHHHHHHHHHHHHHhhCCCC--ceeEEEeEee
Q 037285 825 TVYHGKW-RGTDVAIKRIKKSCFT-----------GR-------SSEQERLTVEFWKEAEILSKLHHP--NVVAFYGVVQ 883 (1094)
Q Consensus 825 tVYKAk~-rGt~VAVKiIkk~~~s-----------e~-------~~eqe~~~~eFlrEIkILkrL~HP--NIVqL~Gv~~ 883 (1094)
.||.|.. .|..+|||+.+..... .+ ............+|.+.|.++..- ++.+++.+-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3888876 5788999998764211 00 011122334566899999999765 466676543
Q ss_pred cCCCCceEEEeeecc--cchhHHHHhhcccccCHHHHHHHHHHHHHHHHH-HHHCCceeccCCCCceEeccCCCCCCcEE
Q 037285 884 DGPGGTLATVAEYMV--DGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEY-LHSKNIVHFDLKCDNLLVNLKDPSRPICK 960 (1094)
Q Consensus 884 d~~~~~L~IVmEYme--gGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaY-LHs~GIIHRDLKPeNILLD~~~~e~g~VK 960 (1094)
.-+|||||++ |..+..+.... ++......++.+++..+.. +|+.||+|+||.+.|||++ ++ .+.
T Consensus 80 -----~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~----~~-~~~ 146 (188)
T PF01163_consen 80 -----RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD----DG-KVY 146 (188)
T ss_dssp -----TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE----TT-CEE
T ss_pred -----CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee----cc-eEE
Confidence 3468999998 65665443322 1233456677788885555 5899999999999999998 33 899
Q ss_pred EEecCCcccc
Q 037285 961 VGDFGLSKIK 970 (1094)
Q Consensus 961 LsDFGLSrl~ 970 (1094)
|+|||.+...
T Consensus 147 iIDf~qav~~ 156 (188)
T PF01163_consen 147 IIDFGQAVDS 156 (188)
T ss_dssp E--GTTEEET
T ss_pred EEecCcceec
Confidence 9999988643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.1e-06 Score=101.33 Aligned_cols=253 Identities=19% Similarity=0.225 Sum_probs=161.3
Q ss_pred eEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEe----ecC-C
Q 037285 813 EEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVV----QDG-P 886 (1094)
Q Consensus 813 ei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~----~d~-~ 886 (1094)
...+.||+|+-+.+|-.-.-+..|| |++....... +. +.+..|.+. .||-+-.-+.|= .-. .
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d~VA-KIYh~Pppa~----~a-------qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~ 81 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRDQVA-KIYHAPPPAA----QA-------QKVAELAATPDAPLLNYRVAWPQATLHGGRR 81 (637)
T ss_pred CCCccccCCccceeeecchhhchhh-eeecCCCchH----HH-------HHHHHhccCCCCcchhhhhcccHHHhhCCCc
Confidence 3457899999999996432233344 7776543211 11 111222222 455433212211 111 1
Q ss_pred CCceEEEeeecccchhHHHHh------hcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEE
Q 037285 887 GGTLATVAEYMVDGSLRHVLV------RKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICK 960 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~------k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VK 960 (1094)
...+.++|..+.+..--..+- +......|..+++.++.++.+.+.||..|.+-+|+.++|+|++ +...|.
T Consensus 82 ~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVs----d~~~V~ 157 (637)
T COG4248 82 GKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVS----DDSKVV 157 (637)
T ss_pred cceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeee----cCceEE
Confidence 123667777776653222221 1224578999999999999999999999999999999999998 778899
Q ss_pred EEecCCcccccCccccCCccCCCcccCccccc-cC--CCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHH----HHH-
Q 037285 961 VGDFGLSKIKRNTLVSGGVRGTLPWMAPELLS-GS--SSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGA----IIG- 1031 (1094)
Q Consensus 961 LsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~-g~--~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~e----ile- 1031 (1094)
|+|-..-..-......-+.+|...|++||... +. ...-+...|.|.||+++++++. |+.||.+..... -.+
T Consensus 158 LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~ 237 (637)
T COG4248 158 LVDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET 237 (637)
T ss_pred EEcccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence 98865433334444455667899999999865 11 1223567899999999999998 599998643210 001
Q ss_pred hHh----------hccCCCC---CC-CcCcHHHHHHHHHhccC--CCCCCCCHHHHHHHHHHHHHH
Q 037285 1032 GIV----------NNTLRPT---IP-SYCDAEWRTLMEECWAP--NPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1032 ~Iv----------~~~lrp~---iP-e~~S~eL~dLI~kCLq~--DPeeRPS~eELLq~L~~L~ta 1081 (1094)
.|. ..++++. .| ..+++.+..|..+|+.. ++.-|||++..+..|..+.++
T Consensus 238 ~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 238 DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 110 1111111 11 34678899999999965 356899999999999888755
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.54 E-value=2.2e-06 Score=100.88 Aligned_cols=213 Identities=18% Similarity=0.174 Sum_probs=148.1
Q ss_pred eEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC--CCceEEEeeeccc
Q 037285 824 GTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP--GGTLATVAEYMVD 899 (1094)
Q Consensus 824 GtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~--~~~L~IVmEYmeg 899 (1094)
.+.|++.. +|..+++|++....... ......-+++++++.|+|||++..+|.... +..+++|++|.++
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~--------~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~ 361 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQS--------TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPS 361 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccC--------cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCC
Confidence 46788765 47889999983221111 011223467899999999999999887322 2368899999875
Q ss_pred -chhHHHHhhc--------------ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 900 -GSLRHVLVRK--------------DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 900 -GSL~d~L~k~--------------~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
++|.++.... +...++..+|.++.|+..||.++|+.|+..+=|.+.+||++ .+..++|+..
T Consensus 362 s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~----G~~RIriS~C 437 (655)
T KOG3741|consen 362 SPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVT----GKMRIRISGC 437 (655)
T ss_pred CchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEee----CcceEEEecc
Confidence 4676654221 23467899999999999999999999999999999999998 5668999888
Q ss_pred CCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCC-CCCCChHHHHHhHhhccCCCCCC
Q 037285 965 GLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEP-YANMHYGAIIGGIVNNTLRPTIP 1043 (1094)
Q Consensus 965 GLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~P-F~~~~~~eile~Iv~~~lrp~iP 1043 (1094)
|......... . |.+.+ -.+-|.-.||.+++.|.||..- +......+.... .+.
T Consensus 438 ~i~Dvl~~d~-----------~--~~le~-----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~--------~I~ 491 (655)
T KOG3741|consen 438 GIMDVLQEDP-----------T--EPLES-----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLT--------RIT 491 (655)
T ss_pred cceeeecCCC-----------C--cchhH-----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHH--------Hhh
Confidence 8765433221 0 11221 1367999999999999998653 222222221011 123
Q ss_pred CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037285 1044 SYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1044 e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L 1075 (1094)
..++.+++++|.-+...++++ -++.+++.++
T Consensus 492 ~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 492 TTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred hhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 467888999999999998886 5677777654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.53 E-value=5.6e-07 Score=94.93 Aligned_cols=110 Identities=21% Similarity=0.167 Sum_probs=81.7
Q ss_pred HHHHHHHHHHhhCCCC--ceeEEEeEeecCCC--CceEEEeeecccc-hhHHHHhhcccccCHHHHHHHHHHHHHHHHHH
Q 037285 858 VEFWKEAEILSKLHHP--NVVAFYGVVQDGPG--GTLATVAEYMVDG-SLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYL 932 (1094)
Q Consensus 858 ~eFlrEIkILkrL~HP--NIVqL~Gv~~d~~~--~~L~IVmEYmegG-SL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYL 932 (1094)
..+.+|...+.+|..- .++..+++...... ...++|+|++++. +|.+++..... ++......++.+++..++-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 3566777777776422 23455555544221 2457899999875 78888876433 56677888999999999999
Q ss_pred HHCCceeccCCCCceEeccCCCCCCcEEEEecCCccc
Q 037285 933 HSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI 969 (1094)
Q Consensus 933 Hs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl 969 (1094)
|.+||+|+|+++.|||++.++ ....+.|+||+.++.
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~-~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDD-GQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCC-CceeEEEEcchhcee
Confidence 999999999999999998433 345899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.29 E-value=3.5e-07 Score=110.23 Aligned_cols=143 Identities=21% Similarity=0.279 Sum_probs=103.3
Q ss_pred HHHHHHHHHHHC-CceeccCCCCceEeccCCCCCCcEEEEecCCcccccCcc----------ccCCccCCCcccCccccc
Q 037285 924 DAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTL----------VSGGVRGTLPWMAPELLS 992 (1094)
Q Consensus 924 QIaeGLaYLHs~-GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~~----------~ss~~~GT~~YmAPEvL~ 992 (1094)
+++.||.|+|.. ++||+.|.|++|.++ .++..||+.|+++....... ......-...|.|||++.
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~n----a~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVN----ANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred cccchhhhhccCcceeecccchhheeec----cCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 455999999965 799999999999999 88899999999876332211 111122356799999998
Q ss_pred cCCCCCCchhhHHHHHHHHHHHH-cCCCCCCCCChHHHHHhHh--hccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHH
Q 037285 993 GSSSKVSEKVDVFSFGIVLWEIL-TGEEPYANMHYGAIIGGIV--NNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFT 1069 (1094)
Q Consensus 993 g~~~kyS~KSDVWSLGVLLyELL-TGk~PF~~~~~~eile~Iv--~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~e 1069 (1094)
+ ...+.++|+|||||++|.++ .|+.-+............. .+...-.....++.++++=|.+++..+...||++.
T Consensus 183 ~--~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~ 260 (700)
T KOG2137|consen 183 G--TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLD 260 (700)
T ss_pred c--ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchh
Confidence 4 56778999999999999999 4666555443322221111 11111223467889999999999999999999777
Q ss_pred HHH
Q 037285 1070 EIA 1072 (1094)
Q Consensus 1070 ELL 1072 (1094)
.+.
T Consensus 261 ~l~ 263 (700)
T KOG2137|consen 261 LLL 263 (700)
T ss_pred hhh
Confidence 654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.9e-05 Score=85.01 Aligned_cols=147 Identities=15% Similarity=0.099 Sum_probs=100.2
Q ss_pred ecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCc--eeEEE--eEeecCCCCceEEE
Q 037285 818 LGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPN--VVAFY--GVVQDGPGGTLATV 893 (1094)
Q Consensus 818 LGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPN--IVqL~--Gv~~d~~~~~L~IV 893 (1094)
-|+|+.+-|+.....|..+-+|.-.......... ..-...|.+|+..|.+|..-+ +.+.. +.-.......-+||
T Consensus 26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~--P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRY--PFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeCCcEEEEEeccCcccccccC--CCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence 3678888899888777777788654221111000 001257889999998885322 33433 22222222346789
Q ss_pred eeeccc-chhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 894 AEYMVD-GSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 894 mEYmeg-GSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
+|-+.+ -+|.+++.... ...+......++.+|+..++-||+.|+.|+|+.+.|||++..+ ...++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g--~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG--KAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC--CeeEEEEEhhccc
Confidence 997754 47888875532 2457777889999999999999999999999999999998322 3459999999776
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.18 E-value=9.5e-06 Score=90.00 Aligned_cols=140 Identities=23% Similarity=0.088 Sum_probs=101.6
Q ss_pred eEEEEecccCceEEEEeeec-CceEEEEEeecCccCC--------------CchhHHHHHHHHHHHHHHHhhCCCC--ce
Q 037285 813 EEQKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTG--------------RSSEQERLTVEFWKEAEILSKLHHP--NV 875 (1094)
Q Consensus 813 ei~kkLGsG~FGtVYKAk~r-Gt~VAVKiIkk~~~se--------------~~~eqe~~~~eFlrEIkILkrL~HP--NI 875 (1094)
.++..||-|--+.||.|... |.++|||.-+....+- ..+...-......+|..+|.+|.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 35678999999999999884 8999999766442110 0111122234566899999999755 66
Q ss_pred eEEEeEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCC
Q 037285 876 VAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPS 955 (1094)
Q Consensus 876 VqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e 955 (1094)
.+.+++- .-.+||||++|-.|...- ++.+..-.++..|++-+.-+-..||||+|+.+=|||++ +
T Consensus 174 P~P~~~n------RHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~----~ 237 (304)
T COG0478 174 PKPIAWN------RHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVT----E 237 (304)
T ss_pred CCccccc------cceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEe----c
Confidence 6666542 567899999887775432 23344555666777777777799999999999999999 7
Q ss_pred CCcEEEEecCCcc
Q 037285 956 RPICKVGDFGLSK 968 (1094)
Q Consensus 956 ~g~VKLsDFGLSr 968 (1094)
++.+.++||-.+.
T Consensus 238 dg~~~vIDwPQ~v 250 (304)
T COG0478 238 DGDIVVIDWPQAV 250 (304)
T ss_pred CCCEEEEeCcccc
Confidence 8899999998765
|
|
| >PF00564 PB1: PB1 domain; InterPro: IPR000270 The Phox and Bem1p domain, is present in many eukaryotic cytoplasmic signalling proteins | Back alignment and domain information |
|---|
Probab=98.17 E-value=7.4e-06 Score=74.30 Aligned_cols=72 Identities=40% Similarity=0.610 Sum_probs=58.5
Q ss_pred eecCceEEEEecCCCChHHHHHHHHHHcCC---ceEEEEeCCCCCCCceeeccChhhHHHHHHHHhhcCCCCCCCeEEEE
Q 037285 107 YVGGETRIIRIRKDISWQILRQKALEVYNQ---VHVIKYQLPGEDLDALVSVSCDEDLQNMMEEYNELGDREGSQRIRMF 183 (1094)
Q Consensus 107 YvGG~triv~v~r~~~~~~l~~kl~~~~~~---~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~r~R~F 183 (1094)
|.|+..|++.+++.++|.+|+.++++.++. .+.|+|+ .+|- .+|++++|+||..|++.+.+. +..++|||
T Consensus 8 ~~~~~~~~~~~~~~~s~~~L~~~i~~~~~~~~~~~~l~Y~--D~dg-D~V~i~sd~Dl~~a~~~~~~~----~~~~lrl~ 80 (84)
T PF00564_consen 8 YGGDIRRIISLPSDVSFDDLRSKIREKFGLLDEDFQLKYK--DEDG-DLVTISSDEDLQEAIEQAKES----GSKTLRLF 80 (84)
T ss_dssp ETTEEEEEEEECSTSHHHHHHHHHHHHHTTSTSSEEEEEE--ETTS-SEEEESSHHHHHHHHHHHHHC----TTSCEEEE
T ss_pred ECCeeEEEEEcCCCCCHHHHHHHHHHHhCCCCccEEEEee--CCCC-CEEEeCCHHHHHHHHHHHHhc----CCCcEEEE
Confidence 333344459999999999999999999885 6778887 3333 799999999999999999875 34589999
Q ss_pred Ee
Q 037285 184 LF 185 (1094)
Q Consensus 184 lF 185 (1094)
+.
T Consensus 81 v~ 82 (84)
T PF00564_consen 81 VQ 82 (84)
T ss_dssp EE
T ss_pred EE
Confidence 86
|
The domain adopts a beta-grasp fold, similar to that found in ubiquitin and Ras-binding domains. A motif, variously termed OPR, PC and AID, represents the most conserved region of the majority of PB1 domains, and is necessary for PB1 domain function. This function is the formation of PB1 domain heterodimers, although not all PB1 domain pairs associate.; GO: 0005515 protein binding; PDB: 1IPG_A 1IP9_A 2KFK_A 1WMH_A 1VD2_A 1WI0_A 1OEY_C 1PQS_A 1Q1O_A 1TZ1_A .... |
| >cd05992 PB1 The PB1 domain is a modular domain mediating specific protein-protein interactions which play a role in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity | Back alignment and domain information |
|---|
Probab=98.07 E-value=2e-05 Score=71.04 Aligned_cols=73 Identities=38% Similarity=0.653 Sum_probs=57.0
Q ss_pred ceeecCceEEEEec-CCCChHHHHHHHHHHcCC---ceEEEEeCCCCCCCceeeccChhhHHHHHHHHhhcCCCCCCCeE
Q 037285 105 LRYVGGETRIIRIR-KDISWQILRQKALEVYNQ---VHVIKYQLPGEDLDALVSVSCDEDLQNMMEEYNELGDREGSQRI 180 (1094)
Q Consensus 105 l~YvGG~triv~v~-r~~~~~~l~~kl~~~~~~---~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~r~ 180 (1094)
++|- |++|.+.|+ ++++|.+|+.++.+.++. .+.|||. .||- .+|++++|+||..|+..+.+ ....++
T Consensus 5 ~~~~-~~~~~~~~~~~~~s~~~L~~~i~~~~~~~~~~~~l~y~--D~e~-d~v~l~sd~Dl~~a~~~~~~----~~~~~l 76 (81)
T cd05992 5 VKYG-GEIRRFVVVSRSISFEDLRSKIAEKFGLDAVSFKLKYP--DEDG-DLVTISSDEDLEEAIEEARR----SGSKKL 76 (81)
T ss_pred EEec-CCCEEEEEecCCCCHHHHHHHHHHHhCCCCCcEEEEee--CCCC-CEEEeCCHHHHHHHHHHHhh----cCCccE
Confidence 3444 566677777 999999999999999985 4556665 4444 78999999999999999965 345688
Q ss_pred EEEEe
Q 037285 181 RMFLF 185 (1094)
Q Consensus 181 R~FlF 185 (1094)
|+|++
T Consensus 77 ~l~v~ 81 (81)
T cd05992 77 RLFVF 81 (81)
T ss_pred EEEeC
Confidence 88875
|
A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as a noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, fungi, animals, and plants. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.97 E-value=6.9e-05 Score=80.35 Aligned_cols=135 Identities=24% Similarity=0.221 Sum_probs=95.8
Q ss_pred CCeeEEEEecccCc-eEEEEeeecCceEEEEEeecCccCCCch------h-------HHHHHHHHHHHHHHHhhCC---C
Q 037285 810 EDLEEQKELGSGTF-GTVYHGKWRGTDVAIKRIKKSCFTGRSS------E-------QERLTVEFWKEAEILSKLH---H 872 (1094)
Q Consensus 810 edYei~kkLGsG~F-GtVYKAk~rGt~VAVKiIkk~~~se~~~------e-------qe~~~~eFlrEIkILkrL~---H 872 (1094)
.+++.++.||.|.- |.||+++..|..+|+|+++.-.+..... . ......-|..|.+...+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 68999999999999 9999999999999999944321111110 0 0133456888998888775 5
Q ss_pred Cce--eEEEeEeecC----------------CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH
Q 037285 873 PNV--VAFYGVVQDG----------------PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHS 934 (1094)
Q Consensus 873 PNI--VqL~Gv~~d~----------------~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs 934 (1094)
.++ |+++||+.-. ....+.||.||..... .+.. .-+.+|.+-|..+|.
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~----~~~~~~~~dl~~~~k 182 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQI----RDIPQMLRDLKILHK 182 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccch----hHHHHHHHHHHHHHH
Confidence 566 9999997421 0113467888775443 1222 234567778889999
Q ss_pred CCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 935 KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 935 ~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.||+-+|+++.|..=. ||+|||.+
T Consensus 183 ~gI~~~Dv~~~ny~~G---------~lvDfs~~ 206 (207)
T PF13095_consen 183 LGIVPRDVKPRNYRGG---------KLVDFSSS 206 (207)
T ss_pred CCeeeccCccccccCC---------EEEecccC
Confidence 9999999999999733 99999964
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00011 Score=79.82 Aligned_cols=144 Identities=16% Similarity=0.133 Sum_probs=96.4
Q ss_pred eeccCCeeEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHH------HHHHHHhhCC---CCcee
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFW------KEAEILSKLH---HPNVV 876 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFl------rEIkILkrL~---HPNIV 876 (1094)
.+...+|.+.+.+-......|.+-...|..+.+|..+... ...++....|. +.+..+.++. .-.+.
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~-----~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~ 101 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREEN-----RRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPA 101 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhh-----hhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccc
Confidence 3556789999999988888899888889999999887642 22333333332 2333333332 22333
Q ss_pred EEEeEeecCC---CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCC
Q 037285 877 AFYGVVQDGP---GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKD 953 (1094)
Q Consensus 877 qL~Gv~~d~~---~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~ 953 (1094)
.++.+..... ....+++|||++|..|.+... +++ .++..|.++|.-||+.|+.|+|+.|.|++++
T Consensus 102 ~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~--- 169 (229)
T PF06176_consen 102 DPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS--- 169 (229)
T ss_pred cceeeeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE---
Confidence 3333322111 114568999999998876542 222 2445677889999999999999999999997
Q ss_pred CCCCcEEEEecCCcc
Q 037285 954 PSRPICKVGDFGLSK 968 (1094)
Q Consensus 954 ~e~g~VKLsDFGLSr 968 (1094)
++.++++||+..+
T Consensus 170 --~~~i~iID~~~k~ 182 (229)
T PF06176_consen 170 --NNGIRIIDTQGKR 182 (229)
T ss_pred --CCcEEEEECcccc
Confidence 3459999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00018 Score=73.97 Aligned_cols=80 Identities=18% Similarity=0.177 Sum_probs=55.2
Q ss_pred EEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCC--ceeEEEeEeecC-CCCceE
Q 037285 815 QKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP--NVVAFYGVVQDG-PGGTLA 891 (1094)
Q Consensus 815 ~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HP--NIVqL~Gv~~d~-~~~~L~ 891 (1094)
++.|+.|..+.||+....+..+++|..... .....+.+|..+++.|... .+.+++...... .....+
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~ 71 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPY 71 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH----------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC----------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccce
Confidence 467999999999999887788999986532 2234566788888777532 355666644322 223578
Q ss_pred EEeeecccchhHH
Q 037285 892 TVAEYMVDGSLRH 904 (1094)
Q Consensus 892 IVmEYmegGSL~d 904 (1094)
++|+++++..+..
T Consensus 72 ~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 72 LLMEYIPGRPLDD 84 (239)
T ss_dssp EEEEEESSEEHHH
T ss_pred EEEEEeccccccc
Confidence 9999999887776
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00021 Score=76.95 Aligned_cols=72 Identities=18% Similarity=0.222 Sum_probs=49.7
Q ss_pred EEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCc--eeEEEeEeecCCCCceEEE
Q 037285 816 KELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPN--VVAFYGVVQDGPGGTLATV 893 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPN--IVqL~Gv~~d~~~~~L~IV 893 (1094)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++..... ...+|
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~----------~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~--~~glv 72 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF----------DKETIKREFDASRKVFSLGIPTPHPFDLVEDGG--RLGLI 72 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC----------CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCC--eeeee
Confidence 56899999999984 35567888875421 0123467888888875433 456677766543 67889
Q ss_pred eeecccch
Q 037285 894 AEYMVDGS 901 (1094)
Q Consensus 894 mEYmegGS 901 (1094)
||++.|.+
T Consensus 73 ~e~i~G~~ 80 (226)
T TIGR02172 73 YELIVGKR 80 (226)
T ss_pred eeecCCcc
Confidence 99998863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00011 Score=88.14 Aligned_cols=147 Identities=19% Similarity=0.232 Sum_probs=93.5
Q ss_pred EEecccCceEEEEeeec-CceEEEEEeecCccC---------------------C-CchhHHHH----------HHHHHH
Q 037285 816 KELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFT---------------------G-RSSEQERL----------TVEFWK 862 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~r-Gt~VAVKiIkk~~~s---------------------e-~~~eqe~~----------~~eFlr 862 (1094)
+-|+.++-|.||+|++. |+.||||+.++.... . +.-..... .-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 46899999999999997 899999999875310 0 00000111 123344
Q ss_pred HHHHHhhCC-----CCceeEEEeEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCc
Q 037285 863 EAEILSKLH-----HPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNI 937 (1094)
Q Consensus 863 EIkILkrL~-----HPNIVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GI 937 (1094)
|...+.+++ .++ +.+=.++.+- .+.-.++|||+.|..+.+....+....+...+.....++. +.-+-..|+
T Consensus 211 EA~n~~~~~~nf~~~~~-v~VP~V~we~-t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgf 286 (517)
T COG0661 211 EAANAERFRENFKDDPD-VYVPKVYWEY-TTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHcCCCCC-eEeceeehhc-cCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCc
Confidence 555555552 233 2222333221 1256789999999999888543334456444433332222 333445899
Q ss_pred eeccCCCCceEeccCCCCCCcEEEEecCCcccc
Q 037285 938 VHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK 970 (1094)
Q Consensus 938 IHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~ 970 (1094)
.|.|..|-||++. .++.+.+.|||+....
T Consensus 287 fHaDpHpGNi~v~----~~g~i~~lDfGi~g~l 315 (517)
T COG0661 287 FHADPHPGNILVR----SDGRIVLLDFGIVGRL 315 (517)
T ss_pred cccCCCccceEEe----cCCcEEEEcCcceecC
Confidence 9999999999999 7789999999998643
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00012 Score=93.10 Aligned_cols=241 Identities=20% Similarity=0.168 Sum_probs=155.4
Q ss_pred ecccCceEEEEeeecC------ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC--c
Q 037285 818 LGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG--T 889 (1094)
Q Consensus 818 LGsG~FGtVYKAk~rG------t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~--~ 889 (1094)
|..-.+|+++..+|.- .++-++.- .+. .....+.+.....|+..+.++.|+|++.++.|-.+.... .
T Consensus 186 ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~---~~~--~~~~k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~ 260 (1351)
T KOG1035|consen 186 LSHLTQGTLLLVKWVEQAQSLSEPIEISHD---YES--TPCGKKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIV 260 (1351)
T ss_pred eccccCceEEEEehhhhHHhhcCcccccCc---ccC--ccchHHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHH
Confidence 6667788888887731 11222110 011 011122233334577788899999999999987654322 2
Q ss_pred eEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE--ecCCc
Q 037285 890 LATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG--DFGLS 967 (1094)
Q Consensus 890 L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs--DFGLS 967 (1094)
+.+..+++..-++...+..-. .++...+..+..++.+||.|+|+....|.-|...-..-.. ....+.+.++ ||+.+
T Consensus 261 ~~v~~~~~s~~~~~~~~q~v~-~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~-~~~e~~~~~sl~~~~ss 338 (1351)
T KOG1035|consen 261 LDVLQEICSKVELRSLLQSVG-SIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKEST-VDGEGVVAISLSDFDSS 338 (1351)
T ss_pred HHHHHhhcCccchHHHHhhcc-ccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccc-cCccceeecchhhhccc
Confidence 334557777777777775544 4788899999999999999999996666655555222211 1145566766 99888
Q ss_pred ccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCc
Q 037285 968 KIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCD 1047 (1094)
Q Consensus 968 rl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S 1047 (1094)
+............-+..|.|+|.......+.+...|+|++|.++..+..|..+-... ..... .++..+.
T Consensus 339 ~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~---~~~~~--------~l~~~~~ 407 (1351)
T KOG1035|consen 339 KPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKS---AVPVS--------LLDVLST 407 (1351)
T ss_pred ccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccc---cchhh--------hhccccc
Confidence 755544433334456678889988754555556689999999999998865542111 11111 1122222
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1048 AEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1048 ~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
....+...+|+..++++|+++.+++.+.-
T Consensus 408 ~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f 436 (1351)
T KOG1035|consen 408 SELLDALPKCLDEDSEERLSALELLTHPF 436 (1351)
T ss_pred hhhhhhhhhhcchhhhhccchhhhhhchh
Confidence 36788999999999999999999987754
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00035 Score=77.12 Aligned_cols=144 Identities=22% Similarity=0.115 Sum_probs=94.4
Q ss_pred EEEecccCceEEEEeee-cCceEEEEEeecCccCCCc---------------hhHHHHHH-HHHHHHHHHhhCC--CCce
Q 037285 815 QKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRS---------------SEQERLTV-EFWKEAEILSKLH--HPNV 875 (1094)
Q Consensus 815 ~kkLGsG~FGtVYKAk~-rGt~VAVKiIkk~~~se~~---------------~eqe~~~~-eFlrEIkILkrL~--HPNI 875 (1094)
...|.+|--+.||+|.. .+..+|||+++.....-.. ......+. -..+|..-|+++. +-.+
T Consensus 53 ~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 53 VGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred EeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 34788899999999875 4788999999865321111 11111111 1235777777774 3444
Q ss_pred eEEEeEeecCCCCceEEEeeecccchh-HHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeccCC
Q 037285 876 VAFYGVVQDGPGGTLATVAEYMVDGSL-RHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKD 953 (1094)
Q Consensus 876 VqL~Gv~~d~~~~~L~IVmEYmegGSL-~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs-~GIIHRDLKPeNILLD~~~ 953 (1094)
.+-+++. .-.+||||+....+ .-.|. .-.+....+..+..++++.|.-|-. .++||+||+.=|||+.
T Consensus 133 P~Pi~~~------~nVLvMEfIg~~g~pAP~Lk--Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~--- 201 (268)
T COG1718 133 PEPIAFR------NNVLVMEFIGDDGLPAPRLK--DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH--- 201 (268)
T ss_pred CCceeec------CCeEEEEeccCCCCCCCCcc--cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE---
Confidence 4555443 34679999965411 11111 1123444677778889999998877 8999999999999997
Q ss_pred CCCCcEEEEecCCccccc
Q 037285 954 PSRPICKVGDFGLSKIKR 971 (1094)
Q Consensus 954 ~e~g~VKLsDFGLSrl~~ 971 (1094)
.+.+.|+||+.|....
T Consensus 202 --~~~p~iID~~QaV~~~ 217 (268)
T COG1718 202 --DGEPYIIDVSQAVTID 217 (268)
T ss_pred --CCeEEEEECccccccC
Confidence 5679999999987544
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00022 Score=75.36 Aligned_cols=130 Identities=29% Similarity=0.345 Sum_probs=93.2
Q ss_pred CeeEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCcee-EEEeEeecCCCCc
Q 037285 811 DLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVV-AFYGVVQDGPGGT 889 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIV-qL~Gv~~d~~~~~ 889 (1094)
..+..+.|++|++|.||+|.|+|..+|+|+-+.... ...+..|+++|..+...++. ++|.+-.
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~----------r~~l~kEakiLeil~g~~~~p~vy~yg~------ 86 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP----------RRNLEKEAKILEILAGEGVTPEVYFYGE------ 86 (201)
T ss_pred hhhhhhhhhcccccEEEEeeccCceEEEEEecCCcc----------hhhHHHHHHHHHHhhhcCCCceEEEech------
Confidence 345568899999999999999999999998765421 24677899999999876665 4444432
Q ss_pred eEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCC--CceEeccCCCCCCcEEEEecCCc
Q 037285 890 LATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKC--DNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 890 L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKP--eNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.++.|||+.|-.|.++.... +..++ ..+++.---|-..||-|+.|.- .||++. ...+.|+||.-|
T Consensus 87 ~~i~me~i~G~~L~~~~~~~----~rk~l----~~vlE~a~~LD~~GI~H~El~~~~k~vlv~-----~~~~~iIDFd~A 153 (201)
T COG2112 87 DFIRMEYIDGRPLGKLEIGG----DRKHL----LRVLEKAYKLDRLGIEHGELSRPWKNVLVN-----DRDVYIIDFDSA 153 (201)
T ss_pred hhhhhhhhcCcchhhhhhcc----cHHHH----HHHHHHHHHHHHhccchhhhcCCceeEEec-----CCcEEEEEccch
Confidence 34569999998988766432 22233 3445554556778999999863 456654 448999999988
Q ss_pred cc
Q 037285 968 KI 969 (1094)
Q Consensus 968 rl 969 (1094)
+.
T Consensus 154 t~ 155 (201)
T COG2112 154 TF 155 (201)
T ss_pred hh
Confidence 74
|
|
| >cd06407 PB1_NLP A PB1 domain is present in NIN like proteins (NLP), a key enzyme in a process of establishment of symbiosis betweeen legumes and nitrogen fixing bacteria (Rhizobium) | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00036 Score=64.84 Aligned_cols=71 Identities=25% Similarity=0.523 Sum_probs=60.5
Q ss_pred ecCceEEEEecCCCChHHHHHHHHHHcC----CceEEEEeCCCCCCCceeeccChhhHHHHHHHHhhcCCCCCCCeEEEE
Q 037285 108 VGGETRIIRIRKDISWQILRQKALEVYN----QVHVIKYQLPGEDLDALVSVSCDEDLQNMMEEYNELGDREGSQRIRMF 183 (1094)
Q Consensus 108 vGG~triv~v~r~~~~~~l~~kl~~~~~----~~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~r~R~F 183 (1094)
.||+++.+.++.+++|.+|+.++++.++ ..+.|||. .+| .-.|+++||+||+.-++-|.. ....++|+|
T Consensus 7 ~~~d~~r~~l~~~~~~~~L~~~i~~r~~~~~~~~f~LkY~--Dde-gd~v~ltsd~DL~eai~i~~~----~~~~~v~l~ 79 (82)
T cd06407 7 YGEEKIRFRLPPSWGFTELKQEIAKRFKLDDMSAFDLKYL--DDD-EEWVLLTCDADLEECIDVYRS----SGSHTIRLL 79 (82)
T ss_pred eCCeEEEEEcCCCCCHHHHHHHHHHHhCCCCCCeeEEEEE--CCC-CCeEEeecHHHHHHHHHHHHH----CCCCeEEEE
Confidence 3889999999999999999999999886 36889998 334 889999999999988887754 356689999
Q ss_pred Ee
Q 037285 184 LF 185 (1094)
Q Consensus 184 lF 185 (1094)
+.
T Consensus 80 v~ 81 (82)
T cd06407 80 VH 81 (82)
T ss_pred ee
Confidence 74
|
The PB1 domain is a modular domain mediating specific protein-protein interaction which play a role in many critical cell processes like osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-inte |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0017 Score=69.38 Aligned_cols=143 Identities=20% Similarity=0.226 Sum_probs=94.4
Q ss_pred EEEecccCceEEEEeeecCceEEEEEeecCccCCCchh--------HHHHHHHHHHHHHHHhhCC------CCceeEEEe
Q 037285 815 QKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSE--------QERLTVEFWKEAEILSKLH------HPNVVAFYG 880 (1094)
Q Consensus 815 ~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~e--------qe~~~~eFlrEIkILkrL~------HPNIVqL~G 880 (1094)
...||+|+.=.||.-- .+....||+............ ......++.+|+.-+..+. +.+|.+++|
T Consensus 6 ~~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred CcccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 3568999999999632 245578898876541100000 0011244556666665555 889999999
Q ss_pred EeecCCCCceEEEeeeccc------chhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCC
Q 037285 881 VVQDGPGGTLATVAEYMVD------GSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP 954 (1094)
Q Consensus 881 v~~d~~~~~L~IVmEYmeg------GSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~ 954 (1094)
++.+.. .+.+|+|.+.+ -+|.+++.... ++. . +...+-+-..||-+++|+.+||+|.||++...+.
T Consensus 85 ~veT~~--G~Glv~e~I~d~dG~~s~TL~~~l~~~~--~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 85 FVETNL--GLGLVVELIRDADGNISPTLEDYLKEGG--LTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred EEecCC--ceEEEEEEEECCCCCcCccHHHHHHcCC--ccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence 999865 67889988743 35788884432 554 3 3333445567889999999999999999985553
Q ss_pred CCCcEEEEe-cCC
Q 037285 955 SRPICKVGD-FGL 966 (1094)
Q Consensus 955 e~g~VKLsD-FGL 966 (1094)
....+.|+| ||-
T Consensus 157 ~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 157 GEFRLVLIDGLGE 169 (199)
T ss_pred CceEEEEEeCCCC
Confidence 343677777 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.001 Score=71.15 Aligned_cols=75 Identities=20% Similarity=0.119 Sum_probs=49.5
Q ss_pred ecccCc-eEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-CCceeEEEeEeecCCCCceEEEee
Q 037285 818 LGSGTF-GTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HPNVVAFYGVVQDGPGGTLATVAE 895 (1094)
Q Consensus 818 LGsG~F-GtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-HPNIVqL~Gv~~d~~~~~L~IVmE 895 (1094)
|-.|+. ..||+....+..+.||+..... .....+|+.+++.+. +--+.+++++.... +..++|||
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~e 72 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP-----------TYELEREAERLRWLAGKLPVPEVIDYGSDD--GRAWLLTS 72 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCc-----------ccchHHHHHHHHHHHhcCCCCeEEEEEecC--CccEEEEE
Confidence 444555 7889987666778888765421 123456777777764 33455777776553 35788999
Q ss_pred ecccchhHHH
Q 037285 896 YMVDGSLRHV 905 (1094)
Q Consensus 896 YmegGSL~d~ 905 (1094)
+++|.+|...
T Consensus 73 ~i~G~~l~~~ 82 (244)
T cd05150 73 AVPGVPAAAL 82 (244)
T ss_pred eeCCccHhHh
Confidence 9998777543
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF00017 SH2: SH2 domain; InterPro: IPR000980 The Src homology 2 (SH2) domain is a protein domain of about 100 amino-acid residues first identified as a conserved sequence region between the oncoproteins Src and Fps [] | Back alignment and domain information |
|---|
Probab=97.49 E-value=2.4e-05 Score=69.98 Aligned_cols=69 Identities=19% Similarity=0.326 Sum_probs=58.0
Q ss_pred cccCCCChhHHHHcCCc---hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCcccccchHH
Q 037285 692 FGQKDVSLIDQEHLGLS---SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSESMQFDA 765 (1094)
Q Consensus 692 Wy~~~IsR~~AE~ll~a---~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~isE~~qFds 765 (1094)
||+++|+|.+||++|.. +| ||.+....| .|.+|+... +.+. |+.|..+....+. ......|.+
T Consensus 1 W~~g~isr~~Ae~~L~~~~~~G~FLvR~s~~~~~-~~~Lsv~~~-----~~v~-h~~I~~~~~~~~~----~~~~~~F~s 69 (77)
T PF00017_consen 1 WFHGFISRQEAERLLMQGKPDGTFLVRPSSSKPG-KYVLSVRFD-----GKVK-HFRINRTENGGYF----LSDGKKFPS 69 (77)
T ss_dssp TBEESSHHHHHHHHHHTTSSTTEEEEEEESSSTT-SEEEEEEET-----TEEE-EEEEEEETTSEEE----SSTSSEBSS
T ss_pred CcCCCCCHHHHHHHHHhcCCCCeEEEEecccccc-ccccccccc-----cccE-EEEEEecCCceEE----ccCCCcCCC
Confidence 99999999999999998 66 999998677 799998886 5777 9999987777666 556666999
Q ss_pred HHHhhh
Q 037285 766 MMENLR 771 (1094)
Q Consensus 766 L~ElLr 771 (1094)
+.+++.
T Consensus 70 l~~LV~ 75 (77)
T PF00017_consen 70 LSDLVE 75 (77)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 988873
|
Similar sequences were later found in many other intracellular signal-transducing proteins []. SH2 domains function as regulatory modules of intracellular signalling cascades by interacting with high affinity to phosphotyrosine-containing target peptides in a sequence-specific, SH2 domains recognise between 3-6 residues C-terminal to the phosphorylated tyrosine in a fashion that differs from one SH2 domain to another, and strictly phosphorylation-dependent manner [, , , ]. They are found in a wide variety of protein contexts e.g., in association with catalytic domains of phospholipase Cy (PLCy) and the non-receptor protein tyrosine kinases; within structural proteins such as fodrin and tensin; and in a group of small adaptor molecules, i.e Crk and Nck. The domains are frequently found as repeats in a single protein sequence and will then often bind both mono- and di-phosphorylated substrates. The structure of the SH2 domain belongs to the alpha+beta class, its overall shape forming a compact flattened hemisphere. The core structural elements comprise a central hydrophobic anti-parallel beta-sheet, flanked by 2 short alpha-helices. The loop between strands 2 and 3 provides many of the binding interactions with the phosphate group of its phosphopeptide ligand, and is hence designated the phosphate binding loop, the phosphorylated ligand binds perpendicular to the beta-sheet and typically interacts with the phosphate binding loop and a hydrophobic binding pocket that interacts with a pY+3 side chain. The N- and C-termini of the domain are close together in space and on the opposite face from the phosphopeptide binding surface and it has been speculated that this has facilitated their integration into surface-exposed regions of host proteins [].; GO: 0005515 protein binding; PDB: 1M27_A 1KA6_A 1D4W_B 1D4T_A 1D1Z_B 1KA7_A 1UUR_A 1UUS_A 1BLJ_A 1BLK_A .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.46 E-value=2.8e-05 Score=93.69 Aligned_cols=182 Identities=18% Similarity=0.161 Sum_probs=126.6
Q ss_pred EEEEecccCceEEEEeeecCce-EEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCc-eeEEEeEeecCCCCceE
Q 037285 814 EQKELGSGTFGTVYHGKWRGTD-VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPN-VVAFYGVVQDGPGGTLA 891 (1094)
Q Consensus 814 i~kkLGsG~FGtVYKAk~rGt~-VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPN-IVqL~Gv~~d~~~~~L~ 891 (1094)
....+++|+++.++|.+...+. ...+.+... ....-++++|.+++||| .+..++-+.. +...+
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~-------------l~~rl~~eLLdK~n~P~~~v~~~~d~~~--E~~~~ 310 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------------LSRRLAIELLDKVNNPNPVVRYLEDYDG--EDYLW 310 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccc-------------hhhHHHHHHHHHccCCCCcccccccCCc--ccccc
Confidence 3456889999999998765332 223333211 22335788999999999 4544444443 34889
Q ss_pred EEeeecccc-hhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccc
Q 037285 892 TVAEYMVDG-SLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK 970 (1094)
Q Consensus 892 IVmEYmegG-SL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~ 970 (1094)
++++++.++ +-...+....-.+.+-+...+++.-++++++||+.-=+|+| ||+.. +...|..||+.....
T Consensus 311 i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-----~~~~~~~~~~v~~~L 381 (829)
T KOG0576|consen 311 IPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-----EEEVKLLDFAVPPQL 381 (829)
T ss_pred hhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-----ccccccccccCCccc
Confidence 999999877 22222211112244445566777788899999998778999 88876 467899999988766
Q ss_pred cCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 037285 971 RNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1021 (1094)
Q Consensus 971 ~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF 1021 (1094)
..........+|+.|+|||+.. ...+..+.|+|++++=..+|.-|-.|-
T Consensus 382 ~~~~~~~t~~~~~~~~~pev~~--~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 382 TRTMKPRTAIGTPEPLAPEVIQ--ENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CcccccccCCCCCCCCCchhhc--ccccccCCCccCCCcchhhcCCCCCCC
Confidence 5554555677999999999887 567788999999998666666666653
|
|
| >smart00252 SH2 Src homology 2 domains | Back alignment and domain information |
|---|
Probab=97.39 E-value=9.2e-05 Score=67.19 Aligned_cols=71 Identities=20% Similarity=0.306 Sum_probs=58.3
Q ss_pred cccccCCCChhHHHHcCCch--h---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCcccccchH
Q 037285 690 VDFGQKDVSLIDQEHLGLSS--G---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSESMQFD 764 (1094)
Q Consensus 690 ~~Wy~~~IsR~~AE~ll~a~--g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~isE~~qFd 764 (1094)
++||+|.|+|.+||++|... | ||.+....| .|.+|+... +.+. |+.|..+..+.|. +.....|.
T Consensus 1 ~~w~~g~i~r~~Ae~lL~~~~~G~FLvR~s~~~~~-~~~Lsv~~~-----~~~~-h~~I~~~~~~~~~----l~~~~~F~ 69 (84)
T smart00252 1 QPWYHGFISREEAEKLLKNEGDGDFLVRDSESEPG-DYVLSVRVK-----GKVK-HYRIRRNEDGKFY----LDGGRKFP 69 (84)
T ss_pred CCeecccCCHHHHHHHHhcCCCcEEEEEcCCCCCC-CEEEEEEEC-----CEEE-EEEEEECCCCcEE----ECCCCccC
Confidence 47999999999999999887 5 999998666 788888875 6777 9999876656677 44467899
Q ss_pred HHHHhhh
Q 037285 765 AMMENLR 771 (1094)
Q Consensus 765 sL~ElLr 771 (1094)
++.+++.
T Consensus 70 sl~eLI~ 76 (84)
T smart00252 70 SLVELVE 76 (84)
T ss_pred CHHHHHH
Confidence 9999883
|
Src homology 2 domains bind phosphotyrosine-containing polypeptides via 2 surface pockets. Specificity is provided via interaction with residues that are distinct from the phosphotyrosine. Only a single occurrence of a SH2 domain has been found in S. cerevisiae. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0014 Score=82.88 Aligned_cols=80 Identities=16% Similarity=0.219 Sum_probs=54.6
Q ss_pred EEEecccCceEEEEeeecC----ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-CCce--eEEEeEeecCC-
Q 037285 815 QKELGSGTFGTVYHGKWRG----TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HPNV--VAFYGVVQDGP- 886 (1094)
Q Consensus 815 ~kkLGsG~FGtVYKAk~rG----t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-HPNI--VqL~Gv~~d~~- 886 (1094)
.+.|+.|.+..+|+..+.+ ..+++|+........ ....+.+|+.+|+.|. |.++ .+++.+|.+..
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~-------~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v 115 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ-------SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV 115 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc-------cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc
Confidence 4678999999999887654 357777654321110 1235678999999985 6655 78888876531
Q ss_pred CCceEEEeeecccch
Q 037285 887 GGTLATVAEYMVDGS 901 (1094)
Q Consensus 887 ~~~L~IVmEYmegGS 901 (1094)
.+..|+||||++|..
T Consensus 116 ~G~~flVME~v~G~~ 130 (822)
T PLN02876 116 IGTAFYIMEYLEGRI 130 (822)
T ss_pred CCCceEEEEecCCcc
Confidence 235789999998764
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.00076 Score=81.39 Aligned_cols=149 Identities=17% Similarity=0.176 Sum_probs=92.3
Q ss_pred EEecccCceEEEEeeec-CceEEEEEeecCccCCCchhH------------------------HH------HHHHHHHHH
Q 037285 816 KELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQ------------------------ER------LTVEFWKEA 864 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~r-Gt~VAVKiIkk~~~se~~~eq------------------------e~------~~~eFlrEI 864 (1094)
+-||.-+.|.||+|+.+ |+.||||+-++.. ...-..+ +. ..-+|.+|+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l-~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGL-EKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcCh-HHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 46899999999999986 6889999877642 1000000 00 012345555
Q ss_pred HHHhh----CCCCc------eeEEEeEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH
Q 037285 865 EILSK----LHHPN------VVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHS 934 (1094)
Q Consensus 865 kILkr----L~HPN------IVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs 934 (1094)
+-..+ +.|-+ |.++|--++. ...++||||+|..+.+.-.-....++...+..-+.++..- -+=.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st----~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~--qIf~ 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLST----KRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLE--QIFK 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCc----ceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHH--HHHh
Confidence 54333 34555 4444443333 5688999999987755433223336665444333332221 2235
Q ss_pred CCceeccCCCCceEeccCCCCCCcEEEEecCCccccc
Q 037285 935 KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKR 971 (1094)
Q Consensus 935 ~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~ 971 (1094)
.|++|.|-.|-||+++.+...+..+.+-|||+.....
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 6899999999999998544457899999999987543
|
|
| >cd06408 PB1_NoxR The PB1 domain is present in the Epichloe festucae NoxR protein (NADPH oxidase regulator), a key regulator of NADPH oxidase isoform, NoxA | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.001 Score=62.52 Aligned_cols=72 Identities=17% Similarity=0.364 Sum_probs=57.5
Q ss_pred cCceEEEEecCCCChHHHHHHHHHHcC--CceEEEEeCCCCCCCceeeccChhhHHHHHHHHhhcCCCCC--CCeEEEEE
Q 037285 109 GGETRIIRIRKDISWQILRQKALEVYN--QVHVIKYQLPGEDLDALVSVSCDEDLQNMMEEYNELGDREG--SQRIRMFL 184 (1094)
Q Consensus 109 GG~triv~v~r~~~~~~l~~kl~~~~~--~~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~--~~r~R~Fl 184 (1094)
+|++|++.|+.+|+|.+|..|+.+.|+ ..++|||+ .| ...|++++++||+-.+.-+-...++.+ -+|+-+.+
T Consensus 10 ~~Dv~~i~v~~~i~f~dL~~kIrdkf~~~~~~~iKyk---DE-GD~iti~sq~DLd~Ai~~a~~~~~~~~~~~~~~e~w~ 85 (86)
T cd06408 10 QDDTRYIMIGPDTGFADFEDKIRDKFGFKRRLKIKMK---DD-GDMITMGDQDDLDMAIDTARSEARKQGSDMGKLEIWV 85 (86)
T ss_pred cCcEEEEEcCCCCCHHHHHHHHHHHhCCCCceEEEEE---cC-CCCccccCHHHHHHHHHHHHHHHHhhcccccceeeec
Confidence 788999999999999999999999997 67889998 34 789999999999999987753322222 24655443
|
NoxA is essential for growth control of the fungal endophyte in plant tissue in the process of symbiotic interaction between a fungi and its plant host. The Epichloe festucae p67(phox)-like regulator, NoxR, dispensable in culture but essential in plants for the symbiotic interaction. Plants infected with a noxR deletion mutant show severe stunting and premature senescence, whereas hyphae in the meristematic tissues show increased branching leading to increased fungal colonization of pseudostem and leaf blade tissue. The PB1 domain is a modular domain mediating specific protein-protein interactions which a play role in many critical cell processes such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is |
| >cd00173 SH2 Src homology 2 domains; Signal transduction, involved in recognition of phosphorylated tyrosine (pTyr) | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.00023 Score=65.34 Aligned_cols=70 Identities=19% Similarity=0.289 Sum_probs=55.7
Q ss_pred ccccCCCChhHHHHcCC--chh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCcccccchHH
Q 037285 691 DFGQKDVSLIDQEHLGL--SSG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSESMQFDA 765 (1094)
Q Consensus 691 ~Wy~~~IsR~~AE~ll~--a~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~isE~~qFds 765 (1094)
+||+++|+|.+||++|. .+| ||.+....| .|.+|+... +.+. |+.|..+....+. ......|.+
T Consensus 1 ~w~~g~i~r~~Ae~~L~~~~~G~FLiR~s~~~~~-~~~Lsv~~~-----~~v~-H~~I~~~~~~~~~----~~~~~~f~s 69 (94)
T cd00173 1 PWYHGPISREEAEELLKKKPDGTFLVRDSESSPG-DYVLSVRVK-----GKVK-HYRIERTDDGYYL----LGEGRSFPS 69 (94)
T ss_pred CccccCCCHHHHHHHHhcCCCceEEEEecCCCCC-CEEEEEEEC-----CEEE-EEEEEECCCCeEE----ecCCCccCC
Confidence 69999999999999999 777 999997566 788888886 4677 9999876654333 124678999
Q ss_pred HHHhhh
Q 037285 766 MMENLR 771 (1094)
Q Consensus 766 L~ElLr 771 (1094)
+.+++.
T Consensus 70 l~eLv~ 75 (94)
T cd00173 70 LPELIE 75 (94)
T ss_pred HHHHHH
Confidence 999983
|
SH2 domains typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0016 Score=68.75 Aligned_cols=97 Identities=24% Similarity=0.147 Sum_probs=76.7
Q ss_pred HHHHHHhhCCC-CceeEEEeEeecCCCCceEEEeeecccchhHHH---HhhcccccCHHHHHHHHHHHHHHHHHHHH---
Q 037285 862 KEAEILSKLHH-PNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHV---LVRKDRFLDRRRRLIIAMDAAFGMEYLHS--- 934 (1094)
Q Consensus 862 rEIkILkrL~H-PNIVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~---L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs--- 934 (1094)
.|.-+|+.+.+ +++++++|.|- -++|+||...+++... +..- ...+|..+++|+.++++.+.+|+.
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG------~~~v~E~~~~~~~~~~~~~l~~~-~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG------RFYVVEYVGAGSLYGIYRPLSQF-LQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC------CEEEEEeecCccccccccccccc-cccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 47778888876 69999999994 2558999987765421 1111 125899999999999999999997
Q ss_pred CCceeccCCCCceEeccCCCCCCcEEEEecCCccc
Q 037285 935 KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI 969 (1094)
Q Consensus 935 ~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl 969 (1094)
..+.-.|++++|+-++ +++.+|++|......
T Consensus 81 ~~~~lcDv~~~nfgv~----~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVN----DDGRLKLIDLDDVFV 111 (188)
T ss_pred CcEEEeecchHHeEEe----CCCcEEEEechhcch
Confidence 3488899999999999 778899999998763
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd06405 PB1_Mekk2_3 The PB1 domain is present in the two mitogen-activated protein kinase kinases MEKK2 and MEKK3 which are two members of the signaling kinase cascade involved in angiogenesis and early cardiovascular development | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0024 Score=58.36 Aligned_cols=69 Identities=26% Similarity=0.454 Sum_probs=58.8
Q ss_pred cCceEEEEecCCCChHHHHHHHHHHcCCceEEEEeCCCCCCCceeeccChhhHHHHHHHHhhcCCCCCCCeEEEEE
Q 037285 109 GGETRIIRIRKDISWQILRQKALEVYNQVHVIKYQLPGEDLDALVSVSCDEDLQNMMEEYNELGDREGSQRIRMFL 184 (1094)
Q Consensus 109 GG~triv~v~r~~~~~~l~~kl~~~~~~~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~r~R~Fl 184 (1094)
-||-||+.++|.+.|.||..|+...||..+.+-|-.- | -||.+.|.|||+.-|+-.|+ ....+ -+|+.|
T Consensus 8 ~gEKRIi~f~RPvkf~dl~~kv~~afGq~mdl~ytn~-e---L~iPl~~Q~DLDkAie~ld~-s~~~k--sLRilL 76 (79)
T cd06405 8 NGEKRIIQFPRPVKFKDLQQKVTTAFGQPMDLHYTNN-E---LLIPLKNQEDLDRAIELLDR-SPHMK--SLRILL 76 (79)
T ss_pred cCceEEEecCCCccHHHHHHHHHHHhCCeeeEEEecc-c---EEEeccCHHHHHHHHHHHcc-Ccccc--ceeEeE
Confidence 4899999999999999999999999999999999754 2 79999999999999999998 33333 456555
|
The PB1 domain of MEKK2 (and/or MEKK3) interacts with the PB1 domain of another member of the kinase cascade Map2k5. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, f |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0032 Score=67.33 Aligned_cols=29 Identities=38% Similarity=0.366 Sum_probs=24.5
Q ss_pred CceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 936 NIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 936 GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
.++|+|+.+.|||++ .+...-|+||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~----~~~i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQ----DGRLSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEE----CCCEEEEEeCcccC
Confidence 489999999999998 45556799999875
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0002 Score=92.59 Aligned_cols=188 Identities=16% Similarity=0.107 Sum_probs=129.4
Q ss_pred EEeeecCc---eEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEEEeeecccchhH
Q 037285 827 YHGKWRGT---DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLR 903 (1094)
Q Consensus 827 YKAk~rGt---~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~IVmEYmegGSL~ 903 (1094)
++++|-+. .+.+|+.+.-.+.. ..+...+-.+.|..-++...|+++...+.-.........+++++|+.+|.+.
T Consensus 1243 ~R~k~Lr~kid~Fk~~I~ke~d~e~---LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f 1319 (2724)
T KOG1826|consen 1243 FRNKWLRSKIDWFKFSIYKEYDFEN---LSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLF 1319 (2724)
T ss_pred eccchHhhhhceeEEEeehhhhHHH---HhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHH
Confidence 45666332 25666665433221 1222333344555566667899998877766655555788999999999999
Q ss_pred HHHhhcc---cccCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCceEeccCCCCCCcEEEEecCCcccc-cCcc
Q 037285 904 HVLVRKD---RFLDRRRRLIIAMDAAFGMEYLHSKN-----IVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK-RNTL 974 (1094)
Q Consensus 904 d~L~k~~---~~Lse~~~l~Ia~QIaeGLaYLHs~G-----IIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~-~~~~ 974 (1094)
+.+.+.- ..+...-+...-.+......-+|+.. .+|++||+-|.++. .+..+|+.++|+.+.. ....
T Consensus 1320 ~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIV----tny~v~~gk~gLdKIknp~~s 1395 (2724)
T KOG1826|consen 1320 SIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIV----TNYNVKLGKGGLDKIKNPVLS 1395 (2724)
T ss_pred HHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhcccee----cCCcccccccccccccCchHh
Confidence 9986542 33444444433333355555555432 79999999999998 7788999999999933 3333
Q ss_pred ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 037285 975 VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN 1023 (1094)
Q Consensus 975 ~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~ 1023 (1094)
......+++.|++|+..+ .-.++.++|+|..|+.+|+...|..+|..
T Consensus 1396 f~Gl~l~sp~~v~qli~N--~ik~t~rsdilr~s~~ly~rs~~n~~fi~ 1442 (2724)
T KOG1826|consen 1396 FFGLELCSPIYVLQLIKN--EIKFTKRSDILRRSLSLYLRSDGNAYFIF 1442 (2724)
T ss_pred hhhhhhCCHHHHHHHHHH--HHhhhhHHHHHHHHHHHHHHhcccHHHHH
Confidence 445566888899999987 45677789999999999999888887653
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.0079 Score=63.74 Aligned_cols=73 Identities=14% Similarity=0.167 Sum_probs=45.0
Q ss_pred EEEecccCceEEEEeeec---CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCc-eeEEEeEeecCCCCce
Q 037285 815 QKELGSGTFGTVYHGKWR---GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPN-VVAFYGVVQDGPGGTL 890 (1094)
Q Consensus 815 ~kkLGsG~FGtVYKAk~r---Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPN-IVqL~Gv~~d~~~~~L 890 (1094)
.+.|..|-...+|+.... +..+++|+....... .....+|+.++..+...+ .+++++.+..
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~---------~~d~~~E~~~~~~l~~~gl~P~v~~~~~~------ 67 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL---------IIDRERELRIHKLLSKHGLAPKLYATFQN------ 67 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc---------eecHHHHHHHHHHHHhCCCCCeEEEEeCC------
Confidence 456788888999998765 467888876532110 012235777777774322 3445443321
Q ss_pred EEEeeecccchh
Q 037285 891 ATVAEYMVDGSL 902 (1094)
Q Consensus 891 ~IVmEYmegGSL 902 (1094)
.+||||++|.++
T Consensus 68 ~~l~e~i~G~~l 79 (235)
T cd05157 68 GLIYEFIPGRTL 79 (235)
T ss_pred cEEEEeeCCCcC
Confidence 369999988665
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.017 Score=63.92 Aligned_cols=33 Identities=21% Similarity=0.196 Sum_probs=25.4
Q ss_pred CceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 936 NIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 936 GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
.++|+|+.+.|||++.+..+.+.++|+||..|.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 489999999999998210013679999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd06401 PB1_TFG The PB1 domain found in TFG protein, an oncogenic gene product and fusion partner to nerve growth factor tyrosine kinase receptor TrkA and to the tyrosine kinase ALK | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.012 Score=54.95 Aligned_cols=53 Identities=26% Similarity=0.347 Sum_probs=44.4
Q ss_pred cCceEEEEecC-CCChHHHHHHHHHHcC------CceEEEEeCCCCCCCceeeccChhhHHHH
Q 037285 109 GGETRIIRIRK-DISWQILRQKALEVYN------QVHVIKYQLPGEDLDALVSVSCDEDLQNM 164 (1094)
Q Consensus 109 GG~triv~v~r-~~~~~~l~~kl~~~~~------~~~~lkyqLp~edld~LisV~~deDl~~m 164 (1094)
||+.|.+.++. .++|.+|+..+..++. ..+.|||.=+ =..||+||+++||.--
T Consensus 8 g~DiR~~~~~~~~~t~~~L~~~v~~~F~~~~~~~~~flIKYkD~---dGDlVTIts~~dL~~A 67 (81)
T cd06401 8 GDDIRRIPIHNEDITYDELLLMMQRVFRGKLGSSDDVLIKYKDE---DGDLITIFDSSDLSFA 67 (81)
T ss_pred CCeEEEEeccCccccHHHHHHHHHHHhccccCCcccEEEEEECC---CCCEEEeccHHHHHHH
Confidence 89999999998 5899999999987765 3688999833 3448999999999765
|
The PB1 domain is a modular domain mediating specific protein-protein interaction in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. The PB1 domains of TFG represent a type I/II PB1 domain. The physiological function of TFG remains unknown. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.011 Score=64.01 Aligned_cols=133 Identities=17% Similarity=0.109 Sum_probs=73.1
Q ss_pred ecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCce-eEEEeEeecCCCCceEEEeee
Q 037285 818 LGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNV-VAFYGVVQDGPGGTLATVAEY 896 (1094)
Q Consensus 818 LGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNI-VqL~Gv~~d~~~~~L~IVmEY 896 (1094)
+..|-...+|+....+..+++|+...... .......+|..+++.+..-.+ .+++.... -++||||
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~--------~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~------~~~v~e~ 69 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCK--------ALGVDRQREYQILQALSALGLAPKPILVNE------HWLLVEW 69 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCcccc--------cccCcHHHHHHHHHHHHhcCCCCceEEEeC------CEEEEEe
Confidence 45677788998877777888887543210 000123467777777753323 34444332 2579999
Q ss_pred cccchhHHH--------------H---hhcc---cccCHHH-HHHHHHH---------HHHHHHHHHH--------CCce
Q 037285 897 MVDGSLRHV--------------L---VRKD---RFLDRRR-RLIIAMD---------AAFGMEYLHS--------KNIV 938 (1094)
Q Consensus 897 megGSL~d~--------------L---~k~~---~~Lse~~-~l~Ia~Q---------IaeGLaYLHs--------~GII 938 (1094)
++|..+... + +... ..++... ......+ +...+..+-. ..++
T Consensus 70 i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 149 (256)
T TIGR02721 70 LEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL 149 (256)
T ss_pred ccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence 988664311 1 1110 1112111 1111111 1112222222 2489
Q ss_pred eccCCCCceEeccCCCCCCcEEEEecCCccc
Q 037285 939 HFDLKCDNLLVNLKDPSRPICKVGDFGLSKI 969 (1094)
Q Consensus 939 HRDLKPeNILLD~~~~e~g~VKLsDFGLSrl 969 (1094)
|+|+.|.||+++ +++ +.|+||..+..
T Consensus 150 H~Dl~~~Nil~~----~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 150 HMDVHAYNLVVT----PQG-LKLIDWEYASD 175 (256)
T ss_pred cCCCCcCcEEEe----CCC-CEEEeccccCc
Confidence 999999999998 444 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.021 Score=66.47 Aligned_cols=148 Identities=20% Similarity=0.134 Sum_probs=98.1
Q ss_pred EEEEecccCceEEEEeee-cCceEEEEEeecCccCCCc-----------------hhHHHHHH-HHHHHHHHHhhCCCCc
Q 037285 814 EQKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRS-----------------SEQERLTV-EFWKEAEILSKLHHPN 874 (1094)
Q Consensus 814 i~kkLGsG~FGtVYKAk~-rGt~VAVKiIkk~~~se~~-----------------~eqe~~~~-eFlrEIkILkrL~HPN 874 (1094)
+-.+|..|--+-||.+.- .|..+|||+++...+.-.. ...++++. -..+|++-|++|+.-.
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 346788999999999876 4788999999865432110 01122222 2235788888887555
Q ss_pred eeEEEeEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCceEeccCC
Q 037285 875 VVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLH-SKNIVHFDLKCDNLLVNLKD 953 (1094)
Q Consensus 875 IVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLH-s~GIIHRDLKPeNILLD~~~ 953 (1094)
|.-.--+... .-.+||+|+. .+=+-.=.-+...++...+..+-.+++.-|.-|- ..++||.||.-=|+|+.
T Consensus 228 IP~PePIlLk----~hVLVM~FlG-rdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh--- 299 (520)
T KOG2270|consen 228 IPCPEPILLK----NHVLVMEFLG-RDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH--- 299 (520)
T ss_pred CCCCCceeee----cceEeeeecc-CCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE---
Confidence 4422222222 3467999995 3322221122334777778888888888888875 56799999999999996
Q ss_pred CCCCcEEEEecCCccccc
Q 037285 954 PSRPICKVGDFGLSKIKR 971 (1094)
Q Consensus 954 ~e~g~VKLsDFGLSrl~~ 971 (1094)
.+.+.|+|.+.+....
T Consensus 300 --dG~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 300 --DGKLYIIDVSQSVEHD 315 (520)
T ss_pred --CCEEEEEEccccccCC
Confidence 6789999999886433
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.10 E-value=0.048 Score=64.28 Aligned_cols=82 Identities=21% Similarity=0.112 Sum_probs=51.5
Q ss_pred EEEecccCceEEEEeeecC--ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC---CCceeEEEeEeecCCCCc
Q 037285 815 QKELGSGTFGTVYHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH---HPNVVAFYGVVQDGPGGT 889 (1094)
Q Consensus 815 ~kkLGsG~FGtVYKAk~rG--t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~---HPNIVqL~Gv~~d~~~~~ 889 (1094)
.+.||.|.+..||++...+ +.++||.-............ .....+..|...|+.+. -.++++++.+..+ .
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wp-l~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~~----~ 105 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWP-LTLDRARIEAEALKIQAKYVPDLVPKVYHYDEE----L 105 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCccccccccccc-ccHHHHHHHHHHHHHHHhhCCCCCCeEEEECCC----C
Confidence 3579999999999998864 37999985422111001000 11245556777777653 3467778777432 5
Q ss_pred eEEEeeecccch
Q 037285 890 LATVAEYMVDGS 901 (1094)
Q Consensus 890 L~IVmEYmegGS 901 (1094)
.++||||+++..
T Consensus 106 ~~lVME~L~~~~ 117 (401)
T PRK09550 106 AVTVMEDLSDHK 117 (401)
T ss_pred CEEEEecCCCcc
Confidence 678999987643
|
|
| >cd06398 PB1_Joka2 The PB1 domain is present in the Nicotiana plumbaginifolia Joka2 protein which interacts with sulfur stress inducible UP9 protein | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.046 Score=52.06 Aligned_cols=70 Identities=20% Similarity=0.352 Sum_probs=54.9
Q ss_pred cCceEEEEecC-----CCChHHHHHHHHHHcC----CceEEEEeCCCCCCCceeeccChhhHHHHHHHHhhcCCCCCCCe
Q 037285 109 GGETRIIRIRK-----DISWQILRQKALEVYN----QVHVIKYQLPGEDLDALVSVSCDEDLQNMMEEYNELGDREGSQR 179 (1094)
Q Consensus 109 GG~triv~v~r-----~~~~~~l~~kl~~~~~----~~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~r 179 (1094)
||++|-+.++. +++|.+|..|+.+.+. ..+.|+|. .+=..+|.++||+||+.-|+..-+ .+...-
T Consensus 8 ~~~~rRf~l~~~~~~~d~~~~~L~~kI~~~f~l~~~~~~~l~Y~---Dedgd~V~l~~D~DL~~a~~~~~~---~~~~~~ 81 (91)
T cd06398 8 GGTLRRFTFPVAENQLDLNMDGLREKVEELFSLSPDADLSLTYT---DEDGDVVTLVDDNDLTDAIQYFCS---GSRLNP 81 (91)
T ss_pred CCEEEEEEeccccccCCCCHHHHHHHHHHHhCCCCCCcEEEEEE---CCCCCEEEEccHHHHHHHHHHHhc---cCCCce
Confidence 78899999995 6999999999999875 46789997 444559999999999988877422 333446
Q ss_pred EEEEE
Q 037285 180 IRMFL 184 (1094)
Q Consensus 180 ~R~Fl 184 (1094)
||+++
T Consensus 82 lrl~v 86 (91)
T cd06398 82 LRIDV 86 (91)
T ss_pred EEEEE
Confidence 77765
|
The PB1 domain is a modular domain mediating specific protein-protein interactions which play a role in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. The PB1 domain module |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=95.94 E-value=0.037 Score=60.81 Aligned_cols=139 Identities=19% Similarity=0.138 Sum_probs=78.3
Q ss_pred EEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCC--ceeEEEeEee----cCCCC
Q 037285 815 QKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP--NVVAFYGVVQ----DGPGG 888 (1094)
Q Consensus 815 ~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HP--NIVqL~Gv~~----d~~~~ 888 (1094)
.+.|..|....+|+....+..+++|+.... . ......|+.++..|..- .+++++.... ....+
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~--~---------~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~ 87 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEKV--S---------AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAG 87 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCCC--C---------hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCC
Confidence 456778888899998776678899987531 0 12344566666666432 2444433210 01123
Q ss_pred ceEEEeeecccchhHH-----------HH---hhccc----------ccCHHHHH----------HHHHHHHHHHHHHHH
Q 037285 889 TLATVAEYMVDGSLRH-----------VL---VRKDR----------FLDRRRRL----------IIAMDAAFGMEYLHS 934 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d-----------~L---~k~~~----------~Lse~~~l----------~Ia~QIaeGLaYLHs 934 (1094)
..++|++|++|..+.. .+ +.... ...+.... .....+..++.++.+
T Consensus 88 ~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~ 167 (296)
T cd05153 88 KPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDA 167 (296)
T ss_pred ceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHh
Confidence 5678999998765421 11 10000 00110000 011122334455543
Q ss_pred -------CCceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 935 -------KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 935 -------~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
.+++|+|+.|.|||++ ++..+.|+||+.+.
T Consensus 168 ~~~~~~~~~l~HgD~~~~Nil~~----~~~~~~iIDfe~a~ 204 (296)
T cd05153 168 FDPSDLPRGVIHADLFRDNVLFD----GDELSGVIDFYFAC 204 (296)
T ss_pred hhhhcCCCcCCccCcCcccEEEe----CCceEEEeehhhhc
Confidence 4699999999999998 55567899999865
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.86 E-value=0.0064 Score=69.67 Aligned_cols=140 Identities=19% Similarity=0.047 Sum_probs=95.9
Q ss_pred eeEEEEecccCceEEEEeeec-CceEEEEEeecCccCCCc--------------hhHHHHHHHHHHHHHHHhhCCC--Cc
Q 037285 812 LEEQKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRS--------------SEQERLTVEFWKEAEILSKLHH--PN 874 (1094)
Q Consensus 812 Yei~kkLGsG~FGtVYKAk~r-Gt~VAVKiIkk~~~se~~--------------~eqe~~~~eFlrEIkILkrL~H--PN 874 (1094)
+.+++.||-|.-+.||.+-+. |++.++|.-+....+-+. ....-......+|...|+.|.- --
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 467889999999999998775 888888865433211100 0111122345578888888753 22
Q ss_pred eeEEEeEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCC
Q 037285 875 VVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP 954 (1094)
Q Consensus 875 IVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~ 954 (1094)
+.+.+++. .-++|||++.+..|.+.-.- .+ .-.+...++.-+.-|-.+|+||+|..-=||++.
T Consensus 174 VPkpiD~~------RH~Vvmelv~g~Pl~~v~~v----~d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~---- 236 (465)
T KOG2268|consen 174 VPKPIDHN------RHCVVMELVDGYPLRQVRHV----ED---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVK---- 236 (465)
T ss_pred CCCccccc------ceeeHHHhhcccceeeeeec----CC---hHHHHHHHHHHHHHHHHcCceecccchheeEEe----
Confidence 34444433 57889999988888664322 12 223555666777888899999999999999998
Q ss_pred CCCcEEEEecCCcc
Q 037285 955 SRPICKVGDFGLSK 968 (1094)
Q Consensus 955 e~g~VKLsDFGLSr 968 (1094)
+...++++||-.+.
T Consensus 237 dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMV 250 (465)
T ss_pred cCCCEEEeechHhh
Confidence 67889999998654
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.70 E-value=0.06 Score=60.07 Aligned_cols=140 Identities=17% Similarity=0.135 Sum_probs=76.4
Q ss_pred EEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCC--ceeEEEeEee----cCCCC
Q 037285 815 QKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP--NVVAFYGVVQ----DGPGG 888 (1094)
Q Consensus 815 ~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HP--NIVqL~Gv~~----d~~~~ 888 (1094)
.+.++.|....+|+....+..+++|+..... . ......|+.++..|... .+++++.... ....+
T Consensus 27 i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~----~------~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g 96 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVGRYILTLYEKRV----K------AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAG 96 (307)
T ss_pred ccccCCccccceEEEEeCCCcEEEEEecCCC----C------HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCC
Confidence 4557778778999887656678888765421 0 01233455566655321 2344433211 11134
Q ss_pred ceEEEeeecccchhH-----------HHH---hhccccc-----------CHHHHH------------HHHHHHHHHHHH
Q 037285 889 TLATVAEYMVDGSLR-----------HVL---VRKDRFL-----------DRRRRL------------IIAMDAAFGMEY 931 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~-----------d~L---~k~~~~L-----------se~~~l------------~Ia~QIaeGLaY 931 (1094)
..+++++|++|..+. ..+ +.....+ .+.... .....+...+++
T Consensus 97 ~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 176 (307)
T TIGR00938 97 KPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDY 176 (307)
T ss_pred eEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHH
Confidence 678999999875421 111 1100000 000000 011123344555
Q ss_pred HHH-------CCceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 932 LHS-------KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 932 LHs-------~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
|.. .+++|+|+.+.||+++ .++.+.|+||+.+.
T Consensus 177 l~~~~~~~~~~~l~HgD~~~~Nvl~~----~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 177 LDKFWPRDLPRGVIHADLFPDNVLFD----GDSVKGVIDFYFAC 216 (307)
T ss_pred HHhhhhhcCCCccCCCCCCcCcEEEE----CCceEEEeeccccc
Confidence 542 5799999999999998 55567899999864
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd06404 PB1_aPKC PB1 domain is an essential modular domain of the atypical protein kinase C (aPKC) which in complex with Par6 and Par3 proteins is crucial for establishment of apical-basal polarity of animal cells | Back alignment and domain information |
|---|
Probab=95.58 E-value=0.09 Score=49.38 Aligned_cols=72 Identities=17% Similarity=0.296 Sum_probs=56.4
Q ss_pred ecCceEEEEecCCCChHHHHHHHHHHcC----CceEEEEeCCCCCCCceeeccChhhHHHHHHHHhhcCCCCCCCeEEEE
Q 037285 108 VGGETRIIRIRKDISWQILRQKALEVYN----QVHVIKYQLPGEDLDALVSVSCDEDLQNMMEEYNELGDREGSQRIRMF 183 (1094)
Q Consensus 108 vGG~triv~v~r~~~~~~l~~kl~~~~~----~~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~r~R~F 183 (1094)
-+|+-+|..++.+++|.+|..|+..+|. .++++||- .+-.-+|++++|++|+.-+..|..-. ..-|-+-
T Consensus 7 y~gdi~it~~d~~~s~e~L~~~v~~~c~~~~~q~ft~kw~---DEEGDp~tiSS~~EL~EA~rl~~~n~----~~~l~ih 79 (83)
T cd06404 7 YNGDIMITSIDPSISLEELCNEVRDMCRFHNDQPFTLKWI---DEEGDPCTISSQMELEEAFRLYELNK----DSELNIH 79 (83)
T ss_pred ecCcEEEEEcCCCcCHHHHHHHHHHHhCCCCCCcEEEEEE---CCCCCceeecCHHHHHHHHHHHHhcC----cccEEEE
Confidence 4677889999999999999999999996 58899998 33334799999999998888885432 2245555
Q ss_pred Eec
Q 037285 184 LFS 186 (1094)
Q Consensus 184 lF~ 186 (1094)
+||
T Consensus 80 vfp 82 (83)
T cd06404 80 VFP 82 (83)
T ss_pred ecC
Confidence 554
|
PB1 domain is a modular domain mediating specific protein-protein interaction which play roles in many critical cell processes. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, fungi, |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.22 Score=55.59 Aligned_cols=30 Identities=27% Similarity=0.402 Sum_probs=25.3
Q ss_pred CCceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 935 KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 935 ~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
.++||+|+.+.|||++ .+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~----~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFE----GDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEE----CCceEEEEeccccc
Confidence 3799999999999998 44556899999875
|
|
| >cd06396 PB1_NBR1 The PB1 domain is an essential part of NBR1 protein, next to BRCA1, a scaffold protein mediating specific protein-protein interaction with both titin protein kinase and with another scaffold protein p62 | Back alignment and domain information |
|---|
Probab=95.51 E-value=0.092 Score=49.18 Aligned_cols=69 Identities=14% Similarity=0.330 Sum_probs=56.5
Q ss_pred cCceEEEEecC--CCChHHHHHHHHHHcC-CceEEEEeCCCCCCCceeeccChhhHHHHHHHHhhcCCCCCCCeEEEEEe
Q 037285 109 GGETRIIRIRK--DISWQILRQKALEVYN-QVHVIKYQLPGEDLDALVSVSCDEDLQNMMEEYNELGDREGSQRIRMFLF 185 (1094)
Q Consensus 109 GG~triv~v~r--~~~~~~l~~kl~~~~~-~~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~r~R~FlF 185 (1094)
||+++.+.++. +.+|.+|.+.+.+.|+ ..+.|||= .|=.--|+++||.||+.-+.-|.| . +..+|+|+.
T Consensus 8 ~~d~~rf~~~~~~~~~~~~L~~ev~~rf~l~~f~lKYl---Dde~e~v~lssd~eLeE~~rl~~~----~-~~~l~~~v~ 79 (81)
T cd06396 8 NGESQSFLVSDSENTTWASVEAMVKVSFGLNDIQIKYV---DEENEEVSVNSQGEYEEALKSAVR----Q-GNLLQMNVY 79 (81)
T ss_pred CCeEEEEEecCCCCCCHHHHHHHHHHHhCCCcceeEEE---cCCCCEEEEEchhhHHHHHHHHHh----C-CCEEEEEEe
Confidence 57788999988 7899999999999998 67789996 455568999999999888887754 2 358888864
|
A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. The NBR1 protein contains a type I PB1 domain. |
| >KOG4792 consensus Crk family adapters [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.19 E-value=0.016 Score=62.88 Aligned_cols=88 Identities=17% Similarity=0.187 Sum_probs=62.5
Q ss_pred hhccccccccccCCCChhHHHHcCCchh-----hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCC-
Q 037285 683 YFRNLAQVDFGQKDVSLIDQEHLGLSSG-----VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPS- 756 (1094)
Q Consensus 683 ~~~~Le~~~Wy~~~IsR~~AE~ll~a~g-----VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~- 756 (1094)
.|+..+.-.||++.|||++|..+|.-.- ||+|+..+| .|.+|+... .+|- ||-|.......-...|+
T Consensus 4 ~FD~~er~swYfg~mSRqeA~~lL~~~r~G~FLvRDSst~pG-dYvLsV~E~-----srVs-hYiIn~~~p~~~~~~~~~ 76 (293)
T KOG4792|consen 4 NFDSSERSSWYFGPMSRQEAVALLQGQRHGVFLVRDSSTSPG-DYVLSVSEN-----SRVS-HYIINSSPPSPAQPPPSR 76 (293)
T ss_pred ccChhhccceecCcccHHHHHHHhcCcceeeEEEecCCCCCC-ceEEEEecC-----ccee-eeeecCCCCCccCCCcce
Confidence 3677888999999999999999887654 999999999 999997764 3455 99887633222222222
Q ss_pred c-ccccchHHHHHhhhcccccc
Q 037285 757 V-SESMQFDAMMENLRTTESDY 777 (1094)
Q Consensus 757 i-sE~~qFdsL~ElLrt~eSdy 777 (1094)
. --...|+.+..+|.-..-+|
T Consensus 77 ~rIgdQ~Fd~lPaLL~fykihy 98 (293)
T KOG4792|consen 77 LRIGDQEFDSLPALLEFYKIHY 98 (293)
T ss_pred eeeccccccchHHHHhheeEee
Confidence 1 12335999998886554454
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=94.87 E-value=0.12 Score=59.49 Aligned_cols=31 Identities=16% Similarity=0.339 Sum_probs=25.7
Q ss_pred CceeccCCCCceEeccCCCCCCcEEEEecCCccc
Q 037285 936 NIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI 969 (1094)
Q Consensus 936 GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl 969 (1094)
.++|+|+++.|||++. .+..+.|+||..+..
T Consensus 201 ~~cH~Dl~~~Nil~~~---~~~~~~lID~Eya~~ 231 (344)
T PLN02236 201 GFCHNDLQYGNIMIDE---ETRAITIIDYEYASY 231 (344)
T ss_pred eEEeCCCCcCcEEEeC---CCCcEEEEeehhccc
Confidence 5899999999999971 246799999998763
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.79 E-value=0.079 Score=63.98 Aligned_cols=153 Identities=20% Similarity=0.314 Sum_probs=93.4
Q ss_pred HHHHHHHHHhhCCCCceeEEEeEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCce
Q 037285 859 EFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIV 938 (1094)
Q Consensus 859 eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GII 938 (1094)
.++....+++.+.|+|+.+.+.+-... ..+..+|||++ +.+|.+++..+. +-... +. .+++.
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~-~~r~IVV~e~~-~~Sled~~~~~~--l~~~s-------~~-------~~~~~ 89 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGK-HERVIVVMEHY-TMSLEDILKTGN--LKDES-------LL-------AHGVL 89 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCc-cceEEEEehhh-ccchHHHHHhcc--cchhh-------hc-------ccccc
Confidence 455667788999999999998876544 34588899988 788999886553 11111 11 12222
Q ss_pred eccCCCCceEeccCCCCCCcEEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCC
Q 037285 939 HFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018 (1094)
Q Consensus 939 HRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk 1018 (1094)
| .||+ +++| -++ |. | |-. ..+|+|||++|.++.+++-|.
T Consensus 90 ~-----~~~~-----------~~td-~~~--------------t~-~--~~~-------~~pKsdVwsl~~i~~el~L~~ 128 (725)
T KOG1093|consen 90 H-----LNII-----------YITD-HFL--------------TK-Y--PSP-------IGPKSDVWSLGFIILELYLGI 128 (725)
T ss_pred e-----ehhh-----------hccc-ccc--------------cc-C--CCC-------CCcchhhhhHHHHHHHHHHhh
Confidence 1 2222 3333 000 00 0 111 114899999999999999999
Q ss_pred CCCCCCChHHHHHhHhhccCCCC----------CCCcCcHHHHHHHHHhccCCCCCCCCHHH
Q 037285 1019 EPYANMHYGAIIGGIVNNTLRPT----------IPSYCDAEWRTLMEECWAPNPAARPSFTE 1070 (1094)
Q Consensus 1019 ~PF~~~~~~eile~Iv~~~lrp~----------iPe~~S~eL~dLI~kCLq~DPeeRPS~eE 1070 (1094)
..|......+....+..-..... +--.++..+.++..+|+-..|..||...+
T Consensus 129 ~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~ 190 (725)
T KOG1093|consen 129 SLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPME 190 (725)
T ss_pred HHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhH
Confidence 88877766665554433222110 11134556678888999998888775443
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.77 E-value=0.31 Score=53.75 Aligned_cols=29 Identities=24% Similarity=0.353 Sum_probs=24.7
Q ss_pred CCceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 935 KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 935 ~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
.+++|+|+.+.||+++ . +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~----~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLK----D-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEe----C-CcEEEEECcccc
Confidence 4689999999999998 3 468899999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.62 E-value=0.23 Score=55.91 Aligned_cols=108 Identities=15% Similarity=0.041 Sum_probs=74.1
Q ss_pred eeEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCC---CceeEEEeEeecC-CC
Q 037285 812 LEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHH---PNVVAFYGVVQDG-PG 887 (1094)
Q Consensus 812 Yei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~H---PNIVqL~Gv~~d~-~~ 887 (1094)
..-.+.||.|..+.||+....+..+.+|..+... . ...|..|...|+.|.- -.++++++++... ..
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~-~---------~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~ 85 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQGNPMPLMARSFS-T---------PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSP 85 (297)
T ss_pred hheeeecCCccceeEEEEEcCCCCEEEEEecccc-c---------chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcC
Confidence 3445679999999999987655567778754310 1 1356788888888853 3678888887643 12
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHC
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSK 935 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~ 935 (1094)
+..++|||++++.++.+. ..+......++.+++++|+-||+.
T Consensus 86 g~~~LVmE~i~G~~~~~~------~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 86 GPDVLLLERLRGVSVEAP------ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred CCeEEEEeccCCEecCCC------CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999887651 123334455667778888888874
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.60 E-value=0.14 Score=58.35 Aligned_cols=30 Identities=27% Similarity=0.269 Sum_probs=25.2
Q ss_pred ceeccCCCCceEeccCCCCCCcEEEEecCCccc
Q 037285 937 IVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI 969 (1094)
Q Consensus 937 IIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl 969 (1094)
++|+|+.+.|||++. +++.++++||..|..
T Consensus 184 ~CHnDl~~~NiL~~~---~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNE---DEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeC---CCCcEEEEcccccCC
Confidence 799999999999961 345799999998763
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.55 E-value=0.63 Score=53.65 Aligned_cols=33 Identities=24% Similarity=0.321 Sum_probs=27.3
Q ss_pred CceeccCCCCceEeccCCCCCCcEEEEecCCcccccC
Q 037285 936 NIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRN 972 (1094)
Q Consensus 936 GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~ 972 (1094)
.++|+|+.+.||+++ ...-+=|.||+++..-+.
T Consensus 199 ~lvHGD~~~gNlii~----~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 199 VLVHGDYRPGNLIID----PGRPTGVLDWELATLGDP 231 (321)
T ss_pred eeeeCCcccCCEEEe----CCCeeEEEeccccccCCc
Confidence 389999999999998 455599999999875443
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1094 | ||||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-42 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-42 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-40 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-39 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-39 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-34 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-31 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-30 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-30 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-30 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-30 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-30 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-30 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-30 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-29 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-29 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-29 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-29 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-29 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-29 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-29 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-29 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-29 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-29 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-29 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-29 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-29 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-29 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 8e-29 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-28 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-28 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-28 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-28 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-28 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-28 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-28 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-28 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-28 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-28 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-28 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-28 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-28 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-28 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-28 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-28 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-28 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-28 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-28 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-28 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-28 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-27 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-27 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-27 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-27 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-27 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-27 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-27 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-27 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-27 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-27 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-27 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-27 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-27 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-27 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-27 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-27 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-27 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-27 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-27 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-27 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-27 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-27 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-27 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-27 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-27 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-27 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-27 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-27 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-27 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-27 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-27 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-27 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-27 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-27 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-27 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-27 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-27 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-27 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 8e-27 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-27 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-27 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-27 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-27 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-26 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-26 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-26 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-26 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-26 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-26 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-26 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-26 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-26 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-26 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-26 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-26 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-26 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-26 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-26 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-26 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-26 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-26 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-26 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-26 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-26 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-26 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-26 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-26 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-26 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-26 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-26 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-26 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-26 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-26 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-26 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-26 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-26 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-26 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-26 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-26 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-26 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-26 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-26 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-26 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-26 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-26 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-26 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-26 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-26 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 8e-26 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-26 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 9e-26 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-25 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-25 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-25 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-25 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-25 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-25 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-25 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-25 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-25 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-25 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-25 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-25 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-25 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-25 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-25 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-25 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-25 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-25 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-25 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-25 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-25 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-25 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-25 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-25 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-25 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-25 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-25 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-25 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-25 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-24 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-24 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-24 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-24 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-24 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-24 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-24 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-24 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-24 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-24 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-24 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-24 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-24 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-24 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-24 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-24 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-24 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-24 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-24 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-24 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-24 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-24 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-24 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-24 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-24 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-24 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-24 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-24 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-24 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-24 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-24 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 7e-24 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-24 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-24 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-24 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 9e-24 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-23 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-23 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-23 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-23 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-23 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-23 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-23 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-23 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-23 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-23 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-23 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-23 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-23 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-23 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-23 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-23 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-23 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-23 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-23 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-23 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-23 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-23 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-23 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-23 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-23 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-23 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-22 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-22 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-22 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-22 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-22 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-22 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-22 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-22 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-22 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-21 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-21 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-21 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-21 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-21 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-21 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-21 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-21 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-21 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-21 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-21 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-21 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-21 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-21 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 7e-21 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-21 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-21 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-21 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-21 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-20 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-20 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-20 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-20 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-20 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-20 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-20 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-20 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-20 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-20 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-20 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-20 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-20 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-20 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-20 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-20 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-20 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-20 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-20 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-20 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-20 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-20 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-20 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-20 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-20 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-20 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-20 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-20 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-19 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-19 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-19 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-19 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-19 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-19 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-19 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-19 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-19 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-19 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-19 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-19 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-19 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-19 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-19 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-19 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-19 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-19 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-19 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-19 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-19 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-19 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-19 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-19 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-19 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-19 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-19 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-19 | ||
| 1oec_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-19 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-19 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-19 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-19 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-19 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-19 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-19 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-19 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-19 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-19 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-19 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-19 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-19 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-19 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-19 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-19 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-19 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-19 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-19 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-19 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-19 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-19 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-19 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-19 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-19 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-19 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-19 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-19 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-19 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-19 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-19 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 9e-19 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-19 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-18 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-18 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-18 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-18 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-18 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-18 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-18 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-18 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-18 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-18 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-18 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-18 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-18 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-18 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-18 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-18 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-18 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-18 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-18 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-17 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-17 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-17 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-17 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-17 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-17 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-17 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-17 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-17 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-17 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-17 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-17 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-17 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-16 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-16 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-16 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-16 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-16 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-16 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-16 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-16 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-16 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-16 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-16 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-16 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-16 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-16 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-16 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-16 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-16 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-16 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-16 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-16 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-16 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-16 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-16 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 9e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-15 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-15 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-15 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-15 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-15 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-15 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-15 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-15 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-14 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-14 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-14 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-14 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 8e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-13 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-13 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-13 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-13 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-13 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-13 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-13 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-13 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-13 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-13 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 8e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-12 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-12 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-12 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-12 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-12 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 8e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 9e-12 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-11 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-11 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-11 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-11 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-11 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 8e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-11 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 9e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 9e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-10 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-10 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 8e-10 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-09 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-09 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-09 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-09 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-09 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-09 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-09 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-09 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-09 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 6e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 9e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-07 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 7e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 9e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-06 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 9e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 9e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-05 |
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1OEC|A Chain A, Fgfr2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 387 bits (996), Expect = e-127
Identities = 100/288 (34%), Positives = 154/288 (53%), Gaps = 14/288 (4%)
Query: 798 DFDVSSVQVIKNEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQER 855
+F S + + + ++E +K++G G FG V+ G+ + VAIK + G + E+
Sbjct: 7 EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK 66
Query: 856 LTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDR 915
EF +E I+S L+HPN+V YG++ + P V E++ G L H L+ K +
Sbjct: 67 FQ-EFQREVFIMSNLNHPNIVKLYGLMHNPP----RMVMEFVPCGDLYHRLLDKAHPIKW 121
Query: 916 RRRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNLKDPSRPIC-KVGDFGLSKIKRN 972
+L + +D A G+EY+ ++N IVH DL+ N+ + D + P+C KV DFGLS+ +
Sbjct: 122 SVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH 181
Query: 973 TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG--AII 1030
+ G+ G WMAPE + +EK D +SF ++L+ ILTGE P+ YG I
Sbjct: 182 S--VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI 239
Query: 1031 GGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078
I LRPTIP C R ++E CW+ +P RP F+ I L L
Sbjct: 240 NMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 380 bits (978), Expect = e-124
Identities = 109/289 (37%), Positives = 159/289 (55%), Gaps = 19/289 (6%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEI 866
I DL ++++G+G+FGTV+ +W G+DVA+K + + F EF +E I
Sbjct: 34 IPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVN------EFLREVAI 87
Query: 867 LSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD--RFLDRRRRLIIAMD 924
+ +L HPN+V F G V P L+ V EY+ GSL +L + LD RRRL +A D
Sbjct: 88 MKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYD 145
Query: 925 AAFGMEYLHSKN--IVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSG-GVRG 981
A GM YLH++N IVH +LK NLLV+ + KV DFGLS++K +T +S G
Sbjct: 146 VAKGMNYLHNRNPPIVHRNLKSPNLLVD----KKYTVKVCDFGLSRLKASTFLSSKSAAG 201
Query: 982 TLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT 1041
T WMAPE+L S +EK DV+SFG++LWE+ T ++P+ N++ ++ + R
Sbjct: 202 TPEWMAPEVLRDEPS--NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE 259
Query: 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQTKGHGN 1090
IP + + ++E CW P RPSF I LR L +A +
Sbjct: 260 IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSD 308
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 376 bits (967), Expect = e-122
Identities = 96/279 (34%), Positives = 140/279 (50%), Gaps = 18/279 (6%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEI 866
I +L ++ +G G FG VY W G +VA+K + + + +EA++
Sbjct: 4 IDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARH----DPDEDISQTIENVRQEAKL 59
Query: 867 LSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAA 926
+ L HPN++A GV P L V E+ G L VL K + + A+ A
Sbjct: 60 FAMLKHPNIIALRGVCLKEP--NLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIA 115
Query: 927 FGMEYLHSKN---IVHFDLKCDNLLVN----LKDPSRPICKVGDFGLSKIKRNTLVSGGV 979
GM YLH + I+H DLK N+L+ D S I K+ DFGL++ T
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA 175
Query: 980 RGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 1039
G WMAPE++ S S+ DV+S+G++LWE+LTGE P+ + A+ G+ N L
Sbjct: 176 -GAYAWMAPEVIRAS--MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA 232
Query: 1040 PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078
IPS C + LME+CW P+P +RPSFT I +L +
Sbjct: 233 LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 375 bits (964), Expect = e-122
Identities = 71/277 (25%), Positives = 120/277 (43%), Gaps = 18/277 (6%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEI 866
I + L +L G ++ G+W+G D+ +K +K ++ R S +F +E
Sbjct: 7 IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSR------DFNEECPR 60
Query: 867 LSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVR-KDRFLDRRRRLIIAMDA 925
L HPNV+ G Q P + +M GSL +VL + +D+ + + A+D
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 926 AFGMEYLHSKN--IVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTL 983
A GM +LH+ I L +++++ ++ + ++ G
Sbjct: 121 ARGMAFLHTLEPLIPRHALNSRSVMIDEDMT----ARISMADVKFSFQSP----GRMYAP 172
Query: 984 PWMAPELLSGSSSKV-SEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTI 1042
W+APE L D++SF ++LWE++T E P+A++ I + LRPTI
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI 232
Query: 1043 PSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079
P LM+ C +PA RP F I L +
Sbjct: 233 PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 356 bits (915), Expect = e-115
Identities = 93/281 (33%), Positives = 145/281 (51%), Gaps = 22/281 (7%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEI 866
I + + + +GSG+FGTVY GKW G DVA+K + + T + F E +
Sbjct: 21 IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPT------PQQLQAFKNEVGV 73
Query: 867 LSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAA 926
L K H N++ F G LA V ++ SL H L + + ++ + IA A
Sbjct: 74 LRKTRHVNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTA 130
Query: 927 FGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVS---GGVRGTL 983
GM+YLH+K+I+H DLK +N+ ++ K+GDFGL+ K S + G++
Sbjct: 131 RGMDYLHAKSIIHRDLKSNNIFLH----EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 984 PWMAPELLSG-SSSKVSEKVDVFSFGIVLWEILTGEEPYANM-HYGAIIGGIVNNTLRPT 1041
WMAPE++ S+ S + DV++FGIVL+E++TG+ PY+N+ + II + +L P
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD 246
Query: 1042 ---IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079
+ S C + LM EC RPSF I + + L+
Sbjct: 247 LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 354 bits (911), Expect = e-114
Identities = 93/298 (31%), Positives = 143/298 (47%), Gaps = 27/298 (9%)
Query: 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWK 862
S+ +I +++E ++ +G G FG V KWR DVAIK+I+ E F
Sbjct: 1 SLHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIE----------SESERKAFIV 50
Query: 863 EAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDR--FLDRRRRLI 920
E LS+++HPN+V YG + + V EY GSL +VL + + +
Sbjct: 51 ELRQLSRVNHPNIVKLYGACLN----PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMS 106
Query: 921 IAMDAAFGMEYLHS---KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSG 977
+ + G+ YLHS K ++H DLK NLL+ + K+ DFG + + + +
Sbjct: 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLL---VAGGTVLKICDFGTACDIQTHMTNN 163
Query: 978 GVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAI-IGGIVNN 1036
+G+ WMAPE+ GS SEK DVFS+GI+LWE++T +P+ + A I V+N
Sbjct: 164 --KGSAAWMAPEVFEGS--NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN 219
Query: 1037 TLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQTKGHGNKPSK 1094
RP + +LM CW+ +P+ RPS EI + L P +
Sbjct: 220 GTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQ 277
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 349 bits (898), Expect = e-112
Identities = 81/297 (27%), Positives = 116/297 (39%), Gaps = 27/297 (9%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEI 866
I E LE + +G G FG VYHG+W G +VAI+ I + E F +E
Sbjct: 30 IPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIE------RDNEDQLKAFKREVMA 82
Query: 867 LSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAA 926
+ H NVV F G P LA + +L V+ LD + IA +
Sbjct: 83 YRQTRHENVVLFMGACMSPP--HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIV 140
Query: 927 FGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSG------GVR 980
GM YLH+K I+H DLK N+ + + DFGL I
Sbjct: 141 KGMGYLHAKGILHKDLKSKNVFYDNGK-----VVITDFGLFSISGVLQAGRREDKLRIQN 195
Query: 981 GTLPWMAPELLSGSSSKV-------SEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI 1033
G L +APE++ S S+ DVF+ G + +E+ E P+ AII +
Sbjct: 196 GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM 255
Query: 1034 VNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQTKGHGN 1090
E ++ CWA RP+FT++ L L + G+
Sbjct: 256 GTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGH 312
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 313 bits (804), Expect = 3e-98
Identities = 93/363 (25%), Positives = 149/363 (41%), Gaps = 72/363 (19%)
Query: 760 SMQFDAMMENLRTTESDYEEGNAGNRNIGLPSLNPSLVDFDVSSVQVIKNEDLEEQKELG 819
SM + E+LR + +G+ GLP L VQ + ++ K++G
Sbjct: 1 SMTYIPPGESLRDLIEQSQSSGSGS---GLPLL-----------VQRTIAKQIQMVKQIG 46
Query: 820 SGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEI--LSKLHHPNVVA 877
G +G V+ GKWRG VA+K + +++E EI + H N++
Sbjct: 47 KGRYGEVWMGKWRGEKVAVKVFFTTEEA-----------SWFRETEIYQTVLMRHENILG 95
Query: 878 FYGVVQDGPGGT--LATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSK 935
F G G L + +Y +GSL L K LD + L +A + G+ +LH++
Sbjct: 96 FIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 936 N--------IVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT-----LVSGGVRGT 982
I H DLK N+LV C + D GL+ + + GT
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVK----KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209
Query: 983 LPWMAPELLSGSSSKVS----EKVDVFSFGIVLWEILTGEE----------PYANM---- 1024
+M PE+L S ++ D++SFG++LWE+ PY ++
Sbjct: 210 KRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269
Query: 1025 -HYGAIIGGIVNNTLRPTIPSY-----CDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078
Y + + LRP+ P+ C + LM ECWA NPA+R + + L +
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329
Query: 1079 STA 1081
S +
Sbjct: 330 SES 332
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 298 bits (766), Expect = 4e-93
Identities = 89/296 (30%), Positives = 124/296 (41%), Gaps = 34/296 (11%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTVEFWKEA 864
+ DL + LG G FG R T + +K + + E +R F KE
Sbjct: 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-----DEETQR---TFLKEV 58
Query: 865 EILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMD 924
+++ L HPNV+ F GV+ L + EY+ G+LR ++ D +R+ A D
Sbjct: 59 KVMRCLEHPNVLKFIGVLYKDK--RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKD 116
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT----------- 973
A GM YLHS NI+H DL N LV V DFGL+++ +
Sbjct: 117 IASGMAYLHSMNIIHRDLNSHNCLVR----ENKNVVVADFGLARLMVDEKTQPEGLRSLK 172
Query: 974 ----LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH-YGA 1028
V G WMAPE+++G S EKVDVFSFGIVL EI+ +
Sbjct: 173 KPDRKKRYTVVGNPYWMAPEMINGRSY--DEKVDVFSFGIVLCEIIGRVNADPDYLPRTM 230
Query: 1029 IIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQ 1084
G V L P C + + C +P RPSF ++ L L +
Sbjct: 231 DFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 282 bits (723), Expect = 1e-86
Identities = 95/368 (25%), Positives = 143/368 (38%), Gaps = 79/368 (21%)
Query: 754 DPSVSESMQFDAMMENLRTTESDYEEGNAGNRNIGLPSLNPSLVDFDVSSVQVIKNEDLE 813
P +SE ++ ++ T+ S GLP L VQ +
Sbjct: 7 RPFISEGTTLKDLIYDMTTSGSGS----------GLPLL-----------VQRTIARTIV 45
Query: 814 EQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEI--LSKLH 871
Q+ +G G FG V+ GKWRG +VA+K S +ER +++EAEI L
Sbjct: 46 LQESIGKGRFGEVWRGKWRGEEVAVKIFS--------SREER---SWFREAEIYQTVMLR 94
Query: 872 HPNVVAFYGVVQDGPGGT--LATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGM 929
H N++ F G L V++Y GSL L + + +A+ A G+
Sbjct: 95 HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGL 152
Query: 930 EYLHSK--------NIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT-----LVS 976
+LH + I H DLK N+LV C + D GL+ + +
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVK----KNGTCCIADLGLAVRHDSATDTIDIAP 208
Query: 977 GGVRGTLPWMAPELLSGSSS----KVSEKVDVFSFGIVLWEILTG------EEPYANMHY 1026
GT +MAPE+L S + + ++ D+++ G+V WEI E Y +Y
Sbjct: 209 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268
Query: 1027 G---------AIIGGIVNNTLRPTIPSY-----CDAEWRTLMEECWAPNPAARPSFTEIA 1072
+ + LRP IP+ +M ECW N AAR + I
Sbjct: 269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328
Query: 1073 SRLRVLST 1080
L LS
Sbjct: 329 KTLSQLSQ 336
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 275 bits (704), Expect = 2e-84
Identities = 79/317 (24%), Positives = 131/317 (41%), Gaps = 58/317 (18%)
Query: 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWK 862
S+Q D+ + +G G +G V+ G W+G +VA+K SS E+ +++
Sbjct: 1 SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIF--------SSRDEK---SWFR 49
Query: 863 EAEI--LSKLHHPNVVAFYGVVQDGPGGT--LATVAEYMVDGSLRHVLVRKDRFLDRRRR 918
E E+ L H N++ F + L + Y GSL L + LD
Sbjct: 50 ETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSC 107
Query: 919 LIIAMDAAFGMEYLHSK--------NIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK 970
L I + A G+ +LH + I H DLK N+LV C + D GL+ +
Sbjct: 108 LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK----KNGQCCIADLGLAVMH 163
Query: 971 RNT-----LVSGGVRGTLPWMAPELLSGS----SSKVSEKVDVFSFGIVLWEILTGEE-- 1019
+ + + GT +MAPE+L + ++VD+++FG+VLWE+
Sbjct: 164 SQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN 223
Query: 1020 --------PYANMH-----YGAIIGGIVNNTLRPTIPSY-----CDAEWRTLMEECWAPN 1061
P+ ++ + + + + RP IP+ LM+ECW N
Sbjct: 224 GIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQN 283
Query: 1062 PAARPSFTEIASRLRVL 1078
P+AR + I L +
Sbjct: 284 PSARLTALRIKKTLTKI 300
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 236 bits (603), Expect = 4e-70
Identities = 69/313 (22%), Positives = 118/313 (37%), Gaps = 54/313 (17%)
Query: 806 VIKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAE 865
++ L+ + G FG V+ + VA+K Q++ + + E
Sbjct: 20 YFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIF---------PIQDKQSWQNEYEVY 70
Query: 866 ILSKLHHPNVVAFYGVVQDGPGGT--LATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAM 923
L + H N++ F G + G L + + GSL L K + IA
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAE 128
Query: 924 DAAFGMEYLHSK----------NIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK--- 970
A G+ YLH I H D+K N+L+ + + + DFGL+
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK-NNLT---ACIADFGLALKFEAG 184
Query: 971 RNTLVSGGVRGTLPWMAPELLSGS---SSKVSEKVDVFSFGIVLWEILTGEEPYANMH-- 1025
++ + G GT +MAPE+L G+ ++D+++ G+VLWE+ +
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244
Query: 1026 ----YGAIIGG----------IVNNTLRPTIPSYCD-----AEWRTLMEECWAPNPAARP 1066
+ IG +V+ RP + Y A +EECW + AR
Sbjct: 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304
Query: 1067 SFTEIASRLRVLS 1079
S + R+ +
Sbjct: 305 SAGCVGERITQMQ 317
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 7e-70
Identities = 92/276 (33%), Positives = 131/276 (47%), Gaps = 24/276 (8%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTVEFWKEA 864
+ +EDL +++G G FG V+ G+ R T VA+K +++ + +F +EA
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-----LPPDLK--AKFLQEA 163
Query: 865 EILSKLHHPNVVAFYGVV-QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAM 923
IL + HPN+V GV Q P + V E + G L + L + L +
Sbjct: 164 RILKQYSHPNIVRLIGVCTQKQP---IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVG 220
Query: 924 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-IKRNTLVSGGVRGT 982
DAA GMEYL SK +H DL N LV K+ + K+ DFG+S+ + G
Sbjct: 221 DAAAGMEYLESKCCIHRDLAARNCLVTEKN----VLKISDFGMSREEADGVYAASGGLRQ 276
Query: 983 LP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLR 1039
+P W APE L + + S + DV+SFGI+LWE + G PY N+ + R
Sbjct: 277 VPVKWTAPEAL--NYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG-GR 333
Query: 1040 PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
P C LME+CWA P RPSF+ I L
Sbjct: 334 LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQEL 369
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 1e-67
Identities = 85/286 (29%), Positives = 128/286 (44%), Gaps = 25/286 (8%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTVEFW 861
I ED+ + LG G FG VY G + +VA+K KK + + +F
Sbjct: 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-----CTLDNK--EKFM 61
Query: 862 KEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLII 921
EA I+ L HP++V G++++ P + E G L H L R L ++
Sbjct: 62 SEAVIMKNLDHPHIVKLIGIIEEEP---TWIIMELYPYGELGHYLERNKNSLKVLTLVLY 118
Query: 922 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRG 981
++ M YL S N VH D+ N+LV S K+GDFGLS+ +
Sbjct: 119 SLQICKAMAYLESINCVHRDIAVRNILVA----SPECVKLGDFGLSRYIEDEDYYKASVT 174
Query: 982 TLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 1038
LP WM+PE S + + + DV+ F + +WEIL+ G++P+ + +IG +
Sbjct: 175 RLPIKWMSPE--SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR 232
Query: 1039 RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQ 1084
P P C TLM CW +P+ RP FTE+ L +
Sbjct: 233 LPK-PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD 277
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 2e-67
Identities = 73/342 (21%), Positives = 120/342 (35%), Gaps = 70/342 (20%)
Query: 797 VDFDVSSVQVIKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERL 856
++ S + ++L+ + +G G +G VY G VA+K S +
Sbjct: 1 MEAAASEPS-LDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVF--------SFANRQ- 50
Query: 857 TVEFWKEAEI--LSKLHHPNVVAFYGVVQDGPGGT---LATVAEYMVDGSLRHVLVRKDR 911
F E I + + H N+ F + V EY +GSL L
Sbjct: 51 --NFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL--SLH 106
Query: 912 FLDRRRRLIIAMDAAFGMEYLHS---------KNIVHFDLKCDNLLVNLKDPSRPICKVG 962
D +A G+ YLH+ I H DL N+LV D + C +
Sbjct: 107 TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK-NDGT---CVIS 162
Query: 963 DFGLSKIKRNTLVSG---------GVRGTLPWMAPELLSGSSS-----KVSEKVDVFSFG 1008
DFGLS + GT+ +MAPE+L G+ + ++VD+++ G
Sbjct: 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALG 222
Query: 1009 IVLWEIL---TGEEPYANMH-----YGAIIGG----------IVNNTLRPTIPSYCD--- 1047
++ WEI T P ++ + +G + RP P
Sbjct: 223 LIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENS 282
Query: 1048 ---AEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQTK 1086
+ +E+CW + AR + R+ L + K
Sbjct: 283 LAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK 324
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 2e-67
Identities = 74/280 (26%), Positives = 125/280 (44%), Gaps = 27/280 (9%)
Query: 806 VIKNEDLEEQKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTVE 859
++K + ++ K LGSG FGTVY G W VAIK ++++ +S + E
Sbjct: 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-----TSPKAN--KE 63
Query: 860 FWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRL 919
EA +++ + +P+V G+ + + + M G L + + + L
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQYLL 120
Query: 920 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-IKRNTLVSGG 978
+ A GM YL + +VH DL N+LV + K+ DFGL+K +
Sbjct: 121 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVK----TPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 979 VRGTLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 1035
G +P WMA E + + + DV+S+G+ +WE++T G +PY + I I+
Sbjct: 177 EGGKVPIKWMALESI--LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILE 233
Query: 1036 NTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
R P C + +M +CW + +RP F E+
Sbjct: 234 KGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEF 273
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 3e-67
Identities = 92/315 (29%), Positives = 140/315 (44%), Gaps = 35/315 (11%)
Query: 786 NIGLPSLNPSLVDFDVSSVQVIKNEDLEEQKELGSGTFGTVYHGKWRG-----TDVAIKR 840
+I L +LNP LV V + + + +G G FG VYHG A+K
Sbjct: 1 HIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 60
Query: 841 IKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDG 900
+ + E +F E I+ HPNV++ G+ G+ V YM G
Sbjct: 61 LNRIT-----DIGEVS--QFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLVVLPYMKHG 112
Query: 901 SLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICK 960
LR+ + + + + + A GM+YL SK VH DL N +++ + K
Sbjct: 113 DLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD----EKFTVK 168
Query: 961 VGDFGLSK-IKRNT--LVSGGVRGTLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEIL 1015
V DFGL++ + V LP WMA E S + K + K DV+SFG++LWE++
Sbjct: 169 VADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE--SLQTQKFTTKSDVWSFGVLLWELM 226
Query: 1016 T-GEEPYANMH----YGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTE 1070
T G PY +++ ++ G R P YC +M +CW P RPSF+E
Sbjct: 227 TRGAPPYPDVNTFDITVYLLQGR-----RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE 281
Query: 1071 IASRL-RVLSTAASQ 1084
+ SR+ + ST +
Sbjct: 282 LVSRISAIFSTFIGE 296
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 2e-66
Identities = 88/283 (31%), Positives = 138/283 (48%), Gaps = 25/283 (8%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTVEFW 861
I+ E +E + +G G FG V+ G + VAIK K +S+ R +F
Sbjct: 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-----TSDSVR--EKFL 64
Query: 862 KEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLII 921
+EA + + HP++V GV+ + P + + E G LR L + LD ++
Sbjct: 65 QEALTMRQFDHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILY 121
Query: 922 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRG 981
A + + YL SK VH D+ N+LV+ S K+GDFGLS+ ++ +G
Sbjct: 122 AYQLSTALAYLESKRFVHRDIAARNVLVS----SNDCVKLGDFGLSRYMEDSTYYKASKG 177
Query: 982 TLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 1038
LP WMAPE + + + + DV+ FG+ +WEIL G +P+ + +IG I N
Sbjct: 178 KLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER 235
Query: 1039 RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081
P P C +LM +CWA +P+ RP FTE+ ++L +
Sbjct: 236 LPM-PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 4e-66
Identities = 82/279 (29%), Positives = 122/279 (43%), Gaps = 24/279 (8%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTVEFW 861
I +DL ++LG G+FG V G+W VA+K +K + + + F
Sbjct: 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD-----FI 69
Query: 862 KEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLII 921
+E + L H N++ YGVV P + V E GSL L +
Sbjct: 70 REVNAMHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY 126
Query: 922 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT----LVSG 977
A+ A GM YL SK +H DL NLL+ +R + K+GDFGL + ++
Sbjct: 127 AVQVAEGMGYLESKRFIHRDLAARNLLLA----TRDLVKIGDFGLMRALPQNDDHYVMQE 182
Query: 978 GVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 1036
+ W APE S + S D + FG+ LWE+ T G+EP+ ++ I+ I
Sbjct: 183 HRKVPFAWCAPE--SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 240
Query: 1037 TLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
R P C + +M +CWA P RP+F + L
Sbjct: 241 GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 6e-66
Identities = 90/274 (32%), Positives = 136/274 (49%), Gaps = 24/274 (8%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAE 865
+K E++ KELGSG FG V GKW+G DVA+K IK+ S ++ EF++EA+
Sbjct: 5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG-----SMSED----EFFQEAQ 55
Query: 866 ILSKLHHPNVVAFYGVV-QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMD 924
+ KL HP +V FYGV ++ P + V EY+ +G L + L + L+ + L + D
Sbjct: 56 TMMKLSHPKLVKFYGVCSKEYP---IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYD 112
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLP 984
GM +L S +H DL N LV+ KV DFG+++ + V P
Sbjct: 113 VCEGMAFLESHQFIHRDLAARNCLVD----RDLCVKVSDFGMTRYVLDDQYVSSVGTKFP 168
Query: 985 --WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPT 1041
W APE+ K S K DV++FGI++WE+ + G+ PY ++ V+ R
Sbjct: 169 VKWSAPEVF--HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV-LKVSQGHRLY 225
Query: 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
P +M CW P RP+F ++ S +
Sbjct: 226 RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSI 259
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 7e-66
Identities = 82/281 (29%), Positives = 131/281 (46%), Gaps = 24/281 (8%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAE 865
I +L +E+GSG FG V+ G W VAIK I++ + +E +F +EAE
Sbjct: 5 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-----AMSEE----DFIEEAE 55
Query: 866 ILSKLHHPNVVAFYGVV-QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMD 924
++ KL HP +V YGV + P + V E+M G L L + L + +D
Sbjct: 56 VMMKLSHPKLVQLYGVCLEQAP---ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 112
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLP 984
GM YL ++H DL N LV + KV DFG+++ + + P
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVG----ENQVIKVSDFGMTRFVLDDQYTSSTGTKFP 168
Query: 985 --WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPT 1041
W +PE+ S S+ S K DV+SFG+++WE+ + G+ PY N ++ ++ R
Sbjct: 169 VKWASPEVF--SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-EDISTGFRLY 225
Query: 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAA 1082
P +M CW P RP+F+ + +L ++ +
Sbjct: 226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG 266
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 1e-65
Identities = 94/309 (30%), Positives = 143/309 (46%), Gaps = 42/309 (13%)
Query: 806 VIKNEDLEEQKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTVE 859
+ + L+ +LG G FG+V ++ VA+K+++ S +Q+R +
Sbjct: 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-----GPDQQR---D 70
Query: 860 FWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRL 919
F +E +IL LH +V + GV +L V EY+ G LR L R LD R L
Sbjct: 71 FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLL 130
Query: 920 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-IKRNT---LV 975
+ + GMEYL S+ VH DL N+LV S K+ DFGL+K + + +V
Sbjct: 131 LYSSQICKGMEYLGSRRCVHRDLAARNILVE----SEAHVKIADFGLAKLLPLDKDYYVV 186
Query: 976 SGGVRGTLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH-----YG 1027
G P W APE L S + S + DV+SFG+VL+E+ T ++ + G
Sbjct: 187 REP--GQSPIFWYAPESL--SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG 242
Query: 1028 AIIGGIVNNTLRPTI--------PSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079
+ L + P C AE LM+ CWAP+P RPSF+ + +L +L
Sbjct: 243 CERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302
Query: 1080 TAASQTKGH 1088
+ + + H
Sbjct: 303 SGSRGCETH 311
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 2e-65
Identities = 92/274 (33%), Positives = 131/274 (47%), Gaps = 24/274 (8%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAE 865
I +DL KELG+G FG V +GKWRG DVAIK IK+ S ++ EF +EA+
Sbjct: 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-----SMSED----EFIEEAK 71
Query: 866 ILSKLHHPNVVAFYGVV-QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMD 924
++ L H +V YGV + P + + EYM +G L + L ++ L + D
Sbjct: 72 VMMNLSHEKLVQLYGVCTKQRP---IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 128
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLP 984
MEYL SK +H DL N LVN + + KV DFGLS+ + + V P
Sbjct: 129 VCEAMEYLESKQFLHRDLAARNCLVN----DQGVVKVSDFGLSRYVLDDEYTSSVGSKFP 184
Query: 985 --WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPT 1041
W PE+L SK S K D+++FG+++WEI + G+ PY I
Sbjct: 185 VRWSPPEVL--MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR 242
Query: 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
P + T+M CW RP+F + S +
Sbjct: 243 -PHLASEKVYTIMYSCWHEKADERPTFKILLSNI 275
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 3e-65
Identities = 91/317 (28%), Positives = 138/317 (43%), Gaps = 42/317 (13%)
Query: 790 PSLNPSLVDFDVSSVQVIKNEDLEEQKELGSGTFGTVYHGKWRG-------TDVAIKRIK 842
P+ + +S ++ + +++ + LG G FG VY G+ G VA+K +
Sbjct: 10 PNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 69
Query: 843 KSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVV-QDGPGGTLATVAEYMVDGS 901
+ C SEQ+ L +F EA I+SK +H N+V GV Q P + E M G
Sbjct: 70 EVC-----SEQDEL--DFLMEALIISKFNHQNIVRCIGVSLQSLP---RFILMELMAGGD 119
Query: 902 LRHVL------VRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPS 955
L+ L + L L +A D A G +YL + +H D+ N L+ P
Sbjct: 120 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 179
Query: 956 RPICKVGDFGLSK-IKRNTLVSGGVRGTLP--WMAPE-LLSGSSSKVSEKVDVFSFGIVL 1011
R + K+GDFG+++ I R + G LP WM PE + G + K D +SFG++L
Sbjct: 180 R-VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG---IFTSKTDTWSFGVLL 235
Query: 1012 WEILT-GEEPYANMH----YGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARP 1066
WEI + G PY + + G R P C +M +CW P RP
Sbjct: 236 WEIFSLGYMPYPSKSNQEVLEFVTSGG-----RMDPPKNCPGPVYRIMTQCWQHQPEDRP 290
Query: 1067 SFTEIASRLRVLSTAAS 1083
+F I R+ +
Sbjct: 291 NFAIILERIEYCTQDPD 307
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 220 bits (564), Expect = 6e-65
Identities = 80/290 (27%), Positives = 124/290 (42%), Gaps = 34/290 (11%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTVEFWKEA 864
+ +G G FG VYHG++ AIK + + Q+ F +E
Sbjct: 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-----EMQQVE--AFLREG 73
Query: 865 EILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMD 924
++ L+HPNV+A G++ G + YM G L + R + + +
Sbjct: 74 LLMRGLNHPNVLALIGIMLPP-EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ 132
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-IKRN--TLVSGGVRG 981
A GMEYL + VH DL N +++ KV DFGL++ I V
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLD----ESFTVKVADFGLARDILDREYYSVQQHRHA 188
Query: 982 TLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH----YGAIIGGIV 1034
LP W A E S + + + K DV+SFG++LWE+LT G PY ++ + G
Sbjct: 189 RLPVKWTALE--SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR- 245
Query: 1035 NNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQ 1084
R P YC +M++CW +PA RP+F + + + +A
Sbjct: 246 ----RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 6e-65
Identities = 96/375 (25%), Positives = 155/375 (41%), Gaps = 35/375 (9%)
Query: 725 TPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSESMQFDAMMENLRTTESDYEEGNAGN 784
P+ GR + + G + + + + +E+ Y +G
Sbjct: 5 DPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGA-NT 63
Query: 785 RNIGLPSLNPSLVDFDVSSVQVIKNEDLEEQKELGSGTFGTVYHGKWRG-----TDVAIK 839
+I L +LNP LV V + + + +G G FG VYHG A+K
Sbjct: 64 VHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK 123
Query: 840 RIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVD 899
+ + E +F E I+ HPNV++ G+ G+ V YM
Sbjct: 124 SLNRIT-----DIGEVS--QFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLVVLPYMKH 175
Query: 900 GSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC 959
G LR+ + + + + + A GM++L SK VH DL N +++ +
Sbjct: 176 GDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD----EKFTV 231
Query: 960 KVGDFGLSK-IKRN--TLVSGGVRGTLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEI 1014
KV DFGL++ + V LP WMA E S + K + K DV+SFG++LWE+
Sbjct: 232 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE--SLQTQKFTTKSDVWSFGVLLWEL 289
Query: 1015 LT-GEEPYANMH----YGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFT 1069
+T G PY +++ ++ G R P YC +M +CW P RPSF+
Sbjct: 290 MTRGAPPYPDVNTFDITVYLLQGR-----RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFS 344
Query: 1070 EIASRLRVLSTAASQ 1084
E+ SR+ + +
Sbjct: 345 ELVSRISAIFSTFIG 359
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 8e-65
Identities = 86/297 (28%), Positives = 123/297 (41%), Gaps = 40/297 (13%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTVEFW 861
I L K LG G FG+V G + VA+K +K SS++E EF
Sbjct: 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKL----DNSSQREIE--EFL 84
Query: 862 KEAEILSKLHHPNVVAFYGVV-QDGPGGTLAT--VAEYMVDGSLRHVLVRKDRFLDRRRR 918
EA + HPNV+ GV + G + +M G L L R +
Sbjct: 85 SEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL-LYSRLETGPKH 143
Query: 919 LI------IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-IKR 971
+ +D A GMEYL ++N +H DL N ++ V DFGLSK I
Sbjct: 144 IPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR----DDMTVCVADFGLSKKIYS 199
Query: 972 NTLVSGGVRGTLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH--- 1025
G +P W+A E L+ + K DV++FG+ +WEI T G PY +
Sbjct: 200 GDYYRQGRIAKMPVKWIAIESLA--DRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257
Query: 1026 -YGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081
Y ++ G R P C E +M CW +P RP+F+ + +L L +
Sbjct: 258 MYDYLLHGH-----RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 1e-64
Identities = 87/292 (29%), Positives = 125/292 (42%), Gaps = 41/292 (14%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTVEFW 861
I + + LG G FG+V + + VA+K +K + + EF
Sbjct: 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKA----DIIASSDIE--EFL 73
Query: 862 KEAEILSKLHHPNVVAFYGVV-QDGPGGTLAT---VAEYMVDGSLRHVLVRKDRFLDRRR 917
+EA + + HP+V GV + G L + +M G L L R +
Sbjct: 74 REAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL-LASRIGENPF 132
Query: 918 RL------IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS-KIK 970
L +D A GMEYL S+N +H DL N ++ V DFGLS KI
Sbjct: 133 NLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA----EDMTVCVADFGLSRKIY 188
Query: 971 RNTLVSGGVRGTLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH-- 1025
G LP W+A E L+ + + DV++FG+ +WEI+T G+ PYA +
Sbjct: 189 SGDYYRQGCASKLPVKWLALESLA--DNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA 246
Query: 1026 --YGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
Y +IGG R P C E LM +CW+ +P RPSFT + L
Sbjct: 247 EIYNYLIGGN-----RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMEL 293
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 2e-64
Identities = 92/293 (31%), Positives = 135/293 (46%), Gaps = 28/293 (9%)
Query: 807 IKNEDLE-EQKELGSGTFGTVYHGKWRG----TDVAIKRIKKSCFTGRSSEQERLTVEFW 861
+K ++L ELG G FG+V G +R DVAIK +K+ G E
Sbjct: 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQ----GTEKADTE---EMM 58
Query: 862 KEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLII 921
+EA+I+ +L +P +V GV Q L V E G L LV K + +
Sbjct: 59 REAQIMHQLDNPYIVRLIGVCQAEA---LMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL 115
Query: 922 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI--KRNTLVSGGV 979
+ GM+YL KN VH DL N+L+ +R K+ DFGLSK ++ +
Sbjct: 116 LHQVSMGMKYLEEKNFVHRDLAARNVLLV----NRHYAKISDFGLSKALGADDSYYTARS 171
Query: 980 RGTLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 1036
G P W APE + + K S + DV+S+G+ +WE L+ G++PY M ++ +
Sbjct: 172 AGKWPLKWYAPECI--NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-AFIEQ 228
Query: 1037 TLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR-VLSTAASQTKGH 1088
R P C E LM +CW RP F + R+R + AS+ +GH
Sbjct: 229 GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 281
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 3e-64
Identities = 91/287 (31%), Positives = 136/287 (47%), Gaps = 26/287 (9%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTVEFWKEA 864
++ D+ + +LG G +G VY G W+ VA+K +K+ + E E EF KEA
Sbjct: 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVE----EFLKEA 60
Query: 865 EILSKLHHPNVVAFYGVV-QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLI-IA 922
++ ++ HPN+V GV ++ P + E+M G+L L +R L+ +A
Sbjct: 61 AVMKEIKHPNLVQLLGVCTREPP---FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 117
Query: 923 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGT 982
+ MEYL KN +H DL N LV + KV DFGLS++ +
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVG----ENHLVKVADFGLSRLMTGDTYTAHAGAK 173
Query: 983 LP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLR 1039
P W APE L+ +K S K DV++FG++LWEI T G PY + + + + R
Sbjct: 174 FPIKWTAPESLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YR 230
Query: 1040 PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQTK 1086
P C + LM CW NP+ RPSF EI + +S +
Sbjct: 231 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 277
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 4e-64
Identities = 101/318 (31%), Positives = 141/318 (44%), Gaps = 53/318 (16%)
Query: 789 LPSLNP---SLVDFDVSSVQVIKNEDLEEQKELGSGTFGTVYHGKWRG-------TDVAI 838
+ S+NP S D V + E + +ELG G+FG VY G +G T VAI
Sbjct: 1 MASVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAI 60
Query: 839 KRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVV-QDGPGGTLATVAEYM 897
K + ++ S +ER+ EF EA ++ + + +VV GVV Q P + E M
Sbjct: 61 KTVNEAA-----SMRERI--EFLNEASVMKEFNCHHVVRLLGVVSQGQP---TLVIMELM 110
Query: 898 VDGSLRHVLVRKDR----------FLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNL 947
G L+ L R R + + +A + A GM YL++ VH DL N
Sbjct: 111 TRGDLKSYL-RSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNC 169
Query: 948 LVNLKDPSRPICKVGDFGLS-KIKRNTLVSGGVRGTLP--WMAPE-LLSGSSSKVSEKVD 1003
+V K+GDFG++ I G +G LP WM+PE L G + D
Sbjct: 170 MVA----EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG---VFTTYSD 222
Query: 1004 VFSFGIVLWEILT-GEEPYANMH----YGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECW 1058
V+SFG+VLWEI T E+PY + ++ G P C LM CW
Sbjct: 223 VWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG-----LLDKPDNCPDMLFELMRMCW 277
Query: 1059 APNPAARPSFTEIASRLR 1076
NP RPSF EI S ++
Sbjct: 278 QYNPKMRPSFLEIISSIK 295
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 4e-64
Identities = 82/280 (29%), Positives = 126/280 (45%), Gaps = 27/280 (9%)
Query: 807 IKNEDLE-EQKELGSGTFGTVYHGKWRG----TDVAIKRIKKSCFTGRSSEQERLTVEFW 861
+ + L E KELGSG FGTV G ++ VA+K +K + + E
Sbjct: 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKN----EANDPALK--DELL 66
Query: 862 KEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLII 921
EA ++ +L +P +V G+ + V E G L L +++R + + + +
Sbjct: 67 AEANVMQQLDNPYIVRMIGICEAES---WMLVMEMAELGPLNKYL-QQNRHVKDKNIIEL 122
Query: 922 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI--KRNTLVSGGV 979
+ GM+YL N VH DL N+L+ ++ K+ DFGLSK
Sbjct: 123 VHQVSMGMKYLEESNFVHRDLAARNVLLV----TQHYAKISDFGLSKALRADENYYKAQT 178
Query: 980 RGTLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 1036
G P W APE + + K S K DV+SFG+++WE + G++PY M + ++
Sbjct: 179 HGKWPVKWYAPECI--NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-AMLEK 235
Query: 1037 TLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076
R P+ C E LM CW + RP F + RLR
Sbjct: 236 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 275
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 5e-64
Identities = 91/279 (32%), Positives = 134/279 (48%), Gaps = 28/279 (10%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEI 866
+ ++L+ + +G G FG V G +RG VA+K IK ++ Q F EA +
Sbjct: 18 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND-----ATAQ-----AFLAEASV 67
Query: 867 LSKLHHPNVVAFYGVV-QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLI-IAMD 924
+++L H N+V GV+ ++ L V EYM GSL L + R + L+ ++D
Sbjct: 68 MTQLRHSNLVQLLGVIVEEKG--GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 125
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLP 984
MEYL N VH DL N+LV+ + KV DFGL+ + + G LP
Sbjct: 126 VCEAMEYLEGNNFVHRDLAARNVLVS----EDNVAKVSDFGLT---KEASSTQD-TGKLP 177
Query: 985 --WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPT 1041
W APE L K S K DV+SFGI+LWEI + G PY + ++ V +
Sbjct: 178 VKWTAPEAL--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-PRVEKGYKMD 234
Query: 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLST 1080
P C +M+ CW + A RPSF ++ +L + T
Sbjct: 235 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 6e-64
Identities = 88/280 (31%), Positives = 131/280 (46%), Gaps = 24/280 (8%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAE 865
+ E L+ + LG+G FG V+ G + G T VA+K +K+ S + F EA
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-----SMSPD----AFLAEAN 60
Query: 866 ILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLI-IAMD 924
++ +L H +V Y VV P + + EYM +GSL L +L+ +A
Sbjct: 61 LMKQLQHQRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLP 984
A GM ++ +N +H DL+ N+LV+ CK+ DFGL+++ + + P
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVS----DTLSCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 985 --WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPT 1041
W APE ++ + K DV+SFGI+L EI+T G PY M +I + R
Sbjct: 174 IKWTAPEAIN--YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YRMV 230
Query: 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081
P C E LM CW P RP+F + S L TA
Sbjct: 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 7e-64
Identities = 95/294 (32%), Positives = 133/294 (45%), Gaps = 26/294 (8%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTVEFW 861
I+ + +K +GSG G V +G+ R VAIK +K +E++R +F
Sbjct: 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-----TERQR--RDFL 98
Query: 862 KEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLII 921
EA I+ + HPN++ GVV G V EYM +GSL L D + + +
Sbjct: 99 SEASIMGQFDHPNIIRLEGVVTRGR--LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGM 156
Query: 922 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI--KRNTLVSGGV 979
GM YL VH DL N+LV+ S +CKV DFGLS++
Sbjct: 157 LRGVGAGMRYLSDLGYVHRDLAARNVLVD----SNLVCKVSDFGLSRVLEDDPDAAYTTT 212
Query: 980 RGTLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 1036
G +P W APE + + S DV+SFG+V+WE+L GE PY NM +I V
Sbjct: 213 GGKIPIRWTAPEAI--AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI-SSVEE 269
Query: 1037 TLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQTKGHGN 1090
R P C LM +CW + A RP F++I S L L + +
Sbjct: 270 GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRATAT 323
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 8e-64
Identities = 91/314 (28%), Positives = 137/314 (43%), Gaps = 42/314 (13%)
Query: 790 PSLNPSLVDFDVSSVQVIKNEDLEEQKELGSGTFGTVYHGKWRG-------TDVAIKRIK 842
P+ + +S ++ + +++ + LG G FG VY G+ G VA+K +
Sbjct: 51 PNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 110
Query: 843 KSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVV-QDGPGGTLATVAEYMVDGS 901
+ C SEQ+ L +F EA I+SK +H N+V GV Q P + E M G
Sbjct: 111 EVC-----SEQDEL--DFLMEALIISKFNHQNIVRCIGVSLQSLP---RFILLELMAGGD 160
Query: 902 LRHVL------VRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPS 955
L+ L + L L +A D A G +YL + +H D+ N L+ P
Sbjct: 161 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 220
Query: 956 RPICKVGDFGLSK-IKRNTLVSGGVRGTLP--WMAPE-LLSGSSSKVSEKVDVFSFGIVL 1011
R + K+GDFG+++ I R G LP WM PE + G + K D +SFG++L
Sbjct: 221 R-VAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG---IFTSKTDTWSFGVLL 276
Query: 1012 WEILT-GEEPYANMH----YGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARP 1066
WEI + G PY + + G R P C +M +CW P RP
Sbjct: 277 WEIFSLGYMPYPSKSNQEVLEFVTSGG-----RMDPPKNCPGPVYRIMTQCWQHQPEDRP 331
Query: 1067 SFTEIASRLRVLST 1080
+F I R+ +
Sbjct: 332 NFAIILERIEYCTQ 345
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 1e-63
Identities = 91/306 (29%), Positives = 134/306 (43%), Gaps = 45/306 (14%)
Query: 806 VIKNEDLEEQKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTVE 859
+ L+ ++LG G FG+V ++ VA+K+++ S +
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----EEHLR----D 57
Query: 860 FWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRL 919
F +E EIL L H N+V + GV L + EY+ GSLR L + +D + L
Sbjct: 58 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 117
Query: 920 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-IKRNTL---V 975
GMEYL +K +H DL N+LV + K+GDFGL+K + ++ V
Sbjct: 118 QYTSQICKGMEYLGTKRYIHRDLATRNILVE----NENRVKIGDFGLTKVLPQDKEFFKV 173
Query: 976 SGGVRGTLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT----------------G 1017
G P W APE L + SK S DV+SFG+VL+E+ T G
Sbjct: 174 KEP--GESPIFWYAPESL--TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 229
Query: 1018 EEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077
+ M +I + NN P P C E +M ECW N RPSF ++A R+
Sbjct: 230 NDKQGQMIVFHLIELLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288
Query: 1078 LSTAAS 1083
+ +
Sbjct: 289 IRDNMA 294
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 2e-63
Identities = 75/290 (25%), Positives = 125/290 (43%), Gaps = 35/290 (12%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRG---------TDVAIKRIKKSCFTGRSSEQERLT 857
I+NEDL + LG GTF ++ G R T+V +K + K+
Sbjct: 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-----HRNYSE-- 57
Query: 858 VEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRR 917
F++ A ++SKL H ++V YGV G V E++ GSL L + ++
Sbjct: 58 -SFFEAASMMSKLSHKHLVLNYGVCVCGD--ENILVQEFVKFGSLDTYLKKNKNCINILW 114
Query: 918 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSR----PICKVGDFGLSKIKRNT 973
+L +A A M +L ++H ++ N+L+ ++ + P K+ D G+S
Sbjct: 115 KLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS---ITV 171
Query: 974 LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGG 1032
L ++ +PW+ PE + + ++ D +SFG LWEI + G++P + + +
Sbjct: 172 LPKDILQERIPWVPPECIE-NPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF 230
Query: 1033 IVNNTL--RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLST 1080
+ P AE L+ C P RPSF I L L T
Sbjct: 231 YEDRHQLPAP-----KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 2e-63
Identities = 86/299 (28%), Positives = 130/299 (43%), Gaps = 41/299 (13%)
Query: 806 VIKNEDLEEQKELGSGTFGTVYHGKWR------GTDVAIKRIKKSCFTGRSSEQERLTVE 859
+ L+ ++LG G FG V ++ G VA+K +K S +
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-----SGGNHI--AD 69
Query: 860 FWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRL 919
KE EIL L+H N+V + G+ + G + + E++ GSL+ L + ++ +++L
Sbjct: 70 LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQL 129
Query: 920 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-IKRNT---LV 975
A+ GM+YL S+ VH DL N+LV S K+GDFGL+K I+ + V
Sbjct: 130 KYAVQICKGMDYLGSRQYVHRDLAARNVLVE----SEHQVKIGDFGLTKAIETDKEYYTV 185
Query: 976 SGGVRGTLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAII-- 1030
P W APE L SK DV+SFG+ L E+LT + + M +
Sbjct: 186 KDD--RDSPVFWYAPECL--MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG 241
Query: 1031 ---GGIVNNTLRPTI--------PSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078
G + L T+ P C E LM +CW P+ R SF + L
Sbjct: 242 PTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 4e-63
Identities = 93/306 (30%), Positives = 137/306 (44%), Gaps = 45/306 (14%)
Query: 806 VIKNEDLEEQKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTVE 859
+ L+ ++LG G FG+V ++ VA+K+++ S + E R +
Sbjct: 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-----TEEHLR---D 88
Query: 860 FWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRL 919
F +E EIL L H N+V + GV L + EY+ GSLR L + +D + L
Sbjct: 89 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 148
Query: 920 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-IKRNT---LV 975
GMEYL +K +H DL N+LV + K+GDFGL+K + ++ V
Sbjct: 149 QYTSQICKGMEYLGTKRYIHRDLATRNILVE----NENRVKIGDFGLTKVLPQDKEYYKV 204
Query: 976 SGGVRGTLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT----------------G 1017
G P W APE L + SK S DV+SFG+VL+E+ T G
Sbjct: 205 KEP--GESPIFWYAPESL--TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 260
Query: 1018 EEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077
+ M +I + NN P P C E +M ECW N RPSF ++A R+
Sbjct: 261 NDKQGQMIVFHLIELLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319
Query: 1078 LSTAAS 1083
+ +
Sbjct: 320 IRDQMA 325
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 6e-63
Identities = 75/280 (26%), Positives = 125/280 (44%), Gaps = 27/280 (9%)
Query: 806 VIKNEDLEEQKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTVE 859
++K + ++ K LGSG FGTVY G W VAIK ++++ +S + E
Sbjct: 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-----TSPKAN--KE 63
Query: 860 FWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRL 919
EA +++ + +P+V G+ + + + M G L + + + L
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQYLL 120
Query: 920 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-IKRNTLVSGG 978
+ A GM YL + +VH DL N+LV + K+ DFGL+K +
Sbjct: 121 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVK----TPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 979 VRGTLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 1035
G +P WMA E S + + DV+S+G+ +WE++T G +PY + I I+
Sbjct: 177 EGGKVPIKWMALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILE 233
Query: 1036 NTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
R P C + +M +CW + +RP F E+
Sbjct: 234 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 273
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 6e-63
Identities = 94/307 (30%), Positives = 131/307 (42%), Gaps = 55/307 (17%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTVE 859
IK D+ ++ELG G FG V+ + VA+K +K + R +
Sbjct: 12 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP------TLAARK--D 63
Query: 860 FWKEAEILSKLHHPNVVAFYGVV-QDGPGGTLATVAEYMVDGSLRHVL------------ 906
F +EAE+L+ L H ++V FYGV P L V EYM G L L
Sbjct: 64 FQREAELLTNLQHEHIVKFYGVCGDGDP---LIMVFEYMKHGDLNKFLRAHGPDAMILVD 120
Query: 907 ---VRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGD 963
+ L + L IA A GM YL S++ VH DL N LV + + K+GD
Sbjct: 121 GQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG----ANLLVKIGD 176
Query: 964 FGLSK-IKRNTLVSGGVRGTLP--WMAPE-LLSGSSSKVSEKVDVFSFGIVLWEILT-GE 1018
FG+S+ + G LP WM PE ++ K + + DV+SFG++LWEI T G+
Sbjct: 177 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR---KFTTESDVWSFGVILWEIFTYGK 233
Query: 1019 EPYANMH----YGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074
+P+ + I G P C E +M CW P R + EI
Sbjct: 234 QPWFQLSNTEVIECITQGR-----VLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKI 288
Query: 1075 LRVLSTA 1081
L L A
Sbjct: 289 LHALGKA 295
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 1e-62
Identities = 97/286 (33%), Positives = 140/286 (48%), Gaps = 27/286 (9%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTVEF 860
I + QK +G+G FG VY G + VAIK +K +E++R V+F
Sbjct: 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-----TEKQR--VDF 93
Query: 861 WKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLI 920
EA I+ + H N++ GV+ + + EYM +G+L L KD + +
Sbjct: 94 LGEAGIMGQFSHHNIIRLEGVISKYK--PMMIITEYMENGALDKFLREKDGEFSVLQLVG 151
Query: 921 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR 980
+ A GM+YL + N VH DL N+LVN S +CKV DFGLS++ + +
Sbjct: 152 MLRGIAAGMKYLANMNYVHRDLAARNILVN----SNLVCKVSDFGLSRVLEDDPEATYTT 207
Query: 981 --GTLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 1035
G +P W APE + S K + DV+SFGIV+WE++T GE PY + ++ I +
Sbjct: 208 SGGKIPIRWTAPEAI--SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND 265
Query: 1036 NTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081
PT P C + LM +CW A RP F +I S L L A
Sbjct: 266 GFRLPT-PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 1e-62
Identities = 94/302 (31%), Positives = 125/302 (41%), Gaps = 54/302 (17%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTVE 859
I + +ELG FG VY G G VAIK +K R E
Sbjct: 6 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-----EGPLRE--E 58
Query: 860 FWKEAEILSKLHHPNVVAFYGVV-QDGPGGTLATVAEYMVDGSLRHVLVRK--------- 909
F EA + ++L HPNVV GVV +D P L+ + Y G L LV +
Sbjct: 59 FRHEAMLRARLQHPNVVCLLGVVTKDQP---LSMIFSYCSHGDLHEFLVMRSPHSDVGST 115
Query: 910 ------DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGD 963
L+ + + A GMEYL S ++VH DL N+LV + K+ D
Sbjct: 116 DDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY----DKLNVKISD 171
Query: 964 FGLS-KIKRNTLVSGGVRGTLP--WMAPE-LLSGSSSKVSEKVDVFSFGIVLWEILT-GE 1018
GL ++ LP WMAPE ++ G K S D++S+G+VLWE+ + G
Sbjct: 172 LGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG---KFSIDSDIWSYGVVLWEVFSYGL 228
Query: 1019 EPYANMH----YGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074
+PY I P C A LM ECW P+ RP F +I SR
Sbjct: 229 QPYCGYSNQDVVEMIRNRQ-----VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 283
Query: 1075 LR 1076
LR
Sbjct: 284 LR 285
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 2e-62
Identities = 89/279 (31%), Positives = 136/279 (48%), Gaps = 28/279 (10%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEI 866
+ ++L+ + +G G FG V G +RG VA+K IK +++ F EA +
Sbjct: 190 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQ------AFLAEASV 239
Query: 867 LSKLHHPNVVAFYGVV-QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLI-IAMD 924
+++L H N+V GV+ ++ L V EYM GSL L + R + L+ ++D
Sbjct: 240 MTQLRHSNLVQLLGVIVEEKG--GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 297
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLP 984
MEYL N VH DL N+LV+ + KV DFGL+K + ++ G LP
Sbjct: 298 VCEAMEYLEGNNFVHRDLAARNVLVS----EDNVAKVSDFGLTK-EASSTQDT---GKLP 349
Query: 985 --WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPT 1041
W APE L K S K DV+SFGI+LWEI + G PY + ++ + +
Sbjct: 350 VKWTAPEAL--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMD 406
Query: 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLST 1080
P C +M+ CW + A RP+F ++ +L + T
Sbjct: 407 APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 3e-62
Identities = 76/279 (27%), Positives = 118/279 (42%), Gaps = 27/279 (9%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTVEF 860
K +L + K LGSG FGTV+ G W V IK I+ S Q
Sbjct: 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK-----SGRQSF--QAV 62
Query: 861 WKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLI 920
+ L H ++V G+ L V +Y+ GSL + + L + L
Sbjct: 63 TDHMLAIGSLDHAHIVRLLGLCPGSS---LQLVTQYLPLGSLLDHVRQHRGALGPQLLLN 119
Query: 921 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-IKRNTLVSGGV 979
+ A GM YL +VH +L N+L+ S +V DFG++ + +
Sbjct: 120 WGVQIAKGMYYLEEHGMVHRNLAARNVLLK----SPSQVQVADFGVADLLPPDDKQLLYS 175
Query: 980 RGTLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 1036
P WMA E S K + + DV+S+G+ +WE++T G EPYA + + ++
Sbjct: 176 EAKTPIKWMALE--SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP-DLLEK 232
Query: 1037 TLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
R P C + +M +CW + RP+F E+A+
Sbjct: 233 GERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEF 271
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 3e-62
Identities = 91/282 (32%), Positives = 130/282 (46%), Gaps = 24/282 (8%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAE 865
I E L + +LG G FG V+ G W G T VAIK +K + E F +EA+
Sbjct: 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-----TMSPE----AFLQEAQ 231
Query: 866 ILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVL-VRKDRFLDRRRRLIIAMD 924
++ KL H +V Y VV + P + V EYM GSL L ++L + + +A
Sbjct: 232 VMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 288
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLP 984
A GM Y+ N VH DL+ N+LV +CKV DFGL+++ + + P
Sbjct: 289 IASGMAYVERMNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 985 --WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPT 1041
W APE + + K DV+SFGI+L E+ T G PY M ++ + R
Sbjct: 345 IKWTAPEAA--LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMP 401
Query: 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAAS 1083
P C LM +CW P RP+F + + L T+
Sbjct: 402 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 3e-62
Identities = 87/285 (30%), Positives = 139/285 (48%), Gaps = 25/285 (8%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTVEFW 861
I+ E +E + +G G FG V+ G + VAIK K +S+ R +F
Sbjct: 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-----TSDSVR--EKFL 439
Query: 862 KEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLII 921
+EA + + HP++V GV+ + P + + E G LR L + LD ++
Sbjct: 440 QEALTMRQFDHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKFSLDLASLILY 496
Query: 922 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRG 981
A + + YL SK VH D+ N+LV+ S K+GDFGLS+ ++ +G
Sbjct: 497 AYQLSTALAYLESKRFVHRDIAARNVLVS----SNDCVKLGDFGLSRYMEDSTYYKASKG 552
Query: 982 TLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 1038
LP WMAPE + + + + DV+ FG+ +WEIL G +P+ + +I G + N
Sbjct: 553 KLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI-GRIENGE 609
Query: 1039 RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAAS 1083
R +P C +LM +CWA +P+ RP FTE+ ++L +
Sbjct: 610 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 5e-62
Identities = 79/302 (26%), Positives = 129/302 (42%), Gaps = 43/302 (14%)
Query: 806 VIKNEDLEEQKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTVE 859
V L++ ++LG G FG V + VA+K +K +
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-------GPQHRSG 79
Query: 860 FWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRL 919
+ +E +IL L+H +++ + G +D +L V EY+ GSLR L + + + L
Sbjct: 80 WKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHS-IGLAQLL 137
Query: 920 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-IKRNT---LV 975
+ A GM YLH+++ +H DL N+L++ + + K+GDFGL+K + V
Sbjct: 138 LFAQQICEGMAYLHAQHYIHRDLAARNVLLD----NDRLVKIGDFGLAKAVPEGHEYYRV 193
Query: 976 SGGVRGTLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAII-- 1030
G P W APE L K DV+SFG+ L+E+LT + + +
Sbjct: 194 RED--GDSPVFWYAPECL--KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIG 249
Query: 1031 ---GGIVNNTLRPTI--------PSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079
G + L + P C AE LM+ CW + RP+F + L+ +
Sbjct: 250 IAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309
Query: 1080 TA 1081
Sbjct: 310 EK 311
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 1e-61
Identities = 88/279 (31%), Positives = 131/279 (46%), Gaps = 26/279 (9%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTVEFW 861
+ ++ K +G+G FG V G+ + VAIK +K +E++R +F
Sbjct: 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-----TEKQR--RDFL 94
Query: 862 KEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLII 921
EA I+ + HPN++ GVV + V EYM +GSL L + D + + +
Sbjct: 95 GEASIMGQFDHPNIIRLEGVVTKSK--PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM 152
Query: 922 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI--KRNTLVSGGV 979
A GM+YL VH DL N+L+N S +CKV DFGL ++
Sbjct: 153 LRGIASGMKYLSDMGYVHRDLAARNILIN----SNLVCKVSDFGLGRVLEDDPEAAYTTR 208
Query: 980 RGTLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 1036
G +P W +PE + + K + DV+S+GIVLWE+++ GE PY M +I +
Sbjct: 209 GGKIPIRWTSPEAI--AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266
Query: 1037 TLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
P P C A LM +CW + RP F +I S L
Sbjct: 267 YRLPP-PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 3e-61
Identities = 98/305 (32%), Positives = 135/305 (44%), Gaps = 53/305 (17%)
Query: 800 DVSSVQVIKNEDLEEQKELGSGTFGTVYHGKWRG----TDVAIKRIKKSCFTGRSSEQER 855
D + V+ D++ Q +G G FG V + + D AIKR+K+ +S+ +
Sbjct: 15 DPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-----ASKDDH 69
Query: 856 LTVEFWKEAEILSKL-HHPNVVAFYGVV-QDGPGGTLATVAEYMVDGSLRHVLVRKDRFL 913
+F E E+L KL HHPN++ G G L EY G+L L RK R L
Sbjct: 70 R--DFAGELEVLCKLGHHPNIINLLGACEHRGY---LYLAIEYAPHGNLLDFL-RKSRVL 123
Query: 914 DRRRR----------------LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRP 957
+ L A D A GM+YL K +H DL N+LV
Sbjct: 124 ETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG----ENY 179
Query: 958 ICKVGDFGLSKIKRNTLVSGGVRGTLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEIL 1015
+ K+ DFGLS+ + + G LP WMA E L+ S + DV+S+G++LWEI+
Sbjct: 180 VAKIADFGLSRGQEVYVKKTM--GRLPVRWMAIESLN--YSVYTTNSDVWSYGVLLWEIV 235
Query: 1016 T-GEEPYANMH----YGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTE 1070
+ G PY M Y + G R P CD E LM +CW P RPSF +
Sbjct: 236 SLGGTPYCGMTCAELYEKLPQGY-----RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ 290
Query: 1071 IASRL 1075
I L
Sbjct: 291 ILVSL 295
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 4e-61
Identities = 90/287 (31%), Positives = 136/287 (47%), Gaps = 26/287 (9%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTVEFWKEA 864
++ D+ + +LG G +G VY G W+ VA+K +K+ + E E EF KEA
Sbjct: 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVE----EFLKEA 267
Query: 865 EILSKLHHPNVVAFYGVV-QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLI-IA 922
++ ++ HPN+V GV ++ P + E+M G+L L +R L+ +A
Sbjct: 268 AVMKEIKHPNLVQLLGVCTREPP---FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 324
Query: 923 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGT 982
+ MEYL KN +H +L N LV + KV DFGLS++ +
Sbjct: 325 TQISSAMEYLEKKNFIHRNLAARNCLVG----ENHLVKVADFGLSRLMTGDTYTAHAGAK 380
Query: 983 LP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLR 1039
P W APE L + +K S K DV++FG++LWEI T G PY + + + + R
Sbjct: 381 FPIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YR 437
Query: 1040 PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQTK 1086
P C + LM CW NP+ RPSF EI + +S +
Sbjct: 438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 484
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 6e-61
Identities = 86/309 (27%), Positives = 126/309 (40%), Gaps = 49/309 (15%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTVE 859
+ L+ K LG G FG V G VA+K +K+ + E
Sbjct: 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-----THSEHR--A 76
Query: 860 FWKEAEILSKL-HHPNVVAFYGVV--QDGPGGTLATVAEYMVDGSLRHVLVRKDR----- 911
E +IL + HH NVV G GP L + E+ G+L L R R
Sbjct: 77 LMSELKILIHIGHHLNVVNLLGACTKPGGP---LMVIVEFCKFGNLSTYL-RSKRNEFVP 132
Query: 912 -----------FLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICK 960
FL + + A GME+L S+ +H DL N+L++ + + K
Sbjct: 133 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----EKNVVK 188
Query: 961 VGDFGLS-KIKRNTLVSGGVRGTLP--WMAPE-LLSGSSSKVSEKVDVFSFGIVLWEILT 1016
+ DFGL+ I ++ LP WMAPE + + + DV+SFG++LWEI +
Sbjct: 189 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR---VYTIQSDVWSFGVLLWEIFS 245
Query: 1017 -GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
G PY + + R P Y E M +CW P+ RP+F+E+ L
Sbjct: 246 LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305
Query: 1076 RVLSTAASQ 1084
L A +Q
Sbjct: 306 GNLLQANAQ 314
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 6e-61
Identities = 86/319 (26%), Positives = 126/319 (39%), Gaps = 62/319 (19%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTVE 859
++E +++G G FG V+ + G T VA+K +K+ S + +
Sbjct: 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-----SADMQA--D 96
Query: 860 FWKEAEILSKLHHPNVVAFYGVV-QDGPGGTLATVAEYMVDGSLRHVLVR---------- 908
F +EA ++++ +PN+V GV P + + EYM G L L
Sbjct: 97 FQREAALMAEFDNPNIVKLLGVCAVGKP---MCLLFEYMAYGDLNEFLRSMSPHTVCSLS 153
Query: 909 -------------KDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPS 955
L +L IA A GM YL + VH DL N LV
Sbjct: 154 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG----E 209
Query: 956 RPICKVGDFGLS-KIKRNTLVSGGVRGTLP--WMAPE-LLSGSSSKVSEKVDVFSFGIVL 1011
+ K+ DFGLS I +P WM PE + + + + DV+++G+VL
Sbjct: 210 NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN---RYTTESDVWAYGVVL 266
Query: 1012 WEILT-GEEPYANMH----YGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARP 1066
WEI + G +PY M + G P C E LM CW+ PA RP
Sbjct: 267 WEIFSYGLQPYYGMAHEEVIYYVRDGN-----ILACPENCPLELYNLMRLCWSKLPADRP 321
Query: 1067 SFTEIASRLRVLSTAASQT 1085
SF I L+ + A T
Sbjct: 322 SFCSIHRILQRMCERAEGT 340
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 7e-61
Identities = 98/313 (31%), Positives = 137/313 (43%), Gaps = 54/313 (17%)
Query: 802 SSVQVIKNEDLEEQKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQE 854
+ V IK D+ + ELG G FG V+ + VA+K +K++ SE
Sbjct: 33 ACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA------SESA 86
Query: 855 RLTVEFWKEAEILSKLHHPNVVAFYGVV-QDGPGGTLATVAEYMVDGSLRHVLVRKDRF- 912
R +F +EAE+L+ L H ++V F+GV + P L V EYM G L L
Sbjct: 87 RQ--DFQREAELLTMLQHQHIVRFFGVCTEGRP---LLMVFEYMRHGDLNRFLRSHGPDA 141
Query: 913 -------------LDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC 959
L + L +A A GM YL + VH DL N LV +
Sbjct: 142 KLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG----QGLVV 197
Query: 960 KVGDFGLSK-IKRNTLVSGGVRGTLP--WMAPE-LLSGSSSKVSEKVDVFSFGIVLWEIL 1015
K+GDFG+S+ I G R LP WM PE +L K + + DV+SFG+VLWEI
Sbjct: 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR---KFTTESDVWSFGVVLWEIF 254
Query: 1016 T-GEEPYANMH----YGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTE 1070
T G++P+ + I G P C E +M CW P R S +
Sbjct: 255 TYGKQPWYQLSNTEAIDCITQGR-----ELERPRACPPEVYAIMRGCWQREPQQRHSIKD 309
Query: 1071 IASRLRVLSTAAS 1083
+ +RL+ L+ A
Sbjct: 310 VHARLQALAQAPP 322
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 2e-60
Identities = 85/282 (30%), Positives = 129/282 (45%), Gaps = 24/282 (8%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAE 865
I E L+ +K+LG+G FG V+ + T VA+K +K S E F EA
Sbjct: 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-----SMSVE----AFLAEAN 235
Query: 866 ILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVL-VRKDRFLDRRRRLIIAMD 924
++ L H +V + VV P + + E+M GSL L + + + +
Sbjct: 236 VMKTLQHDKLVKLHAVVTKEP---IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ 292
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLP 984
A GM ++ +N +H DL+ N+LV+ + +CK+ DFGL+++ + + P
Sbjct: 293 IAEGMAFIEQRNYIHRDLRAANILVS----ASLVCKIADFGLARVIEDNEYTAREGAKFP 348
Query: 985 --WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPT 1041
W APE + + + K DV+SFGI+L EI+T G PY M +I + R
Sbjct: 349 IKWTAPEAI--NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMP 405
Query: 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAAS 1083
P C E +M CW P RP+F I S L TA
Sbjct: 406 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE 447
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 2e-60
Identities = 89/334 (26%), Positives = 137/334 (41%), Gaps = 59/334 (17%)
Query: 790 PSLNPSLVDFDVSSVQV-------IKNEDLEEQKELGSGTFGTVYHGKWRG--------- 833
S +P L VS ++ + L K LG G FG V + G
Sbjct: 10 HSQDPML--AGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEA 67
Query: 834 TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVV-QDGPGGTLA 891
VA+K +K +E++ + E E++ + H N++ G QDGP L
Sbjct: 68 VTVAVKMLKDDA-----TEKDLS--DLVSEMEMMKMIGKHKNIINLLGACTQDGP---LY 117
Query: 892 TVAEYMVDGSLRHVL---------------VRKDRFLDRRRRLIIAMDAAFGMEYLHSKN 936
+ EY G+LR L + + + + A GMEYL S+
Sbjct: 118 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK 177
Query: 937 IVHFDLKCDNLLVNLKDPSRPICKVGDFGLS-KIKRNTLVSGGVRGTLP--WMAPE-LLS 992
+H DL N+LV + K+ DFGL+ I G LP WMAPE L
Sbjct: 178 CIHRDLAARNVLVT----ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD 233
Query: 993 GSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWR 1051
+ + DV+SFG+++WEI T G PY + + + R P+ C E
Sbjct: 234 R---VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH-RMDKPANCTNELY 289
Query: 1052 TLMEECWAPNPAARPSFTEIASRL-RVLSTAASQ 1084
+M +CW P+ RP+F ++ L R+L+ ++
Sbjct: 290 MMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 323
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 4e-60
Identities = 87/306 (28%), Positives = 128/306 (41%), Gaps = 48/306 (15%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTVEFWK 862
L K LG+G FG V G VA+K +K S + ER
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-----AHLTERE--ALMS 75
Query: 863 EAEILSKL-HHPNVVAFYGVV-QDGPGGTLATVAEYMVDGSLRHVLVRKDR--------- 911
E ++LS L +H N+V G GP + EY G L + L R+ R
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGP---TLVITEYCCYGDLLNFL-RRKRDSFICSKTS 131
Query: 912 ---------FLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962
LD L + A GM +L SKN +H DL N+L+ I K+
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT----HGRITKIC 187
Query: 963 DFGLS-KIKRNTLVSGGVRGTLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GE 1018
DFGL+ IK ++ LP WMAPE + + + + DV+S+GI LWE+ + G
Sbjct: 188 DFGLARDIKNDSNYVVKGNARLPVKWMAPESIF--NCVYTFESDVWSYGIFLWELFSLGS 245
Query: 1019 EPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078
PY M + ++ R P + AE +M+ CW +P RP+F +I +
Sbjct: 246 SPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
Query: 1079 STAASQ 1084
+ ++
Sbjct: 306 ISESTN 311
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 6e-60
Identities = 91/282 (32%), Positives = 130/282 (46%), Gaps = 24/282 (8%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAE 865
I E L + +LG G FG V+ G W G T VAIK +K + E F +EA+
Sbjct: 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-----TMSPE----AFLQEAQ 314
Query: 866 ILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVL-VRKDRFLDRRRRLIIAMD 924
++ KL H +V Y VV + P + V EYM GSL L ++L + + +A
Sbjct: 315 VMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 371
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLP 984
A GM Y+ N VH DL+ N+LV +CKV DFGL+++ + + P
Sbjct: 372 IASGMAYVERMNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEYTARQGAKFP 427
Query: 985 --WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPT 1041
W APE + + K DV+SFGI+L E+ T G PY M ++ + R
Sbjct: 428 IKWTAPEAA--LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMP 484
Query: 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAAS 1083
P C LM +CW P RP+F + + L T+
Sbjct: 485 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 1e-59
Identities = 88/302 (29%), Positives = 124/302 (41%), Gaps = 54/302 (17%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTVEFWK 862
++L K LG G FG V T VA+K +K++ S E +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-----SPSELR--DLLS 75
Query: 863 EAEILSKLHHPNVVAFYGVV-QDGPGGTLATVAEYMVDGSLRHVL--------------- 906
E +L +++HP+V+ YG QDGP L + EY GSLR L
Sbjct: 76 EFNVLKQVNHPHVIKLYGACSQDGP---LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 907 --------VRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPI 958
+R L + A + GM+YL +VH DL N+LV
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA----EGRK 188
Query: 959 CKVGDFGLS-KIKRNTLVSGGVRGTLP--WMAPE-LLSGSSSKVSEKVDVFSFGIVLWEI 1014
K+ DFGLS + +G +P WMA E L + + DV+SFG++LWEI
Sbjct: 189 MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH---IYTTQSDVWSFGVLLWEI 245
Query: 1015 LT-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIAS 1073
+T G PY + + + R P C E LM +CW P RP F +I+
Sbjct: 246 VTLGGNPYPGIPPERLFNLLKTGH-RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK 304
Query: 1074 RL 1075
L
Sbjct: 305 DL 306
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 3e-59
Identities = 84/307 (27%), Positives = 129/307 (42%), Gaps = 50/307 (16%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRG---------TDVAIKRIKKSCFTGRSSEQERLTVEF 860
+ L K LG G FG V + G VA+K +K +E++ +
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-----TEKDLS--DL 133
Query: 861 WKEAEILSKL-HHPNVVAFYGVV-QDGPGGTLATVAEYMVDGSLRHVL------------ 906
E E++ + H N++ G QDGP L + EY G+LR L
Sbjct: 134 VSEMEMMKMIGKHKNIINLLGACTQDGP---LYVIVEYASKGNLREYLRARRPPGMEYSY 190
Query: 907 ---VRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGD 963
+ + + + A GMEYL S+ +H DL N+LV + K+ D
Sbjct: 191 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT----ENNVMKIAD 246
Query: 964 FGLS-KIKRNTLVSGGVRGTLP--WMAPE-LLSGSSSKVSEKVDVFSFGIVLWEILT-GE 1018
FGL+ I G LP WMAPE L + + DV+SFG+++WEI T G
Sbjct: 247 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR---VYTHQSDVWSFGVLMWEIFTLGG 303
Query: 1019 EPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL-RV 1077
PY + + + R P+ C E +M +CW P+ RP+F ++ L R+
Sbjct: 304 SPYPGIPVEELFKLLKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362
Query: 1078 LSTAASQ 1084
L+ ++
Sbjct: 363 LTLTTNE 369
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 1e-58
Identities = 93/365 (25%), Positives = 139/365 (38%), Gaps = 59/365 (16%)
Query: 757 VSESMQFDAMMENLRTTESDYEEGNAGNRNIGLPSLNPSLVDFDVSSVQV-----IKNED 811
+E++ F+ M + L + + +
Sbjct: 16 TTENLYFNGMGYYHH----HHHHDYDIPTT-ENLYFQGMLAGVSEYELPEDPRWELPRDR 70
Query: 812 LEEQKELGSGTFGTVYHGKWRG---------TDVAIKRIKKSCFTGRSSEQERLTVEFWK 862
L K LG G FG V + G T VA+K +K ++E++ +
Sbjct: 71 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-----ATEKDLS--DLIS 123
Query: 863 EAEILSKL-HHPNVVAFYGVV-QDGPGGTLATVAEYMVDGSLRHVL-------------- 906
E E++ + H N++ G QDGP L + EY G+LR L
Sbjct: 124 EMEMMKMIGKHKNIINLLGACTQDGP---LYVIVEYASKGNLREYLQARRPPGLEYSYNP 180
Query: 907 -VRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965
+ L + + A A GMEYL SK +H DL N+LV + K+ DFG
Sbjct: 181 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT----EDNVMKIADFG 236
Query: 966 LS-KIKRNTLVSGGVRGTLP--WMAPE-LLSGSSSKVSEKVDVFSFGIVLWEILT-GEEP 1020
L+ I G LP WMAPE L + + DV+SFG++LWEI T G P
Sbjct: 237 LARDIHHIDYYKKTTNGRLPVKWMAPEALFDR---IYTHQSDVWSFGVLLWEIFTLGGSP 293
Query: 1021 YANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLST 1080
Y + + + R PS C E +M +CW P+ RP+F ++ L +
Sbjct: 294 YPGVPVEELFKLLKEGH-RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352
Query: 1081 AASQT 1085
S
Sbjct: 353 LTSNQ 357
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 3e-58
Identities = 95/337 (28%), Positives = 133/337 (39%), Gaps = 59/337 (17%)
Query: 790 PSLNPSLVDFDVSSVQV-----IKNEDLEEQKELGSGTFGTVYHGKWRG-------TDVA 837
S + D + E+LE K LGSG FG V + G VA
Sbjct: 20 GSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVA 79
Query: 838 IKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVV-QDGPGGTLATVAE 895
+K +K+ ER E +++++L H N+V G GP + + E
Sbjct: 80 VKMLKEKA-----DSSERE--ALMSELKMMTQLGSHENIVNLLGACTLSGP---IYLIFE 129
Query: 896 YMVDGSLRHVLVRKDR-----------------------FLDRRRRLIIAMDAAFGMEYL 932
Y G L + L R R L L A A GME+L
Sbjct: 130 YCCYGDLLNYL-RSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL 188
Query: 933 HSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS-KIKRNTLVSGGVRGTLP--WMAPE 989
K+ VH DL N+LV + K+ DFGL+ I ++ LP WMAPE
Sbjct: 189 EFKSCVHRDLAARNVLVT----HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE 244
Query: 990 LLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDA 1048
L + K DV+S+GI+LWEI + G PY + A ++ N + P Y
Sbjct: 245 SLF--EGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATE 302
Query: 1049 EWRTLMEECWAPNPAARPSFTEIASRL-RVLSTAASQ 1084
E +M+ CWA + RPSF + S L L+ A
Sbjct: 303 EIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEA 339
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 3e-58
Identities = 85/302 (28%), Positives = 134/302 (44%), Gaps = 44/302 (14%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTVEFWK 862
+L+ K LG+G FG V G VA+K +K + E+
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-----HADEKE--ALMS 98
Query: 863 EAEILSKL-HHPNVVAFYGVV-QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRR---- 916
E +I+S L H N+V G GP + + EY G L + L RK R L+
Sbjct: 99 ELKIMSHLGQHENIVNLLGACTHGGP---VLVITEYCCYGDLLNFLRRKSRVLETDPAFA 155
Query: 917 --------RRLI-IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967
R L+ + A GM +L SKN +H D+ N+L+ + + K+GDFGL+
Sbjct: 156 IANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT----NGHVAKIGDFGLA 211
Query: 968 -KIKRNTLVSGGVRGTLP--WMAPE-LLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYA 1022
I ++ LP WMAPE + + + DV+S+GI+LWEI + G PY
Sbjct: 212 RDIMNDSNYIVKGNARLPVKWMAPESIFDC---VYTVQSDVWSYGILLWEIFSLGLNPYP 268
Query: 1023 NMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAA 1082
+ + +V + + P++ ++M+ CWA P RP+F +I S L+ +
Sbjct: 269 GILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328
Query: 1083 SQ 1084
+
Sbjct: 329 RR 330
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 5e-58
Identities = 90/296 (30%), Positives = 136/296 (45%), Gaps = 27/296 (9%)
Query: 802 SSVQVIKNEDLEEQKELGSGTFGTVYHGKWRG----TDVAIKRIKKSCFTGRSSEQERLT 857
+ + ++ L ELG G FG+V G +R DVAIK +K+ ++ T
Sbjct: 328 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-------EKADT 380
Query: 858 VEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRR 917
E +EA+I+ +L +P +V GV Q L V E G L LV K +
Sbjct: 381 EEMMREAQIMHQLDNPYIVRLIGVCQAEA---LMLVMEMAGGGPLHKFLVGKREEIPVSN 437
Query: 918 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI--KRNTLV 975
+ + GM+YL KN VH +L N+L+ +R K+ DFGLSK ++
Sbjct: 438 VAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV----NRHYAKISDFGLSKALGADDSYY 493
Query: 976 SGGVRGTLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGG 1032
+ G P W APE + + K S + DV+S+G+ +WE L+ G++PY M G +
Sbjct: 494 TARSAGKWPLKWYAPECI--NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-GPEVMA 550
Query: 1033 IVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR-VLSTAASQTKG 1087
+ R P C E LM +CW RP F + R+R + AS+ +G
Sbjct: 551 FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 606
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 6e-58
Identities = 80/262 (30%), Positives = 127/262 (48%), Gaps = 21/262 (8%)
Query: 816 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
E+G G+F TVY G +VA ++ T SE++R +EAE+L L HP
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT--KSERQRFK----EEAEMLKGLQHP 85
Query: 874 NVVAFYGVVQDGPGG--TLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEY 931
N+V FY + G + V E M G+L+ L ++ + + + G+++
Sbjct: 86 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQF 144
Query: 932 LHSKN--IVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPE 989
LH++ I+H DLKCDN+ + S K+GD GL+ +KR + V GT +MAPE
Sbjct: 145 LHTRTPPIIHRDLKCDNIFITGPTGS---VKIGDLGLATLKRASFAKA-VIGTPEFMAPE 200
Query: 990 LLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP-TIPSYCDA 1048
+ K E VDV++FG+ + E+ T E PY+ A I V + ++P +
Sbjct: 201 MYE---EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257
Query: 1049 EWRTLMEECWAPNPAARPSFTE 1070
E + ++E C N R S +
Sbjct: 258 EVKEIIEGCIRQNKDERYSIKD 279
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 2e-52
Identities = 72/315 (22%), Positives = 114/315 (36%), Gaps = 23/315 (7%)
Query: 760 SMQFDAMMENLRTTESDYEEGNAGNRNIGLPSLNPSLVDFDVSSVQVIKNEDLEEQKELG 819
S D ENL +S ++ G S +D S + + + LG
Sbjct: 8 SSGVDLGTENL-YFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLG 66
Query: 820 SGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVV 876
G++G V+ + + A+KR ++R E K+ HP V
Sbjct: 67 HGSYGEVFKVRSKEDGRLYAVKRSMSP----FRGPKDRA--RKLAEVGSHEKVGQHPCCV 120
Query: 877 AFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKN 936
++G G L E SL+ L + D + +LHS+
Sbjct: 121 RLEQAWEEG--GILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG 177
Query: 937 IVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSS 996
+VH D+K N+ + + CK+GDFGL G +MAPELL GS
Sbjct: 178 LVHLDVKPANIFLGPRG----RCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYG 233
Query: 997 KVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEE 1056
DVFS G+ + E+ E H G + L P + +E R+++
Sbjct: 234 T---AADVFSLGLTILEVACNMELP---HGGEGWQQLRQGYLPPEFTAGLSSELRSVLVM 287
Query: 1057 CWAPNPAARPSFTEI 1071
P+P R + +
Sbjct: 288 MLEPDPKLRATAEAL 302
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 2e-49
Identities = 74/279 (26%), Positives = 121/279 (43%), Gaps = 22/279 (7%)
Query: 798 DFDVSSVQVIKNEDLEEQKE---LGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSE 852
+ D S + + + +E + LG GT+G VY G +AIK I +
Sbjct: 7 EGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPE--------R 58
Query: 853 QERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRF 912
R + +E + L H N+V + G + G + E + GSL +L K
Sbjct: 59 DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN--GFIKIFMEQVPGGSLSALLRSKWGP 116
Query: 913 LDRRRRLI--IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-I 969
L + I G++YLH IVH D+K DN+L+N + K+ DFG SK +
Sbjct: 117 LKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSG---VLKISDFGTSKRL 173
Query: 970 KRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANM-HYGA 1028
+ GTL +MAPE++ + D++S G + E+ TG+ P+ + A
Sbjct: 174 AGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA 233
Query: 1029 IIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPS 1067
+ + + P IP AE + + +C+ P+P R
Sbjct: 234 AMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRAC 272
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 9e-49
Identities = 70/279 (25%), Positives = 121/279 (43%), Gaps = 41/279 (14%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
D +E + +GSG FG V+ K R G IKR+K + +E+ +E + L
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN------NEKAE------REVKAL 58
Query: 868 SKLHHPNVVAFYGVVQDG--------------PGGTLATVAEYMVDGSLRHVLV-RKDRF 912
+KL H N+V + G L E+ G+L + R+
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 913 LDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRN 972
LD+ L + G++Y+HSK +++ DLK N+ + K+GDFGL +N
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK----QVKIGDFGLVTSLKN 174
Query: 973 TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGG 1032
+GTL +M+PE +S ++VD+++ G++L E+L +
Sbjct: 175 DGKRTRSKGTLRYMSPEQISSQD--YGKEVDLYALGLILAELLHVCDTAFETS------K 226
Query: 1033 IVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
+ I D + +TL+++ + P RP+ +EI
Sbjct: 227 FFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEI 265
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-47
Identities = 79/292 (27%), Positives = 131/292 (44%), Gaps = 25/292 (8%)
Query: 790 PSLNPSLVDFDVSSVQVIKNEDLEEQKELGSGTFGTVYH-GKWRGTDVAIKRIKKSCFTG 848
PSL D + +SV ++ + LG G GT+ + G + DVA+KRI CF+
Sbjct: 5 PSLEQDDGD-EETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSF 63
Query: 849 RSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLV 907
+E ++L + HPNV+ ++ +D +A E +L+ +
Sbjct: 64 AD-----------REVQLLRESDEHPNVIRYFCTEKDRQFQYIAI--EL-CAATLQEYVE 109
Query: 908 RKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC-KVGDFGL 966
+KD + + G+ +LHS NIVH DLK N+L+++ + I + DFGL
Sbjct: 110 QKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGL 169
Query: 967 SKI----KRNTLVSGGVRGTLPWMAPELLSGSSSK-VSEKVDVFSFGIVLWEILT-GEEP 1020
K + + GV GT W+APE+LS + + VD+FS G V + +++ G P
Sbjct: 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP 229
Query: 1021 YANMHYGAIIGGIVNNTL-RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
+ + +L + D R L+E+ A +P RPS +
Sbjct: 230 FGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 7e-47
Identities = 65/285 (22%), Positives = 111/285 (38%), Gaps = 39/285 (13%)
Query: 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEI 866
+ E +++GSG FG+V+ R G AIKR KK G EQ L +E
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKP-LAGSVDEQNAL-----REVYA 63
Query: 867 LSKL-HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVL---VRKDRFLDRRRRLIIA 922
+ L H +VV ++ + + EY GSL + R + +
Sbjct: 64 HAVLGQHSHVVRYFSAWAED--DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL 121
Query: 923 MDAAFGMEYLHSKNIVHFDLKCDNLLVN---------------LKDPSRPICKVGDFGLS 967
+ G+ Y+HS ++VH D+K N+ ++ ++ + K+GD G
Sbjct: 122 LQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV 181
Query: 968 KIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH-Y 1026
+ V G ++A E+L + + K D+F+ + + E N +
Sbjct: 182 TRISSPQV---EEGDSRFLANEVLQENYTH-LPKADIFALALTVVCAAGAEPLPRNGDQW 237
Query: 1027 GAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
I G + P IP E+ L++ P+P RPS +
Sbjct: 238 HEIRQGRL-----PRIPQVLSQEFTELLKVMIHPDPERRPSAMAL 277
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 7e-47
Identities = 62/287 (21%), Positives = 123/287 (42%), Gaps = 29/287 (10%)
Query: 794 PSLVDFDVSSVQVIKNEDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSS 851
S VD ++ E +++G G+FG K IK I S R S
Sbjct: 8 SSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINIS----RMS 63
Query: 852 EQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVL-VRKD 910
+ER +E +L+ + HPN+V + ++ G+L V +Y G L + +K
Sbjct: 64 SKEREESR--REVAVLANMKHPNIVQYRESFEEN--GSLYIVMDYCEGGDLFKRINAQKG 119
Query: 911 RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI- 969
+ L + ++++H + I+H D+K N+ + ++GDFG++++
Sbjct: 120 VLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG----TVQLGDFGIARVL 175
Query: 970 -----KRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANM 1024
+ GT +++PE+ + K D+++ G VL+E+ T + +
Sbjct: 176 NSTVELARACI-----GTPYYLSPEICENKP--YNNKSDIWALGCVLYELCTLKHAFEAG 228
Query: 1025 HYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
++ I++ + P + + + R+L+ + + NP RPS I
Sbjct: 229 SMKNLVLKIISGSFPP-VSLHYSYDLRSLVSQLFKRNPRDRPSVNSI 274
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 3e-46
Identities = 82/288 (28%), Positives = 131/288 (45%), Gaps = 44/288 (15%)
Query: 813 EEQKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQ-ERLTVEFWKEAEILSKL 870
+ + +G G FG VY G R G VA+KR S Q EF E E LS
Sbjct: 42 DHKFLIGHGVFGKVYKGVLRDGAKVALKRRT------PESSQGIE---EFETEIETLSFC 92
Query: 871 HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDR---FLDRRRRLIIAMDAAF 927
HP++V+ G + + + +YM +G+L+ L D + +RL I + AA
Sbjct: 93 RHPHLVSLIGFCDER--NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI---KRNTLVSGGVRGTLP 984
G+ YLH++ I+H D+K N+L++ + K+ DFG+SK T +S V+GTL
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLD----ENFVPKITDFGISKKGTELDQTHLSTVVKGTLG 206
Query: 985 WMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN---------------MHYGAI 1029
++ PE +++EK DV+SFG+VL+E+L H
Sbjct: 207 YIDPEYF--IKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 1030 IGGIVNNTLRPTIPSYCDAEWR--TLMEECWAPNPAARPSFTEIASRL 1075
+ IV+ L I ++ + +C A + RPS ++ +L
Sbjct: 265 LEQIVDPNLADKIRP--ESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-46
Identities = 63/292 (21%), Positives = 111/292 (38%), Gaps = 46/292 (15%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
D EE LG G FG V + AIK+I+ + + + E +L
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-----EEKLSTIL----SEVMLL 56
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVA-----------EYMVDGSLRHVLVRKDRFLDRR 916
+ L+H VV +Y + A EY +G+L ++ ++ R
Sbjct: 57 ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116
Query: 917 RRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVS 976
+ + Y+HS+ I+H DLK N+ + D SR + K+GDFGL+K +L
Sbjct: 117 EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNV-KIGDFGLAKNVHRSLDI 172
Query: 977 GGVR---------------GTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1021
+ GT ++A E+L G+ +EK+D++S GI+ +E++
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGH-YNEKIDMYSLGIIFFEMIYPFSTG 231
Query: 1022 ANMH--YGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
+ + P + ++ +P RP +
Sbjct: 232 MERVNILKKLRSVSIE--FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL 281
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 4e-46
Identities = 68/262 (25%), Positives = 109/262 (41%), Gaps = 30/262 (11%)
Query: 815 QKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHH 872
Q +G G+FG V+ K G A+K+++ E E + L
Sbjct: 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL-----EVFRVE--------ELVACAGLSS 109
Query: 873 PNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYL 932
P +V YG V++GP + E + GSL L+++ L R L A G+EYL
Sbjct: 110 PRIVPLYGAVREGP--WVNIFMELLEGGSL-GQLIKQMGCLPEDRALYYLGQALEGLEYL 166
Query: 933 HSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK------IKRNTLVSGGVRGTLPWM 986
H++ I+H D+K DN+L+ + DFG + + ++ L + GT M
Sbjct: 167 HTRRILHGDVKADNVLL---SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHM 223
Query: 987 APELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-LRPTIPSY 1045
APE++ G KVD++S ++ +L G P+ G + I + IP
Sbjct: 224 APEVVMGKPC--DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPS 281
Query: 1046 CDAEWRTLMEECWAPNPAARPS 1067
C ++E P R S
Sbjct: 282 CAPLTAQAIQEGLRKEPVHRAS 303
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 1e-45
Identities = 75/289 (25%), Positives = 120/289 (41%), Gaps = 43/289 (14%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
D E + LG G FG V+ K + D AIKRI+ + E R + +E + L
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP-----NRELAR--EKVMREVKAL 57
Query: 868 SKLHHPNVVAFYGVVQDGP----------GGTLATVAEYMVDGSLRHVLVRKDRFLDRRR 917
+KL HP +V ++ + L + +L+ + + +R R
Sbjct: 58 AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 918 RLI--IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLV 975
+ I + A +E+LHSK ++H DLK N+ + D + KVGDFGL
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD----VVKVGDFGLVTAMDQDEE 173
Query: 976 SGGVR-------------GTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYA 1022
V GT +M+PE + G+S S KVD+FS G++L+E+L
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY--SHKVDIFSLGLILFELLYP--FST 229
Query: 1023 NMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
M + + N P E ++++ +P+P RP I
Sbjct: 230 QMERVRTLTDVRNLKFPPLFTQKYPCE-YVMVQDMLSPSPMERPEAINI 277
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 1e-45
Identities = 68/307 (22%), Positives = 127/307 (41%), Gaps = 33/307 (10%)
Query: 778 EEGNAGNRNIGLPSLNPSLVDFDVSSVQVIKNEDLEEQKELGSGTFGTVYHGKWRGTD-- 835
+E + G + +P P + + +K++G G F VY
Sbjct: 2 DEQSQGMQGPPVPQFQPQKALRPDMGYNTL--ANFRIEKKIGRGQFSEVYRAACLLDGVP 59
Query: 836 VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAE 895
VA+K+++ + R KE ++L +L+HPNV+ +Y + L V E
Sbjct: 60 VALKKVQ---IFDLMDAKARADCI--KEIDLLKQLNHPNVIKYYASFIE--DNELNIVLE 112
Query: 896 YMVDGSLRHVLVR---KDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLK 952
G L ++ + R + R + +E++HS+ ++H D+K N+ +
Sbjct: 113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT 172
Query: 953 DPSRPICKVGDFGLSKI------KRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFS 1006
+ K+GD GL + ++LV GT +M+PE + + + K D++S
Sbjct: 173 G----VVKLGDLGLGRFFSSKTTAAHSLV-----GTPYYMSPERIHE--NGYNFKSDIWS 221
Query: 1007 FGIVLWEILTGEEPYA--NMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAA 1064
G +L+E+ + P+ M+ ++ I P + E R L+ C P+P
Sbjct: 222 LGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEK 281
Query: 1065 RPSFTEI 1071
RP T +
Sbjct: 282 RPDVTYV 288
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-45
Identities = 69/273 (25%), Positives = 119/273 (43%), Gaps = 24/273 (8%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
ED E +G+G++G + + + K + T +E++ L E +L
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT--EAEKQMLV----SEVNLL 59
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLV---RKDRFLDRRRRLIIAMD 924
+L HPN+V +Y + D TL V EY G L V+ ++ ++LD L +
Sbjct: 60 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 925 AAFGMEYLHSKN-----IVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI-KRNTLVSGG 978
++ H ++ ++H DLK N+ ++ K K+GDFGL++I +T +
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ----NVKLGDFGLARILNHDTSFAKT 175
Query: 979 VRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 1038
GT +M+PE ++ +EK D++S G +L+E+ P+ + G I
Sbjct: 176 FVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF 233
Query: 1039 RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
R IP E ++ RPS EI
Sbjct: 234 RR-IPYRYSDELNEIITRMLNLKDYHRPSVEEI 265
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 5e-45
Identities = 70/206 (33%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 818 LGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQ-ERLTVEFWKEAEILSKLHHPNVV 876
+G G FG VY G T VA+K++ ++E+ ++ +F +E ++++K H N+V
Sbjct: 39 MGEGGFGVVYKGYVNNTTVAVKKLAAM--VDITTEELKQ---QFDQEIKVMAKCQHENLV 93
Query: 877 AFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRF--LDRRRRLIIAMDAAFGMEYLHS 934
G DG L V YM +GSL L D L R IA AA G+ +LH
Sbjct: 94 ELLGFSSDG--DDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE 151
Query: 935 KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI---KRNTLVSGGVRGTLPWMAPELL 991
+ +H D+K N+L L + K+ DFGL++ T+++ + GT +MAPE L
Sbjct: 152 NHHIHRDIKSANIL--LDEAFTA--KISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL 207
Query: 992 SGSSSKVSEKVDVFSFGIVLWEILTG 1017
G +++ K D++SFG+VL EI+TG
Sbjct: 208 RG---EITPKSDIYSFGVVLLEIITG 230
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 8e-45
Identities = 59/292 (20%), Positives = 112/292 (38%), Gaps = 43/292 (14%)
Query: 802 SSVQVIKNEDLEEQKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTVEF 860
+ +K K++GSG V+ AIK + ++ + +
Sbjct: 1 NECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDS------Y 54
Query: 861 WKEAEILSKLHHPN--VVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRF-LDRRR 917
E L+KL + ++ Y + V E + L L +K R+
Sbjct: 55 RNEIAYLNKLQQHSDKIIRLYDYEITD--QYIYMVMEC-GNIDLNSWLKKKKSIDPWERK 111
Query: 918 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK--------I 969
M + +H IVH DLK N L+ + K+ DFG++ +
Sbjct: 112 SYWKNM--LEAVHTIHQHGIVHSDLKPANFLI-----VDGMLKLIDFGIANQMQPDTTSV 164
Query: 970 KRNTLVSGGVRGTLPWMAPELLSGSS---------SKVSEKVDVFSFGIVLWEILTGEEP 1020
+++ V GT+ +M PE + S SK+S K DV+S G +L+ + G+ P
Sbjct: 165 VKDSQV-----GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
Query: 1021 YANM-HYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
+ + + + + I++ P + + + +++ C +P R S E+
Sbjct: 220 FQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 3e-44
Identities = 58/286 (20%), Positives = 111/286 (38%), Gaps = 41/286 (14%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAE 865
+K K++GSG V+ AIK + ++ + + E
Sbjct: 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDS------YRNEIA 78
Query: 866 ILSKLHHPN--VVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAM 923
L+KL + ++ Y + V E + L L +K R+
Sbjct: 79 YLNKLQQHSDKIIRLYDYEITD--QYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWK- 134
Query: 924 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK--------IKRNTLV 975
+ + +H IVH DLK N L+ + K+ DFG++ + +++ V
Sbjct: 135 NMLEAVHTIHQHGIVHSDLKPANFLI-----VDGMLKLIDFGIANQMQPDTTSVVKDSQV 189
Query: 976 SGGVRGTLPWMAPELLSGSS---------SKVSEKVDVFSFGIVLWEILTGEEPYANM-H 1025
GT+ +M PE + S SK+S K DV+S G +L+ + G+ P+ + +
Sbjct: 190 -----GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 244
Query: 1026 YGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
+ + I++ P + + + +++ C +P R S E+
Sbjct: 245 QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-43
Identities = 54/235 (22%), Positives = 92/235 (39%), Gaps = 17/235 (7%)
Query: 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEF 860
Q N LG G V+ G+ + G AIK F Q R
Sbjct: 2 GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR----- 56
Query: 861 WKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDR--FLDRRRR 918
E E+L KL+H N+V + + ++ + E+ GSL VL L
Sbjct: 57 --EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114
Query: 919 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGG 978
LI+ D GM +L IVH ++K N++ + + + + K+ DFG ++ +
Sbjct: 115 LIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS 174
Query: 979 VRGTLPWMAPELLSGSSSKV------SEKVDVFSFGIVLWEILTGEEPYANMHYG 1027
+ GT ++ P++ + + VD++S G+ + TG P+
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 6e-43
Identities = 69/299 (23%), Positives = 116/299 (38%), Gaps = 31/299 (10%)
Query: 799 FDVSSVQVIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERL 856
+ + +I N+ ++LG G F V + G A+KRI +Q+R
Sbjct: 18 YFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH------EQQDRE 71
Query: 857 TVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGT--LATVAEYMVDGSLRHVLVR---KDR 911
+ +EA++ +HPN++ G + + G+L + + R K
Sbjct: 72 EAQ--READMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGN 129
Query: 912 FLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKR 971
FL + L + + G+E +H+K H DLK N+L+ + + D G
Sbjct: 130 FLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEG----QPVLMDLGSMNQAC 185
Query: 972 NTLVS----------GGVRGTLPWMAPELLSGSS-SKVSEKVDVFSFGIVLWEILTGEEP 1020
+ R T+ + APEL S S + E+ DV+S G VL+ ++ GE P
Sbjct: 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
Query: 1021 Y-ANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078
Y G + V N L + L+ +P RP + S+L L
Sbjct: 246 YDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 8e-43
Identities = 57/291 (19%), Positives = 111/291 (38%), Gaps = 41/291 (14%)
Query: 802 SSVQVIKNEDLEEQKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTVEF 860
+ +K K++GSG V+ AIK + ++ + +
Sbjct: 48 NECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDS------Y 101
Query: 861 WKEAEILSKLHHPN--VVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRR 918
E L+KL + ++ Y + V E + L L +K R+
Sbjct: 102 RNEIAYLNKLQQHSDKIIRLYDYEITD--QYIYMVMEC-GNIDLNSWLKKKKSIDPWERK 158
Query: 919 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK--------IK 970
+ + +H IVH DLK N L+ + K+ DFG++ +
Sbjct: 159 SYWK-NMLEAVHTIHQHGIVHSDLKPANFLI-----VDGMLKLIDFGIANQMQPDTTSVV 212
Query: 971 RNTLVSGGVRGTLPWMAPELLSGSS---------SKVSEKVDVFSFGIVLWEILTGEEPY 1021
+++ V G + +M PE + S SK+S K DV+S G +L+ + G+ P+
Sbjct: 213 KDSQV-----GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267
Query: 1022 ANM-HYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
+ + + + I++ P + + + +++ C +P R S E+
Sbjct: 268 QQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 5e-42
Identities = 78/214 (36%), Positives = 113/214 (52%), Gaps = 26/214 (12%)
Query: 818 LGSGTFGTVYHGK-WRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVV 876
LG G FG VY G+ GT VA+KR+K+ G E +F E E++S H N++
Sbjct: 38 LGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG----EL---QFQTEVEMISMAVHRNLL 90
Query: 877 AFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDR---FLDRRRRLIIAMDAAFGMEYLH 933
G L V YM +GS+ L + LD +R IA+ +A G+ YLH
Sbjct: 91 RLRGFCMTPTERLL--VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH 148
Query: 934 SK---NIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI--KRNTLVSGGVRGTLPWMAP 988
I+H D+K N+L L + VGDFGL+K+ ++T V+ VRGT+ +AP
Sbjct: 149 DHCDPKIIHRDVKAANIL--LDEEFEA--VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 204
Query: 989 E-LLSGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1021
E L +G K SEK DVF +G++L E++TG+ +
Sbjct: 205 EYLSTG---KSSEKTDVFGYGVMLLELITGQRAF 235
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-41
Identities = 55/233 (23%), Positives = 92/233 (39%), Gaps = 27/233 (11%)
Query: 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEF 860
Q N LG G V+ G+ + G AIK F Q R
Sbjct: 2 GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR----- 56
Query: 861 WKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDR--FLDRRRR 918
E E+L KL+H N+V + + ++ + E+ GSL VL L
Sbjct: 57 --EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114
Query: 919 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI-----KRNT 973
LI+ D GM +L IVH ++K N++ + + + + K+ DFG ++ + +
Sbjct: 115 LIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS 174
Query: 974 LVSGGVRGTLPWMAPELLSGSSSKV------SEKVDVFSFGIVLWEILTGEEP 1020
L GT ++ P++ + + VD++S G+ + TG P
Sbjct: 175 LY-----GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-41
Identities = 71/303 (23%), Positives = 126/303 (41%), Gaps = 45/303 (14%)
Query: 800 DVSSVQVIKNEDLEEQKELGSGTFGTVYH-GKWRGTDVAIKRIKKSCFTGRSSEQERLTV 858
++ + + + +K LG G+ GTV G ++G VA+KR+
Sbjct: 5 NIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD----------- 53
Query: 859 EFWKEAEILSKL-HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRR 917
E ++L++ HPNV+ +Y +A E + +L+ ++ K+ + +
Sbjct: 54 IALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL--EL-CNLNLQDLVESKNVSDENLK 110
Query: 918 RLI------IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC---------KVG 962
+ A G+ +LHS I+H DLK N+LV+ +
Sbjct: 111 LQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170
Query: 963 DFGLSKIKRNTLVSGGVR-----GTLPWMAPELLSGSSS-----KVSEKVDVFSFGIVLW 1012
DFGL K + S GT W APELL S++ +++ +D+FS G V +
Sbjct: 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY 230
Query: 1013 EILT-GEEPYA--NMHYGAIIGGIVN-NTLRPTIPSYCDAEWRTLMEECWAPNPAARPSF 1068
IL+ G+ P+ II GI + + ++ AE L+ + +P RP+
Sbjct: 231 YILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTA 290
Query: 1069 TEI 1071
++
Sbjct: 291 MKV 293
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-40
Identities = 77/269 (28%), Positives = 119/269 (44%), Gaps = 29/269 (10%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKS-CFTGRSSEQERLTVEFWKEAEI 866
ED E + LG G FG VY + + + +A+K + K+ Q R +E EI
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR------REVEI 62
Query: 867 LSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAA 926
S L HPN++ YG D + + EY G++ L + +F ++R I A
Sbjct: 63 QSHLRHPNILRLYGYFHDA--TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 120
Query: 927 FGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK----IKRNTLVSGGVRGT 982
+ Y HSK ++H D+K +NLL+ K+ DFG S +R L GT
Sbjct: 121 -ALSYCHSKRVIHRDIKPENLLLGSAG----ELKIADFGWSVHAPSSRRTDLC-----GT 170
Query: 983 LPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTI 1042
L ++ PE++ G EKVD++S G++ +E L G+ P+ Y I
Sbjct: 171 LDYLPPEMIEGRMH--DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT--F 226
Query: 1043 PSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
P + R L+ NP+ RP E+
Sbjct: 227 PDFVTEGARDLISRLLKHNPSQRPMLREV 255
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 9e-40
Identities = 68/236 (28%), Positives = 109/236 (46%), Gaps = 34/236 (14%)
Query: 805 QVIKNEDLEE----QKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTV 858
V ++ D E ELG G FG VY K + T A K I+ +E L
Sbjct: 10 HVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK-------SEEELE- 61
Query: 859 EFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRR 918
++ E EIL+ HP +V G G L + E+ G++ +++ DR L +
Sbjct: 62 DYIVEIEILATCDHPYIVKLLGAYYHD--GKLWIMIEFCPGGAVDAIMLELDRGLTEPQI 119
Query: 919 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS------KIKRN 972
++ + +LHSK I+H DLK N+L+ L+ ++ DFG+S KR+
Sbjct: 120 QVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG----DIRLADFGVSAKNLKTLQKRD 175
Query: 973 TLVSGGVRGTLPWMAPELLSGSSSKVS---EKVDVFSFGIVLWEILTGEEPYANMH 1025
+ + GT WMAPE++ + K + K D++S GI L E+ E P+ ++
Sbjct: 176 SFI-----GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 6e-39
Identities = 70/268 (26%), Positives = 122/268 (45%), Gaps = 27/268 (10%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
+D + + LG G FG VY + + +A+K + KS + + +L +E EI
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLE-KEGVEHQLR----REIEIQ 68
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
S L HPN++ Y D + + E+ G L L + RF ++R + A
Sbjct: 69 SHLRHPNILRMYNYFHDR--KRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELAD- 125
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK----IKRNTLVSGGVRGTL 983
+ Y H + ++H D+K +NLL+ K K+ DFG S ++R T+ GTL
Sbjct: 126 ALHYCHERKVIHRDIKPENLLMGYKG----ELKIADFGWSVHAPSLRRRTMC-----GTL 176
Query: 984 PWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIP 1043
++ PE++ G + EKVD++ G++ +E L G P+ + + IVN L+ P
Sbjct: 177 DYLPPEMIEGKTH--DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK--FP 232
Query: 1044 SYCDAEWRTLMEECWAPNPAARPSFTEI 1071
+ + L+ + +P R +
Sbjct: 233 PFLSDGSKDLISKLLRYHPPQRLPLKGV 260
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-38
Identities = 67/291 (23%), Positives = 119/291 (40%), Gaps = 34/291 (11%)
Query: 797 VDFDVSSVQVIKNEDLEEQKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQE 854
+ EDL++ E+G G +G+V K G +A+KRI+ T EQ+
Sbjct: 9 LKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR---STVDEKEQK 65
Query: 855 RLTVEFWKEAEILSKL-HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFL 913
+L + +++ + P +V FYG + G E M S K +
Sbjct: 66 QLL----MDLDVVMRSSDCPYIVQFYGALFR--EGDCWICMELM-STSFDKFY--KYVYS 116
Query: 914 DRRRRL------IIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966
+ I + + +L I+H D+K N+L++ K+ DFG+
Sbjct: 117 VLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD----RSGNIKLCDFGI 172
Query: 967 SKIKRNTLVSGGVRGTLPWMAPELLSGSSSKV--SEKVDVFSFGIVLWEILTGEEPYANM 1024
S +++ G P+MAPE + S+S+ + DV+S GI L+E+ TG PY
Sbjct: 173 SGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232
Query: 1025 H-YGAIIGGIVNNTLRPTIPSYCDAEW----RTLMEECWAPNPAARPSFTE 1070
+ + +V P + + + E+ + C + + RP + E
Sbjct: 233 NSVFDQLTQVVKGDP-PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKE 282
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-38
Identities = 76/270 (28%), Positives = 124/270 (45%), Gaps = 31/270 (11%)
Query: 809 NEDLEEQKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEI 866
E + +++G G+FG V+ G VAIK I ++ + + +E +
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE------EAEDEIE-DIQQEITV 73
Query: 867 LSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAA 926
LS+ P V +YG L + EY+ GS +L + LD + I +
Sbjct: 74 LSQCDSPYVTKYYGSYLKD--TKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREIL 129
Query: 927 FGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS------KIKRNTLVSGGVR 980
G++YLHS+ +H D+K N+L++ K+ DFG++ +IKRNT V
Sbjct: 130 KGLDYLHSEKKIHRDIKAANVLLS----EHGEVKLADFGVAGQLTDTQIKRNTFV----- 180
Query: 981 GTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 1040
GT WMAPE++ S+ K D++S GI E+ GE P++ +H ++ I N P
Sbjct: 181 GTPFWMAPEVIKQSA--YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN-PP 237
Query: 1041 TIPSYCDAEWRTLMEECWAPNPAARPSFTE 1070
T+ + +E C P+ RP+ E
Sbjct: 238 TLEGNYSKPLKEFVEACLNKEPSFRPTAKE 267
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-38
Identities = 66/238 (27%), Positives = 98/238 (41%), Gaps = 18/238 (7%)
Query: 816 KELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
+ LG+G FG V + G VAIK+ ++ +ER E +I+ KL+HP
Sbjct: 20 ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELS---PKNRERWC----LEIQIMKKLNHP 72
Query: 874 NVVAFYGVVQDGPGGTLAT----VAEYMVDGSLRHVLVRKDR--FLDRRRRLIIAMDAAF 927
NVV+ V EY G LR L + + L + D +
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMA 987
+ YLH I+H DLK +N+++ K+ D G +K + GTL ++A
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIH-KIIDLGYAKELDQGELCTEFVGTLQYLA 191
Query: 988 PELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSY 1045
PELL K + VD +SFG + +E +TG P+ G V I Y
Sbjct: 192 PELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-38
Identities = 72/272 (26%), Positives = 121/272 (44%), Gaps = 34/272 (12%)
Query: 809 NEDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEI 866
+ +++G G GTVY T VAI+++ +Q + E +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ-------QQPKKE-LIINEILV 70
Query: 867 LSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAA 926
+ + +PN+V + G L V EY+ GSL V+ + +D + + +
Sbjct: 71 MRENKNPNIVNYLDSYLVG--DELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECL 126
Query: 927 FGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS------KIKRNTLVSGGVR 980
+E+LHS ++H D+K DN+L+ + K+ DFG + KR+T+V
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMV----- 177
Query: 981 GTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 1040
GT WMAPE+++ + KVD++S GI+ E++ GE PY N + + I N P
Sbjct: 178 GTPYWMAPEVVTRKA--YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TP 234
Query: 1041 TI--PSYCDAEWRTLMEECWAPNPAARPSFTE 1070
+ P A +R + C + R S E
Sbjct: 235 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKE 266
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-37
Identities = 65/272 (23%), Positives = 117/272 (43%), Gaps = 34/272 (12%)
Query: 809 NEDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEI 866
L+ ++G G+ G V + + + VA+K + +Q+R + E I
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLR-------KQQRRE-LLFNEVVI 95
Query: 867 LSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAA 926
+ H NVV Y G L + E++ G+L ++ L+ + +
Sbjct: 96 MRDYQHFNVVEMYKSYLVG--EELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVL 151
Query: 927 FGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS------KIKRNTLVSGGVR 980
+ YLH++ ++H D+K D++L+ L K+ DFG KR +LV
Sbjct: 152 QALAYLHAQGVIHRDIKSDSILLTLDGR----VKLSDFGFCAQISKDVPKRKSLV----- 202
Query: 981 GTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 1040
GT WMAPE++S S + +VD++S GI++ E++ GE PY + + + ++ P
Sbjct: 203 GTPYWMAPEVISRSLY--ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-PP 259
Query: 1041 TI--PSYCDAEWRTLMEECWAPNPAARPSFTE 1070
+ R +E +P R + E
Sbjct: 260 KLKNSHKVSPVLRDFLERMLVRDPQERATAQE 291
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 77/283 (27%), Positives = 128/283 (45%), Gaps = 42/283 (14%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEA 864
+K +DLE ELG G +G V G +A+KRI+ T S EQ+RL +
Sbjct: 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR---ATVNSQEQKRLL----MDL 56
Query: 865 EI-LSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRL---- 919
+I + + P V FYG + G + E M D SL + +D+ + +
Sbjct: 57 DISMRTVDCPFTVTFYGALFR--EGDVWICMELM-DTSLDKFY---KQVIDKGQTIPEDI 110
Query: 920 --IIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS-----KIKR 971
IA+ +E+LHSK +++H D+K N+L+N + K+ DFG+S + +
Sbjct: 111 LGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLIN----ALGQVKMCDFGISGYLVDDVAK 166
Query: 972 NTLVSGGVRGTLPWMAPELLSGSSSKV--SEKVDVFSFGIVLWEILTGEEPYANM-HYGA 1028
+ G P+MAPE ++ ++ S K D++S GI + E+ PY +
Sbjct: 167 DIDA-----GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ 221
Query: 1029 IIGGIVNNTLRPTIPS-YCDAEWRTLMEECWAPNPAARPSFTE 1070
+ +V P +P+ AE+ +C N RP++ E
Sbjct: 222 QLKQVVEEPS-PQLPADKFSAEFVDFTSQCLKKNSKERPTYPE 263
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-37
Identities = 67/223 (30%), Positives = 103/223 (46%), Gaps = 12/223 (5%)
Query: 805 QVIKNEDLEEQ----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTV 858
Q + + L ++ K LGSG G V R T VAI+ I K F S+ + +
Sbjct: 126 QSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPAL 185
Query: 859 EFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRR 918
E EIL KL+HP ++ V E M G L +V R + +
Sbjct: 186 NVETEIEILKKLNHPCIIKIKNFFDA---EDYYIVLELMEGGELFDKVVGNKRLKEATCK 242
Query: 919 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGG 978
L ++YLH I+H DLK +N+L++ ++ I K+ DFG SKI T +
Sbjct: 243 LYF-YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLI-KITDFGHSKILGETSLMRT 300
Query: 979 VRGTLPWMAPELLSGSSSKV-SEKVDVFSFGIVLWEILTGEEP 1020
+ GT ++APE+L + + VD +S G++L+ L+G P
Sbjct: 301 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 2e-37
Identities = 69/267 (25%), Positives = 108/267 (40%), Gaps = 35/267 (13%)
Query: 816 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
+ LG G F + T A K + KS + + E I L H
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKS-----LLLKPHQREKMSMEISIHRSLAHQ 75
Query: 874 NVVAFYGVVQDGPGGTLAT----VAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGM 929
+VV F+G +D V E SL + R+ + R + G
Sbjct: 76 HVVGFHGFFED------NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL-GC 128
Query: 930 EYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR-----GTLP 984
+YLH ++H DLK NL +N K+GDFGL+ + G R GT
Sbjct: 129 QYLHRNRVIHRDLKLGNLFLNEDL----EVKIGDFGLA----TKVEYDGERKKVLCGTPN 180
Query: 985 WMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPS 1044
++APE+LS S +VDV+S G +++ +L G+ P+ I N IP
Sbjct: 181 YIAPEVLSKKGH--SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS--IPK 236
Query: 1045 YCDAEWRTLMEECWAPNPAARPSFTEI 1071
+ + +L+++ +P ARP+ E+
Sbjct: 237 HINPVAASLIQKMLQTDPTARPTINEL 263
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-37
Identities = 69/263 (26%), Positives = 109/263 (41%), Gaps = 27/263 (10%)
Query: 816 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
+ LG G F + T A K + KS + + E I L H
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKS-----LLLKPHQREKMSMEISIHRSLAHQ 101
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLH 933
+VV F+G +D + V E SL + R+ + R + G +YLH
Sbjct: 102 HVVGFHGFFEDN--DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL-GCQYLH 158
Query: 934 SKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR-----GTLPWMAP 988
++H DLK NL +N K+GDFGL+ + G R GT ++AP
Sbjct: 159 RNRVIHRDLKLGNLFLNEDL----EVKIGDFGLA----TKVEYDGERKKVLCGTPNYIAP 210
Query: 989 ELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDA 1048
E+LS S +VDV+S G +++ +L G+ P+ I N IP + +
Sbjct: 211 EVLSKKGH--SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS--IPKHINP 266
Query: 1049 EWRTLMEECWAPNPAARPSFTEI 1071
+L+++ +P ARP+ E+
Sbjct: 267 VAASLIQKMLQTDPTARPTINEL 289
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-37
Identities = 82/289 (28%), Positives = 128/289 (44%), Gaps = 32/289 (11%)
Query: 793 NPSLVDFDVSSVQVIKN--EDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTG 848
SL D DV+ + + + + +E+G G+FG VY + VAIK++ ++G
Sbjct: 35 AGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS---YSG 91
Query: 849 RSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVR 908
+ S ++ + KE L KL HPN + + G T V EY GS +L
Sbjct: 92 KQSNEKWQDII--KEVRFLQKLRHPNTIQYRGCYLRE--HTAWLVMEYC-LGSASDLLEV 146
Query: 909 KDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968
+ L + A G+ YLHS N++H D+K N+L++ + K+GDFG +
Sbjct: 147 HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS----EPGLVKLGDFGSAS 202
Query: 969 I--KRNTLVSGGVRGTLPWMAPELLSGSSSKV-SEKVDVFSFGIVLWEILTGEEPYANMH 1025
I N+ V GT WMAPE++ KVDV+S GI E+ + P NM+
Sbjct: 203 IMAPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 257
Query: 1026 YGAIIGGIVNNTLRPTIPSYCDAEW----RTLMEECWAPNPAARPSFTE 1070
+ + I N + P+ W R ++ C P RP+
Sbjct: 258 AMSALYHIAQN---ES-PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEV 302
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 5e-37
Identities = 67/281 (23%), Positives = 114/281 (40%), Gaps = 40/281 (14%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEA 864
+K++D E+ ELG+G G V+ K G +A K I + + + ++ +E
Sbjct: 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH---LEIKPAIRNQII----REL 82
Query: 865 EILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRL----- 919
++L + + P +V FYG G ++ E+M GSL D+ L + R+
Sbjct: 83 QVLHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSL-------DQVLKKAGRIPEQIL 133
Query: 920 -IIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPSRPICKVGDFG----LSKIKRNT 973
+++ G+ YL K I+H D+K N+LVN SR K+ DFG L N+
Sbjct: 134 GKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLCDFGVSGQLIDSMANS 189
Query: 974 LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI 1033
V GT +M+PE L G+ S + D++S G+ L E+ G P +
Sbjct: 190 FV-----GTRSYMSPERLQGTH--YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 242
Query: 1034 VNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074
+ + + + E+
Sbjct: 243 GCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDY 283
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 9e-37
Identities = 48/231 (20%), Positives = 84/231 (36%), Gaps = 29/231 (12%)
Query: 810 EDLEEQKELGSG--TFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAE 865
E +G G TV K G V ++RI + E +T E
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLE-----ACSNEMVT-FLQGELH 78
Query: 866 ILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAM-- 923
+ +HPN+V + L V +M GS + ++ F+D L IA
Sbjct: 79 VSKLFNHPNIVPYRATFIAD--NELWVVTSFMAYGSAKDLI--CTHFMDGMNELAIAYIL 134
Query: 924 -DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS------KIKRNTLVS 976
++Y+H VH +K ++L++ + + ++ +
Sbjct: 135 QGVLKALDYIHHMGYVHRSVKASHILIS----VDGKVYLSGLRSNLSMISHGQRQRVVHD 190
Query: 977 GGVR--GTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH 1025
LPW++PE+L + K D++S GI E+ G P+ +M
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 73/288 (25%), Positives = 116/288 (40%), Gaps = 51/288 (17%)
Query: 810 EDLEEQKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
+D E Q+ +GSG V + VAIKRI Q + E KE + +
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLE------KCQTSMD-ELLKEIQAM 67
Query: 868 SKLHHPNVVAFYG--VVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRL------ 919
S+ HHPN+V++Y VV L V + + GS+ ++ + + +
Sbjct: 68 SQCHHPNIVSYYTSFVV----KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTI 123
Query: 920 -IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS----------- 967
I + G+EYLH +H D+K N+L+ ++ DFG+S
Sbjct: 124 ATILREVLEGLEYLHKNGQIHRDVKAGNILLG----EDGSVQIADFGVSAFLATGGDITR 179
Query: 968 KIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG 1027
R T V GT WMAPE++ K D++SFGI E+ TG PY
Sbjct: 180 NKVRKTFV-----GTPCWMAPEVME-QVRGYDFKADIWSFGITAIELATGAAPYHKYPPM 233
Query: 1028 AIIGGIVNN---TLR-PTIPSYCDAEW----RTLMEECWAPNPAARPS 1067
++ + N +L ++ R ++ C +P RP+
Sbjct: 234 KVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 281
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-36
Identities = 79/286 (27%), Positives = 124/286 (43%), Gaps = 35/286 (12%)
Query: 798 DFDVSSVQVI--KNEDLEEQ----KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGR 849
D + I K L E K+LGSG +G V + + T AIK I+K+ +
Sbjct: 19 DLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS 78
Query: 850 SSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRK 909
S+ + +E +L L HPN++ Y +D L V E G L ++ +
Sbjct: 79 SNSK------LLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL--VMECYKGGELFDEIIHR 130
Query: 910 DRFLDRR-RRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968
+F + +I + + + YLH NIVH DLK +NLL+ K+ I K+ DFGLS
Sbjct: 131 MKFNEVDAAVIIKQVLSG--VTYLHKHNIVHRDLKPENLLLESKEKDALI-KIVDFGLSA 187
Query: 969 IKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA 1028
+ N GT ++APE+L K EK DV+S G++L+ +L G P+
Sbjct: 188 VFENQKKMKERLGTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGGQTDQE 244
Query: 1029 IIGGIVNNTLRPTIPSYCDAEWRTLMEE-------CWAPNPAARPS 1067
I+ + ++ EW+ + E + R S
Sbjct: 245 ILRKVEKGK-----YTFDSPEWKNVSEGAKDLIKQMLQFDSQRRIS 285
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 1e-36
Identities = 49/222 (22%), Positives = 87/222 (39%), Gaps = 24/222 (10%)
Query: 816 KELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWK---------EAEI 866
+ L G F + + A+K+ +KS + + + E +I
Sbjct: 37 RTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 867 LSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAA 926
++ + + + G++ + + + EYM + S+ I
Sbjct: 97 ITDIKNEYCLTCEGIITNY--DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154
Query: 927 F-------GMEYLHS-KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGG 978
Y+H+ KNI H D+K N+L+ D + + K+ DFG S+ + + G
Sbjct: 155 CIIKSVLNSFSYIHNEKNICHRDVKPSNILM---DKNGRV-KLSDFGESEYMVDKKIKG- 209
Query: 979 VRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEP 1020
RGT +M PE S SS KVD++S GI L+ + P
Sbjct: 210 SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 2e-36
Identities = 54/179 (30%), Positives = 84/179 (46%), Gaps = 10/179 (5%)
Query: 910 DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK- 968
FL + + A GME+L S+ +H DL N+L++ + + K+ DFGL++
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----EKNVVKICDFGLARD 242
Query: 969 IKRNTLVSGGVRGTLP--WMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH 1025
I ++ LP WMAPE + + + DV+SFG++LWEI + G PY +
Sbjct: 243 IYKDPDYVRKGDARLPLKWMAPE--TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300
Query: 1026 YGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQ 1084
+ R P Y E M +CW P+ RP+F+E+ L L A +Q
Sbjct: 301 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 359
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 7e-15
Identities = 41/171 (23%), Positives = 60/171 (35%), Gaps = 21/171 (12%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTVEFWK 862
+ L+ K LG G FG V G VA+K +K+ ++ E
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-----ATHSEHR--ALMS 74
Query: 863 EAEILSKL-HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLII 921
E +IL + HH NVV G PGG L + E+ G+L L K R +
Sbjct: 75 ELKILIHIGHHLNVVNLLGACTK-PGGPLMVIVEFCKFGNLSTYLRSK-----RNEFVPY 128
Query: 922 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRN 972
A + + DLK + S V + LS ++
Sbjct: 129 KTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 66/269 (24%), Positives = 112/269 (41%), Gaps = 38/269 (14%)
Query: 816 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
LG G+F VY + T +VAIK I K + + + E +I +L HP
Sbjct: 17 NLLGKGSFAGVYRAESIHTGLEVAIKMIDKK-----AMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 874 NVVAFYGVVQDGPGGTLAT----VAEYMVDGSLRHVLVRKDRFL--DRRRRLIIAMDAAF 927
+++ Y +D + V E +G + L + + + R + +
Sbjct: 72 SILELYNYFED------SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI--IT 123
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR-----GT 982
GM YLHS I+H DL NLL+ K+ DFGL+ L + GT
Sbjct: 124 GMLYLHSHGILHRDLTLSNLLLTRNMN----IKIADFGLA----TQLKMPHEKHYTLCGT 175
Query: 983 LPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTI 1042
+++PE+ + S+ + DV+S G + + +L G P+ + +V +
Sbjct: 176 PNYISPEIATRSAH--GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYE--M 231
Query: 1043 PSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
PS+ E + L+ + NPA R S + +
Sbjct: 232 PSFLSIEAKDLIHQLLRRNPADRLSLSSV 260
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-36
Identities = 72/286 (25%), Positives = 123/286 (43%), Gaps = 34/286 (11%)
Query: 798 DFDVSSVQVI--KNEDLEEQ----KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGR 849
+ + ++ + LG G+FG V K + T A+K I K +
Sbjct: 8 HLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQK 67
Query: 850 SSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRK 909
+ ++ +E ++L +L HPN++ Y +D G V E G L ++ +
Sbjct: 68 TDKES-----LLREVQLLKQLDHPNIMKLYEFFEDK--GYFYLVGEVYTGGELFDEIISR 120
Query: 910 DRFLDRR-RRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968
RF + R+I + + + Y+H IVH DLK +NLL+ K I ++ DFGLS
Sbjct: 121 KRFSEVDAARIIRQVLSG--ITYMHKNKIVHRDLKPENLLLESKSKDANI-RIIDFGLST 177
Query: 969 IKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA 1028
+ GT ++APE+L G EK DV+S G++L+ +L+G P+ GA
Sbjct: 178 HFEASKKMKDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPF----NGA 230
Query: 1029 IIGGIVNNTLRPTIPSYCDAEWRTLMEE-------CWAPNPAARPS 1067
I+ + ++ +W+ + E P+ R S
Sbjct: 231 NEYDILKKVEKGKY-TFELPQWKKVSESAKDLIRKMLTYVPSMRIS 275
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-36
Identities = 67/209 (32%), Positives = 98/209 (46%), Gaps = 10/209 (4%)
Query: 816 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
K LGSG G V R T VAIK I K F S+ + + E EIL KL+HP
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRR-RRLIIAMDAAFGMEYL 932
++ V E M G L +V R + + M A ++YL
Sbjct: 76 CIIKIKNFFDA---EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA--VQYL 130
Query: 933 HSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLS 992
H I+H DLK +N+L++ ++ I K+ DFG SKI T + + GT ++APE+L
Sbjct: 131 HENGIIHRDLKPENVLLSSQEEDCLI-KITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 189
Query: 993 GSSSKV-SEKVDVFSFGIVLWEILTGEEP 1020
+ + VD +S G++L+ L+G P
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-36
Identities = 74/279 (26%), Positives = 122/279 (43%), Gaps = 41/279 (14%)
Query: 813 EEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL 870
E + +G+GT+G VY G+ T AIK + + E+E E +E +L K
Sbjct: 27 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----GDEEE----EIKQEINMLKKY 77
Query: 871 -HHPNVVAFYG----VVQDGPGGTLATVAEYMVDGSLRHVL-VRKDRFLDRRRRLIIAMD 924
HH N+ +YG G L V E+ GS+ ++ K L I +
Sbjct: 78 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 137
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS------KIKRNTLVSGG 978
G+ +LH ++H D+K N+L+ K+ DFG+S +RNT +
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLT----ENAEVKLVDFGVSAQLDRTVGRRNTFI--- 190
Query: 979 VRGTLPWMAPELLSGSSSKVS---EKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN 1035
GT WMAPE+++ + + K D++S GI E+ G P +MH + I
Sbjct: 191 --GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 248
Query: 1036 N---TLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
N L+ S ++++ +E C N + RP+ ++
Sbjct: 249 NPAPRLKSKKWS---KKFQSFIESCLVKNHSQRPATEQL 284
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 9e-36
Identities = 61/230 (26%), Positives = 110/230 (47%), Gaps = 27/230 (11%)
Query: 804 VQVIKNEDLEEQ----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLT 857
++ K + +E+ +ELGSG F V + + T + A K IKK R
Sbjct: 2 MEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE 61
Query: 858 VEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRR 917
+E +E IL ++ H NV+ + V ++ L + E + G L L +K+ +
Sbjct: 62 IE--REVSILRQVLHHNVITLHDVYENRTDVVL--ILELVSGGELFDFLAQKESLSEE-- 115
Query: 918 RLIIAMDAAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK 970
+A G+ YLH+K I HFDLK +N+++ K+ P K+ DFGL+
Sbjct: 116 ------EATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
Query: 971 RNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEP 1020
+ + + GT ++APE+++ + + D++S G++ + +L+G P
Sbjct: 170 EDGVEFKNIFGTPEFVAPEIVNYEP--LGLEADMWSIGVITYILLSGASP 217
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-35
Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 31/225 (13%)
Query: 809 NEDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEI 866
E + ++LG G++G+VY + T VAIK++ + E KE I
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP-------VESDLQ---EIIKEISI 77
Query: 867 LSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAA 926
+ + P+VV +YG L V EY GS+ ++ +++ L I
Sbjct: 78 MQQCDSPHVVKYYGSYFKN--TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTL 135
Query: 927 FGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS------KIKRNTLVSGGVR 980
G+EYLH +H D+K N+L+N + K+ DFG++ KRNT++
Sbjct: 136 KGLEYLHFMRKIHRDIKAGNILLN----TEGHAKLADFGVAGQLTDTMAKRNTVI----- 186
Query: 981 GTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH 1025
GT WMAPE++ + D++S GI E+ G+ PYA++H
Sbjct: 187 GTPFWMAPEVIQEIG--YNCVADIWSLGITAIEMAEGKPPYADIH 229
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 61/279 (21%), Positives = 117/279 (41%), Gaps = 35/279 (12%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEA 864
+ DLE E+GSGT G V+ + G +A+K+++ +G E +R+ +
Sbjct: 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR---RSGNKEENKRIL----MDL 74
Query: 865 EILSKLH-HPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAM 923
+++ K H P +V +G + E M + R + R + +
Sbjct: 75 DVVLKSHDCPYIVQCFGTFIT--NTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTV 131
Query: 924 DAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-----IKRNTLVSG 977
+ YL K ++H D+K N+L++ R K+ DFG+S ++
Sbjct: 132 AIVKALYYLKEKHGVIHRDVKPSNILLD----ERGQIKLCDFGISGRLVDDKAKDRSA-- 185
Query: 978 GVRGTLPWMAPELLSGSSSKV---SEKVDVFSFGIVLWEILTGEEPYANMHYG-AIIGGI 1033
G +MAPE + + DV+S GI L E+ TG+ PY N ++ +
Sbjct: 186 ---GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV 242
Query: 1034 VNNTLRPTIPSYCD--AEWRTLMEECWAPNPAARPSFTE 1070
+ P +P + ++++ +++C + RP + +
Sbjct: 243 LQEEP-PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNK 280
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-35
Identities = 63/229 (27%), Positives = 108/229 (47%), Gaps = 29/229 (12%)
Query: 806 VIKNEDLEEQ----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTVE 859
V + E++++ +ELGSG F V + + T A K IKK R +E
Sbjct: 3 VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 860 FWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRL 919
+E IL ++ HPNV+ + V ++ L + E + G L L K+ +
Sbjct: 63 --REVSILKEIQHPNVITLHEVYENKTDVIL--ILELVAGGELFDFLAEKESLTEE---- 114
Query: 920 IIAMDAAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS-KIKR 971
+A G+ YLHS I HFDLK +N+++ ++ +P K+ DFGL+ KI
Sbjct: 115 ----EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 972 NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEP 1020
GT ++APE+++ + + D++S G++ + +L+G P
Sbjct: 171 GNEFKNIF-GTPEFVAPEIVNYEP--LGLEADMWSIGVITYILLSGASP 216
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-35
Identities = 63/220 (28%), Positives = 107/220 (48%), Gaps = 21/220 (9%)
Query: 807 IKNEDLEEQ----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTVEF 860
++ ++ + + LGSG F V+ K R T A+K IKKS SS
Sbjct: 2 MQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS--------L 53
Query: 861 WKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLI 920
E +L K+ H N+V + + V + + G L ++ + + ++ L+
Sbjct: 54 ENEIAVLKKIKHENIVTLEDIYEST--THYYLVMQLVSGGELFDRILERGVYTEKDASLV 111
Query: 921 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR 980
I + ++YLH IVH DLK +NLL + + I + DFGLSK+++N ++S
Sbjct: 112 IQQVLS-AVKYLHENGIVHRDLKPENLLYLTPEENSKI-MITDFGLSKMEQNGIMSTAC- 168
Query: 981 GTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEP 1020
GT ++APE+L+ S+ VD +S G++ + +L G P
Sbjct: 169 GTPGYVAPEVLAQKP--YSKAVDCWSIGVITYILLCGYPP 206
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 6e-35
Identities = 62/299 (20%), Positives = 116/299 (38%), Gaps = 42/299 (14%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEA 864
+ L ++ L G F VY + G + A+KR+ E+ R + +E
Sbjct: 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS-----NEEEKNRAII---QEV 76
Query: 865 EILSKL-HHPNVVAFYGVVQDGPGGTLATVAEYMV-----DGSLRHVLV--RKDRFLDRR 916
+ KL HPN+V F G + AE+++ G L L L
Sbjct: 77 CFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCD 136
Query: 917 RRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTL 974
L I ++++H + I+H DLK +NLL++ + K+ DFG + +
Sbjct: 137 TVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG----TIKLCDFGSATTISHYP 192
Query: 975 VSGG-------------VRGTLPWMAPELLSGSSSK-VSEKVDVFSFGIVLWEILTGEEP 1020
T + PE++ S+ + EK D+++ G +L+ + + P
Sbjct: 193 DYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
Query: 1021 YANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079
+ + I+ G + P + + +L+ NP R S E+ +L+ ++
Sbjct: 253 FEDGAKLRIVNGKYS---IPPHDTQ-YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-34
Identities = 71/296 (23%), Positives = 125/296 (42%), Gaps = 34/296 (11%)
Query: 793 NPSLVDFDVSSVQVI--KNEDLEEQ----KELGSGTFGTVYHGKWRGTD--VAIKRIKKS 844
N ++ + K + E ++LGSG +G V K + AIK IKKS
Sbjct: 13 NLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKS 72
Query: 845 CFTGRSSEQERLTVE-----FWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVD 899
F + +E + E +L L HPN++ + V +D L V E+
Sbjct: 73 QFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYL--VTEFYEG 130
Query: 900 GSLRHVLVRKDRFLDRR-RRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPI 958
G L ++ + +F + ++ + + + YLH NIVH D+K +N+L+ K+ I
Sbjct: 131 GELFEQIINRHKFDECDAANIMKQILSG--ICYLHKHNIVHRDIKPENILLENKNSLLNI 188
Query: 959 CKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
K+ DFGLS GT ++APE+L ++ K DV+S G++++ +L G
Sbjct: 189 -KIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNE---KCDVWSCGVIMYILLCGY 244
Query: 1019 EPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEEC-------WAPNPAARPS 1067
P+ G I+ + + +W+ + +E + R +
Sbjct: 245 PPF----GGQNDQDIIKKVEKGKY-YFDFNDWKNISDEAKELIKLMLTYDYNKRCT 295
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-34
Identities = 74/262 (28%), Positives = 125/262 (47%), Gaps = 29/262 (11%)
Query: 816 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
LG G+FG V K R T + A+K I K+ + + +E E+L KL HP
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST------ILREVELLKKLDHP 81
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRR-RRLIIAMDAAFGMEYL 932
N++ + +++D + V E G L ++++ RF + R+I + + + Y+
Sbjct: 82 NIMKLFEILEDSSSFYI--VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG--ITYM 137
Query: 933 HSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLS 992
H NIVH DLK +N+L+ K+ I K+ DFGLS + GT ++APE+L
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDI-KIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR 196
Query: 993 GSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRT 1052
G EK DV+S G++L+ +L+G P+ YG I+ ++ +WRT
Sbjct: 197 G---TYDEKCDVWSAGVILYILLSGTPPF----YGKNEYDILKRVETGKY-AFDLPQWRT 248
Query: 1053 LMEE-------CWAPNPAARPS 1067
+ ++ +P+ R +
Sbjct: 249 ISDDAKDLIRKMLTFHPSLRIT 270
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-34
Identities = 42/284 (14%), Positives = 80/284 (28%), Gaps = 43/284 (15%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTVE 859
+ ++ + LG G F VY + +K K + E T
Sbjct: 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----PWEFYIGT-- 115
Query: 860 FWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRK----DRFLDR 915
+ E L + FY V E G+L + + ++ + +
Sbjct: 116 --QLMERLKPSMQHMFMKFYSAHLFQ--NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQ 171
Query: 916 RRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC-------KVGDFGLSK 968
+ AM + +E +H I+H D+K DN ++ + + D G S
Sbjct: 172 GLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 969 IKR----NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANM 1024
+ T+ + T + E+LS + ++D F ++ +L G
Sbjct: 232 DMKLFPKGTIFT-AKCETSGFQCVEMLSNKPW--NYQIDYFGVAATVYCMLFGTYMKVKN 288
Query: 1025 HYGAIIGGIVNNTLRPTIPSYCDAE-WRTLMEECWAPNPAARPS 1067
G + W
Sbjct: 289 EGGECK-------PEGLFRRLPHLDMWNEFFHVMLNIPDCHHLP 325
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-34
Identities = 61/230 (26%), Positives = 111/230 (48%), Gaps = 27/230 (11%)
Query: 804 VQVIKNEDLEE----QKELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLT 857
++ K + +E+ +ELGSG F V + + T + A K IKK R
Sbjct: 2 METFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREE 61
Query: 858 VEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRR 917
+E +E IL ++ HPN++ + V ++ L + E + G L L +K+ +
Sbjct: 62 IE--REVSILRQVLHPNIITLHDVYENRTDVVL--ILELVSGGELFDFLAQKESLSEE-- 115
Query: 918 RLIIAMDAAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK 970
+A G+ YLH+K I HFDLK +N+++ K+ P K+ DFGL+
Sbjct: 116 ------EATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
Query: 971 RNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEP 1020
+ + + GT ++APE+++ + + D++S G++ + +L+G P
Sbjct: 170 EDGVEFKNIFGTPEFVAPEIVNYEP--LGLEADMWSIGVITYILLSGASP 217
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 3e-34
Identities = 66/223 (29%), Positives = 110/223 (49%), Gaps = 21/223 (9%)
Query: 805 QVIKNEDLEEQ----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTV 858
+ E+ LG G+FG V K R T + A+K I K+ + +
Sbjct: 13 NLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST----- 67
Query: 859 EFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRR-R 917
+E E+L KL HPN++ + +++D + V E G L ++++ RF +
Sbjct: 68 -ILREVELLKKLDHPNIMKLFEILEDS--SSFYIVGELYTGGELFDEIIKRKRFSEHDAA 124
Query: 918 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSG 977
R+I + + + Y+H NIVH DLK +N+L+ K+ I K+ DFGLS +
Sbjct: 125 RIIKQVFSG--ITYMHKHNIVHRDLKPENILLESKEKDCDI-KIIDFGLSTCFQQNTKMK 181
Query: 978 GVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEP 1020
GT ++APE+L G+ + K DV+S G++L+ +L+G P
Sbjct: 182 DRIGTAYYIAPEVLRGTYDE---KCDVWSAGVILYILLSGTPP 221
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-34
Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 23/220 (10%)
Query: 808 KNEDLEEQ----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTVEFW 861
D+ + +G G++G V +GT A K+I K + +R
Sbjct: 3 TKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKY----FVEDVDRF----K 54
Query: 862 KEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRR-RRLI 920
+E EI+ L HPN++ Y +D + V E G L +V K F + R++
Sbjct: 55 QEIEIMKSLDHPNIIRLYETFEDN--TDIYLVMELCTGGELFERVVHKRVFRESDAARIM 112
Query: 921 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR 980
+ +A + Y H N+ H DLK +N L P P+ K+ DFGL+ + +
Sbjct: 113 KDVLSA--VAYCHKLNVAHRDLKPENFLFLTDSPDSPL-KLIDFGLAARFKPGKMMRTKV 169
Query: 981 GTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEP 1020
GT +++P++L G + D +S G++++ +L G P
Sbjct: 170 GTPYYVSPQVLEGLYGP---ECDEWSAGVMMYVLLCGYPP 206
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-34
Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 28/214 (13%)
Query: 816 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
+ELG G F V + T + A K I + R + + +EA I KL HP
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ------KLEREARICRKLQHP 65
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF------ 927
N+V + +Q+ V + + G L +V ++ + + DA+
Sbjct: 66 NIVRLHDSIQEE--SFHYLVFDLVTGGELFEDIVAREFYSEA--------DASHCIQQIL 115
Query: 928 -GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWM 986
+ Y HS IVH +LK +NLL+ K + K+ DFGL+ ++ G GT ++
Sbjct: 116 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAV-KLADFGLAIEVNDSEAWHGFAGTPGYL 174
Query: 987 APELLSGSSSKVSEKVDVFSFGIVLWEILTGEEP 1020
+PE+L S+ VD+++ G++L+ +L G P
Sbjct: 175 SPEVLKKDP--YSKPVDIWACGVILYILLVGYPP 206
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 129 bits (328), Expect = 2e-33
Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 23/214 (10%)
Query: 816 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
+ELGSG F V + +GT + A K IKK + R +E +E IL ++ HP
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIE--REVNILREIRHP 68
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF------ 927
N++ + + ++ L + E + G L L K+ + +A
Sbjct: 69 NIITLHDIFENKTDVVL--ILELVSGGELFDFLAEKESLTED--------EATQFLKQIL 118
Query: 928 -GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWM 986
G+ YLHSK I HFDLK +N+++ K+ P K+ DFG++ + GT ++
Sbjct: 119 DGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFV 178
Query: 987 APELLSGSSSKVSEKVDVFSFGIVLWEILTGEEP 1020
APE+++ + + D++S G++ + +L+G P
Sbjct: 179 APEIVNYEP--LGLEADMWSIGVITYILLSGASP 210
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-33
Identities = 60/245 (24%), Positives = 105/245 (42%), Gaps = 32/245 (13%)
Query: 789 LPSLNPSLVDFDVSSVQVIKNEDLEEQ----KELGSGTFGTVYHGKWRGT--DVAIKRIK 842
+ S+ S + + + +ELG G F V + T + A K I
Sbjct: 4 MASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN 63
Query: 843 KSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSL 902
+ R + + +EA I KL HPN+V + +Q+ V + + G L
Sbjct: 64 TKKLSARDFQ------KLEREARICRKLQHPNIVRLHDSIQEE--SFHYLVFDLVTGGEL 115
Query: 903 RHVLVRKDRFLDRRRRLIIAMDAAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDPS 955
+V ++ + + DA+ + Y HS IVH +LK +NLL+ K
Sbjct: 116 FEDIVAREFYSEA--------DASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKG 167
Query: 956 RPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEIL 1015
+ K+ DFGL+ ++ G GT +++PE+L S+ VD+++ G++L+ +L
Sbjct: 168 AAV-KLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP--YSKPVDIWACGVILYILL 224
Query: 1016 TGEEP 1020
G P
Sbjct: 225 VGYPP 229
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-33
Identities = 67/236 (28%), Positives = 106/236 (44%), Gaps = 50/236 (21%)
Query: 808 KNEDLEEQ----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTVEFW 861
+++ ++LGSG FG V+ + R + + IK I K RS +
Sbjct: 16 FQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKD----RSQVPME---QIE 68
Query: 862 KEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLII 921
E E+L L HPN++ + V +D + V E G L L+R I+
Sbjct: 69 AEIEVLKSLDHPNIIKIFEVFEDY--HNMYIVMETCEGGEL----------LER----IV 112
Query: 922 A----------MDAAFGM-------EYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964
+ A M Y HS+++VH DLK +N+L P PI K+ DF
Sbjct: 113 SAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPI-KIIDF 171
Query: 965 GLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEP 1020
GL+++ ++ S GT +MAPE+ V+ K D++S G+V++ +LTG P
Sbjct: 172 GLAELFKSDEHSTNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 9e-33
Identities = 45/348 (12%), Positives = 88/348 (25%), Gaps = 49/348 (14%)
Query: 762 QFDAMMENLRTTESDYEEGNAGNRNIGLPSLNPSLVDFDVSSVQVIKNEDLEEQKELGSG 821
E + + + A ++ P + V S+ L+ + L G
Sbjct: 14 LLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVG 73
Query: 822 TFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFY 879
V+ + A+K RS + + ++L +
Sbjct: 74 DRSVVFLVRDVERLEDFALKVFTMGAENSRSELER-----LHEATFAAARLLGESPEEAR 128
Query: 880 G------------------VVQDGPGGTLATVAEYMV-----DGSLRHVLVRKDRFLDRR 916
Q PG VA Y++ L + D R
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 917 R------RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK 970
I+ L SK +VH DNL + +GD
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGR----LMLGDVSALWKV 244
Query: 971 RNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAII 1030
+ + + E L+ S++ + ++ + G+ ++ + P+ + G
Sbjct: 245 GTRGPASS--VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG 302
Query: 1031 GGIVNNTLRPTIPSYCDAEWRTLMEECW-------APNPAARPSFTEI 1071
+ P S L + + R E
Sbjct: 303 SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEA 350
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-32
Identities = 70/226 (30%), Positives = 107/226 (47%), Gaps = 36/226 (15%)
Query: 808 KNEDLEEQ----KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFW 861
+ L + ELG G VY K +GT A+K +KK+ +++ +
Sbjct: 47 NRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT------VDKKIV----R 96
Query: 862 KEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLII 921
E +L +L HPN++ + + +L V E + G L +V K + +R
Sbjct: 97 TEIGVLLRLSHPNIIKLKEIFETPTEISL--VLELVTGGELFDRIVEKGYYSER------ 148
Query: 922 AMDAAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTL 974
DAA + YLH IVH DLK +NLL P P+ K+ DFGLSKI + +
Sbjct: 149 --DAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPL-KIADFGLSKIVEHQV 205
Query: 975 VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEP 1020
+ V GT + APE+L G + +VD++S GI+ + +L G EP
Sbjct: 206 LMKTVCGTPGYCAPEILRGCA--YGPEVDMWSVGIITYILLCGFEP 249
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 9e-32
Identities = 60/242 (24%), Positives = 96/242 (39%), Gaps = 32/242 (13%)
Query: 794 PSLVDFDVSSVQVIKNEDLEEQ-----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCF 846
S VD ++ E+ KELG G F V + T + A K +KK
Sbjct: 8 SSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR 67
Query: 847 TGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHV 905
E E +L P V+ + V ++ L + EY G +
Sbjct: 68 GQDCRA------EILHEIAVLELAKSCPRVINLHEVYENTSEIIL--ILEYAAGGEIF-- 117
Query: 906 LVRKDRFLDRRRRLIIAMDAAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPI 958
L ++ D G+ YLH NIVH DLK N+L++ P I
Sbjct: 118 ----SLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDI 173
Query: 959 CKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
K+ DFG+S+ + + GT ++APE+L+ ++ D+++ GI+ + +LT
Sbjct: 174 -KIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDP--ITTATDMWNIGIIAYMLLTHT 230
Query: 1019 EP 1020
P
Sbjct: 231 SP 232
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 58/267 (21%), Positives = 96/267 (35%), Gaps = 57/267 (21%)
Query: 804 VQVIKNEDLEEQ----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLT 857
Q +L+++ +G G++G V T AIK + K+ + +
Sbjct: 16 FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVE-- 73
Query: 858 VEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRR 917
E ++ KLHHPN+ Y V +D + V E G L L +
Sbjct: 74 -RIKTEVRLMKKLHHPNIARLYEVYEDE--QYICLVMELCHGGHLLDKLNVFIDDSTGKC 130
Query: 918 RLIIAM--------------------------------DAAF-------GMEYLHSKNIV 938
+ + + + YLH++ I
Sbjct: 131 AMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGIC 190
Query: 939 HFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR-----GTLPWMAPELLSG 993
H D+K +N L + + S I K+ DFGLSK GT ++APE+L+
Sbjct: 191 HRDIKPENFLFS-TNKSFEI-KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT 248
Query: 994 SSSKVSEKVDVFSFGIVLWEILTGEEP 1020
++ K D +S G++L +L G P
Sbjct: 249 TNESYGPKCDAWSAGVLLHLLLMGAVP 275
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-31
Identities = 52/228 (22%), Positives = 95/228 (41%), Gaps = 33/228 (14%)
Query: 807 IKNEDLEEQ----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTVEF 860
I E+ +ELG G F V + A I + R ++
Sbjct: 4 ITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK------L 57
Query: 861 WKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLI 920
+EA I L HPN+V + + + G + + + G L +V ++ + +
Sbjct: 58 EREARICRLLKHPNIVRLHDSISEE--GHHYLIFDLVTGGELFEDIVAREYYSEA----- 110
Query: 921 IAMDAAFGM-------EYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-IKRN 972
DA+ + + H +VH +LK +NLL+ K + K+ DFGL+ ++
Sbjct: 111 ---DASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAV-KLADFGLAIEVEGE 166
Query: 973 TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEP 1020
G GT +++PE+L + VD+++ G++L+ +L G P
Sbjct: 167 QQAWFGFAGTPGYLSPEVLRKDP--YGKPVDLWACGVILYILLVGYPP 212
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 70/330 (21%), Positives = 111/330 (33%), Gaps = 80/330 (24%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKS----------------------- 844
D E + +G G FG V+ K + + AIKRI+
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 845 ---------------------------CFTGRSSEQERLTVEFWKEAEILSKLHHPNVVA 877
T + + N V
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 878 FYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLI--IAMDAAFGMEYLHSK 935
P L + +L+ + R+ DR + I + A +E+LHSK
Sbjct: 126 QLQPSS--PKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK 183
Query: 936 NIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI--------------KRNTLVSGGVRG 981
++H DLK N+ + D + KVGDFGL +G V G
Sbjct: 184 GLMHRDLKPSNIFFTMDD----VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV-G 238
Query: 982 TLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT 1041
T +M+PE + G++ S KVD+FS G++L+E+L II + N
Sbjct: 239 TKLYMSPEQIHGNN--YSHKVDIFSLGLILFELLYSFSTQMERV--RIITDVRNLKFPLL 294
Query: 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
E ++++ +P+P RP T+I
Sbjct: 295 FTQKYPQE-HMMVQDMLSPSPTERPEATDI 323
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 73/292 (25%), Positives = 111/292 (38%), Gaps = 56/292 (19%)
Query: 816 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWK----------- 862
E+G G++G V T A+K + K ++ R +
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 863 -------EAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDR 915
E IL KL HPNVV V+ D L V E + G + V +
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV-PTLKPLSED 137
Query: 916 --RR--RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKR 971
R + +I G+EYLH + I+H D+K NLLV I K+ DFG+S
Sbjct: 138 QARFYFQDLIK-----GIEYLHYQKIIHRDIKPSNLLV---GEDGHI-KIADFGVS---- 184
Query: 972 NTLVSGGVR-----GTLPWMAPELLSGSSSKVS-EKVDVFSFGIVLWEILTGEEPY--AN 1023
N GT +MAPE LS + S + +DV++ G+ L+ + G+ P+
Sbjct: 185 NEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244
Query: 1024 MH--YGAIIGGIVNNTLRPTIPSYCD--AEWRTLMEECWAPNPAARPSFTEI 1071
+ + I + P D + + L+ NP +R EI
Sbjct: 245 IMCLHSKIKSQAL------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEI 290
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-31
Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 28/218 (12%)
Query: 816 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
+ +G G F V R T A+K + + FT + +EA I L HP
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTE---DLKREASICHMLKHP 86
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDR---RRRLIIAMDAAFGM- 929
++V G L V E+M L +V++ A+ M
Sbjct: 87 HIVELLETYSSD--GMLYMVFEFMDGADLCFEIVKRADAGFVYSEA-------VASHYMR 137
Query: 930 ------EYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-IKRNTLVSGGVRGT 982
Y H NI+H D+K +L+ K+ S P+ K+G FG++ + + LV+GG GT
Sbjct: 138 QILEALRYCHDNNIIHRDVKPHCVLLASKENSAPV-KLGGFGVAIQLGESGLVAGGRVGT 196
Query: 983 LPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEP 1020
+MAPE++ + VDV+ G++L+ +L+G P
Sbjct: 197 PHFMAPEVVKREP--YGKPVDVWGCGVILFILLSGCLP 232
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-31
Identities = 75/271 (27%), Positives = 120/271 (44%), Gaps = 42/271 (15%)
Query: 815 QKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHH 872
K +G G F V + G +VAIK I K+ + ++L +E I+ L+H
Sbjct: 20 LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL--NPTSLQKLF----REVRIMKILNH 73
Query: 873 PNVVAFYGVVQDGPGGTLAT---VAEYMVDGSLRHVLVRKDRFLDRR-RRL---IIAMDA 925
PN+V + V++ T T + EY G + LV R ++ R I++
Sbjct: 74 PNIVKLFEVIE-----TEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS--- 125
Query: 926 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS-KIKRNTLVSGGVRGTLP 984
++Y H K IVH DLK +NLL+ D I K+ DFG S + + G P
Sbjct: 126 --AVQYCHQKRIVHRDLKAENLLL---DADMNI-KIADFGFSNEFTVGGKLDAFC-GAPP 178
Query: 985 WMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPY--ANMH--YGAIIGGIVNNTLRP 1040
+ APEL G +VDV+S G++L+ +++G P+ N+ ++ G
Sbjct: 179 YAAPELFQGKKY-DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY------ 231
Query: 1041 TIPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
IP Y + L++ NP R + +I
Sbjct: 232 RIPFYMSTDCENLLKRFLVLNPIKRGTLEQI 262
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-31
Identities = 68/267 (25%), Positives = 114/267 (42%), Gaps = 33/267 (12%)
Query: 816 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-- 871
LG G FGTV+ G VAIK I ++ G S + +T E +L K+
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCP--LEVALLWKVGAG 94
Query: 872 --HPNVVAFYGVVQDGPGGTLATVAEYMVDGS-LRHVLVRKDRFLDRR-RRL---IIAMD 924
HP V+ + G L V E + L + K + R ++A
Sbjct: 95 GGHPGVIRLLDWFETQEGFML--VLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA-- 150
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLP 984
+++ HS+ +VH D+K +N+L+ D R K+ DFG + + + GT
Sbjct: 151 ---AIQHCHSRGVVHRDIKDENILI---DLRRGCAKLIDFGSGALLHDEPYTDFD-GTRV 203
Query: 985 WMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPS 1044
+ PE +S + V+S GI+L++++ G+ P+ I+ + P+
Sbjct: 204 YSPPEWISRHQYH-ALPATVWSLGILLYDMVCGDIPFE--RDQEILEAEL------HFPA 254
Query: 1045 YCDAEWRTLMEECWAPNPAARPSFTEI 1071
+ + L+ C AP P++RPS EI
Sbjct: 255 HVSPDCCALIRRCLAPKPSSRPSLEEI 281
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 8e-31
Identities = 61/227 (26%), Positives = 99/227 (43%), Gaps = 23/227 (10%)
Query: 808 KNEDLEEQ----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQ-ERLTVEF 860
E + LG G V + T + A+K I + S+E+ + L
Sbjct: 11 STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 861 WKEAEILSKL-HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRL 919
KE +IL K+ HPN++ + L V + M G L L K ++ R
Sbjct: 71 LKEVDILRKVSGHPNIIQLKDTYETNTFFFL--VFDLMKKGELFDYLTEKVTLSEKETRK 128
Query: 920 IIA--MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSG 977
I+ ++ + LH NIVH DLK +N+L+ D I K+ DFG S
Sbjct: 129 IMRALLEV---ICALHKLNIVHRDLKPENILL---DDDMNI-KLTDFGFSCQLDPGEKLR 181
Query: 978 GVRGTLPWMAPELLSGSSSKV----SEKVDVFSFGIVLWEILTGEEP 1020
V GT ++APE++ S + ++VD++S G++++ +L G P
Sbjct: 182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-30
Identities = 55/244 (22%), Positives = 106/244 (43%), Gaps = 22/244 (9%)
Query: 790 PSLNPSLVDFDVSSVQVIKNEDLEEQ----KELGSGTFGTVYHGKWRGT--DVAIKRIKK 843
+L + + ++ ++ +G G V R T + A+K ++
Sbjct: 70 ENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEV 129
Query: 844 SCFTGRSSEQERLTVEFWKEAEILSKLH-HPNVVAFYGVVQDGPGGTLATVAEYMVDGSL 902
+ + E + +E IL ++ HP+++ + L V + M G L
Sbjct: 130 TAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFL--VFDLMRKGEL 187
Query: 903 RHVLVRKDRFLDRRRRLIIA--MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICK 960
L K ++ R I+ ++A + +LH+ NIVH DLK +N+L+ D + I +
Sbjct: 188 FDYLTEKVALSEKETRSIMRSLLEA---VSFLHANNIVHRDLKPENILL---DDNMQI-R 240
Query: 961 VGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKV----SEKVDVFSFGIVLWEILT 1016
+ DFG S + GT ++APE+L S + ++VD+++ G++L+ +L
Sbjct: 241 LSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLA 300
Query: 1017 GEEP 1020
G P
Sbjct: 301 GSPP 304
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 74/272 (27%), Positives = 113/272 (41%), Gaps = 41/272 (15%)
Query: 816 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
+ LG G +G V R T VA+K + ++ E I L+H
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-------EICINKMLNHE 65
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDR--RR--RLIIAMDAAFGM 929
NVV FYG ++G EY G L + + +R ++A G+
Sbjct: 66 NVVKFYGHRREG--NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GV 118
Query: 930 EYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR---GTLPWM 986
YLH I H D+K +NLL+ D + K+ DFGL+ + R + GTLP++
Sbjct: 119 VYLHGIGITHRDIKPENLLL---DERDNL-KISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 987 APELLSGSSSKVSEKVDVFSFGIVLWEILTG----EEPYANMH-YGAIIGGIVNNTLRPT 1041
APELL +E VDV+S GIVL +L G ++P + Y
Sbjct: 175 APELLKRREFH-AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT------Y 227
Query: 1042 IPSYC--DAEWRTLMEECWAPNPAARPSFTEI 1071
+ + D+ L+ + NP+AR + +I
Sbjct: 228 LNPWKKIDSAPLALLHKILVENPSARITIPDI 259
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 67/274 (24%), Positives = 112/274 (40%), Gaps = 41/274 (14%)
Query: 816 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
LG G++G V A+K +KK + + + KE ++L +L H
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVK----KEIQLLRRLRHK 66
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRR------RRL---IIAMD 924
NV+ V+ + + V EY ++ +L D ++R +I
Sbjct: 67 NVIQLVDVLYNEEKQKMYMVMEY-CVCGMQEML---DSVPEKRFPVCQAHGYFCQLID-- 120
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR---G 981
G+EYLHS+ IVH D+K NLL+ + K+ G+++ R G
Sbjct: 121 ---GLEYLHSQGIVHKDIKPGNLLL---TTGGTL-KISALGVAEALHPFAADDTCRTSQG 173
Query: 982 TLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPY--ANMH--YGAIIGGIVNNT 1037
+ + PE+ +G + KVD++S G+ L+ I TG P+ N++ + I G
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY--- 230
Query: 1038 LRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
IP C L++ PA R S +I
Sbjct: 231 ---AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQI 261
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-30
Identities = 56/283 (19%), Positives = 106/283 (37%), Gaps = 47/283 (16%)
Query: 818 LGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL 870
+ G G +Y D V +K + +G + Q E + L+++
Sbjct: 88 IAHGGLGWIY----LALDRNVNGRPVVLKGLV---HSGDAEAQAM----AMAERQFLAEV 136
Query: 871 HHPNVVAFYGVVQDGPGGTLAT---VAEYMVDG-SLRHVLVRKDRFLDRRRRLIIAMDAA 926
HP++V + V+ V EY V G SL+ +K L + ++
Sbjct: 137 VHPSIVQIFNFVEHTDRHGDPVGYIVMEY-VGGQSLKRSKGQK---LPVAEAIAYLLEIL 192
Query: 927 FGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWM 986
+ YLHS +V+ DLK +N+++ + K+ D G G + GT +
Sbjct: 193 PALSYLHSIGLVYNDLKPENIML---TEEQL--KLIDLG---AVSRINSFGYLYGTPGFQ 244
Query: 987 APELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYC 1046
APE++ + + D+++ G L + G + G+ +
Sbjct: 245 APEIVRTGPTVAT---DIYTVGRTLAALTLDLPTRN----GRYVDGLPEDDPVLKTY--- 294
Query: 1047 DAEWRTLMEECWAPNPAARP-SFTEIASRLR-VLSTAASQTKG 1087
+ L+ P+P R + E++++L VL +Q G
Sbjct: 295 -DSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTG 336
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-30
Identities = 70/320 (21%), Positives = 120/320 (37%), Gaps = 32/320 (10%)
Query: 712 REVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSESMQFDAMMENLR 771
+ L + R+ ++ GQ P + E R
Sbjct: 57 SPCAKSRYTYTTIEGLRAGKQYEFRIIAENKHGQ-------SKPCEPTAPVLIPGDERKR 109
Query: 772 TTESDYEEGNAGNRNIGLPSLNPSLVDFDVSSVQV-----IKNEDLEEQ----KELGSGT 822
D +E R G S N FD+ IK++ + + +ELG+G
Sbjct: 110 RRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGA 169
Query: 823 FGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYG 880
FG V+ R T + A K + S++E + KE + +S L HP +V +
Sbjct: 170 FGVVHRVTERATGNNFAAKFVMTP----HESDKETV----RKEIQTMSVLRHPTLVNLHD 221
Query: 881 VVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHF 940
+D + + E+M G L + + + + G+ ++H N VH
Sbjct: 222 AFEDDNEMVM--IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHL 279
Query: 941 DLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSE 1000
DLK +N++ K + K+ DFGL+ GT + APE+ G V
Sbjct: 280 DLKPENIMFTTKRSNE--LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP--VGY 335
Query: 1001 KVDVFSFGIVLWEILTGEEP 1020
D++S G++ + +L+G P
Sbjct: 336 YTDMWSVGVLSYILLSGLSP 355
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-30
Identities = 49/227 (21%), Positives = 96/227 (42%), Gaps = 34/227 (14%)
Query: 807 IKNEDLEEQ----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTVEF 860
+K + + +ELGSG FG V+ + T K I ++ +
Sbjct: 44 VKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYTV---- 95
Query: 861 WKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLI 920
E I+++LHHP ++ + +D L + E++ G L + +D +
Sbjct: 96 KNEISIMNQLHHPKLINLHDAFEDKYEMVL--ILEFLSGGELFDRIAAEDYKMSEA---- 149
Query: 921 IAMDAAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT 973
+ G++++H +IVH D+K +N++ K S + K+ DFGL+
Sbjct: 150 ---EVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKAS-SV-KIIDFGLATKLNPD 204
Query: 974 LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEP 1020
+ T + APE++ V D+++ G++ + +L+G P
Sbjct: 205 EIVKVTTATAEFAAPEIVDREP--VGFYTDMWAIGVLGYVLLSGLSP 249
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-30
Identities = 46/232 (19%), Positives = 93/232 (40%), Gaps = 51/232 (21%)
Query: 810 EDLEEQ----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTVEFWKE 863
++L E+ ++LG G FG V+ + K +K + ++Q + KE
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-----KGTDQVLV----KKE 51
Query: 864 AEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIA- 922
IL+ H N++ + + + + E++ + +R I
Sbjct: 52 ISILNIARHRNILHLHESFESMEELVM--IFEFISGLDI----------FER----INTS 95
Query: 923 ------MDAAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS-K 968
+ +++LHS NI HFD++ +N++ + S I K+ +FG + +
Sbjct: 96 AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSS-TI-KIIEFGQARQ 153
Query: 969 IKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEP 1020
+K + APE+ VS D++S G +++ +L+G P
Sbjct: 154 LKPGDNFRLLF-TAPEYYAPEVHQHDV--VSTATDMWSLGTLVYVLLSGINP 202
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 59/269 (21%), Positives = 111/269 (41%), Gaps = 35/269 (13%)
Query: 816 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
LGSG FG V+ + +V +K IKK ++ + E ILS++ H
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGS-LRHVLVRKDRFLDR--RR--RLIIAMDAAFG 928
N++ + ++ G V E G L + R R + R +++
Sbjct: 90 NIIKVLDIFENQ--GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS-----A 142
Query: 929 MEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR----GTLP 984
+ YL K+I+H D+K +N+++ K+ DFG + L G + GT+
Sbjct: 143 VGYLRLKDIIHRDIKDENIVIA----EDFTIKLIDFGSA----AYLERGKLFYTFCGTIE 194
Query: 985 WMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPS 1044
+ APE+L G+ + E ++++S G+ L+ ++ E P+ + + P
Sbjct: 195 YCAPEVLMGNPYRGPE-LEMWSLGVTLYTLVFEENPFCE--LEETVEAAI------HPPY 245
Query: 1045 YCDAEWRTLMEECWAPNPAARPSFTEIAS 1073
E +L+ P P R + ++ +
Sbjct: 246 LVSKELMSLVSGLLQPVPERRTTLEKLVT 274
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 61/265 (23%), Positives = 107/265 (40%), Gaps = 31/265 (11%)
Query: 816 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHH- 872
LGSG FG+VY G VAIK ++K + V E +L K+
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP--MEVVLLKKVSSG 106
Query: 873 -PNVVAFYGVVQDGPGGTLATVAEYMV-DGSLRHVLVRKDRFLDR--RR--RLIIAMDAA 926
V+ + L + E L + + + R ++
Sbjct: 107 FSGVIRLLDWFERPDSFVL--ILERPEPVQDLFDFITERGALQEELARSFFWQVLE---- 160
Query: 927 FGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWM 986
+ + H+ ++H D+K +N+L+ D +R K+ DFG + ++T+ + GT +
Sbjct: 161 -AVRHCHNCGVLHRDIKDENILI---DLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYS 215
Query: 987 APELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYC 1046
PE + V+S GI+L++++ G+ P+ + II G V
Sbjct: 216 PPEWIRYHRYH-GRSAAVWSLGILLYDMVCGDIPFEHDE--EIIRGQV------FFRQRV 266
Query: 1047 DAEWRTLMEECWAPNPAARPSFTEI 1071
+E + L+ C A P+ RP+F EI
Sbjct: 267 SSECQHLIRWCLALRPSDRPTFEEI 291
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-29
Identities = 40/317 (12%), Positives = 89/317 (28%), Gaps = 49/317 (15%)
Query: 791 SLNPSLVDFDVSSVQVIKNEDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTG 848
SL + F V S + L LG + T + +
Sbjct: 54 SLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP 113
Query: 849 --------------------RSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888
++ +Q ++ + F +++ ++ +D
Sbjct: 114 SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVL 173
Query: 889 TLATVAEYMVD-----GSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLK 943
+ + M G + + L RL + + + LH +VH L+
Sbjct: 174 SRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLR 233
Query: 944 CDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSS-------- 995
++++ D + + F + V + + PEL + +
Sbjct: 234 PVDIVL---DQRGGV-FLTGFEHLV-RDGARVV--SSVSRGFEPPELEARRATISYHRDR 286
Query: 996 -SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLM 1054
+ ++ D ++ G+V++ I + P I + IP R L+
Sbjct: 287 RTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRS--CKNIPQPV----RALL 340
Query: 1055 EECWAPNPAARPSFTEI 1071
E R +
Sbjct: 341 EGFLRYPKEDRLLPLQA 357
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-29
Identities = 58/220 (26%), Positives = 100/220 (45%), Gaps = 32/220 (14%)
Query: 811 DLEEQKELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILS 868
+ + + LG G FG V+ + T +A K IK ++E + E +++
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR----GMKDKEEV----KNEISVMN 141
Query: 869 KLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF- 927
+L H N++ Y + L V EY+ G L DR +D L +D
Sbjct: 142 QLDHANLIQLYDAFESKNDIVL--VMEYVDGGELF------DRIIDESYNLT-ELDTILF 192
Query: 928 ------GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-IKRNTLVSGGVR 980
G+ ++H I+H DLK +N+L +D I K+ DFGL++ K +
Sbjct: 193 MKQICEGIRHMHQMYILHLDLKPENILCVNRDAK-QI-KIIDFGLARRYKPREKLKVNF- 249
Query: 981 GTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEP 1020
GT ++APE+++ VS D++S G++ + +L+G P
Sbjct: 250 GTPEFLAPEVVNYDF--VSFPTDMWSVGVIAYMLLSGLSP 287
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 70/276 (25%), Positives = 114/276 (41%), Gaps = 34/276 (12%)
Query: 815 QKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHH 872
+LG G TVY + VAIK I + +R F +E S+L H
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIP-PREKEETLKR----FEREVHNSSQLSH 70
Query: 873 PNVVAFYGVVQDGPGGTLATVAEYMVDG-SLRHVLVRKDRFLDRRRRLIIAMDAAFGMEY 931
N+V+ V ++ V EY ++G +L + L + G+++
Sbjct: 71 QNIVSMIDVDEED--DCYYLVMEY-IEGPTLSEYIESHGP-LSVDTAINFTNQILDGIKH 126
Query: 932 LHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLV--SGGVRGTLPWMAPE 989
H IVH D+K N+L+ D ++ + K+ DFG++K T + + V GT+ + +PE
Sbjct: 127 AHDMRIVHRDIKPQNILI---DSNKTL-KIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182
Query: 990 LLSGSSSKVSEKVDVFSFGIVLWEILTGEEPY--------ANMHYGAIIGGIVNNTLRPT 1041
G E D++S GIVL+E+L GE P+ A H + V +R
Sbjct: 183 QAKGE--ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV-PNVTTDVRKD 239
Query: 1042 IPSYCDAEWRTLMEECWAPNPAARP-SFTEIASRLR 1076
IP ++ + A R + E+ L
Sbjct: 240 IP----QSLSNVILRATEKDKANRYKTIQEMKDDLS 271
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-29
Identities = 74/271 (27%), Positives = 110/271 (40%), Gaps = 39/271 (14%)
Query: 816 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
+ LG G +G V R VA+K + ++ E I L+H
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-------EICINKMLNHE 65
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFL-DRRRRL---IIAMDAAFGM 929
NVV FYG ++G EY G L + +R ++A G+
Sbjct: 66 NVVKFYGHRREG--NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GV 118
Query: 930 EYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR---GTLPWM 986
YLH I H D+K +NLL+ D + K+ DFGL+ + R + GTLP++
Sbjct: 119 VYLHGIGITHRDIKPENLLL---DERDNL-KISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 987 APELLSGSSSKVSEKVDVFSFGIVLWEILTG----EEPYANMH-YGAIIGGIVNNTLRPT 1041
APELL +E VDV+S GIVL +L G ++P + Y
Sbjct: 175 APELLKRREFH-AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-----L 228
Query: 1042 IP-SYCDAEWRTLMEECWAPNPAARPSFTEI 1071
P D+ L+ + NP+AR + +I
Sbjct: 229 NPWKKIDSAPLALLHKILVENPSARITIPDI 259
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-29
Identities = 77/299 (25%), Positives = 128/299 (42%), Gaps = 38/299 (12%)
Query: 779 EGNAGNRNIGLPSLNPSLVDFDVSSVQVIKNEDLEEQKELGSGTFGTVYHGKWRGTD--V 836
+G A G SL + + ED + K LG G+F TV + T
Sbjct: 2 DGTAAEPRPGAGSLQHAQPPPQPRKKRP---EDFKFGKILGEGSFSTVVLARELATSREY 58
Query: 837 AIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEY 896
AIK ++K + ++ +T E +++S+L HP V Y QD L Y
Sbjct: 59 AIKILEKRHII-KENKVPYVTRE----RDVMSRLDHPFFVKLYFTFQDD--EKLYFGLSY 111
Query: 897 MVDGSLRHVLVRKDRFLDRRRRLIIA-MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPS 955
+G L + + F + R A + +A EYLH K I+H DLK +N+L+N
Sbjct: 112 AKNGELLKYIRKIGSFDETCTRFYTAEIVSAL--EYLHGKGIIHRDLKPENILLN----E 165
Query: 956 RPICKVGDFGLSKI--------KRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSF 1007
++ DFG +K+ + N+ V GT +++PELL+ S+ S D+++
Sbjct: 166 DMHIQITDFGTAKVLSPESKQARANSFV-----GTAQYVSPELLTEKSACKS--SDLWAL 218
Query: 1008 GIVLWEILTGEEP-YANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAAR 1065
G ++++++ G P A Y I I+ P + R L+E+ + R
Sbjct: 219 GCIIYQLVAGLPPFRAGNEYL-IFQKIIKLEYD--FPEKFFPKARDLVEKLLVLDATKR 274
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 71/270 (26%), Positives = 119/270 (44%), Gaps = 41/270 (15%)
Query: 816 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
LG GTFG V G+ + G VA+K + + ++ +E + L HP
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI-RSLDVVGKIK----REIQNLKLFRHP 71
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDR--RR--RLIIAMDAAFGM 929
+++ Y V+ V EY+ G L + + R + RR + I++ +
Sbjct: 72 HIIKLYQVISTP--TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS-----AV 124
Query: 930 EYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR----GTLPW 985
+Y H +VH DLK +N+L+ D K+ DFGLS N + G G+ +
Sbjct: 125 DYCHRHMVVHRDLKPENVLL---DAHMNA-KIADFGLS----NMMSDGEFLRTSCGSPNY 176
Query: 986 MAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPY--ANMH--YGAIIGGIVNNTLRPT 1041
APE++SG E VD++S G++L+ +L G P+ ++ + I GG+
Sbjct: 177 AAPEVISGRLYAGPE-VDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF------Y 229
Query: 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
IP Y + TL+ +P R + +I
Sbjct: 230 IPEYLNRSVATLLMHMLQVDPLKRATIKDI 259
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 69/281 (24%), Positives = 119/281 (42%), Gaps = 46/281 (16%)
Query: 815 QKELGSGTFGTVYHGKWRGTD------VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILS 868
++ +G G G VY D VA+K + ++ + + R +EA
Sbjct: 39 RRLVGRGGMGDVY----EAEDTVRERIVALKLMSET-LSSDPVFRTR----MQREARTAG 89
Query: 869 KLHHPNVVAFYGVVQDGPGGTLATVAEYMVDG-SLRHVLVRKDRFLDRRRRLIIAMDAAF 927
+L P+VV + + G L ++G L +L R+ L R + I
Sbjct: 90 RLQEPHVVPIHDFGEID--GQLYVDMRL-INGVDLAAMLRRQGP-LAPPRAVAIVRQIGS 145
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLV--SGGVRGTLPW 985
++ H+ H D+K +N+LV+ D + DFG++ + + G GTL +
Sbjct: 146 ALDAAHAAGATHRDVKPENILVSADD----FAYLVDFGIASATTDEKLTQLGNTVGTLYY 201
Query: 986 MAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG---AIIGGIVNN------ 1036
MAPE S S + + D+++ VL+E LTG PY G +++G +N
Sbjct: 202 MAPERFSESH--ATYRADIYALTCVLYECLTGSPPYQ----GDQLSVMGAHINQAIPRPS 255
Query: 1037 TLRPTIPSYCDAEWRTLMEECWAPNPAAR-PSFTEIASRLR 1076
T+RP IP DA ++ A NP R + ++++
Sbjct: 256 TVRPGIPVAFDA----VIARGMAKNPEDRYVTCGDLSAAAH 292
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 72/284 (25%), Positives = 123/284 (43%), Gaps = 45/284 (15%)
Query: 815 QKELGSGTFGTVYHGKWRGTD------VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILS 868
+ LG G V+ D VA+K + ++ S R F +EA+ +
Sbjct: 17 GEILGFGGMSEVH----LARDLRDHRDVAVK-VLRADLARDPSFYLR----FRREAQNAA 67
Query: 869 KLHHPNVVAFY--GVVQDGPGGTLATVAEYMVDG-SLRHVLVRKDRFLDRRRRLIIAMDA 925
L+HP +VA Y G + G V EY VDG +LR ++ + + +R + + DA
Sbjct: 68 ALNHPAIVAVYDTGEAETPAGPLPYIVMEY-VDGVTLRDIVHTEGP-MTPKRAIEVIADA 125
Query: 926 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVS----GGVRG 981
+ + H I+H D+K N+++ + + KV DFG+++ ++ S V G
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMI---SATNAV-KVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 982 TLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPY--------ANMHYGAIIGGI 1033
T +++PE G V + DV+S G VL+E+LTGE P+ A H
Sbjct: 182 TAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP 239
Query: 1034 VNNTLRPTIPSYCDAEWRTLMEECWAPNPAARP-SFTEIASRLR 1076
+ + A+ ++ + A NP R + E+ + L
Sbjct: 240 --SARHEGLS----ADLDAVVLKALAKNPENRYQTAAEMRADLV 277
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 62/276 (22%), Positives = 107/276 (38%), Gaps = 43/276 (15%)
Query: 815 QKELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-H 871
++ LG G G V R T A+K + S + +E + +
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-------------PKARQEVDHHWQASG 80
Query: 872 HPNVVAFYGVVQDGPGGTLAT--VAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGM 929
P++V V ++ G + E M G L R +R + +AA M
Sbjct: 81 GPHIVCILDVYENMHHGKRCLLIIMECMEGGELF------SRIQERGDQAFTEREAAEIM 134
Query: 930 -------EYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGT 982
++LHS NI H D+K +NLL K+ + K+ DFG +K + T
Sbjct: 135 RDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVL-KLTDFGFAKETTQNALQTPC-YT 192
Query: 983 LPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTI 1042
++APE+L K + D++S G++++ +L G P+ + AI G+
Sbjct: 193 PYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY 250
Query: 1043 PSYCDAEWRT-------LMEECWAPNPAARPSFTEI 1071
+ + EW L+ +P R + T+
Sbjct: 251 -GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQF 285
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-28
Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 30/226 (13%)
Query: 807 IKNEDLEE-------QKELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLT 857
+K+ + K LG G+F + + A+K I K R +
Sbjct: 1 MKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK-----RMEANTQ-- 53
Query: 858 VEFWKEAEILSKL-HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRR 916
KE L HPN+V + V D V E + G L + +K F +
Sbjct: 54 ----KEITALKLCEGHPNIVKLHEVFHDQ--LHTFLVMELLNGGELFERIKKKKHFSETE 107
Query: 917 RRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKR--NTL 974
I+ + ++H +VH DLK +NLL ++ + I K+ DFG +++K N
Sbjct: 108 ASYIM-RKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEI-KIIDFGFARLKPPDNQP 165
Query: 975 VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEP 1020
+ TL + APELL+ + E D++S G++L+ +L+G+ P
Sbjct: 166 LKTPC-FTLHYAAPELLNQ--NGYDESCDLWSLGVILYTMLSGQVP 208
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 8e-28
Identities = 54/219 (24%), Positives = 97/219 (44%), Gaps = 26/219 (11%)
Query: 816 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HH 872
LG G V T + A+K I+K RS ++E E+L + H
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR--------VFREVEMLYQCQGH 70
Query: 873 PNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYL 932
NV+ ++ V E M GS+ + ++ F + +++ D A +++L
Sbjct: 71 RNVLELIEFFEEED--RFYLVFEKMRGGSILSHIHKRRHFNELEASVVV-QDVASALDFL 127
Query: 933 HSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR--------GTLP 984
H+K I H DLK +N+L + P+ K+ DF L + + G+
Sbjct: 128 HNKGIAHRDLKPENILCEHPNQVSPV-KICDFDLGSGIKLNGDCSPISTPELLTPCGSAE 186
Query: 985 WMAPELLSGSSSKVS---EKVDVFSFGIVLWEILTGEEP 1020
+MAPE++ S + S ++ D++S G++L+ +L+G P
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 9e-28
Identities = 44/352 (12%), Positives = 91/352 (25%), Gaps = 43/352 (12%)
Query: 752 GVDPSVSESMQFDAMMENLRTTESDYEEGNAGNRNIGLPSLNPSLVDFDVSSVQVIKNED 811
G DP + + + +A + + SL + F V S +
Sbjct: 21 GTDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVS-TSLWNTGQPFRVESELGERPRT 79
Query: 812 LEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSS--------EQERLTVEFW 861
L LG + T + + ++ + RL
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 862 KEAEILSKLH---------HPNVVAFYGVVQDGPGGTLATVAEYM--VDGSLRHVL---- 906
+ + L P V D + + + +L+
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 907 --VRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964
+ L RL + + + LH +VH L+ ++++ D + + F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGV-FLTGF 255
Query: 965 GLSKI--KRNTLVSGGVRGTLPWMAPELLSGS---SSKVSEKVDVFSFGIVLWEILTGEE 1019
G A +L + ++ D ++ G+ ++ I +
Sbjct: 256 EHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
Query: 1020 PYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
P + I + IP R L+E R +
Sbjct: 316 PNTDDAALGGSEWIFRSC--KNIPQPV----RALLEGFLRYPKEDRLLPLQA 361
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-27
Identities = 75/270 (27%), Positives = 117/270 (43%), Gaps = 42/270 (15%)
Query: 816 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
+ LG G+FG V VA+K I + +S R+ +E L L HP
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLK-KSDMHMRVE----REISYLKLLRHP 69
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDR--RR--RLIIAMDAAFGM 929
+++ Y V+ + V EY G L +V K R + RR + II +
Sbjct: 70 HIIKLYDVITTP--TDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIIC-----AI 121
Query: 930 EYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR----GTLPW 985
EY H IVH DLK +NLL+ D + + K+ DFGLS N + G G+ +
Sbjct: 122 EYCHRHKIVHRDLKPENLLL---DDNLNV-KIADFGLS----NIMTDGNFLKTSCGSPNY 173
Query: 986 MAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPY--ANMH--YGAIIGGIVNNTLRPT 1041
APE+++G E VDV+S GIVL+ +L G P+ + + + +
Sbjct: 174 AAPEVINGKLYAGPE-VDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVY------V 226
Query: 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
+P + ++L+ +P R + EI
Sbjct: 227 MPDFLSPGAQSLIRRMIVADPMQRITIQEI 256
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-27
Identities = 78/275 (28%), Positives = 111/275 (40%), Gaps = 47/275 (17%)
Query: 816 KELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
K++GSG FG K VA+K I++ E + +E L HP
Sbjct: 26 KDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-----DENVQ----REIINHRSLRHP 76
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFL-DRRRRL---IIAMDAAFGM 929
N+V F V+ LA + EY G L + RF D R +++ G+
Sbjct: 77 NIVRFKEVILTP--THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS-----GV 129
Query: 930 EYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKR-----NTLVSGGVRGTLP 984
Y HS I H DLK +N L L P K+ DFG SK + V GT
Sbjct: 130 SYCHSMQICHRDLKLENTL--LDGSPAPRLKICDFGYSKSSVLHSQPKSTV-----GTPA 182
Query: 985 WMAPELLSGSSSK--VSEKVDVFSFGIVLWEILTG----EEPYANMHYGAIIGGIVNNTL 1038
++APE+L + + DV+S G+ L+ +L G E+P Y I I++
Sbjct: 183 YIAPEVLLR---QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY 239
Query: 1039 RPTIPSYC--DAEWRTLMEECWAPNPAARPSFTEI 1071
IP E L+ + +PA R S EI
Sbjct: 240 S--IPDDIRISPECCHLISRIFVADPATRISIPEI 272
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-27
Identities = 58/237 (24%), Positives = 100/237 (42%), Gaps = 35/237 (14%)
Query: 800 DVSSVQVIKNEDLEEQ----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQ 853
+ + + +++G G++ + T + A+K I KS
Sbjct: 8 SIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT---- 63
Query: 854 ERLTVEFWKEAEILSKL-HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRF 912
+E EIL + HPN++ V DG + V E M G L ++R+ F
Sbjct: 64 --------EEIEILLRYGQHPNIITLKDVYDDGKYVYV--VTELMKGGELLDKILRQKFF 113
Query: 913 LDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKR- 971
+R ++ +EYLH++ +VH DLK N+L + + ++ DFG +K R
Sbjct: 114 SEREASAVL-FTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172
Query: 972 -----NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN 1023
T T ++APE+L D++S G++L+ +LTG P+AN
Sbjct: 173 ENGLLMTPC-----YTANFVAPEVLER--QGYDAACDIWSLGVLLYTMLTGYTPFAN 222
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-27
Identities = 69/261 (26%), Positives = 115/261 (44%), Gaps = 18/261 (6%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
+ E + +G G+FG V + T A+K + K R + R KE +I+
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVER--NEVRNVF---KELQIM 69
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
L HP +V + QD + V + ++ G LR+ L + F + +L I +
Sbjct: 70 QGLEHPFLVNLWYSFQDE--EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC-ELVM 126
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMA 987
++YL ++ I+H D+K DN+L++ + DF ++ + + GT P+MA
Sbjct: 127 ALDYLQNQRIIHRDMKPDNILLD----EHGHVHITDFNIAAMLPRETQITTMAGTKPYMA 182
Query: 988 PELLSGSSSKV-SEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL--RPTIPS 1044
PE+ S S VD +S G+ +E+L G PY IV+ T PS
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI-RSSTSSKEIVHTFETTVVTYPS 241
Query: 1045 YCDAEWRTLMEECWAPNPAAR 1065
E +L+++ PNP R
Sbjct: 242 AWSQEMVSLLKKLLEPNPDQR 262
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-27
Identities = 64/261 (24%), Positives = 105/261 (40%), Gaps = 39/261 (14%)
Query: 790 PSLNPSLVDFDVSSVQVIKNEDLEEQ-----KELGSGTFGTVYHGKWRGT--DVAIKRIK 842
P F V S IK + + + LG G G V + T A+K ++
Sbjct: 37 PPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ 96
Query: 843 KSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQDGPGGTLAT--VAEYMVD 899
+ +E E+ + P++V V ++ G V E +
Sbjct: 97 DC-------------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 143
Query: 900 GSLRHVLVRKDRFLDRRRRLIIAMDAAFGM-------EYLHSKNIVHFDLKCDNLLVNLK 952
G L R DR + +A+ M +YLHS NI H D+K +NLL K
Sbjct: 144 GELF------SRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSK 197
Query: 953 DPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLW 1012
P+ + K+ DFG +K + T ++APE+L K + D++S G++++
Sbjct: 198 RPNAIL-KLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMY 254
Query: 1013 EILTGEEPYANMHYGAIIGGI 1033
+L G P+ + H AI G+
Sbjct: 255 ILLCGYPPFYSNHGLAISPGM 275
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-26
Identities = 67/263 (25%), Positives = 107/263 (40%), Gaps = 52/263 (19%)
Query: 781 NAGNRNIGLPSLNPSLVDFDVSSVQVIKNEDLEEQ-------KELGSGTFGTVYHGKWRG 833
N + LNP V V + E++ K +G+G+FG V+ K
Sbjct: 4 TMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVE 63
Query: 834 TD-VAIKRIKK-SCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVA----FYGVVQDGPG 887
+D VAIK++ + F R E +I+ + HPNVV FY
Sbjct: 64 SDEVAIKKVLQDKRFKNR-------------ELQIMRIVKHPNVVDLKAFFYSNGDKKDE 110
Query: 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF----------GMEYLHSKNI 937
L V EY+ ++ R +L M + Y+HS I
Sbjct: 111 VFLNLVLEYV-PETVY-------RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGI 162
Query: 938 VHFDLKCDNLLVNLKDPSRPICKVGDFGLSK--IKRNTLVSGGVRGTLPWMAPELLSGSS 995
H D+K NLL++ P + K+ DFG +K I VS + + APEL+ G +
Sbjct: 163 CHRDIKPQNLLLD---PPSGVLKLIDFGSAKILIAGEPNVSYIC--SRYYRAPELIFG-A 216
Query: 996 SKVSEKVDVFSFGIVLWEILTGE 1018
+ + +D++S G V+ E++ G+
Sbjct: 217 TNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-26
Identities = 71/270 (26%), Positives = 119/270 (44%), Gaps = 41/270 (15%)
Query: 816 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
LG GTFG V GK G VA+K + + ++ +E + L HP
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR-SLDVVGKIR----REIQNLKLFRHP 76
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRR-RRL---IIAMDAAFGM 929
+++ Y V+ + V EY+ G L + + R ++ RRL I++ G+
Sbjct: 77 HIIKLYQVISTP--SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS-----GV 129
Query: 930 EYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR----GTLPW 985
+Y H +VH DLK +N+L+ D K+ DFGLS N + G G+ +
Sbjct: 130 DYCHRHMVVHRDLKPENVLL---DAHMNA-KIADFGLS----NMMSDGEFLRTSCGSPNY 181
Query: 986 MAPELLSGSSSKVSEKVDVFSFGIVLWEILTG----EEPYANMHYGAIIGGIVNNTLRPT 1041
APE++SG E VD++S G++L+ +L G ++ + + I GI
Sbjct: 182 AAPEVISGRLYAGPE-VDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF------Y 234
Query: 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
P Y + +L++ +P R + +I
Sbjct: 235 TPQYLNPSVISLLKHMLQVDPMKRATIKDI 264
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 66/261 (25%), Positives = 114/261 (43%), Gaps = 26/261 (9%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
+ + K LG+G+FG V K + + A+K + K + + E E IL
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLNE----KRIL 95
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
++ P +V +D L V EY+ G + L R RF + R A
Sbjct: 96 QAVNFPFLVKLEFSFKDN--SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIVL 152
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI---KRNTLVSGGVRGTLP 984
EYLHS ++++ DLK +NLL++ + +V DFG +K + TL GT
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLID----QQGYIQVTDFGFAKRVKGRTWTLC-----GTPE 203
Query: 985 WMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPS 1044
+APE++ + VD ++ G++++E+ G P+ I IV+ +R PS
Sbjct: 204 ALAPEIILSKGYNKA--VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPS 259
Query: 1045 YCDAEWRTLMEECWAPNPAAR 1065
+ ++ + L+ + R
Sbjct: 260 HFSSDLKDLLRNLLQVDLTKR 280
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 64/289 (22%), Positives = 104/289 (35%), Gaps = 67/289 (23%)
Query: 802 SSVQVIKNEDLEE----QKELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQER 855
S +Q+ KN +++ + LG G G V + T A+K ++ R
Sbjct: 6 SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR------ 59
Query: 856 LTVEFWKEAEILSKL-HHPNVVAFYGVVQDGPGGTLAT--VAEYMVDGSLRHVLVRKDRF 912
E E+ + P++V V ++ G V E + G L R
Sbjct: 60 -------EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL------FSRI 106
Query: 913 LDRRRRLIIAMDAAFGM-------EYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965
DR + +A+ M +YLHS NI H D+K +NLL K P+ + K+ DFG
Sbjct: 107 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAIL-KLTDFG 165
Query: 966 LSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH 1025
A E K D++S G++++ +L G P+ + H
Sbjct: 166 F--------------------AKETTGEKYDK---SCDMWSLGVIMYILLCGYPPFYSNH 202
Query: 1026 YGAIIGGIVNNTLRPTIPSYCDAEWRT-------LMEECWAPNPAARPS 1067
AI G+ + + EW L+ P R +
Sbjct: 203 GLAISPGMKTRIRMGQY-EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT 250
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-25
Identities = 62/223 (27%), Positives = 103/223 (46%), Gaps = 32/223 (14%)
Query: 814 EQKELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSK 869
E ++G GT+G VY K + D A+K+I+ TG S R E +L +
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG---TGISMSACR-------EIALLRE 74
Query: 870 LHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVL--VRKDRFLDRRRRLIIAMDAAF 927
L HPNV++ V + + +Y + L H++ R + + +L M +
Sbjct: 75 LKHPNVISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSL 133
Query: 928 ------GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-----IKRNTLVS 976
G+ YLH+ ++H DLK N+LV + P R K+ D G ++ +K +
Sbjct: 134 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 193
Query: 977 GGVRGTLPWM-APELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
V T W APELL G + ++ +D+++ G + E+LT E
Sbjct: 194 PVVV-TF-WYRAPELLLG-ARHYTKAIDIWAIGCIFAELLTSE 233
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-25
Identities = 55/256 (21%), Positives = 96/256 (37%), Gaps = 30/256 (11%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEA 864
++ +D E K +G G F V K + T A+K + K R E F +E
Sbjct: 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRG-EVSC----FREER 112
Query: 865 EILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMD 924
++L + + QD L V EY V G L +L + + +
Sbjct: 113 DVLVNGDRRWITQLHFAFQDE--NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE 170
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-------IKRNTLVSG 977
++ +H VH D+K DN+L+ D I ++ DFG ++ V
Sbjct: 171 IVMAIDSVHRLGYVHRDIKPDNILL---DRCGHI-RLADFGSCLKLRADGTVRSLVAV-- 224
Query: 978 GVRGTLPWMAPELLSGSSSKVSEK-----VDVFSFGIVLWEILTGEEPYANMHYGAIIGG 1032
GT +++PE+L D ++ G+ +E+ G+ P+ G
Sbjct: 225 ---GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGK 281
Query: 1033 IVNNTLRPTIPSYCDA 1048
IV+ ++P +
Sbjct: 282 IVHYKEHLSLPLVDEG 297
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-25
Identities = 82/331 (24%), Positives = 137/331 (41%), Gaps = 43/331 (12%)
Query: 745 QDSQKTFGVDPSVSESM--QFDAMMENLRTTESDYEEGNAGNRNIGLPSLNPSLVDFDVS 802
++ ++ +V++ + Q A M+ + SD ++ P ++ +F+
Sbjct: 94 EEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYL 153
Query: 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTVEF 860
+ LG GTFG V K + T A+K +KK + E E
Sbjct: 154 KL-------------LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKD-EVAHTLTEN 199
Query: 861 WKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLI 920
+L HP + A Q L V EY G L L R+ F + R R
Sbjct: 200 ----RVLQNSRHPFLTALKYSFQTH--DRLCFVMEYANGGELFFHLSRERVFSEDRARFY 253
Query: 921 IAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGV 979
A + ++YLHS KN+V+ DLK +NL++ D I K+ DFGL K + G
Sbjct: 254 GA-EIVSALDYLHSEKNVVYRDLKLENLML---DKDGHI-KITDFGLCKEG----IKDGA 304
Query: 980 R-----GTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV 1034
GT ++APE+L + + VD + G+V++E++ G P+ N + + I+
Sbjct: 305 TMKTFCGTPEYLAPEVLEDNDYGRA--VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 362
Query: 1035 NNTLRPTIPSYCDAEWRTLMEECWAPNPAAR 1065
+R P E ++L+ +P R
Sbjct: 363 MEEIR--FPRTLGPEAKSLLSGLLKKDPKQR 391
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 64/254 (25%), Positives = 109/254 (42%), Gaps = 30/254 (11%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEA 864
+ ED E K +G G FG V K + D A+K + K R+ E F +E
Sbjct: 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRA-ETAC----FREER 125
Query: 865 EILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVR-KDRFLDRRRRLIIAM 923
++L + + QD L V +Y V G L +L + +DR + R +A
Sbjct: 126 DVLVNGDSKWITTLHYAFQDD--NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLA- 182
Query: 924 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-------IKRNTLVS 976
+ ++ +H + VH D+K DN+L+ D + I ++ DFG ++ + V
Sbjct: 183 EMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHI-RLADFGSCLKLMEDGTVQSSVAV- 237
Query: 977 GGVRGTLPWMAPELLSGSSSKVSE---KVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI 1033
GT +++PE+L + D +S G+ ++E+L GE P+ G I
Sbjct: 238 ----GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 293
Query: 1034 VNNTLRPTIPSYCD 1047
+N+ R P+
Sbjct: 294 MNHKERFQFPTQVT 307
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-24
Identities = 69/253 (27%), Positives = 112/253 (44%), Gaps = 31/253 (12%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEA 864
+K ED E K +G G FG V + + T A+K + K RS + FW+E
Sbjct: 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRS-DSAF----FWEER 120
Query: 865 EILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIA-M 923
+I++ + P VV + QD L V EYM G L +++ ++ R A +
Sbjct: 121 DIMAFANSPWVVQLFYAFQDD--RYLYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEV 177
Query: 924 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-------IKRNTLVS 976
A + +HS +H D+K DN+L+ D S + K+ DFG ++ +T V
Sbjct: 178 VLAL--DAIHSMGFIHRDVKPDNMLL---DKSGHL-KLADFGTCMKMNKEGMVRCDTAV- 230
Query: 977 GGVRGTLPWMAPELLSGSSSKVS--EKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV 1034
GT +++PE+L + D +S G+ L+E+L G+ P+ I+
Sbjct: 231 ----GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 286
Query: 1035 NNTLRPTIPSYCD 1047
N+ T P D
Sbjct: 287 NHKNSLTFPDDND 299
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 2e-24
Identities = 73/263 (27%), Positives = 117/263 (44%), Gaps = 27/263 (10%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
D + K LG GTFG V + + T A+K ++K + E E + +L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD-EVAHTVTE----SRVL 59
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
HP + A Q L V EY G L L R+ F + R R A +
Sbjct: 60 QNTRHPFLTALKYAFQTH--DRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIVS 116
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR-----GT 982
+EYLHS+++V+ D+K +NL++ D I K+ DFGL K +S G GT
Sbjct: 117 ALEYLHSRDVVYRDIKLENLML---DKDGHI-KITDFGLCKEG----ISDGATMKTFCGT 168
Query: 983 LPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTI 1042
++APE+L + + VD + G+V++E++ G P+ N + + I+ +R
Sbjct: 169 PEYLAPEVLEDNDYGRA--VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR--F 224
Query: 1043 PSYCDAEWRTLMEECWAPNPAAR 1065
P E ++L+ +P R
Sbjct: 225 PRTLSPEAKSLLAGLLKKDPKQR 247
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-24
Identities = 71/262 (27%), Positives = 127/262 (48%), Gaps = 28/262 (10%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
+D + + LG+G+FG V+ + R A+K +KK R + E E +L
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDE----RLML 60
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
S + HP ++ +G QD + + +Y+ G L +L + RF + + A +
Sbjct: 61 SIVTHPFIIRMWGTFQDA--QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-EVCL 117
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI---KRNTLVSGGVRGTLP 984
+EYLHSK+I++ DLK +N+L++ K+ DFG +K TL GT
Sbjct: 118 ALEYLHSKDIIYRDLKPENILLD----KNGHIKITDFGFAKYVPDVTYTLC-----GTPD 168
Query: 985 WMAPELLSGSS-SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIP 1043
++APE++S +K +D +SFGI+++E+L G P+ + + I+N LR P
Sbjct: 169 YIAPEVVSTKPYNKS---IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR--FP 223
Query: 1044 SYCDAEWRTLMEECWAPNPAAR 1065
+ + + + L+ + + R
Sbjct: 224 PFFNEDVKDLLSRLITRDLSQR 245
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-24
Identities = 75/362 (20%), Positives = 131/362 (36%), Gaps = 30/362 (8%)
Query: 713 EVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSESMQFDAMMENLRT 772
EV +D R LT + D + E + + L
Sbjct: 91 EVTPDDKRKACGRNLTQNFLSHTGPDLIPEVPRQLVTN---CTQRLEQGPCKDLFQELTR 147
Query: 773 TESDYEEGNAGNRNIGLPSLNPSLVDFDVSSVQVIKNEDLEEQKELGSGTFGTVYHGKWR 832
+Y + N L + Q + + + LG G FG V + R
Sbjct: 148 LTHEYLSVAPFADYLDSIYFNRFL-QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVR 206
Query: 833 GTDV--AIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTL 890
T A K+++K R E L E +IL K++ VV+ + L
Sbjct: 207 ATGKMYACKKLEKKRIKKRKGEAMALN-----EKQILEKVNSRFVVSLAYAYETK--DAL 259
Query: 891 ATVAEYMVDGSLRHVL--VRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLL 948
V M G L+ + + + F + R A + G+E LH + IV+ DLK +N+L
Sbjct: 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA-EICCGLEDLHRERIVYRDLKPENIL 318
Query: 949 VNLKDPSRPICKVGDFGLSK-IKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSF 1007
+ ++ D GL+ + + G V GT+ +MAPE++ S D ++
Sbjct: 319 L----DDHGHIRISDLGLAVHVPEGQTIKGRV-GTVGYMAPEVVKNERYTFS--PDWWAL 371
Query: 1008 GIVLWEILTGEEPY----ANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPA 1063
G +L+E++ G+ P+ + + + + R+L + +PA
Sbjct: 372 GCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE--YSERFSPQARSLCSQLLCKDPA 429
Query: 1064 AR 1065
R
Sbjct: 430 ER 431
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
+ E+ +++G GT+GTV+ K R T VA+KR++ + E + +E +L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
+L H N+V + V+ TL V E+ D L+ + LD
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTL--VFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLK 112
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK---IKRNTLVSGGVRGTLP 984
G+ + HS+N++H DLK NLL+N K+ +FGL++ I + V TL
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLIN----RNGELKLANFGLARAFGIPVRCYSAEVV--TLW 166
Query: 985 WMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1021
+ P++L G + S +D++S G + E+ P
Sbjct: 167 YRPPDVLFG-AKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-24
Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 31/221 (14%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
+ +LG GT+G VY T+ VAIKRI+ E+E + +E +L
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
+L H N++ V+ L + EY + L+ +++D+ + + + +F
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHL--IFEYA-ENDLK-------KYMDKNPDVSMRVIKSF 137
Query: 928 ------GMEYLHSKNIVHFDLKCDNLLVNLKDPS-RPICKVGDFGLSK---IKRNTLVSG 977
G+ + HS+ +H DLK NLL+++ D S P+ K+GDFGL++ I
Sbjct: 138 LYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHE 197
Query: 978 GVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
+ TL + PE+L G S S VD++S + E+L
Sbjct: 198 II--TLWYRPPEILLG-SRHYSTSVDIWSIACIWAEMLMKT 235
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-23
Identities = 61/225 (27%), Positives = 98/225 (43%), Gaps = 46/225 (20%)
Query: 813 EEQKELGSGTFGTVYHGKWR--GTDVAIKRIKK-SCFTGRSSEQERLTVEFWKEAEILSK 869
+ K +G+G+FG VY K G VAIK++ + F R E +I+ K
Sbjct: 57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------------ELQIMRK 103
Query: 870 LHHPNVVA----FYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDA 925
L H N+V FY + L V +Y+ ++ R R +
Sbjct: 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVY-------RVARHYSRAKQTLPV 155
Query: 926 AF----------GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK--IKRNT 973
+ + Y+HS I H D+K NLL++ P + K+ DFG +K ++
Sbjct: 156 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD---PDTAVLKLCDFGSAKQLVRGEP 212
Query: 974 LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
VS + + APEL+ G ++ + +DV+S G VL E+L G+
Sbjct: 213 NVSYIC--SRYYRAPELIFG-ATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-23
Identities = 73/266 (27%), Positives = 121/266 (45%), Gaps = 29/266 (10%)
Query: 810 EDLEEQKELGSGTFGTVY---HGKWRGTDV--AIKRIKKSCFTGRSSEQERLTVEFWKEA 864
E E + LG G +G V+ T A+K +KK+ + + E
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAE----R 72
Query: 865 EILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMD 924
IL ++ HP +V Q G G L + EY+ G L L R+ F++ +A +
Sbjct: 73 NILEEVKHPFIVDLIYAFQTG--GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA-E 129
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR---- 980
+ + +LH K I++ DLK +N+++N + K+ DFGL K + G
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLN----HQGHVKLTDFGLCKES----IHDGTVTHTF 181
Query: 981 -GTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 1039
GT+ +MAPE+L S + VD +S G +++++LTG P+ + I I+ L
Sbjct: 182 CGTIEYMAPEILMRSGHNRA--VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN 239
Query: 1040 PTIPSYCDAEWRTLMEECWAPNPAAR 1065
+P Y E R L+++ N A+R
Sbjct: 240 --LPPYLTQEARDLLKKLLKRNAASR 263
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 57/221 (25%), Positives = 96/221 (43%), Gaps = 35/221 (15%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEF--WKEAE 865
E E+ ++G G++G V+ + R T VAIK+ + ++ ++ +E
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLE--------SEDDPVIKKIALREIR 54
Query: 866 ILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRR-RLIIAMD 924
+L +L HPN+V V + L V EY D ++ H L R R + + I
Sbjct: 55 MLKQLKHPNLVNLLEVFRRK--RRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQT 111
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL-----SKIKRNT-LVSGG 978
+ + H N +H D+K +N+L+ + K+ DFG V+
Sbjct: 112 LQ-AVNFCHKHNCIHRDVKPENILIT----KHSVIKLCDFGFARLLTGPSDYYDDEVA-- 164
Query: 979 VRGTLPWM-APELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
T W +PELL G ++ VDV++ G V E+L+G
Sbjct: 165 ---TR-WYRSPELLVG-DTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 36/284 (12%), Positives = 74/284 (26%), Gaps = 66/284 (23%)
Query: 817 ELGSGTFGTVYHGKWRGTD------VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL 870
G W+ D VA+ + + + + E LS++
Sbjct: 38 FHGGVPPLQF----WQALDTALDRQVALTFVD-----PQGVLPDDVLQETLSRTLRLSRI 88
Query: 871 HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGME 930
P V VV GG + VAE++ GSL+ V D + A +
Sbjct: 89 DKPGVARVLDVVHTRAGGLV--VAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAAD 143
Query: 931 YLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPEL 990
H + + V+ + M
Sbjct: 144 AAHRAGVALSIDHPSRVRVS----IDGDVVLAYPAT-------------------MPD-- 178
Query: 991 LSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN---------TLRPT 1041
+ + D+ G L+ +L P + + + +
Sbjct: 179 -------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRD 231
Query: 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQT 1085
IP + + + R + + + + ++ + A +T
Sbjct: 232 IP----FQISAVAARSVQGDGGIRSA-STLLNLMQQATAVADRT 270
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 1e-22
Identities = 68/220 (30%), Positives = 108/220 (49%), Gaps = 34/220 (15%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILS 868
E ++ +++G GT+G VY K G VA+KRI+ +E E + +E +L
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74
Query: 869 KLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDA-AF 927
+LHHPN+V+ V+ TL V E+M + L+ + LD + + +
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTL--VFEFM-EKDLK-------KVLDENKTGLQDSQIKIY 124
Query: 928 ------GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK---IKRNTLVSGG 978
G+ + H I+H DLK NLL+N S K+ DFGL++ I +
Sbjct: 125 LYQLLRGVAHCHQHRILHRDLKPQNLLIN----SDGALKLADFGLARAFGIPVRSYTHEV 180
Query: 979 VRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
V TL + AP++L G S K S VD++S G + E++TG+
Sbjct: 181 V--TLWYRAPDVLMG-SKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-22
Identities = 65/266 (24%), Positives = 105/266 (39%), Gaps = 25/266 (9%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
+ + + LG G FG V+ + + T A K++ K R Q + E +IL
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMV-----EKKIL 239
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSL----RHVLVRKDRFLDRRRRLIIAM 923
+K+H +V+ + L V M G + +V F + R A
Sbjct: 240 AKVHSRFIVSLAYAFETK--TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA- 296
Query: 924 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK--IKRNTLVSGGVRG 981
G+E+LH +NI++ DLK +N+L++ ++ D GL+ T G G
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLD----DDGNVRISDLGLAVELKAGQTKTKGYA-G 351
Query: 982 TLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR-- 1039
T +MAPELL G S VD F+ G+ L+E++ P+ + L
Sbjct: 352 TPGFMAPELLLGEEYDFS--VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA 409
Query: 1040 PTIPSYCDAEWRTLMEECWAPNPAAR 1065
T P + E +P R
Sbjct: 410 VTYPDKFSPASKDFCEALLQKDPEKR 435
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 2e-22
Identities = 79/280 (28%), Positives = 125/280 (44%), Gaps = 28/280 (10%)
Query: 794 PSLVDFDVSSVQVIKNEDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSS 851
P L S +K ED K LG G+FG V+ +++ T+ AIK +KK
Sbjct: 1 PELNKERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD- 59
Query: 852 EQERLTVEFWKEAEILSK-LHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD 910
+ E VE +LS HP + + Q L V EY+ G L + +
Sbjct: 60 DVECTMVE----KRVLSLAWEHPFLTHMFCTFQTK--ENLFFVMEYLNGGDLMYHIQSCH 113
Query: 911 RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK 970
+F R A + G+++LHSK IV+ DLK DN+L++ K+ DFG+ K
Sbjct: 114 KFDLSRATFYAA-EIILGLQFLHSKGIVYRDLKLDNILLD----KDGHIKIADFGMCKEN 168
Query: 971 RNTLVSGGVR-----GTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH 1025
+ G + GT ++APE+L G S VD +SFG++L+E+L G+ P+
Sbjct: 169 ----MLGDAKTNTFCGTPDYIAPEILLGQKYNHS--VDWWSFGVLLYEMLIGQSPFHGQD 222
Query: 1026 YGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAAR 1065
+ I + P + + E + L+ + + P R
Sbjct: 223 EEELFHSIRMDNPF--YPRWLEKEAKDLLVKLFVREPEKR 260
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 2e-22
Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 20/213 (9%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILS 868
E +++G GT+G VY + G A+K+I+ E E + +E IL
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55
Query: 869 KLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFG 928
+L H N+V Y V+ L V E++ D L+ +L + L+ + G
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVL--VFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 929 MEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK---IKRNTLVSGGVRGTLPW 985
+ Y H + ++H DLK NLL+N K+ DFGL++ I V TL +
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLIN----REGELKIADFGLARAFGIPVRKYTHEIV--TLWY 166
Query: 986 MAPELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
AP++L G S K S +D++S G + E++ G
Sbjct: 167 RAPDVLMG-SKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-22
Identities = 66/269 (24%), Positives = 121/269 (44%), Gaps = 27/269 (10%)
Query: 810 EDLEEQKELGSGTFGTVY---HGKWRGTDV--AIKRIKKSCFTGRSSEQERLTVEFWKEA 864
E+ E K LG+G +G V+ T A+K +KK+ ++ E E
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE----R 109
Query: 865 EILSKL-HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAM 923
++L + P +V + Q L + +Y+ G L L +++RF + ++ +
Sbjct: 110 QVLEHIRQSPFLVTLHYAFQTE--TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG- 166
Query: 924 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR--- 980
+ +E+LH I++ D+K +N+L+ D + + + DFGLSK + R
Sbjct: 167 EIVLALEHLHKLGIIYRDIKLENILL---DSNGHV-VLTDFGLSKEF---VADETERAYD 219
Query: 981 --GTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 1038
GT+ +MAP+++ G S + VD +S G++++E+LTG P+ I L
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 279
Query: 1039 R--PTIPSYCDAEWRTLMEECWAPNPAAR 1065
+ P P A + L++ +P R
Sbjct: 280 KSEPPYPQEMSALAKDLIQRLLMKDPKKR 308
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 3e-22
Identities = 70/266 (26%), Positives = 123/266 (46%), Gaps = 31/266 (11%)
Query: 810 EDLEEQKELGSGTFGTVY---HGKWRGTDV--AIKRIKKSCFTGRSSEQERLTVEFWKEA 864
E K LG G+FG V+ A+K +KK+ R V E
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD------RVRTKMER 77
Query: 865 EILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMD 924
+IL +++HP +V + Q G L + +++ G L L ++ F + + +A +
Sbjct: 78 DILVEVNHPFIVKLHYAFQTE--GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-E 134
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR---- 980
A +++LHS I++ DLK +N+L++ K+ DFGLSK + +
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILLD----EEGHIKLTDFGLSKES----IDHEKKAYSF 186
Query: 981 -GTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 1039
GT+ +MAPE+++ S D +SFG++++E+LTG P+ + I+ L
Sbjct: 187 CGTVEYMAPEVVNRRGHTQS--ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG 244
Query: 1040 PTIPSYCDAEWRTLMEECWAPNPAAR 1065
+P + E ++L+ + NPA R
Sbjct: 245 --MPQFLSPEAQSLLRMLFKRNPANR 268
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 4e-22
Identities = 58/221 (26%), Positives = 98/221 (44%), Gaps = 35/221 (15%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEF--WKEAE 865
E E +G G++G V + + T VAIK+ + + V+ +E +
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLE--------SDDDKMVKKIAMREIK 76
Query: 866 ILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRR-RLIIAMD 924
+L +L H N+V V + L V E++ D ++ L LD + + +
Sbjct: 77 LLKQLRHENLVNLLEVCKKKKRWYL--VFEFV-DHTILDDLELFPNGLDYQVVQKYLFQI 133
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL-----SKIKRNT-LVSGG 978
G+ + HS NI+H D+K +N+LV+ + K+ DFG + + V+
Sbjct: 134 IN-GIGFCHSHNIIHRDIKPENILVS----QSGVVKLCDFGFARTLAAPGEVYDDEVA-- 186
Query: 979 VRGTLPWM-APELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
T W APELL G K + VDV++ G ++ E+ GE
Sbjct: 187 ---TR-WYRAPELLVG-DVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 4e-22
Identities = 76/373 (20%), Positives = 140/373 (37%), Gaps = 35/373 (9%)
Query: 702 QEHLGLSSGVREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVD-PSVSES 760
L + ++ + + + + G Q+ + F V P
Sbjct: 238 DRRLSVEIWDWDLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSE 297
Query: 761 MQFDAMMENLRTTESDYEEGNAGNRNIGLPSLNPSLVDFDVSSVQVIKNEDLEEQKELGS 820
+ + R + + + + + +K D LG
Sbjct: 298 GNEELRQKFERAKIGQGTKAPEEKTANTISKFDNN------GNRDRMKLTDFNFLMVLGK 351
Query: 821 GTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSK-LHHPNVVA 877
G+FG V + +GTD A+K +KK + E VE +L+ P +
Sbjct: 352 GSFGKVMLSERKGTDELYAVKILKKDVVIQDD-DVECTMVE----KRVLALPGKPPFLTQ 406
Query: 878 FYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNI 937
+ Q L V EY+ G L + + + RF + A + A G+ +L SK I
Sbjct: 407 LHSCFQ--TMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA-EIAIGLFFLQSKGI 463
Query: 938 VHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR-----GTLPWMAPELLS 992
++ DLK DN++++ S K+ DFG+ K + GV GT ++APE+++
Sbjct: 464 IYRDLKLDNVMLD----SEGHIKIADFGMCKEN----IWDGVTTKTFCGTPDYIAPEIIA 515
Query: 993 GSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRT 1052
S VD ++FG++L+E+L G+ P+ + I+ + + P E
Sbjct: 516 YQPYGKS--VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA--YPKSMSKEAVA 571
Query: 1053 LMEECWAPNPAAR 1065
+ + +P R
Sbjct: 572 ICKGLMTKHPGKR 584
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 6e-22
Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 46/220 (20%)
Query: 818 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQE-------RLTVEFWKEAEILS 868
LG G F TVY + + T+ VAIK+IK RS ++ R E ++L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIK---LGHRSEAKDGINRTALR-------EIKLLQ 67
Query: 869 KLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF- 927
+L HPN++ +L V ++M + L ++ D L + A+
Sbjct: 68 ELSHPNIIGLLDAFGHKSNISL--VFDFM-ETDLEVII------KDNSLVLTPSHIKAYM 118
Query: 928 -----GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK---IKRNTLVSGGV 979
G+EYLH I+H DLK +NLL++ + K+ DFGL+K V
Sbjct: 119 LMTLQGLEYLHQHWILHRDLKPNNLLLD----ENGVLKLADFGLAKSFGSPNRAYTHQVV 174
Query: 980 RGTLPWM-APELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
T W APELL G + VD+++ G +L E+L
Sbjct: 175 --TR-WYRAPELLFG-ARMYGVGVDMWAVGCILAELLLRV 210
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 1e-21
Identities = 70/220 (31%), Positives = 104/220 (47%), Gaps = 45/220 (20%)
Query: 818 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQE--------RLTVEFWKEAEIL 867
LG+GT+ TVY G + T VA+K +K + E R E ++
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVK--------LDSEEGTPSTAIR-------EISLM 57
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
+L H N+V Y V+ TL V E+M D L+ + + R L + + F
Sbjct: 58 KELKHENIVRLYDVIHTENKLTL--VFEFM-DNDLKKYM-DSRTVGNTPRGLELNLVKYF 113
Query: 928 ------GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK---IKRNTLVSGG 978
G+ + H I+H DLK NLL+N R K+GDFGL++ I NT S
Sbjct: 114 QWQLLQGLAFCHENKILHRDLKPQNLLIN----KRGQLKLGDFGLARAFGIPVNTFSSEV 169
Query: 979 VRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
V TL + AP++L G S S +D++S G +L E++TG+
Sbjct: 170 V--TLWYRAPDVLMG-SRTYSTSIDIWSCGCILAEMITGK 206
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 2e-21
Identities = 78/367 (21%), Positives = 132/367 (35%), Gaps = 42/367 (11%)
Query: 707 LSSGVREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSESMQFDAM 766
S + + L P + V L Q F P + E Q
Sbjct: 104 CSREIFDTYIMKELLACSHPFSKSAIEH--VQGHLVKKQVPPDLF--QPYIEEICQNLRG 159
Query: 767 MENLRTTESDYEEGNAGNRNIGLPSLNPSLVDFDVSSVQVIKNEDLEEQKELGSGTFGTV 826
+ ESD +N+ L +++ ++ DF V + +G G FG V
Sbjct: 160 DVFQKFIESDKFTRFCQWKNVEL-NIHLTMNDFSVHRI-------------IGRGGFGEV 205
Query: 827 YHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH---HPNVVAFYGV 881
Y + T A+K + K + E L E +LS + P +V
Sbjct: 206 YGCRKADTGKMYAMKCLDKKRIKMKQGETLALN-----ERIMLSLVSTGDCPFIVCMSYA 260
Query: 882 VQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFD 941
L+ + + M G L + L + F + R A + G+E++H++ +V+ D
Sbjct: 261 FHTP--DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGLEHMHNRFVVYRD 317
Query: 942 LKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEK 1001
LK N+L++ ++ D GL+ V GT +MAPE+L
Sbjct: 318 LKPANILLD----EHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQ-KGVAYDSS 371
Query: 1002 VDVFSFGIVLWEILTGEEPY---ANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECW 1058
D FS G +L+++L G P+ I + + +P E R+L+E
Sbjct: 372 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE--LPDSFSPELRSLLEGLL 429
Query: 1059 APNPAAR 1065
+ R
Sbjct: 430 QRDVNRR 436
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-21
Identities = 71/286 (24%), Positives = 124/286 (43%), Gaps = 28/286 (9%)
Query: 788 GLPSLNPSLVDFDVSSVQVIKNEDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSC 845
G + V+S + ++ E + LG G+FG V + + T A+K +KK
Sbjct: 1 GPKESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDV 60
Query: 846 FTGRSSEQERLTVEFWKEAEILSK-LHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRH 904
+ E E ILS +HP + + Q L V E++ G L
Sbjct: 61 ILQDD-DVECTMTE----KRILSLARNHPFLTQLFCCFQ--TPDRLFFVMEFVNGGDLMF 113
Query: 905 VLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964
+ + RF + R R A + + +LH K I++ DLK DN+L++ CK+ DF
Sbjct: 114 HIQKSRRFDEARARFYAA-EIISALMFLHDKGIIYRDLKLDNVLLD----HEGHCKLADF 168
Query: 965 GLSKIKRNTLVSGGVR-----GTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEE 1019
G+ K + GV GT ++APE+L + VD ++ G++L+E+L G
Sbjct: 169 GMCKEG----ICNGVTTATFCGTPDYIAPEILQEMLYGPA--VDWWAMGVLLYEMLCGHA 222
Query: 1020 PYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAAR 1065
P+ + + I+N+ + P++ + +++ NP R
Sbjct: 223 PFEAENEDDLFEAILNDEVV--YPTWLHEDATGILKSFMTKNPTMR 266
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-21
Identities = 60/280 (21%), Positives = 120/280 (42%), Gaps = 37/280 (13%)
Query: 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTVEF 860
++ + +D + + +G G++ V + + TD A+K +KK + + + E
Sbjct: 2 AMDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDE-DIDWVQTE- 59
Query: 861 WKEAEILSK-LHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRL 919
+ + +HP +V + Q L V EY+ G L + R+ + + R
Sbjct: 60 ---KHVFEQASNHPFLVGLHSCFQTE--SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF 114
Query: 920 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGV 979
A + + + YLH + I++ DLK DN+L++ S K+ D+G+ K + G
Sbjct: 115 YSA-EISLALNYLHERGIIYRDLKLDNVLLD----SEGHIKLTDYGMCKEG----LRPGD 165
Query: 980 R-----GTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGG-- 1032
GT ++APE+L G S VD ++ G++++E++ G P+ +
Sbjct: 166 TTSTFCGTPNYIAPEILRGEDYGFS--VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 223
Query: 1033 -------IVNNTLRPTIPSYCDAEWRTLMEECWAPNPAAR 1065
I+ +R IP + ++++ +P R
Sbjct: 224 EDYLFQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKER 261
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 5e-21
Identities = 68/264 (25%), Positives = 115/264 (43%), Gaps = 28/264 (10%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
D LG G+FG V + +GTD A+K +KK + E VE +L
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD-DVECTMVE----KRVL 74
Query: 868 SK-LHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAA 926
+ P + + Q L V EY+ G L + + + RF + A + A
Sbjct: 75 ALPGKPPFLTQLHSCFQ--TMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA-EIA 131
Query: 927 FGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR-----G 981
G+ +L SK I++ DLK DN++++ S K+ DFG+ K + GV G
Sbjct: 132 IGLFFLQSKGIIYRDLKLDNVMLD----SEGHIKIADFGMCKEN----IWDGVTTKTFCG 183
Query: 982 TLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT 1041
T ++APE+++ S VD ++FG++L+E+L G+ P+ + I+ + +
Sbjct: 184 TPDYIAPEIIAYQPYGKS--VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA-- 239
Query: 1042 IPSYCDAEWRTLMEECWAPNPAAR 1065
P E + + +P R
Sbjct: 240 YPKSMSKEAVAICKGLMTKHPGKR 263
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 5e-21
Identities = 80/299 (26%), Positives = 130/299 (43%), Gaps = 28/299 (9%)
Query: 775 SDYEEGNAGNRNIGLPSLNPSLVDFDVSSVQVIKNEDLEEQKELGSGTFGTVYHGKWRGT 834
S +E N N P ++ SS K D K +G G+FG V + +
Sbjct: 3 SQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAE 62
Query: 835 DV--AIKRIKKSCFTGRSSEQERLTVEFWKEAEILSK-LHHPNVVAFYGVVQDGPGGTLA 891
+V A+K ++K + E++ + E +L K + HP +V + Q L
Sbjct: 63 EVFYAVKVLQKKAILKKK-EEKHIMSE----RNVLLKNVKHPFLVGLHFSFQTA--DKLY 115
Query: 892 TVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNL 951
V +Y+ G L + L R+ FL+ R R A + A + YLHS NIV+ DLK +N+L++
Sbjct: 116 FVLDYINGGELFYHLQRERCFLEPRARFYAA-EIASALGYLHSLNIVYRDLKPENILLD- 173
Query: 952 KDPSRPICKVGDFGLSKIKRNTLVSGGVR-----GTLPWMAPELLSGSSSKVSEKVDVFS 1006
S+ + DFGL K + GT ++APE+L + VD +
Sbjct: 174 ---SQGHIVLTDFGLCKEN----IEHNSTTSTFCGTPEYLAPEVLHKQPYDRT--VDWWC 224
Query: 1007 FGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAAR 1065
G VL+E+L G P+ + + + I+N L+ + R L+E + R
Sbjct: 225 LGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ--LKPNITNSARHLLEGLLQKDRTKR 281
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 7e-21
Identities = 65/222 (29%), Positives = 101/222 (45%), Gaps = 38/222 (17%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQE--------RLTVE 859
E + +LG GT+ TVY GK + TD VA+K I+ E E R
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR--------LEHEEGAPCTAIR---- 49
Query: 860 FWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRL 919
E +L L H N+V + ++ TL V EY+ D L+ L ++
Sbjct: 50 ---EVSLLKDLKHANIVTLHDIIHTEKSLTL--VFEYL-DKDLKQYLDDCGNIINMHNVK 103
Query: 920 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK---IKRNTLVS 976
+ G+ Y H + ++H DLK NLL+N R K+ DFGL++ I T +
Sbjct: 104 LFLFQLLRGLAYCHRQKVLHRDLKPQNLLIN----ERGELKLADFGLARAKSIPTKTYDN 159
Query: 977 GGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
V TL + P++L G S+ S ++D++ G + +E+ TG
Sbjct: 160 EVV--TLWYRPPDILLG-STDYSTQIDMWGVGCIFYEMATGR 198
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 4e-20
Identities = 59/273 (21%), Positives = 117/273 (42%), Gaps = 37/273 (13%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
+D + + +G G++ V + + TD A++ +KK + + + E +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDE-DIDWVQTE----KHVF 106
Query: 868 SK-LHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAA 926
+ +HP +V + Q L V EY+ G L + R+ + + R A + +
Sbjct: 107 EQASNHPFLVGLHSCFQTE--SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EIS 163
Query: 927 FGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR-----G 981
+ YLH + I++ DLK DN+L++ S K+ D+G+ K + G G
Sbjct: 164 LALNYLHERGIIYRDLKLDNVLLD----SEGHIKLTDYGMCKEG----LRPGDTTSTFCG 215
Query: 982 TLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGG--------- 1032
T ++APE+L G S VD ++ G++++E++ G P+ +
Sbjct: 216 TPNYIAPEILRGEDYGFS--VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 273
Query: 1033 IVNNTLRPTIPSYCDAEWRTLMEECWAPNPAAR 1065
I+ +R IP + ++++ +P R
Sbjct: 274 ILEKQIR--IPRSLSVKAASVLKSFLNKDPKER 304
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 4e-20
Identities = 51/220 (23%), Positives = 89/220 (40%), Gaps = 37/220 (16%)
Query: 818 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNV 875
+G GTFG V+ + R T VA+K++ +E+E + +E +IL L H NV
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKILQLLKHENV 78
Query: 876 VAFYGVV------QDGPGGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFG 928
V + + G++ V ++ + L +L +F + ++ M G
Sbjct: 79 VNLIEICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLSNVLVKFTLSEIKRVMQMLLN-G 136
Query: 929 MEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWM-- 986
+ Y+H I+H D+K N+L+ + K+ DFGL+ S
Sbjct: 137 LYYIHRNKILHRDMKAANVLIT----RDGVLKLADFGLA-----RAFSLAKNSQPNRYTN 187
Query: 987 --------APELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
PELL G +D++ G ++ E+ T
Sbjct: 188 RVVTLWYRPPELLLG-ERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 5e-20
Identities = 61/235 (25%), Positives = 95/235 (40%), Gaps = 53/235 (22%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFW-----K 862
E E+G G +GTVY + + VA+K ++ +
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV--------PNGGGGGGGLPISTVR 60
Query: 863 EAEILSKLH---HPNVVAFYGVVQDGPGGTLAT---VAEYMVDGSLRHVLVRKDRFLDRR 916
E +L +L HPNVV V V E++ D LR +LD+
Sbjct: 61 EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLR-------TYLDKA 112
Query: 917 RRLIIAMDAA--------FGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968
+ + G+++LH+ IVH DLK +N+LV S K+ DFGL++
Sbjct: 113 PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT----SGGTVKLADFGLAR 168
Query: 969 I----KRNT-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
I T +V V TL + APE+L S + VD++S G + E+ +
Sbjct: 169 IYSYQMALTPVV---V--TLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRK 216
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 60/232 (25%), Positives = 98/232 (42%), Gaps = 49/232 (21%)
Query: 810 EDLEEQKELGSGTFGTVY---HGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEI 866
+ E E+G G +G V+ K G VA+KR++ + +E + + +E +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAV 64
Query: 867 LSKLH---HPNVVAFYGVVQDGPGGTLAT---VAEYMVDGSLRHVLVRKDRFLDRRRRLI 920
L L HPNVV + V V E++ D L +LD+
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLT-------TYLDKVPEPG 116
Query: 921 IAMDAA--------FGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKR- 971
+ + G+++LHS +VH DLK N+LV S K+ DFGL++I
Sbjct: 117 VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT----SSGQIKLADFGLARIYSF 172
Query: 972 -----NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
+ +V TL + APE+L S + VD++S G + E+ +
Sbjct: 173 QMALTSVVV------TLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRK 216
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-19
Identities = 61/224 (27%), Positives = 99/224 (44%), Gaps = 38/224 (16%)
Query: 813 EEQKELGSGTFGTVYHGKWR--GTDVAIKRI-KKSCFTGRSSEQERLTVEFWKEAEILSK 869
+ ++ G GTFGTV GK + G VAIK++ + F R ++ ++ L+
Sbjct: 26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNR-------ELQIMQD---LAV 75
Query: 870 LHHPNVVA----FYGVVQDGPGGT-LATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMD 924
LHHPN+V FY + + L V EY+ +L + R+ +
Sbjct: 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCC---RNYYRRQVAPPPILI 131
Query: 925 AAF------GMEYLH--SKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI--KRNTL 974
F + LH S N+ H D+K N+LVN + K+ DFG +K
Sbjct: 132 KVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN---EADGTLKLCDFGSAKKLSPSEPN 188
Query: 975 VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
V+ + + APEL+ G + + VD++S G + E++ GE
Sbjct: 189 VAYIC--SRYYRAPELIFG-NQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 3e-19
Identities = 48/239 (20%), Positives = 99/239 (41%), Gaps = 40/239 (16%)
Query: 794 PSLVDFDVSSVQVIKNEDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSS 851
D++ V+ +D + ++LG G + V+ + V +K +K +
Sbjct: 20 REYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKK 75
Query: 852 EQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD 910
+ +R E +IL L PN++ +V+D T A V E++ + + +
Sbjct: 76 KIKR-------EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---Q 125
Query: 911 RFLDRRRRLIIAMDAAF----GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966
D R + + ++Y HS I+H D+K N++++ + + D+GL
Sbjct: 126 TLTDYDIRFYM-----YEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI---DWGL 177
Query: 967 SKI-----KRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEP 1020
++ + N V+ + + PELL +D++S G +L ++ +EP
Sbjct: 178 AEFYHPGQEYNVRVA-----SRYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 61/233 (26%), Positives = 101/233 (43%), Gaps = 53/233 (22%)
Query: 813 EEQKELGSGTFGTVYHGKWRGTD------VAIKRIKKSCFTGRSSEQERLTVEFWKEAEI 866
+ K LG G G V + D VAIK+I T S + L +E +I
Sbjct: 14 MDLKPLGCGGNGLV----FSAVDNDCDKRVAIKKIV---LTDPQSVKHAL-----REIKI 61
Query: 867 LSKLHHPNVVAFYGVVQDGPGGTLAT------------VAEYMVDGSLRHVLVRKDRFLD 914
+ +L H N+V + ++ V EYM + L ++ + L+
Sbjct: 62 IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDL-ANVLEQGPLLE 119
Query: 915 RRRRLIIAMDAAF----GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC--KVGDFGLSK 968
RL + + G++Y+HS N++H DLK NL +N +D K+GDFGL++
Sbjct: 120 EHARLFM-----YQLLRGLKYIHSANVLHRDLKPANLFINTED-----LVLKIGDFGLAR 169
Query: 969 IKRNTLVSGGVR----GTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTG 1017
I G T + +P LL S + ++ +D+++ G + E+LTG
Sbjct: 170 IMDPHYSHKGHLSEGLVTKWYRSPRLL-LSPNNYTKAIDMWAAGCIFAEMLTG 221
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 6e-18
Identities = 49/249 (19%), Positives = 88/249 (35%), Gaps = 62/249 (24%)
Query: 813 EEQKELGSGTFGTVYHGKWR--GTDVAIKRIKK-SCFTGRSSEQERLTVEFWKEAEILSK 869
K LG+G+FG V G A+K++ + + R E +I+
Sbjct: 10 SLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR-------------ELDIMKV 56
Query: 870 LHHPNVVA----FYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRR-------- 917
L H N++ FY + P + G V +
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 918 ---------RLIIAMDAAF-----------------GMEYLHSKNIVHFDLKCDNLLVNL 951
+++ + + + ++HS I H D+K NLLVN
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN- 175
Query: 952 KDPSRPICKVGDFGLSKI--KRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGI 1009
K+ DFG +K V+ + + APEL+ G +++ + +D++S G
Sbjct: 176 --SKDNTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLG-ATEYTPSIDLWSIGC 230
Query: 1010 VLWEILTGE 1018
V E++ G+
Sbjct: 231 VFGELILGK 239
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-17
Identities = 47/219 (21%), Positives = 84/219 (38%), Gaps = 25/219 (11%)
Query: 813 EEQKELGSGTFGTV---YHGKWRGTDVAIKRIKKSCFTGRSS---EQERLTVEFWKEAEI 866
Q+ + SG++G V + G VAIKR+ + GR+ L +E +
Sbjct: 25 TVQRFISSGSYGAVCAGVDSE--GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 867 LSKLHHPNVVAFYGVVQDGPGGTLAT---VAEYMVDGSLRHVLVRKDRFL--DRRRRLII 921
L+ HHPN++ + + V E M L V+ + + + +
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMY 141
Query: 922 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC--KVGDFGLSKIKRNTLVSGGV 979
+ G+ LH +VH DL N+L+ + DF L++
Sbjct: 142 HI--LLGLHVLHEAGVVHRDLHPGNILLADN------NDITICDFNLAREDTADANKTHY 193
Query: 980 RGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
+ APEL+ ++ VD++S G V+ E+ +
Sbjct: 194 VTHRWYRAPELV-MQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 7e-17
Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 815 QKELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHH 872
K +GSG G V + +VAIK++ + F ++ + +E ++ ++H
Sbjct: 30 LKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAY-----RELVLMKCVNH 83
Query: 873 PNVVAFYGVVQDGPGGTLAT------VAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAA 926
N++ V P +L V E M D +L +++ + +R L+ M
Sbjct: 84 KNIIGLLNVFT--PQKSLEEFQDVYIVMELM-DANL-CQVIQMELDHERMSYLLYQM--L 137
Query: 927 FGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWM 986
G+++LHS I+H DLK N++V S K+ DFGL++ + + T +
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILDFGLARTAGTSFMMTPYVVTRYYR 193
Query: 987 APELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
APE++ E VD++S G ++ E++ G
Sbjct: 194 APEVI--LGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 39/220 (17%)
Query: 813 EEQKELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL 870
+GSG +G+V K G VAIK++ + F + +E +L +
Sbjct: 27 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-PFQSEIFAKRAY-----RELLLLKHM 80
Query: 871 HHPNVVAFYGVVQDGPGGTLAT------VAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMD 924
H NV+ V P +L V +M L+ ++ +F + + + ++
Sbjct: 81 QHENVIGLLDVFT--PASSLRNFYDFYLVMPFM-QTDLQKIM--GLKFSEEKIQYLV--- 132
Query: 925 AAF----GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC--KVGDFGLSKIKRNTLVSGG 978
+ G++Y+HS +VH DLK NL VN C K+ DFGL++ + +G
Sbjct: 133 --YQMLKGLKYIHSAGVVHRDLKPGNLAVNED------CELKILDFGLARHADAEM-TGY 183
Query: 979 VRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
V T + APE++ S ++ VD++S G ++ E+LTG+
Sbjct: 184 V-VTRWYRAPEVI-LSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 2e-16
Identities = 58/231 (25%), Positives = 91/231 (39%), Gaps = 49/231 (21%)
Query: 813 EEQKELGSGTFGTV---YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSK 869
+ + LG G +G V H G VAIK+I F L +E +IL
Sbjct: 14 QLKSLLGEGAYGVVCSATHKP-TGEIVAIKKI--EPFDKPLFALRTL-----REIKILKH 65
Query: 870 LHHPNVVAFYGVVQDGPGGTLAT---VAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAA 926
H N++ + + + + E M L H ++ D + I
Sbjct: 66 FKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSDDHIQYFI----- 118
Query: 927 F----GMEYLHSKNIVHFDLKCDNLLVN----LKDPSRPICKVGDFGLS-KIKRNTLVSG 977
+ ++ LH N++H DLK NLL+N LK +C DFGL+ I + +
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLK-----VC---DFGLARIIDESAADNS 170
Query: 978 GVRGTLPWM----------APELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
G M APE++ +S+K S +DV+S G +L E+
Sbjct: 171 EPTGQQSGMVEFVATRWYRAPEVM-LTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 4e-16
Identities = 56/217 (25%), Positives = 101/217 (46%), Gaps = 38/217 (17%)
Query: 816 KELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
+ +GSG +G V G VAIK++ + F + +E +L + H
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAY-----RELRLLKHMRHE 84
Query: 874 NVVAFYGVVQDGPGGTLAT------VAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
NV+ V P TL V +M L L++ ++ + R + ++ +
Sbjct: 85 NVIGLLDVFT--PDETLDDFTDFYLVMPFM-GTDL-GKLMKHEKLGEDRIQFLV-----Y 135
Query: 928 ----GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC--KVGDFGLSKIKRNTLVSGGVRG 981
G+ Y+H+ I+H DLK NL VN C K+ DFGL++ + + +G V
Sbjct: 136 QMLKGLRYIHAAGIIHRDLKPGNLAVNED------CELKILDFGLARQADSEM-TGYV-V 187
Query: 982 TLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
T + APE++ + + ++ VD++S G ++ E++TG+
Sbjct: 188 TRWYRAPEVI-LNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 8e-16
Identities = 51/212 (24%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 813 EEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL 870
+ K +GSG G V D VAIK++ + F ++ + +E ++ +
Sbjct: 65 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAY-----RELVLMKCV 118
Query: 871 HHPNVVAFYGVVQDGPGGT----LATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAA 926
+H N+++ V + V E M D +L +++ + +R L+ M
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL-CQVIQMELDHERMSYLLYQMLC- 175
Query: 927 FGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWM 986
G+++LHS I+H DLK N++V S K+ DFGL++ + + T +
Sbjct: 176 -GIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILDFGLARTAGTSFMMTPYVVTRYYR 230
Query: 987 APELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
APE++ E VD++S G ++ E++ +
Sbjct: 231 APEVI--LGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-15
Identities = 57/227 (25%), Positives = 94/227 (41%), Gaps = 58/227 (25%)
Query: 816 KELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
+GSG +G+V G VA+K++ + F + +E +L + H
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTY-----RELRLLKHMKHE 88
Query: 874 NVVAFYGVVQDGPGGTLAT------VAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
NV+ V P +L V M L + +V+ + D + +I +
Sbjct: 89 NVIGLLDVFT--PARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLI-----Y 139
Query: 928 ----GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC--KVGDFGLSKIKRNTLVSGGVRG 981
G++Y+HS +I+H DLK NL VN C K+ DFGL+ R
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAVNED------CELKILDFGLA------------RH 181
Query: 982 TLPWM----------APELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
T M APE++ + ++ VD++S G ++ E+LTG
Sbjct: 182 TADEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 4e-15
Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 36/221 (16%)
Query: 813 EEQKELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL 870
+G G +G V + VAIK+I S F ++ Q L +E +IL +
Sbjct: 30 TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTL-----REIKILLRF 82
Query: 871 HHPNVVAFYGVVQDGPGGTLAT---VAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
H N++ +++ + V + M + L + L++ + + +
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDL-YKLLKTQHLSNDHICYFL-----Y 135
Query: 928 ----GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC--KVGDFGLSKIKRNTLVSGGVR- 980
G++Y+HS N++H DLK NLL+N C K+ DFGL+++ G
Sbjct: 136 QILRGLKYIHSANVLHRDLKPSNLLLNTT------CDLKICDFGLARVADPDHDHTGFLT 189
Query: 981 ---GTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
T + APE++ +S ++ +D++S G +L E+L+
Sbjct: 190 EYVATRWYRAPEIM-LNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-14
Identities = 49/251 (19%), Positives = 93/251 (37%), Gaps = 57/251 (22%)
Query: 813 EEQKELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL 870
+ +G G++G VY + K +VAIK++ + F + L +E IL++L
Sbjct: 29 IIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-MFEDLIDCKRIL-----REITILNRL 82
Query: 871 HHPNVVAFYGVVQDGPGGTLAT---VAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
++ Y ++ V E D L+ + + + I+ +
Sbjct: 83 KSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTIL-----Y 136
Query: 928 ----GMEYLHSKNIVHFDLKCDNLLVN----LKDPSRPICKVGDFGLS------------ 967
G ++H I+H DLK N L+N +K +C DFGL+
Sbjct: 137 NLLLGENFIHESGIIHRDLKPANCLLNQDCSVK-----VC---DFGLARTINSEKDTNIV 188
Query: 968 -KIKRNTLVSGGVRGTLPWM----------APELLSGSSSKVSEKVDVFSFGIVLWEILT 1016
++ N + + APEL+ ++ +D++S G + E+L
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELIL-LQENYTKSIDIWSTGCIFAELLN 247
Query: 1017 GEEPYANMHYG 1027
+ + N
Sbjct: 248 MLQSHINDPTN 258
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 8e-14
Identities = 64/253 (25%), Positives = 105/253 (41%), Gaps = 60/253 (23%)
Query: 797 VDFDVSSVQVIKNEDLEEQKELGSGTFGTV---YHGKWRGTDVAIKRIKKSCFTGRSSEQ 853
VD V E K+LG G +G V + G VA+K+I F + Q
Sbjct: 3 VDRHVL-------RKYELVKKLGKGAYGIVWKSIDRR-TGEVVAVKKIFD-AFQNSTDAQ 53
Query: 854 ERLTVEFWKEAEILSKLH-HPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRF 912
+E IL++L H N+V V++ + V +YM + L H ++R +
Sbjct: 54 RTF-----REIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDL-HAVIRANIL 106
Query: 913 LDRRRRLIIAMDAAF----GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC--KVGDFGL 966
++ ++ + ++YLHS ++H D+K N+L+N + C KV DFGL
Sbjct: 107 EPVHKQYVV-----YQLIKVIKYLHSGGLLHRDMKPSNILLNAE------CHVKVADFGL 155
Query: 967 S------------KIKRNTLVSGGVRGTLPWM----------APELLSGSSSKVSEKVDV 1004
S + P + APE+L S+K ++ +D+
Sbjct: 156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILL-GSTKYTKGIDM 214
Query: 1005 FSFGIVLWEILTG 1017
+S G +L EIL G
Sbjct: 215 WSLGCILGEILCG 227
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 2e-13
Identities = 58/303 (19%), Positives = 108/303 (35%), Gaps = 65/303 (21%)
Query: 764 DAMMENLRTTESDYEEGNAGNRNIGLPSLNPSLVDFDVSSVQVIKNEDLEEQKELGSGTF 823
+ ++ + ++ + + S+ D+ + + E + +G+G++
Sbjct: 14 SGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIP-------DRYEIRHLIGTGSY 66
Query: 824 GTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGV 881
G V + VAIK+I + F + L +E IL++L+H +VV +
Sbjct: 67 GHVCEAYDKLEKRVVAIKKILR-VFEDLIDCKRIL-----REIAILNRLNHDHVVKVLDI 120
Query: 882 VQDGPGGTLAT---VAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF----GMEYLHS 934
V V E D + + + + ++ + G++Y+HS
Sbjct: 121 VIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLL-----YNLLVGVKYVHS 174
Query: 935 KNIVHFDLKCDNLLVNLKDPSRPIC--KVGDFGLS------------------KIKRNTL 974
I+H DLK N LVN C KV DFGL+ + N +
Sbjct: 175 AGILHRDLKPANCLVNQD------CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 975 VSGGVRGTLPWM----------APELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANM 1024
+ + APEL+ +E +DV+S G + E+L +
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELI-LLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287
Query: 1025 HYG 1027
H
Sbjct: 288 HAD 290
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 71.8 bits (175), Expect = 2e-13
Identities = 46/280 (16%), Positives = 77/280 (27%), Gaps = 67/280 (23%)
Query: 805 QVIKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEA 864
+ E L+ +++G G FG V+ T VAIK I + ++ E E
Sbjct: 15 HCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74
Query: 865 EILSKLH---------HPNVVAFYG--VVQDG--------------------------PG 887
I +L + VQ
Sbjct: 75 IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSK-NIVHFDLKCDN 946
L V E+ G + K L + I + + H DL N
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTKLSSLATAKS--ILHQLTASLAVAEASLRFEHRDLHWGN 192
Query: 947 LLVNLKDPSRPICKVG----------------DFGLSKIKRNTLVSGGVRGTLPWMAPEL 990
+L+ + + D+ LS+++R G V M +L
Sbjct: 193 VLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLER----DGIVVFCDVSMDEDL 248
Query: 991 LSGSSSKVSEKVDVFSF-GIVLWEILTGEEPYAN---MHY 1026
+G + D++ PY+N +HY
Sbjct: 249 FTGDGDY---QFDIYRLMKKENNNRWGEYHPYSNVLWLHY 285
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 3e-13
Identities = 63/262 (24%), Positives = 103/262 (39%), Gaps = 44/262 (16%)
Query: 777 YEEGNAGNRNIGLPS-LNPSLVDFDVSSVQVIKNEDL----EEQKELGSGTFGTVY--HG 829
Y G + G+ N D D S + ++ + E K +G G+FG V +
Sbjct: 59 YFLGLNAKKRQGMTGGPNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYD 118
Query: 830 KWRGTDVAIKRIK-KSCFTGRSSEQERLTVEFWKEAEILSKL------HHPNVVAFYGVV 882
VA+K ++ + F Q E IL L + NV+
Sbjct: 119 HKVHQHVALKMVRNEKRFH----RQAAE------EIRILEHLRKQDKDNTMNVIHMLENF 168
Query: 883 QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLI--IAMDAAFGMEYLHSKNIVHF 940
+ E + +L ++ +K++F L+ A ++ LH I+H
Sbjct: 169 TFR--NHICMTFELL-SMNLYELI-KKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHC 224
Query: 941 DLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT----LVSGGVRGTLPWMAPELLSGSSS 996
DLK +N+L LK R KV DFG S + + S R APE++ G +
Sbjct: 225 DLKPENIL--LKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYR------APEVILG--A 274
Query: 997 KVSEKVDVFSFGIVLWEILTGE 1018
+ +D++S G +L E+LTG
Sbjct: 275 RYGMPIDMWSLGCILAELLTGY 296
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 5e-12
Identities = 46/225 (20%), Positives = 97/225 (43%), Gaps = 39/225 (17%)
Query: 816 KELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL--- 870
++LG G F TV+ K T VA+K ++ ++E E ++L ++
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE---------DEIKLLQRVNDA 75
Query: 871 --HHPNVVAFYGVVQ-------DGPGGT-LATVAEYMVDGSLRHVLVRKDRF----LDRR 916
+ + +++ GP G + V E + +L ++ +K L
Sbjct: 76 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALI-KKYEHRGIPLIYV 133
Query: 917 RRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPS--RPICKVGDFGLSKIKRNT 973
++ I+ G++Y+H + I+H D+K +N+L+ + D K+ D G +
Sbjct: 134 KQ--ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 191
Query: 974 LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
+ T + +PE+L G+ D++S +++E++TG+
Sbjct: 192 YTNSIQ--TREYRSPEVLLGA--PWGCGADIWSTACLIFELITGD 232
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 8e-11
Identities = 43/179 (24%), Positives = 72/179 (40%), Gaps = 25/179 (13%)
Query: 802 SSVQVIKNEDLEEQKELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTVE 859
S ++ + K++G G FG + GK + VAIK S +L +E
Sbjct: 1 SMGVLMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK------LEPMKSRAPQLHLE 54
Query: 860 FWKEAEILSKLHH-PNVVAFYGVVQDGPGGTLATVAEYMV----DGSLRHVLVRKDRFLD 914
++ + L P V ++G MV SL + DR
Sbjct: 55 -YRFYKQLGSGDGIPQVY-YFGPCGK---------YNAMVLELLGPSLEDLFDLCDRTFS 103
Query: 915 RRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRP-ICKVGDFGLSKIKRN 972
+ L+IA+ MEY+HSKN+++ D+K +N L+ + + DF L+K +
Sbjct: 104 LKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 65.3 bits (158), Expect = 9e-11
Identities = 80/673 (11%), Positives = 185/673 (27%), Gaps = 213/673 (31%)
Query: 335 NQPGGLSGGYQYSVLQVQNPQMTVKQGMALPDGSIQPDSD--TEKVS--PLDKPVPSWPY 390
+SG + + + V++ + + ++ + + + + Y
Sbjct: 56 MSKDAVSGTLRLFWTLLSKQEEMVQKFV---EEVLRINYKFLMSPIKTEQRQPSMMTRMY 112
Query: 391 DDKLMKHFAVEEAAVSVGIPRVDIPPLFPPKSEGKHQEPGKVS--PPADTLNAASKFSND 448
++ + + +F + VS P L A
Sbjct: 113 IEQRDRLYND--------------NQVFAKYN---------VSRLQPYLKLRQA------ 143
Query: 449 DLCSMSS-------GALGPGH--------RDSEINPIDSSYLEPPVPPQRIY----RSEK 489
L + G LG G ++ +I+ ++
Sbjct: 144 -LLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQC---------KMDFKIFWLNLKNCN 193
Query: 490 IPREQLDLLNRLSKSDDSLGSQFIMSQSHSDVVQPDPVSEPNEKVQKEDQTFENELTQLQ 549
P L++L +L D + + D S N K++ + EL +L
Sbjct: 194 SPETVLEMLQKLLYQIDPNWTS-----------RSDHSS--NIKLRIHS--IQAELRRLL 238
Query: 550 KHKEFADAISQTNSKPSEEILD-VQEPRQGIPDALANNETNDPVDYNKKPLVDDGLPSES 608
K K + + + +L VQ + +A + + K L+
Sbjct: 239 KSKPYENCLL---------VLLNVQNAK--AWNAF---------NLSCKILL---TTRFK 275
Query: 609 SINDVYQGISSVGVSTQQRVDISVDIDDRFPRDFLSDIYSKAL------ISEDSSGIITL 662
+ D + +T + + D + + K L + +
Sbjct: 276 QVTDF------LSAATTTHISL-DHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPR 328
Query: 663 HKDGAGISVNMENHEPKRWSYFRNLAQVDFGQKDVSLIDQEHLGLSSGVREVREEDGRLY 722
+ I+ ++ + W ++ V+ + ++I+ L E R+ ++
Sbjct: 329 RL--SIIAESIRDG-LATWDNWK---HVNCDKLT-TIIESSLNVLEPA--EYRK----MF 375
Query: 723 H----FTPLTDDGAPKGRVDSQLNFGQDSQKTFGV---DPSVSESMQFDAMMENLRTTES 775
F P + + + D S+ M + E
Sbjct: 376 DRLSVF--------PP---SAHI-----PTILLSLIWFDVIKSDVMVVVNKLHKYSLVEK 419
Query: 776 DYEEGNAGNRNI---------GLPSLNPSLVDFDVSSVQVIKNEDLEEQKE-------LG 819
+E +I +L+ S+VD + + ++DL +G
Sbjct: 420 QPKESTISIPSIYLELKVKLENEYALHRSIVDHY-NIPKTFDSDDLIPPYLDQYFYSHIG 478
Query: 820 SGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEF-WKEAEILSKLHHPNVVAF 878
+H +K R + + ++F + E K+ H
Sbjct: 479 -------HH------------LKNIEHPERMTLFRMVFLDFRFLEQ----KIRHD----- 510
Query: 879 YGVVQDGPGGTLATVAE---YMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSK 935
+ G L T+ + Y + + D +R I+ + SK
Sbjct: 511 -STAWNASGSILNTLQQLKFY------KPYICDNDPKYERLVNAILDFLPKIEENLICSK 563
Query: 936 --NIVHFDLKCDN 946
+++ L ++
Sbjct: 564 YTDLLRIALMAED 576
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 7e-07
Identities = 103/630 (16%), Positives = 199/630 (31%), Gaps = 188/630 (29%)
Query: 462 HRDSEINPIDSSY------LEPP---------VP--PQRIYRSEKI--------PREQLD 496
H D E Y E V P+ I E+I
Sbjct: 6 HMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTL 65
Query: 497 LL--------NRLSKS--DDSLGS--QFIMSQSHSDVVQPDPV----SEPNEKVQKEDQT 540
L + + ++ L +F+MS ++ QP + E +++ ++Q
Sbjct: 66 RLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQV 125
Query: 541 F-ENELTQLQKHKEFADAISQTNSKPSEEILDVQEPRQGIPDA----LANNETNDPVDYN 595
F + +++LQ + + A+ + +P++ +L + G+ + +A + Y
Sbjct: 126 FAKYNVSRLQPYLKLRQALLEL--RPAKNVL-I----DGVLGSGKTWVALDVCL---SYK 175
Query: 596 KKPLVDDG-----LPSESSINDVYQGISS----VGVSTQQRVDISV-------DIDDRFP 639
+ +D L + +S V + + + + R D S I
Sbjct: 176 VQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELR 235
Query: 640 RDFLSDIYSKALISEDSSGIITLHKDGAGISVNMENHEPKRWSYFRNLAQVDFGQK---- 695
R S Y L+ ++ N++N K W+ F + K
Sbjct: 236 RLLKSKPYENCLL------VL----L------NVQN--AKAWNAF------NLSCKILLT 271
Query: 696 --DVSLIDQEHLGLSSGVREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDS--QKTF 751
+ D LS+ D TP D+ K + L+ ++
Sbjct: 272 TRFKQVTDF----LSAATTTHISLDHHSMTLTP--DEV--KSLLLKYLDCRPQDLPREVL 323
Query: 752 GVDPSVSESMQFDAMMENLRTTESDYEEGNAGNRNIGLPSLNPSLVDFDVSSVQVIKNED 811
+P S+ + + T ++ +++ L ++++ SS+ V++ +
Sbjct: 324 TTNPRRL-SI-IAESIRDGLATWDNW-------KHVNCDKLT-TIIE---SSLNVLEPAE 370
Query: 812 LEEQ-KELG---------SGTFGTVYHGKWRGT------DVAIKRIKKSCFTGRSSEQER 855
+ L + + W V K K S + E
Sbjct: 371 YRKMFDRLSVFPPSAHIPTILLSLI----WFDVIKSDVMVVVNKLHKYSLVEKQPKESTI 426
Query: 856 ----LTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAE--YM----------VD 899
+ +E + E LH ++V Y + + L Y ++
Sbjct: 427 SIPSIYLELKVKLENEYALHR-SIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIE 485
Query: 900 GSLRHVLVRK---D-RFLDRR-RRLIIAMDAAFGMEYLHSKNIVHFDLK------CDNLL 948
R L R D RFL+++ R A +A+ + N + LK CDN
Sbjct: 486 HPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSI-----LNTLQ-QLKFYKPYICDN-- 537
Query: 949 VNLKDP--SRPICKVGDFGLSKIKRNTLVS 976
DP R + + DF L KI+ N + S
Sbjct: 538 ----DPKYERLVNAILDF-LPKIEENLICS 562
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 8e-07
Identities = 65/420 (15%), Positives = 126/420 (30%), Gaps = 105/420 (25%)
Query: 684 FRNLAQV-------DFGQKDVSLIDQEHLGLSSGVREVREEDGRLYHFTPLTDDGAPKGR 736
++++ V +F KDV D LS E+ +
Sbjct: 18 YKDILSVFEDAFVDNFDCKDVQ--DMPKSILSK--EEIDH----------IIMSKDAVSG 63
Query: 737 VDSQLNFGQDSQKTFGVDPSVSESMQ--FDAMMENLRTTESD-------YEEGNAGNRNI 787
Q+ V V E ++ + +M ++T + Y E R+
Sbjct: 64 TLRLFWTLLSKQEE-MVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIE----QRDR 118
Query: 788 GLPSLNPSLVDFDVSSVQVIKNEDLEEQ-KELGSGTFGTVYHGKWRGTDVAIKRIKKSCF 846
L + N ++VS +Q L + EL + G G+ K+
Sbjct: 119 -LYNDNQVFAKYNVSRLQPYLK--LRQALLELRPAKNVLI-DGV-LGSG-------KTWV 166
Query: 847 TGRSSEQERLTVE-----FW--------KEA--EILSKLHHPNVVAFYGVVQDGPGGTLA 891
++ + FW E E+L KL + + + D
Sbjct: 167 ALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLY-QIDPNWTSRSDHSSNIKL 225
Query: 892 TVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIV-HFDLKCDNLL-- 948
+ + LR +L K L++ ++ + + F+L C LL
Sbjct: 226 RIHS--IQAELRRLLKSKPY----ENCLLVLLN-------VQNAKAWNAFNLSCKILLTT 272
Query: 949 --------VNLKDPSRPICKVGDFGLSKIKRNTLVSG--GVR-GTLPWMAPELLSGSSSK 997
++ + L+ + +L+ R LP E+L+ + +
Sbjct: 273 RFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLP---REVLTTNPRR 329
Query: 998 VSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEEC 1057
+S + G+ W+ + II +N L P AE+R + +
Sbjct: 330 LSIIAESIRDGLATWDNW---KHVNCDKLTTIIESSLNV-LEP-------AEYRKMFDRL 378
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 8e-04
Identities = 40/269 (14%), Positives = 80/269 (29%), Gaps = 59/269 (21%)
Query: 87 KVLCSFGG--KILPRPSDGKL-RYVGGETRIIRIRKDISWQILRQKALEVYNQVHVIKYQ 143
K +F KIL ++ ++ T S + + + + + Q
Sbjct: 257 KAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQ 316
Query: 144 -LPGEDLD------ALVSVSCDEDLQNMMEEYNELGDREGSQRIRMFLFSMSDLAEAQSC 196
LP E L ++++ S + L + + + + + I L + AE +
Sbjct: 317 DLPREVLTTNPRRLSIIAESIRDGL-ATWDNWKHVNCDKLTTIIESSLNVLEP-AEYRKM 374
Query: 197 ---LSSMDGDSEIQFVVAVNGMDSGSRNSLNLHGLRSSSANDLEELGGHNIERETSRVVV 253
LS + I ++ L + I+ + VV
Sbjct: 375 FDRLSVFPPSAHIPTIL-------------------------LSLIWFDVIKSDVMVVVN 409
Query: 254 DSARVSTPPLTGNIAPSS-TIHSSRVIIPSSSNAHETYPQFHHDQRLHRRETREYPLHHA 312
+ S + S+ +I S + E + ++ LHR Y +
Sbjct: 410 KLHKYSL--VEKQPKESTISIPSIYL---------ELKVKLENEYALHRSIVDHYNIPKT 458
Query: 313 CDPSNYSP-------YGEIPYSMPLHEHS 334
D + P Y I + + EH
Sbjct: 459 FDSDDLIPPYLDQYFYSHIGHHLKNIEHP 487
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 35/164 (21%), Positives = 63/164 (38%), Gaps = 13/164 (7%)
Query: 816 KELGSGTFGTVYHG-KWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEA---EILSKLH 871
+G G FG +Y V + ++F++ A E + K
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 872 HPNVVAFYGVVQ-DGPGGTLATVAEY--MV----DGSLRHVLVRKDRFLDRRRRLIIAMD 924
+ + GV + G G Y M+ L+ + + R+ L +++
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLR 160
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968
+EY+H VH D+K NLL+N K+P + + D+GL+
Sbjct: 161 ILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ--VYLVDYGLAY 202
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 44/167 (26%), Positives = 71/167 (42%), Gaps = 31/167 (18%)
Query: 816 KELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHH- 872
+++GSG+FG +Y G G +VAIK ++ +L E++I +
Sbjct: 15 RKIGSGSFGDIYLGTDIAAGEEVAIKLEC------VKTKHPQLH----IESKIYKMMQGG 64
Query: 873 ---PNVVAFYGVVQDGPGGTLATVAEYMV----DGSLRHVLVRKDRFLDRRRRLIIAMDA 925
P + + G D MV SL + R + L++A
Sbjct: 65 VGIPTIR-WCGAEGD---------YNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQM 114
Query: 926 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRN 972
+EY+HSKN +H D+K DN L+ L + + DFGL+K R+
Sbjct: 115 ISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYII-DFGLAKKYRD 160
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 27/182 (14%), Positives = 53/182 (29%), Gaps = 39/182 (21%)
Query: 816 KELGSGTFGTVYHG----------KWRGTDVAIK--RIKKSCFTGRSSEQERLTVEFWKE 863
G +Y + ++K F ++ Q +
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 864 AEILSKLHHPNVVAFYG----------VVQDGPGGTLATVAEYMVDG--SLRHVLVRKDR 911
+ L + G +V G +L + + S R VL R
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 912 FLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKR 971
LD +E+LH VH ++ +N+ V+ +D S+ + +G +
Sbjct: 168 LLDA-------------LEFLHENEYVHGNVTAENIFVDPEDQSQ--VTLAGYGFAFRYC 212
Query: 972 NT 973
+
Sbjct: 213 PS 214
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 58/224 (25%), Positives = 88/224 (39%), Gaps = 49/224 (21%)
Query: 816 KELGSGTFGTVYHGKWRGTD--VAIKRIK-KSCFTGRSSEQERLTVEFWKEAEILSKL-- 870
+G G+FG V R VAIK IK K F Q + E +L +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL----NQAQ------IEVRLLELMNK 109
Query: 871 ------HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRF----LDRRRRLI 920
++ +V L V E + +L +L R F L+ R+
Sbjct: 110 HDTEMKYY--IVHLKRHFMFR--NHLCLVFEML-SYNLYDLL-RNTNFRGVSLNLTRK-- 161
Query: 921 IAMDAAFGMEYLHSK--NIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT----L 974
A + +L + +I+H DLK +N+L L +P R K+ DFG S +
Sbjct: 162 FAQQMCTALLFLATPELSIIHCDLKPENIL--LCNPKRSAIKIVDFGSSCQLGQRIYQYI 219
Query: 975 VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGE 1018
S R +PE+L G +D++S G +L E+ TGE
Sbjct: 220 QSRFYR------SPEVLLGM--PYDLAIDMWSLGCILVEMHTGE 255
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 38/165 (23%), Positives = 68/165 (41%), Gaps = 25/165 (15%)
Query: 816 KELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHH- 872
+ +G G+FG ++ G VAIK R S+ +L E ++ ++L+
Sbjct: 16 RRIGEGSFGVIFEGTNLLNNQQVAIKFEP------RRSDAPQLRDE-YRTYKLLAGCTGI 68
Query: 873 PNVVAFYGVVQDGPGGTLATVAEYMV----DGSLRHVLVRKDRFLDRRRRLIIAMDAAFG 928
PNV ++G +V SL +L R + + A
Sbjct: 69 PNVY-YFGQEGLH---------NVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLAR 118
Query: 929 MEYLHSKNIVHFDLKCDNLLVNLKDPSRP-ICKVGDFGLSKIKRN 972
++ +H K++V+ D+K DN L+ + + V DFG+ K R+
Sbjct: 119 VQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 40/170 (23%), Positives = 63/170 (37%), Gaps = 28/170 (16%)
Query: 816 KELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTVEF------------- 860
K++GSG FG +Y + A +K E L E
Sbjct: 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKV-----EYQENGPLFSELKFYQRVAKKDCIK 97
Query: 861 -WKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDG-SLRHVLVRKDRFLDRRRR 918
W E + L L P G+ + V E + G L+ + + F +
Sbjct: 98 KWIERKQLDYLGIPLFY-GSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTF-KKSTV 153
Query: 919 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968
L + + +EY+H VH D+K NLL+ K+P + + D+GLS
Sbjct: 154 LQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQ--VYLADYGLSY 201
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 58.9 bits (142), Expect = 6e-09
Identities = 41/165 (24%), Positives = 71/165 (43%), Gaps = 25/165 (15%)
Query: 816 KELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-H 872
+++GSG+FG +Y G +VAIK ++ +L E++I L
Sbjct: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLEN------VKTKHPQLL----YESKIYRILQGG 62
Query: 873 PNVVAFYGVVQDGPGGTLATVAEYMV----DGSLRHVLVRKDRFLDRRRRLIIAMDAAFG 928
+ +G +V SL + R L + L++A
Sbjct: 63 TGIPNVRWFGVEGD-------YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
Query: 929 MEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT 973
+E++HSK+ +H D+K DN L+ L + + + DFGL+K R+T
Sbjct: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII-DFGLAKKYRDT 159
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 3e-08
Identities = 49/264 (18%), Positives = 90/264 (34%), Gaps = 73/264 (27%)
Query: 816 KELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL--- 870
++LG G F TV+ VA+K + KS + + E +L +
Sbjct: 43 RKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALD--------EIRLLKSVRNS 93
Query: 871 --HHPN---VVAFYGVVQ-DGPGGT-LATVAEYMVDGSLRHVLVR-KDRFLDRRRRLIIA 922
+ PN VV + G GT + V E + L +++ + L I
Sbjct: 94 DPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKII 152
Query: 923 MDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPS-------------------------- 955
G++YLH+K I+H D+K +N+L+++ +
Sbjct: 153 QQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 956 -------------------RPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSS 996
+ K+ D G + T + + E+L G S
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF--TEDIQTRQYRSLEVLIG--S 268
Query: 997 KVSEKVDVFSFGIVLWEILTGEEP 1020
+ D++S + +E+ TG+
Sbjct: 269 GYNTPADIWSTACMAFELATGDYL 292
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 1e-06
Identities = 55/252 (21%), Positives = 88/252 (34%), Gaps = 63/252 (25%)
Query: 805 QVIKNEDLEEQ----KELGSGTFGTV---YHGKWRGTDVAIKRIK-KSCFTGRSSEQERL 856
+ L + LG G FG V K G VA+K +K + E R
Sbjct: 5 ICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYC----EAARS 60
Query: 857 TVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEY-----MV----DGSLRHVLV 907
E ++L L+ + + + VQ + E+ +V S +
Sbjct: 61 ------EIQVLEHLNTTDPNSTFRCVQ------MLEWFEHHGHICIVFELLGLSTYDFI- 107
Query: 908 RKDRFLDRRRRLI--IAMDAAFGMEYLHSKNIVHFDLKCDNLLVN--------------- 950
+++ FL R I +A + +LHS + H DLK +N+L
Sbjct: 108 KENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167
Query: 951 LKDPSRPICKVGDFGLSKIKRNT----LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFS 1006
+ P KV DFG + + + R APE++ S+ DV+S
Sbjct: 168 ERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYR------APEVILA--LGWSQPCDVWS 219
Query: 1007 FGIVLWEILTGE 1018
G +L E G
Sbjct: 220 IGCILIEYYLGF 231
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 47/253 (18%), Positives = 86/253 (33%), Gaps = 65/253 (25%)
Query: 805 QVIKNEDLEEQ----KELGSGTFGTVY----HGKWRGTDVAIKRIK-KSCFTGRSSEQER 855
+ L+E+ LG GTFG V H + + VA+K I+ + E R
Sbjct: 10 VCRIGDWLQERYEIVGNLGEGTFGKVVECLDHAR-GKSQVALKIIRNVGKYR----EAAR 64
Query: 856 LTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEY---------MVDGSLRHVL 906
L E +L K+ + + V ++ + ++ + L
Sbjct: 65 L------EINVLKKIKEKDKENKFLCVL------MSDWFNFHGHMCIAFELLGKNTFEFL 112
Query: 907 VRKDRFLDRRRRLI--IAMDAAFGMEYLHSKNIVHFDLKCDNLLVN-------------- 950
+++ F + +A + +LH + H DLK +N+L
Sbjct: 113 -KENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSC 171
Query: 951 -LKDPSRPICKVGDFGLSKIKRNT----LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVF 1005
K +V DFG + + + R PE++ ++ DV+
Sbjct: 172 EEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYR------PPEVILE--LGWAQPCDVW 223
Query: 1006 SFGIVLWEILTGE 1018
S G +L+E G
Sbjct: 224 SIGCILFEYYRGF 236
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 48/254 (18%), Positives = 91/254 (35%), Gaps = 63/254 (24%)
Query: 805 QVIKNEDLEEQ----KELGSGTFGTVY--HGKWRGTDVAIKRIK-KSCFTGRSSEQERLT 857
K L +++G GTFG V A+K ++ +T ++
Sbjct: 26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYT----RSAKI- 80
Query: 858 VEFWKEAEILSKL-----HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRF 912
EA+IL K+ ++ N+V ++G + + E + SL ++ ++ +
Sbjct: 81 -----EADILKKIQNDDINNNNIVKYHGKFMYY--DHMCLIFE-PLGPSLYEII-TRNNY 131
Query: 913 LDRRRRLI--IAMDAAFGMEYLHSKNIVHFDLKCDNLLVN-------------------- 950
I ++ + YL ++ H DLK +N+L++
Sbjct: 132 NGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191
Query: 951 -LKDPSRPICKVGDFGLSKIKRNTLVSGGV-----RGTLPWMAPELLSGSSSKVSEKVDV 1004
+ K+ DFG ++ + R APE++ D+
Sbjct: 192 QIYRTKSTGIKLIDFG-CATFKSDYHGSIINTRQYR------APEVILN--LGWDVSSDM 242
Query: 1005 FSFGIVLWEILTGE 1018
+SFG VL E+ TG
Sbjct: 243 WSFGCVLAELYTGS 256
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1094 | |||
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.83 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.52 | |
| 2cu1_A | 103 | Mitogen-activated protein kinase kinase kinase 2; | 99.25 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.14 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 98.91 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.91 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.88 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.79 | |
| 2eo3_A | 111 | CRK-like protein; phosphorylation, repeat, SH2 dom | 98.57 | |
| 2dly_A | 121 | FYN-related kinase; BRK family kinase, structural | 98.52 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.51 | |
| 4d8k_A | 175 | Tyrosine-protein kinase LCK; protein kinases, SH2 | 98.39 | |
| 1aot_F | 106 | FYN protein-tyrosine kinase; SH2 domain, signal tr | 98.34 | |
| 1lkk_A | 105 | Human P56 tyrosine kinase; complex (tyrosine kinas | 98.33 | |
| 2ekx_A | 110 | Cytoplasmic tyrosine-protein kinase BMX; SH2 domai | 98.32 | |
| 3us4_A | 98 | Megakaryocyte-associated tyrosine-protein kinase; | 98.3 | |
| 1blj_A | 114 | P55 BLK protein tyrosine kinase; signal transducti | 98.27 | |
| 3maz_A | 125 | Signal-transducing adaptor protein 1; modular doma | 98.26 | |
| 3k2m_A | 112 | Proto-oncogene tyrosine-protein kinase ABL1; engin | 98.26 | |
| 2dm0_A | 125 | Tyrosine-protein kinase TXK; TEC family kinase, st | 98.24 | |
| 3s9k_A | 118 | Tyrosine-protein kinase ITK/TSK; proline isomeriza | 98.24 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.21 | |
| 1d4t_A | 104 | T cell signal transduction molecule SAP; SH2 domai | 98.2 | |
| 3eaz_A | 106 | Tyrosine-protein kinase CSK; SH2, disulfide, oxidi | 98.19 | |
| 2ecd_A | 119 | Tyrosine-protein kinase ABL2; SH2 domain, phosphot | 98.18 | |
| 2ge9_A | 125 | Tyrosine-protein kinase BTK; SH2 domain, structure | 98.17 | |
| 2vif_A | 141 | Suppressor of cytokine signalling 6; growth regula | 98.16 | |
| 2el8_A | 118 | Signal-transducing adaptor protein 2; SH2 domain, | 98.13 | |
| 2ysx_A | 119 | Signaling inositol polyphosphate phosphatase SHIP | 98.13 | |
| 1ka6_A | 128 | SH2 domain protein 1A; SH2 domain, protein-peptide | 98.12 | |
| 1vd2_A | 89 | Protein kinase C, IOTA type; PB1 domain, OPCA moti | 98.09 | |
| 2dx0_A | 138 | Phospholipase C, gamma 2; phosphoric diester hydro | 98.09 | |
| 3ov1_A | 117 | Growth factor receptor-bound protein 2; GRB2 SH2 d | 98.07 | |
| 1rja_A | 100 | Tyrosine-protein kinase 6; human protein tyrosine | 98.07 | |
| 1mil_A | 104 | SHC adaptor protein; SH2 domain, phosphorylation, | 98.04 | |
| 2cs0_A | 119 | Hematopoietic SH2 domain containing; ALX, FLJ14886 | 98.03 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.02 | |
| 2hdv_A | 111 | SH2-B PH domain containing signaling mediator 1 ga | 98.01 | |
| 2crh_A | 138 | VAV proto-oncogene; oncoprotein, structural genomi | 98.0 | |
| 1r1p_A | 100 | GRB2-related adaptor protein 2; SH2, GADS, phospho | 97.99 | |
| 2bbu_A | 164 | Suppressor of cytokine signaling 3; SH2 domain, ex | 97.97 | |
| 2iug_A | 120 | Phosphatidylinositol 3-kinase regulatory alpha sub | 97.95 | |
| 1wqu_A | 114 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 97.94 | |
| 2gsb_A | 119 | RAS GTPase-activating protein 1; GAP, RAS P21 prot | 97.92 | |
| 1i3z_A | 103 | EWS/FLI1 activated transcript 2; SH2 domain phosph | 97.92 | |
| 2eo6_A | 141 | B-cell linker protein; SH2, cytoplasmic adapter pr | 97.92 | |
| 1jyr_A | 96 | Growth factor receptor-bound protein 2; receptor b | 97.91 | |
| 3pqz_A | 117 | Growth factor receptor-bound protein 7; SH2, binds | 97.91 | |
| 2dlz_A | 118 | Protein VAV-2; RHO family guanine nucleotide excha | 97.9 | |
| 2dvj_A | 230 | V-CRK sarcoma virus CT10 oncogene homolog, isoform | 97.88 | |
| 3tkz_A | 109 | Tyrosine-protein phosphatase non-receptor type 11; | 97.88 | |
| 1h9o_A | 112 | Phosphatidylinositol 3-kinase; transferase/recepto | 97.87 | |
| 2cia_A | 102 | Cytoplasmic protein NCK2; SH2-domain, SH3 domain, | 97.86 | |
| 2izv_A | 187 | Suppressor of cytokine signaling 4; signal transdu | 97.86 | |
| 2kk6_A | 116 | Proto-oncogene tyrosine-protein kinase FER; method | 97.85 | |
| 2eob_A | 124 | 1-phosphatidylinositol-4,5-bisphosphate phosphodie | 97.84 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.82 | |
| 2lnw_A | 122 | VAV-2, guanine nucleotide exchange factor VAV2; si | 97.81 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.8 | |
| 2hmh_A | 152 | Suppressor of cytokine signaling 3; SOCS3, GP130, | 97.78 | |
| 2oq1_A | 254 | Tyrosine-protein kinase ZAP-70; tandem SH2 domains | 97.76 | |
| 2eyz_A | 304 | V-CRK sarcoma virus CT10 oncogene homolog isoform | 97.71 | |
| 2c9w_A | 169 | Suppressor of cytokine signaling 2; growth regulat | 97.69 | |
| 2aug_A | 126 | Growth factor receptor-bound protein 14; phosphory | 97.69 | |
| 2kno_A | 131 | Tensin-like C1 domain-containing phosphatase; SH2 | 97.69 | |
| 1a81_A | 254 | SYK kinase; complex (transferase-peptide), SYK, ki | 97.68 | |
| 3qwx_X | 174 | Cell death abnormality protein 2; cell engulfment, | 97.68 | |
| 1a81_A | 254 | SYK kinase; complex (transferase-peptide), SYK, ki | 97.66 | |
| 1nrv_A | 105 | Growth factor receptor-bound protein 10; dimer, si | 97.64 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 97.64 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.63 | |
| 2oq1_A | 254 | Tyrosine-protein kinase ZAP-70; tandem SH2 domains | 97.63 | |
| 2lqn_A | 303 | CRK-like protein; SH2, SH3, V-CRK sarcoma virus CT | 96.79 | |
| 4fbn_A | 246 | 1-phosphatidylinositol 4,5-bisphosphate phosphodi | 97.61 | |
| 3qwy_A | 308 | Cell death abnormality protein 2; cell engulfment, | 97.57 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.47 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.45 | |
| 2y3a_B | 302 | Phosphatidylinositol 3-kinase regulatory subunit; | 97.45 | |
| 1ju5_A | 109 | CRK; CRK, SH2, SH3, adaptor protein, phosphopeptid | 97.4 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 97.36 | |
| 3hhm_B | 373 | NISH2 P85alpha; PI3KCA, PI3K, PIK3R1, phosphatidil | 97.33 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.04 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.01 | |
| 2jrh_A | 94 | Mitogen-activated protein kinase kinase kinase 3; | 97.0 | |
| 3hhm_B | 373 | NISH2 P85alpha; PI3KCA, PI3K, PIK3R1, phosphatidil | 96.93 | |
| 4fbn_A | 246 | 1-phosphatidylinositol 4,5-bisphosphate phosphodi | 96.87 | |
| 1gri_A | 217 | Growth factor bound protein 2; SH2, SH3, signal tr | 96.83 | |
| 2c60_A | 111 | Human mitogen-activated protein kinase kinase kina | 96.82 | |
| 2npt_B | 100 | Mitogen-activated protein kinase kinase kinase 2; | 96.79 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.71 | |
| 2shp_A | 525 | SHP-2, SYP, SHPTP-2; tyrosine phosphatase, insulin | 96.67 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.62 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.31 | |
| 2b3o_A | 532 | Tyrosine-protein phosphatase, non-receptor type 6; | 96.16 | |
| 3ps5_A | 595 | Tyrosine-protein phosphatase non-receptor type 6; | 96.16 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.09 | |
| 3ps5_A | 595 | Tyrosine-protein phosphatase non-receptor type 6; | 96.08 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.77 | |
| 2cr4_A | 126 | 3BP-2, SH3 domain-binding protein 2; structural ge | 95.74 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.72 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.61 | |
| 2b3o_A | 532 | Tyrosine-protein phosphatase, non-receptor type 6; | 95.58 | |
| 2shp_A | 525 | SHP-2, SYP, SHPTP-2; tyrosine phosphatase, insulin | 95.56 | |
| 1q1o_A | 98 | Cell division control protein 24; PB1 domain, PCCR | 95.53 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 95.37 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.15 | |
| 2kkc_A | 102 | Sequestosome-1; P62, PB1, autophagy, ubiquitin-pro | 95.03 | |
| 1pqs_A | 77 | Cell division control protein 24; alpha and beta p | 95.02 | |
| 2ktr_A | 117 | Sequestosome-1; autophagy, NF-KB signaling, HOMO-o | 94.79 | |
| 1oey_A | 83 | P67-PHOX, neutrophil cytosol factor 2; immune syst | 93.98 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 93.73 | |
| 2yt6_A | 109 | Adult MALE urinary bladder cDNA, riken FULL- lengt | 93.66 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.49 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.3 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 92.05 | |
| 2bkf_A | 87 | Zinc-finger protein NBR1 (NEXT to breast cancer 1; | 89.89 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.86 | |
| 1wmh_B | 86 | Partitioning defective-6 homolog alpha; kinase, PB | 89.01 | |
| 1wj6_A | 101 | KIAA0049 protein, RSGI RUH-024; PB1 domain, protei | 88.56 | |
| 1ip9_A | 85 | BEM1 protein; ubiquitin alpha/beta roll, signaling | 88.23 | |
| 1oey_J | 107 | P40-PHOX, neutrophil cytosol factor 4; immune syst | 82.67 |
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=485.66 Aligned_cols=383 Identities=27% Similarity=0.460 Sum_probs=309.9
Q ss_pred ccccccCCCCchh-hhccccccccccCCCChhHHHHcCC----chh---hhhhhhcCCceeEEeeeccCCCCCCcccccc
Q 037285 670 SVNMENHEPKRWS-YFRNLAQVDFGQKDVSLIDQEHLGL----SSG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQL 741 (1094)
Q Consensus 670 s~~~~~~~~~~~~-~~~~Le~~~Wy~~~IsR~~AE~ll~----a~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy 741 (1094)
.+++++..|+|++ ...+|+.++|||++|+|.+||.+|+ .+| ||+|....| .|.+|+........+.++ ||
T Consensus 49 ~~g~~G~~P~~yv~~~~~le~~~W~~g~i~r~~ae~~L~~~~~~~G~FLvR~s~~~~g-~y~lsv~~~~~~~~~~v~-H~ 126 (454)
T 1qcf_A 49 ATRKEGYIPSNYVARVDSLETEEWFFKGISRKDAERQLLAPGNMLGSFMIRDSETTKG-SYSLSVRDYDPRQGDTVK-HY 126 (454)
T ss_dssp TTCCEEEEEGGGEEETTCGGGSTTEETTCCHHHHHHHHHSTTCCTTCEEEEECSSSTT-SEEEEEEEEETTTEEEEE-EE
T ss_pred CCCceEEecchhcccccccccccccccccchhhhhhhhhcCCCCCceEEEEECcCCCC-eEEEEEEecccCCCCceE-EE
Confidence 4568899999998 5789999999999999999999884 445 999988788 899998875434446777 99
Q ss_pred cccccCCCccccCCCcccccchHHHHHhhhcccccccccCCCCC-cCCCCCCCCCCcccCCCcceeeccCCeeEEEEecc
Q 037285 742 NFGQDSQKTFGVDPSVSESMQFDAMMENLRTTESDYEEGNAGNR-NIGLPSLNPSLVDFDVSSVQVIKNEDLEEQKELGS 820 (1094)
Q Consensus 742 ~I~~dsq~r~~vtp~isE~~qFdsL~ElLrt~eSdyee~nagn~-~l~~P~lnpsl~~~dlssv~eIs~edYei~kkLGs 820 (1094)
.|.....+.++ +.....|.++.+++.. |...+.+.. ....++.............|++..++|++.+.||+
T Consensus 127 ~I~~~~~g~~~----i~~~~~F~sl~eLv~~----y~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~ 198 (454)
T 1qcf_A 127 KIRTLDNGGFY----ISPRSTFSTLQELVDH----YKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGA 198 (454)
T ss_dssp EEEECTTSCEE----SSSSSCBSSHHHHHHH----HTSSCTTSSSCCCSBCCCCCCCCCCCTTCSBCCGGGEEEEEEEEC
T ss_pred EEEEcCCCcEE----EeCccccCCHHHHHHH----HHhccCCccccccccccccCccccccccceeechHHeEEEEEccc
Confidence 99887777788 5666788888888742 222222211 11122221111111123568899999999999999
Q ss_pred cCceEEEEeeec-CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEEEeeeccc
Q 037285 821 GTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVD 899 (1094)
Q Consensus 821 G~FGtVYKAk~r-Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~IVmEYmeg 899 (1094)
|+||.||+|+++ +..||||+++.... ....|.+|+.+|++++||||+++++++... .+++||||+.+
T Consensus 199 G~fg~V~~~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~---~~~lv~e~~~~ 266 (454)
T 1qcf_A 199 GQFGEVWMATYNKHTKVAVKTMKPGSM---------SVEAFLAEANVMKTLQHDKLVKLHAVVTKE---PIYIITEFMAK 266 (454)
T ss_dssp CSSEEEEEEEETTTEEEEEEEECTTSB---------CHHHHHHHHHHHTTCCCTTBCCEEEEECSS---SCEEEECCCTT
T ss_pred CCceEEEEEEECCccEEEEEEecCCCc---------cHHHHHHHHHHHhhCCCCCEeeEEEEEeCC---ccEEEEeecCC
Confidence 999999999986 57799999976421 135788999999999999999999998743 68999999999
Q ss_pred chhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccCc--ccc
Q 037285 900 GSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT--LVS 976 (1094)
Q Consensus 900 GSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~--~~s 976 (1094)
|+|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+|||+++..... ...
T Consensus 267 g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~----~~~~~kl~DFG~a~~~~~~~~~~~ 342 (454)
T 1qcf_A 267 GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS----ASLVCKIADFGLARVIEDNEYTAR 342 (454)
T ss_dssp CBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC----TTCCEEECSTTGGGGBCCHHHHTT
T ss_pred CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEC----CCCcEEEeeCCCceEcCCCceecc
Confidence 99999997543 3588999999999999999999999999999999999998 7889999999999864332 222
Q ss_pred CCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHH
Q 037285 977 GGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLME 1055 (1094)
Q Consensus 977 s~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~ 1055 (1094)
....+|..|+|||++. ...++.++|||||||+||||+| |+.||......++...+. ...+...+..++.++.+||.
T Consensus 343 ~~~~~~~~y~aPE~~~--~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~ 419 (454)
T 1qcf_A 343 EGAKFPIKWTAPEAIN--FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEELYNIMM 419 (454)
T ss_dssp CSSSSCGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-HTCCCCCCTTSCHHHHHHHH
T ss_pred CCCcccccccCHHHhc--cCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHH
Confidence 3345778999999998 4568999999999999999999 999999998888777654 45667778899999999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1056 ECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1056 kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
+||+.||.+|||+.+|++.|+.+.++
T Consensus 420 ~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 420 RCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred HHccCChhHCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999998644
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=460.63 Aligned_cols=265 Identities=32% Similarity=0.551 Sum_probs=223.9
Q ss_pred cceeeccCCeeEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEe
Q 037285 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVV 882 (1094)
Q Consensus 803 sv~eIs~edYei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~ 882 (1094)
..|+|..++|++.++||+|+||+||+|++++ .||||+++.... .......|.+|+.+|++|+|||||++++++
T Consensus 29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~------~~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 101 (307)
T 3omv_A 29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDP------TPEQFQAFRNEVAVLRKTRHVNILLFMGYM 101 (307)
T ss_dssp CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSC------CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCC------CHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 4589999999999999999999999999875 599999875321 123346899999999999999999999998
Q ss_pred ecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 883 QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 883 ~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
.++ .++||||||++|+|.++|......+++..++.|+.||+.||+|||+++||||||||+|||++ +++.+||+
T Consensus 102 ~~~---~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~----~~~~~Ki~ 174 (307)
T 3omv_A 102 TKD---NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLH----EGLTVKIG 174 (307)
T ss_dssp CSS---SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEE----TTEEEEEC
T ss_pred ECC---eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEEC----CCCcEEEe
Confidence 653 58999999999999999987777799999999999999999999999999999999999999 78899999
Q ss_pred ecCCcccccC---ccccCCccCCCcccCccccccC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccC
Q 037285 963 DFGLSKIKRN---TLVSGGVRGTLPWMAPELLSGS-SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 1038 (1094)
Q Consensus 963 DFGLSrl~~~---~~~ss~~~GT~~YmAPEvL~g~-~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~l 1038 (1094)
|||+|+.... .......+||+.|||||++.+. ...|+.++|||||||+||||+||+.||........+..++....
T Consensus 175 DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~ 254 (307)
T 3omv_A 175 DFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGY 254 (307)
T ss_dssp CCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTC
T ss_pred eccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCC
Confidence 9999985432 2233456799999999999743 34689999999999999999999999998776665555555443
Q ss_pred C-C---CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1039 R-P---TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1039 r-p---~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
. + ..+..+++++.+||.+||+.||++||||.+|+++|+.++.+
T Consensus 255 ~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 255 ASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp CCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred CCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 3 2 34567899999999999999999999999999999988743
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-53 Score=480.24 Aligned_cols=380 Identities=28% Similarity=0.484 Sum_probs=306.0
Q ss_pred cccccCCCCchh-hhccccccccccCCCChhHHHHcCCch----h---hhhhhhcCCceeEEeeeccCCCCCCccccccc
Q 037285 671 VNMENHEPKRWS-YFRNLAQVDFGQKDVSLIDQEHLGLSS----G---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLN 742 (1094)
Q Consensus 671 ~~~~~~~~~~~~-~~~~Le~~~Wy~~~IsR~~AE~ll~a~----g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~ 742 (1094)
+++++..|+|+. ...+++.++|||++|+|.+||.+|+.. | ||+|....| .|.+|+.+...+..+.++ ||.
T Consensus 45 ~g~~G~~P~~yv~~~~~le~~~w~~g~~~r~~ae~~L~~~~~~~G~FLvR~s~~~~g-~y~lsv~~~~~~~~~~v~-h~~ 122 (452)
T 1fmk_A 45 TGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKG-AYCLSVSDFDNAKGLNVK-HYK 122 (452)
T ss_dssp TCCEEEEEGGGEEETTSGGGSTTEEETCCHHHHHHHHTCTTSCTTEEEEEECSSSTT-CEEEEEEEEETTTEEEEE-EEE
T ss_pred CCcccccCcccccccccccccccccCCccHHHHHHHhccCCCCCceEEEEeCCCCCC-ceEEEEEeeccCCCCcEE-EEE
Confidence 568899999999 578899999999999999999999865 5 999988788 899999875444446778 999
Q ss_pred ccccCCCccccCCCcccccchHHHHHhhhcccccccccCCCCCc--CC--CCCCCCCCcccCCCcceeeccCCeeEEEEe
Q 037285 743 FGQDSQKTFGVDPSVSESMQFDAMMENLRTTESDYEEGNAGNRN--IG--LPSLNPSLVDFDVSSVQVIKNEDLEEQKEL 818 (1094)
Q Consensus 743 I~~dsq~r~~vtp~isE~~qFdsL~ElLrt~eSdyee~nagn~~--l~--~P~lnpsl~~~dlssv~eIs~edYei~kkL 818 (1094)
|.....+.|+ +.+...|.++.+++.. +.....+.. +. .+...+..... ....|++..++|++.++|
T Consensus 123 I~~~~~g~~~----~~~~~~F~Sl~~Li~~-----y~~~~~~l~~~l~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~l 192 (452)
T 1fmk_A 123 IRKLDSGGFY----ITSRTQFNSLQQLVAY-----YSKHADGLCHRLTTVCPTSKPQTQGL-AKDAWEIPRESLRLEVKL 192 (452)
T ss_dssp EEECTTSCEE----SSTTSEESSHHHHHHH-----HTTCCTTSSSCCCEECCCCCCCCSSS-STTCSBCCGGGEEEEEEE
T ss_pred EEEcCCCCEE----EecCcccCCHHHHHHH-----hhhccccchhhccccccccccccCCC-CccccccChhHceeeeee
Confidence 9987777788 6677889999888843 222222211 11 11111111111 135688999999999999
Q ss_pred cccCceEEEEeeecC-ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEEEeeec
Q 037285 819 GSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYM 897 (1094)
Q Consensus 819 GsG~FGtVYKAk~rG-t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~IVmEYm 897 (1094)
|+|+||.||+|++++ ..||||+++..... ...|.+|+.+|++++||||+++++++.+. .+++||||+
T Consensus 193 G~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---~~~iv~e~~ 260 (452)
T 1fmk_A 193 GQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---------PEAFLQEAQVMKKLRHEKLVQLYAVVSEE---PIYIVTEYM 260 (452)
T ss_dssp EECSSCEEEEEEETTTEEEEEEECCTTSSC---------HHHHHHHHHHHHHCCCTTBCCEEEEECSS---SCEEEECCC
T ss_pred cCCCCeEEEEEEECCCceEEEEEeccCCCC---------HHHHHHHHHHHHhCCCCCEeeEEEEEcCC---ceEEEehhh
Confidence 999999999999975 56999998764321 24688999999999999999999999763 689999999
Q ss_pred ccchhHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccCc--c
Q 037285 898 VDGSLRHVLVRK-DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT--L 974 (1094)
Q Consensus 898 egGSL~d~L~k~-~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~--~ 974 (1094)
.+|+|.+++... ...+++..++.|+.||+.||+|||+++|+||||||+|||++ .++.+||+|||+++..... .
T Consensus 261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~----~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----GGGCEEECCCCTTC--------
T ss_pred cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEC----CCCCEEECCCccceecCCCcee
Confidence 999999999754 34589999999999999999999999999999999999998 6789999999999854322 2
Q ss_pred ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHH
Q 037285 975 VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTL 1053 (1094)
Q Consensus 975 ~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dL 1053 (1094)
......+|..|+|||++. ...++.++|||||||++|||+| |+.||......+....+ ..+.++..+..++..+.+|
T Consensus 337 ~~~~~~~~~~y~aPE~~~--~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-~~~~~~~~~~~~~~~l~~l 413 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYRMPCPPECPESLHDL 413 (452)
T ss_dssp ------CCGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-HTTCCCCCCTTSCHHHHHH
T ss_pred cccCCcccccccCHhHHh--cCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHH
Confidence 223345788999999998 4578999999999999999999 99999998888777665 4556777888999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1054 MEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1054 I~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
|.+||+.||++|||+.+|++.|..+...
T Consensus 414 i~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 414 MCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 9999999999999999999999988744
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=476.38 Aligned_cols=374 Identities=29% Similarity=0.500 Sum_probs=299.1
Q ss_pred ccccCCCCchhhh-------ccccccccccCCCChhHHHHcCCc--hh---hhhhhhcCCceeEEeeeccCCCCCCcccc
Q 037285 672 NMENHEPKRWSYF-------RNLAQVDFGQKDVSLIDQEHLGLS--SG---VREVREEDGRLYHFTPLTDDGAPKGRVDS 739 (1094)
Q Consensus 672 ~~~~~~~~~~~~~-------~~Le~~~Wy~~~IsR~~AE~ll~a--~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~s 739 (1094)
++++..|+|++.- ..|+.++||||.|+|.+||.+|.. +| ||++....| .|.+++... +.++
T Consensus 55 g~~G~~P~~yv~~~~~~~~~~~~~~~~wyhg~i~r~~ae~~L~~~~~G~FlvR~S~~~~g-~~~Lsv~~~-----~~v~- 127 (450)
T 1k9a_A 55 GREGIIPANYVQKREGVKAGTKLSLMPWFHGKITREQAERLLYPPETGLFLVRESTNYPG-DYTLCVSCE-----GKVE- 127 (450)
T ss_dssp CCEEEEEGGGEEECCCCCCCTTEESCTTBCTTCCHHHHHHHTCSCCTTEEEEEECSSSTT-SEEEEEECS-----SSEE-
T ss_pred CceeeechhccccccccccccccccccccccCcCHHHhhhhhccCCCceEEEEecCCCCC-ceEEEEEeC-----Ceee-
Confidence 5667778887732 457999999999999999999984 46 999988788 788888664 6777
Q ss_pred cccccccCCCccccCCCcccccchHHHHHhhhcccccccccCCCCCc-CCCCCCCCCCc--ccC-CCcceeeccCCeeEE
Q 037285 740 QLNFGQDSQKTFGVDPSVSESMQFDAMMENLRTTESDYEEGNAGNRN-IGLPSLNPSLV--DFD-VSSVQVIKNEDLEEQ 815 (1094)
Q Consensus 740 hy~I~~dsq~r~~vtp~isE~~qFdsL~ElLrt~eSdyee~nagn~~-l~~P~lnpsl~--~~d-lssv~eIs~edYei~ 815 (1094)
||.|.. ..+.++ +.+...|.++.+++.. |.....+... +..+....... ... ....|++..++|++.
T Consensus 128 H~~I~~-~~~~~~----i~~~~~F~sl~eLv~~----y~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 198 (450)
T 1k9a_A 128 HYRIMY-HASKLS----IDEEVYFENLMQLVEH----YTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLL 198 (450)
T ss_dssp EEEEEE-ETTEEE----SSSSSCBSSHHHHHHH----HHHCCTTSSSCCCEECCCTTCEEHHHHHHHTTCBCCGGGEEEE
T ss_pred EEEEEe-cCCceE----eccccccccHHHHHhh----hcccccchhhhccccccccCcccchhhhcccccccChHHeEEE
Confidence 999954 445577 6677788888887742 2211111111 11111111110 000 124578889999999
Q ss_pred EEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEEEee
Q 037285 816 KELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAE 895 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~IVmE 895 (1094)
+.||+|+||.||+|+++++.||||+++... ....|.+|+.+|++++||||+++++++.+. ...+++|||
T Consensus 199 ~~lG~G~fg~V~~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~iv~e 267 (450)
T 1k9a_A 199 QTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----------TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTE 267 (450)
T ss_dssp EEEEECSSEEEEEEEETTEEEEEEEESSCT----------TSHHHHHHHHHHHTCCCTTBCCEEEEEECT-TSCEEEEEE
T ss_pred eeecCcCCeeEEEEEecCCeEEEEEeCCch----------HHHHHHHHHHHHHhccCCCEEEEEEEEEcC-CCceEEEEE
Confidence 999999999999999999999999997542 125688999999999999999999998764 236899999
Q ss_pred ecccchhHHHHhhccc-ccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccCcc
Q 037285 896 YMVDGSLRHVLVRKDR-FLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTL 974 (1094)
Q Consensus 896 YmegGSL~d~L~k~~~-~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~~ 974 (1094)
|+.+|+|.+++..... .+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+|||+++......
T Consensus 268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~----~~~~~kl~DfG~a~~~~~~~ 343 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS----EDNVAKVSDFGLTKEASSTQ 343 (450)
T ss_dssp CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC----TTSCEEECCCTTCEECC---
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEC----CCCCEEEeeCCCcccccccc
Confidence 9999999999987653 379999999999999999999999999999999999998 77899999999998543322
Q ss_pred ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHH
Q 037285 975 VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTL 1053 (1094)
Q Consensus 975 ~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dL 1053 (1094)
. ...++..|+|||++. ...++.++|||||||+||||+| |+.||......++...+ ..+.++..+..+++.+.+|
T Consensus 344 ~--~~~~~~~y~aPE~~~--~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-~~~~~~~~p~~~~~~l~~l 418 (450)
T 1k9a_A 344 D--TGKLPVKWTAPEALR--EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMDAPDGCPPAVYDV 418 (450)
T ss_dssp -----CCCTTTSCHHHHH--SSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH-HTTCCCCCCTTCCHHHHHH
T ss_pred c--CCCCCcceeCHHHhc--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCcCCHHHHHH
Confidence 2 235788999999998 5678999999999999999998 99999998877777655 4566778889999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1054 MEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1054 I~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
|.+||+.||.+|||+.+|++.|+.+...
T Consensus 419 i~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 419 MKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 9999999999999999999999998754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=459.02 Aligned_cols=261 Identities=36% Similarity=0.585 Sum_probs=226.2
Q ss_pred ceeeccCCeeEEEEecccCceEEEEeeec-------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCcee
Q 037285 804 VQVIKNEDLEEQKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVV 876 (1094)
Q Consensus 804 v~eIs~edYei~kkLGsG~FGtVYKAk~r-------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIV 876 (1094)
++.|..++|.+.++||+|+||+||+|++. +..||||+++... .....+|.+|+.+|++|+|||||
T Consensus 7 ~~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--------~~~~~~f~~E~~il~~l~HpnIV 78 (299)
T 4asz_A 7 VQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--------DNARKDFHREAELLTNLQHEHIV 78 (299)
T ss_dssp CCBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC--------HHHHHHHHHHHHHHTTCCCTTBC
T ss_pred hcccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC--------hHHHHHHHHHHHHHHhCCCCCCc
Confidence 45688899999999999999999999874 4569999987531 22346799999999999999999
Q ss_pred EEEeEeecCCCCceEEEeeecccchhHHHHhhcc------------cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 037285 877 AFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD------------RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKC 944 (1094)
Q Consensus 877 qL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~------------~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKP 944 (1094)
+++++|.+.. .++||||||++|+|.++|...+ ..+++..++.|+.||+.||+|||+++||||||||
T Consensus 79 ~l~g~~~~~~--~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp 156 (299)
T 4asz_A 79 KFYGVCVEGD--PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLAT 156 (299)
T ss_dssp CEEEEECSSS--SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred cEEEEEeeCC--EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCH
Confidence 9999998865 8999999999999999997542 3589999999999999999999999999999999
Q ss_pred CceEeccCCCCCCcEEEEecCCcccccC---ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCC
Q 037285 945 DNLLVNLKDPSRPICKVGDFGLSKIKRN---TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEP 1020 (1094)
Q Consensus 945 eNILLD~~~~e~g~VKLsDFGLSrl~~~---~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~P 1020 (1094)
+|||++ .++.+||+|||+|+.... ........||+.|||||++. ...|+.++|||||||+||||+| |+.|
T Consensus 157 ~NILl~----~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~--~~~~~~k~DVwS~Gvvl~Ellt~G~~P 230 (299)
T 4asz_A 157 RNCLVG----ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM--YRKFTTESDVWSLGVVLWEIFTYGKQP 230 (299)
T ss_dssp GGEEEC----GGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred hhEEEC----CCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHc--CCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 999999 788999999999985322 22233456899999999998 4678999999999999999999 9999
Q ss_pred CCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1021 YANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1021 F~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
|......+++..+.. +.++..|..+++++++||.+||+.||++||||.+|.+.|+.+..+
T Consensus 231 f~~~~~~~~~~~i~~-~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 231 WYQLSNNEVIECITQ-GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp TTTSCHHHHHHHHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHc-CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 999998888877654 456678899999999999999999999999999999999998754
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=483.72 Aligned_cols=375 Identities=29% Similarity=0.490 Sum_probs=305.6
Q ss_pred cccccCCCCchh-hhccccccccccCCCChhHHHHcCCc--hh---hhhhhhcCCceeEEeeeccCCCCCCccccccccc
Q 037285 671 VNMENHEPKRWS-YFRNLAQVDFGQKDVSLIDQEHLGLS--SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFG 744 (1094)
Q Consensus 671 ~~~~~~~~~~~~-~~~~Le~~~Wy~~~IsR~~AE~ll~a--~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~ 744 (1094)
.+.++.+|+||. .+.+|+.++||||.|+|.+||.+|.. +| ||++....| .|.+|+... +.++ ||.|.
T Consensus 85 ~~~~G~~P~~yv~~~~~le~~~wyhg~i~r~~ae~ll~~~~~G~fLvR~s~~~~~-~~~lsv~~~-----~~v~-h~~I~ 157 (495)
T 1opk_A 85 KNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPG-QRSISLRYE-----GRVY-HYRIN 157 (495)
T ss_dssp SSCEEEEEGGGEEESSSGGGSTTEEEECCHHHHHHHGGGCCTTEEEEEECSSSTT-CEEEEEEET-----TEEE-EEECE
T ss_pred cCCcceeccccccccccccchhhhccCCCHHHHHHHhhCCCCceEEEEeCCCCCC-ceEEEEeeC-----CeEE-EEEEE
Confidence 355688999999 57899999999999999999999976 56 999998788 899998875 6788 99998
Q ss_pred ccCCCccccCCCcccccchHHHHHhhhcccccccccCCCCCc--CCCCCCC---CCCcccC-CCcceeeccCCeeEEEEe
Q 037285 745 QDSQKTFGVDPSVSESMQFDAMMENLRTTESDYEEGNAGNRN--IGLPSLN---PSLVDFD-VSSVQVIKNEDLEEQKEL 818 (1094)
Q Consensus 745 ~dsq~r~~vtp~isE~~qFdsL~ElLrt~eSdyee~nagn~~--l~~P~ln---psl~~~d-lssv~eIs~edYei~kkL 818 (1094)
....+.++ +.....|.++.+++... .....+.. +..+... +...... ....|++..++|++.++|
T Consensus 158 ~~~~g~~~----~~~~~~F~sl~eLv~~~-----~~~~~g~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 228 (495)
T 1opk_A 158 TASDGKLY----VSSESRFNTLAELVHHH-----STVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKL 228 (495)
T ss_dssp ECTTSCEE----SSTTSCBSSHHHHHHHH-----TTCCTTSSSCCCEECCCCSCCCCSSSCSSSSCCBCCGGGEEEEEES
T ss_pred ecCCCceE----eccCccchhHHHHhhhh-----cccccccchhccccccccccccccccCccccccccCHHHceeeeEe
Confidence 87777777 56666788888887432 22211111 1111111 0111111 124578889999999999
Q ss_pred cccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEEEeee
Q 037285 819 GSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEY 896 (1094)
Q Consensus 819 GsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~IVmEY 896 (1094)
|+|+||.||+|+++ +..||||+++.... ...+|.+|+.+|++++||||++++++|.... .+++||||
T Consensus 229 G~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~~lv~E~ 297 (495)
T 1opk_A 229 GGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---------EVEEFLKEAAVMKEIKHPNLVQLLGVCTREP--PFYIITEF 297 (495)
T ss_dssp GGGTTSSEEEEEEGGGTEEEEEEECCSSSS---------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCEEEEEC
T ss_pred cCCCCeEEEEEEEcCCCeEEEEEEecCccc---------chHHHHHHHHHHHhcCCCCEeeEEEEEecCC--cEEEEEEc
Confidence 99999999999986 67899999875421 1357889999999999999999999998755 89999999
Q ss_pred cccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccCc--
Q 037285 897 MVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT-- 973 (1094)
Q Consensus 897 megGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~-- 973 (1094)
+.+|+|.+++.... ..+++..++.|+.||+.||+|||+++|+||||||+|||++ .++.+||+|||+++.....
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~----~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG----ENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----GGGCEEECCTTCEECCTTCCE
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEC----CCCcEEEeecccceeccCCce
Confidence 99999999997643 4589999999999999999999999999999999999998 6789999999999864322
Q ss_pred cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHH
Q 037285 974 LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRT 1052 (1094)
Q Consensus 974 ~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~d 1052 (1094)
.......++..|+|||++. ...++.++|||||||+||||+| |+.||......++...+ ....+...+..++..+.+
T Consensus 374 ~~~~~~~~~~~y~aPE~~~--~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~ 450 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRMERPEGCPEKVYE 450 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHH--HCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-HTTCCCCCCTTCCHHHHH
T ss_pred eecCCCcCCcceeCHhHHh--cCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHH
Confidence 2233445678999999998 4568899999999999999999 99999998877766554 566777788899999999
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1053 LMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1053 LI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
||.+||+.||.+|||+.+|++.|+.+.
T Consensus 451 li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 451 LMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 999999999999999999999998874
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-52 Score=459.78 Aligned_cols=261 Identities=35% Similarity=0.582 Sum_probs=222.3
Q ss_pred cceeeccCCeeEEEEecccCceEEEEeeec-------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCce
Q 037285 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNV 875 (1094)
Q Consensus 803 sv~eIs~edYei~kkLGsG~FGtVYKAk~r-------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNI 875 (1094)
..+.|..++|.+.++||+|+||+||+|+++ +..||||+++... +....+|.+|+.+|++|+||||
T Consensus 34 ~~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--------~~~~~~f~~E~~il~~l~HpnI 105 (329)
T 4aoj_A 34 CVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--------ESARQDFQREAELLTMLQHQHI 105 (329)
T ss_dssp CSCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS--------HHHHHHHHHHHHHHTTCCCTTB
T ss_pred hhcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC--------HHHHHHHHHHHHHHHhCCCCCC
Confidence 345677889999999999999999999874 4679999986431 2234679999999999999999
Q ss_pred eEEEeEeecCCCCceEEEeeecccchhHHHHhhcc--------------cccCHHHHHHHHHHHHHHHHHHHHCCceecc
Q 037285 876 VAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD--------------RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFD 941 (1094)
Q Consensus 876 VqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~--------------~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRD 941 (1094)
|+++++|.+.. .++||||||++|+|.+++.... ..+++..++.|+.||+.||+|||+++|||||
T Consensus 106 V~l~g~~~~~~--~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRD 183 (329)
T 4aoj_A 106 VRFFGVCTEGR--PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRD 183 (329)
T ss_dssp CCEEEEECSSS--SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred CcEEEEEEECC--EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeeccc
Confidence 99999998865 8999999999999999997532 3589999999999999999999999999999
Q ss_pred CCCCceEeccCCCCCCcEEEEecCCcccccC---ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-C
Q 037285 942 LKCDNLLVNLKDPSRPICKVGDFGLSKIKRN---TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-G 1017 (1094)
Q Consensus 942 LKPeNILLD~~~~e~g~VKLsDFGLSrl~~~---~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-G 1017 (1094)
|||+|||++ .++.+||+|||+|+.... ........||+.|||||++. ...|+.++|||||||+||||+| |
T Consensus 184 LKp~NILl~----~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~--~~~~~~~sDvwS~Gvvl~Ellt~G 257 (329)
T 4aoj_A 184 LATRNCLVG----QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL--YRKFTTESDVWSFGVVLWEIFTYG 257 (329)
T ss_dssp CCGGGEEEE----TTTEEEECCCC----------------CCCCGGGCCHHHHT--TCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred ccHhhEEEC----CCCcEEEcccccceeccCCCcceecCcccccccccChhhhc--CCCCCccccccchHHHHHHHHcCC
Confidence 999999999 789999999999985422 22334567999999999998 5678999999999999999999 9
Q ss_pred CCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 037285 1018 EEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLST 1080 (1094)
Q Consensus 1018 k~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~t 1080 (1094)
+.||......+++..+. .+.++..|..+++++.+||.+||+.||++||||.+|+++|+.+..
T Consensus 258 ~~Pf~~~~~~~~~~~i~-~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 258 KQPWYQLSNTEAIDCIT-QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp CCTTCSSCHHHHHHHHH-HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHH-cCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 99999999888877764 456778899999999999999999999999999999999999864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=463.26 Aligned_cols=360 Identities=29% Similarity=0.432 Sum_probs=279.4
Q ss_pred hccccccccccCCCChhHHHHcCCchh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCcccc
Q 037285 684 FRNLAQVDFGQKDVSLIDQEHLGLSSG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSES 760 (1094)
Q Consensus 684 ~~~Le~~~Wy~~~IsR~~AE~ll~a~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~isE~ 760 (1094)
..+|+.++||||.|+|.+||.+|..+| ||+|.. .+ .|.+|+... +.++ ||.|..... ++ ..+.
T Consensus 7 ~~~l~~~~wyhg~i~r~~a~~lL~~~G~flvR~s~~-~~-~~~lsv~~~-----~~~~-h~~i~~~~~--~~----~~~~ 72 (377)
T 3cbl_A 7 QKPLHEQLWYHGAIPRAEVAELLVHSGDFLVRESQG-KQ-EYVLSVLWD-----GLPR-HFIIQSLDN--LY----RLEG 72 (377)
T ss_dssp GSCGGGCTTBCTTCCHHHHHHHCCSTTEEEEEECC---C-CEEEEC----------CC-EEEC----C--CC----CC--
T ss_pred ccccccCCccCCCCCHHHHHHHHhcCCCEEEEEeCC-CC-cEEEEEEEC-----CCcc-chhhccccc--eE----Eecc
Confidence 457999999999999999999999999 999977 44 799998875 6777 999976432 44 3455
Q ss_pred cchHHHHHhhhcccccccccCCCCCcCCCCCCCCCCcccCCCcceeeccCCeeEEEEecccCceEEEEeeec--CceEEE
Q 037285 761 MQFDAMMENLRTTESDYEEGNAGNRNIGLPSLNPSLVDFDVSSVQVIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAI 838 (1094)
Q Consensus 761 ~qFdsL~ElLrt~eSdyee~nagn~~l~~P~lnpsl~~~dlssv~eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAV 838 (1094)
..|.++.+++..... ........... ..........|.+..++|++.+.||+|+||.||+|+++ ++.|||
T Consensus 73 ~~F~sl~~LI~~y~~----~~~~l~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vav 144 (377)
T 3cbl_A 73 EGFPSIPLLIDHLLS----TQQPLTKKSGV----VLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAV 144 (377)
T ss_dssp --CCSHHHHHHHHHH----HTCCC-----C----CCCEECCCCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEE
T ss_pred eeccchHHHHHHHhh----ccCCcccccCc----ccccCccccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEE
Confidence 678888888743211 11111000000 01111112457888999999999999999999999985 788999
Q ss_pred EEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHH
Q 037285 839 KRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRR 918 (1094)
Q Consensus 839 KiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~ 918 (1094)
|+++... .......|.+|+.+|++++||||+++++++.... .+++||||+++|+|.+++......+++..+
T Consensus 145 K~~~~~~-------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 215 (377)
T 3cbl_A 145 KSCRETL-------PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ--PIYIVMELVQGGDFLTFLRTEGARLRVKTL 215 (377)
T ss_dssp EECCTTS-------CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS--SCEEEEECCTTCBHHHHHHHHGGGCCHHHH
T ss_pred EEccccC-------CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC--CcEEEEEcCCCCCHHHHHHhcCCCCCHHHH
Confidence 9987531 1223456889999999999999999999998754 899999999999999999877667999999
Q ss_pred HHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccCcccc---CCccCCCcccCccccccCC
Q 037285 919 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVS---GGVRGTLPWMAPELLSGSS 995 (1094)
Q Consensus 919 l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~~~s---s~~~GT~~YmAPEvL~g~~ 995 (1094)
+.++.||+.||+|||+++|+||||||+|||++ .++.+||+|||+++........ ....++..|+|||++. .
T Consensus 216 ~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~----~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~ 289 (377)
T 3cbl_A 216 LQMVGDAAAGMEYLESKCCIHRDLAARNCLVT----EKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALN--Y 289 (377)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHH--H
T ss_pred HHHHHHHHHHHHHHHHCCcCCcccCHHHEEEc----CCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhc--c
Confidence 99999999999999999999999999999998 7789999999999854332211 1223567899999998 4
Q ss_pred CCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 996 SKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 996 ~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
..++.++|||||||++|||+| |..||......+....+ ....+...+..++..+.+||.+||+.||.+|||+.+|++.
T Consensus 290 ~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 368 (377)
T 3cbl_A 290 GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV-EKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQE 368 (377)
T ss_dssp CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 568899999999999999998 99999998887766554 5556677888999999999999999999999999999999
Q ss_pred HHHHHHH
Q 037285 1075 LRVLSTA 1081 (1094)
Q Consensus 1075 L~~L~ta 1081 (1094)
|+.+...
T Consensus 369 L~~i~~~ 375 (377)
T 3cbl_A 369 LQSIRKR 375 (377)
T ss_dssp HHHHHHH
T ss_pred HHHHHhh
Confidence 9998753
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-52 Score=456.92 Aligned_cols=260 Identities=35% Similarity=0.552 Sum_probs=225.2
Q ss_pred cceeeccCCeeEEEEecccCceEEEEeeec-------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCce
Q 037285 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNV 875 (1094)
Q Consensus 803 sv~eIs~edYei~kkLGsG~FGtVYKAk~r-------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNI 875 (1094)
..++|..+++++.++||+|+||+||+|++. ++.||||+++.... .....+|.+|+.+|++|+||||
T Consensus 19 ~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~-------~~~~~~f~~E~~il~~l~HpNI 91 (308)
T 4gt4_A 19 KLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE-------GPLREEFRHEAMLRARLQHPNV 91 (308)
T ss_dssp CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC-------C-CHHHHHHHHHHHHHCCCTTB
T ss_pred CcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC-------hHHHHHHHHHHHHHHhCCCCCC
Confidence 345678889999999999999999999974 45799999875421 1223679999999999999999
Q ss_pred eEEEeEeecCCCCceEEEeeecccchhHHHHhhc---------------ccccCHHHHHHHHHHHHHHHHHHHHCCceec
Q 037285 876 VAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRK---------------DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHF 940 (1094)
Q Consensus 876 VqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~---------------~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHR 940 (1094)
|+++|+|.+.. .++||||||++|+|.++|... ...+++..++.|+.||+.||+|||+++||||
T Consensus 92 V~l~g~~~~~~--~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHR 169 (308)
T 4gt4_A 92 VCLLGVVTKDQ--PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHK 169 (308)
T ss_dssp CCEEEEECSSS--SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred CCcceEEEECC--EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCC
Confidence 99999998755 899999999999999999653 2358999999999999999999999999999
Q ss_pred cCCCCceEeccCCCCCCcEEEEecCCcccccC---ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-
Q 037285 941 DLKCDNLLVNLKDPSRPICKVGDFGLSKIKRN---TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT- 1016 (1094)
Q Consensus 941 DLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~---~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT- 1016 (1094)
||||+||||+ +++.+||+|||+|+.... ........||+.|||||++. ...|+.++|||||||+||||+|
T Consensus 170 DLK~~NILl~----~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~--~~~~s~ksDVwSfGvvl~El~t~ 243 (308)
T 4gt4_A 170 DLATRNVLVY----DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIM--YGKFSIDSDIWSYGVVLWEVFSY 243 (308)
T ss_dssp CCSGGGEEEC----GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CccccceEEC----CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHh--CCCCCccchhhhHHHHHHHHHhC
Confidence 9999999999 788999999999985422 22344567999999999998 4679999999999999999999
Q ss_pred CCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1017 GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1017 Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
|+.||.+....+++..+. .+.++..|..|+.++.+||.+||+.||.+||||.+|+++|+.+
T Consensus 244 g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 244 GLQPYCGYSNQDVVEMIR-NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp TCCTTTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCCCCCCCHHHHHHHHH-cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 899999999888887764 4556778899999999999999999999999999999999764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=486.36 Aligned_cols=379 Identities=29% Similarity=0.493 Sum_probs=309.3
Q ss_pred cccccCCCCchh-hhccccccccccCCCChhHHHHcCCch----h---hhhhhhcCCceeEEeeeccCCCCCCccccccc
Q 037285 671 VNMENHEPKRWS-YFRNLAQVDFGQKDVSLIDQEHLGLSS----G---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLN 742 (1094)
Q Consensus 671 ~~~~~~~~~~~~-~~~~Le~~~Wy~~~IsR~~AE~ll~a~----g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~ 742 (1094)
+++++..|+|++ ..+.++.++||||+|+|.+||.+|+.. | ||++....| .|.+++.+......+.++ ||.
T Consensus 128 ~g~~G~~P~~yv~~~~~l~~~~wy~g~i~r~~ae~~L~~~~~~~G~FLvR~S~~~~g-~y~lsv~~~~~~~~~~v~-h~~ 205 (535)
T 2h8h_A 128 TGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKG-AYCLSVSDFDNAKGLNVK-HYK 205 (535)
T ss_dssp TCCEEEEEGGGEEETTSGGGSTTBCCSCCHHHHHHHHTCTTCCTTEEEEEECSSSTT-CEEEEEEEEETTTEEEEE-EEE
T ss_pred CCcceEecchhhcccccccccceeccccCHHHHHHHhccCCCCCCeEEEEecCCCCC-cEEEEEEeeccCCCCceE-EEE
Confidence 567889999999 578899999999999999999999865 5 999988778 899999875444446778 999
Q ss_pred ccccCCCccccCCCcccccchHHHHHhhhcccccccccCCCCCc--CC--CCCCCCCCcccCCCcceeeccCCeeEEEEe
Q 037285 743 FGQDSQKTFGVDPSVSESMQFDAMMENLRTTESDYEEGNAGNRN--IG--LPSLNPSLVDFDVSSVQVIKNEDLEEQKEL 818 (1094)
Q Consensus 743 I~~dsq~r~~vtp~isE~~qFdsL~ElLrt~eSdyee~nagn~~--l~--~P~lnpsl~~~dlssv~eIs~edYei~kkL 818 (1094)
|.....+.|+ +.+...|.++.+++. ++..+..... +. .+...+....+ ....|++..++|++.++|
T Consensus 206 I~~~~~g~~~----i~~~~~F~SL~eLv~-----~y~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~l 275 (535)
T 2h8h_A 206 IRKLDSGGFY----ITSRTQFNSLQQLVA-----YYSKHADGLCHRLTTVCPTSKPQTQGL-AKDAWEIPRESLRLEVKL 275 (535)
T ss_dssp EBC-CCSCEE----EETTEEESSHHHHHH-----HHHHCCTTSSSCCCEECCCCCCCCSSS-STTCSBCCGGGEEEEEEE
T ss_pred EEEcCCCcEE----eeccccccChHHhhe-----eeccccCcccccccccccccccccccc-Cccceecchhhhhhheec
Confidence 9987777788 667788999988884 2222222211 11 11111111111 135688999999999999
Q ss_pred cccCceEEEEeeecC-ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEEEeeec
Q 037285 819 GSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYM 897 (1094)
Q Consensus 819 GsG~FGtVYKAk~rG-t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~IVmEYm 897 (1094)
|+|+||.||+|++++ ..||||+++..... ..+|.+|+.+|++|+||||+++++++.+. .+++||||+
T Consensus 276 G~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~hpniv~~~~~~~~~---~~~lv~e~~ 343 (535)
T 2h8h_A 276 GQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---------PEAFLQEAQVMKKLRHEKLVQLYAVVSEE---PIYIVTEYM 343 (535)
T ss_dssp EECSSEEEEEEEETTTEEEEEEEECTTSSC---------HHHHHHHHHHHHHCCCTTBCCEEEEECSS---SCEEEECCC
T ss_pred ccCCCeEEEEEEECCCceEEEEEeCCCCCC---------HHHHHHHHHHHHhCCCCCEeeEEEEEeec---cceEeeehh
Confidence 999999999999975 56999999764321 24688999999999999999999999763 689999999
Q ss_pred ccchhHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccCc--c
Q 037285 898 VDGSLRHVLVRK-DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT--L 974 (1094)
Q Consensus 898 egGSL~d~L~k~-~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~--~ 974 (1094)
.+|+|.+++... ...+++..++.|+.||+.||+|||+++|+||||||+|||++ .++.+||+|||+++..... .
T Consensus 344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~----~~~~~kl~DFG~a~~~~~~~~~ 419 (535)
T 2h8h_A 344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEYT 419 (535)
T ss_dssp TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----GGGCEEECCTTSTTTCCCHHHH
T ss_pred cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEc----CCCcEEEcccccceecCCCcee
Confidence 999999999754 34589999999999999999999999999999999999998 6789999999999864332 1
Q ss_pred ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHH
Q 037285 975 VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTL 1053 (1094)
Q Consensus 975 ~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dL 1053 (1094)
......++..|+|||++. ...++.++|||||||+||||++ |+.||......++...+ ..+.+...+..++..+.+|
T Consensus 420 ~~~~~~~~~~y~aPE~~~--~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i-~~~~~~~~~~~~~~~l~~l 496 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYRMPCPPECPESLHDL 496 (535)
T ss_dssp TTCSTTSCGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHH-HTTCCCCCCTTCCHHHHHH
T ss_pred cccCCcCcccccCHHHhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHH
Confidence 223445788999999998 4578999999999999999999 99999998888877665 4566777788999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHH
Q 037285 1054 MEECWAPNPAARPSFTEIASRLRVLST 1080 (1094)
Q Consensus 1054 I~kCLq~DPeeRPS~eELLq~L~~L~t 1080 (1094)
|.+||+.||++|||+.+|++.|+.+..
T Consensus 497 i~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 497 MCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred HHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 999999999999999999999998764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=458.97 Aligned_cols=267 Identities=31% Similarity=0.525 Sum_probs=230.5
Q ss_pred cceeeccCCeeEEEEecccCceEEEEeeecC-------ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCC-Cc
Q 037285 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHH-PN 874 (1094)
Q Consensus 803 sv~eIs~edYei~kkLGsG~FGtVYKAk~rG-------t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~H-PN 874 (1094)
..|+|..++|++.++||+|+||+||+|++.+ +.||||+++.... ......|.+|+.+|.++.| ||
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~-------~~~~~~~~~E~~il~~l~hhpn 129 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-------HSEHRALMSELKILIHIGHHLN 129 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC-------HHHHHHHHHHHHHHHHHCCCTT
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-------hHHHHHHHHHHHHHHHcCCCCc
Confidence 3589999999999999999999999998854 3599999875421 1224678999999999965 99
Q ss_pred eeEEEeEeecCCCCceEEEeeecccchhHHHHhhcc---------------cccCHHHHHHHHHHHHHHHHHHHHCCcee
Q 037285 875 VVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD---------------RFLDRRRRLIIAMDAAFGMEYLHSKNIVH 939 (1094)
Q Consensus 875 IVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~---------------~~Lse~~~l~Ia~QIaeGLaYLHs~GIIH 939 (1094)
||+++++|.+. ...++||||||++|+|.++|.... ..+++..++.|+.||+.||+|||+++|||
T Consensus 130 IV~l~g~~~~~-~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiH 208 (353)
T 4ase_A 130 VVNLLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIH 208 (353)
T ss_dssp BCCEEEEECCT-TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred EEEEEEEEEec-CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeec
Confidence 99999999754 247899999999999999997532 34899999999999999999999999999
Q ss_pred ccCCCCceEeccCCCCCCcEEEEecCCcccccC---ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc
Q 037285 940 FDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRN---TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT 1016 (1094)
Q Consensus 940 RDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~---~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT 1016 (1094)
|||||+|||++ +++.+||+|||+|+.... .......+||+.|||||++. ...|+.++|||||||+||||+|
T Consensus 209 RDLK~~NILl~----~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~--~~~y~~ksDVwS~Gv~l~El~t 282 (353)
T 4ase_A 209 RDLAARNILLS----EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFS 282 (353)
T ss_dssp SCCSGGGEEEC----GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHTT
T ss_pred CccCccceeeC----CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHh--cCCCCCcccEeehHHHHHHHHh
Confidence 99999999999 788999999999985422 22344567999999999998 4678999999999999999998
Q ss_pred -CCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 037285 1017 -GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAAS 1083 (1094)
Q Consensus 1017 -Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s 1083 (1094)
|+.||.+....+.+...+..+.++..|..+++++++||.+||+.||++||||.+|+++|..+..+..
T Consensus 283 ~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~ 350 (353)
T 4ase_A 283 LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 350 (353)
T ss_dssp TSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence 9999998876666666667788889999999999999999999999999999999999999875543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=453.20 Aligned_cols=254 Identities=22% Similarity=0.416 Sum_probs=216.7
Q ss_pred ccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~ 885 (1094)
+.++|+++++||+|+||+||+|+++ |+.||||++.+.... ......|.+|+.+|++|+|||||++++++.+.
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~------~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~ 95 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS------SKEREESRREVAVLANMKHPNIVQYRESFEEN 95 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC------HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence 4478999999999999999999875 788999999865332 22346789999999999999999999999886
Q ss_pred CCCceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
. .+|||||||++|+|.++|...+ ..+++..++.|+.||+.||+|||++|||||||||+||||+ .++.+||+||
T Consensus 96 ~--~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~----~~g~vKl~DF 169 (350)
T 4b9d_A 96 G--SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT----KDGTVQLGDF 169 (350)
T ss_dssp T--EEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEEC----TTCCEEECST
T ss_pred C--EEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC----CCCCEEEccc
Confidence 5 8999999999999999997554 4578999999999999999999999999999999999998 7889999999
Q ss_pred CCcccccCc-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCC
Q 037285 965 GLSKIKRNT-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIP 1043 (1094)
Q Consensus 965 GLSrl~~~~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iP 1043 (1094)
|+|+..... ......+||+.|||||++. ...|+.++|||||||+||||+||+.||...+..+++..+....+ +..+
T Consensus 170 Gla~~~~~~~~~~~~~~GT~~YmAPE~l~--~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-~~~~ 246 (350)
T 4b9d_A 170 GIARVLNSTVELARACIGTPYYLSPEICE--NKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF-PPVS 246 (350)
T ss_dssp TEESCCCHHHHHHHHHHSCCTTCCHHHHT--TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-CCCC
T ss_pred ccceeecCCcccccccCCCccccCHHHHC--CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCC
Confidence 999865432 2234467999999999998 45789999999999999999999999999998888888877654 4567
Q ss_pred CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1044 SYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1044 e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
..++.++++||.+||+.||++|||+.+++++-+
T Consensus 247 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~ 279 (350)
T 4b9d_A 247 LHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGF 279 (350)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhcCHH
Confidence 789999999999999999999999999998644
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-50 Score=433.23 Aligned_cols=252 Identities=28% Similarity=0.426 Sum_probs=204.6
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||+|+||+||+|+++ |+.||||++.+..... ......+.+|+.+|++++|||||++++++.+..
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~- 86 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAK-----SDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD- 86 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-----------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCC-----HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC-
Confidence 58999999999999999999874 7889999998654322 223457889999999999999999999998865
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+|+||||+ +|+|.+++.+.+ .+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|
T Consensus 87 -~~~ivmEy~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~----~~~~vkl~DFGla 159 (275)
T 3hyh_A 87 -EIIMVIEYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLD----EHLNVKIADFGLS 159 (275)
T ss_dssp -EEEEEEECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC----TTCCEEECCSSCC
T ss_pred -EEEEEEeCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEEC----CCCCEEEeecCCC
Confidence 899999999 689999997655 599999999999999999999999999999999999998 7889999999999
Q ss_pred ccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCc
Q 037285 968 KIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCD 1047 (1094)
Q Consensus 968 rl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S 1047 (1094)
+...........+||+.|||||++.+ ...++.++|||||||++|+|+||+.||...+..++...+.... ..+|..++
T Consensus 160 ~~~~~~~~~~~~~GT~~Y~APE~~~~-~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~--~~~p~~~s 236 (275)
T 3hyh_A 160 NIMTDGNFLKTSCGSPNYAAPEVISG-KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV--YTLPKFLS 236 (275)
T ss_dssp ---------------CTTSCHHHHSS-SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--CCCCTTSC
T ss_pred eecCCCCccCCeeECcccCChhhhcC-CCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC--CCCCCCCC
Confidence 87655555556789999999999984 2234689999999999999999999999988888777776654 35678899
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1048 AEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1048 ~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
+++++||.+||+.||++|||+.+++++-|-
T Consensus 237 ~~~~~li~~~L~~dP~~R~s~~eil~hpw~ 266 (275)
T 3hyh_A 237 PGAAGLIKRMLIVNPLNRISIHEIMQDDWF 266 (275)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHCHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHcCccc
Confidence 999999999999999999999999998664
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-50 Score=442.63 Aligned_cols=254 Identities=25% Similarity=0.391 Sum_probs=221.6
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
...++|++++.||+|+||+||+|+.+ ++.||||++.+.... .+.....+.+|+++|++|+|||||++++++.+
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~-----~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 103 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-----KENKVPYVTRERDVMSRLDHPFFVKLYFTFQD 103 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCC-----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence 34578999999999999999999875 788999999764321 12234678899999999999999999999998
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
.. .+|||||||.+|+|.+++.+.+ .+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus 104 ~~--~~yivmEy~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~----~~g~vKl~DF 176 (311)
T 4aw0_A 104 DE--KLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN----EDMHIQITDF 176 (311)
T ss_dssp SS--EEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTSCEEECCC
T ss_pred CC--EEEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEc----CCCCEEEEEc
Confidence 65 8999999999999999997665 599999999999999999999999999999999999998 7889999999
Q ss_pred CCccccc---CccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCC
Q 037285 965 GLSKIKR---NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT 1041 (1094)
Q Consensus 965 GLSrl~~---~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~ 1041 (1094)
|+|+... ........+||+.|||||++.+ ..|+.++|||||||++|+|+||+.||...+..++...+....+ .
T Consensus 177 Gla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~--~ 252 (311)
T 4aw0_A 177 GTAKVLSPESKQARANSFVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY--D 252 (311)
T ss_dssp TTCEECCTTTTCCCBCCCCSCGGGCCHHHHHH--SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--C
T ss_pred CCceecCCCCCcccccCcccCcccCCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--C
Confidence 9998643 2233456789999999999984 5688999999999999999999999999988888888877654 5
Q ss_pred CCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1042 iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
+|..+++++++||.+||..||.+|||+.+++.+-+
T Consensus 253 ~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~ 287 (311)
T 4aw0_A 253 FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 287 (311)
T ss_dssp CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHH
T ss_pred CCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHH
Confidence 77889999999999999999999999998755433
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=466.33 Aligned_cols=368 Identities=28% Similarity=0.445 Sum_probs=288.3
Q ss_pred hhccccccccccCCCChhHHHHcCCc----hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCC
Q 037285 683 YFRNLAQVDFGQKDVSLIDQEHLGLS----SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDP 755 (1094)
Q Consensus 683 ~~~~Le~~~Wy~~~IsR~~AE~ll~a----~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp 755 (1094)
....|+.++||||+|+|.+||.+|.. +| ||+| ...| .|.+|+... +.++ ||.|..+..+.|+
T Consensus 154 ~~~~~~~~~wyhg~i~r~~ae~~L~~~~~~~G~FLvR~s-~~~~-~~~lsv~~~-----~~v~-h~~I~~~~~g~~~--- 222 (613)
T 2ozo_A 154 ATTAHERMPWYHSSLTREEAERKLYSGAQTDGKFLLRPR-KEQG-TYALSLIYG-----KTVY-HYLISQDKAGKYC--- 222 (613)
T ss_dssp TTSCTTTSTTBCTTCCHHHHHHHHSSSCCCTTCEEEEEC-SSTT-EEEEEEEET-----TEEE-EEEEEECTTCCEE---
T ss_pred cccccccCCccccCCCHHHHHHHHhhcCCCCceEEEEec-CCCC-CEEEEEEEC-----CeEE-EEEEEECCCCCEE---
Confidence 45678999999999999999999984 56 9999 5567 899999885 7888 9999987777788
Q ss_pred CcccccchHHHHHhhhcccccccccCCCCCc--CCCCCCCC---------------------------------------
Q 037285 756 SVSESMQFDAMMENLRTTESDYEEGNAGNRN--IGLPSLNP--------------------------------------- 794 (1094)
Q Consensus 756 ~isE~~qFdsL~ElLrt~eSdyee~nagn~~--l~~P~lnp--------------------------------------- 794 (1094)
+.+...|.++.+++.. +..+..+.. +..|+...
T Consensus 223 -~~~~~~F~sl~~Lv~~-----y~~~~~~l~~~L~~pC~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (613)
T 2ozo_A 223 -IPEGTKFDTLWQLVEY-----LKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEP 296 (613)
T ss_dssp -CTTSCEESSHHHHHHH-----HHHCCTTCSSCCCSBCCC----------------------------------------
T ss_pred -ECCCCCcCCHHHHHHH-----HhhCCCCceeccccccccccccccccccCcccCCCCccccccccccccccccCCCCCc
Confidence 5566789999988842 222221110 11111000
Q ss_pred --------------CCccc--------CC-CcceeeccCCeeEEE-EecccCceEEEEeeec----CceEEEEEeecCcc
Q 037285 795 --------------SLVDF--------DV-SSVQVIKNEDLEEQK-ELGSGTFGTVYHGKWR----GTDVAIKRIKKSCF 846 (1094)
Q Consensus 795 --------------sl~~~--------dl-ssv~eIs~edYei~k-kLGsG~FGtVYKAk~r----Gt~VAVKiIkk~~~ 846 (1094)
....+ .+ ...+.+..+++.+.+ +||+|+||.||+|.++ +..||||+++....
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~ 376 (613)
T 2ozo_A 297 ARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE 376 (613)
T ss_dssp -------------CCCCSCSSSSSCSCSSCCCCSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS
T ss_pred cccCCCCCCCCCCCccccccCCcCChhHhcccceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC
Confidence 00000 00 012345556677766 8999999999999874 35699999976421
Q ss_pred CCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHH
Q 037285 847 TGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAA 926 (1094)
Q Consensus 847 se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIa 926 (1094)
.....+|.+|+.+|++++|||||++++++... .+++||||+.+|+|.+++......+++..++.|+.||+
T Consensus 377 -------~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~ 446 (613)
T 2ozo_A 377 -------KADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 446 (613)
T ss_dssp -------STTHHHHHHHHHHHTTCCCTTBCCEEEEEESS---SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHH
T ss_pred -------hHHHHHHHHHHHHHHhCCCCCEeeEEEEeccC---CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHH
Confidence 11235788999999999999999999999763 59999999999999999987766799999999999999
Q ss_pred HHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccCc----cccCCccCCCcccCccccccCCCCCCchh
Q 037285 927 FGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT----LVSGGVRGTLPWMAPELLSGSSSKVSEKV 1002 (1094)
Q Consensus 927 eGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~----~~ss~~~GT~~YmAPEvL~g~~~kyS~KS 1002 (1094)
.||+|||+++|+||||||+|||++ .++.+||+|||+++..... .......+|+.|+|||++. ...++.++
T Consensus 447 ~~L~~LH~~~iiHrDlkp~NILl~----~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~--~~~~~~~s 520 (613)
T 2ozo_A 447 MGMKYLEEKNFVHRNLAARNVLLV----NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN--FRKFSSRS 520 (613)
T ss_dssp HHHHHHHHTTCCCSCCSGGGEEEE----ETTEEEECCCSTTTTCC--------------CCTTSCHHHHH--HCCCCHHH
T ss_pred HHHHHHHHCCEEcCcCCHHHEEEc----CCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhc--CCCCCcHH
Confidence 999999999999999999999999 7789999999999854321 1122234568999999998 45789999
Q ss_pred hHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1003 DVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1003 DVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
|||||||+||||++ |+.||......++...+ ..+.++..+..++.++.+||.+||+.||++||++.+|++.|+.+...
T Consensus 521 DvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i-~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 521 DVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH-HcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 99999999999998 99999998888777665 45567778889999999999999999999999999999999998766
Q ss_pred hhc
Q 037285 1082 ASQ 1084 (1094)
Q Consensus 1082 ~s~ 1084 (1094)
...
T Consensus 600 ~~~ 602 (613)
T 2ozo_A 600 LAS 602 (613)
T ss_dssp HSC
T ss_pred hcc
Confidence 543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=443.36 Aligned_cols=253 Identities=27% Similarity=0.414 Sum_probs=217.4
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.+.|++.++||+|+||+||+|+++ |+.||||+++...+ +.+|+.+|++|+|||||++++++.+..
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------------~~~E~~il~~l~HpnIV~l~~~~~~~~ 123 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------------RVEELVACAGLSSPRIVPLYGAVREGP 123 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------------CTHHHHTTTTCCCTTBCCEEEEEEETT
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------------HHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 457899999999999999999985 78899999986432 236999999999999999999999865
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCC-cEEEEecC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRP-ICKVGDFG 965 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g-~VKLsDFG 965 (1094)
.+|||||||++|+|.+++.+.+ .+++..+..++.||+.||+|||+++||||||||+||||+ .++ .+||+|||
T Consensus 124 --~~~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~----~~g~~vKl~DFG 196 (336)
T 4g3f_A 124 --WVNIFMELLEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS----SDGSRAALCDFG 196 (336)
T ss_dssp --EEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEC----TTSCCEEECCCT
T ss_pred --EEEEEEeccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEe----CCCCEEEEeeCC
Confidence 8999999999999999997665 599999999999999999999999999999999999998 555 69999999
Q ss_pred CcccccCc------cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCC
Q 037285 966 LSKIKRNT------LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 1039 (1094)
Q Consensus 966 LSrl~~~~------~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lr 1039 (1094)
+|+..... ......+||+.|||||++. ...|+.++|||||||+||||+||+.||......+++..+......
T Consensus 197 la~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~--~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~ 274 (336)
T 4g3f_A 197 HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM--GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPP 274 (336)
T ss_dssp TCEEC------------CCCCCCGGGCCHHHHT--TCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCG
T ss_pred CCeEccCCCcccceecCCccccCccccCHHHHC--CCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCC
Confidence 99854321 1223467999999999998 457899999999999999999999999987777777666665433
Q ss_pred -CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 037285 1040 -PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAAS 1083 (1094)
Q Consensus 1040 -p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s 1083 (1094)
..++..+++++.+||.+||..||.+|||+.||+++|........
T Consensus 275 ~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 275 IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 24677899999999999999999999999999999998876544
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=444.22 Aligned_cols=250 Identities=24% Similarity=0.386 Sum_probs=216.8
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
+.|++.++||+|+||+||+|+++ |+.||||++....... ...+.+|+.+|++|+|||||+++++|.+..
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--------~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~- 144 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--------RELLFNEVVIMRDYQHENVVEMYNSYLVGD- 144 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--------GGGGHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--------HHHHHHHHHHHHhCCCCCCCcEEEEEEECC-
Confidence 56999999999999999999985 7889999997643211 234678999999999999999999999865
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+|||||||++|+|.+++.+. .+++..+..++.||+.||+|||++|||||||||+|||++ .++.+||+|||+|
T Consensus 145 -~~~ivmEy~~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~----~~g~vKl~DFGla 217 (346)
T 4fih_A 145 -ELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT----HDGRVKLSDFGFC 217 (346)
T ss_dssp -EEEEEECCCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCCEEECCCTTC
T ss_pred -EEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEC----CCCCEEEecCcCc
Confidence 899999999999999998653 489999999999999999999999999999999999999 7889999999999
Q ss_pred cccc-CccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccC-CCCCCCc
Q 037285 968 KIKR-NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL-RPTIPSY 1045 (1094)
Q Consensus 968 rl~~-~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~l-rp~iPe~ 1045 (1094)
+... ........+||+.|||||++. ...|+.++|||||||+||||++|+.||.+....+.+..+..... ....+..
T Consensus 218 ~~~~~~~~~~~~~~GTp~YmAPEvl~--~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~ 295 (346)
T 4fih_A 218 AQVSKEVPRRKSLVGTPYWMAPELIS--RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHK 295 (346)
T ss_dssp EECCSSSCCBCCCCSCGGGCCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGG
T ss_pred eecCCCCCcccccccCcCcCCHHHHC--CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCcccc
Confidence 8653 334455678999999999998 45789999999999999999999999999888887777655422 2233457
Q ss_pred CcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1046 CDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1046 ~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
+++++++||.+||..||++|||+.+++++-+-
T Consensus 296 ~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~ 327 (346)
T 4fih_A 296 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 327 (346)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence 89999999999999999999999999997654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=429.62 Aligned_cols=253 Identities=30% Similarity=0.477 Sum_probs=210.4
Q ss_pred CCe-eEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC-
Q 037285 810 EDL-EEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG- 885 (1094)
Q Consensus 810 edY-ei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~- 885 (1094)
.+| ++.++||+|+||+||+|+++ +..||||++...... ......|.+|+.+|++|+|||||+++++|.+.
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~ 98 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT------KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC------HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc
Confidence 344 77889999999999999986 677999999765322 22346789999999999999999999998642
Q ss_pred -CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeccCCCCCCcEEEE
Q 037285 886 -PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 886 -~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~G--IIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
....+|||||||.+|+|.+++.+.. .+++..+..|+.||+.||+|||+++ ||||||||+|||++. .++.+||+
T Consensus 99 ~~~~~~~lvmEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~---~~g~vKl~ 174 (290)
T 3fpq_A 99 KGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG---PTGSVKIG 174 (290)
T ss_dssp TTEEEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESS---TTSCEEEC
T ss_pred CCCcEEEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEEC---CCCCEEEE
Confidence 2346899999999999999997654 5999999999999999999999998 999999999999971 36789999
Q ss_pred ecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhcc-CCCC
Q 037285 963 DFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-LRPT 1041 (1094)
Q Consensus 963 DFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~-lrp~ 1041 (1094)
|||+|+..... .....+||+.|||||++.+ .|+.++|||||||+||||+||+.||........+...+... ....
T Consensus 175 DFGla~~~~~~-~~~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~ 250 (290)
T 3fpq_A 175 DLGLATLKRAS-FAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS 250 (290)
T ss_dssp CTTGGGGCCTT-SBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG
T ss_pred eCcCCEeCCCC-ccCCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCC
Confidence 99999865433 2345679999999999873 58999999999999999999999998766554443333433 3344
Q ss_pred CCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1042 iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
++..+++++++||.+||..||++|||+.++++|-+
T Consensus 251 ~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~ 285 (290)
T 3fpq_A 251 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285 (290)
T ss_dssp GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 56678899999999999999999999999998643
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=437.16 Aligned_cols=254 Identities=27% Similarity=0.392 Sum_probs=213.7
Q ss_pred eeccCCeeEEEEecccCceEEEEeee-----cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEe
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYG 880 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~-----rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~G 880 (1094)
.+.+++|++++.||+|+||+||+|+. .++.||||++++....... ...+.+|+.+|++|+|||||++++
T Consensus 20 ~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~------~~~~~~E~~il~~l~HpnIv~l~~ 93 (304)
T 3ubd_A 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD------RVRTKMERDILVEVNHPFIVKLHY 93 (304)
T ss_dssp CCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE------CC------CCCCCCCCTTEECEEE
T ss_pred cCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH------HHHHHHHHHHHHHCCCCCCCeEEE
Confidence 35568999999999999999999976 2567999999765332111 135778999999999999999999
Q ss_pred EeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEE
Q 037285 881 VVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICK 960 (1094)
Q Consensus 881 v~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VK 960 (1094)
++.+.. .+|+|||||++|+|.+++.+.+ .+++..+..++.||+.||+|||++||+||||||+|||++ .++.+|
T Consensus 94 ~~~~~~--~~~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~----~~g~vK 166 (304)
T 3ubd_A 94 AFQTEG--KLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD----EEGHIK 166 (304)
T ss_dssp EEEETT--EEEEEECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC----TTSCEE
T ss_pred EEEECC--EEEEEEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEc----CCCCEE
Confidence 999865 8999999999999999997655 599999999999999999999999999999999999999 788999
Q ss_pred EEecCCcccc-cCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCC
Q 037285 961 VGDFGLSKIK-RNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 1039 (1094)
Q Consensus 961 LsDFGLSrl~-~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lr 1039 (1094)
|+|||+|+.. .........+||+.|||||++. ...|+.++|||||||++|||+||+.||.+.+..+++..+....
T Consensus 167 l~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~--~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-- 242 (304)
T 3ubd_A 167 LTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN--RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK-- 242 (304)
T ss_dssp EESSEEEEC-----CCCCSCCCCGGGCCHHHHH--TSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--
T ss_pred ecccccceeccCCCccccccccCcccCCHHHhc--cCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC--
Confidence 9999999853 3333445678999999999998 4578899999999999999999999999999888888887654
Q ss_pred CCCCCcCcHHHHHHHHHhccCCCCCCCC-----HHHHHHHHH
Q 037285 1040 PTIPSYCDAEWRTLMEECWAPNPAARPS-----FTEIASRLR 1076 (1094)
Q Consensus 1040 p~iPe~~S~eL~dLI~kCLq~DPeeRPS-----~eELLq~L~ 1076 (1094)
..+|..+++++++||.+||+.||++||| ++++++|-+
T Consensus 243 ~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~ 284 (304)
T 3ubd_A 243 LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284 (304)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGG
T ss_pred CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCcc
Confidence 3577889999999999999999999998 578887643
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=446.59 Aligned_cols=250 Identities=24% Similarity=0.386 Sum_probs=217.2
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
+.|++.++||+|+||.||+|+++ |+.||||++....... ...+.+|+.+|++|+|||||+++++|.+..
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--------~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~- 221 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--------RELLFNEVVIMRDYQHENVVEMYNSYLVGD- 221 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--------GGGHHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--------HHHHHHHHHHHHhCCCCCCCceEEEEEECC-
Confidence 56999999999999999999985 7889999997543211 235779999999999999999999999865
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+|||||||++|+|.+++... .+++..+..++.||+.||+|||++|||||||||+||||+ .++.+||+|||+|
T Consensus 222 -~~~iVmEy~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~----~~g~vKl~DFGla 294 (423)
T 4fie_A 222 -ELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT----HDGRVKLSDFGFC 294 (423)
T ss_dssp -EEEEEEECCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEEC----TTCCEEECCCTTC
T ss_pred -EEEEEEeCCCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc----CCCCEEEecCccc
Confidence 899999999999999998653 489999999999999999999999999999999999999 7889999999999
Q ss_pred cccc-CccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccC-CCCCCCc
Q 037285 968 KIKR-NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL-RPTIPSY 1045 (1094)
Q Consensus 968 rl~~-~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~l-rp~iPe~ 1045 (1094)
+... ........+||+.|||||++. ...|+.++|||||||++|||++|+.||.+....+.+..+..... ....+..
T Consensus 295 ~~~~~~~~~~~~~~GTp~YmAPEvl~--~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~ 372 (423)
T 4fie_A 295 AQVSKEVPRRKSLVGTPYWMAPELIS--RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHK 372 (423)
T ss_dssp EECCSSCCCBCCCEECTTTCCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTS
T ss_pred eECCCCCccccccccCcCcCCHHHHC--CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCccccc
Confidence 8543 333455678999999999998 45789999999999999999999999999888887777655432 2334567
Q ss_pred CcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1046 CDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1046 ~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
+++++++||.+||..||++|||+.++++|-+-
T Consensus 373 ~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~ 404 (423)
T 4fie_A 373 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 404 (423)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcCHHh
Confidence 89999999999999999999999999997554
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=461.75 Aligned_cols=363 Identities=27% Similarity=0.467 Sum_probs=281.7
Q ss_pred ccccccccccCCCChhHHHHcCCc----hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCc
Q 037285 685 RNLAQVDFGQKDVSLIDQEHLGLS----SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSV 757 (1094)
Q Consensus 685 ~~Le~~~Wy~~~IsR~~AE~ll~a----~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~i 757 (1094)
..++.++||||+|+|.+||.+|.. +| ||+| ...| .|.+|+.+. +.++ ||.|..+..+.|+ +
T Consensus 161 ~~~~~~~Wy~g~isr~~ae~~L~~~~~~~G~FLvR~s-~~~g-~y~lsv~~~-----~~v~-h~~i~~~~~g~~~----~ 228 (635)
T 4fl3_A 161 TAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRAR-DNNG-SYALCLLHE-----GKVL-HYRIDKDKTGKLS----I 228 (635)
T ss_dssp SCGGGSTTBCCSCCHHHHHHHHHSSSCCTTCEEEEES-SSSS-CEEEEEEET-----TEEE-EEEEEECTTSCEE----S
T ss_pred cccccCCceeccCCHHHHHHHHHcCCCCCceEEEEec-CCCC-CEEEEEEEC-----CEEE-EEEEEECCCCCEE----e
Confidence 567889999999999999998864 56 9999 5577 999999996 7888 9999887778888 6
Q ss_pred ccccchHHHHHhhhcccccccccCCCCCc--CCCCCCCCC------------Cc--------------------------
Q 037285 758 SESMQFDAMMENLRTTESDYEEGNAGNRN--IGLPSLNPS------------LV-------------------------- 797 (1094)
Q Consensus 758 sE~~qFdsL~ElLrt~eSdyee~nagn~~--l~~P~lnps------------l~-------------------------- 797 (1094)
.+...|.++.+++. |+..+..+.. +..|+.... ..
T Consensus 229 ~~~~~F~sl~~Lv~-----~y~~~~~~l~~~L~~p~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (635)
T 4fl3_A 229 PEGKKFDTLWQLVE-----HYSYKADGLLRVLTVPCQKIGTQGNVNFGGRPQLPGSHPATWSAGGIISRIKSYSFPKPGH 303 (635)
T ss_dssp TTCCCBSSHHHHHH-----HHTTCCTTSSSCCCSBCCC------------------------------------------
T ss_pred CCCCccCCHHHHHH-----HhhhCCCCCccccCccCcCccccccccccCCCCCCCcCccccccccccccccccccCCccc
Confidence 66668999999883 3322222111 111111000 00
Q ss_pred ------------------cc--------------------C-------------C-CcceeeccCCeeEE-EEecccCce
Q 037285 798 ------------------DF--------------------D-------------V-SSVQVIKNEDLEEQ-KELGSGTFG 824 (1094)
Q Consensus 798 ------------------~~--------------------d-------------l-ssv~eIs~edYei~-kkLGsG~FG 824 (1094)
.+ + . ...+.+....+.+. ++||+|+||
T Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~LG~G~fG 383 (635)
T 4fl3_A 304 RKSSPAQGNRQESTVSFNPYEPELAPWAADKGPQREALPMDTEVFESPFADPEEIRPKEVYLDRKLLTLEDKELGSGNFG 383 (635)
T ss_dssp ----------------------------------CCCCGGGSTTSSCTTCSTTSCCCSSSBCCGGGEEEEEEEEEECSSE
T ss_pred cccccccccCCcccccCCCCCCCCCccccccCcccccCCCcccccccccCChhHcCcccccccchhccccCCEeccCCCE
Confidence 00 0 0 01122333444443 489999999
Q ss_pred EEEEeeec----CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEEEeeecccc
Q 037285 825 TVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDG 900 (1094)
Q Consensus 825 tVYKAk~r----Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~IVmEYmegG 900 (1094)
.||+|.++ +..||||+++.... ......+|.+|+.+|++++|||||++++++... .+++||||+.+|
T Consensus 384 ~Vy~~~~~~~~~~~~vAvK~~~~~~~------~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~---~~~lv~E~~~~g 454 (635)
T 4fl3_A 384 TVKKGYYQMKKVVKTVAVKILKNEAN------DPALKDELLAEANVMQQLDNPYIVRMIGICEAE---SWMLVMEMAELG 454 (635)
T ss_dssp EEEEEEEECSSCEEEEEEEEECGGGG------CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS---SEEEEEECCTTE
T ss_pred EEEEEEEcCCCcceEEEEEEeccccC------CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CEEEEEEccCCC
Confidence 99999763 46799999976422 123346789999999999999999999999753 588999999999
Q ss_pred hhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccCc----ccc
Q 037285 901 SLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT----LVS 976 (1094)
Q Consensus 901 SL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~----~~s 976 (1094)
+|.+++.... .+++..++.|+.||+.||+|||+++|+||||||+|||++ .++.+||+|||+++..... ...
T Consensus 455 ~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~----~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 455 PLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV----TQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp EHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE----ETTEEEECCTTHHHHTTC--------
T ss_pred CHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEe----CCCCEEEEEcCCccccccCccccccc
Confidence 9999997554 589999999999999999999999999999999999999 7789999999999854321 122
Q ss_pred CCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHH
Q 037285 977 GGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLME 1055 (1094)
Q Consensus 977 s~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~ 1055 (1094)
....+|+.|+|||++. ...++.++|||||||+||||++ |+.||......++...+ ....++..+..++.++.+||.
T Consensus 530 ~~~~~t~~y~APE~~~--~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i-~~~~~~~~p~~~~~~l~~li~ 606 (635)
T 4fl3_A 530 THGKWPVKWYAPECIN--YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-EKGERMGCPAGCPREMYDLMN 606 (635)
T ss_dssp -----CGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-HTTCCCCCCTTCCHHHHHHHH
T ss_pred cCCCCceeeeChhhhc--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHH
Confidence 2344678899999998 5578999999999999999998 99999998887776655 455677788899999999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1056 ECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1056 kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
+||+.||++||++.+|++.|+.+...
T Consensus 607 ~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 607 LCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp HHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999999999998643
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=424.44 Aligned_cols=257 Identities=30% Similarity=0.448 Sum_probs=205.7
Q ss_pred CCeeEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC--
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG-- 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~-- 887 (1094)
.+|.+.++||+|+||+||+|+++|+.||||++.... . . ...+..|+..+.+++|||||+++++|.+...
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~------~-~--~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~ 73 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE------E-R--SWFREAEIYQTVMLRHENILGFIAADNKDNGTW 73 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG------H-H--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc------h-h--hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCc
Confidence 368899999999999999999999999999986431 1 1 1223356777778999999999999986432
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCceEeccCCCCCCcE
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSK--------NIVHFDLKCDNLLVNLKDPSRPIC 959 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~--------GIIHRDLKPeNILLD~~~~e~g~V 959 (1094)
..++||||||++|+|.+++... .+++..++.++.|++.||+|||++ +||||||||+|||++ .++.+
T Consensus 74 ~~~~lV~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~----~~~~~ 147 (303)
T 3hmm_A 74 TQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK----KNGTC 147 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEEC----TTSCE
T ss_pred eEEEEEecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEEC----CCCCE
Confidence 2589999999999999999754 489999999999999999999987 899999999999999 78899
Q ss_pred EEEecCCcccccCcc-----ccCCccCCCcccCccccccCC----CCCCchhhHHHHHHHHHHHHcCCCCCCCC------
Q 037285 960 KVGDFGLSKIKRNTL-----VSGGVRGTLPWMAPELLSGSS----SKVSEKVDVFSFGIVLWEILTGEEPYANM------ 1024 (1094)
Q Consensus 960 KLsDFGLSrl~~~~~-----~ss~~~GT~~YmAPEvL~g~~----~kyS~KSDVWSLGVLLyELLTGk~PF~~~------ 1024 (1094)
||+|||+|+...... .....+||+.|||||++.+.. ..++.++|||||||+||||+||+.||...
T Consensus 148 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p 227 (303)
T 3hmm_A 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp EECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred EEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc
Confidence 999999998543321 223457999999999997421 24678999999999999999997765321
Q ss_pred ---------ChHHHHHhHhhccCCCCCCCc-----CcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1025 ---------HYGAIIGGIVNNTLRPTIPSY-----CDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1025 ---------~~~eile~Iv~~~lrp~iPe~-----~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
........+....+++.+|.. ++..+.+||.+||+.||++||||.+|++.|+.+...
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred chhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 123444455667777777654 335789999999999999999999999999998743
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=414.65 Aligned_cols=248 Identities=28% Similarity=0.420 Sum_probs=190.8
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC-
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP- 886 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~- 886 (1094)
++|++++.||+|+||+||+|+++ |..||||+++... .+.....+.+|+.+|++|+|||||+++++|.+..
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-------~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~ 77 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-------RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNT 77 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-------SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCc
Confidence 46999999999999999999885 7889999997542 1233467889999999999999999999987532
Q ss_pred ---------CCceEEEeeecccchhHHHHhhccc--ccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCC
Q 037285 887 ---------GGTLATVAEYMVDGSLRHVLVRKDR--FLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPS 955 (1094)
Q Consensus 887 ---------~~~L~IVmEYmegGSL~d~L~k~~~--~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e 955 (1094)
...+|+|||||.+|+|.+++..... ..++..++.++.||++||+|||++|||||||||+|||++ .
T Consensus 78 ~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~----~ 153 (299)
T 4g31_A 78 TEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT----M 153 (299)
T ss_dssp ---------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----T
T ss_pred cccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEEC----C
Confidence 1247999999999999999976542 345667889999999999999999999999999999998 7
Q ss_pred CCcEEEEecCCcccccCcc-------------ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 037285 956 RPICKVGDFGLSKIKRNTL-------------VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYA 1022 (1094)
Q Consensus 956 ~g~VKLsDFGLSrl~~~~~-------------~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~ 1022 (1094)
++.+||+|||+|+...... .....+||+.|||||++. ...|+.++|||||||++|||++ ||.
T Consensus 154 ~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~--~~~y~~~~DiwSlGvilyell~---Pf~ 228 (299)
T 4g31_A 154 DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIH--GNSYSHKVDIFSLGLILFELLY---PFS 228 (299)
T ss_dssp TCCEEECCCCCC--------------------------CCCTTSCHHHHT--TCCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred CCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHc--CCCCCCHHHHHHHHHHHHHHcc---CCC
Confidence 7899999999998543211 123457999999999998 4578999999999999999996 776
Q ss_pred CCChH-HHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1023 NMHYG-AIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1023 ~~~~~-eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
..... ..+..+... ..+......++.+.+||.+||+.||.+|||+.+++++
T Consensus 229 ~~~~~~~~~~~~~~~-~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 229 TQMERVRTLTDVRNL-KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp SHHHHHHHHHHHHTT-CCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CccHHHHHHHHHhcC-CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 53222 222222222 2222223345678899999999999999999999985
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=420.44 Aligned_cols=255 Identities=23% Similarity=0.318 Sum_probs=211.5
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC--
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG-- 885 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~-- 885 (1094)
++|++++.||+|+||+||+|+++ |+.||||++++.... ......+.+|+.+|++|+|||||++++++...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 127 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV------VTNAKRTLRELKILKHFKHDNIIAIKDILRPTVP 127 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSS------HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccc------hHHHHHHHHHHHHHHhcCCCCcceEeeeeecccc
Confidence 68999999999999999999885 788999999754211 22345788999999999999999999998643
Q ss_pred --CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEe
Q 037285 886 --PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGD 963 (1094)
Q Consensus 886 --~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsD 963 (1094)
....+|||||||. |+|.+++...+ .+++..+..++.||+.||.|||++|||||||||+|||++ .++.+||+|
T Consensus 128 ~~~~~~~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~----~~~~~Ki~D 201 (398)
T 4b99_A 128 YGEFKSVYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVN----ENCELKIGD 201 (398)
T ss_dssp TTTCCCEEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTCCEEECC
T ss_pred cccCCEEEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccC----CCCCEEEee
Confidence 2347999999995 77999987654 599999999999999999999999999999999999999 788999999
Q ss_pred cCCcccccC-----ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccC
Q 037285 964 FGLSKIKRN-----TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 1038 (1094)
Q Consensus 964 FGLSrl~~~-----~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~l 1038 (1094)
||+|+.... .......+||+.|||||++.+ ...++.++|||||||++|||++|+.||.+.+..+.+..+.....
T Consensus 202 FGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~-~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g 280 (398)
T 4b99_A 202 FGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLS-LHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLG 280 (398)
T ss_dssp CTTCBCC-------CCCCCSSCCCCTTCCHHHHTT-CSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHC
T ss_pred cceeeecccCccccccccccceeChHhcCHHHhcC-CCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcC
Confidence 999985321 223345789999999999875 34578999999999999999999999999888777766544221
Q ss_pred CCC----------------------C-------CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1039 RPT----------------------I-------PSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1039 rp~----------------------i-------Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
.+. . ...+++++.+||.+||..||.+|||+.++++|-+-
T Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f 348 (398)
T 4b99_A 281 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFL 348 (398)
T ss_dssp CCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred CCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhh
Confidence 111 0 12467899999999999999999999999987553
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=429.31 Aligned_cols=253 Identities=21% Similarity=0.321 Sum_probs=221.0
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||+|+||+||+|+.+ |..||||++.... ......+.+|+.+|++|+|||||+++++|.+..
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--------~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~- 227 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--------ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN- 227 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--------HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSS-
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--------hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-
Confidence 58999999999999999999885 7889999997642 112356789999999999999999999999865
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+|||||||.+|+|.++|......+++..+..++.||+.||.|||+++|+||||||+|||++.+ ..+.+||+|||+|
T Consensus 228 -~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~--~~~~vKl~DFG~a 304 (573)
T 3uto_A 228 -EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK--RSNELKLIDFGLT 304 (573)
T ss_dssp -EEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS--SCCCEEECCCSSC
T ss_pred -EEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCC--CCCCEEEeeccce
Confidence 9999999999999999997766679999999999999999999999999999999999999732 3478999999999
Q ss_pred ccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCC--CCCCc
Q 037285 968 KIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP--TIPSY 1045 (1094)
Q Consensus 968 rl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp--~iPe~ 1045 (1094)
+...........+||+.|||||++. ...|+.++|||||||+||||++|+.||.+....+.+..+....+.. .....
T Consensus 305 ~~~~~~~~~~~~~GT~~y~APEv~~--~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 382 (573)
T 3uto_A 305 AHLDPKQSVKVTTGTAEFAAPEVAE--GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG 382 (573)
T ss_dssp EECCTTSEEEEECSSGGGCCHHHHT--TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTT
T ss_pred eEccCCCceeeeEECccccCHHHhC--CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccC
Confidence 9766555555678999999999998 4578999999999999999999999999999888888877665443 23356
Q ss_pred CcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1046 CDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1046 ~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
++.++++||.+||..||.+|||+.++++|-+
T Consensus 383 ~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw 413 (573)
T 3uto_A 383 ISEDGKDFIRKLLLADPNTRMTIHQALEHPW 413 (573)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCcC
Confidence 8999999999999999999999999998644
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=385.13 Aligned_cols=266 Identities=41% Similarity=0.701 Sum_probs=221.9
Q ss_pred ceeeccCCeeEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEee
Q 037285 804 VQVIKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQ 883 (1094)
Q Consensus 804 v~eIs~edYei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~ 883 (1094)
.+.+..++|++.+.||+|+||.||+|++++..||||++...... ......+.+|+.+|++++||||+++++++.
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 104 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFH------AERVNEFLREVAIMKRLRHPNIVLFMGAVT 104 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCS------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCC------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 34577789999999999999999999999999999998764321 233467889999999999999999999998
Q ss_pred cCCCCceEEEeeecccchhHHHHhhcc--cccCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeccCCCCCCcE
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLVRKD--RFLDRRRRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNLKDPSRPIC 959 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~k~~--~~Lse~~~l~Ia~QIaeGLaYLHs~G--IIHRDLKPeNILLD~~~~e~g~V 959 (1094)
+.. .+++||||+.+|+|.+++.... ..+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+
T Consensus 105 ~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~----~~~~~ 178 (309)
T 3p86_A 105 QPP--NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD----KKYTV 178 (309)
T ss_dssp STT--CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEEC----TTCCE
T ss_pred ECC--ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEe----CCCcE
Confidence 765 7999999999999999997653 24899999999999999999999999 99999999999998 77899
Q ss_pred EEEecCCcccccCc-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccC
Q 037285 960 KVGDFGLSKIKRNT-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 1038 (1094)
Q Consensus 960 KLsDFGLSrl~~~~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~l 1038 (1094)
||+|||+++..... .......||+.|+|||++. ...++.++|||||||++|+|++|+.||......+....+.....
T Consensus 179 kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~ 256 (309)
T 3p86_A 179 KVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR--DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK 256 (309)
T ss_dssp EECCCC-----------------CCTTSCHHHHT--TCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCC
T ss_pred EECCCCCCccccccccccccCCCCccccChhhhc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC
Confidence 99999999854332 2233456999999999998 45678999999999999999999999999988887777766677
Q ss_pred CCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 037285 1039 RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAAS 1083 (1094)
Q Consensus 1039 rp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s 1083 (1094)
...++..+++.+.+||.+||+.||.+|||+.+|++.|+.+.....
T Consensus 257 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 257 RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 778888999999999999999999999999999999999875443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=399.84 Aligned_cols=247 Identities=20% Similarity=0.255 Sum_probs=196.4
Q ss_pred CCeeEEEEecccCceEEEEeeec-----CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEee
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQ 883 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r-----Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~~ 883 (1094)
++|++.++||+|+||+||+|+.+ ++.||||.+.+.. ....+.+|+++|+++ +|||||++++++.
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----------~~~~~~~E~~~l~~~~~h~nIv~l~~~~~ 90 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----------HPIRIAAELQCLTVAGGQDNVMGVKYCFR 90 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----------CHHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----------CHHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence 57999999999999999999763 4679999986531 123567899999998 6999999999998
Q ss_pred cCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEe
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGD 963 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsD 963 (1094)
+.. .+|+|||||++|+|.+++. .+++..+..++.||+.||+|||++||+||||||+|||++. ..+.+||+|
T Consensus 91 ~~~--~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~---~~~~~kl~D 161 (361)
T 4f9c_A 91 KND--HVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNR---RLKKYALVD 161 (361)
T ss_dssp ETT--EEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET---TTTEEEECC
T ss_pred ECC--EEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeC---CCCeEEECc
Confidence 865 8999999999999999983 3899999999999999999999999999999999999982 237899999
Q ss_pred cCCcccccCc-----------------------------cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHH
Q 037285 964 FGLSKIKRNT-----------------------------LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEI 1014 (1094)
Q Consensus 964 FGLSrl~~~~-----------------------------~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyEL 1014 (1094)
||+|+..... ......+||+.|+|||++.+ ...|+.++||||+||++|||
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~y~~~~DiWSlG~il~el 240 (361)
T 4f9c_A 162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK-CPNQTTAIDMWSAGVIFLSL 240 (361)
T ss_dssp CTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTT-CSCCCTHHHHHHHHHHHHHH
T ss_pred CCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCCccchhhhHHHHHHH
Confidence 9999743221 11223579999999999974 34588999999999999999
Q ss_pred HcCCCCCCCCC-hHHHHHhHhhc----------------------------------------------------cCCCC
Q 037285 1015 LTGEEPYANMH-YGAIIGGIVNN----------------------------------------------------TLRPT 1041 (1094)
Q Consensus 1015 LTGk~PF~~~~-~~eile~Iv~~----------------------------------------------------~lrp~ 1041 (1094)
+||+.||.... ..+.+..+..- .....
T Consensus 241 l~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 320 (361)
T 4f9c_A 241 LSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLE 320 (361)
T ss_dssp HHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC---------------------
T ss_pred HHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccc
Confidence 99999995433 22222221110 00001
Q ss_pred CCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1042 iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
....+++++.+||.+||..||.+|+|++++++|-+
T Consensus 321 ~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~ 355 (361)
T 4f9c_A 321 GWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPF 355 (361)
T ss_dssp -CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGG
T ss_pred ccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcc
Confidence 12357889999999999999999999999998743
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=369.45 Aligned_cols=260 Identities=32% Similarity=0.606 Sum_probs=226.0
Q ss_pred ceeeccCCeeEEEEecccCceEEEEeeec-CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEe
Q 037285 804 VQVIKNEDLEEQKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVV 882 (1094)
Q Consensus 804 v~eIs~edYei~kkLGsG~FGtVYKAk~r-Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~ 882 (1094)
.|.+..++|++.+.||+|+||.||+|++. +..||||++...... ...+.+|+.++++++||||+++++++
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~ 74 (269)
T 4hcu_A 4 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---------EEDFIEEAEVMMKLSHPKLVQLYGVC 74 (269)
T ss_dssp -CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC---------HHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC---------HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 46788899999999999999999999984 677999999764321 24688999999999999999999999
Q ss_pred ecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 883 QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 883 ~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
.+.. .+++||||+.+++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+
T Consensus 75 ~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~----~~~~~kl~ 148 (269)
T 4hcu_A 75 LEQA--PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG----ENQVIKVS 148 (269)
T ss_dssp CSSS--SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----GGGCEEEC
T ss_pred ecCC--ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEc----CCCCEEec
Confidence 8754 89999999999999999987777799999999999999999999999999999999999998 67789999
Q ss_pred ecCCcccccCc--cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCC
Q 037285 963 DFGLSKIKRNT--LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLR 1039 (1094)
Q Consensus 963 DFGLSrl~~~~--~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lr 1039 (1094)
|||+++..... .......+|+.|+|||++. ...++.++||||||+++|+|++ |+.||......+....+. ....
T Consensus 149 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~-~~~~ 225 (269)
T 4hcu_A 149 DFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS--FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFR 225 (269)
T ss_dssp CTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCC
T ss_pred cccccccccccccccccCcccccccCCHHHhc--CCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-cCcc
Confidence 99999854332 2223445778899999997 4568999999999999999999 999999988887776664 4456
Q ss_pred CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1040 PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1040 p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
...+..++..+.++|.+||+.||.+|||+.+++++|+.+...
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 226 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 667788899999999999999999999999999999998753
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=363.15 Aligned_cols=261 Identities=27% Similarity=0.466 Sum_probs=227.7
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
+.+..++|++.+.||+|+||.||+|++++..||||+++..... ......|.+|+.++++++||||+++++++.+
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 78 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWS------TRKSRDFNEECPRLRIFSHPNVLPVLGACQS 78 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCC------HHHHHHHHHHGGGGCCCSCTTEECEEEEECT
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccC------HHHHHHHHHHHHHHHhcCCCchhheEEEEcc
Confidence 4566789999999999999999999999999999999764221 2234578899999999999999999999988
Q ss_pred CCCCceEEEeeecccchhHHHHhhccc-ccCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeccCCCCCCcEEE
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDR-FLDRRRRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNLKDPSRPICKV 961 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~-~Lse~~~l~Ia~QIaeGLaYLHs~G--IIHRDLKPeNILLD~~~~e~g~VKL 961 (1094)
.....+++||||+++|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.++|
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~----~~~~~~l 154 (271)
T 3kmu_A 79 PPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID----EDMTARI 154 (271)
T ss_dssp TTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEEC----TTSCEEE
T ss_pred CCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEc----CCcceeE
Confidence 655689999999999999999976543 5899999999999999999999999 99999999999998 7788999
Q ss_pred EecCCcccccCccccCCccCCCcccCccccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCC
Q 037285 962 GDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSS-SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 1040 (1094)
Q Consensus 962 sDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~-~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp 1040 (1094)
+|||++..... ....+|+.|+|||++.+.. ..++.++|||||||++|+|++|+.||...........+.....++
T Consensus 155 ~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 230 (271)
T 3kmu_A 155 SMADVKFSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP 230 (271)
T ss_dssp EGGGSCCTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC
T ss_pred Eeccceeeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC
Confidence 99998764322 2345899999999997422 233458999999999999999999999998888888888888888
Q ss_pred CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1041 TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1041 ~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
..+..++..+.++|.+||+.||.+|||+.++++.|..+.
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 231 TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 889999999999999999999999999999999999875
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=382.26 Aligned_cols=267 Identities=31% Similarity=0.527 Sum_probs=226.4
Q ss_pred cceeeccCCeeEEEEecccCceEEEEeeec-------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCc
Q 037285 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPN 874 (1094)
Q Consensus 803 sv~eIs~edYei~kkLGsG~FGtVYKAk~r-------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPN 874 (1094)
..|++..++|++.+.||+|+||.||+|++. ++.||||+++... .......+.+|+.+|.++ +|||
T Consensus 15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~hpn 87 (359)
T 3vhe_A 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-------THSEHRALMSELKILIHIGHHLN 87 (359)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-------CHHHHHHHHHHHHHHHHHCCCTT
T ss_pred ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-------CHHHHHHHHHHHHHHHhhcCCcc
Confidence 357788899999999999999999999853 3679999997532 122245788999999999 7999
Q ss_pred eeEEEeEeecCCCCceEEEeeecccchhHHHHhhccc-------------------------------------------
Q 037285 875 VVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDR------------------------------------------- 911 (1094)
Q Consensus 875 IVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~------------------------------------------- 911 (1094)
|+++++++.+. ...+++||||+.+|+|.+++.....
T Consensus 88 iv~~~~~~~~~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (359)
T 3vhe_A 88 VVNLLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSG 166 (359)
T ss_dssp BCCEEEEECST-TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------
T ss_pred eeeeeeeeecC-CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccc
Confidence 99999999764 3468999999999999999976432
Q ss_pred ----------------------ccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCccc
Q 037285 912 ----------------------FLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI 969 (1094)
Q Consensus 912 ----------------------~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl 969 (1094)
.+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~----~~~~~kl~Dfg~a~~ 242 (359)
T 3vhe_A 167 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----EKNVVKICDFGLARD 242 (359)
T ss_dssp -----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----GGGCEEECCCGGGSC
T ss_pred cccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc----CCCcEEEEeccceee
Confidence 289999999999999999999999999999999999998 678899999999985
Q ss_pred ccC---ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCCCCCc
Q 037285 970 KRN---TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSY 1045 (1094)
Q Consensus 970 ~~~---~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~iPe~ 1045 (1094)
... ........+|+.|+|||++. ...++.++|||||||++|+|+| |+.||........+............+..
T Consensus 243 ~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (359)
T 3vhe_A 243 IYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDY 320 (359)
T ss_dssp TTSCTTCEEC--CEECGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTT
T ss_pred ecccccchhccccCCCceeEChhhhc--CCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCC
Confidence 422 12233456788999999998 4578899999999999999998 99999988766666666666677778888
Q ss_pred CcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 037285 1046 CDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAAS 1083 (1094)
Q Consensus 1046 ~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s 1083 (1094)
+++++.++|.+||+.||.+|||+.+|+++|..+..+..
T Consensus 321 ~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 358 (359)
T 3vhe_A 321 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 358 (359)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHT
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHhc
Confidence 99999999999999999999999999999999987654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=424.77 Aligned_cols=257 Identities=22% Similarity=0.313 Sum_probs=212.8
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
++.++|++++.||+|+||+||+|+.+ |..||||++.+..+.... .+........++.+++.++|||||+++++|.+
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~--~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--GETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTT--CHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhh--hHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence 45678999999999999999999885 788999999865332111 12222333455777888899999999999998
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
.. .+|+|||||.||+|.++|.+.+ .+++..+..++.||+.||+|||++|||||||||+||||+ .++++||+||
T Consensus 264 ~~--~lylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld----~~G~vKL~DF 336 (689)
T 3v5w_A 264 PD--KLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD----EHGHVRISDL 336 (689)
T ss_dssp SS--EEEEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC----TTSCEEECCC
T ss_pred CC--EEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEe----CCCCEEeccc
Confidence 65 8999999999999999997765 599999999999999999999999999999999999999 7889999999
Q ss_pred CCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---hHHHHHhHhhccCCCC
Q 037285 965 GLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH---YGAIIGGIVNNTLRPT 1041 (1094)
Q Consensus 965 GLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~---~~eile~Iv~~~lrp~ 1041 (1094)
|+|+...... ..+.+||+.|||||++.. ...|+.++|||||||+||||++|+.||.... ..++...+... ...
T Consensus 337 GlA~~~~~~~-~~t~~GTp~YmAPEvl~~-~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~--~~~ 412 (689)
T 3v5w_A 337 GLACDFSKKK-PHASVGTHGYMAPEVLQK-GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--AVE 412 (689)
T ss_dssp TTCEECSSCC-CCSCCSCGGGCCHHHHST-TCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC--CCC
T ss_pred ceeeecCCCC-CCCccCCcCccCHHHHhC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC--CCC
Confidence 9998654433 345689999999999963 3468999999999999999999999997532 23344444333 345
Q ss_pred CCCcCcHHHHHHHHHhccCCCCCCCC-----HHHHHHHHH
Q 037285 1042 IPSYCDAEWRTLMEECWAPNPAARPS-----FTEIASRLR 1076 (1094)
Q Consensus 1042 iPe~~S~eL~dLI~kCLq~DPeeRPS-----~eELLq~L~ 1076 (1094)
+|..+++++++||.+||..||.+|++ +.+|++|-+
T Consensus 413 ~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hpf 452 (689)
T 3v5w_A 413 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 452 (689)
T ss_dssp CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGG
T ss_pred CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCcc
Confidence 78889999999999999999999997 789988754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=367.55 Aligned_cols=261 Identities=35% Similarity=0.585 Sum_probs=223.4
Q ss_pred cceeeccCCeeEEEEecccCceEEEEeeecC-ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeE
Q 037285 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGV 881 (1094)
Q Consensus 803 sv~eIs~edYei~kkLGsG~FGtVYKAk~rG-t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv 881 (1094)
..|.+..++|++.+.||+|+||.||++++++ ..||||+++..... ..++.+|+.++++++||||++++++
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~ 87 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---------EDEFIEEAKVMMNLSHEKLVQLYGV 87 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC---------HHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC---------HHHHHHHHHHHhcCCCCCEeeEEEE
Confidence 3567888999999999999999999999875 57999999764321 2467899999999999999999999
Q ss_pred eecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEE
Q 037285 882 VQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKV 961 (1094)
Q Consensus 882 ~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKL 961 (1094)
+.+.. .+++||||+.+++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||
T Consensus 88 ~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~----~~~~~kl 161 (283)
T 3gen_A 88 CTKQR--PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN----DQGVVKV 161 (283)
T ss_dssp ECSSS--SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC----TTSCEEE
T ss_pred EecCC--CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEc----CCCCEEE
Confidence 98754 89999999999999999987666799999999999999999999999999999999999998 7789999
Q ss_pred EecCCcccccCc--cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccC
Q 037285 962 GDFGLSKIKRNT--LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 1038 (1094)
Q Consensus 962 sDFGLSrl~~~~--~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~l 1038 (1094)
+|||+++..... .......+|+.|+|||++. ...++.++||||||+++|+|+| |+.||......+....+. ...
T Consensus 162 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~ 238 (283)
T 3gen_A 162 SDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM--YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGL 238 (283)
T ss_dssp CSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHH--HCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTC
T ss_pred ccccccccccccccccccCCccCcccCCHHHhc--cCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh-ccc
Confidence 999999854332 1223345678899999998 4568999999999999999998 999999988877776654 445
Q ss_pred CCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1039 RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1039 rp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
....+..++..+.+||.+||+.||.+|||+.+++++|.++...
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 239 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 6667788899999999999999999999999999999998754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=386.14 Aligned_cols=265 Identities=29% Similarity=0.514 Sum_probs=225.2
Q ss_pred ceeeccCCeeEEEEecccCceEEEEeeec---------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCC
Q 037285 804 VQVIKNEDLEEQKELGSGTFGTVYHGKWR---------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHP 873 (1094)
Q Consensus 804 v~eIs~edYei~kkLGsG~FGtVYKAk~r---------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HP 873 (1094)
.+.+..++|++.+.||+|+||.||+|++. +..||||+++... .+.....+.+|+.+|+++ +||
T Consensus 75 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~hp 147 (370)
T 2psq_A 75 KWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-------TEKDLSDLVSEMEMMKMIGKHK 147 (370)
T ss_dssp TTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-------BHHHHHHHHHHHHHHHHSCCCT
T ss_pred cccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-------CHHHHHHHHHHHHHHHHhcCCC
Confidence 35667789999999999999999999863 2359999987531 123356789999999999 899
Q ss_pred ceeEEEeEeecCCCCceEEEeeecccchhHHHHhhcc---------------cccCHHHHHHHHHHHHHHHHHHHHCCce
Q 037285 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD---------------RFLDRRRRLIIAMDAAFGMEYLHSKNIV 938 (1094)
Q Consensus 874 NIVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~---------------~~Lse~~~l~Ia~QIaeGLaYLHs~GII 938 (1094)
||++++++|.+.. .+++||||+.+|+|.+++.... ..+++..++.++.||+.||+|||++||+
T Consensus 148 nIv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv 225 (370)
T 2psq_A 148 NIINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI 225 (370)
T ss_dssp TBCCEEEEECSSS--SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred CEeeEEEEEccCC--CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 9999999998754 8999999999999999997643 2478999999999999999999999999
Q ss_pred eccCCCCceEeccCCCCCCcEEEEecCCcccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHH
Q 037285 939 HFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEIL 1015 (1094)
Q Consensus 939 HRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELL 1015 (1094)
||||||+|||++ .++.+||+|||+++..... .......+|+.|+|||++. ...++.++|||||||++|||+
T Consensus 226 HrDlkp~NIll~----~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~DvwslG~il~ell 299 (370)
T 2psq_A 226 HRDLAARNVLVT----ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIF 299 (370)
T ss_dssp CSCCCGGGEEEC----TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHH--TCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccchhhEEEC----CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhc--CCCCCcHHHHHHHHHHHHHHH
Confidence 999999999998 7889999999999854322 2223345788999999998 457899999999999999999
Q ss_pred c-CCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhc
Q 037285 1016 T-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQ 1084 (1094)
Q Consensus 1016 T-Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s~ 1084 (1094)
| |+.||......+....+ ....++..+..++.++.+||.+||+.||.+||++.+|++.|+.+.+....
T Consensus 300 t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~ 368 (370)
T 2psq_A 300 TLGGSPYPGIPVEELFKLL-KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 368 (370)
T ss_dssp TTSCCSSTTCCGGGHHHHH-HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred cCCCCCCCCCCHHHHHHHH-hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcc
Confidence 9 99999988877766554 45566778889999999999999999999999999999999999866543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=379.90 Aligned_cols=264 Identities=35% Similarity=0.600 Sum_probs=224.2
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeec-----CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEE
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFY 879 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~r-----Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~ 879 (1094)
+++..++|++.+.||+|+||.||+|+++ +..||||+++... .......|.+|+.+|++++||||++++
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~ 116 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-------TERQRRDFLSEASIMGQFDHPNIIRLE 116 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-------CHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-------CHHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 4567789999999999999999999884 3459999997531 123346788999999999999999999
Q ss_pred eEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcE
Q 037285 880 GVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC 959 (1094)
Q Consensus 880 Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~V 959 (1094)
+++.+.. .+++||||+.+++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+
T Consensus 117 ~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~----~~~~~ 190 (325)
T 3kul_A 117 GVVTRGR--LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVD----SNLVC 190 (325)
T ss_dssp EEECGGG--CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCE
T ss_pred EEEEeCC--ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEC----CCCCE
Confidence 9998754 89999999999999999987766799999999999999999999999999999999999998 78899
Q ss_pred EEEecCCcccccCc----cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHh
Q 037285 960 KVGDFGLSKIKRNT----LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIV 1034 (1094)
Q Consensus 960 KLsDFGLSrl~~~~----~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv 1034 (1094)
||+|||+++..... .......+|+.|+|||++. ...++.++|||||||++|+|++ |+.||......+....+.
T Consensus 191 kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~ 268 (325)
T 3kul_A 191 KVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA--FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268 (325)
T ss_dssp EECCCSSCEECC----CCEECC---CCGGGSCHHHHH--HCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH
T ss_pred EECCCCcccccccCccceeeccCCCCcccccCHhHhc--CCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 99999999854322 1222334677899999998 4568899999999999999999 999999988888777664
Q ss_pred hccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhc
Q 037285 1035 NNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQ 1084 (1094)
Q Consensus 1035 ~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s~ 1084 (1094)
...+...+..++..+.+||.+||..||.+|||+.+|++.|+.+......
T Consensus 269 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 269 -EGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp -TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred -cCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 4456667788999999999999999999999999999999998755433
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=364.25 Aligned_cols=262 Identities=36% Similarity=0.632 Sum_probs=214.1
Q ss_pred eeccCCeeEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~ 885 (1094)
++..++|++.+.||+|+||.||+|++++..||||+++..... ........+.+|+.++++++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDE----DISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE 78 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC--------------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcc----cHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 356689999999999999999999999999999998754221 1123346788999999999999999999999875
Q ss_pred CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCceEeccCCC----CCCc
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKN---IVHFDLKCDNLLVNLKDP----SRPI 958 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~G---IIHRDLKPeNILLD~~~~----e~g~ 958 (1094)
. .+++||||+.+++|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.... .++.
T Consensus 79 ~--~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~ 154 (271)
T 3dtc_A 79 P--NLCLVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKI 154 (271)
T ss_dssp ----CEEEEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCC
T ss_pred C--ceEEEEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcc
Confidence 5 89999999999999999853 35899999999999999999999999 999999999999983221 2678
Q ss_pred EEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccC
Q 037285 959 CKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 1038 (1094)
Q Consensus 959 VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~l 1038 (1094)
+||+|||+++....... ....||+.|+|||++. ...++.++||||||+++|+|++|+.||...........+.....
T Consensus 155 ~kl~Dfg~~~~~~~~~~-~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 231 (271)
T 3dtc_A 155 LKITDFGLAREWHRTTK-MSAAGAYAWMAPEVIR--ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL 231 (271)
T ss_dssp EEECCCCC--------------CCGGGSCHHHHH--HCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCC
T ss_pred eEEccCCcccccccccc-cCCCCccceeCHHHhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCC
Confidence 99999999985443322 2346899999999998 45688999999999999999999999999888888777777777
Q ss_pred CCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1039 RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1039 rp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
....+..++..+.++|.+||+.||.+|||+.+++++|+.+
T Consensus 232 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 232 ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 7788889999999999999999999999999999999754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=363.73 Aligned_cols=258 Identities=34% Similarity=0.608 Sum_probs=222.9
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeecC-ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEee
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQ 883 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~rG-t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~ 883 (1094)
+++..++|++.+.||+|+||.||+|++++ ..||||+++..... ..++.+|+.++++++||||+++++++.
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~~ 73 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS---------EDEFFQEAQTMMKLSHPKLVKFYGVCS 73 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC---------HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred eEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc---------HHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 35677899999999999999999999875 47999999764321 245789999999999999999999998
Q ss_pred cCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEe
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGD 963 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsD 963 (1094)
+.. .+++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 74 ~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~----~~~~~~l~D 147 (268)
T 3sxs_A 74 KEY--PIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVD----RDLCVKVSD 147 (268)
T ss_dssp SSS--SEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEEC----TTCCEEECC
T ss_pred cCC--ceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEEC----CCCCEEEcc
Confidence 754 89999999999999999988776799999999999999999999999999999999999998 778999999
Q ss_pred cCCcccccCc--cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCC
Q 037285 964 FGLSKIKRNT--LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 1040 (1094)
Q Consensus 964 FGLSrl~~~~--~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp 1040 (1094)
||+++..... .......+|+.|+|||++. ...++.++||||||+++|+|++ |+.||...........+. .....
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~ 224 (268)
T 3sxs_A 148 FGMTRYVLDDQYVSSVGTKFPVKWSAPEVFH--YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRL 224 (268)
T ss_dssp TTCEEECCTTCEEECCSCCCCGGGCCHHHHH--HSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCC
T ss_pred CccceecchhhhhcccCCCcCcccCCHHHHh--ccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH-cCCCC
Confidence 9999854332 2223345677899999997 4467889999999999999999 999999988877776653 44455
Q ss_pred CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 037285 1041 TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLST 1080 (1094)
Q Consensus 1041 ~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~t 1080 (1094)
..+..+++.+.++|.+||+.||.+|||+.+++++|+.+..
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 225 YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 6677889999999999999999999999999999998864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=380.30 Aligned_cols=253 Identities=26% Similarity=0.450 Sum_probs=220.5
Q ss_pred cCCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||+|+||.||+|++ +|+.||||++...... ......+.+|+.+|++++||||+++++++....
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 87 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN------PTSLQKLFREVRIMKILNHPNIVKLFEVIETEK 87 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 46899999999999999999987 4788999999765321 233456889999999999999999999998755
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+++||||+.+|+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+
T Consensus 88 --~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~----~~~~~kl~DFG~ 160 (328)
T 3fe3_A 88 --TLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLD----ADMNIKIADFGF 160 (328)
T ss_dssp --EEEEEECCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTSCEEECSTTC
T ss_pred --EEEEEEECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEc----CCCCEEEeeccC
Confidence 8999999999999999997664 489999999999999999999999999999999999998 788999999999
Q ss_pred cccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcC
Q 037285 967 SKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYC 1046 (1094)
Q Consensus 967 Srl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~ 1046 (1094)
++...........+||+.|+|||++.+ ....+.++|||||||++|+|++|+.||......+....+....+ .+|..+
T Consensus 161 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~p~~~ 237 (328)
T 3fe3_A 161 SNEFTVGGKLDAFCGAPPYAAPELFQG-KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY--RIPFYM 237 (328)
T ss_dssp CGGGSSSCGGGTTSSSGGGCCHHHHHT-CCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCTTS
T ss_pred ceecCCCCccccccCCcceeCcccccC-CCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCCCC
Confidence 986555444556789999999999984 22335899999999999999999999999988888877766654 456788
Q ss_pred cHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1047 DAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1047 S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
+.++.+||.+||..||.+|||+.+++++-+-
T Consensus 238 s~~~~~li~~~L~~dP~~R~t~~eil~h~~~ 268 (328)
T 3fe3_A 238 STDCENLLKRFLVLNPIKRGTLEQIMKDRWI 268 (328)
T ss_dssp CHHHHHHHHHHCCSSTTTSCCHHHHTTCTTT
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcCHhh
Confidence 9999999999999999999999999988654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=370.04 Aligned_cols=264 Identities=33% Similarity=0.516 Sum_probs=216.1
Q ss_pred eeeccCCeeEEEEecccCceEEEEeee------cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEE
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKW------RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAF 878 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~------rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL 878 (1094)
..+...+|++.+.||+|+||.||+|++ .+..||||++.... ......+.+|+.+|++++||||+++
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~ 76 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--------EEHLRDFEREIEILKSLQHDNIVKY 76 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC--------HHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC--------HHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 356678999999999999999999985 36789999986431 2234578899999999999999999
Q ss_pred EeEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCc
Q 037285 879 YGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPI 958 (1094)
Q Consensus 879 ~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~ 958 (1094)
++++.......+++||||+.+++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++ .++.
T Consensus 77 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~----~~~~ 152 (295)
T 3ugc_A 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE----NENR 152 (295)
T ss_dssp EEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE----ETTE
T ss_pred EEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEc----CCCe
Confidence 999875433468999999999999999988776799999999999999999999999999999999999999 7789
Q ss_pred EEEEecCCcccccCc----cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH-------
Q 037285 959 CKVGDFGLSKIKRNT----LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG------- 1027 (1094)
Q Consensus 959 VKLsDFGLSrl~~~~----~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~------- 1027 (1094)
+||+|||+++..... .......++..|+|||++. ...++.++|||||||++|+|+||..||......
T Consensus 153 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~ 230 (295)
T 3ugc_A 153 VKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT--ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 230 (295)
T ss_dssp EEECCCCSCC-------------CTTCGGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCT
T ss_pred EEEccCcccccccCCcceeeeccCCCCccceeCcHHhc--CCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcC
Confidence 999999999854322 1222334677899999998 456899999999999999999999998653221
Q ss_pred --------HHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 037285 1028 --------AIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAA 1082 (1094)
Q Consensus 1028 --------eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~ 1082 (1094)
...........+...+..++.++.+||.+||+.||.+|||+.+|++.|+.+....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 231 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp TCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 0122233445566778889999999999999999999999999999999987543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=372.92 Aligned_cols=264 Identities=33% Similarity=0.514 Sum_probs=217.7
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEe
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVV 882 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~ 882 (1094)
+.+..++|++.++||+|+||.||+|+++ +..||+|.+... .......|.+|+.+|++++||||+++++++
T Consensus 5 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 76 (310)
T 3s95_A 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--------DEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76 (310)
T ss_dssp EEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--------CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred eeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--------CHHHHHHHHHHHHHHHhCCCcCcccEEEEE
Confidence 4567889999999999999999999985 678999988542 123346788999999999999999999999
Q ss_pred ecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 883 QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 883 ~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
.+.. .+++||||+.+++|.+++......+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+
T Consensus 77 ~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~----~~~~~kl~ 150 (310)
T 3s95_A 77 YKDK--RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVR----ENKNVVVA 150 (310)
T ss_dssp EETT--EEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEC----TTSCEEEC
T ss_pred ecCC--eeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEEC----CCCCEEEe
Confidence 8865 89999999999999999988667799999999999999999999999999999999999998 78889999
Q ss_pred ecCCcccccCccc---------------cCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH
Q 037285 963 DFGLSKIKRNTLV---------------SGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG 1027 (1094)
Q Consensus 963 DFGLSrl~~~~~~---------------ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~ 1027 (1094)
|||+++....... .....||+.|+|||++. ...++.++|||||||++|+|++|..||......
T Consensus 151 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~ 228 (310)
T 3s95_A 151 DFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN--GRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPR 228 (310)
T ss_dssp CCTTCEECC--------------------CCCCSCGGGCCHHHHT--TCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCB
T ss_pred ecccceecccccccccccccccccccccccccCCCcceeCHHHhc--CCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhh
Confidence 9999985432211 11456999999999998 467889999999999999999999998754321
Q ss_pred HHH-HhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhc
Q 037285 1028 AII-GGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQ 1084 (1094)
Q Consensus 1028 eil-e~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s~ 1084 (1094)
... ............+..+++.+.+||.+||+.||++|||+.+|++.|+.+......
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 229 TMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp CTTSSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 100 000011111234567888999999999999999999999999999999876543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=365.75 Aligned_cols=266 Identities=31% Similarity=0.500 Sum_probs=227.2
Q ss_pred CcceeeccCCeeEEEEecccCceEEEEeeec-------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCC
Q 037285 802 SSVQVIKNEDLEEQKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHP 873 (1094)
Q Consensus 802 ssv~eIs~edYei~kkLGsG~FGtVYKAk~r-------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HP 873 (1094)
...|++..++|++.+.||+|+||.||+|++. +..||||++..... ......+.+|+.+++++ +||
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~ 87 (313)
T 1t46_A 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-------LTEREALMSELKVLSYLGNHM 87 (313)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-------HHHHHHHHHHHHHHHHHCCCT
T ss_pred ccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh-------HHHHHHHHHHHHHHhhcccCC
Confidence 3457788899999999999999999999852 46799999975421 12246788999999999 999
Q ss_pred ceeEEEeEeecCCCCceEEEeeecccchhHHHHhhccc-----------------ccCHHHHHHHHHHHHHHHHHHHHCC
Q 037285 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDR-----------------FLDRRRRLIIAMDAAFGMEYLHSKN 936 (1094)
Q Consensus 874 NIVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~-----------------~Lse~~~l~Ia~QIaeGLaYLHs~G 936 (1094)
||+++++++.... ..++||||+.+|+|.+++..... .+++..++.++.||+.||.|||+++
T Consensus 88 ~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 165 (313)
T 1t46_A 88 NIVNLLGACTIGG--PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN 165 (313)
T ss_dssp TBCCEEEEECSSS--SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CeeeEEEEEecCC--CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999999998754 89999999999999999976542 3899999999999999999999999
Q ss_pred ceeccCCCCceEeccCCCCCCcEEEEecCCcccccCcc---ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHH
Q 037285 937 IVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTL---VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWE 1013 (1094)
Q Consensus 937 IIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~~---~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyE 1013 (1094)
|+||||||+|||++ .++.+||+|||+++...... ......+|+.|+|||++. ...++.++|||||||++|+
T Consensus 166 i~H~dlkp~Nil~~----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~e 239 (313)
T 1t46_A 166 CIHRDLAARNILLT----HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF--NCVYTFESDVWSYGIFLWE 239 (313)
T ss_dssp CCCSCCSGGGEEEE----TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH--HCCCCHHHHHHHHHHHHHH
T ss_pred eecCCCccceEEEc----CCCCEEEccccccccccccccceeccCCCCcceeeChHHhc--CCCCChHHHHHHHHHHHHH
Confidence 99999999999998 78899999999998543321 223445778899999987 4568899999999999999
Q ss_pred HHc-CCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 037285 1014 ILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAA 1082 (1094)
Q Consensus 1014 LLT-Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~ 1082 (1094)
|+| |+.||.................+...+..++..+.+||.+||..||.+|||+.+|+++|+++....
T Consensus 240 llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 240 LFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp HHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHhCCCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 999 999999887666666666667777778889999999999999999999999999999999987653
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=373.77 Aligned_cols=262 Identities=32% Similarity=0.558 Sum_probs=221.4
Q ss_pred eeccCCeeEEEEecccCceEEEEeeecC-------ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEE
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAF 878 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~rG-------t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL 878 (1094)
.+..++|++.+.||+|+||.||+|++.+ ..||||+++... .......+.+|+.++++++||||+++
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~hp~iv~~ 115 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-------SADMQADFQREAALMAEFDNPNIVKL 115 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-------CHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-------CHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 5667899999999999999999999864 679999987532 12334678899999999999999999
Q ss_pred EeEeecCCCCceEEEeeecccchhHHHHhhcc-----------------------cccCHHHHHHHHHHHHHHHHHHHHC
Q 037285 879 YGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD-----------------------RFLDRRRRLIIAMDAAFGMEYLHSK 935 (1094)
Q Consensus 879 ~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~-----------------------~~Lse~~~l~Ia~QIaeGLaYLHs~ 935 (1094)
++++.+.. .+++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++
T Consensus 116 ~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~ 193 (343)
T 1luf_A 116 LGVCAVGK--PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER 193 (343)
T ss_dssp EEEECSSS--SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEccCC--ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 99998754 8999999999999999997642 4689999999999999999999999
Q ss_pred CceeccCCCCceEeccCCCCCCcEEEEecCCcccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHH
Q 037285 936 NIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLW 1012 (1094)
Q Consensus 936 GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLy 1012 (1094)
+|+||||||+|||++ .++.+||+|||+++..... .......+|+.|+|||++. ...++.++|||||||++|
T Consensus 194 ~ivH~Dlkp~NIl~~----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~Di~slG~il~ 267 (343)
T 1luf_A 194 KFVHRDLATRNCLVG----ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF--YNRYTTESDVWAYGVVLW 267 (343)
T ss_dssp TCCCSCCSGGGEEEC----GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH--HCCCCHHHHHHHHHHHHH
T ss_pred CeecCCCCcceEEEC----CCCeEEEeecCCCcccccCccccccCCCcccceecChhhhc--cCCcCcccccHHHHHHHH
Confidence 999999999999998 6789999999999743221 2223445788999999998 456899999999999999
Q ss_pred HHHc-CCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 037285 1013 EILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAAS 1083 (1094)
Q Consensus 1013 ELLT-Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s 1083 (1094)
+|+| |+.||......+....+.. ......+..++..+.+||.+||+.||.+|||+.+|+++|+.+.....
T Consensus 268 el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 268 EIFSYGLQPYYGMAHEEVIYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp HHHTTTCCTTTTSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred HHHhcCCCcCCCCChHHHHHHHhC-CCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 9999 9999999888777766644 34456778899999999999999999999999999999999875443
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=358.68 Aligned_cols=258 Identities=32% Similarity=0.615 Sum_probs=224.1
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeec-CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEee
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQ 883 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~r-Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~ 883 (1094)
|.+..++|++.+.||+|+||.||+|++. +..||||++...... ...+.+|+.++++++||||+++++++.
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~ 73 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---------EEDFIEEAEVMMKLSHPKLVQLYGVCL 73 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC---------HHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC---------HHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 6678899999999999999999999985 567999999764221 246789999999999999999999998
Q ss_pred cCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEe
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGD 963 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsD 963 (1094)
+.. .+++||||+++++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|
T Consensus 74 ~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~----~~~~~kl~d 147 (267)
T 3t9t_A 74 EQA--PICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG----ENQVIKVSD 147 (267)
T ss_dssp SSS--SCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC----GGGCEEECC
T ss_pred cCC--CeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEC----CCCCEEEcc
Confidence 754 89999999999999999987766789999999999999999999999999999999999998 678899999
Q ss_pred cCCcccccCc--cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCC
Q 037285 964 FGLSKIKRNT--LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 1040 (1094)
Q Consensus 964 FGLSrl~~~~--~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp 1040 (1094)
||+++..... .......+|..|+|||++. ...++.++||||||+++|+|++ |+.||......+....+. ...+.
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~-~~~~~ 224 (267)
T 3t9t_A 148 FGMTRFVLDDQYTSSTGTKFPVKWASPEVFS--FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRL 224 (267)
T ss_dssp TTGGGGBCCHHHHSTTSTTCCGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCC
T ss_pred cccccccccccccccccccccccccChhhhc--CCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHh-cCCcC
Confidence 9999854322 1223345778899999997 4567899999999999999999 999999988877776654 44556
Q ss_pred CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 037285 1041 TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLST 1080 (1094)
Q Consensus 1041 ~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~t 1080 (1094)
..+..++..+.++|.+||+.||.+||++.+++++|+.+..
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 6677889999999999999999999999999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=374.48 Aligned_cols=266 Identities=32% Similarity=0.491 Sum_probs=224.1
Q ss_pred CcceeeccCCeeEEEEecccCceEEEEeeec-------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCC
Q 037285 802 SSVQVIKNEDLEEQKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHP 873 (1094)
Q Consensus 802 ssv~eIs~edYei~kkLGsG~FGtVYKAk~r-------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HP 873 (1094)
...|++..++|++.+.||+|+||.||+|++. +..||||++..... ......+.+|+.+|+++ +||
T Consensus 37 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~~hp 109 (344)
T 1rjb_A 37 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-------SSEREALMSELKMMTQLGSHE 109 (344)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------CHHHHHHHHHHHHHCCCT
T ss_pred CcCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC-------HHHHHHHHHHHHHHHhhcCCC
Confidence 3457888899999999999999999999862 34699999975321 12235788999999999 899
Q ss_pred ceeEEEeEeecCCCCceEEEeeecccchhHHHHhhccc----------------------ccCHHHHHHHHHHHHHHHHH
Q 037285 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDR----------------------FLDRRRRLIIAMDAAFGMEY 931 (1094)
Q Consensus 874 NIVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~----------------------~Lse~~~l~Ia~QIaeGLaY 931 (1094)
||+++++++.... .+++||||+++|+|.+++..... .+++..++.++.||+.||.|
T Consensus 110 ~iv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 187 (344)
T 1rjb_A 110 NIVNLLGACTLSG--PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 187 (344)
T ss_dssp TBCCEEEEECSSS--SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHH
T ss_pred CeeeEEEEEeeCC--ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHH
Confidence 9999999998754 89999999999999999976542 37899999999999999999
Q ss_pred HHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHH
Q 037285 932 LHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFG 1008 (1094)
Q Consensus 932 LHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLG 1008 (1094)
||++||+||||||+|||++ .++.+||+|||+++..... .......+|+.|+|||++. ...++.++||||||
T Consensus 188 LH~~~ivH~Dikp~NIll~----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~Di~slG 261 (344)
T 1rjb_A 188 LEFKSCVHRDLAARNVLVT----HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF--EGIYTIKSDVWSYG 261 (344)
T ss_dssp HHHTTEEETTCSGGGEEEE----TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH--HCCCCHHHHHHHHH
T ss_pred HHhCCcccCCCChhhEEEc----CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhc--cCCCChhHhHHHHH
Confidence 9999999999999999999 7889999999999844221 2233445788999999997 45688999999999
Q ss_pred HHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 037285 1009 IVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAA 1082 (1094)
Q Consensus 1009 VLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~ 1082 (1094)
|++|+|+| |..||.....................+..++.++.+||.+||..||.+|||+.+|+++|+.+....
T Consensus 262 ~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 262 ILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp HHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred HHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 99999998 999999887766666666777777788889999999999999999999999999999999987543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=379.37 Aligned_cols=268 Identities=31% Similarity=0.531 Sum_probs=228.6
Q ss_pred cceeeccCCeeEEEEecccCceEEEEeeecC---------ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CC
Q 037285 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKWRG---------TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HH 872 (1094)
Q Consensus 803 sv~eIs~edYei~kkLGsG~FGtVYKAk~rG---------t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~H 872 (1094)
..|++..++|++.+.||+|+||.||+|++.+ ..||||+++... .......+.+|+.+++++ +|
T Consensus 62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h 134 (382)
T 3tt0_A 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-------TEKDLSDLISEMEMMKMIGKH 134 (382)
T ss_dssp TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-------CHHHHHHHHHHHHHHHHHCCC
T ss_pred cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-------CHHHHHHHHHHHHHHHHhcCC
Confidence 3467888999999999999999999998632 469999987541 123346788999999999 89
Q ss_pred CceeEEEeEeecCCCCceEEEeeecccchhHHHHhhcc---------------cccCHHHHHHHHHHHHHHHHHHHHCCc
Q 037285 873 PNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD---------------RFLDRRRRLIIAMDAAFGMEYLHSKNI 937 (1094)
Q Consensus 873 PNIVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~---------------~~Lse~~~l~Ia~QIaeGLaYLHs~GI 937 (1094)
|||+++++++.+.. .+++||||+.+|+|.+++.... ..+++..++.++.||+.||+|||+++|
T Consensus 135 pnIv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 212 (382)
T 3tt0_A 135 KNIINLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC 212 (382)
T ss_dssp TTBCCEEEEECSSS--SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred chhhhheeeeccCC--ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 99999999998754 8999999999999999997653 348999999999999999999999999
Q ss_pred eeccCCCCceEeccCCCCCCcEEEEecCCcccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHH
Q 037285 938 VHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEI 1014 (1094)
Q Consensus 938 IHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyEL 1014 (1094)
+||||||+|||++ .++.+||+|||+++..... .......+|+.|+|||++. ...++.++|||||||++|+|
T Consensus 213 vH~Dlkp~NIll~----~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~DiwslG~il~el 286 (382)
T 3tt0_A 213 IHRDLAARNVLVT----EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF--DRIYTHQSDVWSFGVLLWEI 286 (382)
T ss_dssp CCSCCCGGGEEEC----TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHH--SCCCCHHHHHHHHHHHHHHH
T ss_pred ecCCCCcceEEEc----CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhc--CCCCCchhHHHHHHHHHHHH
Confidence 9999999999998 7789999999999854322 2233445788999999998 46789999999999999999
Q ss_pred Hc-CCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhcCC
Q 037285 1015 LT-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQTK 1086 (1094)
Q Consensus 1015 LT-Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s~pe 1086 (1094)
++ |..||......+....+ ....+...+..++.++.+||.+||+.||.+|||+.+|+++|+.+.......+
T Consensus 287 lt~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 287 FTLGGSPYPGVPVEELFKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp HTTSCCSSTTCCHHHHHHHH-HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred HhCCCCCCCCCCHHHHHHHH-HcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 99 99999988877766655 4555667788899999999999999999999999999999999986654433
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=362.50 Aligned_cols=268 Identities=36% Similarity=0.648 Sum_probs=221.7
Q ss_pred ceeeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeE
Q 037285 804 VQVIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGV 881 (1094)
Q Consensus 804 v~eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv 881 (1094)
...+..++|++.+.||+|+||.||+|++. ++.||||++....... ..........+.+|+.++++++||||++++++
T Consensus 13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 91 (287)
T 4f0f_A 13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEG-ETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL 91 (287)
T ss_dssp CCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTC-CHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeecccccc-chhHHHHHHHHHHHHHHHHhCCCCCchhhhee
Confidence 34566789999999999999999999884 6789999987643221 11111122578899999999999999999999
Q ss_pred eecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeccCC-CCCCc
Q 037285 882 VQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNLKD-PSRPI 958 (1094)
Q Consensus 882 ~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~G--IIHRDLKPeNILLD~~~-~e~g~ 958 (1094)
+.+. .++||||+.+++|.+++......+++..++.++.||+.||+|||+++ |+||||||+|||++..+ .....
T Consensus 92 ~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~ 167 (287)
T 4f0f_A 92 MHNP----PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVC 167 (287)
T ss_dssp ETTT----TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred ecCC----CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCcee
Confidence 9764 36899999999999999877777999999999999999999999999 99999999999998322 12234
Q ss_pred EEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHH--HHhHhhc
Q 037285 959 CKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAI--IGGIVNN 1036 (1094)
Q Consensus 959 VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~ei--le~Iv~~ 1036 (1094)
+||+|||+++..... .....||+.|+|||++.+....++.++|||||||++|+|++|+.||........ ...+...
T Consensus 168 ~kl~Dfg~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 245 (287)
T 4f0f_A 168 AKVADFGLSQQSVHS--VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE 245 (287)
T ss_dssp EEECCCTTCBCCSSC--EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS
T ss_pred EEeCCCCcccccccc--ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc
Confidence 999999999854332 234568999999999964456678999999999999999999999987654433 4555566
Q ss_pred cCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1037 TLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1037 ~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
...+.++..+++.+.++|.+||+.||.+|||+.+|++.|+++
T Consensus 246 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 246 GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 777888899999999999999999999999999999999753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=361.82 Aligned_cols=261 Identities=31% Similarity=0.578 Sum_probs=212.8
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeec-----CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEE
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFY 879 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~r-----Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~ 879 (1094)
+++..++|++.+.||+|+||.||+|++. +..||||.+.... .......+.+|+.++++++||||++++
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~ 82 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-------SDSVREKFLQEALTMRQFDHPHIVKLI 82 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-------SHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-------CHHHHHHHHHHHHHHHhCCCCccceEE
Confidence 4677789999999999999999999874 2359999876431 123346788999999999999999999
Q ss_pred eEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcE
Q 037285 880 GVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC 959 (1094)
Q Consensus 880 Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~V 959 (1094)
+++.+. ..++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 83 ~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~ 155 (281)
T 1mp8_A 83 GVITEN---PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS----SNDCV 155 (281)
T ss_dssp EEECSS---SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE----ETTEE
T ss_pred EEEccC---ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEEC----CCCCE
Confidence 998543 68999999999999999987766799999999999999999999999999999999999999 67899
Q ss_pred EEEecCCcccccCcc--ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhc
Q 037285 960 KVGDFGLSKIKRNTL--VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 1036 (1094)
Q Consensus 960 KLsDFGLSrl~~~~~--~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~ 1036 (1094)
||+|||+++...... ......+|+.|+|||++. ...++.++|||||||++|+|++ |..||......+....+..
T Consensus 156 kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~- 232 (281)
T 1mp8_A 156 KLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN--FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN- 232 (281)
T ss_dssp EECC-------------------CCGGGCCHHHHH--HCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-
T ss_pred EECccccccccCcccccccccCCCcccccChhhcc--cCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHc-
Confidence 999999998543322 122334678899999997 4568899999999999999997 9999998887777666544
Q ss_pred cCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 037285 1037 TLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAA 1082 (1094)
Q Consensus 1037 ~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~ 1082 (1094)
......+..++..+.++|.+||+.||.+|||+.+|+++|+.+....
T Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 233 GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 3445677889999999999999999999999999999999987543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=380.55 Aligned_cols=267 Identities=28% Similarity=0.510 Sum_probs=224.5
Q ss_pred cceeeccCCeeEEEEecccCceEEEEeeec-------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCce
Q 037285 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNV 875 (1094)
Q Consensus 803 sv~eIs~edYei~kkLGsG~FGtVYKAk~r-------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNI 875 (1094)
..+++..++|++.+.||+|+||.||+|++. +..||||+++... .......+.+|+.++++++||||
T Consensus 64 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~hpnI 136 (367)
T 3l9p_A 64 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-------SEQDELDFLMEALIISKFNHQNI 136 (367)
T ss_dssp GSCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-------CHHHHHHHHHHHHHHHHCCCTTB
T ss_pred chhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-------ChhhHHHHHHHHHHHHhCCCCCC
Confidence 456677889999999999999999999864 3469999986431 12223568899999999999999
Q ss_pred eEEEeEeecCCCCceEEEeeecccchhHHHHhhcc------cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEe
Q 037285 876 VAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD------RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV 949 (1094)
Q Consensus 876 VqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~------~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILL 949 (1094)
+++++++.+.. ..++||||+.+|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 137 v~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 214 (367)
T 3l9p_A 137 VRCIGVSLQSL--PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLL 214 (367)
T ss_dssp CCEEEEECSSS--SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred CeEEEEEecCC--CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE
Confidence 99999998754 7899999999999999997653 358999999999999999999999999999999999999
Q ss_pred ccCCCCCCcEEEEecCCccccc---CccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 037285 950 NLKDPSRPICKVGDFGLSKIKR---NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH 1025 (1094)
Q Consensus 950 D~~~~e~g~VKLsDFGLSrl~~---~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~ 1025 (1094)
+..+ .+..+||+|||+++... .........+|+.|+|||++. ...++.++|||||||++|||++ |..||....
T Consensus 215 ~~~~-~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~DvwslG~il~ellt~g~~pf~~~~ 291 (367)
T 3l9p_A 215 TCPG-PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFM--EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 291 (367)
T ss_dssp SCSS-TTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ecCC-CCceEEECCCccccccccccccccCCCcCCcccEECHHHhc--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 8433 34569999999997431 122233456789999999997 4568999999999999999998 999999988
Q ss_pred hHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 037285 1026 YGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAA 1082 (1094)
Q Consensus 1026 ~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~ 1082 (1094)
..+....+.. ..+...+..++..+.+||.+||+.||.+|||+.+|+++|+.+....
T Consensus 292 ~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 292 NQEVLEFVTS-GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp HHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HHHHHHHHHc-CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 8877766644 4456667889999999999999999999999999999999987553
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=359.48 Aligned_cols=271 Identities=32% Similarity=0.536 Sum_probs=229.1
Q ss_pred eeeccCCeeEEE-EecccCceEEEEeeec----CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEE
Q 037285 805 QVIKNEDLEEQK-ELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFY 879 (1094)
Q Consensus 805 ~eIs~edYei~k-kLGsG~FGtVYKAk~r----Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~ 879 (1094)
+.+..++|.+.+ .||+|+||.||+|.++ +..||||+++... .......+.+|+.++++++||||++++
T Consensus 4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~~ 76 (287)
T 1u59_A 4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-------EKADTEEMMREAQIMHQLDNPYIVRLI 76 (287)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-------CHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-------chhHHHHHHHHHHHHHhCCCCCEeEEE
Confidence 356678888887 9999999999999863 5679999997541 123346788999999999999999999
Q ss_pred eEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcE
Q 037285 880 GVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC 959 (1094)
Q Consensus 880 Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~V 959 (1094)
+++... .+++||||+.+++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+
T Consensus 77 ~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~ 149 (287)
T 1u59_A 77 GVCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV----NRHYA 149 (287)
T ss_dssp EEEESS---SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE----ETTEE
T ss_pred EEecCC---CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEc----CCCCE
Confidence 999543 68999999999999999977666799999999999999999999999999999999999998 67899
Q ss_pred EEEecCCcccccCc----cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHh
Q 037285 960 KVGDFGLSKIKRNT----LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIV 1034 (1094)
Q Consensus 960 KLsDFGLSrl~~~~----~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv 1034 (1094)
||+|||+++..... .......+|+.|+|||++. ...++.++|||||||++|+|+| |+.||......+....+
T Consensus 150 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i- 226 (287)
T 1u59_A 150 KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN--FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI- 226 (287)
T ss_dssp EECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHH--HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH-
T ss_pred EECcccceeeeccCcceeeccccccccccccCHHHhc--cCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH-
Confidence 99999999854322 1122344688999999997 4567899999999999999998 99999988877766655
Q ss_pred hccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhcCCCCCCCC
Q 037285 1035 NNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQTKGHGNKP 1092 (1094)
Q Consensus 1035 ~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s~pe~~~~kp 1092 (1094)
....++.++..++..+.++|.+||..||.+||++.+|+++|+.+..+...+...+.+-
T Consensus 227 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~ 284 (287)
T 1u59_A 227 EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHHH 284 (287)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSSCCCT
T ss_pred hcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccCCccc
Confidence 4455567788899999999999999999999999999999999998877666555443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=364.89 Aligned_cols=264 Identities=26% Similarity=0.367 Sum_probs=212.4
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCch------------------hHHHHHHHHHHHHHH
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSS------------------EQERLTVEFWKEAEI 866 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~------------------eqe~~~~eFlrEIkI 866 (1094)
+..++|++.+.||+|+||.||+|+.. ++.||||++.......... ........+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 34578999999999999999999874 6789999997653221100 011223568899999
Q ss_pred HhhCCCCceeEEEeEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 037285 867 LSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDN 946 (1094)
Q Consensus 867 LkrL~HPNIVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeN 946 (1094)
|++++||||+++++++.+.....+++||||+.+++|.+++.. ..+++..++.++.||+.||.|||+++|+||||||+|
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 999999999999999987555689999999999999886533 358999999999999999999999999999999999
Q ss_pred eEeccCCCCCCcEEEEecCCcccccC-ccccCCccCCCcccCccccccCCCC-CCchhhHHHHHHHHHHHHcCCCCCCCC
Q 037285 947 LLVNLKDPSRPICKVGDFGLSKIKRN-TLVSGGVRGTLPWMAPELLSGSSSK-VSEKVDVFSFGIVLWEILTGEEPYANM 1024 (1094)
Q Consensus 947 ILLD~~~~e~g~VKLsDFGLSrl~~~-~~~ss~~~GT~~YmAPEvL~g~~~k-yS~KSDVWSLGVLLyELLTGk~PF~~~ 1024 (1094)
||++ .++.+||+|||+++.... ........||+.|+|||++.+.... ++.++|||||||++|+|++|+.||...
T Consensus 168 il~~----~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 168 LLVG----EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp EEEC----TTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEEC----CCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 9998 778999999999985433 2223455799999999999743222 478899999999999999999999988
Q ss_pred ChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1025 HYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1025 ~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
........+............++..+.+||.+||+.||.+|||+.+++++-+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~ 295 (298)
T 2zv2_A 244 RIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295 (298)
T ss_dssp SHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHH
T ss_pred cHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcc
Confidence 7777666665555544445578999999999999999999999999998755
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=366.08 Aligned_cols=250 Identities=26% Similarity=0.410 Sum_probs=213.2
Q ss_pred cCCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
..+|++.+.||+|+||.||+|++ .++.||||++...... ....+.+|+.++++++||||+++++++....
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--------KKELIINEILVMRENKNPNIVNYLDSYLVGD 90 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS--------CHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--------HHHHHHHHHHHHhcCCCCCCCeEeEEEEECC
Confidence 35799999999999999999976 4788999998754321 1245788999999999999999999998865
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+++||||+.+|+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 91 --~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~----~~~~~kl~Dfg~ 162 (297)
T 3fxz_A 91 --ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG----MDGSVKLTDFGF 162 (297)
T ss_dssp --EEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCCEEECCCTT
T ss_pred --EEEEEEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEC----CCCCEEEeeCCC
Confidence 899999999999999999754 489999999999999999999999999999999999998 778999999999
Q ss_pred cccccC-ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhcc-CCCCCCC
Q 037285 967 SKIKRN-TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-LRPTIPS 1044 (1094)
Q Consensus 967 Srl~~~-~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~-lrp~iPe 1044 (1094)
++.... ........||+.|+|||++. ...++.++|||||||++|+|++|+.||...........+.... .....+.
T Consensus 163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (297)
T 3fxz_A 163 CAQITPEQSKRSTMVGTPYWMAPEVVT--RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE 240 (297)
T ss_dssp CEECCSTTCCBCCCCSCGGGCCHHHHH--CSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGG
T ss_pred ceecCCcccccCCccCCcCccChhhhc--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCcc
Confidence 885432 22334567999999999998 4568899999999999999999999999887766555544332 2344567
Q ss_pred cCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1045 YCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1045 ~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
.++..+.+||.+||+.||.+|||+.+++++-+
T Consensus 241 ~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~ 272 (297)
T 3fxz_A 241 KLSAIFRDFLNRCLEMDVEKRGSAKELLQHQF 272 (297)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhhChh
Confidence 88999999999999999999999999998654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=375.97 Aligned_cols=254 Identities=26% Similarity=0.394 Sum_probs=219.1
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
++.++|++.+.||+|+||.||+|+.+ ++.||||++++.... .......+.+|+.+|++++||||+++++++.+
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 76 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-----AKDEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh-----hhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe
Confidence 34578999999999999999999875 788999999764211 12234567889999999999999999999988
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
.. .+++||||+.+|+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus 77 ~~--~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~----~~g~vkL~DF 149 (337)
T 1o6l_A 77 HD--RLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD----KDGHIKITDF 149 (337)
T ss_dssp SS--EEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEECCC
T ss_pred CC--EEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEEC----CCCCEEEeec
Confidence 65 8999999999999999997654 589999999999999999999999999999999999998 7889999999
Q ss_pred CCcccc-cCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCC
Q 037285 965 GLSKIK-RNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIP 1043 (1094)
Q Consensus 965 GLSrl~-~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iP 1043 (1094)
|+++.. .........+||+.|+|||++. ...++.++|||||||++|||++|+.||...........+..... .+|
T Consensus 150 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~p 225 (337)
T 1o6l_A 150 GLCKEGISDGATMKTFCGTPEYLAPEVLE--DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI--RFP 225 (337)
T ss_dssp TTCBCSCCTTCCBCCCEECGGGCCGGGGS--SSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCC
T ss_pred cchhhcccCCCcccccccChhhCChhhhc--CCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCC
Confidence 999853 2233345667999999999998 45688999999999999999999999999888877777766543 467
Q ss_pred CcCcHHHHHHHHHhccCCCCCCC-----CHHHHHHHHH
Q 037285 1044 SYCDAEWRTLMEECWAPNPAARP-----SFTEIASRLR 1076 (1094)
Q Consensus 1044 e~~S~eL~dLI~kCLq~DPeeRP-----S~eELLq~L~ 1076 (1094)
..++.++.+||.+||+.||.+|| ++.+|+++-+
T Consensus 226 ~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~ 263 (337)
T 1o6l_A 226 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCC
Confidence 78999999999999999999999 8999998754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=362.29 Aligned_cols=261 Identities=31% Similarity=0.503 Sum_probs=222.1
Q ss_pred ceeeccCCeeEEEEecccCceEEEEeeec-------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCcee
Q 037285 804 VQVIKNEDLEEQKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVV 876 (1094)
Q Consensus 804 v~eIs~edYei~kkLGsG~FGtVYKAk~r-------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIV 876 (1094)
.+.+...+|++.+.||+|+||.||+|++. +..||||++.... .......+.+|+.+|++++||||+
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~hp~iv 89 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-------SPSELRDLLSEFNVLKQVNHPHVI 89 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-------CHHHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-------CHHHHHHHHHHHHHHhhCCCCcee
Confidence 45677889999999999999999999762 3679999987531 123346788999999999999999
Q ss_pred EEEeEeecCCCCceEEEeeecccchhHHHHhhcc-----------------------cccCHHHHHHHHHHHHHHHHHHH
Q 037285 877 AFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD-----------------------RFLDRRRRLIIAMDAAFGMEYLH 933 (1094)
Q Consensus 877 qL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~-----------------------~~Lse~~~l~Ia~QIaeGLaYLH 933 (1094)
++++++.+.. .+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||
T Consensus 90 ~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH 167 (314)
T 2ivs_A 90 KLYGACSQDG--PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA 167 (314)
T ss_dssp CEEEEECSSS--SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEecCC--ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH
Confidence 9999998754 8999999999999999997643 24899999999999999999999
Q ss_pred HCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHHHH
Q 037285 934 SKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIV 1010 (1094)
Q Consensus 934 s~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVL 1010 (1094)
+++|+||||||+|||++ .++.+||+|||+++..... .......+|+.|+|||++. ...++.++|||||||+
T Consensus 168 ~~~ivH~dikp~NIli~----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~i 241 (314)
T 2ivs_A 168 EMKLVHRDLAARNILVA----EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF--DHIYTTQSDVWSFGVL 241 (314)
T ss_dssp HTTEECCCCSGGGEEEE----TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHH--HCEECHHHHHHHHHHH
T ss_pred HCCCcccccchheEEEc----CCCCEEEccccccccccccccceeccCCCCcccccChhhhc--CCCcCchhhHHHHHHH
Confidence 99999999999999999 7789999999999854322 1223345788899999998 4567899999999999
Q ss_pred HHHHHc-CCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 037285 1011 LWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLST 1080 (1094)
Q Consensus 1011 LyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~t 1080 (1094)
+|+|++ |+.||...........+ ........+..++..+.++|.+||+.||.+||++.+|+++|+++..
T Consensus 242 l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 242 LWEIVTLGGNPYPGIPPERLFNLL-KTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp HHHHHTTSCCSSTTCCGGGHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHh-hcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999 99999988877666554 4455666778899999999999999999999999999999999864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=373.47 Aligned_cols=263 Identities=25% Similarity=0.361 Sum_probs=213.1
Q ss_pred ceeeccCCeeEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEee
Q 037285 804 VQVIKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQ 883 (1094)
Q Consensus 804 v~eIs~edYei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~ 883 (1094)
-+.+...+|++.++||+|+||.||+|+++++.||||++.... .....+.+|+.+|++++||||+++++++.
T Consensus 18 n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 88 (322)
T 3soc_A 18 NLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD---------KQSWQNEYEVYSLPGMKHENILQFIGAEK 88 (322)
T ss_dssp CEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG---------HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred ccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc---------hHHHHHHHHHHHHhcCCCCCchhhcceec
Confidence 356788899999999999999999999999999999986431 12234556999999999999999999998
Q ss_pred cCC--CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHC----------CceeccCCCCceEecc
Q 037285 884 DGP--GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSK----------NIVHFDLKCDNLLVNL 951 (1094)
Q Consensus 884 d~~--~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~----------GIIHRDLKPeNILLD~ 951 (1094)
... ...+++||||+.+|+|.+++... .+++..++.++.||+.||+|||+. +|+||||||+|||++
T Consensus 89 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~- 165 (322)
T 3soc_A 89 RGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK- 165 (322)
T ss_dssp EECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEEC-
T ss_pred cCCCCCceEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEEC-
Confidence 643 23479999999999999999654 489999999999999999999999 999999999999998
Q ss_pred CCCCCCcEEEEecCCcccccCc---cccCCccCCCcccCccccccCC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 037285 952 KDPSRPICKVGDFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSS---SKVSEKVDVFSFGIVLWEILTGEEPYANMH 1025 (1094)
Q Consensus 952 ~~~e~g~VKLsDFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~---~kyS~KSDVWSLGVLLyELLTGk~PF~~~~ 1025 (1094)
.++.+||+|||+++..... .......||+.|+|||++.+.. ..++.++|||||||++|||+||+.||....
T Consensus 166 ---~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 242 (322)
T 3soc_A 166 ---NNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242 (322)
T ss_dssp ---TTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred ---CCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence 7789999999999754322 1233456899999999987421 245678999999999999999999997532
Q ss_pred ----------------hHHHHHhHhhccCCCCCCCc-----CcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1026 ----------------YGAIIGGIVNNTLRPTIPSY-----CDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1026 ----------------~~eile~Iv~~~lrp~iPe~-----~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
.......+.....++..+.. ++.++.+||.+||+.||++|||+.+|++.|+.+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 12233333344444444332 345699999999999999999999999999998753
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=363.88 Aligned_cols=267 Identities=31% Similarity=0.530 Sum_probs=223.9
Q ss_pred ceeeccCCeeEEEEecccCceEEEEeeec-------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCce
Q 037285 804 VQVIKNEDLEEQKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNV 875 (1094)
Q Consensus 804 v~eIs~edYei~kkLGsG~FGtVYKAk~r-------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNI 875 (1094)
.|.+..++|++.+.||+|+||.||+|++. +..||||++.... .......+.+|+.+++++ +||||
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~hp~i 93 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-------THSEHRALMSELKILIHIGHHLNV 93 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-------CHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-------CcHHHHHHHHHHHHHHhcccCCCe
Confidence 45677889999999999999999999852 3679999987542 122335788999999999 79999
Q ss_pred eEEEeEeecCCCCceEEEeeecccchhHHHHhhccc---------------ccCHHHHHHHHHHHHHHHHHHHHCCceec
Q 037285 876 VAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDR---------------FLDRRRRLIIAMDAAFGMEYLHSKNIVHF 940 (1094)
Q Consensus 876 VqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~---------------~Lse~~~l~Ia~QIaeGLaYLHs~GIIHR 940 (1094)
+++++++... ...+++||||+.+++|.+++..... .+++..++.++.||+.||.|||+++|+||
T Consensus 94 v~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~ 172 (316)
T 2xir_A 94 VNLLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR 172 (316)
T ss_dssp CCEEEEECCT-TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred eeEEEEEecC-CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence 9999998764 3468999999999999999976543 28899999999999999999999999999
Q ss_pred cCCCCceEeccCCCCCCcEEEEecCCcccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-
Q 037285 941 DLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT- 1016 (1094)
Q Consensus 941 DLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT- 1016 (1094)
||||+|||++ .++.+||+|||+++..... .......+|+.|+|||++. ...++.++|||||||++|+|+|
T Consensus 173 dikp~Nil~~----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~t~ 246 (316)
T 2xir_A 173 DLAARNILLS----EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSL 246 (316)
T ss_dssp CCSGGGEEEC----GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTT
T ss_pred cCccceEEEC----CCCCEEECCCccccccccCccceeccCCCcceeecCchhhc--cccccchhHHHHHHHHHHHHHhC
Confidence 9999999998 6788999999999854321 2233455788999999998 4568899999999999999998
Q ss_pred CCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhc
Q 037285 1017 GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQ 1084 (1094)
Q Consensus 1017 Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s~ 1084 (1094)
|+.||.....................+..+++.+.++|.+||+.||.+|||+.+|+++|..+..+..+
T Consensus 247 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 314 (316)
T 2xir_A 247 GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 314 (316)
T ss_dssp SCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred CCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcc
Confidence 99999887765555555555666677888999999999999999999999999999999999876543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=356.19 Aligned_cols=262 Identities=33% Similarity=0.583 Sum_probs=223.9
Q ss_pred cceeeccCCeeEEEEecccCceEEEEeeecC-ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeE
Q 037285 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGV 881 (1094)
Q Consensus 803 sv~eIs~edYei~kkLGsG~FGtVYKAk~rG-t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv 881 (1094)
..|++..++|++.+.||+|+||.||+|++++ ..||||.+..... ....+.+|+.+|++++||||++++++
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~~i~~~~~~ 76 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM---------SPDAFLAEANLMKQLQHQRLVRLYAV 76 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS---------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc---------cHHHHHHHHHHHHhCCCcCcceEEEE
Confidence 3577888999999999999999999999864 5799999875421 12468899999999999999999999
Q ss_pred eecCCCCceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEE
Q 037285 882 VQDGPGGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICK 960 (1094)
Q Consensus 882 ~~d~~~~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VK 960 (1094)
+... ..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+|
T Consensus 77 ~~~~---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~----~~~~~k 149 (279)
T 1qpc_A 77 VTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS----DTLSCK 149 (279)
T ss_dssp ECSS---SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTSCEE
T ss_pred EcCC---CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEc----CCCCEE
Confidence 8753 5899999999999999997543 3589999999999999999999999999999999999998 778999
Q ss_pred EEecCCcccccCc--cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhcc
Q 037285 961 VGDFGLSKIKRNT--LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNT 1037 (1094)
Q Consensus 961 LsDFGLSrl~~~~--~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~ 1037 (1094)
|+|||+++..... .......++..|+|||++. ...++.++||||||+++|+|++ |+.||......+....+ ...
T Consensus 150 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-~~~ 226 (279)
T 1qpc_A 150 IADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN--YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-ERG 226 (279)
T ss_dssp ECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHH--HCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-HTT
T ss_pred ECCCcccccccCcccccccCCCCccCccChhhhc--cCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHH-hcc
Confidence 9999999854332 2223445788999999997 4567899999999999999999 99999988877766655 445
Q ss_pred CCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 037285 1038 LRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAAS 1083 (1094)
Q Consensus 1038 lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s 1083 (1094)
.....+..++..+.++|.+||..||.+|||+.+|++.|+.+.++..
T Consensus 227 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 227 YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 5666778899999999999999999999999999999999986543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=360.53 Aligned_cols=263 Identities=35% Similarity=0.602 Sum_probs=208.5
Q ss_pred cceeeccCCeeEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEe
Q 037285 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVV 882 (1094)
Q Consensus 803 sv~eIs~edYei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~ 882 (1094)
..++|..++|++.++||+|+||.||+|++.+ .||||+++.... .......|.+|+.+|++++||||+++++++
T Consensus 17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 89 (289)
T 3og7_A 17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAP------TPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89 (289)
T ss_dssp -CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSC------CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCC------CHHHHHHHHHHHHHHHhCCCCcEEEEEeec
Confidence 3467888999999999999999999998865 599999875421 123346788999999999999999999976
Q ss_pred ecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 883 QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 883 ~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
... .+++||||+.+++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+
T Consensus 90 ~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~----~~~~~kl~ 162 (289)
T 3og7_A 90 TAP---QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH----EDNTVKIG 162 (289)
T ss_dssp CSS---SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE----TTTEEEEC
T ss_pred cCC---ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC----CCCCEEEc
Confidence 543 68999999999999999977777799999999999999999999999999999999999999 77899999
Q ss_pred ecCCcccccC---ccccCCccCCCcccCcccccc-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhc-c
Q 037285 963 DFGLSKIKRN---TLVSGGVRGTLPWMAPELLSG-SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN-T 1037 (1094)
Q Consensus 963 DFGLSrl~~~---~~~ss~~~GT~~YmAPEvL~g-~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~-~ 1037 (1094)
|||+++.... ........||+.|+|||++.. ....++.++|||||||++|+|++|+.||........+...... .
T Consensus 163 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 242 (289)
T 3og7_A 163 DFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGS 242 (289)
T ss_dssp CCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTS
T ss_pred cceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccc
Confidence 9999974332 222234568999999999862 1346788999999999999999999999887665544444333 2
Q ss_pred CCC---CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1038 LRP---TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1038 lrp---~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
..+ .....++..+.+||.+||+.||.+|||+.+|++.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 243 LSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 222 234578899999999999999999999999999999875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=361.18 Aligned_cols=262 Identities=29% Similarity=0.472 Sum_probs=212.0
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeecC---------ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCce
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWRG---------TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNV 875 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~rG---------t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNI 875 (1094)
.++..++|++.+.||+|+||.||+|+++. ..||+|++.... ......+.+|+.++++++||||
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--------~~~~~~~~~E~~~l~~l~h~~i 74 (289)
T 4fvq_A 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--------RNYSESFFEAASMMSKLSHKHL 74 (289)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--------GGGHHHHHHHHHHHHTSCCTTB
T ss_pred EEechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--------HHHHHHHHHHHHHHHhCCCCCE
Confidence 45677899999999999999999998752 359999986531 2234678899999999999999
Q ss_pred eEEEeEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCC
Q 037285 876 VAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPS 955 (1094)
Q Consensus 876 VqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e 955 (1094)
+++++++.+.. ..++||||+.+++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++ .
T Consensus 75 v~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~----~ 148 (289)
T 4fvq_A 75 VLNYGVCVCGD--ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLI----R 148 (289)
T ss_dssp CCEEEEECCTT--CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----E
T ss_pred eEEEEEEEeCC--CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEe----c
Confidence 99999998755 78999999999999999988776799999999999999999999999999999999999998 3
Q ss_pred CCc--------EEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCh
Q 037285 956 RPI--------CKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHY 1026 (1094)
Q Consensus 956 ~g~--------VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~ 1026 (1094)
++. +||+|||++....... ...+|..|+|||++.+ ...++.++|||||||++|+|++ +..||.....
T Consensus 149 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~ 224 (289)
T 4fvq_A 149 EEDRKTGNPPFIKLSDPGISITVLPKD---ILQERIPWVPPECIEN-PKNLNLATDKWSFGTTLWEICSGGDKPLSALDS 224 (289)
T ss_dssp CCBGGGTBCCEEEECCCCSCTTTSCHH---HHHHTTTTSCHHHHHC-GGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred CCcccccccceeeeccCcccccccCcc---ccCCcCcccCHHHhCC-CCCCCchhHHHHHHHHHHHHHcCCCCCccccch
Confidence 443 9999999987543322 2347889999999974 2568999999999999999999 5556666555
Q ss_pred HHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhcCCC
Q 037285 1027 GAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQTKG 1087 (1094)
Q Consensus 1027 ~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s~pe~ 1087 (1094)
....... .. ....+..++.++.+||.+||+.||.+|||+.+++++|+.+.++...+.+
T Consensus 225 ~~~~~~~-~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~~ 282 (289)
T 4fvq_A 225 QRKLQFY-ED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRG 282 (289)
T ss_dssp HHHHHHH-HT--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--------
T ss_pred HHHHHHh-hc--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCCC
Confidence 4443332 22 3345666788899999999999999999999999999999876555444
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=371.57 Aligned_cols=256 Identities=20% Similarity=0.230 Sum_probs=219.6
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||+|+||.||+|+++ +..||+|.+.... .....+.+|+.+|++++||||+++++++.+..
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 74 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---------TDQVLVKKEISILNIARHRNILHLHESFESME 74 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---------HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc---------ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC
Confidence 368999999999999999999885 6789999986431 12245789999999999999999999998865
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.. .++.+||+|||+
T Consensus 75 --~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~--~~~~~kl~Dfg~ 150 (321)
T 1tki_A 75 --ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR--RSSTIKIIEFGQ 150 (321)
T ss_dssp --EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS--SCCCEEECCCTT
T ss_pred --EEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccC--CCCCEEEEECCC
Confidence 8999999999999999997766679999999999999999999999999999999999999821 267899999999
Q ss_pred cccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCC--CC
Q 037285 967 SKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTI--PS 1044 (1094)
Q Consensus 967 Srl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~i--Pe 1044 (1094)
++............||+.|+|||++. ...++.++|||||||++|+|++|..||......+....+......... ..
T Consensus 151 a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 228 (321)
T 1tki_A 151 ARQLKPGDNFRLLFTAPEYYAPEVHQ--HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK 228 (321)
T ss_dssp CEECCTTCEEEEEESCGGGSCHHHHT--TCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred CeECCCCCccccccCChhhcCcHHhc--CCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhc
Confidence 98655444444566899999999998 445789999999999999999999999998888888777666544221 24
Q ss_pred cCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1045 YCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1045 ~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
.++.++.+||.+||..||.+|||+.+++++-+-..
T Consensus 229 ~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 263 (321)
T 1tki_A 229 EISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence 67899999999999999999999999999887643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=375.58 Aligned_cols=257 Identities=25% Similarity=0.380 Sum_probs=219.8
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||+|+||.||+|.++ +..||||++...... ......+.+|+.+|++++||||+++++++.+..
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 101 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS------ARDFQKLEREARICRKLQHPNIVRLHDSIQEES 101 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence 358999999999999999999885 678999999765321 223456889999999999999999999998765
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
..++||||+.+|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++..+ ..+.+||+|||+
T Consensus 102 --~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~-~~~~~kl~DfG~ 177 (362)
T 2bdw_A 102 --FHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA-KGAAVKLADFGL 177 (362)
T ss_dssp --EEEEEECCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSS-TTCCEEECCCTT
T ss_pred --EEEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCC-CCCCEEEeecCc
Confidence 8999999999999999987654 589999999999999999999999999999999999998332 345799999999
Q ss_pred cccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCC--C
Q 037285 967 SKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIP--S 1044 (1094)
Q Consensus 967 Srl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iP--e 1044 (1094)
++............||+.|+|||++. ...++.++|||||||++|+|++|+.||......+....+....+....+ .
T Consensus 178 a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 255 (362)
T 2bdw_A 178 AIEVNDSEAWHGFAGTPGYLSPEVLK--KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD 255 (362)
T ss_dssp CBCCTTCCSCCCSCSCTTTCCHHHHT--TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGG
T ss_pred ceEecCCcccccCCCCccccCHHHHc--cCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCccccc
Confidence 98665544445567999999999998 4568899999999999999999999999988888777776665543332 4
Q ss_pred cCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1045 YCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1045 ~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
.++.++.+||.+||..||.+||++.+++++-+-
T Consensus 256 ~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 288 (362)
T 2bdw_A 256 TVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 288 (362)
T ss_dssp GSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 578999999999999999999999999987654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=380.80 Aligned_cols=261 Identities=33% Similarity=0.607 Sum_probs=213.5
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeec-----CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEE
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFY 879 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~r-----Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~ 879 (1094)
+++...+|++.+.||+|+||.||+|+++ +..||||+++... .+.....|.+|+.+|++++||||++++
T Consensus 40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~ 112 (373)
T 2qol_A 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-------TEKQRRDFLGEASIMGQFDHPNIIRLE 112 (373)
T ss_dssp CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-------CHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-------CHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 4567789999999999999999999874 4669999987531 123346789999999999999999999
Q ss_pred eEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcE
Q 037285 880 GVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC 959 (1094)
Q Consensus 880 Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~V 959 (1094)
+++.+.. .+++||||+++|+|.+++......+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+
T Consensus 113 ~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~~ 186 (373)
T 2qol_A 113 GVVTKSK--PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN----SNLVC 186 (373)
T ss_dssp EEECSSS--SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCCE
T ss_pred EEEeeCC--ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEc----CCCCE
Confidence 9998754 89999999999999999987766799999999999999999999999999999999999998 78899
Q ss_pred EEEecCCcccccCcc----ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHh
Q 037285 960 KVGDFGLSKIKRNTL----VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIV 1034 (1094)
Q Consensus 960 KLsDFGLSrl~~~~~----~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv 1034 (1094)
||+|||+++...... ......+|..|+|||++. ...++.++|||||||++|||++ |+.||......+....+
T Consensus 187 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i- 263 (373)
T 2qol_A 187 KVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV- 263 (373)
T ss_dssp EECCC----------------------CTTSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHH-
T ss_pred EECcCccccccccCCccceeccCCCcCCCccChhhhc--cCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-
Confidence 999999998543221 112233577899999998 4578999999999999999998 99999998887776655
Q ss_pred hccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1035 NNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1035 ~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
....+...+..++..+.+||.+||+.||.+||++.+|++.|+.+...
T Consensus 264 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 264 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp HTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 44455566778999999999999999999999999999999998754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=366.58 Aligned_cols=270 Identities=20% Similarity=0.301 Sum_probs=216.7
Q ss_pred eeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEee
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQ 883 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~ 883 (1094)
.+...+|++.+.||+|+||.||+|++. ++.||||++...... .....+.+|+.+|++++||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 77 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-------RPVDVQMREFEVLKKLNHKNIVKLFAIEE 77 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-------SCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc-------chHHHHHHHHHHHHhcCCCCcceEEEEee
Confidence 345678999999999999999999986 788999999754321 12356779999999999999999999998
Q ss_pred cCCCCceEEEeeecccchhHHHHhhccc--ccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEE
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLVRKDR--FLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKV 961 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~k~~~--~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKL 961 (1094)
......+++||||+.+++|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||+.......+.+||
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL 157 (319)
T 4euu_A 78 ETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKL 157 (319)
T ss_dssp CTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEE
T ss_pred cCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEE
Confidence 7665688999999999999999976543 38999999999999999999999999999999999998322226778999
Q ss_pred EecCCcccccCccccCCccCCCcccCccccccC------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh----HHHHH
Q 037285 962 GDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGS------SSKVSEKVDVFSFGIVLWEILTGEEPYANMHY----GAIIG 1031 (1094)
Q Consensus 962 sDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~------~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~----~eile 1031 (1094)
+|||+++............||+.|+|||++... ...++.++|||||||++|||+||+.||..... .+.+.
T Consensus 158 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 237 (319)
T 4euu_A 158 TDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (319)
T ss_dssp CCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHH
T ss_pred ccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH
Confidence 999999866554444556799999999998521 35678999999999999999999999975432 33333
Q ss_pred hHhhccCC-----------------------CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 037285 1032 GIVNNTLR-----------------------PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAA 1082 (1094)
Q Consensus 1032 ~Iv~~~lr-----------------------p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~ 1082 (1094)
.+...... ..++..++..+.++|.+||+.||++|||+.+++++..+.....
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~~ 311 (319)
T 4euu_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRG 311 (319)
T ss_dssp HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC--
T ss_pred HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhcC
Confidence 33332211 0122344567899999999999999999999999998865443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=357.07 Aligned_cols=258 Identities=35% Similarity=0.609 Sum_probs=216.7
Q ss_pred ceeeccCCeeEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEee
Q 037285 804 VQVIKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQ 883 (1094)
Q Consensus 804 v~eIs~edYei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~ 883 (1094)
.|.+..++|++.+.||+|+||.||+++++++.||||+++... ....+.+|+.++++++||||+++++++.
T Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 84 (278)
T 1byg_A 15 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----------TAQAFLAEASVMTQLRHSNLVQLLGVIV 84 (278)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------------HHHHHTHHHHTTCCCTTBCCEEEEEC
T ss_pred cccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh----------HHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 456778899999999999999999999999999999986531 1356889999999999999999999976
Q ss_pred cCCCCceEEEeeecccchhHHHHhhccc-ccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLVRKDR-FLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~k~~~-~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
.. ...+++||||+.+++|.+++..... .+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+
T Consensus 85 ~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~~l~ 159 (278)
T 1byg_A 85 EE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS----EDNVAKVS 159 (278)
T ss_dssp CC---CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----TTSCEEEC
T ss_pred cC-CCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEe----CCCcEEEe
Confidence 54 2478999999999999999976542 378999999999999999999999999999999999998 77899999
Q ss_pred ecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCC
Q 037285 963 DFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPT 1041 (1094)
Q Consensus 963 DFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~ 1041 (1094)
|||+++...... ....++..|+|||++. ...++.++||||||+++|+|+| |+.||......+....+ .......
T Consensus 160 Dfg~~~~~~~~~--~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~-~~~~~~~ 234 (278)
T 1byg_A 160 DFGLTKEASSTQ--DTGKLPVKWTAPEALR--EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMD 234 (278)
T ss_dssp CCCC--------------CCTTTSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH-TTTCCCC
T ss_pred eccccccccccc--cCCCccccccCHHHhC--CCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-hcCCCCC
Confidence 999988543322 2235788999999997 4568899999999999999998 99999988777766655 4455667
Q ss_pred CCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1042 iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
.+..+++.+.++|.+||+.||.+|||+.++++.|+.+...
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 235 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 7788999999999999999999999999999999999764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=361.95 Aligned_cols=263 Identities=25% Similarity=0.331 Sum_probs=216.7
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
+..++|++.+.||+|+||.||+|++. +..||||++...... .+.....+.+|+.++++++||||+++++++..
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 82 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPRE-----KEETLKRFEREVHNSSQLSHQNIVSMIDVDEE 82 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSC-----CHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccc-----cHHHHHHHHHHHHHHhcCCCCCCceEEEeeee
Confidence 34578999999999999999999874 678999998754321 23345678899999999999999999999987
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
.. .+++||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 83 ~~--~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~----~~~~~kl~Df 155 (294)
T 4eqm_A 83 DD--CYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILID----SNKTLKIFDF 155 (294)
T ss_dssp SS--EEEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCEEECCC
T ss_pred CC--eEEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEEEeC
Confidence 54 8999999999999999997664 589999999999999999999999999999999999998 7789999999
Q ss_pred CCcccccCc--cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCC--
Q 037285 965 GLSKIKRNT--LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP-- 1040 (1094)
Q Consensus 965 GLSrl~~~~--~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp-- 1040 (1094)
|+++..... .......||+.|+|||++. ...++.++|||||||++|+|+||+.||...................
T Consensus 156 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T 4eqm_A 156 GIAKALSETSLTQTNHVLGTVQYFSPEQAK--GEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVT 233 (294)
T ss_dssp SSSTTC-------------CCSSCCHHHHH--TCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHH
T ss_pred CCccccccccccccCccccCccccCHhHhc--CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcc
Confidence 999854332 2233456899999999998 4567889999999999999999999999888776655554443321
Q ss_pred -CCCCcCcHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHHHHhh
Q 037285 1041 -TIPSYCDAEWRTLMEECWAPNPAARP-SFTEIASRLRVLSTAAS 1083 (1094)
Q Consensus 1041 -~iPe~~S~eL~dLI~kCLq~DPeeRP-S~eELLq~L~~L~ta~s 1083 (1094)
..+..++..+.++|.+||..||.+|| ++.++.+.|..+.....
T Consensus 234 ~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 234 TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 23456889999999999999999998 99999999988764433
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=365.75 Aligned_cols=266 Identities=31% Similarity=0.543 Sum_probs=226.3
Q ss_pred cceeeccCCeeEEEEecccCceEEEEeeecC-------ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCc
Q 037285 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPN 874 (1094)
Q Consensus 803 sv~eIs~edYei~kkLGsG~FGtVYKAk~rG-------t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPN 874 (1094)
..+++..++|++.+.||+|+||.||+|.+.+ ..||+|.+.... .......+.+|+.+|+++ +|||
T Consensus 39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~ 111 (333)
T 2i1m_A 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-------HADEKEALMSELKIMSHLGQHEN 111 (333)
T ss_dssp GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-------CHHHHHHHHHHHHHHHHHCCCTT
T ss_pred ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-------ChHHHHHHHHHHHHHHhhcCCCC
Confidence 4577888999999999999999999998743 369999987542 122346788999999999 8999
Q ss_pred eeEEEeEeecCCCCceEEEeeecccchhHHHHhhcc-------------cccCHHHHHHHHHHHHHHHHHHHHCCceecc
Q 037285 875 VVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD-------------RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFD 941 (1094)
Q Consensus 875 IVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~-------------~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRD 941 (1094)
|+++++++.... .+++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||+++|+|||
T Consensus 112 iv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~D 189 (333)
T 2i1m_A 112 IVNLLGACTHGG--PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRD 189 (333)
T ss_dssp BCCEEEEECSSS--SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred eeeEEEEEecCC--ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCC
Confidence 999999998754 8999999999999999997542 3478999999999999999999999999999
Q ss_pred CCCCceEeccCCCCCCcEEEEecCCcccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-C
Q 037285 942 LKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-G 1017 (1094)
Q Consensus 942 LKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-G 1017 (1094)
|||+|||++ .++.+||+|||+++..... .......+|+.|+|||++. ...++.++|||||||++|+|+| |
T Consensus 190 lkp~NIl~~----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~t~g 263 (333)
T 2i1m_A 190 VAARNVLLT----NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF--DCVYTVQSDVWSYGILLWEIFSLG 263 (333)
T ss_dssp CSGGGCEEE----GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred cccceEEEC----CCCeEEECccccccccccccceeecCCCCCCccccCHHHhc--cCCCChHHHHHHHHHHHHHHHcCC
Confidence 999999998 7789999999999843221 1223345678999999998 4568899999999999999998 9
Q ss_pred CCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 037285 1018 EEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAAS 1083 (1094)
Q Consensus 1018 k~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s 1083 (1094)
..||...........+.........+..++..+.+||.+||+.||.+|||+.+|+++|+.+.....
T Consensus 264 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 329 (333)
T 2i1m_A 264 LNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR 329 (333)
T ss_dssp CCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhh
Confidence 999998776666666667777777788899999999999999999999999999999999876543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=368.74 Aligned_cols=260 Identities=28% Similarity=0.551 Sum_probs=215.2
Q ss_pred ceeeccCCeeEEEEecccCceEEEEeeec--Cce----EEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeE
Q 037285 804 VQVIKNEDLEEQKELGSGTFGTVYHGKWR--GTD----VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVA 877 (1094)
Q Consensus 804 v~eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~----VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVq 877 (1094)
...+..++|++.+.||+|+||.||+|++. +.. ||+|.++... .......|.+|+.++++++||||++
T Consensus 9 ~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~ 81 (327)
T 3poz_A 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-------SPKANKEILDEAYVMASVDNPHVCR 81 (327)
T ss_dssp SEECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------------CHHHHHHHHHHHHHCCBTTBCC
T ss_pred HhhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-------CHHHHHHHHHHHHHHHhCCCCCEeE
Confidence 34567789999999999999999999874 333 5777765421 1223467889999999999999999
Q ss_pred EEeEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCC
Q 037285 878 FYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRP 957 (1094)
Q Consensus 878 L~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g 957 (1094)
++++|... ..++|+||+.+|+|.+++......+++..++.|+.||+.||.|||+++|+||||||+|||++ .++
T Consensus 82 ~~~~~~~~---~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~----~~~ 154 (327)
T 3poz_A 82 LLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK----TPQ 154 (327)
T ss_dssp EEEEEESS---SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE----ETT
T ss_pred EEEEEecC---CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEEC----CCC
Confidence 99999874 47899999999999999988777799999999999999999999999999999999999998 778
Q ss_pred cEEEEecCCcccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhH
Q 037285 958 ICKVGDFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGI 1033 (1094)
Q Consensus 958 ~VKLsDFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~I 1033 (1094)
.+||+|||+++..... .......+|..|+|||++. ...++.++|||||||++|||+| |+.||......+....+
T Consensus 155 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 232 (327)
T 3poz_A 155 HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232 (327)
T ss_dssp EEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred CEEEccCcceeEccCCcccccccCCCccccccChHHhc--cCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHH
Confidence 9999999999854322 1222345688999999998 4578999999999999999999 99999988777665544
Q ss_pred hhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 037285 1034 VNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLST 1080 (1094)
Q Consensus 1034 v~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~t 1080 (1094)
........+..++..+.++|.+||+.||.+||++.+|+++|..+..
T Consensus 233 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 233 -EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp -HTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred -HcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 4455566778899999999999999999999999999999998864
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=356.71 Aligned_cols=260 Identities=32% Similarity=0.555 Sum_probs=218.8
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeecC-----ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEE
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFY 879 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~rG-----t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~ 879 (1094)
+.+..++|++.+.||+|+||.||+|++.+ ..||||.+.... .......+.+|+.++++++||||++++
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~~ 79 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-------TLDNKEKFMSEAVIMKNLDHPHIVKLI 79 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-------CHHHHHHHHHHHHHHHHHCCTTBCCEE
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-------CchHHHHHHHHHHHHHhCCCCCcceEE
Confidence 45677899999999999999999998743 249999987542 122346788999999999999999999
Q ss_pred eEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcE
Q 037285 880 GVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC 959 (1094)
Q Consensus 880 Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~V 959 (1094)
+++.+. ..++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 80 ~~~~~~---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~ 152 (281)
T 3cc6_A 80 GIIEEE---PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVA----SPECV 152 (281)
T ss_dssp EEECSS---SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE----ETTEE
T ss_pred EEEcCC---CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEC----CCCcE
Confidence 998754 57899999999999999987766799999999999999999999999999999999999998 67899
Q ss_pred EEEecCCcccccCcc--ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhc
Q 037285 960 KVGDFGLSKIKRNTL--VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 1036 (1094)
Q Consensus 960 KLsDFGLSrl~~~~~--~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~ 1036 (1094)
||+|||+++...... ......+|+.|+|||++. ...++.++|||||||++|+|+| |+.||...........+..
T Consensus 153 kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~- 229 (281)
T 3cc6_A 153 KLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESIN--FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK- 229 (281)
T ss_dssp EECCCCGGGCC---------CCCCCGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHH-
T ss_pred EeCccCCCcccccccccccccCCCCcceeCchhhc--cCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhc-
Confidence 999999998543321 223345788999999997 4568899999999999999998 9999988777766655533
Q ss_pred cCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1037 TLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1037 ~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
......+..+++.+.++|.+||..||.+|||+.+++++|+.+...
T Consensus 230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 230 GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 344566778999999999999999999999999999999998754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=356.85 Aligned_cols=262 Identities=34% Similarity=0.606 Sum_probs=225.4
Q ss_pred ceeeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeE
Q 037285 804 VQVIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGV 881 (1094)
Q Consensus 804 v~eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv 881 (1094)
.|++...+|++.+.||+|+||.||+|.++ +..||||++.... .....+.+|+.++++++||||++++++
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~E~~~l~~l~h~~i~~~~~~ 77 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---------MEVEEFLKEAAVMKEIKHPNLVQLLGV 77 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---------THHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---------HHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 46778899999999999999999999986 6789999986531 123568899999999999999999999
Q ss_pred eecCCCCceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEE
Q 037285 882 VQDGPGGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICK 960 (1094)
Q Consensus 882 ~~d~~~~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VK 960 (1094)
+.+.. .+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+|
T Consensus 78 ~~~~~--~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~----~~~~~~ 151 (288)
T 3kfa_A 78 CTREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG----ENHLVK 151 (288)
T ss_dssp ECSSS--SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEEC----GGGCEE
T ss_pred EccCC--CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEc----CCCCEE
Confidence 98755 8999999999999999997643 4589999999999999999999999999999999999998 677899
Q ss_pred EEecCCcccccCc--cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhcc
Q 037285 961 VGDFGLSKIKRNT--LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNT 1037 (1094)
Q Consensus 961 LsDFGLSrl~~~~--~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~ 1037 (1094)
|+|||+++..... .......+|+.|+|||++. ...++.++||||||+++|+|++ |..||...........+ ...
T Consensus 152 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~-~~~ 228 (288)
T 3kfa_A 152 VADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKD 228 (288)
T ss_dssp ECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-HTT
T ss_pred EccCccceeccCCccccccCCccccCcCChhhhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-hcc
Confidence 9999999854332 2233445678899999998 4568899999999999999999 99999988877666554 455
Q ss_pred CCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 037285 1038 LRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAAS 1083 (1094)
Q Consensus 1038 lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s 1083 (1094)
.+...+..++..+.+||.+||..||.+|||+.++++.|..+.....
T Consensus 229 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~ 274 (288)
T 3kfa_A 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274 (288)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 6667788899999999999999999999999999999999876543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=351.35 Aligned_cols=258 Identities=25% Similarity=0.376 Sum_probs=220.5
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||+|+||.||+|.++ +..||+|++...... ......+.+|+.++++++||||+++++++....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS------ARDFQKLEREARICRKLQHPNIVRLHDSIQEES 78 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC------HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCC
Confidence 468999999999999999999875 678999999765321 223456889999999999999999999998755
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
..++||||+.+++|.+++.... .+++..++.++.||+.||.|||+++|+||||||+|||++.++ ..+.+||+|||+
T Consensus 79 --~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~~~~kl~Dfg~ 154 (284)
T 3kk8_A 79 --FHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA-KGAAVKLADFGL 154 (284)
T ss_dssp --EEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSS-TTCCEEECCCTT
T ss_pred --EEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCC-CCCcEEEeecee
Confidence 8899999999999999887654 589999999999999999999999999999999999998332 345699999999
Q ss_pred cccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCC--C
Q 037285 967 SKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIP--S 1044 (1094)
Q Consensus 967 Srl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iP--e 1044 (1094)
+.............||+.|+|||++. ...++.++||||||+++|+|++|+.||...........+.........+ .
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T 3kk8_A 155 AIEVNDSEAWHGFAGTPGYLSPEVLK--KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD 232 (284)
T ss_dssp CEECCSSCBCCCSCSCGGGCCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTT
T ss_pred eEEcccCccccCCCCCcCCcCchhhc--CCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhc
Confidence 98665555545567999999999998 4567899999999999999999999999988888777776655443332 4
Q ss_pred cCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1045 YCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1045 ~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
.+++++.+||.+||+.||.+|||+.+++++-+-.
T Consensus 233 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~ 266 (284)
T 3kk8_A 233 TVTPEAKSLIDSMLTVNPKKRITADQALKVPWIC 266 (284)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHH
T ss_pred ccCHHHHHHHHHHcccChhhCCCHHHHhcCcccc
Confidence 6889999999999999999999999999986654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=365.33 Aligned_cols=263 Identities=36% Similarity=0.613 Sum_probs=219.5
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeecC------ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEE
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAF 878 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~rG------t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL 878 (1094)
+++..++|++.+.||+|+||.||+|+++. ..||||+++... .......+.+|+.++++++||||+++
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~ 111 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-------TEKQRVDFLGEAGIMGQFSHHNIIRL 111 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-------CHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-------CHHHHHHHHHHHHHHHhCCCCCCCcE
Confidence 46778899999999999999999998753 249999987532 12234578899999999999999999
Q ss_pred EeEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCc
Q 037285 879 YGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPI 958 (1094)
Q Consensus 879 ~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~ 958 (1094)
++++.... .+++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.
T Consensus 112 ~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~----~~~~ 185 (333)
T 1mqb_A 112 EGVISKYK--PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN----SNLV 185 (333)
T ss_dssp EEEECSSS--SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCC
T ss_pred EEEEecCC--CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEEC----CCCc
Confidence 99998754 89999999999999999987766799999999999999999999999999999999999998 7789
Q ss_pred EEEEecCCcccccCcc----ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhH
Q 037285 959 CKVGDFGLSKIKRNTL----VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGI 1033 (1094)
Q Consensus 959 VKLsDFGLSrl~~~~~----~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~I 1033 (1094)
+||+|||+++...... ......+|..|+|||++. ...++.++|||||||++|+|++ |+.||......+....+
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~ 263 (333)
T 1mqb_A 186 CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS--YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263 (333)
T ss_dssp EEECCCCC-----------------CCCGGGSCHHHHH--SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred EEECCCCcchhhccccccccccCCCCccccccCchhcc--cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 9999999998543221 122234678899999997 4578999999999999999999 99999988887777665
Q ss_pred hhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 037285 1034 VNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAAS 1083 (1094)
Q Consensus 1034 v~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s 1083 (1094)
. ...+...+..++..+.++|.+||+.||.+||++.+|++.|+.+.....
T Consensus 264 ~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 264 N-DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp H-TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred H-CCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 4 445556677899999999999999999999999999999999875533
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=378.25 Aligned_cols=255 Identities=26% Similarity=0.414 Sum_probs=213.1
Q ss_pred eeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEe
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVV 882 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~ 882 (1094)
.+..++|++.+.||+|+||.||+|+++ ++.||||++++... ........+.+|+.+|+.+ +||||+++++++
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~-----~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~ 93 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVI-----LQDDDVECTMTEKRILSLARNHPFLTQLFCCF 93 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-----HHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHh-----cchhHHHHHHHHHHHHHhccCCCceeeEEEEE
Confidence 456689999999999999999999875 67899999976421 1223345677899999988 699999999999
Q ss_pred ecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 883 QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 883 ~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
.+.. .+|+||||+.+|+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+
T Consensus 94 ~~~~--~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~----~~g~ikL~ 166 (353)
T 3txo_A 94 QTPD--RLFFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLD----HEGHCKLA 166 (353)
T ss_dssp ECSS--EEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEEC
T ss_pred EeCC--EEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEEC----CCCCEEEc
Confidence 8865 8999999999999999997654 489999999999999999999999999999999999998 78899999
Q ss_pred ecCCcccc-cCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCC
Q 037285 963 DFGLSKIK-RNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT 1041 (1094)
Q Consensus 963 DFGLSrl~-~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~ 1041 (1094)
|||+++.. .........+||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+..... .
T Consensus 167 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~--~ 242 (353)
T 3txo_A 167 DFGMCKEGICNGVTTATFCGTPDYIAPEILQ--EMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV--V 242 (353)
T ss_dssp CCTTCBCSCC---------CCGGGCCHHHHH--HHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--C
T ss_pred cccceeecccCCccccccCCCcCeEChhhcC--CCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--C
Confidence 99999853 2333345567999999999998 44678999999999999999999999999988888888876544 4
Q ss_pred CCCcCcHHHHHHHHHhccCCCCCCCCH------HHHHHHHH
Q 037285 1042 IPSYCDAEWRTLMEECWAPNPAARPSF------TEIASRLR 1076 (1094)
Q Consensus 1042 iPe~~S~eL~dLI~kCLq~DPeeRPS~------eELLq~L~ 1076 (1094)
+|..++..+.+||.+||..||.+||++ .+|+++-+
T Consensus 243 ~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~ 283 (353)
T 3txo_A 243 YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPF 283 (353)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGG
T ss_pred CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCc
Confidence 677899999999999999999999998 78887643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=376.47 Aligned_cols=261 Identities=23% Similarity=0.345 Sum_probs=218.9
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.+.|++.+.||+|+||.||+|+.+ |..||||++++....... .......+.+|+.+|++++||||+++++++.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 88 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASR--RGVCREEIEREVSILRQVLHPNIITLHDVYENRT 88 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCS--SSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEcccccccc--chhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence 357999999999999999999885 788999999876432211 0112356889999999999999999999998755
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+++||||+.+|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++..+.....+||+|||+
T Consensus 89 --~~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 89 --DVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp --EEEEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred --EEEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 8999999999999999997654 5899999999999999999999999999999999999983222223799999999
Q ss_pred cccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCC--CCCC
Q 037285 967 SKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP--TIPS 1044 (1094)
Q Consensus 967 Srl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp--~iPe 1044 (1094)
++...........+||+.|+|||++. ...++.++|||||||++|+|++|..||......+....+....+.. ....
T Consensus 166 a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (361)
T 2yab_A 166 AHEIEDGVEFKNIFGTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS 243 (361)
T ss_dssp CEECCTTCCCCCCCSCGGGCCHHHHT--TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred ceEcCCCCccccCCCCccEECchHHc--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhcc
Confidence 98665544445667999999999998 4568899999999999999999999999988888877776554432 1225
Q ss_pred cCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1045 YCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1045 ~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
.++..+++||.+||..||.+|||+.+++++-+
T Consensus 244 ~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 275 (361)
T 2yab_A 244 QTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (361)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred CCCHHHHHHHHHHCCCChhHCcCHHHHhcCcC
Confidence 67899999999999999999999999997654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=354.80 Aligned_cols=264 Identities=19% Similarity=0.236 Sum_probs=215.8
Q ss_pred eeccCCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEe
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVV 882 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~ 882 (1094)
.+..++|++.+.||+|+||.||+|++ .+..||||++...... ..+.+|+.+++++ +|+||+++++++
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~e~~~~~~l~~~~~i~~~~~~~ 75 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----------PQLRDEYRTYKLLAGCTGIPNVYYFG 75 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----------CCHHHHHHHHHHTTTCTTCCCEEEEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----------HHHHHHHHHHHHHhcCCCCCeEEeec
Confidence 45567899999999999999999985 5788999998754211 2466899999999 799999999999
Q ss_pred ecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCC-CCCCcEEE
Q 037285 883 QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKD-PSRPICKV 961 (1094)
Q Consensus 883 ~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~-~e~g~VKL 961 (1094)
.... ..++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++ .....+||
T Consensus 76 ~~~~--~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl 152 (298)
T 1csn_A 76 QEGL--HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYV 152 (298)
T ss_dssp EETT--EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred CCCc--eeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEE
Confidence 8755 899999999 9999999987766799999999999999999999999999999999999998432 13445999
Q ss_pred EecCCcccccCcc--------ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---hHHHH
Q 037285 962 GDFGLSKIKRNTL--------VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH---YGAII 1030 (1094)
Q Consensus 962 sDFGLSrl~~~~~--------~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~---~~eil 1030 (1094)
+|||+++...... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||.... .....
T Consensus 153 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 230 (298)
T 1csn_A 153 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL--GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY 230 (298)
T ss_dssp CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT--TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH
T ss_pred EECccccccccccccccccccCccCCCCCcccCCchhhc--CCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHH
Confidence 9999998543321 234556999999999998 4568999999999999999999999998743 33333
Q ss_pred HhHhhccCCC---CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhc
Q 037285 1031 GGIVNNTLRP---TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQ 1084 (1094)
Q Consensus 1031 e~Iv~~~lrp---~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s~ 1084 (1094)
..+....... .....++.++.++|.+||+.||.+||++.+|++.|..+......
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 231 ERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp HHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 3332222111 22346789999999999999999999999999999999866443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=357.90 Aligned_cols=261 Identities=31% Similarity=0.497 Sum_probs=214.9
Q ss_pred eeccCCeeEEEEecccCceEEEEeee------cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEE
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKW------RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFY 879 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~------rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~ 879 (1094)
.+...+|++.+.||+|+||.||+|++ .+..||||++..... ......+.+|+.+|++++||||++++
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~i~~~~ 89 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-------GNHIADLKKEIEILRNLYHENIVKYK 89 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------------CCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc-------chhHHHHHHHHHHHHhCCCCCeeeee
Confidence 45567899999999999999999984 367899999975421 12235688999999999999999999
Q ss_pred eEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcE
Q 037285 880 GVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC 959 (1094)
Q Consensus 880 Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~V 959 (1094)
+++.......+++||||+.+++|.+++......+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+
T Consensus 90 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~----~~~~~ 165 (302)
T 4e5w_A 90 GICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE----SEHQV 165 (302)
T ss_dssp EEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE----ETTEE
T ss_pred eEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEc----CCCCE
Confidence 99987654579999999999999999977766799999999999999999999999999999999999998 67899
Q ss_pred EEEecCCcccccCc----cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-----------
Q 037285 960 KVGDFGLSKIKRNT----LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANM----------- 1024 (1094)
Q Consensus 960 KLsDFGLSrl~~~~----~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~----------- 1024 (1094)
||+|||+++..... .......+|..|+|||++. ...++.++|||||||++|+|+||..|+...
T Consensus 166 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 243 (302)
T 4e5w_A 166 KIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLM--QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPT 243 (302)
T ss_dssp EECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHH--HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSC
T ss_pred EECcccccccccCCCcceeccCCCCCCccccCCeeec--CCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCc
Confidence 99999999854332 2233455788899999997 456788999999999999999999876432
Q ss_pred ---ChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1025 ---HYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1025 ---~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
..............+...+..+++.+.+||.+||+.||.+|||+.++++.|+.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 244 HGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp CGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1222233344555666778889999999999999999999999999999999874
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=366.69 Aligned_cols=261 Identities=23% Similarity=0.344 Sum_probs=216.8
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.+.|++.+.||+|+||.||+|+.+ +..||||++......... .......+.+|+.+|++++||||+++++++.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 87 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSR--RGVSREDIEREVSILKEIQHPNVITLHEVYENKT 87 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCS--SSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEcccccccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 357999999999999999999885 788999999875432111 0112356889999999999999999999998755
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+++||||+.+++|.+++.... .+++..++.++.||+.||.|||+++|+||||||+|||++..+.....+||+|||+
T Consensus 88 --~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 88 --DVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp --EEEEEEECCCSCBHHHHHTTSS-CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred --EEEEEEEcCCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 8999999999999999997654 5899999999999999999999999999999999999983332334899999999
Q ss_pred cccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCC--CCC
Q 037285 967 SKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT--IPS 1044 (1094)
Q Consensus 967 Srl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~--iPe 1044 (1094)
++............||+.|+|||++. ...++.++|||||||++|+|++|+.||......+....+........ ...
T Consensus 165 a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (326)
T 2y0a_A 165 AHKIDFGNEFKNIFGTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242 (326)
T ss_dssp CEECCTTSCCCCCCSCTTTCCHHHHT--TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred CeECCCCCccccccCCcCcCCceeec--CCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccc
Confidence 98655444444567999999999997 45688999999999999999999999998887777766655433221 224
Q ss_pred cCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1045 YCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1045 ~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
.++..+.+||.+||..||.+|||+.+++++-+
T Consensus 243 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 274 (326)
T 2y0a_A 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274 (326)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 67899999999999999999999999998643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=366.02 Aligned_cols=257 Identities=28% Similarity=0.422 Sum_probs=209.5
Q ss_pred eeeccCCeeEEEEecccCceEEEEeee-----cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEE
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFY 879 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~-----rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~ 879 (1094)
..+..++|++.+.||+|+||.||+++. .+..||||++++..... .......+.+|+.+|++++||||++++
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~ 87 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR----NAKDTAHTKAERNILEEVKHPFIVDLI 87 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC------------------HHHHHHHCCCTTBCCEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhh----hhhHHHHHHHHHHHHHhCCCCCcccee
Confidence 346678999999999999999999986 46789999998653221 112234577899999999999999999
Q ss_pred eEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcE
Q 037285 880 GVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC 959 (1094)
Q Consensus 880 Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~V 959 (1094)
+++.... .+++||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 88 ~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~----~~~~~ 160 (327)
T 3a62_A 88 YAFQTGG--KLYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLN----HQGHV 160 (327)
T ss_dssp EEEECSS--CEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC----TTSCE
T ss_pred EEEEcCC--EEEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEEC----CCCcE
Confidence 9998755 8999999999999999997654 489999999999999999999999999999999999998 77899
Q ss_pred EEEecCCccccc-CccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccC
Q 037285 960 KVGDFGLSKIKR-NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 1038 (1094)
Q Consensus 960 KLsDFGLSrl~~-~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~l 1038 (1094)
||+|||+++... .........||+.|+|||++. ...++.++|||||||++|+|++|+.||...........+....
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~- 237 (327)
T 3a62_A 161 KLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILM--RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK- 237 (327)
T ss_dssp EECCCSCC----------CTTSSCCTTSCHHHHT--TSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-
T ss_pred EEEeCCcccccccCCccccccCCCcCccCHhhCc--CCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-
Confidence 999999997432 223334567999999999998 4567899999999999999999999999988888777776653
Q ss_pred CCCCCCcCcHHHHHHHHHhccCCCCCCC-----CHHHHHHHHH
Q 037285 1039 RPTIPSYCDAEWRTLMEECWAPNPAARP-----SFTEIASRLR 1076 (1094)
Q Consensus 1039 rp~iPe~~S~eL~dLI~kCLq~DPeeRP-----S~eELLq~L~ 1076 (1094)
..++..++.++.+||.+||..||.+|| ++.+++++-+
T Consensus 238 -~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~ 279 (327)
T 3a62_A 238 -LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279 (327)
T ss_dssp -CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGG
T ss_pred -CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCc
Confidence 346778899999999999999999999 8889988755
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=367.71 Aligned_cols=258 Identities=29% Similarity=0.517 Sum_probs=214.8
Q ss_pred eeccCCeeEEEEecccCceEEEEeeec--Cce----EEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEE
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWR--GTD----VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFY 879 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~----VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~ 879 (1094)
.+..++|++.+.||+|+||.||+|++. +.. ||+|.+....... ....+.+|+.++++++||||++++
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~ 81 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ-------SFQAVTDHMLAIGSLDHAHIVRLL 81 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCS-------CBCSCCHHHHHHHTCCCTTBCCEE
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHH-------HHHHHHHHHHHHhcCCCCCcCeEE
Confidence 456789999999999999999999874 343 7777765432111 113466799999999999999999
Q ss_pred eEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcE
Q 037285 880 GVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC 959 (1094)
Q Consensus 880 Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~V 959 (1094)
+++... .+++||||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 82 ~~~~~~---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~----~~~~~ 154 (325)
T 3kex_A 82 GLCPGS---SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLK----SPSQV 154 (325)
T ss_dssp EEECBS---SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEES----SSSCE
T ss_pred EEEcCC---ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEEC----CCCeE
Confidence 998643 68999999999999999987666799999999999999999999999999999999999998 67889
Q ss_pred EEEecCCcccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhh
Q 037285 960 KVGDFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 1035 (1094)
Q Consensus 960 KLsDFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~ 1035 (1094)
||+|||+++..... .......+|..|+|||++. ...++.++|||||||++|+|+| |+.||......+....+ .
T Consensus 155 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~ 231 (325)
T 3kex_A 155 QVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH--FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL-E 231 (325)
T ss_dssp EECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH-H
T ss_pred EECCCCcccccCcccccccccCCCCcccccChHHhc--cCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH-H
Confidence 99999999854322 2233455788999999998 4568999999999999999999 99999988776665554 4
Q ss_pred ccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 037285 1036 NTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLST 1080 (1094)
Q Consensus 1036 ~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~t 1080 (1094)
.......+..++.++.++|.+||..||.+||++.+++++|..+..
T Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 232 KGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp TTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred cCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 445566777889999999999999999999999999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=364.06 Aligned_cols=267 Identities=28% Similarity=0.512 Sum_probs=224.4
Q ss_pred cceeeccCCeeEEEEecccCceEEEEeeec---------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CC
Q 037285 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKWR---------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HH 872 (1094)
Q Consensus 803 sv~eIs~edYei~kkLGsG~FGtVYKAk~r---------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~H 872 (1094)
..|.+..++|++.+.||+|+||.||+|++. +..||||+++... .......+.+|+.+++++ +|
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h 100 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-------TEKDLSDLVSEMEMMKMIGKH 100 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-------CHHHHHHHHHHHHHHHHHCCC
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-------cHHHHHHHHHHHHHHHHhhcC
Confidence 346778899999999999999999999863 3569999987531 123346788999999999 89
Q ss_pred CceeEEEeEeecCCCCceEEEeeecccchhHHHHhhcc---------------cccCHHHHHHHHHHHHHHHHHHHHCCc
Q 037285 873 PNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD---------------RFLDRRRRLIIAMDAAFGMEYLHSKNI 937 (1094)
Q Consensus 873 PNIVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~---------------~~Lse~~~l~Ia~QIaeGLaYLHs~GI 937 (1094)
|||+++++++.+.. .+++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||+++|
T Consensus 101 p~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i 178 (334)
T 2pvf_A 101 KNIINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC 178 (334)
T ss_dssp TTBCCEEEEECSSS--CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred CCEeeEEEEEccCC--ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 99999999998754 8999999999999999997643 238899999999999999999999999
Q ss_pred eeccCCCCceEeccCCCCCCcEEEEecCCcccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHH
Q 037285 938 VHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEI 1014 (1094)
Q Consensus 938 IHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyEL 1014 (1094)
+||||||+|||++ .++.+||+|||+++..... .......+|+.|+|||++. ...++.++|||||||++|+|
T Consensus 179 vH~Dlkp~NIll~----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el 252 (334)
T 2pvf_A 179 IHRDLAARNVLVT----ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEI 252 (334)
T ss_dssp ECSCCSGGGEEEC----TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHH--HCEECHHHHHHHHHHHHHHH
T ss_pred eCCCCccceEEEc----CCCCEEEccccccccccccccccccCCCCcccceeChHHhc--CCCcChHHHHHHHHHHHHHH
Confidence 9999999999998 7789999999999854332 1223345788999999997 34678999999999999999
Q ss_pred Hc-CCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhcC
Q 037285 1015 LT-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQT 1085 (1094)
Q Consensus 1015 LT-Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s~p 1085 (1094)
++ |+.||......+....+ ....+...+..++..+.++|.+||+.||.+|||+.+|++.|+.+.+.....
T Consensus 253 lt~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~ 323 (334)
T 2pvf_A 253 FTLGGSPYPGIPVEELFKLL-KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 323 (334)
T ss_dssp HTTSCCSSTTCCHHHHHHHH-HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred HhCCCCCcCcCCHHHHHHHH-hcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccC
Confidence 99 99999988877766555 344556677889999999999999999999999999999999998665443
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=352.30 Aligned_cols=267 Identities=29% Similarity=0.468 Sum_probs=219.1
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
+..++|++.+.||+|+||.||+|+++ +..||||++..... ........+.+|+.++++++||||+++++++.+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD 80 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEecccc-----chhhHHHHHHHHHHHHHcCCCCCCcchhheEec
Confidence 45578999999999999999999885 56799999875321 122234568899999999999999999999987
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
.. .+++||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 81 ~~--~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~----~~~~~~l~Df 153 (279)
T 3fdn_A 81 AT--RVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG----SAGELKIADF 153 (279)
T ss_dssp SS--EEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEEC----TTSCEEECSC
T ss_pred CC--EEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEc----CCCCEEEEec
Confidence 65 8999999999999999997654 489999999999999999999999999999999999998 7789999999
Q ss_pred CCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCC
Q 037285 965 GLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPS 1044 (1094)
Q Consensus 965 GLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe 1044 (1094)
|++........ ....+|+.|+|||++. ...++.++||||||+++|+|++|+.||......+....+... ...++.
T Consensus 154 g~~~~~~~~~~-~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~ 228 (279)
T 3fdn_A 154 GWSVHAPSSRR-TDLCGTLDYLPPEMIE--GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFTFPD 228 (279)
T ss_dssp CEESCC---------CCCCTTCCHHHHT--TCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--CCCCCT
T ss_pred cccccCCcccc-cccCCCCCccCHhHhc--cCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC--CCCCCC
Confidence 99865433322 3456899999999998 456788999999999999999999999998887777666443 334677
Q ss_pred cCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhcCCCCCCC
Q 037285 1045 YCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQTKGHGNK 1091 (1094)
Q Consensus 1045 ~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s~pe~~~~k 1091 (1094)
.++..+.+||.+||+.||.+|||+.+|+++.+--. ....+..+.++
T Consensus 229 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~-~~~~~~~~~~~ 274 (279)
T 3fdn_A 229 FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA-NSSKPSNCQNK 274 (279)
T ss_dssp TSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHH-HCSSCCCC---
T ss_pred cCCHHHHHHHHHHhccChhhCCCHHHHhhCccccC-CccCccccccc
Confidence 89999999999999999999999999999977644 33333344433
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=363.10 Aligned_cols=262 Identities=34% Similarity=0.540 Sum_probs=218.5
Q ss_pred eccCCeeEEEEecccCceEEEEeee------cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEe
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKW------RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYG 880 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~------rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~G 880 (1094)
+..++|++.+.||+|+||.||+|++ .+..||||++.... ......+.+|+.++++++||||+++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~~i~~~~~ 91 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--------PDQQRDFQREIQILKALHSDFIVKYRG 91 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC--------HHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC--------HHHHHHHHHHHHHHHhcCCCceeEEEE
Confidence 5668999999999999999999985 36779999987531 223456889999999999999999999
Q ss_pred EeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEE
Q 037285 881 VVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICK 960 (1094)
Q Consensus 881 v~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VK 960 (1094)
++.......+++||||+++++|.+++......+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+|
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~----~~~~~k 167 (327)
T 3lxl_A 92 VSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE----SEAHVK 167 (327)
T ss_dssp EEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE----ETTEEE
T ss_pred EEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEEC----CCCCEE
Confidence 9886555689999999999999999987666799999999999999999999999999999999999998 778999
Q ss_pred EEecCCcccccCcc----ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH---------
Q 037285 961 VGDFGLSKIKRNTL----VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG--------- 1027 (1094)
Q Consensus 961 LsDFGLSrl~~~~~----~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~--------- 1027 (1094)
|+|||+++...... ......+|..|+|||++. ...++.++|||||||++|+|++|+.||......
T Consensus 168 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 245 (327)
T 3lxl_A 168 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS--DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER 245 (327)
T ss_dssp ECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHH--HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC---
T ss_pred EcccccceecccCCccceeeccCCccccccCHHHhc--cCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccccc
Confidence 99999998543221 223345788899999998 456789999999999999999999998653321
Q ss_pred -----HHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 037285 1028 -----AIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAA 1082 (1094)
Q Consensus 1028 -----eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~ 1082 (1094)
..+........+...+..+++.+.+||.+||+.||.+|||+.+|+++|+.+....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 246 DVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp -CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred ccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 2233344556666778889999999999999999999999999999999986543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=355.72 Aligned_cols=263 Identities=32% Similarity=0.553 Sum_probs=215.1
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeec---Cc--eEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEE
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWR---GT--DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFY 879 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~r---Gt--~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~ 879 (1094)
..+..++|++.+.||+|+||.||+|++. +. .||||+++..... .......+.+|+.++++++||||++++
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~ 87 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-----QPEAMDDFIREVNAMHSLDHRNLIRLY 87 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC-------------CHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccC-----CHHHHHHHHHHHHHHHhCCCCCcccEE
Confidence 3566789999999999999999999863 22 5899998754221 123456788999999999999999999
Q ss_pred eEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcE
Q 037285 880 GVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC 959 (1094)
Q Consensus 880 Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~V 959 (1094)
+++... ..++||||+.+++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+
T Consensus 88 ~~~~~~---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~----~~~~~ 160 (291)
T 1u46_A 88 GVVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA----TRDLV 160 (291)
T ss_dssp EEECSS---SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE----ETTEE
T ss_pred EEEccC---CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEc----CCCCE
Confidence 999864 48899999999999999987766799999999999999999999999999999999999998 67899
Q ss_pred EEEecCCcccccCcc----ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHh
Q 037285 960 KVGDFGLSKIKRNTL----VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIV 1034 (1094)
Q Consensus 960 KLsDFGLSrl~~~~~----~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv 1034 (1094)
||+|||+++...... ......+|..|+|||++. ...++.++||||||+++|+|++ |+.||......+....+.
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~ 238 (291)
T 1u46_A 161 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK--TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238 (291)
T ss_dssp EECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHH--HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred EEccccccccccccccchhhhccCCCCceeeCchhhc--CCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHH
Confidence 999999998543221 222345778899999997 3457899999999999999999 999999998888888777
Q ss_pred hccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1035 NNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1035 ~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
........+..++..+.++|.+||..||.+|||+.+|+++|.++...
T Consensus 239 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 239 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 77777777788999999999999999999999999999999988643
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=362.22 Aligned_cols=255 Identities=29% Similarity=0.374 Sum_probs=206.9
Q ss_pred ccCCeeEEEEecccCceEEEEeeec-CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~r-Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
..++|++.++||+|+||+||+|++. ++.||||++..... .+.....+.+|+.+|++++||||+++++++.+..
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 92 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE------DEGIPSTAIREISLLKELHHPNIVSLIDVIHSER 92 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccc------cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC
Confidence 3478999999999999999999984 68899999875421 2233457889999999999999999999998755
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+++||||+. ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 93 --~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~----~~~~~kl~Dfg~ 165 (311)
T 3niz_A 93 --CLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLIN----SDGALKLADFGL 165 (311)
T ss_dssp --CEEEEEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEECCCTT
T ss_pred --EEEEEEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEEC----CCCCEEEccCcC
Confidence 8999999997 578888877666799999999999999999999999999999999999998 778999999999
Q ss_pred cccccCc-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCC-----
Q 037285 967 SKIKRNT-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP----- 1040 (1094)
Q Consensus 967 Srl~~~~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp----- 1040 (1094)
++..... .......+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||......+.+..+......+
T Consensus 166 a~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 244 (311)
T 3niz_A 166 ARAFGIPVRSYTHEVVTLWYRAPDVLMG-SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREW 244 (311)
T ss_dssp CEETTSCCC---CCCCCCTTCCHHHHTT-CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTS
T ss_pred ceecCCCcccccCCcccCCcCCHHHhcC-CCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHh
Confidence 9864322 22334568999999999874 3467899999999999999999999998877665555443311100
Q ss_pred -----------------------CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1041 -----------------------TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1041 -----------------------~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
.....+++++.+||.+||+.||.+|||+.+++++-+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 303 (311)
T 3niz_A 245 PQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303 (311)
T ss_dssp GGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred hhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence 011246788999999999999999999999998643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=361.60 Aligned_cols=263 Identities=29% Similarity=0.494 Sum_probs=207.4
Q ss_pred eeccCCeeEEEEecccCceEEEEeeecCc-----eEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEe
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWRGT-----DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYG 880 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~rGt-----~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~G 880 (1094)
.+..++|++.+.||+|+||.||+|+++.. .||||+++..... ......+.+|+.++++++||||+++++
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~ 92 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA------SSDIEEFLREAACMKEFDHPHVAKLVG 92 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------------CHHHHHHHHHHHHHTTCCCTTBCCCCE
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC------HHHHHHHHHHHHHHHHCCCCceehhhc
Confidence 46678999999999999999999987532 6999998764321 123467889999999999999999999
Q ss_pred EeecCCCC----ceEEEeeecccchhHHHHhhcc-----cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEecc
Q 037285 881 VVQDGPGG----TLATVAEYMVDGSLRHVLVRKD-----RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNL 951 (1094)
Q Consensus 881 v~~d~~~~----~L~IVmEYmegGSL~d~L~k~~-----~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~ 951 (1094)
++...... ..++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 93 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~- 171 (323)
T 3qup_A 93 VSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA- 171 (323)
T ss_dssp EEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-
T ss_pred eeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEc-
Confidence 99765411 2389999999999999986543 1489999999999999999999999999999999999998
Q ss_pred CCCCCCcEEEEecCCcccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChH
Q 037285 952 KDPSRPICKVGDFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYG 1027 (1094)
Q Consensus 952 ~~~e~g~VKLsDFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ 1027 (1094)
.++.+||+|||+++..... .......+++.|+|||++. ...++.++|||||||++|+|++ |+.||......
T Consensus 172 ---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~ 246 (323)
T 3qup_A 172 ---EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLA--DNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA 246 (323)
T ss_dssp ---TTSCEEECCCCC-----------------CCGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred ---CCCCEEEeeccccccccccccccccccccCcccccCchhhc--CCCCCCccchhhHHHHHHHHHhCCCCCccccChH
Confidence 7789999999999854322 1122344678899999998 4568999999999999999999 99999998888
Q ss_pred HHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1028 AIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1028 eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
+....+... .....+..++.++.+||.+||+.||.+|||+.++++.|+.+...
T Consensus 247 ~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 247 EIYNYLIGG-NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp GHHHHHHTT-CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHhcC-CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 777766443 34556778899999999999999999999999999999998643
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=357.74 Aligned_cols=255 Identities=29% Similarity=0.519 Sum_probs=203.2
Q ss_pred eccCCeeEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhh--CCCCceeEEEeEeec
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSK--LHHPNVVAFYGVVQD 884 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkr--L~HPNIVqL~Gv~~d 884 (1094)
+..++|++.+.||+|+||.||+|+++++.||||++.... ...+.+|..++.. ++||||+++++++..
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~ 73 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD-----------EKSWFRETELYNTVMLRHENILGFIASDMT 73 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG-----------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc-----------chhhHHHHHHHHHhhccCcCeeeEEEeecc
Confidence 446789999999999999999999999999999986431 1345556666665 899999999998754
Q ss_pred C--CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCceEeccCCC
Q 037285 885 G--PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLH--------SKNIVHFDLKCDNLLVNLKDP 954 (1094)
Q Consensus 885 ~--~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLH--------s~GIIHRDLKPeNILLD~~~~ 954 (1094)
. ....+++||||+.+|+|.+++... .+++..++.++.||+.||+||| +++|+||||||+|||++
T Consensus 74 ~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~---- 147 (301)
T 3q4u_A 74 SRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK---- 147 (301)
T ss_dssp EETTEEEEEEEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEEC----
T ss_pred ccCCCceeEEehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEc----
Confidence 2 223689999999999999999543 5899999999999999999999 99999999999999998
Q ss_pred CCCcEEEEecCCcccccCcc-----ccCCccCCCcccCccccccCCC----CCCchhhHHHHHHHHHHHHcC--------
Q 037285 955 SRPICKVGDFGLSKIKRNTL-----VSGGVRGTLPWMAPELLSGSSS----KVSEKVDVFSFGIVLWEILTG-------- 1017 (1094)
Q Consensus 955 e~g~VKLsDFGLSrl~~~~~-----~ss~~~GT~~YmAPEvL~g~~~----kyS~KSDVWSLGVLLyELLTG-------- 1017 (1094)
.++.+||+|||+++...... ......||+.|+|||++.+... .++.++|||||||++|||+||
T Consensus 148 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~ 227 (301)
T 3q4u_A 148 KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227 (301)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccc
Confidence 77899999999997533221 1223469999999999984221 345799999999999999999
Q ss_pred --CCCCCCCC-----hHHHHHhHhhccCCCCCCC-----cCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1018 --EEPYANMH-----YGAIIGGIVNNTLRPTIPS-----YCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1018 --k~PF~~~~-----~~eile~Iv~~~lrp~iPe-----~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
+.||.... .......+.....++..+. .++..+.+||.+||+.||.+|||+.+|++.|+++
T Consensus 228 ~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 228 DYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 88886532 2222222333334444442 2567899999999999999999999999999886
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=360.39 Aligned_cols=256 Identities=35% Similarity=0.607 Sum_probs=209.7
Q ss_pred eeccCCeeEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~ 885 (1094)
.+..++|++.+.||+|+||.||+|++++..||||.+... .....|.+|+.+|++++||||+++++++.+
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 72 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----------SERKAFIVELRQLSRVNHPNIVKLYGACLN- 72 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST----------THHHHHHHHHHHHHHCCCTTBCCEEEBCTT-
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh----------hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-
Confidence 466789999999999999999999999999999998542 123578899999999999999999999874
Q ss_pred CCCceEEEeeecccchhHHHHhhccc--ccCHHHHHHHHHHHHHHHHHHHH---CCceeccCCCCceEeccCCCCCC-cE
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKDR--FLDRRRRLIIAMDAAFGMEYLHS---KNIVHFDLKCDNLLVNLKDPSRP-IC 959 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~~--~Lse~~~l~Ia~QIaeGLaYLHs---~GIIHRDLKPeNILLD~~~~e~g-~V 959 (1094)
..++||||+++++|.+++..... .++...++.++.||++||+|||+ ++|+||||||+|||++ .++ .+
T Consensus 73 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~----~~~~~~ 145 (307)
T 2eva_A 73 ---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV----AGGTVL 145 (307)
T ss_dssp ---TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEE----TTTTEE
T ss_pred ---CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEe----CCCCEE
Confidence 57899999999999999976542 47889999999999999999999 8999999999999998 455 48
Q ss_pred EEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH-HHHhHhhccC
Q 037285 960 KVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA-IIGGIVNNTL 1038 (1094)
Q Consensus 960 KLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~e-ile~Iv~~~l 1038 (1094)
||+|||+++...... ....||+.|+|||++. ...++.++|||||||++|+|++|+.||....... ..........
T Consensus 146 kl~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 221 (307)
T 2eva_A 146 KICDFGTACDIQTHM--TNNKGSAAWMAPEVFE--GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT 221 (307)
T ss_dssp EECCCCC--------------CCTTSSCHHHHT--CCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC
T ss_pred EEccccccccccccc--ccCCCCCceEChhhhC--CCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC
Confidence 999999997543322 2345899999999998 4578899999999999999999999998654322 1222233445
Q ss_pred CCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 037285 1039 RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAAS 1083 (1094)
Q Consensus 1039 rp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s 1083 (1094)
++..+..++..+.+||.+||+.||.+|||+.++++.|..+.....
T Consensus 222 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 222 RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence 566777899999999999999999999999999999999976543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=358.16 Aligned_cols=253 Identities=25% Similarity=0.349 Sum_probs=206.1
Q ss_pred CCeeEEEEecccCceEEEEeeec-CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r-Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
++|++.+.||+|+||.||+|++. +..||||++...... +.....+.+|+.++++++||||+++++++....
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 73 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED------EGIPSTTIREISILKELKHSNIVKLYDVIHTKK-- 73 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG------GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS--
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccc------cccchhHHHHHHHHHhcCCCCEeeeeeEEccCC--
Confidence 57999999999999999999885 788999998754211 122356778999999999999999999998754
Q ss_pred ceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 889 TLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
.+++||||+.+ +|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 74 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~kl~Dfg~~~ 148 (288)
T 1ob3_A 74 RLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN----REGELKIADFGLAR 148 (288)
T ss_dssp CEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTSCEEECCTTHHH
T ss_pred eEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCCEEEeECcccc
Confidence 89999999975 89999887666799999999999999999999999999999999999998 77899999999998
Q ss_pred cccCc-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccC---------
Q 037285 969 IKRNT-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL--------- 1038 (1094)
Q Consensus 969 l~~~~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~l--------- 1038 (1094)
..... .......+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||......+.+..+.....
T Consensus 149 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T 1ob3_A 149 AFGIPVRKYTHEIVTLWYRAPDVLMG-SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227 (288)
T ss_dssp HHCC---------CCCTTCCHHHHTT-CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred ccCccccccccccccccccCchheeC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchh
Confidence 54322 22233468999999999874 34578999999999999999999999998877665554432100
Q ss_pred -------CC-----------CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1039 -------RP-----------TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1039 -------rp-----------~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
.+ .+...++.++.+||.+||+.||.+|||+.+++++-+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 283 (288)
T 1ob3_A 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283 (288)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred hhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 00 112357899999999999999999999999998643
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=356.16 Aligned_cols=262 Identities=30% Similarity=0.525 Sum_probs=218.2
Q ss_pred eeccCCeeEEE-EecccCceEEEEeeec----CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEe
Q 037285 806 VIKNEDLEEQK-ELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYG 880 (1094)
Q Consensus 806 eIs~edYei~k-kLGsG~FGtVYKAk~r----Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~G 880 (1094)
.+...+|++.+ .||+|+||.||+|.+. +..||||+++... ........+.+|+.++++++||||+++++
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 85 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA------NDPALKDELLAEANVMQQLDNPYIVRMIG 85 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----------CHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc------cCHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 45667899988 9999999999999653 4679999987542 11233467889999999999999999999
Q ss_pred EeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEE
Q 037285 881 VVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICK 960 (1094)
Q Consensus 881 v~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VK 960 (1094)
++.. ..+++||||+.+++|.+++.... .+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+|
T Consensus 86 ~~~~---~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~----~~~~~k 157 (291)
T 1xbb_A 86 ICEA---ESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV----TQHYAK 157 (291)
T ss_dssp EEES---SSEEEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE----ETTEEE
T ss_pred EECC---CCcEEEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEe----CCCcEE
Confidence 9943 36899999999999999997654 489999999999999999999999999999999999999 678999
Q ss_pred EEecCCcccccCcc----ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhh
Q 037285 961 VGDFGLSKIKRNTL----VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 1035 (1094)
Q Consensus 961 LsDFGLSrl~~~~~----~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~ 1035 (1094)
|+|||+++...... ......+|+.|+|||++. ...++.++||||||+++|+|++ |+.||......+....+ .
T Consensus 158 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~-~ 234 (291)
T 1xbb_A 158 ISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN--YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-E 234 (291)
T ss_dssp ECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHH--HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-H
T ss_pred EccCCcceeeccCCCcccccccCCCCceeeChHHhc--cCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-H
Confidence 99999998543221 112234678899999997 4457889999999999999999 99999998877766555 4
Q ss_pred ccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhc
Q 037285 1036 NTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQ 1084 (1094)
Q Consensus 1036 ~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s~ 1084 (1094)
...++..+..++..+.++|.+||+.||.+||++.+|++.|+.+......
T Consensus 235 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 283 (291)
T 1xbb_A 235 KGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 283 (291)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhh
Confidence 4555667888999999999999999999999999999999999866543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=360.06 Aligned_cols=261 Identities=32% Similarity=0.527 Sum_probs=220.7
Q ss_pred cceeeccCCeeEEEEecccCceEEEEeeec-------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCce
Q 037285 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNV 875 (1094)
Q Consensus 803 sv~eIs~edYei~kkLGsG~FGtVYKAk~r-------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNI 875 (1094)
..|++..++|++.+.||+|+||.||+|+++ +..||||.+.... .......+.+|+.++++++||||
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i 90 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-------SMRERIEFLNEASVMKEFNCHHV 90 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-------CHHHHHHHHHHHHHGGGCCCTTB
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-------CHHHHHHHHHHHHHHHhcCCCCE
Confidence 456778889999999999999999999875 4669999986431 12233568899999999999999
Q ss_pred eEEEeEeecCCCCceEEEeeecccchhHHHHhhcc---------cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 037285 876 VAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD---------RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDN 946 (1094)
Q Consensus 876 VqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~---------~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeN 946 (1094)
+++++++.+.. ..++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 91 ~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~N 168 (322)
T 1p4o_A 91 VRLLGVVSQGQ--PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARN 168 (322)
T ss_dssp CCEEEEECSSS--SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGG
T ss_pred eeeEEEEccCC--ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccce
Confidence 99999998754 8999999999999999997543 346899999999999999999999999999999999
Q ss_pred eEeccCCCCCCcEEEEecCCcccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 037285 947 LLVNLKDPSRPICKVGDFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYA 1022 (1094)
Q Consensus 947 ILLD~~~~e~g~VKLsDFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~ 1022 (1094)
||++ .++.+||+|||+++..... .......+|+.|+|||++. ...++.++|||||||++|+|++ |+.||.
T Consensus 169 Ili~----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~~g~~p~~ 242 (322)
T 1p4o_A 169 CMVA----EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK--DGVFTTYSDVWSFGVVLWEIATLAEQPYQ 242 (322)
T ss_dssp EEEC----TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHHTSCCTTT
T ss_pred EEEc----CCCeEEECcCccccccccccccccccCCCCCCCccChhhhc--cCCCCchhhHHHHHHHHHHHHhcCCCccc
Confidence 9998 7789999999999854322 1222345688999999998 4568899999999999999999 899999
Q ss_pred CCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1023 NMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1023 ~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
.....+....+.... ....+..++..+.+||.+||+.||.+|||+.+++++|+.+.
T Consensus 243 ~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 243 GLSNEQVLRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp TSCHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred cCCHHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 988877776665443 34567789999999999999999999999999999998764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=365.84 Aligned_cols=252 Identities=25% Similarity=0.437 Sum_probs=218.2
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
+..++|++.+.||+|+||.||+|+.+ |+.||||++++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~ 77 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-----RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD 77 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe
Confidence 34578999999999999999999874 788999999764211 11224567789999999999999999999987
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
.. .+++||||+.+|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 78 ~~--~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~----~~g~~kL~Df 150 (318)
T 1fot_A 78 AQ--QIFMIMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD----KNGHIKITDF 150 (318)
T ss_dssp SS--EEEEEECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC----TTSCEEECCC
T ss_pred CC--EEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEc----CCCCEEEeec
Confidence 65 8999999999999999997654 489999999999999999999999999999999999998 7889999999
Q ss_pred CCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCC
Q 037285 965 GLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPS 1044 (1094)
Q Consensus 965 GLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe 1044 (1094)
|+++..... ....+||+.|+|||++. ...++.++|||||||++|||++|+.||...........+..... .+|.
T Consensus 151 g~a~~~~~~--~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~p~ 224 (318)
T 1fot_A 151 GFAKYVPDV--TYTLCGTPDYIAPEVVS--TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL--RFPP 224 (318)
T ss_dssp SSCEECSSC--BCCCCSCTTTCCHHHHT--TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC--CCCT
T ss_pred CcceecCCc--cccccCCccccCHhHhc--CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCC
Confidence 999865433 23467999999999998 45688999999999999999999999999888888877776543 4677
Q ss_pred cCcHHHHHHHHHhccCCCCCCC-----CHHHHHHHHH
Q 037285 1045 YCDAEWRTLMEECWAPNPAARP-----SFTEIASRLR 1076 (1094)
Q Consensus 1045 ~~S~eL~dLI~kCLq~DPeeRP-----S~eELLq~L~ 1076 (1094)
.++.++.++|.+||..||.+|| ++.+|+++-+
T Consensus 225 ~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~ 261 (318)
T 1fot_A 225 FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261 (318)
T ss_dssp TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCcc
Confidence 8999999999999999999999 8999997644
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=353.84 Aligned_cols=253 Identities=25% Similarity=0.325 Sum_probs=204.9
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.++||+|+||+||+|+++ ++.||||++...... ......+.+|+.++++++||||+++++++.+..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 74 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD------EGVPSSALREICLLKELKHKNIVRLHDVLHSDK- 74 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS------TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCc------CCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCC-
Confidence 57999999999999999999984 678999999765321 223356789999999999999999999998865
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++||||+.+ +|.+++......+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 75 -~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~----~~~~~kl~Dfg~~ 148 (292)
T 3o0g_A 75 -KLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN----RNGELKLANFGLA 148 (292)
T ss_dssp -EEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECCCTTC
T ss_pred -EEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEEEeecccc
Confidence 89999999975 56666655556699999999999999999999999999999999999999 7789999999999
Q ss_pred ccccC-ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCC-CCCCChHHHHHhHhhccCC------
Q 037285 968 KIKRN-TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEP-YANMHYGAIIGGIVNNTLR------ 1039 (1094)
Q Consensus 968 rl~~~-~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~P-F~~~~~~eile~Iv~~~lr------ 1039 (1094)
+.... ........+|+.|+|||++.+ ...++.++|||||||++|+|++|..| |........+..+......
T Consensus 149 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~ 227 (292)
T 3o0g_A 149 RAFGIPVRCYSAEVVTLWYRPPDVLFG-AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp EECCSCCSCCCSCCSCGGGCCHHHHTT-CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTC
T ss_pred eecCCccccccCCccccCCcChHHHcC-CCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhh
Confidence 85432 223344568999999999974 33478999999999999999997777 5555555554444321110
Q ss_pred ---------------------CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1040 ---------------------PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1040 ---------------------p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
......++..+++||.+||+.||++|||+.+++++-+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 285 (292)
T 3o0g_A 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred hhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcc
Confidence 0112347889999999999999999999999998643
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=353.23 Aligned_cols=267 Identities=23% Similarity=0.424 Sum_probs=207.8
Q ss_pred ccCCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~ 885 (1094)
...+|++.+.||+|+||.||+|.. .+..||||++....... ......+.+|+.++++++||||+++++++...
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 104 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMD-----AKARADCIKEIDLLKQLNHPNVIKYYASFIED 104 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCC-----HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccC-----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 346899999999999999999986 47889999997542221 23346788999999999999999999999886
Q ss_pred CCCceEEEeeecccchhHHHHhh---cccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVR---KDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k---~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
. .+++||||+.+++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 105 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~----~~~~~kl~ 178 (310)
T 2wqm_A 105 N--ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT----ATGVVKLG 178 (310)
T ss_dssp T--EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCEEEC
T ss_pred C--cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEc----CCCCEEEE
Confidence 5 89999999999999999864 235689999999999999999999999999999999999998 77899999
Q ss_pred ecCCcccccCc-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--hHHHHHhHhhccCC
Q 037285 963 DFGLSKIKRNT-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH--YGAIIGGIVNNTLR 1039 (1094)
Q Consensus 963 DFGLSrl~~~~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~--~~eile~Iv~~~lr 1039 (1094)
|||+++..... .......+++.|+|||++. ...++.++||||||+++|+|++|+.||.... .......+......
T Consensus 179 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 256 (310)
T 2wqm_A 179 DLGLGRFFSSKTTAAHSLVGTPYYMSPERIH--ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP 256 (310)
T ss_dssp CC------------------CCSSCCHHHHT--TCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSC
T ss_pred eccceeeecCCCccccccCCCeeEeChHHhC--CCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCC
Confidence 99998754322 2223456899999999998 4578899999999999999999999997543 23444444444444
Q ss_pred CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhcCCC
Q 037285 1040 PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQTKG 1087 (1094)
Q Consensus 1040 p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s~pe~ 1087 (1094)
......++.++.+||.+||..||.+|||+.+|++.|+.+.+....|.+
T Consensus 257 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~ 304 (310)
T 2wqm_A 257 PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304 (310)
T ss_dssp CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC----
T ss_pred CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhh
Confidence 444467899999999999999999999999999999999977665543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=369.03 Aligned_cols=257 Identities=26% Similarity=0.347 Sum_probs=201.4
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
...++|++.+.||+|+||.||+++.+ ++.||||++...... ...+.+|+.++++++||||+++++++.+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~hpniv~~~~~~~~ 87 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---------DENVQREIINHRSLRHPNIVRFKEVILT 87 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---------CHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---------cHHHHHHHHHHHhCCCCCCCcEEEEEee
Confidence 34578999999999999999999884 678999999764321 1457789999999999999999999987
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
.. .+++||||+.+|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.. ..+.+||+||
T Consensus 88 ~~--~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~--~~~~~kl~Df 162 (361)
T 3uc3_A 88 PT--HLAIIMEYASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGS--PAPRLKICDF 162 (361)
T ss_dssp SS--EEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSS--SSCCEEECCC
T ss_pred CC--EEEEEEEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC--CCceEEEeec
Confidence 65 8999999999999999997654 48999999999999999999999999999999999999721 2335999999
Q ss_pred CCcccccCccccCCccCCCcccCccccccCCCCCCc-hhhHHHHHHHHHHHHcCCCCCCCCCh----HHHHHhHhhccCC
Q 037285 965 GLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSE-KVDVFSFGIVLWEILTGEEPYANMHY----GAIIGGIVNNTLR 1039 (1094)
Q Consensus 965 GLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~-KSDVWSLGVLLyELLTGk~PF~~~~~----~eile~Iv~~~lr 1039 (1094)
|+++............||+.|+|||++.+ ..++. ++|||||||++|+|++|+.||..... ...+..+......
T Consensus 163 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 240 (361)
T 3uc3_A 163 GYSKSSVLHSQPKSTVGTPAYIAPEVLLR--QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYS 240 (361)
T ss_dssp CCC---------------CTTSCHHHHHC--SSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCC
T ss_pred CccccccccCCCCCCcCCCCcCChhhhcC--CCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCC
Confidence 99985443333445679999999999974 34444 48999999999999999999987543 3344444444444
Q ss_pred CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1040 PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1040 p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
......+++++.+||.+||..||.+|||+.+++++-+-..
T Consensus 241 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 241 IPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK 280 (361)
T ss_dssp CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence 3444468999999999999999999999999999877643
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=367.35 Aligned_cols=254 Identities=22% Similarity=0.366 Sum_probs=212.7
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEee
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQ 883 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~~ 883 (1094)
+..++|++.+.||+|+||.||+|+++ ++.||||++++..... ......+.+|+.+++++ +||||+++++++.
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~ 80 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVND-----DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ 80 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCS-----HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcc-----hHHHHHHHHHHHHHHhcCCCCccCeEEEEEE
Confidence 45678999999999999999999985 6789999998754322 23345677899999988 8999999999998
Q ss_pred cCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEe
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGD 963 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsD 963 (1094)
+.. .+++||||+.+|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 81 ~~~--~~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~----~~g~~kL~D 153 (345)
T 3a8x_A 81 TES--RLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD----SEGHIKLTD 153 (345)
T ss_dssp CSS--EEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEECC
T ss_pred eCC--EEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC----CCCCEEEEe
Confidence 855 8999999999999999997654 589999999999999999999999999999999999998 788999999
Q ss_pred cCCcccc-cCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC---------ChHHHHHhH
Q 037285 964 FGLSKIK-RNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANM---------HYGAIIGGI 1033 (1094)
Q Consensus 964 FGLSrl~-~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~---------~~~eile~I 1033 (1094)
||+++.. .........+||+.|+|||++. ...++.++|||||||++|||++|+.||... ........+
T Consensus 154 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i 231 (345)
T 3a8x_A 154 YGMCKEGLRPGDTTSTFCGTPNYIAPEILR--GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 231 (345)
T ss_dssp GGGCBCSCCTTCCBCCCCSCGGGCCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH
T ss_pred ccccccccCCCCcccccCCCccccCccccC--CCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH
Confidence 9999853 2233345567999999999998 456789999999999999999999999752 222333444
Q ss_pred hhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCH------HHHHHHHH
Q 037285 1034 VNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSF------TEIASRLR 1076 (1094)
Q Consensus 1034 v~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~------eELLq~L~ 1076 (1094)
... ...+|..++.++.+||.+||+.||.+||++ .+++++-+
T Consensus 232 ~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~ 278 (345)
T 3a8x_A 232 LEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278 (345)
T ss_dssp HHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGG
T ss_pred HcC--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCc
Confidence 333 345678899999999999999999999985 78887644
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=348.51 Aligned_cols=256 Identities=22% Similarity=0.304 Sum_probs=216.7
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||+|+||.||+|+++ +..||+|.+...... ....+.+|+.++++++||||+++++++.+..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--------DVDRFKQEIEIMKSLDHPNIIRLYETFEDNT 79 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--------CHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--------hHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 357999999999999999999886 457999998764321 1356889999999999999999999998755
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+++||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+..++ .++.+||+|||+
T Consensus 80 --~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~~~~l~Dfg~ 155 (277)
T 3f3z_A 80 --DIYLVMELCTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDS-PDSPLKLIDFGL 155 (277)
T ss_dssp --EEEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS-TTCCEEECCCTT
T ss_pred --eEEEEEeccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCC-CCCcEEEEeccc
Confidence 8999999999999999987654 489999999999999999999999999999999999994222 678899999999
Q ss_pred cccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCC--C
Q 037285 967 SKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIP--S 1044 (1094)
Q Consensus 967 Srl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iP--e 1044 (1094)
+.............+|+.|+|||++.+ .++.++||||||+++|+|++|+.||......+....+.......... .
T Consensus 156 ~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (277)
T 3f3z_A 156 AARFKPGKMMRTKVGTPYYVSPQVLEG---LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWL 232 (277)
T ss_dssp CEECCTTSCBCCCCSCTTTCCHHHHTT---CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHT
T ss_pred ceeccCccchhccCCCCCccChHHhcc---cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhh
Confidence 986555444455679999999999874 37889999999999999999999999988888777776654432211 2
Q ss_pred cCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1045 YCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1045 ~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
.+++.+.+||.+||+.||.+|||+.+++++-+--.
T Consensus 233 ~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 233 NVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 57899999999999999999999999998766543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=379.96 Aligned_cols=257 Identities=22% Similarity=0.306 Sum_probs=217.9
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||+|+||.||+|..+ |..+|+|++..... .......+.+|+.+|++++||||+++++++.+..
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~------~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 83 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL------SARDHQKLEREARICRLLKHPNIVRLHDSISEEG 83 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC------HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSS
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC------CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECC
Confidence 368999999999999999999874 78899999976532 1223457889999999999999999999998755
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+++||||+.+|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++... .++.+||+|||+
T Consensus 84 --~~~lv~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~-~~~~vkL~DFG~ 159 (444)
T 3soa_A 84 --HHYLIFDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKL-KGAAVKLADFGL 159 (444)
T ss_dssp --EEEEEECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSS-TTCCEEECCCSS
T ss_pred --EEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccC-CCCcEEEccCce
Confidence 8999999999999999997664 499999999999999999999999999999999999998432 457899999999
Q ss_pred cccccC-ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCC--
Q 037285 967 SKIKRN-TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIP-- 1043 (1094)
Q Consensus 967 Srl~~~-~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iP-- 1043 (1094)
++.... ........||+.|+|||++. ...++.++|||||||++|+|++|+.||......+....+.........+
T Consensus 160 a~~~~~~~~~~~~~~gt~~Y~APE~l~--~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 237 (444)
T 3soa_A 160 AIEVEGEQQAWFGFAGTPGYLSPEVLR--KDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEW 237 (444)
T ss_dssp CBCCCTTCCBCCCSCSCGGGCCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTT
T ss_pred eEEecCCCceeecccCCcccCCHHHhc--CCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcccc
Confidence 985433 22334567999999999998 4568899999999999999999999999988888888877765543333
Q ss_pred CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1044 SYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1044 e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
..+++++.+||.+||+.||.+|||+.+++++-+-
T Consensus 238 ~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~ 271 (444)
T 3soa_A 238 DTVTPEAKDLINKMLTINPSKRITAAEALKHPWI 271 (444)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccc
Confidence 4689999999999999999999999999987554
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=372.59 Aligned_cols=254 Identities=29% Similarity=0.449 Sum_probs=215.2
Q ss_pred eeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEe
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVV 882 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~ 882 (1094)
.+..++|++.+.||+|+||.||+|+++ ++.||||++++.... .......+..|..++.++ +||||+++++++
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~ 87 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL-----MDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 87 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhh-----hhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE
Confidence 356689999999999999999999985 678999999764211 112234567889999876 899999999999
Q ss_pred ecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 883 QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 883 ~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
.+.. .+++||||+.+|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+
T Consensus 88 ~~~~--~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~----~~g~vkL~ 160 (345)
T 1xjd_A 88 QTKE--NLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD----KDGHIKIA 160 (345)
T ss_dssp ECSS--EEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEEC
T ss_pred EeCC--EEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEEC----CCCCEEEe
Confidence 8865 8999999999999999997654 489999999999999999999999999999999999998 77899999
Q ss_pred ecCCccccc-CccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCC
Q 037285 963 DFGLSKIKR-NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT 1041 (1094)
Q Consensus 963 DFGLSrl~~-~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~ 1041 (1094)
|||+++... ........+||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+.... +.
T Consensus 161 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~ 236 (345)
T 1xjd_A 161 DFGMCKENMLGDAKTNTFCGTPDYIAPEILL--GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--PF 236 (345)
T ss_dssp CCTTCBCCCCTTCCBCCCCSCGGGCCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CC
T ss_pred EChhhhhcccCCCcccCCCCCcccCChhhhc--CCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--CC
Confidence 999998532 223345678999999999998 4568899999999999999999999999988888777776553 45
Q ss_pred CCCcCcHHHHHHHHHhccCCCCCCCCHH-HHHHHH
Q 037285 1042 IPSYCDAEWRTLMEECWAPNPAARPSFT-EIASRL 1075 (1094)
Q Consensus 1042 iPe~~S~eL~dLI~kCLq~DPeeRPS~e-ELLq~L 1075 (1094)
++..++.++.+||.+||..||.+||++. +|+++-
T Consensus 237 ~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp 271 (345)
T 1xjd_A 237 YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHP 271 (345)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSG
T ss_pred CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCc
Confidence 6778999999999999999999999997 776543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=359.56 Aligned_cols=268 Identities=28% Similarity=0.516 Sum_probs=221.0
Q ss_pred CcceeeccCCeeEEEEecccCceEEEEeeec-------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCc
Q 037285 802 SSVQVIKNEDLEEQKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPN 874 (1094)
Q Consensus 802 ssv~eIs~edYei~kkLGsG~FGtVYKAk~r-------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPN 874 (1094)
...+++..++|++.+.||+|+||.||+|++. +..||||++.... .......+.+|+.++++++|||
T Consensus 22 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~ 94 (327)
T 2yfx_A 22 SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-------SEQDELDFLMEALIISKFNHQN 94 (327)
T ss_dssp GGSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-------CHHHHHHHHHHHHHHHHCCCTT
T ss_pred hhcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-------chhhHHHHHHHHHHHhhCCCCC
Confidence 4456778899999999999999999999853 4579999986431 1223357889999999999999
Q ss_pred eeEEEeEeecCCCCceEEEeeecccchhHHHHhhcc------cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceE
Q 037285 875 VVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD------RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLL 948 (1094)
Q Consensus 875 IVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~------~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNIL 948 (1094)
|+++++++.... ..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 95 iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIl 172 (327)
T 2yfx_A 95 IVRCIGVSLQSL--PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCL 172 (327)
T ss_dssp BCCEEEEECSSS--SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred CCeEEEEEcCCC--CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEE
Confidence 999999998754 7899999999999999997654 34889999999999999999999999999999999999
Q ss_pred eccCCCCCCcEEEEecCCcccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 037285 949 VNLKDPSRPICKVGDFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANM 1024 (1094)
Q Consensus 949 LD~~~~e~g~VKLsDFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~ 1024 (1094)
++..+ ....+||+|||+++..... .......+|+.|+|||++. ...++.++|||||||++|+|+| |+.||...
T Consensus 173 i~~~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 249 (327)
T 2yfx_A 173 LTCPG-PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFM--EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249 (327)
T ss_dssp ESCSS-TTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EecCC-CcceEEECccccccccccccccccCCCcCCCcceeCHhHhc--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCc
Confidence 98433 3557999999998743211 1223345788999999997 4568899999999999999998 99999988
Q ss_pred ChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 037285 1025 HYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAA 1082 (1094)
Q Consensus 1025 ~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~ 1082 (1094)
...+....+. .......+..++..+.+||.+||+.||.+||++.+|+++|+.+....
T Consensus 250 ~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 250 SNQEVLEFVT-SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp CHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 8777666554 34455667789999999999999999999999999999999987543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=368.98 Aligned_cols=251 Identities=25% Similarity=0.370 Sum_probs=218.6
Q ss_pred ccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~ 885 (1094)
..++|++.+.||+|+||.||+|+++ +..||||++.+... ........+.+|+.+|++++||||+++++++.+.
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 113 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-----VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHh-----ccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 4578999999999999999999885 78899999976421 1122345788999999999999999999999886
Q ss_pred CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecC
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFG 965 (1094)
. .+++||||+.+|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 114 ~--~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~----~~g~~kL~DFg 186 (350)
T 1rdq_E 114 S--NLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID----QQGYIQVTDFG 186 (350)
T ss_dssp S--EEEEEEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECCCT
T ss_pred C--EEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEEC----CCCCEEEcccc
Confidence 5 8999999999999999997654 489999999999999999999999999999999999998 78899999999
Q ss_pred CcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCc
Q 037285 966 LSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSY 1045 (1094)
Q Consensus 966 LSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~ 1045 (1094)
+++..... ....+||+.|+|||++. ...++.++|||||||++|+|++|+.||......+....+.... ..+|..
T Consensus 187 ~a~~~~~~--~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~p~~ 260 (350)
T 1rdq_E 187 FAKRVKGR--TWTLCGTPEALAPEIIL--SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSH 260 (350)
T ss_dssp TCEECSSC--BCCCEECGGGCCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTT
T ss_pred cceeccCC--cccccCCccccCHHHhc--CCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC--CCCCCC
Confidence 99865433 23467999999999998 4568899999999999999999999999988888887776654 356778
Q ss_pred CcHHHHHHHHHhccCCCCCCCC-----HHHHHHHHH
Q 037285 1046 CDAEWRTLMEECWAPNPAARPS-----FTEIASRLR 1076 (1094)
Q Consensus 1046 ~S~eL~dLI~kCLq~DPeeRPS-----~eELLq~L~ 1076 (1094)
++.++.+||.+||+.||.+||+ +.+|+++-+
T Consensus 261 ~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~ 296 (350)
T 1rdq_E 261 FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296 (350)
T ss_dssp CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcC
Confidence 9999999999999999999998 899988754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=349.29 Aligned_cols=258 Identities=29% Similarity=0.540 Sum_probs=213.9
Q ss_pred CeeEEEEecccCceEEEEeeec--C---ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--G---TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--G---t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~ 885 (1094)
.|.+.++||+|+||.||+|++. + ..||+|.+.... .......+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 94 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-------EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP 94 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-------SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-------cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC
Confidence 4667799999999999999863 2 259999986421 123346788999999999999999999999765
Q ss_pred CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecC
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFG 965 (1094)
. ...++||||+.+++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||
T Consensus 95 ~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~----~~~~~kl~Dfg 169 (298)
T 3pls_A 95 E-GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLD----ESFTVKVADFG 169 (298)
T ss_dssp S-SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----TTCCEEECCTT
T ss_pred C-CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc----CCCcEEeCcCC
Confidence 3 345899999999999999987667799999999999999999999999999999999999998 77899999999
Q ss_pred CcccccCc-----cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCC
Q 037285 966 LSKIKRNT-----LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLR 1039 (1094)
Q Consensus 966 LSrl~~~~-----~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lr 1039 (1094)
+++..... .......+|+.|+|||.+. ...++.++|||||||++|+|++ +.+||...........+ .....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~-~~~~~ 246 (298)
T 3pls_A 170 LARDILDREYYSVQQHRHARLPVKWTALESLQ--TYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL-AQGRR 246 (298)
T ss_dssp SSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHT--TCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHH-HTTCC
T ss_pred CcccccCCcccccccCcCCCCCccccChhhhc--cCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHh-hcCCC
Confidence 99743221 2223345788999999998 5578999999999999999999 55556665555555444 44555
Q ss_pred CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 037285 1040 PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAAS 1083 (1094)
Q Consensus 1040 p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s 1083 (1094)
...+..++..+.++|.+||+.||.+|||+.++++.|+.+..+..
T Consensus 247 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 247 LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 66778899999999999999999999999999999999986543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=352.72 Aligned_cols=257 Identities=26% Similarity=0.431 Sum_probs=215.4
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||+|+||.||+++++ +..||+|++...... ......+.+|+.++++++||||+++++++....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT------EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT 78 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC
Confidence 468999999999999999999885 678999999764321 223467889999999999999999999886544
Q ss_pred CCceEEEeeecccchhHHHHhhcc---cccCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCceEeccCCCCCCc
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKD---RFLDRRRRLIIAMDAAFGMEYLHSKN-----IVHFDLKCDNLLVNLKDPSRPI 958 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~---~~Lse~~~l~Ia~QIaeGLaYLHs~G-----IIHRDLKPeNILLD~~~~e~g~ 958 (1094)
...+++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~----~~~~ 154 (279)
T 2w5a_A 79 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD----GKQN 154 (279)
T ss_dssp GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEEC----SSSC
T ss_pred CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEc----CCCC
Confidence 458999999999999999997543 34899999999999999999999999 99999999999998 7789
Q ss_pred EEEEecCCcccccCc-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhcc
Q 037285 959 CKVGDFGLSKIKRNT-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 1037 (1094)
Q Consensus 959 VKLsDFGLSrl~~~~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~ 1037 (1094)
+||+|||+++..... .......+|+.|+|||++. ...++.++||||||+++|+|++|+.||......+....+...
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~- 231 (279)
T 2w5a_A 155 VKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMN--RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG- 231 (279)
T ss_dssp EEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHH--CC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-
T ss_pred EEEecCchheeeccccccccccCCCccccChHHhc--cCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhc-
Confidence 999999998754332 1122346899999999998 456889999999999999999999999998877766665444
Q ss_pred CCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1038 LRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1038 lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
..+.++..++.++.++|.+||+.||.+||++.+|+++++..
T Consensus 232 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 232 KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred ccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 34567778999999999999999999999999999987653
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=348.35 Aligned_cols=262 Identities=23% Similarity=0.366 Sum_probs=213.6
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||+|+||.||+|++. ++.||||+++........ .......+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSR--RGVSREEIEREVNILREIRHPNIITLHDIFENKT 81 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCS--SSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccc--cchHHHHHHHHHHHHHhCCCCCeeehhheecCCC
Confidence 357999999999999999999985 688999999876433211 1112357889999999999999999999998755
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+++||||+.+++|.+++.... .+++..++.++.||+.||.|||+++|+||||||+|||++..+.....+||+|||+
T Consensus 82 --~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 82 --DVVLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp --EEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred --eEEEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 8999999999999999997654 5899999999999999999999999999999999999984333344899999999
Q ss_pred cccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCC--CCCC
Q 037285 967 SKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP--TIPS 1044 (1094)
Q Consensus 967 Srl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp--~iPe 1044 (1094)
+.............+|+.|+|||++. ...++.++||||||+++|+|++|+.||......+....+....... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T 3bhy_A 159 AHKIEAGNEFKNIFGTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFS 236 (283)
T ss_dssp CEECC--------CCCGGGCCHHHHT--TCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred ceeccCCCcccccCCCcCccCcceec--CCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcc
Confidence 98654443344556899999999997 4568899999999999999999999999888777666654433321 1224
Q ss_pred cCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1045 YCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1045 ~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
.++..+.+||.+||..||.+||++.+++++-+-
T Consensus 237 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 269 (283)
T 3bhy_A 237 NTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWI 269 (283)
T ss_dssp TCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHH
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHH
Confidence 678899999999999999999999999986544
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=370.22 Aligned_cols=274 Identities=17% Similarity=0.156 Sum_probs=209.7
Q ss_pred eeccCCeeEEEEecccCceEEEEeeec-------CceEEEEEeecCccCCC---chhHHHHHHHHHHHHHHHhhCCCCce
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGR---SSEQERLTVEFWKEAEILSKLHHPNV 875 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~r-------Gt~VAVKiIkk~~~se~---~~eqe~~~~eFlrEIkILkrL~HPNI 875 (1094)
.+..++|++.+.||+|+||.||+|.++ +..||||++........ ....+.....+..|+..+..++||||
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp CTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred ccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 355679999999999999999999874 35799999875421000 00000111234567777888999999
Q ss_pred eEEEeEeecCCC--CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCC
Q 037285 876 VAFYGVVQDGPG--GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKD 953 (1094)
Q Consensus 876 VqL~Gv~~d~~~--~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~ 953 (1094)
+++++++..... ..+++||||+ +++|.+++......+++..++.|+.||+.||+|||+++|+||||||+|||++..
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~- 188 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK- 188 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESS-
T ss_pred CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecC-
Confidence 999999876422 3589999999 999999998876779999999999999999999999999999999999999732
Q ss_pred CCCCcEEEEecCCcccccCcc--------ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 037285 954 PSRPICKVGDFGLSKIKRNTL--------VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH 1025 (1094)
Q Consensus 954 ~e~g~VKLsDFGLSrl~~~~~--------~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~ 1025 (1094)
.++.+||+|||+++...... ......||+.|+|||++. ...++.++|||||||++|||+||+.||....
T Consensus 189 -~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 189 -NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHN--GVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp -CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHT--TCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred -CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhC--CCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 45789999999997543211 113345999999999998 4568999999999999999999999998643
Q ss_pred hHHHHHhHhhccCCCC---------CCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhc
Q 037285 1026 YGAIIGGIVNNTLRPT---------IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQ 1084 (1094)
Q Consensus 1026 ~~eile~Iv~~~lrp~---------iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s~ 1084 (1094)
................ ....++.++.++|.+||..||.+||++.+|++.|..+......
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~ 333 (364)
T 3op5_A 266 KDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS 333 (364)
T ss_dssp TCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred cCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 2221111111111000 1256789999999999999999999999999999998866443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=365.78 Aligned_cols=254 Identities=29% Similarity=0.449 Sum_probs=217.6
Q ss_pred CCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
..|++.+.||+|+||.||+|+. .+..||||++..... ........+.+|+.+|++++||||+++++++....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~- 127 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-----QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH- 127 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc-----cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-
Confidence 4699999999999999999986 478899999975421 12334467889999999999999999999998865
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++||||+. |+|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 128 -~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~~kL~DfG~a 201 (348)
T 1u5q_A 128 -TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS----EPGLVKLGDFGSA 201 (348)
T ss_dssp -EEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE----TTTEEEECCCTTC
T ss_pred -eEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC----CCCCEEEeeccCc
Confidence 8999999997 688888876666799999999999999999999999999999999999999 7889999999999
Q ss_pred ccccCccccCCccCCCcccCcccccc-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcC
Q 037285 968 KIKRNTLVSGGVRGTLPWMAPELLSG-SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYC 1046 (1094)
Q Consensus 968 rl~~~~~~ss~~~GT~~YmAPEvL~g-~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~ 1046 (1094)
+..... ....||+.|+|||++.+ ....++.++|||||||++|||++|+.||........+..+.........+..+
T Consensus 202 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (348)
T 1u5q_A 202 SIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW 278 (348)
T ss_dssp BSSSSB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTS
T ss_pred eecCCC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Confidence 865432 34569999999999853 24568899999999999999999999999888777776666665555556778
Q ss_pred cHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1047 DAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1047 S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
+..+.+||.+||+.||.+|||+.+++++.+-.
T Consensus 279 ~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~ 310 (348)
T 1u5q_A 279 SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 310 (348)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHhhChhhh
Confidence 99999999999999999999999999887654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=361.76 Aligned_cols=262 Identities=24% Similarity=0.290 Sum_probs=213.0
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||+|+||.||+|+++ +..||||++....... ........+.+|+.+|++++||||+++++++.+..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQ---INPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcc---cCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 368999999999999999999885 5679999997642211 01223467889999999999999999999998755
Q ss_pred CCceEEEeeecccchhHHHHhhc---------------------------------------ccccCHHHHHHHHHHHHH
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRK---------------------------------------DRFLDRRRRLIIAMDAAF 927 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~---------------------------------------~~~Lse~~~l~Ia~QIae 927 (1094)
.+++||||+.+|+|.+++... ...+++..++.++.||+.
T Consensus 102 --~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 102 --YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp --EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred --eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 899999999999999998521 112467788899999999
Q ss_pred HHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccC-----ccccCCccCCCcccCccccccCCCCCCchh
Q 037285 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRN-----TLVSGGVRGTLPWMAPELLSGSSSKVSEKV 1002 (1094)
Q Consensus 928 GLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~-----~~~ss~~~GT~~YmAPEvL~g~~~kyS~KS 1002 (1094)
||+|||+++|+||||||+|||++.+ ....+||+|||+++.... ........||+.|+|||++.+....++.++
T Consensus 180 ~l~~LH~~~ivH~Dlkp~NIll~~~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 180 ALHYLHNQGICHRDIKPENFLFSTN--KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHHTTEECCCCCGGGEEESCS--SSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHHCCccccCCChhhEEEecC--CCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999999999999999999999721 234899999999984322 112234568999999999975557789999
Q ss_pred hHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCC--cCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1003 DVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPS--YCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1003 DVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe--~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
|||||||++|+|++|+.||......+....+.........+. .+++.+.+||.+||..||.+||++.+++++-+-
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~ 334 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWI 334 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhh
Confidence 999999999999999999999988888887777665444332 478999999999999999999999999997654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=358.89 Aligned_cols=259 Identities=24% Similarity=0.358 Sum_probs=206.6
Q ss_pred ccCCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~ 885 (1094)
..++|++.+.||+|+||.||+|++ .++.||||++...... .......+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 84 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLAR-----DPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE 84 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTT-----SHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccC-----CHHHHHHHHHHHHHHHcCCCCCcceEEEeeecc
Confidence 347899999999999999999997 4678999999764321 233456788999999999999999999998754
Q ss_pred CC--CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEe
Q 037285 886 PG--GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGD 963 (1094)
Q Consensus 886 ~~--~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsD 963 (1094)
.. ...++||||+++++|.+++.... .+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|
T Consensus 85 ~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~----~~~~~kl~D 159 (311)
T 3ork_A 85 TPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS----ATNAVKVMD 159 (311)
T ss_dssp ETTEEEEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTSCEEECC
T ss_pred CCCCcccEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc----CCCCEEEee
Confidence 31 13599999999999999997654 589999999999999999999999999999999999998 778899999
Q ss_pred cCCcccccCc----cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCC
Q 037285 964 FGLSKIKRNT----LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 1039 (1094)
Q Consensus 964 FGLSrl~~~~----~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lr 1039 (1094)
||+++..... .......||+.|+|||++. ...++.++|||||||++|+|++|+.||..................
T Consensus 160 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 237 (311)
T 3ork_A 160 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR--GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI 237 (311)
T ss_dssp CSCC------------------CCTTCCHHHHH--TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC
T ss_pred ccCcccccccccccccccccCcCcccCCHHHhc--CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC
Confidence 9999854321 2223456899999999998 457899999999999999999999999998877776666555433
Q ss_pred CC--CCCcCcHHHHHHHHHhccCCCCCCCCHHHHHH-HHHHH
Q 037285 1040 PT--IPSYCDAEWRTLMEECWAPNPAARPSFTEIAS-RLRVL 1078 (1094)
Q Consensus 1040 p~--iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq-~L~~L 1078 (1094)
+. ....++.++.+||.+||+.||.+||++.+++. .|..+
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 238 PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 22 23458899999999999999999996665554 44444
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=359.72 Aligned_cols=260 Identities=34% Similarity=0.567 Sum_probs=217.6
Q ss_pred eeccCCeeEEEEecccCceEEEEeeec--Cce--EEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEe
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWR--GTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYG 880 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~--VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~G 880 (1094)
.+..++|++.+.||+|+||.||+|+++ +.. +|||.++.... ......+.+|+.+|+++ +||||+++++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~-------~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 93 (327)
T 1fvr_A 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-------KDDHRDFAGELEVLCKLGHHPNIINLLG 93 (327)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------------CHHHHHHHHHTTCCCCTTBCCEEE
T ss_pred cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccc-------hHHHHHHHHHHHHHHhccCCCchhhhce
Confidence 456689999999999999999999874 443 59998875311 12235678999999999 8999999999
Q ss_pred EeecCCCCceEEEeeecccchhHHHHhhcc---------------cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 037285 881 VVQDGPGGTLATVAEYMVDGSLRHVLVRKD---------------RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCD 945 (1094)
Q Consensus 881 v~~d~~~~~L~IVmEYmegGSL~d~L~k~~---------------~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPe 945 (1094)
++.+.. .+++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 94 ~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~ 171 (327)
T 1fvr_A 94 ACEHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR 171 (327)
T ss_dssp EEEETT--EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred eeeeCC--ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccc
Confidence 998865 8999999999999999997643 35899999999999999999999999999999999
Q ss_pred ceEeccCCCCCCcEEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 037285 946 NLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANM 1024 (1094)
Q Consensus 946 NILLD~~~~e~g~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~ 1024 (1094)
|||++ .++.+||+|||+++............+++.|+|||++. ...++.++|||||||++|+|+| |+.||...
T Consensus 172 NIl~~----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~ellt~g~~pf~~~ 245 (327)
T 1fvr_A 172 NILVG----ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN--YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 245 (327)
T ss_dssp GEEEC----GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHH--HCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred eEEEc----CCCeEEEcccCcCccccccccccCCCCCccccChhhhc--cccCCchhcchHHHHHHHHHHcCCCCCCCCC
Confidence 99998 67799999999998543333333445788999999997 4467899999999999999998 99999998
Q ss_pred ChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1025 HYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1025 ~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
...+....+ ........+..++..+.+||.+||..||.+|||+.+++++|..+...
T Consensus 246 ~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 246 TCAELYEKL-PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp CHHHHHHHG-GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cHHHHHHHh-hcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 887776655 44455667778999999999999999999999999999999998754
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=369.96 Aligned_cols=255 Identities=24% Similarity=0.362 Sum_probs=217.1
Q ss_pred eeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEe
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVV 882 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~ 882 (1094)
.+..++|++.+.||+|+||.||+|+++ ++.||||++++.... .......+..|..+|..+ +||||+++++++
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~-----~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~ 90 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI-----QDDDVECTMVEKRVLALPGKPPFLTQLHSCF 90 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----cchHHHHHHHHHHHHHhcCCCCEEeeEEEEE
Confidence 356689999999999999999999986 467999999764221 122345677899999888 799999999999
Q ss_pred ecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 883 QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 883 ~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
.+.. .+|+||||+.+|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 91 ~~~~--~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~----~~g~vkL~ 163 (353)
T 2i0e_A 91 QTMD--RLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD----SEGHIKIA 163 (353)
T ss_dssp ECSS--EEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEEC
T ss_pred EcCC--EEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEc----CCCcEEEE
Confidence 8865 8999999999999999997654 489999999999999999999999999999999999998 78899999
Q ss_pred ecCCcccc-cCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCC
Q 037285 963 DFGLSKIK-RNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT 1041 (1094)
Q Consensus 963 DFGLSrl~-~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~ 1041 (1094)
|||+++.. .........+||+.|+|||++. ...++.++|||||||++|||++|+.||......++...+..... .
T Consensus 164 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~--~ 239 (353)
T 2i0e_A 164 DFGMCKENIWDGVTTKTFCGTPDYIAPEIIA--YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV--A 239 (353)
T ss_dssp CCTTCBCCCCTTCCBCCCCSCGGGCCHHHHT--TCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--C
T ss_pred eCCcccccccCCcccccccCCccccChhhhc--CCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC--C
Confidence 99999853 2233445678999999999998 45688999999999999999999999999888888888776543 4
Q ss_pred CCCcCcHHHHHHHHHhccCCCCCCCC-----HHHHHHHHH
Q 037285 1042 IPSYCDAEWRTLMEECWAPNPAARPS-----FTEIASRLR 1076 (1094)
Q Consensus 1042 iPe~~S~eL~dLI~kCLq~DPeeRPS-----~eELLq~L~ 1076 (1094)
+|..++.++.+||.+||..||.+||+ +.+|+++-+
T Consensus 240 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~ 279 (353)
T 2i0e_A 240 YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 279 (353)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGG
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCcc
Confidence 67789999999999999999999994 688887643
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=352.26 Aligned_cols=257 Identities=31% Similarity=0.554 Sum_probs=213.8
Q ss_pred CCeeEEEEecccCceEEEEeeecC-----ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~rG-----t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
.+|++.+.||+|+||.||+|++.. ..||+|.+.... .......+.+|+.++++++||||+++++++..
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 97 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-------DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 97 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-------SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-------CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc
Confidence 468899999999999999998742 248999886421 12334678899999999999999999999765
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
. .+..++||||+.+++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+||
T Consensus 98 ~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~----~~~~~kl~Df 172 (298)
T 3f66_A 98 S-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD----EKFTVKVADF 172 (298)
T ss_dssp S-SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----TTCCEEECSC
T ss_pred C-CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEC----CCCCEEECcc
Confidence 3 3478899999999999999987777789999999999999999999999999999999999998 7889999999
Q ss_pred CCcccccCcc-----ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccC
Q 037285 965 GLSKIKRNTL-----VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 1038 (1094)
Q Consensus 965 GLSrl~~~~~-----~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~l 1038 (1094)
|+++...... ......+|+.|+|||++. ...++.++|||||||++|+|++ |..||......+....+. ...
T Consensus 173 g~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~-~~~ 249 (298)
T 3f66_A 173 GLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ--TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGR 249 (298)
T ss_dssp GGGCCCSCGGGCBC-----CCBCGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH-TTC
T ss_pred cccccccccchhccccccCCCCCccccChHHhc--CCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-cCC
Confidence 9998543221 223345778999999997 4568899999999999999999 677787776666655553 344
Q ss_pred CCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1039 RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1039 rp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
....+..++..+.++|.+||+.||.+|||+.++++.|..+...
T Consensus 250 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 250 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 5566778999999999999999999999999999999998754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=372.90 Aligned_cols=254 Identities=26% Similarity=0.405 Sum_probs=213.3
Q ss_pred cCCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||+|+||.||+|++ .++.||||++...... .......+.+|+.+|+.++||||+++++++....
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 82 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLK-----KSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT 82 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHcc-----chhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence 36899999999999999999998 4788999999754211 1112346789999999999999999999998865
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+++||||+ +|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 83 --~~~lv~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~----~~~~~kl~DFG~ 154 (336)
T 3h4j_B 83 --DIVMVIEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLD----DNLNVKIADFGL 154 (336)
T ss_dssp --EEEEEECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEEC----TTCCEEECCSSC
T ss_pred --EEEEEEECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEc----CCCCEEEEEecc
Confidence 899999999 788999887654 489999999999999999999999999999999999999 788999999999
Q ss_pred cccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcC
Q 037285 967 SKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYC 1046 (1094)
Q Consensus 967 Srl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~ 1046 (1094)
++...........+||+.|+|||++.+ ....+.++|||||||++|+|++|+.||...........+.. ....+|..+
T Consensus 155 s~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~ 231 (336)
T 3h4j_B 155 SNIMTDGNFLKTSCGSPNYAAPEVING-KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS--CVYVMPDFL 231 (336)
T ss_dssp TBTTTTSBTTCCCTTSTTTSCGGGSCC-SGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCS--SCCCCCTTS
T ss_pred ceeccCCcccccccCCcCcCCHHHHcC-CCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHc--CCCCCcccC
Confidence 986655555556779999999999984 22237899999999999999999999987655443333222 123467788
Q ss_pred cHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1047 DAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1047 S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
++.+.+||.+||..||.+|||+.+++++-+--
T Consensus 232 s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 263 (336)
T 3h4j_B 232 SPGAQSLIRRMIVADPMQRITIQEIRRDPWFN 263 (336)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHhChhhc
Confidence 99999999999999999999999999987754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=360.76 Aligned_cols=256 Identities=21% Similarity=0.240 Sum_probs=209.5
Q ss_pred eccCCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEee
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQ 883 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~~ 883 (1094)
+..++|++.+.||+|+||.||+|+. +++.||||++...... ..+.+|+.++++| +||||+++++++.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~E~~~l~~l~~h~~i~~~~~~~~ 75 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----------PQLHLEYRFYKQLGSGDGIPQVYYFGP 75 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----------CCHHHHHHHHHHHCSCTTSCCEEEEEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----------HHHHHHHHHHHHhhCCCCCCEEEEEEe
Confidence 3457899999999999999999986 4788999998754211 2467899999999 9999999999998
Q ss_pred cCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCc-----
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPI----- 958 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~----- 958 (1094)
... ..++||||+ +++|.+++......+++..++.++.||+.||+|||+++|+||||||+|||++ .++.
T Consensus 76 ~~~--~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~----~~~~~~~~~ 148 (330)
T 2izr_A 76 CGK--YNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIG----RPGNKTQQV 148 (330)
T ss_dssp ETT--EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----CGGGTCTTS
T ss_pred cCC--ccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec----cCCCCCCce
Confidence 865 899999999 9999999987666799999999999999999999999999999999999998 4444
Q ss_pred EEEEecCCcccccCcc--------ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH---
Q 037285 959 CKVGDFGLSKIKRNTL--------VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG--- 1027 (1094)
Q Consensus 959 VKLsDFGLSrl~~~~~--------~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~--- 1027 (1094)
+||+|||+++...... ......||+.|+|||++. ...++.++|||||||++|||++|+.||......
T Consensus 149 ~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~ 226 (330)
T 2izr_A 149 IHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHL--GKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK 226 (330)
T ss_dssp EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT--TCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHH
T ss_pred EEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHc--CCCCCchhHHHHHHHHHHHHhcCCCCccccccccHH
Confidence 9999999998543221 124567999999999998 456899999999999999999999999875432
Q ss_pred HHHHhHhhccCCCC---CCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 037285 1028 AIIGGIVNNTLRPT---IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAA 1082 (1094)
Q Consensus 1028 eile~Iv~~~lrp~---iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~ 1082 (1094)
+....+........ ....++ ++.++|.+||+.||.+||++.+|++.|..+....
T Consensus 227 ~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 227 ERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp HHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 33333322211111 122355 9999999999999999999999999999987654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=367.47 Aligned_cols=253 Identities=22% Similarity=0.292 Sum_probs=210.6
Q ss_pred CCeeE--EEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC
Q 037285 810 EDLEE--QKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 810 edYei--~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~ 885 (1094)
..|.+ .+.||+|+||.||+|++. |..||||+++... ......+.+|+.+|++++||||+++++++...
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 158 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--------MKDKEEVKNEISVMNQLDHANLIQLYDAFESK 158 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS--------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--------cccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 34444 678999999999999874 7889999997642 12235788999999999999999999999886
Q ss_pred CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecC
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFG 965 (1094)
. .+++||||+++++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||+..+ ..+.+||+|||
T Consensus 159 ~--~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~--~~~~~kl~DFG 234 (373)
T 2x4f_A 159 N--DIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNR--DAKQIKIIDFG 234 (373)
T ss_dssp S--EEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEET--TTTEEEECCCS
T ss_pred C--EEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecC--CCCcEEEEeCC
Confidence 5 8999999999999999997766679999999999999999999999999999999999999411 46789999999
Q ss_pred CcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCC--CC
Q 037285 966 LSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT--IP 1043 (1094)
Q Consensus 966 LSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~--iP 1043 (1094)
+++............||+.|+|||++. ...++.++|||||||++|+|++|+.||......+.+..+....+... ..
T Consensus 235 ~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 312 (373)
T 2x4f_A 235 LARRYKPREKLKVNFGTPEFLAPEVVN--YDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEF 312 (373)
T ss_dssp SCEECCTTCBCCCCCSSCTTCCHHHHT--TCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGG
T ss_pred CceecCCccccccccCCCcEeChhhcc--CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhh
Confidence 998665544445567999999999997 45688999999999999999999999999888887777766554432 22
Q ss_pred CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1044 SYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1044 e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
..++.++.+||.+||+.||.+|||+.+++++-+
T Consensus 313 ~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~ 345 (373)
T 2x4f_A 313 QDISEEAKEFISKLLIKEKSWRISASEALKHPW 345 (373)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcC
Confidence 467899999999999999999999999998655
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=367.84 Aligned_cols=261 Identities=25% Similarity=0.350 Sum_probs=211.7
Q ss_pred ccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~ 885 (1094)
..++|++.+.||+|+||.||+|+++ ++.||||++......... ......+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 98 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSP---GLSTEDLKREASICHMLKHPHIVELLETYSSD 98 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSS---SCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccc---cchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 3468999999999999999999874 788999999753221110 01235688999999999999999999999885
Q ss_pred CCCceEEEeeecccchhHHHHhhcc---cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKD---RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~---~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
. .+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++..+ ....+||+
T Consensus 99 ~--~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~-~~~~vkl~ 175 (351)
T 3c0i_A 99 G--MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKE-NSAPVKLG 175 (351)
T ss_dssp T--EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSS-TTCCEEEC
T ss_pred C--EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCC-CCCcEEEe
Confidence 5 8999999999999988886542 3489999999999999999999999999999999999998332 34569999
Q ss_pred ecCCcccccCc-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCC
Q 037285 963 DFGLSKIKRNT-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT 1041 (1094)
Q Consensus 963 DFGLSrl~~~~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~ 1041 (1094)
|||+++..... .......||+.|+|||++. ...++.++|||||||++|+|++|+.||... .......+....+...
T Consensus 176 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~ 252 (351)
T 3c0i_A 176 GFGVAIQLGESGLVAGGRVGTPHFMAPEVVK--REPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMN 252 (351)
T ss_dssp CCTTCEECCTTSCBCCCCCSCGGGCCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCC
T ss_pred cCcceeEecCCCeeecCCcCCcCccCHHHHc--CCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCC
Confidence 99999855432 2234567999999999998 456789999999999999999999999875 3444555544433221
Q ss_pred --CCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1042 --IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1042 --iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
....++.++.+||.+||..||.+|||+.+++++-+-
T Consensus 253 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~ 290 (351)
T 3c0i_A 253 PRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWL 290 (351)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhh
Confidence 114678999999999999999999999999987554
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=348.05 Aligned_cols=261 Identities=25% Similarity=0.346 Sum_probs=199.9
Q ss_pred eeccCCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEee
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQ 883 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~ 883 (1094)
++..++|++.+.||+|+||.||+|++ .++.||||+++... ........+.++...++.++||||+++++++.
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~ 76 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV------NSQEQKRLLMDLDISMRTVDCPFTVTFYGALF 76 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---------CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc------CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee
Confidence 46678999999999999999999998 47889999987542 11222234445556688899999999999998
Q ss_pred cCCCCceEEEeeecccchhHHHHhh---cccccCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeccCCCCCCcE
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLVR---KDRFLDRRRRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPSRPIC 959 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~k---~~~~Lse~~~l~Ia~QIaeGLaYLHs~-GIIHRDLKPeNILLD~~~~e~g~V 959 (1094)
+.. ..++||||++ |+|.+++.. ....+++..++.++.||+.||.|||++ ||+||||||+|||++ .++.+
T Consensus 77 ~~~--~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~----~~~~~ 149 (290)
T 3fme_A 77 REG--DVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLIN----ALGQV 149 (290)
T ss_dssp CSS--SEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEEC----TTCCE
T ss_pred ccC--CEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEEC----CCCCE
Confidence 754 8999999997 588777654 345699999999999999999999998 999999999999998 67899
Q ss_pred EEEecCCcccccCccccCCccCCCcccCcccccc--CCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-ChHHHHHhHhhc
Q 037285 960 KVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSG--SSSKVSEKVDVFSFGIVLWEILTGEEPYANM-HYGAIIGGIVNN 1036 (1094)
Q Consensus 960 KLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g--~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~-~~~eile~Iv~~ 1036 (1094)
||+|||+++............||+.|+|||++.. ....++.++|||||||++|+|++|+.||... ............
T Consensus 150 kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 229 (290)
T 3fme_A 150 KMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE 229 (290)
T ss_dssp EBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHS
T ss_pred EEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhcc
Confidence 9999999986554444445569999999999731 1456889999999999999999999999864 334444444454
Q ss_pred cCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1037 TLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1037 ~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
......+..++.++.+||.+||+.||.+|||+.+++++-+--.
T Consensus 230 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 230 PSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp CCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred CCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 4444445678999999999999999999999999999766543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=362.43 Aligned_cols=259 Identities=28% Similarity=0.550 Sum_probs=213.9
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeec--Cce----EEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEE
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWR--GTD----VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAF 878 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~----VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL 878 (1094)
..+..++|++.+.||+|+||.||+|++. +.. ||+|.+..... ......+.+|+.++++++||||+++
T Consensus 10 ~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~-------~~~~~~~~~E~~~l~~l~hp~iv~~ 82 (327)
T 3lzb_A 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-------PKANKEILDEAYVMASVDNPHVCRL 82 (327)
T ss_dssp EECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSS-------CCCHHHHHHHHHHHTTCCBTTBCCC
T ss_pred cccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccC-------HHHHHHHHHHHHHHHhCCCCCeeEE
Confidence 4567789999999999999999999874 444 46666643221 1123568899999999999999999
Q ss_pred EeEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCc
Q 037285 879 YGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPI 958 (1094)
Q Consensus 879 ~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~ 958 (1094)
++++... ..++|++|+.+|+|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++ .++.
T Consensus 83 ~~~~~~~---~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~----~~~~ 155 (327)
T 3lzb_A 83 LGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK----TPQH 155 (327)
T ss_dssp CEEEESS---SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE----ETTE
T ss_pred EEEEecC---CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEc----CCCC
Confidence 9999875 48899999999999999988777799999999999999999999999999999999999998 6789
Q ss_pred EEEEecCCcccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHh
Q 037285 959 CKVGDFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIV 1034 (1094)
Q Consensus 959 VKLsDFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv 1034 (1094)
+||+|||+++..... .......+|+.|+|||++. ...++.++|||||||++|+|++ |+.||......+....+
T Consensus 156 ~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~- 232 (327)
T 3lzb_A 156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL- 232 (327)
T ss_dssp EEECCTTC----------------CCCGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-
T ss_pred EEEccCcceeEccCccccccccCCCccccccCHHHHc--CCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH-
Confidence 999999999854322 1222344678899999998 4568999999999999999999 99999988877766554
Q ss_pred hccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 037285 1035 NNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLST 1080 (1094)
Q Consensus 1035 ~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~t 1080 (1094)
........+..++.++.+||.+||..||.+||++.+|++.|..+..
T Consensus 233 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 233 EKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred HcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 4455566778899999999999999999999999999999999873
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=375.66 Aligned_cols=255 Identities=21% Similarity=0.360 Sum_probs=211.5
Q ss_pred eeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEe
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVV 882 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~ 882 (1094)
.+..++|++.++||+|+||.||+|+++ ++.||||++++..... ......+.+|..+|.++ +||||+++++++
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~-----~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~ 122 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVND-----DEDIDWVQTEKHVFEQASNHPFLVGLHSCF 122 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC---------CCHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccC-----HHHHHHHHHHHHHHHhcCCCCCcCeeEEEE
Confidence 456689999999999999999999885 5779999998754332 11224567889999887 899999999999
Q ss_pred ecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 883 QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 883 ~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
.+.. .+++||||+.+|+|..++.... .+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+
T Consensus 123 ~~~~--~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~----~~g~ikL~ 195 (396)
T 4dc2_A 123 QTES--RLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD----SEGHIKLT 195 (396)
T ss_dssp ECSS--EEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEEC
T ss_pred EECC--EEEEEEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEC----CCCCEEEe
Confidence 8865 8999999999999999997654 599999999999999999999999999999999999999 78899999
Q ss_pred ecCCccc-ccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---------hHHHHHh
Q 037285 963 DFGLSKI-KRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH---------YGAIIGG 1032 (1094)
Q Consensus 963 DFGLSrl-~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~---------~~eile~ 1032 (1094)
|||+++. ..........+||+.|+|||++. ...++.++|||||||++|||++|+.||.... .......
T Consensus 196 DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~--~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~ 273 (396)
T 4dc2_A 196 DYGMCKEGLRPGDTTSTFCGTPNYIAPEILR--GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 273 (396)
T ss_dssp CCTTCBCCCCTTCCBCCCCBCGGGCCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHH
T ss_pred ecceeeecccCCCccccccCCcccCCchhhc--CCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHH
Confidence 9999985 33334455678999999999998 4578899999999999999999999996432 2223344
Q ss_pred HhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCH------HHHHHHHH
Q 037285 1033 IVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSF------TEIASRLR 1076 (1094)
Q Consensus 1033 Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~------eELLq~L~ 1076 (1094)
+... ...+|..++.++.+||.+||+.||.+||++ .+|+++-+
T Consensus 274 i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpf 321 (396)
T 4dc2_A 274 ILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321 (396)
T ss_dssp HHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTT
T ss_pred Hhcc--ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcc
Confidence 4333 345778899999999999999999999984 78877654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=354.38 Aligned_cols=265 Identities=30% Similarity=0.486 Sum_probs=212.9
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeecC-----ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEE
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFY 879 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~rG-----t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~ 879 (1094)
..+..++|++.+.||+|+||.||+|++.. ..||||++..... .......+.+|+.++++++||||++++
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~ 102 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS------SQREIEEFLSEAACMKDFSHPNVIRLL 102 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC------CHHHHHHHHHHHHHHHTCCCTTBCCCC
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc------chhHHHHHHHHHHHHhcCCCCCeeeee
Confidence 34667899999999999999999998742 3699999875421 123346788999999999999999999
Q ss_pred eEeecCCCC---ceEEEeeecccchhHHHHhh-----cccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEecc
Q 037285 880 GVVQDGPGG---TLATVAEYMVDGSLRHVLVR-----KDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNL 951 (1094)
Q Consensus 880 Gv~~d~~~~---~L~IVmEYmegGSL~d~L~k-----~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~ 951 (1094)
+++...... ..++||||+.+++|.+++.. ....+++..++.++.||+.||.|||+++|+||||||+|||++
T Consensus 103 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~- 181 (313)
T 3brb_A 103 GVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR- 181 (313)
T ss_dssp EEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEEC-
T ss_pred EEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc-
Confidence 999865322 45999999999999999853 234689999999999999999999999999999999999998
Q ss_pred CCCCCCcEEEEecCCcccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChH
Q 037285 952 KDPSRPICKVGDFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYG 1027 (1094)
Q Consensus 952 ~~~e~g~VKLsDFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~ 1027 (1094)
.++.+||+|||+++..... .......+++.|+|||++. ...++.++|||||||++|+|++ |..||......
T Consensus 182 ---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 256 (313)
T 3brb_A 182 ---DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA--DRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH 256 (313)
T ss_dssp ---TTSCEEECSCSCC----------------CCGGGSCHHHHH--SSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred ---CCCcEEEeecCcceecccccccCcccccCCCccccCchhhc--CCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH
Confidence 7789999999999854322 1122344788999999998 4678999999999999999999 99999988877
Q ss_pred HHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 037285 1028 AIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAA 1082 (1094)
Q Consensus 1028 eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~ 1082 (1094)
.....+.. ..+...+..++..+.++|.+||..||.+|||+.+|+++|+.+....
T Consensus 257 ~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 257 EMYDYLLH-GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp GHHHHHHT-TCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHHHc-CCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 77666544 4456677889999999999999999999999999999999987543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=368.48 Aligned_cols=257 Identities=20% Similarity=0.329 Sum_probs=208.8
Q ss_pred eccCCeeEEEEeccc--CceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEe
Q 037285 807 IKNEDLEEQKELGSG--TFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVV 882 (1094)
Q Consensus 807 Is~edYei~kkLGsG--~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~ 882 (1094)
....+|++.++||+| +||.||+|+++ +..||||++...... ......+.+|+.+|++++|||||++++++
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 95 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS------NEMVTFLQGELHVSKLFNHPNIVPYRATF 95 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC------HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC------hHHHHHHHHHHHHHHhCCCCCCCcEeEEE
Confidence 456789999999999 99999999985 788999999865321 23456788899999999999999999999
Q ss_pred ecCCCCceEEEeeecccchhHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEE
Q 037285 883 QDGPGGTLATVAEYMVDGSLRHVLVRK-DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKV 961 (1094)
Q Consensus 883 ~d~~~~~L~IVmEYmegGSL~d~L~k~-~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKL 961 (1094)
.+.. .+++||||+.+|+|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||
T Consensus 96 ~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~----~~~~~kl 169 (389)
T 3gni_B 96 IADN--ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS----VDGKVYL 169 (389)
T ss_dssp EETT--EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCCEEE
T ss_pred EECC--EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEEE
Confidence 9865 899999999999999999765 24589999999999999999999999999999999999998 7889999
Q ss_pred EecCCcccccC--------ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhH
Q 037285 962 GDFGLSKIKRN--------TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI 1033 (1094)
Q Consensus 962 sDFGLSrl~~~--------~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~I 1033 (1094)
+|||++..... ........||+.|+|||++.+....++.++|||||||++|+|++|+.||...........+
T Consensus 170 ~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 249 (389)
T 3gni_B 170 SGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK 249 (389)
T ss_dssp CCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC
T ss_pred cccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 99998863211 1112234689999999999854467899999999999999999999999876655544333
Q ss_pred hhccCC--------------------------------------------CCCCCcCcHHHHHHHHHhccCCCCCCCCHH
Q 037285 1034 VNNTLR--------------------------------------------PTIPSYCDAEWRTLMEECWAPNPAARPSFT 1069 (1094)
Q Consensus 1034 v~~~lr--------------------------------------------p~iPe~~S~eL~dLI~kCLq~DPeeRPS~e 1069 (1094)
...... ...+..+++.+.+||.+||+.||.+|||+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ 329 (389)
T 3gni_B 250 LNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAS 329 (389)
T ss_dssp --------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred hcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHH
Confidence 221110 123455788999999999999999999999
Q ss_pred HHHHHH
Q 037285 1070 EIASRL 1075 (1094)
Q Consensus 1070 ELLq~L 1075 (1094)
+++++-
T Consensus 330 ell~hp 335 (389)
T 3gni_B 330 TLLNHS 335 (389)
T ss_dssp HHTTSG
T ss_pred HHhcCH
Confidence 999773
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=353.85 Aligned_cols=261 Identities=27% Similarity=0.339 Sum_probs=207.1
Q ss_pred eccCCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC---CCCceeEEEeE
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL---HHPNVVAFYGV 881 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL---~HPNIVqL~Gv 881 (1094)
+..++|++.++||+|+||+||+|++ .++.||||++......... ......+.+|+.+++++ +||||++++++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~ 82 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGG---GGLPISTVREVALLRRLEAFEHPNVVRLMDV 82 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTS---SCCCHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccc---cccchhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence 4467999999999999999999986 4788999999754321111 11113445666666655 59999999999
Q ss_pred eecCCCC---ceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCC
Q 037285 882 VQDGPGG---TLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRP 957 (1094)
Q Consensus 882 ~~d~~~~---~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g 957 (1094)
+...... .+++||||+. ++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++ .++
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~----~~~ 157 (308)
T 3g33_A 83 CATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT----SGG 157 (308)
T ss_dssp EEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEEC----TTS
T ss_pred eeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc----CCC
Confidence 9765322 4789999996 69999987654 3489999999999999999999999999999999999998 778
Q ss_pred cEEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhcc
Q 037285 958 ICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 1037 (1094)
Q Consensus 958 ~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~ 1037 (1094)
.+||+|||+++............||+.|+|||++. ...++.++|||||||++|+|++|+.||...........+....
T Consensus 158 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (308)
T 3g33_A 158 TVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLL--QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 235 (308)
T ss_dssp CEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHH--TSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHH
T ss_pred CEEEeeCccccccCCCcccCCccccccccCchHHc--CCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 99999999998665544445567999999999998 4568899999999999999999999999988877766654421
Q ss_pred CCCC-------------------------CCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1038 LRPT-------------------------IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1038 lrp~-------------------------iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
..+. ....++..+.+||.+||+.||.+|||+.+++++-+-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~ 300 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 300 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC
T ss_pred CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccc
Confidence 1100 113467899999999999999999999999987553
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=379.73 Aligned_cols=256 Identities=27% Similarity=0.398 Sum_probs=210.4
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEe
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVV 882 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~ 882 (1094)
..+..++|++.+.||+|+||.||+|+.+ +..||||++....... ......+.+|+.+|++++||||+++++++
T Consensus 143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~l~~~~ 217 (446)
T 4ejn_A 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA-----KDEVAHTLTENRVLQNSRHPFLTALKYSF 217 (446)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC------------------CCCCCSCTTSCCEEEEE
T ss_pred cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhh-----hHHHHHHHHHHHHHHhCCCCeEeeEEEEE
Confidence 3456678999999999999999999874 6789999997643211 22235677899999999999999999999
Q ss_pred ecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeccCCCCCCcEEE
Q 037285 883 QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPSRPICKV 961 (1094)
Q Consensus 883 ~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs-~GIIHRDLKPeNILLD~~~~e~g~VKL 961 (1094)
.... .+++||||+.+|+|.+++.... .+++..+..++.||+.||+|||+ +||+||||||+|||++ .++.+||
T Consensus 218 ~~~~--~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~----~~~~~kl 290 (446)
T 4ejn_A 218 QTHD--RLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD----KDGHIKI 290 (446)
T ss_dssp EETT--EEEEEECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEEC----SSSCEEE
T ss_pred eeCC--EEEEEEeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEEC----CCCCEEE
Confidence 8865 8999999999999999997654 58999999999999999999998 9999999999999998 7789999
Q ss_pred EecCCcccc-cCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCC
Q 037285 962 GDFGLSKIK-RNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 1040 (1094)
Q Consensus 962 sDFGLSrl~-~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp 1040 (1094)
+|||+++.. .........+||+.|+|||++. ...++.++|||||||++|||++|+.||...........+.....
T Consensus 291 ~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-- 366 (446)
T 4ejn_A 291 TDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE--DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-- 366 (446)
T ss_dssp CCCCCCCTTCC-----CCSSSCGGGCCHHHHH--TSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--
T ss_pred ccCCCceeccCCCcccccccCCccccCHhhcC--CCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC--
Confidence 999999853 2233344567999999999998 45789999999999999999999999999888887777766544
Q ss_pred CCCCcCcHHHHHHHHHhccCCCCCCC-----CHHHHHHHHH
Q 037285 1041 TIPSYCDAEWRTLMEECWAPNPAARP-----SFTEIASRLR 1076 (1094)
Q Consensus 1041 ~iPe~~S~eL~dLI~kCLq~DPeeRP-----S~eELLq~L~ 1076 (1094)
.++..+++++.+||.+||+.||.+|| ++.+++++-+
T Consensus 367 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~ 407 (446)
T 4ejn_A 367 RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407 (446)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCcc
Confidence 46778999999999999999999999 9999998644
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=358.52 Aligned_cols=252 Identities=23% Similarity=0.307 Sum_probs=203.0
Q ss_pred eeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEe
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVV 882 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~ 882 (1094)
.+..++|++.++||+|+||+||+|++. ++.||||++...... ......+..|+..+.++ +||||++++++|
T Consensus 53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~ 126 (311)
T 3p1a_A 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRG------PKDRARKLAEVGSHEKVGQHPCCVRLEQAW 126 (311)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCS------HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccC------hHHHHHHHHHHHHHHHhcCCCcEEEEEEEE
Confidence 344578999999999999999999985 788999998654211 11223455566666555 899999999999
Q ss_pred ecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 883 QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 883 ~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
.+.. .+++||||+ +++|.+++......+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+
T Consensus 127 ~~~~--~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~----~~~~~kl~ 199 (311)
T 3p1a_A 127 EEGG--ILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG----PRGRCKLG 199 (311)
T ss_dssp EETT--EEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----GGGCEEEC
T ss_pred EeCC--EEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC----CCCCEEEc
Confidence 8755 899999999 7789998887777799999999999999999999999999999999999998 67889999
Q ss_pred ecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCC
Q 037285 963 DFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTI 1042 (1094)
Q Consensus 963 DFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~i 1042 (1094)
|||+++............||+.|+|||++.+ .++.++|||||||++|||++|..|+... .....+......+.+
T Consensus 200 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~---~~~~~~~~~~~~~~~ 273 (311)
T 3p1a_A 200 DFGLLVELGTAGAGEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGG---EGWQQLRQGYLPPEF 273 (311)
T ss_dssp CCTTCEECC------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSSH---HHHHHHTTTCCCHHH
T ss_pred cceeeeecccCCCCcccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCc---cHHHHHhccCCCccc
Confidence 9999986655544555679999999999874 5889999999999999999997766543 223333333333445
Q ss_pred CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1043 PSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1043 Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
+..++.++.+||.+||+.||++|||+.+++++-+
T Consensus 274 ~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 307 (311)
T 3p1a_A 274 TAGLSSELRSVLVMMLEPDPKLRATAEALLALPV 307 (311)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred ccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCcc
Confidence 5678999999999999999999999999998643
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=357.86 Aligned_cols=262 Identities=29% Similarity=0.490 Sum_probs=216.9
Q ss_pred eccCCeeEEEEecccCceEEEEeee------cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEe
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKW------RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYG 880 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~------rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~G 880 (1094)
+....|++.++||+|+||.||++.+ .++.||||+++... .......+.+|+.+|++++||||+++++
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 100 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-------GPQHRSGWKQEIDILRTLYHEHIIKYKG 100 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-------CHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-------ChHHHHHHHHHHHHHHhCCCcchhhEEE
Confidence 4444559999999999999998865 36779999997541 1233467889999999999999999999
Q ss_pred EeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEE
Q 037285 881 VVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICK 960 (1094)
Q Consensus 881 v~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VK 960 (1094)
++.+.....+++||||+.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+|
T Consensus 101 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~----~~~~~k 174 (318)
T 3lxp_A 101 CCEDAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLD----NDRLVK 174 (318)
T ss_dssp EEEETTTTEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEE
T ss_pred EEecCCCceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEc----CCCCEE
Confidence 99876556899999999999999999654 389999999999999999999999999999999999998 778999
Q ss_pred EEecCCcccccCcc----ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH---------
Q 037285 961 VGDFGLSKIKRNTL----VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG--------- 1027 (1094)
Q Consensus 961 LsDFGLSrl~~~~~----~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~--------- 1027 (1094)
|+|||+++...... ......+|..|+|||++. ...++.++|||||||++|+|+||+.||......
T Consensus 175 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 252 (318)
T 3lxp_A 175 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK--EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ 252 (318)
T ss_dssp ECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHH--HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCC
T ss_pred ECCccccccccccccccccccCCCCCceeeChHHhc--CCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccc
Confidence 99999998543321 223345788899999998 446788999999999999999999998753221
Q ss_pred -----HHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 037285 1028 -----AIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAAS 1083 (1094)
Q Consensus 1028 -----eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s 1083 (1094)
..+............+..++.++.+||.+||+.||.+|||+.+|++.|+.+.....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 253 GQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred cchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 12233445556667788899999999999999999999999999999999986644
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=360.30 Aligned_cols=258 Identities=23% Similarity=0.322 Sum_probs=211.4
Q ss_pred eeccCCeeEEEEecccCceEEEEeeec-CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCC--CceeEEEeEe
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHH--PNVVAFYGVV 882 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~r-Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~H--PNIVqL~Gv~ 882 (1094)
.+...+|++.+.||+|+||.||++... +..||||++..... .......+.+|+.+|++++| +||+++++++
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 78 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA------DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 78 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTC------CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeecccc------chHHHHHHHHHHHHHHhhhhcCCceEEEeeeE
Confidence 456778999999999999999999875 67799999975421 12334678899999999986 9999999999
Q ss_pred ecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 883 QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 883 ~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
.... .+++||| +.+++|.+++.... .+++..++.++.||+.||.|||+++|+||||||+|||++ ++.+||+
T Consensus 79 ~~~~--~~~lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-----~~~~kl~ 149 (343)
T 3dbq_A 79 ITDQ--YIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-----DGMLKLI 149 (343)
T ss_dssp ECSS--EEEEEEC-CCSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-----TTEEEEC
T ss_pred eeCC--EEEEEEe-CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-----CCcEEEe
Confidence 8765 8999999 56889999997654 589999999999999999999999999999999999997 4679999
Q ss_pred ecCCcccccCcc---ccCCccCCCcccCcccccc---------CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh-HHH
Q 037285 963 DFGLSKIKRNTL---VSGGVRGTLPWMAPELLSG---------SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY-GAI 1029 (1094)
Q Consensus 963 DFGLSrl~~~~~---~ss~~~GT~~YmAPEvL~g---------~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~-~ei 1029 (1094)
|||+++...... ......||+.|+|||++.+ ....++.++|||||||++|+|++|+.||..... ...
T Consensus 150 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 229 (343)
T 3dbq_A 150 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 229 (343)
T ss_dssp CCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH
T ss_pred ecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH
Confidence 999998543221 2334579999999999863 125688999999999999999999999987543 344
Q ss_pred HHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1030 IGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1030 le~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
...+........++..++..+.+||.+||+.||.+|||+.+++++.+--
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~ 278 (343)
T 3dbq_A 230 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278 (343)
T ss_dssp HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred HHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccc
Confidence 4555555666777888899999999999999999999999999987753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=373.04 Aligned_cols=256 Identities=25% Similarity=0.407 Sum_probs=215.1
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEe
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVV 882 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~ 882 (1094)
+.+..++|++.+.||+|+||.||+++++ +..||||++.+... ........+.+|+.+|++++|||||++++++
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~-----~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~ 84 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKC-----VERNEVRNVFKELQIMQGLEHPFLVNLWYSF 84 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhc-----ccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 4566789999999999999999999885 57799999976421 1122345788999999999999999999999
Q ss_pred ecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 883 QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 883 ~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
.+.. .+++||||+.+|+|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 85 ~~~~--~~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~----~~g~vkL~ 157 (384)
T 4fr4_A 85 QDEE--DMFMVVDLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLD----EHGHVHIT 157 (384)
T ss_dssp ECSS--EEEEEECCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEEC
T ss_pred EeCC--EEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEC----CCCCEEEe
Confidence 8865 8999999999999999997654 589999999999999999999999999999999999998 78899999
Q ss_pred ecCCcccccCccccCCccCCCcccCccccccC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---hHHHHHhHhhccC
Q 037285 963 DFGLSKIKRNTLVSGGVRGTLPWMAPELLSGS-SSKVSEKVDVFSFGIVLWEILTGEEPYANMH---YGAIIGGIVNNTL 1038 (1094)
Q Consensus 963 DFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~-~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~---~~eile~Iv~~~l 1038 (1094)
|||+++...........+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.... ..+....+.. .
T Consensus 158 DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--~ 235 (384)
T 4fr4_A 158 DFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET--T 235 (384)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH--C
T ss_pred ccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh--c
Confidence 99999876555555667899999999998742 2357899999999999999999999997543 2333333322 2
Q ss_pred CCCCCCcCcHHHHHHHHHhccCCCCCCCC-HHHHHHH
Q 037285 1039 RPTIPSYCDAEWRTLMEECWAPNPAARPS-FTEIASR 1074 (1094)
Q Consensus 1039 rp~iPe~~S~eL~dLI~kCLq~DPeeRPS-~eELLq~ 1074 (1094)
...++..++..+.+||.+||..||.+||+ +.+|+++
T Consensus 236 ~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 236 VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 34567789999999999999999999998 7887764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=356.80 Aligned_cols=261 Identities=23% Similarity=0.334 Sum_probs=216.5
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||+|+||.||+|++. +..||||++......... .......+.+|+.+|++++||||+++++++.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASR--RGVSREEIEREVSILRQVLHHNVITLHDVYENRT 88 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCS--SSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccc--cchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 457999999999999999999885 678999999875432211 1112356889999999999999999999998755
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+++||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++..+.....+||+|||+
T Consensus 89 --~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 89 --DVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp --EEEEEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred --EEEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 8999999999999999997654 5899999999999999999999999999999999999983222223799999999
Q ss_pred cccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCC--CCCC
Q 037285 967 SKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP--TIPS 1044 (1094)
Q Consensus 967 Srl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp--~iPe 1044 (1094)
++............||+.|+|||++. ...++.++|||||||++|+|++|+.||......+....+....... ....
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (321)
T 2a2a_A 166 AHEIEDGVEFKNIFGTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS 243 (321)
T ss_dssp CEECCTTCCCCCCCSCGGGCCHHHHT--TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred ceecCccccccccCCCCCccCccccc--CCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhc
Confidence 98655544445567999999999997 4568899999999999999999999999888877776665443321 1225
Q ss_pred cCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1045 YCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1045 ~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
.++..+.+||.+||..||.+|||+.+++++-+
T Consensus 244 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~ 275 (321)
T 2a2a_A 244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (321)
T ss_dssp TCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTT
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 67899999999999999999999999998644
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=351.72 Aligned_cols=253 Identities=26% Similarity=0.413 Sum_probs=192.7
Q ss_pred CCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||+|+||.||+|++ .+..||||++..... ........+.+|+.++++++||||+++++++.+..
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 84 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAM-----YKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN- 84 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS-
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhh-----hhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC-
Confidence 5799999999999999999987 478899999975321 11223467889999999999999999999998755
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++||||+.+++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 85 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~----~~~~~kl~dfg~~ 159 (278)
T 3cok_A 85 -YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLT----RNMNIKIADFGLA 159 (278)
T ss_dssp -EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEEC----TTCCEEECCCTTC
T ss_pred -eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCCEEEEeecce
Confidence 89999999999999999987766799999999999999999999999999999999999998 7789999999999
Q ss_pred ccccCc-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcC
Q 037285 968 KIKRNT-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYC 1046 (1094)
Q Consensus 968 rl~~~~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~ 1046 (1094)
...... .......+|+.|+|||++. ...++.++||||||+++|+|++|+.||...........+.... ...+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~ 235 (278)
T 3cok_A 160 TQLKMPHEKHYTLCGTPNYISPEIAT--RSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD--YEMPSFL 235 (278)
T ss_dssp EECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSC--CCCCTTS
T ss_pred eeccCCCCcceeccCCCCcCCcchhc--CCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcc--cCCcccc
Confidence 854322 2223456899999999997 4567889999999999999999999998776555444433322 3456778
Q ss_pred cHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1047 DAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1047 S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
+.++.+||.+||+.||.+|||+.+++++-+-
T Consensus 236 ~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 266 (278)
T 3cok_A 236 SIEAKDLIHQLLRRNPADRLSLSSVLDHPFM 266 (278)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHTTSTTT
T ss_pred CHHHHHHHHHHcccCHhhCCCHHHHhcCccc
Confidence 9999999999999999999999999986543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=349.71 Aligned_cols=253 Identities=26% Similarity=0.358 Sum_probs=206.7
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||+|+||.||+++++ +..||+|++...... .....+.+|+.+|++++||||+++++++.+..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 93 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-------VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH- 93 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-------SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-------hhHHHHHHHHHHHHhCCCchHHhHHHheecCC-
Confidence 68999999999999999999875 678999999765321 11356789999999999999999999998755
Q ss_pred CceEEEeeecccchhHHHHhhc---ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 888 GTLATVAEYMVDGSLRHVLVRK---DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~---~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
.+++||||+.+++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++..+ ..+.+||+||
T Consensus 94 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~-~~~~~kl~Df 171 (285)
T 3is5_A 94 -NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTS-PHSPIKIIDF 171 (285)
T ss_dssp -EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSS-TTCCEEECCC
T ss_pred -eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCC-CCCCEEEEee
Confidence 899999999999999988543 35699999999999999999999999999999999999996322 5678999999
Q ss_pred CCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCC-CC
Q 037285 965 GLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT-IP 1043 (1094)
Q Consensus 965 GLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~-iP 1043 (1094)
|+++............+|+.|+|||++. ..++.++|||||||++|+|++|+.||......+............. ..
T Consensus 172 g~a~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (285)
T 3is5_A 172 GLAELFKSDEHSTNAAGTALYMAPEVFK---RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVEC 248 (285)
T ss_dssp CCCCC----------CTTGGGCCHHHHT---TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--
T ss_pred ecceecCCcccCcCcccccCcCChHHhc---cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccccc
Confidence 9998655444445567999999999986 3578999999999999999999999999887776665544333222 22
Q ss_pred CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037285 1044 SYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1044 e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L 1075 (1094)
..+++.+.+||.+||+.||.+|||+.+++++-
T Consensus 249 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 280 (285)
T 3is5_A 249 RPLTPQAVDLLKQMLTKDPERRPSAAQVLHHE 280 (285)
T ss_dssp CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSG
T ss_pred CcCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 34789999999999999999999999999764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=363.62 Aligned_cols=254 Identities=29% Similarity=0.351 Sum_probs=207.4
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||+|+||.||+|+++ ++.||||++...... .....+.+|+.++++++||||+++++++.+..
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~- 78 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-------DCPENIKKEICINKMLNHENVVKFYGHRREGN- 78 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------------CHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-------chHHHHHHHHHHHHhCCCCCCCeEEEEEecCC-
Confidence 68999999999999999999875 678999998754211 12246778999999999999999999998765
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
..++||||+.+++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 79 -~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~----~~~~~kl~Dfg~a 152 (323)
T 3tki_A 79 -IQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD----ERDNLKISDFGLA 152 (323)
T ss_dssp -EEEEEEECCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEEECCCTTC
T ss_pred -eEEEEEEcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEe----CCCCEEEEEeecc
Confidence 8999999999999999986554 489999999999999999999999999999999999998 7789999999999
Q ss_pred ccccC---ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH-HHHHhHhhccCCCCCC
Q 037285 968 KIKRN---TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-AIIGGIVNNTLRPTIP 1043 (1094)
Q Consensus 968 rl~~~---~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~-eile~Iv~~~lrp~iP 1043 (1094)
+.... ........||+.|+|||++.+ ...++.++|||||||++|+|++|+.||...... ................
T Consensus 153 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 231 (323)
T 3tki_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKR-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231 (323)
T ss_dssp EECEETTEECCBCSCCSCGGGSCHHHHHC-SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTG
T ss_pred ceeccCCcccccCCCccCcCccCcHHhcc-CCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCcc
Confidence 75321 222335679999999999974 223477999999999999999999999876543 2222232333333333
Q ss_pred CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1044 SYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1044 e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
..++..+.+||.+||..||.+|||+.+++++.+-.
T Consensus 232 ~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~ 266 (323)
T 3tki_A 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266 (323)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhc
Confidence 56889999999999999999999999999886653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=345.14 Aligned_cols=256 Identities=25% Similarity=0.417 Sum_probs=209.0
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
+..++|++.+.||+|+||.||+|+++ ++.||||++..... ........+.+|+.++++++||||+++++++..
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 82 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI-----RSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST 82 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccc-----cchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 45578999999999999999999885 78899999875321 112234578899999999999999999999987
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
.. .+++||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+|+||||+|||++ .++.+||+||
T Consensus 83 ~~--~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~~l~df 155 (276)
T 2h6d_A 83 PT--DFFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLD----AHMNAKIADF 155 (276)
T ss_dssp SS--EEEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEEC----TTSCEEECCC
T ss_pred CC--eEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEEC----CCCCEEEeec
Confidence 55 8999999999999999997654 489999999999999999999999999999999999998 7788999999
Q ss_pred CCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCC
Q 037285 965 GLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPS 1044 (1094)
Q Consensus 965 GLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe 1044 (1094)
|++.............+|+.|+|||++.+ ....+.++||||||+++|+|++|+.||...........+.... ...+.
T Consensus 156 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~ 232 (276)
T 2h6d_A 156 GLSNMMSDGEFLRTSCGSPNYAAPEVISG-RLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV--FYIPE 232 (276)
T ss_dssp CGGGCCCC-------------CCTGGGTT-SCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCT
T ss_pred ccccccCCCcceecccCCccccCHHHHcC-CCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc--ccCch
Confidence 99986554433345568999999999984 2234689999999999999999999999888777766654443 34567
Q ss_pred cCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1045 YCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1045 ~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
.++..+.++|.+||+.||.+|||+.+++++-+-
T Consensus 233 ~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~ 265 (276)
T 2h6d_A 233 YLNRSVATLLMHMLQVDPLKRATIKDIREHEWF 265 (276)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHH
T ss_pred hcCHHHHHHHHHHccCChhhCCCHHHHHhChhh
Confidence 789999999999999999999999999997654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=357.47 Aligned_cols=254 Identities=26% Similarity=0.377 Sum_probs=195.3
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||+|+||.||+|+++ +..||||+++..... .....+.+|+.+|++++||||+++++++....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 76 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE-------GTPSTAIREISLMKELKHENIVRLYDVIHTEN 76 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTT-------CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTT
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc-------ccHHHHHHHHHHHHhcCCCCcceEEEEEEECC
Confidence 468999999999999999999875 788999999754311 11245778999999999999999999998755
Q ss_pred CCceEEEeeecccchhHHHHhhcc-----cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEE
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKD-----RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKV 961 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~-----~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKL 961 (1094)
.+++||||+. ++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 77 --~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~----~~~~~kl 149 (317)
T 2pmi_A 77 --KLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLIN----KRGQLKL 149 (317)
T ss_dssp --EEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEE
T ss_pred --eEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEc----CCCCEEE
Confidence 8999999997 68999886543 3589999999999999999999999999999999999998 7789999
Q ss_pred EecCCcccccCc-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccC--
Q 037285 962 GDFGLSKIKRNT-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL-- 1038 (1094)
Q Consensus 962 sDFGLSrl~~~~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~l-- 1038 (1094)
+|||+++..... .......+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||......+.+..+.....
T Consensus 150 ~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 228 (317)
T 2pmi_A 150 GDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMG-SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTP 228 (317)
T ss_dssp CCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTT-CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred CcCccceecCCCcccCCCCcccccccCchHhhC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 999999854322 22334568999999999874 34678999999999999999999999998887766655433110
Q ss_pred ------------------------------CCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1039 ------------------------------RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1039 ------------------------------rp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
.+..+..++.++.+||.+||+.||.+|||+.+++++-+-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f 297 (317)
T 2pmi_A 229 NESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297 (317)
T ss_dssp CTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred ChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhh
Confidence 001123568899999999999999999999999987553
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=367.87 Aligned_cols=254 Identities=28% Similarity=0.377 Sum_probs=200.0
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-CCceeEEEeEeecC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HPNVVAFYGVVQDG 885 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-HPNIVqL~Gv~~d~ 885 (1094)
..+|++.+.||+|+||.||+|.++ ++.||||++..... .......+.+|+.+|+++. ||||+++++++...
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~------~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 81 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ------NSTDAQRTFREIMILTELSGHENIVNLLNVLRAD 81 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--C------CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccccc------ChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC
Confidence 468999999999999999999874 78899999865321 1223456789999999997 99999999999876
Q ss_pred CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecC
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFG 965 (1094)
....+|+|||||. ++|..++... .+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||
T Consensus 82 ~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~----~~~~~kl~DFG 154 (388)
T 3oz6_A 82 NDRDVYLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLN----AECHVKVADFG 154 (388)
T ss_dssp TSSCEEEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEECCCT
T ss_pred CCCEEEEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEc----CCCCEEecCCc
Confidence 5567999999997 6898888653 589999999999999999999999999999999999998 78899999999
Q ss_pred CcccccC----------------------ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 037285 966 LSKIKRN----------------------TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN 1023 (1094)
Q Consensus 966 LSrl~~~----------------------~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~ 1023 (1094)
+++.... .......+||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~ 233 (388)
T 3oz6_A 155 LSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG-STKYTKGIDMWSLGCILGEILCGKPIFPG 233 (388)
T ss_dssp TCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT-CCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcC-CCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence 9975321 111234579999999999974 35689999999999999999999999998
Q ss_pred CChHHHHHhHhhccCCCC---------------------------------------------CCCcCcHHHHHHHHHhc
Q 037285 1024 MHYGAIIGGIVNNTLRPT---------------------------------------------IPSYCDAEWRTLMEECW 1058 (1094)
Q Consensus 1024 ~~~~eile~Iv~~~lrp~---------------------------------------------iPe~~S~eL~dLI~kCL 1058 (1094)
......+..+......+. .+..+++++.+||.+||
T Consensus 234 ~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L 313 (388)
T 3oz6_A 234 SSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL 313 (388)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC
T ss_pred CCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhh
Confidence 887766655542111100 11257889999999999
Q ss_pred cCCCCCCCCHHHHHHHHH
Q 037285 1059 APNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1059 q~DPeeRPS~eELLq~L~ 1076 (1094)
..||.+|||+.+++++-+
T Consensus 314 ~~dP~~R~t~~e~l~Hp~ 331 (388)
T 3oz6_A 314 QFNPNKRISANDALKHPF 331 (388)
T ss_dssp CSSGGGSCCHHHHTTSTT
T ss_pred ccCcccCCCHHHHhCCHH
Confidence 999999999999999844
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=347.05 Aligned_cols=263 Identities=22% Similarity=0.285 Sum_probs=211.4
Q ss_pred cCCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||+|+||.||+|++ .++.||||++...... ..+.+|+.++++++|++++..+.++...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~e~~~l~~l~~~~~i~~~~~~~~~- 76 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----------PQLHIESKIYKMMQGGVGIPTIRWCGAE- 76 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----------CHHHHHHHHHHHHTTSTTCCCEEEEEEE-
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----------hHHHHHHHHHHHhhcCCCCCccccccCC-
Confidence 47899999999999999999986 4788999998754211 2477899999999998877666665432
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
....++||||+ +++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++..+ .++.+||+|||+
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~-~~~~~kl~Dfg~ 154 (296)
T 3uzp_A 77 GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGK-KGNLVYIIDFGL 154 (296)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGG-GTTCEEECCCTT
T ss_pred CCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCC-CCCeEEEeeCCC
Confidence 34789999999 9999999986666799999999999999999999999999999999999994221 567899999999
Q ss_pred cccccCcc--------ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh---HHHHHhHhh
Q 037285 967 SKIKRNTL--------VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY---GAIIGGIVN 1035 (1094)
Q Consensus 967 Srl~~~~~--------~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~---~eile~Iv~ 1035 (1094)
++...... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||..... .+....+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 232 (296)
T 3uzp_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHL--GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 232 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHT--TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH
T ss_pred cccccccccccccccccccccccccccCChhhhc--CCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcc
Confidence 98543321 124557999999999998 45689999999999999999999999986432 222222222
Q ss_pred ccCCC---CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhcCC
Q 037285 1036 NTLRP---TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQTK 1086 (1094)
Q Consensus 1036 ~~lrp---~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s~pe 1086 (1094)
..... .....++..+.++|.+||+.||.+|||+.+|++.|+.+........
T Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~ 286 (296)
T 3uzp_A 233 KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 286 (296)
T ss_dssp HHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred cccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcc
Confidence 21111 1235688999999999999999999999999999999987765443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=371.39 Aligned_cols=253 Identities=21% Similarity=0.315 Sum_probs=216.4
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||+|+||.||+|..+ +..||+|++.... ......+.+|+.+|++++||||+++++++.+..
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~- 121 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--------PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY- 121 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--------HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS-
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--------hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCC-
Confidence 58999999999999999999885 6789999987542 112346789999999999999999999998755
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++||||+.+|+|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.. ..+.+||+|||++
T Consensus 122 -~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~--~~~~vkL~DFG~a 198 (387)
T 1kob_A 122 -EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK--KASSVKIIDFGLA 198 (387)
T ss_dssp -EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST--TCCCEEECCCTTC
T ss_pred -EEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecC--CCCceEEEecccc
Confidence 8999999999999999998766679999999999999999999999999999999999999722 3467999999999
Q ss_pred ccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCC--CCCCCc
Q 037285 968 KIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR--PTIPSY 1045 (1094)
Q Consensus 968 rl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lr--p~iPe~ 1045 (1094)
+............||+.|+|||++. ...++.++|||||||++|+|++|+.||......+.+..+....+. ......
T Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 276 (387)
T 1kob_A 199 TKLNPDEIVKVTTATAEFAAPEIVD--REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS 276 (387)
T ss_dssp EECCTTSCEEEECSSGGGCCHHHHT--TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTT
T ss_pred eecCCCcceeeeccCCCccCchhcc--CCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccc
Confidence 8655443334456999999999998 456889999999999999999999999998877777766554433 233456
Q ss_pred CcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1046 CDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1046 ~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
++.++.+||.+||..||.+|||+.+++++.+
T Consensus 277 ~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 307 (387)
T 1kob_A 277 VSPEAKDFIKNLLQKEPRKRLTVHDALEHPW 307 (387)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhhCcc
Confidence 8999999999999999999999999998754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=351.30 Aligned_cols=253 Identities=23% Similarity=0.317 Sum_probs=203.8
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.++||+|+||.||+|++. +..||||++.... ........+.+|+.++++++||||+++++++....
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 75 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE------DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR- 75 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC------C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc------cchHHHHHHHHHHHHHHhCCCCCccchhheeecCC-
Confidence 57999999999999999999985 7889999986542 12334467889999999999999999999998765
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++||||+.+++|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 76 -~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~----~~~~~kl~Dfg~~ 149 (311)
T 4agu_A 76 -RLHLVFEYCDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT----KHSVIKLCDFGFA 149 (311)
T ss_dssp -EEEEEEECCSEEHHHHHHHTSS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECCCTTC
T ss_pred -eEEEEEEeCCCchHHHHHhhhc-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEc----CCCCEEEeeCCCc
Confidence 8999999999999998876544 489999999999999999999999999999999999998 7789999999999
Q ss_pred ccccC-ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhc----------
Q 037285 968 KIKRN-TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN---------- 1036 (1094)
Q Consensus 968 rl~~~-~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~---------- 1036 (1094)
+.... ........+|..|+|||++.+ ...++.++|||||||++|+|++|+.||......+....+...
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
T 4agu_A 150 RLLTGPSDYYDDEVATRWYRSPELLVG-DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 228 (311)
T ss_dssp EECC------------GGGCCHHHHHT-CSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred hhccCcccccCCCcCCccccChHHHhc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccc
Confidence 85432 222334568999999999874 356789999999999999999999999988766554433221
Q ss_pred ---------cCCCCC----------CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1037 ---------TLRPTI----------PSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1037 ---------~lrp~i----------Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
...... ...++..+.+||.+||+.||.+|||+.+++++-+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 287 (311)
T 4agu_A 229 VFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287 (311)
T ss_dssp HHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGG
T ss_pred ccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChH
Confidence 000000 0357888999999999999999999999998744
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=378.15 Aligned_cols=258 Identities=27% Similarity=0.419 Sum_probs=219.4
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||+|+||+||+|+++ +..||||++.+..... .....+.+|+.+|++++||||+++++++.+..
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 94 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN------KDTSTILREVELLKKLDHPNIMKLFEILEDSS 94 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC------SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc------hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCC
Confidence 368999999999999999999885 7889999997543221 12356789999999999999999999998855
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+++||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++..+ ..+.+||+|||+
T Consensus 95 --~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~-~~~~~kl~Dfg~ 170 (486)
T 3mwu_A 95 --SFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE-KDCDIKIIDFGL 170 (486)
T ss_dssp --EEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSS-TTCCEEECSCSC
T ss_pred --EEEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCC-CCCCEEEEECCc
Confidence 8999999999999999987654 589999999999999999999999999999999999996332 467899999999
Q ss_pred cccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCC--C
Q 037285 967 SKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIP--S 1044 (1094)
Q Consensus 967 Srl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iP--e 1044 (1094)
++............||+.|+|||++.+ .++.++|||||||++|+|++|+.||......+.+..+....+....+ .
T Consensus 171 a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 247 (486)
T 3mwu_A 171 STCFQQNTKMKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR 247 (486)
T ss_dssp TTTBCCC----CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGG
T ss_pred CeECCCCCccCCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccC
Confidence 986555444455679999999999974 48899999999999999999999999998888888877765554433 4
Q ss_pred cCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1045 YCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1045 ~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
.++.++++||.+||..||.+|||+.+++++.+-..
T Consensus 248 ~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 282 (486)
T 3mwu_A 248 TISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (486)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence 67899999999999999999999999999876543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=355.34 Aligned_cols=250 Identities=28% Similarity=0.428 Sum_probs=197.7
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||+|+||.||+|+++ +..||||+++.... +.....+.+|+.+|++++||||++++++|.+...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 78 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-------ELAREKVMREVKALAKLEHPGIVRYFNAWLETPP 78 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST-------TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCS
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc-------hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEecc
Confidence 57999999999999999999985 78899999975421 1234578899999999999999999999865431
Q ss_pred -------------------------------------------------------CceEEEeeecccchhHHHHhhcc--
Q 037285 888 -------------------------------------------------------GTLATVAEYMVDGSLRHVLVRKD-- 910 (1094)
Q Consensus 888 -------------------------------------------------------~~L~IVmEYmegGSL~d~L~k~~-- 910 (1094)
..+++||||+.+++|.+++....
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 158 (332)
T 3qd2_B 79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL 158 (332)
T ss_dssp CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG
T ss_pred chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc
Confidence 13899999999999999997654
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccCc-------------cccC
Q 037285 911 RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT-------------LVSG 977 (1094)
Q Consensus 911 ~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~-------------~~ss 977 (1094)
...++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++..... ....
T Consensus 159 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T 3qd2_B 159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT----MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234 (332)
T ss_dssp GGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEECCCTTCEECSCC--------------CCC
T ss_pred cchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEe----CCCCEEEeecCcccccccchhhcccccccccccccc
Confidence 2356667899999999999999999999999999999998 7789999999999854332 1223
Q ss_pred CccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHh
Q 037285 978 GVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEEC 1057 (1094)
Q Consensus 978 ~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kC 1057 (1094)
...||+.|+|||++. ...++.++|||||||++|+|++|..|+.. .......+ .....+......++.+.+||.+|
T Consensus 235 ~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~ 309 (332)
T 3qd2_B 235 GQVGTKLYMSPEQIH--GNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDV-RNLKFPLLFTQKYPQEHMMVQDM 309 (332)
T ss_dssp SCC-CGGGSCHHHHH--CCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHH-HTTCCCHHHHHHCHHHHHHHHHH
T ss_pred ccCCCcCccChHHhc--CCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHh-hccCCCcccccCChhHHHHHHHH
Confidence 456999999999998 45789999999999999999998776432 11222222 22222222234567889999999
Q ss_pred ccCCCCCCCCHHHHHHHH
Q 037285 1058 WAPNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1058 Lq~DPeeRPS~eELLq~L 1075 (1094)
|+.||.+|||+.+++++-
T Consensus 310 l~~~p~~Rps~~~~l~~~ 327 (332)
T 3qd2_B 310 LSPSPTERPEATDIIENA 327 (332)
T ss_dssp HCSSGGGSCCHHHHHHST
T ss_pred ccCCCCcCCCHHHHhhch
Confidence 999999999999999763
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=345.89 Aligned_cols=252 Identities=28% Similarity=0.444 Sum_probs=209.1
Q ss_pred ccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec-
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD- 884 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d- 884 (1094)
...+|++.+.||+|+||.||+|++. ++.||||++.... ..+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 76 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------------EKAEREVKALAKLDHVNIVHYNGCWDGF 76 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------------GGGHHHHHHHHHCCCTTBCCEEEEEEEE
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------------HHHHHHHHHHHhCCCCCEEEEeeeEecc
Confidence 3468999999999999999999985 7889999997541 235689999999999999999998854
Q ss_pred -------------CCCCceEEEeeecccchhHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEec
Q 037285 885 -------------GPGGTLATVAEYMVDGSLRHVLVRK-DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVN 950 (1094)
Q Consensus 885 -------------~~~~~L~IVmEYmegGSL~d~L~k~-~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD 950 (1094)
.....+++||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 156 (284)
T 2a19_B 77 DYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV 156 (284)
T ss_dssp EEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred ccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEc
Confidence 1123589999999999999999754 34689999999999999999999999999999999999999
Q ss_pred cCCCCCCcEEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 037285 951 LKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAII 1030 (1094)
Q Consensus 951 ~~~~e~g~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eil 1030 (1094)
.++.+||+|||+++............+|+.|+|||++. ...++.++|||||||++|+|++|..||... ....
T Consensus 157 ----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~ 228 (284)
T 2a19_B 157 ----DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQIS--SQDYGKEVDLYALGLILAELLHVCDTAFET--SKFF 228 (284)
T ss_dssp ----ETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHH--CSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHH
T ss_pred ----CCCCEEECcchhheeccccccccccCCcccccChhhhc--cCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHH
Confidence 67899999999998655444444556999999999998 456889999999999999999999887432 1222
Q ss_pred HhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 037285 1031 GGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAAS 1083 (1094)
Q Consensus 1031 e~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s 1083 (1094)
..+. ...++..++..+.++|.+||+.||.+|||+.+++++|+.+.....
T Consensus 229 ~~~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 229 TDLR----DGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp HHHH----TTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred HHhh----cccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 2222 223456788999999999999999999999999999999875543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=356.93 Aligned_cols=264 Identities=33% Similarity=0.515 Sum_probs=216.4
Q ss_pred eeeccCCeeEEEEecccCceEEEEeee------cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEE
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKW------RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAF 878 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~------rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL 878 (1094)
..+...+|++.+.||+|+||.||+|++ .+..||||++.... ......+.+|+.++++++||||+++
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~ 107 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--------EEHLRDFEREIEILKSLQHDNIVKY 107 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC--------SHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC--------HHHHHHHHHHHHHHHhCCCCCeeeE
Confidence 345677899999999999999999985 36789999987531 1234578899999999999999999
Q ss_pred EeEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCc
Q 037285 879 YGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPI 958 (1094)
Q Consensus 879 ~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~ 958 (1094)
++++.......+++||||+++++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++ .++.
T Consensus 108 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~----~~~~ 183 (326)
T 2w1i_A 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE----NENR 183 (326)
T ss_dssp EEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE----ETTE
T ss_pred EEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEc----CCCc
Confidence 999876554578999999999999999987766799999999999999999999999999999999999998 6789
Q ss_pred EEEEecCCcccccCcc----ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH-------
Q 037285 959 CKVGDFGLSKIKRNTL----VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG------- 1027 (1094)
Q Consensus 959 VKLsDFGLSrl~~~~~----~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~------- 1027 (1094)
+||+|||+++...... ......++..|+|||++.+ ..++.++|||||||++|+|+||..||......
T Consensus 184 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~ 261 (326)
T 2w1i_A 184 VKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 261 (326)
T ss_dssp EEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCT
T ss_pred EEEecCcchhhccccccccccccCCCCceeEECchhhcC--CCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhcc
Confidence 9999999998543321 1223446778999999983 45789999999999999999999998643110
Q ss_pred --------HHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 037285 1028 --------AIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAA 1082 (1094)
Q Consensus 1028 --------eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~ 1082 (1094)
..+...+....+...+..++.++.+||.+||+.||.+|||+.+|++.|+.+....
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 262 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp TCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 0112233444556677889999999999999999999999999999999998654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=351.26 Aligned_cols=264 Identities=22% Similarity=0.312 Sum_probs=196.6
Q ss_pred cceeeccCCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-CCceeEEE
Q 037285 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HPNVVAFY 879 (1094)
Q Consensus 803 sv~eIs~edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-HPNIVqL~ 879 (1094)
...++...+|++.+.||+|+||.||+|++ .+..||||++.... ......+.+|+.+++++. ||||++++
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~~h~~iv~~~ 92 (337)
T 3ll6_A 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--------EEKNRAIIQEVCFMKKLSGHPNIVQFC 92 (337)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS--------HHHHHHHHHHHHHHHHHTTSTTBCCEE
T ss_pred ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc--------hHHHHHHHHHHHHHHHhccCCChhhcc
Confidence 34567778999999999999999999998 47889999986531 223456889999999996 99999999
Q ss_pred eEeec------CCCCceEEEeeecccchhHHHHhh--cccccCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEe
Q 037285 880 GVVQD------GPGGTLATVAEYMVDGSLRHVLVR--KDRFLDRRRRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLV 949 (1094)
Q Consensus 880 Gv~~d------~~~~~L~IVmEYmegGSL~d~L~k--~~~~Lse~~~l~Ia~QIaeGLaYLHs~G--IIHRDLKPeNILL 949 (1094)
+++.. .....+++||||+. |+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~ 171 (337)
T 3ll6_A 93 SAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL 171 (337)
T ss_dssp EEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE
T ss_pred ccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE
Confidence 99852 22336899999995 789888865 3345999999999999999999999999 9999999999999
Q ss_pred ccCCCCCCcEEEEecCCcccccCccc-------------cCCccCCCcccCcccccc-CCCCCCchhhHHHHHHHHHHHH
Q 037285 950 NLKDPSRPICKVGDFGLSKIKRNTLV-------------SGGVRGTLPWMAPELLSG-SSSKVSEKVDVFSFGIVLWEIL 1015 (1094)
Q Consensus 950 D~~~~e~g~VKLsDFGLSrl~~~~~~-------------ss~~~GT~~YmAPEvL~g-~~~kyS~KSDVWSLGVLLyELL 1015 (1094)
+ .++.+||+|||+++....... .....+|+.|+|||++.. ....++.++|||||||++|+|+
T Consensus 172 ~----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~ 247 (337)
T 3ll6_A 172 S----NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLC 247 (337)
T ss_dssp C----TTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHH
T ss_pred C----CCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHH
Confidence 9 778999999999985432211 113458999999999831 2456889999999999999999
Q ss_pred cCCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 037285 1016 TGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAAS 1083 (1094)
Q Consensus 1016 TGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s 1083 (1094)
+|+.||......... ........+..++..+.+||.+||+.||.+|||+.+++++|+.+.....
T Consensus 248 ~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 248 FRQHPFEDGAKLRIV----NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp HSSCCC----------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred hCCCCCcchhHHHhh----cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 999999865543332 3333444456677889999999999999999999999999999986543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=345.17 Aligned_cols=257 Identities=26% Similarity=0.422 Sum_probs=218.6
Q ss_pred eeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEee
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQ 883 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~ 883 (1094)
.+..++|++.+.||+|+||.||+|++. +..||||++..... ........+.+|+.++++++||||+++++++.
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 84 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL-----EKEGVEHQLRREIEIQSHLRHPNILRMYNYFH 84 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEccccc-----chHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE
Confidence 355678999999999999999999885 56799999875321 11222356889999999999999999999998
Q ss_pred cCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEe
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGD 963 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsD 963 (1094)
+.. .+++||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 85 ~~~--~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~kl~D 157 (284)
T 2vgo_A 85 DRK--RIYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMG----YKGELKIAD 157 (284)
T ss_dssp CSS--EEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC----TTCCEEECC
T ss_pred cCC--EEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEc----CCCCEEEec
Confidence 754 8999999999999999997654 489999999999999999999999999999999999998 678899999
Q ss_pred cCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCC
Q 037285 964 FGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIP 1043 (1094)
Q Consensus 964 FGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iP 1043 (1094)
||++....... .....|++.|+|||++. ...++.++||||||+++|+|++|+.||......+....+... ...++
T Consensus 158 fg~~~~~~~~~-~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~ 232 (284)
T 2vgo_A 158 FGWSVHAPSLR-RRTMCGTLDYLPPEMIE--GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV--DLKFP 232 (284)
T ss_dssp CTTCEECSSSC-BCCCCSCGGGCCHHHHT--TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--CCCCC
T ss_pred ccccccCcccc-cccccCCCCcCCHHHhc--cCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc--ccCCC
Confidence 99987544322 23456899999999998 456788999999999999999999999988877776666543 33467
Q ss_pred CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1044 SYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1044 e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
..++..+.++|.+||..||.+||++.+++++-+-..
T Consensus 233 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~ 268 (284)
T 2vgo_A 233 PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268 (284)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHH
T ss_pred CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHh
Confidence 788999999999999999999999999999766543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=348.51 Aligned_cols=259 Identities=24% Similarity=0.320 Sum_probs=213.1
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||+|+||.||++.+. +..||||++....... .......+.+|+.++++++||||+++++++.....
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRR----IPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEK 80 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHH----STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC--
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccc----cchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Confidence 57999999999999999999884 6789999997542110 01234678899999999999999999999865545
Q ss_pred CceEEEeeecccchhHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 888 GTLATVAEYMVDGSLRHVLVR-KDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k-~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
..+++||||+.++ |.+++.. ....+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+
T Consensus 81 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~----~~~~~kl~dfg~ 155 (305)
T 2wtk_C 81 QKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLT----TGGTLKISALGV 155 (305)
T ss_dssp -CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEEECCCTT
T ss_pred CeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc----CCCcEEeecccc
Confidence 5899999999877 6666654 345689999999999999999999999999999999999998 778999999999
Q ss_pred cccccC---ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCC
Q 037285 967 SKIKRN---TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIP 1043 (1094)
Q Consensus 967 Srl~~~---~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iP 1043 (1094)
+..... ........||+.|+|||++.+....++.++|||||||++|+|++|+.||......+....+.... ..++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~--~~~~ 233 (305)
T 2wtk_C 156 AEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS--YAIP 233 (305)
T ss_dssp CEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC--CCCC
T ss_pred ccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC--CCCC
Confidence 985432 22223456899999999997544445789999999999999999999999888777776665543 3467
Q ss_pred CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1044 SYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1044 e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
..++..+.+||.+||..||.+|||+.+++++.+-..
T Consensus 234 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 269 (305)
T 2wtk_C 234 GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK 269 (305)
T ss_dssp SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHS
T ss_pred CccCHHHHHHHHHHccCChhhCCCHHHHhcCccccc
Confidence 789999999999999999999999999999876643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=363.99 Aligned_cols=253 Identities=26% Similarity=0.354 Sum_probs=197.2
Q ss_pred ccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~ 885 (1094)
..++|++.+.||+|+||.||+|+++ +..||||+++... ....+.+|+.+|++++||||+++++++...
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 120 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----------DKKIVRTEIGVLLRLSHPNIIKLKEIFETP 120 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------------CHHHHHCCCTTBCCEEEEEECS
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----------hHHHHHHHHHHHHhCCCCCCcceeeeEecC
Confidence 3467999999999999999999985 5679999997542 124577899999999999999999999875
Q ss_pred CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecC
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFG 965 (1094)
. .+++||||+.+++|.+++.... .+++..++.++.||+.||.|||+++|+||||||+|||++..+ .++.+||+|||
T Consensus 121 ~--~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~-~~~~~kl~Dfg 196 (349)
T 2w4o_A 121 T--EISLVLELVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPA-PDAPLKIADFG 196 (349)
T ss_dssp S--EEEEEECCCCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSS-TTCCEEECCCC
T ss_pred C--eEEEEEEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCC-CCCCEEEccCc
Confidence 5 8999999999999999997654 489999999999999999999999999999999999997322 47889999999
Q ss_pred CcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH-HHHhHhhccCCC--CC
Q 037285 966 LSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA-IIGGIVNNTLRP--TI 1042 (1094)
Q Consensus 966 LSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~e-ile~Iv~~~lrp--~i 1042 (1094)
+++............||+.|+|||++. ...++.++|||||||++|+|++|+.||....... ....+....... ..
T Consensus 197 ~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~ 274 (349)
T 2w4o_A 197 LSKIVEHQVLMKTVCGTPGYCAPEILR--GCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPW 274 (349)
T ss_dssp ----------------CGGGSCHHHHT--TCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTT
T ss_pred cccccCcccccccccCCCCccCHHHhc--CCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCch
Confidence 998655444444567999999999998 4568999999999999999999999998766544 444444433322 22
Q ss_pred CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1043 PSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1043 Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
...++.++.+||.+||..||.+|||+.+++++-+
T Consensus 275 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 308 (349)
T 2w4o_A 275 WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPW 308 (349)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred hhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 3568899999999999999999999999998654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=378.20 Aligned_cols=257 Identities=27% Similarity=0.408 Sum_probs=215.1
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||+|+||.||+|+++ +..||||++.+...... ....+.+|+.+|++++||||+++++++.+..
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 109 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS------SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKR 109 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C------TTHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch------HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence 357999999999999999999985 67899999986532211 1346789999999999999999999998755
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+++|||||.+|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++..+ ..+.+||+|||+
T Consensus 110 --~~~lv~e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-~~~~~kl~DfG~ 185 (494)
T 3lij_A 110 --NYYLVMECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKE-KDALIKIVDFGL 185 (494)
T ss_dssp --EEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS-TTCCEEECCCTT
T ss_pred --EEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCC-CCCcEEEEECCC
Confidence 8999999999999999887654 489999999999999999999999999999999999997332 356799999999
Q ss_pred cccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCC--C
Q 037285 967 SKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIP--S 1044 (1094)
Q Consensus 967 Srl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iP--e 1044 (1094)
++............||+.|+|||++.+ .++.++|||||||++|+|++|+.||......+....+....+....+ .
T Consensus 186 a~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 262 (494)
T 3lij_A 186 SAVFENQKKMKERLGTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWK 262 (494)
T ss_dssp CEECBTTBCBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGT
T ss_pred CeECCCCccccccCCCcCeeCHHHHcc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcc
Confidence 986655544556679999999999863 58899999999999999999999999999888888877765544333 4
Q ss_pred cCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1045 YCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1045 ~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
.++..+.+||.+||+.||.+|||+.+++++-+-.
T Consensus 263 ~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~ 296 (494)
T 3lij_A 263 NVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIK 296 (494)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHH
T ss_pred cCCHHHHHHHHHHCCCChhhCccHHHHhcCcccc
Confidence 6889999999999999999999999999876543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=355.15 Aligned_cols=250 Identities=24% Similarity=0.378 Sum_probs=211.1
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
.|...+.||+|+||.||+|+.+ |+.||||++...... ....+.+|+.++++++||||+++++++....
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-- 115 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--------RRELLFNEVVIMRDYQHFNVVEMYKSYLVGE-- 115 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------SHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh--------HHHHHHHHHHHHHhCCCCCcceEEEEEEECC--
Confidence 4677789999999999999874 788999999754211 1346789999999999999999999998865
Q ss_pred ceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 889 TLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
.+++||||+.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 116 ~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~----~~~~~kl~Dfg~~~ 189 (321)
T 2c30_A 116 ELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLT----LDGRVKLSDFGFCA 189 (321)
T ss_dssp EEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCCEEECCCTTCE
T ss_pred EEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCcEEEeeeeeee
Confidence 899999999999999998643 489999999999999999999999999999999999998 77899999999998
Q ss_pred cccCc-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCC-CCCCCcC
Q 037285 969 IKRNT-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR-PTIPSYC 1046 (1094)
Q Consensus 969 l~~~~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lr-p~iPe~~ 1046 (1094)
..... .......||+.|+|||++. ...++.++|||||||++|+|++|+.||......+....+...... ...+..+
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (321)
T 2c30_A 190 QISKDVPKRKSLVGTPYWMAPEVIS--RSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKV 267 (321)
T ss_dssp ECCSSSCCBCCCCSCGGGCCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGS
T ss_pred ecccCccccccccCCccccCHhhhc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccC
Confidence 54332 2234567999999999997 456889999999999999999999999988877766655443221 1223467
Q ss_pred cHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1047 DAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1047 S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
+..+.++|.+||+.||.+|||+.+++++.+-.
T Consensus 268 ~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~ 299 (321)
T 2c30_A 268 SPVLRDFLERMLVRDPQERATAQELLDHPFLL 299 (321)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGG
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence 89999999999999999999999999876653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=382.30 Aligned_cols=260 Identities=23% Similarity=0.331 Sum_probs=218.1
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
+..++|++.++||+|+||+||+|+++ ++.||||++.+.... .......+.+|+.++.+++||||++++++|.+
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~-----~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML-----KRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH-----HTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhh-----hHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 45679999999999999999999985 577999999763211 11112347789999999999999999999988
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
.. .+++|||||.+|+|.+++.+....+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+||
T Consensus 146 ~~--~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~----~~g~vkL~DF 219 (437)
T 4aw2_A 146 DN--NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD----MNGHIRLADF 219 (437)
T ss_dssp SS--EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECCC
T ss_pred CC--EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEc----CCCCEEEcch
Confidence 65 89999999999999999987656799999999999999999999999999999999999999 7889999999
Q ss_pred CCcccccC--ccccCCccCCCcccCcccccc---CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCC
Q 037285 965 GLSKIKRN--TLVSGGVRGTLPWMAPELLSG---SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 1039 (1094)
Q Consensus 965 GLSrl~~~--~~~ss~~~GT~~YmAPEvL~g---~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lr 1039 (1094)
|+++.... .......+||+.|+|||++.. ....++.++|||||||++|||++|+.||......+....++.....
T Consensus 220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~ 299 (437)
T 4aw2_A 220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER 299 (437)
T ss_dssp TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc
Confidence 99975432 222344679999999999862 2346789999999999999999999999998888888777654333
Q ss_pred CCCC---CcCcHHHHHHHHHhccCCCCC--CCCHHHHHHHHHH
Q 037285 1040 PTIP---SYCDAEWRTLMEECWAPNPAA--RPSFTEIASRLRV 1077 (1094)
Q Consensus 1040 p~iP---e~~S~eL~dLI~kCLq~DPee--RPS~eELLq~L~~ 1077 (1094)
..+| ..+++++++||++||..+|++ |+++.+++++-+-
T Consensus 300 ~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff 342 (437)
T 4aw2_A 300 FQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFF 342 (437)
T ss_dssp CCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGG
T ss_pred ccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCcc
Confidence 3333 458999999999999888888 9999999987654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=370.70 Aligned_cols=252 Identities=28% Similarity=0.387 Sum_probs=207.9
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHH-HhhCCCCceeEEEeEee
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEI-LSKLHHPNVVAFYGVVQ 883 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkI-LkrL~HPNIVqL~Gv~~ 883 (1094)
+..++|++.+.||+|+||.||+|+++ +..||||++++..... ......+.+|..+ ++.++||||+++++++.
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~-----~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~ 109 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK-----KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ 109 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC------------------CCBCCCCCTTBCCEEEEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh-----hHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE
Confidence 45679999999999999999999985 5679999998764332 1223455667776 46789999999999998
Q ss_pred cCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEe
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGD 963 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsD 963 (1094)
+.. .+|+||||+.+|+|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 110 ~~~--~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~----~~g~ikL~D 182 (373)
T 2r5t_A 110 TAD--KLYFVLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD----SQGHIVLTD 182 (373)
T ss_dssp CSS--EEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCEEECC
T ss_pred eCC--EEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC----CCCCEEEee
Confidence 865 8999999999999999997654 489999999999999999999999999999999999999 788999999
Q ss_pred cCCcccc-cCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCC
Q 037285 964 FGLSKIK-RNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTI 1042 (1094)
Q Consensus 964 FGLSrl~-~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~i 1042 (1094)
||+++.. .........+||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+..... .+
T Consensus 183 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~--~~ 258 (373)
T 2r5t_A 183 FGLCKENIEHNSTTSTFCGTPEYLAPEVLH--KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL--QL 258 (373)
T ss_dssp CCBCGGGBCCCCCCCSBSCCCCCCCHHHHT--TCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC--CC
T ss_pred CccccccccCCCccccccCCccccCHHHhC--CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc--CC
Confidence 9999853 3333445678999999999998 45688999999999999999999999999888888887776543 46
Q ss_pred CCcCcHHHHHHHHHhccCCCCCCCCH----HHHHHH
Q 037285 1043 PSYCDAEWRTLMEECWAPNPAARPSF----TEIASR 1074 (1094)
Q Consensus 1043 Pe~~S~eL~dLI~kCLq~DPeeRPS~----eELLq~ 1074 (1094)
+..++..+.+||.+||+.||.+||++ .+|+++
T Consensus 259 ~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h 294 (373)
T 2r5t_A 259 KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSH 294 (373)
T ss_dssp CSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTS
T ss_pred CCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCC
Confidence 67899999999999999999999987 455554
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=352.35 Aligned_cols=258 Identities=31% Similarity=0.567 Sum_probs=203.9
Q ss_pred ccCCeeEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhh--CCCCceeEEEeEeecC
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSK--LHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkr--L~HPNIVqL~Gv~~d~ 885 (1094)
..++|++.+.||+|+||.||+|++++..||||++.... ...+.+|..++.. ++||||+++++++...
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE-----------EASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG-----------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred cccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc-----------cchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 34689999999999999999999999999999986431 1234455555554 4899999999998875
Q ss_pred CC--CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCceEeccCCCC
Q 037285 886 PG--GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSK--------NIVHFDLKCDNLLVNLKDPS 955 (1094)
Q Consensus 886 ~~--~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~--------GIIHRDLKPeNILLD~~~~e 955 (1094)
.. ..+++||||+.+|+|.+++... .+++..++.++.||+.||.|||++ +|+||||||+|||++ .
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~----~ 177 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK----K 177 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC----T
T ss_pred CCCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC----C
Confidence 22 4789999999999999999654 489999999999999999999999 999999999999998 7
Q ss_pred CCcEEEEecCCcccccCcc-----ccCCccCCCcccCccccccCCCCCC----chhhHHHHHHHHHHHHcC---------
Q 037285 956 RPICKVGDFGLSKIKRNTL-----VSGGVRGTLPWMAPELLSGSSSKVS----EKVDVFSFGIVLWEILTG--------- 1017 (1094)
Q Consensus 956 ~g~VKLsDFGLSrl~~~~~-----~ss~~~GT~~YmAPEvL~g~~~kyS----~KSDVWSLGVLLyELLTG--------- 1017 (1094)
++.+||+|||+++...... ......||+.|+|||++.+...... .++|||||||++|||+||
T Consensus 178 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~ 257 (337)
T 3mdy_A 178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257 (337)
T ss_dssp TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccc
Confidence 7899999999997433221 1224569999999999974222211 249999999999999999
Q ss_pred -CCCCCCCC-----hHHHHHhHhhccCCCCCCC-----cCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 037285 1018 -EEPYANMH-----YGAIIGGIVNNTLRPTIPS-----YCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAA 1082 (1094)
Q Consensus 1018 -k~PF~~~~-----~~eile~Iv~~~lrp~iPe-----~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~ 1082 (1094)
..||.... .......+.....++.++. .++..+.+||.+||+.||.+|||+.+|+++|+.+....
T Consensus 258 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 258 YQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp CCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred ccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 77775432 2223333334444555553 56678999999999999999999999999999998543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=361.96 Aligned_cols=259 Identities=22% Similarity=0.333 Sum_probs=218.7
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEeecCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~~d~~ 886 (1094)
++|++.+.||+|+||.||+|+++ |+.||||++............+.....+.+|+.+++++ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 57999999999999999999885 78899999976532222233344556788999999999 7999999999998754
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+++||||+.+++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+|||+
T Consensus 174 --~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~----~~~~ikl~DfG~ 246 (365)
T 2y7j_A 174 --FMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD----DNMQIRLSDFGF 246 (365)
T ss_dssp --EEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEEECCCTT
T ss_pred --EEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCCEEEEecCc
Confidence 8999999999999999997654 589999999999999999999999999999999999998 778999999999
Q ss_pred cccccCccccCCccCCCcccCccccccC----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCC
Q 037285 967 SKIKRNTLVSGGVRGTLPWMAPELLSGS----SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTI 1042 (1094)
Q Consensus 967 Srl~~~~~~ss~~~GT~~YmAPEvL~g~----~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~i 1042 (1094)
+.............||+.|+|||++.+. ...++.++|||||||++|+|++|+.||...........+.........
T Consensus 247 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 326 (365)
T 2y7j_A 247 SCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSS 326 (365)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCH
T ss_pred ccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence 9865544444556799999999998632 235788999999999999999999999988877777666555444332
Q ss_pred C--CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037285 1043 P--SYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1043 P--e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L 1075 (1094)
+ ..++..+.+||.+||..||.+|||+.+++++-
T Consensus 327 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 361 (365)
T 2y7j_A 327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHP 361 (365)
T ss_dssp HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 2 46788999999999999999999999999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=346.30 Aligned_cols=255 Identities=26% Similarity=0.343 Sum_probs=217.9
Q ss_pred ccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~ 885 (1094)
...+|++.+.||+|+||.||++++. +..||+|++....... ......+.+|+.++++++||||+++++++.+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 87 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK-----PHQREKMSMEISIHRSLAHQHVVGFHGFFEDN 87 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCS-----HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccC-----HHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC
Confidence 4568999999999999999999985 6789999987653221 23346788999999999999999999999875
Q ss_pred CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecC
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFG 965 (1094)
. .+++||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 88 ~--~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~kl~dfg 160 (294)
T 2rku_A 88 D--FVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN----EDLEVKIGDFG 160 (294)
T ss_dssp S--EEEEEEECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEECCCT
T ss_pred C--EEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEc----CCCCEEEEecc
Confidence 5 8999999999999999887654 589999999999999999999999999999999999998 77899999999
Q ss_pred CcccccC-ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCC
Q 037285 966 LSKIKRN-TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPS 1044 (1094)
Q Consensus 966 LSrl~~~-~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe 1044 (1094)
+++.... ........+|+.|+|||++. ...++.++||||||+++|+|++|+.||......+....+.... ..++.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~ 236 (294)
T 2rku_A 161 LATKVEYDGERKKVLCGTPNYIAPEVLS--KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE--YSIPK 236 (294)
T ss_dssp TCEECCSTTCCBCCCCSCCSSCCHHHHT--TSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--CCCCT
T ss_pred CceecccCccccccccCCCCcCCcchhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc--CCCcc
Confidence 9985432 22234456899999999997 4567889999999999999999999999888777666654443 34667
Q ss_pred cCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1045 YCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1045 ~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
.++..+.++|.+||+.||.+|||+.+++++.+-.
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~ 270 (294)
T 2rku_A 237 HINPVAASLIQKMLQTDPTARPTINELLNDEFFT 270 (294)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH
T ss_pred ccCHHHHHHHHHHcccChhhCcCHHHHhhChhee
Confidence 8899999999999999999999999999986654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=356.20 Aligned_cols=265 Identities=25% Similarity=0.402 Sum_probs=203.2
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHH--HHHHhhCCCCceeEEEeEe
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKE--AEILSKLHHPNVVAFYGVV 882 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrE--IkILkrL~HPNIVqL~Gv~ 882 (1094)
+.+..++|++.+.||+|+||.||+|+++++.||||++.... ...+..| +..+..++||||+++++++
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~~~~~~~~h~~i~~~~~~~ 76 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-----------RQNFINEKNIYRVPLMEHDNIARFIVGD 76 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG-----------HHHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc-----------hhhHHHHHHHHHHHhccCcchhhheecc
Confidence 34567899999999999999999999999999999987531 1223334 4444568999999999855
Q ss_pred ec---CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHC---------CceeccCCCCceEec
Q 037285 883 QD---GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSK---------NIVHFDLKCDNLLVN 950 (1094)
Q Consensus 883 ~d---~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~---------GIIHRDLKPeNILLD 950 (1094)
.. .....+++||||+++|+|.+++.... .++..++.++.||+.||.|||+. +|+||||||+|||++
T Consensus 77 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~ 154 (336)
T 3g2f_A 77 ERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK 154 (336)
T ss_dssp EEECTTSCEEEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEEC
T ss_pred cccccCCCceEEEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEc
Confidence 32 22336789999999999999996554 58889999999999999999999 999999999999998
Q ss_pred cCCCCCCcEEEEecCCcccccCc---------cccCCccCCCcccCccccccCC-----CCCCchhhHHHHHHHHHHHHc
Q 037285 951 LKDPSRPICKVGDFGLSKIKRNT---------LVSGGVRGTLPWMAPELLSGSS-----SKVSEKVDVFSFGIVLWEILT 1016 (1094)
Q Consensus 951 ~~~~e~g~VKLsDFGLSrl~~~~---------~~ss~~~GT~~YmAPEvL~g~~-----~kyS~KSDVWSLGVLLyELLT 1016 (1094)
.++.+||+|||+++..... .......||+.|+|||++.+.. ..++.++|||||||++|||++
T Consensus 155 ----~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~ 230 (336)
T 3g2f_A 155 ----NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230 (336)
T ss_dssp ----TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHT
T ss_pred ----CCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHh
Confidence 7789999999999754321 1122446999999999997421 345678999999999999999
Q ss_pred CCCCCCCCC------------------hHHHHHhHhhccCCCCCCCc------CcHHHHHHHHHhccCCCCCCCCHHHHH
Q 037285 1017 GEEPYANMH------------------YGAIIGGIVNNTLRPTIPSY------CDAEWRTLMEECWAPNPAARPSFTEIA 1072 (1094)
Q Consensus 1017 Gk~PF~~~~------------------~~eile~Iv~~~lrp~iPe~------~S~eL~dLI~kCLq~DPeeRPS~eELL 1072 (1094)
|..||.... .......+.....++.++.. ++..+.+||.+||+.||.+|||+.+++
T Consensus 231 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l 310 (336)
T 3g2f_A 231 RCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAE 310 (336)
T ss_dssp TBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred cCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHH
Confidence 977653211 11122222334445555544 345899999999999999999999999
Q ss_pred HHHHHHHHHhhcCC
Q 037285 1073 SRLRVLSTAASQTK 1086 (1094)
Q Consensus 1073 q~L~~L~ta~s~pe 1086 (1094)
+.|+.+......-.
T Consensus 311 ~~L~~ll~~~~~~~ 324 (336)
T 3g2f_A 311 ERMAELMMIWERNK 324 (336)
T ss_dssp HHHHHHHHCCCC--
T ss_pred HHHHHHHHHHHhcc
Confidence 99999986655443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=366.33 Aligned_cols=258 Identities=22% Similarity=0.313 Sum_probs=212.8
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeec-CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC--CCceeEEEeE
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH--HPNVVAFYGV 881 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~r-Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~--HPNIVqL~Gv 881 (1094)
..+...+|++.+.||+|+||.||+|... +..||||++..... .......+.+|+.+|++|. ||||++++++
T Consensus 51 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~ 124 (390)
T 2zmd_A 51 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA------DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 124 (390)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC------CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred ccccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc------cHHHHHHHHHHHHHHHHcccCCCeEEEEEEE
Confidence 3455667999999999999999999875 67899999976421 1234567889999999996 5999999999
Q ss_pred eecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEE
Q 037285 882 VQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKV 961 (1094)
Q Consensus 882 ~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKL 961 (1094)
+.... .+++||| +.+++|.+++.... .+++..++.++.||+.||.|||+++|+||||||+|||++ ++.+||
T Consensus 125 ~~~~~--~~~lv~E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-----~~~~kl 195 (390)
T 2zmd_A 125 EITDQ--YIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-----DGMLKL 195 (390)
T ss_dssp EECSS--EEEEEEE-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-----SSCEEE
T ss_pred EecCC--EEEEEEe-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-----CCeEEE
Confidence 98765 8999999 66899999997655 589999999999999999999999999999999999996 367999
Q ss_pred EecCCcccccCcc---ccCCccCCCcccCccccccC---------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh-HH
Q 037285 962 GDFGLSKIKRNTL---VSGGVRGTLPWMAPELLSGS---------SSKVSEKVDVFSFGIVLWEILTGEEPYANMHY-GA 1028 (1094)
Q Consensus 962 sDFGLSrl~~~~~---~ss~~~GT~~YmAPEvL~g~---------~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~-~e 1028 (1094)
+|||+++...... ......||+.|+|||++.+. ...++.++|||||||++|+|++|+.||..... ..
T Consensus 196 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~ 275 (390)
T 2zmd_A 196 IDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 275 (390)
T ss_dssp CCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH
T ss_pred EecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH
Confidence 9999998543221 23455799999999998641 23688999999999999999999999987543 34
Q ss_pred HHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1029 IIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1029 ile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
.+..+........++...+.++.+||.+||..||.+|||+.+++++.+-
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 324 (390)
T 2zmd_A 276 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324 (390)
T ss_dssp HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred HHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCc
Confidence 5555666666667788889999999999999999999999999988665
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=358.93 Aligned_cols=267 Identities=29% Similarity=0.400 Sum_probs=217.3
Q ss_pred cceeeccCCeeEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEe
Q 037285 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVV 882 (1094)
Q Consensus 803 sv~eIs~edYei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~ 882 (1094)
..|.+..++|++.+.||+|+||.||+|++++ .||+|+++....... ....+.+|+.++++++||||+++++++
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~ 98 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNED------QLKAFKREVMAYRQTRHENVVLFMGAC 98 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCC------CCCCCCTTGGGGTTCCCTTBCCCCEEE
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHH------HHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence 4567888999999999999999999999865 599999875432211 113466799999999999999999999
Q ss_pred ecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 883 QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 883 ~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
.... .+++||||+.+++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+
T Consensus 99 ~~~~--~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-----~~~~~l~ 171 (319)
T 2y4i_B 99 MSPP--HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-----NGKVVIT 171 (319)
T ss_dssp ECSS--CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC-------CCEEC
T ss_pred ecCC--ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-----CCCEEEe
Confidence 8765 79999999999999999987666799999999999999999999999999999999999997 4589999
Q ss_pred ecCCcccccC------ccccCCccCCCcccCccccccC-------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 037285 963 DFGLSKIKRN------TLVSGGVRGTLPWMAPELLSGS-------SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAI 1029 (1094)
Q Consensus 963 DFGLSrl~~~------~~~ss~~~GT~~YmAPEvL~g~-------~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~ei 1029 (1094)
|||+++.... ........||+.|+|||++.+. ...++.++|||||||++|+|++|+.||........
T Consensus 172 Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 251 (319)
T 2y4i_B 172 DFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI 251 (319)
T ss_dssp CCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH
T ss_pred ecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999874321 1122234588999999998742 24578999999999999999999999999888777
Q ss_pred HHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 037285 1030 IGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAAS 1083 (1094)
Q Consensus 1030 le~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s 1083 (1094)
...+.........+..++.++.++|.+||..||.+|||+.+|++.|+.+.....
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 252 IWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp HHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred HHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 766655443333344688899999999999999999999999999999876543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=345.75 Aligned_cols=262 Identities=22% Similarity=0.291 Sum_probs=206.8
Q ss_pred cCCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||+|+||.||+|++ .++.||||++...... ..+.+|+.++++++|++++..+.++...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~e~~~l~~l~~~~~i~~~~~~~~~- 76 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----------PQLHIESKIYKMMQGGVGIPTIRWCGAE- 76 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----------CCHHHHHHHHHHHTTSTTCCCEEEEEEE-
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----------hHHHHHHHHHHHhcCCCCCCeeeeecCC-
Confidence 46899999999999999999986 4788999987654221 2467899999999988877777666432
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
....++||||+ +++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++..+ .++.+||+|||+
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~-~~~~~kL~Dfg~ 154 (296)
T 4hgt_A 77 GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGK-KGNLVYIIDFGL 154 (296)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGG-GTTCEEECCCTT
T ss_pred CCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccC-CCCeEEEecCcc
Confidence 34789999999 9999999987666799999999999999999999999999999999999993111 678899999999
Q ss_pred cccccCcc--------ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH---HHHHhHhh
Q 037285 967 SKIKRNTL--------VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG---AIIGGIVN 1035 (1094)
Q Consensus 967 Srl~~~~~--------~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~---eile~Iv~ 1035 (1094)
++...... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||...... .....+..
T Consensus 155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 232 (296)
T 4hgt_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHL--GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 232 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHT--TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH
T ss_pred ceeccCcccCccCCCCcccccCCCccccchHHhc--CCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhc
Confidence 98543321 223457899999999998 456899999999999999999999999865432 22222222
Q ss_pred ccCCC---CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhcC
Q 037285 1036 NTLRP---TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQT 1085 (1094)
Q Consensus 1036 ~~lrp---~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s~p 1085 (1094)
..... .....++..+.+||.+||+.||++|||+.+|++.|+.+.......
T Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~ 285 (296)
T 4hgt_A 233 KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp HHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred ccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCC
Confidence 21111 122567899999999999999999999999999999998765543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=343.68 Aligned_cols=261 Identities=24% Similarity=0.295 Sum_probs=219.0
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCC-chhHHHHHHHHHHHHHHHhhCC-CCceeEEEeEeec
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGR-SSEQERLTVEFWKEAEILSKLH-HPNVVAFYGVVQD 884 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~-~~eqe~~~~eFlrEIkILkrL~-HPNIVqL~Gv~~d 884 (1094)
.++|++.+.||+|+||.||+|+++ ++.||||++........ ....+.....+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 478999999999999999999884 67899999976432111 1222344567889999999996 9999999999987
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
.. .+++||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+|+||||+|||++ .++.+||+||
T Consensus 96 ~~--~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~kl~df 168 (298)
T 1phk_A 96 NT--FFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD----DDMNIKLTDF 168 (298)
T ss_dssp SS--EEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEEECCC
T ss_pred CC--eEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEc----CCCcEEEecc
Confidence 54 8999999999999999997654 589999999999999999999999999999999999998 7788999999
Q ss_pred CCcccccCccccCCccCCCcccCcccccc----CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCC
Q 037285 965 GLSKIKRNTLVSGGVRGTLPWMAPELLSG----SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 1040 (1094)
Q Consensus 965 GLSrl~~~~~~ss~~~GT~~YmAPEvL~g----~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp 1040 (1094)
|++.............+|+.|+|||++.+ ....++.++||||||+++|+|++|+.||...........+.......
T Consensus 169 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (298)
T 1phk_A 169 GFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 248 (298)
T ss_dssp TTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred cchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCccc
Confidence 99986554444445678999999999852 13457889999999999999999999999888777777666655543
Q ss_pred CCC--CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1041 TIP--SYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1041 ~iP--e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
..+ ..++..+.+||.+||+.||.+|||+.+++++-+
T Consensus 249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (298)
T 1phk_A 249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 286 (298)
T ss_dssp CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChH
Confidence 333 467899999999999999999999999987543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=352.53 Aligned_cols=256 Identities=29% Similarity=0.473 Sum_probs=206.7
Q ss_pred eeEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceE
Q 037285 812 LEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLA 891 (1094)
Q Consensus 812 Yei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~ 891 (1094)
|...+.||+|+||.||+|+++++.||||++....... .+.....+.+|+.++++++||||+++++++.... .++
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~ 106 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDIT----TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGD--DLC 106 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSC----TTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCE
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcc----hHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCC--ceE
Confidence 3345889999999999999999999999987542211 1233467889999999999999999999998754 899
Q ss_pred EEeeecccchhHHHHhhc--ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCccc
Q 037285 892 TVAEYMVDGSLRHVLVRK--DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI 969 (1094)
Q Consensus 892 IVmEYmegGSL~d~L~k~--~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl 969 (1094)
+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~kl~Dfg~~~~ 182 (307)
T 2nru_A 107 LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLD----EAFTAKISDFGLARA 182 (307)
T ss_dssp EEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC----TTCCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEc----CCCcEEEeecccccc
Confidence 999999999999998643 24589999999999999999999999999999999999998 778999999999985
Q ss_pred ccC---ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHH----HhHhhc------
Q 037285 970 KRN---TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAII----GGIVNN------ 1036 (1094)
Q Consensus 970 ~~~---~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eil----e~Iv~~------ 1036 (1094)
... ........||+.|+|||++.+ .++.++|||||||++|+|++|+.||......... ..+...
T Consensus 183 ~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (307)
T 2nru_A 183 SEKFAQTVMTSRIVGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIED 259 (307)
T ss_dssp CCSCSSCEECSSCCSCGGGCCHHHHTT---EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHH
T ss_pred cccccccccccccCCCcCcCChHHhcC---CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhh
Confidence 432 222334568999999999874 4788999999999999999999999875432211 111110
Q ss_pred ---cCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 037285 1037 ---TLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLST 1080 (1094)
Q Consensus 1037 ---~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~t 1080 (1094)
......+..++..+.++|.+||+.||.+|||+.+|+++|+.+.+
T Consensus 260 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 260 YIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred hccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 11112234456789999999999999999999999999999864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=365.77 Aligned_cols=269 Identities=18% Similarity=0.193 Sum_probs=202.3
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeec-----CceEEEEEeecCccCCCch---hHHHHHHHHHHHHHHHhhCCCCcee
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSS---EQERLTVEFWKEAEILSKLHHPNVV 876 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~r-----Gt~VAVKiIkk~~~se~~~---eqe~~~~eFlrEIkILkrL~HPNIV 876 (1094)
..+..++|++.+.||+|+||.||+|++. +..||||++.........+ ..+.....+.+|+.+++.++||||+
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~ 111 (345)
T 2v62_A 32 DDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIP 111 (345)
T ss_dssp ECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred ccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcc
Confidence 3456689999999999999999999984 4679999987542100000 0011123467889999999999999
Q ss_pred EEEeEeecC--CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCC
Q 037285 877 AFYGVVQDG--PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP 954 (1094)
Q Consensus 877 qL~Gv~~d~--~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~ 954 (1094)
++++++... ....+++||||+ +++|.+++.... .+++..++.++.||+.||+|||+++|+||||||+|||++.+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-- 187 (345)
T 2v62_A 112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK-- 187 (345)
T ss_dssp CEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESS--
T ss_pred eeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccC--
Confidence 999998762 234899999999 999999997665 69999999999999999999999999999999999999822
Q ss_pred CCCcEEEEecCCcccccCc--------cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh
Q 037285 955 SRPICKVGDFGLSKIKRNT--------LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY 1026 (1094)
Q Consensus 955 e~g~VKLsDFGLSrl~~~~--------~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~ 1026 (1094)
..+.+||+|||+++..... .......||+.|+|||++. ...++.++|||||||++|||++|+.||.....
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 265 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHK--GVALSRRSDVEILGYCMLRWLCGKLPWEQNLK 265 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHH--TCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhc--CCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 1238999999999754221 1113456999999999998 45789999999999999999999999965322
Q ss_pred -HHHHHhHhhccCCCCCC---------CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 037285 1027 -GAIIGGIVNNTLRPTIP---------SYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLST 1080 (1094)
Q Consensus 1027 -~eile~Iv~~~lrp~iP---------e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~t 1080 (1094)
....... .......++ ..++.++.++|.+||..||.+||++.+|++.|+.+..
T Consensus 266 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 266 DPVAVQTA-KTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp CHHHHHHH-HHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred ccHHHHHH-HHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 1111111 111111122 2688999999999999999999999999999998764
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=375.29 Aligned_cols=263 Identities=25% Similarity=0.344 Sum_probs=201.7
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||+|+||.||+|.++ +..||||++.+................+.+|+.+|++++||||+++++++...
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~- 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS-
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 468999999999999999999875 57899999987543322222222334578999999999999999999998653
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+++||||+.+|+|.+++.... .+++..++.++.||+.||+|||+++|+||||||+|||++..+ ....+||+|||+
T Consensus 213 --~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~-~~~~~kl~DFG~ 288 (419)
T 3i6u_A 213 --DYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE-EDCLIKITDFGH 288 (419)
T ss_dssp --EEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS-SSCCEEECCSST
T ss_pred --ceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCC-CcceEEEeeccc
Confidence 5899999999999999886554 589999999999999999999999999999999999997332 355799999999
Q ss_pred cccccCccccCCccCCCcccCcccccc-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCC---C
Q 037285 967 SKIKRNTLVSGGVRGTLPWMAPELLSG-SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT---I 1042 (1094)
Q Consensus 967 Srl~~~~~~ss~~~GT~~YmAPEvL~g-~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~---i 1042 (1094)
++...........+||+.|+|||++.+ ....++.++|||||||++|+|++|+.||........+........... .
T Consensus 289 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~ 368 (419)
T 3i6u_A 289 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368 (419)
T ss_dssp TTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHH
T ss_pred ceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchh
Confidence 987655544556779999999999863 235678899999999999999999999987554332222222222211 2
Q ss_pred CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1043 PSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1043 Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
...++..+.+||.+||+.||.+|||+.+++++-+
T Consensus 369 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 402 (419)
T 3i6u_A 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 402 (419)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred hcccCHHHHHHHHHHccCChhHCcCHHHHhCCcc
Confidence 2457899999999999999999999999998754
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=361.36 Aligned_cols=256 Identities=30% Similarity=0.495 Sum_probs=207.8
Q ss_pred cCCeeEEEEecccCceEEEEeeec-CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r-Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
.++|++.+.||+|+||.||+|+++ +..||||++..... .....+.+|+.++++++||||+++++++....
T Consensus 38 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 108 (321)
T 2qkw_B 38 TNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS--------QGIEEFETEIETLSFCRHPHLVSLIGFCDERN- 108 (321)
T ss_dssp CCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS--------SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT-
T ss_pred HhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh--------HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC-
Confidence 468999999999999999999985 68899998765321 12356889999999999999999999998754
Q ss_pred CceEEEeeecccchhHHHHhhcc---cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKD---RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~---~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
.+++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 109 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~----~~~~~kl~Df 183 (321)
T 2qkw_B 109 -EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLD----ENFVPKITDF 183 (321)
T ss_dssp -CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEEC----TTCCEEECCC
T ss_pred -eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEEC----CCCCEEEeec
Confidence 8999999999999999986543 3489999999999999999999999999999999999998 7889999999
Q ss_pred CCcccccC---ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHH---H----HhH-
Q 037285 965 GLSKIKRN---TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAI---I----GGI- 1033 (1094)
Q Consensus 965 GLSrl~~~---~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~ei---l----e~I- 1033 (1094)
|+++.... ........||+.|+|||++. ...++.++|||||||++|+|+||+.||......+. . ...
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 261 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFI--KGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCHHHHH--HCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT
T ss_pred ccccccccccccccccccCCCccccCHHHhc--CCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc
Confidence 99985322 22233455899999999997 34688999999999999999999999976432211 0 000
Q ss_pred -------hhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 037285 1034 -------VNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLST 1080 (1094)
Q Consensus 1034 -------v~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~t 1080 (1094)
.........+..++..+.++|.+||+.||++|||+.+++++|+.+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 01111122333456778999999999999999999999999998864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=341.59 Aligned_cols=253 Identities=23% Similarity=0.352 Sum_probs=207.7
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEeecC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQDG 885 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~~d~ 885 (1094)
.++|++.+.||+|+||.||+|++. +..||||++...... ......+.+|+.++.++ +||||+++++++.+.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~ 83 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG------SVDEQNALREVYAHAVLGQHSHVVRYFSAWAED 83 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT------SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc------cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC
Confidence 368999999999999999999985 788999999864321 11235678899999999 899999999999876
Q ss_pred CCCceEEEeeecccchhHHHHhhcc---cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCC---------
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKD---RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKD--------- 953 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~---~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~--------- 953 (1094)
. .+++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++..+
T Consensus 84 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~ 161 (289)
T 1x8b_A 84 D--HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEG 161 (289)
T ss_dssp T--EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------
T ss_pred C--eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccc
Confidence 5 8999999999999999997642 4589999999999999999999999999999999999997332
Q ss_pred ------CCCCcEEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH
Q 037285 954 ------PSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG 1027 (1094)
Q Consensus 954 ------~e~g~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~ 1027 (1094)
.....+||+|||++....... ...||+.|+|||++.+ ...++.++|||||||++|+|++|..++.....
T Consensus 162 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~- 236 (289)
T 1x8b_A 162 DEDDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQE-NYTHLPKADIFALALTVVCAAGAEPLPRNGDQ- 236 (289)
T ss_dssp --------CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTT-CCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH-
T ss_pred ccccccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcC-CCCCCchhhHHHHHHHHHHHhcCCCCCcchhH-
Confidence 134579999999998654332 2358999999999974 34567899999999999999999987754432
Q ss_pred HHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1028 AIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1028 eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
...+ .....+.++..++..+.+||.+||+.||.+|||+.+++++.+-
T Consensus 237 --~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~ 283 (289)
T 1x8b_A 237 --WHEI-RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 283 (289)
T ss_dssp --HHHH-HTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC
T ss_pred --HHHH-HcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHh
Confidence 2223 3344566778899999999999999999999999999987543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=377.59 Aligned_cols=258 Identities=25% Similarity=0.370 Sum_probs=216.7
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
+..++|++.+.||+|+||.||+|+++ +..||||++++.... .......+.+|+.+++.++||||++++++|.+
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~-----~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-----KRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-----HTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhh-----hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 45678999999999999999999885 677999999763211 11112346789999999999999999999988
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
.. .+|+||||+.+|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus 141 ~~--~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~----~~g~ikL~DF 212 (410)
T 3v8s_A 141 DR--YLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD----KSGHLKLADF 212 (410)
T ss_dssp SS--EEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECCC
T ss_pred CC--EEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeEC----CCCCEEEecc
Confidence 65 899999999999999998654 489999999999999999999999999999999999998 7889999999
Q ss_pred CCcccccCcc--ccCCccCCCcccCccccccCCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCC
Q 037285 965 GLSKIKRNTL--VSGGVRGTLPWMAPELLSGSSS--KVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 1040 (1094)
Q Consensus 965 GLSrl~~~~~--~ss~~~GT~~YmAPEvL~g~~~--kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp 1040 (1094)
|+++...... .....+||+.|+|||++.+... .++.++|||||||++|||++|+.||...........+.......
T Consensus 213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~ 292 (410)
T 3v8s_A 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL 292 (410)
T ss_dssp TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc
Confidence 9998544322 3346679999999999974321 27889999999999999999999999988888887776654323
Q ss_pred CCC--CcCcHHHHHHHHHhccCCCCC--CCCHHHHHHHHHH
Q 037285 1041 TIP--SYCDAEWRTLMEECWAPNPAA--RPSFTEIASRLRV 1077 (1094)
Q Consensus 1041 ~iP--e~~S~eL~dLI~kCLq~DPee--RPS~eELLq~L~~ 1077 (1094)
.+| ..++.++++||.+||..+|.+ ||++.+|++|.+-
T Consensus 293 ~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f 333 (410)
T 3v8s_A 293 TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 333 (410)
T ss_dssp CCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGG
T ss_pred cCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccc
Confidence 333 468999999999999998988 9999999998664
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=377.76 Aligned_cols=259 Identities=22% Similarity=0.298 Sum_probs=215.8
Q ss_pred eeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEee
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQ 883 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~ 883 (1094)
.+..++|++.+.||+|+||.||+++.+ ++.||||++.+... ........+.+|+.+|.+++||||+++++++.
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~-----~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDM-----LKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHh-----hhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 355679999999999999999999884 78899999975321 11222345778999999999999999999998
Q ss_pred cCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEe
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGD 963 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsD 963 (1094)
+.. .+|+||||+.+|+|.+++.+.+..+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|
T Consensus 132 ~~~--~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld----~~g~vkL~D 205 (412)
T 2vd5_A 132 DEN--YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLD----RCGHIRLAD 205 (412)
T ss_dssp CSS--EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECC
T ss_pred eCC--EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeec----CCCCEEEee
Confidence 865 89999999999999999987666799999999999999999999999999999999999999 788999999
Q ss_pred cCCcccccCc--cccCCccCCCcccCccccccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhc
Q 037285 964 FGLSKIKRNT--LVSGGVRGTLPWMAPELLSGS-----SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN 1036 (1094)
Q Consensus 964 FGLSrl~~~~--~~ss~~~GT~~YmAPEvL~g~-----~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~ 1036 (1094)
||+++..... ......+||+.|+|||++... ...++.++|||||||++|||++|+.||......+....+...
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~ 285 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY 285 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 9999854332 223346799999999998731 245789999999999999999999999998888877777653
Q ss_pred cCC---CCCCCcCcHHHHHHHHHhccCCCCCC---CCHHHHHHHHH
Q 037285 1037 TLR---PTIPSYCDAEWRTLMEECWAPNPAAR---PSFTEIASRLR 1076 (1094)
Q Consensus 1037 ~lr---p~iPe~~S~eL~dLI~kCLq~DPeeR---PS~eELLq~L~ 1076 (1094)
... +..+..++.++++||.+||. +|.+| |++.+|++|-+
T Consensus 286 ~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpf 330 (412)
T 2vd5_A 286 KEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPF 330 (412)
T ss_dssp HHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGG
T ss_pred ccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCC
Confidence 222 23346789999999999999 99998 59999998755
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=379.65 Aligned_cols=257 Identities=25% Similarity=0.441 Sum_probs=220.7
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
+..++|.+.+.||+|+||.||+|++. |+.||||++..... ........+.+|+.+|+.++||||+++++++..
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~-----~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~ 87 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKI-----RSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST 87 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHH-----HHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc-----cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 34578999999999999999999875 78899999975421 112234578899999999999999999999988
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
.. .+++||||+.+|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus 88 ~~--~~~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~----~~~~vkL~DF 160 (476)
T 2y94_A 88 PS--DIFMVMEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLD----AHMNAKIADF 160 (476)
T ss_dssp SS--EEEEEEECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEC----TTCCEEECCC
T ss_pred CC--EEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEe----cCCCeEEEec
Confidence 65 8999999999999999997654 589999999999999999999999999999999999998 7789999999
Q ss_pred CCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCC
Q 037285 965 GLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPS 1044 (1094)
Q Consensus 965 GLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe 1044 (1094)
|+++...........+||+.|+|||++.+ ....+.++|||||||++|+|++|+.||...........+..... ..+.
T Consensus 161 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~p~ 237 (476)
T 2y94_A 161 GLSNMMSDGEFLRTSCGSPNYAAPEVISG-RLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF--YTPQ 237 (476)
T ss_dssp SSCEECCTTCCBCCCCSCSTTCCHHHHTT-CCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC--CCCT
T ss_pred cchhhccccccccccCCCcCeEChhhccC-CCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc--CCCc
Confidence 99986655444456679999999999984 22347899999999999999999999998887777777765543 4567
Q ss_pred cCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1045 YCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1045 ~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
.+++++.+||.+||..||.+|||+.+|+++-+-.
T Consensus 238 ~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~ 271 (476)
T 2y94_A 238 YLNPSVISLLKHMLQVDPMKRATIKDIREHEWFK 271 (476)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHH
T ss_pred cCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhh
Confidence 7899999999999999999999999999976653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=376.23 Aligned_cols=264 Identities=28% Similarity=0.398 Sum_probs=217.5
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCC-----chhHHHHHHHHHHHHHHHhhCCCCceeEEEeE
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGR-----SSEQERLTVEFWKEAEILSKLHHPNVVAFYGV 881 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~-----~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv 881 (1094)
.++|++.++||+|+||+||+|+.+ +..||||++.+...... ....+.....+.+|+.+|++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 468999999999999999999985 57899999986543211 00112334678899999999999999999999
Q ss_pred eecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEE
Q 037285 882 VQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKV 961 (1094)
Q Consensus 882 ~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKL 961 (1094)
+.+.. .+++|||||.+|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++..+ ....+||
T Consensus 115 ~~~~~--~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-~~~~~kl 190 (504)
T 3q5i_A 115 FEDKK--YFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKN-SLLNIKI 190 (504)
T ss_dssp EECSS--EEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTT-CCSSEEE
T ss_pred EEcCC--EEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCC-CCccEEE
Confidence 98765 8999999999999999997654 489999999999999999999999999999999999998322 2347999
Q ss_pred EecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCC
Q 037285 962 GDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT 1041 (1094)
Q Consensus 962 sDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~ 1041 (1094)
+|||+++............||+.|+|||++.+ .++.++|||||||++|+|++|+.||......+.+..+....+...
T Consensus 191 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 267 (504)
T 3q5i_A 191 VDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD 267 (504)
T ss_dssp CCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred EECCCCEEcCCCCccccccCCcCCCCHHHhcc---CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 99999986655444455679999999999873 578999999999999999999999999988888888776655433
Q ss_pred CC--CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1042 IP--SYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1042 iP--e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
.+ ..++.++.+||.+||..||.+|||+.+++++-+--.
T Consensus 268 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 307 (504)
T 3q5i_A 268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307 (504)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhh
Confidence 22 568899999999999999999999999999877543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=353.79 Aligned_cols=266 Identities=25% Similarity=0.332 Sum_probs=211.1
Q ss_pred cceeeccCCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEe
Q 037285 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYG 880 (1094)
Q Consensus 803 sv~eIs~edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~G 880 (1094)
....+..++|++.+.||+|+||.||+++. .++.||||++.... ......+.+|+.++++++||||+++++
T Consensus 22 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~ 93 (317)
T 2buj_A 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--------QQDREEAQREADMHRLFNHPNILRLVA 93 (317)
T ss_dssp EEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS--------HHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred cEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC--------HHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 34567888999999999999999999986 47889999986531 223457889999999999999999999
Q ss_pred EeecC--CCCceEEEeeecccchhHHHHhh---cccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCC
Q 037285 881 VVQDG--PGGTLATVAEYMVDGSLRHVLVR---KDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPS 955 (1094)
Q Consensus 881 v~~d~--~~~~L~IVmEYmegGSL~d~L~k---~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e 955 (1094)
++... ....+++||||+.+++|.+++.. ....+++..++.++.||+.||.|||+++|+||||||+|||++ .
T Consensus 94 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~----~ 169 (317)
T 2buj_A 94 YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG----D 169 (317)
T ss_dssp EEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----T
T ss_pred EEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc----C
Confidence 98632 23478999999999999999876 345689999999999999999999999999999999999998 7
Q ss_pred CCcEEEEecCCcccccCcc----------ccCCccCCCcccCccccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 037285 956 RPICKVGDFGLSKIKRNTL----------VSGGVRGTLPWMAPELLSGSS-SKVSEKVDVFSFGIVLWEILTGEEPYANM 1024 (1094)
Q Consensus 956 ~g~VKLsDFGLSrl~~~~~----------~ss~~~GT~~YmAPEvL~g~~-~kyS~KSDVWSLGVLLyELLTGk~PF~~~ 1024 (1094)
++.+||+|||+++...... ......||+.|+|||++.+.. ..++.++|||||||++|+|++|+.||...
T Consensus 170 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 249 (317)
T 2buj_A 170 EGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMV 249 (317)
T ss_dssp TSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHH
T ss_pred CCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhh
Confidence 7889999999987432111 011234799999999987422 23688999999999999999999999642
Q ss_pred Ch--HHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1025 HY--GAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1025 ~~--~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
.. ..... ..........+..++..+.++|.+||+.||.+|||+.+|+++|+.+...
T Consensus 250 ~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 250 FQKGDSVAL-AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp HHTTSCHHH-HHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred hcccchhhH-HhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 11 11111 2223334444567899999999999999999999999999999988643
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=376.97 Aligned_cols=261 Identities=26% Similarity=0.397 Sum_probs=222.6
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
+..++|++.+.||+|+||.||+|+.+ +..||||++........ .....+.+|+.+|++++||||+++++++.+
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 97 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQK-----TDKESLLREVQLLKQLDHPNIMKLYEFFED 97 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBS-----SCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccc-----hHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 34568999999999999999999884 78899999976543211 123568899999999999999999999987
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
.. .+++||||+.+|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++... .++.+||+||
T Consensus 98 ~~--~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-~~~~~kl~Df 173 (484)
T 3nyv_A 98 KG--YFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKS-KDANIRIIDF 173 (484)
T ss_dssp SS--EEEEEECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS-TTCCEEECCT
T ss_pred CC--EEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCC-CCCcEEEEee
Confidence 54 8999999999999999997654 489999999999999999999999999999999999996322 5678999999
Q ss_pred CCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCC-
Q 037285 965 GLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIP- 1043 (1094)
Q Consensus 965 GLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iP- 1043 (1094)
|+++............||+.|+|||++.+ .++.++|||||||++|+|++|+.||......+.+..+....+....+
T Consensus 174 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 250 (484)
T 3nyv_A 174 GLSTHFEASKKMKDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQ 250 (484)
T ss_dssp THHHHBCCCCSHHHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGG
T ss_pred eeeEEcccccccccCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 99986544433344569999999999974 57899999999999999999999999999888888887766554443
Q ss_pred -CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1044 -SYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1044 -e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
..++..+++||.+||..||.+|||+.+++++-+-..
T Consensus 251 ~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~ 287 (484)
T 3nyv_A 251 WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287 (484)
T ss_dssp GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcc
Confidence 468899999999999999999999999999877643
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=369.75 Aligned_cols=259 Identities=30% Similarity=0.536 Sum_probs=208.7
Q ss_pred CCeeEEEEecccCceEEEEeeecC-----ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~rG-----t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
..|++.+.||+|+||.||+|++.+ ..||||.++... .......|.+|+.+|++++||||+++++++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 161 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-------DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 161 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-------CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc
Confidence 357889999999999999998742 348999886421 11234678899999999999999999998765
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
. .+..++||||+.+|+|.+++......+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+||
T Consensus 162 ~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~----~~~~~kL~DF 236 (373)
T 3c1x_A 162 S-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD----EKFTVKVADF 236 (373)
T ss_dssp C-SSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCCEEECCC
T ss_pred C-CCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEEC----CCCCEEEeec
Confidence 3 2478899999999999999987777789999999999999999999999999999999999998 7789999999
Q ss_pred CCcccccCc-----cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccC
Q 037285 965 GLSKIKRNT-----LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 1038 (1094)
Q Consensus 965 GLSrl~~~~-----~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~l 1038 (1094)
|+++..... .......+|+.|+|||++. ...++.++|||||||++|||+| |..||......+....+ ....
T Consensus 237 G~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~-~~~~ 313 (373)
T 3c1x_A 237 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ--TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGR 313 (373)
T ss_dssp ---------------------CCGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH-HTTC
T ss_pred cccccccccccccccccCCCCCcccccChHHhc--CCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH-HcCC
Confidence 999843221 1122345778999999998 4578999999999999999999 78889877766655544 3444
Q ss_pred CCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 037285 1039 RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAAS 1083 (1094)
Q Consensus 1039 rp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s 1083 (1094)
+...+..++..+.++|.+||+.||.+|||+.+|++.|+.+.....
T Consensus 314 ~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 314 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 566678899999999999999999999999999999999885543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=364.71 Aligned_cols=254 Identities=24% Similarity=0.373 Sum_probs=209.8
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEeecC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQDG 885 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~~d~ 885 (1094)
.++|++.+.||+|+||.||+|+++ +..||||++.+... .+.+|+.+|.++ +||||+++++++.+.
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------------~~~~E~~~l~~~~~hp~iv~~~~~~~~~ 88 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------------DPTEEIEILLRYGQHPNIITLKDVYDDG 88 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------------CCHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------------ChHHHHHHHHHhcCCCCcCeEEEEEEcC
Confidence 367999999999999999999885 67899999976421 123577788877 799999999999876
Q ss_pred CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecC
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFG 965 (1094)
. .+++||||+.+|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+...+...+.+||+|||
T Consensus 89 ~--~~~lv~E~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg 165 (342)
T 2qr7_A 89 K--YVYVVTELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFG 165 (342)
T ss_dssp S--EEEEEECCCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred C--EEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence 5 8999999999999999997654 589999999999999999999999999999999999986333234569999999
Q ss_pred CcccccC-ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC---ChHHHHHhHhhccCCCC
Q 037285 966 LSKIKRN-TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANM---HYGAIIGGIVNNTLRPT 1041 (1094)
Q Consensus 966 LSrl~~~-~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~---~~~eile~Iv~~~lrp~ 1041 (1094)
+++.... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||... ...++...+....+...
T Consensus 166 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 243 (342)
T 2qr7_A 166 FAKQLRAENGLLMTPCYTANFVAPEVLER--QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLS 243 (342)
T ss_dssp TCEECBCTTCCBCCSSCCSSCCCHHHHHH--HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCC
T ss_pred CcccCcCCCCceeccCCCccccCHHHhcC--CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccC
Confidence 9985432 233345678999999999973 45788999999999999999999999863 44555555555444322
Q ss_pred --CCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1042 --IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1042 --iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
....++.++.+||.+||..||.+||++.+++++-+-..
T Consensus 244 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 244 GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 33568999999999999999999999999999887643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=354.81 Aligned_cols=254 Identities=26% Similarity=0.351 Sum_probs=217.7
Q ss_pred ccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~ 885 (1094)
...+|++.+.||+|+||.||++++. +..||+|++....... ......+.+|+.++++++||||+++++++.+.
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 113 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK-----PHQREKMSMEISIHRSLAHQHVVGFHGFFEDN 113 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCS-----HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcC-----HHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 4568999999999999999999885 5779999997653221 23346788999999999999999999999875
Q ss_pred CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecC
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFG 965 (1094)
. .+++||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 114 ~--~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~----~~~~~kl~Dfg 186 (335)
T 2owb_A 114 D--FVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN----EDLEVKIGDFG 186 (335)
T ss_dssp S--EEEEEECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC----TTCCEEECCCT
T ss_pred C--eEEEEEecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEc----CCCCEEEeecc
Confidence 5 8999999999999999887654 589999999999999999999999999999999999998 77889999999
Q ss_pred Cccccc-CccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCC
Q 037285 966 LSKIKR-NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPS 1044 (1094)
Q Consensus 966 LSrl~~-~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe 1044 (1094)
+++... .........||..|+|||++. ...++.++|||||||++|+|++|+.||......+....+.... ..++.
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~ 262 (335)
T 2owb_A 187 LATKVEYDGERKKVLCGTPNYIAPEVLS--KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE--YSIPK 262 (335)
T ss_dssp TCEECCSTTCCBCCCCSCCSSCCHHHHH--TSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC--CCCCT
T ss_pred CceecccCcccccccCCCccccCHHHhc--cCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC--CCCCc
Confidence 998543 222334456899999999998 4567899999999999999999999999888777666665543 34667
Q ss_pred cCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1045 YCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1045 ~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
.++..+.+||.+||+.||.+|||+.+++++-+-
T Consensus 263 ~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~ 295 (335)
T 2owb_A 263 HINPVAASLIQKMLQTDPTARPTINELLNDEFF 295 (335)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 889999999999999999999999999997664
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=348.81 Aligned_cols=256 Identities=26% Similarity=0.384 Sum_probs=208.4
Q ss_pred ccCCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEeec
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQD 884 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~~d 884 (1094)
..++|++.+.||+|+||.||+|++ .+..||||++...... ...+.+|+.+++++ +||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---------EEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---------THHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---------HHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 457899999999999999999998 4788999998754211 24677899999998 79999999999976
Q ss_pred CC----CCceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcE
Q 037285 885 GP----GGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC 959 (1094)
Q Consensus 885 ~~----~~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~V 959 (1094)
.. ...+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+|||++ .++.+
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~----~~~~~ 168 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT----ENAEV 168 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC----TTCCE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEc----CCCCE
Confidence 32 347999999999999999997643 4689999999999999999999999999999999999998 77889
Q ss_pred EEEecCCcccccCc-cccCCccCCCcccCccccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhh
Q 037285 960 KVGDFGLSKIKRNT-LVSGGVRGTLPWMAPELLSGS---SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN 1035 (1094)
Q Consensus 960 KLsDFGLSrl~~~~-~~ss~~~GT~~YmAPEvL~g~---~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~ 1035 (1094)
||+|||++...... .......||+.|+|||++... ...++.++|||||||++|+|++|+.||...........+..
T Consensus 169 kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 248 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 248 (326)
T ss_dssp EECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred EEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc
Confidence 99999998854322 223345689999999998631 34578899999999999999999999998887766666555
Q ss_pred ccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1036 NTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1036 ~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
.......+..++..+.+||.+||..||.+||++.+++++-+
T Consensus 249 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~ 289 (326)
T 2x7f_A 249 NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPF 289 (326)
T ss_dssp SCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHH
T ss_pred CccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChH
Confidence 54444455678999999999999999999999999998654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=357.95 Aligned_cols=258 Identities=25% Similarity=0.311 Sum_probs=201.6
Q ss_pred ccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~ 885 (1094)
..++|++.++||+|+||.||+|++. ++.||||+++.... .......+.+|+.+|++++||||+++++++.+.
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE------EEGVPGTAIREVSLLKELQHRNIIELKSVIHHN 105 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------------CHHHHHHGGGCCCTTBCCEEEEEEET
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc------ccccchhHHHHHHHHHHcCCCCcceEEEEEecC
Confidence 4568999999999999999999764 78899999975421 122345677899999999999999999999886
Q ss_pred CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCC-CCCCcEEEEec
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKD-PSRPICKVGDF 964 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~-~e~g~VKLsDF 964 (1094)
. .+++||||+. |+|.+++.... .+++..++.++.||+.||.|||+++|+||||||+|||++..+ ...+.+||+||
T Consensus 106 ~--~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df 181 (329)
T 3gbz_A 106 H--RLHLIFEYAE-NDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDF 181 (329)
T ss_dssp T--EEEEEEECCS-EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred C--EEEEEEecCC-CCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcC
Confidence 5 8999999997 59999987654 489999999999999999999999999999999999996333 25667999999
Q ss_pred CCcccccC-ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCC--
Q 037285 965 GLSKIKRN-TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT-- 1041 (1094)
Q Consensus 965 GLSrl~~~-~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~-- 1041 (1094)
|+++.... ........+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||......+.+..+......+.
T Consensus 182 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (329)
T 3gbz_A 182 GLARAFGIPIRQFTHEIITLWYRPPEILLG-SRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT 260 (329)
T ss_dssp THHHHHC-----------CCTTCCHHHHTT-CCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred CCccccCCcccccCCCcCCccccCHHHhcC-CCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchh
Confidence 99985432 222334568999999999974 34579999999999999999999999998887766655543211110
Q ss_pred --------------C------------CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1042 --------------I------------PSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1042 --------------i------------Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
+ +..++.++.+||.+||+.||.+|||+.+++++-+
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 321 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcc
Confidence 0 1126789999999999999999999999998643
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=345.87 Aligned_cols=254 Identities=28% Similarity=0.442 Sum_probs=207.9
Q ss_pred eeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEee
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQ 883 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~ 883 (1094)
....++|++.+.||+|+||.||+|+++ |..||||.+..... ...+.+|+.++++++||||+++++++.
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----------~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----------LQEIIKEISIMQQCDSPHVVKYYGSYF 94 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----------CHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----------HHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence 445678999999999999999999885 78899999975421 246788999999999999999999998
Q ss_pred cCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEe
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGD 963 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsD 963 (1094)
... .+++||||+.+++|.+++......+++..++.++.||+.||.|||++||+|+||||+|||++ .++.+||+|
T Consensus 95 ~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~kl~d 168 (314)
T 3com_A 95 KNT--DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLN----TEGHAKLAD 168 (314)
T ss_dssp ETT--EEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCCEEECC
T ss_pred eCC--EEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEEC----CCCCEEEee
Confidence 754 89999999999999999976666799999999999999999999999999999999999998 678899999
Q ss_pred cCCcccccCc-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccC-CCC
Q 037285 964 FGLSKIKRNT-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL-RPT 1041 (1094)
Q Consensus 964 FGLSrl~~~~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~l-rp~ 1041 (1094)
||++...... .......+|+.|+|||++. ...++.++||||||+++|+|++|+.||...........+..... ...
T Consensus 169 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 246 (314)
T 3com_A 169 FGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ--EIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFR 246 (314)
T ss_dssp CTTCEECBTTBSCBCCCCSCGGGCCHHHHS--SSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS
T ss_pred cccchhhhhhccccCccCCCCCccChhhcC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccC
Confidence 9999754332 2233456899999999998 45688999999999999999999999998776655544433221 222
Q ss_pred CCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1042 iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
.+..++..+.+||.+||..||.+|||+.+++++-+-
T Consensus 247 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~ 282 (314)
T 3com_A 247 KPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFV 282 (314)
T ss_dssp SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred CcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHH
Confidence 355678999999999999999999999999986543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=344.47 Aligned_cols=254 Identities=28% Similarity=0.434 Sum_probs=217.4
Q ss_pred ccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~ 885 (1094)
..+.|++.+.||+|+||.||+|++. +..||||++...... .....+.+|+.++++++||||+++++++...
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 92 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-------DEIEDIQQEITVLSQCDSPYVTKYYGSYLKD 92 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-------TTHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-------HHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 4567999999999999999999874 678999999764321 1235688999999999999999999999875
Q ss_pred CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecC
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFG 965 (1094)
. .+++||||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 93 ~--~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~kl~Dfg 164 (303)
T 3a7i_A 93 T--KLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS----EHGEVKLADFG 164 (303)
T ss_dssp T--EEEEEEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECCCT
T ss_pred C--eEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEEC----CCCCEEEeecc
Confidence 5 89999999999999999864 3589999999999999999999999999999999999998 77899999999
Q ss_pred CcccccCc-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCC
Q 037285 966 LSKIKRNT-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPS 1044 (1094)
Q Consensus 966 LSrl~~~~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe 1044 (1094)
++...... .......+|+.|+|||++. ...++.++||||||+++|+|++|+.||...........+. ....+.++.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~ 241 (303)
T 3a7i_A 165 VAGQLTDTQIKRNTFVGTPFWMAPEVIK--QSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-KNNPPTLEG 241 (303)
T ss_dssp TCEECBTTBCCBCCCCSCGGGCCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-HSCCCCCCS
T ss_pred cceecCccccccCccCCCcCccCHHHHh--cCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhh-cCCCCCCcc
Confidence 99754332 2234456899999999998 4567889999999999999999999999887776665543 344556777
Q ss_pred cCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1045 YCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1045 ~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
.++..+.+||.+||+.||.+|||+.+|+++.+-..
T Consensus 242 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 242 NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp SCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence 89999999999999999999999999999877654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=367.75 Aligned_cols=254 Identities=24% Similarity=0.304 Sum_probs=199.2
Q ss_pred CCeeEE-EEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHh-hCCCCceeEEEeEeec-
Q 037285 810 EDLEEQ-KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILS-KLHHPNVVAFYGVVQD- 884 (1094)
Q Consensus 810 edYei~-kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILk-rL~HPNIVqL~Gv~~d- 884 (1094)
++|.+. +.||+|+||.||+|+++ +..||||++... ..+.+|+.++. .++||||+++++++..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~ 127 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------------PKARREVELHWRASQCPHIVRIVDVYENL 127 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------------hhHHHHHHHHHHhcCCCCcceEeEEEeec
Confidence 567776 78999999999999885 678999998642 24567888774 4589999999998864
Q ss_pred -CCCCceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 885 -GPGGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 885 -~~~~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
.....+++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..+ .++.+||+
T Consensus 128 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-~~~~~kl~ 206 (400)
T 1nxk_A 128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR-PNAILKLT 206 (400)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS-TTCCEEEC
T ss_pred ccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCC-CCccEEEE
Confidence 12337899999999999999997653 4589999999999999999999999999999999999998322 26889999
Q ss_pred ecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH----HHHhHhhccC
Q 037285 963 DFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA----IIGGIVNNTL 1038 (1094)
Q Consensus 963 DFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~e----ile~Iv~~~l 1038 (1094)
|||+++...........+||+.|+|||++. ...++.++|||||||++|+|++|+.||....... ....+....+
T Consensus 207 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~ 284 (400)
T 1nxk_A 207 DFGFAKETTSHNSLTTPCYTPYYVAPEVLG--PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 284 (400)
T ss_dssp CCTTCEECC-----------CTTCCGGGSC--CCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCC
T ss_pred ecccccccCCCCccccCCCCCCccCHhhcC--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcc
Confidence 999998655444445567899999999997 4678899999999999999999999997654322 2333333333
Q ss_pred CCCC--CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1039 RPTI--PSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1039 rp~i--Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
.... ...++.++.+||.+||..||.+|||+.+|+++.+-..
T Consensus 285 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 327 (400)
T 1nxk_A 285 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 327 (400)
T ss_dssp CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence 3222 2468999999999999999999999999999987653
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=351.14 Aligned_cols=262 Identities=23% Similarity=0.325 Sum_probs=206.3
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||+|+||.||+|++. ++.||||++..... ........+.+|+.++++++||||+++++++....
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLS-----SDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG 107 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGG-----GSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccc-----cCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence 468999999999999999999874 67899999875421 12334567889999999999999999999998855
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+++||||+.+++|.+++.... .+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+
T Consensus 108 --~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~----~~~~~kl~Dfg~ 180 (309)
T 2h34_A 108 --QLYVDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS----ADDFAYLVDFGI 180 (309)
T ss_dssp --EEEEEEECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTSCEEECSCCC
T ss_pred --eEEEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEc----CCCCEEEecCcc
Confidence 8999999999999999997654 589999999999999999999999999999999999998 678999999999
Q ss_pred cccccCc--cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCC--CCC
Q 037285 967 SKIKRNT--LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR--PTI 1042 (1094)
Q Consensus 967 Srl~~~~--~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lr--p~i 1042 (1094)
+...... .......+|+.|+|||++. ...++.++||||||+++|+|++|+.||...........+ ..... ...
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~ 257 (309)
T 2h34_A 181 ASATTDEKLTQLGNTVGTLYYMAPERFS--ESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAIPRPSTV 257 (309)
T ss_dssp ----------------CCGGGCCGGGTC--C----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH-HSCCCCGGGT
T ss_pred CccccccccccccccCCCcCccCHHHHc--CCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh-ccCCCCcccc
Confidence 8754332 2223456899999999997 456788999999999999999999999887655433333 32222 134
Q ss_pred CCcCcHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHHHHhhcC
Q 037285 1043 PSYCDAEWRTLMEECWAPNPAARP-SFTEIASRLRVLSTAASQT 1085 (1094)
Q Consensus 1043 Pe~~S~eL~dLI~kCLq~DPeeRP-S~eELLq~L~~L~ta~s~p 1085 (1094)
+..++..+.++|.+||+.||.+|| ++.++++.|+.+.......
T Consensus 258 ~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~ 301 (309)
T 2h34_A 258 RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQD 301 (309)
T ss_dssp STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-----
T ss_pred CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhccc
Confidence 567889999999999999999999 9999999999876554433
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=357.23 Aligned_cols=258 Identities=27% Similarity=0.414 Sum_probs=212.2
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEe
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVV 882 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~ 882 (1094)
.++..++|++.+.||+|+||.||+|++. +..||+|++.... .......+.+|+.+|++++||||+++++++
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 100 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-------KPAIRNQIIRELQVLHECNSPYIVGFYGAF 100 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-------CHHHHHHHHHHHGGGGGCCCTTBCCEEEEE
T ss_pred cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-------CHHHHHHHHHHHHHHHHCCCCCEEEEeEEE
Confidence 3566789999999999999999999986 7789999987642 123346788999999999999999999999
Q ss_pred ecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeccCCCCCCcEEE
Q 037285 883 QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPSRPICKV 961 (1094)
Q Consensus 883 ~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~-GIIHRDLKPeNILLD~~~~e~g~VKL 961 (1094)
.... .+++||||+.+++|.+++.... .+++..++.++.||+.||.|||+. ||+||||||+|||++ .++.+||
T Consensus 101 ~~~~--~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~----~~~~~kl 173 (360)
T 3eqc_A 101 YSDG--EISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN----SRGEIKL 173 (360)
T ss_dssp EETT--EEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC----TTCCEEE
T ss_pred EECC--EEEEEEECCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEEC----CCCCEEE
Confidence 8755 8999999999999999997654 489999999999999999999996 999999999999999 7788999
Q ss_pred EecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHH-----------
Q 037285 962 GDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAII----------- 1030 (1094)
Q Consensus 962 sDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eil----------- 1030 (1094)
+|||+++...... .....||+.|+|||++. ...++.++|||||||++|+|++|+.||......+..
T Consensus 174 ~Dfg~~~~~~~~~-~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 250 (360)
T 3eqc_A 174 CDFGVSGQLIDSM-ANSFVGTRSYMSPERLQ--GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 250 (360)
T ss_dssp CCCCCCHHHHHHC-----CCCCTTCCHHHHT--TCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------
T ss_pred EECCCCccccccc-ccCCCCCCCeECHHHHc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccC
Confidence 9999997442221 23456899999999998 457899999999999999999999999876654322
Q ss_pred -------------------------------HhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1031 -------------------------------GGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1031 -------------------------------e~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
..+............++.++.+||.+||+.||.+|||+.+++++-+--.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 330 (360)
T 3eqc_A 251 AETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330 (360)
T ss_dssp -----------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred CCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence 1122222222223457889999999999999999999999999877544
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=346.57 Aligned_cols=254 Identities=24% Similarity=0.342 Sum_probs=213.5
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||+|+||.||++++. ++.||||+++..... ....+.+|+.++++++||||+++++++.+..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF--------RDSSLENEIAVLKKIKHENIVTLEDIYESTT 79 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------------HHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc--------chHHHHHHHHHHHhCCCCCeeehhhhcccCC
Confidence 468999999999999999999874 788999999754211 1245778999999999999999999998755
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+++||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+...+ .++.+||+|||+
T Consensus 80 --~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~-~~~~~kl~Dfg~ 155 (304)
T 2jam_A 80 --HYYLVMQLVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPE-ENSKIMITDFGL 155 (304)
T ss_dssp --EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSS-TTCCEEBCSCST
T ss_pred --EEEEEEEcCCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCC-CCCCEEEccCCc
Confidence 8999999999999999987654 489999999999999999999999999999999999994211 678899999999
Q ss_pred cccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCC--CCCC
Q 037285 967 SKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP--TIPS 1044 (1094)
Q Consensus 967 Srl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp--~iPe 1044 (1094)
++...... .....||+.|+|||++. ...++.++|||||||++|+|++|+.||...........+....... ....
T Consensus 156 ~~~~~~~~-~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (304)
T 2jam_A 156 SKMEQNGI-MSTACGTPGYVAPEVLA--QKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWD 232 (304)
T ss_dssp TCCCCCBT-THHHHSCCCBCCTTTBS--SCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTT
T ss_pred ceecCCCc-cccccCCCCccChHHhc--cCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccc
Confidence 97544322 22345899999999998 4568899999999999999999999999888877777766554432 3346
Q ss_pred cCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1045 YCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1045 ~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
.++..+.+||.+||..||.+|||+.+++++.+-
T Consensus 233 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 265 (304)
T 2jam_A 233 DISESAKDFICHLLEKDPNERYTCEKALSHPWI 265 (304)
T ss_dssp TSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence 789999999999999999999999999987654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=359.50 Aligned_cols=258 Identities=32% Similarity=0.511 Sum_probs=205.4
Q ss_pred eccCCeeEEEEecccCceEEEEeeec-CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r-Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~ 885 (1094)
+..++|++.+.||+|+||.||+|++. ++.||||++....... ....+.+|+.++++++||||+++++++...
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 99 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG-------GELQFQTEVEMISMAVHRNLLRLRGFCMTP 99 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred HHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch-------HHHHHHHHHHHHHhccCCCccceEEEEecC
Confidence 45678999999999999999999874 7889999987643211 112578899999999999999999999875
Q ss_pred CCCceEEEeeecccchhHHHHhhcc---cccCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCceEeccCCCCCCcE
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKD---RFLDRRRRLIIAMDAAFGMEYLHSK---NIVHFDLKCDNLLVNLKDPSRPIC 959 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~---~~Lse~~~l~Ia~QIaeGLaYLHs~---GIIHRDLKPeNILLD~~~~e~g~V 959 (1094)
. ..++||||+.+|+|.+++.... ..+++..++.++.||+.||+|||++ ||+||||||+|||++ .++.+
T Consensus 100 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~----~~~~~ 173 (326)
T 3uim_A 100 T--ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD----EEFEA 173 (326)
T ss_dssp S--CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEEC----TTCCE
T ss_pred C--ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEEC----CCCCE
Confidence 5 7899999999999999997643 3489999999999999999999999 999999999999998 77899
Q ss_pred EEEecCCcccccC--ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-----h---HHH
Q 037285 960 KVGDFGLSKIKRN--TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH-----Y---GAI 1029 (1094)
Q Consensus 960 KLsDFGLSrl~~~--~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~-----~---~ei 1029 (1094)
||+|||+++.... ........||+.|+|||++. ...++.++|||||||++|+|++|+.||.... . ...
T Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 251 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS--TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251 (326)
T ss_dssp EECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHH--HSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred EeccCccccccCcccccccccccCCcCccCHHHhc--cCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence 9999999985432 22334456999999999997 3457899999999999999999999995211 0 111
Q ss_pred HHhHhh---------ccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1030 IGGIVN---------NTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1030 le~Iv~---------~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
+..... .......+...+..+.++|.+||+.||.+|||+.+|+++|+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp HTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred HHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 111111 11111222334577999999999999999999999999998644
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=351.93 Aligned_cols=257 Identities=32% Similarity=0.532 Sum_probs=210.9
Q ss_pred ccCCeeEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhh--CCCCceeEEEeEeecC
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSK--LHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkr--L~HPNIVqL~Gv~~d~ 885 (1094)
..++|++.+.||+|+||.||+|+++++.||||++.... ...+.+|+.++.. ++||||+++++++...
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----------ERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG-----------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred ccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh-----------HHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 34689999999999999999999999999999986431 2456778888887 7899999999999875
Q ss_pred CC--CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCceEeccCCCC
Q 037285 886 PG--GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLH--------SKNIVHFDLKCDNLLVNLKDPS 955 (1094)
Q Consensus 886 ~~--~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLH--------s~GIIHRDLKPeNILLD~~~~e 955 (1094)
.. ..+++||||+.+|+|.+++.+. .+++..++.++.||+.||.||| +++|+||||||+|||++ .
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~----~ 182 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK----K 182 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEEC----T
T ss_pred CCccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEEC----C
Confidence 32 2789999999999999999654 4899999999999999999999 89999999999999998 7
Q ss_pred CCcEEEEecCCcccccCcc-----ccCCccCCCcccCccccccCCC----CCCchhhHHHHHHHHHHHHcC---------
Q 037285 956 RPICKVGDFGLSKIKRNTL-----VSGGVRGTLPWMAPELLSGSSS----KVSEKVDVFSFGIVLWEILTG--------- 1017 (1094)
Q Consensus 956 ~g~VKLsDFGLSrl~~~~~-----~ss~~~GT~~YmAPEvL~g~~~----kyS~KSDVWSLGVLLyELLTG--------- 1017 (1094)
++.+||+|||+++...... ......||+.|+|||++.+... .++.++|||||||++|+|+||
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 262 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262 (342)
T ss_dssp TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence 7899999999997543322 2244569999999999974211 233689999999999999999
Q ss_pred -CCCCCCCC-----hHHHHHhHhhccCCCCCCC-----cCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1018 -EEPYANMH-----YGAIIGGIVNNTLRPTIPS-----YCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1018 -k~PF~~~~-----~~eile~Iv~~~lrp~iPe-----~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
..||.... .......+.....++.++. .++..+.+||.+||+.||.+|||+.+|+++|+.+...
T Consensus 263 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 263 YQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp CCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 78887642 2344444445555655554 3456899999999999999999999999999998754
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=357.65 Aligned_cols=255 Identities=26% Similarity=0.364 Sum_probs=204.1
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||+|+||.||+|++. +..||||++...... .....+.+|+.+|++++||||+++++++....
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 73 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-------GAPCTAIREVSLLKDLKHANIVTLHDIIHTEK- 73 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------------CCCCCCCHHHHSCCCCTTBCCEEEEEECSS-
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-------ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCC-
Confidence 57999999999999999999885 678999998653211 11123457999999999999999999998755
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++||||+. |+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 -~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~----~~~~~kl~Dfg~a 147 (324)
T 3mtl_A 74 -SLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLIN----ERGELKLADFGLA 147 (324)
T ss_dssp -CEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEEC----TTCCEEECSSSEE
T ss_pred -EEEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEEC----CCCCEEEccCccc
Confidence 8999999997 689999887777799999999999999999999999999999999999998 7789999999999
Q ss_pred ccccC-ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCC---C--
Q 037285 968 KIKRN-TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP---T-- 1041 (1094)
Q Consensus 968 rl~~~-~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp---~-- 1041 (1094)
+.... ........+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||......+.+..+......+ .
T Consensus 148 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 226 (324)
T 3mtl_A 148 RAKSIPTKTYDNEVVTLWYRPPDILLG-STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226 (324)
T ss_dssp ECC------------CGGGCCHHHHTT-CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccccCCccccccccCcccccChhhhcC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhch
Confidence 85432 222334568999999999874 3567899999999999999999999999988776665543321111 0
Q ss_pred -----------------------CCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1042 -----------------------IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1042 -----------------------iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
....++.++.+||.+||+.||.+|||+.+++++-+-..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 287 (324)
T 3mtl_A 227 GILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS 287 (324)
T ss_dssp TGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred hhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhh
Confidence 11246788999999999999999999999999766544
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=355.32 Aligned_cols=261 Identities=27% Similarity=0.376 Sum_probs=202.9
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||+|+||.||+|+++ +..||||++..................+.+|+.+|++++||||+++++++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 87 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 87 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-
Confidence 468999999999999999999885 57899999976533211111222334678999999999999999999999764
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+++||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++..+ ....+||+|||+
T Consensus 88 --~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~-~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 88 --DYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE-EDCLIKITDFGH 163 (322)
T ss_dssp --SEEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS-SSCCEEECCCTT
T ss_pred --ceEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCC-CCCeEEEccCcc
Confidence 4899999999999999987544 589999999999999999999999999999999999998332 345699999999
Q ss_pred cccccCccccCCccCCCcccCcccccc-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH-HHHhHhhccCC--CCC
Q 037285 967 SKIKRNTLVSGGVRGTLPWMAPELLSG-SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA-IIGGIVNNTLR--PTI 1042 (1094)
Q Consensus 967 Srl~~~~~~ss~~~GT~~YmAPEvL~g-~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~e-ile~Iv~~~lr--p~i 1042 (1094)
++............||+.|+|||++.+ ....++.++|||||||++|+|++|+.||....... ....+...... +..
T Consensus 164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (322)
T 2ycf_A 164 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243 (322)
T ss_dssp CEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHH
T ss_pred ceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchh
Confidence 986554433334568999999999742 24567899999999999999999999998654432 22223222221 112
Q ss_pred CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1043 PSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1043 Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
...++..+.+||.+||..||.+||++.+++++
T Consensus 244 ~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 24678999999999999999999999999864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=355.65 Aligned_cols=253 Identities=22% Similarity=0.289 Sum_probs=205.3
Q ss_pred eccCCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-----CCceeEEE
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-----HPNVVAFY 879 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-----HPNIVqL~ 879 (1094)
+..++|++.++||+|+||.||+|++ .+..||||+++.. ......+..|+.+++++. ||||++++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---------KKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---------HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---------hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 4457999999999999999999998 4678999998642 123345678999999986 99999999
Q ss_pred eEeecCCCCceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCC-----
Q 037285 880 GVVQDGPGGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKD----- 953 (1094)
Q Consensus 880 Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~----- 953 (1094)
+++.... .+++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++...
T Consensus 103 ~~~~~~~--~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 179 (360)
T 3llt_A 103 GKFMYYD--HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSL 179 (360)
T ss_dssp EEEEETT--EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEE
T ss_pred ceeeECC--eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccc
Confidence 9998865 899999999 999999997654 3589999999999999999999999999999999999997210
Q ss_pred ----------------CCCCcEEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcC
Q 037285 954 ----------------PSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTG 1017 (1094)
Q Consensus 954 ----------------~e~g~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTG 1017 (1094)
...+.+||+|||+++..... .....||+.|+|||++. ...++.++|||||||++|+|++|
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g 255 (360)
T 3llt_A 180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVIL--NLGWDVSSDMWSFGCVLAELYTG 255 (360)
T ss_dssp EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHT--TCCCCTTHHHHHHHHHHHHHHHS
T ss_pred cchhcccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHc--CCCCCCccchHHHHHHHHHHHHC
Confidence 12678999999999864432 23456899999999998 45689999999999999999999
Q ss_pred CCCCCCCChHHHHHhHhhccCCC------------------------CCC--------------------CcCcHHHHHH
Q 037285 1018 EEPYANMHYGAIIGGIVNNTLRP------------------------TIP--------------------SYCDAEWRTL 1053 (1094)
Q Consensus 1018 k~PF~~~~~~eile~Iv~~~lrp------------------------~iP--------------------e~~S~eL~dL 1053 (1094)
+.||......+.+..+....... ..+ ...++.+.+|
T Consensus 256 ~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 335 (360)
T 3llt_A 256 SLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDF 335 (360)
T ss_dssp SCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHH
T ss_pred CCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHH
Confidence 99999877666554432211100 001 1123678899
Q ss_pred HHHhccCCCCCCCCHHHHHHHH
Q 037285 1054 MEECWAPNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1054 I~kCLq~DPeeRPS~eELLq~L 1075 (1094)
|.+||+.||.+|||+.+++++-
T Consensus 336 i~~~L~~dP~~Rpta~elL~hp 357 (360)
T 3llt_A 336 LYSILQIDPTLRPSPAELLKHK 357 (360)
T ss_dssp HHHHCCSSGGGSCCHHHHTTSG
T ss_pred HHHHhcCChhhCCCHHHHhcCc
Confidence 9999999999999999998763
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=346.28 Aligned_cols=254 Identities=28% Similarity=0.416 Sum_probs=209.2
Q ss_pred ccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~ 885 (1094)
..++|++.+.||+|+||.||+|++. +..||+|++.... ......+.+|+.++++++||||+++++++...
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 88 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--------EEELEDYIVEIEILATCDHPYIVKLLGAYYHD 88 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--------HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC
Confidence 3468999999999999999999985 6789999986532 11235788999999999999999999999875
Q ss_pred CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecC
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFG 965 (1094)
. .+++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 89 ~--~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~kl~Dfg 162 (302)
T 2j7t_A 89 G--KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMT----LEGDIRLADFG 162 (302)
T ss_dssp ---CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC----TTSCEEECCCH
T ss_pred C--eEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEC----CCCCEEEEECC
Confidence 4 89999999999999999987666799999999999999999999999999999999999998 67889999999
Q ss_pred Cccccc-CccccCCccCCCcccCcccccc---CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCC-C
Q 037285 966 LSKIKR-NTLVSGGVRGTLPWMAPELLSG---SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR-P 1040 (1094)
Q Consensus 966 LSrl~~-~~~~ss~~~GT~~YmAPEvL~g---~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lr-p 1040 (1094)
++.... .........||..|+|||++.. ....++.++|||||||++|+|++|+.||...........+...... .
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (302)
T 2j7t_A 163 VSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL 242 (302)
T ss_dssp HHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred CCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc
Confidence 876321 1112234568999999999841 1456788999999999999999999999988877766665544332 2
Q ss_pred CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037285 1041 TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1041 ~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L 1075 (1094)
..+..++..+.++|.+||+.||.+|||+.+++++-
T Consensus 243 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 277 (302)
T 2j7t_A 243 LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHP 277 (302)
T ss_dssp SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTST
T ss_pred CCccccCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 34567889999999999999999999999998753
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=358.37 Aligned_cols=259 Identities=26% Similarity=0.322 Sum_probs=206.3
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
..+|++.+.||+|+||.||+|++. |..||||++....... ........+.+|+.++++++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSE---AKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC---------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcch---hhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 468999999999999999999885 6789999987543211 11122346779999999999999999999998754
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+++||||+.+ +|..++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 86 --~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~----~~~~~kl~Dfg~ 158 (346)
T 1ua2_A 86 --NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD----ENGVLKLADFGL 158 (346)
T ss_dssp --CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTCCEEECCCGG
T ss_pred --ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEc----CCCCEEEEeccc
Confidence 89999999975 88888877766789999999999999999999999999999999999998 778999999999
Q ss_pred cccccC-ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCC----
Q 037285 967 SKIKRN-TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT---- 1041 (1094)
Q Consensus 967 Srl~~~-~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~---- 1041 (1094)
++.... ........+|+.|+|||++.+ ...++.++|||||||++|+|++|..||......+.+..+......+.
T Consensus 159 a~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 159 AKSFGSPNRAYTHQVVTRWYRAPELLFG-ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 237 (346)
T ss_dssp GSTTTSCCCCCCCSCCCCTTCCHHHHTT-CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ceeccCCcccCCcccccccccCchHhhC-CCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Confidence 985432 223344568999999999874 34578999999999999999999999998887776665544211110
Q ss_pred ----------------------CCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1042 ----------------------IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1042 ----------------------iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
+...++.++.+||.+||..||.+|||+.+++++.+--
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~ 296 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 296 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGT
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhh
Confidence 0134578999999999999999999999999987653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=361.89 Aligned_cols=252 Identities=23% Similarity=0.333 Sum_probs=207.8
Q ss_pred cCCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||+|+||.||+|++ .+..||||++..................+.+|+.+|++++||||+++++++.+..
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 35899999999999999999976 4788999999876433211111112234667999999999999999999998755
Q ss_pred CCceEEEeeecccc-hhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecC
Q 037285 887 GGTLATVAEYMVDG-SLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965 (1094)
Q Consensus 887 ~~~L~IVmEYmegG-SL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFG 965 (1094)
.+++||||+.+| +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 103 --~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~----~~~~~kL~Dfg 175 (335)
T 3dls_A 103 --FFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIA----EDFTIKLIDFG 175 (335)
T ss_dssp --EEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTSCEEECCCT
T ss_pred --EEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEc----CCCcEEEeecc
Confidence 899999999777 9999987654 489999999999999999999999999999999999998 77899999999
Q ss_pred CcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCc
Q 037285 966 LSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSY 1045 (1094)
Q Consensus 966 LSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~ 1045 (1094)
+++............||+.|+|||++.+ ...++.++|||||||++|+|++|+.||..... .... ....+..
T Consensus 176 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~--~~~~~~~ 246 (335)
T 3dls_A 176 SAAYLERGKLFYTFCGTIEYCAPEVLMG-NPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEA--AIHPPYL 246 (335)
T ss_dssp TCEECCTTCCBCEECSCGGGCCHHHHTT-CCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTT--CCCCSSC
T ss_pred cceECCCCCceeccCCCccccChhhhcC-CCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhh--ccCCCcc
Confidence 9986655444455679999999999984 22337899999999999999999999976321 1111 2334567
Q ss_pred CcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1046 CDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1046 ~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
++.++.+||.+||+.||.+|||+.+|+++.+
T Consensus 247 ~~~~l~~li~~~L~~dP~~Rps~~ell~hp~ 277 (335)
T 3dls_A 247 VSKELMSLVSGLLQPVPERRTTLEKLVTDPW 277 (335)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 8999999999999999999999999999865
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=369.91 Aligned_cols=268 Identities=21% Similarity=0.309 Sum_probs=216.0
Q ss_pred eeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEee
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQ 883 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~ 883 (1094)
.....+|++.++||+|+||.||+|++. +..||||++...... .....+.+|+.+|++++||||+++++++.
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 77 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-------RPVDVQMREFEVLKKLNHKNIVKLFAIEE 77 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-------SCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc-------chHHHHHHHHHHHHhcCCCCCCeEEEeec
Confidence 345678999999999999999999986 788999999754321 12356778999999999999999999998
Q ss_pred cCCCCceEEEeeecccchhHHHHhhccc--ccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEE
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLVRKDR--FLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKV 961 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~k~~~--~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKL 961 (1094)
......+++||||+.+|+|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||+.......+.+||
T Consensus 78 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL 157 (396)
T 4eut_A 78 ETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKL 157 (396)
T ss_dssp CTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEE
T ss_pred cCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEE
Confidence 7665678999999999999999976542 38999999999999999999999999999999999998322226778999
Q ss_pred EecCCcccccCccccCCccCCCcccCccccccC------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC----hHHHHH
Q 037285 962 GDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGS------SSKVSEKVDVFSFGIVLWEILTGEEPYANMH----YGAIIG 1031 (1094)
Q Consensus 962 sDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~------~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~----~~eile 1031 (1094)
+|||+++............||+.|+|||++.+. ...++.++|||||||++|||++|+.||.... ..+.+.
T Consensus 158 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 237 (396)
T 4eut_A 158 TDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (396)
T ss_dssp CCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHH
T ss_pred ecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHH
Confidence 999999866555444556799999999998631 1356789999999999999999999997532 334444
Q ss_pred hHhhccCCC-----------------------CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 037285 1032 GIVNNTLRP-----------------------TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLST 1080 (1094)
Q Consensus 1032 ~Iv~~~lrp-----------------------~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~t 1080 (1094)
.+....... .+...++..+.++|.+||..||++||++.++++.|..+..
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 443332110 1123345678999999999999999999999999988764
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=341.33 Aligned_cols=254 Identities=30% Similarity=0.479 Sum_probs=208.5
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC-
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG- 885 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~- 885 (1094)
...|++.+.||+|+||.||+|.+. +..||+|++...... ......+.+|+.+|++++||||+++++++...
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT------KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC------HHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc
Confidence 446889999999999999999885 567999998764321 22346788999999999999999999998642
Q ss_pred -CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeccCCCCCCcEEEE
Q 037285 886 -PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 886 -~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~G--IIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
....+++||||+.+++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++ ..++.+||+
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~---~~~~~~kl~ 174 (290)
T 1t4h_A 99 KGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT---GPTGSVKIG 174 (290)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES---STTSCEEEC
T ss_pred CCCceEEEEEEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE---CCCCCEEEe
Confidence 2346899999999999999997654 4899999999999999999999999 99999999999996 146789999
Q ss_pred ecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhcc-CCCC
Q 037285 963 DFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-LRPT 1041 (1094)
Q Consensus 963 DFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~-lrp~ 1041 (1094)
|||++........ ....||+.|+|||++.+ .++.++|||||||++|+|++|+.||................ ....
T Consensus 175 Dfg~~~~~~~~~~-~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (290)
T 1t4h_A 175 DLGLATLKRASFA-KAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS 250 (290)
T ss_dssp CTTGGGGCCTTSB-EESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG
T ss_pred eCCCccccccccc-ccccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccc
Confidence 9999975443322 23468999999999873 48899999999999999999999998865544443333333 3334
Q ss_pred CCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1042 iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
++..+++++.+||.+||+.||.+|||+.+++++-+
T Consensus 251 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 285 (290)
T 1t4h_A 251 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285 (290)
T ss_dssp GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred cCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcc
Confidence 55667889999999999999999999999998643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=342.06 Aligned_cols=256 Identities=27% Similarity=0.424 Sum_probs=216.5
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||+|+||.||+|++. +..||||++....... .....+.+|+.++++++||||+++++++....
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN------KDTSTILREVELLKKLDHPNIMKLFEILEDSS 94 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS------SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch------HHHHHHHHHHHHHHhccCCCccEEEEEEeCCC
Confidence 468999999999999999999884 7889999997653221 12356889999999999999999999998754
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+++||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++..+ ....+||+|||+
T Consensus 95 --~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~-~~~~~kL~Dfg~ 170 (287)
T 2wei_A 95 --SFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE-KDCDIKIIDFGL 170 (287)
T ss_dssp --EEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS-TTCCEEECSTTG
T ss_pred --eEEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCC-CcccEEEeccCc
Confidence 8999999999999999887654 489999999999999999999999999999999999997332 355799999999
Q ss_pred cccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCC--C
Q 037285 967 SKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIP--S 1044 (1094)
Q Consensus 967 Srl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iP--e 1044 (1094)
++............+|+.|+|||++.+ .++.++||||||+++|+|++|+.||......+....+.........+ .
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (287)
T 2wei_A 171 STCFQQNTKMKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR 247 (287)
T ss_dssp GGTBCCCSSCSCHHHHHTTCCHHHHTT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGT
T ss_pred ceeecCCCccccccCcccccChHHhcC---CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhh
Confidence 986544433344558899999999874 47899999999999999999999999988887777776655543333 4
Q ss_pred cCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1045 YCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1045 ~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
.++.++.++|.+||..||.+|||+.+++++-+-
T Consensus 248 ~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~ 280 (287)
T 2wei_A 248 TISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280 (287)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHH
T ss_pred hcCHHHHHHHHHHcccChhhCcCHHHHhcCHHH
Confidence 678999999999999999999999999997553
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=339.13 Aligned_cols=252 Identities=29% Similarity=0.360 Sum_probs=206.8
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||+|+||.||+|+++ ++.||||++...... .....+.+|+.++++++||||+++++++.+..
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 78 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-------DCPENIKKEICINKMLNHENVVKFYGHRREGN- 78 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-------THHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-------hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCC-
Confidence 57999999999999999999885 788999999754211 12356789999999999999999999998755
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
..++||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+|+||||+|||++ .++.+||+|||++
T Consensus 79 -~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~kl~dfg~~ 152 (276)
T 2yex_A 79 -IQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD----ERDNLKISDFGLA 152 (276)
T ss_dssp -EEEEEEECCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEEECCCTTC
T ss_pred -EEEEEEEecCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEc----cCCCEEEeeCCCc
Confidence 8999999999999999986543 589999999999999999999999999999999999998 7788999999999
Q ss_pred ccccC---ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH-HHHhHhhccCCCCCC
Q 037285 968 KIKRN---TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA-IIGGIVNNTLRPTIP 1043 (1094)
Q Consensus 968 rl~~~---~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~e-ile~Iv~~~lrp~iP 1043 (1094)
..... ........||+.|+|||++.+ ...++.++||||||+++|+|++|+.||....... ...............
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 231 (276)
T 2yex_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKR-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231 (276)
T ss_dssp EECEETTEECCBCCCCSCGGGCCGGGGTC-SSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTG
T ss_pred cccCCCcchhcccCCccccCccChHHHhc-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCch
Confidence 75321 122334568999999999974 2234779999999999999999999998765432 223332322222233
Q ss_pred CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1044 SYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1044 e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
..++..+.+||.+||+.||.+|||+.+++++.+
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 264 (276)
T 2yex_A 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRW 264 (276)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred hhcCHHHHHHHHHHCCCCchhCCCHHHHhcCcc
Confidence 568899999999999999999999999998644
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=346.02 Aligned_cols=251 Identities=19% Similarity=0.253 Sum_probs=204.5
Q ss_pred eeccCCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-CCceeEEEeEe
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HPNVVAFYGVV 882 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-HPNIVqL~Gv~ 882 (1094)
....++|++.+.||+|+||.||+|++ .++.||||+++... ...+.+|+.+|++++ ||||+++++++
T Consensus 32 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~~~~~i~~~~~~~ 100 (330)
T 3nsz_A 32 WGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----------KKKIKREIKILENLRGGPNIITLADIV 100 (330)
T ss_dssp CEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----------HHHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred ccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----------hHHHHHHHHHHHHcCCCCCEEEeeeee
Confidence 34567999999999999999999977 47889999986431 246789999999997 99999999999
Q ss_pred ecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCC-cEEE
Q 037285 883 QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRP-ICKV 961 (1094)
Q Consensus 883 ~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g-~VKL 961 (1094)
.+......++||||+.+++|.+++. .+++..++.++.||+.||+|||++||+||||||+|||++ .++ .+||
T Consensus 101 ~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~----~~~~~~kl 172 (330)
T 3nsz_A 101 KDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID----HEHRKLRL 172 (330)
T ss_dssp ECTTTCCEEEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE----TTTTEEEE
T ss_pred ccCCCCceEEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEc----CCCCEEEE
Confidence 8755568999999999999999884 388999999999999999999999999999999999998 444 8999
Q ss_pred EecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-hHHHHHhHhh-----
Q 037285 962 GDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH-YGAIIGGIVN----- 1035 (1094)
Q Consensus 962 sDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~-~~eile~Iv~----- 1035 (1094)
+|||+++............+|..|+|||++.+ ...++.++|||||||++|+|++|+.||.... ..+.+..+..
T Consensus 173 ~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~ 251 (330)
T 3nsz_A 173 IDWGLAEFYHPGQEYNVRVASRYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 251 (330)
T ss_dssp CCCTTCEECCTTCCCCSCCSCGGGCCHHHHTT-CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHH
T ss_pred EeCCCceEcCCCCccccccccccccChhhhcC-CCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCc
Confidence 99999986554444455678999999999874 3568899999999999999999999995432 2222111100
Q ss_pred --------cc----------------------CCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1036 --------NT----------------------LRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1036 --------~~----------------------lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
.. .....+..++.++.+||.+||+.||.+|||+.+++++-+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~ 322 (330)
T 3nsz_A 252 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322 (330)
T ss_dssp HHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGG
T ss_pred hhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCcc
Confidence 00 111122337899999999999999999999999998644
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=341.35 Aligned_cols=257 Identities=26% Similarity=0.420 Sum_probs=208.0
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
+..++|.....||+|+||.||+|++. +..||||.+.... ......+.+|+.++++++||||+++++++..
T Consensus 19 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 90 (295)
T 2clq_A 19 YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--------SRYSQPLHEEIALHKHLKHKNIVQYLGSFSE 90 (295)
T ss_dssp ECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--------C---HHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred ccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--------hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe
Confidence 44455666679999999999999974 6789999987542 1123568899999999999999999999987
Q ss_pred CCCCceEEEeeecccchhHHHHhhccc--ccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDR--FLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~--~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
.. .+++||||+.+++|.+++..... .+++..++.++.||+.||.|||++||+|+||||+|||++. .++.+||+
T Consensus 91 ~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~---~~~~~kl~ 165 (295)
T 2clq_A 91 NG--FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT---YSGVLKIS 165 (295)
T ss_dssp TT--EEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET---TTCCEEEC
T ss_pred CC--cEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEEC---CCCCEEEe
Confidence 55 89999999999999999976532 4568889999999999999999999999999999999981 26789999
Q ss_pred ecCCcccccC-ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH-HHHhHhhccCCC
Q 037285 963 DFGLSKIKRN-TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA-IIGGIVNNTLRP 1040 (1094)
Q Consensus 963 DFGLSrl~~~-~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~e-ile~Iv~~~lrp 1040 (1094)
|||+++.... ........||+.|+|||++.+....++.++||||||+++|+|++|+.||....... ...........+
T Consensus 166 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (295)
T 2clq_A 166 DFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP 245 (295)
T ss_dssp CTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCC
T ss_pred ecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccc
Confidence 9999985432 22233456899999999997533457899999999999999999999997654332 222222334556
Q ss_pred CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1041 TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1041 ~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
.++..++.++.+||.+||+.||++||++.+++++-+
T Consensus 246 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~ 281 (295)
T 2clq_A 246 EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEF 281 (295)
T ss_dssp CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGG
T ss_pred cccccCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 778889999999999999999999999999997644
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=354.18 Aligned_cols=257 Identities=22% Similarity=0.293 Sum_probs=207.1
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||+|+||.||+|+++ ++.||||++....... .....+.+|+.+|++++||||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 89 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE------GFPITALREIKILQLLKHENVVNLIEICRTKA 89 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS------SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc------cchHHHHHHHHHHHhccCCCcccHhheeeccc
Confidence 368999999999999999999984 6889999986653221 11245778999999999999999999987643
Q ss_pred ------CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEE
Q 037285 887 ------GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICK 960 (1094)
Q Consensus 887 ------~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VK 960 (1094)
.+.+++||||+. ++|...+......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+|
T Consensus 90 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~----~~~~~k 164 (351)
T 3mi9_A 90 SPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT----RDGVLK 164 (351)
T ss_dssp -------CEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEE
T ss_pred cccccCCceEEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc----CCCCEE
Confidence 346899999997 477777766666799999999999999999999999999999999999998 778999
Q ss_pred EEecCCcccccC-----ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhh
Q 037285 961 VGDFGLSKIKRN-----TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN 1035 (1094)
Q Consensus 961 LsDFGLSrl~~~-----~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~ 1035 (1094)
|+|||+++.... ........||+.|+|||++.+ ...++.++|||||||++|+|++|+.||...........+..
T Consensus 165 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 243 (351)
T 3mi9_A 165 LADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG-ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243 (351)
T ss_dssp ECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTT-CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred EccchhcccccccccccccccCCcccccCccCchhhcC-CCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 999999985431 122234568999999999874 34578999999999999999999999998887666555433
Q ss_pred ccC--CCCC-CCc---------------------------CcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1036 NTL--RPTI-PSY---------------------------CDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1036 ~~l--rp~i-Pe~---------------------------~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
... .+.. +.. .++.+.+||.+||..||.+|||+.+++++-+-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 315 (351)
T 3mi9_A 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315 (351)
T ss_dssp HHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCc
Confidence 211 1111 110 26779999999999999999999999998654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=364.90 Aligned_cols=259 Identities=26% Similarity=0.394 Sum_probs=210.1
Q ss_pred eeccCCeeEEEEecccCceEEEEeee-----cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEE
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFY 879 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~-----rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~ 879 (1094)
.+..++|++.+.||+|+||.||++++ .+..||||+++....... ......+.+|+.+|+++ +||||++++
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~E~~~l~~l~~h~~iv~~~ 125 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK----AKTTEHTRTERQVLEHIRQSPFLVTLH 125 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE----ESSGGGCCCHHHHHHHHHTCTTBCCEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhh----hhHHHHHHHHHHHHHHccCCCceeEEE
Confidence 34557999999999999999999987 468899999875432110 01123456789999999 699999999
Q ss_pred eEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcE
Q 037285 880 GVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC 959 (1094)
Q Consensus 880 Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~V 959 (1094)
+++.... .+++||||+.+++|.+++.... .+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+
T Consensus 126 ~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~~ 198 (355)
T 1vzo_A 126 YAFQTET--KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD----SNGHV 198 (355)
T ss_dssp EEEEETT--EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCE
T ss_pred EEEeeCc--eEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCcE
Confidence 9998765 8999999999999999997654 489999999999999999999999999999999999998 77899
Q ss_pred EEEecCCcccccC--ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC----hHHHHHhH
Q 037285 960 KVGDFGLSKIKRN--TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH----YGAIIGGI 1033 (1094)
Q Consensus 960 KLsDFGLSrl~~~--~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~----~~eile~I 1033 (1094)
||+|||+++.... ........||+.|+|||++.+....++.++|||||||++|+|++|+.||.... ...+...+
T Consensus 199 kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 278 (355)
T 1vzo_A 199 VLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI 278 (355)
T ss_dssp EESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH
T ss_pred EEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH
Confidence 9999999985322 22233457999999999998545567899999999999999999999997543 22333333
Q ss_pred hhccCCCCCCCcCcHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHH
Q 037285 1034 VNNTLRPTIPSYCDAEWRTLMEECWAPNPAARP-----SFTEIASRLRV 1077 (1094)
Q Consensus 1034 v~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRP-----S~eELLq~L~~ 1077 (1094)
.. ..+.++..++..+.+||.+||..||.+|| ++.+++++++-
T Consensus 279 ~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f 325 (355)
T 1vzo_A 279 LK--SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325 (355)
T ss_dssp HH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred hc--cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence 22 23456778899999999999999999999 99999988754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=361.46 Aligned_cols=253 Identities=23% Similarity=0.262 Sum_probs=204.0
Q ss_pred eccCCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
....+|++.+.||+|+||.||+|++ +|..||||++..... ...+|+.+|+.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------------~~~~E~~il~~l~hpnIv~l~~~~~~ 71 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------------YKNRELDIMKVLDHVNIIKLVDYFYT 71 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------------SCCHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------------hHHHHHHHHHHcCCCCccchhheeee
Confidence 3457899999999999999999987 478899999875421 12368999999999999999999854
Q ss_pred C------------------------------------CCCceEEEeeecccchhHHHHhh---cccccCHHHHHHHHHHH
Q 037285 885 G------------------------------------PGGTLATVAEYMVDGSLRHVLVR---KDRFLDRRRRLIIAMDA 925 (1094)
Q Consensus 885 ~------------------------------------~~~~L~IVmEYmegGSL~d~L~k---~~~~Lse~~~l~Ia~QI 925 (1094)
. ....+++||||+. ++|.+.+.. ....+++..++.++.||
T Consensus 72 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi 150 (383)
T 3eb0_A 72 TGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQL 150 (383)
T ss_dssp C-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHH
T ss_pred cCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHH
Confidence 2 2235889999997 577666643 34569999999999999
Q ss_pred HHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHH
Q 037285 926 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVF 1005 (1094)
Q Consensus 926 aeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVW 1005 (1094)
+.||+|||++||+||||||+|||++. .++.+||+|||+++............+|+.|+|||++.+ ...++.++|||
T Consensus 151 ~~aL~~LH~~gi~H~Dikp~Nil~~~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~Diw 226 (383)
T 3eb0_A 151 FRAVGFIHSLGICHRDIKPQNLLVNS---KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLG-ATEYTPSIDLW 226 (383)
T ss_dssp HHHHHHHHTTTEECSCCCGGGEEEET---TTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTT-CSSCCTHHHHH
T ss_pred HHHHHHHHHCcCccCccCHHHEEEcC---CCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcC-CCCCCcchhhh
Confidence 99999999999999999999999971 467899999999986544444455678999999999874 34589999999
Q ss_pred HHHHHHHHHHcCCCCCCCCChHHHHHhHhhccC---------------------------CCCCCCcCcHHHHHHHHHhc
Q 037285 1006 SFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL---------------------------RPTIPSYCDAEWRTLMEECW 1058 (1094)
Q Consensus 1006 SLGVLLyELLTGk~PF~~~~~~eile~Iv~~~l---------------------------rp~iPe~~S~eL~dLI~kCL 1058 (1094)
||||++|+|++|+.||......+.+..++.... ...++..++.++.+||.+||
T Consensus 227 slG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 306 (383)
T 3eb0_A 227 SIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQIL 306 (383)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC
T ss_pred hHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHc
Confidence 999999999999999999887766655543111 11135568899999999999
Q ss_pred cCCCCCCCCHHHHHHHHH
Q 037285 1059 APNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1059 q~DPeeRPS~eELLq~L~ 1076 (1094)
..||.+|||+.+++++-+
T Consensus 307 ~~dP~~R~t~~e~l~hp~ 324 (383)
T 3eb0_A 307 RYEPDLRINPYEAMAHPF 324 (383)
T ss_dssp CSSGGGSCCHHHHHTSGG
T ss_pred cCChhhCCCHHHHhcCHH
Confidence 999999999999997543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=357.00 Aligned_cols=252 Identities=23% Similarity=0.331 Sum_probs=203.2
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
..+|++.+.||+|+||.||+|+++ |+.||||++.... ..+.....+.+|+.+|++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 97 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF------QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 97 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT------SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc------cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCC
Confidence 468999999999999999999874 7889999986532 11334567889999999999999999999997642
Q ss_pred C----CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 887 G----GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 887 ~----~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
. ..+++||||+ +++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~----~~~~~kl~ 170 (367)
T 1cm8_A 98 TLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN----EDCELKIL 170 (367)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEEC
T ss_pred ccccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEc----CCCCEEEE
Confidence 1 3569999999 8899999875 3589999999999999999999999999999999999998 78899999
Q ss_pred ecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCC---
Q 037285 963 DFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR--- 1039 (1094)
Q Consensus 963 DFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lr--- 1039 (1094)
|||+++..... .....+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+......+..+......
T Consensus 171 Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~ 247 (367)
T 1cm8_A 171 DFGLARQADSE--MTGYVVTRWYRAPEVILN-WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 247 (367)
T ss_dssp CCTTCEECCSS--CCSSCSCGGGCCTHHHHT-TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred eeecccccccc--cCcCcCCCCcCCHHHHhC-CCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 99999865432 234568999999999874 356889999999999999999999999988776655544321110
Q ss_pred --------------------------CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1040 --------------------------PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1040 --------------------------p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
..+...+++.+.+||.+||..||.+|||+.+++++-+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~ 310 (367)
T 1cm8_A 248 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 310 (367)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred HHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChH
Confidence 0122456889999999999999999999999998643
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=346.09 Aligned_cols=257 Identities=21% Similarity=0.293 Sum_probs=200.4
Q ss_pred cCCeeEE-EEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEeec
Q 037285 809 NEDLEEQ-KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQD 884 (1094)
Q Consensus 809 ~edYei~-kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~~d 884 (1094)
.+.|++. +.||+|+||.||+|++. +..||||++..... .....+.+|+.+|.++ +||||+++++++.+
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~ 82 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--------HIRSRVFREVEMLYQCQGHRNVLELIEFFEE 82 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--------CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--------hhHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 3578885 78999999999999874 78899999975421 1134678999999885 79999999999988
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
.. .+++||||+.+++|.+++.... .+++..++.++.||+.||+|||+++|+||||||+|||++..+ ....+||+||
T Consensus 83 ~~--~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~~~~kl~Df 158 (316)
T 2ac3_A 83 ED--RFYLVFEKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPN-QVSPVKICDF 158 (316)
T ss_dssp TT--EEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSS-SSCSEEECCT
T ss_pred CC--EEEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCC-CcCceEEEEc
Confidence 65 8999999999999999997654 589999999999999999999999999999999999998322 2345999999
Q ss_pred CCcccccCc--------cccCCccCCCcccCccccccCC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCh-------
Q 037285 965 GLSKIKRNT--------LVSGGVRGTLPWMAPELLSGSS---SKVSEKVDVFSFGIVLWEILTGEEPYANMHY------- 1026 (1094)
Q Consensus 965 GLSrl~~~~--------~~ss~~~GT~~YmAPEvL~g~~---~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~------- 1026 (1094)
|+++..... .......||+.|+|||++.+.. ..++.++|||||||++|+|++|+.||.....
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 238 (316)
T 2ac3_A 159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR 238 (316)
T ss_dssp TCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC--
T ss_pred cCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc
Confidence 998743211 1122345899999999986311 3467899999999999999999999987542
Q ss_pred --------HHHHHhHhhccCCCCC--CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1027 --------GAIIGGIVNNTLRPTI--PSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1027 --------~eile~Iv~~~lrp~i--Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
......+......... ...++..+.+||.+||..||.+|||+.+++++-+-
T Consensus 239 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 299 (316)
T 2ac3_A 239 GEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299 (316)
T ss_dssp --CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTC
T ss_pred cccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhh
Confidence 2233334333322111 13578899999999999999999999999997553
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=354.05 Aligned_cols=262 Identities=22% Similarity=0.287 Sum_probs=204.5
Q ss_pred cCCeeEEEEecccCceEEEEeeec-CceEEEEEeecCccCCCc---hhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRS---SEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r-Gt~VAVKiIkk~~~se~~---~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
.++|++.+.||+|+||.||+|... +..||||++......... .........+.+|+.+|++++||||+++++++..
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 100 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH 100 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence 478999999999999999999764 788999999764332211 1123345678999999999999999999999854
Q ss_pred C---CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEE
Q 037285 885 G---PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKV 961 (1094)
Q Consensus 885 ~---~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKL 961 (1094)
. ....+++||||+. |+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 101 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~----~~~~~kl 175 (362)
T 3pg1_A 101 FEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA----DNNDITI 175 (362)
T ss_dssp CCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTCCEEE
T ss_pred ccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEc----CCCCEEE
Confidence 2 2336899999997 688888877666799999999999999999999999999999999999998 7788999
Q ss_pred EecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCC-
Q 037285 962 GDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP- 1040 (1094)
Q Consensus 962 sDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp- 1040 (1094)
+|||+++............+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||......+.+..+......+
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 254 (362)
T 3pg1_A 176 CDFNLAREDTADANKTHYVTHRWYRAPELVMQ-FKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254 (362)
T ss_dssp CCTTC---------------CGGGCCHHHHTT-CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred EecCcccccccccccceecccceecCcHHhcC-CCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 99999985544444445678999999999874 3568899999999999999999999999887766655543311110
Q ss_pred -----------------------------CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1041 -----------------------------TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1041 -----------------------------~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
.....+++.+.+||.+||+.||.+|||+.+++++-+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 319 (362)
T 3pg1_A 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPY 319 (362)
T ss_dssp HHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred hHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCch
Confidence 012346788999999999999999999999998754
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=346.81 Aligned_cols=258 Identities=28% Similarity=0.418 Sum_probs=194.4
Q ss_pred eeeccCCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEe
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVV 882 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~ 882 (1094)
+.+..++|++.+.||+|+||.||+|.+ ++..||||++..... ......+.+|+.++++++||||+++++++
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 82 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-------QTSMDELLKEIQAMSQCHHPNIVSYYTSF 82 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------------CCCCCCCTTBCCEEEEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-------chhHHHHHHHHHHHhhcCCCCEeeEEEEE
Confidence 567788999999999999999999987 478899998864321 12235678999999999999999999999
Q ss_pred ecCCCCceEEEeeecccchhHHHHhh-------cccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCC
Q 037285 883 QDGPGGTLATVAEYMVDGSLRHVLVR-------KDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPS 955 (1094)
Q Consensus 883 ~d~~~~~L~IVmEYmegGSL~d~L~k-------~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e 955 (1094)
.... ..++||||+.+++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++ .
T Consensus 83 ~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~----~ 156 (303)
T 2vwi_A 83 VVKD--ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLG----E 156 (303)
T ss_dssp ESSS--CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC----T
T ss_pred eecC--CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEc----C
Confidence 8765 79999999999999999864 234589999999999999999999999999999999999998 7
Q ss_pred CCcEEEEecCCcccccCc------cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 037285 956 RPICKVGDFGLSKIKRNT------LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAI 1029 (1094)
Q Consensus 956 ~g~VKLsDFGLSrl~~~~------~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~ei 1029 (1094)
++.+||+|||++...... .......||+.|+|||++.+ ...++.++|||||||++|+|++|+.||........
T Consensus 157 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 235 (303)
T 2vwi_A 157 DGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQ-VRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV 235 (303)
T ss_dssp TCCEEECCCHHHHHCC---------------CCCTTCCHHHHHH-HHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH
T ss_pred CCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhcc-ccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH
Confidence 789999999998743221 12234568999999999863 23578899999999999999999999998776655
Q ss_pred HHhHhhccCC--------CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1030 IGGIVNNTLR--------PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1030 le~Iv~~~lr--------p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
.......... ......++.++.+||.+||+.||.+||++.+++++-+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 290 (303)
T 2vwi_A 236 LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKF 290 (303)
T ss_dssp HHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTT
T ss_pred HHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence 5444332221 1233567899999999999999999999999998643
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=352.98 Aligned_cols=257 Identities=25% Similarity=0.318 Sum_probs=206.9
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
...++|++.+.||+|+||.||+|++. +..||||++..... .......+.+|+.++++++||||+++++++.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 95 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD------DKMVKKIAMREIKLLKQLRHENLVNLLEVCKK 95 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC------chHHHHHHHHHHHHHhhCCCCCEeeEEEEeec
Confidence 34578999999999999999999985 67899999875421 12334567899999999999999999999987
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
.. .+++||||+.+++|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 96 ~~--~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~----~~~~~kl~Df 168 (331)
T 4aaa_A 96 KK--RWYLVFEFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVS----QSGVVKLCDF 168 (331)
T ss_dssp TT--EEEEEEECCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCEEECCC
T ss_pred CC--EEEEEEecCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEc----CCCcEEEEeC
Confidence 65 8999999999999988875544 489999999999999999999999999999999999998 7789999999
Q ss_pred CCcccccC-ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhc-------
Q 037285 965 GLSKIKRN-TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN------- 1036 (1094)
Q Consensus 965 GLSrl~~~-~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~------- 1036 (1094)
|+++.... ........+|..|+|||++.+ ...++.++|||||||++|+|++|+.||......+....+...
T Consensus 169 g~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 247 (331)
T 4aaa_A 169 GFARTLAAPGEVYDDEVATRWYRAPELLVG-DVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPR 247 (331)
T ss_dssp TTC------------CCCCCTTCCHHHHTT-CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred CCceeecCCccccCCCcCCccccCcccccC-CCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Confidence 99975432 222334568999999999974 346789999999999999999999999988766555443221
Q ss_pred ------------cCC-CCC---------CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1037 ------------TLR-PTI---------PSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1037 ------------~lr-p~i---------Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
... +.. ...++..+.+||.+||+.||.+|||+.+++++-+-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f 310 (331)
T 4aaa_A 248 HQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310 (331)
T ss_dssp HHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred hhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence 000 000 12468899999999999999999999999987654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=354.69 Aligned_cols=257 Identities=16% Similarity=0.172 Sum_probs=206.7
Q ss_pred ccCCeeEEEEecccCceEEEEeeec----------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeE
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWR----------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVA 877 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~r----------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVq 877 (1094)
..++|++.+.||+|+||.||+|++. +..||||++... ..+.+|+.++++++||||++
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------------~~~~~E~~~l~~l~h~niv~ 106 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------------GRLFNEQNFFQRAAKPLQVN 106 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------------STHHHHHHHHHHHCCHHHHH
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------------chHHHHHHHHHHhcccchhh
Confidence 4579999999999999999999874 567999998753 24678999999999999987
Q ss_pred ---------------EEeEeecCCCCceEEEeeecccchhHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHHCCceecc
Q 037285 878 ---------------FYGVVQDGPGGTLATVAEYMVDGSLRHVLVRK-DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFD 941 (1094)
Q Consensus 878 ---------------L~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~-~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRD 941 (1094)
+++++... ...+++||||+ +++|.+++... ...+++..++.++.||+.||.|||+++|+|||
T Consensus 107 ~~~~~~~~~~~~i~~~~~~~~~~-~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~D 184 (352)
T 2jii_A 107 KWKKLYSTPLLAIPTCMGFGVHQ-DKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGN 184 (352)
T ss_dssp HHHHHTTCTTCSCCCCCEEEEET-TTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSC
T ss_pred hhhhhccCCccCccchhhccccC-CcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCC
Confidence 56666542 34899999999 99999999865 35699999999999999999999999999999
Q ss_pred CCCCceEeccCCCCCC--cEEEEecCCcccccCcc--------ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHH
Q 037285 942 LKCDNLLVNLKDPSRP--ICKVGDFGLSKIKRNTL--------VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVL 1011 (1094)
Q Consensus 942 LKPeNILLD~~~~e~g--~VKLsDFGLSrl~~~~~--------~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLL 1011 (1094)
|||+|||++ .++ .+||+|||+++...... ......||+.|+|||++. ...++.++|||||||++
T Consensus 185 ikp~NIl~~----~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il 258 (352)
T 2jii_A 185 VTAENIFVD----PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHK--GCGPSRRSDLQSLGYCM 258 (352)
T ss_dssp CCGGGEEEE----TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHT--TCCCCHHHHHHHHHHHH
T ss_pred CCHHHEEEc----CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHc--cCCCCchhhHHHHHHHH
Confidence 999999998 566 89999999997543211 113346999999999998 45789999999999999
Q ss_pred HHHHcCCCCCCCCC-hHHHHHhHhh--ccCCCCCC------CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 037285 1012 WEILTGEEPYANMH-YGAIIGGIVN--NTLRPTIP------SYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAA 1082 (1094)
Q Consensus 1012 yELLTGk~PF~~~~-~~eile~Iv~--~~lrp~iP------e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~ 1082 (1094)
|+|++|+.||.... ....+..... ......+. ..++.++.+||.+||..||.+|||+.+|++.|+.+....
T Consensus 259 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 259 LKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL 338 (352)
T ss_dssp HHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence 99999999998764 2222222111 11111111 246899999999999999999999999999999998665
Q ss_pred hcC
Q 037285 1083 SQT 1085 (1094)
Q Consensus 1083 s~p 1085 (1094)
...
T Consensus 339 ~~~ 341 (352)
T 2jii_A 339 RVS 341 (352)
T ss_dssp TCC
T ss_pred CCC
Confidence 543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=365.61 Aligned_cols=256 Identities=25% Similarity=0.290 Sum_probs=189.0
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||+|+||.||+|+++ ++.||||++..... .......+.+|+.+|++++||||+++++++....
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 125 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE------DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKD 125 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTS------SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhc------CHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence 368999999999999999999774 68899999865321 1233467889999999999999999999985432
Q ss_pred ---CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEe
Q 037285 887 ---GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGD 963 (1094)
Q Consensus 887 ---~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsD 963 (1094)
...+|+||||+ +++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 126 ~~~~~~~~lv~e~~-~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~----~~~~~kl~D 199 (458)
T 3rp9_A 126 VEKFDELYVVLEIA-DSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVN----QDCSVKVCD 199 (458)
T ss_dssp TTTCCCEEEEECCC-SEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTCCEEECC
T ss_pred cccCceEEEEEecc-ccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEEC----CCCCEeecc
Confidence 24789999998 57899988654 4599999999999999999999999999999999999999 788999999
Q ss_pred cCCcccccCc----------------------------cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHH
Q 037285 964 FGLSKIKRNT----------------------------LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEIL 1015 (1094)
Q Consensus 964 FGLSrl~~~~----------------------------~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELL 1015 (1094)
||+++..... ......+||+.|+|||++.. ...++.++||||||||||||+
T Consensus 200 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~~DiwSlG~il~ell 278 (458)
T 3rp9_A 200 FGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL-QENYTEAIDVWSIGCIFAELL 278 (458)
T ss_dssp CTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTT-CCCCCTHHHHHHHHHHHHHHH
T ss_pred cccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhC-CCCCCcHhHHHHHHHHHHHHH
Confidence 9999854321 11234568999999998753 456899999999999999999
Q ss_pred c-----------CCCCCCCCCh--------------------HHHHHhHhh----------------------ccCC---
Q 037285 1016 T-----------GEEPYANMHY--------------------GAIIGGIVN----------------------NTLR--- 1039 (1094)
Q Consensus 1016 T-----------Gk~PF~~~~~--------------------~eile~Iv~----------------------~~lr--- 1039 (1094)
+ |+.+|.+... ...+..+.. ..+.
T Consensus 279 tg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~ 358 (458)
T 3rp9_A 279 NMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKRE 358 (458)
T ss_dssp TTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCC
T ss_pred HhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCC
Confidence 9 6677755431 111111100 0000
Q ss_pred ----CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1040 ----PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1040 ----p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
......++.++.+||.+||..||.+|||+.+++++-+-
T Consensus 359 ~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f 400 (458)
T 3rp9_A 359 GTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFF 400 (458)
T ss_dssp CCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred CCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhh
Confidence 00113458899999999999999999999999998654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=370.37 Aligned_cols=253 Identities=23% Similarity=0.324 Sum_probs=200.8
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||+|+||.||+|++. ++.||||++.... ........+.+|+.+|++++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~------~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 134 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF------QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 134 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG------GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc------cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCC
Confidence 478999999999999999999874 6789999997642 12333467889999999999999999999997542
Q ss_pred ----CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 887 ----GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 887 ----~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
...+++||||+.++ |.+.+.. .+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+
T Consensus 135 ~~~~~~~~~lv~E~~~~~-l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~----~~~~~kl~ 206 (464)
T 3ttj_A 135 TLEEFQDVYLVMELMDAN-LCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKIL 206 (464)
T ss_dssp STTTCCEEEEEEECCSEE-HHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCEEEC
T ss_pred ccccCCeEEEEEeCCCCC-HHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEe----CCCCEEEE
Confidence 23679999999765 5555533 389999999999999999999999999999999999999 78899999
Q ss_pred ecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCC--
Q 037285 963 DFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP-- 1040 (1094)
Q Consensus 963 DFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp-- 1040 (1094)
|||+++............||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..++.....+
T Consensus 207 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~ 284 (464)
T 3ttj_A 207 DFGLARTAGTSFMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 284 (464)
T ss_dssp CCCCC-----CCCC----CCCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred EEEeeeecCCCcccCCCcccccccCHHHHcC--CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 9999987655544556779999999999984 578899999999999999999999999988766655543321100
Q ss_pred ------------------CC---------CCc-----------CcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1041 ------------------TI---------PSY-----------CDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1041 ------------------~i---------Pe~-----------~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
.. +.. .+.++.+||.+||..||.+|||+.+++++-+-
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~ 359 (464)
T 3ttj_A 285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359 (464)
T ss_dssp HHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred HHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhh
Confidence 00 000 15678999999999999999999999987643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=352.14 Aligned_cols=257 Identities=23% Similarity=0.318 Sum_probs=210.2
Q ss_pred cCCeeEE-EEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-CCceeEEEeEeec
Q 037285 809 NEDLEEQ-KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HPNVVAFYGVVQD 884 (1094)
Q Consensus 809 ~edYei~-kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-HPNIVqL~Gv~~d 884 (1094)
.+.|.+. +.||+|+||.||+|++. ++.||||++...... ......+.+|+.+++++. ||||+++++++..
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~ 100 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG------QDCRAEILHEIAVLELAKSCPRVINLHEVYEN 100 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETT------EECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc------hHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence 3567776 89999999999999885 788999999764321 112356889999999995 6999999999987
Q ss_pred CCCCceEEEeeecccchhHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEe
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRK-DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGD 963 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~-~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsD 963 (1094)
.. .+++||||+.+|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++... ..+.+||+|
T Consensus 101 ~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~-~~~~~kL~D 177 (327)
T 3lm5_A 101 TS--EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIY-PLGDIKIVD 177 (327)
T ss_dssp SS--EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBT-TBCCEEECC
T ss_pred CC--eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCC-CCCcEEEee
Confidence 55 899999999999999998543 35689999999999999999999999999999999999998321 267899999
Q ss_pred cCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCC--CC
Q 037285 964 FGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR--PT 1041 (1094)
Q Consensus 964 FGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lr--p~ 1041 (1094)
||+++............||+.|+|||++. ...++.++|||||||++|+|++|+.||......+....+...... ..
T Consensus 178 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 255 (327)
T 3lm5_A 178 FGMSRKIGHACELREIMGTPEYLAPEILN--YDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEE 255 (327)
T ss_dssp GGGCEEC---------CCCGGGCCHHHHT--TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred CccccccCCccccccccCCcCccCCeeec--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCch
Confidence 99998665544445567999999999998 557889999999999999999999999998887776665544332 33
Q ss_pred CCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1042 iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
....++..+.+||.+||+.||.+|||+.+++++.+
T Consensus 256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~ 290 (327)
T 3lm5_A 256 TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSW 290 (327)
T ss_dssp TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGG
T ss_pred hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHh
Confidence 34578999999999999999999999999998755
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=361.73 Aligned_cols=256 Identities=14% Similarity=0.056 Sum_probs=189.3
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC--CCCceeEEE-----
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL--HHPNVVAFY----- 879 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL--~HPNIVqL~----- 879 (1094)
..+|++.+.||+|+||.||+|++. ++.||||++...... .......+.+|+.+++.| +||||++++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~ 135 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAEN-----SRSELERLHEATFAAARLLGESPEEARDRRRLLL 135 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTT-----HHHHHHHHHHHHHHHHHHHC----------CBCC
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccc-----cccHHHHHHHHHHHHHHhcccChhhhhhceeEEe
Confidence 346999999999999999999974 678999999875321 233345667775444444 699988865
Q ss_pred --eEeecCCC---------------CceEEEeeecccchhHHHHhhcccccCHHHH------HHHHHHHHHHHHHHHHCC
Q 037285 880 --GVVQDGPG---------------GTLATVAEYMVDGSLRHVLVRKDRFLDRRRR------LIIAMDAAFGMEYLHSKN 936 (1094)
Q Consensus 880 --Gv~~d~~~---------------~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~------l~Ia~QIaeGLaYLHs~G 936 (1094)
+++..... ..+++||||+. |+|.+++...+..+.+..+ +.|+.||+.||+|||++|
T Consensus 136 p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ 214 (371)
T 3q60_A 136 PSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG 214 (371)
T ss_dssp CCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC
Confidence 34432211 24899999998 9999999876555666666 788899999999999999
Q ss_pred ceeccCCCCceEeccCCCCCCcEEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc
Q 037285 937 IVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT 1016 (1094)
Q Consensus 937 IIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT 1016 (1094)
|+||||||+|||++ .++.+||+|||+++....... ...+|+.|+|||++.+....++.++|||||||+||+|+|
T Consensus 215 ivHrDikp~NIll~----~~~~~kL~DFG~a~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 215 LVHGHFTPDNLFIM----PDGRLMLGDVSALWKVGTRGP--ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp EEETTCSGGGEEEC----TTSCEEECCGGGEEETTCEEE--GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred CccCcCCHHHEEEC----CCCCEEEEecceeeecCCCcc--CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 99999999999999 778999999999986544332 345779999999997433678999999999999999999
Q ss_pred CCCCCCCCChHHHH--H-----hHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1017 GEEPYANMHYGAII--G-----GIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1017 Gk~PF~~~~~~eil--e-----~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
|+.||......... . ..............++..+.+||.+||+.||++|||+.+++++-+
T Consensus 289 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 355 (371)
T 3q60_A 289 LFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE 355 (371)
T ss_dssp SSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHH
T ss_pred CCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHH
Confidence 99999876432110 0 000112222233578999999999999999999999999987544
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=336.52 Aligned_cols=250 Identities=25% Similarity=0.392 Sum_probs=199.1
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC-
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP- 886 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~- 886 (1094)
++|++.+.||+|+||.||+|++. +..||||++... ......+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 76 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---------EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRN 76 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCC
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---------HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcc
Confidence 57999999999999999999874 788999998642 223467889999999999999999999886531
Q ss_pred ----------CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCC
Q 037285 887 ----------GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSR 956 (1094)
Q Consensus 887 ----------~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~ 956 (1094)
...+++||||+.+++|.+++......+++..++.++.||+.||+|||+++|+||||||+|||++ .+
T Consensus 77 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~----~~ 152 (303)
T 1zy4_A 77 FVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID----ES 152 (303)
T ss_dssp CCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TT
T ss_pred hhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEc----CC
Confidence 3478999999999999999987766788999999999999999999999999999999999998 77
Q ss_pred CcEEEEecCCcccccCc---------------cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 037285 957 PICKVGDFGLSKIKRNT---------------LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1021 (1094)
Q Consensus 957 g~VKLsDFGLSrl~~~~---------------~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF 1021 (1094)
+.+||+|||+++..... .......||+.|+|||++.+ ...++.++|||||||++|+|++ ||
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~---p~ 228 (303)
T 1zy4_A 153 RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG-TGHYNEKIDMYSLGIIFFEMIY---PF 228 (303)
T ss_dssp SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTS-CSCCCTHHHHHHHHHHHHHHHS---CC
T ss_pred CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccC-CCCCcchhhHHHHHHHHHHHHh---cc
Confidence 88999999999754321 12234568999999999874 3468899999999999999998 55
Q ss_pred CCCC-hHHHHHhHhhc--cCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1022 ANMH-YGAIIGGIVNN--TLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1022 ~~~~-~~eile~Iv~~--~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
.... .......+... .+.+.++..++..+.+||.+||+.||.+|||+.+++++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (303)
T 1zy4_A 229 STGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGW 286 (303)
T ss_dssp SSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSC
T ss_pred CCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCC
Confidence 4322 22333333222 2334455667888999999999999999999999998644
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=340.33 Aligned_cols=258 Identities=23% Similarity=0.386 Sum_probs=192.3
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEe
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVV 882 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~ 882 (1094)
+.+..++|++.+.||+|+||.||+|+++ +..||||++..... .+.....+..+..+++.++||||+++++++
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~ 93 (318)
T 2dyl_A 20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN------KEENKRILMDLDVVLKSHDCPYIVQCFGTF 93 (318)
T ss_dssp EECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC------HHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred hhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc------chHHHHHHHHHHHHHHhcCCCceeeEEEEE
Confidence 4556789999999999999999999985 78899999976421 122223344555678888999999999999
Q ss_pred ecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeccCCCCCCcEEE
Q 037285 883 QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPSRPICKV 961 (1094)
Q Consensus 883 ~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~-GIIHRDLKPeNILLD~~~~e~g~VKL 961 (1094)
.... .+++||||+ ++.+..++......+++..++.++.||+.||.|||++ ||+||||||+|||++ .++.+||
T Consensus 94 ~~~~--~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~----~~~~~kl 166 (318)
T 2dyl_A 94 ITNT--DVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD----ERGQIKL 166 (318)
T ss_dssp ECSS--EEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEEC----TTSCEEE
T ss_pred ecCC--cEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEEC----CCCCEEE
Confidence 8765 899999999 5666666665556799999999999999999999995 999999999999998 7789999
Q ss_pred EecCCcccccCccccCCccCCCcccCcccccc---CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-hHHHHHhHhhcc
Q 037285 962 GDFGLSKIKRNTLVSGGVRGTLPWMAPELLSG---SSSKVSEKVDVFSFGIVLWEILTGEEPYANMH-YGAIIGGIVNNT 1037 (1094)
Q Consensus 962 sDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g---~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~-~~eile~Iv~~~ 1037 (1094)
+|||+++............+|+.|+|||++.+ ....++.++|||||||++|+|++|+.||.... ..+....+...
T Consensus 167 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~- 245 (318)
T 2dyl_A 167 CDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE- 245 (318)
T ss_dssp CCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHS-
T ss_pred EECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhcc-
Confidence 99999975544333444568999999999853 14467889999999999999999999998744 34444444333
Q ss_pred CCCCCC--CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1038 LRPTIP--SYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1038 lrp~iP--e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
..+..+ ..++.++.+||.+||+.||.+||++.+|+++.+
T Consensus 246 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (318)
T 2dyl_A 246 EPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSF 286 (318)
T ss_dssp CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred CCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHH
Confidence 233333 357899999999999999999999999998654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=350.43 Aligned_cols=258 Identities=17% Similarity=0.194 Sum_probs=207.0
Q ss_pred ceeeccCCeeEEEEecccCceEEEEeee-------cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC---CC
Q 037285 804 VQVIKNEDLEEQKELGSGTFGTVYHGKW-------RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH---HP 873 (1094)
Q Consensus 804 v~eIs~edYei~kkLGsG~FGtVYKAk~-------rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~---HP 873 (1094)
...+..++|++.++||+|+||.||+|.+ .+..||||++.... ..++.+|+.++++++ |+
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~~~~l~~~~~~ 127 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----------PWEFYIGTQLMERLKPSMQH 127 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----------HHHHHHHHHHHHHSCGGGGG
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----------hhHHHHHHHHHHHhhhhhhh
Confidence 4567778999999999999999999942 36789999987531 235677888888887 99
Q ss_pred ceeEEEeEeecCCCCceEEEeeecccchhHHHHhh----cccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEe
Q 037285 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVR----KDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV 949 (1094)
Q Consensus 874 NIVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k----~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILL 949 (1094)
||+++++++.... ..++||||+.+|+|.+++.. ....+++..++.|+.||+.||+|||+++|+||||||+|||+
T Consensus 128 ~iv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll 205 (365)
T 3e7e_A 128 MFMKFYSAHLFQN--GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFIL 205 (365)
T ss_dssp GBCCEEEEEECSS--CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE
T ss_pred hhhhhheeeecCC--CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEe
Confidence 9999999998765 88999999999999999975 23569999999999999999999999999999999999999
Q ss_pred ccC-------CCCCCcEEEEecCCcccc---cCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCC
Q 037285 950 NLK-------DPSRPICKVGDFGLSKIK---RNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEE 1019 (1094)
Q Consensus 950 D~~-------~~e~g~VKLsDFGLSrl~---~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~ 1019 (1094)
+.. ....+.+||+|||+++.. .........+||+.|+|||++.+ ..++.++|||||||++|||+||+.
T Consensus 206 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~ 283 (365)
T 3e7e_A 206 GNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN--KPWNYQIDYFGVAATVYCMLFGTY 283 (365)
T ss_dssp CGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT--CCBSTHHHHHHHHHHHHHHHHSSC
T ss_pred cccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC--CCCCccccHHHHHHHHHHHHhCCC
Confidence 830 112789999999999743 23333455679999999999984 558999999999999999999999
Q ss_pred CCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCC-CCHHHHHHHHHHHHHHh
Q 037285 1020 PYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAAR-PSFTEIASRLRVLSTAA 1082 (1094)
Q Consensus 1020 PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeR-PS~eELLq~L~~L~ta~ 1082 (1094)
||........ .....+ .....+..+.+++.+||+.+|.+| |++.++.+.|..+....
T Consensus 284 pf~~~~~~~~---~~~~~~---~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 284 MKVKNEGGEC---KPEGLF---RRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp CCEEEETTEE---EECSCC---TTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ccccCCCCce---eechhc---cccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 9965432110 001111 111346789999999999999999 58899999998887553
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=354.24 Aligned_cols=250 Identities=24% Similarity=0.323 Sum_probs=185.9
Q ss_pred CeeEE---EEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-CCceeEEEeEeec
Q 037285 811 DLEEQ---KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HPNVVAFYGVVQD 884 (1094)
Q Consensus 811 dYei~---kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-HPNIVqL~Gv~~d 884 (1094)
+|++. +.||+|+||.||+|+++ ++.||||++.+. ....+.+|+.+++++. ||||+++++++.+
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~ 77 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----------MEANTQKEITALKLCEGHPNIVKLHEVFHD 77 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----------GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc
Confidence 45543 78999999999999985 678999998653 1245678999999997 9999999999987
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
.. .+++||||+.+|+|.+++.... .+++..++.++.||+.||.|||+++|+||||||+|||++..+ ....+||+||
T Consensus 78 ~~--~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~-~~~~~kl~Df 153 (325)
T 3kn6_A 78 QL--HTFLVMELLNGGELFERIKKKK-HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDEN-DNLEIKIIDF 153 (325)
T ss_dssp SS--EEEEEECCCCSCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC-----CEEEECCC
T ss_pred CC--EEEEEEEccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCC-CcccEEEecc
Confidence 65 8999999999999999997654 599999999999999999999999999999999999997322 3448999999
Q ss_pred CCcccccC-ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh-------HHHHHhHhhc
Q 037285 965 GLSKIKRN-TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY-------GAIIGGIVNN 1036 (1094)
Q Consensus 965 GLSrl~~~-~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~-------~eile~Iv~~ 1036 (1094)
|+++.... .......++|+.|+|||++. ...++.++|||||||++|+|++|+.||..... .+....+...
T Consensus 154 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~ 231 (325)
T 3kn6_A 154 GFARLKPPDNQPLKTPCFTLHYAAPELLN--QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG 231 (325)
T ss_dssp TTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT
T ss_pred ccceecCCCCCcccccCCCcCccCHHHhc--CCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC
Confidence 99985432 22234456899999999997 45789999999999999999999999986433 3444444433
Q ss_pred cCCCCC--CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1037 TLRPTI--PSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1037 ~lrp~i--Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
...... ...++.++.+||.+||..||.+|||+.+++++-+-
T Consensus 232 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~ 274 (325)
T 3kn6_A 232 DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWL 274 (325)
T ss_dssp CCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGG
T ss_pred CCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhh
Confidence 332111 13578999999999999999999999999977554
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=385.75 Aligned_cols=254 Identities=24% Similarity=0.367 Sum_probs=217.4
Q ss_pred eeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEe
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVV 882 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~ 882 (1094)
.+..++|++.+.||+|+||.||+|+++ ++.||||++++.... .......+..|..+|..+ +||+|+++++++
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~-----~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~ 411 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI-----QDDDVECTMVEKRVLALPGKPPFLTQLHSCF 411 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHH-----HTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccc-----cHHHHHHHHHHHHHHHhccCCCeEEEEEEEE
Confidence 456689999999999999999999985 567999999864211 122235677899999887 799999999999
Q ss_pred ecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 883 QDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 883 ~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
.+.. .+|+||||+.+|+|..++...+ .+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+
T Consensus 412 ~~~~--~~~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~----~~g~ikL~ 484 (674)
T 3pfq_A 412 QTMD--RLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD----SEGHIKIA 484 (674)
T ss_dssp BCSS--EEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEEC----SSSCEEEC
T ss_pred EeCC--EEEEEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEc----CCCcEEEe
Confidence 8755 8999999999999999997765 489999999999999999999999999999999999999 78899999
Q ss_pred ecCCcccc-cCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCC
Q 037285 963 DFGLSKIK-RNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT 1041 (1094)
Q Consensus 963 DFGLSrl~-~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~ 1041 (1094)
|||+++.. .........+||+.|+|||++. ...++.++|||||||+||||++|+.||...+..++...+.... ..
T Consensus 485 DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~--~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~~ 560 (674)
T 3pfq_A 485 DFGMCKENIWDGVTTKTFCGTPDYIAPEIIA--YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--VA 560 (674)
T ss_dssp CCTTCEECCCTTCCBCCCCSCSSSCCHHHHT--CCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC--CC
T ss_pred ecceeeccccCCcccccccCCCcccCHhhhc--CCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC--CC
Confidence 99999853 2333445678999999999998 4578999999999999999999999999998888888887654 35
Q ss_pred CCCcCcHHHHHHHHHhccCCCCCCCCH-----HHHHHHH
Q 037285 1042 IPSYCDAEWRTLMEECWAPNPAARPSF-----TEIASRL 1075 (1094)
Q Consensus 1042 iPe~~S~eL~dLI~kCLq~DPeeRPS~-----eELLq~L 1075 (1094)
+|..++.++.+||.+||..||.+||++ .+|+++-
T Consensus 561 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ 599 (674)
T 3pfq_A 561 YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 599 (674)
T ss_dssp CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSG
T ss_pred CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCc
Confidence 778899999999999999999999987 7887653
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=364.19 Aligned_cols=249 Identities=13% Similarity=0.057 Sum_probs=193.1
Q ss_pred ccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHH---HHHhhCCCCceeEEE---
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEA---EILSKLHHPNVVAFY--- 879 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEI---kILkrL~HPNIVqL~--- 879 (1094)
..++|++.+.||+|+||.||+|++. |+.||||++....... ......+.+|+ .+|++++|||||+++
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~ 145 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP-----SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 145 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CC-----TTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCB
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccc-----hHHHHHHHHHHHHHHhccccCCHHHHHHHhhh
Confidence 3568999999999999999999874 7899999998643222 12345688899 555566899999998
Q ss_pred ----eEeecCCC----------C-----ceEEEeeecccchhHHHHhhccc------ccCHHHHHHHHHHHHHHHHHHHH
Q 037285 880 ----GVVQDGPG----------G-----TLATVAEYMVDGSLRHVLVRKDR------FLDRRRRLIIAMDAAFGMEYLHS 934 (1094)
Q Consensus 880 ----Gv~~d~~~----------~-----~L~IVmEYmegGSL~d~L~k~~~------~Lse~~~l~Ia~QIaeGLaYLHs 934 (1094)
+++..... . ..++||||+ +|+|.+++..... .+++..++.|+.||+.||+|||+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 224 (377)
T 3byv_A 146 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 224 (377)
T ss_dssp CCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence 55554311 0 278999999 6899999976532 23358888999999999999999
Q ss_pred CCceeccCCCCceEeccCCCCCCcEEEEecCCcccccCccccCCccCCCcccCccccccC---------CCCCCchhhHH
Q 037285 935 KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGS---------SSKVSEKVDVF 1005 (1094)
Q Consensus 935 ~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~---------~~kyS~KSDVW 1005 (1094)
+||+||||||+|||++ .++.+||+|||+++..... .....| +.|+|||++.+. ...++.++|||
T Consensus 225 ~~ivHrDikp~NIll~----~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dvw 297 (377)
T 3byv_A 225 YGLVHTYLRPVDIVLD----QRGGVFLTGFEHLVRDGAR--VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAW 297 (377)
T ss_dssp TTEECSCCCGGGEEEC----TTCCEEECCGGGCEETTCE--EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHH
T ss_pred CCeecCCCCHHHEEEc----CCCCEEEEechhheecCCc--ccCCCC-cCccChhhhcccccccccccccccCChhhhHH
Confidence 9999999999999999 6789999999999864432 234557 999999999842 01689999999
Q ss_pred HHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037285 1006 SFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1006 SLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L 1075 (1094)
||||++|||++|+.||...........+.. ....++.++.+||.+||..||.+|||+.+++++-
T Consensus 298 SlG~il~elltg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp 361 (377)
T 3byv_A 298 ALGLVIYWIWCADLPITKDAALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETP 361 (377)
T ss_dssp HHHHHHHHHHHSSCCC------CCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSH
T ss_pred HHHHHHHHHHHCCCCCcccccccchhhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhCh
Confidence 999999999999999987654433333221 2357789999999999999999999999999743
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=340.56 Aligned_cols=255 Identities=27% Similarity=0.335 Sum_probs=205.9
Q ss_pred cCCeeEEEEecccCceEEEEeeec---CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC---CCCceeEEEeEe
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR---GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL---HHPNVVAFYGVV 882 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r---Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL---~HPNIVqL~Gv~ 882 (1094)
.++|++.+.||+|+||.||+|++. +..||||++......... ...+.+|+.+++++ +||||+++++++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~e~~~l~~l~~~~h~~i~~~~~~~ 83 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM------PLSTIREVAVLRHLETFEHPNVVRLFDVC 83 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC------BCTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccC------CchhhHHHHHHHhhhccCCCCeEeeeeee
Confidence 468999999999999999999873 577999999764322111 12344666666655 899999999998
Q ss_pred ec---CCCCceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCc
Q 037285 883 QD---GPGGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPI 958 (1094)
Q Consensus 883 ~d---~~~~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~ 958 (1094)
.. .....+++||||+. |+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.
T Consensus 84 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~----~~~~ 158 (326)
T 1blx_A 84 TVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT----SSGQ 158 (326)
T ss_dssp EEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTCC
T ss_pred eecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEc----CCCC
Confidence 62 12347899999997 69999987653 3489999999999999999999999999999999999998 7789
Q ss_pred EEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccC
Q 037285 959 CKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 1038 (1094)
Q Consensus 959 VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~l 1038 (1094)
+||+|||+++............+|..|+|||++. ...++.++|||||||++|+|++|+.||........+..+.....
T Consensus 159 ~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (326)
T 1blx_A 159 IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL--QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236 (326)
T ss_dssp EEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHT--TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EEEecCcccccccCCCCccccccccceeCHHHHh--cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcC
Confidence 9999999998655444445567899999999998 45688999999999999999999999998887766655543110
Q ss_pred C-------------------------CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1039 R-------------------------PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1039 r-------------------------p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
. ..+...++..+.+||.+||..||.+|||+.+++++-+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 299 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 0 1123467899999999999999999999999997643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=339.52 Aligned_cols=260 Identities=23% Similarity=0.310 Sum_probs=211.6
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeec-CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC--CCceeEEEeE
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH--HPNVVAFYGV 881 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~r-Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~--HPNIVqL~Gv 881 (1094)
..+...+|++.+.||+|+||.||++++. +..||||++..... .......+.+|+.++++++ |+||++++++
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA------DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSC------CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccc------cccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 4567788999999999999999999875 67799999975421 1233467889999999997 5999999999
Q ss_pred eecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEE
Q 037285 882 VQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKV 961 (1094)
Q Consensus 882 ~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKL 961 (1094)
+.... .+++||| +.+++|.+++.... .+++..++.++.||+.||.|||+++|+||||||+|||++ ++.+||
T Consensus 97 ~~~~~--~~~lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-----~~~~kL 167 (313)
T 3cek_A 97 EITDQ--YIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-----DGMLKL 167 (313)
T ss_dssp EECSS--EEEEEEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-----TTEEEE
T ss_pred eecCC--EEEEEEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-----CCeEEE
Confidence 98765 8999999 66899999997654 589999999999999999999999999999999999997 378999
Q ss_pred EecCCcccccCcc---ccCCccCCCcccCccccccC---------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh-HH
Q 037285 962 GDFGLSKIKRNTL---VSGGVRGTLPWMAPELLSGS---------SSKVSEKVDVFSFGIVLWEILTGEEPYANMHY-GA 1028 (1094)
Q Consensus 962 sDFGLSrl~~~~~---~ss~~~GT~~YmAPEvL~g~---------~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~-~e 1028 (1094)
+|||+++...... ......||+.|+|||++.+. ...++.++|||||||++|+|++|+.||..... ..
T Consensus 168 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (313)
T 3cek_A 168 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 247 (313)
T ss_dssp CCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH
T ss_pred eeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH
Confidence 9999998543221 22345689999999998741 14688999999999999999999999987543 34
Q ss_pred HHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1029 IIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1029 ile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
....+........++..++..+.++|.+||+.||.+||++.+++++.+-..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~ 298 (313)
T 3cek_A 248 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298 (313)
T ss_dssp HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred HHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence 445555556666778888999999999999999999999999999876543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=359.10 Aligned_cols=256 Identities=22% Similarity=0.288 Sum_probs=198.0
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||+|+||.||+|+++ +..||||++.... ........+.+|+.+|++++||||+++++++....
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 98 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF------EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDD 98 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT------TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh------cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence 468999999999999999999875 6779999997532 11233467889999999999999999999987642
Q ss_pred C---CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEe
Q 037285 887 G---GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGD 963 (1094)
Q Consensus 887 ~---~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsD 963 (1094)
. ..+|+||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 99 ~~~~~~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~----~~~~~kL~D 172 (432)
T 3n9x_A 99 LLKFDELYIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLN----QDCSVKVCD 172 (432)
T ss_dssp TTTCCCEEEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEECC
T ss_pred CCcCCeEEEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEEC----CCCCEEEcc
Confidence 1 46899999986 6999998654 4589999999999999999999999999999999999998 788999999
Q ss_pred cCCcccccCcc-----------------------ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCC
Q 037285 964 FGLSKIKRNTL-----------------------VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEP 1020 (1094)
Q Consensus 964 FGLSrl~~~~~-----------------------~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~P 1020 (1094)
||+++...... .....+||+.|+|||++.. ...++.++|||||||++|||++|..|
T Consensus 173 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~~DiwSlG~il~ell~g~~p 251 (432)
T 3n9x_A 173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL-QENYTKSIDIWSTGCIFAELLNMLQS 251 (432)
T ss_dssp CTTCEEC-------------------------------CCCCCTTCCHHHHTT-CSCCCTHHHHHHHHHHHHHHHTTCTT
T ss_pred CCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhc-CCCCCcccccchHHHHHHHHHhcccc
Confidence 99998543221 1245679999999998753 45689999999999999999985444
Q ss_pred -----------CCCCCh-----------------HHHHHhHh-----------------------hc-cCCCCC-----C
Q 037285 1021 -----------YANMHY-----------------GAIIGGIV-----------------------NN-TLRPTI-----P 1043 (1094)
Q Consensus 1021 -----------F~~~~~-----------------~eile~Iv-----------------------~~-~lrp~i-----P 1043 (1094)
|.+... ...+..+. .. ...... .
T Consensus 252 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (432)
T 3n9x_A 252 HINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKY 331 (432)
T ss_dssp TCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHS
T ss_pred cccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHC
Confidence 433220 11111110 00 000000 1
Q ss_pred CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1044 SYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1044 e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
..+++++.+||.+||..||.+|||+.+++++-+-
T Consensus 332 ~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f 365 (432)
T 3n9x_A 332 PSISDDGINLLESMLKFNPNKRITIDQALDHPYL 365 (432)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGG
T ss_pred CCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhh
Confidence 3578999999999999999999999999987553
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=336.94 Aligned_cols=254 Identities=25% Similarity=0.332 Sum_probs=200.9
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC-
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG- 885 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~- 885 (1094)
.++|++.+.||+|+||.||+|++. ++.||||++.... ......+.+|+.++++++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 81 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--------PQSVKHALREIKIIRRLDHDNIVKVFEILGPSG 81 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS--------HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTS
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC--------hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccc
Confidence 478999999999999999999885 6889999986431 23346788999999999999999999987432
Q ss_pred -----------CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCC
Q 037285 886 -----------PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP 954 (1094)
Q Consensus 886 -----------~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~ 954 (1094)
....+++||||+. |+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--- 155 (320)
T 2i6l_A 82 SQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--- 155 (320)
T ss_dssp CBCCC----CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET---
T ss_pred cccccccccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC---
Confidence 2347899999997 699999864 35899999999999999999999999999999999999972
Q ss_pred CCCcEEEEecCCcccccCc----cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 037285 955 SRPICKVGDFGLSKIKRNT----LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAII 1030 (1094)
Q Consensus 955 e~g~VKLsDFGLSrl~~~~----~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eil 1030 (1094)
.++.+||+|||+++..... .......+|..|+|||++.+ ...++.++|||||||++|+|++|+.||......+..
T Consensus 156 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 234 (320)
T 2i6l_A 156 EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM 234 (320)
T ss_dssp TTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHC-TTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCeEEEccCccccccCCCcccccccccccccccccCcHHhcC-cccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 4568999999999854321 12233457899999999864 356899999999999999999999999988776655
Q ss_pred HhHhhccCC-----------------------C-----CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1031 GGIVNNTLR-----------------------P-----TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1031 e~Iv~~~lr-----------------------p-----~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
..+...... + .....++.++.+||.+||+.||.+|||+.+++++-+-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 309 (320)
T 2i6l_A 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309 (320)
T ss_dssp HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHH
T ss_pred HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccc
Confidence 544332110 0 0124578999999999999999999999999987654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=362.05 Aligned_cols=251 Identities=25% Similarity=0.272 Sum_probs=200.8
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC--
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG-- 885 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~-- 885 (1094)
.+|++.+.||+|+||.||+|+++ +..||||++..... .+.+|+.+|++|+||||++++++|...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------------~~~~E~~il~~l~hpniv~l~~~~~~~~~ 121 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------FKNRELQIMRKLDHCNIVRLRYFFYSSGE 121 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------------SCCHHHHHHHTCCCTTBCCEEEEEEEEET
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------------hHHHHHHHHHHcCCCCccceeeEEeccCC
Confidence 47999999999999999999984 78899999865321 123689999999999999999988532
Q ss_pred --CCCceEEEeeecccchhHHHHh---hcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEE
Q 037285 886 --PGGTLATVAEYMVDGSLRHVLV---RKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICK 960 (1094)
Q Consensus 886 --~~~~L~IVmEYmegGSL~d~L~---k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VK 960 (1094)
....+++||||+.+ +|.+.+. .....+++..++.++.||+.||+|||++||+||||||+|||++. +.+.+|
T Consensus 122 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~---~~~~~k 197 (420)
T 1j1b_A 122 KKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP---DTAVLK 197 (420)
T ss_dssp TTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEET---TTTEEE
T ss_pred CCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeC---CCCeEE
Confidence 12247899999976 5555443 23456999999999999999999999999999999999999982 345789
Q ss_pred EEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhcc---
Q 037285 961 VGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT--- 1037 (1094)
Q Consensus 961 LsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~--- 1037 (1094)
|+|||+++............+|+.|+|||++.+ ...++.++|||||||+||||++|+.||......+.+..++...
T Consensus 198 l~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p 276 (420)
T 1j1b_A 198 LCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG-ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 276 (420)
T ss_dssp ECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTT-CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred eccchhhhhcccCCCceeeeeCCCcCCHHHHcC-CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999999986544433445678999999999874 3468899999999999999999999999887666555443310
Q ss_pred -----------C-CCC------------CCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1038 -----------L-RPT------------IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1038 -----------l-rp~------------iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
+ ... ++..++.++.+||.+||..||.+|||+.+++++-+-
T Consensus 277 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f 340 (420)
T 1j1b_A 277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340 (420)
T ss_dssp CHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred CHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhh
Confidence 0 001 234568899999999999999999999999987554
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=351.08 Aligned_cols=256 Identities=20% Similarity=0.218 Sum_probs=196.8
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC--------CCcee
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH--------HPNVV 876 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~--------HPNIV 876 (1094)
+..++|++.++||+|+||.||+|++. ++.||||++... ......+.+|+.+|++++ |+||+
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv 104 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---------EHYTETALDEIRLLKSVRNSDPNDPNREMVV 104 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---------HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBC
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---------CcchHHHHHHHHHHHHHhhcCCCCCCcceee
Confidence 44679999999999999999999874 678999998643 223456788999999985 78899
Q ss_pred EEEeEeecC--CCCceEEEeeecccchhHHHHh-hcccccCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeccC
Q 037285 877 AFYGVVQDG--PGGTLATVAEYMVDGSLRHVLV-RKDRFLDRRRRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLK 952 (1094)
Q Consensus 877 qL~Gv~~d~--~~~~L~IVmEYmegGSL~d~L~-k~~~~Lse~~~l~Ia~QIaeGLaYLHs~-GIIHRDLKPeNILLD~~ 952 (1094)
++++++... ....+++||||+ +++|.+++. .....+++..++.++.||+.||.|||++ ||+||||||+|||++.+
T Consensus 105 ~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~ 183 (397)
T 1wak_A 105 QLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVN 183 (397)
T ss_dssp CEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCC
T ss_pred eeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEecc
Confidence 999998721 234799999999 455555554 4335699999999999999999999998 99999999999999832
Q ss_pred CC---------------------------------------------CCCcEEEEecCCcccccCccccCCccCCCcccC
Q 037285 953 DP---------------------------------------------SRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMA 987 (1094)
Q Consensus 953 ~~---------------------------------------------e~g~VKLsDFGLSrl~~~~~~ss~~~GT~~YmA 987 (1094)
+. ....+||+|||+++..... .....||+.|+|
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~a 261 (397)
T 1wak_A 184 EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRS 261 (397)
T ss_dssp HHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCC
T ss_pred chhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccC
Confidence 10 1137999999999865433 234568999999
Q ss_pred ccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh------HHHHHhHhhc------------cC-----------
Q 037285 988 PELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY------GAIIGGIVNN------------TL----------- 1038 (1094)
Q Consensus 988 PEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~------~eile~Iv~~------------~l----------- 1038 (1094)
||++. ...++.++|||||||+||+|+||+.||..... ...+..+... .+
T Consensus 262 PE~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 339 (397)
T 1wak_A 262 LEVLI--GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDL 339 (397)
T ss_dssp HHHHH--TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSB
T ss_pred Chhhc--CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccc
Confidence 99998 45688999999999999999999999976542 1111111110 00
Q ss_pred -----------------CCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1039 -----------------RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1039 -----------------rp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
....+..++..+.+||.+||+.||++|||+.+++++-+
T Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 394 (397)
T 1wak_A 340 KHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPW 394 (397)
T ss_dssp SSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGG
T ss_pred ccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcc
Confidence 00112334567899999999999999999999998643
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=350.39 Aligned_cols=253 Identities=23% Similarity=0.303 Sum_probs=197.2
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
..+|++.+.||+|+||.||+|+.. +..||||++..... .......+.+|+.++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 97 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ------NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK 97 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS------SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC------ChHHHHHHHHHHHHHHhcCCCCccceEEeecccc
Confidence 468999999999999999999874 67899999975421 1233467889999999999999999999997642
Q ss_pred ----CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 887 ----GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 887 ----~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
...+++||||+. ++|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 98 ~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~----~~~~~kl~ 169 (371)
T 2xrw_A 98 SLEEFQDVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKIL 169 (371)
T ss_dssp STTTCCEEEEEEECCS-EEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTSCEEEC
T ss_pred ccccccceEEEEEcCC-CCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc----CCCCEEEE
Confidence 136899999996 568777742 489999999999999999999999999999999999998 77899999
Q ss_pred ecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCC---
Q 037285 963 DFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR--- 1039 (1094)
Q Consensus 963 DFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lr--- 1039 (1094)
|||+++............||+.|+|||++. ...++.++|||||||++|+|++|+.||........+..+......
T Consensus 170 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 247 (371)
T 2xrw_A 170 DFGLARTAGTSFMMTPYVVTRYYRAPEVIL--GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 247 (371)
T ss_dssp CCCC----------------CTTCCHHHHT--TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCH
T ss_pred EeecccccccccccCCceecCCccCHHHhc--CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 999998655443444567999999999998 456889999999999999999999999988776665555432111
Q ss_pred -----------------CCC--------------CC------cCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1040 -----------------PTI--------------PS------YCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1040 -----------------p~i--------------Pe------~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
+.+ +. ..+..+.+||.+||..||.+|||+.+++++-+-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~ 322 (371)
T 2xrw_A 248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 322 (371)
T ss_dssp HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcch
Confidence 000 00 125678999999999999999999999998764
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=340.25 Aligned_cols=253 Identities=21% Similarity=0.242 Sum_probs=203.4
Q ss_pred eccCCeeEEEEecccCceEEEEeee---cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCC------ceeE
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKW---RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP------NVVA 877 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~---rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HP------NIVq 877 (1094)
+..++|++.+.||+|+||.||+|.+ .+..||||+++.. ......+.+|+.++++++|+ +|++
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~ 81 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---------DRYCEAARSEIQVLEHLNTTDPNSTFRCVQ 81 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---------HHHHHHHHHHHHHHHHHHHHCTTCTTCBCC
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---------CchhHHHHHHHHHHHHhhhcCCCCceeeEe
Confidence 3457999999999999999999976 3678999998642 22345677899999888765 4999
Q ss_pred EEeEeecCCCCceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCC-
Q 037285 878 FYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPS- 955 (1094)
Q Consensus 878 L~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e- 955 (1094)
+++++.... .+++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++..+..
T Consensus 82 ~~~~~~~~~--~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~ 158 (339)
T 1z57_A 82 MLEWFEHHG--HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTE 158 (339)
T ss_dssp EEEEEEETT--EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEE
T ss_pred eecccccCC--cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEecccccc
Confidence 999998765 899999999 899999987654 358899999999999999999999999999999999999832100
Q ss_pred --------------CCcEEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 037285 956 --------------RPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1021 (1094)
Q Consensus 956 --------------~g~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF 1021 (1094)
++.+||+|||+++..... .....||+.|+|||++. ...++.++|||||||++|||++|+.||
T Consensus 159 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~g~~pf 234 (339)
T 1z57_A 159 AYNPKIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVIL--ALGWSQPCDVWSIGCILIEYYLGFTVF 234 (339)
T ss_dssp EEC----CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHT--TSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ccCCccccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhh--CCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 567999999999864432 23456899999999998 456899999999999999999999999
Q ss_pred CCCChHHHHHhHhhccCC------------------------------------------CCCCCcCcHHHHHHHHHhcc
Q 037285 1022 ANMHYGAIIGGIVNNTLR------------------------------------------PTIPSYCDAEWRTLMEECWA 1059 (1094)
Q Consensus 1022 ~~~~~~eile~Iv~~~lr------------------------------------------p~iPe~~S~eL~dLI~kCLq 1059 (1094)
......+....+...... ...+..++..+.+||.+||+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 314 (339)
T 1z57_A 235 PTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE 314 (339)
T ss_dssp CCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhC
Confidence 987766544332111000 01122346788999999999
Q ss_pred CCCCCCCCHHHHHHHH
Q 037285 1060 PNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1060 ~DPeeRPS~eELLq~L 1075 (1094)
.||.+|||+.+++++-
T Consensus 315 ~dP~~Rpt~~ell~hp 330 (339)
T 1z57_A 315 YDPAKRITLREALKHP 330 (339)
T ss_dssp SSTTTSCCHHHHTTSG
T ss_pred cCcccccCHHHHhcCH
Confidence 9999999999999763
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=345.56 Aligned_cols=254 Identities=24% Similarity=0.331 Sum_probs=205.0
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||+|+||.||+|++. |..||||++.... .......+.+|+.++++++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 82 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-------KPLFALRTLREIKILKHFKHENIITIFNIQRPDS 82 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-------SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-------cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccc
Confidence 468999999999999999999985 7889999986421 1233456789999999999999999999986531
Q ss_pred ---CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEe
Q 037285 887 ---GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGD 963 (1094)
Q Consensus 887 ---~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsD 963 (1094)
...+++||||+. ++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 83 ~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~----~~~~~kl~D 155 (353)
T 2b9h_A 83 FENFNEVYIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN----SNCDLKVCD 155 (353)
T ss_dssp STTCCCEEEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC----TTCCEEECC
T ss_pred cCccceEEEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc----CCCcEEEEe
Confidence 247899999996 6899988653 589999999999999999999999999999999999998 778999999
Q ss_pred cCCcccccCcc-----------ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHh
Q 037285 964 FGLSKIKRNTL-----------VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGG 1032 (1094)
Q Consensus 964 FGLSrl~~~~~-----------~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~ 1032 (1094)
||+++...... ......||+.|+|||++.+ ...++.++|||||||++|+|++|+.||........+..
T Consensus 156 fg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 234 (353)
T 2b9h_A 156 FGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT-SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234 (353)
T ss_dssp CTTCEECC----------------CCCCCCGGGCCHHHHHS-CCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred cccccccccccccccCccccccchhhccccccccCCeeecc-CCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 99998543211 1223468999999998763 35689999999999999999999999998876554433
Q ss_pred HhhccCCC------------------------------CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1033 IVNNTLRP------------------------------TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1033 Iv~~~lrp------------------------------~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
+......+ .....++.++.+||.+||..||.+|||+.+++++-+-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 309 (353)
T 2b9h_A 235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309 (353)
T ss_dssp HHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence 32110000 0113578899999999999999999999999987554
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=349.97 Aligned_cols=254 Identities=22% Similarity=0.327 Sum_probs=207.3
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
..+|++.+.||+|+||.||+|++. +..||||++.... .......+.+|+.+|++++||||+++++++....
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 98 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-------HQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 98 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-------CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-------CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCC
Confidence 368999999999999999999874 6789999986421 1233467889999999999999999999986532
Q ss_pred ---CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEe
Q 037285 887 ---GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGD 963 (1094)
Q Consensus 887 ---~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsD 963 (1094)
...+++||||+. ++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 99 ~~~~~~~~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~----~~~~~kl~D 171 (364)
T 3qyz_A 99 IEQMKDVYIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN----TTCDLKICD 171 (364)
T ss_dssp TTTCCCEEEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEECC
T ss_pred ccccceEEEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEEC----CCCCEEEEe
Confidence 236899999996 6899988654 489999999999999999999999999999999999998 778899999
Q ss_pred cCCcccccCcc----ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCC
Q 037285 964 FGLSKIKRNTL----VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 1039 (1094)
Q Consensus 964 FGLSrl~~~~~----~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lr 1039 (1094)
||+++...... ......||+.|+|||++.+ ...++.++|||||||++|+|++|+.||......+.+..+......
T Consensus 172 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 250 (364)
T 3qyz_A 172 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 250 (364)
T ss_dssp CTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHT-BCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCS
T ss_pred CcceEecCCCCCccccccccccccCCCCCHHhcC-CCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCC
Confidence 99998543221 1234579999999998763 345789999999999999999999999988776655554321110
Q ss_pred C-----------------------------CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1040 P-----------------------------TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1040 p-----------------------------~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
+ .+...++.++.+||.+||..||.+|||+.+++++-+-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 317 (364)
T 3qyz_A 251 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317 (364)
T ss_dssp CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred CCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcch
Confidence 0 0113568899999999999999999999999987654
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=342.95 Aligned_cols=262 Identities=23% Similarity=0.377 Sum_probs=187.9
Q ss_pred cceeeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHH-HHhhCCCCceeEEE
Q 037285 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAE-ILSKLHHPNVVAFY 879 (1094)
Q Consensus 803 sv~eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIk-ILkrL~HPNIVqL~ 879 (1094)
..|.+..++|++.+.||+|+||.||+|.++ ++.||||++..... ......+..|+. +++.++||||++++
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~~~~~~~h~niv~~~ 87 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-------EKEQKQLLMDLDVVMRSSDCPYIVQFY 87 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-------HHHHHHHHHHHHHHHSSCCCTTBCCEE
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-------chHHHHHHHHHHHHHHcCCCCcEeeee
Confidence 456778899999999999999999999985 78899999975421 112234555665 67788999999999
Q ss_pred eEeecCCCCceEEEeeecccchhHHHHhh----cccccCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeccCCC
Q 037285 880 GVVQDGPGGTLATVAEYMVDGSLRHVLVR----KDRFLDRRRRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDP 954 (1094)
Q Consensus 880 Gv~~d~~~~~L~IVmEYmegGSL~d~L~k----~~~~Lse~~~l~Ia~QIaeGLaYLHs~-GIIHRDLKPeNILLD~~~~ 954 (1094)
+++.... ..++||||+.+ +|.+++.. ....+++..++.++.|++.||.|||++ ||+||||||+|||++
T Consensus 88 ~~~~~~~--~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~---- 160 (327)
T 3aln_A 88 GALFREG--DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD---- 160 (327)
T ss_dssp EEEECSS--EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEE----
T ss_pred eEEEeCC--ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEc----
Confidence 9998754 89999999975 77777653 245689999999999999999999999 999999999999998
Q ss_pred CCCcEEEEecCCcccccCccccCCccCCCcccCcccccc--CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH-HHHH
Q 037285 955 SRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSG--SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-AIIG 1031 (1094)
Q Consensus 955 e~g~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g--~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~-eile 1031 (1094)
.++.+||+|||+++............||+.|+|||++.. ....++.++|||||||++|+|++|+.||...... +.+.
T Consensus 161 ~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 240 (327)
T 3aln_A 161 RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT 240 (327)
T ss_dssp TTTEEEECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------C
T ss_pred CCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHH
Confidence 788999999999986544433344468999999999842 1346789999999999999999999999875432 2222
Q ss_pred hHhhccCCCCC----CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1032 GIVNNTLRPTI----PSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1032 ~Iv~~~lrp~i----Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
.+.. ...+.+ ...++..+.+||.+||..||.+|||+.+|+++.+-..
T Consensus 241 ~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 241 QVVK-GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp CCCC-SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHhc-CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 2222 122222 2457899999999999999999999999998766544
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=347.40 Aligned_cols=261 Identities=22% Similarity=0.317 Sum_probs=212.1
Q ss_pred eccCCeeEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchh---------HHHHHHHHHHHHHHHhhCCCCceeE
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSE---------QERLTVEFWKEAEILSKLHHPNVVA 877 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~e---------qe~~~~eFlrEIkILkrL~HPNIVq 877 (1094)
+..++|++.+.||+|+||.||+|++.+..||||++........... .......+.+|+.++++++||||++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 4457999999999999999999999889999999976432211000 0011257889999999999999999
Q ss_pred EEeEeecCCCCceEEEeeecccchhHHH------Hhhc-ccccCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEe
Q 037285 878 FYGVVQDGPGGTLATVAEYMVDGSLRHV------LVRK-DRFLDRRRRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLV 949 (1094)
Q Consensus 878 L~Gv~~d~~~~~L~IVmEYmegGSL~d~------L~k~-~~~Lse~~~l~Ia~QIaeGLaYLHs-~GIIHRDLKPeNILL 949 (1094)
+++++.+.. .+++||||+++++|.++ +... ...+++..++.++.||+.||.|||+ +||+||||||+|||+
T Consensus 108 ~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 108 CEGIITNYD--EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185 (348)
T ss_dssp CSEEEESSS--EEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred EEEEEeeCC--eEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence 999998865 89999999999999998 5442 4568999999999999999999999 999999999999999
Q ss_pred ccCCCCCCcEEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCc-hhhHHHHHHHHHHHHcCCCCCCCCCh-H
Q 037285 950 NLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSE-KVDVFSFGIVLWEILTGEEPYANMHY-G 1027 (1094)
Q Consensus 950 D~~~~e~g~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~-KSDVWSLGVLLyELLTGk~PF~~~~~-~ 1027 (1094)
+ .++.+||+|||++...... ......+|..|+|||++.+. ..++. ++|||||||++|+|++|+.||..... .
T Consensus 186 ~----~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 259 (348)
T 2pml_X 186 D----KNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNE-SSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV 259 (348)
T ss_dssp C----TTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSC-CCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred c----CCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 8 7789999999999865433 23445689999999999842 24555 99999999999999999999998776 5
Q ss_pred HHHHhHhhccCCCCC-----------------CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037285 1028 AIIGGIVNNTLRPTI-----------------PSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1028 eile~Iv~~~lrp~i-----------------Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L 1075 (1094)
+....+......... ...++..+.+||.+||+.||.+|||+.+++++-
T Consensus 260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp 324 (348)
T 2pml_X 260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE 324 (348)
T ss_dssp HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 555555443322111 156889999999999999999999999999854
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=347.52 Aligned_cols=258 Identities=24% Similarity=0.230 Sum_probs=195.6
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
...++|++.+.||+|+||.||+|+++ +..||||++...... ...+.+++..+..++||||+++++++..
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~~~l~~l~h~niv~~~~~~~~ 90 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---------RNRELQIMQDLAVLHHPNIVQLQSYFYT 90 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---------CCHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---------cHHHHHHHHHHHhcCCCCcccHHHhhhc
Confidence 34578999999999999999999985 678999998654211 1245577888889999999999999865
Q ss_pred CC-----CCceEEEeeecccchhHHHHh---hcccccCHHHHHHHHHHHHHHHHHHH--HCCceeccCCCCceEeccCCC
Q 037285 885 GP-----GGTLATVAEYMVDGSLRHVLV---RKDRFLDRRRRLIIAMDAAFGMEYLH--SKNIVHFDLKCDNLLVNLKDP 954 (1094)
Q Consensus 885 ~~-----~~~L~IVmEYmegGSL~d~L~---k~~~~Lse~~~l~Ia~QIaeGLaYLH--s~GIIHRDLKPeNILLD~~~~ 954 (1094)
.. ...+++||||+.++. ...+. .....+++..++.++.||+.||.||| ++||+||||||+|||++
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~l-~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~---- 165 (360)
T 3e3p_A 91 LGERDRRDIYLNVVMEYVPDTL-HRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN---- 165 (360)
T ss_dssp ECSSCTTCEEEEEEEECCSCBH-HHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEE----
T ss_pred cccccccceeEEEEeecccccH-HHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEe----
Confidence 32 123889999998653 33332 23446899999999999999999999 99999999999999998
Q ss_pred C-CCcEEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhH
Q 037285 955 S-RPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI 1033 (1094)
Q Consensus 955 e-~g~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~I 1033 (1094)
. ++.+||+|||+++............||+.|+|||++.+ ...++.++|||||||++|+|++|+.||........+..+
T Consensus 166 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 244 (360)
T 3e3p_A 166 EADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFG-NQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI 244 (360)
T ss_dssp TTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTT-CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcC-CCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHH
Confidence 4 67999999999986655444455678999999999864 345789999999999999999999999998877666555
Q ss_pred hhccC------------------------------CCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1034 VNNTL------------------------------RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1034 v~~~l------------------------------rp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
..... .......++.++.+||.+||+.||.+|||+.+++++-+--.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 320 (360)
T 3e3p_A 245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDE 320 (360)
T ss_dssp HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGG
T ss_pred HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccc
Confidence 43111 01122236788999999999999999999999999866543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=373.12 Aligned_cols=254 Identities=23% Similarity=0.365 Sum_probs=213.3
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
+..++|++.+.||+|+||.||+|+++ |+.||||++.+.... .......+.+|+.+|++++||||+++++++.+
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~-----~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 256 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK-----KRKGYQGAMVEKKILAKVHSRFIVSLAYAFET 256 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhh-----hhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee
Confidence 55678999999999999999999884 788999999764221 12224568899999999999999999999987
Q ss_pred CCCCceEEEeeecccchhHHHHhhcc---cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEE
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKD---RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKV 961 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~---~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKL 961 (1094)
.. .+|+||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 257 ~~--~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~----~~g~vkL 330 (543)
T 3c4z_A 257 KT--DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLD----DDGNVRI 330 (543)
T ss_dssp SS--EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTSCEEE
T ss_pred CC--EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEe----CCCCEEE
Confidence 65 8999999999999999987542 3589999999999999999999999999999999999999 7889999
Q ss_pred EecCCcccccCc-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC----hHHHHHhHhhc
Q 037285 962 GDFGLSKIKRNT-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH----YGAIIGGIVNN 1036 (1094)
Q Consensus 962 sDFGLSrl~~~~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~----~~eile~Iv~~ 1036 (1094)
+|||+++..... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||.... ..++...+...
T Consensus 331 ~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~--~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~ 408 (543)
T 3c4z_A 331 SDLGLAVELKAGQTKTKGYAGTPGFMAPELLL--GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ 408 (543)
T ss_dssp CCCTTCEECCTTCCCBCCCCSCTTTSCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC
T ss_pred eecceeeeccCCCcccccccCCccccChhhhc--CCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc
Confidence 999999864432 2334568999999999998 4578899999999999999999999998753 34455555443
Q ss_pred cCCCCCCCcCcHHHHHHHHHhccCCCCCCCCH-----HHHHHHH
Q 037285 1037 TLRPTIPSYCDAEWRTLMEECWAPNPAARPSF-----TEIASRL 1075 (1094)
Q Consensus 1037 ~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~-----eELLq~L 1075 (1094)
...+|..++..+.+||.+||..||.+||++ .+|+++-
T Consensus 409 --~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hp 450 (543)
T 3c4z_A 409 --AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHP 450 (543)
T ss_dssp --CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSG
T ss_pred --ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCc
Confidence 335677899999999999999999999964 7787653
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=379.03 Aligned_cols=260 Identities=32% Similarity=0.580 Sum_probs=219.7
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeec-----CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEE
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFY 879 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~r-----Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~ 879 (1094)
+++..++|++.+.||+|+||.||+|++. +..||||.++... .......|.+|+.+|++++||||++++
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~l~ 457 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-------SDSVREKFLQEALTMRQFDHPHIVKLI 457 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-------CHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-------CHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 4566789999999999999999999874 2458999876431 123446788999999999999999999
Q ss_pred eEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcE
Q 037285 880 GVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC 959 (1094)
Q Consensus 880 Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~V 959 (1094)
+++.+. .+++||||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 458 ~~~~~~---~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~----~~~~v 530 (656)
T 2j0j_A 458 GVITEN---PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS----SNDCV 530 (656)
T ss_dssp EEECSS---SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE----ETTEE
T ss_pred EEEecC---ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEe----CCCCE
Confidence 998643 68999999999999999987666699999999999999999999999999999999999999 67899
Q ss_pred EEEecCCcccccCcc--ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhc
Q 037285 960 KVGDFGLSKIKRNTL--VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 1036 (1094)
Q Consensus 960 KLsDFGLSrl~~~~~--~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~ 1036 (1094)
||+|||+++...... ......+|+.|+|||++. ...++.++|||||||++|||++ |..||......+....+..
T Consensus 531 kL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~- 607 (656)
T 2j0j_A 531 KLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN--FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN- 607 (656)
T ss_dssp EECCCCCCCSCCC----------CCGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHH-
T ss_pred EEEecCCCeecCCCcceeccCCCCCcceeCHHHhc--CCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-
Confidence 999999998543322 122344678999999997 4578999999999999999997 9999999888877776644
Q ss_pred cCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1037 TLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1037 ~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
..+...+..++..+.+||.+||..||.+|||+.+|++.|..+...
T Consensus 608 ~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 608 GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 445567888999999999999999999999999999999998654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=356.70 Aligned_cols=257 Identities=25% Similarity=0.340 Sum_probs=188.8
Q ss_pred CeeE-EEEecccCceEEEEeeec----CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC
Q 037285 811 DLEE-QKELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 811 dYei-~kkLGsG~FGtVYKAk~r----Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~ 885 (1094)
.|++ .++||+|+||.||+|+++ +..||||++...... ..+.+|+.+|++|+||||+++++++...
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----------MSACREIALLRELKHPNVISLQKVFLSH 90 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----------HHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----------HHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence 4555 457999999999999964 567999998754221 3577899999999999999999999765
Q ss_pred CCCceEEEeeecccchhHHHHhhcc--------cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCC
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKD--------RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRP 957 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~--------~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g 957 (1094)
....+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||+...+...+
T Consensus 91 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 91 ADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp TTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTT
T ss_pred CCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCC
Confidence 5568999999996 57777775322 24899999999999999999999999999999999999954434778
Q ss_pred cEEEEecCCcccccCc----cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH------
Q 037285 958 ICKVGDFGLSKIKRNT----LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG------ 1027 (1094)
Q Consensus 958 ~VKLsDFGLSrl~~~~----~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~------ 1027 (1094)
.+||+|||+++..... .......||+.|+|||++.+ ...++.++|||||||++|+|++|+.||......
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~ 248 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG-ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTT-CCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CC
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcC-CCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccccc
Confidence 9999999999854322 22334578999999999974 345899999999999999999999999755431
Q ss_pred ---HHHHhHhhccCCCC------------------------------------CCCcCcHHHHHHHHHhccCCCCCCCCH
Q 037285 1028 ---AIIGGIVNNTLRPT------------------------------------IPSYCDAEWRTLMEECWAPNPAARPSF 1068 (1094)
Q Consensus 1028 ---eile~Iv~~~lrp~------------------------------------iPe~~S~eL~dLI~kCLq~DPeeRPS~ 1068 (1094)
+.+..+......+. .....+..+.+||.+||..||.+|||+
T Consensus 249 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta 328 (405)
T 3rgf_A 249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS 328 (405)
T ss_dssp CCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH
T ss_pred chHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH
Confidence 22222211100000 011126678999999999999999999
Q ss_pred HHHHHHHHHHH
Q 037285 1069 TEIASRLRVLS 1079 (1094)
Q Consensus 1069 eELLq~L~~L~ 1079 (1094)
.+++++-+-..
T Consensus 329 ~e~L~hp~f~~ 339 (405)
T 3rgf_A 329 EQAMQDPYFLE 339 (405)
T ss_dssp HHHHTSGGGTS
T ss_pred HHHhcChhhcc
Confidence 99999877643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=376.86 Aligned_cols=255 Identities=23% Similarity=0.346 Sum_probs=214.8
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
+..++|++.+.||+|+||.||+|+.+ |..||||++.+.... .......+.+|+.+|++++||||+++++++.+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~-----~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 255 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-----KRKGEAMALNEKQILEKVNSRFVVSLAYAYET 255 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhh-----hhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee
Confidence 56678999999999999999999884 788999999764221 11223567899999999999999999999988
Q ss_pred CCCCceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEe
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGD 963 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsD 963 (1094)
.. .+++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 256 ~~--~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld----~~g~vKL~D 329 (576)
T 2acx_A 256 KD--ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLD----DHGHIRISD 329 (576)
T ss_dssp SS--EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTSCEEECC
T ss_pred CC--EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEe----CCCCeEEEe
Confidence 65 8999999999999999987653 3489999999999999999999999999999999999999 788999999
Q ss_pred cCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC----hHHHHHhHhhccCC
Q 037285 964 FGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH----YGAIIGGIVNNTLR 1039 (1094)
Q Consensus 964 FGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~----~~eile~Iv~~~lr 1039 (1094)
||+++...........+||+.|+|||++. ...++.++|||||||++|||++|+.||.... ...+...+.. ..
T Consensus 330 FGla~~~~~~~~~~~~~GT~~Y~APEvl~--~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~--~~ 405 (576)
T 2acx_A 330 LGLAVHVPEGQTIKGRVGTVGYMAPEVVK--NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE--VP 405 (576)
T ss_dssp CTTCEECCTTCCEECCCSCGGGCCHHHHT--TCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH--CC
T ss_pred cccceecccCccccccCCCccccCHHHHc--CCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc--cc
Confidence 99998655443344567999999999998 4568899999999999999999999998753 2333333322 23
Q ss_pred CCCCCcCcHHHHHHHHHhccCCCCCCC-----CHHHHHHHHH
Q 037285 1040 PTIPSYCDAEWRTLMEECWAPNPAARP-----SFTEIASRLR 1076 (1094)
Q Consensus 1040 p~iPe~~S~eL~dLI~kCLq~DPeeRP-----S~eELLq~L~ 1076 (1094)
..++..++.++.+||.+||..||.+|| ++.+|++|-+
T Consensus 406 ~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hpf 447 (576)
T 2acx_A 406 EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL 447 (576)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGG
T ss_pred ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChh
Confidence 456778999999999999999999999 7899998744
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=354.86 Aligned_cols=252 Identities=21% Similarity=0.261 Sum_probs=204.3
Q ss_pred ccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC------CCCceeEEE
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL------HHPNVVAFY 879 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL------~HPNIVqL~ 879 (1094)
...+|++.+.||+|+||.||+|++. +..||||+++.. ......+.+|+.+++.+ +|+||++++
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---------~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~ 165 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---------KRFHRQAAEEIRILEHLRKQDKDNTMNVIHML 165 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---------HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---------cchHHHHHHHHHHHHHHhhccccCCcCEEEEE
Confidence 3468999999999999999999875 678999998653 22334566788887776 578999999
Q ss_pred eEeecCCCCceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCc
Q 037285 880 GVVQDGPGGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPI 958 (1094)
Q Consensus 880 Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~ 958 (1094)
+++.... .+++||||+. ++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++ .++.
T Consensus 166 ~~~~~~~--~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~----~~~~ 238 (429)
T 3kvw_A 166 ENFTFRN--HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLK----QQGR 238 (429)
T ss_dssp EEEEETT--EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEES----STTS
T ss_pred eecccCC--eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc----cCCC
Confidence 9998865 8999999995 68888887654 4589999999999999999999999999999999999998 4444
Q ss_pred --EEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhc
Q 037285 959 --CKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN 1036 (1094)
Q Consensus 959 --VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~ 1036 (1094)
+||+|||+++..... .....||+.|+|||++. ...++.++|||||||++|||+||+.||......+.+..+...
T Consensus 239 ~~vkL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~ 314 (429)
T 3kvw_A 239 SGIKVIDFGSSCYEHQR--VYTYIQSRFYRAPEVIL--GARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIEL 314 (429)
T ss_dssp CCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHH--TBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred cceEEeecccceecCCc--ccccCCCCCccChHHHh--CCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 999999999765433 23457899999999998 456899999999999999999999999988776655444321
Q ss_pred cCCC---------------------------------------------------------CCCCcCcHHHHHHHHHhcc
Q 037285 1037 TLRP---------------------------------------------------------TIPSYCDAEWRTLMEECWA 1059 (1094)
Q Consensus 1037 ~lrp---------------------------------------------------------~iPe~~S~eL~dLI~kCLq 1059 (1094)
.-.+ .++...++.+.+||.+||+
T Consensus 315 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~ 394 (429)
T 3kvw_A 315 LGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLE 394 (429)
T ss_dssp HCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTC
T ss_pred cCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCC
Confidence 0000 0112347889999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHH
Q 037285 1060 PNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1060 ~DPeeRPS~eELLq~L~~L~ 1079 (1094)
.||.+|||+.+++++-+-..
T Consensus 395 ~dP~~Rpta~e~L~Hpw~~~ 414 (429)
T 3kvw_A 395 WDPAVRMTPGQALRHPWLRR 414 (429)
T ss_dssp SSTTTSCCHHHHHTSTTTC-
T ss_pred CChhhCCCHHHHhCChhhcc
Confidence 99999999999999866543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=353.54 Aligned_cols=253 Identities=23% Similarity=0.276 Sum_probs=202.0
Q ss_pred ccCCeeEEEEecccCceEEEEeeec-CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~r-Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
...+|++.+.||+|+||.||+|++. +..||+|.+..... ...+|+.+|+.++||||+++++++....
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~------------~~~~E~~il~~l~h~niv~l~~~~~~~~ 105 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR------------FKNRELQIMRIVKHPNVVDLKAFFYSNG 105 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT------------SCCHHHHHHHTCCCTTBCCEEEEEEEES
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc------------hHHHHHHHHHhCCCCCcceEEEEEEecC
Confidence 3457999999999999999999985 45599998865321 1126899999999999999999986432
Q ss_pred ----CCceEEEeeecccchhHHHHh--hcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEE
Q 037285 887 ----GGTLATVAEYMVDGSLRHVLV--RKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICK 960 (1094)
Q Consensus 887 ----~~~L~IVmEYmegGSL~d~L~--k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VK 960 (1094)
...+++||||+.++.+..... .....+++..++.++.||+.||+|||++||+||||||+|||++ ..++.+|
T Consensus 106 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~---~~~~~~k 182 (394)
T 4e7w_A 106 DKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD---PPSGVLK 182 (394)
T ss_dssp SSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---TTTTEEE
T ss_pred CCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEc---CCCCcEE
Confidence 224889999998765544332 2245689999999999999999999999999999999999997 2467899
Q ss_pred EEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccC--
Q 037285 961 VGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL-- 1038 (1094)
Q Consensus 961 LsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~l-- 1038 (1094)
|+|||+++............+|+.|+|||++.+ ...++.++|||||||++|||++|+.||.+....+.+..+.....
T Consensus 183 L~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p 261 (394)
T 4e7w_A 183 LIDFGSAKILIAGEPNVSYICSRYYRAPELIFG-ATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP 261 (394)
T ss_dssp ECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTT-CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred EeeCCCcccccCCCCCcccccCcCccCHHHHcC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999999986544444445678999999999874 34589999999999999999999999998877665554433100
Q ss_pred -------------CC------------CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1039 -------------RP------------TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1039 -------------rp------------~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
.. .++..+++++.+||.+||..||.+|||+.+++++-+
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 324 (394)
T 4e7w_A 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324 (394)
T ss_dssp CHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred CHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChh
Confidence 00 123347889999999999999999999999998744
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=348.73 Aligned_cols=256 Identities=23% Similarity=0.323 Sum_probs=205.6
Q ss_pred ceeeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeE
Q 037285 804 VQVIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGV 881 (1094)
Q Consensus 804 v~eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv 881 (1094)
.|++. .+|.+.+.||+|+||.||+|+++ |+.||||++..... .+.....+.+|+.++++++||||++++++
T Consensus 37 ~~~l~-~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 109 (371)
T 4exu_A 37 AWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ------SEIFAKRAYRELLLLKHMQHENVIGLLDV 109 (371)
T ss_dssp EEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS------SHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred eeccc-ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc------chhHHHHHHHHHHHHHhcCCCCchhhhhh
Confidence 34443 68999999999999999999874 78899999975421 23345678899999999999999999999
Q ss_pred eecCCCC----ceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCC
Q 037285 882 VQDGPGG----TLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRP 957 (1094)
Q Consensus 882 ~~d~~~~----~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g 957 (1094)
+...... .+++||||+. ++|.+++.. .+++..++.++.||+.||+|||++||+||||||+|||++ .++
T Consensus 110 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~----~~~ 181 (371)
T 4exu_A 110 FTPASSLRNFYDFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN----EDC 181 (371)
T ss_dssp ECSCSSSTTCCCCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTC
T ss_pred eeccCCcccceeEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEEC----CCC
Confidence 9865421 2399999997 688887732 389999999999999999999999999999999999998 778
Q ss_pred cEEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhcc
Q 037285 958 ICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 1037 (1094)
Q Consensus 958 ~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~ 1037 (1094)
.+||+|||+++..... .....+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||......+.+..+....
T Consensus 182 ~~kL~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~ 258 (371)
T 4exu_A 182 ELKILDFGLARHADAE--MTGYVVTRWYRAPEVILS-WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 258 (371)
T ss_dssp CEEECSTTCC----------CTTCCCTTSCHHHHSC-CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred CEEEEecCcccccccC--cCCcccCccccCHHHhcC-CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 9999999999854432 234568999999999874 3568899999999999999999999999887766555543311
Q ss_pred CCC-----------------------------CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1038 LRP-----------------------------TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1038 lrp-----------------------------~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
..+ .....+++.+.+||.+||+.||.+|||+.+++++-+-
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 327 (371)
T 4exu_A 259 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 327 (371)
T ss_dssp CCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred CCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccc
Confidence 100 0123568899999999999999999999999988654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=343.17 Aligned_cols=252 Identities=23% Similarity=0.332 Sum_probs=203.5
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
..+|.+.+.||+|+||.||+|+++ |..||||++..... .+.....+.+|+.++++++||||+++++++....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 96 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ------SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS 96 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTS------SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccccc------chHHHHHHHHHHHHHHhcCCCCcccHhheEeccc
Confidence 468999999999999999999874 78899999875421 1334567889999999999999999999998653
Q ss_pred C----CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 887 G----GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 887 ~----~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
. ..+++||||+. ++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 97 ~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~----~~~~~kl~ 168 (353)
T 3coi_A 97 SLRNFYDFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN----EDCELKIL 168 (353)
T ss_dssp SGGGCCCCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC----TTCCEEEC
T ss_pred ccccceeEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeEC----CCCcEEEe
Confidence 1 13599999997 688877743 489999999999999999999999999999999999998 77899999
Q ss_pred ecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhc------
Q 037285 963 DFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN------ 1036 (1094)
Q Consensus 963 DFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~------ 1036 (1094)
|||+++..... .....+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||......+.+..+...
T Consensus 169 Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 245 (353)
T 3coi_A 169 DFGLARHADAE--MTGYVVTRWYRAPEVILS-WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGT 245 (353)
T ss_dssp STTCTTC----------CCSBCCSCHHHHSC-CSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCH
T ss_pred ecccccCCCCC--ccccccCcCcCCHHHHhC-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99999854432 234568999999999874 356889999999999999999999999987766554443221
Q ss_pred --------------------cCC---CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1037 --------------------TLR---PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1037 --------------------~lr---p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
..+ ......++.++.+||.+||..||.+|||+.+++++-+-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f 309 (353)
T 3coi_A 246 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309 (353)
T ss_dssp HHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred HHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence 001 12234678999999999999999999999999987553
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=336.96 Aligned_cols=255 Identities=20% Similarity=0.221 Sum_probs=201.4
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--C-ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCc------eeE
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--G-TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPN------VVA 877 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--G-t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPN------IVq 877 (1094)
+..++|++.+.||+|+||.||+|++. + ..||||+++.. ......+.+|+.++++++|++ ++.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~ 86 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---------GKYREAARLEINVLKKIKEKDKENKFLCVL 86 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---------HHHHHHHHHHHHHHHHHHHHCTTSCSCBCC
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---------ccchhHHHHHHHHHHHHhhcCCCCceeEEE
Confidence 34579999999999999999999874 3 67999998642 123356778999999987665 999
Q ss_pred EEeEeecCCCCceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCC---
Q 037285 878 FYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKD--- 953 (1094)
Q Consensus 878 L~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~--- 953 (1094)
+++++.... .+++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..+
T Consensus 87 ~~~~~~~~~--~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~ 163 (355)
T 2eu9_A 87 MSDWFNFHG--HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFET 163 (355)
T ss_dssp EEEEEEETT--EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEE
T ss_pred eeeeeeeCC--eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccc
Confidence 999998755 899999999 556666665443 5689999999999999999999999999999999999994221
Q ss_pred ------------CCCCcEEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 037285 954 ------------PSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1021 (1094)
Q Consensus 954 ------------~e~g~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF 1021 (1094)
...+.+||+|||+++...... ....||+.|+|||++. ...++.++|||||||++|+|++|+.||
T Consensus 164 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~g~~pf 239 (355)
T 2eu9_A 164 LYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH--TTIVATRHYRPPEVIL--ELGWAQPCDVWSIGCILFEYYRGFTLF 239 (355)
T ss_dssp EECCC-CCCEEEESCCCEEECCCTTCEETTSCC--CSSCSCGGGCCHHHHT--TCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccccccccCCCcEEEeecCccccccccc--cCCcCCCcccCCeeee--cCCCCCccchHHHHHHHHHHHhCCCCC
Confidence 157889999999998644322 3456899999999998 456889999999999999999999999
Q ss_pred CCCChHHHHHhHhhccCC------------------------------------------CCCCCcCcHHHHHHHHHhcc
Q 037285 1022 ANMHYGAIIGGIVNNTLR------------------------------------------PTIPSYCDAEWRTLMEECWA 1059 (1094)
Q Consensus 1022 ~~~~~~eile~Iv~~~lr------------------------------------------p~iPe~~S~eL~dLI~kCLq 1059 (1094)
......+.+..+...... .......+..+.+||.+||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 319 (355)
T 2eu9_A 240 QTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE 319 (355)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence 987766544332221000 00111234578999999999
Q ss_pred CCCCCCCCHHHHHHHHHH
Q 037285 1060 PNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1060 ~DPeeRPS~eELLq~L~~ 1077 (1094)
.||.+|||+.+++++-+-
T Consensus 320 ~dP~~Rpt~~e~l~hp~f 337 (355)
T 2eu9_A 320 FDPAQRITLAEALLHPFF 337 (355)
T ss_dssp SSTTTSCCHHHHTTSGGG
T ss_pred CChhhCcCHHHHhcChhh
Confidence 999999999999976543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=353.03 Aligned_cols=257 Identities=21% Similarity=0.289 Sum_probs=192.3
Q ss_pred ceeeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeE
Q 037285 804 VQVIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGV 881 (1094)
Q Consensus 804 v~eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv 881 (1094)
.|++ .++|++.+.||+|+||.||+|++. |..||||++..... .......+.+|+.+|++++||||++++++
T Consensus 24 ~~~~-~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 96 (367)
T 2fst_X 24 IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ------SIIHAKRTYRELRLLKHMKHENVIGLLDV 96 (367)
T ss_dssp EEEE-ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTS------SHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred ccCC-CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcccc------CHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 3444 378999999999999999999864 78899999865321 12334678899999999999999999999
Q ss_pred eecCC----CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCC
Q 037285 882 VQDGP----GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRP 957 (1094)
Q Consensus 882 ~~d~~----~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g 957 (1094)
+.... ...+++||||+ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++ .++
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~----~~~ 169 (367)
T 2fst_X 97 FTPARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN----EDC 169 (367)
T ss_dssp ECSCSSGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTC
T ss_pred EecCCccccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEEC----CCC
Confidence 87531 23689999999 7899998865 3589999999999999999999999999999999999998 788
Q ss_pred cEEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhcc
Q 037285 958 ICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 1037 (1094)
Q Consensus 958 ~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~ 1037 (1094)
.+||+|||+++..... .....+|..|+|||++.+ ...++.++|||||||++|+|++|+.||.+......+..+....
T Consensus 170 ~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~ 246 (367)
T 2fst_X 170 ELKILDFGLARHTADE--MTGYVATRWYRAPEIMLN-WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 246 (367)
T ss_dssp CEEECC-----------------CCCTTCCHHHHTT-CCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred CEEEeecccccccccc--CCCcCcCcCccChHHHcC-CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 9999999999864432 234568999999999874 3568899999999999999999999999887766555443211
Q ss_pred CC---------------------CCC--------CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1038 LR---------------------PTI--------PSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1038 lr---------------------p~i--------Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
.. +.. ...+++.+.+||.+||..||.+|||+.+++++-+-
T Consensus 247 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~ 315 (367)
T 2fst_X 247 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315 (367)
T ss_dssp CSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred CCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhh
Confidence 00 000 12467889999999999999999999999987543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=360.91 Aligned_cols=258 Identities=22% Similarity=0.289 Sum_probs=207.4
Q ss_pred ccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCC-CceeEEEeEeec
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHH-PNVVAFYGVVQD 884 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~H-PNIVqL~Gv~~d 884 (1094)
..++|++.++||+|+||.||+|++. +..||||++...... ..+.+|+.+++.|+| ++|+.+..++..
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----------~~~~~E~~il~~L~~~~~i~~i~~~~~~ 74 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----------PQLLYESKIYRILQGGTGIPNVRWFGVE 74 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----------CCHHHHHHHHHHTTTSTTCCCEEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----------HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 3578999999999999999999874 788999988754321 246789999999987 455555555555
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
.. ..++||||+ +++|.+++......+++..++.|+.||+.||+|||+++|+||||||+||||+..+ ..+.+||+||
T Consensus 75 ~~--~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~-~~~~vkL~DF 150 (483)
T 3sv0_A 75 GD--YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIIDF 150 (483)
T ss_dssp TT--EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGG-GTTCEEECCC
T ss_pred CC--EEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCC-CCCeEEEEeC
Confidence 43 889999999 9999999987666799999999999999999999999999999999999994211 5788999999
Q ss_pred CCcccccCcc--------ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh---HHHHHhH
Q 037285 965 GLSKIKRNTL--------VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY---GAIIGGI 1033 (1094)
Q Consensus 965 GLSrl~~~~~--------~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~---~eile~I 1033 (1094)
|+++...... ......||+.|+|||++. ...++.++|||||||+||||++|+.||..... .+.+..+
T Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i 228 (483)
T 3sv0_A 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHL--GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228 (483)
T ss_dssp TTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT--TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHH
T ss_pred CcceeccCCccccccccccccccCCCccccCHHHhc--CCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHH
Confidence 9998543321 122567999999999998 45689999999999999999999999987543 2222222
Q ss_pred hhccCC---CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1034 VNNTLR---PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1034 v~~~lr---p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
...... ..+...++.++.+||.+||+.+|++||++.+|++.|+.+...
T Consensus 229 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 229 SEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp HHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred hhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 222111 122356789999999999999999999999999999998654
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=340.76 Aligned_cols=260 Identities=18% Similarity=0.247 Sum_probs=202.4
Q ss_pred eeeccCCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-----------
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH----------- 871 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~----------- 871 (1094)
..+...+|++.+.||+|+||.||+|++ .++.||||++... ......+.+|+.++++++
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~ 84 (373)
T 1q8y_A 14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---------KVYTEAAEDEIKLLQRVNDADNTKEDSMG 84 (373)
T ss_dssp CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---------HHHHHHHHHHHHHHHHHHHTCCSHHHHHH
T ss_pred CcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---------ccchhhhhHHHHHHHHhhcccccchhccc
Confidence 345678999999999999999999987 4788999998643 122356778999988886
Q ss_pred CCceeEEEeEeecC--CCCceEEEeeecccchhHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCce
Q 037285 872 HPNVVAFYGVVQDG--PGGTLATVAEYMVDGSLRHVLVRK-DRFLDRRRRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNL 947 (1094)
Q Consensus 872 HPNIVqL~Gv~~d~--~~~~L~IVmEYmegGSL~d~L~k~-~~~Lse~~~l~Ia~QIaeGLaYLHs~-GIIHRDLKPeNI 947 (1094)
|+||+++++++... ....+++||||+ +++|.+++... ...+++..++.++.||+.||+|||++ ||+||||||+||
T Consensus 85 ~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NI 163 (373)
T 1q8y_A 85 ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENV 163 (373)
T ss_dssp HTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGE
T ss_pred cchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHe
Confidence 89999999998753 223689999999 89999998764 34589999999999999999999998 999999999999
Q ss_pred EeccCC--CCCCcEEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 037285 948 LVNLKD--PSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH 1025 (1094)
Q Consensus 948 LLD~~~--~e~g~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~ 1025 (1094)
|++..+ ...+.+||+|||+++..... .....+|+.|+|||++. ...++.++|||||||++|+|+||+.||....
T Consensus 164 ll~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 164 LMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLL--GAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp EEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHH--TCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EEeccCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHh--CCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 996322 24458999999999865433 23346899999999998 4568899999999999999999999998654
Q ss_pred h------HHHHHhHhhcc----------------------------------------CCCCCCCcCcHHHHHHHHHhcc
Q 037285 1026 Y------GAIIGGIVNNT----------------------------------------LRPTIPSYCDAEWRTLMEECWA 1059 (1094)
Q Consensus 1026 ~------~eile~Iv~~~----------------------------------------lrp~iPe~~S~eL~dLI~kCLq 1059 (1094)
. ...+..+.... ....++..++.++.+||.+||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 319 (373)
T 1q8y_A 240 GHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ 319 (373)
T ss_dssp -----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGC
T ss_pred ccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhc
Confidence 2 11121111100 0112334556789999999999
Q ss_pred CCCCCCCCHHHHHHHHHHH
Q 037285 1060 PNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1060 ~DPeeRPS~eELLq~L~~L 1078 (1094)
.||.+|||+.+++++-+-.
T Consensus 320 ~dP~~Rpt~~ell~hp~f~ 338 (373)
T 1q8y_A 320 LDPRKRADAGGLVNHPWLK 338 (373)
T ss_dssp SSTTTCBCHHHHHTCGGGT
T ss_pred cCccccCCHHHHhhChhhh
Confidence 9999999999999976543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=338.91 Aligned_cols=255 Identities=24% Similarity=0.318 Sum_probs=179.4
Q ss_pred cCCeeEEE-EecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC
Q 037285 809 NEDLEEQK-ELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 809 ~edYei~k-kLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~ 885 (1094)
.++|++.+ .||+|+||.||+|+++ ++.||||++.... .... .....++.+.||||+++++++...
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~---e~~~~~~~~~h~~i~~~~~~~~~~ 94 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---------KARQ---EVDHHWQASGGPHIVCILDVYENM 94 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---------HHHH---HHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---------HHHH---HHHHHHHhcCCCChHHHHHHHhhc
Confidence 46899855 6999999999999886 7889999986531 1111 222345677999999999998652
Q ss_pred --CCCceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 886 --PGGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 886 --~~~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
....+++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..+ ..+.+||+
T Consensus 95 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~-~~~~~kl~ 173 (336)
T 3fhr_A 95 HHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKE-KDAVLKLT 173 (336)
T ss_dssp ETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS-TTCCEEEC
T ss_pred cCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecC-CCceEEEe
Confidence 1236899999999999999997654 4699999999999999999999999999999999999997332 35679999
Q ss_pred ecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHh----Hhhcc-
Q 037285 963 DFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGG----IVNNT- 1037 (1094)
Q Consensus 963 DFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~----Iv~~~- 1037 (1094)
|||+++...... .....+|+.|+|||++. ...++.++|||||||++|+|++|+.||........... +....
T Consensus 174 Dfg~~~~~~~~~-~~~~~~t~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (336)
T 3fhr_A 174 DFGFAKETTQNA-LQTPCYTPYYVAPEVLG--PEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY 250 (336)
T ss_dssp CCTTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred ccccceeccccc-cccCCCCcCccChhhhC--CCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccc
Confidence 999998554332 23456899999999987 45678899999999999999999999977654433211 11111
Q ss_pred -CCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1038 -LRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1038 -lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
........++.++.+||.+||+.||.+|||+.+++++.+-..
T Consensus 251 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 251 GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 112223568999999999999999999999999999877643
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=332.71 Aligned_cols=255 Identities=25% Similarity=0.374 Sum_probs=197.6
Q ss_pred eeccCCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC----CCCceeEEE
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL----HHPNVVAFY 879 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL----~HPNIVqL~ 879 (1094)
+...++|++.+.||+|+||.||+|++ .+..||||++......... .......+.+|+.++.++ +||||++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWS--PLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC----------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccc--cchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 34457899999999999999999987 4678999999764322111 011123455788899888 899999999
Q ss_pred eEeecCCCCceEEEeee-cccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCc
Q 037285 880 GVVQDGPGGTLATVAEY-MVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPI 958 (1094)
Q Consensus 880 Gv~~d~~~~~L~IVmEY-megGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~ 958 (1094)
+++.... ..++|||| +.+++|.+++.... .+++..++.++.||+.||.|||+++|+||||||+|||++. .++.
T Consensus 105 ~~~~~~~--~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~---~~~~ 178 (312)
T 2iwi_A 105 DWFETQE--GFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL---RRGC 178 (312)
T ss_dssp EEC-------CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEET---TTTE
T ss_pred EEEecCC--eEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeC---CCCe
Confidence 9998754 78999999 78999999997654 4899999999999999999999999999999999999972 4578
Q ss_pred EEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccC
Q 037285 959 CKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 1038 (1094)
Q Consensus 959 VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~l 1038 (1094)
+||+|||+++....... ....+|..|+|||++.+ ....+.++|||||||++|+|++|+.||.... + +...
T Consensus 179 ~kl~dfg~~~~~~~~~~-~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~----~~~~-- 248 (312)
T 2iwi_A 179 AKLIDFGSGALLHDEPY-TDFDGTRVYSPPEWISR-HQYHALPATVWSLGILLYDMVCGDIPFERDQ--E----ILEA-- 248 (312)
T ss_dssp EEECCCSSCEECCSSCB-CCCCSCTTTSCHHHHHH-SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----HHHT--
T ss_pred EEEEEcchhhhcccCcc-cccCCcccccCceeeec-CCCCCccchHHHHHHHHHHHHHCCCCCCChH--H----Hhhh--
Confidence 99999999986544332 34568999999999874 2233568999999999999999999997532 1 1122
Q ss_pred CCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1039 RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1039 rp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
...++..++..+.+||.+||+.||.+|||+.+++++.+-.
T Consensus 249 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~ 288 (312)
T 2iwi_A 249 ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQ 288 (312)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTC
T ss_pred ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence 2346678899999999999999999999999999876543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=337.43 Aligned_cols=254 Identities=22% Similarity=0.334 Sum_probs=204.1
Q ss_pred eeeccCCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC--CCceeEEEe
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH--HPNVVAFYG 880 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~--HPNIVqL~G 880 (1094)
.....++|++.+.||+|+||.||+|++ .+..||||++........... .....+.+|+.++++++ |+||+++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~--~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--PNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEEC--TTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhh--hhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 344567899999999999999999987 467899999986543221000 01124567899999996 599999999
Q ss_pred EeecCCCCceEEEeeeccc-chhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcE
Q 037285 881 VVQDGPGGTLATVAEYMVD-GSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC 959 (1094)
Q Consensus 881 v~~d~~~~~L~IVmEYmeg-GSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~V 959 (1094)
++.... .+++||||+.+ ++|.+++.... .+++..++.++.||+.||+|||+++|+||||||+|||++. .++.+
T Consensus 116 ~~~~~~--~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~---~~~~~ 189 (320)
T 3a99_A 116 WFERPD--SFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL---NRGEL 189 (320)
T ss_dssp EEECSS--EEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET---TTTEE
T ss_pred EEecCC--cEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeC---CCCCE
Confidence 998765 89999999976 89999997654 5899999999999999999999999999999999999972 35789
Q ss_pred EEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCC
Q 037285 960 KVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 1039 (1094)
Q Consensus 960 KLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lr 1039 (1094)
||+|||+++....... ....||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.... . +... .
T Consensus 190 kL~Dfg~~~~~~~~~~-~~~~gt~~y~aPE~~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~--~----~~~~--~ 259 (320)
T 3a99_A 190 KLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--E----IIRG--Q 259 (320)
T ss_dssp EECCCTTCEECCSSCB-CCCCSCGGGSCHHHHHH-SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----HHHC--C
T ss_pred EEeeCccccccccccc-cCCCCCccCCChHHhcc-CCCCCccchHHhHHHHHHHHHHCCCCCCChh--h----hhcc--c
Confidence 9999999986544322 34568999999999874 2234688999999999999999999997532 1 1122 2
Q ss_pred CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1040 PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1040 p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
..++..++.++.+||.+||..||.+|||+.+|+++.+
T Consensus 260 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~ 296 (320)
T 3a99_A 260 VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 296 (320)
T ss_dssp CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHh
Confidence 2356678999999999999999999999999998643
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=340.94 Aligned_cols=250 Identities=22% Similarity=0.222 Sum_probs=200.7
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-CC-----ceeEEEe
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HP-----NVVAFYG 880 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-HP-----NIVqL~G 880 (1094)
.++|++.+.||+|+||.||+|++. ++.||||+++.. ......+.+|+.+++.++ |+ +|+++++
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~ 123 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---------KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR 123 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---------HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---------HHHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence 478999999999999999999875 678999998643 223456677888888775 44 4999999
Q ss_pred EeecCCCCceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHH--HCCceeccCCCCceEeccCCCCCC
Q 037285 881 VVQDGPGGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLH--SKNIVHFDLKCDNLLVNLKDPSRP 957 (1094)
Q Consensus 881 v~~d~~~~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLH--s~GIIHRDLKPeNILLD~~~~e~g 957 (1094)
++.... .+++||||+. ++|.+++.... ..+++..+..++.||+.||.||| +.||+||||||+|||++.+ .++
T Consensus 124 ~~~~~~--~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~--~~~ 198 (382)
T 2vx3_A 124 HFMFRN--HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNP--KRS 198 (382)
T ss_dssp EEEETT--EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESST--TSC
T ss_pred eeccCC--ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecC--CCC
Confidence 998765 8999999995 59999987654 45899999999999999999999 5789999999999999521 467
Q ss_pred cEEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhcc
Q 037285 958 ICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 1037 (1094)
Q Consensus 958 ~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~ 1037 (1094)
.+||+|||+++..... .....+|+.|+|||++. ...++.++|||||||++|||+||+.||......+.+..+....
T Consensus 199 ~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~--~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 274 (382)
T 2vx3_A 199 AIKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLL--GMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVL 274 (382)
T ss_dssp CEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHT--TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred cEEEEeccCceecccc--cccccCCccccChHHHc--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 8999999999865433 23456899999999998 4568899999999999999999999999887766655543311
Q ss_pred CCCC----------------CCC----------------------------------------------cCcHHHHHHHH
Q 037285 1038 LRPT----------------IPS----------------------------------------------YCDAEWRTLME 1055 (1094)
Q Consensus 1038 lrp~----------------iPe----------------------------------------------~~S~eL~dLI~ 1055 (1094)
..+. ++. .....+.+||.
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 354 (382)
T 2vx3_A 275 GIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLIL 354 (382)
T ss_dssp CSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHH
T ss_pred CCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHH
Confidence 0000 000 00147899999
Q ss_pred HhccCCCCCCCCHHHHHHHHH
Q 037285 1056 ECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1056 kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
+||+.||++|||+.+++++-+
T Consensus 355 ~mL~~dP~~Rpta~e~L~hp~ 375 (382)
T 2vx3_A 355 RMLDYDPKTRIQPYYALQHSF 375 (382)
T ss_dssp HHTCSCTTTSCCHHHHTTSGG
T ss_pred HhcCCChhhCCCHHHHhcCcc
Confidence 999999999999999998754
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=350.76 Aligned_cols=257 Identities=29% Similarity=0.410 Sum_probs=197.6
Q ss_pred ceeeccCCeeEEEEecccCceE-EEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeE
Q 037285 804 VQVIKNEDLEEQKELGSGTFGT-VYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGV 881 (1094)
Q Consensus 804 v~eIs~edYei~kkLGsG~FGt-VYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv 881 (1094)
...+...+|++.+.||+|+||+ ||++.+.++.||||++..... ..+.+|+.+|+++ +|||||+++++
T Consensus 18 ~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----------~~~~~E~~~l~~l~~HpnIv~l~~~ 86 (432)
T 3p23_A 18 VVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----------SFADREVQLLRESDEHPNVIRYFCT 86 (432)
T ss_dssp CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----------EECHHHHHHHHHSCCCTTBCCEEEE
T ss_pred cEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----------HHHHHHHHHHHhccCCCCcCeEEEE
Confidence 4566777899999999999998 556777899999999875422 1245799999999 79999999999
Q ss_pred eecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCC-CCCCcEE
Q 037285 882 VQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKD-PSRPICK 960 (1094)
Q Consensus 882 ~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~-~e~g~VK 960 (1094)
+.+.. .+++||||+. |+|.+++......+.+..++.++.||+.||.|||+++|+||||||+|||++..+ .....+|
T Consensus 87 ~~~~~--~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~k 163 (432)
T 3p23_A 87 EKDRQ--FQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAM 163 (432)
T ss_dssp EEETT--EEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEE
T ss_pred EecCC--EEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEE
Confidence 98765 8999999995 699999987665566667788999999999999999999999999999996322 1345689
Q ss_pred EEecCCcccccCc----cccCCccCCCcccCccccccC-CCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHh
Q 037285 961 VGDFGLSKIKRNT----LVSGGVRGTLPWMAPELLSGS-SSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIV 1034 (1094)
Q Consensus 961 LsDFGLSrl~~~~----~~ss~~~GT~~YmAPEvL~g~-~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv 1034 (1094)
|+|||+++..... .......||+.|+|||++.+. ...++.++|||||||++|||+| |..||.............
T Consensus 164 L~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~ 243 (432)
T 3p23_A 164 ISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLG 243 (432)
T ss_dssp ECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTT
T ss_pred EecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhc
Confidence 9999999854322 223446799999999998742 3456789999999999999999 999997655444322221
Q ss_pred hccCCC-CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1035 NNTLRP-TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1035 ~~~lrp-~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
...... ..+...+..+.+||.+||+.||.+|||+.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 244 ACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp CCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 111111 1123345678999999999999999999999964
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=342.24 Aligned_cols=250 Identities=27% Similarity=0.381 Sum_probs=188.7
Q ss_pred cCCeeEEEEecccCceEEEE-eeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYH-GKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYK-Ak~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~~d~~ 886 (1094)
.+.|...+.||+|+||+||. +..+|+.||||++.... ...+.+|+.+|+++ +||||+++++++.+..
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-----------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 82 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----------CDIALMEIKLLTESDDHPNVIRYYCSETTDR 82 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-----------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred hheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-----------HHHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence 45567789999999999964 55678999999986531 23567899999876 8999999999998755
Q ss_pred CCceEEEeeecccchhHHHHhhcccc------cCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCC-------
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRF------LDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKD------- 953 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~------Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~------- 953 (1094)
.+++||||+. |+|.+++...... .++..++.++.||+.||+|||+++|+||||||+|||++..+
T Consensus 83 --~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~ 159 (434)
T 2rio_A 83 --FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQ 159 (434)
T ss_dssp --EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCT
T ss_pred --eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccc
Confidence 8999999995 6999999765421 12234577999999999999999999999999999997321
Q ss_pred --CCCCcEEEEecCCcccccCcc-----ccCCccCCCcccCccccccC-----CCCCCchhhHHHHHHHHHHHHc-CCCC
Q 037285 954 --PSRPICKVGDFGLSKIKRNTL-----VSGGVRGTLPWMAPELLSGS-----SSKVSEKVDVFSFGIVLWEILT-GEEP 1020 (1094)
Q Consensus 954 --~e~g~VKLsDFGLSrl~~~~~-----~ss~~~GT~~YmAPEvL~g~-----~~kyS~KSDVWSLGVLLyELLT-Gk~P 1020 (1094)
.....+||+|||+++...... ......||+.|+|||++.+. ...++.++|||||||++|||+| |+.|
T Consensus 160 ~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~P 239 (434)
T 2rio_A 160 TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239 (434)
T ss_dssp TCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCT
T ss_pred cCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCC
Confidence 245689999999998543321 12345699999999999741 2568899999999999999999 9999
Q ss_pred CCCCChHHHHHhHhhccCCCCC-----CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1021 YANMHYGAIIGGIVNNTLRPTI-----PSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1021 F~~~~~~eile~Iv~~~lrp~i-----Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
|....... ..+......... ...++.++.+||.+||+.||.+|||+.+|+++
T Consensus 240 f~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 240 FGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp TCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 97654433 222232222111 12346789999999999999999999999874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=321.91 Aligned_cols=234 Identities=14% Similarity=0.067 Sum_probs=189.5
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
+..++|++.+.||+|+||.||+|++. ++.||||++...... .......|.+|+.++.+++||||+++++++.+
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 102 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVL-----PDDVLQETLSRTLRLSRIDKPGVARVLDVVHT 102 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCS-----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECccccc-----CHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE
Confidence 45578999999999999999999986 788999999765322 12345678899999999999999999999988
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
.. .+|+||||+.+++|.+++... .....++.|+.||+.||+|||++||+||||||+|||++ .++.+||+++
T Consensus 103 ~~--~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~----~~g~~kl~~~ 173 (286)
T 3uqc_A 103 RA--GGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS----IDGDVVLAYP 173 (286)
T ss_dssp TT--EEEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE----TTSCEEECSC
T ss_pred CC--cEEEEEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEc----CCCCEEEEec
Confidence 64 899999999999999999542 35567888999999999999999999999999999999 7788998744
Q ss_pred CCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHH---hHhhccCCC-
Q 037285 965 GLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIG---GIVNNTLRP- 1040 (1094)
Q Consensus 965 GLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile---~Iv~~~lrp- 1040 (1094)
+ |++ .++.++|||||||++|+|+||+.||........+. .........
T Consensus 174 ~-------------------~~~---------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 225 (286)
T 3uqc_A 174 A-------------------TMP---------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEP 225 (286)
T ss_dssp C-------------------CCT---------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCH
T ss_pred c-------------------ccC---------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCCh
Confidence 3 333 25789999999999999999999998765433211 111111111
Q ss_pred -CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 037285 1041 -TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAAS 1083 (1094)
Q Consensus 1041 -~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s 1083 (1094)
.....++..+.+||.+||+.||.+| |+.++++.|..+.....
T Consensus 226 ~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 226 ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 1235688999999999999999999 99999999999875544
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=317.23 Aligned_cols=233 Identities=25% Similarity=0.358 Sum_probs=184.1
Q ss_pred CCeeEE-EEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHH-hhCCCCceeEEEeEeec-
Q 037285 810 EDLEEQ-KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL-SKLHHPNVVAFYGVVQD- 884 (1094)
Q Consensus 810 edYei~-kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkIL-krL~HPNIVqL~Gv~~d- 884 (1094)
++|.+. +.||+|+||.||+|.+. +..||||++... ..+.+|+.++ +.++||||+++++++..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~ 83 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------------PKARREVELHWRASQCPHIVRIVDVYENL 83 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------------HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence 567777 78999999999999874 678999998642 3456788887 56689999999999865
Q ss_pred -CCCCceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 885 -GPGGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 885 -~~~~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
.....+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++..+ .++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~~~kl~ 162 (299)
T 3m2w_A 84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR-PNAILKLT 162 (299)
T ss_dssp ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS-TTCCEEEC
T ss_pred cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCC-CCCcEEEe
Confidence 22347899999999999999997654 3699999999999999999999999999999999999998322 26789999
Q ss_pred ecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCC--C
Q 037285 963 DFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR--P 1040 (1094)
Q Consensus 963 DFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lr--p 1040 (1094)
|||++.... ...++.++|||||||++|+|++|+.||.................. .
T Consensus 163 Dfg~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 219 (299)
T 3m2w_A 163 DFGFAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 219 (299)
T ss_dssp CCTTCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCC
T ss_pred ccccccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccc
Confidence 999986322 124677999999999999999999999876554433222111111 1
Q ss_pred CCC----CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1041 TIP----SYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1041 ~iP----e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
..+ ..++.++.+||.+||+.||.+|||+.+++++.+-..
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~ 262 (299)
T 3m2w_A 220 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 262 (299)
T ss_dssp SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcc
Confidence 122 457899999999999999999999999999877654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-36 Score=335.25 Aligned_cols=247 Identities=14% Similarity=0.059 Sum_probs=184.4
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCC-Cce---------e
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHH-PNV---------V 876 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~H-PNI---------V 876 (1094)
..+|...+.||+|+||+||+|++. |+.||||++...... .......|.+|+.+++.++| .|+ +
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~-----~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~ 151 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP-----PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 151 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC---------CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBC
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCc-----cHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccc
Confidence 345888999999999999999986 889999998743211 12224568899999999987 211 1
Q ss_pred ------------EEEeEeecCC---CCceEEEeeecccchhHHHHh------hcccccCHHHHHHHHHHHHHHHHHHHHC
Q 037285 877 ------------AFYGVVQDGP---GGTLATVAEYMVDGSLRHVLV------RKDRFLDRRRRLIIAMDAAFGMEYLHSK 935 (1094)
Q Consensus 877 ------------qL~Gv~~d~~---~~~L~IVmEYmegGSL~d~L~------k~~~~Lse~~~l~Ia~QIaeGLaYLHs~ 935 (1094)
.+..++.... ...++++|+++ +++|.+++. .....+++..++.++.||+.||+|||++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 230 (413)
T 3dzo_A 152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY 230 (413)
T ss_dssp CCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred cchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 1111111111 12456666654 789998884 2244588889999999999999999999
Q ss_pred CceeccCCCCceEeccCCCCCCcEEEEecCCcccccCccccCCccCCCcccCcccccc--------CCCCCCchhhHHHH
Q 037285 936 NIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSG--------SSSKVSEKVDVFSF 1007 (1094)
Q Consensus 936 GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g--------~~~kyS~KSDVWSL 1007 (1094)
+|+||||||+|||++ .++.+||+|||+++..... ....+| +.|+|||++.+ ....++.++|||||
T Consensus 231 ~iiHrDiKp~NILl~----~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl 303 (413)
T 3dzo_A 231 GLVHTYLRPVDIVLD----QRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303 (413)
T ss_dssp TEECSCCCGGGEEEC----TTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred CcccCCcccceEEEe----cCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence 999999999999999 7778999999999865443 334567 99999999831 14457889999999
Q ss_pred HHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1008 GIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1008 GVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
||++|||+||+.||...........+.. ....++..+.+||.+||+.||.+||++.+++++
T Consensus 304 Gvil~elltg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 304 GLAIYWIWCADLPNTDDAALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHHHHHSSCCCCTTGGGSCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHHCCCCCCCcchhhhHHHHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 9999999999999987665443333322 123578999999999999999999998777644
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=330.45 Aligned_cols=254 Identities=17% Similarity=0.168 Sum_probs=189.1
Q ss_pred eccCCeeEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC---------CCceeE
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH---------HPNVVA 877 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~---------HPNIVq 877 (1094)
+..++|++.+.||+|+||.||+|+++|+.||||++..................+.+|+.+|+.++ ||||++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 45578999999999999999999999999999999876432111111222356778888888875 777777
Q ss_pred EEeEee-----------------c-----------CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHH
Q 037285 878 FYGVVQ-----------------D-----------GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGM 929 (1094)
Q Consensus 878 L~Gv~~-----------------d-----------~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGL 929 (1094)
+++++. + .....+++||||+.+|++.+.+.+ ..+++..++.++.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence 777643 1 013489999999999987776644 4589999999999999999
Q ss_pred HHHH-HCCceeccCCCCceEeccCCC----------------CCCcEEEEecCCcccccCccccCCccCCCcccCccccc
Q 037285 930 EYLH-SKNIVHFDLKCDNLLVNLKDP----------------SRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLS 992 (1094)
Q Consensus 930 aYLH-s~GIIHRDLKPeNILLD~~~~----------------e~g~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~ 992 (1094)
.||| +++|+||||||+|||++..+. ....+||+|||+|+..... ...||+.|+|||++.
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~ 250 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFT 250 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGC
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhc
Confidence 9999 999999999999999983220 1128999999999865433 236999999999998
Q ss_pred cCCCCCCchhhHHHHHHH-HHHHHcCCCCCCCCCh-HHHHHhHhhcc-CCCC----CCCcCcHHHHHHHHHhccCCCCCC
Q 037285 993 GSSSKVSEKVDVFSFGIV-LWEILTGEEPYANMHY-GAIIGGIVNNT-LRPT----IPSYCDAEWRTLMEECWAPNPAAR 1065 (1094)
Q Consensus 993 g~~~kyS~KSDVWSLGVL-LyELLTGk~PF~~~~~-~eile~Iv~~~-lrp~----iPe~~S~eL~dLI~kCLq~DPeeR 1065 (1094)
+. . +.++|||||+++ .+++++|..||..... ......+.... .... .+..+++++.+||.+||..|
T Consensus 251 g~--~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d---- 323 (336)
T 2vuw_A 251 GD--G-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS---- 323 (336)
T ss_dssp CC--S-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----
T ss_pred CC--C-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----
Confidence 53 2 789999998777 7778889999854321 11222222211 1111 12346788999999999976
Q ss_pred CCHHHHH-HH
Q 037285 1066 PSFTEIA-SR 1074 (1094)
Q Consensus 1066 PS~eELL-q~ 1074 (1094)
|+.+++ ++
T Consensus 324 -sa~e~l~~H 332 (336)
T 2vuw_A 324 -SATDLLCQH 332 (336)
T ss_dssp -SHHHHHHHC
T ss_pred -CHHHHHhcC
Confidence 899998 65
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=351.97 Aligned_cols=243 Identities=21% Similarity=0.254 Sum_probs=193.3
Q ss_pred eccCCeeEEEEecccCceEEEEeeec---CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEee
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR---GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQ 883 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r---Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~ 883 (1094)
+..++|++.+.||+|+||.||+|++. ++.||||++.... .......+.+|+.+|++++||||+++++++.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 149 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-------DAEAQAMAMAERQFLAEVVHPSIVQIFNFVE 149 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-------CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-------CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEe
Confidence 44579999999999999999999874 6789999886431 1223457889999999999999999999998
Q ss_pred cCCCC---ceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEE
Q 037285 884 DGPGG---TLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICK 960 (1094)
Q Consensus 884 d~~~~---~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VK 960 (1094)
..... ..|+||||+++++|.+++.. .+++..++.|+.||+.||.|||++||+||||||+|||++ . +.+|
T Consensus 150 ~~~~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~----~-~~~k 221 (681)
T 2pzi_A 150 HTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT----E-EQLK 221 (681)
T ss_dssp EECTTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----S-SCEE
T ss_pred ecCCCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEe----C-CcEE
Confidence 65311 16999999999999988754 589999999999999999999999999999999999998 3 3899
Q ss_pred EEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCC
Q 037285 961 VGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 1040 (1094)
Q Consensus 961 LsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp 1040 (1094)
|+|||+++..... ....||+.|+|||++.+ .++.++|||||||++|+|++|..||...... ....
T Consensus 222 l~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~---~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------~~~~ 286 (681)
T 2pzi_A 222 LIDLGAVSRINSF---GYLYGTPGFQAPEIVRT---GPTVATDIYTVGRTLAALTLDLPTRNGRYVD---------GLPE 286 (681)
T ss_dssp ECCCTTCEETTCC---SCCCCCTTTSCTTHHHH---CSCHHHHHHHHHHHHHHHHSCCCEETTEECS---------SCCT
T ss_pred EEecccchhcccC---CccCCCccccCHHHHcC---CCCCceehhhhHHHHHHHHhCCCCCcccccc---------cccc
Confidence 9999999865443 34569999999999874 2488999999999999999999988652110 0100
Q ss_pred CC-CCcCcHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHH
Q 037285 1041 TI-PSYCDAEWRTLMEECWAPNPAARP-SFTEIASRLRVLS 1079 (1094)
Q Consensus 1041 ~i-Pe~~S~eL~dLI~kCLq~DPeeRP-S~eELLq~L~~L~ 1079 (1094)
.. ...++..+.+||.+||+.||.+|| +++++...|..+.
T Consensus 287 ~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 287 DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 00 012357899999999999999999 5677777776654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=347.35 Aligned_cols=254 Identities=26% Similarity=0.354 Sum_probs=197.3
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec--
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD-- 884 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d-- 884 (1094)
.++|++.+.||+|+||.||+|.+. |..||||++.... .......+.+|+.+|++++||||+++++++..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~-------~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~ 85 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL-------SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQ 85 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC-------CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTC
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC-------CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccc
Confidence 368999999999999999999874 6889999986531 12334678899999999999999999999765
Q ss_pred --CCCCceEEEeeecccchhHHHHhhcc--cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEE
Q 037285 885 --GPGGTLATVAEYMVDGSLRHVLVRKD--RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICK 960 (1094)
Q Consensus 885 --~~~~~L~IVmEYmegGSL~d~L~k~~--~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VK 960 (1094)
......++||||+.+|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++..+ ....+|
T Consensus 86 ~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g-~~~~vK 164 (676)
T 3qa8_A 86 KLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGP-QRLIHK 164 (676)
T ss_dssp CCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCS-SSCEEE
T ss_pred cccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCC-CceeEE
Confidence 12447899999999999999997643 2588999999999999999999999999999999999998332 344699
Q ss_pred EEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhH-------
Q 037285 961 VGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI------- 1033 (1094)
Q Consensus 961 LsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~I------- 1033 (1094)
|+|||+++............||+.|+|||++. ...++.++|||||||++|+|++|+.||........+...
T Consensus 165 L~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~--~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 165 IIDLGYAKELDQGELCTEFVGTLQYLAPELLE--QKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242 (676)
T ss_dssp ECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSC--CSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-----
T ss_pred EcccccccccccccccccccCCcccCChHHhc--cCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccch
Confidence 99999998765555555667999999999997 457889999999999999999999999765332211000
Q ss_pred ---h----hccC--------CCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHH
Q 037285 1034 ---V----NNTL--------RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIA 1072 (1094)
Q Consensus 1034 ---v----~~~l--------rp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELL 1072 (1094)
. .... ...+...++..+.+||.+||..||.+|||+.+++
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 0 0000 0112234678899999999999999999998844
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=289.02 Aligned_cols=191 Identities=16% Similarity=0.074 Sum_probs=133.3
Q ss_pred EEecccCceEEEEeee--cCceEEEEEeecCccCCC--chhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEeecCCCCce
Q 037285 816 KELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGR--SSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQDGPGGTL 890 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~--~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~~d~~~~~L 890 (1094)
..++.|++|.+..++. .|+.+|||++.+...... ....+....+|.+|+++|+++ .|+||+++++++.+.. .+
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~--~~ 317 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQ--SG 317 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSS--EE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECC--EE
Confidence 4567788887776544 589999999987643322 233455567899999999999 6999999999998865 89
Q ss_pred EEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccc
Q 037285 891 ATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK 970 (1094)
Q Consensus 891 ~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~ 970 (1094)
||||||++|++|.++|...+ .++.. .|+.||+.||+|||++|||||||||+|||++ .++.+||+|||+|+..
T Consensus 318 yLVMEyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~----~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 318 WLVMEKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVD----ARQHARLIDFGSIVTT 389 (569)
T ss_dssp EEEEECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEEC----TTSCEEECCCTTEESC
T ss_pred EEEEecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEEC----CCCCEEEeecccCeeC
Confidence 99999999999999997665 46654 4789999999999999999999999999998 7889999999999854
Q ss_pred cC-ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCC
Q 037285 971 RN-TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEE 1019 (1094)
Q Consensus 971 ~~-~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~ 1019 (1094)
.. .......+||+.|||||++.+ .+..++|+|++|+++++|.++..
T Consensus 390 ~~~~~~~~t~vGTp~YmAPE~l~g---~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 390 PQDCSWPTNLVQSFFVFVNELFAE---NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp C---CCSHHHHHHHHHHHHHHC--------------------CCCCTTHH
T ss_pred CCCCccccCceechhhccHHHhCC---CCCCcccccccccchhhhccccc
Confidence 33 233345679999999999974 35678999999999887755433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.5e-26 Score=267.06 Aligned_cols=193 Identities=19% Similarity=0.159 Sum_probs=147.3
Q ss_pred eEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceEE
Q 037285 813 EEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLAT 892 (1094)
Q Consensus 813 ei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~I 892 (1094)
...+.||+|+||.||+|++.+..+++|....................+.+|+.+|++++||||+++..++.... ..++
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~--~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD--NKRI 416 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT--TTEE
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC--ccEE
Confidence 34678999999999999988999999987664333222233334567899999999999999994444444433 6799
Q ss_pred EeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccC
Q 037285 893 VAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRN 972 (1094)
Q Consensus 893 VmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~ 972 (1094)
||||+++++|.+++.. ++.++.||++||+|||+++|+||||||+|||++ . .+||+|||+++....
T Consensus 417 VmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~----~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 417 MMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD----K--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEES----S--SEEECCCTTCEECCC
T ss_pred EEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEEC----C--eEEEEECccCEECCC
Confidence 9999999999999865 567999999999999999999999999999998 4 899999999996544
Q ss_pred ccc--------cCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 037285 973 TLV--------SGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYA 1022 (1094)
Q Consensus 973 ~~~--------ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~ 1022 (1094)
... .....||+.|||||++.+....|+..+|+|+..+-..+.+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 211 23467999999999998533567788999999988888777666653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=2.5e-21 Score=208.78 Aligned_cols=152 Identities=18% Similarity=0.025 Sum_probs=115.7
Q ss_pred CCeeEEEEecccCceEEEEeeec-CceEEEEEeecCccCCC--chhHH--------HHHHHHHHHHHHHhhCCCCceeEE
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGR--SSEQE--------RLTVEFWKEAEILSKLHHPNVVAF 878 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r-Gt~VAVKiIkk~~~se~--~~eqe--------~~~~eFlrEIkILkrL~HPNIVqL 878 (1094)
..|.+.+.||+|+||.||+|.+. |..||||+++....... ....+ .....+.+|+.+|++++ | +++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred eEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 34667799999999999999984 78899999975321110 00000 23467889999999999 4 555
Q ss_pred EeEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCc
Q 037285 879 YGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPI 958 (1094)
Q Consensus 879 ~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~ 958 (1094)
++++... ..++||||+++++|.+ +.. .....++.||+.||.|||++||+||||||+|||++ ++.
T Consensus 167 ~~~~~~~---~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-----~~~ 230 (282)
T 1zar_A 167 PKVYAWE---GNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-----EEG 230 (282)
T ss_dssp CCEEEEE---TTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-----TTE
T ss_pred CeEEecc---ceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-----CCc
Confidence 5655442 5799999999999988 421 22446999999999999999999999999999998 468
Q ss_pred EEEEecCCcccccCccccCCccCCCcccCccccc
Q 037285 959 CKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLS 992 (1094)
Q Consensus 959 VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~ 992 (1094)
+||+|||+++. +..++|||++.
T Consensus 231 vkl~DFG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 231 IWIIDFPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp EEECCCTTCEE------------TTSTTHHHHHH
T ss_pred EEEEECCCCeE------------CCCCCHHHHHH
Confidence 99999999862 34578999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.9e-18 Score=183.16 Aligned_cols=143 Identities=17% Similarity=0.102 Sum_probs=106.3
Q ss_pred eeEEEEecccCceEEEEeee--cCce--EEEEEeecCccCCCc----------------hhHHHHHHHHHHHHHHHhhCC
Q 037285 812 LEEQKELGSGTFGTVYHGKW--RGTD--VAIKRIKKSCFTGRS----------------SEQERLTVEFWKEAEILSKLH 871 (1094)
Q Consensus 812 Yei~kkLGsG~FGtVYKAk~--rGt~--VAVKiIkk~~~se~~----------------~eqe~~~~eFlrEIkILkrL~ 871 (1094)
|++.+.||+|+||.||+|.+ .|.. ||||+++........ .........+.+|+.+|.+|.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67889999999999999998 6888 999998654211000 001122346788999999998
Q ss_pred CCce--eEEEeEeecCCCCceEEEeeeccc-c----hhHHHHhhcccccCHHHHHHHHHHHHHHHHHHH-HCCceeccCC
Q 037285 872 HPNV--VAFYGVVQDGPGGTLATVAEYMVD-G----SLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLH-SKNIVHFDLK 943 (1094)
Q Consensus 872 HPNI--VqL~Gv~~d~~~~~L~IVmEYmeg-G----SL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLH-s~GIIHRDLK 943 (1094)
|+++ +.++.+ . ..++||||+.+ | +|.++... .++..+..++.||+.+|.||| +.||+|||||
T Consensus 129 ~~~i~~p~~~~~--~----~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlk 198 (258)
T 1zth_A 129 EAGVSVPQPYTY--M----KNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLS 198 (258)
T ss_dssp HTTCCCCCEEEE--E----TTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCS
T ss_pred hCCCCCCeEEEc--C----CCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCC
Confidence 8754 344432 1 57899999943 4 66665432 234567789999999999999 9999999999
Q ss_pred CCceEeccCCCCCCcEEEEecCCcccc
Q 037285 944 CDNLLVNLKDPSRPICKVGDFGLSKIK 970 (1094)
Q Consensus 944 PeNILLD~~~~e~g~VKLsDFGLSrl~ 970 (1094)
|+|||++ . .++|+|||+|...
T Consensus 199 p~NILl~----~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EYNIMYI----D--KVYFIDMGQAVTL 219 (258)
T ss_dssp TTSEEES----S--SEEECCCTTCEET
T ss_pred HHHEEEc----C--cEEEEECcccccC
Confidence 9999998 4 8999999999743
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.52 E-value=1.9e-14 Score=164.08 Aligned_cols=145 Identities=13% Similarity=0.032 Sum_probs=99.1
Q ss_pred eeEEEEecccCceEEEEeee-cCceEEEEEeecCccCCC------------chhHHH--HHHHHHHHHHHHhhCCCCcee
Q 037285 812 LEEQKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGR------------SSEQER--LTVEFWKEAEILSKLHHPNVV 876 (1094)
Q Consensus 812 Yei~kkLGsG~FGtVYKAk~-rGt~VAVKiIkk~~~se~------------~~eqe~--~~~eFlrEIkILkrL~HPNIV 876 (1094)
|++.+.||+|+||.||+|.. .|+.||||+++.....-+ ...... ......+|...|.+|.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 78999999999999999987 478999999865321100 000001 111223567777777554432
Q ss_pred --EEEeEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCC
Q 037285 877 --AFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP 954 (1094)
Q Consensus 877 --qL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~ 954 (1094)
..+++ . ..+|||||+.+++|..+.. ......++.||+.+|.+||+.|||||||||.|||++.++.
T Consensus 177 vp~p~~~--~----~~~LVME~i~G~~L~~l~~-------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 177 VPEPIAQ--S----RHTIVMSLVDALPMRQVSS-------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKD 243 (397)
T ss_dssp CCCEEEE--E----TTEEEEECCSCEEGGGCCC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEEC
T ss_pred CCeeeec--c----CceEEEEecCCccHhhhcc-------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCC
Confidence 22222 1 2478999999998865432 1234567899999999999999999999999999983221
Q ss_pred C------CCcEEEEecCCccc
Q 037285 955 S------RPICKVGDFGLSKI 969 (1094)
Q Consensus 955 e------~g~VKLsDFGLSrl 969 (1094)
. ...+.|+||+.+..
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEE
T ss_pred cccccccccceEEEEeCCccc
Confidence 0 11489999998764
|
| >2cu1_A Mitogen-activated protein kinase kinase kinase 2; PB1 domain, MAPK/ERK kinase kinase 2, MEK kinase 2, MEKK 2, signaling protein; NMR {Homo sapiens} SCOP: d.15.2.2 | Back alignment and structure |
|---|
Probab=99.25 E-value=2.3e-11 Score=113.21 Aligned_cols=74 Identities=19% Similarity=0.363 Sum_probs=65.1
Q ss_pred cCceEEEEecCCCChHHHHHHHHHHcCCceEEEEeCCCCCCCceeeccChhhHHHHHHHHhhcCCCCCCCeEEEEEecCC
Q 037285 109 GGETRIIRIRKDISWQILRQKALEVYNQVHVIKYQLPGEDLDALVSVSCDEDLQNMMEEYNELGDREGSQRIRMFLFSMS 188 (1094)
Q Consensus 109 GG~triv~v~r~~~~~~l~~kl~~~~~~~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~r~R~FlF~~~ 188 (1094)
+||+||+.|+|.|+|.||..|+.++||..+.|.|+ +++.||+++|+|||++.||+|||.. .. .-||+||-+..
T Consensus 16 ~GEkRIi~f~RPv~f~eL~~Kv~~~fGq~ldL~y~----n~EllIpl~sQeDLDkaIellDrss-~~--kSLrIlL~~~~ 88 (103)
T 2cu1_A 16 RGEKRILQFPRPVKLEDLRSKAKIAFGQSMDLHYT----NNELVIPLTTQDDLDKAVELLDRSI-HM--KSLKILLVING 88 (103)
T ss_dssp TTEEEEEEEESSCCHHHHHHHHHHHHSSCEEEEEC----SSSSCEECCSHHHHHHHHHHHHHCS-SC--CSEEEEEEECC
T ss_pred cCeEEEEeccCCccHHHHHHHHHHHhCCeeeEEEe----cceEEEeccCHHHHHHHHHHHccCC-cc--cceEEEEecCC
Confidence 57899999999999999999999999999999999 9999999999999999999999962 22 34566777555
Q ss_pred C
Q 037285 189 D 189 (1094)
Q Consensus 189 ~ 189 (1094)
.
T Consensus 89 ~ 89 (103)
T 2cu1_A 89 S 89 (103)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.14 E-value=1.6e-10 Score=120.59 Aligned_cols=139 Identities=17% Similarity=0.059 Sum_probs=107.9
Q ss_pred CCeeEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-CCceeEEEeEeecCCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-HPNIVqL~Gv~~d~~~~ 888 (1094)
..|++...++.|+++.||++...+..+++|+........ ...+.+|+.+|+.|. +..+.++++++... +
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~--------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~ 83 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--------TYDVEREKDMMLWLEGKLPVPKVLHFERHD--G 83 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS--------TTCHHHHHHHHHHHTTTSCCCCEEEEEEET--T
T ss_pred ccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC--------HHHHHHHHHHHHHHhcCCCCCeEEEEEecC--C
Confidence 357888889999999999998778899999986531111 124668889998884 66788899888764 4
Q ss_pred ceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH----------------------------------
Q 037285 889 TLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHS---------------------------------- 934 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs---------------------------------- 934 (1094)
..++||||++|.+|.+.+. +......++.+++++|..||+
T Consensus 84 ~~~lv~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T 3tm0_A 84 WSNLLMSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEEEEECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGG
T ss_pred ceEEEEEecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccc
Confidence 7899999999999987642 112234678899999999998
Q ss_pred -------------------------CCceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 935 -------------------------KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 935 -------------------------~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
..++|+|++|.|||++ .+..+.|+||+.+.
T Consensus 158 ~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~----~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK----DGKVSGFIDLGRSG 212 (263)
T ss_dssp GSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE----TTEEEEECCCTTCE
T ss_pred ccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE----CCcEEEEEEchhcc
Confidence 4489999999999998 45556799999764
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=98.91 E-value=3e-11 Score=139.86 Aligned_cols=173 Identities=12% Similarity=0.117 Sum_probs=94.1
Q ss_pred cccccccCCCCchhhhccccccccc-----cCCCChhHHHHcCCc-hh---hhhhhhcCCceeEEeeeccCCCCCCcccc
Q 037285 669 ISVNMENHEPKRWSYFRNLAQVDFG-----QKDVSLIDQEHLGLS-SG---VREVREEDGRLYHFTPLTDDGAPKGRVDS 739 (1094)
Q Consensus 669 ~s~~~~~~~~~~~~~~~~Le~~~Wy-----~~~IsR~~AE~ll~a-~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~s 739 (1094)
..++.++++|+++.+-..|+..+|| ||.|+|.+||.+|.. +| ||+|...+| .|.+|+.+. +.++
T Consensus 25 ~~~~~~g~~P~~~v~~~~~~~~~wy~~~w~hg~i~r~~ae~lL~~~~G~FLvR~S~~~~g-~~~Lsv~~~-----~~v~- 97 (463)
T 3cxl_A 25 YQLQQEAPHPRRITCTCEVENRPKYYGREFHGMISREAADQLLIVAEGSYLIRESQRQPG-TYTLALRFG-----SQTR- 97 (463)
T ss_dssp HHHHHHSCCCEECCCCCCCTTCCTTCCTTBCCSCCHHHHHHHHTTSTTEEEEEECSSSTT-CEEEEEECS-----SSEE-
T ss_pred cCcCccCCCCcCccCCccccCCCCccccccccCCCHHHHHHHHcCCCCeEEEeccCCCCC-CEEEEEEEC-----CEEE-
Confidence 3456899999999998899999999 999999999999975 67 999998888 799999886 7888
Q ss_pred cccccccCCCccccCCCcccccchHHHHHhhhcccccccccCCCCCcCCCCCCCCCCcccCCCcceeeccCCeeEEEEec
Q 037285 740 QLNFGQDSQKTFGVDPSVSESMQFDAMMENLRTTESDYEEGNAGNRNIGLPSLNPSLVDFDVSSVQVIKNEDLEEQKELG 819 (1094)
Q Consensus 740 hy~I~~dsq~r~~vtp~isE~~qFdsL~ElLrt~eSdyee~nagn~~l~~P~lnpsl~~~dlssv~eIs~edYei~kkLG 819 (1094)
||.|.. .+.|+. . ...|.++.+++...--.++......... ... .+. .+.++||
T Consensus 98 H~~I~~--~g~~~~----~-~~~F~sl~~Lv~dGl~~~~~~~~~~~~~---------l~~------~i~----~l~~~lG 151 (463)
T 3cxl_A 98 NFRLYY--DGKHFV----G-EKRFESIHDLVTDGLITLYIETKAAEYI---------AKM------TIN----PIYEHVG 151 (463)
T ss_dssp EEECEE--SSSEES----S-SCCBSCHHHHHHHHHHHHHHHHHTHHHH---------HHT------TSS----CSTTTSS
T ss_pred EEEEec--CCeEEE----C-CCccCCHHHHHHHHHHhhhccCCCcchh---------hcc------ccc----cccccCC
Confidence 999976 455663 2 3579999888851000011111100000 000 000 2334566
Q ss_pred ccCceEEEEeeecC--ceEEE------EEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEee
Q 037285 820 SGTFGTVYHGKWRG--TDVAI------KRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQ 883 (1094)
Q Consensus 820 sG~FGtVYKAk~rG--t~VAV------KiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~ 883 (1094)
||.||+|.+.+ .+||| |..+...+. +.....|.+|..++++++|||+++.+++..
T Consensus 152 ---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~------~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 152 ---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVS------EKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp ---BCCC---------CCBGGGC-----------------------------------------CBCCCEEE
T ss_pred ---chhhhcccccccCCchhhhhccCcccccccccc------ccccccccccccccccccccccCCCcceEE
Confidence 99999999975 57888 665543221 223356888999999999999999988654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.91 E-value=4.8e-09 Score=107.63 Aligned_cols=131 Identities=18% Similarity=0.079 Sum_probs=92.2
Q ss_pred eeEEEEecccCceEEEEeeec-CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCc--eeEEEeEeecCCCC
Q 037285 812 LEEQKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPN--VVAFYGVVQDGPGG 888 (1094)
Q Consensus 812 Yei~kkLGsG~FGtVYKAk~r-Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPN--IVqL~Gv~~d~~~~ 888 (1094)
+.+....+.|..+.||++... |..+++|+...... ..+.+|+.+++.+.+.+ +.+++++.... +
T Consensus 22 ~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~~-----------~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~--~ 88 (264)
T 1nd4_A 22 YDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----------NELQDEAARLSWLATTGVPCAAVLDVVTEA--G 88 (264)
T ss_dssp CEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----------SCHHHHHHHHHHHHTTTCCBCCEEEEEECS--S
T ss_pred CceEecccCCCCceEEEEecCCCCeEEEEeCCcccc-----------hhhhHHHHHHHHHHhCCCCCCeEEEeccCC--C
Confidence 444333346667999998764 56799998754310 23567888888885444 55688877654 3
Q ss_pred ceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCC--------------------------------
Q 037285 889 TLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKN-------------------------------- 936 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~G-------------------------------- 936 (1094)
..++||||++|.+|. ... .+ ...++.++++.|..||+..
T Consensus 89 ~~~~v~e~i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (264)
T 1nd4_A 89 RDWLLLGEVPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLD 159 (264)
T ss_dssp CEEEEEECCSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCC
T ss_pred CCEEEEEecCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhh
Confidence 689999999999884 211 12 1245667777777777643
Q ss_pred --------------------------ceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 937 --------------------------IVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 937 --------------------------IIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
++|+|++|.|||++ .+..+.|+||+.+.
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~----~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 160 EEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVE----NGRFSGFIDCGRLG 213 (264)
T ss_dssp GGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE----TTEEEEECCCTTCE
T ss_pred hhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE----CCcEEEEEcchhcc
Confidence 99999999999998 45566799999865
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.88 E-value=5.6e-09 Score=114.60 Aligned_cols=143 Identities=18% Similarity=0.213 Sum_probs=104.7
Q ss_pred EEEecccCceEEEEeeecCceEEEEEee--cCccCCCchhHHHHHHHHHHHHHHHhhCC--CCceeEEEeEeecCCC-Cc
Q 037285 815 QKELGSGTFGTVYHGKWRGTDVAIKRIK--KSCFTGRSSEQERLTVEFWKEAEILSKLH--HPNVVAFYGVVQDGPG-GT 889 (1094)
Q Consensus 815 ~kkLGsG~FGtVYKAk~rGt~VAVKiIk--k~~~se~~~eqe~~~~eFlrEIkILkrL~--HPNIVqL~Gv~~d~~~-~~ 889 (1094)
.+.|+.|.++.||+....+..+++|+.. ..... .....+.+|+.+|+.|. +..+++++.++.+... +.
T Consensus 43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~-------~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~ 115 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLL-------PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR 115 (359)
T ss_dssp EEECCC-CCSCEEEEECSSCEEEEECCCC-----------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred EEEcCCcccceEEEEEECCceEEEEeCCCCCCCCC-------CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence 5678999999999998877888998765 32110 11235668999999887 4557888888876421 45
Q ss_pred eEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-----------------------------------
Q 037285 890 LATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHS----------------------------------- 934 (1094)
Q Consensus 890 L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs----------------------------------- 934 (1094)
.++||||++|..+.+.. -..++...+..++.++++.|..||+
T Consensus 116 ~~~vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 116 AFYIMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp CEEEEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred eEEEEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 78999999988875421 1236778888899999999999997
Q ss_pred -----------------------CCceeccCCCCceEeccCCCCCCcEEEEecCCccc
Q 037285 935 -----------------------KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI 969 (1094)
Q Consensus 935 -----------------------~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl 969 (1094)
..++|+|+++.|||++.++ ...+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~--~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTE--PRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSS--SCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCC--CcEEEEECcccccc
Confidence 3589999999999998221 13479999999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.79 E-value=1.3e-08 Score=109.50 Aligned_cols=184 Identities=21% Similarity=0.206 Sum_probs=119.3
Q ss_pred EEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-CCc--eeEEEeEeecCC-CCceE
Q 037285 816 KELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HPN--VVAFYGVVQDGP-GGTLA 891 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-HPN--IVqL~Gv~~d~~-~~~L~ 891 (1094)
+.++.|.+..||+.. ..+++|+.... .....+.+|+.+|+.+. +.. +.+++....... ....|
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~~----------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~ 92 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKHS----------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSF 92 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESSH----------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSC
T ss_pred EecCCCCcceEEEEC---CEEEEEecCCc----------chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcce
Confidence 348999999999874 56888985421 22356778999998873 322 445555443321 12357
Q ss_pred EEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 037285 892 TVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHS------------------------------------- 934 (1094)
Q Consensus 892 IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs------------------------------------- 934 (1094)
+||++++|.+|..... ..++...+..++.+++..|+.||+
T Consensus 93 ~vm~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (304)
T 3sg8_A 93 AGFTKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ 169 (304)
T ss_dssp EEEECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred EEEcccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence 8999999999875432 236777778888888888888885
Q ss_pred ---------------------CCceeccCCCCceEeccCCCCCCcEEEEecCCcccccCccccCCccC-----C------
Q 037285 935 ---------------------KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRG-----T------ 982 (1094)
Q Consensus 935 ---------------------~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~~~ss~~~G-----T------ 982 (1094)
..++|+|+++.||+++.+ ....+.|+||+.+.............. .
T Consensus 170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~--~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE--KNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT--TTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHH
T ss_pred HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCC--CCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHH
Confidence 137999999999999821 145689999999875332111000000 0
Q ss_pred ----CcccC-ccccccCCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 037285 983 ----LPWMA-PELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1021 (1094)
Q Consensus 983 ----~~YmA-PEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF 1021 (1094)
..... |+... ......+.|+++.++|.+.+|..+|
T Consensus 248 ~l~~Y~~~~~~~~~~----r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLE----KYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHTCSCHHHHHH----HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHcCCCCcHHHHH----HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 01111 22221 1122368999999999999998875
|
| >2eo3_A CRK-like protein; phosphorylation, repeat, SH2 domain, SH3 domain, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.57 E-value=1.4e-08 Score=96.13 Aligned_cols=87 Identities=17% Similarity=0.203 Sum_probs=73.6
Q ss_pred ccccccCCCCchhhhccccccccccCCCChhHHHHcCC--chh---hhhhhhcCCceeEEeeeccCCCCCCccccccccc
Q 037285 670 SVNMENHEPKRWSYFRNLAQVDFGQKDVSLIDQEHLGL--SSG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFG 744 (1094)
Q Consensus 670 s~~~~~~~~~~~~~~~~Le~~~Wy~~~IsR~~AE~ll~--a~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~ 744 (1094)
|+++++++|+|+.+ ++...|||+.|+|.+||.+|. .+| ||+|....| .|.+|+... +.++ ||.|.
T Consensus 2 ~~g~~G~ip~n~v~---~~~~~Wyhg~isR~~Ae~lL~~~~~G~FLVR~S~~~~g-~y~LSv~~~-----~~v~-H~~I~ 71 (111)
T 2eo3_A 2 SSGSSGMSSARFDS---SDRSAWYMGPVSRQEAQTRLQGQRHGMFLVRDSSTCPG-DYVLSVSEN-----SRVS-HYIIN 71 (111)
T ss_dssp CCCCCCSCSCCCCT---TCHHHHEEESCCHHHHHHHHSSCCTTCEEEEECSSSSS-CEEEEEEET-----TEEE-EEEEE
T ss_pred CCCccccccccccc---cCCCCcccCCCCHHHHHHHhcCCCCceEEEEeecCCCC-CEEEEEEeC-----CeEE-EEEEE
Confidence 47899999999975 577999999999999999998 667 999998778 899998875 7788 99998
Q ss_pred ccCCCccccCCCcccccchHHHHHhhh
Q 037285 745 QDSQKTFGVDPSVSESMQFDAMMENLR 771 (1094)
Q Consensus 745 ~dsq~r~~vtp~isE~~qFdsL~ElLr 771 (1094)
.+..+.|.. . ...|.++.+++.
T Consensus 72 ~~~~g~~~l----~-~~~F~sl~~LV~ 93 (111)
T 2eo3_A 72 SLPNRRFKI----G-DQEFDHLPALLE 93 (111)
T ss_dssp EETTTEEEE----T-TCCBSSHHHHHH
T ss_pred EcCCCCEEE----C-CcccCCHHHHHH
Confidence 766677773 2 468999999984
|
| >2dly_A FYN-related kinase; BRK family kinase, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=98.52 E-value=5.2e-08 Score=93.62 Aligned_cols=84 Identities=18% Similarity=0.216 Sum_probs=70.9
Q ss_pred CCCchhh-hccccccccccCCCChhHHHHcCCc----hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCC
Q 037285 677 EPKRWSY-FRNLAQVDFGQKDVSLIDQEHLGLS----SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQ 748 (1094)
Q Consensus 677 ~~~~~~~-~~~Le~~~Wy~~~IsR~~AE~ll~a----~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq 748 (1094)
+|+|+++ ..+|+...|||+.|+|.+||.+|.. +| ||++....| .|.+|+... +.++ ||.|..+..
T Consensus 2 ~psnyv~~~~~l~~~~WyhG~isR~eAe~lL~~~~~~~G~FLVR~S~~~~g-~y~LSv~~~-----~~v~-H~~I~~~~~ 74 (121)
T 2dly_A 2 SSGSSGAEDRSLQAEPWFFGAIKRADAEKQLLYSENQTGAFLIRESESQKG-DFSLSVLDE-----GVVK-HYRIRRLDE 74 (121)
T ss_dssp CSCCCCCSSGGGGGCSSBCSSCCHHHHHHHHTSSSCCTTCEEEEECSSSSS-CEEEEEESS-----SCEE-EEEEEECSS
T ss_pred CCccccccccccCcCCccccCCCHHHHHHHHhcCCCCCCEEEEEcCCCCCC-ceEEEEEEC-----CeEE-EEEEEEcCC
Confidence 6888885 5789999999999999999998875 35 999988777 799998885 7788 999988777
Q ss_pred CccccCCCcccccchHHHHHhhh
Q 037285 749 KTFGVDPSVSESMQFDAMMENLR 771 (1094)
Q Consensus 749 ~r~~vtp~isE~~qFdsL~ElLr 771 (1094)
+.|+ +.....|.++.+++.
T Consensus 75 g~~~----l~~~~~F~sl~eLV~ 93 (121)
T 2dly_A 75 GGFF----LTRRKVFSTLNEFVN 93 (121)
T ss_dssp SCEE----EETTEEESSHHHHHH
T ss_pred CCEE----ECCCCccCCHHHHHH
Confidence 7788 556788999999993
|
| >4d8k_A Tyrosine-protein kinase LCK; protein kinases, SH2 domain, SH3 domain, structural genomics center for structural genomics, JCSG; 2.36A {Homo sapiens} PDB: 1lck_A* 1x27_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=7.1e-08 Score=97.60 Aligned_cols=95 Identities=19% Similarity=0.209 Sum_probs=77.9
Q ss_pred ccccccCCCCchh-hhccccccccccCCCChhHHHHcCCc----hh---hhhhhhcCCceeEEeeeccCCCCCCcccccc
Q 037285 670 SVNMENHEPKRWS-YFRNLAQVDFGQKDVSLIDQEHLGLS----SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQL 741 (1094)
Q Consensus 670 s~~~~~~~~~~~~-~~~~Le~~~Wy~~~IsR~~AE~ll~a----~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy 741 (1094)
++++++.+|+++. ....|+...||++.|+|.+||.+|.. +| ||+|....| .|.+|+.+......+.++ ||
T Consensus 53 ~~g~~G~vP~~yv~~~~~l~~~~w~~g~isr~~ae~lL~~~~~~~G~FLVR~S~~~~g-~y~LSv~~~~~~~~~~v~-H~ 130 (175)
T 4d8k_A 53 TTGQEGFIPFNFVAKANSLEPEPWFFKNLSRKDAERQLLAPGNTHGSFLIRESESTAG-SFSLSVRDFDQNQGEVVK-HY 130 (175)
T ss_dssp TTCCEEEEEGGGEEETTCSTTCTTBCSSCCHHHHHHHHHSTTCCTTCEEEEECSSSTT-CEEEEEEEECTTSCEEEE-EE
T ss_pred CCCceeeeccccccccccccccceecCcccHHHHHHHHhcCCCCCCEEEEEECCCCCC-eEEEEEEeCcccCCCceE-EE
Confidence 3557788999998 46779999999999999999999955 56 999987788 899998874333446788 99
Q ss_pred cccccCCCccccCCCcccccchHHHHHhh
Q 037285 742 NFGQDSQKTFGVDPSVSESMQFDAMMENL 770 (1094)
Q Consensus 742 ~I~~dsq~r~~vtp~isE~~qFdsL~ElL 770 (1094)
.|.....+.|+ +.....|.++.+++
T Consensus 131 ~I~~~~~g~~~----~~~~~~F~sl~~LV 155 (175)
T 4d8k_A 131 KIRNLDNGGFY----ISPRITFPGLHELV 155 (175)
T ss_dssp EEEECSSSCEE----SSTTSEESSHHHHH
T ss_pred EEEECCCCCEE----ECCCCccCCHHHHH
Confidence 99887777788 55667899999999
|
| >1aot_F FYN protein-tyrosine kinase; SH2 domain, signal transduction, peptide complex, complex (proto-oncogene/early protein); HET: PTR; NMR {Homo sapiens} SCOP: d.93.1.1 PDB: 1aou_F* | Back alignment and structure |
|---|
Probab=98.34 E-value=1.9e-07 Score=87.17 Aligned_cols=80 Identities=16% Similarity=0.245 Sum_probs=65.1
Q ss_pred cccccccccCCCChhHHHHcCCc----hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCcc
Q 037285 686 NLAQVDFGQKDVSLIDQEHLGLS----SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVS 758 (1094)
Q Consensus 686 ~Le~~~Wy~~~IsR~~AE~ll~a----~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~is 758 (1094)
+|+...|||++|+|.+||.+|.. +| ||++....| .|.+|+....+...+.++ ||.|..+..+.|+ +.
T Consensus 1 sl~~~~Wyhg~isR~~Ae~lL~~~g~~~G~FLVR~S~~~~g-~~~LSv~~~~~~~~~~v~-H~~I~~~~~g~~~----l~ 74 (106)
T 1aot_F 1 SIQAEEWYFGKLGRKDAERQLLSFGNPRGTFLIRESETTKG-AYSLSIRDWDDMKGDHVK-HYKIRKLDNGGYY----IT 74 (106)
T ss_dssp CCCSSSSCCBSCCHHHHHHHHHTTTCCTTEECCBCBSSSSS-BBCCEEECCBTTTBCCEE-ECCBEEETTTEEE----EE
T ss_pred CCccCccCCCCCCHHHHHHHHhhCCCCCcEEEEEeCCCCCC-CEEEEEEecccCCCCcEE-EEEEEEeCCCCEE----EC
Confidence 58899999999999999998864 56 999998788 899998864333347788 9999876667787 55
Q ss_pred cccchHHHHHhhh
Q 037285 759 ESMQFDAMMENLR 771 (1094)
Q Consensus 759 E~~qFdsL~ElLr 771 (1094)
+...|.++.+++.
T Consensus 75 ~~~~F~sl~~LV~ 87 (106)
T 1aot_F 75 TRAQFETLQQLVQ 87 (106)
T ss_dssp TTEEESSHHHHHH
T ss_pred CCCccCCHHHHHH
Confidence 6788999999993
|
| >1lkk_A Human P56 tyrosine kinase; complex (tyrosine kinase/peptide); HET: PTR; 1.00A {Homo sapiens} SCOP: d.93.1.1 PDB: 1lcj_A* 1bhf_A* 1bhh_A 1lkl_A* 1bhh_B 1fbz_A* 1ijr_A* 1cwd_L* 1cwe_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=2e-07 Score=86.78 Aligned_cols=79 Identities=22% Similarity=0.247 Sum_probs=63.6
Q ss_pred ccccccccCCCChhHHHHcCC----chh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCccc
Q 037285 687 LAQVDFGQKDVSLIDQEHLGL----SSG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSE 759 (1094)
Q Consensus 687 Le~~~Wy~~~IsR~~AE~ll~----a~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~isE 759 (1094)
|+.+.|||++|+|.+||.+|. .+| ||+|....| .|.+|+........+.++ ||.|..+..+.|+ +..
T Consensus 1 l~~~~Wyhg~isR~~Ae~lL~~~~~~~G~FLVR~S~~~~g-~~~LSv~~~~~~~~~~v~-H~~I~~~~~g~~~----l~~ 74 (105)
T 1lkk_A 1 LEPEPWFFKNLSRKDAERQLLAPGNTHGSFLIRESESTAG-SFSLSVRDFDQNQGEVVK-HYKIRNLDNGGFY----ISP 74 (105)
T ss_dssp CCCCTTBCTTCCHHHHHHHHTSTTCCTTCEEEEECSSSTT-CEEEEEEEEETTTEEEEE-EEEEEECTTSCEE----SST
T ss_pred CCcCceecCCCCHHHHHHHHHhcCCCCceEEEEECCCCCC-cEEEEEEEcccCCCCcEE-EEEEEECCCCCEE----ECC
Confidence 678999999999999999987 455 999988788 899998874222236788 9999887667787 555
Q ss_pred ccchHHHHHhhh
Q 037285 760 SMQFDAMMENLR 771 (1094)
Q Consensus 760 ~~qFdsL~ElLr 771 (1094)
...|.++.+++.
T Consensus 75 ~~~F~sl~~LI~ 86 (105)
T 1lkk_A 75 RITFPGLHELVR 86 (105)
T ss_dssp TSCBSSHHHHHH
T ss_pred CceeCCHHHHHH
Confidence 678999999993
|
| >2ekx_A Cytoplasmic tyrosine-protein kinase BMX; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.32 E-value=2.1e-07 Score=87.74 Aligned_cols=82 Identities=21% Similarity=0.319 Sum_probs=66.2
Q ss_pred hhhccccccccccCCCChhHHHHcCC---chh---hhhhhhcCCceeEEeeeccC-CCCCCcccccccccccCCCccccC
Q 037285 682 SYFRNLAQVDFGQKDVSLIDQEHLGL---SSG---VREVREEDGRLYHFTPLTDD-GAPKGRVDSQLNFGQDSQKTFGVD 754 (1094)
Q Consensus 682 ~~~~~Le~~~Wy~~~IsR~~AE~ll~---a~g---VR~s~~~~G~~y~~S~l~~~-ga~~g~v~shy~I~~dsq~r~~vt 754 (1094)
++-++|+.+.|||++|+|.+||.+|. .+| ||++ ...| .|.+|+.+.. +...+.++ ||.|..+..+.|+
T Consensus 3 ~~~~~l~~~~Wyhg~isR~~Ae~lL~~~~~~G~FLVR~S-~~~g-~y~LSv~~~~~~~~~~~v~-H~~I~~~~~g~~~-- 77 (110)
T 2ekx_A 3 SGSSGLDDYDWFAGNISRSQSEQLLRQKGKEGAFMVRNS-SQVG-MYTVSLFSKAVNDKKGTVK-HYHVHTNAENKLY-- 77 (110)
T ss_dssp CCSSCTTTSSSBCCSCCHHHHHHHHHHTCCTTEEEEEEC-SSTT-CEEEEECCCCSSCSSCCCE-EEECEECTTCCEE--
T ss_pred CccCcccCCCeecCCCCHHHHHHHHhccCCCceEEEEec-CCCC-CEEEEEEeccccCCCCcEE-EEEEEECCCCCEE--
Confidence 35578999999999999999999998 556 9999 4467 8999988753 22346788 9999887777788
Q ss_pred CCcccccchHHHHHhh
Q 037285 755 PSVSESMQFDAMMENL 770 (1094)
Q Consensus 755 p~isE~~qFdsL~ElL 770 (1094)
+.+...|.++.+++
T Consensus 78 --l~~~~~F~sl~~LV 91 (110)
T 2ekx_A 78 --LAENYCFDSIPKLI 91 (110)
T ss_dssp --SSTTCCCSCHHHHH
T ss_pred --ECCCCccCCHHHHH
Confidence 55567899999999
|
| >3us4_A Megakaryocyte-associated tyrosine-protein kinase; SH2 domain, signaling protein, structural genomics, joint CE structural genomics, JCSG; 1.50A {Homo sapiens} SCOP: d.93.1.1 PDB: 1jwo_A | Back alignment and structure |
|---|
Probab=98.30 E-value=2.9e-07 Score=84.80 Aligned_cols=73 Identities=16% Similarity=0.164 Sum_probs=61.2
Q ss_pred cccccccccCCCChhHHHHcCC--chh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCcccc
Q 037285 686 NLAQVDFGQKDVSLIDQEHLGL--SSG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSES 760 (1094)
Q Consensus 686 ~Le~~~Wy~~~IsR~~AE~ll~--a~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~isE~ 760 (1094)
+|+.++|||++|+|.+||.+|. .+| ||+|....| .|.+|+... +.++ ||.|.. ..+.|+ +...
T Consensus 1 ~L~~~~Wyhg~isr~~Ae~lL~~~~~G~FLVR~S~~~~g-~y~LSv~~~-----~~v~-H~~I~~-~~~~~~----~~~~ 68 (98)
T 3us4_A 1 GLSLMPWFHGKISGQEAVQQLQPPEDGLFLVRESARHPG-DYVLCVSFG-----RDVI-HYRVLH-RDGHLT----IDEA 68 (98)
T ss_dssp -CTTCTTBCCSCCHHHHHHHTCSCCTTCEEEEECSSSTT-CEEEEEEET-----TEEE-EEEEEE-ETTEEE----SSSS
T ss_pred CCccCcccCCCCCHHHHHHHccCCCCcEEEEEeCCCCCC-cEEEEEEEC-----CceE-EEEEEE-eCCEEE----ECCC
Confidence 5889999999999999999998 667 999988778 899998885 7788 999987 445677 4456
Q ss_pred cchHHHHHhh
Q 037285 761 MQFDAMMENL 770 (1094)
Q Consensus 761 ~qFdsL~ElL 770 (1094)
..|.++.+++
T Consensus 69 ~~F~sl~~Lv 78 (98)
T 3us4_A 69 VFFCNLMDMV 78 (98)
T ss_dssp SEESSHHHHH
T ss_pred CccCCHHHHH
Confidence 7899999998
|
| >1blj_A P55 BLK protein tyrosine kinase; signal transduction, transferase, phosphotransferase, phosphorylation; NMR {Mus musculus} SCOP: d.93.1.1 PDB: 1blk_A | Back alignment and structure |
|---|
Probab=98.27 E-value=4.4e-07 Score=85.84 Aligned_cols=81 Identities=15% Similarity=0.198 Sum_probs=65.5
Q ss_pred hccccccccccCCCChhHHHHcCC----chh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCC
Q 037285 684 FRNLAQVDFGQKDVSLIDQEHLGL----SSG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPS 756 (1094)
Q Consensus 684 ~~~Le~~~Wy~~~IsR~~AE~ll~----a~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~ 756 (1094)
.++|+...|||++|+|.+||.+|. .+| ||+|....| .|.+|+..... ..+.++ ||.|..+..+.|+
T Consensus 6 ~~~l~~~~Wyhg~isR~~Ae~lL~~~g~~~G~FLVR~S~~~~g-~y~LSv~~~~~-~~~~v~-H~~I~~~~~g~~~---- 78 (114)
T 1blj_A 6 VETLEVEKWFFRTISRKDAERQLLAPMNKAGSFLIRESESNKG-AFSLSVKDITT-QGEVVK-HYKIRSLDNGGYY---- 78 (114)
T ss_dssp SCCSCCSSSBCCSCCHHHHHHHHSSTTCCTTCEEBCBCTTCSS-CEEEEECBCCT-TTCBCC-CEEEEEETTTEEE----
T ss_pred cCccccCCccCCCCCHHHHHHHHhhCCCCCceEEEEeCCCCCC-CEEEEEEEecC-CCCcEE-EEEEEEcCCCCEE----
Confidence 367999999999999999999987 455 999998788 89999887421 136778 9999886667777
Q ss_pred cccccchHHHHHhhh
Q 037285 757 VSESMQFDAMMENLR 771 (1094)
Q Consensus 757 isE~~qFdsL~ElLr 771 (1094)
+.....|.++.+++.
T Consensus 79 l~~~~~F~sl~~LV~ 93 (114)
T 1blj_A 79 ISPRITFPTLQALVQ 93 (114)
T ss_dssp EETTEEESSHHHHHH
T ss_pred ECCCcccCCHHHHHH
Confidence 556788999999993
|
| >3maz_A Signal-transducing adaptor protein 1; modular domain, phosphotyrosine, specificity, cytoplasm, phosphoprotein, SH2 domain, signaling protein; HET: PTR; 1.90A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.26 E-value=1.6e-07 Score=91.77 Aligned_cols=87 Identities=13% Similarity=0.145 Sum_probs=65.9
Q ss_pred hhccccccccccCCCChhHHHHcCCc---hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCC
Q 037285 683 YFRNLAQVDFGQKDVSLIDQEHLGLS---SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPS 756 (1094)
Q Consensus 683 ~~~~Le~~~Wy~~~IsR~~AE~ll~a---~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~ 756 (1094)
++..|+.++||+++|+|.+||++|.. .| ||++.. .+ .|.+|+.+.. ..+.|+ ||+|.+. .+.|+
T Consensus 8 ~~~~l~~epWff~~isR~eAE~lL~~~~~~GaFLVR~Se~-~~-~ySLSVR~~~--~~~~VK-HYkI~~~-~G~y~---- 77 (125)
T 3maz_A 8 YVDVLNPMPACFYTVSRKEATEMLQKNPSLGNMILRPGSD-SR-NYSITIRQEI--DIPRIK-HYKVMSV-GQNYT---- 77 (125)
T ss_dssp ---CCCCCCTTBCCCCHHHHHHHHHHCGGGCSEEEEECTT-SS-SEEEEEEECS--SSCEEE-EEEEEEE-TTEEE----
T ss_pred ccccccCCCCCcCCCCHHHHHHHHhccCCCCcEEEEeCCC-CC-CEEEEEEecC--CCCCEe-eeEEEEe-CCEEE----
Confidence 67889999999999999999998854 34 999965 44 8999988731 136788 9999987 68888
Q ss_pred cc--cccchHHHHHhhhcccccccccCCCC
Q 037285 757 VS--ESMQFDAMMENLRTTESDYEEGNAGN 784 (1094)
Q Consensus 757 is--E~~qFdsL~ElLrt~eSdyee~nagn 784 (1094)
+. +...|.++.+++ +|+..++.+
T Consensus 78 I~~~~~~~F~SL~eLV-----~yY~~~adG 102 (125)
T 3maz_A 78 IELEKPVTLPNLFSVI-----DYFVKETRG 102 (125)
T ss_dssp ECSSSCEEESSHHHHH-----HHHHHHTTT
T ss_pred EecCCCcCcCCHHHHH-----HHHHhCCCc
Confidence 55 567899999999 555554444
|
| >3k2m_A Proto-oncogene tyrosine-protein kinase ABL1; engineered binding protein, antibody mimic, protein-protein SH2 domain, ATP-binding, phosphoprotein; 1.75A {Homo sapiens} PDB: 3uyo_A 3t04_A 1ab2_A | Back alignment and structure |
|---|
Probab=98.26 E-value=3.2e-07 Score=86.65 Aligned_cols=75 Identities=25% Similarity=0.272 Sum_probs=63.6
Q ss_pred cccccccccCCCChhHHHHcCCc--hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCcccc
Q 037285 686 NLAQVDFGQKDVSLIDQEHLGLS--SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSES 760 (1094)
Q Consensus 686 ~Le~~~Wy~~~IsR~~AE~ll~a--~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~isE~ 760 (1094)
+|+.+.|||++|+|.+||.+|.. +| ||+|....| .|.+|+... +.++ ||.|..+..+.++ +...
T Consensus 1 sL~~~~Wyhg~isR~~Ae~lL~~~~~G~FLVR~S~~~~g-~y~LSv~~~-----~~v~-H~~I~~~~~g~~~----~~~~ 69 (112)
T 3k2m_A 1 SLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPG-QRSISLRYE-----GRVY-HYRINTASDGKLY----VSSE 69 (112)
T ss_dssp CGGGSTTEEESCCHHHHHHHTTTCCTTEEEEEECSSSTT-CEEEEEEET-----TEEE-EEEEEECTTSCEE----SSTT
T ss_pred CCccCcceeeCCCHHHHHHHhccCCCceEEEEeCCCCCC-CEEEEEEeC-----CcEE-EEEEEECCCCcEE----ECCC
Confidence 58999999999999999999986 66 999988778 899998885 7788 9999887777777 4456
Q ss_pred cchHHHHHhhh
Q 037285 761 MQFDAMMENLR 771 (1094)
Q Consensus 761 ~qFdsL~ElLr 771 (1094)
..|.++.+++.
T Consensus 70 ~~F~sl~~LV~ 80 (112)
T 3k2m_A 70 SRFNTLAELVH 80 (112)
T ss_dssp CCBSSHHHHHH
T ss_pred CeECCHHHHHH
Confidence 68999999993
|
| >2dm0_A Tyrosine-protein kinase TXK; TEC family kinase, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.24 E-value=6.3e-07 Score=86.50 Aligned_cols=80 Identities=18% Similarity=0.312 Sum_probs=64.3
Q ss_pred ccccccccccCCCChhHHHHcCC---chh---hhhhhhcCCceeEEeeeccC-CCCCCcccccccccccCCCccccCCCc
Q 037285 685 RNLAQVDFGQKDVSLIDQEHLGL---SSG---VREVREEDGRLYHFTPLTDD-GAPKGRVDSQLNFGQDSQKTFGVDPSV 757 (1094)
Q Consensus 685 ~~Le~~~Wy~~~IsR~~AE~ll~---a~g---VR~s~~~~G~~y~~S~l~~~-ga~~g~v~shy~I~~dsq~r~~vtp~i 757 (1094)
.+|+.+.|||++|+|.+||.+|. .+| ||++ ...| .|.+|+.... +...+.++ ||.|..+..+.|+ +
T Consensus 11 ~~l~~~~WyhG~isR~eAe~lL~~~~~~G~FLVR~S-~~~g-~y~LSv~~~~~~~~~~~v~-H~~I~~~~~g~~~----l 83 (125)
T 2dm0_A 11 TNLEIYEWYHRNITRNQAEHLLRQESKEGAFIVRDS-RHLG-SYTISVFMGARRSTEAAIK-HYQIKKNDSGQWY----V 83 (125)
T ss_dssp CCCTTSSSBCCSCCHHHHHHHHHHHCSTTCBCEEEE-TTEE-EEEEEEECCCSSSSSCCEE-EEEEEECTTCCEE----S
T ss_pred cccccCCcccCCCCHHHHHHHHhhcCCCCEEEEEec-CCCC-CEEEEEEeccccCCCCcEE-EEEEEEcCCCCEE----E
Confidence 35899999999999999999998 556 9999 4466 8999988753 22346788 9999887777787 5
Q ss_pred ccccchHHHHHhhh
Q 037285 758 SESMQFDAMMENLR 771 (1094)
Q Consensus 758 sE~~qFdsL~ElLr 771 (1094)
.+...|.++.+++.
T Consensus 84 ~~~~~F~sl~eLV~ 97 (125)
T 2dm0_A 84 AERHAFQSIPELIW 97 (125)
T ss_dssp SSSCCCSSHHHHHH
T ss_pred CCCCccCCHHHHHH
Confidence 55678999999993
|
| >3s9k_A Tyrosine-protein kinase ITK/TSK; proline isomerization, CIS proline, domain swapped dimer, SH transferase; HET: CIT; 2.35A {Mus musculus} PDB: 2etz_A* 2eu0_A* 1lui_A 1luk_A 1lum_A 1lun_A 2k79_B 2k7a_B | Back alignment and structure |
|---|
Probab=98.24 E-value=5.6e-07 Score=85.36 Aligned_cols=81 Identities=25% Similarity=0.329 Sum_probs=63.8
Q ss_pred hccccccccccCCCChhHHHHcCCc---hh---hhhhhhcCCceeEEeeeccC-CCCCCcccccccc--cccCCCccccC
Q 037285 684 FRNLAQVDFGQKDVSLIDQEHLGLS---SG---VREVREEDGRLYHFTPLTDD-GAPKGRVDSQLNF--GQDSQKTFGVD 754 (1094)
Q Consensus 684 ~~~Le~~~Wy~~~IsR~~AE~ll~a---~g---VR~s~~~~G~~y~~S~l~~~-ga~~g~v~shy~I--~~dsq~r~~vt 754 (1094)
-++|+.+.||+++|+|.+||.+|.. +| ||+| ...| .|.+|+.... +...+.++ ||.| .....+.|+
T Consensus 3 ~~~l~~~~Wyhg~isR~~Ae~lL~~~~~~G~FLVR~S-~~~g-~y~LSv~~~~~~~~~~~v~-H~~I~~~~~~~g~~~-- 77 (118)
T 3s9k_A 3 PNNLETYEWYNKSISRDKAEKLLLDTGKEGAFMVRDS-RTPG-TYTVSVFTKAIISENPCIK-HYHIKETNDSPKRYY-- 77 (118)
T ss_dssp --CGGGSTTBCTTCCHHHHHHHHHHHCCTTCEEEEEC-SSTT-CEEEEEEECCSCSSSCEEE-EEEEEECSCSSCCEE--
T ss_pred ccccccCceecCCCCHHHHHHHHHhcCCCCeEEEEee-CCCC-CEEEEEEecccccCCCceE-EEEEeEEECCCCCEE--
Confidence 4679999999999999999999976 56 9999 6677 8999988853 23346788 9999 445666777
Q ss_pred CCcccccchHHHHHhhh
Q 037285 755 PSVSESMQFDAMMENLR 771 (1094)
Q Consensus 755 p~isE~~qFdsL~ElLr 771 (1094)
+.+...|.++.+++.
T Consensus 78 --~~~~~~F~sl~~LV~ 92 (118)
T 3s9k_A 78 --VAEKYVFDSIPLLIQ 92 (118)
T ss_dssp --EECSCCCSCHHHHHH
T ss_pred --ECCCcccCCHHHHHH
Confidence 556778999999993
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=2e-05 Score=85.43 Aligned_cols=137 Identities=22% Similarity=0.188 Sum_probs=89.8
Q ss_pred EEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCC---ceeEEEeEeecCCCCceEE
Q 037285 816 KELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP---NVVAFYGVVQDGPGGTLAT 892 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HP---NIVqL~Gv~~d~~~~~L~I 892 (1094)
+.++.|....||+. +..+++|+... ......+.+|..+|+.|.+. .+.+++.++... .+..++
T Consensus 25 ~~l~~G~~n~v~~v---g~~~VlR~~~~----------~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~-~g~~~~ 90 (306)
T 3tdw_A 25 ESLGEGFRNYAILV---NGDWVFRFPKS----------QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRS-DGNPFV 90 (306)
T ss_dssp EEEEECSSEEEEEE---TTTEEEEEESS----------HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECT-TSCEEE
T ss_pred eecCCCcceeEEEE---CCEEEEEecCC----------chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccC-CCceEE
Confidence 45788999999987 67788987432 12235678899999998742 356666666532 346779
Q ss_pred EeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHC-------------------------------------
Q 037285 893 VAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSK------------------------------------- 935 (1094)
Q Consensus 893 VmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~------------------------------------- 935 (1094)
||+|++|..|...... .++......++.++.+.|..||+.
T Consensus 91 v~e~i~G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~ 167 (306)
T 3tdw_A 91 GYRKVQGQILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDES 167 (306)
T ss_dssp EEECCCSEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHH
T ss_pred EEeccCCeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchh
Confidence 9999999888663211 123344444444444444444431
Q ss_pred -----------------------CceeccCCCCceEeccCCCCCCcEEEEecCCccc
Q 037285 936 -----------------------NIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI 969 (1094)
Q Consensus 936 -----------------------GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl 969 (1094)
.++|+|+++.|||++........+.|+||+.+..
T Consensus 168 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 168 LRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3699999999999982111134458999998764
|
| >1d4t_A T cell signal transduction molecule SAP; SH2 domain, tyrosine kinase, signal transduction, peptide recognition, signaling protein; 1.10A {Homo sapiens} SCOP: d.93.1.1 PDB: 1d1z_A 1d4w_A* 1m27_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=4.8e-07 Score=84.33 Aligned_cols=78 Identities=17% Similarity=0.239 Sum_probs=62.1
Q ss_pred ccccccccCCCChhHHHHcCC---chh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCC-ccc
Q 037285 687 LAQVDFGQKDVSLIDQEHLGL---SSG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPS-VSE 759 (1094)
Q Consensus 687 Le~~~Wy~~~IsR~~AE~ll~---a~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~-isE 759 (1094)
|+.+.|||++|+|.+||.+|. .+| ||+|....| .|.+|+... +.++ ||.|..+..+.|..... -..
T Consensus 1 l~~~~Wyhg~isR~~Ae~lL~~~~~~G~FLVR~S~~~~g-~~~LSv~~~-----~~v~-H~~I~~~~~g~~~l~~~~g~~ 73 (104)
T 1d4t_A 1 MDAVAVYHGKISRETGEKLLLATGLDGSYLLRDSESVPG-VYCLCVLYH-----GYIY-TYRVSQTETGSWSAETAPGVH 73 (104)
T ss_dssp CTTCTTBCCSCCHHHHHHHHHHHCCTTEEEEEECSSSTT-CEEEEEEET-----TEEE-EEEEEECTTSCEEECBCTTSC
T ss_pred CCCCceEccCCCHHHHHHHHHhcCCCCEEEEeeCCCCCC-CEEEEEEEC-----CeEE-EEEEEECCCCeEEEeccCCCC
Confidence 678999999999999999997 556 999987778 899998885 6788 99998766676773311 013
Q ss_pred ccchHHHHHhhh
Q 037285 760 SMQFDAMMENLR 771 (1094)
Q Consensus 760 ~~qFdsL~ElLr 771 (1094)
...|.++.+++.
T Consensus 74 ~~~F~sl~~LV~ 85 (104)
T 1d4t_A 74 KRYFRKIKNLIS 85 (104)
T ss_dssp CCCBSSHHHHHH
T ss_pred CcccCCHHHHHH
Confidence 678999999993
|
| >3eaz_A Tyrosine-protein kinase CSK; SH2, disulfide, oxidized reduced, ATP-binding, cell membrane, cytoplasm, membrane, nucleotide-binding, phosphoprotein; 1.31A {Homo sapiens} PDB: 3eac_A | Back alignment and structure |
|---|
Probab=98.19 E-value=6.3e-07 Score=83.81 Aligned_cols=74 Identities=20% Similarity=0.354 Sum_probs=62.3
Q ss_pred ccccccccccCCCChhHHHHcCC--chh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCccc
Q 037285 685 RNLAQVDFGQKDVSLIDQEHLGL--SSG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSE 759 (1094)
Q Consensus 685 ~~Le~~~Wy~~~IsR~~AE~ll~--a~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~isE 759 (1094)
.+|+.++|||++|+|.+||.+|. .+| ||+|....| .|.+|+... +.++ ||.|..+ .+.|+ +.+
T Consensus 3 ~~L~~~~Wyhg~isr~~Ae~lL~~~~~G~FLVR~S~~~~g-~~~LSv~~~-----~~v~-H~~I~~~-~g~~~----l~~ 70 (106)
T 3eaz_A 3 TKLSLMPWFHGKITREQAERLLYPPETGLFLVRESTNYPG-DYTLCVSSD-----GKVE-HYRIMYH-ASKLS----IDE 70 (106)
T ss_dssp CTGGGCTTBCCSCCHHHHHHHTCSCCTTEEEEEECTTSTT-CEEEEEEET-----TEEE-EEECEEE-TTEEE----SSS
T ss_pred cccccCCCcCCCCCHHHHHHHhCCCCCCEEEEEECCCCCC-cEEEEEEeC-----CceE-EEEEEec-CCEEE----ECC
Confidence 36889999999999999999998 667 999988788 899998875 7788 9999863 56677 555
Q ss_pred ccchHHHHHhh
Q 037285 760 SMQFDAMMENL 770 (1094)
Q Consensus 760 ~~qFdsL~ElL 770 (1094)
...|.++.+++
T Consensus 71 ~~~F~sl~~Lv 81 (106)
T 3eaz_A 71 EVYFENLMQLV 81 (106)
T ss_dssp SSCBSSHHHHH
T ss_pred CCccCCHHHHH
Confidence 67899999998
|
| >2ecd_A Tyrosine-protein kinase ABL2; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.18 E-value=6.4e-07 Score=85.93 Aligned_cols=77 Identities=22% Similarity=0.256 Sum_probs=65.1
Q ss_pred hccccccccccCCCChhHHHHcCCc--hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCcc
Q 037285 684 FRNLAQVDFGQKDVSLIDQEHLGLS--SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVS 758 (1094)
Q Consensus 684 ~~~Le~~~Wy~~~IsR~~AE~ll~a--~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~is 758 (1094)
.+.|+.+.|||+.|+|.+||.+|.. +| ||++....| .|.+|+... +.++ ||.|..+..+.|+ +.
T Consensus 10 ~~~l~~~~WyhG~isR~~Ae~lL~~~~~G~FLVR~S~~~~g-~y~LSv~~~-----~~v~-H~~I~~~~~g~~~----l~ 78 (119)
T 2ecd_A 10 VNSLEKHSWYHGPVSRSAAEYLLSSLINGSFLVRESESSPG-QLSISLRYE-----GRVY-HYRINTTADGKVY----VT 78 (119)
T ss_dssp SCCCCCSSSEEEECCHHHHHHHHHTSCTTBEEEEEESSSTT-EEEEEEECS-----SCEE-EECCCCCSSSCCC----CC
T ss_pred ccccccCccccCCCCHHHHHHHhcCCCCCeEEEEeCCCCCC-CEEEEEEEC-----CeEE-EEEEEEcCCCCEE----Ec
Confidence 4679999999999999999999864 55 999998788 899998885 6788 9999887777777 44
Q ss_pred cccchHHHHHhhh
Q 037285 759 ESMQFDAMMENLR 771 (1094)
Q Consensus 759 E~~qFdsL~ElLr 771 (1094)
....|.++.+++.
T Consensus 79 ~~~~F~sl~~LV~ 91 (119)
T 2ecd_A 79 AESRFSTLAELVH 91 (119)
T ss_dssp SSCCCSSHHHHHH
T ss_pred CCCcCCCHHHHHH
Confidence 5678999999994
|
| >2ge9_A Tyrosine-protein kinase BTK; SH2 domain, structure, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.17 E-value=5.4e-07 Score=87.21 Aligned_cols=81 Identities=19% Similarity=0.326 Sum_probs=65.4
Q ss_pred hccccccccccCCCChhHHHHcCC---chh---hhhhhhcCCceeEEeeeccC-CCCCCcccccccccccCCCccccCCC
Q 037285 684 FRNLAQVDFGQKDVSLIDQEHLGL---SSG---VREVREEDGRLYHFTPLTDD-GAPKGRVDSQLNFGQDSQKTFGVDPS 756 (1094)
Q Consensus 684 ~~~Le~~~Wy~~~IsR~~AE~ll~---a~g---VR~s~~~~G~~y~~S~l~~~-ga~~g~v~shy~I~~dsq~r~~vtp~ 756 (1094)
.++|+...||+++|+|.+||.+|. .+| ||+| ...| .|.+|+.... +...+.++ ||.|..+..+.|+
T Consensus 5 ~~~l~~~~WyhG~isR~eAe~lL~~~g~~G~FLVR~S-s~~g-~y~LSv~~~~~~~~~~~v~-H~~I~~~~~g~~~---- 77 (125)
T 2ge9_A 5 EDSIEMYEWYSKHMTRSQAEQLLKQEGKEGGFIVRDS-SKAG-KYTVSVFAKSTGDPQGVIR-HYVVCSTPQSQYY---- 77 (125)
T ss_dssp CCSSCCSSSEETTCCHHHHHHHHHHHTCTTEEEEEEC-SSSC-CEEEEEEESSSSSTTCEEE-EEECEEETTTEEE----
T ss_pred ccccccCCccccCCCHHHHHHHHhhcCCCceEEEEec-CCCC-CEEEEEEeccccCCCCeEE-EEEEEEcCCCCEE----
Confidence 357999999999999999999998 556 9999 4577 8999988753 22346788 9999887777787
Q ss_pred cccccchHHHHHhhh
Q 037285 757 VSESMQFDAMMENLR 771 (1094)
Q Consensus 757 isE~~qFdsL~ElLr 771 (1094)
+.+...|.++.+++.
T Consensus 78 l~~~~~F~sl~eLV~ 92 (125)
T 2ge9_A 78 LAEKHLFSTIPELIN 92 (125)
T ss_dssp SSTTSCBSSHHHHHH
T ss_pred ECCCCcCCCHHHHHH
Confidence 556678999999993
|
| >2vif_A Suppressor of cytokine signalling 6; growth regulation, signal transduction inhibitor, KIT regula phosphotyrosine, signaling protein; HET: PTR; 1.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.16 E-value=4.5e-07 Score=89.37 Aligned_cols=93 Identities=10% Similarity=0.138 Sum_probs=69.7
Q ss_pred ccccccCCCCchh-hhccccccccccCCCChhHHHHcCCc--hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccc
Q 037285 670 SVNMENHEPKRWS-YFRNLAQVDFGQKDVSLIDQEHLGLS--SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNF 743 (1094)
Q Consensus 670 s~~~~~~~~~~~~-~~~~Le~~~Wy~~~IsR~~AE~ll~a--~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I 743 (1094)
.++....+|.++. ....|+...||||.|+|.+||.+|.. +| ||++....| .|.+++... +.++ ||.|
T Consensus 3 ~~~~~~~~~~~~v~~~~~l~~~~WyhG~isR~eAe~lL~~~~~G~FLVR~S~~~~~-~~~LSv~~~-----~~v~-H~~I 75 (141)
T 2vif_A 3 VQSSGPMDVTSLTEELKKLAKQGWYWGPITRWEAEGKLANVPDGSFLVRDSSDDRY-LLSLSFRSH-----GKTL-HTRI 75 (141)
T ss_dssp CCCC-------HHHHHHHHHHHTCBCCSCCHHHHHHHTTTSCTTCEEEEECSSTTC-SEEEEEEET-----TEEE-EEEE
T ss_pred cccCCCCchhhhhcchhhhccCCCcccCCCHHHHHHHhcCCCCceEEEEecCCCCC-CEEEEEEEC-----CEEE-EEEE
Confidence 4556677888888 67899999999999999999999976 67 999998777 899998875 6788 9999
Q ss_pred cccCCCccccCCCcccccchHHHHHhhh
Q 037285 744 GQDSQKTFGVDPSVSESMQFDAMMENLR 771 (1094)
Q Consensus 744 ~~dsq~r~~vtp~isE~~qFdsL~ElLr 771 (1094)
..+ .+.|+.... .+...|.++.+++.
T Consensus 76 ~~~-~g~~~l~~~-~~~~~F~sl~eLI~ 101 (141)
T 2vif_A 76 EHS-NGRFSFYEQ-PDVEGHTSIVDLIE 101 (141)
T ss_dssp EEE-TTEEEETTC-CSCCCBSSHHHHHH
T ss_pred EEE-CCEEEEeec-CCCCccCCHHHHHH
Confidence 876 667772211 15778999999984
|
| >2el8_A Signal-transducing adaptor protein 2; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.13 E-value=7.2e-07 Score=85.63 Aligned_cols=78 Identities=12% Similarity=0.060 Sum_probs=62.8
Q ss_pred ccccccccccCCCChhHHHHcCCc---hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCcc
Q 037285 685 RNLAQVDFGQKDVSLIDQEHLGLS---SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVS 758 (1094)
Q Consensus 685 ~~Le~~~Wy~~~IsR~~AE~ll~a---~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~is 758 (1094)
++++..+|||++|+|.+||.+|.. +| ||+|....| .|.+|+.... ...+.|+ ||.|.. ..+.|+ +.
T Consensus 16 r~~~~~~WyhG~isR~eAe~lL~~~~~~G~FLVR~S~~~~g-~y~LSv~~~~-~~~~~v~-H~~I~~-~~g~~~----i~ 87 (118)
T 2el8_A 16 RRALETPSCFLKVSRLEAQLLLERYPECGNLLLRPSGDGAD-GVSVTTRQMH-NGTHVVR-HYKVKR-EGPKYV----ID 87 (118)
T ss_dssp CCCSSSCTTCCCCCHHHHHHHHHHSSTTCSBEEEECCSSSS-SEEEEECCCB-TTBCCCE-EECBCC-BTTBCC----BS
T ss_pred ccccCCCceecCCCHHHHHHHHhhCCCCcEEEEeeCCCCCC-ceEEEEEEec-CCCCcEE-EEEEEE-cCCEEE----Ee
Confidence 467889999999999999999965 55 999998778 8999988732 1236788 999987 566677 55
Q ss_pred cccch--HHHHHhh
Q 037285 759 ESMQF--DAMMENL 770 (1094)
Q Consensus 759 E~~qF--dsL~ElL 770 (1094)
....| .++.+++
T Consensus 88 ~~~~F~~~sL~eLV 101 (118)
T 2el8_A 88 VEQPFSCTSLDAVV 101 (118)
T ss_dssp SSSCCCCSSHHHHH
T ss_pred CCCeECCCCHHHHH
Confidence 56678 9999999
|
| >2ysx_A Signaling inositol polyphosphate phosphatase SHIP II; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.13 E-value=6.5e-07 Score=85.67 Aligned_cols=82 Identities=15% Similarity=0.089 Sum_probs=65.6
Q ss_pred hhccccccccccCCCChhHHHHcCCc---hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCC
Q 037285 683 YFRNLAQVDFGQKDVSLIDQEHLGLS---SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPS 756 (1094)
Q Consensus 683 ~~~~Le~~~Wy~~~IsR~~AE~ll~a---~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~ 756 (1094)
.+.+|+...|||++|+|.+||.+|.. +| ||++....| .|.+|+... +.++ ||.|..+..+.|+....
T Consensus 3 ~~~~~~~~~WyhG~isR~eAe~lL~~~~~~G~FLVR~S~~~~g-~y~LSv~~~-----~~v~-H~~I~~~~~g~~~l~~~ 75 (119)
T 2ysx_A 3 SGSSGMVPCWNHGNITRSKAEELLSRTGKDGSFLVRASESISR-AYALCVLYR-----NCVY-TYRILPNEDDKFTVQAS 75 (119)
T ss_dssp CCCSSCCCSSEEESCCHHHHHHHHHHHCCTTEEEEEECSSCTT-SEEEEEECS-----SCEE-EEEEEECTTSCEEECCS
T ss_pred CccCCCCCccccCCCCHHHHHHHHhhcCCCCEEEEEeCCCCCC-CEEEEEEEC-----CEEE-EEEEEEcCCCCEEEecc
Confidence 35688999999999999999999976 56 999998777 899998875 6788 99998766777774321
Q ss_pred c-ccccchHHHHHhhh
Q 037285 757 V-SESMQFDAMMENLR 771 (1094)
Q Consensus 757 i-sE~~qFdsL~ElLr 771 (1094)
. .....|.++.+++.
T Consensus 76 ~g~~~~~F~sl~eLV~ 91 (119)
T 2ysx_A 76 EGVSMRFFTKLDQLIE 91 (119)
T ss_dssp CSSSCCCBSSHHHHHH
T ss_pred CCcCCcccCCHHHHHH
Confidence 1 01468999999993
|
| >1ka6_A SH2 domain protein 1A; SH2 domain, protein-peptide complex, immune system; HET: PTR; NMR {Homo sapiens} SCOP: d.93.1.1 PDB: 1ka7_A | Back alignment and structure |
|---|
Probab=98.12 E-value=1.2e-06 Score=85.02 Aligned_cols=78 Identities=17% Similarity=0.239 Sum_probs=62.1
Q ss_pred ccccccccCCCChhHHHHcCC---chh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCC-ccc
Q 037285 687 LAQVDFGQKDVSLIDQEHLGL---SSG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPS-VSE 759 (1094)
Q Consensus 687 Le~~~Wy~~~IsR~~AE~ll~---a~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~-isE 759 (1094)
|+.+.|||++|+|.+||.+|. .+| ||+|....| .|.+|+... +.++ ||.|..+..+.|..... -..
T Consensus 1 l~~~~WyhG~isR~eAe~lL~~~~~~G~FLVR~S~~~~g-~y~LSv~~~-----~~v~-H~~I~~~~~g~~~l~~~~g~~ 73 (128)
T 1ka6_A 1 MDAVAVYHGKISRETGEKLLLATGLDGSYLLRDSESVPG-VYCLCVLYH-----GYIY-TYRVSQTETGSWSAETAPGVH 73 (128)
T ss_dssp CCCCSSBCCSCCHHHHHHHHHHHCCTTCEEEEECSSSTT-CEEEEEESS-----SCEE-EEEEEECTTSCEEEECSTTSC
T ss_pred CCCCcccCCCCCHHHHHHHHhcCCCCCEEEEeecCCCCC-CEEEEEEeC-----CEEE-EEEEEECCCCeEEEeecCCCC
Confidence 678999999999999999997 456 999987778 899998885 6788 99998766666772210 013
Q ss_pred ccchHHHHHhhh
Q 037285 760 SMQFDAMMENLR 771 (1094)
Q Consensus 760 ~~qFdsL~ElLr 771 (1094)
...|.++.+++.
T Consensus 74 ~~~F~sl~~LV~ 85 (128)
T 1ka6_A 74 KRYFRKIKNLIS 85 (128)
T ss_dssp CCEESSHHHHHH
T ss_pred CCccCCHHHHHH
Confidence 678999999994
|
| >1vd2_A Protein kinase C, IOTA type; PB1 domain, OPCA motif, APKC, ZIP/P62, MEK5, molecular recognition, transferase; NMR {Homo sapiens} SCOP: d.15.2.2 PDB: 1wmh_A | Back alignment and structure |
|---|
Probab=98.09 E-value=3e-05 Score=71.71 Aligned_cols=70 Identities=19% Similarity=0.335 Sum_probs=60.1
Q ss_pred CceEEEEecCCCChHHHHHHHHHHcC----CceEEEEeCCCCCCCceeeccChhhHHHHHHHHhhcCCCCCCCeEEEEEe
Q 037285 110 GETRIIRIRKDISWQILRQKALEVYN----QVHVIKYQLPGEDLDALVSVSCDEDLQNMMEEYNELGDREGSQRIRMFLF 185 (1094)
Q Consensus 110 G~triv~v~r~~~~~~l~~kl~~~~~----~~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~r~R~FlF 185 (1094)
|+.|++.|+.+++|.+|..|+.++|+ ..+++||- .|| ..+|.+++|+||+..+.-|..- ....|.+.+|
T Consensus 15 gdi~~~~v~~~i~~~~L~~kv~~~~~~~~~~~f~lky~--DEe-GD~itisSd~EL~eAl~l~~~n----~~~~l~ihvf 87 (89)
T 1vd2_A 15 GDIMITHFEPSISFEGLCNEVRDMCSFDNEQLFTMKWI--DEE-GDPCTVSSQLELEEAFRLYELN----KDSELLIHVF 87 (89)
T ss_dssp SCEEEEEECTTCCHHHHHHHHHHHTTCCSSCCEEEEEC--CSS-SCCEECCSHHHHHHHHHHHHHT----SCCCEEEEEE
T ss_pred CeEEEEECCCCCCHHHHHHHHHHHhCCCCCCeEEEEEE--CCC-CCcccccCHHHHHHHHHHHHcc----CCCCEEEEEc
Confidence 34789999999999999999999997 56899998 565 8899999999999999999763 2457888888
Q ss_pred c
Q 037285 186 S 186 (1094)
Q Consensus 186 ~ 186 (1094)
|
T Consensus 88 ~ 88 (89)
T 1vd2_A 88 P 88 (89)
T ss_dssp E
T ss_pred c
Confidence 6
|
| >2dx0_A Phospholipase C, gamma 2; phosphoric diester hydrolase, structural genomics, NPPSFA, national project on protein structural and functional analyses; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.09 E-value=7e-07 Score=87.80 Aligned_cols=90 Identities=16% Similarity=0.178 Sum_probs=66.7
Q ss_pred cccccCCCCchhhhccccccccccCCC-ChhHHHHcCC--------chh---hhhhhhcCCceeEEeeeccCCCCCCccc
Q 037285 671 VNMENHEPKRWSYFRNLAQVDFGQKDV-SLIDQEHLGL--------SSG---VREVREEDGRLYHFTPLTDDGAPKGRVD 738 (1094)
Q Consensus 671 ~~~~~~~~~~~~~~~~Le~~~Wy~~~I-sR~~AE~ll~--------a~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~ 738 (1094)
..++..+.....+-..++...|||++| +|.+||.+|. .+| ||++....| .|.+|+... +.++
T Consensus 3 ~g~~~~l~~~~~~~~~~~~~~WyhG~i~sR~eAe~lL~~~c~~~g~~~G~FLVR~S~~~~g-~y~LSv~~~-----~~v~ 76 (138)
T 2dx0_A 3 SGSSGEPVQDTPPTELHFGEKWFHKKVESRTSAEKLLQEYCAETGAKDGTFLVRESETFPN-DYTLSFWRS-----GRVQ 76 (138)
T ss_dssp ---------CCCGGGTTSCCTTBCTTCCCHHHHHHHHHHHHTTTTCCTTCEEEEECSSSTT-CEEEEEEET-----TEEE
T ss_pred CCccCCcCCCCCCcccccCCCcccCCCCCHHHHHHHHHhhccccCCCCCEEEEEeCCCCCC-CeEEEEEEC-----CeEE
Confidence 344455555556777899999999999 8999999997 445 999998778 899999875 7888
Q ss_pred ccccccccCCC---ccccCCCcccccchHHHHHhhh
Q 037285 739 SQLNFGQDSQK---TFGVDPSVSESMQFDAMMENLR 771 (1094)
Q Consensus 739 shy~I~~dsq~---r~~vtp~isE~~qFdsL~ElLr 771 (1094)
||.|.....+ +|+ +.+...|.++.+++.
T Consensus 77 -H~~I~~~~~gg~~~~~----l~~~~~F~sl~eLI~ 107 (138)
T 2dx0_A 77 -HCRIRSTMENGVMKYY----LTDNLTFNSIYALIQ 107 (138)
T ss_dssp -EEEEEEEEETTEEEEE----SSTTSCBSSHHHHHH
T ss_pred -EEEEEEecCCCceEEE----eCCCCcCCCHHHHHH
Confidence 9999875443 577 555678999999994
|
| >3ov1_A Growth factor receptor-bound protein 2; GRB2 SH2 domain, phosphotyrosine binding, signaling protein, signaling protein-antagonist complex; HET: PTR; 1.60A {Homo sapiens} SCOP: d.93.1.1 PDB: 3imj_A* 3in7_A* 3imd_A* 3kfj_A* 3n8m_A* 3in8_A* 3s8l_A* 3s8n_A* 3s8o_A* 2huy_A* 2h5k_A* 2huw_A* 2h46_E* 3c7i_A* 3n84_A* 1fhs_A 1bm2_A* 1bmb_A* 3ove_A* 1fyr_A* ... | Back alignment and structure |
|---|
Probab=98.07 E-value=1.7e-06 Score=82.88 Aligned_cols=74 Identities=12% Similarity=0.188 Sum_probs=61.8
Q ss_pred cccccccccCCCChhHHHHcCCc---hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCccc
Q 037285 686 NLAQVDFGQKDVSLIDQEHLGLS---SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSE 759 (1094)
Q Consensus 686 ~Le~~~Wy~~~IsR~~AE~ll~a---~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~isE 759 (1094)
.|+.+.||+|+|+|.+||.+|.. +| ||+|....| .|.+|+... +.++ ||.|..+..+.|+. .+
T Consensus 2 ~L~~~~WyhG~isR~eAe~lL~~~~~~G~FLVR~S~~~~g-~y~LSv~~~-----~~v~-H~~I~~~~~g~~~l----~~ 70 (117)
T 3ov1_A 2 EMKPHPWFFGKIPRAKAEEMLSKQRHDGAFLIRESESAPG-DFSLSVKFG-----NDVQ-HFKVLRDGAGKYFL----WV 70 (117)
T ss_dssp -CCCCTTBCCSCCHHHHHHHHHTCCSTTBEEEEECSSSTT-CEEEEEEET-----TEEE-EEECEECTTSCEES----SS
T ss_pred CcccCCcccCCCCHHHHHHHHhCCCCCCcEEEEeCCCCCC-CEEEEEecC-----CceE-EEEEEECCCCeEEE----CC
Confidence 47889999999999999999987 46 999988777 899998885 7788 99998777777873 33
Q ss_pred ccchHHHHHhhh
Q 037285 760 SMQFDAMMENLR 771 (1094)
Q Consensus 760 ~~qFdsL~ElLr 771 (1094)
..|.++.+++.
T Consensus 71 -~~F~sl~eLV~ 81 (117)
T 3ov1_A 71 -VKFNSLNELVD 81 (117)
T ss_dssp -CEESSHHHHHH
T ss_pred -CCcCCHHHHHH
Confidence 58999999984
|
| >1rja_A Tyrosine-protein kinase 6; human protein tyrosine kinase-6 (PTK6/BRK), SRC homology 2(S domain, solution structure, backbone dynamics, transferase; NMR {Homo sapiens} SCOP: d.93.1.1 | Back alignment and structure |
|---|
Probab=98.07 E-value=1.6e-06 Score=80.36 Aligned_cols=71 Identities=11% Similarity=0.088 Sum_probs=60.2
Q ss_pred cccccCCCChhHHHHcCCc----hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCcccccc
Q 037285 690 VDFGQKDVSLIDQEHLGLS----SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSESMQ 762 (1094)
Q Consensus 690 ~~Wy~~~IsR~~AE~ll~a----~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~isE~~q 762 (1094)
+.|||+.|+|.+||.+|.. +| ||+|....| .|.+|+... +.++ ||.|..+..+.|+ +.+...
T Consensus 2 ~~Wyhg~isR~~Ae~lL~~~g~~~G~FLVR~S~~~~g-~~~LSv~~~-----~~v~-H~~I~~~~~g~~~----l~~~~~ 70 (100)
T 1rja_A 2 EPWFFGCISRSEAVRRLQAEGNATGAFLIRVSEKPSA-DYVLSVRDT-----QAVR-HYKIWRRAGGRLH----LNEAVS 70 (100)
T ss_dssp CCCBCTTCCHHHHHHHHSSTTCSSCCEEEEECSSSSS-CEEEEECTT-----SSCE-EEEEEECSSSCEE----EETTEE
T ss_pred CCcccCCCCHHHHHHHHhccCCCCCEEEEEeCCCCCC-CEEEEEEEC-----CEEE-EEEEEEcCCCcEE----ECCCCc
Confidence 6899999999999999986 55 999998777 799998875 6788 9999887777787 556788
Q ss_pred hHHHHHhhh
Q 037285 763 FDAMMENLR 771 (1094)
Q Consensus 763 FdsL~ElLr 771 (1094)
|.++.+++.
T Consensus 71 F~sl~~LV~ 79 (100)
T 1rja_A 71 FLSLPELVN 79 (100)
T ss_dssp ESSHHHHHH
T ss_pred cCCHHHHHH
Confidence 999999993
|
| >1mil_A SHC adaptor protein; SH2 domain, phosphorylation, collagen, growth regulation, transforming protein, alternative initiation; 2.70A {Homo sapiens} SCOP: d.93.1.1 PDB: 1tce_A* | Back alignment and structure |
|---|
Probab=98.04 E-value=1.7e-06 Score=80.89 Aligned_cols=74 Identities=22% Similarity=0.275 Sum_probs=61.4
Q ss_pred ccccccccccCCCChhHHHHcCCchh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCccccc
Q 037285 685 RNLAQVDFGQKDVSLIDQEHLGLSSG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSESM 761 (1094)
Q Consensus 685 ~~Le~~~Wy~~~IsR~~AE~ll~a~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~isE~~ 761 (1094)
++|+.+.||||+|+|.+||.+|..+| ||+|....| .|.+|+... +.++ ||.|. +..+.|.. +..
T Consensus 2 ~~l~~~~Wyhg~isR~~Ae~lL~~~G~FLVR~S~~~~g-~~~LSv~~~-----~~v~-H~~I~-~~~g~~~~-----~~~ 68 (104)
T 1mil_A 2 SQLRGEPWFHGKLSRREAEALLQLNGDFLVRESTTTPG-QYVLTGLQS-----GQPK-HLLLV-DPEGVVRT-----KDH 68 (104)
T ss_dssp CSTTTCTTBCSSCCHHHHHTTCCSTTEEEEEECCSSCS-SEEEEEEET-----TEEE-EEEEB-CTTSSEEC-----SSC
T ss_pred CccccCCcCCCCCCHHHHHHHhccCCcEEEEeCCCCCC-CEEEEEEEC-----CEEE-EEEEE-eCCCEEEE-----CCc
Confidence 36899999999999999999999999 999988777 899998885 6788 99986 34455552 357
Q ss_pred chHHHHHhhh
Q 037285 762 QFDAMMENLR 771 (1094)
Q Consensus 762 qFdsL~ElLr 771 (1094)
.|.++.+++.
T Consensus 69 ~F~sl~~LI~ 78 (104)
T 1mil_A 69 RFESVSHLIS 78 (104)
T ss_dssp EESSHHHHHH
T ss_pred eeCCHHHHHH
Confidence 8999999984
|
| >2cs0_A Hematopoietic SH2 domain containing; ALX, FLJ14886, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: d.93.1.1 | Back alignment and structure |
|---|
Probab=98.03 E-value=2.5e-06 Score=81.84 Aligned_cols=78 Identities=15% Similarity=0.129 Sum_probs=63.2
Q ss_pred hhccccccccccCCCChhHHHHcCCc--hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCc
Q 037285 683 YFRNLAQVDFGQKDVSLIDQEHLGLS--SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSV 757 (1094)
Q Consensus 683 ~~~~Le~~~Wy~~~IsR~~AE~ll~a--~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~i 757 (1094)
.+..++...|||++|+|.+||.+|.. +| ||++....| |.+|+... +.++ ||.|..+..++|+..
T Consensus 9 ~~~~~~~~~WyhG~isR~~Ae~lL~~~~~G~FLVR~S~~~~~--y~LSv~~~-----~~v~-H~~I~~~~~g~~~l~--- 77 (119)
T 2cs0_A 9 QLAQDGVPEWFHGAISREDAENLLESQPLGSFLIRVSHSHVG--YTLSYKAQ-----SSCC-HFMVKLLDDGTFMIP--- 77 (119)
T ss_dssp CCCSSSCCSSBCSSCCHHHHHHHHHTSCTTCEEEEECSSSSS--EEEEECCS-----SSCE-EEEEEECTTSCEECT---
T ss_pred hhccccCCCccccCCCHHHHHHHhcCCCCCEEEEEecCCCCC--EEEEEEEC-----CEEE-EEEEEEcCCCcEEEe---
Confidence 45678889999999999999999965 55 999998777 99998875 6788 999988766677722
Q ss_pred ccccchHHHHHhhh
Q 037285 758 SESMQFDAMMENLR 771 (1094)
Q Consensus 758 sE~~qFdsL~ElLr 771 (1094)
.+...|.++.+++.
T Consensus 78 ~~~~~F~sl~eLV~ 91 (119)
T 2cs0_A 78 GEKVAHTSLDALVT 91 (119)
T ss_dssp TCSCCBSSHHHHHH
T ss_pred cCCCcCCCHHHHHH
Confidence 25678999999994
|
| >2hdv_A SH2-B PH domain containing signaling mediator 1 gamma isoform; adapter protein, signaling protein; 2.00A {Mus musculus} PDB: 2hdx_A* 1rpy_A 1rqq_C* | Back alignment and structure |
|---|
Probab=98.01 E-value=9.3e-07 Score=83.71 Aligned_cols=75 Identities=20% Similarity=0.297 Sum_probs=63.0
Q ss_pred ccccccccccCCCChhHHHHcCC-----chh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCC
Q 037285 685 RNLAQVDFGQKDVSLIDQEHLGL-----SSG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPS 756 (1094)
Q Consensus 685 ~~Le~~~Wy~~~IsR~~AE~ll~-----a~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~ 756 (1094)
+.|+.+.|||+.|+|.+||.+|. .+| ||++....| .|.+|+... +.++ ||.|..+..+.|..
T Consensus 4 ~~l~~~~WyhG~isR~~Ae~lL~~~g~~~~G~FLVR~S~~~~g-~y~LSv~~~-----~~v~-H~~I~~~~~g~~~l--- 73 (111)
T 2hdv_A 4 QPLSGYPWFHGMLSRLKAAQLVLEGGTGSHGVFLVRQSETRRG-ECVLTFNFQ-----GKAK-HLRLSLNAAGQCRV--- 73 (111)
T ss_dssp CCGGGSTTEEEECCHHHHHHHHHTTGGGGTTEEEEEECSSCTT-EEEEEEEET-----TEEE-EEEEEECTTCCEEE---
T ss_pred cccccCCCcCCCCCHHHHHHHHHHcCCCCCCeEEEEecCCCCC-CEEEEEEeC-----CeEE-EEEEEEcCCCCEEe---
Confidence 46889999999999999999997 566 999988788 799998885 7888 99998766677773
Q ss_pred cccccchHHHHHhhh
Q 037285 757 VSESMQFDAMMENLR 771 (1094)
Q Consensus 757 isE~~qFdsL~ElLr 771 (1094)
. ...|.++.+++.
T Consensus 74 -~-~~~F~sl~~LV~ 86 (111)
T 2hdv_A 74 -Q-HLHFQSIFDMLE 86 (111)
T ss_dssp -T-TEEESSHHHHHH
T ss_pred -C-CceeCCHHHHHH
Confidence 3 578999999994
|
| >2crh_A VAV proto-oncogene; oncoprotein, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} PDB: 2ror_A* 2lct_A* | Back alignment and structure |
|---|
Probab=98.00 E-value=2.9e-06 Score=83.58 Aligned_cols=75 Identities=12% Similarity=0.190 Sum_probs=63.3
Q ss_pred ccccccccccCCCChhHHHHcCCc--hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCccc
Q 037285 685 RNLAQVDFGQKDVSLIDQEHLGLS--SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSE 759 (1094)
Q Consensus 685 ~~Le~~~Wy~~~IsR~~AE~ll~a--~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~isE 759 (1094)
.+|+...|||+.|+|.+||.+|.. +| ||++....| .|.+|+... +.++ ||.|. ...++|+ +.+
T Consensus 21 ~~~~~~~WyhG~isR~eAe~lL~~~~~G~FLVR~S~~~~g-~y~LSv~~~-----~~v~-H~~I~-~~~g~~~----l~~ 88 (138)
T 2crh_A 21 QDLSVHLWYAGPMERAGAESILANRSDGTFLVRQRVKDAA-EFAISIKYN-----VEVK-HIKIM-TAEGLYR----ITE 88 (138)
T ss_dssp SCGGGSSSBCCSCCHHHHHHHTTTSCTTEEEEECCSSTTC-CCEEEEEET-----TEEE-EEECE-EETTEEE----SST
T ss_pred CCCCcCCcccCCCCHHHHHHHhcCCCCCEEEEEECCCCCC-CEEEEEEEC-----CeEE-EEEEE-eCCCEEE----ECC
Confidence 567899999999999999999987 77 999988777 899998885 6788 99995 5666777 555
Q ss_pred ccchHHHHHhhh
Q 037285 760 SMQFDAMMENLR 771 (1094)
Q Consensus 760 ~~qFdsL~ElLr 771 (1094)
...|.++.+++.
T Consensus 89 ~~~F~sl~eLV~ 100 (138)
T 2crh_A 89 KKAFRGLTELVE 100 (138)
T ss_dssp TCCBSSHHHHHH
T ss_pred CCccCCHHHHHH
Confidence 678999999984
|
| >1r1p_A GRB2-related adaptor protein 2; SH2, GADS, phosphopeptide, peptide binding protein; HET: PTR; 1.80A {Mus musculus} SCOP: d.93.1.1 PDB: 1r1q_A* 1r1s_A* | Back alignment and structure |
|---|
Probab=97.99 E-value=1.8e-06 Score=80.36 Aligned_cols=74 Identities=12% Similarity=0.228 Sum_probs=62.0
Q ss_pred cccccccccCCCChhHHHHcCCc--hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCcccc
Q 037285 686 NLAQVDFGQKDVSLIDQEHLGLS--SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSES 760 (1094)
Q Consensus 686 ~Le~~~Wy~~~IsR~~AE~ll~a--~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~isE~ 760 (1094)
.|+...|||+.|+|.+||.+|.. +| ||+|...+| .|.+|+... +.++ ||.|..+..+.|+.. .
T Consensus 5 ~l~~~~Wyhg~isR~~Ae~lL~~~~~G~FLVR~S~~~~g-~~~LSv~~~-----~~v~-H~~I~~~~~g~~~l~----~- 72 (100)
T 1r1p_A 5 DIEFPEWFHEGLSRHQAENLLMGKDIGFFIIRASQSSPG-DFSISVRHE-----DDVQ-HFKVMRDTKGNYFLW----T- 72 (100)
T ss_dssp -CTTTTTSCTTCCHHHHHHHHHTSCTTBEEEEECSSSTT-CEEEEEECS-----SSEE-EEECEECTTCCEESS----S-
T ss_pred EeccCCccccCCCHHHHHHHhcCCCCCEEEEEecCCCCC-CEEEEEEEC-----CEEE-EEEEEEcCCCCEEEe----C-
Confidence 48999999999999999999977 77 999998788 799998885 6788 999988767777733 2
Q ss_pred cchHHHHHhhh
Q 037285 761 MQFDAMMENLR 771 (1094)
Q Consensus 761 ~qFdsL~ElLr 771 (1094)
..|.++.+++.
T Consensus 73 ~~F~sl~~LV~ 83 (100)
T 1r1p_A 73 EKFPSLNKLVD 83 (100)
T ss_dssp CEESSHHHHHH
T ss_pred CEeCCHHHHHH
Confidence 58999999993
|
| >2bbu_A Suppressor of cytokine signaling 3; SH2 domain, extended SH2 subdomain, PEST motif, protein complex, cytokine regulator; HET: PTR; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=97.97 E-value=3.9e-06 Score=85.25 Aligned_cols=81 Identities=15% Similarity=0.250 Sum_probs=64.0
Q ss_pred hhccccccccccCCCChhHHHHcC--Cchh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCC-
Q 037285 683 YFRNLAQVDFGQKDVSLIDQEHLG--LSSG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPS- 756 (1094)
Q Consensus 683 ~~~~Le~~~Wy~~~IsR~~AE~ll--~a~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~- 756 (1094)
....|+...|||++|+|.+||.+| ..+| ||+|....| .|.+|+.+. +.++ ||.|.. ..+.|+....
T Consensus 16 ~~~~L~~~~WyhG~IsR~eAe~lL~~~~~GtFLVR~S~s~~g-~y~LSvr~~-----~~v~-H~rI~~-~~g~f~l~~~~ 87 (164)
T 2bbu_A 16 AVRKLQESGFYWSAVTGGEANLLLSAEPAGTFLIRDSSDQRH-FFTLSVKTQ-----SGTK-NLRIQC-EGGSFSLQSDP 87 (164)
T ss_dssp HHHHHHHTSCCCTTSCHHHHHHHHHHSSTTCCEEEECSTTSC-CEEEEECCT-----TCCE-EEECEE-ETTEEESSSCC
T ss_pred hhhhhccCCccCCCCCHHHHHHHhcCCCCCCEEEEECCCCCC-CEEEEEEEC-----CceE-EEEEEe-CCCeEEEecCc
Confidence 456899999999999999999999 3566 999998777 899998875 6778 999986 5566773321
Q ss_pred --cccccchHHHHHhhh
Q 037285 757 --VSESMQFDAMMENLR 771 (1094)
Q Consensus 757 --isE~~qFdsL~ElLr 771 (1094)
......|.++.+++.
T Consensus 88 ~~~~~~~~F~SL~eLV~ 104 (164)
T 2bbu_A 88 RSTQPVPRFDCVLKLVH 104 (164)
T ss_dssp CCCSSCTTCCHHHHHHH
T ss_pred ccccCCCccCCHHHHHH
Confidence 122378999999993
|
| >2iug_A Phosphatidylinositol 3-kinase regulatory alpha subunit; transferase, polymorphism, UBL conjugation, phosphorylation, SH2, PI3K, SH2 domain; 1.89A {Homo sapiens} PDB: 2iuh_A* 2iui_A* 1fu5_A* 1fu6_A 1oo3_A 1oo4_A* 2pna_A 2pnb_A | Back alignment and structure |
|---|
Probab=97.95 E-value=1.6e-06 Score=83.15 Aligned_cols=76 Identities=18% Similarity=0.297 Sum_probs=63.5
Q ss_pred hccccccccccCCCChhHHHHcCCc--hh---hhhhhhc-CCceeEEeeeccCCCCCCcccccccccccCCCccccCCCc
Q 037285 684 FRNLAQVDFGQKDVSLIDQEHLGLS--SG---VREVREE-DGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSV 757 (1094)
Q Consensus 684 ~~~Le~~~Wy~~~IsR~~AE~ll~a--~g---VR~s~~~-~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~i 757 (1094)
-..|+...|||+.|+|.+||.+|.. +| ||+|... .| .|.+|+... +.++ ||.|..+ .+.|+ +
T Consensus 5 ~~~l~~~~WyhG~isR~eAe~lL~~~~~G~FLVR~S~~~~~g-~y~LSv~~~-----~~v~-H~~I~~~-~g~~~----l 72 (120)
T 2iug_A 5 NMSLQNAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHG-DYTLTLRKG-----GNNK-LIKIFHR-DGKYG----F 72 (120)
T ss_dssp CHHHHTCTTBCCSCCHHHHHHHHTTCCTTEEEEEECSSGGGC-SEEEEEEET-----TEEE-EEEEEEE-TTEEE----S
T ss_pred ccccccCCccccCCCHHHHHHHhcCCCCcEEEEECCCCCCCC-cEEEEEEEC-----CEEE-EEEEEEc-CCEEE----E
Confidence 4578999999999999999999987 67 9999986 67 899998875 6777 9999875 56777 4
Q ss_pred ccccchHHHHHhhh
Q 037285 758 SESMQFDAMMENLR 771 (1094)
Q Consensus 758 sE~~qFdsL~ElLr 771 (1094)
.....|.++.+++.
T Consensus 73 ~~~~~F~sl~~LI~ 86 (120)
T 2iug_A 73 SDPLTFSSVVELIN 86 (120)
T ss_dssp SSSCCBSSHHHHHH
T ss_pred CCCCccCCHHHHHH
Confidence 45678999999984
|
| >1wqu_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; SH2 domain, feline sarcoma oncogene, structural genomics; NMR {Homo sapiens} PDB: 2dcr_A | Back alignment and structure |
|---|
Probab=97.94 E-value=3.2e-06 Score=80.56 Aligned_cols=82 Identities=16% Similarity=0.152 Sum_probs=65.3
Q ss_pred cccCCCCchhhhccccccccccCCCChhHHHHcCCchh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCC
Q 037285 673 MENHEPKRWSYFRNLAQVDFGQKDVSLIDQEHLGLSSG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQK 749 (1094)
Q Consensus 673 ~~~~~~~~~~~~~~Le~~~Wy~~~IsR~~AE~ll~a~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~ 749 (1094)
+++++|.. -..|+.+.|||++|+|.+||.+|..+| ||++.... .|.+|+... +.++ ||.|... .+
T Consensus 2 ~~g~vp~~---~~~l~~~~WyhG~isR~eAe~lL~~~G~FLVR~S~~~~--~y~LSv~~~-----~~v~-H~~I~~~-~g 69 (114)
T 1wqu_A 2 SSGSSGEV---QKPLHEQLWYHGAIPRAEVAELLVHSGDFLVRESQGKQ--EYVLSVLWD-----GLPR-HFIIQSL-DN 69 (114)
T ss_dssp CCCCCCGG---GSCGGGCTTEEESCCHHHHHTTCCSTTEEEEEECSSSC--CEEEEEEET-----TEEE-EEECEEC-SS
T ss_pred CccccCCc---ccccccCCcEeeCCCHHHHHHHhccCCeEEEEEcCCCC--CEEEEEEEC-----CEEE-EEEEEec-CC
Confidence 45666663 467899999999999999999999999 99998744 899998885 6788 9999764 34
Q ss_pred ccccCCCcccccchHHHHHhhh
Q 037285 750 TFGVDPSVSESMQFDAMMENLR 771 (1094)
Q Consensus 750 r~~vtp~isE~~qFdsL~ElLr 771 (1094)
.|. .+...|.++.+++.
T Consensus 70 ~~~-----~~~~~F~sl~~LV~ 86 (114)
T 1wqu_A 70 LYR-----LEGEGFPSIPLLID 86 (114)
T ss_dssp SEE-----SSSCCBSSHHHHHH
T ss_pred EEE-----ECCCCCCCHHHHHH
Confidence 454 23578999999984
|
| >2gsb_A RAS GTPase-activating protein 1; GAP, RAS P21 protein activator, P120GAP, rasgap, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.92 E-value=4.3e-06 Score=80.23 Aligned_cols=76 Identities=11% Similarity=0.111 Sum_probs=62.7
Q ss_pred hccccccccccCCCChhHHHHcCCch---h---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCc
Q 037285 684 FRNLAQVDFGQKDVSLIDQEHLGLSS---G---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSV 757 (1094)
Q Consensus 684 ~~~Le~~~Wy~~~IsR~~AE~ll~a~---g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~i 757 (1094)
.+.|+...|||++|+|.+||.+|... | ||++....| .|.+|+... +.++ ||.|..+..+.|..
T Consensus 10 ~~~l~~~~WyhG~isR~~Ae~lL~~~g~~G~FLVR~S~~~~g-~y~LSv~~~-----~~v~-H~~I~~~~~g~~~l---- 78 (119)
T 2gsb_A 10 EDPHEGKIWFHGKISKQEAYNLLMTVGQVCSFLVRPSDNTPG-DYSLYFRTN-----ENIQ-RFKICPTPNNQFMM---- 78 (119)
T ss_dssp CCSGGGCSSBCCSSCHHHHHHHHHHTCCSSEEEEEECSSSTT-CEEEEEECS-----SCBC-CCCEEEETTTEEEE----
T ss_pred CcccccCCcccCCCCHHHHHHHHhhcCCCCeEEEEeCCCCCC-ceEEEEEEC-----CEEE-EEEEEEcCCCCEEE----
Confidence 35689999999999999999999764 4 999998778 899998875 6788 99998776677773
Q ss_pred ccccchHHHHHhhh
Q 037285 758 SESMQFDAMMENLR 771 (1094)
Q Consensus 758 sE~~qFdsL~ElLr 771 (1094)
. ...|.++.+++.
T Consensus 79 ~-~~~F~sl~~LI~ 91 (119)
T 2gsb_A 79 G-GRYYNSIGDIID 91 (119)
T ss_dssp S-SCCBSCHHHHHH
T ss_pred C-CcccCCHHHHHH
Confidence 2 357999999984
|
| >1i3z_A EWS/FLI1 activated transcript 2; SH2 domain phosphotyrosine signal transduction lymphocyte, signaling protein; HET: PTR; 2.15A {Mus musculus} SCOP: d.93.1.1 | Back alignment and structure |
|---|
Probab=97.92 E-value=2.7e-06 Score=79.08 Aligned_cols=76 Identities=12% Similarity=0.156 Sum_probs=59.9
Q ss_pred ccccccCCCChhHHHHcCCc---hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCc-cccc
Q 037285 689 QVDFGQKDVSLIDQEHLGLS---SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSV-SESM 761 (1094)
Q Consensus 689 ~~~Wy~~~IsR~~AE~ll~a---~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~i-sE~~ 761 (1094)
.+.|||++|+|.+||.+|.. +| ||+|....| .|.+|+... +.++ ||.|..+..+.|...... ....
T Consensus 2 ~~~Wyhg~isR~~Ae~lL~~~~~~G~FLVR~S~~~~g-~~~LSv~~~-----~~v~-H~~I~~~~~g~~~l~~~~g~~~~ 74 (103)
T 1i3z_A 2 DLPYYHGCLTKRECEALLLKGGVDGNFLIRDSESVPG-ALCLCVSFK-----KLVY-SYRIFREKHGYYRIETDAHTPRT 74 (103)
T ss_dssp CCTTEESSCCHHHHHHHHHTTCSTTEEEEEECSSSTT-CEEEEEECS-----SSEE-EEEEEECTTSCEEECBCTTSCCC
T ss_pred CCccccCCCCHHHHHHHHhhcCCCceEEEEeCCCCCC-CEEEEEEEC-----CEEE-EEEEEECCCCeEEEeccCCCCCc
Confidence 46899999999999999975 56 999988778 899998875 7788 999987667777733110 1467
Q ss_pred chHHHHHhhh
Q 037285 762 QFDAMMENLR 771 (1094)
Q Consensus 762 qFdsL~ElLr 771 (1094)
.|.++.+++.
T Consensus 75 ~F~sl~~LV~ 84 (103)
T 1i3z_A 75 IFPNLQELVS 84 (103)
T ss_dssp EESSSHHHHH
T ss_pred ccCCHHHHHH
Confidence 8999999983
|
| >2eo6_A B-cell linker protein; SH2, cytoplasmic adapter protein, B-cell adapter containing SH2 domain protein; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=97.92 E-value=3e-06 Score=83.59 Aligned_cols=82 Identities=11% Similarity=0.101 Sum_probs=63.5
Q ss_pred hhccccccccccCCCChhHHHHcCC---chh---hhhhhh--cCCceeEEeeeccCCCCCCcccccccccccCCCc-ccc
Q 037285 683 YFRNLAQVDFGQKDVSLIDQEHLGL---SSG---VREVRE--EDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKT-FGV 753 (1094)
Q Consensus 683 ~~~~Le~~~Wy~~~IsR~~AE~ll~---a~g---VR~s~~--~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r-~~v 753 (1094)
.-..|+.+.|||++|+|.+||.+|. .+| ||++.. ..| .|.+++... +.++ ||.|.....++ |..
T Consensus 16 ~~~~l~~~~WyhG~isR~eAe~lL~~~~~~G~FLVR~S~~~~~~g-~y~LSv~~~-----~~v~-H~~I~~~~~g~~~~l 88 (141)
T 2eo6_A 16 QEAELLGKPWYAGACDRKSAEEALHRSNKDGSFLIRKSSGHDSKQ-PYTLVAFFN-----KRVY-NIPVRFIEATKQYAL 88 (141)
T ss_dssp HHHTTTTCSSEEESCCHHHHHHHHHHHCCTTCBCEEECSTTCSSC-SEEEEEEET-----TEEE-EEEECEETTTTEECS
T ss_pred cccccCCCCeEecCCCHHHHHHHhhccCCCceEEEEECCCCCCCC-CEEEEEEEC-----CEEE-EEEEEEeCCCCEEEE
Confidence 5678999999999999999999994 456 999986 566 899999886 6788 99998655555 452
Q ss_pred CCCcccccchHHHHHhhh
Q 037285 754 DPSVSESMQFDAMMENLR 771 (1094)
Q Consensus 754 tp~isE~~qFdsL~ElLr 771 (1094)
.........|.++.+++.
T Consensus 89 ~~~~~~~~~F~sl~eLV~ 106 (141)
T 2eo6_A 89 GKKKNGEEYFGSVVEIVN 106 (141)
T ss_dssp SSCCTTCCCBSSHHHHHH
T ss_pred ccccCCCCccCCHHHHHH
Confidence 211124578999999994
|
| >1jyr_A Growth factor receptor-bound protein 2; receptor binding, regulatory, inhibitor, signaling protein-I complex; HET: PTR; 1.55A {Homo sapiens} SCOP: d.93.1.1 PDB: 1jyq_A* 1jyu_A 1qg1_E* 1x0n_A* 2aob_A* 2aoa_A* 3n7y_A* 1tze_E* 1zfp_E* 3mxc_A* 3mxy_A* 1cj1_A* | Back alignment and structure |
|---|
Probab=97.91 E-value=4.5e-06 Score=77.09 Aligned_cols=71 Identities=13% Similarity=0.201 Sum_probs=59.3
Q ss_pred ccccccCCCChhHHHHcCCc---hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCcccccc
Q 037285 689 QVDFGQKDVSLIDQEHLGLS---SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSESMQ 762 (1094)
Q Consensus 689 ~~~Wy~~~IsR~~AE~ll~a---~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~isE~~q 762 (1094)
.+.|||++|+|.+||.+|.. +| ||+|....| .|.+|+... +.++ ||.|..+..+.|.. .. ..
T Consensus 2 ~~~Wyhg~isR~~Ae~lL~~~~~~G~FLVR~S~~~~g-~~~LSv~~~-----~~v~-H~~I~~~~~g~~~l----~~-~~ 69 (96)
T 1jyr_A 2 SMAWFFGKIPRAKAEEMLSKQRHDGAFLIRESESAPG-DFSLSVKFG-----NDVQ-HFKVLRDGAGKYFL----WV-VK 69 (96)
T ss_dssp CCTTBCCSCCHHHHHHHHHTCCSTTBEEEEECSSSTT-CEEEEEEET-----TEEE-EEECEECTTSCEES----SS-CE
T ss_pred CcceeccCCCHHHHHHHHhcCCCCcEEEEEecCCCCC-CEEEEEEeC-----CeEE-EEEEEEcCCCCEEE----CC-cc
Confidence 46899999999999999987 56 999988778 799999885 6788 99998876777773 33 67
Q ss_pred hHHHHHhhh
Q 037285 763 FDAMMENLR 771 (1094)
Q Consensus 763 FdsL~ElLr 771 (1094)
|.++.+++.
T Consensus 70 F~sl~~LV~ 78 (96)
T 1jyr_A 70 FNSLNELVD 78 (96)
T ss_dssp ESSHHHHHH
T ss_pred cCCHHHHHH
Confidence 999999993
|
| >3pqz_A Growth factor receptor-bound protein 7; SH2, binds phosphotyrosine, tyrosine kinases, cytoplasmic, P binding; 2.41A {Homo sapiens} PDB: 1mw4_A* 2l4k_A* 2qms_A | Back alignment and structure |
|---|
Probab=97.91 E-value=2.7e-06 Score=80.81 Aligned_cols=80 Identities=10% Similarity=0.022 Sum_probs=60.0
Q ss_pred hhccccccccccCCCChhHHHHcCCc----hh---hhhhhhcCCceeEEeeeccCCCCCCccccccccccc-CCCccccC
Q 037285 683 YFRNLAQVDFGQKDVSLIDQEHLGLS----SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQD-SQKTFGVD 754 (1094)
Q Consensus 683 ~~~~Le~~~Wy~~~IsR~~AE~ll~a----~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~d-sq~r~~vt 754 (1094)
.-..++...|||++|+|.+||.+|.. +| ||+|....| .|.+|+... +.++ ||.|... ..++++..
T Consensus 7 ~~~~~~~~~Wyhg~isR~~Ae~lL~~~g~~~G~FLVR~S~~~~g-~y~LSv~~~-----~~v~-H~~I~~~~~~g~~~~~ 79 (117)
T 3pqz_A 7 SAAIHRTQLWFHGRISREESQRLIGQQGLVDGLFLVRESQRNPQ-GFVLSLCHL-----QKVK-HYLILPSEEEGRLYFS 79 (117)
T ss_dssp --CGGGGCTTBCCSCCHHHHHHHHHHTTCCTTEEEEEECCC-CC-CEEEEEEET-----TEEE-EEEEEEECCTTCCEEE
T ss_pred ChhhcccCccccCCCCHHHHHHHHhcCCCCCCEEEEEecCCCCC-cEEEEEEeC-----CeeE-EEEEEEecCCCCEEEE
Confidence 34567889999999999999999965 56 999998777 899998885 7888 9999874 34444311
Q ss_pred CCcccccchHHHHHhh
Q 037285 755 PSVSESMQFDAMMENL 770 (1094)
Q Consensus 755 p~isE~~qFdsL~ElL 770 (1094)
. ......|.++.+++
T Consensus 80 ~-~~~~~~F~sl~~LV 94 (117)
T 3pqz_A 80 M-DDGQTRFTDLLQLV 94 (117)
T ss_dssp S-STTSSCBSSHHHHH
T ss_pred E-CCCCcccCCHHHHH
Confidence 1 11356899999999
|
| >2dlz_A Protein VAV-2; RHO family guanine nucleotide exchange factor, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.90 E-value=4e-06 Score=80.30 Aligned_cols=76 Identities=16% Similarity=0.231 Sum_probs=63.7
Q ss_pred hccccccccccCCCChhHHHHcCCc--hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCcc
Q 037285 684 FRNLAQVDFGQKDVSLIDQEHLGLS--SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVS 758 (1094)
Q Consensus 684 ~~~Le~~~Wy~~~IsR~~AE~ll~a--~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~is 758 (1094)
...|+.+.|||++|+|.+||.+|.. +| ||++....| .|.+|+... +.++ ||.|..+ .+.|+ +.
T Consensus 10 ~~~l~~~~WyhG~isR~~Ae~lL~~~~~G~FLVR~S~~~~g-~y~LSv~~~-----~~v~-H~~I~~~-~g~~~----l~ 77 (118)
T 2dlz_A 10 EIDYTAYPWFAGNMERQQTDNLLKSHASGTYLIRERPAEAE-RFAISIKFN-----DEVK-HIKVVEK-DNWIH----IT 77 (118)
T ss_dssp CCCGGGSTTEEESCCHHHHHHHHHHSCTTBEEEECCSCSSC-CEEEEEECS-----SSEE-EEEEEEE-TTEEE----ST
T ss_pred ccccccCCceecCCCHHHHHHHhcCCCCCEEEEEeCCCCCC-CEEEEEEEC-----CcEE-EEEEEEc-CCEEE----Ee
Confidence 4568999999999999999999977 77 999988777 899998875 6788 9999874 56677 55
Q ss_pred cccchHHHHHhhh
Q 037285 759 ESMQFDAMMENLR 771 (1094)
Q Consensus 759 E~~qFdsL~ElLr 771 (1094)
+...|.++.+++.
T Consensus 78 ~~~~F~sl~~LV~ 90 (118)
T 2dlz_A 78 EAKKFDSLLELVE 90 (118)
T ss_dssp TSCCBSSHHHHHH
T ss_pred CCcccCCHHHHHH
Confidence 5678999999994
|
| >2dvj_A V-CRK sarcoma virus CT10 oncogene homolog, isoform A; SH3, SH2, signal transduction, adapter molecule, signaling protein; HET: PTR; NMR {Homo sapiens} PDB: 2eyy_A 2eyv_A 2eyw_A | Back alignment and structure |
|---|
Probab=97.88 E-value=7.4e-06 Score=86.66 Aligned_cols=81 Identities=15% Similarity=0.206 Sum_probs=63.3
Q ss_pred CCCCchhhhccccccccccCCCChhHHHHcCCc--hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCC-
Q 037285 676 HEPKRWSYFRNLAQVDFGQKDVSLIDQEHLGLS--SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQK- 749 (1094)
Q Consensus 676 ~~~~~~~~~~~Le~~~Wy~~~IsR~~AE~ll~a--~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~- 749 (1094)
+||+|+ ..|+.+.|||++|+|.+||.+|.. +| ||+|....| .|.+|+... +.++ ||.|.....+
T Consensus 2 ~i~~~~---~~l~~~~WyhG~isR~eAe~lL~~~~~G~FLVR~S~~~~g-~y~LSv~~~-----~~v~-H~~I~~~~~~~ 71 (230)
T 2dvj_A 2 AMAGNF---DSEERSSWYWGRLSRQEAVALLQGQRHGVFLVRDSSTSPG-DYVLSVSEN-----SRVS-HYIINSSGPRP 71 (230)
T ss_dssp -CCSCC---CSSSSSSSCCSSCCTTHHHHHHTTSSSSCBEEECCSSCTT-SCEEECCCS-----SSCC-CEECBCCCSCC
T ss_pred CcCccc---ccccCCCcccCCCCHHHHHHHhcCCCCceEEEEeCCCCCC-CEEEEEEEC-----CEEE-EEEEEeCCCCc
Confidence 566665 478899999999999999999975 56 999998788 899998875 6788 9999865421
Q ss_pred ----------------ccccCCCcccccchHHHHHhhh
Q 037285 750 ----------------TFGVDPSVSESMQFDAMMENLR 771 (1094)
Q Consensus 750 ----------------r~~vtp~isE~~qFdsL~ElLr 771 (1094)
.|. + +...|.++.+++.
T Consensus 72 ~~~~~~~~~~~g~~~~~~~----~-~~~~F~sl~~LV~ 104 (230)
T 2dvj_A 72 PVPPSPAQPPPGVSPSRLR----I-GDQEFDSLPALLE 104 (230)
T ss_dssp SSSSSSSSTTTSCCCCCEE----S-SSCEESSHHHHHT
T ss_pred ccccccccccccccceEEE----e-CCceeCCHHHHHH
Confidence 233 2 4568999999994
|
| >3tkz_A Tyrosine-protein phosphatase non-receptor type 11; SH2 domain, protein protein interactions, PTR residues, HYDR peptide complex; HET: PTR; 1.80A {Homo sapiens} PDB: 3tl0_A* 1aya_A* 1ayb_A* 1ayc_A* 1ayd_A | Back alignment and structure |
|---|
Probab=97.88 E-value=2.8e-06 Score=79.82 Aligned_cols=74 Identities=14% Similarity=0.325 Sum_probs=56.6
Q ss_pred cccccccccCCCChhHHHHcCCc---hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCccc
Q 037285 686 NLAQVDFGQKDVSLIDQEHLGLS---SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSE 759 (1094)
Q Consensus 686 ~Le~~~Wy~~~IsR~~AE~ll~a---~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~isE 759 (1094)
.|+..+||+++|+|.+||.+|.. +| ||+|....| .|.+|+... +.++ ||.|..+ .+.|. +..
T Consensus 3 ~l~~~~Wyhg~isr~~Ae~lL~~~~~~G~FLVR~S~~~~g-~y~LSv~~~-----~~v~-H~~I~~~-~~~~~----~~~ 70 (109)
T 3tkz_A 3 HMTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPG-DFTLSVRRN-----GAVT-HIKIQNT-GDYYD----LYG 70 (109)
T ss_dssp ----CCSBCTTCCHHHHHHHHHHHCCTTEEEEEECSSSTT-CEEEEEEET-----TEEE-EEEEEEC-SSCEE----SSS
T ss_pred ccccCCceecCCCHHHHHHHHhcCCCCCEEEEEecCCCCC-CEEEEEEEC-----CEEE-EEEEEeC-CCEEE----ecC
Confidence 47889999999999999999976 56 999998777 899998885 7888 9999764 33444 334
Q ss_pred ccchHHHHHhhh
Q 037285 760 SMQFDAMMENLR 771 (1094)
Q Consensus 760 ~~qFdsL~ElLr 771 (1094)
...|.++.+++.
T Consensus 71 ~~~F~sl~~LV~ 82 (109)
T 3tkz_A 71 GEKFATLAELVQ 82 (109)
T ss_dssp SCCBSSHHHHHH
T ss_pred CcccCCHHHHHH
Confidence 567999999983
|
| >1h9o_A Phosphatidylinositol 3-kinase; transferase/receptor, complex (phosphotransferase/receptor), phosphotransferase, SH2 domain; HET: PTR; 1.79A {Homo sapiens} SCOP: d.93.1.1 PDB: 1pic_A* 1bfi_A 1bfj_A 1qad_A | Back alignment and structure |
|---|
Probab=97.87 E-value=4.3e-06 Score=79.19 Aligned_cols=76 Identities=17% Similarity=0.271 Sum_probs=59.7
Q ss_pred hccccccccccCCCChhHHHHcCC--chh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCcc
Q 037285 684 FRNLAQVDFGQKDVSLIDQEHLGL--SSG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVS 758 (1094)
Q Consensus 684 ~~~Le~~~Wy~~~IsR~~AE~ll~--a~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~is 758 (1094)
+..++...|||++|+|.+||.+|. .+| ||+| ...| .|.+|+... +.++ ||.|..+..+ ++. ..
T Consensus 4 ~~~~~~~~Wyhg~isR~~Ae~lL~~~~~G~FLVR~S-~~~g-~y~LSv~~~-----~~v~-H~~I~~~~~g-~~~---~~ 71 (112)
T 1h9o_A 4 IPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRES-SKQG-CYACSVVVD-----GEVK-HCVINKTATG-YGF---AE 71 (112)
T ss_dssp CGGGSGGGTBCCSCCHHHHHHHHTTCCTTEEEEEEC-SSTT-CEEEEEEET-----TEEE-EEEEEEETTE-EES---ST
T ss_pred CccccCCCcccCCCCHHHHHHHhcCCCCceEEEeec-CCCC-CEEEEEEEC-----CEEE-EEEEEEcCCc-eEE---eC
Confidence 356889999999999999999994 666 9999 6577 899998885 6788 9999876544 431 23
Q ss_pred cccchHHHHHhhh
Q 037285 759 ESMQFDAMMENLR 771 (1094)
Q Consensus 759 E~~qFdsL~ElLr 771 (1094)
....|.++.+++.
T Consensus 72 ~~~~F~sl~~LV~ 84 (112)
T 1h9o_A 72 PYNLYSSLKELVL 84 (112)
T ss_dssp TCCCBSSHHHHHH
T ss_pred CCCCcCCHHHHHH
Confidence 3567999999984
|
| >2cia_A Cytoplasmic protein NCK2; SH2-domain, SH3 domain, phosphorylation, binding specificity; HET: PTR MPD; 1.45A {Homo sapiens} PDB: 1z3k_A 2ci9_A* 2ci8_A* | Back alignment and structure |
|---|
Probab=97.86 E-value=2.8e-06 Score=79.17 Aligned_cols=73 Identities=11% Similarity=0.158 Sum_probs=56.9
Q ss_pred cccccccccCCCChhHHHHcCC---chh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCccc
Q 037285 686 NLAQVDFGQKDVSLIDQEHLGL---SSG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSE 759 (1094)
Q Consensus 686 ~Le~~~Wy~~~IsR~~AE~ll~---a~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~isE 759 (1094)
+++...|||++|+|.+||.+|+ .+| ||+|....| .|.+|+... +.++ ||.|. ...+.|. +..
T Consensus 1 ~p~~~~Wyhg~isR~~Ae~lL~~~~~~G~FLVR~S~~~~g-~~~LSv~~~-----~~v~-H~~I~-~~~g~~~----l~~ 68 (102)
T 2cia_A 1 GPLGSEWYYGNVTRHQAECALNERGVEGDFLIRDSESSPS-DFSVSLKAS-----GKNK-HFKVQ-LVDNVYC----IGQ 68 (102)
T ss_dssp ----CTTBCCSCCHHHHHHHHHHHCCTTEEEEEECSSSTT-CEEEEECCS-----SSCE-EEEEE-EETTEEE----ETT
T ss_pred CCcCCccccCCCCHHHHHHHHhhCCCCcEEEEEECCCCCC-CEEEEEEeC-----CeeE-EEEEE-ecCCEEE----ECC
Confidence 3578999999999999999996 456 999998778 899998875 6788 99998 4556677 333
Q ss_pred ccchHHHHHhhh
Q 037285 760 SMQFDAMMENLR 771 (1094)
Q Consensus 760 ~~qFdsL~ElLr 771 (1094)
..|.++.+++.
T Consensus 69 -~~F~sl~~LV~ 79 (102)
T 2cia_A 69 -RRFHTMDELVE 79 (102)
T ss_dssp -EEESSHHHHHH
T ss_pred -cCcCCHHHHHH
Confidence 57999999984
|
| >2izv_A Suppressor of cytokine signaling 4; signal transduction inhibitor, growth regulation, signal transduction, SH2 domain, nuclear protein; 2.55A {Homo sapiens} SCOP: a.271.1.1 d.93.1.1 | Back alignment and structure |
|---|
Probab=97.86 E-value=2e-06 Score=89.11 Aligned_cols=99 Identities=13% Similarity=0.055 Sum_probs=67.0
Q ss_pred CCCccccccccCCCCchhhhccccccccccCCCChhHHHHcCCc--hh---hhhhhhcCCceeEEeeeccCCCCCCcccc
Q 037285 665 DGAGISVNMENHEPKRWSYFRNLAQVDFGQKDVSLIDQEHLGLS--SG---VREVREEDGRLYHFTPLTDDGAPKGRVDS 739 (1094)
Q Consensus 665 ~~~~~s~~~~~~~~~~~~~~~~Le~~~Wy~~~IsR~~AE~ll~a--~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~s 739 (1094)
+|.-.+.+-..+++........|+.+.||+|+|+|.+||.+|.. +| ||+|...++ .+++++.+. +.++
T Consensus 9 ~~~~~~~~~~~~~~~~v~~~~~l~~~~WYhG~isR~eAE~lL~~~~dGtFLVR~S~~~~~-~lsLSvr~~-----~~v~- 81 (187)
T 2izv_A 9 SGVDLGTENLYFQSMLVPDLLQINNNPCYWGVMDKYAAEALLEGKPEGTFLLRDSAQEDY-LFSVSFRRY-----SRSL- 81 (187)
T ss_dssp --------CCSCEEEECTTHHHHHHCTTEEEECCHHHHHHHHTTCCTTEEEEEECSSTTC-SEEEEEEET-----TEEE-
T ss_pred CccccCCCccccccccccchhhcccCCccccCCCHHHHHHHhcCCCCCcEEEEECCCCCc-eEEEEEeeC-----CeEE-
Confidence 34444444555554444467789999999999999999999974 56 999997444 788888765 6788
Q ss_pred cccccccCCCccccCCCcccccchHHHHHhhh
Q 037285 740 QLNFGQDSQKTFGVDPSVSESMQFDAMMENLR 771 (1094)
Q Consensus 740 hy~I~~dsq~r~~vtp~isE~~qFdsL~ElLr 771 (1094)
||.|..+ .+.|+..........|+++.+++.
T Consensus 82 H~rI~~~-~g~f~l~~~~~~~~~F~SL~eLV~ 112 (187)
T 2izv_A 82 HARIEQW-NHNFSFDAHDPCVFHSPDITGLLE 112 (187)
T ss_dssp EEECEEE-TTEEESCTTCTTSCCBSSHHHHHH
T ss_pred EEEEEEC-CCEEEEeccCCCccccCCHHHHHH
Confidence 9999875 566763321111247999999994
|
| >2kk6_A Proto-oncogene tyrosine-protein kinase FER; methods development, SH2, NESG, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.85 E-value=3.9e-06 Score=80.53 Aligned_cols=77 Identities=21% Similarity=0.333 Sum_probs=64.2
Q ss_pred hhhccccccccccCCCChhHHHHcCCchh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCcc
Q 037285 682 SYFRNLAQVDFGQKDVSLIDQEHLGLSSG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVS 758 (1094)
Q Consensus 682 ~~~~~Le~~~Wy~~~IsR~~AE~ll~a~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~is 758 (1094)
+-+..++...||+|.|+|.+||.+|..+| ||+|....| .|.+|+... +.++ ||.|.. ..+.|..
T Consensus 9 ~~~~~~~~~~WyhG~isR~eAe~lL~~~G~FLVR~S~~~~g-~y~LSv~~~-----~~v~-H~~I~~-~~g~y~~----- 75 (116)
T 2kk6_A 9 SHMKPLAEQDWYHGAIPRIEAQELLKKQGDFLVRESHGKPG-EYVLSVYSD-----GQRR-HFIIQY-VDNMYRF----- 75 (116)
T ss_dssp SSCCCTTTCTTEEESCCHHHHHHTCCSTTCEEEEECTTCTT-CEEEEEEET-----TEEE-EEEEEE-ETTEEES-----
T ss_pred ccccccccCCCccCCCCHHHHHHHhccCCcEEEEECCCCCC-cEEEEEEEC-----CeEE-EEEEEe-cCCEEEE-----
Confidence 35778999999999999999999999999 999998788 899998875 6788 999985 4455552
Q ss_pred cccchHHHHHhhh
Q 037285 759 ESMQFDAMMENLR 771 (1094)
Q Consensus 759 E~~qFdsL~ElLr 771 (1094)
+...|.++.+++.
T Consensus 76 ~~~~F~sl~eLV~ 88 (116)
T 2kk6_A 76 EGTGFSNIPQLID 88 (116)
T ss_dssp SSCEESCHHHHHH
T ss_pred CCCEeCCHHHHHH
Confidence 3568999999984
|
| >2eob_A 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma 2; SH2, phosphoinositide phospholipase C, PLC-gamma-2, phospholipase C-gamma-2; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=97.84 E-value=5.5e-06 Score=80.04 Aligned_cols=75 Identities=17% Similarity=0.251 Sum_probs=60.3
Q ss_pred hccccccccccCCCChhHHHHcCC---chh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCc
Q 037285 684 FRNLAQVDFGQKDVSLIDQEHLGL---SSG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSV 757 (1094)
Q Consensus 684 ~~~Le~~~Wy~~~IsR~~AE~ll~---a~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~i 757 (1094)
-+.|+...|||++|+|.+||.+|. .+| ||++. ..| .|.+|+... +.++ ||.|..+ .+.|. +
T Consensus 13 ~~~l~~~~WyhG~isR~eAe~lL~~~~~~G~FLVR~S~-~~g-~y~LSv~~~-----~~v~-H~~I~~~-~~~~~----~ 79 (124)
T 2eob_A 13 PNPHESKPWYYDRLSRGEAEDMLMRIPRDGAFLIRKRE-GTD-SYAITFRAR-----GKVK-HCRINRD-GRHFV----L 79 (124)
T ss_dssp SCSTTTSTTEESSCCHHHHHHHHHHCCSSSEEEEECCT-TSS-CEEEEEEET-----TEEE-EEEEEES-SSCEE----S
T ss_pred ccccCcCCCeecCCCHHHHHHHHhcCCCCCEEEEEecC-CCC-CEEEEEEeC-----CeEE-EEEEEEC-CCEEE----E
Confidence 457899999999999999999998 456 99999 677 899998885 6788 9999864 34455 3
Q ss_pred ccccchHHHHHhhh
Q 037285 758 SESMQFDAMMENLR 771 (1094)
Q Consensus 758 sE~~qFdsL~ElLr 771 (1094)
.....|.++.+++.
T Consensus 80 ~~~~~F~sl~~LV~ 93 (124)
T 2eob_A 80 GTSAYFESLVELVS 93 (124)
T ss_dssp SSSCCBSSHHHHHH
T ss_pred CCCCcCCCHHHHHH
Confidence 44456999999993
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.82 E-value=0.00021 Score=74.60 Aligned_cols=129 Identities=19% Similarity=0.118 Sum_probs=86.6
Q ss_pred ecccCce-EEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-CCceeEEEeEeecCCCCceEEE
Q 037285 818 LGSGTFG-TVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HPNVVAFYGVVQDGPGGTLATV 893 (1094)
Q Consensus 818 LGsG~FG-tVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-HPNIVqL~Gv~~d~~~~~L~IV 893 (1094)
+..|..+ .||+.... +..+++|+-... ....+.+|..+|+.|. +--+.+++.++.+.. ..++|
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~--~~~lv 98 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS-----------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPD--DAWLL 98 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH-----------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETT--EEEEE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC-----------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECC--eEEEE
Confidence 4445444 68886553 467899986532 1245678888888774 223667888887654 78999
Q ss_pred eeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 037285 894 AEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHS--------------------------------------- 934 (1094)
Q Consensus 894 mEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs--------------------------------------- 934 (1094)
||+++|.++.+...... .....++.+++..|..||+
T Consensus 99 me~l~G~~~~~~~~~~~-----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (272)
T 4gkh_A 99 TTAIPGKTAFQVLEEYP-----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNG 173 (272)
T ss_dssp EECCCSEEHHHHHHHCG-----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTT
T ss_pred EEeeCCccccccccCCH-----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccc
Confidence 99999988877653221 1122344455555555553
Q ss_pred ------------C-------CceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 935 ------------K-------NIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 935 ------------~-------GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
. .++|+|+.+.|||++ ..+.+-|+||+.+.
T Consensus 174 ~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~----~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 174 WPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFD----EGKLIGCIDVGRVG 222 (272)
T ss_dssp CCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEE----TTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEE----CCeEEEEEECcccc
Confidence 1 179999999999998 55667799999875
|
| >2lnw_A VAV-2, guanine nucleotide exchange factor VAV2; signaling protein; HET: PTR; NMR {Homo sapiens} PDB: 2lnx_A | Back alignment and structure |
|---|
Probab=97.81 E-value=8.2e-06 Score=78.76 Aligned_cols=78 Identities=15% Similarity=0.222 Sum_probs=63.8
Q ss_pred hhhccccccccccCCCChhHHHHcCC--chh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCC
Q 037285 682 SYFRNLAQVDFGQKDVSLIDQEHLGL--SSG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPS 756 (1094)
Q Consensus 682 ~~~~~Le~~~Wy~~~IsR~~AE~ll~--a~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~ 756 (1094)
.....|+..+||++.|+|.+||.+|. .+| ||+|....| .|.+|+... +.++ ||.|..+ .+.|+
T Consensus 14 ~~~~~l~~~~WyhG~isR~eAe~lL~~~~~G~FLVR~S~~~~g-~y~LSv~~~-----~~v~-H~~I~~~-~~~~~---- 81 (122)
T 2lnw_A 14 SREIDYTAYPWFAGNMERQQTDNLLKSHASGTYLIRERPAEAE-RFAISIKFN-----DEVK-HIKVVEK-DNWIH---- 81 (122)
T ss_dssp CSCCCSTTSTTBCCSCCHHHHHHHHHHSCTTBEEEEECCCSSE-EEEEEEECS-----SCEE-EEEEEEE-TTEEE----
T ss_pred CccCCcccCcCCCcCCCHHHHHHHhcCCCCCeEEEEeCCCCCC-cEEEEEEeC-----CcEE-EEEEEEc-CCEEE----
Confidence 34578999999999999999999995 466 999987677 899998885 7788 9999864 34566
Q ss_pred cccccchHHHHHhhh
Q 037285 757 VSESMQFDAMMENLR 771 (1094)
Q Consensus 757 isE~~qFdsL~ElLr 771 (1094)
+.+...|.++.+++.
T Consensus 82 l~~~~~F~sl~eLV~ 96 (122)
T 2lnw_A 82 ITEAKKFDSLLELVE 96 (122)
T ss_dssp SSSSCCBSSHHHHHH
T ss_pred ECCCCeECCHHHHHH
Confidence 556788999999984
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.80 E-value=3.1e-05 Score=84.58 Aligned_cols=84 Identities=11% Similarity=-0.012 Sum_probs=52.5
Q ss_pred eEEEEe-cccCceEEEEeeec--------CceEEEEEeecCcc-CCCchhHHHHHHHHHHHHHHHhhCCC---CceeEEE
Q 037285 813 EEQKEL-GSGTFGTVYHGKWR--------GTDVAIKRIKKSCF-TGRSSEQERLTVEFWKEAEILSKLHH---PNVVAFY 879 (1094)
Q Consensus 813 ei~kkL-GsG~FGtVYKAk~r--------Gt~VAVKiIkk~~~-se~~~eqe~~~~eFlrEIkILkrL~H---PNIVqL~ 879 (1094)
...+.| +.|....+|+.... +..+++|+...... .... ...+.+|+.+|+.|.. -.+.+++
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~------~~~~~~E~~~l~~L~~~~~vpvP~v~ 96 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP------TYRLDHQFEVIRLVGELTDVPVPRVR 96 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS------CCCHHHHHHHHHHHHHHCCSCCCCEE
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc------hhHHHHHHHHHHHHhhcCCCCCCcEE
Confidence 345678 88999999988765 66788887654210 0000 0234567777776642 3466777
Q ss_pred eEeecCC-CCceEEEeeecccchh
Q 037285 880 GVVQDGP-GGTLATVAEYMVDGSL 902 (1094)
Q Consensus 880 Gv~~d~~-~~~L~IVmEYmegGSL 902 (1094)
.++.+.. .+..++||||++|..+
T Consensus 97 ~~~~~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 97 WIETTGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp EEECSSTTTSSCEEEEECCCCBCC
T ss_pred EEccCCCccCCceEEEEecCCCCh
Confidence 7765431 1346789999987654
|
| >2hmh_A Suppressor of cytokine signaling 3; SOCS3, GP130, PTyr, peptide complex, cytokine regulator; HET: PTR; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=97.78 E-value=4e-06 Score=84.00 Aligned_cols=81 Identities=15% Similarity=0.258 Sum_probs=63.9
Q ss_pred hhccccccccccCCCChhHHHHcCC--chh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCC-
Q 037285 683 YFRNLAQVDFGQKDVSLIDQEHLGL--SSG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPS- 756 (1094)
Q Consensus 683 ~~~~Le~~~Wy~~~IsR~~AE~ll~--a~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~- 756 (1094)
....|+...|||++|+|.+||.+|. .+| ||++....| .|.+|+... +.++ ||.|.. ..+.|+....
T Consensus 27 ~~~~l~~~~WyhG~isR~eAe~lL~~~~~G~FLVR~S~~~~g-~y~LSv~~~-----~~v~-H~rI~~-~~g~f~l~~~~ 98 (152)
T 2hmh_A 27 AVRKLQESGFYWSAVTGGEANLLLSAEPAGTFLIRDSSDQRH-FFTLSVKTQ-----SGTK-NLRIQX-EGGSFSLQSDP 98 (152)
T ss_dssp HHHHHHHTSSEETTCCHHHHHHHHHTSCTTEEEEEECCSTTC-SEEEEEEET-----TEEE-EEEEEC-GGGCBEECBCT
T ss_pred hhhhhccCCCcCCCCCHHHHHHHhcCCCCCcEEEEeCCCCCC-cEEEEEEcC-----CceE-EEEEEe-cCCEEEEeccc
Confidence 4567999999999999999999995 566 999998777 899999885 6788 999987 5566773321
Q ss_pred --cccccchHHHHHhhh
Q 037285 757 --VSESMQFDAMMENLR 771 (1094)
Q Consensus 757 --isE~~qFdsL~ElLr 771 (1094)
..+...|.++.+++.
T Consensus 99 ~~~~~~~~F~SL~eLV~ 115 (152)
T 2hmh_A 99 RSTQPVPRFDXVLKLVH 115 (152)
T ss_dssp TCSSCCCCBSSHHHHHH
T ss_pred ccccccCccCCHHHHHH
Confidence 122378999999993
|
| >2oq1_A Tyrosine-protein kinase ZAP-70; tandem SH2 domains, ZAP-70, tyrosine kinase, transferase; HET: PTR; 1.90A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1m61_A | Back alignment and structure |
|---|
Probab=97.76 E-value=1e-05 Score=86.73 Aligned_cols=77 Identities=16% Similarity=0.262 Sum_probs=64.9
Q ss_pred hhccccccccccCCCChhHHHHcCC----chh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCC
Q 037285 683 YFRNLAQVDFGQKDVSLIDQEHLGL----SSG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDP 755 (1094)
Q Consensus 683 ~~~~Le~~~Wy~~~IsR~~AE~ll~----a~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp 755 (1094)
+...|+.+.|||++|+|.+||.+|. .+| ||+| ...| .|.+|+... +.++ ||.|..+..+.|+
T Consensus 152 ~~~~l~~~~Wyhg~isR~~Ae~lL~~~g~~~G~FLVR~S-~~~g-~~~LSv~~~-----~~v~-H~~I~~~~~g~~~--- 220 (254)
T 2oq1_A 152 ATTAHERMPWYHSSLTREEAERKLYSGAQTDGKFLLRPR-KEQG-TYALSLIYG-----KTVY-HYLISQDKAGKYC--- 220 (254)
T ss_dssp HHHGGGGSTTBCSSCCHHHHHHHHHSSCCCTTEEEEEEC-SSTT-EEEEEEEET-----TEEE-EEEEEECTTSCEE---
T ss_pred cccccCCCcccccCCCHHHHHHHHHhcCCCCceEEEEec-CCCC-CEEEEEEEC-----CeEE-EEEEEEcCCCCEE---
Confidence 4578899999999999999999997 456 9999 6677 899999885 7888 9999987777788
Q ss_pred CcccccchHHHHHhhh
Q 037285 756 SVSESMQFDAMMENLR 771 (1094)
Q Consensus 756 ~isE~~qFdsL~ElLr 771 (1094)
+.....|.++.+++.
T Consensus 221 -~~~~~~F~sl~~LV~ 235 (254)
T 2oq1_A 221 -IPEGTKFDTLWQLVE 235 (254)
T ss_dssp -STTSCCBSSHHHHHH
T ss_pred -ECCCceECCHHHHHH
Confidence 555688999999993
|
| >2eyz_A V-CRK sarcoma virus CT10 oncogene homolog isoform A; SH2, SH3, signaling protein; NMR {Homo sapiens} PDB: 2l3s_A 2l3p_A 2l3q_A 2ggr_A | Back alignment and structure |
|---|
Probab=97.71 E-value=2.4e-05 Score=86.00 Aligned_cols=76 Identities=18% Similarity=0.221 Sum_probs=61.6
Q ss_pred hccccccccccCCCChhHHHHcCC--chh---hhhhhhcCCceeEEeeeccCCCCCCccccccccccc------------
Q 037285 684 FRNLAQVDFGQKDVSLIDQEHLGL--SSG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQD------------ 746 (1094)
Q Consensus 684 ~~~Le~~~Wy~~~IsR~~AE~ll~--a~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~d------------ 746 (1094)
++.|+.+.|||++|+|.+||.+|+ .+| ||+|....| .|.+|+... +.++ ||.|...
T Consensus 5 ~~~~~~~~WyhG~isR~eAe~lL~~~~~G~FLVR~S~~~~g-~y~LSv~~~-----~~v~-H~~I~~~~~~~~~~~~~~~ 77 (304)
T 2eyz_A 5 FDSEERSSWYWGRLSRQEAVALLQGQRHGVFLVRDSSTSPG-DYVLSVSEN-----SRVS-HYIINSSGPRPPVPPSPAQ 77 (304)
T ss_dssp CCCSSSSSSCCCCCCSSHHHHTTTTCCSSCEECCSCCSSSS-CCEEEECSS-----SSCE-EEECCCCSSCCSSCCCCCC
T ss_pred cccccCCCCccCCCCHHHHHHHhcCCCCCEEEEEeCCCCCC-CEEEEEEEC-----CEEE-EEEEeeccccccccccccc
Confidence 678999999999999999999998 666 999998778 799998875 6788 9999872
Q ss_pred -----CCCccccCCCcccccchHHHHHhhh
Q 037285 747 -----SQKTFGVDPSVSESMQFDAMMENLR 771 (1094)
Q Consensus 747 -----sq~r~~vtp~isE~~qFdsL~ElLr 771 (1094)
....|. -....|.++.+++.
T Consensus 78 ~~~~~~~~~~~-----~~~~~F~sl~~LV~ 102 (304)
T 2eyz_A 78 PPPGVSPSRLR-----IGDQEFDSLPALLE 102 (304)
T ss_dssp CSSSSSCCCCC-----BTTBCCSCHHHHHT
T ss_pred cccccCCCeEE-----eCCcEECCHHHHHH
Confidence 233333 23568999999994
|
| >2c9w_A Suppressor of cytokine signaling 2; growth regulation, SH2 domain, signal transduction inhibitor nuclear protein; 1.9A {Homo sapiens} SCOP: a.271.1.1 d.93.1.1 | Back alignment and structure |
|---|
Probab=97.69 E-value=7.9e-06 Score=82.89 Aligned_cols=81 Identities=19% Similarity=0.266 Sum_probs=63.6
Q ss_pred hhccccccccccCCCChhHHHHcCCc--hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCc
Q 037285 683 YFRNLAQVDFGQKDVSLIDQEHLGLS--SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSV 757 (1094)
Q Consensus 683 ~~~~Le~~~Wy~~~IsR~~AE~ll~a--~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~i 757 (1094)
....|+...||||.|+|.+||.+|.. +| ||+|....| .|++|+.+. +.++ ||.|..+ .+.|+.....
T Consensus 10 ~~~~l~~~~WyhG~isR~eAe~lL~~~~~G~FLVR~S~~~~~-~~~LSv~~~-----~~v~-H~rI~~~-~g~~~l~~~~ 81 (169)
T 2c9w_A 10 ALRELGQTGWYWGSMTVNEAKEKLKEAPEGTFLIRDSSHSDY-LLTISVKTS-----AGPT-NLRIEYQ-DGKFRLDSII 81 (169)
T ss_dssp HHHHHHHTSCBCTTCCHHHHHHHHTTSCTTCEEEEECCSTTC-SEEEEEEET-----TEEE-EEEEEEE-TTEEEECTTT
T ss_pred HHHhcccCCccccCCCHHHHHHHcCCCCCcEEEEecCCCCCC-eEEEEEEEC-----CeeE-EEEEEEe-CCEEEEcccc
Confidence 45679999999999999999999975 56 999998777 899998885 6777 9999874 6667733210
Q ss_pred ---ccccchHHHHHhhh
Q 037285 758 ---SESMQFDAMMENLR 771 (1094)
Q Consensus 758 ---sE~~qFdsL~ElLr 771 (1094)
.....|.++.+++.
T Consensus 82 ~~~~~~~~F~sl~eLI~ 98 (169)
T 2c9w_A 82 CVKSKLKQFDSVVHLID 98 (169)
T ss_dssp TTGGGCCCBSCHHHHHH
T ss_pred CccccCCCCCCHHHHHH
Confidence 11267999999984
|
| >2aug_A Growth factor receptor-bound protein 14; phosphorylation, SH2 domain, signaling protein; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.69 E-value=9.8e-06 Score=78.73 Aligned_cols=79 Identities=8% Similarity=0.122 Sum_probs=60.9
Q ss_pred hccccccccccCCCChhHHHHcCCc----hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccC-CCccccCC
Q 037285 684 FRNLAQVDFGQKDVSLIDQEHLGLS----SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDS-QKTFGVDP 755 (1094)
Q Consensus 684 ~~~Le~~~Wy~~~IsR~~AE~ll~a----~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~ds-q~r~~vtp 755 (1094)
-..++...||+++|+|.+||.+|.. +| ||++....| .|.+|+... +.++ ||.|..+. .++++..
T Consensus 20 ~~~l~~~~WyhG~isR~eAe~lL~~~g~~~G~FLVR~S~~~~g-~y~LSv~~~-----~~v~-H~~I~~~~~~G~~~~~- 91 (126)
T 2aug_A 20 HMIHRSQPWFHHKISRDEAQRLIIQQGLVDGVFLVRDSQSNPK-TFVLSMSHG-----QKIK-HFQIIPVEDDGEMFHT- 91 (126)
T ss_dssp --CGGGSTTEETTCCHHHHHHHHHTTTCCTTEEEEEECSSSSC-CEEEEEEET-----TEEE-EEEEEEEEETTEEEEE-
T ss_pred ccccccCCcccCCCCHHHHHHHHhccCCCCCEEEEeecCCCCC-CEEEEEEcC-----CeEE-EEEEEEECCCCeEEEE-
Confidence 3568899999999999999999975 45 999988778 899998885 6788 99998743 4555421
Q ss_pred Ccc-cccchHHHHHhhh
Q 037285 756 SVS-ESMQFDAMMENLR 771 (1094)
Q Consensus 756 ~is-E~~qFdsL~ElLr 771 (1094)
+. ....|.++.+++.
T Consensus 92 -l~~~~~~F~SL~eLV~ 107 (126)
T 2aug_A 92 -LDDGHTRFTDLIQLVE 107 (126)
T ss_dssp -SSTTSSCBSSHHHHHH
T ss_pred -eCCCCCccCCHHHHHH
Confidence 22 2467999999993
|
| >2kno_A Tensin-like C1 domain-containing phosphatase; SH2 domain, TENC1, solution structure, cell junctio membrane, hydrolase, membrane, metal-binding; NMR {Homo sapiens} PDB: 2l6k_A | Back alignment and structure |
|---|
Probab=97.69 E-value=1.6e-05 Score=77.60 Aligned_cols=85 Identities=9% Similarity=0.019 Sum_probs=63.2
Q ss_pred hhccccccccccCCCChhHHHHcCC--chh---hhhhhhcCCceeEEeeeccCCC-----C-----CCcccccccccccC
Q 037285 683 YFRNLAQVDFGQKDVSLIDQEHLGL--SSG---VREVREEDGRLYHFTPLTDDGA-----P-----KGRVDSQLNFGQDS 747 (1094)
Q Consensus 683 ~~~~Le~~~Wy~~~IsR~~AE~ll~--a~g---VR~s~~~~G~~y~~S~l~~~ga-----~-----~g~v~shy~I~~ds 747 (1094)
.+..++...||+++|+|.+||.+|. .+| ||+|....| .|.+|+....+. . .+.|+ ||.|....
T Consensus 13 ~~~~~~~~~Wyhg~isR~eAe~lL~~~~~G~FLVR~S~s~~g-~y~LSv~~~~~~~~~~~~~g~~~~~~v~-H~~I~~~~ 90 (131)
T 2kno_A 13 PRGSDTSKFWYKPHLSRDQAIALLKDKDPGAFLIRDSHSFQG-AYGLALKVATPPPSAQPWKGDPVEQLVR-HFLIETGP 90 (131)
T ss_dssp CCCCCCHHHHBCTTCCHHHHHHHHTTSCTTBEEEEECSSSTT-EEEEEEECSCCSSSSSSCCSCHHHHHEE-EEEEECCS
T ss_pred cccccccCCceecCCCHHHHHHHhcCCCCCeEEEecCCCCCC-CEEEEEEeCCCCcccccccccccCCceE-EEEEEECC
Confidence 4566888999999999999999995 456 999988788 899998875210 0 13677 99998755
Q ss_pred CCccccCCCcccccchHHHHHhhh
Q 037285 748 QKTFGVDPSVSESMQFDAMMENLR 771 (1094)
Q Consensus 748 q~r~~vtp~isE~~qFdsL~ElLr 771 (1094)
.+ |+..- ......|.++.+++.
T Consensus 91 ~g-~~l~g-~~~~~~F~SL~eLV~ 112 (131)
T 2kno_A 91 KG-VKIKG-CPSEPYFGSLSALVS 112 (131)
T ss_dssp SC-CCEET-CSSCCCCCSHHHHHH
T ss_pred CC-CEEec-CCCCCccCCHHHHHH
Confidence 44 66210 146678999999993
|
| >1a81_A SYK kinase; complex (transferase-peptide), SYK, kinase, SH2 domain; HET: PTR; 3.00A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=97.68 E-value=1.6e-05 Score=85.18 Aligned_cols=74 Identities=11% Similarity=0.179 Sum_probs=62.5
Q ss_pred ccccccccCCCChhHHHHcCC----chh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCccc
Q 037285 687 LAQVDFGQKDVSLIDQEHLGL----SSG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSE 759 (1094)
Q Consensus 687 Le~~~Wy~~~IsR~~AE~ll~----a~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~isE 759 (1094)
.+.++|||++|+|.+||.+|+ .+| ||+|....| .|.+|+... +.++ ||.|..+..+.|+ +..
T Consensus 2 ~~~~~Wy~g~isR~~Ae~lL~~~g~~~G~FLVR~S~~~~g-~y~LSv~~~-----~~v~-H~~I~~~~~g~~~----l~~ 70 (254)
T 1a81_A 2 ANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLG-GFALSVAHG-----RKAH-HYTIERELNGTYA----IAG 70 (254)
T ss_dssp TTSSTTBCSSCCHHHHHHHHHHTTCCTTEEEEEECSSSTT-CEEEEEEET-----TEEE-EEEEEECTTSCEE----ETT
T ss_pred CccCccccCCCCHHHHHHHHhcCCCCCcEEEEEecCCCCC-CEEEEEEEC-----CeeE-EEEEEEcCCCCEE----eCC
Confidence 467899999999999999994 456 999999778 899998875 6788 9999986777788 555
Q ss_pred ccchHHHHHhhh
Q 037285 760 SMQFDAMMENLR 771 (1094)
Q Consensus 760 ~~qFdsL~ElLr 771 (1094)
...|.++.+++.
T Consensus 71 ~~~F~sl~eLv~ 82 (254)
T 1a81_A 71 GRTHASPADLCH 82 (254)
T ss_dssp SCCBSSHHHHHH
T ss_pred CCCcCCHHHHHH
Confidence 678999999993
|
| >3qwx_X Cell death abnormality protein 2; cell engulfment, signaling protein; 2.01A {Caenorhabditis elegans} | Back alignment and structure |
|---|
Probab=97.68 E-value=9.5e-06 Score=81.96 Aligned_cols=76 Identities=16% Similarity=0.146 Sum_probs=61.2
Q ss_pred hhccccccccccCCCChhHHHHcCCc----hh---hhhhhhcCCceeEEeeeccCCCCCCc---ccccccccc---cCC-
Q 037285 683 YFRNLAQVDFGQKDVSLIDQEHLGLS----SG---VREVREEDGRLYHFTPLTDDGAPKGR---VDSQLNFGQ---DSQ- 748 (1094)
Q Consensus 683 ~~~~Le~~~Wy~~~IsR~~AE~ll~a----~g---VR~s~~~~G~~y~~S~l~~~ga~~g~---v~shy~I~~---dsq- 748 (1094)
.++.|+.++|||++|+|.+||.+|.. +| ||+| ...| .|.+|+... +. ++ ||.|.. +..
T Consensus 5 ~~~~l~~~~Wyhg~isR~~Ae~lL~~~~~~~G~FLVR~S-~~~g-~y~LSv~~~-----~~~~~v~-H~~I~~~~~~~~g 76 (174)
T 3qwx_X 5 GFDPFEWRSFYFPGMSREEAHKLLGEPQVSIGTFLMRDS-SRPG-EYSLTVREA-----DEGNAVC-HYLIERGEPKEDG 76 (174)
T ss_dssp CSCGGGGGGGEETTCCHHHHHHHHHSTTCCTTEEEEEEC-SSTT-CEEEEEECC-----SSSSCEE-EEEEEECCCCTTS
T ss_pred ccCccccCCCccCCCCHHHHHHHHhccCCCCCeEEEEec-CCCC-CEEEEEEEC-----CCCCceE-EEEEEeccCCCCC
Confidence 57889999999999999999999977 56 9999 6677 899998885 44 77 999976 333
Q ss_pred ---CccccCCCcccccchHHHHHhhh
Q 037285 749 ---KTFGVDPSVSESMQFDAMMENLR 771 (1094)
Q Consensus 749 ---~r~~vtp~isE~~qFdsL~ElLr 771 (1094)
..|. +. ...|.++.+++.
T Consensus 77 ~~~~~~~----~~-~~~F~sl~eLv~ 97 (174)
T 3qwx_X 77 TAAAGVK----IA-NQSFPDIPALLN 97 (174)
T ss_dssp SSCCCEE----ET-TEEESSHHHHHH
T ss_pred cccceEE----EC-CeecCcHHHHhh
Confidence 3566 32 668999998884
|
| >1a81_A SYK kinase; complex (transferase-peptide), SYK, kinase, SH2 domain; HET: PTR; 3.00A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=97.66 E-value=1.4e-05 Score=85.77 Aligned_cols=77 Identities=18% Similarity=0.371 Sum_probs=64.8
Q ss_pred hhccccccccccCCCChhHHHHcCC----chh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCC
Q 037285 683 YFRNLAQVDFGQKDVSLIDQEHLGL----SSG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDP 755 (1094)
Q Consensus 683 ~~~~Le~~~Wy~~~IsR~~AE~ll~----a~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp 755 (1094)
.-..++.+.|||++|+|.+||.+|. .+| ||++ ...| .|.+|+... +.++ ||.|..+..+.|+
T Consensus 151 ~~~~~~~~~Wyhg~isR~~Ae~lL~~~g~~~G~FLVR~S-~~~g-~~~LSv~~~-----~~v~-H~~I~~~~~g~~~--- 219 (254)
T 1a81_A 151 ATTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRAR-DNNG-SYALCLLHE-----GKVL-HYRIDKDKTGKLS--- 219 (254)
T ss_dssp HHTSGGGSTTEEEECCHHHHHHHHHSSCCCTTCEEEEEC-SSSS-CEEEEEEET-----TEEE-EEEEEECTTSCEE---
T ss_pred cccccccCCccccCCCHHHHHHHHHhcCCCCceEEEEec-CCCC-CEEEEEEEC-----CEEE-EEEEEEcCCCCEE---
Confidence 4567899999999999999999997 456 9999 6677 899999885 7888 9999887777788
Q ss_pred CcccccchHHHHHhhh
Q 037285 756 SVSESMQFDAMMENLR 771 (1094)
Q Consensus 756 ~isE~~qFdsL~ElLr 771 (1094)
+.....|.++.+++.
T Consensus 220 -l~~~~~F~sl~~LV~ 234 (254)
T 1a81_A 220 -IPEGKKFDTLWQLVE 234 (254)
T ss_dssp -CTTSCCBSCHHHHHH
T ss_pred -ecCCcccCCHHHHHH
Confidence 555678999999993
|
| >1nrv_A Growth factor receptor-bound protein 10; dimer, signaling protein; 1.65A {Homo sapiens} SCOP: d.93.1.1 PDB: 3m7f_A | Back alignment and structure |
|---|
Probab=97.64 E-value=1.6e-05 Score=74.24 Aligned_cols=74 Identities=8% Similarity=0.158 Sum_probs=55.7
Q ss_pred cccccccCCCChhHHHHcCCc----hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccC-CCc-cccCCCcc
Q 037285 688 AQVDFGQKDVSLIDQEHLGLS----SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDS-QKT-FGVDPSVS 758 (1094)
Q Consensus 688 e~~~Wy~~~IsR~~AE~ll~a----~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~ds-q~r-~~vtp~is 758 (1094)
+...||+++|+|.+||.+|.. +| ||+|....| .|.+|+... +.++ ||.|..+. .++ ++. +.
T Consensus 3 ~~~~Wyhg~isR~~Ae~lL~~~g~~~G~FLVR~S~~~~g-~~~LSv~~~-----~~v~-H~~I~~~~~~g~~~~~---~~ 72 (105)
T 1nrv_A 3 RTQHWFHGRISREESHRIIKQQGLVDGLFLLRDSQSNPK-AFVLTLCHH-----QKIK-NFQILPCEDDGQTFFS---LD 72 (105)
T ss_dssp TTSTTBCTTCCHHHHHHHHHHTTCCTTEEEEEECSSCTT-CEEEEEEET-----TEEE-EEEEEEC-----CCEE---SS
T ss_pred ccCcccCCCCCHHHHHHHHHhcCCCCceEEEEeCCCCCC-CEEEEEEeC-----CEEE-EEEEEEEcCCCCEEEE---Ec
Confidence 467999999999999999974 45 999988777 899998885 6788 99998643 332 230 22
Q ss_pred -cccchHHHHHhhh
Q 037285 759 -ESMQFDAMMENLR 771 (1094)
Q Consensus 759 -E~~qFdsL~ElLr 771 (1094)
....|.++.+++.
T Consensus 73 ~~~~~F~sl~~LV~ 86 (105)
T 1nrv_A 73 DGNTKFSDLIQLVD 86 (105)
T ss_dssp TTSSCBSSHHHHHH
T ss_pred CCCcccCCHHHHHH
Confidence 2467999999993
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=97.64 E-value=1.6e-05 Score=95.26 Aligned_cols=77 Identities=9% Similarity=0.156 Sum_probs=65.7
Q ss_pred hccccccccccCCCChhHHHHcCCc----hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCC
Q 037285 684 FRNLAQVDFGQKDVSLIDQEHLGLS----SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPS 756 (1094)
Q Consensus 684 ~~~Le~~~Wy~~~IsR~~AE~ll~a----~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~ 756 (1094)
.++|+.++||+|+|+|.+||.+|.. +| ||+|....| .|++|+.+. +.++ ||.|.....+.|+
T Consensus 7 ~~~l~~~~Wy~g~isr~~Ae~~L~~~~~~~G~FLvR~S~~~~g-~y~lsv~~~-----~~v~-h~~i~~~~~g~~~---- 75 (635)
T 4fl3_A 7 ADSANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLG-GFALSVAHG-----RKAH-HYTIERELNGTYA---- 75 (635)
T ss_dssp --CCTTCTTBCBSCCHHHHHHHHHHTTCCTTEEEEEECTTSSS-CEEEEEEET-----TEEE-EEEEEECTTSCEE----
T ss_pred cchhhcCCccCCCCCHHHHHHHHhcCCCCCceEEEeecccCCC-CEEEEEEeC-----CEEE-eEEEEEcCCCCEE----
Confidence 3679999999999999999999966 56 999999888 899999986 7888 9999887777888
Q ss_pred cccccchHHHHHhhh
Q 037285 757 VSESMQFDAMMENLR 771 (1094)
Q Consensus 757 isE~~qFdsL~ElLr 771 (1094)
+.....|.++.+++.
T Consensus 76 ~~~~~~f~sl~~Lv~ 90 (635)
T 4fl3_A 76 IAGGRTHASPADLCH 90 (635)
T ss_dssp STTCCCBSSHHHHHH
T ss_pred eCCCCccCCHHHHHH
Confidence 666778999999993
|
| >2oq1_A Tyrosine-protein kinase ZAP-70; tandem SH2 domains, ZAP-70, tyrosine kinase, transferase; HET: PTR; 1.90A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1m61_A | Back alignment and structure |
|---|
Probab=97.63 E-value=2.3e-05 Score=84.00 Aligned_cols=75 Identities=16% Similarity=0.166 Sum_probs=62.9
Q ss_pred cccccccccCCCChhHHHHcCC----chh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCcc
Q 037285 686 NLAQVDFGQKDVSLIDQEHLGL----SSG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVS 758 (1094)
Q Consensus 686 ~Le~~~Wy~~~IsR~~AE~ll~----a~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~is 758 (1094)
.++..+|||++|+|.+||.+|+ .+| ||+|....| .|.+|+... +.++ ||.|..+..+.|+ +.
T Consensus 2 ~~~~~~Wyhg~isR~~Ae~lL~~~~~~~G~FLVR~S~~~~g-~y~LSv~~~-----~~v~-H~~I~~~~~g~~~----l~ 70 (254)
T 2oq1_A 2 PAAHLPFFYGSISRAEAEEHLKLAGMADGLFLLRQCLRSLG-GYVLSLVHD-----VRFH-HFPIERQLNGTYA----IA 70 (254)
T ss_dssp TTTTCTTBCBSCCHHHHHHHHHHTTCCTTCEEEEECSSSTT-CEEEEEEET-----TEEE-EEEEEECTTSCEE----ET
T ss_pred ccccCCccCCCCCHHHHHHHHhccCCCCcEEEEEeCCCCCC-CEEEEEEEC-----CeEE-EEEEEEeCCCCEE----eC
Confidence 5678999999999999999994 466 999998777 899998875 7788 9999987777788 54
Q ss_pred cccchHHHHHhhh
Q 037285 759 ESMQFDAMMENLR 771 (1094)
Q Consensus 759 E~~qFdsL~ElLr 771 (1094)
....|.++.+++.
T Consensus 71 ~~~~F~sl~~LV~ 83 (254)
T 2oq1_A 71 GGKAHCGPAELCE 83 (254)
T ss_dssp TSCCBSSHHHHHH
T ss_pred CCCccCCHHHHHH
Confidence 5578999999994
|
| >2lqn_A CRK-like protein; SH2, SH3, V-CRK sarcoma virus CT10 oncogene homolog (avian)- signaling protein; NMR {Homo sapiens} PDB: 2lqw_A* | Back alignment and structure |
|---|
Probab=96.79 E-value=7.6e-06 Score=89.92 Aligned_cols=77 Identities=18% Similarity=0.228 Sum_probs=64.6
Q ss_pred hhccccccccccCCCChhHHHHcCCc--hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCc
Q 037285 683 YFRNLAQVDFGQKDVSLIDQEHLGLS--SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSV 757 (1094)
Q Consensus 683 ~~~~Le~~~Wy~~~IsR~~AE~ll~a--~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~i 757 (1094)
.++.|+.+.|||+.|+|.+||.+|.. +| ||++....| .|.+|+.+. +.++ ||.|..+..+.|. +
T Consensus 5 ~~d~~~~~~Wyhg~isR~~Ae~lL~~~~~G~FLvR~S~~~~g-~~~LSv~~~-----~~v~-H~~I~~~~~g~~~----~ 73 (303)
T 2lqn_A 5 RFDSSDRSAWYMGPVSRQEAQTRLQGQRHGMFLVRDSSTCPG-DYVLSVSEN-----SRVS-HYIINSLPNRRFK----I 73 (303)
Confidence 47889999999999999999999988 77 999988788 799998875 6788 9999886666565 3
Q ss_pred ccccchHHHHHhhh
Q 037285 758 SESMQFDAMMENLR 771 (1094)
Q Consensus 758 sE~~qFdsL~ElLr 771 (1094)
. ...|.++.+++.
T Consensus 74 ~-~~~F~sl~~Lv~ 86 (303)
T 2lqn_A 74 G-DQEFDHLPALLE 86 (303)
Confidence 3 378999999994
|
| >4fbn_A 1-phosphatidylinositol 4,5-bisphosphate phosphodi gamma-1; SH2 domain, plcgamma specific array, interaction domain, FIB growth factor receptor 1; 2.40A {Homo sapiens} PDB: 4ey0_A* 3gqi_B* 2fci_A* 2pld_A* 2ple_A* | Back alignment and structure |
|---|
Probab=97.61 E-value=1.9e-05 Score=84.78 Aligned_cols=72 Identities=18% Similarity=0.274 Sum_probs=59.2
Q ss_pred ccccccCCC-----ChhHHHHcCC--------chh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCC---C
Q 037285 689 QVDFGQKDV-----SLIDQEHLGL--------SSG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQ---K 749 (1094)
Q Consensus 689 ~~~Wy~~~I-----sR~~AE~ll~--------a~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq---~ 749 (1094)
..+||||+| +|.+||++|+ .+| ||+|....| .|++|+... |+++ ||.|..... .
T Consensus 3 ~e~WfhG~i~~~~~sR~~AE~lL~~~~~~~~~~dG~FLVR~S~s~~G-~y~LSv~~~-----~~v~-H~~I~~~~~~g~~ 75 (246)
T 4fbn_A 3 NEKWFHGKLGAGRDGRHIAERLLTEYCIETGAPDGSFLVRESETFVG-DYTLSFWRN-----GKVQ-HCRIHSRQDAGTP 75 (246)
T ss_dssp CCTTBCCCCSCC-CHHHHHHHHHHHHHHHHTCCTTCEEEEECSSSTT-CEEEEEEET-----TEEE-EEEEEEECGGGCC
T ss_pred CCCCcCCccccccCCHHHHHHHHHHhhhccCCCCCEEEEEcCCCCCC-CEEEEEEEC-----CEEE-EEEEEEECCCCce
Confidence 468999999 7999999995 345 999999889 899999886 7888 999975443 2
Q ss_pred ccccCCCcccccchHHHHHhhh
Q 037285 750 TFGVDPSVSESMQFDAMMENLR 771 (1094)
Q Consensus 750 r~~vtp~isE~~qFdsL~ElLr 771 (1094)
.++ +.+...|.++.+++.
T Consensus 76 ~~~----~~~~~~F~sl~~LV~ 93 (246)
T 4fbn_A 76 KFF----LTDNLVFDSLYDLIT 93 (246)
T ss_dssp EEE----EETTEEESSHHHHHH
T ss_pred eEE----ecCCcccCCHHHHHH
Confidence 456 677788999999994
|
| >3qwy_A Cell death abnormality protein 2; cell engulfment, signaling protein; 2.52A {Caenorhabditis elegans} | Back alignment and structure |
|---|
Probab=97.57 E-value=1.5e-05 Score=87.57 Aligned_cols=87 Identities=15% Similarity=0.156 Sum_probs=61.2
Q ss_pred ccccCCCCchhhhccccccccccCCCChhHHHHcCCc----hh---hhhhhhcCCceeEEeeeccCCCCCCccccccccc
Q 037285 672 NMENHEPKRWSYFRNLAQVDFGQKDVSLIDQEHLGLS----SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFG 744 (1094)
Q Consensus 672 ~~~~~~~~~~~~~~~Le~~~Wy~~~IsR~~AE~ll~a----~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~ 744 (1094)
..+..+|++ +++|+.+.|||++|+|.+||++|+. +| ||+| ...| .|.+|+.... ....|+ ||.|.
T Consensus 26 g~~~~~~~~---~~~l~~~~Wyhg~i~R~~Ae~lL~~~~~~~G~FLVR~S-~~~g-~y~LSv~~~~--~~~~v~-H~~I~ 97 (308)
T 3qwy_A 26 GGQQMTTNG---FDPFEWRSFYFPGMSREEAHKLLGEPQVSIGTFLMRDS-SRPG-EYSLTVREAD--EGNAVC-HYLIE 97 (308)
T ss_dssp --------C---CCGGGGGGGEETTCCHHHHHHHHHSTTCCTTEEEEEEC-SSTT-CEEEEEECCS--SSSCEE-EEEEE
T ss_pred CCccccccc---cCcccccccccCCCCHHHHHHHHhccCCCCceEEEEcc-CCCC-CEEEEEEeCC--CCCceE-EEEEe
Confidence 345555654 5789999999999999999999977 56 9999 7677 8999998861 112378 99997
Q ss_pred c-cCC------CccccCCCcccccchHHHHHhhh
Q 037285 745 Q-DSQ------KTFGVDPSVSESMQFDAMMENLR 771 (1094)
Q Consensus 745 ~-dsq------~r~~vtp~isE~~qFdsL~ElLr 771 (1094)
. ... ..|+ +. ...|.++.+++.
T Consensus 98 ~~~~~~~g~~~g~~~----~~-~~~F~Sl~eLv~ 126 (308)
T 3qwy_A 98 RGEPKEDGTAAAGVK----IA-NQSFPDIPALLN 126 (308)
T ss_dssp ECCCCTTTTCCCCEE----ET-TEEESSHHHHHH
T ss_pred eccCCCcCcccceEE----Ee-CeeeCCHHHHHH
Confidence 6 332 5666 33 368999988884
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00031 Score=78.21 Aligned_cols=81 Identities=17% Similarity=0.065 Sum_probs=47.2
Q ss_pred EEEecccCceEEEEeee--cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCC--C-ceeEEEeEeecCCCCc
Q 037285 815 QKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHH--P-NVVAFYGVVQDGPGGT 889 (1094)
Q Consensus 815 ~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~H--P-NIVqL~Gv~~d~~~~~ 889 (1094)
.+.||.|.++.||++.. .+..++||........... ........+..|..+|+.+.. + .+.+++.+. .. .
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~-~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~--~ 109 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGE-SWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TE--M 109 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC--------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TT--T
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCC-CCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CC--c
Confidence 45799999999999965 3578999986532110000 000011345567888877632 3 345666543 22 4
Q ss_pred eEEEeeecccc
Q 037285 890 LATVAEYMVDG 900 (1094)
Q Consensus 890 L~IVmEYmegG 900 (1094)
.++||||+.+.
T Consensus 110 ~~lvmE~l~g~ 120 (397)
T 2olc_A 110 AVTVMEDLSHL 120 (397)
T ss_dssp TEEEECCCTTS
T ss_pred cEEEEEeCCCc
Confidence 57899999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.45 E-value=0.0012 Score=70.40 Aligned_cols=30 Identities=23% Similarity=0.205 Sum_probs=26.1
Q ss_pred CCceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 935 KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 935 ~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
..++|+|+++.|||++ .++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~----~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLG----ENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEEC----GGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEe----CCCcEEEEehhhcc
Confidence 5699999999999997 45679999999875
|
| >2y3a_B Phosphatidylinositol 3-kinase regulatory subunit; transferase, phosphoinositide 3-kinase, RTK; HET: GD9; 3.30A {Mus musculus} | Back alignment and structure |
|---|
Probab=97.45 E-value=7.6e-05 Score=82.66 Aligned_cols=76 Identities=14% Similarity=0.242 Sum_probs=60.5
Q ss_pred hccccccccccCCCChhHHHHcC--Cchh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCcc
Q 037285 684 FRNLAQVDFGQKDVSLIDQEHLG--LSSG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVS 758 (1094)
Q Consensus 684 ~~~Le~~~Wy~~~IsR~~AE~ll--~a~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~is 758 (1094)
...|+...||||.|+|.+||.+| ..+| ||+| ..+| .|.+|+... |.|+ ||.|.....+ ++. ..
T Consensus 188 ~~~l~~~~WyhG~IsR~eAE~lL~~~~~GtFLVR~S-s~~g-~y~LSv~~~-----~~V~-H~rI~~~~~g-~~~---~~ 255 (302)
T 2y3a_B 188 LPHHEERTWYVGKINRTQAEEMLSGKRDGTFLIRES-SQRG-CYACSVVVD-----GDTK-HCVIYRTATG-FGF---AE 255 (302)
T ss_dssp CGGGSSTTTBCCSCCHHHHHHHHTTSCTTBEEBCCC-SSTT-CEEEEEECS-----SSEE-EEEEEEETTE-EES---BT
T ss_pred cccccCCCccCCCCCHHHHHHHhcCCCCCcEEEEec-cCCC-ceEEEEEeC-----CeeE-EEEEEECCCc-eEE---eC
Confidence 46789999999999999999999 4566 9999 6677 899999885 6788 9999875544 441 23
Q ss_pred cccchHHHHHhhh
Q 037285 759 ESMQFDAMMENLR 771 (1094)
Q Consensus 759 E~~qFdsL~ElLr 771 (1094)
....|.++.+++.
T Consensus 256 ~~~~F~SL~eLV~ 268 (302)
T 2y3a_B 256 PYNLYGSLKELVL 268 (302)
T ss_dssp TBCCCSSHHHHHH
T ss_pred CCCCCCCHHHHHH
Confidence 3467999999994
|
| >1ju5_A CRK; CRK, SH2, SH3, adaptor protein, phosphopeptide, protein binding/transferase complex; HET: PTR; NMR {Homo sapiens} SCOP: d.93.1.1 | Back alignment and structure |
|---|
Probab=97.40 E-value=4.6e-05 Score=71.77 Aligned_cols=69 Identities=17% Similarity=0.235 Sum_probs=54.7
Q ss_pred ccccCCCChhHHHHcCCc--hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCC-----------------
Q 037285 691 DFGQKDVSLIDQEHLGLS--SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQ----------------- 748 (1094)
Q Consensus 691 ~Wy~~~IsR~~AE~ll~a--~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq----------------- 748 (1094)
+|||++|+|.+||.+|.. +| ||++....| .|.+|+... +.++ ||.|.....
T Consensus 1 ~Wyhg~isr~~Ae~lL~~~~~G~FLVR~S~~~~g-~y~LSv~~~-----~~v~-H~~I~~~~~~g~~~~~~~~~~~g~~~ 73 (109)
T 1ju5_A 1 SWYWGRLSRQEAVALLQGQRHGVFLVRDSSTSPG-DYVLSVSEN-----SRVS-HYIINSSGPRPPVPPSPAQPPPGVSP 73 (109)
T ss_dssp CCEETTCCHHHHHHHHTTCCTTEEEEEECSSSTT-EEEEEEECS-----SCEE-EEEEECCSSSSCCCCCCSSCCTTCCC
T ss_pred CccccCCCHHHHHHHhcCCCCCEEEEEecCCCCC-CEEEEEEEC-----CeEE-EEEEEECCCCcccccccccccccccc
Confidence 599999999999999976 56 999998788 899998875 6777 999876442
Q ss_pred CccccCCCcccccchHHHHHhhh
Q 037285 749 KTFGVDPSVSESMQFDAMMENLR 771 (1094)
Q Consensus 749 ~r~~vtp~isE~~qFdsL~ElLr 771 (1094)
..|. + +...|.++.+++.
T Consensus 74 ~~~~----l-~~~~F~sl~~LV~ 91 (109)
T 1ju5_A 74 SRLR----I-GDQEFDSLPALLE 91 (109)
T ss_dssp CCEE----E-TTEEESSHHHHHH
T ss_pred cEEE----e-CCcccCCHHHHHH
Confidence 1233 2 3568999999994
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.36 E-value=9e-05 Score=88.23 Aligned_cols=75 Identities=16% Similarity=0.188 Sum_probs=63.0
Q ss_pred cccccccccCCCChhHHHHcC----Cchh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCcc
Q 037285 686 NLAQVDFGQKDVSLIDQEHLG----LSSG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVS 758 (1094)
Q Consensus 686 ~Le~~~Wy~~~IsR~~AE~ll----~a~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~is 758 (1094)
.++..+||||+|+|.+||.+| ..+| ||+|....| .|.+|+... +.++ ||.|.....+.|+ +.
T Consensus 4 ~~~~~~W~~g~i~r~~ae~~L~~~~~~~G~fLvR~s~~~~g-~~~ls~~~~-----~~~~-h~~i~~~~~g~~~----~~ 72 (613)
T 2ozo_A 4 PAAHLPFFYGSISRAEAEEHLKLAGMADGLFLLRQCLRSLG-GYVLSLVHD-----VRFH-HFPIERQLNGTYA----IA 72 (613)
T ss_dssp TTSSCTTBCBSCCHHHHHHHHHTTTCCTTEEEEEECTTBTT-CEEEEEEET-----TEEE-EEEEEECTTSCEE----ET
T ss_pred CCCCCCCcCccCCHHHHHHHHhccCCCCCeEEEEecCCCCC-CEEEEEEEC-----CeEE-EEEEEECCCCcEE----EC
Confidence 456788999999999999999 3346 999999888 899998885 7888 9999877777787 55
Q ss_pred cccchHHHHHhhh
Q 037285 759 ESMQFDAMMENLR 771 (1094)
Q Consensus 759 E~~qFdsL~ElLr 771 (1094)
....|.++.+++.
T Consensus 73 ~~~~f~sl~~Lv~ 85 (613)
T 2ozo_A 73 GGKAHCGPAELCE 85 (613)
T ss_dssp TSCCBSSHHHHHH
T ss_pred CCCCcCCHHHHHH
Confidence 6677999999993
|
| >3hhm_B NISH2 P85alpha; PI3KCA, PI3K, PIK3R1, phosphatidilynositol 3,4,5- triphosphate, wortmannin, H1047R, ATP-binding, disease mutation, kinase; HET: KWT; 2.80A {Homo sapiens} PDB: 3hiz_B 2rd0_B 4a55_B* 3mtt_A | Back alignment and structure |
|---|
Probab=97.33 E-value=7.2e-05 Score=85.00 Aligned_cols=75 Identities=19% Similarity=0.317 Sum_probs=62.6
Q ss_pred ccccccccccCCCChhHHHHcCC--chh---hhhhhhc-CCceeEEeeeccCCCCCCcccccccccccCCCccccCCCcc
Q 037285 685 RNLAQVDFGQKDVSLIDQEHLGL--SSG---VREVREE-DGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVS 758 (1094)
Q Consensus 685 ~~Le~~~Wy~~~IsR~~AE~ll~--a~g---VR~s~~~-~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~is 758 (1094)
.+|+.++||||+|+|.+||.+|. .+| ||+|... +| .|++|+... +.+. ||.|... .+.|+ +.
T Consensus 5 ~sL~~~~WYhG~IsR~eAE~lL~~~~dG~FLVR~S~s~~~g-~y~LSvr~~-----~~v~-H~rI~~~-~g~y~----l~ 72 (373)
T 3hhm_B 5 MSLQNAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHG-DYTLTLRKG-----GNNK-LIKIFHR-DGKYG----FS 72 (373)
T ss_dssp CGGGGCTTEEESCCHHHHHHHTTTCCTTEEEEEECSCC--C-CEEEEEEET-----TEEE-EEEECCS-SSCBC----SS
T ss_pred CCcccCCccCCCCCHHHHHHHhcCCCCCCEEEeccCCCCCC-CEEEEEEEC-----CeeE-EEEEEec-CCeEE----eC
Confidence 57999999999999999999998 667 9999986 67 899998886 6788 9999864 46677 56
Q ss_pred cccchHHHHHhhh
Q 037285 759 ESMQFDAMMENLR 771 (1094)
Q Consensus 759 E~~qFdsL~ElLr 771 (1094)
+...|.++.+++.
T Consensus 73 ~~~~F~SL~eLV~ 85 (373)
T 3hhm_B 73 DPLTFSSVVELIN 85 (373)
T ss_dssp SSCCBSSSHHHHH
T ss_pred CCCCcCCHHHHHH
Confidence 6677999999984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0028 Score=71.48 Aligned_cols=79 Identities=15% Similarity=0.148 Sum_probs=47.0
Q ss_pred HCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccCccccCCcc--CCCcccCccccccCC-CCCCchhhHHHHHHH
Q 037285 934 SKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVR--GTLPWMAPELLSGSS-SKVSEKVDVFSFGIV 1010 (1094)
Q Consensus 934 s~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~~~ss~~~--GT~~YmAPEvL~g~~-~kyS~KSDVWSLGVL 1010 (1094)
...++|+|+++.|||++ .++ ++|+||+.+..-.......... ....|++|+...... ..-.....+..+...
T Consensus 231 ~~~liHGDl~~~Nil~~----~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVT----QDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQ 305 (420)
T ss_dssp CCEEECSCCSGGGEEEC----SSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEe----CCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHH
Confidence 45699999999999997 344 9999999987433211100000 113456665543110 111234556678888
Q ss_pred HHHHHcC
Q 037285 1011 LWEILTG 1017 (1094)
Q Consensus 1011 LyELLTG 1017 (1094)
+|+.+++
T Consensus 306 ~~~~y~~ 312 (420)
T 2pyw_A 306 TWNLFNK 312 (420)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 8887764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0069 Score=64.70 Aligned_cols=141 Identities=13% Similarity=0.090 Sum_probs=94.5
Q ss_pred cchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeccCCCCCCcEEEEecCCcccccCccccC
Q 037285 899 DGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSG 977 (1094)
Q Consensus 899 gGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs-~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~~~ss 977 (1094)
.-+|.+.|...+.+++++++|.+|.|.+.+|.-+-. ..-..+=+.|..|++. .+|.|.+.+ ..+.
T Consensus 32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~----~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVW----RDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEE----TTSCEEECC-C------------
T ss_pred cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEe----cCCceeccc-cccc---------
Confidence 458999999999999999999999999999877622 1112333456888887 666676653 1110
Q ss_pred CccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHh
Q 037285 978 GVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEEC 1057 (1094)
Q Consensus 978 ~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kC 1057 (1094)
.....+.|||... ...+.+.=|||||+++|..+--..| ..-+..+++.+-+||..|
T Consensus 98 --~~~~~~~~pe~~~---~~~te~~~IysLG~tLY~ALDygL~-------------------e~eE~eLS~~LE~LL~~M 153 (229)
T 2yle_A 98 --AGEPPPVAGKLGY---SQCMETEVIESLGIIIYKALDYGLK-------------------ENEERELSPPLEQLIDHM 153 (229)
T ss_dssp -----------CCSS---SSSCHHHHHHHHHHHHHHHHTTTCC-------------------TTEEECCCHHHHHHHHHH
T ss_pred --ccccCCCChhhcc---ccchHHHHHHHHHHHHHHHhhcCCC-------------------cccchhhCHHHHHHHHHH
Confidence 1123466888763 2456889999999999988853332 223346788999999888
Q ss_pred ccC-------------------------CCCCCCCHHHHHHHHHH
Q 037285 1058 WAP-------------------------NPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1058 Lq~-------------------------DPeeRPS~eELLq~L~~ 1077 (1094)
... .+..|+++++|++....
T Consensus 154 t~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~ 198 (229)
T 2yle_A 154 ANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAA 198 (229)
T ss_dssp TTCCC--------------------CCSCCCCCCSHHHHHHHHHT
T ss_pred HhcccccccccccccccccccccccccccccCcCCHHHHHHHHHh
Confidence 755 24578899999877654
|
| >2jrh_A Mitogen-activated protein kinase kinase kinase 3; kinase signaling domain, transferase; NMR {Homo sapiens} PDB: 2pph_A | Back alignment and structure |
|---|
Probab=97.00 E-value=0.004 Score=57.30 Aligned_cols=73 Identities=19% Similarity=0.409 Sum_probs=61.3
Q ss_pred cCceEEEEecCCCChHHHHHHHHHHcCCceEEEEeCCCCCCCceeeccChhhHHHHHHHHhhcCCCCCCCeEEEEEecCC
Q 037285 109 GGETRIIRIRKDISWQILRQKALEVYNQVHVIKYQLPGEDLDALVSVSCDEDLQNMMEEYNELGDREGSQRIRMFLFSMS 188 (1094)
Q Consensus 109 GG~triv~v~r~~~~~~l~~kl~~~~~~~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~r~R~FlF~~~ 188 (1094)
-||-||+-++|.++|.+|..|+...||..+.+-|- +. .-+|.+.|.+||+.-|+-.||- +.---||+.|-...
T Consensus 12 ~gEKRIi~f~RPvkf~dl~qkv~~afGq~ldl~y~--nn--EL~iPL~~Q~DLDkAvelLDrs---~~mkSLRIlL~~~~ 84 (94)
T 2jrh_A 12 NGERRIIAFSRPVKYEDVEHKVTTVFGQPLDLHYM--NN--ELSILLKNQDDLDKAIDILDRS---SSMKSLRILLLSQD 84 (94)
T ss_dssp TTEEEEEEECSSCCHHHHHHHHHHHHCSSEEEEEE--CS--SCEEECCSHHHHHHHHHHHHHS---TTTTEEEEEEEECS
T ss_pred cCceEEEecCCCccHHHHHHHHHHHhCCeeeeEEe--cc--eeEEeccCHHHHHHHHHHhccC---ccccceEEEEEcCC
Confidence 37899999999999999999999999999999998 33 3599999999999999999984 22235677776433
|
| >3hhm_B NISH2 P85alpha; PI3KCA, PI3K, PIK3R1, phosphatidilynositol 3,4,5- triphosphate, wortmannin, H1047R, ATP-binding, disease mutation, kinase; HET: KWT; 2.80A {Homo sapiens} PDB: 3hiz_B 2rd0_B 4a55_B* 3mtt_A | Back alignment and structure |
|---|
Probab=96.93 E-value=0.00013 Score=82.90 Aligned_cols=73 Identities=16% Similarity=0.195 Sum_probs=0.0
Q ss_pred hccccccccccCCCChhHHHHcCCc--hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCcc
Q 037285 684 FRNLAQVDFGQKDVSLIDQEHLGLS--SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVS 758 (1094)
Q Consensus 684 ~~~Le~~~Wy~~~IsR~~AE~ll~a--~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~is 758 (1094)
+..++..+||||+|+|.+||.+|.. +| ||+| ..+| .|.+|+... +.|+ ||.|.....+.+. +.
T Consensus 295 ~~~~~~~~WyhG~isR~~AE~LL~~~~~G~FLVR~S-s~~g-~y~LSv~~~-----~~v~-H~~I~~~~~g~~~----~~ 362 (373)
T 3hhm_B 295 LPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRES-SKQG-CYACSVVVD-----GEVK-HCVINKTATGYGF----AE 362 (373)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccccCCCCcCCCCCHHHHHHHhccCCCCcEEEEec-CCCC-CEEEEEEEC-----CeEE-EEEEEEcCCCcEE----eC
Confidence 4577889999999999999999976 66 9999 6577 899998885 7888 9999876665555 44
Q ss_pred cccchHHHHH
Q 037285 759 ESMQFDAMME 768 (1094)
Q Consensus 759 E~~qFdsL~E 768 (1094)
....|.++.+
T Consensus 363 ~~~~F~SL~e 372 (373)
T 3hhm_B 363 PYNLYSSLKE 372 (373)
T ss_dssp ----------
T ss_pred CCCCCCChhh
Confidence 4466777654
|
| >4fbn_A 1-phosphatidylinositol 4,5-bisphosphate phosphodi gamma-1; SH2 domain, plcgamma specific array, interaction domain, FIB growth factor receptor 1; 2.40A {Homo sapiens} PDB: 4ey0_A* 3gqi_B* 2fci_A* 2pld_A* 2ple_A* | Back alignment and structure |
|---|
Probab=96.87 E-value=0.00022 Score=76.45 Aligned_cols=75 Identities=15% Similarity=0.278 Sum_probs=59.0
Q ss_pred hhccccccccccCCCChhHHHHcCCc---hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCC
Q 037285 683 YFRNLAQVDFGQKDVSLIDQEHLGLS---SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPS 756 (1094)
Q Consensus 683 ~~~~Le~~~Wy~~~IsR~~AE~ll~a---~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~ 756 (1094)
..+.++...|||++|+|.+||.+|.. +| ||++.+ .| .|.+|+... |.++ |+.|..+. .++
T Consensus 115 ~~~~~~~~~Wyhg~isr~~Ae~lL~~~~~~G~FLVR~s~~-~g-~y~Lsv~~~-----~~v~-H~~I~~~~--~~~---- 180 (246)
T 4fbn_A 115 QTNAHESKEWYHASLTRAQAEHMLMRVPRDGAFLVRKRNE-PN-SYAISFRAE-----GKIK-HCRVQQEG--QTV---- 180 (246)
T ss_dssp CSCGGGGSTTEESSCCHHHHHHHHHTSCCTTEEEEEECSS-TT-EEEEEEEET-----TEEE-EEEEEEET--TEE----
T ss_pred ccCCcccCCeeecCccHHHHHHHHhhCCCCCeEEEEecCC-CC-CEEEEEEeC-----CCeE-EEEEEeCC--CEE----
Confidence 35678899999999999999999954 45 999854 67 899999886 7888 99998643 334
Q ss_pred cccccchHHHHHhhh
Q 037285 757 VSESMQFDAMMENLR 771 (1094)
Q Consensus 757 isE~~qFdsL~ElLr 771 (1094)
......|+++.+++.
T Consensus 181 ~~~~~~F~sL~~Lv~ 195 (246)
T 4fbn_A 181 MLGNSEFDSLVDLIS 195 (246)
T ss_dssp EETTEEESCHHHHHH
T ss_pred EeCCCccCCHHHHHH
Confidence 334567999999993
|
| >1gri_A Growth factor bound protein 2; SH2, SH3, signal transduction adaptor; 3.10A {Homo sapiens} SCOP: b.34.2.1 b.34.2.1 d.93.1.1 PDB: 1aze_A 2a37_A 2azv_A 2a36_A 2azs_A | Back alignment and structure |
|---|
Probab=96.83 E-value=0.00081 Score=69.57 Aligned_cols=86 Identities=13% Similarity=0.191 Sum_probs=67.1
Q ss_pred cccccCCCCchhhhccccccccccCCCChhHHHHcC---Cchh---hhhhhhcCCceeEEeeeccCCCCCCccccccccc
Q 037285 671 VNMENHEPKRWSYFRNLAQVDFGQKDVSLIDQEHLG---LSSG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFG 744 (1094)
Q Consensus 671 ~~~~~~~~~~~~~~~~Le~~~Wy~~~IsR~~AE~ll---~a~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~ 744 (1094)
.++++..|.++.. +....||++.|+|.+||.+| ...| ||++...+| .|.+++... +.++ ||.|.
T Consensus 42 ~g~~G~~P~~yv~---~~~~~w~~g~isr~~ae~lL~~~~~~G~fLvR~S~~~~g-~~~LSv~~~-----~~v~-h~~I~ 111 (217)
T 1gri_A 42 NGKDGFIPKNYIE---MKPHPWFFGKIPRAKAEEMLSKQRHDGAFLIRESESAPG-DFSLSVKFG-----NDVQ-HFKVL 111 (217)
T ss_dssp SSCEEEEEGGGEE---CCCCSSBCTTCCHHHHHHHHHTCSSTTCEEEEECSSSTT-CEEEEEEET-----TEEE-EEEEE
T ss_pred CCccceECCcccc---cccchhhcccCCHHHHHHHHhccCCCceEEEEccCCCCC-CEEEEEEEC-----CEEE-EEEEE
Confidence 4577888888876 44689999999999999988 3445 999988788 888888774 5677 99998
Q ss_pred ccCCCccccCCCcccccchHHHHHhhh
Q 037285 745 QDSQKTFGVDPSVSESMQFDAMMENLR 771 (1094)
Q Consensus 745 ~dsq~r~~vtp~isE~~qFdsL~ElLr 771 (1094)
.+..+.++. . ...|.++.+++.
T Consensus 112 ~~~~g~~~~----~-~~~f~sl~eLv~ 133 (217)
T 1gri_A 112 RDGAGKYFL----W-VVKFNSLNELVD 133 (217)
T ss_dssp ECSSSCEES----S-SCEESSHHHHHH
T ss_pred EcCCCCEEE----e-eeEcCCHHHHHH
Confidence 877777763 2 456888877773
|
| >2c60_A Human mitogen-activated protein kinase kinase kinase 3 isoform 2; MAP3K3, MAP/ERK kinase kinase 3, MAPKKK3, MEKK3, serine threonine phosphorylation; HET: MSE; 1.25A {Homo sapiens} SCOP: d.15.2.2 PDB: 2o2v_B | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0057 Score=57.58 Aligned_cols=70 Identities=19% Similarity=0.401 Sum_probs=58.7
Q ss_pred cCceEEEEecCCCChHHHHHHHHHHcCCceEEEEeCCCCCCCceeeccChhhHHHHHHHHhhcCCCCCCCeEEEEEe
Q 037285 109 GGETRIIRIRKDISWQILRQKALEVYNQVHVIKYQLPGEDLDALVSVSCDEDLQNMMEEYNELGDREGSQRIRMFLF 185 (1094)
Q Consensus 109 GG~triv~v~r~~~~~~l~~kl~~~~~~~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~r~R~FlF 185 (1094)
-||-||+-++|.++|.+|..|+...+|..+.+-|- +. .-+|.+.|.+||+.-|+-.||-. .-. -||+.|-
T Consensus 39 ~gEKRIiqf~RPvkf~dl~qkv~~afGq~ldl~y~--nn--EL~IPL~~Q~DLDkAvelLDrs~-~mk--SLRIlL~ 108 (111)
T 2c60_A 39 NGERRIIAFSRPVKYEDVEHKVTTVFGQPLDLHYM--NN--ELSILLKNQDDLDKAIDILDRSS-SMK--SLRILLL 108 (111)
T ss_dssp TTEEEEEEECSSCCHHHHHHHHHHHHSSCCEEEEE--CS--SCEEECCSHHHHHHHHHHHHHCS-SCC--SEEEEEE
T ss_pred cCceEEEecCCCccHHHHHHHHHHHhCCeeeeEEe--cc--eEEEecccHHHHHHHHHHhccCc-ccc--ceEEEEe
Confidence 36899999999999999999999999999999998 33 35899999999999999999842 222 4566654
|
| >2npt_B Mitogen-activated protein kinase kinase kinase 2; MAP2K5, MEK5, MKK PRKMK5, MAP kinase kinase 5, PHOX, PHOX-domain; 1.75A {Homo sapiens} SCOP: d.15.2.2 | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0056 Score=57.00 Aligned_cols=69 Identities=20% Similarity=0.406 Sum_probs=58.4
Q ss_pred CceEEEEecCCCChHHHHHHHHHHcCCceEEEEeCCCCCCCceeeccChhhHHHHHHHHhhcCCCCCCCeEEEEEe
Q 037285 110 GETRIIRIRKDISWQILRQKALEVYNQVHVIKYQLPGEDLDALVSVSCDEDLQNMMEEYNELGDREGSQRIRMFLF 185 (1094)
Q Consensus 110 G~triv~v~r~~~~~~l~~kl~~~~~~~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~r~R~FlF 185 (1094)
||-||+-++|.+.|.||..|+...||..+.+-|- +. .-+|-+.|.+||+.-|+-.||-. .-. -||+.|-
T Consensus 29 gEkRIi~f~RPv~f~el~~kv~~afGq~ldl~y~--nn--EL~iPL~~Q~DLDkAvelLDrs~-~~k--SLrIlL~ 97 (100)
T 2npt_B 29 GEKRILQFPRPVKLEDLRSKAKIAFGQSMDLHYT--NN--ELVIPLTTQDDLDKAVELLDRSI-HMK--SLKILLV 97 (100)
T ss_dssp TEEEEEEECSSCCHHHHHHHHHHHHTSCEEEEEE--ET--TEEEECCCHHHHHHHHHHHHHCS-SCC--SEEEEEE
T ss_pred CceEEEecCCCccHHHHHHHHHHHhCCeeeeEEe--cc--eeEEecccHHHHHHHHHHhccCc-ccc--ceEEEEe
Confidence 6799999999999999999999999999999998 33 36899999999999999999842 222 4566654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0026 Score=68.22 Aligned_cols=71 Identities=17% Similarity=0.096 Sum_probs=41.6
Q ss_pred EEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCce-eEEEeEeecCCCCceEEE
Q 037285 815 QKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNV-VAFYGVVQDGPGGTLATV 893 (1094)
Q Consensus 815 ~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNI-VqL~Gv~~d~~~~~L~IV 893 (1094)
.+.|+.|....+|+. ..+++|+........ ....+|+.+++.+..-++ .++++++.+ .-++|
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~~---------~~r~~E~~~l~~l~~~g~~P~~~~~~~~----~~~~v 85 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEEY---------INRANEAVAAREAAKAGVSPEVLHVDPA----TGVMV 85 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC----C---------CCHHHHHHHHHHHHHTTSSCCEEEECTT----TCCEE
T ss_pred eeEcCCcccccccee----eeEEEECCCCCccce---------eCHHHHHHHHHHHHHcCCCCceEEEECC----CCEEE
Confidence 567889999999998 668889876431100 112346666665532222 455554432 34678
Q ss_pred eeec-ccchh
Q 037285 894 AEYM-VDGSL 902 (1094)
Q Consensus 894 mEYm-egGSL 902 (1094)
+||+ ++.+|
T Consensus 86 ~e~i~~g~~l 95 (301)
T 3dxq_A 86 TRYIAGAQTM 95 (301)
T ss_dssp EECCTTCEEC
T ss_pred EeecCCCccC
Confidence 9999 65554
|
| >2shp_A SHP-2, SYP, SHPTP-2; tyrosine phosphatase, insulin signaling, SH2 protein; HET: CAT; 2.00A {Homo sapiens} SCOP: c.45.1.2 d.93.1.1 d.93.1.1 | Back alignment and structure |
|---|
Probab=96.67 E-value=0.00043 Score=81.33 Aligned_cols=73 Identities=14% Similarity=0.303 Sum_probs=58.7
Q ss_pred ccccccccCCCChhHHHHcCCc---hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCcccc
Q 037285 687 LAQVDFGQKDVSLIDQEHLGLS---SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSES 760 (1094)
Q Consensus 687 Le~~~Wy~~~IsR~~AE~ll~a---~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~isE~ 760 (1094)
|+...||||+|+|.+||.+|.. +| ||+|...+| .|.+|+... +.++ ||.|.. ..+.|. +...
T Consensus 1 l~~~~Wyhg~i~r~~Ae~lL~~~~~~G~FLvR~S~~~~g-~~~Lsv~~~-----~~v~-H~~I~~-~~~~~~----l~~~ 68 (525)
T 2shp_A 1 MKSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPG-DLTLSVRRN-----GAVT-HIKIQN-TGDYYD----LYGG 68 (525)
T ss_dssp -CCSTTBCSSCCHHHHHHHHHHHCCTTEEEEEECSSSTT-CEEEEEEET-----TEEE-EEEEEC-SSSCEE----ETTS
T ss_pred CCCCCcccCCCCHHHHHHHHHhCCCCCcEEeeccCCCCC-cEEEEEEEC-----CEEE-EEEEEe-cCCeEE----ECCC
Confidence 5788999999999999999965 45 999998888 799998875 7788 999975 344555 4456
Q ss_pred cchHHHHHhhh
Q 037285 761 MQFDAMMENLR 771 (1094)
Q Consensus 761 ~qFdsL~ElLr 771 (1094)
..|.++.+++.
T Consensus 69 ~~F~sl~eLv~ 79 (525)
T 2shp_A 69 EKFATLAELVQ 79 (525)
T ss_dssp CEESSHHHHHH
T ss_pred CeECCHHHHHH
Confidence 67999999884
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.62 E-value=0.012 Score=65.03 Aligned_cols=75 Identities=23% Similarity=0.216 Sum_probs=57.0
Q ss_pred EEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC---CCceeEEEeEeecCCCCceE
Q 037285 815 QKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH---HPNVVAFYGVVQDGPGGTLA 891 (1094)
Q Consensus 815 ~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~---HPNIVqL~Gv~~d~~~~~L~ 891 (1094)
.+.|+.|.+..+|+....+..+++|+.... ....+.+|...|+.|. ...+++++.++... +..+
T Consensus 41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~-----------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~--g~~~ 107 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEVQTVFVKINERS-----------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ--GHSF 107 (312)
T ss_dssp EEEECCSSSSEEEEEESSSCEEEEEEEEGG-----------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS--SEEE
T ss_pred eEEeCCccceeeeEEEECCCeEEEEeCCcc-----------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC--CceE
Confidence 467899999999998877788999987542 1245678888888774 35677888887654 4789
Q ss_pred EEeeecccchh
Q 037285 892 TVAEYMVDGSL 902 (1094)
Q Consensus 892 IVmEYmegGSL 902 (1094)
+||||+++..+
T Consensus 108 lvme~l~G~~~ 118 (312)
T 3jr1_A 108 LLLEALNKSKN 118 (312)
T ss_dssp EEEECCCCCCC
T ss_pred EEEEeccCCCC
Confidence 99999988653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.31 E-value=0.0082 Score=64.35 Aligned_cols=141 Identities=13% Similarity=0.094 Sum_probs=74.5
Q ss_pred EEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCc--eeEEEeEeec----CCC
Q 037285 814 EQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPN--VVAFYGVVQD----GPG 887 (1094)
Q Consensus 814 i~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPN--IVqL~Gv~~d----~~~ 887 (1094)
-.+.|+.|....+|+....+..+++|+..... . ...+..|+.++..|...+ +.+++..... ...
T Consensus 26 ~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~-~---------~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~ 95 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTTKDPLILTLYEKRV-E---------KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELS 95 (322)
T ss_dssp EEEEECC---EEEEEEEESSCCEEEEEECC-------------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEET
T ss_pred EeeccCCCcccceEEEEeCCccEEEEEeCCCC-C---------HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEEC
Confidence 35678889889999987766678999886521 0 012334666665553211 2333321100 001
Q ss_pred CceEEEeeecccchhH-----------HH---Hhhc--c--cc----cC---HHHHHH------------HHHHHHHHHH
Q 037285 888 GTLATVAEYMVDGSLR-----------HV---LVRK--D--RF----LD---RRRRLI------------IAMDAAFGME 930 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~-----------d~---L~k~--~--~~----Ls---e~~~l~------------Ia~QIaeGLa 930 (1094)
+..+++|+|++|..+. .. ++.. . .. .. +...+. +...+...+.
T Consensus 96 g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~ 175 (322)
T 2ppq_A 96 GRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEID 175 (322)
T ss_dssp TEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHH
T ss_pred CEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHH
Confidence 3568899999875431 01 1111 0 00 01 111000 0112344555
Q ss_pred HHHH-------CCceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 931 YLHS-------KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 931 YLHs-------~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
+|.. .+++|+|+.+.|||++ .+..+.|+||+.+.
T Consensus 176 ~l~~~~~~~~~~~liHgDl~~~Nil~~----~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 176 YLAAHWPKDLPAGVIHADLFQDNVFFL----GDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHCCCSSCEEEECSCCCGGGEEEE----TTEEEEECCCTTCE
T ss_pred HHHhhCcccCCcccCCCCCCccCEEEe----CCceEEEecchhcc
Confidence 6653 3599999999999998 44455799999875
|
| >2b3o_A Tyrosine-protein phosphatase, non-receptor type 6; protein tyrosine phosphatase, SHP-1, signaling, hydrolase; 2.80A {Homo sapiens} PDB: 1x6c_A 2rmx_A* 2yu7_A* | Back alignment and structure |
|---|
Probab=96.16 E-value=0.0013 Score=77.42 Aligned_cols=70 Identities=20% Similarity=0.329 Sum_probs=56.7
Q ss_pred cccccCCCChhHHHHcCCc---hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCcccccch
Q 037285 690 VDFGQKDVSLIDQEHLGLS---SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSESMQF 763 (1094)
Q Consensus 690 ~~Wy~~~IsR~~AE~ll~a---~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~isE~~qF 763 (1094)
..||||+|+|.+||.+|.. +| ||+|....| .|.+|+... +.++ ||.|.. ..+.|. +.....|
T Consensus 2 ~~Wyhg~i~r~~Ae~lL~~~~~~G~FLvR~S~~~~g-~~~Lsv~~~-----~~v~-H~~I~~-~~~~~~----~~~~~~F 69 (532)
T 2b3o_A 2 VRWFHRDLSGLDAETLLKGRGVHGSFLARPSRKNQG-DFSLSVRVG-----DQVT-HIRIQN-SGDFYD----LYGGEKF 69 (532)
T ss_dssp CTTBCSSCCHHHHHHHHHHHCCTTEEEEEECSSSSS-EEEEEEEET-----TEEE-EEEEEC-SSSCEE----ETTSCEE
T ss_pred CCceeCCCCHHHHHHHHHhcCCCCCEEEecCCCCCC-ceEEEEEEC-----CEEE-EEEEEe-cCCEEE----ECCCccc
Confidence 5799999999999999984 45 999998788 899999885 7888 999975 344454 4455679
Q ss_pred HHHHHhhh
Q 037285 764 DAMMENLR 771 (1094)
Q Consensus 764 dsL~ElLr 771 (1094)
.++.+++.
T Consensus 70 ~sl~~Lv~ 77 (532)
T 2b3o_A 70 ATLTELVE 77 (532)
T ss_dssp SCHHHHHH
T ss_pred CCHHHHHH
Confidence 99999884
|
| >3ps5_A Tyrosine-protein phosphatase non-receptor type 6; SH2, PTP, hydrolase, signaling protein; 3.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.16 E-value=0.0013 Score=78.50 Aligned_cols=70 Identities=20% Similarity=0.329 Sum_probs=58.1
Q ss_pred cccccCCCChhHHHHcCCch---h---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCcccccch
Q 037285 690 VDFGQKDVSLIDQEHLGLSS---G---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSESMQF 763 (1094)
Q Consensus 690 ~~Wy~~~IsR~~AE~ll~a~---g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~isE~~qF 763 (1094)
..||||+|+|.+||.+|... | ||+|....| .|.+|+... +.++ ||.|.. ..+.|+ +.....|
T Consensus 2 ~~Wy~g~isr~~Ae~lL~~~~~~G~FLvR~S~~~~g-~y~LSv~~~-----~~v~-H~~I~~-~~~~~~----~~~~~~F 69 (595)
T 3ps5_A 2 VRWFHRDLSGLDAETLLKGRGVHGSFLARPSRKNQG-DFSLSVRVG-----DQVT-HIRIQN-SGDFYD----LYGGEKF 69 (595)
T ss_dssp CSCCCSSCCHHHHHHHHHHHCCTTCEEEEECSSSTT-SEEEEEEET-----TEEE-EEEEEE-CSSCEE----SSSSCCB
T ss_pred CCccCCCCCHHHHHHHHhhCCCCCEEEEeecCCCCC-ceEEEEEEC-----CEEE-EEEEEe-CCCcEE----EecCccc
Confidence 47999999999999999754 5 999999888 899999986 7888 999975 445566 5567779
Q ss_pred HHHHHhhh
Q 037285 764 DAMMENLR 771 (1094)
Q Consensus 764 dsL~ElLr 771 (1094)
.++.+++.
T Consensus 70 ~sl~eLv~ 77 (595)
T 3ps5_A 70 ATLTELVE 77 (595)
T ss_dssp SSHHHHHH
T ss_pred cchhhhhh
Confidence 99999984
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.09 E-value=0.0084 Score=68.56 Aligned_cols=72 Identities=14% Similarity=0.270 Sum_probs=46.3
Q ss_pred EEEecccCceEEEEeeec---------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCce-eEEEeEeec
Q 037285 815 QKELGSGTFGTVYHGKWR---------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNV-VAFYGVVQD 884 (1094)
Q Consensus 815 ~kkLGsG~FGtVYKAk~r---------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNI-VqL~Gv~~d 884 (1094)
.+.|+.|....||++... +..+++|+..... . ...+..|..+++.|...++ +++++.+..
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-----~-----~~~li~E~~~l~~L~~~g~~P~l~~~~~~ 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-----T-----ESHLVAESVIFTLLSERHLGPKLYGIFSG 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-----C-----HHHHHHHHHHHHHHHHTTSSSCEEEEETT
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-----c-----HHHHHHHHHHHHHHHhCCCCCcEEEEeCC
Confidence 467888988999998764 3678899874310 0 0234468888877753333 566766532
Q ss_pred CCCCceEEEeeecccchh
Q 037285 885 GPGGTLATVAEYMVDGSL 902 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL 902 (1094)
.+|+||++|.+|
T Consensus 148 ------g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 ------GRLEEYIPSRPL 159 (429)
T ss_dssp ------EEEECCCCEEEC
T ss_pred ------CEEEEEeCCccc
Confidence 278999976443
|
| >3ps5_A Tyrosine-protein phosphatase non-receptor type 6; SH2, PTP, hydrolase, signaling protein; 3.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.08 E-value=0.0014 Score=78.32 Aligned_cols=80 Identities=19% Similarity=0.208 Sum_probs=62.1
Q ss_pred ccccccccccCCCChhHHHHcCCchh------hhhhhhcCCceeEEeeeccCCC----CCCcccccccccccCCCccccC
Q 037285 685 RNLAQVDFGQKDVSLIDQEHLGLSSG------VREVREEDGRLYHFTPLTDDGA----PKGRVDSQLNFGQDSQKTFGVD 754 (1094)
Q Consensus 685 ~~Le~~~Wy~~~IsR~~AE~ll~a~g------VR~s~~~~G~~y~~S~l~~~ga----~~g~v~shy~I~~dsq~r~~vt 754 (1094)
...+...||++.|+|.+||.+|...| ||+|...+| .|.+|+.+.... ...++. ||.|.. ..+.|+
T Consensus 103 ~~p~~~~Wy~g~~~r~eAe~lL~~~~~~G~FLVR~S~~~~g-~y~LSv~~~~~~~~~~~~~~v~-H~~I~~-~~~~~~-- 177 (595)
T 3ps5_A 103 SDPTSERWYHGHMSGGQAETLLQAKGEPWTFLVRESLSQPG-DFVLSVLSDQPKAGPGSPLRVT-HIKVMC-EGGRYT-- 177 (595)
T ss_dssp CCSCCSTTEEESCCHHHHHHHHHHHCCTTEEEEEECSSSTT-CEEEEEEEEEESSSTTSCEEEE-EEEEBC-GGGCBB--
T ss_pred ccccccccccccCCHHHHHHHHhccCCCceEEEEecCCCCC-cEEEEEEECCccccccCCCceE-EEEEEE-eCCEEE--
Confidence 34567899999999999999997655 999988888 899999886311 111667 999976 456677
Q ss_pred CCcccccchHHHHHhhh
Q 037285 755 PSVSESMQFDAMMENLR 771 (1094)
Q Consensus 755 p~isE~~qFdsL~ElLr 771 (1094)
+.....|+++.+++.
T Consensus 178 --~~~~~~F~sl~~LV~ 192 (595)
T 3ps5_A 178 --VGGLETFDSLTDLVE 192 (595)
T ss_dssp --SSSSCCBSSHHHHHH
T ss_pred --EcCCcCCCCHHHHHH
Confidence 566778999999984
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.77 E-value=0.024 Score=61.32 Aligned_cols=36 Identities=28% Similarity=0.217 Sum_probs=27.1
Q ss_pred CCceeccCCCCceEeccCCCCCCcEEEEecCCcccc
Q 037285 935 KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK 970 (1094)
Q Consensus 935 ~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~ 970 (1094)
..++|+|+.+.|||++.+......+.|+||+.+..-
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 469999999999999721111257999999998743
|
| >2cr4_A 3BP-2, SH3 domain-binding protein 2; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.74 E-value=0.0017 Score=63.29 Aligned_cols=83 Identities=7% Similarity=0.039 Sum_probs=61.1
Q ss_pred ccccCCCCchhh-hccccccccccCCCChhHHHHcCCc-hh---hhhhhhcCCceeEEeeeccCCCCCCccccccccccc
Q 037285 672 NMENHEPKRWSY-FRNLAQVDFGQKDVSLIDQEHLGLS-SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQD 746 (1094)
Q Consensus 672 ~~~~~~~~~~~~-~~~Le~~~Wy~~~IsR~~AE~ll~a-~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~d 746 (1094)
-+...+|+|+.+ ..+|+.++|||.-+. .... +| ||+|. ..| .|++|+.+.. .+.|+ ||.|...
T Consensus 11 ~~~~~iPsnyv~~~~~l~~~~Wyh~Ll~------~g~~~dG~FLVR~S~-~~g-~y~LSv~~~~---~~~vk-H~rI~~~ 78 (126)
T 2cr4_A 11 EKVPLPNSVFVNTTESCEVERLFKATSP------RGEPQDGLYCIRNSS-TKS-GKVLVVWDET---SNKVR-NYRIFEK 78 (126)
T ss_dssp CSCSSCTTTBCSCCCHHHHHHHHHHHST------TSCCCTTCEEEEECS-STT-CEEEEEEETT---TTEEC-CEECEEE
T ss_pred EEcCCCCHhhcCcccccccCCCHHHHhh------CCCCCCCeEEEEecC-CCC-CEEEEEEeCC---CCCEE-EEEEEEC
Confidence 455679999995 557999999991111 1222 36 99999 688 8999998841 25778 9999875
Q ss_pred CCCccccCCCcccccchHHHHHhhh
Q 037285 747 SQKTFGVDPSVSESMQFDAMMENLR 771 (1094)
Q Consensus 747 sq~r~~vtp~isE~~qFdsL~ElLr 771 (1094)
.. +++ +.+...|.++.+++.
T Consensus 79 ~~-~~~----i~~~~~F~sL~eLV~ 98 (126)
T 2cr4_A 79 DS-KFY----LEGEVLFVSVGSMVE 98 (126)
T ss_dssp TT-EEE----SSSSCEESSHHHHHH
T ss_pred CC-eEE----EcCCccCCCHHHHHH
Confidence 54 677 667788999999994
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.72 E-value=0.011 Score=65.20 Aligned_cols=72 Identities=14% Similarity=0.158 Sum_probs=40.0
Q ss_pred EEEecccCceEEEEeeecC----------ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCc-eeEEEeEee
Q 037285 815 QKELGSGTFGTVYHGKWRG----------TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPN-VVAFYGVVQ 883 (1094)
Q Consensus 815 ~kkLGsG~FGtVYKAk~rG----------t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPN-IVqL~Gv~~ 883 (1094)
.+.|+.|....+|+....+ ..+++|+.....- .. .+...|..+++.|...+ ..++++.+.
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~--------~~-~~~~~E~~~l~~L~~~g~~P~~~~~~~ 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD--------EL-YNTISEFEVYKTMSKYKIAPQLLNTFN 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG--------GT-SCHHHHHHHHHHHHHTTSSCCEEEEET
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc--------ce-ecHHHHHHHHHHHHhcCCCCceEEecC
Confidence 3567888888999987653 5788887653210 00 11235677776664223 345665441
Q ss_pred cCCCCceEEEeeecccch
Q 037285 884 DGPGGTLATVAEYMVDGS 901 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGS 901 (1094)
-++||+|++|..
T Consensus 109 ------~~~v~e~i~G~~ 120 (369)
T 3c5i_A 109 ------GGRIEEWLYGDP 120 (369)
T ss_dssp ------TEEEEECCCSEE
T ss_pred ------CcEEEEEecCCc
Confidence 257899998754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.61 E-value=0.017 Score=65.38 Aligned_cols=139 Identities=14% Similarity=0.117 Sum_probs=75.8
Q ss_pred EEecccCceEEEEeeec---------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-CCceeEEEeEeecC
Q 037285 816 KELGSGTFGTVYHGKWR---------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HPNVVAFYGVVQDG 885 (1094)
Q Consensus 816 kkLGsG~FGtVYKAk~r---------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-HPNIVqL~Gv~~d~ 885 (1094)
+.|..|....+|+.... +..+++|+.-.. . .....+.+|..+++.|. +.-..++++++.+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~-------~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~- 125 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--L-------QGVDSLVLESVMFAILAERSLGPQLYGVFPE- 125 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT-
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--c-------chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC-
Confidence 45667878888887763 357888875321 0 01234557888887774 2223566666543
Q ss_pred CCCceEEEeeecccchhHH--------------HH---hhcc----cccC--HHHHHHHHHHHH----------------
Q 037285 886 PGGTLATVAEYMVDGSLRH--------------VL---VRKD----RFLD--RRRRLIIAMDAA---------------- 926 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d--------------~L---~k~~----~~Ls--e~~~l~Ia~QIa---------------- 926 (1094)
.+||||++|.+|.. .| +... +... +.++..+..++.
T Consensus 126 -----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~ 200 (379)
T 3feg_A 126 -----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMY 200 (379)
T ss_dssp -----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHT
T ss_pred -----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhH
Confidence 27999998765421 11 1110 1111 234444443332
Q ss_pred ---HHHHHHH----HC----CceeccCCCCceEeccCCCCCCcEEEEecCCccc
Q 037285 927 ---FGMEYLH----SK----NIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI 969 (1094)
Q Consensus 927 ---eGLaYLH----s~----GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl 969 (1094)
..+..|. .. .++|+|+.+.|||++.+....+.+.|+||..+..
T Consensus 201 ~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 201 SLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp THHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 1233333 22 4999999999999983211236899999998863
|
| >2b3o_A Tyrosine-protein phosphatase, non-receptor type 6; protein tyrosine phosphatase, SHP-1, signaling, hydrolase; 2.80A {Homo sapiens} PDB: 1x6c_A 2rmx_A* 2yu7_A* | Back alignment and structure |
|---|
Probab=95.58 E-value=0.0037 Score=73.57 Aligned_cols=77 Identities=18% Similarity=0.188 Sum_probs=58.4
Q ss_pred cccccccCCCChhHHHHcCCc---hh---hhhhhhcCCceeEEeeeccCC----CCCCcccccccccccCCCccccCCCc
Q 037285 688 AQVDFGQKDVSLIDQEHLGLS---SG---VREVREEDGRLYHFTPLTDDG----APKGRVDSQLNFGQDSQKTFGVDPSV 757 (1094)
Q Consensus 688 e~~~Wy~~~IsR~~AE~ll~a---~g---VR~s~~~~G~~y~~S~l~~~g----a~~g~v~shy~I~~dsq~r~~vtp~i 757 (1094)
+.+.||++.|+|.+||.+|.. +| ||+|...+| .|.+++.+... .....++ |+.|..+ .+.|+ +
T Consensus 106 ~~~~w~~g~i~r~~Ae~lL~~~~~~G~FLVR~S~~~~g-~y~Lsv~~~~~~~~~~~~~~v~-h~~I~~~-~g~~~----l 178 (532)
T 2b3o_A 106 TSERWYHGHMSGGQAETLLQAKGEPWTFLVRESLSQPG-DFVLSVLSDQPKAGPGSPLRVT-HIKVMCE-GGRYT----V 178 (532)
T ss_dssp GGCTTBCTTCCHHHHHHHHHHHCCTTEEEEEECSSSTT-CEEEEEEEEEEC----CCEEEE-EEEEBCC-TTSBB----S
T ss_pred ccccccccccchHHHHHHHhcCCCCceEEEecCCCCCC-ceEEEEEecCccccccCCCceE-EEEEEEc-CCcee----e
Confidence 568999999999999999974 45 999988788 79999987630 0112556 9988875 55666 4
Q ss_pred ccccchHHHHHhhh
Q 037285 758 SESMQFDAMMENLR 771 (1094)
Q Consensus 758 sE~~qFdsL~ElLr 771 (1094)
.....|.++.+++.
T Consensus 179 ~~~~~F~sl~eLV~ 192 (532)
T 2b3o_A 179 GGLETFDSLTDLVE 192 (532)
T ss_dssp SSSCCBSSHHHHHH
T ss_pred CCCcccCcHHHHHh
Confidence 45667999988884
|
| >2shp_A SHP-2, SYP, SHPTP-2; tyrosine phosphatase, insulin signaling, SH2 protein; HET: CAT; 2.00A {Homo sapiens} SCOP: c.45.1.2 d.93.1.1 d.93.1.1 | Back alignment and structure |
|---|
Probab=95.56 E-value=0.0032 Score=73.90 Aligned_cols=78 Identities=19% Similarity=0.262 Sum_probs=60.4
Q ss_pred ccccccccCCCChhHHHHcCCc---hh---hhhhhhcCCceeEEeeeccCC-----CCCCcccccccccccCCCccccCC
Q 037285 687 LAQVDFGQKDVSLIDQEHLGLS---SG---VREVREEDGRLYHFTPLTDDG-----APKGRVDSQLNFGQDSQKTFGVDP 755 (1094)
Q Consensus 687 Le~~~Wy~~~IsR~~AE~ll~a---~g---VR~s~~~~G~~y~~S~l~~~g-----a~~g~v~shy~I~~dsq~r~~vtp 755 (1094)
++...||+++|+|.+||.+|.. +| ||+|...+| .|.+|+..... ...+.++ |+.|... .+.|+
T Consensus 107 p~~~~w~~g~~~r~~Ae~lL~~~~~~G~FLVR~S~~~~g-~y~LSv~~~~~~~~~~~~~~~v~-H~~I~~~-~g~~~--- 180 (525)
T 2shp_A 107 PTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPG-DFVLSVRTGDDKGESNDGKSKVT-HVMIRCQ-ELKYD--- 180 (525)
T ss_dssp CTTCTTBCCSCCHHHHHHHHHHTCCTTEEEEEECSSSTT-CEEEEEEECC-----CCCCCEEE-EEEEEEE-TTEEE---
T ss_pred cccceeecccCCHHHHHHHHhccCCCceEEEEecCCCCC-CEEEEEEECCccccccccccceE-EEEEEec-CCeEE---
Confidence 4678999999999999999984 46 999998888 89999988631 1223667 9999765 55666
Q ss_pred CcccccchHHHHHhhh
Q 037285 756 SVSESMQFDAMMENLR 771 (1094)
Q Consensus 756 ~isE~~qFdsL~ElLr 771 (1094)
+.....|.++.+++.
T Consensus 181 -l~~~~~F~sL~eLV~ 195 (525)
T 2shp_A 181 -VGGGERFDSLTDLVE 195 (525)
T ss_dssp -SSSSCCBSSHHHHHH
T ss_pred -ECCCceeCcHHHHHH
Confidence 445567999998884
|
| >1q1o_A Cell division control protein 24; PB1 domain, PCCR, PC motif, OPCA motif, yeast, cell polarity, protein-protein interaction; NMR {Saccharomyces cerevisiae} SCOP: d.15.2.2 PDB: 2kfj_A 2kfk_B | Back alignment and structure |
|---|
Probab=95.53 E-value=0.037 Score=52.12 Aligned_cols=68 Identities=21% Similarity=0.209 Sum_probs=51.9
Q ss_pred CceEEEEecCCCChHHHHHHHHHHcCC--------ceEEEEeCCCCCCCceeeccChhhHHHHHHHHhhcCCCCCCCeEE
Q 037285 110 GETRIIRIRKDISWQILRQKALEVYNQ--------VHVIKYQLPGEDLDALVSVSCDEDLQNMMEEYNELGDREGSQRIR 181 (1094)
Q Consensus 110 G~triv~v~r~~~~~~l~~kl~~~~~~--------~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~r~R 181 (1094)
++++.+.|+.+|+|.+|..|+.+.++. .+.|||| .+=...|.+.+||||.-.++..... +.++|-
T Consensus 22 ~d~~~i~V~~~i~f~~L~~kI~~Kl~~~~~~~i~~~~klkYk---DEdGD~Vtl~sddDl~~A~e~~~e~----~~~~l~ 94 (98)
T 1q1o_A 22 SEIFTLLVEKVWNFDDLIMAINSKISNTHNNNISPITKIKYQ---DEDGDFVVLGSDEDWNVAKEMLAEN----NEKFLN 94 (98)
T ss_dssp CEEEEEEECTTCCHHHHHHHHHHHHHHHCSSCCCCCCCEEEE---CSSSCEEEECSHHHHHHHHHHHHHT----TCCEEE
T ss_pred CcEEEEEecCCCCHHHHHHHHHHHHcCCccccccceeEEEEE---cCCCCEEEEcCHHHHHHHHHHHHhh----hcCeEE
Confidence 689999999999999999998876552 2579999 3322699999999999999887432 234555
Q ss_pred EEE
Q 037285 182 MFL 184 (1094)
Q Consensus 182 ~Fl 184 (1094)
+.+
T Consensus 95 Iwv 97 (98)
T 1q1o_A 95 IRL 97 (98)
T ss_dssp EEE
T ss_pred EEE
Confidence 443
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=95.37 E-value=0.045 Score=58.18 Aligned_cols=81 Identities=17% Similarity=0.125 Sum_probs=54.0
Q ss_pred eccCCeeEEEEecccCceEEEEeeec-CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCC---CceeEEEeEe
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHH---PNVVAFYGVV 882 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r-Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~H---PNIVqL~Gv~ 882 (1094)
+...++.-.+.+|.|..+.||+.... |+.|.+|+........ ...|..|+..|+.|.- --+++++++.
T Consensus 12 l~G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~--------~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~ 83 (288)
T 3f7w_A 12 LTGREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL--------DGLFRAEALGLDWLGRSFGSPVPQVAGWD 83 (288)
T ss_dssp HHCCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC--------TTHHHHHHHHHHHHTCSTTCCSCCEEEEE
T ss_pred hcCCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch--------hhHHHHHHHHHHHHHhhCCCCcceEEecc
Confidence 34455666788999999999999874 7889999765432111 1246678888887742 2345555542
Q ss_pred ecCCCCceEEEeeecccch
Q 037285 883 QDGPGGTLATVAEYMVDGS 901 (1094)
Q Consensus 883 ~d~~~~~L~IVmEYmegGS 901 (1094)
.-++||||+.++.
T Consensus 84 ------~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 84 ------DRTLAMEWVDERP 96 (288)
T ss_dssp ------TTEEEEECCCCCC
T ss_pred ------CceEEEEeecccC
Confidence 2367899987654
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.15 E-value=0.059 Score=57.82 Aligned_cols=73 Identities=16% Similarity=0.113 Sum_probs=42.8
Q ss_pred EecccCceEEEEeeec-CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCC--ceeEEEeEeecCC-----CC
Q 037285 817 ELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP--NVVAFYGVVQDGP-----GG 888 (1094)
Q Consensus 817 kLGsG~FGtVYKAk~r-Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HP--NIVqL~Gv~~d~~-----~~ 888 (1094)
.|+ |....||+.... |..+++|+....... ...+..|..++..|... .+++++.. ++. .+
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~---------~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g 100 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWT---------ADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQG 100 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTSC---------HHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETT
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCCC---------HHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECC
Confidence 455 778889988764 567999998643111 12344566666666321 23444432 111 23
Q ss_pred ceEEEeeecccch
Q 037285 889 TLATVAEYMVDGS 901 (1094)
Q Consensus 889 ~L~IVmEYmegGS 901 (1094)
..++||+|++|..
T Consensus 101 ~~~~l~~~i~G~~ 113 (328)
T 1zyl_A 101 FYFAVFPSVGGRQ 113 (328)
T ss_dssp EEEEEEECCCCEE
T ss_pred EEEEEEEecCCCC
Confidence 5678999998754
|
| >2kkc_A Sequestosome-1; P62, PB1, autophagy, ubiquitin-proteasome system, NF-KB signaling, alternative splicing, apoptosis, cytoplasm, differentiation; NMR {Rattus norvegicus} PDB: 2ktr_B | Back alignment and structure |
|---|
Probab=95.03 E-value=0.074 Score=50.41 Aligned_cols=67 Identities=18% Similarity=0.225 Sum_probs=54.1
Q ss_pred ecCceEEEEecCC-----------CChHHHHHHHHHHc----CCceEEEEeCCCCCCCceeeccChhhHHHHHHHHhhcC
Q 037285 108 VGGETRIIRIRKD-----------ISWQILRQKALEVY----NQVHVIKYQLPGEDLDALVSVSCDEDLQNMMEEYNELG 172 (1094)
Q Consensus 108 vGG~triv~v~r~-----------~~~~~l~~kl~~~~----~~~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~ 172 (1094)
.|+|.|=.+++++ .+|.+|+.++..+| +..+.|||. .+=.-||.+++||||...+..-
T Consensus 18 ~~~EiRRF~l~~~~~p~~~~~~~~~s~~~L~~~V~~lFp~l~~~~f~l~Y~---DedGDlItiSsDeEL~~Al~~~---- 90 (102)
T 2kkc_A 18 AAREIRRFSFCFSPEPEAEAAAGPGPCERLLSRVAVLFPALRPGGFQAHYR---AERGDLVAFSSDEELTMAMSYV---- 90 (102)
T ss_dssp CEEEEEEEEEESSSCSCSSSCCSCCHHHHHHHHHHHHCTTSCSSCEEEEEE---CTTCCEEEECSHHHHHHHHHHC----
T ss_pred CCCceEEEEeccCCCcccccccccccHHHHHHHHHHHccccCCCcEEEEEE---CCCCCEEEecCHHHHHHHHHhc----
Confidence 3689999999874 48999999999998 467999999 2234499999999999888753
Q ss_pred CCCCCCeEEEEE
Q 037285 173 DREGSQRIRMFL 184 (1094)
Q Consensus 173 ~~~~~~r~R~Fl 184 (1094)
...-||||+
T Consensus 91 ---~~~~lRlyV 99 (102)
T 2kkc_A 91 ---KDDIFRIYI 99 (102)
T ss_dssp ---CSSEEEEEE
T ss_pred ---CCCeEEEEE
Confidence 135788886
|
| >1pqs_A Cell division control protein 24; alpha and beta protein, cell cycle; NMR {Saccharomyces cerevisiae} SCOP: d.15.2.2 PDB: 1tz1_A | Back alignment and structure |
|---|
Probab=95.02 E-value=0.054 Score=48.91 Aligned_cols=68 Identities=22% Similarity=0.219 Sum_probs=53.8
Q ss_pred ceEEEEecCCCChHHHHHHHHHHcC--------CceEEEEeCCCCCCCceeeccChhhHHHHHHHHhhcCCCCCCCeEEE
Q 037285 111 ETRIIRIRKDISWQILRQKALEVYN--------QVHVIKYQLPGEDLDALVSVSCDEDLQNMMEEYNELGDREGSQRIRM 182 (1094)
Q Consensus 111 ~triv~v~r~~~~~~l~~kl~~~~~--------~~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~r~R~ 182 (1094)
+++.|.|+.+|+|.+|..|+.+.++ ..+.|||| .| =+..|++.+|+||.--++..... +.+++-+
T Consensus 2 D~~~i~V~~~i~f~~L~~kI~~kl~~~~~~~~~~~~~lkYk--DE-dGD~Vti~sddDl~~A~~~~~~~----~~~~lei 74 (77)
T 1pqs_A 2 EIFTLLVEKVWNFDDLIMAINSKISNTHNNNISPITKIKYQ--DE-DGDFVVLGSDEDWNVAKEMLAEN----NEKFLNI 74 (77)
T ss_dssp CEEEEECTTCCCSHHHHHHHHHHTTTTTSSCSCSTTCCEEE--ET-TTEEEECCSTTHHHHHHHHHHHH----CCCEEEE
T ss_pred CEEEEEeCCCCCHHHHHHHHHHHHcccccccccceeEEEEE--cC-CCCEEEEcCHHHHHHHHHHHHhh----hcCeEEE
Confidence 6899999999999999999998776 33679999 33 44699999999999988876432 2456766
Q ss_pred EEe
Q 037285 183 FLF 185 (1094)
Q Consensus 183 FlF 185 (1094)
.+|
T Consensus 75 Wv~ 77 (77)
T 1pqs_A 75 RLY 77 (77)
T ss_dssp ECC
T ss_pred EEC
Confidence 655
|
| >2ktr_A Sequestosome-1; autophagy, NF-KB signaling, HOMO-oligomer, PB1 dimer, signaling protein, transport protein; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=94.79 E-value=0.069 Score=51.74 Aligned_cols=67 Identities=18% Similarity=0.232 Sum_probs=53.8
Q ss_pred ecCceEEEEecCCC-----------ChHHHHHHHHHHc----CCceEEEEeCCCCCCCceeeccChhhHHHHHHHHhhcC
Q 037285 108 VGGETRIIRIRKDI-----------SWQILRQKALEVY----NQVHVIKYQLPGEDLDALVSVSCDEDLQNMMEEYNELG 172 (1094)
Q Consensus 108 vGG~triv~v~r~~-----------~~~~l~~kl~~~~----~~~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~ 172 (1094)
.++|.|=++++++. +|..|+.|+..++ +..|.|||. .+=.-||.+++||||..-+..-.
T Consensus 33 ~~~EIRRF~l~~~~~p~~~~~~~~~s~~~L~~kV~~lFp~L~~~~f~l~Yk---DEdGDlItISsDeEL~~Al~~~~--- 106 (117)
T 2ktr_A 33 AAREIRRFSFCFSPEPEAEAAAGPGPSERLLSRVAVLFPALRPGGFQAHYR---AERGDLVAFSSDEELTMAMSYVK--- 106 (117)
T ss_dssp CEEEEEEEEECSSSCSCSSSCCSCCHHHHHHHHHHHHCTTSCSSCEEEEEE---CTTCCEEEECSHHHHHHHHHHCC---
T ss_pred CCCcEEEEEeccCCCccccccccCCCHHHHHHHHHHHccccCCCcEEEEEE---CCCCCEEEecCHHHHHHHHHhcC---
Confidence 35899999998653 9999999999999 467999999 22344999999999998887531
Q ss_pred CCCCCCeEEEEE
Q 037285 173 DREGSQRIRMFL 184 (1094)
Q Consensus 173 ~~~~~~r~R~Fl 184 (1094)
..-||+|+
T Consensus 107 ----~~~lRlyV 114 (117)
T 2ktr_A 107 ----DDIFRIYI 114 (117)
T ss_dssp ----SSEEEEEE
T ss_pred ----CCeEEEEE
Confidence 35788886
|
| >1oey_A P67-PHOX, neutrophil cytosol factor 2; immune system, PB1 heterodimer/complex, NADPH oxidase, PB1 D heterodimerization; 2.0A {Homo sapiens} SCOP: d.15.2.2 | Back alignment and structure |
|---|
Probab=93.98 E-value=0.16 Score=46.43 Aligned_cols=65 Identities=9% Similarity=0.211 Sum_probs=51.3
Q ss_pred ceEEEEecCCCChHHHHHHHHHHcC---CceEEEEeCCCCCCCceeeccChhhHHHHHHHHhhcCCCCCCCeEEEEEe
Q 037285 111 ETRIIRIRKDISWQILRQKALEVYN---QVHVIKYQLPGEDLDALVSVSCDEDLQNMMEEYNELGDREGSQRIRMFLF 185 (1094)
Q Consensus 111 ~triv~v~r~~~~~~l~~kl~~~~~---~~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~r~R~FlF 185 (1094)
.|..|.|+++++|++|+.|+++-.. ....|.|.-+ +=..++ +.+||||+.++.. .+.+||.|+.+
T Consensus 14 ~tvairvp~~~~y~~L~~~l~~kL~l~~~~~~LsYk~~--~s~~~v-i~~d~dl~~aw~~-------~~n~~LtL~C~ 81 (83)
T 1oey_A 14 YTVVMKTQPGLPYSQVRDMVSKKLELRLEHTKLSYRPR--DSNELV-PLSEDSMKDAWGQ-------VKNYCLTLWCE 81 (83)
T ss_dssp SEEEEEECTTCCHHHHHHHHHHHTTCCGGGCCEEECCT--TCSSCE-ECCTTTHHHHHTT-------CBTTEEEEEEC
T ss_pred EEEEEECCCCCCHHHHHHHHHHHhCCCcceeEEEeeCC--CCCCee-ccChHHHHHHHHh-------ccCCcEEEEEe
Confidence 7999999999999999999999776 3456889855 556677 9999999988742 23447777754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=93.73 E-value=0.14 Score=59.41 Aligned_cols=73 Identities=15% Similarity=0.144 Sum_probs=45.9
Q ss_pred EEEecccCceEEEEeeecC--ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCce-eEEEeEeecCCCCceE
Q 037285 815 QKELGSGTFGTVYHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNV-VAFYGVVQDGPGGTLA 891 (1094)
Q Consensus 815 ~kkLGsG~FGtVYKAk~rG--t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNI-VqL~Gv~~d~~~~~L~ 891 (1094)
.+.|+.|-...+|+....+ ..+++|+..... .. . .+..+|..+|+.|...++ .++++++.. .
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~~-~------idR~~E~~vl~~L~~~gl~P~ll~~~~~------G 177 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT--DE-I------INREREKKISCILYNKNIAKKIYVFFTN------G 177 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C--CS-C------SCHHHHHHHHHHHTTSSSBCCEEEEETT------E
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh--hh-h------cCHHHHHHHHHHHHhcCCCCCEEEEeCC------e
Confidence 4578889999999998765 778899874321 00 0 011368888888864444 567776631 2
Q ss_pred EEeeecccchh
Q 037285 892 TVAEYMVDGSL 902 (1094)
Q Consensus 892 IVmEYmegGSL 902 (1094)
+||||++|.+|
T Consensus 178 ~v~e~I~G~~l 188 (458)
T 2qg7_A 178 RIEEFMDGYAL 188 (458)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEeeCCccC
Confidence 49999987544
|
| >2yt6_A Adult MALE urinary bladder cDNA, riken FULL- length enriched library, clone:9530076O17...; SH3_1 domain; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=93.66 E-value=0.0043 Score=57.86 Aligned_cols=39 Identities=10% Similarity=0.014 Sum_probs=34.2
Q ss_pred ccccccCCCCchh-hhccccccccccCCCChhHHHHcCCc
Q 037285 670 SVNMENHEPKRWS-YFRNLAQVDFGQKDVSLIDQEHLGLS 708 (1094)
Q Consensus 670 s~~~~~~~~~~~~-~~~~Le~~~Wy~~~IsR~~AE~ll~a 708 (1094)
.+++.+..|.++. .+.+++.++||+++|+|.+||++|++
T Consensus 69 ~~g~~G~~P~~yv~~~~~~~~~~w~~g~isR~~Ae~lL~~ 108 (109)
T 2yt6_A 69 ATGKSGYIPSNYVVPADSIQAEEWYFGKMGRKDAESGPSS 108 (109)
T ss_dssp SSCCEEEECTTTEEESSSCTTTHHHHHCCCSCCCCCCSCC
T ss_pred CCCCEEEechHHcEECCcccccccccCCcCHHHHHHHhhC
Confidence 3567888999998 57789999999999999999999976
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.49 E-value=0.23 Score=57.20 Aligned_cols=29 Identities=31% Similarity=0.421 Sum_probs=25.3
Q ss_pred CceeccCCCCceEeccCCCCCCcEEEEecCCccc
Q 037285 936 NIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI 969 (1094)
Q Consensus 936 GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl 969 (1094)
.++|+|+.+.||+ + ..+.+.|+||..+..
T Consensus 263 ~~~H~D~~~~N~l-~----~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 263 VFAHNDLQENNLL-Q----TQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEECSCCCGGGEE-E----CSSCEEECCCTTCEE
T ss_pred eEECCCCCcccee-c----CCCcEEEEecccCCc
Confidence 3899999999999 5 577899999999873
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=92.05 E-value=0.35 Score=53.18 Aligned_cols=32 Identities=19% Similarity=0.264 Sum_probs=27.0
Q ss_pred CCceeccCCCCceEeccCCCCCCcEEEEecCCcccc
Q 037285 935 KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK 970 (1094)
Q Consensus 935 ~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~ 970 (1094)
..++|+|+.+.||+++ .++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~----~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVG----NEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEEC----GGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEe----CCCeEEEEECCCCeeC
Confidence 3599999999999998 4567999999987743
|
| >2bkf_A Zinc-finger protein NBR1 (NEXT to breast cancer 1; PB1 domain, interaction domain, Z finger; 1.56A {Homo sapiens} SCOP: d.15.2.2 PDB: 2g4s_A | Back alignment and structure |
|---|
Probab=89.89 E-value=1.5 Score=40.59 Aligned_cols=69 Identities=12% Similarity=0.274 Sum_probs=53.8
Q ss_pred cCceEEEEe--cCCCChHHHHHHHHHHcC-CceEEEEeCCCCCCCceeeccChhhHHHHHHHHhhcCCCCCCCeEEEEEe
Q 037285 109 GGETRIIRI--RKDISWQILRQKALEVYN-QVHVIKYQLPGEDLDALVSVSCDEDLQNMMEEYNELGDREGSQRIRMFLF 185 (1094)
Q Consensus 109 GG~triv~v--~r~~~~~~l~~kl~~~~~-~~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~r~R~FlF 185 (1094)
.|+++.+-| .|.++|.+|.+.+...|| ..+.|||- .+=+-.|+|+++++++.++.-+.. ....|++++|
T Consensus 14 ~ge~~rf~vs~~~~~tweel~~mvk~~f~L~~~~ikY~---DEenD~v~i~Sq~E~eEAlkva~k-----~~n~L~m~v~ 85 (87)
T 2bkf_A 14 KNEIQSFLVSDPENTTWADIEAMVKVSFDLNTIQIKYL---DEENEEVSINSQGEYEEALKMAVK-----QGNQLQMQVH 85 (87)
T ss_dssp TTEEEEEEESCGGGCCHHHHHHHHHHHHTCSSEEEEEE---CTTSCEEEECSHHHHHHHHHHHHH-----TTTEEEEEEE
T ss_pred cCCeeEEEeccCCCCCHHHHHHHHHHHcCCCceEEEEE---cCCCCEEEEecHHHHHHHHHHhcc-----CCCEEEEEEe
Confidence 456777444 679999999999999999 78889998 555679999999999888775432 2346888776
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.86 E-value=0.64 Score=52.34 Aligned_cols=33 Identities=21% Similarity=0.217 Sum_probs=26.2
Q ss_pred ceeccCCCCceEeccC--CCCCCcEEEEecCCccc
Q 037285 937 IVHFDLKCDNLLVNLK--DPSRPICKVGDFGLSKI 969 (1094)
Q Consensus 937 IIHRDLKPeNILLD~~--~~e~g~VKLsDFGLSrl 969 (1094)
++|+|+.+.|||+... +.+...++|+||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999521 12467899999999873
|
| >1wmh_B Partitioning defective-6 homolog alpha; kinase, PB1 domain, OPCA motif, APKC, cell polarity, transferase/cell cycle complex; 1.50A {Homo sapiens} SCOP: d.15.2.2 | Back alignment and structure |
|---|
Probab=89.01 E-value=1.5 Score=40.45 Aligned_cols=67 Identities=13% Similarity=0.218 Sum_probs=51.5
Q ss_pred eecCceEEEEecCC--CChHHHHHHHHHHcC---CceEEEEeCCCCCCCceeeccChhhHHHHHHHHhhcCCCCCCCeEE
Q 037285 107 YVGGETRIIRIRKD--ISWQILRQKALEVYN---QVHVIKYQLPGEDLDALVSVSCDEDLQNMMEEYNELGDREGSQRIR 181 (1094)
Q Consensus 107 YvGG~triv~v~r~--~~~~~l~~kl~~~~~---~~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~r~R 181 (1094)
.-|+|.|=.+++|+ .+|.+|..++..+.. .++.|+|.= +| ..||.++|||+|..-+. ... .-||
T Consensus 12 kf~aE~RRFs~d~~~~~~fe~f~~lv~~lh~L~~~~f~i~Y~D--~d-GDLlpInnDdnl~~Al~-------~a~-plLR 80 (86)
T 1wmh_B 12 KFDAEFRRFALPRASVSGFQEFSRLLRAVHQIPGLDVLLGYTD--AH-GDLLPLTNDDSLHRALA-------SGP-PPLR 80 (86)
T ss_dssp EETTEEEEEEEEGGGCCCHHHHHHHHHHHTTCTTCCCEEEEEC--TT-SCEEECCSHHHHHHHTT-------SSS-SCEE
T ss_pred ecCCeeeEeEccCCCCCCHHHHHHHHHHHcCCCCCCEEEEEEC--CC-CCEeeecCHHHHHHHHH-------hCC-CcEE
Confidence 45889999999987 799999999999875 578999993 33 45999999998764332 222 2788
Q ss_pred EEE
Q 037285 182 MFL 184 (1094)
Q Consensus 182 ~Fl 184 (1094)
+|+
T Consensus 81 l~I 83 (86)
T 1wmh_B 81 LLV 83 (86)
T ss_dssp EEE
T ss_pred EEE
Confidence 886
|
| >1wj6_A KIAA0049 protein, RSGI RUH-024; PB1 domain, protein binding, structural genomics, riken structural genomics/proteomics initiative; NMR {Homo sapiens} SCOP: d.15.2.2 | Back alignment and structure |
|---|
Probab=88.56 E-value=2.8 Score=39.62 Aligned_cols=69 Identities=12% Similarity=0.247 Sum_probs=53.7
Q ss_pred CceEEEE--ecCCCChHHHHHHHHHHcC-CceEEEEeCCCCCCCceeeccChhhHHHHHHHHhhcCCCCCCCeEEEEEec
Q 037285 110 GETRIIR--IRKDISWQILRQKALEVYN-QVHVIKYQLPGEDLDALVSVSCDEDLQNMMEEYNELGDREGSQRIRMFLFS 186 (1094)
Q Consensus 110 G~triv~--v~r~~~~~~l~~kl~~~~~-~~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~r~R~FlF~ 186 (1094)
|+++.+- -.|.++|.+|.+.+...|+ ..+.|||- .+=+-.|+|+++++++.++--+.. ....|++++|-
T Consensus 23 ge~~rF~Vs~~~~~tweel~~mvk~~f~L~~~~IkY~---DEenD~V~i~Sq~E~eEAlkva~k-----~~n~L~m~V~~ 94 (101)
T 1wj6_A 23 NEIQSFLVSDPENTTWADIEAMVKVSFDLNTIQIKYL---DEENEEVSINSQGEYEEALKMAVK-----QGNQLQMQVHE 94 (101)
T ss_dssp TEEEEEEESCTTTSCHHHHHHHHHHHHCCSSBCCEEE---CTTSCEECCCSHHHHHHHHHHHHH-----HTSEEEEECCB
T ss_pred CCeeEEEecCCCCCCHHHHHHHHHHHcCCCceEEEEe---cCCCCEEEEecHHHHHHHHHHhcc-----CCCEEEEEEee
Confidence 3456644 4779999999999999999 77889997 555679999999999888775532 23468998884
|
| >1ip9_A BEM1 protein; ubiquitin alpha/beta roll, signaling protein; NMR {Saccharomyces cerevisiae} SCOP: d.15.2.2 PDB: 1ipg_A 2kfk_A | Back alignment and structure |
|---|
Probab=88.23 E-value=3.1 Score=38.29 Aligned_cols=56 Identities=13% Similarity=0.251 Sum_probs=42.6
Q ss_pred cCceEEEEecCCCChHHHHHHHHHHcC-CceEEEEeCCCCCCCceeeccChhhHHHHHHH
Q 037285 109 GGETRIIRIRKDISWQILRQKALEVYN-QVHVIKYQLPGEDLDALVSVSCDEDLQNMMEE 167 (1094)
Q Consensus 109 GG~triv~v~r~~~~~~l~~kl~~~~~-~~~~lkyqLp~edld~LisV~~deDl~~m~~e 167 (1094)
.++--++.||-+|+|.+|..|+..-.. ..+.+.+-. .|.... .+.+|+||...|..
T Consensus 20 ~DDIiAIrvP~di~~~~L~dKi~~RLk~~~~~l~~yk-de~~g~--~i~sD~dl~~aiqr 76 (85)
T 1ip9_A 20 KDDIFALMLKGDTTYKELRSKIAPRIDTDNFKLQTKL-FDGSGE--EIKTDSQVSNIIQA 76 (85)
T ss_dssp TTCCEEEEECSCCCHHHHHHHHHHHHTSSCEEEEECC-SSSCCS--CCCSHHHHHHHHHT
T ss_pred cCcEEEEECCCCCCHHHHHHHHHHHhcccceEEEEec-CCCCCC--cccCHHHHHHHHHh
Confidence 345568999999999999999998665 344433333 666666 99999999998864
|
| >1oey_J P40-PHOX, neutrophil cytosol factor 4; immune system, PB1 heterodimer/complex, NADPH oxidase, PB1 D heterodimerization; 2.0A {Homo sapiens} SCOP: d.15.2.2 | Back alignment and structure |
|---|
Probab=82.67 E-value=3.5 Score=39.15 Aligned_cols=57 Identities=19% Similarity=0.248 Sum_probs=47.5
Q ss_pred cCceEEEEecCCC----ChHHHHHHHHHHcC-CceEEEEeCCCCCCCceeeccChhhHHHHHHHH
Q 037285 109 GGETRIIRIRKDI----SWQILRQKALEVYN-QVHVIKYQLPGEDLDALVSVSCDEDLQNMMEEY 168 (1094)
Q Consensus 109 GG~triv~v~r~~----~~~~l~~kl~~~~~-~~~~lkyqLp~edld~LisV~~deDl~~m~~ey 168 (1094)
|-.+|=|+|.-++ +|.||...+...+. .+++|+|+=+..| ||-+-+|||+..|+.+-
T Consensus 17 ~~~irdI~veedl~~~P~ykdLl~lmr~~F~~~DIaLNYrD~eGD---LIrilddeDv~lmi~~s 78 (107)
T 1oey_J 17 ISTIKDIAVEEDLSSTPLLKDLLELTRREFQREDIALNYRDAEGD---LVRLLSDEDVALMVRQA 78 (107)
T ss_dssp EEEEEEEEECSCTTCCCCHHHHHHHHHHHHCCSSEEEEEECTTSC---EEECCSHHHHHHHHHHC
T ss_pred CceeeeEEEccccccCCCHHHHHHHHHHHhcccceeeeeecCCCC---EEEEcchHHHHHHHHHh
Confidence 5567888887765 59999999999887 6899999955444 79999999999999987
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1094 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-72 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-67 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 9e-67 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-65 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-65 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-64 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-64 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-64 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-64 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-63 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-63 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-63 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-62 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-61 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-61 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-61 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-60 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-60 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-60 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-59 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-59 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-58 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-57 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-57 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-57 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-56 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-56 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-56 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-56 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-56 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-56 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-56 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-55 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-55 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-53 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-53 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-53 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-52 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-50 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-49 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-48 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-48 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-48 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-47 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-47 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-46 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-44 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-44 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-42 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-42 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-42 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-39 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-37 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-33 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-17 | |
| d1ip9a_ | 85 | d.15.2.2 (A:) Bud emergence mediator Bemp1 {Baker' | 7e-05 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (607), Expect = 8e-72
Identities = 88/281 (31%), Positives = 143/281 (50%), Gaps = 22/281 (7%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEI 866
I + + + +GSG+FGTVY GKW G DVA+K + + T + + F E +
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQ------AFKNEVGV 57
Query: 867 LSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAA 926
L K H N++ F G LA V ++ SL H L + + + + IA A
Sbjct: 58 LRKTRHVNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTA 114
Query: 927 FGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK---RNTLVSGGVRGTL 983
GM+YLH+K+I+H DLK +N+ ++ K+GDFGL+ +K + + G++
Sbjct: 115 QGMDYLHAKSIIHRDLKSNNIFLH----EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 170
Query: 984 PWMAPELLSG-SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR--- 1039
WMAPE++ + S + DV++FGIVL+E++TG+ PY+N++ I +V
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 230
Query: 1040 -PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079
+ S C + LM EC RP F +I + + +L+
Sbjct: 231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (576), Expect = 1e-67
Identities = 92/276 (33%), Positives = 134/276 (48%), Gaps = 22/276 (7%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEI 866
+ ++L+ + +G G FG V G +RG VA+K IK + F EA +
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN----------DATAQAFLAEASV 53
Query: 867 LSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDR-FLDRRRRLIIAMDA 925
+++L H N+V GV+ + GG L V EYM GSL L + R L L ++D
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 112
Query: 926 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPW 985
MEYL N VH DL N+LV+ + KV DFGL+K +T +G + + W
Sbjct: 113 CEAMEYLEGNNFVHRDLAARNVLVS----EDNVAKVSDFGLTKEASSTQDTG--KLPVKW 166
Query: 986 MAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPS 1044
APE L K S K DV+SFGI+LWEI + G PY + ++ + + P
Sbjct: 167 TAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPD 223
Query: 1045 YCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLST 1080
C +M+ CW + A RPSF ++ +L + T
Sbjct: 224 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (569), Expect = 9e-67
Identities = 93/274 (33%), Positives = 129/274 (47%), Gaps = 22/274 (8%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAE 865
I +DL KELG+G FG V +GKWR DVAIK IK+ S E EF +EA+
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG------SMSED---EFIEEAK 51
Query: 866 ILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDA 925
++ L H +V YGV + + EYM +G L + L ++ L + D
Sbjct: 52 VMMNLSHEKLVQLYGVCTKQ--RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 109
Query: 926 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI--KRNTLVSGGVRGTL 983
MEYL SK +H DL N LVN + + KV DFGLS+ S G + +
Sbjct: 110 CEAMEYLESKQFLHRDLAARNCLVN----DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV 165
Query: 984 PWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTI 1042
W PE+L S K S K D+++FG+++WEI + G+ PY I LR
Sbjct: 166 RWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-LRLYR 222
Query: 1043 PSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076
P + T+M CW RP+F + S +
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 4e-65
Identities = 92/294 (31%), Positives = 134/294 (45%), Gaps = 28/294 (9%)
Query: 806 VIKNEDLE-EQKELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTVEF 860
+K ++L ELG G FG+V G +R DVAIK +K+ ++ T E
Sbjct: 4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-------TEKADTEEM 56
Query: 861 WKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLI 920
+EA+I+ +L +P +V GV Q L V E G L LV K +
Sbjct: 57 MREAQIMHQLDNPYIVRLIGVCQAEA---LMLVMEMAGGGPLHKFLVGKREEIPVSNVAE 113
Query: 921 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI----KRNTLVS 976
+ + GM+YL KN VH DL N+L+ +R K+ DFGLSK
Sbjct: 114 LLHQVSMGMKYLEEKNFVHRDLAARNVLLV----NRHYAKISDFGLSKALGADDSYYTAR 169
Query: 977 GGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 1035
+ L W APE ++ K S + DV+S+G+ +WE L+ G++PY M ++ I
Sbjct: 170 SAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 227
Query: 1036 NTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR-VLSTAASQTKGH 1088
R P C E LM +CW RP F + R+R + AS+ +GH
Sbjct: 228 G-KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 280
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (558), Expect = 4e-65
Identities = 79/267 (29%), Positives = 128/267 (47%), Gaps = 21/267 (7%)
Query: 812 LEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSK 869
L+ E+G G+F TVY G T VA ++ T ++ F +EAE+L
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR------FKEEAEMLKG 64
Query: 870 LHHPNVVAFYGVVQDGP--GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
L HPN+V FY + + V E M G+L+ L ++ + + +
Sbjct: 65 LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILK 123
Query: 928 GMEYLHSKN--IVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPW 985
G+++LH++ I+H DLKCDN+ + S K+GD GL+ +KR + + V GT +
Sbjct: 124 GLQFLHTRTPPIIHRDLKCDNIFITGPTGS---VKIGDLGLATLKRASF-AKAVIGTPEF 179
Query: 986 MAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP-TIPS 1044
MAPE+ K E VDV++FG+ + E+ T E PY+ A I V + ++P +
Sbjct: 180 MAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK 236
Query: 1045 YCDAEWRTLMEECWAPNPAARPSFTEI 1071
E + ++E C N R S ++
Sbjct: 237 VAIPEVKEIIEGCIRQNKDERYSIKDL 263
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 219 bits (559), Expect = 1e-64
Identities = 74/274 (27%), Positives = 117/274 (42%), Gaps = 22/274 (8%)
Query: 805 QVIKNEDLEEQ----KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTV 858
++ +D E+ +E+G G+FG VY + VAIK++ S Q+
Sbjct: 6 ELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD---- 61
Query: 859 EFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRR 918
KE L KL HPN + + G T V EY + + + V K + L
Sbjct: 62 -IIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWLVMEYCLGSASDLLEVHK-KPLQEVEI 117
Query: 919 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGG 978
+ A G+ YLHS N++H D+K N+L++ + K+GDFG + I
Sbjct: 118 AAVTHGALQGLAYLHSHNMIHRDVKAGNILLS----EPGLVKLGDFGSASIMAPA---NS 170
Query: 979 VRGTLPWMAPELLSGSS-SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 1037
GT WMAPE++ + KVDV+S GI E+ + P NM+ + + I N
Sbjct: 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 230
Query: 1038 LRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
+ +R ++ C P RP+ +
Sbjct: 231 SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (555), Expect = 1e-64
Identities = 82/281 (29%), Positives = 123/281 (43%), Gaps = 24/281 (8%)
Query: 806 VIKNEDLEEQKELGSGTFGTVYHGKWRGTD-----VAIKRIKKSCFTGRSSEQERLTVEF 860
+I +DL ++LG G+FG V G+W VA+K +K + + +F
Sbjct: 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-----DF 58
Query: 861 WKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLI 920
+E + L H N++ YGVV P + V E GSL L +
Sbjct: 59 IREVNAMHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSR 115
Query: 921 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI----KRNTLVS 976
A+ A GM YL SK +H DL NLL+ +D + K+GDFGL + + ++
Sbjct: 116 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRD----LVKIGDFGLMRALPQNDDHYVMQ 171
Query: 977 GGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 1035
+ W APE L S D + FG+ LWE+ T G+EP+ ++ I+ I
Sbjct: 172 EHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229
Query: 1036 NTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076
R P C + +M +CWA P RP+F + L
Sbjct: 230 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 2e-64
Identities = 82/279 (29%), Positives = 124/279 (44%), Gaps = 22/279 (7%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAE 865
+ E L+ + LG+G FG V+ G + T VA+K +K+ + F EA
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---------AFLAEAN 60
Query: 866 ILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRF-LDRRRRLIIAMD 924
++ +L H +V Y VV P + + EYM +GSL L L + L +A
Sbjct: 61 LMKQLQHQRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI--KRNTLVSGGVRGT 982
A GM ++ +N +H DL+ N+LV+ CK+ DFGL+++ G +
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVS----DTLSCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 983 LPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTI 1042
+ W APE ++ + K DV+SFGI+L EI+T + + R
Sbjct: 174 IKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 231
Query: 1043 PSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081
P C E LM CW P RP+F + S L TA
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 8e-64
Identities = 78/274 (28%), Positives = 123/274 (44%), Gaps = 20/274 (7%)
Query: 806 VIKNEDLEEQKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEA 864
VI +L +E+GSG FG V+ G W VAIK I++ + +F +EA
Sbjct: 1 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---------DFIEEA 51
Query: 865 EILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMD 924
E++ KL HP +V YGV + + V E+M G L L + L + +D
Sbjct: 52 EVMMKLSHPKLVQLYGVCLEQ--APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 109
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI--KRNTLVSGGVRGT 982
GM YL ++H DL N LV + KV DFG+++ S G +
Sbjct: 110 VCEGMAYLEEACVIHRDLAARNCLVG----ENQVIKVSDFGMTRFVLDDQYTSSTGTKFP 165
Query: 983 LPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTI 1042
+ W +PE+ S S + S K DV+SFG+++WE+ + + + + ++ R
Sbjct: 166 VKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 223
Query: 1043 PSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076
P +M CW P RP+F+ + +L
Sbjct: 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 5e-63
Identities = 64/273 (23%), Positives = 113/273 (41%), Gaps = 24/273 (8%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
ED E +G+G++G + + + K + T + E +L
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQM------LVSEVNLL 57
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDR---FLDRRRRLIIAMD 924
+L HPN+V +Y + D TL V EY G L V+ + + +LD L +
Sbjct: 58 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 117
Query: 925 AAFGMEYLHSKN-----IVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-IKRNTLVSGG 978
++ H ++ ++H DLK N+ ++ + K+GDFGL++ + +T +
Sbjct: 118 LTLALKECHRRSDGGHTVLHRDLKPANVFLD----GKQNVKLGDFGLARILNHDTSFAKA 173
Query: 979 VRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 1038
GT +M+PE ++ +EK D++S G +L+E+ P+ + G I
Sbjct: 174 FVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK- 230
Query: 1039 RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
IP E ++ RPS EI
Sbjct: 231 FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 263
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 5e-63
Identities = 76/264 (28%), Positives = 125/264 (47%), Gaps = 19/264 (7%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
ED E + LG G FG VY + + + +A+K + K+ E+ + + +E EI
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-----QLEKAGVEHQLRREVEIQ 60
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
S L HPN++ YG D + + EY G++ L + +F ++R I + A
Sbjct: 61 SHLRHPNILRLYGYFHDA--TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELAN 117
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMA 987
+ Y HSK ++H D+K +NLL+ S K+ DFG S ++ + GTL ++
Sbjct: 118 ALSYCHSKRVIHRDIKPENLLLG----SAGELKIADFGWSVHAPSSR-RTTLCGTLDYLP 172
Query: 988 PELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCD 1047
PE++ G EKVD++S G++ +E L G+ P+ Y I + T P +
Sbjct: 173 PEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVT 228
Query: 1048 AEWRTLMEECWAPNPAARPSFTEI 1071
R L+ NP+ RP E+
Sbjct: 229 EGARDLISRLLKHNPSQRPMLREV 252
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 7e-63
Identities = 72/278 (25%), Positives = 120/278 (43%), Gaps = 25/278 (8%)
Query: 805 QVIKNEDLEEQ----KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTV 858
V ++ + E+ ELG G FG VY + + T A K I SE+E
Sbjct: 3 HVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK------SEEEL--E 54
Query: 859 EFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRR 918
++ E +IL+ HPN+V L + E+ G++ V++ +R L +
Sbjct: 55 DYMVEIDILASCDHPNIVKLLDAFYYE--NNLWILIEFCAGGAVDAVMLELERPLTESQI 112
Query: 919 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-IKRNTLVSG 977
++ + YLH I+H DLK N+L K+ DFG+S R
Sbjct: 113 QVVCKQTLDALNYLHDNKIIHRDLKAGNILFT----LDGDIKLADFGVSAKNTRTIQRRD 168
Query: 978 GVRGTLPWMAPELLSGSSSK---VSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV 1034
GT WMAPE++ +SK K DV+S GI L E+ E P+ ++ ++ I
Sbjct: 169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA 228
Query: 1035 NN-TLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
+ PS + ++ +++C N AR + +++
Sbjct: 229 KSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 1e-62
Identities = 79/272 (29%), Positives = 120/272 (44%), Gaps = 26/272 (9%)
Query: 814 EQKELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSK 869
E KELGSG FGTV G ++ VA+K +K + L E EA ++ +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE------ANDPALKDELLAEANVMQQ 64
Query: 870 LHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGM 929
L +P +V G+ + V E G L L + + + + + + GM
Sbjct: 65 LDNPYIVRMIGICEAES---WMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGM 120
Query: 930 EYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI----KRNTLVSGGVRGTLPW 985
+YL N VH DL N+L+ ++ K+ DFGLSK + + + W
Sbjct: 121 KYLEESNFVHRDLAARNVLLV----TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 176
Query: 986 MAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPS 1044
APE ++ K S K DV+SFG+++WE + G++PY M + + R P+
Sbjct: 177 YAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMGCPA 233
Query: 1045 YCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076
C E LM CW + RP F + RLR
Sbjct: 234 GCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 3e-61
Identities = 91/311 (29%), Positives = 141/311 (45%), Gaps = 27/311 (8%)
Query: 786 NIGLPSLNPSLVDFDVSSVQVIKNEDLEEQKELGSGTFGTVYHGKWRGTD-----VAIKR 840
+I L +LNP LV V + + + +G G FG VYHG D A+K
Sbjct: 3 HIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 62
Query: 841 IKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDG 900
+ + G S+ F E I+ HPNV++ G+ G + V YM G
Sbjct: 63 LNRITDIGEVSQ-------FLTEGIIMKDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHG 114
Query: 901 SLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICK 960
LR+ + + + + + A GM++L SK VH DL N +++ + K
Sbjct: 115 DLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD----EKFTVK 170
Query: 961 VGDFGLSKIKRN-----TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEIL 1015
V DFGL++ + G + + WMA E L K + K DV+SFG++LWE++
Sbjct: 171 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELM 228
Query: 1016 T-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074
T G PY +++ I ++ R P YC +M +CW P RPSF+E+ SR
Sbjct: 229 TRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
Query: 1075 L-RVLSTAASQ 1084
+ + ST +
Sbjct: 288 ISAIFSTFIGE 298
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 6e-61
Identities = 83/278 (29%), Positives = 134/278 (48%), Gaps = 25/278 (8%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTD-----VAIKRIKKSCFTGRSSEQERLTVEFW 861
I+ E +E + +G G FG V+ G + + VAIK K + + +F
Sbjct: 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-------TSDSVREKFL 56
Query: 862 KEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLII 921
+EA + + HP++V GV+ + P + + E G LR L + LD ++
Sbjct: 57 QEALTMRQFDHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILY 113
Query: 922 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI--KRNTLVSGGV 979
A + + YL SK VH D+ N+LV+ S K+GDFGLS+ +
Sbjct: 114 AYQLSTALAYLESKRFVHRDIAARNVLVS----SNDCVKLGDFGLSRYMEDSTYYKASKG 169
Query: 980 RGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 1038
+ + WMAPE ++ + + DV+ FG+ +WEIL G +P+ + +IG I N
Sbjct: 170 KLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE- 226
Query: 1039 RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076
R +P C +LM +CWA +P+ RP FTE+ ++L
Sbjct: 227 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 7e-61
Identities = 90/303 (29%), Positives = 128/303 (42%), Gaps = 49/303 (16%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTVE 859
E+LE K LGSG FG V + G VA+K +K+ ++ ER
Sbjct: 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE-----KADSSER--EA 86
Query: 860 FWKEAEILSKL-HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDR------- 911
E +++++L H N+V G G + + EY G L + L K
Sbjct: 87 LMSELKMMTQLGSHENIVNLLGACTLS--GPIYLIFEYCCYGDLLNYLRSKREKFSEDEI 144
Query: 912 ---------------FLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSR 956
L L A A GME+L K+ VH DL N+LV
Sbjct: 145 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT----HG 200
Query: 957 PICKVGDFGLSKI---KRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWE 1013
+ K+ DFGL++ N +V G R + WMAPE L + K DV+S+GI+LWE
Sbjct: 201 KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG--IYTIKSDVWSYGILLWE 258
Query: 1014 ILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIA 1072
I + G PY + A ++ N + P Y E +M+ CWA + RPSF +
Sbjct: 259 IFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318
Query: 1073 SRL 1075
S L
Sbjct: 319 SFL 321
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 2e-60
Identities = 94/290 (32%), Positives = 137/290 (47%), Gaps = 25/290 (8%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTD------VAIKRIKKSCFTGRSSEQERLTVEF 860
I + QK +G+G FG VY G + + VAIK +K +E++R V+F
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-----YTEKQR--VDF 56
Query: 861 WKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLI 920
EA I+ + H N++ GV+ + + EYM +G+L L KD + +
Sbjct: 57 LGEAGIMGQFSHHNIIRLEGVISKYKPMMI--ITEYMENGALDKFLREKDGEFSVLQLVG 114
Query: 921 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI----KRNTLVS 976
+ A GM+YL + N VH DL N+LVN S +CKV DFGLS++ T +
Sbjct: 115 MLRGIAAGMKYLANMNYVHRDLAARNILVN----SNLVCKVSDFGLSRVLEDDPEATYTT 170
Query: 977 GGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN 1036
G + + W APE +S K + DV+SFGIV+WE++T E + +N+
Sbjct: 171 SGGKIPIRWTAPEAISYR--KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND 228
Query: 1037 TLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQTK 1086
R P C + LM +CW A RP F +I S L L A K
Sbjct: 229 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLK 278
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 206 bits (525), Expect = 2e-60
Identities = 89/293 (30%), Positives = 135/293 (46%), Gaps = 25/293 (8%)
Query: 791 SLNPSLVDFDVSSVQVIKNEDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTG 848
+++PS ++D ++ D+ + +LG G +G VY G W+ VA+K +K+
Sbjct: 1 AMDPSSPNYDKWE---MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV 57
Query: 849 RSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVR 908
EF KEA ++ ++ HPN+V GV P + T E+M G+L L
Sbjct: 58 E---------EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT--EFMTYGNLLDYLRE 106
Query: 909 KDRF-LDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967
+R + L +A + MEYL KN +H DL N LV + KV DFGLS
Sbjct: 107 CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG----ENHLVKVADFGLS 162
Query: 968 KIKRN--TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH 1025
++ G + + W APE L+ + K S K DV++FG++LWEI T
Sbjct: 163 RLMTGDTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGI 220
Query: 1026 YGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078
+ + ++ R P C + LM CW NP+ RPSF EI +
Sbjct: 221 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 2e-60
Identities = 73/282 (25%), Positives = 128/282 (45%), Gaps = 27/282 (9%)
Query: 804 VQVIKNEDLEEQKELGSGTFGTVYHGKWRGTD------VAIKRIKKSCFTGRSSEQERLT 857
++++K + ++ K LGSG FGTVY G W VAIK ++++ +
Sbjct: 3 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-------TSPKAN 55
Query: 858 VEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRR 917
E EA +++ + +P+V G+ T+ + + M G L + + +
Sbjct: 56 KEILDEAYVMASVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQY 112
Query: 918 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI---KRNTL 974
L + A GM YL + +VH DL N+LV + K+ DFGL+K+ +
Sbjct: 113 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK----TPQHVKITDFGLAKLLGAEEKEY 168
Query: 975 VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGI 1033
+ G + + WMA E + + + DV+S+G+ +WE++T G +PY + I I
Sbjct: 169 HAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-I 225
Query: 1034 VNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
+ R P C + +M +CW + +RP F E+
Sbjct: 226 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 5e-60
Identities = 85/273 (31%), Positives = 122/273 (44%), Gaps = 22/273 (8%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTD-VAIKRIKKSCFTGRSSEQERLTVEFWKEAE 865
I E L + +LG G FG V+ G W GT VAIK +K + F +EA+
Sbjct: 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---------AFLQEAQ 64
Query: 866 ILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSL-RHVLVRKDRFLDRRRRLIIAMD 924
++ KL H +V Y VV + P + V EYM GSL + ++L + + +A
Sbjct: 65 VMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 121
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI--KRNTLVSGGVRGT 982
A GM Y+ N VH DL+ N+LV +CKV DFGL+++ G +
Sbjct: 122 IASGMAYVERMNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEYTARQGAKFP 177
Query: 983 LPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTI 1042
+ W APE + + K DV+SFGI+L E+ T + V R
Sbjct: 178 IKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 235
Query: 1043 PSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
P C LM +CW P RP+F + + L
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 202 bits (515), Expect = 6e-59
Identities = 85/319 (26%), Positives = 131/319 (41%), Gaps = 56/319 (17%)
Query: 792 LNPSLVDFDVSSVQVIKNEDLEEQKELGSGTFGTVYHGKWR-------GTDVAIKRIKKS 844
LNP L+ + ++E +++G G FG V+ + T VA+K +K+
Sbjct: 1 LNPKLLSLEYPR------NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE 54
Query: 845 CFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRH 904
+ +F +EA ++++ +PN+V GV G + + EYM G L
Sbjct: 55 -------ASADMQADFQREAALMAEFDNPNIVKLLGVCAVG--KPMCLLFEYMAYGDLNE 105
Query: 905 VLVRKDRF-----------------------LDRRRRLIIAMDAAFGMEYLHSKNIVHFD 941
L L +L IA A GM YL + VH D
Sbjct: 106 FLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165
Query: 942 LKCDNLLVNLKDPSRPICKVGDFGLSKI---KRNTLVSGGVRGTLPWMAPELLSGSSSKV 998
L N LV + K+ DFGLS+ G + WM PE + + +
Sbjct: 166 LATRNCLVG----ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN--RY 219
Query: 999 SEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEEC 1057
+ + DV+++G+VLWEI + G +PY M + +I + + P C E LM C
Sbjct: 220 TTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN-ILACPENCPLELYNLMRLC 278
Query: 1058 WAPNPAARPSFTEIASRLR 1076
W+ PA RPSF I L+
Sbjct: 279 WSKLPADRPSFCSIHRILQ 297
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 202 bits (514), Expect = 7e-59
Identities = 88/282 (31%), Positives = 134/282 (47%), Gaps = 28/282 (9%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTD-----VAIKRIKKSCFTGRSSEQERLTVEFW 861
I ++ ++ +G+G FG V G + VAIK +K +E++R +F
Sbjct: 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-----YTEKQR--RDFL 75
Query: 862 KEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLII 921
EA I+ + HPNV+ GVV + + E+M +GSL L + D + + +
Sbjct: 76 SEASIMGQFDHPNVIHLEGVVTKS--TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGM 133
Query: 922 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI------KRNTLV 975
A GM+YL N VH DL N+LVN S +CKV DFGLS+
Sbjct: 134 LRGIAAGMKYLADMNYVHRDLAARNILVN----SNLVCKVSDFGLSRFLEDDTSDPTYTS 189
Query: 976 SGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIV 1034
+ G + + W APE + K + DV+S+GIV+WE+++ GE PY +M +I I
Sbjct: 190 ALGGKIPIRWTAPEAIQYR--KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE 247
Query: 1035 NNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076
+ R P C + LM +CW + RP F +I + L
Sbjct: 248 QD-YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 1e-58
Identities = 91/296 (30%), Positives = 131/296 (44%), Gaps = 37/296 (12%)
Query: 802 SSVQVIKNEDLEEQKELGSGTFGTVYHGKWRGT----DVAIKRIKKSCFTGRSSEQERLT 857
+ V+ D++ Q +G G FG V + + D AIKR+K+ S + R
Sbjct: 2 TIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----ASKDDHR-- 55
Query: 858 VEFWKEAEILSKL-HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRF---- 912
+F E E+L KL HHPN++ G + G L EY G+L L +
Sbjct: 56 -DFAGELEVLCKLGHHPNIINLLGACE--HRGYLYLAIEYAPHGNLLDFLRKSRVLETDP 112
Query: 913 -----------LDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKV 961
L ++ L A D A GM+YL K +H DL N+LV + K+
Sbjct: 113 AFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG----ENYVAKI 168
Query: 962 GDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEP 1020
DFGLS+ + + R + WMA E L+ S + DV+S+G++LWEI++ G P
Sbjct: 169 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTP 226
Query: 1021 YANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076
Y M + + R P CD E LM +CW P RPSF +I L
Sbjct: 227 YCGMTCAELYEKLPQG-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 2e-57
Identities = 73/310 (23%), Positives = 127/310 (40%), Gaps = 62/310 (20%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEA 864
+K++D E+ ELG+G G V+ + + +A K I + + + +E
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-------IKPAIRNQIIREL 55
Query: 865 EILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMD 924
++L + + P +V FYG G ++ E+M GSL VL + R + + +++
Sbjct: 56 QVLHECNSPYIVGFYGAFYSD--GEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIA 112
Query: 925 AAFGMEYLHSKN-IVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTL 983
G+ YL K+ I+H D+K N+LVN SR K+ DFG+S +++ + V GT
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLCDFGVSGQLIDSMANSFV-GTR 167
Query: 984 PWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPY---------------------- 1021
+M+PE L G+ S + D++S G+ L E+ G P
Sbjct: 168 SYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225
Query: 1022 --------------------ANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPN 1061
M ++ IVN E++ + +C N
Sbjct: 226 TPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 285
Query: 1062 PAARPSFTEI 1071
PA R ++
Sbjct: 286 PAERADLKQL 295
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 2e-57
Identities = 68/267 (25%), Positives = 113/267 (42%), Gaps = 22/267 (8%)
Query: 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEI 866
+ +++G G GTVY G +VAI+++ + ++E E +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ----QQPKKEL----IINEILV 70
Query: 867 LSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAA 926
+ + +PN+V + G L V EY+ GSL V+ + + +
Sbjct: 71 MRENKNPNIVNYLDSYLVG--DELWVVMEYLAGGSLTDVVTETCMDEGQIAA--VCRECL 126
Query: 927 FGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-IKRNTLVSGGVRGTLPW 985
+E+LHS ++H D+K DN+L+ K+ DFG I + GT W
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLG----MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 986 MAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN-TLRPTIPS 1044
MAPE+++ KVD++S GI+ E++ GE PY N + + I N T P
Sbjct: 183 MAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE 240
Query: 1045 YCDAEWRTLMEECWAPNPAARPSFTEI 1071
A +R + C + R S E+
Sbjct: 241 KLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 9e-57
Identities = 82/295 (27%), Positives = 117/295 (39%), Gaps = 38/295 (12%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTVE 859
L K LG+G FG V VA+K +K S + ER
Sbjct: 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-----AHLTER--EA 72
Query: 860 FWKEAEILSKL-HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRK--------- 909
E ++LS L +H N+V G G G + EY G L + L RK
Sbjct: 73 LMSELKVLSYLGNHMNIVNLLGACTIG--GPTLVITEYCCYGDLLNFLRRKRDSFICSKT 130
Query: 910 --------DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKV 961
+ LD L + A GM +L SKN +H DL N+L+ IC
Sbjct: 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT-HGRITKICDF 189
Query: 962 GDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEP- 1020
G K N +V G R + WMAPE + + + DV+S+GI LWE+ +
Sbjct: 190 GLARDIKNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFSLGSSP 247
Query: 1021 YANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075
Y M + ++ R P + AE +M+ CW +P RP+F +I +
Sbjct: 248 YPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 1e-56
Identities = 65/274 (23%), Positives = 121/274 (44%), Gaps = 15/274 (5%)
Query: 806 VIKNEDLEE----QKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVE 859
V + E++++ +ELGSG F V + + T A K IKK SS + +
Sbjct: 2 VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTK--SSRRGVSRED 59
Query: 860 FWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRL 919
+E IL ++ HPNV+ + V ++ + + E + G L L K+ +
Sbjct: 60 IEREVSILKEIQHPNVITLHEVYENK--TDVILILELVAGGELFDFLAEKESLTEEEATE 117
Query: 920 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGV 979
+ G+ YLHS I HFDLK +N+++ ++ +P K+ DFGL+ +
Sbjct: 118 FLKQ-ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 176
Query: 980 RGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI--VNNT 1037
GT ++APE+++ + + D++S G++ + +L+G P+ + + VN
Sbjct: 177 FGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 234
Query: 1038 LRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
S A + + +P R + +
Sbjct: 235 FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 2e-56
Identities = 68/278 (24%), Positives = 120/278 (43%), Gaps = 21/278 (7%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEA 864
+ ED + K LG G+F TV + T AIK ++K R +E +E
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEK-----RHIIKENKVPYVTRER 59
Query: 865 EILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMD 924
+++S+L HP V Y QD L Y +G L + + F + R A +
Sbjct: 60 DVMSRLDHPFFVKLYFTFQDD--EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-E 116
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI---KRNTLVSGGVRG 981
+EYLH K I+H DLK +N+L+N ++ DFG +K+ + + G
Sbjct: 117 IVSALEYLHGKGIIHRDLKPENILLN----EDMHIQITDFGTAKVLSPESKQARANSFVG 172
Query: 982 TLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT 1041
T +++PELL+ + D+++ G ++++++ G P+ + I I+ L
Sbjct: 173 TAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK--LEYD 228
Query: 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079
P + R L+E+ + R E+ + +
Sbjct: 229 FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 197 bits (502), Expect = 2e-56
Identities = 53/267 (19%), Positives = 106/267 (39%), Gaps = 18/267 (6%)
Query: 809 NEDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEI 866
+ + +ELGSG FG V+ + T K I ++ E I
Sbjct: 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYT----VKNEISI 79
Query: 867 LSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAA 926
+++LHHP ++ + +D + + E++ G L + +D + + A
Sbjct: 80 MNQLHHPKLINLHDAFEDK--YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQAC 137
Query: 927 FGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWM 986
G++++H +IVH D+K +N++ K S K+ DFGL+ + T +
Sbjct: 138 EGLKHMHEHSIVHLDIKPENIMCETKKASS--VKIIDFGLATKLNPDEIVKVTTATAEFA 195
Query: 987 APELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN--TLRPTIPS 1044
APE++ V D+++ G++ + +L+G P+A + + S
Sbjct: 196 APEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS 253
Query: 1045 YCDAEWRTLMEECWAPNPAARPSFTEI 1071
E + ++ P R + +
Sbjct: 254 SVSPEAKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 2e-56
Identities = 75/268 (27%), Positives = 108/268 (40%), Gaps = 21/268 (7%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
ED + + LG G +G V R T+ VA+K + R+ + KE I
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK----RAVDCPE---NIKKEICIN 57
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
L+H NVV FYG + G EY G + D +
Sbjct: 58 KMLNHENVVKFYGHRR--EGNIQYLFLEYC-SGGELFDRIEPDIGMPEPDAQRFFHQLMA 114
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKR---NTLVSGGVRGTLP 984
G+ YLH I H D+K +NLL++ R K+ DFGL+ + R + + GTLP
Sbjct: 115 GVVYLHGIGITHRDIKPENLLLD----ERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 170
Query: 985 WMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGE-EPYANMHYGAIIGGIVNNTLRPTIP 1043
++APELL +E VDV+S GIVL +L GE
Sbjct: 171 YVAPELLKR-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 229
Query: 1044 SYCDAEWRTLMEECWAPNPAARPSFTEI 1071
D+ L+ + NP+AR + +I
Sbjct: 230 KKIDSAPLALLHKILVENPSARITIPDI 257
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 196 bits (499), Expect = 3e-56
Identities = 56/266 (21%), Positives = 108/266 (40%), Gaps = 18/266 (6%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
+ + +ELG+G FG V+ R T A K + S++E KE + +
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKET----VRKEIQTM 77
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
S L HP +V + +D + + E+M G L + + + +
Sbjct: 78 SVLRHPTLVNLHDAFEDD--NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK 135
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMA 987
G+ ++H N VH DLK +N++ K + K+ DFGL+ GT + A
Sbjct: 136 GLCHMHENNYVHLDLKPENIMFTTKRSNE--LKLIDFGLTAHLDPKQSVKVTTGTAEFAA 193
Query: 988 PELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN--TLRPTIPSY 1045
PE+ G V D++S G++ + +L+G P+ + + + + + + S
Sbjct: 194 PEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG 251
Query: 1046 CDAEWRTLMEECWAPNPAARPSFTEI 1071
+ + + + +P R + +
Sbjct: 252 ISEDGKDFIRKLLLADPNTRMTIHQA 277
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 194 bits (495), Expect = 4e-56
Identities = 71/272 (26%), Positives = 118/272 (43%), Gaps = 21/272 (7%)
Query: 808 KNEDLEE----QKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFW 861
+ ED+ + + LG+G F V + + T VAIK I K G+
Sbjct: 3 QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGS-------ME 55
Query: 862 KEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLII 921
E +L K+ HPN+VA + + G G L + + + G L +V K + +R +I
Sbjct: 56 NEIAVLHKIKHPNIVALDDIYESG--GHLYLIMQLVSGGELFDRIVEKGFYTERDASRLI 113
Query: 922 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRG 981
++YLH IVH DLK +NLL D I + DFGLSK++ V G
Sbjct: 114 F-QVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKI-MISDFGLSKMEDPGSVLSTACG 171
Query: 982 TLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT 1041
T ++APE+L+ S+ VD +S G++ + +L G P+ + + + I+
Sbjct: 172 TPGYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD 229
Query: 1042 IPSY--CDAEWRTLMEECWAPNPAARPSFTEI 1071
P + + + +P R + +
Sbjct: 230 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 6e-56
Identities = 79/309 (25%), Positives = 122/309 (39%), Gaps = 54/309 (17%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSK 869
+ Q+ +G G FG V+ GKWRG +VA+K +E + E
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSS---------REERSWFREAEIYQTVM 53
Query: 870 LHHPNVVAFYGVVQ--DGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
L H N++ F +G L V++Y GSL L R ++ + +A+ A
Sbjct: 54 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK--LALSTAS 111
Query: 928 GMEYLHS--------KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRN-----TL 974
G+ +LH I H DLK N+LV C + D GL+ + +
Sbjct: 112 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVK----KNGTCCIADLGLAVRHDSATDTIDI 167
Query: 975 VSGGVRGTLPWMAPELLSGSSS----KVSEKVDVFSFGIVLWEILTG----------EEP 1020
GT +MAPE+L S + + ++ D+++ G+V WEI + P
Sbjct: 168 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227
Query: 1021 YANMHYG-----AIIGGIVNNTLRPTIPSY-----CDAEWRTLMEECWAPNPAARPSFTE 1070
Y ++ + + LRP IP+ +M ECW N AAR +
Sbjct: 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287
Query: 1071 IASRLRVLS 1079
I L LS
Sbjct: 288 IKKTLSQLS 296
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 2e-55
Identities = 52/266 (19%), Positives = 103/266 (38%), Gaps = 19/266 (7%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
E ++LG G FG V+ + K +K + ++Q KE IL
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-----KGTDQVL----VKKEISIL 55
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
+ H N++ + + L + E++ + + L+ R +
Sbjct: 56 NIARHRNILHLHESFESM--EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE 113
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMA 987
+++LHS NI HFD++ +N++ + S K+ +FG ++ + + + A
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTRRSST--IKIIEFGQARQLKPGDNFRLLFTAPEYYA 171
Query: 988 PELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN--TLRPTIPSY 1045
PE+ VS D++S G +++ +L+G P+ II I+N T
Sbjct: 172 PEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKE 229
Query: 1046 CDAEWRTLMEECWAPNPAARPSFTEI 1071
E ++ +R + +E
Sbjct: 230 ISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 191 bits (485), Expect = 4e-55
Identities = 66/272 (24%), Positives = 114/272 (41%), Gaps = 17/272 (6%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQ-ERLTVEFWKEAEI 866
E+ E ++ LG G V + T A+K I + S+E+ + L KE +I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 867 LSKLH-HPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDA 925
L K+ HPN++ + V + M G L L K ++ R I+
Sbjct: 63 LRKVSGHPNIIQLKDTYETNT--FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR-AL 119
Query: 926 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPW 985
+ LH NIVH DLK +N+L++ K+ DFG S V GT +
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLD----DDMNIKLTDFGFSCQLDPGEKLREVCGTPSY 175
Query: 986 MAPELLSGS----SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT 1041
+APE++ S ++VD++S G++++ +L G P+ + ++ I++ +
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 235
Query: 1042 IPSYCD--AEWRTLMEECWAPNPAARPSFTEI 1071
P + D + L+ P R + E
Sbjct: 236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 5e-53
Identities = 86/290 (29%), Positives = 127/290 (43%), Gaps = 36/290 (12%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTVE 859
+ E + +ELG G+FG VY G +G VAIK + ++ +S +ER +E
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-----ASMRER--IE 69
Query: 860 FWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRF------- 912
F EA ++ + + +VV GVV G + E M G L+ L
Sbjct: 70 FLNEASVMKEFNCHHVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 127
Query: 913 --LDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI- 969
+ + +A + A GM YL++ VH DL N +V K+GDFG+++
Sbjct: 128 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA----EDFTVKIGDFGMTRDI 183
Query: 970 --KRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEE-PYANMHY 1026
G + WM+PE L + DV+SFG+VLWEI T E PY +
Sbjct: 184 YETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 241
Query: 1027 GAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076
++ ++ L P C LM CW NP RPSF EI S ++
Sbjct: 242 EQVLRFVMEGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 5e-53
Identities = 79/296 (26%), Positives = 120/296 (40%), Gaps = 39/296 (13%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTVE 859
+ L+ K LG G FG V G D VA+K +K+ +
Sbjct: 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG------ATHSEHRAL 63
Query: 860 FWKEAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDR-------- 911
+ ++ HH NVV G PGG L + E+ G+L L K
Sbjct: 64 MSELKILIHIGHHLNVVNLLGACTK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122
Query: 912 -------FLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964
FL + + A GME+L S+ +H DL N+L++ + + K+ DF
Sbjct: 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----EKNVVKICDF 178
Query: 965 GLSKI---KRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEE-P 1020
GL++ + + G R L WMAPE + + + DV+SFG++LWEI + P
Sbjct: 179 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASP 236
Query: 1021 YANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076
Y + + R P Y E M +CW P+ RP+F+E+ L
Sbjct: 237 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 184 bits (467), Expect = 8e-53
Identities = 63/275 (22%), Positives = 118/275 (42%), Gaps = 15/275 (5%)
Query: 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEI 866
++ E + LG G V+ + DVA+K ++ + + F +EA+
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRAD-----LARDPSFYLRFRREAQN 60
Query: 867 LSKLHHPNVVAFYGVVQD--GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMD 924
+ L+HP +VA Y + G V EY+ +LR ++ + +R +IA D
Sbjct: 61 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA-D 119
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLP 984
A + + H I+H D+K N++++ + + + ++ + + V GT
Sbjct: 120 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 985 WMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP--TI 1042
+++PE G V + DV+S G VL+E+LTGE P+ ++ V P
Sbjct: 180 YLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 237
Query: 1043 PSYCDAEWRTLMEECWAPNPAARP-SFTEIASRLR 1076
A+ ++ + A NP R + E+ + L
Sbjct: 238 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 1e-52
Identities = 74/265 (27%), Positives = 119/265 (44%), Gaps = 20/265 (7%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
ED K LG G+FG V+ +++ T+ AIK +KK + E +L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVEC-----TMVEKRVL 56
Query: 868 SK-LHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAA 926
S HP + + Q L V EY+ G L + + +F D R A +
Sbjct: 57 SLAWEHPFLTHMFCTFQTK--ENLFFVMEYLNGGDLMYHIQSCHKF-DLSRATFYAAEII 113
Query: 927 FGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-IKRNTLVSGGVRGTLPW 985
G+++LHSK IV+ DLK DN+L++ K+ DFG+ K + GT +
Sbjct: 114 LGLQFLHSKGIVYRDLKLDNILLD----KDGHIKIADFGMCKENMLGDAKTNTFCGTPDY 169
Query: 986 MAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSY 1045
+APE+L G K + VD +SFG++L+E+L G+ P+ + I + P P +
Sbjct: 170 IAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRW 225
Query: 1046 CDAEWRTLMEECWAPNPAARPSFTE 1070
+ E + L+ + + P R
Sbjct: 226 LEKEAKDLLVKLFVREPEKRLGVRG 250
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 1e-52
Identities = 81/300 (27%), Positives = 124/300 (41%), Gaps = 40/300 (13%)
Query: 807 IKNEDLEEQKELGSGTFGTVYHGKWRGTD---------VAIKRIKKSCFTGRSSEQERLT 857
+ + L K LG G FG V + G D VA+K +K ++E++
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-----ATEKDL-- 62
Query: 858 VEFWKEAEILSKL-HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVL---------- 906
+ E E++ + H N++ G G L + EY G+LR L
Sbjct: 63 SDLISEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEY 120
Query: 907 -----VRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKV 961
+ L + + A A GMEYL SK +H DL N+LV +D I
Sbjct: 121 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADF 179
Query: 962 GDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEP 1020
G + R + WMAPE L + + DV+SFG++LWEI T G P
Sbjct: 180 GLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSP 237
Query: 1021 YANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL-RVLS 1079
Y + + ++ R PS C E +M +CW P+ RP+F ++ L R+++
Sbjct: 238 YPGVPVEELFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 5e-50
Identities = 57/261 (21%), Positives = 103/261 (39%), Gaps = 21/261 (8%)
Query: 815 QKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH- 871
LGSG FG+VY G + VAIK ++K + E +L K+
Sbjct: 9 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG--TRVPMEVVLLKKVSS 66
Query: 872 -HPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGME 930
V+ + + + E + + L +
Sbjct: 67 GFSGVIRLLDWFERP--DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 931 YLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPEL 990
+ H+ ++H D+K +N+L+ D +R K+ DFG + ++T+ + GT + PE
Sbjct: 125 HCHNCGVLHRDIKDENILI---DLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSPPEW 180
Query: 991 LSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEW 1050
+ V+S GI+L++++ G+ P+ + II G + +E
Sbjct: 181 IRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--EIIRG------QVFFRQRVSSEC 231
Query: 1051 RTLMEECWAPNPAARPSFTEI 1071
+ L+ C A P+ RP+F EI
Sbjct: 232 QHLIRWCLALRPSDRPTFEEI 252
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 8e-49
Identities = 64/269 (23%), Positives = 106/269 (39%), Gaps = 28/269 (10%)
Query: 815 QKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-H 871
+ LG G G V + T A+K ++ + +E E+ +
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------------PKARREVELHWRASQ 63
Query: 872 HPNVVAFYGVVQDG--PGGTLATVAEYMVDGSLRHVLVRK-DRFLDRRRRLIIAMDAAFG 928
P++V V ++ L V E + G L + + D+ R I
Sbjct: 64 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123
Query: 929 MEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAP 988
++YLHS NI H D+K +NLL K P+ I K+ DFG +K + T ++AP
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTSKRPN-AILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 182
Query: 989 ELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTI------ 1042
E+L K + D++S G++++ +L G P+ + H AI G+
Sbjct: 183 EVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240
Query: 1043 PSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
S E + L+ P R + TE
Sbjct: 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 174 bits (443), Expect = 2e-48
Identities = 58/261 (22%), Positives = 100/261 (38%), Gaps = 14/261 (5%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
D + +G G FG VY + G A+K + K + + E L + ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI--KMKQGETLALNERIMLSLV 61
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
S P +V L+ + + M G L + L + F + R A
Sbjct: 62 STGDCPFIVCMSYAFHTP--DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE-IIL 118
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMA 987
G+E++H++ +V+ DLK N+L++ ++ D GL+ GT +MA
Sbjct: 119 GLEHMHNRFVVYRDLKPANILLD----EHGHVRISDLGLACDFSKKK-PHASVGTHGYMA 173
Query: 988 PELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN-TLRPTIPSYC 1046
PE+L D FS G +L+++L G P+ T+ +P
Sbjct: 174 PEVLQK-GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 232
Query: 1047 DAEWRTLMEECWAPNPAARPS 1067
E R+L+E + R
Sbjct: 233 SPELRSLLEGLLQRDVNRRLG 253
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 171 bits (435), Expect = 3e-48
Identities = 58/277 (20%), Positives = 103/277 (37%), Gaps = 31/277 (11%)
Query: 816 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHP 873
+++GSG+FG +Y G G +VAIK + + E++I +
Sbjct: 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLECV----------KTKHPQLHIESKIYKMMQGG 62
Query: 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLH 933
+ G V E + SL + R + L++A +EY+H
Sbjct: 63 VGIPTIRWCGA-EGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 934 SKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT--------LVSGGVRGTLPW 985
SKN +H D+K DN L+ L + + DFGL+K R+ + + GT +
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYII-DFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 986 MAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN------NTLR 1039
+ G + S + D+ S G VL G P+ + +T
Sbjct: 180 ASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237
Query: 1040 PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076
+ +E+ T + C + +P ++ + R
Sbjct: 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 172 bits (436), Expect = 4e-48
Identities = 65/260 (25%), Positives = 125/260 (48%), Gaps = 20/260 (7%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
+D + + LG+G+FG V+ + R G A+K +KK + E +L
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEH-----TNDERLML 58
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
S + HP ++ +G QD + + +Y+ G L +L + RF + + A +
Sbjct: 59 SIVTHPFIIRMWGTFQDA--QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-EVCL 115
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMA 987
+EYLHSK+I++ DLK +N+L++ K+ DFG +K + + + GT ++A
Sbjct: 116 ALEYLHSKDIIYRDLKPENILLD----KNGHIKITDFGFAKYVPDVTYT--LCGTPDYIA 169
Query: 988 PELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCD 1047
PE++S ++ +D +SFGI+++E+L G P+ + + I+N P + +
Sbjct: 170 PEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFPPFFN 225
Query: 1048 AEWRTLMEECWAPNPAARPS 1067
+ + L+ + + R
Sbjct: 226 EDVKDLLSRLITRDLSQRLG 245
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 6e-47
Identities = 67/297 (22%), Positives = 115/297 (38%), Gaps = 46/297 (15%)
Query: 809 NEDLEEQKELGSGTFGTVYHGKWR---GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAE 865
++ E E+G G +G V+ + G VA+KR++ + +E + + +E
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQ------TGEEGMPLSTIREVA 59
Query: 866 ILSKL---HHPNVVAFYGVVQDGP---GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRL 919
+L L HPNVV + V L V E++ ++ + +
Sbjct: 60 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK 119
Query: 920 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGV 979
+ G+++LHS +VH DLK N+LV S K+ DFGL++I + V
Sbjct: 120 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVT----SSGQIKLADFGLARIYSFQMALTSV 175
Query: 980 RGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 1039
TL + APE+L S + VD++S G + E+ + + +G I++
Sbjct: 176 VVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233
Query: 1040 PT-------------------------IPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
P + D + L+ +C NPA R S
Sbjct: 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 168 bits (425), Expect = 6e-47
Identities = 51/280 (18%), Positives = 93/280 (33%), Gaps = 33/280 (11%)
Query: 815 QKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-H 871
+ +G G+FG ++ G VAIK + + E L
Sbjct: 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR----------RSDAPQLRDEYRTYKLLAG 59
Query: 872 HPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEY 931
+ Y Q+G + ++ SL +L R + + A ++
Sbjct: 60 CTGIPNVYYFGQEG---LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 116
Query: 932 LHSKNIVHFDLKCDNLLVNLKDPSRPIC-KVGDFGLSKIKRNTLVS--------GGVRGT 982
+H K++V+ D+K DN L+ + V DFG+ K R+ + + GT
Sbjct: 117 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
Query: 983 LPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAI------IGGIVNN 1036
+M+ G + S + D+ + G V L G P+ + IG +
Sbjct: 177 ARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234
Query: 1037 TLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076
T + + E+ M A P + +
Sbjct: 235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 4e-46
Identities = 67/261 (25%), Positives = 110/261 (42%), Gaps = 19/261 (7%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
D + K LG GTFG V + + T A+K ++K + E+ +L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAH-----TVTESRVL 59
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
HP + A Q L V EY G L L R+ F + R R A +
Sbjct: 60 QNTRHPFLTALKYAFQTH--DRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIVS 116
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-IKRNTLVSGGVRGTLPWM 986
+EYLHS+++V+ D+K +NL+++ K+ DFGL K + GT ++
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLD----KDGHIKITDFGLCKEGISDGATMKTFCGTPEYL 172
Query: 987 APELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYC 1046
APE+L + VD + G+V++E++ G P+ N + + I+ P
Sbjct: 173 APEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTL 228
Query: 1047 DAEWRTLMEECWAPNPAARPS 1067
E ++L+ +P R
Sbjct: 229 SPEAKSLLAGLLKKDPKQRLG 249
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 1e-44
Identities = 62/292 (21%), Positives = 112/292 (38%), Gaps = 43/292 (14%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
E+ ++ +++G GT+G VY + + T VA+K+I+ +E E + +E +L
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLD------TETEGVPSTAIREISLL 55
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
+L+HPN+V V+ L V E++ + + +
Sbjct: 56 KELNHPNIVKLLDVIHTE--NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPW-M 986
G+ + HS ++H DLK NLL+N + K+ DFGL++ + + W
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLIN----TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 169
Query: 987 APELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT----- 1041
APE+L G S VD++S G + E++T + + I P
Sbjct: 170 APEILLGCK-YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 228
Query: 1042 ----------------------IPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
+ D + R+L+ + +P R S
Sbjct: 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 5e-44
Identities = 67/268 (25%), Positives = 122/268 (45%), Gaps = 21/268 (7%)
Query: 810 EDLEEQKELGSGTFGTVY-----HGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEA 864
E+ E K LG+G +G V+ G G A+K +KK+ ++ E E
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH----TRTER 79
Query: 865 EILSKL-HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAM 923
++L + P +V + Q L + +Y+ G L L +++RF + ++ +
Sbjct: 80 QVLEHIRQSPFLVTLHYAFQTE--TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG- 136
Query: 924 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK--IKRNTLVSGGVRG 981
+ +E+LH I++ D+K +N+L++ S + DFGLSK + T + G
Sbjct: 137 EIVLALEHLHKLGIIYRDIKLENILLD----SNGHVVLTDFGLSKEFVADETERAYDFCG 192
Query: 982 TLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR-- 1039
T+ +MAP+++ G S + VD +S G++++E+LTG P+ I L+
Sbjct: 193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 252
Query: 1040 PTIPSYCDAEWRTLMEECWAPNPAARPS 1067
P P A + L++ +P R
Sbjct: 253 PPYPQEMSALAKDLIQRLLMKDPKKRLG 280
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 5e-43
Identities = 69/288 (23%), Positives = 112/288 (38%), Gaps = 40/288 (13%)
Query: 813 EEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL 870
E+ LG G F TVY + + T+ VAIK+IK RS ++ + +E ++L +L
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLG---HRSEAKDGINRTALREIKLLQEL 57
Query: 871 HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGME 930
HPN++ ++ V ++M + + + M G+E
Sbjct: 58 SHPNIIGLLDAFGHK--SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLM-TLQGLE 114
Query: 931 YLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK-IKRNTLVSGGVRGTLPWMAPE 989
YLH I+H DLK +NLL++ + K+ DFGL+K T + APE
Sbjct: 115 YLHQHWILHRDLKPNNLLLD----ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPE 170
Query: 990 LLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT-------- 1041
LL G+ VD+++ G +L E+L + I PT
Sbjct: 171 LLFGAR-MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229
Query: 1042 ------------------IPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
I S + L++ + NP AR + T+
Sbjct: 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 155 bits (392), Expect = 1e-42
Identities = 58/290 (20%), Positives = 103/290 (35%), Gaps = 41/290 (14%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILS 868
E +++G GT+G VY + G A+K+I+ E E + +E IL
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLE------KEDEGIPSTTIREISILK 55
Query: 869 KLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFG 928
+L H N+V Y V+ L +D L+ +L + L+ + G
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLV---FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 929 MEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAP 988
+ Y H + ++H DLK NLL+N K+ DFGL++ + W
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLIN----REGELKIADFGLARAFGIPVRKYTHEIVTLWYRA 168
Query: 989 ELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSY--- 1045
+ S K S +D++S G + E++ G + + + I P ++
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228
Query: 1046 ------------------------CDAEWRTLMEECWAPNPAARPSFTEI 1071
D L+ + +P R + +
Sbjct: 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-42
Identities = 58/296 (19%), Positives = 111/296 (37%), Gaps = 51/296 (17%)
Query: 813 EEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL 870
+G G +G V VAIK+I E + +E +IL +
Sbjct: 11 TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF-------EHQTYCQRTLREIKILLRF 63
Query: 871 HHPNVVAFYGVVQDGPGGTLAT--VAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFG 928
H N++ +++ + + +++ L +L K + L G
Sbjct: 64 RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL--KTQHLSNDHICYFLYQILRG 121
Query: 929 MEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI----KRNTLVSGGVRGTLP 984
++Y+HS N++H DLK NLL+N + K+ DFGL+++ +T T
Sbjct: 122 LKYIHSANVLHRDLKPSNLLLN----TTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177
Query: 985 WMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT--- 1041
+ APE++ S ++ +D++S G +L E+L+ + HY + I+ P+
Sbjct: 178 YRAPEIMLN-SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236
Query: 1042 --------------------------IPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
+ D++ L+++ NP R +
Sbjct: 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 154 bits (391), Expect = 9e-42
Identities = 62/259 (23%), Positives = 114/259 (44%), Gaps = 20/259 (7%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
+ + K LG+G+FG V K + + A+K + K + + + E IL
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-----QKVVKLKQIEHTLNEKRIL 95
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
++ P +V +D L V EY+ G + L R RF + R A
Sbjct: 96 QAVNFPFLVKLEFSFKDNS--NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIVL 152
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMA 987
EYLHS ++++ DLK +NLL++ + +V DFG +K + + + GT +A
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQG----YIQVTDFGFAKRVKGRTWT--LCGTPEALA 206
Query: 988 PELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCD 1047
PE++ ++ VD ++ G++++E+ G P+ I IV+ + PS+
Sbjct: 207 PEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFS 262
Query: 1048 AEWRTLMEECWAPNPAARP 1066
++ + L+ + R
Sbjct: 263 SDLKDLLRNLLQVDLTKRF 281
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 2e-41
Identities = 59/305 (19%), Positives = 107/305 (35%), Gaps = 55/305 (18%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
E+ ++G GTFG V+ + R T VA+K++ +E+E + +E +IL
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME------NEKEGFPITALREIKIL 63
Query: 868 SKLHHPNVVAFYGVVQDGP------GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLII 921
L H NVV + + G++ V ++ + +F + ++
Sbjct: 64 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 123
Query: 922 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVS----- 976
M G+ Y+H I+H D+K N+L+ + K+ DFGL++ S
Sbjct: 124 QM-LLNGLYYIHRNKILHRDMKAANVLIT----RDGVLKLADFGLARAFSLAKNSQPNRY 178
Query: 977 GGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN 1036
TL + PELL G +D++ G ++ E+ T + I
Sbjct: 179 TNRVVTLWYRPPELLLGER-DYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237
Query: 1037 TLRPTIPSY------------------------------CDAEWRTLMEECWAPNPAARP 1066
T + D L+++ +PA R
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297
Query: 1067 SFTEI 1071
+
Sbjct: 298 DSDDA 302
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 7e-41
Identities = 65/296 (21%), Positives = 104/296 (35%), Gaps = 51/296 (17%)
Query: 811 DLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILS 868
+ K +G+G+FG VY K + VAIK++ + +E +I+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD------------KRFKNRELQIMR 68
Query: 869 KLHHPNVVAFYGVVQDGP----GGTLATVAEYMVDGSLRHVL--VRKDRFLDRRRRLIIA 922
KL H N+V L V +Y+ + R R + L +
Sbjct: 69 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 923 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGT 982
+ Y+HS I H D+K NLL+ DP + K+ DFG +K + +
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLL---DPDTAVLKLCDFGSAKQLVRGEPNVSYICS 185
Query: 983 LPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT- 1041
+ APEL+ G ++ + +DV+S G VL E+L G+ + + I+ PT
Sbjct: 186 RYYRAPELIFG-ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244
Query: 1042 --------------------------IPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
E L P AR + E
Sbjct: 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 5e-39
Identities = 61/292 (20%), Positives = 108/292 (36%), Gaps = 43/292 (14%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
+ E+ +++G GT+GTV+ K R T VA+KR++ + E + +E +L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLD------DDDEGVPSSALREICLL 55
Query: 868 SKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAF 927
+L H N+V + V+ TL V E+ ++ + +
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTL--VFEFCDQDLKKYFDSCNGDLDPEIVKSFLF-QLLK 112
Query: 928 GMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMA 987
G+ + HS+N++H DLK NLL+N K+ +FGL++ + W
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLIN----RNGELKLANFGLARAFGIPVRCYSAEVVTLWYR 168
Query: 988 PELLSGSSSKVSEKVDVFSFGIVLWEILTGEEP-YANMHYGAIIGGIVNNTLRPT----- 1041
P + + S +D++S G + E+ P + + I PT
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228
Query: 1042 ----------------------IPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
+ +A R L++ NP R S E
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 143 bits (361), Expect = 5e-38
Identities = 50/317 (15%), Positives = 113/317 (35%), Gaps = 58/317 (18%)
Query: 794 PSLVDFDVSSVQVIKNEDLEEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSS 851
D++ V+ +D + ++LG G + V+ + V +K +K
Sbjct: 19 REYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-------V 71
Query: 852 EQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD 910
++++ +E +IL L PN++ +V+D T A V E++ + + +
Sbjct: 72 KKKK----IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---- 123
Query: 911 RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIK 970
+ L + ++Y HS I+H D+K N++++ + ++ D+GL++
Sbjct: 124 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH---RKLRLIDWGLAEFY 180
Query: 971 RNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPY--------- 1021
+ + PELL +D++S G +L ++ +EP+
Sbjct: 181 HPGQEYNVRVASRYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 239
Query: 1022 -----------------------ANMHYGAIIGGIVNNTLRPTIPS----YCDAEWRTLM 1054
+ + I+G + S E +
Sbjct: 240 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 299
Query: 1055 EECWAPNPAARPSFTEI 1071
++ + +R + E
Sbjct: 300 DKLLRYDHQSRLTAREA 316
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 2e-37
Identities = 59/294 (20%), Positives = 114/294 (38%), Gaps = 51/294 (17%)
Query: 813 EEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL 870
+ + +GSG +G V G VAIK++ + + E ++E +L +
Sbjct: 21 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP------FQSELFAKRAYRELRLLKHM 74
Query: 871 HHPNVVAFYGVVQDGPGGTLAT----VAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAA 926
H NV+ V T V +M G+ L++ ++ + R + ++
Sbjct: 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVY-QML 131
Query: 927 FGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWM 986
G+ Y+H+ I+H DLK NL VN K+ DFGL++ + + T +
Sbjct: 132 KGLRYIHAAGIIHRDLKPGNLAVN----EDCELKILDFGLARQADSEMTG--YVVTRWYR 185
Query: 987 APELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP------ 1040
APE++ + ++ VD++S G ++ E++TG+ + + + I+ T P
Sbjct: 186 APEVILNWM-RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244
Query: 1041 -----------------------TIPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
+I + L+E+ + R + E
Sbjct: 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 4e-33
Identities = 54/296 (18%), Positives = 110/296 (37%), Gaps = 49/296 (16%)
Query: 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEIL 867
E + +GSG +G+V G VA+K++ + + +++ ++E +L
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR------TYRELRLL 71
Query: 868 SKLHHPNVVAFYGVVQDGPG---GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMD 924
+ H NV+ V + +++ L ++ K + L +
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI--VKCQKLTDDHVQFLIYQ 129
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLP 984
G++Y+HS +I+H DLK NL VN K+ DFGL++ + + T
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDDEMTG--YVATRW 183
Query: 985 WMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT--- 1041
+ APE++ ++ VD++S G ++ E+LTG + + + I+ P
Sbjct: 184 YRAPEIMLNWM-HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242
Query: 1042 --------------------------IPSYCDAEWRTLMEECWAPNPAARPSFTEI 1071
+ + L+E+ + R + +
Sbjct: 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 9e-33
Identities = 55/265 (20%), Positives = 104/265 (39%), Gaps = 23/265 (8%)
Query: 813 EEQKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL 870
+ K +GSG G V D VAIK++ + + + ++E ++ +
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP------FQNQTHAKRAYRELVLMKCV 73
Query: 871 HHPNVVAFYGVVQDGP----GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAA 926
+H N+++ V + V E M + + LD R +
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI----QMELDHERMSYLLYQML 129
Query: 927 FGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWM 986
G+++LHS I+H DLK N++V S K+ DFGL++ + + T +
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILDFGLARTAGTSFMMTPYVVTRYYR 185
Query: 987 APELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYC 1046
APE++ G E VD++S G ++ E++ + + Y ++ P P +
Sbjct: 186 APEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC-PEFM 242
Query: 1047 DAEWRTLMEECWAPNPAARPSFTEI 1071
T+ A +F ++
Sbjct: 243 KKLQPTVRNYVENRPKYAGLTFPKL 267
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 112 bits (281), Expect = 2e-27
Identities = 42/224 (18%), Positives = 93/224 (41%), Gaps = 9/224 (4%)
Query: 805 QVIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWK 862
+ K+ ++LG G F TV+ K T VA+K ++ ++E E ++
Sbjct: 8 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVN 67
Query: 863 EAEI--LSKLHHPNVVAFYGVVQDGP--GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRR 918
+A+ + +++ G + V E + + L + + R +
Sbjct: 68 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127
Query: 919 LIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSG 977
I+ G++Y+H + I+H D+K +N+L+ + D + ++ L
Sbjct: 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187
Query: 978 GVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPY 1021
T + +PE+L G + D++S +++E++TG+ +
Sbjct: 188 NSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLF 229
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 79.8 bits (196), Expect = 1e-17
Identities = 30/164 (18%), Positives = 52/164 (31%), Gaps = 30/164 (18%)
Query: 816 KELGSGTFGTVYHGK-WRGTDVAIK--RIKKSCFTGRSSEQERLTVEFWKEA-------- 864
K +G G V++ + + +K ++ + F +++ + F A
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 865 EILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMD 924
L KL V Y + A + E + L V V +
Sbjct: 66 RALQKLQGLAVPKVYAWEGN------AVLMELIDAKELYRVRVENPDE--------VLDM 111
Query: 925 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968
+ + + IVH DL N+LV S + DF S
Sbjct: 112 ILEEVAKFYHRGIVHGDLSQYNVLV-----SEEGIWIIDFPQSV 150
|
| >d1ip9a_ d.15.2.2 (A:) Bud emergence mediator Bemp1 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 85 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Bud emergence mediator Bemp1 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 40.1 bits (94), Expect = 7e-05
Identities = 11/98 (11%), Positives = 33/98 (33%), Gaps = 20/98 (20%)
Query: 75 SSEASDSSATKMKVLCSFGGKILPRPSDGKLRYVGGETRIIRIRKDISWQILRQKALEVY 134
+ +S S K+ K Y + + ++ D +++ LR K
Sbjct: 2 AMGSSTSGLKTTKI---------------KFYY-KDDIFALMLKGDTTYKELRSKIAPRI 45
Query: 135 N-QVHVIKYQLPGEDLDALVSVSCDEDLQNMMEEYNEL 171
+ ++ + + + D + N+++ ++
Sbjct: 46 DTDNFKLQTK---LFDGSGEEIKTDSQVSNIIQAKLKI 80
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1094 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1blja_ | 114 | P55 Blk protein tyrosine kinase {Mouse (Mus muscul | 98.43 | |
| d1o48a_ | 106 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 98.42 | |
| d1g83a2 | 104 | Tyrosine kinase Fyn {Human (Homo sapiens) [TaxId: | 98.4 | |
| d1lkka_ | 105 | p56-lck tyrosine kinase {Human (Homo sapiens) [Tax | 98.4 | |
| d1luia_ | 108 | Itk/tsk protein tyrosine kinase {Mouse (Mus muscul | 98.33 | |
| d1opka2 | 101 | Abl tyrosine kinase {Mouse (Mus musculus) [TaxId: | 98.33 | |
| d2oq1a1 | 130 | Tyrosine-protein kinase zap-70 {Human (Homo sapien | 98.32 | |
| d1qcfa2 | 103 | Hemopoetic cell kinase Hck {Human (Homo sapiens) [ | 98.23 | |
| d1rjaa_ | 100 | Tyrosine-protein kinase 6 (Breast tumor kinase, Br | 98.22 | |
| d1d4ta_ | 104 | The Xlp protein Sap {Human (Homo sapiens) [TaxId: | 98.13 | |
| d2oq1a2 | 124 | Tyrosine-protein kinase zap-70 {Human (Homo sapien | 98.1 | |
| d1k9aa2 | 101 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 98.09 | |
| d1jwoa_ | 97 | Csk homologous kinase Chk {Human (Homo sapiens) [T | 98.07 | |
| d1a81a1 | 129 | Syk tyrosine kinase {Human (Homo sapiens) [TaxId: | 98.06 | |
| d1ip9a_ | 85 | Bud emergence mediator Bemp1 {Baker's yeast (Sacch | 98.05 | |
| d1mila_ | 104 | Shc adaptor protein {Human (Homo sapiens) [TaxId: | 98.01 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.0 | |
| d1a81a2 | 125 | Syk tyrosine kinase {Human (Homo sapiens) [TaxId: | 97.96 | |
| d1i3za_ | 103 | Ews/fli1 activated transcript 2, Eat2 {Mouse (Mus | 97.95 | |
| d1rpya_ | 86 | Adaptor protein Aps {Rat (Rattus norvegicus) [TaxI | 97.95 | |
| d1r1qa_ | 97 | GRB2-related adaptor protein 2 (MONA, GRID) {Mouse | 97.88 | |
| d1nrva_ | 105 | Growth factor receptor-bound protein 10, GRB10 {Hu | 97.86 | |
| d2izva2 | 112 | Suppressor of cytokine signaling 4, SOCS-4 {Human | 97.73 | |
| d1jyra_ | 96 | Growth factor receptor-bound protein 2 (GRB2) {Hum | 97.72 | |
| d1fu6a_ | 111 | Phosphatidylinositol 3-kinase, p85-alpha subunit { | 97.68 | |
| d2fcia1 | 105 | Phospholipase C-gamma-1 {Cow (Bos taurus) [TaxId: | 97.64 | |
| d2shpa2 | 109 | Tyrosine phoshatase shp-2 {Human (Homo sapiens) [T | 97.57 | |
| d2qmsa1 | 113 | Growth factor receptor-bound protein 7 {Human (Hom | 97.57 | |
| d2eyva1 | 109 | Crk proto-oncogen {Human (Homo sapiens) [TaxId: 96 | 97.52 | |
| d2c9wa2 | 103 | Suppressor of cytokine signaling 2, SOCS-2 {Human | 97.51 | |
| d1qada_ | 107 | Phosphatidylinositol 3-kinase, p85-alpha subunit { | 97.43 | |
| d2shpa3 | 108 | Tyrosine phoshatase shp-2 {Human (Homo sapiens) [T | 97.19 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.16 | |
| d2cs0a1 | 106 | Hematopoietic SH2 domain containing protein HSH2D | 97.13 | |
| d1xa6a2 | 141 | Beta-chimaerin, N-terminal domain {Human (Homo sap | 97.06 | |
| d2c60a1 | 80 | Mitogen-activated protein kinase kinase kinase 3, | 97.02 | |
| d2nptb1 | 82 | Mitogen-activated protein kinase kinase kinase 2, | 97.01 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.64 | |
| d2bkfa1 | 85 | Next to BRCA1 gene 1 protein, NBR1 (KIAA0049) {Hum | 96.59 | |
| d1uura3 | 131 | STAT homologue {Dictyostelium discoideum [TaxId: 4 | 96.35 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.45 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 94.25 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.67 | |
| d1bg1a3 | 141 | STAT3b {Mouse (Mus musculus) [TaxId: 10090]} | 93.61 | |
| d1wmha_ | 83 | Protein kinase C, iota type {Human (Homo sapiens) | 87.44 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-51 Score=440.37 Aligned_cols=264 Identities=33% Similarity=0.568 Sum_probs=222.1
Q ss_pred ceeeccCCeeEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEee
Q 037285 804 VQVIKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQ 883 (1094)
Q Consensus 804 v~eIs~edYei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~ 883 (1094)
-|+|..++|++.+.||+|+||+||+|++++ .||||+++...... .....|.+|+.+|++++|||||++++++.
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~------~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 74 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTP------QQLQAFKNEVGVLRKTRHVNILLFMGYST 74 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCT------THHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCH------HHHHHHHHHHHHHHhCCCCCEeeeeEEEe
Confidence 478899999999999999999999998865 59999997653321 22467899999999999999999999986
Q ss_pred cCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEe
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGD 963 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsD 963 (1094)
+. .+++|||||++|+|.+++......+++..++.|+.||++||+|||+++||||||||+|||++ .++.+||+|
T Consensus 75 ~~---~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~----~~~~~Kl~D 147 (276)
T d1uwha_ 75 AP---QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH----EDLTVKIGD 147 (276)
T ss_dssp SS---SCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE----TTSSEEECC
T ss_pred cc---EEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEc----CCCCEEEcc
Confidence 53 68999999999999999987767799999999999999999999999999999999999999 788999999
Q ss_pred cCCcccccC---ccccCCccCCCcccCccccccC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCC
Q 037285 964 FGLSKIKRN---TLVSGGVRGTLPWMAPELLSGS-SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 1039 (1094)
Q Consensus 964 FGLSrl~~~---~~~ss~~~GT~~YmAPEvL~g~-~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lr 1039 (1094)
||+|+.... ........||+.|||||++.+. ...|+.++|||||||+||||+||+.||........+.........
T Consensus 148 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 227 (276)
T d1uwha_ 148 FGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL 227 (276)
T ss_dssp CCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSC
T ss_pred ccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC
Confidence 999985432 2233456799999999999743 345899999999999999999999999987766555555444433
Q ss_pred C----CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1040 P----TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1040 p----~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
. ..+..+++++.+||.+||+.||.+|||+.+|+++|+.+..+
T Consensus 228 ~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 228 SPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp CCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 2 34567899999999999999999999999999999998753
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=427.53 Aligned_cols=257 Identities=32% Similarity=0.617 Sum_probs=215.7
Q ss_pred eccCCeeEEEEecccCceEEEEeeec-CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r-Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~ 885 (1094)
|.+++|++.+.||+|+||+||+|++. +..||||+++..... ..+|.+|+.+|++++|||||+++++|.+.
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---------~~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 72 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---------EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC---------HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc---------HHHHHHHHHHHHhcCCCCcccccceeccC
Confidence 56789999999999999999999986 567999998754211 24688999999999999999999999875
Q ss_pred CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecC
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFG 965 (1094)
. .+++||||+.+|+|.+++......+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+|||
T Consensus 73 ~--~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~----~~~~~Kl~DFG 146 (263)
T d1sm2a_ 73 A--PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG----ENQVIKVSDFG 146 (263)
T ss_dssp S--SCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEEC----GGGCEEECSCC
T ss_pred C--ceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeec----CCCCeEecccc
Confidence 5 89999999999999999987777799999999999999999999999999999999999999 78899999999
Q ss_pred CcccccCc--cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCCC
Q 037285 966 LSKIKRNT--LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTI 1042 (1094)
Q Consensus 966 LSrl~~~~--~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~i 1042 (1094)
+++..... .......||+.|+|||++. ...++.++|||||||++|||+| |++||......++...+ ..+.++..
T Consensus 147 la~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i-~~~~~~~~ 223 (263)
T d1sm2a_ 147 MTRFVLDDQYTSSTGTKFPVKWASPEVFS--FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-STGFRLYK 223 (263)
T ss_dssp ------------------CTTSCCHHHHT--TCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHH-HHTCCCCC
T ss_pred hheeccCCCceeecceecCcccCChHHhc--CCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHH-HhcCCCCC
Confidence 99854332 2233456899999999998 4578999999999999999999 67777777776666655 45677788
Q ss_pred CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1043 PSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1043 Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
|..+++++.+||.+||+.||++|||+++|+++|+++..+
T Consensus 224 p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 899999999999999999999999999999999998643
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-50 Score=426.35 Aligned_cols=261 Identities=33% Similarity=0.574 Sum_probs=224.2
Q ss_pred CcceeeccCCeeEEEEecccCceEEEEeeecC-ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEe
Q 037285 802 SSVQVIKNEDLEEQKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYG 880 (1094)
Q Consensus 802 ssv~eIs~edYei~kkLGsG~FGtVYKAk~rG-t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~G 880 (1094)
.+.|+|..++|++.+.||+|+||+||+|++++ ..||||+++.... ..+.|.+|+.+|++++|||||++++
T Consensus 5 ~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~---------~~~~~~~E~~~l~~l~HpnIv~~~g 75 (272)
T d1qpca_ 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM---------SPDAFLAEANLMKQLQHQRLVRLYA 75 (272)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS---------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC---------CHHHHHHHHHHHHhCCCCCEeEEEe
Confidence 35688999999999999999999999999974 6799999875421 1246899999999999999999999
Q ss_pred EeecCCCCceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcE
Q 037285 881 VVQDGPGGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC 959 (1094)
Q Consensus 881 v~~d~~~~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~V 959 (1094)
++.+. .+++||||+++|+|.+++.... ..+++..++.|+.||++||.|||+++|+||||||+||||+ +++.+
T Consensus 76 ~~~~~---~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~----~~~~~ 148 (272)
T d1qpca_ 76 VVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS----DTLSC 148 (272)
T ss_dssp EECSS---SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTSCE
T ss_pred eeccC---CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeee----cccce
Confidence 98653 5799999999999999875543 3589999999999999999999999999999999999999 78899
Q ss_pred EEEecCCcccccCc--cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCChHHHHHhHhhc
Q 037285 960 KVGDFGLSKIKRNT--LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTG-EEPYANMHYGAIIGGIVNN 1036 (1094)
Q Consensus 960 KLsDFGLSrl~~~~--~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTG-k~PF~~~~~~eile~Iv~~ 1036 (1094)
||+|||+|+..... .......||+.|+|||++. ...++.++|||||||++|||+|| .+||......+....+ ..
T Consensus 149 Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~--~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i-~~ 225 (272)
T d1qpca_ 149 KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN--YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-ER 225 (272)
T ss_dssp EECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHH--HCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-HT
T ss_pred eeccccceEEccCCccccccccCCcccccChHHHh--CCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHH-Hh
Confidence 99999999865432 2334556899999999998 45689999999999999999995 5566666666666555 56
Q ss_pred cCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1037 TLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1037 ~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
+.++..|..+++++.+||.+||+.||++|||+.+|++.|..+.++
T Consensus 226 ~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 226 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 677888899999999999999999999999999999999988754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.7e-50 Score=431.38 Aligned_cols=260 Identities=32% Similarity=0.547 Sum_probs=223.1
Q ss_pred ceeeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeE
Q 037285 804 VQVIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGV 881 (1094)
Q Consensus 804 v~eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv 881 (1094)
.|+|..++|++.++||+|+||+||+|+++ ++.||||+++.... ...+|.+|+.+|++++|||||+++++
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---------~~~~~~~E~~il~~l~HpnIv~~~~~ 81 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---------EVEEFLKEAAVMKEIKHPNLVQLLGV 81 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc---------hHHHHHHHHHHHHhCCCCCEecCCcc
Confidence 57899999999999999999999999985 67899999875421 12468899999999999999999999
Q ss_pred eecCCCCceEEEeeecccchhHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEE
Q 037285 882 VQDGPGGTLATVAEYMVDGSLRHVLVRK-DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICK 960 (1094)
Q Consensus 882 ~~d~~~~~L~IVmEYmegGSL~d~L~k~-~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VK 960 (1094)
|.+.. .+++|||||++|+|.+++... ...+++..++.|+.||+.||+|||+++|+||||||+|||++ .++.+|
T Consensus 82 ~~~~~--~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~----~~~~~K 155 (287)
T d1opja_ 82 CTREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG----ENHLVK 155 (287)
T ss_dssp ECSSS--SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----GGGCEE
T ss_pred EeeCC--eeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEEC----CCCcEE
Confidence 98765 899999999999999998754 45689999999999999999999999999999999999998 778999
Q ss_pred EEecCCcccccCc--cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccC
Q 037285 961 VGDFGLSKIKRNT--LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 1038 (1094)
Q Consensus 961 LsDFGLSrl~~~~--~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~l 1038 (1094)
|+|||+|+..... .......||+.|+|||++. ...|+.++|||||||++|||++|..||........+...+....
T Consensus 156 l~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~ 233 (287)
T d1opja_ 156 VADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY 233 (287)
T ss_dssp ECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHH--HCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred EccccceeecCCCCceeeccccccccccChHHHc--CCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCC
Confidence 9999999864332 2333455889999999998 45789999999999999999996665544433444445557778
Q ss_pred CCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 037285 1039 RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLST 1080 (1094)
Q Consensus 1039 rp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~t 1080 (1094)
++..+..+++++.+||.+||+.||++|||+.+|++.|+.+..
T Consensus 234 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 234 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 888999999999999999999999999999999999988753
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-49 Score=428.81 Aligned_cols=259 Identities=34% Similarity=0.604 Sum_probs=215.0
Q ss_pred eeccCCeeEEEEecccCceEEEEeeec--Cc---eEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEe
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWR--GT---DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYG 880 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~r--Gt---~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~G 880 (1094)
++..++|++.++||+|+||+||+|+++ +. .||||.+.... .+.....|.+|+.+|++++|||||++++
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~l~g 94 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-------TEKQRRDFLSEASIMGQFDHPNVIHLEG 94 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-------CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-------CHHHHHHHHHHHHHHHhCCCCCCccEEE
Confidence 466788999999999999999999885 22 48888876431 1223467899999999999999999999
Q ss_pred EeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEE
Q 037285 881 VVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICK 960 (1094)
Q Consensus 881 v~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VK 960 (1094)
+|.+.. .+++|||||++|+|.+++......+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+|
T Consensus 95 ~~~~~~--~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~----~~~~~K 168 (299)
T d1jpaa_ 95 VVTKST--PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVN----SNLVCK 168 (299)
T ss_dssp EECSSS--SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCCEE
T ss_pred EEeeCC--EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEEC----CCCcEE
Confidence 998754 89999999999999999987777799999999999999999999999999999999999999 788999
Q ss_pred EEecCCcccccCcc------ccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhH
Q 037285 961 VGDFGLSKIKRNTL------VSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGI 1033 (1094)
Q Consensus 961 LsDFGLSrl~~~~~------~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~I 1033 (1094)
|+|||+++...... ......+|+.|||||++. ...++.++|||||||+||||+| |+.||......+++..+
T Consensus 169 l~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i 246 (299)
T d1jpaa_ 169 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ--YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI 246 (299)
T ss_dssp ECCC-----------------------CGGGSCHHHHH--SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred ECCcccceEccCCCCcceeeecccccCCccccCHHHHh--cCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99999998543221 122345789999999998 5678999999999999999998 89999999888777766
Q ss_pred hhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 037285 1034 VNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLST 1080 (1094)
Q Consensus 1034 v~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~t 1080 (1094)
..+.++..+..++..+.+||.+||+.||.+|||+.+|++.|+++..
T Consensus 247 -~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 247 -EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp -HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -HcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 4556777888999999999999999999999999999999998764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-50 Score=434.93 Aligned_cols=263 Identities=33% Similarity=0.508 Sum_probs=225.4
Q ss_pred CCCcceeeccCCeeEEEEecccCceEEEEeeecC-------ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-C
Q 037285 800 DVSSVQVIKNEDLEEQKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-H 871 (1094)
Q Consensus 800 dlssv~eIs~edYei~kkLGsG~FGtVYKAk~rG-------t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~ 871 (1094)
.....|+|..++|++.++||+|+||+||+|++.+ ..||||.+..... ......|.+|+.+|+++ +
T Consensus 27 ~~~~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~~ 99 (325)
T d1rjba_ 27 EYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-------SSEREALMSELKMMTQLGS 99 (325)
T ss_dssp CCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------CHHHHHHHHHHHHHCC
T ss_pred CCCccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC-------HHHHHHHHHHHHHHHHhcC
Confidence 3345688999999999999999999999998853 2489998865321 12235788999999998 8
Q ss_pred CCceeEEEeEeecCCCCceEEEeeecccchhHHHHhhcc----------------------cccCHHHHHHHHHHHHHHH
Q 037285 872 HPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD----------------------RFLDRRRRLIIAMDAAFGM 929 (1094)
Q Consensus 872 HPNIVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~----------------------~~Lse~~~l~Ia~QIaeGL 929 (1094)
|||||++++++.+.. .+++|||||++|+|.++|.... ..+++..++.++.||+.||
T Consensus 100 HpnIv~l~~~~~~~~--~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl 177 (325)
T d1rjba_ 100 HENIVNLLGACTLSG--PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGM 177 (325)
T ss_dssp CTTBCCEEEEECSSS--SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHH
T ss_pred CCcEeEEEEEEeeCC--eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHH
Confidence 999999999998865 8999999999999999997543 2488999999999999999
Q ss_pred HHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHH
Q 037285 930 EYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFS 1006 (1094)
Q Consensus 930 aYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWS 1006 (1094)
+|||+++||||||||+|||++ .++.+||+|||+|+..... .......||+.|||||++. ...++.++||||
T Consensus 178 ~yLH~~~IiHRDlKp~Nill~----~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~~DiwS 251 (325)
T d1rjba_ 178 EFLEFKSCVHRDLAARNVLVT----HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF--EGIYTIKSDVWS 251 (325)
T ss_dssp HHHHHTTEEETTCSGGGEEEE----TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH--HCCCCHHHHHHH
T ss_pred HHHHhCCeeeccCchhccccc----cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHc--CCCCCcceeccc
Confidence 999999999999999999999 7889999999999854322 2233456899999999998 457899999999
Q ss_pred HHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1007 FGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1007 LGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
|||++|||+| |+.||.+......+..++..+.++..|..+++++++||.+||+.||++|||+++|+++|..
T Consensus 252 ~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 252 YGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp HHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 9999999998 8999998887777777888888889999999999999999999999999999999999863
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=421.30 Aligned_cols=252 Identities=36% Similarity=0.607 Sum_probs=223.0
Q ss_pred ccCCeeEEEEecccCceEEEEeeecC-ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~rG-t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
++++|++.++||+|+||+||+|++++ ..||||++++.... ..+|.+|+.++++++||||++++++|.+..
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~---------~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~ 72 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---------EDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 72 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC---------HHHHHHHHHHHHTCCCTTBCCEEEEECCSS
T ss_pred ChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC---------HHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Confidence 56789999999999999999999964 57999999865321 246889999999999999999999998754
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+++||||+.+|+|.+++......+++..++.|+.||++||+|||++||+||||||+|||++ .++.+||+|||+
T Consensus 73 --~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~----~~~~~kl~DfG~ 146 (258)
T d1k2pa_ 73 --PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN----DQGVVKVSDFGL 146 (258)
T ss_dssp --SEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEEC----TTCCEEECCCSS
T ss_pred --ceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEc----CCCcEEECcchh
Confidence 89999999999999999887777799999999999999999999999999999999999999 788999999999
Q ss_pred cccccCc--cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCCCC
Q 037285 967 SKIKRNT--LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIP 1043 (1094)
Q Consensus 967 Srl~~~~--~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~iP 1043 (1094)
++..... .......+|+.|+|||++. ...++.++|||||||++|||+| |+.||......++...+. .+.++..|
T Consensus 147 a~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~p 223 (258)
T d1k2pa_ 147 SRYVLDDEYTSSVGSKFPVRWSPPEVLM--YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRP 223 (258)
T ss_dssp CCBCSSSSCCCCCCSCCCGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCCCC
T ss_pred heeccCCCceeecccCCCCCcCCcHHhc--CCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH-hCCCCCCc
Confidence 9854332 2233456899999999998 4578999999999999999998 899999999888877664 56678889
Q ss_pred CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1044 SYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1044 e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
..+++++.+||.+||+.||++|||+.+|+++|.+
T Consensus 224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 9999999999999999999999999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=424.62 Aligned_cols=253 Identities=26% Similarity=0.449 Sum_probs=207.6
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||+|+||+||+|+++ |+.||||++...... +.....+.+|+++|++++|||||++++++.+..
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 76 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT------EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT 76 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC------HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC--
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC------HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC
Confidence 368999999999999999999885 778999999765322 223467889999999999999999999998765
Q ss_pred CCceEEEeeecccchhHHHHhhc---ccccCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCceEeccCCCCCCc
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRK---DRFLDRRRRLIIAMDAAFGMEYLHSKN-----IVHFDLKCDNLLVNLKDPSRPI 958 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~---~~~Lse~~~l~Ia~QIaeGLaYLHs~G-----IIHRDLKPeNILLD~~~~e~g~ 958 (1094)
...+|+|||||++|+|.+++.+. ...+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.
T Consensus 77 ~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~----~~~~ 152 (269)
T d2java1 77 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD----GKQN 152 (269)
T ss_dssp --CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEEC----TTSC
T ss_pred CCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcC----CCCc
Confidence 56899999999999999998643 356999999999999999999999876 99999999999999 7789
Q ss_pred EEEEecCCcccccC-ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhcc
Q 037285 959 CKVGDFGLSKIKRN-TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 1037 (1094)
Q Consensus 959 VKLsDFGLSrl~~~-~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~ 1037 (1094)
+||+|||+|+.... ........||+.|||||++. ...|+.++|||||||++|||+||+.||......++...+....
T Consensus 153 vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~--~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~ 230 (269)
T d2java1 153 VKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMN--RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK 230 (269)
T ss_dssp EEECCHHHHHHC-----------CCCSCCCHHHHT--TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC
T ss_pred EEEeeccceeecccCCCccccCCCCcccCCHHHHc--CCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999986433 23344567999999999998 4578999999999999999999999999988888777776554
Q ss_pred CCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1038 LRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1038 lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
. ..++..+++++.+||.+||+.||.+|||+.+|+++
T Consensus 231 ~-~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 231 F-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp C-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred C-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 4 45778899999999999999999999999999876
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-49 Score=424.08 Aligned_cols=260 Identities=33% Similarity=0.556 Sum_probs=223.8
Q ss_pred eeccCCeeEEEE-ecccCceEEEEeeec----CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEe
Q 037285 806 VIKNEDLEEQKE-LGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYG 880 (1094)
Q Consensus 806 eIs~edYei~kk-LGsG~FGtVYKAk~r----Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~G 880 (1094)
.+..++|.+.+. ||+|+||+||+|.++ +..||||+++... ......+|.+|+.+|++++|||||++++
T Consensus 4 ~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-------~~~~~~~~~~E~~il~~l~HpnIv~l~g 76 (285)
T d1u59a_ 4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-------EKADTEEMMREAQIMHQLDNPYIVRLIG 76 (285)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-------CHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred eecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-------CHHHHHHHHHHHHHHHhCCCCCEeeEee
Confidence 456678888884 999999999999874 3469999987532 1223467899999999999999999999
Q ss_pred EeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEE
Q 037285 881 VVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICK 960 (1094)
Q Consensus 881 v~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VK 960 (1094)
++..+ .+++|||||++|+|.+++......+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+|
T Consensus 77 ~~~~~---~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~----~~~~~K 149 (285)
T d1u59a_ 77 VCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV----NRHYAK 149 (285)
T ss_dssp EEESS---SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE----ETTEEE
T ss_pred eeccC---eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeec----cCCcee
Confidence 99754 58999999999999999877666799999999999999999999999999999999999999 788999
Q ss_pred EEecCCcccccCc----cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhh
Q 037285 961 VGDFGLSKIKRNT----LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 1035 (1094)
Q Consensus 961 LsDFGLSrl~~~~----~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~ 1035 (1094)
|+|||+++..... .......||+.|+|||++. ...++.++|||||||++|||+| |+.||......++...+ .
T Consensus 150 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i-~ 226 (285)
T d1u59a_ 150 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN--FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-E 226 (285)
T ss_dssp ECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHH--HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH-H
T ss_pred eccchhhhcccccccccccccccccCccccChHHHh--CCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH-H
Confidence 9999999854322 2223456899999999998 4578999999999999999998 99999998877776655 5
Q ss_pred ccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 037285 1036 NTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAA 1082 (1094)
Q Consensus 1036 ~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~ 1082 (1094)
.+.++..|..+++++.+||.+||+.||++||||.+|++.|+.+..+.
T Consensus 227 ~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 227 QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 56678889999999999999999999999999999999999876543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=421.76 Aligned_cols=252 Identities=29% Similarity=0.484 Sum_probs=219.6
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||+|+||+||+|+++ ++.||||++.+... ........+.+|+.+|++++|||||++++++.+..
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~-----~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 79 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 79 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHc-----cChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC
Confidence 468999999999999999999985 67899999975422 12223467889999999999999999999999865
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+++|||||++|+|.+++.+.. .+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+
T Consensus 80 --~~~ivmEy~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~----~~~~~kl~DFG~ 152 (263)
T d2j4za1 80 --RVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG----SAGELKIADFGW 152 (263)
T ss_dssp --EEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCEEECCCCS
T ss_pred --EEEEEEeecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceec----CCCCEeecccce
Confidence 8999999999999999997654 499999999999999999999999999999999999999 778999999999
Q ss_pred cccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcC
Q 037285 967 SKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYC 1046 (1094)
Q Consensus 967 Srl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~ 1046 (1094)
|+....... ....||+.|+|||++. ...++.++|||||||++|+|++|+.||......+....+.... ..+|..+
T Consensus 153 a~~~~~~~~-~~~~Gt~~Y~APE~~~--~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~ 227 (263)
T d2j4za1 153 SVHAPSSRR-TTLCGTLDYLPPEMIE--GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE--FTFPDFV 227 (263)
T ss_dssp CSCCCCCCC-EETTEEGGGCCHHHHT--TCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--CCCCTTS
T ss_pred eeecCCCcc-cccCCCCcccCHHHHc--CCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCccC
Confidence 986544332 3456999999999998 4568899999999999999999999999988888777765543 4577889
Q ss_pred cHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1047 DAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1047 S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
++++++||.+||+.||.+|||+.+++++-+-
T Consensus 228 s~~~~~li~~~L~~dp~~R~t~~eil~hp~~ 258 (263)
T d2j4za1 228 TEGARDLISRLLKHNPSQRPMLREVLEHPWI 258 (263)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTCHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHcCcCc
Confidence 9999999999999999999999999997654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-49 Score=420.02 Aligned_cols=260 Identities=35% Similarity=0.607 Sum_probs=217.1
Q ss_pred eeccCCeeEEEEecccCceEEEEeeecC------ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEE
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFY 879 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~rG------t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~ 879 (1094)
+|.+++|++.++||+|+||.||+|++++ ..||||++..... +....+|.+|+.+|++++|||||+++
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~-------~~~~~~~~~E~~il~~l~H~nIv~~~ 75 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT-------EKQRVDFLGEAGIMGQFSHHNIIRLE 75 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC-------HHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC-------hHHHHHHHHHHHHHHhcCCCCEeeee
Confidence 5778899999999999999999998853 2599999865321 22345789999999999999999999
Q ss_pred eEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcE
Q 037285 880 GVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC 959 (1094)
Q Consensus 880 Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~V 959 (1094)
|++.+.. .+++||||+.+++|.+++......+++..++.++.||+.||+|||+++|+||||||+||||+ .++.+
T Consensus 76 g~~~~~~--~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~----~~~~~ 149 (283)
T d1mqba_ 76 GVISKYK--PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN----SNLVC 149 (283)
T ss_dssp EEECSSS--SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCCE
T ss_pred EEEecCC--ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEEC----CCCeE
Confidence 9998755 89999999999999999887777799999999999999999999999999999999999999 78899
Q ss_pred EEEecCCcccccCc----cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCC-CCCCCCChHHHHHhHh
Q 037285 960 KVGDFGLSKIKRNT----LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGE-EPYANMHYGAIIGGIV 1034 (1094)
Q Consensus 960 KLsDFGLSrl~~~~----~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk-~PF~~~~~~eile~Iv 1034 (1094)
||+|||+++..... .......||+.|+|||++. ...++.++|||||||++|||++|. +||......+++.. +
T Consensus 150 Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~--~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~-i 226 (283)
T d1mqba_ 150 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS--YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA-I 226 (283)
T ss_dssp EECCCCC-----------------CCCGGGSCHHHHH--SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-H
T ss_pred EEcccchhhcccCCCccceEeccCCCCccccCHHHHc--cCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHH-H
Confidence 99999999854321 1223456899999999998 567899999999999999999954 45555555555544 4
Q ss_pred hccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1035 NNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1035 ~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
..+.++..+..++..+.+||.+||+.||++|||+.+|++.|+.+...
T Consensus 227 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp HTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred hccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 66778888999999999999999999999999999999999988654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-49 Score=415.86 Aligned_cols=260 Identities=32% Similarity=0.578 Sum_probs=215.9
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeecC-----ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEE
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFY 879 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~rG-----t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~ 879 (1094)
|+|..++|++.+.||+|+||.||+|++.. ..||||.++... .......|.+|+.+|++++|||||+++
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~l~ 74 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-------SDSVREKFLQEALTMRQFDHPHIVKLI 74 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-------SHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-------CHHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 67888999999999999999999998742 348888875421 123346789999999999999999999
Q ss_pred eEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcE
Q 037285 880 GVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC 959 (1094)
Q Consensus 880 Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~V 959 (1094)
+++.+. .+++||||+.+|+|.+++......+++..++.++.||++||.|||+++|+||||||+|||++ .++.+
T Consensus 75 ~~~~~~---~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~----~~~~~ 147 (273)
T d1mp8a_ 75 GVITEN---PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS----SNDCV 147 (273)
T ss_dssp EEECSS---SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE----ETTEE
T ss_pred EEEecC---eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeec----CCCcE
Confidence 999643 68999999999999999887777799999999999999999999999999999999999999 77899
Q ss_pred EEEecCCcccccC--ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhc
Q 037285 960 KVGDFGLSKIKRN--TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 1036 (1094)
Q Consensus 960 KLsDFGLSrl~~~--~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~ 1036 (1094)
||+|||+|+.... ........||+.|+|||++. ...++.++|||||||++|||+| |..||......++...+. .
T Consensus 148 Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~--~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~-~ 224 (273)
T d1mp8a_ 148 KLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN--FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-N 224 (273)
T ss_dssp EECC-------------------CCGGGCCHHHHH--HCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-T
T ss_pred EEccchhheeccCCcceeccceecCcccchhhHhc--cCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH-c
Confidence 9999999985432 22334456899999999998 4578999999999999999998 899999998888887764 4
Q ss_pred cCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1037 TLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1037 ~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
+.++.++..+++.+.+||.+||..||++|||+.+|+++|..+...
T Consensus 225 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 225 GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 556678889999999999999999999999999999999988643
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-49 Score=422.51 Aligned_cols=252 Identities=25% Similarity=0.379 Sum_probs=216.9
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
+.|++++.||+|+||+||+|+++ +..||||++..... .....|.+|+++|++++|||||++++++.+..
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--------~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~- 82 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE--------EELEDYMVEIDILASCDHPNIVKLLDAFYYEN- 82 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS--------GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH--------HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-
Confidence 46899999999999999999985 67899999976421 11246789999999999999999999998865
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++|||||.+|+|.+++.+..+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|
T Consensus 83 -~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~----~~~~~Kl~DFG~a 157 (288)
T d2jfla1 83 -NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFT----LDGDIKLADFGVS 157 (288)
T ss_dssp -EEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECCCTTC
T ss_pred -eEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeEC----CCCCEEEEechhh
Confidence 89999999999999999877667799999999999999999999999999999999999999 7789999999999
Q ss_pred ccccC-ccccCCccCCCcccCcccccc---CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccC-CCCC
Q 037285 968 KIKRN-TLVSGGVRGTLPWMAPELLSG---SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL-RPTI 1042 (1094)
Q Consensus 968 rl~~~-~~~ss~~~GT~~YmAPEvL~g---~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~l-rp~i 1042 (1094)
+.... ........||+.|+|||++.+ ....|+.++|||||||++|||+||+.||......+.+..+..... ....
T Consensus 158 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 237 (288)
T d2jfla1 158 AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ 237 (288)
T ss_dssp EECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSS
T ss_pred hccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 75432 223345679999999999853 234578999999999999999999999999888888777766543 2344
Q ss_pred CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037285 1043 PSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1043 Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L 1075 (1094)
+..+++++++||.+||+.||.+|||+.+++++-
T Consensus 238 ~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp 270 (288)
T d2jfla1 238 PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHP 270 (288)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSG
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 568899999999999999999999999999863
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-48 Score=415.97 Aligned_cols=252 Identities=32% Similarity=0.543 Sum_probs=211.5
Q ss_pred CeeEE-EEecccCceEEEEeeec----CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC
Q 037285 811 DLEEQ-KELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 811 dYei~-kkLGsG~FGtVYKAk~r----Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~ 885 (1094)
.+.+. ++||+|+||+||+|.++ ++.||||+++.... ......+|.+|+.+|++++|||||+++++|..+
T Consensus 7 ~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~------~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~ 80 (277)
T d1xbba_ 7 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN------DPALKDELLAEANVMQQLDNPYIVRMIGICEAE 80 (277)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS
T ss_pred hCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC------CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC
Confidence 34443 57999999999999874 24699999875421 123346799999999999999999999999753
Q ss_pred CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecC
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFG 965 (1094)
.+++||||+++|+|.+++.... .+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+|||
T Consensus 81 ---~~~lvmE~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~----~~~~~kl~DFG 152 (277)
T d1xbba_ 81 ---SWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV----TQHYAKISDFG 152 (277)
T ss_dssp ---SEEEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE----ETTEEEECCCT
T ss_pred ---CEEEEEEcCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccc----ccCcccccchh
Confidence 5789999999999999987654 599999999999999999999999999999999999999 78899999999
Q ss_pred CcccccCc----cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCC
Q 037285 966 LSKIKRNT----LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 1040 (1094)
Q Consensus 966 LSrl~~~~----~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp 1040 (1094)
+++..... .......||+.|+|||++. ...++.++|||||||++|||+| |+.||.+....++...+ ..+.++
T Consensus 153 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~--~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i-~~~~~~ 229 (277)
T d1xbba_ 153 LSKALRADENYYKAQTHGKWPVKWYAPECIN--YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-EKGERM 229 (277)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHH--HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-HTTCCC
T ss_pred hhhhccccccccccccccCCCceecCchhhc--CCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHH-HcCCCC
Confidence 99854322 1223456899999999998 4568999999999999999998 99999998887766655 456678
Q ss_pred CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1041 TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1041 ~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
..|..++.++++||.+||+.||++|||+.+|++.|+...
T Consensus 230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 889999999999999999999999999999999888764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=414.39 Aligned_cols=257 Identities=35% Similarity=0.610 Sum_probs=220.4
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
|+|..++|++.+.||+|+||.||+|+++|+.||||+++... ..+.|.+|+++|++++||||++++++|.+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~----------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~ 71 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----------TAQAFLAEASVMTQLRHSNLVQLLGVIVE 71 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------------HHHHHTHHHHTTCCCTTBCCEEEEECC
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH----------HHHHHHHHHHHHHhCCCCCEeeEEEEEEe
Confidence 78999999999999999999999999999999999996532 12568899999999999999999999875
Q ss_pred CCCCceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEe
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGD 963 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsD 963 (1094)
.. ..+++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|
T Consensus 72 ~~-~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~----~~~~~kl~d 146 (262)
T d1byga_ 72 EK-GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS----EDNVAKVSD 146 (262)
T ss_dssp C---CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----TTSCEEECC
T ss_pred cC-CcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheec----CCCCEeecc
Confidence 42 36899999999999999996543 4589999999999999999999999999999999999999 788999999
Q ss_pred cCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhhccCCCCC
Q 037285 964 FGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPTI 1042 (1094)
Q Consensus 964 FGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~i 1042 (1094)
||+++...... ....+|..|+|||++. ...++.++|||||||++|||+| |+.||......++...+ ..+.++.+
T Consensus 147 fg~s~~~~~~~--~~~~~~~~y~aPE~l~--~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i-~~~~~~~~ 221 (262)
T d1byga_ 147 FGLTKEASSTQ--DTGKLPVKWTAPEALR--EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMDA 221 (262)
T ss_dssp CCC--------------CCTTTSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH-TTTCCCCC
T ss_pred cccceecCCCC--ccccccccCCChHHHh--CCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHH-HcCCCCCC
Confidence 99998654432 2345789999999998 4578999999999999999998 79999988888777766 45677888
Q ss_pred CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1043 PSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1043 Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
+..+++++++||.+||+.||.+|||+.+|+++|+.+++.
T Consensus 222 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 999999999999999999999999999999999998754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-48 Score=420.20 Aligned_cols=249 Identities=27% Similarity=0.411 Sum_probs=215.3
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
.+|++.++||+|+||+||+|+++ |+.||||++...... ..+.+.+|+.+|++++|||||++++++.+..
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~- 90 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--------KKELIINEILVMRENKNPNIVNYLDSYLVGD- 90 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--------CHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--------HHHHHHHHHHHHHhCCCCCEeeEeEEEEECC-
Confidence 47999999999999999999875 788999999764321 1246889999999999999999999999865
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+|+|||||.+|+|.+++.+. .+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|
T Consensus 91 -~~~ivmEy~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~----~~~~vkl~DFG~a 163 (293)
T d1yhwa1 91 -ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG----MDGSVKLTDFGFC 163 (293)
T ss_dssp -EEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCCEEECCCTTC
T ss_pred -EEEEEEEecCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEEC----CCCcEeeccchhh
Confidence 899999999999999987653 589999999999999999999999999999999999998 6789999999999
Q ss_pred cccc-CccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhcc-CCCCCCCc
Q 037285 968 KIKR-NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-LRPTIPSY 1045 (1094)
Q Consensus 968 rl~~-~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~-lrp~iPe~ 1045 (1094)
+... ........+||+.|+|||++. ...++.++|||||||++|+|+||+.||.+......+..+.... .....+..
T Consensus 164 ~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (293)
T d1yhwa1 164 AQITPEQSKRSTMVGTPYWMAPEVVT--RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241 (293)
T ss_dssp EECCSTTCCBCCCCSCGGGCCHHHHS--SSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGG
T ss_pred eeeccccccccccccCCCccChhhhc--CCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccc
Confidence 8543 333445667999999999998 4568899999999999999999999999888777666555443 33456678
Q ss_pred CcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1046 CDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1046 ~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
+++++++||.+||+.||.+|||+.++++|-+
T Consensus 242 ~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~ 272 (293)
T d1yhwa1 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQF 272 (293)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHTTCGG
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 9999999999999999999999999998644
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.5e-48 Score=422.04 Aligned_cols=251 Identities=28% Similarity=0.428 Sum_probs=217.6
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
.|+.++.||+|+||+||+|+++ +..||||++..... ........+.+|+.+|++++|||||++++++.+..
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-----~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-- 88 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-----QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-- 88 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS-----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhc-----cCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC--
Confidence 5999999999999999999874 67799999976432 12334567899999999999999999999998865
Q ss_pred ceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 889 TLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
.+++|||||.+|+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+
T Consensus 89 ~~~iv~E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~----~~~~~Kl~DFG~a~ 163 (309)
T d1u5ra_ 89 TAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS----EPGLVKLGDFGSAS 163 (309)
T ss_dssp EEEEEEECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE----TTTEEEECCCTTCB
T ss_pred EEEEEEEecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEC----CCCCEEEeeccccc
Confidence 899999999999997766544 4599999999999999999999999999999999999999 78899999999998
Q ss_pred cccCccccCCccCCCcccCccccccC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCc
Q 037285 969 IKRNTLVSGGVRGTLPWMAPELLSGS-SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCD 1047 (1094)
Q Consensus 969 l~~~~~~ss~~~GT~~YmAPEvL~g~-~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S 1047 (1094)
..... ....||+.|||||++.+. ...|+.++|||||||++|||++|+.||......+.+..+.........+..++
T Consensus 164 ~~~~~---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s 240 (309)
T d1u5ra_ 164 IMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS 240 (309)
T ss_dssp SSSSB---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSC
T ss_pred ccCCC---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCC
Confidence 65432 345799999999998742 34689999999999999999999999999888888877777666555667789
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1048 AEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1048 ~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
+++++||.+||+.||.+|||+.++++|-+
T Consensus 241 ~~~~~li~~~L~~dP~~Rpt~~ell~Hp~ 269 (309)
T d1u5ra_ 241 EYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (309)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHHhCHH
Confidence 99999999999999999999999987533
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-48 Score=416.24 Aligned_cols=260 Identities=23% Similarity=0.340 Sum_probs=222.8
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||+|+||+||+|+++ |+.||||++++........ ......|.+|+.+|++|+|||||++++++.+..
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~- 86 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRR--GVSREDIEREVSILKEIQHPNVITLHEVYENKT- 86 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSS--SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhh--hHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-
Confidence 57999999999999999999985 7889999998764432211 122467889999999999999999999999865
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++|||||++|+|.+++...+ .+++..++.++.||+.||+|||+++|+||||||+|||++..+.....+||+|||++
T Consensus 87 -~~~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 87 -DVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp -EEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred -EEEEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhh
Confidence 8999999999999999997654 59999999999999999999999999999999999999855444557999999999
Q ss_pred ccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCC--CCCc
Q 037285 968 KIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT--IPSY 1045 (1094)
Q Consensus 968 rl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~--iPe~ 1045 (1094)
+............||+.|+|||++. ...++.++|||||||++|||+||+.||.+.+..+.+..+........ .+..
T Consensus 165 ~~~~~~~~~~~~~~t~~y~APE~~~--~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (293)
T d1jksa_ 165 HKIDFGNEFKNIFGTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242 (293)
T ss_dssp EECTTSCBCSCCCCCGGGCCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred hhcCCCccccccCCCCcccCHHHHc--CCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCC
Confidence 8766555555667999999999998 45789999999999999999999999999988888877766544322 3357
Q ss_pred CcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1046 CDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1046 ~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
++.++++||.+||+.||.+|||+.+++++-+
T Consensus 243 ~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 273 (293)
T d1jksa_ 243 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 273 (293)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 8999999999999999999999999998643
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=418.07 Aligned_cols=252 Identities=29% Similarity=0.360 Sum_probs=207.6
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||+|+||+||+|+++ |+.||||++...... .....+.+|+.+|++++|||||++++++.+..
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-------~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~- 76 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-------DCPENIKKEICINKMLNHENVVKFYGHRREGN- 76 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------------CHHHHHHHHHTCCCTTBCCEEEEEEETT-
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-------hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCc-
Confidence 57999999999999999999985 778999999764221 12346889999999999999999999999865
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+|+|||||.+|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|
T Consensus 77 -~~~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~----~~~~~KL~DFG~a 150 (271)
T d1nvra_ 77 -IQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD----ERDNLKISDFGLA 150 (271)
T ss_dssp -EEEEEEECCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC----TTCCEEECCCTTC
T ss_pred -eeEEEEeccCCCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEEC----CCCCEEEccchhh
Confidence 8999999999999999986544 599999999999999999999999999999999999998 6788999999999
Q ss_pred ccccC---ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH-HHHhHhhccCCCCCC
Q 037285 968 KIKRN---TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA-IIGGIVNNTLRPTIP 1043 (1094)
Q Consensus 968 rl~~~---~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~e-ile~Iv~~~lrp~iP 1043 (1094)
+.... .......+||+.|||||++.+ ...++.++|||||||++|||+||+.||....... ...............
T Consensus 151 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 229 (271)
T d1nvra_ 151 TVFRYNNRERLLNKMCGTLPYVAPELLKR-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 229 (271)
T ss_dssp EECEETTEECCBCCCCSCGGGSCTHHHHC-SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTG
T ss_pred eeeccCCccccccceeeCcCccCHhHhcC-CCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCcc
Confidence 85422 223345679999999999984 2234678999999999999999999997755433 223333333333334
Q ss_pred CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1044 SYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1044 e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
..+++++.+||.+||+.||.+|||+.+++++-+
T Consensus 230 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpw 262 (271)
T d1nvra_ 230 KKIDSAPLALLHKILVENPSARITIPDIKKDRW 262 (271)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence 578999999999999999999999999988644
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-48 Score=415.19 Aligned_cols=266 Identities=31% Similarity=0.521 Sum_probs=217.3
Q ss_pred cceeeccCCeeEEEEecccCceEEEEeeecC-------ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCc
Q 037285 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPN 874 (1094)
Q Consensus 803 sv~eIs~edYei~kkLGsG~FGtVYKAk~rG-------t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPN 874 (1094)
..|+|..++|++.++||+|+||.||+|++.+ +.||||+++.... ......+.+|..++.++ +|+|
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~-------~~~~~~~~~e~~~l~~~~~h~~ 78 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-------HSEHRALMSELKILIHIGHHLN 78 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C-------HHHHHHHHHHHHHHHHHCCCTT
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-------cHHHHHHHHHHHHHHhhcCCCe
Confidence 3578888999999999999999999998742 4699999875321 22235677888888776 6899
Q ss_pred eeEEEeEeecCCCCceEEEeeecccchhHHHHhhcc---------------cccCHHHHHHHHHHHHHHHHHHHHCCcee
Q 037285 875 VVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD---------------RFLDRRRRLIIAMDAAFGMEYLHSKNIVH 939 (1094)
Q Consensus 875 IVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~---------------~~Lse~~~l~Ia~QIaeGLaYLHs~GIIH 939 (1094)
|+.+++++... ...+++|||||++|+|.+++.... ..+++..++.++.||+.||+|||+++|||
T Consensus 79 iv~~~~~~~~~-~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivH 157 (299)
T d1ywna1 79 VVNLLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIH 157 (299)
T ss_dssp BCCEEEEECST-TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred EEEeeeeeccC-CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcC
Confidence 99999988754 347899999999999999996542 24889999999999999999999999999
Q ss_pred ccCCCCceEeccCCCCCCcEEEEecCCcccccC---ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc
Q 037285 940 FDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRN---TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT 1016 (1094)
Q Consensus 940 RDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~---~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT 1016 (1094)
|||||+|||++ .++.+||+|||+|+.... ........||+.|+|||++. ...++.++|||||||++|||+|
T Consensus 158 rDlKp~NILl~----~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~--~~~~~~~sDiwS~Gvil~ellt 231 (299)
T d1ywna1 158 RDLAARNILLS----EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFS 231 (299)
T ss_dssp SCCCGGGEEEC----GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHT
T ss_pred CcCCccceeEC----CCCcEEEccCcchhhccccccccccCceeeCccccchhHhh--cCCCCcccceeehHHHHHHHHh
Confidence 99999999998 778999999999985332 22334567999999999998 4678999999999999999998
Q ss_pred C-CCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 037285 1017 G-EEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAA 1082 (1094)
Q Consensus 1017 G-k~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~ 1082 (1094)
| ..||......+.+...+..+.++..+..+++++++||.+||+.||++|||+.+|+++|+.+..+.
T Consensus 232 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 232 LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp TSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence 5 56898877666666667777888899999999999999999999999999999999999986543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=420.40 Aligned_cols=254 Identities=25% Similarity=0.367 Sum_probs=217.7
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
+.+++|++.+.||+|+||+||+|+++ ++.||||++.+... ..+.....+.+|+.+|++++|||||++++++.+
T Consensus 5 ~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-----~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 79 (288)
T d1uu3a_ 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI-----IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD 79 (288)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC
T ss_pred CCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHc-----cCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE
Confidence 34578999999999999999999885 67899999976422 122334678899999999999999999999988
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
.. .+|+|||||.+|+|.+++...+ .+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+||
T Consensus 80 ~~--~~~ivmEy~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~----~~~~vkl~DF 152 (288)
T d1uu3a_ 80 DE--KLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN----EDMHIQITDF 152 (288)
T ss_dssp SS--EEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTSCEEECCC
T ss_pred CC--EEEEEEEccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccC----CCceEEeccc
Confidence 65 8999999999999999987665 599999999999999999999999999999999999999 7789999999
Q ss_pred CCcccccC---ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCC
Q 037285 965 GLSKIKRN---TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT 1041 (1094)
Q Consensus 965 GLSrl~~~---~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~ 1041 (1094)
|+|+.... .......+||+.|+|||++. ...++.++|||||||++|+|+||+.||...+..++...+.... ..
T Consensus 153 G~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~--~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~--~~ 228 (288)
T d1uu3a_ 153 GTAKVLSPESKQARANSFVGTAQYVSPELLT--EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE--YD 228 (288)
T ss_dssp TTCEECC----------CCCCGGGCCHHHHH--TCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC--CC
T ss_pred ccceecccCCcccccccccCCccccCceeec--cCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC--CC
Confidence 99986432 22334567999999999998 4578999999999999999999999999988888887776654 35
Q ss_pred CCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1042 IPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1042 iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
+|..+++++++||.+||+.||.+|||+++++++.+
T Consensus 229 ~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~ 263 (288)
T d1uu3a_ 229 FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263 (288)
T ss_dssp CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHH
Confidence 67889999999999999999999999999866544
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-48 Score=421.67 Aligned_cols=254 Identities=26% Similarity=0.368 Sum_probs=203.6
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.+.|++.+.||+|+||+||+|+++ ++.||||++.+..... ....+.+|+.+|++++|||||++++++.+..
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 80 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-------KEGSMENEIAVLHKIKHPNIVALDDIYESGG 80 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------------CHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-------HHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 357999999999999999999885 6789999998653321 1245778999999999999999999998865
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+|+|||||++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||+...+ .++.+||+|||+
T Consensus 81 --~~~lvmE~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~-~~~~vkl~DFG~ 156 (307)
T d1a06a_ 81 --HLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLD-EDSKIMISDFGL 156 (307)
T ss_dssp --EEEEEECCCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS-TTCCEEECCC--
T ss_pred --EEEEEEeccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccC-CCceEEEeccce
Confidence 8999999999999999997654 599999999999999999999999999999999999996332 568899999999
Q ss_pred cccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCC--CCCC
Q 037285 967 SKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP--TIPS 1044 (1094)
Q Consensus 967 Srl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp--~iPe 1044 (1094)
|+...........+||+.|||||++. ...|+.++|||||||++|+|++|+.||......+....+....... ..+.
T Consensus 157 a~~~~~~~~~~~~~GT~~y~APE~~~--~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (307)
T d1a06a_ 157 SKMEDPGSVLSTACGTPGYVAPEVLA--QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWD 234 (307)
T ss_dssp ----------------CTTSCHHHHT--TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTT
T ss_pred eEEccCCCeeeeeeeCccccCcHHHc--CCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCcccc
Confidence 98765555555677999999999998 4568999999999999999999999999988888888777765543 3346
Q ss_pred cCcHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037285 1045 YCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1045 ~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L 1075 (1094)
.+++++.+||.+||..||.+|||+.+++++-
T Consensus 235 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 265 (307)
T d1a06a_ 235 DISDSAKDFIRHLMEKDPEKRFTCEQALQHP 265 (307)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred CCCHHHHHHHHHHccCCHhHCcCHHHHhcCH
Confidence 7899999999999999999999999999863
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-48 Score=414.07 Aligned_cols=259 Identities=32% Similarity=0.563 Sum_probs=216.8
Q ss_pred eeccCCeeEEEEecccCceEEEEeeecC-----ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEe
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYG 880 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~rG-----t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~G 880 (1094)
.|..++|++.+.||+|+||.||+|++++ ..||||++++.... .+....+|.+|+.+|++++|||||++++
T Consensus 4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~-----~~~~~~~~~~Ei~~l~~l~H~nIv~~~g 78 (273)
T d1u46a_ 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-----QPEAMDDFIREVNAMHSLDHRNLIRLYG 78 (273)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC-------------CHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred EEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcC-----CHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 3667899999999999999999998742 35899998765322 1234467999999999999999999999
Q ss_pred EeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEE
Q 037285 881 VVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICK 960 (1094)
Q Consensus 881 v~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VK 960 (1094)
+|.+. .+++||||+++|+|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+|
T Consensus 79 ~~~~~---~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~----~~~~vk 151 (273)
T d1u46a_ 79 VVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA----TRDLVK 151 (273)
T ss_dssp EECSS---SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE----ETTEEE
T ss_pred EEeec---chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccc----ccccee
Confidence 99763 57899999999999999887777799999999999999999999999999999999999999 678999
Q ss_pred EEecCCcccccCc----cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHhh
Q 037285 961 VGDFGLSKIKRNT----LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 1035 (1094)
Q Consensus 961 LsDFGLSrl~~~~----~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv~ 1035 (1094)
|+|||+++..... .......+|..|+|||++. ...++.++|||||||++|||+| |+.||...+..+....+..
T Consensus 152 l~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~ 229 (273)
T d1u46a_ 152 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK--TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229 (273)
T ss_dssp ECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHH--HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred eccchhhhhcccCCCcceecCccccCcccCCHHHHh--CCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHh
Confidence 9999999854322 2223345788999999998 4568899999999999999998 8999999999999998888
Q ss_pred ccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 037285 1036 NTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVL 1078 (1094)
Q Consensus 1036 ~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L 1078 (1094)
...++..+..++..+.+||.+||+.||++||||.+|++.|.+.
T Consensus 230 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 230 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 8888888999999999999999999999999999999988874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=416.97 Aligned_cols=259 Identities=28% Similarity=0.550 Sum_probs=218.4
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeec--Cc----eEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEE
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWR--GT----DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAF 878 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~r--Gt----~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL 878 (1094)
..+..++|+++++||+|+||+||+|++. |+ .||||.++... ......+|.+|+.+|++++|||||++
T Consensus 4 ~~~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~l 76 (317)
T d1xkka_ 4 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-------SPKANKEILDEAYVMASVDNPHVCRL 76 (317)
T ss_dssp EECCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----------CTHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccCCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-------CHHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 3456778999999999999999999885 33 48888876431 12234678999999999999999999
Q ss_pred EeEeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCc
Q 037285 879 YGVVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPI 958 (1094)
Q Consensus 879 ~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~ 958 (1094)
+++|.+. ..+++|||+.+|+|.+++......+++..++.++.||+.||+|||+++|+||||||+|||++ .++.
T Consensus 77 ~g~~~~~---~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~----~~~~ 149 (317)
T d1xkka_ 77 LGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK----TPQH 149 (317)
T ss_dssp EEEEESS---SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE----ETTE
T ss_pred EEEEecC---CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeC----CCCC
Confidence 9999875 57889999999999999988877899999999999999999999999999999999999999 7889
Q ss_pred EEEEecCCcccccC---ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhHh
Q 037285 959 CKVGDFGLSKIKRN---TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIV 1034 (1094)
Q Consensus 959 VKLsDFGLSrl~~~---~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLT-Gk~PF~~~~~~eile~Iv 1034 (1094)
+||+|||+|+.... ........||+.|+|||++. ...++.++|||||||++|||+| |..||......++...+
T Consensus 150 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~--~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i- 226 (317)
T d1xkka_ 150 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL- 226 (317)
T ss_dssp EEECCCSHHHHTTTTCC--------CCTTTSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH-
T ss_pred eEeeccccceecccccccccccccccCccccChHHHh--cCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH-
Confidence 99999999985432 22233456899999999998 4578999999999999999998 89999988877765544
Q ss_pred hccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 037285 1035 NNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLST 1080 (1094)
Q Consensus 1035 ~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~t 1080 (1094)
..+.++..|..+++++.+||.+||+.||.+|||+.+|+++|..+..
T Consensus 227 ~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 227 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp HHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 5567778889999999999999999999999999999999998753
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.4e-47 Score=424.27 Aligned_cols=252 Identities=21% Similarity=0.323 Sum_probs=220.0
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||+|+||.||+|+++ |..||||++.... ......+.+|+.+|++|+|||||++++++.+..
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~- 96 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--------ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN- 96 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--------HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT-
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--------hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-
Confidence 58999999999999999999885 7889999987542 112356889999999999999999999999865
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++|||||.+|+|.+++......+++..++.++.||+.||+|||++|||||||||+|||++.+ .++.+||+|||++
T Consensus 97 -~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~--~~~~vkL~DFG~a 173 (350)
T d1koaa2 97 -EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK--RSNELKLIDFGLT 173 (350)
T ss_dssp -EEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST--TSCCEEECCCTTC
T ss_pred -EEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccC--CCCeEEEeecchh
Confidence 8999999999999999997666679999999999999999999999999999999999999622 3578999999999
Q ss_pred ccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCC--CCCc
Q 037285 968 KIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT--IPSY 1045 (1094)
Q Consensus 968 rl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~--iPe~ 1045 (1094)
+............||+.|||||++. ...++.++|||||||++|+|+||+.||.+.+..+.+..+....+... ....
T Consensus 174 ~~~~~~~~~~~~~gT~~Y~aPEv~~--~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 251 (350)
T d1koaa2 174 AHLDPKQSVKVTTGTAEFAAPEVAE--GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG 251 (350)
T ss_dssp EECCTTSCEEEECSCTTTCCHHHHH--TCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGG
T ss_pred eecccccccceecCcccccCHHHHc--CCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccC
Confidence 9766555555677999999999998 45678999999999999999999999999888888888776655432 2346
Q ss_pred CcHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037285 1046 CDAEWRTLMEECWAPNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1046 ~S~eL~dLI~kCLq~DPeeRPS~eELLq~L 1075 (1094)
+++++++||.+||..||.+|||+.+++++-
T Consensus 252 ~s~~~~~li~~~L~~dP~~R~t~~eil~hp 281 (350)
T d1koaa2 252 ISEDGKDFIRKLLLADPNTRMTIHQALEHP 281 (350)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHHHST
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 889999999999999999999999999873
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=408.17 Aligned_cols=249 Identities=31% Similarity=0.506 Sum_probs=207.5
Q ss_pred eeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC--CC
Q 037285 812 LEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG--PG 887 (1094)
Q Consensus 812 Yei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~--~~ 887 (1094)
|++.++||+|+||+||+|+++ +..||+|.+...... +.....|.+|+++|++++|||||++++++.+. ..
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 84 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT------KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 84 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC------HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccC
Confidence 367789999999999999885 567999999765322 22345788999999999999999999998642 23
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeccCCCCCCcEEEEecC
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNLKDPSRPICKVGDFG 965 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~G--IIHRDLKPeNILLD~~~~e~g~VKLsDFG 965 (1094)
..+++||||+++|+|.+++.+.. .+++..+..++.||+.||+|||+++ |+||||||+|||++. .++.+||+|||
T Consensus 85 ~~~~ivmE~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~---~~~~~Kl~DFG 160 (270)
T d1t4ha_ 85 KCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG---PTGSVKIGDLG 160 (270)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS---TTSCEEECCTT
T ss_pred CEEEEEEeCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeC---CCCCEEEeecC
Confidence 46899999999999999997654 5899999999999999999999998 999999999999961 46789999999
Q ss_pred CcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHH-HhHhhccCCCCCCC
Q 037285 966 LSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAII-GGIVNNTLRPTIPS 1044 (1094)
Q Consensus 966 LSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eil-e~Iv~~~lrp~iPe 1044 (1094)
+|+...... ....+||+.|||||++.+ .++.++|||||||++|||++|+.||........+ ..+........++.
T Consensus 161 la~~~~~~~-~~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 236 (270)
T d1t4ha_ 161 LATLKRASF-AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK 236 (270)
T ss_dssp GGGGCCTTS-BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGG
T ss_pred cceeccCCc-cCCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCc
Confidence 998654432 234679999999999873 5899999999999999999999999876655444 44433333344566
Q ss_pred cCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1045 YCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1045 ~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
.+++++++||.+||+.||++|||+.++++|
T Consensus 237 ~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 237 VAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp CCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 788999999999999999999999999876
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=417.39 Aligned_cols=254 Identities=28% Similarity=0.443 Sum_probs=208.4
Q ss_pred eeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEee
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQ 883 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~ 883 (1094)
++..++|++.++||+|+||+||+|+++ |..||||+++.... ......+.+|+.+|++++|||||+++++|.
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 74 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-------PAIRNQIIRELQVLHECNSPYIVGFYGAFY 74 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC-------TTHHHHHHHHGGGGGGCCCTTBCCEEEEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC-------HHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 356789999999999999999999985 67899999976421 122357889999999999999999999999
Q ss_pred cCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 884 DGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 884 d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs-~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
+.. .+++|||||.+|+|.+++.+.+ .+++..+..++.||+.||.|||+ +||+||||||+|||++ .++.+||+
T Consensus 75 ~~~--~~~iVmEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~----~~~~vkl~ 147 (322)
T d1s9ja_ 75 SDG--EISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLC 147 (322)
T ss_dssp CSS--EEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC----TTCCEEEC
T ss_pred ECC--EEEEEEEcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeEC----CCCCEEEe
Confidence 865 8999999999999999997665 49999999999999999999997 5999999999999998 78899999
Q ss_pred ecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHH------------
Q 037285 963 DFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAII------------ 1030 (1094)
Q Consensus 963 DFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eil------------ 1030 (1094)
|||+|+...... ....+||+.|+|||++. ...|+.++|||||||++|||++|+.||......+..
T Consensus 148 DFGla~~~~~~~-~~~~~GT~~Y~APEvl~--~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~ 224 (322)
T d1s9ja_ 148 DFGVSGQLIDSM-ANSFVGTRSYMSPERLQ--GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 224 (322)
T ss_dssp CCCCCHHHHHHT-C---CCSSCCCCHHHHH--CSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------
T ss_pred eCCCccccCCCc-cccccCCccccCchHHc--CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcc
Confidence 999998543322 23467999999999998 457899999999999999999999999765432211
Q ss_pred ------------------------------HhHhhccCCCCCC-CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1031 ------------------------------GGIVNNTLRPTIP-SYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1031 ------------------------------e~Iv~~~lrp~iP-e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
..+. ....+..+ ..++.++.+||.+||..||.+|||++++++|-+-
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~ 301 (322)
T d1s9ja_ 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIV-NEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301 (322)
T ss_dssp ---------------------CCCCHHHHHHHHH-TSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred cCCcccccccccccccccccccchhHHHHHhhhh-ccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhh
Confidence 0011 11111222 2467899999999999999999999999997543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=412.98 Aligned_cols=260 Identities=34% Similarity=0.603 Sum_probs=216.6
Q ss_pred cceeeccCCeeEEEEecccCceEEEEeeecC-ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeE
Q 037285 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGV 881 (1094)
Q Consensus 803 sv~eIs~edYei~kkLGsG~FGtVYKAk~rG-t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv 881 (1094)
..|+|..++|++.+.||+|+||.||+|++++ ..||||+++..... .+.|.+|+.+|++++|||||+++++
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~---------~~~~~~E~~~l~~l~h~nIv~~~g~ 80 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---------PEAFLQEAQVMKKLRHEKLVQLYAV 80 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC---------HHHHHHHHHHHHhcccCCEeEEEEE
Confidence 4578899999999999999999999999965 57999998754211 2568899999999999999999999
Q ss_pred eecCCCCceEEEeeecccchhHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEE
Q 037285 882 VQDGPGGTLATVAEYMVDGSLRHVLVRK-DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICK 960 (1094)
Q Consensus 882 ~~d~~~~~L~IVmEYmegGSL~d~L~k~-~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VK 960 (1094)
|.+. .+++||||+.+|+|..++... ...+++..++.++.||+.||+|||+++|+||||||+||||+ .++.+|
T Consensus 81 ~~~~---~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~----~~~~~k 153 (285)
T d1fmka3 81 VSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG----ENLVCK 153 (285)
T ss_dssp ECSS---SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----GGGCEE
T ss_pred EecC---CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEEC----CCCcEE
Confidence 8653 588999999999999888654 35699999999999999999999999999999999999998 778999
Q ss_pred EEecCCcccccCc--cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCChHHHHHhHhhcc
Q 037285 961 VGDFGLSKIKRNT--LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTG-EEPYANMHYGAIIGGIVNNT 1037 (1094)
Q Consensus 961 LsDFGLSrl~~~~--~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTG-k~PF~~~~~~eile~Iv~~~ 1037 (1094)
|+|||+++..... .......||+.|+|||++. ...++.++|||||||++|||+|| ++||......+.+..+ ...
T Consensus 154 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i-~~~ 230 (285)
T d1fmka3 154 VADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERG 230 (285)
T ss_dssp ECCCCTTC--------------CCGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-HTT
T ss_pred EcccchhhhccCCCceeeccccccccccChHHHh--CCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH-Hhc
Confidence 9999999854322 2233456899999999998 56789999999999999999995 5555666666565554 456
Q ss_pred CCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1038 LRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1038 lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
.++..+..+++++.+||.+||+.||++||++.+|+++|..+.+.
T Consensus 231 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 231 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 67778899999999999999999999999999999999887643
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-47 Score=410.05 Aligned_cols=259 Identities=31% Similarity=0.546 Sum_probs=221.3
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeecC-------ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeE
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVA 877 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~rG-------t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVq 877 (1094)
+++..++|++.+.||+|+||+||+|++++ +.||||+++... ......+|.+|+.+|++++||||++
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-------~~~~~~~~~~E~~il~~l~h~niv~ 80 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-------SADMQADFQREAALMAEFDNPNIVK 80 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-------CHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-------ChHHHHHHHHHHHHHHhcCCCCccc
Confidence 45677899999999999999999999854 569999986532 1223467899999999999999999
Q ss_pred EEeEeecCCCCceEEEeeecccchhHHHHhhcc-----------------------cccCHHHHHHHHHHHHHHHHHHHH
Q 037285 878 FYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD-----------------------RFLDRRRRLIIAMDAAFGMEYLHS 934 (1094)
Q Consensus 878 L~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~-----------------------~~Lse~~~l~Ia~QIaeGLaYLHs 934 (1094)
++++|.+.. .+++||||+.+|+|.+++.... ..+++..++.++.||+.||+|||+
T Consensus 81 ~~~~~~~~~--~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~ 158 (301)
T d1lufa_ 81 LLGVCAVGK--PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE 158 (301)
T ss_dssp EEEEECSSS--SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ceeeeccCC--ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc
Confidence 999998754 8999999999999999986432 247899999999999999999999
Q ss_pred CCceeccCCCCceEeccCCCCCCcEEEEecCCcccccC---ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHH
Q 037285 935 KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRN---TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVL 1011 (1094)
Q Consensus 935 ~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~---~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLL 1011 (1094)
++||||||||+|||++ .++.+||+|||+|+.... ........+|+.|+|||++. ...|+.++|||||||++
T Consensus 159 ~~ivHrDlKp~NILld----~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~t~ksDVwS~Gvvl 232 (301)
T d1lufa_ 159 RKFVHRDLATRNCLVG----ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF--YNRYTTESDVWAYGVVL 232 (301)
T ss_dssp TTCCCSCCSGGGEEEC----GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH--HCCCCHHHHHHHHHHHH
T ss_pred CCeEeeEEcccceEEC----CCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHc--cCCCChhhhhccchhhH
Confidence 9999999999999999 778999999999984322 22334456889999999998 56789999999999999
Q ss_pred HHHHcCC-CCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1012 WEILTGE-EPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1012 yELLTGk-~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
|||++|. .||......++...+. .+.++..|..+++++.+||.+||+.||.+||||.+|+++|+++.
T Consensus 233 ~ell~~~~~p~~~~~~~e~~~~v~-~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 233 WEIFSYGLQPYYGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHccCCCCCCCCCHHHHHHHHH-cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 9999975 6899988888877764 45567788899999999999999999999999999999999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.6e-47 Score=420.37 Aligned_cols=251 Identities=21% Similarity=0.324 Sum_probs=219.5
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++.+.||+|+||.||+|+++ |+.||||++.... . .....+.+|+.+|++|+|||||+++++|.+..
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~- 99 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-----P---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKY- 99 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----H---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS-
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-----h---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-
Confidence 57999999999999999999874 7889999987642 1 11346789999999999999999999998755
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+|+|||||.+|+|.+++......+++..++.|+.||+.||+|||++||+||||||+|||++.. ..+.+||+|||+|
T Consensus 100 -~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~--~~~~vkL~DFGla 176 (352)
T d1koba_ 100 -EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK--KASSVKIIDFGLA 176 (352)
T ss_dssp -EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST--TCCCEEECCCTTC
T ss_pred -EEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccccccccc--CCCeEEEeecccc
Confidence 8999999999999999887776679999999999999999999999999999999999999732 3578999999999
Q ss_pred ccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCC--CCCCCc
Q 037285 968 KIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR--PTIPSY 1045 (1094)
Q Consensus 968 rl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lr--p~iPe~ 1045 (1094)
+............||+.|+|||++. ...++.++|||||||++|+|+||+.||.+....+.+..+...... ......
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 254 (352)
T d1koba_ 177 TKLNPDEIVKVTTATAEFAAPEIVD--REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS 254 (352)
T ss_dssp EECCTTSCEEEECSSGGGCCHHHHT--TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTT
T ss_pred eecCCCCceeeccCcccccCHHHHc--CCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccC
Confidence 9766555555567999999999998 567899999999999999999999999999888888877665543 234467
Q ss_pred CcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1046 CDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1046 ~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
+++++.+||.+||+.||.+|||+.+++++
T Consensus 255 ~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 255 VSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 89999999999999999999999999986
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-47 Score=416.06 Aligned_cols=253 Identities=26% Similarity=0.390 Sum_probs=221.1
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeec
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQD 884 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d 884 (1094)
|+.++|++++.||+|+||.||+|+.+ |+.||||++++.... .......+.+|+.+|++++||||+++++++.+
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~-----~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 76 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-----AKDEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhcc-----CHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc
Confidence 45678999999999999999999874 788999999864321 12234668899999999999999999999998
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
.. .+|+|||||.+|+|.+++.+.+ .+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus 77 ~~--~~~iv~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~----~~g~vkl~DF 149 (337)
T d1o6la_ 77 HD--RLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD----KDGHIKITDF 149 (337)
T ss_dssp SS--EEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEECCC
T ss_pred cc--ccccceeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEec----CCCCEEEeec
Confidence 65 8999999999999999987665 489999999999999999999999999999999999999 7889999999
Q ss_pred CCccccc-CccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCC
Q 037285 965 GLSKIKR-NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIP 1043 (1094)
Q Consensus 965 GLSrl~~-~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iP 1043 (1094)
|+|+... ........+||+.|+|||++. ...|+.++|||||||++|||++|+.||...+..++...+.... ..+|
T Consensus 150 G~a~~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~--~~~p 225 (337)
T d1o6la_ 150 GLCKEGISDGATMKTFCGTPEYLAPEVLE--DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFP 225 (337)
T ss_dssp TTCBCSCCTTCCBCCCEECGGGCCGGGGS--SSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCC
T ss_pred ccccccccCCcccccceeCHHHhhhhhcc--CCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC--CCCC
Confidence 9998543 333445678999999999998 4578899999999999999999999999999888887776654 4578
Q ss_pred CcCcHHHHHHHHHhccCCCCCCCC-----HHHHHHHH
Q 037285 1044 SYCDAEWRTLMEECWAPNPAARPS-----FTEIASRL 1075 (1094)
Q Consensus 1044 e~~S~eL~dLI~kCLq~DPeeRPS-----~eELLq~L 1075 (1094)
..+++++++||.+||+.||.+|++ +.++++|-
T Consensus 226 ~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp 262 (337)
T d1o6la_ 226 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred ccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCc
Confidence 899999999999999999999994 89998863
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2e-46 Score=402.00 Aligned_cols=259 Identities=24% Similarity=0.285 Sum_probs=224.2
Q ss_pred cCCeeEEEEecccCceEEEEeee--cCceEEEEEeecCccCCCc-hhHHHHHHHHHHHHHHHhhCC-CCceeEEEeEeec
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRS-SEQERLTVEFWKEAEILSKLH-HPNVVAFYGVVQD 884 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~--rGt~VAVKiIkk~~~se~~-~eqe~~~~eFlrEIkILkrL~-HPNIVqL~Gv~~d 884 (1094)
.++|++.+.||+|+||+||+|+. .|+.||||++.+....... ...+.....+.+|+.+|++++ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 36899999999999999999987 4688999999876544322 223445567899999999997 9999999999998
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
.. .+|||||||++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus 82 ~~--~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~----~~~~~kl~DF 154 (277)
T d1phka_ 82 NT--FFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD----DDMNIKLTDF 154 (277)
T ss_dssp SS--EEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEEECCC
T ss_pred Cc--ceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEc----CCCCeEEccc
Confidence 55 8999999999999999997655 599999999999999999999999999999999999998 7889999999
Q ss_pred CCcccccCccccCCccCCCcccCcccccc----CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCC
Q 037285 965 GLSKIKRNTLVSGGVRGTLPWMAPELLSG----SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 1040 (1094)
Q Consensus 965 GLSrl~~~~~~ss~~~GT~~YmAPEvL~g----~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp 1040 (1094)
|+++............||+.|+|||++.+ ....++.++|||||||++|+|+||+.||...........+.......
T Consensus 155 G~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~ 234 (277)
T d1phka_ 155 GFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 234 (277)
T ss_dssp TTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred hheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 99997665555556779999999999863 23457889999999999999999999999998888887777765543
Q ss_pred CC--CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1041 TI--PSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1041 ~i--Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
.. ...+++++++||.+||+.||.+|||+.+|+++
T Consensus 235 ~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 235 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 33 34789999999999999999999999999876
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=406.17 Aligned_cols=268 Identities=31% Similarity=0.503 Sum_probs=230.9
Q ss_pred cCCCcceeeccCCeeEEEEecccCceEEEEeeecC-------ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-
Q 037285 799 FDVSSVQVIKNEDLEEQKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL- 870 (1094)
Q Consensus 799 ~dlssv~eIs~edYei~kkLGsG~FGtVYKAk~rG-------t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL- 870 (1094)
+.....|+|..++|++.++||+|+||.||+|++++ +.||||+++.... ......|.+|+.+++++
T Consensus 12 ~~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-------~~~~~~~~~E~~~~~~l~ 84 (311)
T d1t46a_ 12 LPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-------LTEREALMSELKVLSYLG 84 (311)
T ss_dssp SCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-------HHHHHHHHHHHHHHHHHC
T ss_pred CCCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC-------HHHHHHHHHHHHHHHhcc
Confidence 33345788999999999999999999999998742 4699999975421 22345788999999999
Q ss_pred CCCceeEEEeEeecCCCCceEEEeeecccchhHHHHhhcc-----------------cccCHHHHHHHHHHHHHHHHHHH
Q 037285 871 HHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD-----------------RFLDRRRRLIIAMDAAFGMEYLH 933 (1094)
Q Consensus 871 ~HPNIVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~-----------------~~Lse~~~l~Ia~QIaeGLaYLH 933 (1094)
+|||||+++++|.+.. .+++|||||++|+|.+++.... ..+++..++.++.||+.||+|||
T Consensus 85 ~HpnIv~~~g~~~~~~--~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH 162 (311)
T d1t46a_ 85 NHMNIVNLLGACTIGG--PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA 162 (311)
T ss_dssp CCTTBCCEEEEECSSS--SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCEEEEEEEEeeCC--EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 6999999999998865 7999999999999999986543 25899999999999999999999
Q ss_pred HCCceeccCCCCceEeccCCCCCCcEEEEecCCcccccC---ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHH
Q 037285 934 SKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRN---TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIV 1010 (1094)
Q Consensus 934 s~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~---~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVL 1010 (1094)
+++|+||||||+|||++ ..+.+||+|||+++.... ........||+.|+|||++. ...++.++|||||||+
T Consensus 163 ~~~ivHrDLKp~NIl~~----~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DIwS~G~~ 236 (311)
T d1t46a_ 163 SKNCIHRDLAARNILLT----HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF--NCVYTFESDVWSYGIF 236 (311)
T ss_dssp HTTCCCSCCSGGGEEEE----TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH--HCCCCHHHHHHHHHHH
T ss_pred hCCeeeccccccccccc----ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhc--CCCCCCcccccchHHH
Confidence 99999999999999999 788999999999985432 23334567899999999998 4578999999999999
Q ss_pred HHHHHc-CCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1011 LWEILT-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1011 LyELLT-Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
+|||+| |.+||......+.+..++..+.++..+..++.++.+||.+||+.||.+|||+.+|++.|+++...
T Consensus 237 l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 237 LWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 999998 77778777777777778888889999999999999999999999999999999999999987644
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.1e-46 Score=396.75 Aligned_cols=259 Identities=25% Similarity=0.372 Sum_probs=214.3
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++.+.||+|+||+||+|+++ |+.||||++++.... .......|.+|+.+|++++|||||++++++....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~ 80 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLAR-----DPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 80 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTT-----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhcc-----CHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc
Confidence 367999999999999999999874 788999999765322 1334567899999999999999999999987543
Q ss_pred C--CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEec
Q 037285 887 G--GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDF 964 (1094)
Q Consensus 887 ~--~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDF 964 (1094)
. ..+|+||||+++++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++ .++.++|+||
T Consensus 81 ~~~~~~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~----~~~~~~l~d~ 155 (277)
T d1o6ya_ 81 PAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS----ATNAVKVMDF 155 (277)
T ss_dssp SSSEEEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE----TTSCEEECCC
T ss_pred CCCceEEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccC----ccccceeehh
Confidence 2 35889999999999999887654 589999999999999999999999999999999999999 7888999999
Q ss_pred CCcccccC----ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCC
Q 037285 965 GLSKIKRN----TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 1040 (1094)
Q Consensus 965 GLSrl~~~----~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp 1040 (1094)
|.++.... .......+||+.|+|||++. ...++.++|||||||++|||+||+.||......+....+......+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~--~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 156 GIARAIADSGNSVTQTAAVIGTAQYLSPEQAR--GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 233 (277)
T ss_dssp TTCEECC----------------TTCCHHHHT--TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC
T ss_pred hhhhhhccccccccccccccCcccccCHHHHc--CCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCC
Confidence 99874322 12334567999999999998 4578999999999999999999999999988888777776665443
Q ss_pred --CCCCcCcHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHH
Q 037285 1041 --TIPSYCDAEWRTLMEECWAPNPAARP-SFTEIASRLRVLS 1079 (1094)
Q Consensus 1041 --~iPe~~S~eL~dLI~kCLq~DPeeRP-S~eELLq~L~~L~ 1079 (1094)
.....+++++.+||.+||+.||.+|| |++++++.|.++.
T Consensus 234 ~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 23457899999999999999999999 8999999998875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=404.24 Aligned_cols=262 Identities=31% Similarity=0.539 Sum_probs=221.1
Q ss_pred cceeeccCCeeEEEEecccCceEEEEeeecC---------ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CC
Q 037285 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKWRG---------TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HH 872 (1094)
Q Consensus 803 sv~eIs~edYei~kkLGsG~FGtVYKAk~rG---------t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~H 872 (1094)
..|+|..++|++++.||+|+||.||+|+..+ ..||||++++.. .+....++.+|...+.++ +|
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-------~~~~~~~~~~e~~~l~~~~~H 78 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-------TEKDLSDLISEMEMMKMIGKH 78 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-------CHHHHHHHHHHHHHHHHHCCC
T ss_pred CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-------ChHHHHHHHHHHHHHHHhcCC
Confidence 3478899999999999999999999998642 359999987542 123346788899999888 79
Q ss_pred CceeEEEeEeecCCCCceEEEeeecccchhHHHHhhcc---------------cccCHHHHHHHHHHHHHHHHHHHHCCc
Q 037285 873 PNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD---------------RFLDRRRRLIIAMDAAFGMEYLHSKNI 937 (1094)
Q Consensus 873 PNIVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~---------------~~Lse~~~l~Ia~QIaeGLaYLHs~GI 937 (1094)
||||+++++|.+.. .+++||||+.+|+|.+++.... ..+++..++.++.||+.||+|||+++|
T Consensus 79 pnIv~~~~~~~~~~--~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~i 156 (299)
T d1fgka_ 79 KNIINLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC 156 (299)
T ss_dssp TTBCCEEEEECSSS--SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CeEEecccccccCC--eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCE
Confidence 99999999998754 8999999999999999996543 358999999999999999999999999
Q ss_pred eeccCCCCceEeccCCCCCCcEEEEecCCcccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHH
Q 037285 938 VHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEI 1014 (1094)
Q Consensus 938 IHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyEL 1014 (1094)
|||||||+|||++ .++.+||+|||+++..... .......+|+.|+|||++. ...|+.++|||||||++|||
T Consensus 157 vHrDiKp~NiLl~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~--~~~y~~k~DiwS~Gvvl~el 230 (299)
T d1fgka_ 157 IHRDLAARNVLVT----EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF--DRIYTHQSDVWSFGVLLWEI 230 (299)
T ss_dssp CCSCCSGGGEEEC----TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHH
T ss_pred Eeeeecccceeec----CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhc--CCCCCchhhhHHhHHHHHHh
Confidence 9999999999999 7889999999999854322 2234456899999999998 46789999999999999999
Q ss_pred Hc-CCCCCCCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 037285 1015 LT-GEEPYANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLST 1080 (1094)
Q Consensus 1015 LT-Gk~PF~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~t 1080 (1094)
++ |..||......++...+ ..+.++..|..+++++.+||.+||+.||.+|||+.+|++.|+++.+
T Consensus 231 l~~g~~p~~~~~~~~~~~~i-~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 231 FTLGGSPYPGVPVEELFKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HTTSCCSSTTCCHHHHHHHH-HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCCCCCCCCCCHHHHHHHH-HcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 98 79999988887766554 5677888899999999999999999999999999999999999864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-46 Score=409.19 Aligned_cols=249 Identities=26% Similarity=0.439 Sum_probs=217.8
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++++.||+|+||+||+|+++ |+.||||++++... ........+.+|+.+|++++|||||++++++.+..
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-----~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 77 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV-----VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ 77 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHc-----cCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC
Confidence 368999999999999999999875 78899999976422 11223467889999999999999999999999865
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+|+|||||.+|+|..++.... .+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+
T Consensus 78 --~~~ivmE~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~----~~g~vkL~DFG~ 150 (316)
T d1fota_ 78 --QIFMIMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD----KNGHIKITDFGF 150 (316)
T ss_dssp --EEEEEECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC----TTSCEEECCCSS
T ss_pred --eeeeEeeecCCccccccccccc-cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEc----CCCCEEEecCcc
Confidence 9999999999999999887655 488899999999999999999999999999999999999 788999999999
Q ss_pred cccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcC
Q 037285 967 SKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYC 1046 (1094)
Q Consensus 967 Srl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~ 1046 (1094)
|+...... ...+||+.|||||++. ...|+.++|||||||++|+|+||+.||...+..+....+..... .+|..+
T Consensus 151 a~~~~~~~--~~~~Gt~~Y~APE~l~--~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~--~~p~~~ 224 (316)
T d1fota_ 151 AKYVPDVT--YTLCGTPDYIAPEVVS--TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL--RFPPFF 224 (316)
T ss_dssp CEECSSCB--CCCCSCTTTCCHHHHT--TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC--CCCTTS
T ss_pred ceEecccc--ccccCcccccCHHHHc--CCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC--CCCCCC
Confidence 98655433 3467999999999998 45688999999999999999999999999988888888776543 467789
Q ss_pred cHHHHHHHHHhccCCCCCCC-----CHHHHHHHH
Q 037285 1047 DAEWRTLMEECWAPNPAARP-----SFTEIASRL 1075 (1094)
Q Consensus 1047 S~eL~dLI~kCLq~DPeeRP-----S~eELLq~L 1075 (1094)
++++.++|.+||..||.+|+ |+++|++|-
T Consensus 225 s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp 258 (316)
T d1fota_ 225 NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP 258 (316)
T ss_dssp CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred CHHHHHHHHHHhhhCHHhccccchhhHHHHHcCc
Confidence 99999999999999999996 899999863
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=406.48 Aligned_cols=259 Identities=34% Similarity=0.551 Sum_probs=219.4
Q ss_pred eeccCCeeEEEEecccCceEEEEeeecC--c--eEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEe
Q 037285 806 VIKNEDLEEQKELGSGTFGTVYHGKWRG--T--DVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYG 880 (1094)
Q Consensus 806 eIs~edYei~kkLGsG~FGtVYKAk~rG--t--~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~G 880 (1094)
.|+.++|++.++||+|+||+||+|++++ . .||||.++.... ......|.+|+.+|+++ +|||||++++
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~E~~~l~~l~~HpnIv~~~~ 78 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-------KDDHRDFAGELEVLCKLGHHPNIINLLG 78 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------------CHHHHHHHHHTTCCCCTTBCCEEE
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC-------hHHHHHHHHHHHHHHhccCCCCEeeEEE
Confidence 4566899999999999999999999853 3 478888764321 11235789999999999 7999999999
Q ss_pred EeecCCCCceEEEeeecccchhHHHHhhc---------------ccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 037285 881 VVQDGPGGTLATVAEYMVDGSLRHVLVRK---------------DRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCD 945 (1094)
Q Consensus 881 v~~d~~~~~L~IVmEYmegGSL~d~L~k~---------------~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPe 945 (1094)
+|.+.. .+++||||+++|+|.+++... ...+++..++.++.||+.||.|||+++|+||||||+
T Consensus 79 ~~~~~~--~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~ 156 (309)
T d1fvra_ 79 ACEHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR 156 (309)
T ss_dssp EEEETT--EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EEecCC--eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccc
Confidence 999865 899999999999999998643 246899999999999999999999999999999999
Q ss_pred ceEeccCCCCCCcEEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcC-CCCCCCC
Q 037285 946 NLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTG-EEPYANM 1024 (1094)
Q Consensus 946 NILLD~~~~e~g~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTG-k~PF~~~ 1024 (1094)
|||++ .++.+||+|||+++............||..|+|||.+. ...++.++|||||||++|||++| ..||...
T Consensus 157 NIL~~----~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~sDvwSfGvil~ell~~~~~p~~~~ 230 (309)
T d1fvra_ 157 NILVG----ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN--YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 230 (309)
T ss_dssp GEEEC----GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHH--HCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred eEEEc----CCCceEEccccccccccccccccceecCCcccchHHhc--cCCCCccceeehhHHHHHHHHhcCCCCCCCC
Confidence 99999 77899999999998655444444556899999999998 45789999999999999999996 5678888
Q ss_pred ChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 037285 1025 HYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLST 1080 (1094)
Q Consensus 1025 ~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~t 1080 (1094)
+..++...+ ..+.++..+..+++++.+||.+||+.||++|||+.+|+++|.++..
T Consensus 231 ~~~~~~~~i-~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 231 TCAELYEKL-PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp CHHHHHHHG-GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHH-HhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 888877765 4456788888999999999999999999999999999999999874
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-46 Score=407.31 Aligned_cols=254 Identities=20% Similarity=0.244 Sum_probs=219.2
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~ 886 (1094)
.++|++++.||+|+||+||+|+++ ++.||||+++... .. ...+.+|+.+|++++|||||++++++.+..
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~------~~---~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 74 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG------TD---QVLVKKEISILNIARHRNILHLHESFESME 74 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT------HH---HHHHHHHHHHHHHSCCTTBCCEEEEEEETT
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc------cc---HHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 368999999999999999999885 6789999997642 11 235779999999999999999999998865
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+|+|||||.+|+|.+++...+..+++..++.++.||+.||+|||++||+||||||+|||++.+ ....+||+|||+
T Consensus 75 --~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~--~~~~ikl~DFG~ 150 (321)
T d1tkia_ 75 --ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR--RSSTIKIIEFGQ 150 (321)
T ss_dssp --EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS--SCCCEEECCCTT
T ss_pred --EEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCC--CceEEEEcccch
Confidence 8999999999999999998766679999999999999999999999999999999999999732 346899999999
Q ss_pred cccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCC--CCC
Q 037285 967 SKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPT--IPS 1044 (1094)
Q Consensus 967 Srl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~--iPe 1044 (1094)
++............+|+.|+|||.+. ...++.++|||||||++|+|++|+.||......+.+..+....+... ...
T Consensus 151 ~~~~~~~~~~~~~~~t~~y~ape~~~--~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 228 (321)
T d1tkia_ 151 ARQLKPGDNFRLLFTAPEYYAPEVHQ--HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK 228 (321)
T ss_dssp CEECCTTCEEEEEESCGGGSCHHHHT--TCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred hhccccCCcccccccccccccchhcc--CCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhcc
Confidence 98665544444567899999999998 45688999999999999999999999999998888888877654422 123
Q ss_pred cCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1045 YCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1045 ~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
.+++++++||.+||..||.+|||+.+++++-+-
T Consensus 229 ~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~ 261 (321)
T d1tkia_ 229 EISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261 (321)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 688999999999999999999999999997543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-46 Score=402.10 Aligned_cols=262 Identities=32% Similarity=0.516 Sum_probs=224.7
Q ss_pred CcceeeccCCeeEEEEecccCceEEEEeeec-------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCc
Q 037285 802 SSVQVIKNEDLEEQKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPN 874 (1094)
Q Consensus 802 ssv~eIs~edYei~kkLGsG~FGtVYKAk~r-------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPN 874 (1094)
.+.|+|..++|++.+.||+|+||+||+|.++ ++.||||+++... . ......|.+|+.++++++|||
T Consensus 12 ~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-----~--~~~~~~~~~E~~il~~l~h~n 84 (308)
T d1p4oa_ 12 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-----S--MRERIEFLNEASVMKEFNCHH 84 (308)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-----C--HHHHHHHHHHHHHGGGCCCTT
T ss_pred ccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-----C--hHHHHHHHHHHHHHHHcCCCC
Confidence 3468899999999999999999999999875 3579999986431 1 223457899999999999999
Q ss_pred eeEEEeEeecCCCCceEEEeeecccchhHHHHhhcc---------cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 037285 875 VVAFYGVVQDGPGGTLATVAEYMVDGSLRHVLVRKD---------RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCD 945 (1094)
Q Consensus 875 IVqL~Gv~~d~~~~~L~IVmEYmegGSL~d~L~k~~---------~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPe 945 (1094)
||+++++|.... .+++||||+.+|+|.+++.... ..+++..++.++.||++||.|||+++|+||||||+
T Consensus 85 Iv~~~~~~~~~~--~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~ 162 (308)
T d1p4oa_ 85 VVRLLGVVSQGQ--PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAAR 162 (308)
T ss_dssp BCCEEEEECSSS--SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGG
T ss_pred EeeeeeEEecCC--ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCC
Confidence 999999998755 8999999999999999986532 23688999999999999999999999999999999
Q ss_pred ceEeccCCCCCCcEEEEecCCcccccCc---cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcC-CCCC
Q 037285 946 NLLVNLKDPSRPICKVGDFGLSKIKRNT---LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTG-EEPY 1021 (1094)
Q Consensus 946 NILLD~~~~e~g~VKLsDFGLSrl~~~~---~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTG-k~PF 1021 (1094)
|||++ .++.+||+|||+++..... .......+|+.|+|||.+. ...++.++|||||||++|||+|| +.||
T Consensus 163 NiLld----~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~--~~~~~~~~Dv~S~G~il~El~t~~~~p~ 236 (308)
T d1p4oa_ 163 NCMVA----EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK--DGVFTTYSDVWSFGVVLWEIATLAEQPY 236 (308)
T ss_dssp GEEEC----TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred ceeec----CCceEEEeecccceeccCCcceeeccceecccccCCHHHHc--cCCCCcccccccHHHHHHHHHhCCCCCC
Confidence 99999 7889999999999854322 2233446899999999998 45788999999999999999997 5889
Q ss_pred CCCChHHHHHhHhhccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 037285 1022 ANMHYGAIIGGIVNNTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLS 1079 (1094)
Q Consensus 1022 ~~~~~~eile~Iv~~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ 1079 (1094)
......+....+.+ +.++..+..++..+.+||.+||+.||.+|||+.+|+++|++..
T Consensus 237 ~~~~~~~~~~~i~~-~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 237 QGLSNEQVLRFVME-GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp TTSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred CCCCHHHHHHHHHh-CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 99888888776654 4567778899999999999999999999999999999998764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.1e-46 Score=409.68 Aligned_cols=248 Identities=25% Similarity=0.379 Sum_probs=217.3
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++++.||+|+||.||+|+++ |+.||||++.+... ........+.+|+.+|++++|||||++++++.+..
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~-----~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~- 114 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-----VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS- 114 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHc-----cCHHHHHHHHHHHHHHHHcCCCcEeeccccccccc-
Confidence 68999999999999999999885 78899999975422 11223457889999999999999999999998865
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++||||+.+|+|..++.+.+ .+++..++.++.||+.||.|||+++||||||||+|||++ .++.+||+|||+|
T Consensus 115 -~~~~v~e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~----~~g~ikL~DFG~a 188 (350)
T d1rdqe_ 115 -NLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID----QQGYIQVTDFGFA 188 (350)
T ss_dssp -EEEEEEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECCCTTC
T ss_pred -ccccccccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccC----CCCCEEeeeceee
Confidence 8999999999999999997665 599999999999999999999999999999999999998 7789999999999
Q ss_pred ccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCcCc
Q 037285 968 KIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCD 1047 (1094)
Q Consensus 968 rl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~~S 1047 (1094)
+...... ....||+.|||||++. ...++.++|||||||++|||+||+.||...+.......+..... ..+..++
T Consensus 189 ~~~~~~~--~~~~Gt~~Y~APE~~~--~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s 262 (350)
T d1rdqe_ 189 KRVKGRT--WTLCGTPEALAPEIIL--SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV--RFPSHFS 262 (350)
T ss_dssp EECSSCB--CCCEECGGGCCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCTTCC
T ss_pred eeccccc--ccccCccccCCHHHHc--CCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC--CCCccCC
Confidence 8655432 3467999999999998 45688999999999999999999999999888888887766543 4677899
Q ss_pred HHHHHHHHHhccCCCCCCC-----CHHHHHHHH
Q 037285 1048 AEWRTLMEECWAPNPAARP-----SFTEIASRL 1075 (1094)
Q Consensus 1048 ~eL~dLI~kCLq~DPeeRP-----S~eELLq~L 1075 (1094)
+++.+||.+||..||.+|+ |+++|++|-
T Consensus 263 ~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp 295 (350)
T d1rdqe_ 263 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred HHHHHHHHHHhhhCHHhccccccccHHHHHcCc
Confidence 9999999999999999994 899999864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-46 Score=398.43 Aligned_cols=252 Identities=25% Similarity=0.300 Sum_probs=202.1
Q ss_pred EEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCCceE
Q 037285 814 EQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGGTLA 891 (1094)
Q Consensus 814 i~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~~L~ 891 (1094)
.+++||+|+||+||+|+++ |+.||||+++...... ..+.....+.+|+.+|++++|||||++++++.+.. .++
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~--~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSE---AKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS--NIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC---------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT--CCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhh---hhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC--cee
Confidence 4688999999999999874 6789999997653221 11223356889999999999999999999998865 899
Q ss_pred EEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCccccc
Q 037285 892 TVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKR 971 (1094)
Q Consensus 892 IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl~~ 971 (1094)
+||||+.++++..++. ....+++..+..++.||+.||+|||++||+||||||+|||++ ..+.+||+|||+++...
T Consensus 77 ivmE~~~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~----~~~~~KL~DFG~a~~~~ 151 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD----ENGVLKLADFGLAKSFG 151 (299)
T ss_dssp EEEECCSEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTCCEEECCCGGGSTTT
T ss_pred ehhhhhcchHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEec----CCCccccccCccccccC
Confidence 9999999888776654 445689999999999999999999999999999999999999 78899999999998543
Q ss_pred C-ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCC----------
Q 037285 972 N-TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP---------- 1040 (1094)
Q Consensus 972 ~-~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp---------- 1040 (1094)
. .......+||+.|+|||++.. ...++.++|||||||++|||+||+.||......+.+..+......+
T Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 152 SPNRAYTHQVVTRWYRAPELLFG-ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp SCCCCCCCSCCCCTTCCHHHHTT-CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred CCcccccceecChhhccHHHHcc-CCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhc
Confidence 3 233345679999999999874 3457999999999999999999999999888777666554321100
Q ss_pred --------CC--------CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1041 --------TI--------PSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1041 --------~i--------Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
.. ...+++++.+||.+||..||++|||+.++++|-+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~ 282 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 282 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHh
Confidence 00 1246789999999999999999999999998744
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-45 Score=410.29 Aligned_cols=258 Identities=22% Similarity=0.302 Sum_probs=209.8
Q ss_pred ccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG 885 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~ 885 (1094)
+.++|++.++||+|+||.||+|+++ |..||||++.+..+.. ...+........|+.+++.++|||||++++++.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~--~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~ 79 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM--KQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 79 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH--HTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcch--hhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC
Confidence 4578999999999999999999885 7889999997543211 01111222334557788888999999999999886
Q ss_pred CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecC
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFG 965 (1094)
. .+|+|||||.+|+|.+++.+.. .+++..++.++.||+.||.|||++|||||||||+|||++ ..+.+||+|||
T Consensus 80 ~--~~~ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~----~~g~iKl~DFG 152 (364)
T d1omwa3 80 D--KLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD----EHGHVRISDLG 152 (364)
T ss_dssp S--EEEEEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----SSSCEEECCCT
T ss_pred C--EEEEEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEc----CCCcEEEeeec
Confidence 5 8999999999999999997664 489999999999999999999999999999999999998 77899999999
Q ss_pred CcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhH-hhccCCCCCCC
Q 037285 966 LSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI-VNNTLRPTIPS 1044 (1094)
Q Consensus 966 LSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~I-v~~~lrp~iPe 1044 (1094)
+|+...... .....||+.|+|||++.. ...|+.++|||||||+||||+||+.||............ ........++.
T Consensus 153 la~~~~~~~-~~~~~GT~~y~APE~~~~-~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 230 (364)
T d1omwa3 153 LACDFSKKK-PHASVGTHGYMAPEVLQK-GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 230 (364)
T ss_dssp TCEECSSSC-CCSCCSCGGGCCHHHHST-TCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCS
T ss_pred eeeecCCCc-ccccccccccchhHHhhc-CCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Confidence 998654433 334579999999999863 346889999999999999999999999875543322211 12233455677
Q ss_pred cCcHHHHHHHHHhccCCCCCCCC-----HHHHHHHHH
Q 037285 1045 YCDAEWRTLMEECWAPNPAARPS-----FTEIASRLR 1076 (1094)
Q Consensus 1045 ~~S~eL~dLI~kCLq~DPeeRPS-----~eELLq~L~ 1076 (1094)
.+++++++||.+||..||.+||| +++|++|-+
T Consensus 231 ~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~ 267 (364)
T d1omwa3 231 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 267 (364)
T ss_dssp SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGG
T ss_pred CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCcc
Confidence 89999999999999999999999 799987643
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-46 Score=404.22 Aligned_cols=249 Identities=29% Similarity=0.462 Sum_probs=213.3
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHh-hCCCCceeEEEeEeecCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILS-KLHHPNVVAFYGVVQDGP 886 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILk-rL~HPNIVqL~Gv~~d~~ 886 (1094)
++|++.+.||+|+||+||+|+++ ++.||||++++.... .......+..|..++. .++|||||++++++.+..
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~-----~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL-----MDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhcc-----ChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCC
Confidence 57999999999999999999984 788999999764211 1122345667777665 689999999999999865
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
.+|+|||||++|+|.+++.... .+++..+..++.||+.||+|||+++|+||||||+|||++ .++.+||+|||+
T Consensus 77 --~~yivmEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~----~~~~~kl~DFG~ 149 (320)
T d1xjda_ 77 --NLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD----KDGHIKIADFGM 149 (320)
T ss_dssp --EEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEECCCTT
T ss_pred --ceeEEEeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeec----CCCceeccccch
Confidence 8999999999999999997655 489999999999999999999999999999999999999 788999999999
Q ss_pred ccccc-CccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCCCc
Q 037285 967 SKIKR-NTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSY 1045 (1094)
Q Consensus 967 Srl~~-~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iPe~ 1045 (1094)
++... .........||+.|+|||++. ...++.++|||||||++|+|+||+.||.+....++...+... .+.+|..
T Consensus 150 a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~~p~~ 225 (320)
T d1xjda_ 150 CKENMLGDAKTNTFCGTPDYIAPEILL--GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRW 225 (320)
T ss_dssp CBCCCCTTCCBCCCCSCGGGCCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTT
T ss_pred hhhcccccccccccCCCCCcCCHHHHc--CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCcc
Confidence 98543 233344567999999999998 457889999999999999999999999998888888777655 3567888
Q ss_pred CcHHHHHHHHHhccCCCCCCCCHH-HHHHH
Q 037285 1046 CDAEWRTLMEECWAPNPAARPSFT-EIASR 1074 (1094)
Q Consensus 1046 ~S~eL~dLI~kCLq~DPeeRPS~e-ELLq~ 1074 (1094)
+++++++||.+||..||.+||++. +|++|
T Consensus 226 ~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 226 LEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp SCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred CCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 999999999999999999999995 78754
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=398.53 Aligned_cols=255 Identities=30% Similarity=0.511 Sum_probs=211.4
Q ss_pred EEEEecccCceEEEEeeecC-----ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 814 EQKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 814 i~kkLGsG~FGtVYKAk~rG-----t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
+.++||+|+||+||+|++.. ..||||+++... ......+|.+|+++|++++|||||+++|++.+. .+
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~ 102 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-------DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EG 102 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC-------CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET-TT
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc-------CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec-CC
Confidence 46789999999999998742 258999986421 123356799999999999999999999998754 24
Q ss_pred ceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 889 TLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
.+++|||||++|+|.+++......+++..++.++.|++.||.|||+.+|+||||||+|||++ +++.+||+|||+++
T Consensus 103 ~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~----~~~~~kL~DFG~~~ 178 (311)
T d1r0pa_ 103 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD----EKFTVKVADFGLAR 178 (311)
T ss_dssp EEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----TTCCEEECSSGGGC
T ss_pred ceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeEC----CCCCEEEecccchh
Confidence 78999999999999999987777788999999999999999999999999999999999998 78899999999998
Q ss_pred cccCc-----cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCC
Q 037285 969 IKRNT-----LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIP 1043 (1094)
Q Consensus 969 l~~~~-----~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iP 1043 (1094)
..... .......||+.|+|||++. ...++.++||||||+++|||+||..||........+...+..+.++..|
T Consensus 179 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p 256 (311)
T d1r0pa_ 179 DMYDKEFDSVHNKTGAKLPVKWMALESLQ--TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 256 (311)
T ss_dssp CTTTTTCCCTTCTTCSSCCGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCC
T ss_pred hccccccccceecccccccccccChHHHh--cCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence 54322 1223356899999999988 4678999999999999999999777776544333233334556778888
Q ss_pred CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 037285 1044 SYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAA 1082 (1094)
Q Consensus 1044 e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~ 1082 (1094)
..+++++.+||.+||+.||++||++.+|+++|+.+....
T Consensus 257 ~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 257 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence 999999999999999999999999999999999998653
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=404.95 Aligned_cols=252 Identities=25% Similarity=0.335 Sum_probs=204.5
Q ss_pred CCeeEEE-EecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC-CCCceeEEEeEeec-
Q 037285 810 EDLEEQK-ELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL-HHPNVVAFYGVVQD- 884 (1094)
Q Consensus 810 edYei~k-kLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL-~HPNIVqL~Gv~~d- 884 (1094)
++|++.+ .||+|+||+||+|+++ ++.||||+++.. ..+.+|+.++.++ +|||||+++++|.+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~ 77 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------------PKARREVELHWRASQCPHIVRIVDVYENL 77 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------------HHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence 5798875 5999999999999874 678999998653 3466899887654 89999999999865
Q ss_pred -CCCCceEEEeeecccchhHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 885 -GPGGTLATVAEYMVDGSLRHVLVRKD-RFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 885 -~~~~~L~IVmEYmegGSL~d~L~k~~-~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
..+..+|+|||||++|+|.+++.+.+ ..+++..++.++.||+.||+|||++||+||||||+|||++..+ ..+.+||+
T Consensus 78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~-~~~~~Kl~ 156 (335)
T d2ozaa1 78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR-PNAILKLT 156 (335)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSS-TTCCEEEC
T ss_pred ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccc-cccccccc
Confidence 22347999999999999999997653 4699999999999999999999999999999999999998433 46789999
Q ss_pred ecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCC--C
Q 037285 963 DFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR--P 1040 (1094)
Q Consensus 963 DFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lr--p 1040 (1094)
|||+|+............||+.|+|||++. ...|+.++|||||||+||+|+||+.||.+.........+...... .
T Consensus 157 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~ 234 (335)
T d2ozaa1 157 DFGFAKETTSHNSLTTPCYTPYYVAPEVLG--PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 234 (335)
T ss_dssp CCTTCEECCCCCCCCCCSCCCSSCCCCCCC--GGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSS
T ss_pred ccceeeeccCCCccccccCCcccCCcHHHc--CCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCC
Confidence 999998665555556678999999999998 456899999999999999999999999876654443333222111 1
Q ss_pred CCC----CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1041 TIP----SYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1041 ~iP----e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
.+| ..+++++.+||.+||+.||.+|||+.+++++-+-
T Consensus 235 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 275 (335)
T d2ozaa1 235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 275 (335)
T ss_dssp SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHH
T ss_pred CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHh
Confidence 122 2578999999999999999999999999997554
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-45 Score=390.97 Aligned_cols=252 Identities=25% Similarity=0.341 Sum_probs=205.5
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|++++.||+|+||+||+|+++ |+.||||+++..... +.....+.+|+++|++++|||||++++++.+..
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~- 74 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET------EGVPSTAIREISLLKELNHPNIVKLLDVIHTEN- 74 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT-
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC------hHHHHHHHHHHHHHHhCCCCcEEEecccccccc-
Confidence 58999999999999999999885 788999999754211 223457889999999999999999999999865
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++||||+.++.+..........+++..+..++.||+.||+|||++|||||||||+|||++ .++.+||+|||+|
T Consensus 75 -~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~----~~~~~kl~DFG~a 149 (298)
T d1gz8a_ 75 -KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN----TEGAIKLADFGLA 149 (298)
T ss_dssp -EEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTSCEEECSTTHH
T ss_pred -ceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeec----ccCcceeccCCcc
Confidence 89999999976666555555556799999999999999999999999999999999999998 6789999999999
Q ss_pred ccccC-ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCC-------
Q 037285 968 KIKRN-TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR------- 1039 (1094)
Q Consensus 968 rl~~~-~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lr------- 1039 (1094)
+.... ........||+.|+|||++.. ...++.++|||||||++|+|++|+.||...+..+.+..+......
T Consensus 150 ~~~~~~~~~~~~~~gt~~y~apE~~~~-~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 228 (298)
T d1gz8a_ 150 RAFGVPVRTYTHEVVTLWYRAPEILLG-CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 228 (298)
T ss_dssp HHHCCCSBCTTCCBCCCTTCCHHHHTT-CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred eeccCCcccceeecccceeeehhhhcc-ccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcc
Confidence 85432 333445579999999999874 345688999999999999999999999988776655544321100
Q ss_pred ---------CCC-----------CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1040 ---------PTI-----------PSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1040 ---------p~i-----------Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
... ...++.++.+||.+||..||.+|||+.+|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000 12457889999999999999999999999987
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=387.16 Aligned_cols=255 Identities=26% Similarity=0.322 Sum_probs=209.1
Q ss_pred cCCeeEEEEecccCceEEEEeeec---CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhC---CCCceeEEEeEe
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR---GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKL---HHPNVVAFYGVV 882 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r---Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL---~HPNIVqL~Gv~ 882 (1094)
.++|+++++||+|+||+||+|++. ++.||||+++........ ...+.+|+.+|+.| +||||++++++|
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~------~~~~~~E~~~l~~l~~~~HpnIv~~~~~~ 79 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM------PLSTIREVAVLRHLETFEHPNVVRLFDVC 79 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC------BCTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH------HHHHHHHHHHHHHHhhcCCCCcceeeeee
Confidence 468999999999999999999874 456999999765332211 12344666666655 899999999998
Q ss_pred ecC---CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcE
Q 037285 883 QDG---PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPIC 959 (1094)
Q Consensus 883 ~d~---~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~V 959 (1094)
... ....++++|||+.++.+..........+++..++.++.||+.||+|||+++|+||||||+|||++ ..+.+
T Consensus 80 ~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~----~~~~~ 155 (305)
T d1blxa_ 80 TVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT----SSGQI 155 (305)
T ss_dssp EEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTCCE
T ss_pred cccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEc----CCCCe
Confidence 632 23478999999999988777666666799999999999999999999999999999999999999 77899
Q ss_pred EEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccC-
Q 037285 960 KVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL- 1038 (1094)
Q Consensus 960 KLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~l- 1038 (1094)
||+|||+++............||+.|+|||++. ...|+.++|||||||++|||+||+.||...+..+.+..+.....
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~--~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 233 (305)
T d1blxa_ 156 KLADFGLARIYSFQMALTSVVVTLWYRAPEVLL--QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233 (305)
T ss_dssp EECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHT--TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred eecchhhhhhhcccccCCCcccChhhcCcchhc--CCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCC
Confidence 999999998766555566778999999999998 46789999999999999999999999998887776655433100
Q ss_pred ------------------------CCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037285 1039 ------------------------RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1039 ------------------------rp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L 1075 (1094)
...+...+++.+.+||.+||+.||.+|||+.++++|-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hp 294 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 294 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCh
Confidence 0112345788999999999999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.7e-44 Score=383.86 Aligned_cols=251 Identities=24% Similarity=0.332 Sum_probs=204.9
Q ss_pred CCeeEEEEecccCceEEEEeeec-CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r-Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~~ 888 (1094)
++|++.++||+|+||+||+|+++ |+.||||+++..... +.....+.+|+.+|++++|||||++++++....
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-- 73 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED------EGIPSTTIREISILKELKHSNIVKLYDVIHTKK-- 73 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG------GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS--
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcC------hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC--
Confidence 58999999999999999999885 688999999764221 223467889999999999999999999999865
Q ss_pred ceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 889 TLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
.++++|||+.++.+..+... .+.+++..+..++.||+.||+|||+++||||||||+|||++ .++.+||+|||++.
T Consensus 74 ~~~i~~e~~~~~~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~----~~~~~kl~DfG~a~ 148 (286)
T d1ob3a_ 74 RLVLVFEHLDQDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN----REGELKIADFGLAR 148 (286)
T ss_dssp CEEEEEECCSEEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTSCEEECCTTHHH
T ss_pred ceeEEEEeehhhhHHHHHhh-cCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEc----CCCCEEecccccce
Confidence 89999999987777666544 45699999999999999999999999999999999999998 77899999999998
Q ss_pred cccC-ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCC--------
Q 037285 969 IKRN-TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR-------- 1039 (1094)
Q Consensus 969 l~~~-~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lr-------- 1039 (1094)
.... ........+++.|+|||.+.+ ...++.++|||||||++|||++|+.||......+.+..+......
T Consensus 149 ~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (286)
T d1ob3a_ 149 AFGIPVRKYTHEIVTLWYRAPDVLMG-SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227 (286)
T ss_dssp HHCC---------CCCTTCCHHHHTT-CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred ecccCccccceecccchhhhHHHHhC-CCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccc
Confidence 5433 223344568999999999874 345789999999999999999999999988776665544321000
Q ss_pred -------------------CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1040 -------------------PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1040 -------------------p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
......+++.+.+||++||+.||++|||+.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11234568899999999999999999999999875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-44 Score=387.70 Aligned_cols=257 Identities=30% Similarity=0.451 Sum_probs=203.5
Q ss_pred CCeeEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC--
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG-- 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~-- 887 (1094)
.+|.+.+.||+|+||.||+|+++|..||||+++... .. ...+..|+..+.+++|||||++++++.+...
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~-------~~--~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~ 73 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-------ER--SWFREAEIYQTVMLRHENILGFIAADNKDNGTW 73 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG-------HH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc-------hh--HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcc
Confidence 478899999999999999999999999999986431 11 1122345556678899999999999986432
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH--------CCceeccCCCCceEeccCCCCCCcE
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHS--------KNIVHFDLKCDNLLVNLKDPSRPIC 959 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs--------~GIIHRDLKPeNILLD~~~~e~g~V 959 (1094)
..+++|||||.+|+|.+++.+. .+++..++.++.|++.||.|||+ ++|+||||||+||||+ .++.+
T Consensus 74 ~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~----~~~~~ 147 (303)
T d1vjya_ 74 TQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK----KNGTC 147 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC----TTSCE
T ss_pred eEEEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEc----CCCCe
Confidence 2589999999999999999764 48999999999999999999996 5899999999999998 78899
Q ss_pred EEEecCCcccccCc-----cccCCccCCCcccCccccccCCC----CCCchhhHHHHHHHHHHHHcCCCCCCCC------
Q 037285 960 KVGDFGLSKIKRNT-----LVSGGVRGTLPWMAPELLSGSSS----KVSEKVDVFSFGIVLWEILTGEEPYANM------ 1024 (1094)
Q Consensus 960 KLsDFGLSrl~~~~-----~~ss~~~GT~~YmAPEvL~g~~~----kyS~KSDVWSLGVLLyELLTGk~PF~~~------ 1024 (1094)
||+|||+++..... .......||+.|+|||++.+... .++.++|||||||+||||+||..||...
T Consensus 148 Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~ 227 (303)
T d1vjya_ 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp EECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred EEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc
Confidence 99999999854321 12334679999999999874221 2577999999999999999998876431
Q ss_pred ---------ChHHHHHhHhhccCCCCCCCcC-----cHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 037285 1025 ---------HYGAIIGGIVNNTLRPTIPSYC-----DAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTA 1081 (1094)
Q Consensus 1025 ---------~~~eile~Iv~~~lrp~iPe~~-----S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta 1081 (1094)
..............++.++... ...+.+||.+||+.||++|||+.+|++.|.++...
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 1223334444556666665432 34689999999999999999999999999998754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=385.46 Aligned_cols=249 Identities=22% Similarity=0.347 Sum_probs=203.5
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC--CCceeEEEeEeec
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH--HPNVVAFYGVVQD 884 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~--HPNIVqL~Gv~~d 884 (1094)
.++|++.+.||+|+||+||+|+++ |+.||||++.+.......... ....+.+|+.+|++++ |||||++++++.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~--~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~ 80 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP--NGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 80 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECT--TCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhh--HHHHHHHHHHHHHHhccCCCCccEEEEEEee
Confidence 358999999999999999999985 788999999875443221110 1123567999999987 8999999999988
Q ss_pred CCCCceEEEeeeccc-chhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEe
Q 037285 885 GPGGTLATVAEYMVD-GSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGD 963 (1094)
Q Consensus 885 ~~~~~L~IVmEYmeg-GSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsD 963 (1094)
.. .+++||||+.+ +++.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++. +.+.+||+|
T Consensus 81 ~~--~~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~---~~~~vkl~D 154 (273)
T d1xwsa_ 81 PD--SFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL---NRGELKLID 154 (273)
T ss_dssp SS--EEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET---TTTEEEECC
T ss_pred CC--eEEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEec---CCCeEEECc
Confidence 65 89999999976 57777776554 5999999999999999999999999999999999999982 346899999
Q ss_pred cCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccCCCCCC
Q 037285 964 FGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIP 1043 (1094)
Q Consensus 964 FGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~lrp~iP 1043 (1094)
||+|+...... .....||+.|+|||++.+ ...++.++|||||||++|||+||+.||.... . +... ...++
T Consensus 155 FG~a~~~~~~~-~~~~~GT~~y~aPE~~~~-~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~----i~~~--~~~~~ 224 (273)
T d1xwsa_ 155 FGSGALLKDTV-YTDFDGTRVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--E----IIRG--QVFFR 224 (273)
T ss_dssp CTTCEECCSSC-BCCCCSCGGGSCHHHHHH-SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----HHHC--CCCCS
T ss_pred cccceeccccc-ccccccCCCcCCHHHHcC-CCCCCcccccccceeeehhHhhCCCCCCCch--H----Hhhc--ccCCC
Confidence 99998654433 335679999999999974 2234678999999999999999999997532 2 2222 23466
Q ss_pred CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037285 1044 SYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1044 e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L 1075 (1094)
..+++++++||.+||..||++|||+++++++-
T Consensus 225 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp 256 (273)
T d1xwsa_ 225 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHP 256 (273)
T ss_dssp SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred CCCCHHHHHHHHHHccCCHhHCcCHHHHhcCH
Confidence 78999999999999999999999999999864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-43 Score=384.79 Aligned_cols=248 Identities=25% Similarity=0.279 Sum_probs=201.0
Q ss_pred CeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC---
Q 037285 811 DLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG--- 885 (1094)
Q Consensus 811 dYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~--- 885 (1094)
+|+..++||+|+||+||+|+++ |+.||||+++.... .+.+|+.+|++++||||++++++|...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~ 88 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------FKNRELQIMRKLDHCNIVRLRYFFYSSGEK 88 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------------SCCHHHHHHHHCCCTTBCCEEEEEEEC--C
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------------HHHHHHHHHHhcCCCCCCcEEEEEEecCcc
Confidence 6999999999999999999985 77899999976421 123699999999999999999998542
Q ss_pred -CCCceEEEeeecccchhHHHHh--hcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEE
Q 037285 886 -PGGTLATVAEYMVDGSLRHVLV--RKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVG 962 (1094)
Q Consensus 886 -~~~~L~IVmEYmegGSL~d~L~--k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLs 962 (1094)
...++++|||||+++.+..+.. .....+++..+..++.||+.||+|||++||+||||||+|||++. ++..+||+
T Consensus 89 ~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~---~~~~~kl~ 165 (350)
T d1q5ka_ 89 KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP---DTAVLKLC 165 (350)
T ss_dssp CSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT---TTCCEEEC
T ss_pred CCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEec---CCCceeEe
Confidence 2336899999998775544432 23456999999999999999999999999999999999999982 23489999
Q ss_pred ecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhcc-----
Q 037285 963 DFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT----- 1037 (1094)
Q Consensus 963 DFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~----- 1037 (1094)
|||+++............||..|+|||.+.+ ...++.++|||||||++|||++|+.||......+.+..+....
T Consensus 166 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~ 244 (350)
T d1q5ka_ 166 DFGSAKQLVRGEPNVSYICSRYYRAPELIFG-ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244 (350)
T ss_dssp CCTTCEECCTTSCCCSCCSCTTSCCHHHHTT-CSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred cccchhhccCCcccccccccccccChHHhhc-ccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChH
Confidence 9999986655444556679999999999874 4568999999999999999999999999887766555443210
Q ss_pred ----------CC------------CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1038 ----------LR------------PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1038 ----------lr------------p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
.. ......+++++.+||.+||..||++|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 01123578899999999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-42 Score=371.60 Aligned_cols=257 Identities=22% Similarity=0.279 Sum_probs=201.2
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeE-EEeEeecCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVA-FYGVVQDGP 886 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVq-L~Gv~~d~~ 886 (1094)
++|++.+.||+|+||+||+|++. |+.||||++...... .++..|++++++++|+|++. ++.++.+..
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~ 76 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----------PQLHIESKIYKMMQGGVGIPTIRWCGAEGD 76 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----------CCHHHHHHHHHHSTTSTTCCCEEEEEEETT
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----------HHHHHHHHHHHHccCCCcccEEEEEEecCC
Confidence 57999999999999999999975 778999998764221 23668999999998776555 455555543
Q ss_pred CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCC
Q 037285 887 GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGL 966 (1094)
Q Consensus 887 ~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGL 966 (1094)
..++||||+ +++|...+......+++..++.++.||+.||+|||++||+||||||+|||++..+ .+..+||+|||+
T Consensus 77 --~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~-~~~~vkl~DFG~ 152 (299)
T d1ckia_ 77 --YNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGK-KGNLVYIIDFGL 152 (299)
T ss_dssp --EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGG-GTTCEEECCCSS
T ss_pred --EEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccC-CCceeeeeccCc
Confidence 888999999 5666666666666799999999999999999999999999999999999987433 456899999999
Q ss_pred cccccCc--------cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhH---hh
Q 037285 967 SKIKRNT--------LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI---VN 1035 (1094)
Q Consensus 967 Srl~~~~--------~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~I---v~ 1035 (1094)
|+..... .......||+.|+|||++. ...++.++|||||||++|||+||+.||...........+ ..
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~ 230 (299)
T d1ckia_ 153 AKKYRDARTHQHIPYRENKNLTGTARYASINTHL--GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 230 (299)
T ss_dssp CEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHT--TBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH
T ss_pred ceeccccccccceeccccCCcCCCccccCHHHHh--CCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc
Confidence 9854321 1234567999999999998 456899999999999999999999999876544332221 11
Q ss_pred cc---CCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 037285 1036 NT---LRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAA 1082 (1094)
Q Consensus 1036 ~~---lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~ 1082 (1094)
.. ..+.....+++++.+||.+||+.+|++||++.+|.+.|+.+....
T Consensus 231 ~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 231 KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp HHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 11 111234578999999999999999999999999999998875443
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=378.63 Aligned_cols=254 Identities=23% Similarity=0.327 Sum_probs=202.3
Q ss_pred ceeeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeE
Q 037285 804 VQVIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGV 881 (1094)
Q Consensus 804 v~eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv 881 (1094)
.|++ .++|+++++||+|+||+||+|+++ |+.||||++++... .+.....+.+|+.+|++++|||||+++++
T Consensus 13 ~~~~-~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~------~~~~~~~~~~Ei~il~~l~hpniv~l~~~ 85 (346)
T d1cm8a_ 13 AWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ------SELFAKRAYRELRLLKHMRHENVIGLLDV 85 (346)
T ss_dssp EECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS------SHHHHHHHHHHHHHHHHCCBTTBCCCSEE
T ss_pred eeec-CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc------ChHHHHHHHHHHHHHHhcCCCCeeEEEEE
Confidence 3555 579999999999999999999875 78899999975421 13345678899999999999999999999
Q ss_pred eecCC----CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCC
Q 037285 882 VQDGP----GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRP 957 (1094)
Q Consensus 882 ~~d~~----~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g 957 (1094)
|.... ...+|+||||+ +.+|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++ .++
T Consensus 86 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~----~~~ 158 (346)
T d1cm8a_ 86 FTPDETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN----EDC 158 (346)
T ss_dssp ECSCSSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTC
T ss_pred eccCccccccceEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcc----ccc
Confidence 97643 12579999999 6677776644 3599999999999999999999999999999999999999 788
Q ss_pred cEEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhcc
Q 037285 958 ICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 1037 (1094)
Q Consensus 958 ~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~ 1037 (1094)
.+||+|||+|+...... ....||+.|+|||++.+ ...++.++|||||||++|+|++|+.||...+....+.......
T Consensus 159 ~~kl~Dfg~a~~~~~~~--~~~~~t~~y~aPE~~~~-~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~ 235 (346)
T d1cm8a_ 159 ELKILDFGLARQADSEM--TGYVVTRWYRAPEVILN-WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 235 (346)
T ss_dssp CEEECCCTTCEECCSSC--CSSCSCGGGCCTHHHHT-TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred ccccccccceeccCCcc--ccccccccccCHHHHcC-CCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhcc
Confidence 99999999998655432 34569999999999874 3457899999999999999999999998877655443322210
Q ss_pred CC-----------------------------CCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037285 1038 LR-----------------------------PTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASR 1074 (1094)
Q Consensus 1038 lr-----------------------------p~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~ 1074 (1094)
.. ......+++++.+||.+||..||.+|||+.++++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 11234578899999999999999999999999987
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=373.57 Aligned_cols=255 Identities=22% Similarity=0.269 Sum_probs=201.2
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCC-
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGP- 886 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~- 886 (1094)
++|+++++||+|+||+||+|+++ |+.||||++...... +.....+.+|+.+|++++||||+++++++....
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~ 83 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK------EGFPITALREIKILQLLKHENVVNLIEICRTKAS 83 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT------TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc------hHHHHHHHHHHHHHHHhcCCCccceEeeeecccc
Confidence 68999999999999999999985 788999998764322 122356789999999999999999999986532
Q ss_pred -----CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEE
Q 037285 887 -----GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKV 961 (1094)
Q Consensus 887 -----~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKL 961 (1094)
...+++||||+.++.+..+. .....+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 84 ~~~~~~~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~----~~~~~kl 158 (318)
T d3blha1 84 PYNRCKGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT----RDGVLKL 158 (318)
T ss_dssp -------CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTSCEEE
T ss_pred cccccCceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeec----CCCcEEe
Confidence 23689999999877776554 4445689999999999999999999999999999999999999 7889999
Q ss_pred EecCCcccccC-----ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhc
Q 037285 962 GDFGLSKIKRN-----TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN 1036 (1094)
Q Consensus 962 sDFGLSrl~~~-----~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~ 1036 (1094)
+|||+++.... .......+||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+.........+...
T Consensus 159 ~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~ 237 (318)
T d3blha1 159 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG-ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237 (318)
T ss_dssp CCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTT-CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred eecceeeecccccccccccccceecCHHHhhHHHHcC-CCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHh
Confidence 99999974332 122234569999999999874 346789999999999999999999999988776655544331
Q ss_pred cCC--CCCC----------------------------CcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1037 TLR--PTIP----------------------------SYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1037 ~lr--p~iP----------------------------e~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
... +... ...++++.+||.+||..||++|||++++++|-+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpf 307 (318)
T d3blha1 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307 (318)
T ss_dssp HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred cCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChh
Confidence 111 0000 013567889999999999999999999998865
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.6e-42 Score=373.73 Aligned_cols=248 Identities=19% Similarity=0.266 Sum_probs=202.5
Q ss_pred cCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-CCceeEEEeEeecC
Q 037285 809 NEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HPNVVAFYGVVQDG 885 (1094)
Q Consensus 809 ~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-HPNIVqL~Gv~~d~ 885 (1094)
.++|+++++||+|+||+||+|+++ |+.||||+++... ...+.+|+.+|++++ ||||+++++++...
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~ 102 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----------KKKIKREIKILENLRGGPNIITLADIVKDP 102 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----------HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----------HHHHHHHHHHHHhccCCCCCcEEEEEEEec
Confidence 468999999999999999999975 7889999987531 245778999999995 99999999999876
Q ss_pred CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecC
Q 037285 886 PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFG 965 (1094)
Q Consensus 886 ~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFG 965 (1094)
....+++|||||.+++|..+. +.+++..+..++.||+.||+|||++||+||||||+|||++. ++..+||+|||
T Consensus 103 ~~~~~~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~---~~~~vkl~DFG 175 (328)
T d3bqca1 103 VSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH---EHRKLRLIDWG 175 (328)
T ss_dssp TTCSEEEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET---TTTEEEECCGG
T ss_pred CCCceeEEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcC---CCCeeeecccc
Confidence 566899999999999997654 35899999999999999999999999999999999999982 34579999999
Q ss_pred CcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH-HHHhHhh---------
Q 037285 966 LSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA-IIGGIVN--------- 1035 (1094)
Q Consensus 966 LSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~e-ile~Iv~--------- 1035 (1094)
+|+............+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||....... ....+..
T Consensus 176 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~ 254 (328)
T d3bqca1 176 LAEFYHPGQEYNVRVASRYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 254 (328)
T ss_dssp GCEECCTTCCCCSCCSCGGGCCHHHHTT-CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHH
T ss_pred cceeccCCCcccccccCccccCcccccC-CCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhh
Confidence 9987655545556679999999999874 3457899999999999999999999997654321 1111100
Q ss_pred --------------------------ccCCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037285 1036 --------------------------NTLRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1036 --------------------------~~lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L 1075 (1094)
..........+++++.+||++||..||.+|||++++++|-
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp 320 (328)
T d3bqca1 255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 320 (328)
T ss_dssp HHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 0001112234688999999999999999999999999864
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-42 Score=362.67 Aligned_cols=252 Identities=25% Similarity=0.300 Sum_probs=204.5
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDGPG 887 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~~~ 887 (1094)
++|+++++||+|+||+||+|++. ++.||||+++..... +.....+.+|+.+|++++||||+++++++.+..
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~- 74 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD------EGVPSSALREICLLKELKHKNIVRLHDVLHSDK- 74 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS------TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCC------hHHHHHHHHHHHHHHhcCcCCEEeecccccccc-
Confidence 58999999999999999999985 677999999765321 234567889999999999999999999999866
Q ss_pred CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEecCCc
Q 037285 888 GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 967 (1094)
Q Consensus 888 ~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLS 967 (1094)
.+++|++++.+++|..++... +.+++..+..++.|++.||+|||+++|+||||||+|||++ .++.+||+|||.+
T Consensus 75 -~~~iv~~~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~----~~~~~kl~DFG~a 148 (292)
T d1unla_ 75 -KLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN----RNGELKLANFGLA 148 (292)
T ss_dssp -EEEEEEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCCEEECCCTTC
T ss_pred -ceeEEeeeccccccccccccc-cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccc----cCCceeeeecchh
Confidence 899999999999988877554 4589999999999999999999999999999999999998 6778999999999
Q ss_pred ccccCc-cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCC-CCChHHHHHhHhhcc--------
Q 037285 968 KIKRNT-LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYA-NMHYGAIIGGIVNNT-------- 1037 (1094)
Q Consensus 968 rl~~~~-~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~-~~~~~eile~Iv~~~-------- 1037 (1094)
+..... .......++..|+|||++.. ...++.++|||||||++|||++|+.||. ..+..+....+....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (292)
T d1unla_ 149 RAFGIPVRCYSAEVVTLWYRPPDVLFG-AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp EECCSCCSCCCSCCSCGGGCCHHHHTT-CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTC
T ss_pred hcccCCCccceeeccccchhhhhHhcc-CCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhh
Confidence 865432 23334457888999999874 3346899999999999999999999864 344444333322110
Q ss_pred -------------------CCCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037285 1038 -------------------LRPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1038 -------------------lrp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L 1075 (1094)
........+++.+.+||++||+.||.+|||+++++++-
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp 284 (292)
T d1unla_ 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred hhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcCh
Confidence 01112345678999999999999999999999999863
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-42 Score=375.17 Aligned_cols=256 Identities=21% Similarity=0.291 Sum_probs=201.0
Q ss_pred eeeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEe
Q 037285 805 QVIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVV 882 (1094)
Q Consensus 805 ~eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~ 882 (1094)
++|. ++|+++++||+|+||+||+|+.+ |+.||||++.+.. .......+.+|+.+|++|+||||+++++++
T Consensus 4 ~~i~-~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-------~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~ 75 (345)
T d1pmea_ 4 FDVG-PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-------HQTYCQRTLREIKILLRFRHENIIGINDII 75 (345)
T ss_dssp CCCC-TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-------CHHHHHHHHHHHHHHHHCCCTTBCCCCEEE
T ss_pred cCcC-CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-------ChHHHHHHHHHHHHHHHcCCCCCCcEEEEE
Confidence 4443 47999999999999999999874 7889999997531 123346788999999999999999999998
Q ss_pred ecCCC--CceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEE
Q 037285 883 QDGPG--GTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICK 960 (1094)
Q Consensus 883 ~d~~~--~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VK 960 (1094)
..... ...+++++|+.+|+|.+++... .+++..+..++.||+.||+|||++|||||||||+|||++ ..+.+|
T Consensus 76 ~~~~~~~~~~~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~----~~~~~k 149 (345)
T d1pmea_ 76 RAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN----TTCDLK 149 (345)
T ss_dssp CCSSTTTCCCEEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEE
T ss_pred eeccccccceEEEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEEC----CCCCEE
Confidence 65421 1234555677799999999654 489999999999999999999999999999999999998 778999
Q ss_pred EEecCCcccccCc----cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhc
Q 037285 961 VGDFGLSKIKRNT----LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN 1036 (1094)
Q Consensus 961 LsDFGLSrl~~~~----~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~ 1036 (1094)
|+|||+++..... .......||+.|+|||++.. ...++.++||||+||++|+|++|+.||...............
T Consensus 150 l~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~ 228 (345)
T d1pmea_ 150 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI 228 (345)
T ss_dssp ECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTT-BCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred EcccCceeeccCCCccceeeccccccceechHHHhhc-CCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhh
Confidence 9999999854222 22344569999999999864 446788999999999999999999999887655443332111
Q ss_pred cCC----------------------C-------CCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037285 1037 TLR----------------------P-------TIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRL 1075 (1094)
Q Consensus 1037 ~lr----------------------p-------~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L 1075 (1094)
... . .....++.++.+||.+||..||.+|||+.+++++-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hp 296 (345)
T d1pmea_ 229 LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 296 (345)
T ss_dssp HCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred ccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 000 0 01234678899999999999999999999999873
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-43 Score=382.63 Aligned_cols=258 Identities=26% Similarity=0.400 Sum_probs=210.0
Q ss_pred eccCCeeEEEEecccCceEEEEeee-----cCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCC-CceeEEEe
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHH-PNVVAFYG 880 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~-----rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~H-PNIVqL~G 880 (1094)
+..++|++++.||+|+||+||+|+. +|+.||||++++...... ......+.+|+.+|++++| |||+++++
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~----~~~~~~~~~E~~il~~l~h~pnIv~~~~ 96 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK----AKTTEHTRTERQVLEHIRQSPFLVTLHY 96 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE----ESSGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccc----hHHHHHHHHHHHHHHhccCCCeEEEeee
Confidence 3457899999999999999999975 367899999876432211 1122456789999999976 89999999
Q ss_pred EeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEE
Q 037285 881 VVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICK 960 (1094)
Q Consensus 881 v~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VK 960 (1094)
++.+.. .+++||||+.+|+|.+++..... +.+..+..++.||+.||+|||+++|+||||||+|||++ .++.+|
T Consensus 97 ~~~~~~--~~~~v~e~~~~~~L~~~i~~~~~-~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~----~~~~vk 169 (322)
T d1vzoa_ 97 AFQTET--KLHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD----SNGHVV 169 (322)
T ss_dssp EEEETT--EEEEEECCCCSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCEE
T ss_pred eeccCC--ceeeeeecccccHHHHHHHhccc-ccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeec----CCCCEE
Confidence 998865 89999999999999999976654 78889999999999999999999999999999999999 778999
Q ss_pred EEecCCcccccC--ccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhc--
Q 037285 961 VGDFGLSKIKRN--TLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN-- 1036 (1094)
Q Consensus 961 LsDFGLSrl~~~--~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~-- 1036 (1094)
|+|||+++.... ........|++.|+|||.+.+....++.++|||||||+||+|+||+.||...........+...
T Consensus 170 L~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~ 249 (322)
T d1vzoa_ 170 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 249 (322)
T ss_dssp ESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH
T ss_pred EeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc
Confidence 999999985432 2333456799999999999865667889999999999999999999999876544333333222
Q ss_pred cCCCCCCCcCcHHHHHHHHHhccCCCCCCC-----CHHHHHHHH
Q 037285 1037 TLRPTIPSYCDAEWRTLMEECWAPNPAARP-----SFTEIASRL 1075 (1094)
Q Consensus 1037 ~lrp~iPe~~S~eL~dLI~kCLq~DPeeRP-----S~eELLq~L 1075 (1094)
...+.++..+++++.+||.+||..||++|| |++++++|-
T Consensus 250 ~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hp 293 (322)
T d1vzoa_ 250 KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 293 (322)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCH
Confidence 234556778999999999999999999999 589998753
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.3e-41 Score=363.28 Aligned_cols=262 Identities=19% Similarity=0.227 Sum_probs=211.1
Q ss_pred ccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCC-CceeEEEeEeec
Q 037285 808 KNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHH-PNVVAFYGVVQD 884 (1094)
Q Consensus 808 s~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~H-PNIVqL~Gv~~d 884 (1094)
..++|++.++||+|+||+||+|++. |+.||||++...... ..+.+|+++++.|.| +|++.+++++..
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----------~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 72 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----------PQLRDEYRTYKLLAGCTGIPNVYYFGQE 72 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----------CCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----------HHHHHHHHHHHHhcCCCCCCEEEEEeec
Confidence 3578999999999999999999874 788999988654211 235678888888875 899999999987
Q ss_pred CCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCC-CCCCcEEEEe
Q 037285 885 GPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKD-PSRPICKVGD 963 (1094)
Q Consensus 885 ~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~-~e~g~VKLsD 963 (1094)
.. ..++||||+ +++|.+++......+++..+..++.|++.||+|||++||+||||||+|||++... ...+.+||+|
T Consensus 73 ~~--~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~D 149 (293)
T d1csna_ 73 GL--HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVD 149 (293)
T ss_dssp TT--EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred CC--ccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcc
Confidence 55 899999998 7899999887777799999999999999999999999999999999999997422 1357899999
Q ss_pred cCCcccccCc--------cccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH---HHHHh
Q 037285 964 FGLSKIKRNT--------LVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG---AIIGG 1032 (1094)
Q Consensus 964 FGLSrl~~~~--------~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~---eile~ 1032 (1094)
||+|+..... .......||+.|||||++. ...++.++|||||||++|||+||+.||...... .....
T Consensus 150 FG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~--~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~ 227 (293)
T d1csna_ 150 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL--GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER 227 (293)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT--TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred cceeEEcccCccccceeecccCceEEchhhcCHHHhc--CCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHH
Confidence 9999854221 1234567999999999998 457899999999999999999999999865432 22222
Q ss_pred HhhccC---CCCCCCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhc
Q 037285 1033 IVNNTL---RPTIPSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRVLSTAASQ 1084 (1094)
Q Consensus 1033 Iv~~~l---rp~iPe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~L~ta~s~ 1084 (1094)
+..... ...+...+++++.++|..||..+|++||+++.|.+.|.++......
T Consensus 228 i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~ 282 (293)
T d1csna_ 228 IGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 282 (293)
T ss_dssp HHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCC
Confidence 222111 1123456889999999999999999999999999999988655443
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-42 Score=373.77 Aligned_cols=258 Identities=21% Similarity=0.289 Sum_probs=206.0
Q ss_pred cceeeccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEe
Q 037285 803 SVQVIKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYG 880 (1094)
Q Consensus 803 sv~eIs~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~G 880 (1094)
++|++ +++|+++++||+|+||+||+|+++ |+.||||++.+.... ......+.+|+.+|++|+|||||++++
T Consensus 12 ~~~~~-~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~~~~~~~Ei~il~~l~h~~iv~~~~ 84 (348)
T d2gfsa1 12 TIWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS------IIHAKRTYRELRLLKHMKHENVIGLLD 84 (348)
T ss_dssp SEEEE-ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSS------HHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred ccccC-CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcC------hHHHHHHHHHHHHHHhcCCCCeeeEEE
Confidence 46777 478999999999999999999874 788999999764211 223456889999999999999999999
Q ss_pred EeecCC---CCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCC
Q 037285 881 VVQDGP---GGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRP 957 (1094)
Q Consensus 881 v~~d~~---~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g 957 (1094)
++.... ....+++|+|+.+|+|.+++..+ .+++..+..++.||+.||+|||++||+||||||+|||++ .++
T Consensus 85 ~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~----~~~ 158 (348)
T d2gfsa1 85 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN----EDC 158 (348)
T ss_dssp EECSCSSTTTCCCCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTC
T ss_pred EEeeccccccCceEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccc----ccc
Confidence 986432 22456677888899999998543 599999999999999999999999999999999999999 778
Q ss_pred cEEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhcc
Q 037285 958 ICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 1037 (1094)
Q Consensus 958 ~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~ 1037 (1094)
.+|++|||++...... .....||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 159 ~~kl~dfg~a~~~~~~--~~~~~g~~~y~apE~~~~-~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~ 235 (348)
T d2gfsa1 159 ELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLN-WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235 (348)
T ss_dssp CEEECCC----CCTGG--GSSSCHHHHTSCHHHHTT-CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cccccccchhcccCcc--cccccccccccCchhhcC-CccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999999754433 234568999999999774 3456889999999999999999999999877665554443321
Q ss_pred CCC---------------------CC--------CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 037285 1038 LRP---------------------TI--------PSYCDAEWRTLMEECWAPNPAARPSFTEIASRLR 1076 (1094)
Q Consensus 1038 lrp---------------------~i--------Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~ 1076 (1094)
..+ .. ...+++++.+||.+||..||.+|||+.++++|-+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~ 303 (348)
T d2gfsa1 236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303 (348)
T ss_dssp CCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHh
Confidence 111 00 1246889999999999999999999999998643
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-41 Score=370.03 Aligned_cols=252 Identities=22% Similarity=0.293 Sum_probs=193.1
Q ss_pred CCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCCCCceeEEEeEeecC--
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLHHPNVVAFYGVVQDG-- 885 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~HPNIVqL~Gv~~d~-- 885 (1094)
++|+++++||+|+||+||+|+++ |+.||||++.+.... +.....+.+|+.+|++++|||||+++++|...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~------~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~ 90 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN------QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT 90 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS------HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcC------HHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccc
Confidence 57999999999999999999985 788999999865321 23345788999999999999999999999643
Q ss_pred --CCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEEEEe
Q 037285 886 --PGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICKVGD 963 (1094)
Q Consensus 886 --~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VKLsD 963 (1094)
....+|+|||||.++.+.. +. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+|++|
T Consensus 91 ~~~~~~~~iv~Ey~~~~l~~~-~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~----~~~~~kl~d 162 (355)
T d2b1pa1 91 LEEFQDVYLVMELMDANLCQV-IQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILD 162 (355)
T ss_dssp TTTCCEEEEEEECCSEEHHHH-HT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCCEEECC
T ss_pred cccCceeEEEEeccchHHHHh-hh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccc----cccceeeec
Confidence 2347899999997665544 32 3489999999999999999999999999999999999999 778899999
Q ss_pred cCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhHhhccC-----
Q 037285 964 FGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL----- 1038 (1094)
Q Consensus 964 FGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~eile~Iv~~~l----- 1038 (1094)
||+++............+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||...+.......+.....
T Consensus 163 f~~~~~~~~~~~~~~~~~t~~y~aPE~l~~--~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~ 240 (355)
T d2b1pa1 163 FGLARTAGTSFMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_dssp CCC---------------CCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred hhhhhccccccccccccccccccChhhhcC--CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHH
Confidence 999987665555556679999999999984 5788999999999999999999999988776554443321100
Q ss_pred -----------------CCC------------C------CCcCcHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 037285 1039 -----------------RPT------------I------PSYCDAEWRTLMEECWAPNPAARPSFTEIASRLRV 1077 (1094)
Q Consensus 1039 -----------------rp~------------i------Pe~~S~eL~dLI~kCLq~DPeeRPS~eELLq~L~~ 1077 (1094)
... . ....+.++.+||++||..||++|||+++|++|-+-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~ 314 (355)
T d2b1pa1 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314 (355)
T ss_dssp HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred HHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCccc
Confidence 000 0 01135678999999999999999999999988543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-36 Score=330.71 Aligned_cols=257 Identities=18% Similarity=0.235 Sum_probs=188.9
Q ss_pred eccCCeeEEEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-----------CC
Q 037285 807 IKNEDLEEQKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-----------HP 873 (1094)
Q Consensus 807 Is~edYei~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-----------HP 873 (1094)
+...+|+++++||+|+||+||+|+++ |+.||||++++. ......+.+|+.+|+.++ |+
T Consensus 10 ~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---------~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~ 80 (362)
T d1q8ya_ 10 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---------KVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 80 (362)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---------HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHT
T ss_pred ccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---------ccchHHHHHHHHHHHHhcchhhhhhhhcCcC
Confidence 45567999999999999999999874 788999999754 122345677888888775 57
Q ss_pred ceeEEEeEeecCCCCceEEEeeecccchh--HHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEec
Q 037285 874 NVVAFYGVVQDGPGGTLATVAEYMVDGSL--RHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVN 950 (1094)
Q Consensus 874 NIVqL~Gv~~d~~~~~L~IVmEYmegGSL--~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs-~GIIHRDLKPeNILLD 950 (1094)
||+++++++........+++|+++..+.. ..........+++..+..++.||+.||+|||+ .||+||||||+|||++
T Consensus 81 ~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~ 160 (362)
T d1q8ya_ 81 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME 160 (362)
T ss_dssp TBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEE
T ss_pred ceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeee
Confidence 89999998865434466667776654433 22233344568999999999999999999998 8899999999999997
Q ss_pred cCCC--CCCcEEEEecCCcccccCccccCCccCCCcccCccccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH-
Q 037285 951 LKDP--SRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG- 1027 (1094)
Q Consensus 951 ~~~~--e~g~VKLsDFGLSrl~~~~~~ss~~~GT~~YmAPEvL~g~~~kyS~KSDVWSLGVLLyELLTGk~PF~~~~~~- 1027 (1094)
..+. ....+||+|||.+...... .....||+.|+|||++. ...++.++|||||||++++|++|+.||......
T Consensus 161 ~~~~~~~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~ 236 (362)
T d1q8ya_ 161 IVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLL--GAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 236 (362)
T ss_dssp EEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHH--TCCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred ccCcccccceeeEeecccccccccc--cccccccccccChhhcc--ccCCCccccccchHHHHHHHHHCCCCCCCCcccc
Confidence 3321 1135999999999854432 23456999999999998 457889999999999999999999999754321
Q ss_pred -----HHHHhHhh----------------------c----cC--------------CCCCCCcCcHHHHHHHHHhccCCC
Q 037285 1028 -----AIIGGIVN----------------------N----TL--------------RPTIPSYCDAEWRTLMEECWAPNP 1062 (1094)
Q Consensus 1028 -----eile~Iv~----------------------~----~l--------------rp~iPe~~S~eL~dLI~kCLq~DP 1062 (1094)
........ . .. ........++++.+||.+||..||
T Consensus 237 ~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP 316 (362)
T d1q8ya_ 237 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316 (362)
T ss_dssp --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred ccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCCh
Confidence 11100000 0 00 011122346788999999999999
Q ss_pred CCCCCHHHHHHHHH
Q 037285 1063 AARPSFTEIASRLR 1076 (1094)
Q Consensus 1063 eeRPS~eELLq~L~ 1076 (1094)
.+|||++++++|-+
T Consensus 317 ~~Rpta~e~L~Hp~ 330 (362)
T d1q8ya_ 317 RKRADAGGLVNHPW 330 (362)
T ss_dssp TTCBCHHHHHTCGG
T ss_pred hHCcCHHHHhcCcc
Confidence 99999999998743
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=6.1e-22 Score=198.25 Aligned_cols=171 Identities=17% Similarity=0.009 Sum_probs=120.4
Q ss_pred eeEEEEecccCceEEEEeee-cCceEEEEEeecCccCCCc----------hhHHHHHHHHHHHHHHHhhCCCCceeEEEe
Q 037285 812 LEEQKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRS----------SEQERLTVEFWKEAEILSKLHHPNVVAFYG 880 (1094)
Q Consensus 812 Yei~kkLGsG~FGtVYKAk~-rGt~VAVKiIkk~~~se~~----------~eqe~~~~eFlrEIkILkrL~HPNIVqL~G 880 (1094)
+.+.++||+|+||+||+|+. +|..||||+++........ .........+.+|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 35789999999999999986 5788999988643221000 011122344567889999999999998886
Q ss_pred EeecCCCCceEEEeeecccchhHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeccCCCCCCcEE
Q 037285 881 VVQDGPGGTLATVAEYMVDGSLRHVLVRKDRFLDRRRRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPSRPICK 960 (1094)
Q Consensus 881 v~~d~~~~~L~IVmEYmegGSL~d~L~k~~~~Lse~~~l~Ia~QIaeGLaYLHs~GIIHRDLKPeNILLD~~~~e~g~VK 960 (1094)
+. ..+++|||+.+..+.+ ++...+..++.||+.+|+|||++||+||||||+|||++ + ..++
T Consensus 82 ~~------~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~----~-~~~~ 142 (191)
T d1zara2 82 WE------GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----E-EGIW 142 (191)
T ss_dssp EE------TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----T-TEEE
T ss_pred ec------CCEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee----C-CCEE
Confidence 63 2368999998876533 34445667899999999999999999999999999998 3 3589
Q ss_pred EEecCCcccccCccccCCccCCCcccC------ccccccCCCCCCchhhHHHHHHHH
Q 037285 961 VGDFGLSKIKRNTLVSGGVRGTLPWMA------PELLSGSSSKVSEKVDVFSFGIVL 1011 (1094)
Q Consensus 961 LsDFGLSrl~~~~~~ss~~~GT~~YmA------PEvL~g~~~kyS~KSDVWSLGVLL 1011 (1094)
|+|||+|+........ .|+. .+.+. ..|+.++|+||+.--+
T Consensus 143 liDFG~a~~~~~~~~~-------~~l~rd~~~~~~~f~---r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 143 IIDFPQSVEVGEEGWR-------EILERDVRNIITYFS---RTYRTEKDINSAIDRI 189 (191)
T ss_dssp ECCCTTCEETTSTTHH-------HHHHHHHHHHHHHHH---HHHCCCCCHHHHHHHH
T ss_pred EEECCCcccCCCCCcH-------HHHHHHHHHHHHHHc---CCCCCcccHHHHHHHH
Confidence 9999999754322111 1111 12222 3567789999975433
|
| >d1blja_ d.93.1.1 (A:) P55 Blk protein tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: P55 Blk protein tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.43 E-value=6.1e-08 Score=90.01 Aligned_cols=81 Identities=15% Similarity=0.205 Sum_probs=64.5
Q ss_pred hccccccccccCCCChhHHHHcCCc----hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCC
Q 037285 684 FRNLAQVDFGQKDVSLIDQEHLGLS----SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPS 756 (1094)
Q Consensus 684 ~~~Le~~~Wy~~~IsR~~AE~ll~a----~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~ 756 (1094)
.++|+..+||+++|+|.+||.+|+. +| ||++....| .|.+++... ....+.|. ||.|.+...+.|+
T Consensus 6 ~~~l~~e~Wy~g~isR~eAe~~L~~~~~~~G~FLVR~S~~~~g-~~~Lsv~~~-~~~~~~v~-H~~i~~~~~g~~~---- 78 (114)
T d1blja_ 6 VETLEVEKWFFRTISRKDAERQLLAPMNKAGSFLIRESESNKG-AFSLSVKDI-TTQGEVVK-HYKIRSLDNGGYY---- 78 (114)
T ss_dssp SCCSCCSSSBCCSCCHHHHHHHHSSTTCCTTCEEBCBCTTCSS-CEEEEECBC-CTTTCBCC-CEEEEEETTTEEE----
T ss_pred cCccccCCCcCCCCCHHHHHHHHHhcCCCCceEEEeccCCCCC-CeEEEEEee-ccCCCEEE-EEEEEEcCCCCEE----
Confidence 5789999999999999999987743 45 999988777 788888764 22234566 9999887777788
Q ss_pred cccccchHHHHHhhh
Q 037285 757 VSESMQFDAMMENLR 771 (1094)
Q Consensus 757 isE~~qFdsL~ElLr 771 (1094)
+.+...|.++.+++.
T Consensus 79 l~~~~~F~sl~eLV~ 93 (114)
T d1blja_ 79 ISPRITFPTLQALVQ 93 (114)
T ss_dssp EETTEEESSHHHHHH
T ss_pred ecCCceECCHHHHHH
Confidence 666778999999993
|
| >d1o48a_ d.93.1.1 (A:) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.42 E-value=3.7e-08 Score=90.37 Aligned_cols=79 Identities=19% Similarity=0.267 Sum_probs=65.2
Q ss_pred cccccccccCCCChhHHHHcCCc----hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCcc
Q 037285 686 NLAQVDFGQKDVSLIDQEHLGLS----SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVS 758 (1094)
Q Consensus 686 ~Le~~~Wy~~~IsR~~AE~ll~a----~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~is 758 (1094)
+||..+||+++|+|.+||.+|.. +| ||+|...+| .|.+|+.......+..|. |+.+.....+.++ +.
T Consensus 1 ~l~~~~Wy~g~i~R~eAe~lL~~~~~~~G~FLVR~S~~~~g-~y~LSv~~~~~~~~~~i~-h~~i~~~~~g~~~----~~ 74 (106)
T d1o48a_ 1 SIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKG-AYCLSVSDFDNAKGLNVK-HYKIRKLDSGGFY----IT 74 (106)
T ss_dssp CGGGSTTEEESCCHHHHHHHHCCTTCCTTCEEEEECSSSTT-CEEEEEEEEETTTEEEEE-EEEEEECTTSCEE----SS
T ss_pred CcccCCccCCCCCHHHHHHHHHhcCCCCCcEEEEcccCCCC-CEEEEEEecccCcccceE-EEEEEEecCCCEE----Ec
Confidence 58999999999999999998864 45 999988788 899998776444555666 9988887777787 56
Q ss_pred cccchHHHHHhh
Q 037285 759 ESMQFDAMMENL 770 (1094)
Q Consensus 759 E~~qFdsL~ElL 770 (1094)
....|.++.+++
T Consensus 75 ~~~~F~sl~eLV 86 (106)
T d1o48a_ 75 SRTQFNSLQQLV 86 (106)
T ss_dssp TTSEESSHHHHH
T ss_pred CCeeECCHHHHH
Confidence 677899999999
|
| >d1g83a2 d.93.1.1 (A:142-245) Tyrosine kinase Fyn {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine kinase Fyn species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.40 E-value=4.2e-08 Score=89.53 Aligned_cols=80 Identities=16% Similarity=0.237 Sum_probs=65.8
Q ss_pred ccccccccccCCCChhHHHHcCCc----hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCc
Q 037285 685 RNLAQVDFGQKDVSLIDQEHLGLS----SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSV 757 (1094)
Q Consensus 685 ~~Le~~~Wy~~~IsR~~AE~ll~a----~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~i 757 (1094)
++|+..+||+++|+|.+||++|.. +| ||+|...+| .|.+|+........+.|. |+.|.....+.++ +
T Consensus 1 ~~l~~~~Wy~g~i~R~eAe~~L~~~g~~~G~FLVR~S~~~~g-~~~Lsv~~~~~~~~~~v~-h~~i~~~~~g~~~----~ 74 (104)
T d1g83a2 1 DSIQAEEWYFGKLGRKDAERQLLSFGNPRGTFLIRESETTKG-AYSLSIRDWDDMKGDHVK-HYKIRKLDNGGYY----I 74 (104)
T ss_dssp TSGGGSSSBCTTCCHHHHHHHHHSTTCCTTCEEEEECSSSTT-CEEEEEEEECSSSCEEEE-EEEEEECTTSCEE----E
T ss_pred CccccCCCcCCCCCHHHHHHHHHhcCCCCCcEEEeccCCCCC-CeEEEEEEeecCcCCeEE-EEEEEEcCCCCEE----e
Confidence 578999999999999999998854 45 999998888 899988776444567788 9999877777777 4
Q ss_pred ccccchHHHHHhh
Q 037285 758 SESMQFDAMMENL 770 (1094)
Q Consensus 758 sE~~qFdsL~ElL 770 (1094)
.....|.++.+++
T Consensus 75 ~~~~~F~sl~~LV 87 (104)
T d1g83a2 75 TTRAQFETLQQLV 87 (104)
T ss_dssp TTTEEESSHHHHH
T ss_pred cCCcccCCHHHHH
Confidence 5566799999999
|
| >d1lkka_ d.93.1.1 (A:) p56-lck tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: p56-lck tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.40 E-value=5.3e-08 Score=89.06 Aligned_cols=79 Identities=22% Similarity=0.245 Sum_probs=62.4
Q ss_pred ccccccccCCCChhHHHHcCCc----hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCccc
Q 037285 687 LAQVDFGQKDVSLIDQEHLGLS----SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSE 759 (1094)
Q Consensus 687 Le~~~Wy~~~IsR~~AE~ll~a----~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~isE 759 (1094)
||.++||+++|+|.+||.+|+. +| ||+|...+| .|.+++..........|. ||.|.....+.++ +..
T Consensus 1 le~~pWy~g~isR~eAe~~L~~~~~~~GtFLVR~S~~~~g-~~~lsv~~~~~~~~~~v~-h~~i~~~~~~~~~----~~~ 74 (105)
T d1lkka_ 1 LEPEPWFFKNLSRKDAERQLLAPGNTHGSFLIRESESTAG-SFSLSVRDFDQNQGEVVK-HYKIRNLDNGGFY----ISP 74 (105)
T ss_dssp CCCCTTBCTTCCHHHHHHHHTSTTCCTTCEEEEECSSSTT-CEEEEEEEEETTTEEEEE-EEEEEECTTSCEE----SST
T ss_pred CccCCccCCCCCHHHHHHHHHhcCCCCCcEEEEccCCCCC-CEEEEEEEcccCCCccEE-EEEEEEcCCCCEE----ecC
Confidence 6889999999999999998844 45 999988788 788988775322333456 9999887777787 555
Q ss_pred ccchHHHHHhhh
Q 037285 760 SMQFDAMMENLR 771 (1094)
Q Consensus 760 ~~qFdsL~ElLr 771 (1094)
...|.++.+++.
T Consensus 75 ~~~F~sl~~LV~ 86 (105)
T d1lkka_ 75 RITFPGLHELVR 86 (105)
T ss_dssp TSCBSSHHHHHH
T ss_pred CcccCCHHHHHH
Confidence 677999999993
|
| >d1luia_ d.93.1.1 (A:) Itk/tsk protein tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Itk/tsk protein tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.33 E-value=1e-07 Score=87.84 Aligned_cols=80 Identities=24% Similarity=0.346 Sum_probs=61.3
Q ss_pred ccccccccccCCCChhHHHHcCCc---hh---hhhhhhcCCceeEEeeeccC-CCCCCcccccccccccC--CCccccCC
Q 037285 685 RNLAQVDFGQKDVSLIDQEHLGLS---SG---VREVREEDGRLYHFTPLTDD-GAPKGRVDSQLNFGQDS--QKTFGVDP 755 (1094)
Q Consensus 685 ~~Le~~~Wy~~~IsR~~AE~ll~a---~g---VR~s~~~~G~~y~~S~l~~~-ga~~g~v~shy~I~~ds--q~r~~vtp 755 (1094)
++|++++||+++|+|.+||.+|.. +| ||+|.. .| .|.+|+.... ....+.++ ||.|.... ...++
T Consensus 1 ~~l~~~~Wy~g~isR~eAe~lL~~~~~~G~FLVR~S~~-~g-~y~LSv~~~~~~~~~~~i~-h~~I~~~~~~~~~~~--- 74 (108)
T d1luia_ 1 NNLETYEWYNKSISRDKAEKLLLDTGKEGAFMVRDSRT-PG-TYTVSVFTKAIISENPCIK-HYHIKETNDSPKRYY--- 74 (108)
T ss_dssp CCCTTSTTBCTTCCHHHHHHHHHHHCCTTEEEEEECCT-TT-CEEEEEECSCCTTTCSCEE-EEECEECCCSSCCEE---
T ss_pred CccccCCCcCCCCCHHHHHHHHHhcCCCCeEEEEecCC-CC-CEEEEEEecCCcccCCcee-EEEEEEecCCCceee---
Confidence 589999999999999999999963 45 999965 67 7999988764 23445667 99987644 33445
Q ss_pred CcccccchHHHHHhhh
Q 037285 756 SVSESMQFDAMMENLR 771 (1094)
Q Consensus 756 ~isE~~qFdsL~ElLr 771 (1094)
+.+...|.++.+++.
T Consensus 75 -~~~~~~F~sl~~LV~ 89 (108)
T d1luia_ 75 -VAEKYVFDSIPLLIQ 89 (108)
T ss_dssp -SSSSCCBSSHHHHHH
T ss_pred -cCCCcccCCHHHHHH
Confidence 456678999999993
|
| >d1opka2 d.93.1.1 (A:140-240) Abl tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Abl tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.33 E-value=7.3e-08 Score=87.63 Aligned_cols=75 Identities=25% Similarity=0.272 Sum_probs=63.7
Q ss_pred cccccccccCCCChhHHHHcCCc--hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCcccc
Q 037285 686 NLAQVDFGQKDVSLIDQEHLGLS--SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSES 760 (1094)
Q Consensus 686 ~Le~~~Wy~~~IsR~~AE~ll~a--~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~isE~ 760 (1094)
+||+..||+++|+|.+||.+|.. +| ||+|....| .|.+|+... +.+. |+.|.....+.+. +...
T Consensus 1 sLe~~~Wy~g~isR~eAe~lL~~~~~G~FLVR~S~~~~~-~~~LSv~~~-----~~v~-H~~I~~~~~g~~~----~~~~ 69 (101)
T d1opka2 1 SLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPG-QRSISLRYE-----GRVY-HYRINTASDGKLY----VSSE 69 (101)
T ss_dssp SGGGSTTEEEECCHHHHHHHGGGCCTTEEEEEECSSSTT-CEEEEEEET-----TEEE-EEECEECTTSCEE----SSTT
T ss_pred CcccCcccCCCCCHHHHHHHhcCCCCCeEEEEecCCCCC-CEEEEEEcC-----cceE-EEEeEECCCCCEE----eCCC
Confidence 68999999999999999999985 55 999988778 799998876 7788 9999887777776 4556
Q ss_pred cchHHHHHhhh
Q 037285 761 MQFDAMMENLR 771 (1094)
Q Consensus 761 ~qFdsL~ElLr 771 (1094)
..|+++.+++.
T Consensus 70 ~~F~sl~~LI~ 80 (101)
T d1opka2 70 SRFNTLAELVH 80 (101)
T ss_dssp SCBSSHHHHHH
T ss_pred cccCCHHHHHH
Confidence 67999999994
|
| >d2oq1a1 d.93.1.1 (A:5-134) Tyrosine-protein kinase zap-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine-protein kinase zap-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.32 E-value=1.4e-08 Score=97.22 Aligned_cols=119 Identities=13% Similarity=0.137 Sum_probs=79.9
Q ss_pred ccccccccCCCChhHHHHcCCc----hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCccc
Q 037285 687 LAQVDFGQKDVSLIDQEHLGLS----SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSE 759 (1094)
Q Consensus 687 Le~~~Wy~~~IsR~~AE~ll~a----~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~isE 759 (1094)
++...||+++|+|.+||.+|.. +| ||+|....| .|.+|+.+. +.+. ||.|..+.++.++ +..
T Consensus 3 ~~~~pWy~g~i~R~~Ae~~L~~~g~~~G~FLVR~S~~~~g-~yvLSv~~~-----~~v~-H~~I~~~~~g~~~----l~~ 71 (130)
T d2oq1a1 3 AAHLPFFYGSISRAEAEEHLKLAGMADGLFLLRQCLRSLG-GYVLSLVHD-----VRFH-HFPIERQLNGTYA----IAG 71 (130)
T ss_dssp TTTCTTBCBSCCHHHHHHHHHHTTCCTTCEEEEECSSSTT-CEEEEEEET-----TEEE-EEEEEECTTSCEE----ETT
T ss_pred ccCCCCccCCCCHHHHHHHHHhcCCCCceEEEEecCCCCc-cEEEEEeeC-----CceE-EEEEEEcCCCcee----ccC
Confidence 4567899999999999999964 45 999988888 899998885 7788 9999887777777 555
Q ss_pred ccchHHHHHhhhcccccccccCCCCCc--CCCCCCCCCCcccCCCcceeeccCCeeEEEEecccCceEEEE
Q 037285 760 SMQFDAMMENLRTTESDYEEGNAGNRN--IGLPSLNPSLVDFDVSSVQVIKNEDLEEQKELGSGTFGTVYH 828 (1094)
Q Consensus 760 ~~qFdsL~ElLrt~eSdyee~nagn~~--l~~P~lnpsl~~~dlssv~eIs~edYei~kkLGsG~FGtVYK 828 (1094)
...|.++.+++ +|+..+..+.. +..|+..+...... ...++. ..+.+|+|.||.||+
T Consensus 72 ~~~F~sl~~Lv-----~~Y~~~~~gL~~~L~~P~~r~~~~~~~-~~~~~~------~~~~~~~~~~~~~w~ 130 (130)
T d2oq1a1 72 GKAHCGPAELC-----EFYSRDPDGLPCNLRKPCNRPSGLEPQ-PGVFDC------LRDAMVRDYVRQTWK 130 (130)
T ss_dssp SCCBSSHHHHH-----HHHHHCCTTSSSCCCSBCCCCTTCCCB-CCHHHH------HHHHHHHHHHHHHHC
T ss_pred CCCcCCHHHHH-----HHHhhCCCCCCccCCccCCCCCCCCCC-cchHHH------HHHHHHHhhccCccC
Confidence 66799999999 44444433322 23333222111100 011111 236789999988774
|
| >d1qcfa2 d.93.1.1 (A:146-248) Hemopoetic cell kinase Hck {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Hemopoetic cell kinase Hck species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.23 E-value=2e-07 Score=84.71 Aligned_cols=76 Identities=18% Similarity=0.190 Sum_probs=61.2
Q ss_pred cccccCCCChhHHHHcC----Cchh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCcccccc
Q 037285 690 VDFGQKDVSLIDQEHLG----LSSG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSESMQ 762 (1094)
Q Consensus 690 ~~Wy~~~IsR~~AE~ll----~a~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~isE~~q 762 (1094)
++||+++|+|.+||.+| ..+| ||+|....| .|.+++.......++.|. |+.|..+..+.++ +.....
T Consensus 1 e~Wy~g~isR~eAe~~L~~~~~~~G~FLVR~S~~~~g-~~~Lsv~~~~~~~~~~v~-H~~i~~~~~g~~~----~~~~~~ 74 (103)
T d1qcfa2 1 EEWFFKGISRKDAERQLLAPGNMLGSFMIRDSETTKG-SYSLSVRDYDPRQGDTVK-HYKIRTLDNGGFY----ISPRST 74 (103)
T ss_dssp STTEETTCCHHHHHHHHHSTTCCTTCEEEEECSSSTT-SEEEEEEEEETTTEEEEE-EEEEEECTTSCEE----SSSSSC
T ss_pred CCccCCCCCHHHHHHHHhhcCCCCCcEEEEccCCCCC-CeEEEEEecCCCcCceEE-EEEEEEcCCCcee----ecCCcc
Confidence 48999999999999988 3456 999999888 899988765434446777 9999888778787 555667
Q ss_pred hHHHHHhhh
Q 037285 763 FDAMMENLR 771 (1094)
Q Consensus 763 FdsL~ElLr 771 (1094)
|.++.+++.
T Consensus 75 F~sl~~LV~ 83 (103)
T d1qcfa2 75 FSTLQELVD 83 (103)
T ss_dssp BSSHHHHHH
T ss_pred cCCHHHHHH
Confidence 999999993
|
| >d1rjaa_ d.93.1.1 (A:) Tyrosine-protein kinase 6 (Breast tumor kinase, Brk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine-protein kinase 6 (Breast tumor kinase, Brk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.22 E-value=2.6e-07 Score=83.98 Aligned_cols=71 Identities=11% Similarity=0.082 Sum_probs=60.3
Q ss_pred cccccCCCChhHHHHcCCch----h---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCcccccc
Q 037285 690 VDFGQKDVSLIDQEHLGLSS----G---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSESMQ 762 (1094)
Q Consensus 690 ~~Wy~~~IsR~~AE~ll~a~----g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~isE~~q 762 (1094)
.+||+++|+|.+||++|... | ||+|...+| .|.+|+.+. |.+. |+.|.++..+.|+ +.....
T Consensus 2 epWy~g~isR~~Ae~~L~~~~~~~G~FLvR~S~~~~g-~y~LSv~~~-----~~v~-H~~I~~~~~g~~~----l~~~~~ 70 (100)
T d1rjaa_ 2 EPWFFGCISRSEAVRRLQAEGNATGAFLIRVSEKPSA-DYVLSVRDT-----QAVR-HYKIWRRAGGRLH----LNEAVS 70 (100)
T ss_dssp CCCBCTTCCHHHHHHHHSSTTCSSCCEEEEECSSSSS-CEEEEECTT-----SSCE-EEEEEECSSSCEE----EETTEE
T ss_pred CCCcCCCCCHHHHHHHHhccCCCCCeEEeecCCCCCC-CEEEEEEcC-----CCce-EEEEEECCCCCEE----ecCCCc
Confidence 58999999999999999754 4 999988778 899998875 7788 9999987777787 566778
Q ss_pred hHHHHHhhh
Q 037285 763 FDAMMENLR 771 (1094)
Q Consensus 763 FdsL~ElLr 771 (1094)
|.++.+++.
T Consensus 71 F~sl~~LV~ 79 (100)
T d1rjaa_ 71 FLSLPELVN 79 (100)
T ss_dssp ESSHHHHHH
T ss_pred cCCHHHHHH
Confidence 999999993
|
| >d1d4ta_ d.93.1.1 (A:) The Xlp protein Sap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: The Xlp protein Sap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.13 E-value=3.9e-07 Score=82.49 Aligned_cols=78 Identities=17% Similarity=0.253 Sum_probs=61.5
Q ss_pred ccccccccCCCChhHHHHcCCc---hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCC-ccc
Q 037285 687 LAQVDFGQKDVSLIDQEHLGLS---SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPS-VSE 759 (1094)
Q Consensus 687 Le~~~Wy~~~IsR~~AE~ll~a---~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~-isE 759 (1094)
||.++||||+|+|.+||.+|.. +| ||+|....| .|.+|+... +.+. |+.|.....+.+..... ...
T Consensus 1 le~~pwyhG~isR~eAe~lL~~~~~~G~FLVR~S~~~~g-~~~Lsv~~~-----~~v~-H~~I~~~~~~~~~~~~~~~~~ 73 (104)
T d1d4ta_ 1 MDAVAVYHGKISRETGEKLLLATGLDGSYLLRDSESVPG-VYCLCVLYH-----GYIY-TYRVSQTETGSWSAETAPGVH 73 (104)
T ss_dssp CTTCTTBCCSCCHHHHHHHHHHHCCTTEEEEEECSSSTT-CEEEEEEET-----TEEE-EEEEEECTTSCEEECBCTTSC
T ss_pred CCcCCccccCCCHHHHHHHHhhCCCCCeEEEEecCCCCC-CEEEEEecC-----CCce-EEEEEEcCCCcEEEeeccCCC
Confidence 6889999999999999999964 36 999988788 788888876 6777 99998877766653322 234
Q ss_pred ccchHHHHHhhh
Q 037285 760 SMQFDAMMENLR 771 (1094)
Q Consensus 760 ~~qFdsL~ElLr 771 (1094)
...|.++.+++.
T Consensus 74 ~~~F~sl~~Li~ 85 (104)
T d1d4ta_ 74 KRYFRKIKNLIS 85 (104)
T ss_dssp CCCBSSHHHHHH
T ss_pred CcccCCHHHHHH
Confidence 557999999883
|
| >d2oq1a2 d.93.1.1 (A:135-258) Tyrosine-protein kinase zap-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine-protein kinase zap-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.10 E-value=5.1e-07 Score=85.41 Aligned_cols=75 Identities=16% Similarity=0.283 Sum_probs=61.5
Q ss_pred hccccccccccCCCChhHHHHcCC----chh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCC
Q 037285 684 FRNLAQVDFGQKDVSLIDQEHLGL----SSG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPS 756 (1094)
Q Consensus 684 ~~~Le~~~Wy~~~IsR~~AE~ll~----a~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~ 756 (1094)
-...|.++||+++|+|.+||++|. .+| ||.+.. .| .|.+|+... +.+. ||.|..+..+.|.
T Consensus 23 ~~~~e~~pWyhg~isR~eAe~lL~~~~~~dGtFLVR~S~~-~g-~yvLSv~~~-----~~v~-H~~I~~~~~g~~~---- 90 (124)
T d2oq1a2 23 TTAHERMPWYHSSLTREEAERKLYSGAQTDGKFLLRPRKE-QG-TYALSLIYG-----KTVY-HYLISQDKAGKYC---- 90 (124)
T ss_dssp HHGGGGSTTBCSSCCHHHHHHHHHSSCCCTTEEEEEECSS-TT-EEEEEEEET-----TEEE-EEEEEECTTSCEE----
T ss_pred cccccCCCCccCCCCHHHHHHHHhhcCCCCceEEeEecCC-CC-CEEEEeecC-----CceE-EEEEEECCCCCEE----
Confidence 345578899999999999999984 346 999965 67 799998875 7788 9999987777787
Q ss_pred cccccchHHHHHhh
Q 037285 757 VSESMQFDAMMENL 770 (1094)
Q Consensus 757 isE~~qFdsL~ElL 770 (1094)
+.....|.++.+++
T Consensus 91 l~~~~~F~sl~~LV 104 (124)
T d2oq1a2 91 IPEGTKFDTLWQLV 104 (124)
T ss_dssp STTSCCBSSHHHHH
T ss_pred eCCCcccCCHHHHH
Confidence 45567799999999
|
| >d1k9aa2 d.93.1.1 (A:77-177) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.09 E-value=6.2e-07 Score=81.71 Aligned_cols=72 Identities=19% Similarity=0.349 Sum_probs=59.5
Q ss_pred ccccccccCCCChhHHHHcCCc--hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCccccc
Q 037285 687 LAQVDFGQKDVSLIDQEHLGLS--SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSESM 761 (1094)
Q Consensus 687 Le~~~Wy~~~IsR~~AE~ll~a--~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~isE~~ 761 (1094)
|..++||+++|+|.+||.+|.. +| ||+|....| .|.+|+... +.++ ||.|..+. +.|+ +.+..
T Consensus 1 l~~~PWy~g~isR~~Ae~lL~~~~~G~FLVR~S~~~~g-~y~LSv~~~-----~~v~-H~~I~~~~-~~~~----~~~~~ 68 (101)
T d1k9aa2 1 LSLMPWFHGKITREQAERLLYPPETGLFLVRESTNYPG-DYTLCVSCE-----GKVE-HYRIMYHA-SKLS----IDEEV 68 (101)
T ss_dssp EESCTTBCTTCCHHHHHHHTCSCCTTEEEEEECSSSTT-SEEEEEECS-----SSEE-EEEEEEET-TEEE----SSSSS
T ss_pred CCcCCccCCCCCHHHHHHHHcCCCCCCEEEeccCCCCC-CEEEEEEeC-----CccE-EEEEEEcC-CCce----ecCCc
Confidence 5678999999999999999955 55 999988777 789998875 7788 99998744 4576 55677
Q ss_pred chHHHHHhh
Q 037285 762 QFDAMMENL 770 (1094)
Q Consensus 762 qFdsL~ElL 770 (1094)
.|.++.+++
T Consensus 69 ~F~sl~~LV 77 (101)
T d1k9aa2 69 YFENLMQLV 77 (101)
T ss_dssp CBSSHHHHH
T ss_pred ccCCHHHHH
Confidence 899999999
|
| >d1jwoa_ d.93.1.1 (A:) Csk homologous kinase Chk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Csk homologous kinase Chk species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.07 E-value=7.2e-07 Score=80.61 Aligned_cols=73 Identities=16% Similarity=0.165 Sum_probs=59.8
Q ss_pred ccccccccCCCChhHHHHcCCc--hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCccccc
Q 037285 687 LAQVDFGQKDVSLIDQEHLGLS--SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSESM 761 (1094)
Q Consensus 687 Le~~~Wy~~~IsR~~AE~ll~a--~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~isE~~ 761 (1094)
|..++||+++|+|.+||.+|.. +| ||+|....| .|.+|+... +.+. |+.|..+ .+.++ +.+..
T Consensus 1 ls~~PWy~g~isR~eAe~~L~~~~~G~FLVR~S~~~~g-~~vLSv~~~-----~~v~-H~~I~~~-~~~~~----~~~~~ 68 (97)
T d1jwoa_ 1 LSLMPWFHGKISGQEAVQQLQPPEDGLFLVRESARHPG-DYVLCVSFG-----RDVI-HYRVLHR-DGHLT----IDEAV 68 (97)
T ss_dssp CTTCTTEEESCCHHHHHHHTCSCCTTCEEEEECSSSTT-CEEEEEEET-----TEEE-EEEEEES-SSEES----STTSC
T ss_pred CCcCCccCCCCCHHHHHHHhcCCCCCeEEEEecCCCCc-cEEEEEEec-----CceE-EEEEEEc-CCcEE----ecCCc
Confidence 5679999999999999999964 35 999988788 889998875 6777 9999764 45677 55667
Q ss_pred chHHHHHhhh
Q 037285 762 QFDAMMENLR 771 (1094)
Q Consensus 762 qFdsL~ElLr 771 (1094)
.|.++.+++.
T Consensus 69 ~F~sl~~LI~ 78 (97)
T d1jwoa_ 69 FFCNLMDMVE 78 (97)
T ss_dssp CBSCHHHHHH
T ss_pred ccCCHHHHHH
Confidence 8999999993
|
| >d1a81a1 d.93.1.1 (A:9-137) Syk tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Syk tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.06 E-value=5.6e-07 Score=85.80 Aligned_cols=74 Identities=9% Similarity=0.170 Sum_probs=62.4
Q ss_pred ccccccccCCCChhHHHHcCCc----hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCccc
Q 037285 687 LAQVDFGQKDVSLIDQEHLGLS----SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSE 759 (1094)
Q Consensus 687 Le~~~Wy~~~IsR~~AE~ll~a----~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~isE 759 (1094)
.+.++|||++|+|.+||.+|.. +| ||+|....| .|.+|+... +.+. ||.|..+..+.++ +..
T Consensus 2 ~~~~PWyhg~isR~~Ae~lL~~~g~~dG~FLVR~S~~~~g-~y~LSv~~~-----~~v~-H~~I~~~~~g~~~----i~~ 70 (129)
T d1a81a1 2 ANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLG-GFALSVAHG-----RKAH-HYTIERELNGTYA----IAG 70 (129)
T ss_dssp TTSSTTBCSSCCHHHHHHHHHHTTCCTTEEEEEECSSSTT-CEEEEEEET-----TEEE-EEEEEECTTSCEE----ETT
T ss_pred CCCCCcccCCCCHHHHHHHHHhcCCCCccEEEEccCCCCc-ceEEEeeec-----ccce-EEEEEEcCCCCee----ecC
Confidence 5678999999999999999954 45 999998788 899998886 7888 9999887777787 556
Q ss_pred ccchHHHHHhhh
Q 037285 760 SMQFDAMMENLR 771 (1094)
Q Consensus 760 ~~qFdsL~ElLr 771 (1094)
...|.++.+++.
T Consensus 71 ~~~F~sl~eLV~ 82 (129)
T d1a81a1 71 GRTHASPADLCH 82 (129)
T ss_dssp SCCBSSHHHHHH
T ss_pred CcccCCHHHHHH
Confidence 677999999993
|
| >d1ip9a_ d.15.2.2 (A:) Bud emergence mediator Bemp1 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Bud emergence mediator Bemp1 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.05 E-value=6.5e-06 Score=73.16 Aligned_cols=71 Identities=11% Similarity=0.135 Sum_probs=58.0
Q ss_pred CCCCCeEEEEeecCCccccCCCCCCceeecCceEEEEecCCCChHHHHHHHHHHcC-CceEEEEeCCCCCCCceeeccCh
Q 037285 80 DSSATKMKVLCSFGGKILPRPSDGKLRYVGGETRIIRIRKDISWQILRQKALEVYN-QVHVIKYQLPGEDLDALVSVSCD 158 (1094)
Q Consensus 80 ~~~~~~vk~mcSyGG~i~pr~~d~~l~YvGG~triv~v~r~~~~~~l~~kl~~~~~-~~~~lkyqLp~edld~LisV~~d 158 (1094)
.+...+||+-+.|+ +++|++.|+.+++|.+|+.++.+.++ ..+.|||+ .|-+.+|+++||
T Consensus 7 ~~~~~~ikVKv~~~----------------~D~~~~~l~~~it~~dL~~kI~~rf~~~~~~lkY~---Dedgd~v~i~sD 67 (85)
T d1ip9a_ 7 TSGLKTTKIKFYYK----------------DDIFALMLKGDTTYKELRSKIAPRIDTDNFKLQTK---LFDGSGEEIKTD 67 (85)
T ss_dssp CCCCCCEEEEECBT----------------TCCEEEEECSCCCHHHHHHHHHHHHTSSCEEEEEC---CSSSCCSCCCSH
T ss_pred CCCCCCEEEEEEEC----------------CcEEEEEeCCCCCHHHHHHHHHHHhCCCceEEEEE---cCCCCEEEEeCH
Confidence 34444577777775 56899999999999999999999886 67889999 444678999999
Q ss_pred hhHHHHHHHHh
Q 037285 159 EDLQNMMEEYN 169 (1094)
Q Consensus 159 eDl~~m~~eyd 169 (1094)
+||+.+|++..
T Consensus 68 ~Dl~~ai~~~~ 78 (85)
T d1ip9a_ 68 SQVSNIIQAKL 78 (85)
T ss_dssp HHHHHHHHTTC
T ss_pred HHHHHHHHhcC
Confidence 99999998553
|
| >d1mila_ d.93.1.1 (A:) Shc adaptor protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Shc adaptor protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.01 E-value=9.6e-07 Score=80.97 Aligned_cols=74 Identities=20% Similarity=0.264 Sum_probs=61.0
Q ss_pred ccccccccccCCCChhHHHHcCCchh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCccccc
Q 037285 685 RNLAQVDFGQKDVSLIDQEHLGLSSG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSESM 761 (1094)
Q Consensus 685 ~~Le~~~Wy~~~IsR~~AE~ll~a~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~isE~~ 761 (1094)
..|+..+||+|+|+|.+||.+|+.+| ||+|...+| .|.+|+... +.+. |+.|.. ..+.+. .+..
T Consensus 2 ~~l~~~pWyhG~i~R~~Ae~lL~~~G~FLVR~S~~~~g-~~vLSv~~~-----~~v~-H~~I~~-~~~~~~-----~~~~ 68 (104)
T d1mila_ 2 SQLRGEPWFHGKLSRREAEALLQLNGDFLVRESTTTPG-QYVLTGLQS-----GQPK-HLLLVD-PEGVVR-----TKDH 68 (104)
T ss_dssp CSTTTCTTBCSSCCHHHHHTTCCSTTEEEEEECCSSCS-SEEEEEEET-----TEEE-EEEEBC-TTSSEE-----CSSC
T ss_pred cccccCCCcCCCCCHHHHHHHHhcCCcEEEEecCCCCC-CEEEEEEEc-----cccc-eEEEEe-CCCEEE-----eCCe
Confidence 36899999999999999999999999 999988788 889998886 7788 999965 344444 2345
Q ss_pred chHHHHHhhh
Q 037285 762 QFDAMMENLR 771 (1094)
Q Consensus 762 qFdsL~ElLr 771 (1094)
.|.++.+++.
T Consensus 69 ~F~sl~~LV~ 78 (104)
T d1mila_ 69 RFESVSHLIS 78 (104)
T ss_dssp EESSHHHHHH
T ss_pred eECCHHHHHH
Confidence 7999999994
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.00 E-value=1.4e-05 Score=80.63 Aligned_cols=87 Identities=11% Similarity=-0.008 Sum_probs=58.0
Q ss_pred CCeeEEEEecccCceEEEEeeecCceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-CCceeEEEeEeecCCCC
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HPNVVAFYGVVQDGPGG 888 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~rGt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-HPNIVqL~Gv~~d~~~~ 888 (1094)
+.|+..+..+.++...||+....+..+.||+........ ...+.+|..++..|. +--+.+++.++... +
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~--------~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~--~ 83 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--------TYDVEREKDMMLWLEGKLPVPKVLHFERHD--G 83 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS--------TTCHHHHHHHHHHHTTTSCCCCEEEEEEET--T
T ss_pred hceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccc--------hhhHHHHHHHHHHHhccCCCCcEEEEEecC--C
Confidence 456666665556667899988778888999876542111 123456777776664 32356677776654 3
Q ss_pred ceEEEeeecccchhHHHH
Q 037285 889 TLATVAEYMVDGSLRHVL 906 (1094)
Q Consensus 889 ~L~IVmEYmegGSL~d~L 906 (1094)
..++||++++|.++....
T Consensus 84 ~~~lv~~~l~G~~~~~~~ 101 (263)
T d1j7la_ 84 WSNLLMSEADGVLCSEEY 101 (263)
T ss_dssp EEEEEEECCSSEEHHHHT
T ss_pred ceEEEEEecccccccccc
Confidence 788999999998876543
|
| >d1a81a2 d.93.1.1 (A:138-262) Syk tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Syk tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.96 E-value=1e-06 Score=83.40 Aligned_cols=75 Identities=19% Similarity=0.387 Sum_probs=59.4
Q ss_pred ccccccccccCCCChhHHHHcCC----chh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCc
Q 037285 685 RNLAQVDFGQKDVSLIDQEHLGL----SSG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSV 757 (1094)
Q Consensus 685 ~~Le~~~Wy~~~IsR~~AE~ll~----a~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~i 757 (1094)
..-+.++|||++|+|.+||++|. .+| ||++.. .| .|.+|+.+. |.+. ||.|..+.++.|. +
T Consensus 24 ~~he~~pWyhg~isR~~Ae~lL~~~g~~~G~FLVR~S~~-~~-~yvLSv~~~-----~~v~-H~~I~~~~~g~~~----~ 91 (125)
T d1a81a2 24 TAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDN-NG-SYALCLLHE-----GKVL-HYRIDKDKTGKLS----I 91 (125)
T ss_dssp TSGGGSTTEEEECCHHHHHHHHHSSCCCTTCEEEEECSS-SS-CEEEEEEET-----TEEE-EEEEEECTTSCEE----C
T ss_pred cccccCCccCCCCCHHHHHHHHHhcCCCCceEEEEecCC-CC-CEEEEeecc-----ccce-eEeeeEcCCCcEe----c
Confidence 34567889999999999999874 446 998855 56 699998875 7888 9999987777777 4
Q ss_pred ccccchHHHHHhhh
Q 037285 758 SESMQFDAMMENLR 771 (1094)
Q Consensus 758 sE~~qFdsL~ElLr 771 (1094)
.....|.++.+++.
T Consensus 92 ~~~~~F~sL~~LI~ 105 (125)
T d1a81a2 92 PEGKKFDTLWQLVE 105 (125)
T ss_dssp TTSCCBSCHHHHHH
T ss_pred cCCcccCCHHHHHH
Confidence 44567999999993
|
| >d1i3za_ d.93.1.1 (A:) Ews/fli1 activated transcript 2, Eat2 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Ews/fli1 activated transcript 2, Eat2 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.95 E-value=1.1e-06 Score=80.20 Aligned_cols=76 Identities=12% Similarity=0.147 Sum_probs=60.0
Q ss_pred ccccccCCCChhHHHHcCCch---h---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCC-ccccc
Q 037285 689 QVDFGQKDVSLIDQEHLGLSS---G---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPS-VSESM 761 (1094)
Q Consensus 689 ~~~Wy~~~IsR~~AE~ll~a~---g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~-isE~~ 761 (1094)
.++||+++|+|.+||.+|..+ | ||+|....| .|.+|+.+. +.|. ||.|.+...+.+..... ..+..
T Consensus 2 d~PWy~g~isR~~AE~lL~~~~~~G~FLVR~S~~~~g-~~~LSv~~~-----~~v~-H~~I~~~~~g~~~~~~~~~~~~~ 74 (103)
T d1i3za_ 2 DLPYYHGCLTKRECEALLLKGGVDGNFLIRDSESVPG-ALCLCVSFK-----KLVY-SYRIFREKHGYYRIETDAHTPRT 74 (103)
T ss_dssp CCTTEESSCCHHHHHHHHHTTCSTTEEEEEECSSSTT-CEEEEEECS-----SSEE-EEEEEECTTSCEEECBCTTSCCC
T ss_pred CCCcccCCCCHHHHHHHHHhCCCCCeEEEEecCCCCC-CEEEEEEeC-----CeEE-EEEeEEcCCCcEEEeccCCcCcc
Confidence 478999999999999988544 5 999988888 899998886 7888 99998767766664333 23456
Q ss_pred chHHHHHhhh
Q 037285 762 QFDAMMENLR 771 (1094)
Q Consensus 762 qFdsL~ElLr 771 (1094)
.|.++.+++.
T Consensus 75 ~F~sl~~LV~ 84 (103)
T d1i3za_ 75 IFPNLQELVS 84 (103)
T ss_dssp EESSSHHHHH
T ss_pred ccCCHHHHHH
Confidence 7999999883
|
| >d1rpya_ d.93.1.1 (A:) Adaptor protein Aps {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Adaptor protein Aps species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=97.95 E-value=1.3e-06 Score=77.08 Aligned_cols=74 Identities=18% Similarity=0.284 Sum_probs=56.8
Q ss_pred cccccccccCCCChhHHHHcCCc-----hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCc
Q 037285 686 NLAQVDFGQKDVSLIDQEHLGLS-----SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSV 757 (1094)
Q Consensus 686 ~Le~~~Wy~~~IsR~~AE~ll~a-----~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~i 757 (1094)
.|+.++||+++|+|.+||++|.. +| ||+|....| .|.+|+... +.+. |+.|..+... ++ .
T Consensus 1 el~~~pWyhg~isR~~Ae~lL~~~~~~~dG~FLvR~S~~~~g-~~~Lsv~~~-----~~v~-h~~I~~~~~~-~~----~ 68 (86)
T d1rpya_ 1 ELSDYPWFHGTLSRVKAAQLVLAGGPRSHGLFVIRQSETRPG-ECVLTFNFQ-----GKAK-HLRLSLNGHG-QC----H 68 (86)
T ss_dssp CGGGSTTBCTTCCHHHHHHHHHTTGGGGTTCEEEEECSSSTT-CEEEEEEET-----TEEE-EEEC----CC-CH----H
T ss_pred CCccCcccCCCCCHHHHHHHHHhCCCCCCceEEEEecCCCCC-cEEEEEEEC-----CceE-EEEEEEcCCc-eE----E
Confidence 37889999999999999999943 46 999988777 789998875 7888 9999876544 44 3
Q ss_pred ccccchHHHHHhhh
Q 037285 758 SESMQFDAMMENLR 771 (1094)
Q Consensus 758 sE~~qFdsL~ElLr 771 (1094)
.+...|.++.+++.
T Consensus 69 ~~~~~F~sl~~LV~ 82 (86)
T d1rpya_ 69 VQHLWFQSVFDMLR 82 (86)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred eCCCeeCCHHHHHH
Confidence 45678999999883
|
| >d1r1qa_ d.93.1.1 (A:) GRB2-related adaptor protein 2 (MONA, GRID) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: GRB2-related adaptor protein 2 (MONA, GRID) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.88 E-value=2.5e-06 Score=77.09 Aligned_cols=74 Identities=12% Similarity=0.218 Sum_probs=60.0
Q ss_pred cccccccccCCCChhHHHHcC--Cchh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCcccc
Q 037285 686 NLAQVDFGQKDVSLIDQEHLG--LSSG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSES 760 (1094)
Q Consensus 686 ~Le~~~Wy~~~IsR~~AE~ll--~a~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~isE~ 760 (1094)
.++..+||+++|+|.+||.+| ..+| ||+|....| .|.+|+... +.+. |+.|..+..+.+.. ..
T Consensus 2 d~~~~~Wy~g~isR~~Ae~lL~~~~~G~FLVR~S~~~~g-~~~LSv~~~-----~~v~-H~~I~~~~~g~~~~-----~~ 69 (97)
T d1r1qa_ 2 DIEFPEWFHEGLSRHQAENLLMGKDIGFFIIRASQSSPG-DFSISVRHE-----DDVQ-HFKVMRDTKGNYFL-----WT 69 (97)
T ss_dssp CCSCCTTBCTTCCHHHHHHHHHTSCTTCEEEEECSSSTT-CEEEEEECS-----SSEE-EEECEECTTCCEES-----SS
T ss_pred CcccCCccCCCCCHHHHHHHHhcCCCCCEEEeecCCCCC-CEEEEEEec-----CCeE-EEEEEEcCCCeEEe-----CC
Confidence 367889999999999999999 4556 999988788 789998775 6787 99999877766652 23
Q ss_pred cchHHHHHhhh
Q 037285 761 MQFDAMMENLR 771 (1094)
Q Consensus 761 ~qFdsL~ElLr 771 (1094)
..|.++.+++.
T Consensus 70 ~~F~sl~~LV~ 80 (97)
T d1r1qa_ 70 EKFPSLNKLVD 80 (97)
T ss_dssp CCBSSHHHHHH
T ss_pred CCcCCHHHHHH
Confidence 46999999993
|
| >d1nrva_ d.93.1.1 (A:) Growth factor receptor-bound protein 10, GRB10 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Growth factor receptor-bound protein 10, GRB10 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.86 E-value=1.9e-06 Score=78.53 Aligned_cols=76 Identities=7% Similarity=0.091 Sum_probs=53.8
Q ss_pred cccccccCCCChhHHHHcCCc----hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCcccc
Q 037285 688 AQVDFGQKDVSLIDQEHLGLS----SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSES 760 (1094)
Q Consensus 688 e~~~Wy~~~IsR~~AE~ll~a----~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~isE~ 760 (1094)
+..+||+++|+|.+||++|.. +| ||+|....| .|.+|+... +.|. ||.|.....+..+.-......
T Consensus 3 ~~~~Wyhg~isR~~Ae~lL~~~g~~dG~FLVR~S~~~~g-~y~LSv~~~-----~~v~-H~~I~~~~~~~~~~~~~~~~~ 75 (105)
T d1nrva_ 3 RTQHWFHGRISREESHRIIKQQGLVDGLFLLRDSQSNPK-AFVLTLCHH-----QKIK-NFQILPCEDDGQTFFSLDDGN 75 (105)
T ss_dssp TTSTTBCTTCCHHHHHHHHHHTTCCTTEEEEEECSSCTT-CEEEEEEET-----TEEE-EEEEEEC-----CCEESSTTS
T ss_pred ccCcccCCCCCHHHHHHHHhhcCCCCceEEEEeCCCCCC-CEEEEEEEC-----Ccee-EEEEEEecCCCeEEEEECCCC
Confidence 457899999999999999954 46 999988778 799998875 7787 999976443221100011234
Q ss_pred cchHHHHHhh
Q 037285 761 MQFDAMMENL 770 (1094)
Q Consensus 761 ~qFdsL~ElL 770 (1094)
..|.++.+++
T Consensus 76 ~~F~sl~~LV 85 (105)
T d1nrva_ 76 TKFSDLIQLV 85 (105)
T ss_dssp SCBSSHHHHH
T ss_pred cccCCHHHHH
Confidence 5699999998
|
| >d2izva2 d.93.1.1 (A:274-385) Suppressor of cytokine signaling 4, SOCS-4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Suppressor of cytokine signaling 4, SOCS-4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.73 E-value=3.2e-06 Score=78.04 Aligned_cols=81 Identities=15% Similarity=0.062 Sum_probs=63.2
Q ss_pred hhccccccccccCCCChhHHHHcCCc--hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCc
Q 037285 683 YFRNLAQVDFGQKDVSLIDQEHLGLS--SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSV 757 (1094)
Q Consensus 683 ~~~~Le~~~Wy~~~IsR~~AE~ll~a--~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~i 757 (1094)
....|+...||+|+|+|.+||.+|.. +| ||+|....| .|.+|+... +.+. |+.|..+ .+.|+.....
T Consensus 4 ~~~~l~~~~Wy~g~isR~~Ae~lL~~~~~GtFLVR~S~~~~~-~~~LSv~~~-----~~v~-H~~I~~~-~~~~~l~~~~ 75 (112)
T d2izva2 4 DLLQINNNPCYWGVMDKYAAEALLEGKPEGTFLLRDSAQEDY-LFSVSFRRY-----SRSL-HARIEQW-NHNFSFDAHD 75 (112)
T ss_dssp THHHHHHCTTEEEECCHHHHHHHHTTCCTTEEEEEECSSTTC-SEEEEEEET-----TEEE-EEECEEE-TTEEESCTTC
T ss_pred ChHHhccCCCcCCCCCHHHHHHHHccCCCCcEEEeecCCCCC-CeEEEEEec-----CCce-EEEEEEe-CCeEEEeecc
Confidence 45678899999999999999999874 56 999998787 799998886 6787 9999874 4556643333
Q ss_pred ccccchHHHHHhhh
Q 037285 758 SESMQFDAMMENLR 771 (1094)
Q Consensus 758 sE~~qFdsL~ElLr 771 (1094)
.....|.++.+++.
T Consensus 76 ~~~~~F~sl~~LV~ 89 (112)
T d2izva2 76 PCVFHSPDITGLLE 89 (112)
T ss_dssp TTSCCBSSHHHHHH
T ss_pred cCcccCCCHHHHHH
Confidence 33457999999984
|
| >d1jyra_ d.93.1.1 (A:) Growth factor receptor-bound protein 2 (GRB2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Growth factor receptor-bound protein 2 (GRB2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.72 E-value=4e-06 Score=75.71 Aligned_cols=70 Identities=13% Similarity=0.186 Sum_probs=56.9
Q ss_pred ccccccCCCChhHHHHcCCc---hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCcccccc
Q 037285 689 QVDFGQKDVSLIDQEHLGLS---SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSESMQ 762 (1094)
Q Consensus 689 ~~~Wy~~~IsR~~AE~ll~a---~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~isE~~q 762 (1094)
.++||+++|+|.+||.+|.. +| ||++....| .|.+|+.+. +.+. ||.|.++..+.+. .....
T Consensus 2 s~pWy~g~isR~~Ae~lL~~~~~~G~FLvR~S~~~~g-~~~LSv~~~-----~~v~-H~~I~~~~~g~~~-----~~~~~ 69 (96)
T d1jyra_ 2 SMAWFFGKIPRAKAEEMLSKQRHDGAFLIRESESAPG-DFSLSVKFG-----NDVQ-HFKVLRDGAGKYF-----LWVVK 69 (96)
T ss_dssp CCTTBCCSCCHHHHHHHHHTCCSTTBEEEEECSSSTT-CEEEEEEET-----TEEE-EEECEECTTSCEE-----SSSCE
T ss_pred CCCccCCCCCHHHHHHHHhhCCCCCeEEEEecCCCCC-CEEEEEEeC-----CceE-EEEEEECCCCeEE-----eCCcc
Confidence 47899999999999999853 46 999988778 789998886 6788 9999887766554 23456
Q ss_pred hHHHHHhh
Q 037285 763 FDAMMENL 770 (1094)
Q Consensus 763 FdsL~ElL 770 (1094)
|.++.+++
T Consensus 70 F~sl~~LV 77 (96)
T d1jyra_ 70 FNSLNELV 77 (96)
T ss_dssp ESSHHHHH
T ss_pred CCCHHHHH
Confidence 99999999
|
| >d1fu6a_ d.93.1.1 (A:) Phosphatidylinositol 3-kinase, p85-alpha subunit {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Phosphatidylinositol 3-kinase, p85-alpha subunit species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=97.68 E-value=8.7e-06 Score=74.52 Aligned_cols=76 Identities=17% Similarity=0.273 Sum_probs=59.1
Q ss_pred ccccccccccCCCChhHHHHcCCc--hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCccc
Q 037285 685 RNLAQVDFGQKDVSLIDQEHLGLS--SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSE 759 (1094)
Q Consensus 685 ~~Le~~~Wy~~~IsR~~AE~ll~a--~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~isE 759 (1094)
.+|+..+||+++|+|.+||.+|.. +| ||++....+..|.+++... +.+. |+.|.. ..+.|+ +..
T Consensus 6 ~~l~~~~WyhG~isR~eAe~lL~~~~~G~FLVR~S~~~~~~~~~ls~~~~-----~~~~-H~~I~~-~~~~~~----~~~ 74 (111)
T d1fu6a_ 6 MSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKG-----GNNK-SIKIFH-RDGKYG----FSD 74 (111)
T ss_dssp CCCSCCSSCCSSCCSHHHHHHSSSCSSCCCCCBSSCCSSSCCSBCEEEET-----TEEE-ECCCCC-TTTCCC----TTT
T ss_pred CccCcCcCCCCCCCHHHHHHHhCcCCCCEEEEEeccCCCCccEEEEEecC-----CceE-EEEEEE-cCCeEE----ECC
Confidence 368899999999999999999975 45 9999875554777777665 6777 998875 345566 455
Q ss_pred ccchHHHHHhhh
Q 037285 760 SMQFDAMMENLR 771 (1094)
Q Consensus 760 ~~qFdsL~ElLr 771 (1094)
...|.++.+++.
T Consensus 75 ~~~F~sl~~LV~ 86 (111)
T d1fu6a_ 75 PLTFNSVVELIN 86 (111)
T ss_dssp TSCCCCTTHHHH
T ss_pred CcccCCHHHHHH
Confidence 668999999884
|
| >d2fcia1 d.93.1.1 (A:1-105) Phospholipase C-gamma-1 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Phospholipase C-gamma-1 species: Cow (Bos taurus) [TaxId: 9913]
Probab=97.64 E-value=9e-06 Score=74.51 Aligned_cols=72 Identities=15% Similarity=0.295 Sum_probs=54.6
Q ss_pred cccccccccCCCChhHHHHcCCc---hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCccc
Q 037285 686 NLAQVDFGQKDVSLIDQEHLGLS---SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSE 759 (1094)
Q Consensus 686 ~Le~~~Wy~~~IsR~~AE~ll~a---~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~isE 759 (1094)
..|..+||+++|+|.+||++|.. +| ||++.+ .| .|.+|+.+. +.+. ||.|..+. .++ ...
T Consensus 5 ~he~~~Wy~g~i~R~eAe~lL~~~~~~G~FLVR~S~~-~~-~yvLSv~~~-----~~v~-H~~I~~~~--~~~----~~~ 70 (105)
T d2fcia1 5 IHESKEWYHASLTRAQAEHMLMRVPRDGAFLVRKRNE-PN-SYAISFRAE-----GKIK-HCRVQQEG--QTV----MLG 70 (105)
T ss_dssp TTSSSCCCCSSSCSHHHHHHHHHSSSSCCEEEEECSS-TT-CEEEEEEET-----TEEC-CCEEBCCS--SCE----ECS
T ss_pred ccccCCCccCCCCHHHHHHHHHhCCCCCeEEEEecCC-CC-CEEEEEEec-----cccE-EEEEEecC--CeE----ecC
Confidence 34677899999999999999854 35 999954 67 799998875 6788 99997642 233 233
Q ss_pred ccchHHHHHhhh
Q 037285 760 SMQFDAMMENLR 771 (1094)
Q Consensus 760 ~~qFdsL~ElLr 771 (1094)
...|.++.+++.
T Consensus 71 ~~~F~sl~~LV~ 82 (105)
T d2fcia1 71 NSEFDSLVDLIS 82 (105)
T ss_dssp SSEESTTHHHHH
T ss_pred CcccCCHHHHHH
Confidence 456999999983
|
| >d2shpa2 d.93.1.1 (A:2-110) Tyrosine phoshatase shp-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine phoshatase shp-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.57 E-value=7.6e-06 Score=75.23 Aligned_cols=72 Identities=14% Similarity=0.287 Sum_probs=57.5
Q ss_pred cccccccCCCChhHHHHcCCc---hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCccccc
Q 037285 688 AQVDFGQKDVSLIDQEHLGLS---SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSESM 761 (1094)
Q Consensus 688 e~~~Wy~~~IsR~~AE~ll~a---~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~isE~~ 761 (1094)
+..+||++.|+|.+||.+|.. +| ||+|....| .|.+|+... +.+. |+.|... .+.++ +....
T Consensus 1 ~~~~Wy~g~isR~~Ae~lL~~~~~~G~FLvR~S~~~~g-~y~LSv~~~-----~~v~-H~~I~~~-~~~~~----~~~~~ 68 (109)
T d2shpa2 1 KSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPG-DLTLSVRRN-----GAVT-HIKIQNT-GDYYD----LYGGE 68 (109)
T ss_dssp CCSTTBCSSCCHHHHHHHHHHHCCTTEEEEEECSSSTT-CEEEEEEET-----TEEE-EEEEECS-SSCEE----ETTSC
T ss_pred CCCccccCCCCHHHHHHHHhhCCCCCeEEEEecCCCCC-CEEEEEEeC-----CcEE-EEEEEEc-CCeEE----EcCCc
Confidence 356899999999999999865 46 999988788 799998875 7788 9999764 45566 44456
Q ss_pred chHHHHHhhh
Q 037285 762 QFDAMMENLR 771 (1094)
Q Consensus 762 qFdsL~ElLr 771 (1094)
.|.++.+++.
T Consensus 69 ~F~sl~~LV~ 78 (109)
T d2shpa2 69 KFATLAELVQ 78 (109)
T ss_dssp EESSHHHHHH
T ss_pred ccCCHHHHHH
Confidence 7999999984
|
| >d2qmsa1 d.93.1.1 (A:420-532) Growth factor receptor-bound protein 7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Growth factor receptor-bound protein 7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.57 E-value=8e-06 Score=75.53 Aligned_cols=76 Identities=11% Similarity=0.055 Sum_probs=55.4
Q ss_pred ccccccccCCCChhHHHHcCC----chh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccC-CCccccCCCcc
Q 037285 687 LAQVDFGQKDVSLIDQEHLGL----SSG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDS-QKTFGVDPSVS 758 (1094)
Q Consensus 687 Le~~~Wy~~~IsR~~AE~ll~----a~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~ds-q~r~~vtp~is 758 (1094)
.+...||+++|+|.+||++|. .+| ||++...+| .|.+|+.+. |.+. |+.|.... ...+... ...
T Consensus 7 h~~~~Wy~g~isR~~Ae~lL~~~g~~dG~FLvR~S~~~~g-~y~LSv~~~-----~~v~-H~~I~~~~~~~~~~~~-~~~ 78 (113)
T d2qmsa1 7 HRTQLWFHGRISREESQRLIGQQGLVDGLFLVRESQRNPQ-GFVLSLCHL-----QKVK-HYLILPSEEEGRLYFS-MDD 78 (113)
T ss_dssp TTCCTTEEEEBCHHHHHHHHHHTTCCTTEEEEEECSSCTT-CEEEEEEET-----TEEE-EEEEEEEESSSCEEEE-SST
T ss_pred hcCCCccCCCCCHHHHHHHHhccCCCCccEEEEeccCCCC-CEEEEEEeC-----CeEE-EEEEEEeCCCCeEEEE-ecC
Confidence 355689999999999999995 446 999998778 799998875 6788 99986533 2222211 112
Q ss_pred cccchHHHHHhh
Q 037285 759 ESMQFDAMMENL 770 (1094)
Q Consensus 759 E~~qFdsL~ElL 770 (1094)
....|.++.+++
T Consensus 79 ~~~~F~sl~~LI 90 (113)
T d2qmsa1 79 GQTRFTDLLQLV 90 (113)
T ss_dssp TSSCBSSHHHHH
T ss_pred CCcccCCHHHHH
Confidence 345699999999
|
| >d2eyva1 d.93.1.1 (A:12-120) Crk proto-oncogen {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Crk proto-oncogen species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.52 E-value=3.2e-05 Score=70.00 Aligned_cols=74 Identities=16% Similarity=0.155 Sum_probs=53.6
Q ss_pred ccccCCCChhHHHHcCC--chh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCC---------
Q 037285 691 DFGQKDVSLIDQEHLGL--SSG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPS--------- 756 (1094)
Q Consensus 691 ~Wy~~~IsR~~AE~ll~--a~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~--------- 756 (1094)
.||+++|+|.+||++|. .+| ||+|....| .|.+|+... +.+. ||.|.............
T Consensus 1 sWy~g~isR~~Ae~lL~~~~~G~FLVR~S~~~~~-~~~LS~~~~-----~~v~-H~~I~~~~~~~~~~~~~~~~~~~~~~ 73 (109)
T d2eyva1 1 SWYWGRLSRQEAVALLQGQRHGVFLVRDSSTSPG-DYVLSVSEN-----SRVS-HYIINSSGPRPPVPPSPAQPPPGVSP 73 (109)
T ss_dssp TSCCBCCCHHHHHHHCSSCSTTCEEEECCCSSSS-CEEEEEEET-----TEEE-EEEEECCCCSSCCCSSSSCCCCSCCC
T ss_pred CCCCCCCCHHHHHHHhcCCCCCeEEeeecCCCCC-CEEEEEEEC-----CEEE-EEEEEEcCCcceeecccccccccccc
Confidence 59999999999999995 346 999988777 799998875 6777 89887644322211110
Q ss_pred ---cccccchHHHHHhhh
Q 037285 757 ---VSESMQFDAMMENLR 771 (1094)
Q Consensus 757 ---isE~~qFdsL~ElLr 771 (1094)
..+...|.++.+++.
T Consensus 74 ~~~~~~~~~F~sl~~LV~ 91 (109)
T d2eyva1 74 SRLRIGDQEFDSLPALLE 91 (109)
T ss_dssp CCEEETTEEESSHHHHHH
T ss_pred ceEEeCCeeeCCHHHHHH
Confidence 123457999999994
|
| >d2c9wa2 d.93.1.1 (A:32-134) Suppressor of cytokine signaling 2, SOCS-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Suppressor of cytokine signaling 2, SOCS-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.51 E-value=1.1e-05 Score=73.06 Aligned_cols=81 Identities=19% Similarity=0.240 Sum_probs=61.0
Q ss_pred hhccccccccccCCCChhHHHHcCCc--hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccC--C
Q 037285 683 YFRNLAQVDFGQKDVSLIDQEHLGLS--SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVD--P 755 (1094)
Q Consensus 683 ~~~~Le~~~Wy~~~IsR~~AE~ll~a--~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vt--p 755 (1094)
.+..|+..+||+++|+|.+||.+|.. +| ||+|...+| .|.+|+... +.+. |+.|.... +.|..+ .
T Consensus 8 ~~~~l~~~~Wy~g~i~R~~Ae~~L~~~~~GtFLVR~S~~~~~-~~~LSv~~~-----~~v~-H~~I~~~~-~~~~~~~~~ 79 (103)
T d2c9wa2 8 ALRELGQTGWYWGSMTVNEAKEKLKEAPEGTFLIRDSSHSDY-LLTISVKTS-----AGPT-NLRIEYQD-GKFRLDSII 79 (103)
T ss_dssp HHHHHHHTSCBCTTCCHHHHHHHHTTSCTTCEEEEECCSTTC-SEEEEEEET-----TEEE-EEEEEEET-TEEEECTTT
T ss_pred HHHHHhhCCCcCCCCCHHHHHHHhcCCCCCceEEeccCCCCC-CEEEEEEEC-----CEEE-EEEEEEcC-CeEeeCCcc
Confidence 56789999999999999999999974 45 999998777 788888765 6677 98887643 333321 1
Q ss_pred C-cccccchHHHHHhhh
Q 037285 756 S-VSESMQFDAMMENLR 771 (1094)
Q Consensus 756 ~-isE~~qFdsL~ElLr 771 (1094)
. ......|.++.+++.
T Consensus 80 ~~~~~~~~F~sl~~LI~ 96 (103)
T d2c9wa2 80 CVKSKLKQFDSVVHLID 96 (103)
T ss_dssp TTGGGCCCBSCHHHHHH
T ss_pred ccccCCCccCCHHHHHH
Confidence 1 344567999999884
|
| >d1qada_ d.93.1.1 (A:) Phosphatidylinositol 3-kinase, p85-alpha subunit {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Phosphatidylinositol 3-kinase, p85-alpha subunit species: Cow (Bos taurus) [TaxId: 9913]
Probab=97.43 E-value=1.8e-05 Score=72.22 Aligned_cols=74 Identities=16% Similarity=0.167 Sum_probs=56.6
Q ss_pred cccccccccCCCChhHHHHcCC--chh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCcccc
Q 037285 686 NLAQVDFGQKDVSLIDQEHLGL--SSG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSES 760 (1094)
Q Consensus 686 ~Le~~~Wy~~~IsR~~AE~ll~--a~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~isE~ 760 (1094)
.++..+||+++|+|.+||.+|. .+| ||++.+ .| .|.+|+... +.+. |+.|..+..+.+. ....
T Consensus 5 ~~~~~~Wy~g~isR~eAe~lL~~~~~G~FLVR~S~~-~~-~y~Lsv~~~-----~~v~-H~~I~~~~~g~~~----~~~~ 72 (107)
T d1qada_ 5 HHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSK-QG-CYACSVVVD-----GEVK-HCVINKTATGYGF----AEPY 72 (107)
T ss_dssp GGSGGGTEEEECCHHHHHHHHTTCCTTEEEEEEC----C-CEEEEEEET-----TEEE-EEEEEEETTEEES----STTC
T ss_pred ccCCCcccCCCCCHHHHHHHHcCCCCCcEEEEecCC-CC-CEEEEEEec-----CCeE-EEEEEECCCCeEE----cCCC
Confidence 4788899999999999999884 346 999965 66 688888775 7788 9999887766554 3445
Q ss_pred cchHHHHHhhh
Q 037285 761 MQFDAMMENLR 771 (1094)
Q Consensus 761 ~qFdsL~ElLr 771 (1094)
..|.++.+++.
T Consensus 73 ~~F~sl~~LI~ 83 (107)
T d1qada_ 73 NLYSSLKELVL 83 (107)
T ss_dssp CCBSSHHHHHH
T ss_pred CccCCHHHHHH
Confidence 57999999983
|
| >d2shpa3 d.93.1.1 (A:111-218) Tyrosine phoshatase shp-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine phoshatase shp-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.19 E-value=4.7e-05 Score=68.91 Aligned_cols=74 Identities=20% Similarity=0.288 Sum_probs=54.3
Q ss_pred ccccCCCChhHHHHcCCc---hh---hhhhhhcCCceeEEeeeccCC-----CCCCcccccccccccCCCccccCCCccc
Q 037285 691 DFGQKDVSLIDQEHLGLS---SG---VREVREEDGRLYHFTPLTDDG-----APKGRVDSQLNFGQDSQKTFGVDPSVSE 759 (1094)
Q Consensus 691 ~Wy~~~IsR~~AE~ll~a---~g---VR~s~~~~G~~y~~S~l~~~g-----a~~g~v~shy~I~~dsq~r~~vtp~isE 759 (1094)
-||+|.|+|.+||++|.. +| ||+|....| .|.+|+.+... ...+.+. |+.+.. ..+.++ +..
T Consensus 1 rWyhG~i~R~~Ae~lL~~~~~~G~FLVR~S~~~~g-~~~LSv~~~~~~~~~~~~~~~~~-h~~i~~-~~~~~~----~~~ 73 (108)
T d2shpa3 1 RWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPG-DFVLSVRTGDDKGESNDGKSKVT-HVMIRC-QELKYD----VGG 73 (108)
T ss_dssp TTBCCSCCHHHHHHHHHHTCCTTEEEEEECSSSTT-CEEEEEEECC-----CCCCCEEE-EEEEEE-ETTEEE----SSS
T ss_pred CCCcCCCCHHHHHHHHhhcCCCCeEEEEecCCCCC-CeEEEEEecCcccccccccccee-eEEEEe-CCCceE----eCC
Confidence 399999999999999963 46 999988777 88998887532 1234445 777764 334566 445
Q ss_pred ccchHHHHHhhh
Q 037285 760 SMQFDAMMENLR 771 (1094)
Q Consensus 760 ~~qFdsL~ElLr 771 (1094)
...|.++.+++.
T Consensus 74 ~~~F~sl~~LV~ 85 (108)
T d2shpa3 74 GERFDSLTDLVE 85 (108)
T ss_dssp SCCBSSHHHHHH
T ss_pred CcccCCHHHHHH
Confidence 667999999984
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.16 E-value=0.00056 Score=68.18 Aligned_cols=72 Identities=21% Similarity=0.117 Sum_probs=45.5
Q ss_pred ecccC-ceEEEEeeecC-ceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC--CCceeEEEeEeecCCCCceEEE
Q 037285 818 LGSGT-FGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH--HPNVVAFYGVVQDGPGGTLATV 893 (1094)
Q Consensus 818 LGsG~-FGtVYKAk~rG-t~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~--HPNIVqL~Gv~~d~~~~~L~IV 893 (1094)
+..|. -+.||+....+ ..+++|....... ..+..|..+|+.|. .-.+.+++.++.+. +..++|
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~--~~~~~v 84 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----------NELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWLL 84 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----------SCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEEE
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----------hHHHHHHHHHHHHHhcCCCCCceeeecccc--cceEEE
Confidence 34444 36789887754 5588887654321 12445666666553 23356777776654 378899
Q ss_pred eeecccchh
Q 037285 894 AEYMVDGSL 902 (1094)
Q Consensus 894 mEYmegGSL 902 (1094)
|++++|.++
T Consensus 85 ~~~i~G~~~ 93 (255)
T d1nd4a_ 85 LGEVPGQDL 93 (255)
T ss_dssp EECCSSEET
T ss_pred EEeeecccc
Confidence 999987665
|
| >d2cs0a1 d.93.1.1 (A:8-113) Hematopoietic SH2 domain containing protein HSH2D {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Hematopoietic SH2 domain containing protein HSH2D species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.13 E-value=6.5e-05 Score=68.27 Aligned_cols=72 Identities=17% Similarity=0.149 Sum_probs=55.2
Q ss_pred ccccccCCCChhHHHHcCCc--hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCcccccch
Q 037285 689 QVDFGQKDVSLIDQEHLGLS--SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSESMQF 763 (1094)
Q Consensus 689 ~~~Wy~~~IsR~~AE~ll~a--~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~isE~~qF 763 (1094)
.-+||+++|+|.+||++|.. +| ||++....+ |.+++... +.+. |+.|.....+.+.. ......|
T Consensus 8 ~~pWy~g~isR~eAe~lL~~~~~G~FLvR~S~~~~~--y~Lsv~~~-----~~~~-h~~I~~~~~g~~~~---~~~~~~F 76 (106)
T d2cs0a1 8 VPEWFHGAISREDAENLLESQPLGSFLIRVSHSHVG--YTLSYKAQ-----SSCC-HFMVKLLDDGTFMI---PGEKVAH 76 (106)
T ss_dssp CCSSBCSSCCHHHHHHHHHTSCTTCEEEEECSSSSS--EEEEECCS-----SSCE-EEEEEECTTSCEEC---TTCSCCB
T ss_pred CCCCccCCCCHHHHHHHHcCCCCCcEEEEecCCCCC--EEEEEEec-----CCce-eEEEEEcCCCCEEE---ecCCccC
Confidence 45799999999999999886 45 999977555 88887765 5666 99998777665551 2455679
Q ss_pred HHHHHhhh
Q 037285 764 DAMMENLR 771 (1094)
Q Consensus 764 dsL~ElLr 771 (1094)
.++.+++.
T Consensus 77 ~sl~eLV~ 84 (106)
T d2cs0a1 77 TSLDALVT 84 (106)
T ss_dssp SSHHHHHH
T ss_pred CCHHHHHH
Confidence 99999983
|
| >d1xa6a2 d.93.1.1 (A:21-161) Beta-chimaerin, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Beta-chimaerin, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.06 E-value=4e-05 Score=73.92 Aligned_cols=71 Identities=15% Similarity=0.097 Sum_probs=53.8
Q ss_pred cccccccccCCCChhHHHHcCCc-hh---hhhhhhcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCccccc
Q 037285 686 NLAQVDFGQKDVSLIDQEHLGLS-SG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVSESM 761 (1094)
Q Consensus 686 ~Le~~~Wy~~~IsR~~AE~ll~a-~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~isE~~ 761 (1094)
.+....||||.|+|.+||.+|.. +| ||+|....| .|.+|+... +++. ||.|..+ ++++. .+ .
T Consensus 31 ~~~~~~wyhG~isR~eAe~lL~~~dGsFLVR~S~~~~g-~y~LSv~~~-----~~v~-H~~I~~~--g~~~~----~~-~ 96 (141)
T d1xa6a2 31 PKYYGREFHGIISREQADELLGGVEGAYILRESQRQPG-CYTLALRFG-----NQTL-NYRLFHD--GKHFV----GE-K 96 (141)
T ss_dssp SCSSCSSEEEECCHHHHHHHHCSCTTBEEEEECSSSTT-CEEEEEEET-----TEEE-ECCCEES--SSEEC----SS-S
T ss_pred cccccceeeccCCHHHHHHHHcCCCCeEEEEecCCCCC-CEEEEEEEC-----CEEE-EEEEEEC--CCEEE----CC-C
Confidence 35556899999999999999975 57 999988778 799998886 7888 9998764 34442 22 2
Q ss_pred chHHHHHhh
Q 037285 762 QFDAMMENL 770 (1094)
Q Consensus 762 qFdsL~ElL 770 (1094)
.|+++.+++
T Consensus 97 ~F~sl~eLV 105 (141)
T d1xa6a2 97 RFESIHDLV 105 (141)
T ss_dssp CCCCSSHHH
T ss_pred eECCHHHHH
Confidence 577776665
|
| >d2c60a1 d.15.2.2 (A:43-122) Mitogen-activated protein kinase kinase kinase 3, MEKK 3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Mitogen-activated protein kinase kinase kinase 3, MEKK 3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.02 E-value=0.0018 Score=56.07 Aligned_cols=69 Identities=20% Similarity=0.409 Sum_probs=58.6
Q ss_pred cCceEEEEecCCCChHHHHHHHHHHcCCceEEEEeCCCCCCCceeeccChhhHHHHHHHHhhcCCCCCCCeEEEEE
Q 037285 109 GGETRIIRIRKDISWQILRQKALEVYNQVHVIKYQLPGEDLDALVSVSCDEDLQNMMEEYNELGDREGSQRIRMFL 184 (1094)
Q Consensus 109 GG~triv~v~r~~~~~~l~~kl~~~~~~~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~r~R~Fl 184 (1094)
-||-||+-++|.++|.+|..|+...||..+.+-|- +.+ -+|.++|.+||+.-|+-.||-. ...+ ||+.|
T Consensus 10 ~gEkRIi~f~RPv~~~dl~~kv~~afGq~ldl~y~--n~E--l~IPl~~Q~DLDkAvellDrs~-~~ks--LrilL 78 (80)
T d2c60a1 10 NGERRIIAFSRPVKYEDVEHKVTTVFGQPLDLHYM--NNE--LSILLKNQDDLDKAIDILDRSS-SMKS--LRILL 78 (80)
T ss_dssp TTEEEEEEECSSCCHHHHHHHHHHHHSSCCEEEEE--CSS--CEEECCSHHHHHHHHHHHHHCS-SCCS--EEEEE
T ss_pred cCceEEEecCCCccHHHHHHHHHHHhCCeeeeEEe--cCe--EEEecccHHHHHHHHHHHccCc-ccce--eEEEE
Confidence 47899999999999999999999999999999998 333 5799999999999999999842 2233 66665
|
| >d2nptb1 d.15.2.2 (B:42-123) Mitogen-activated protein kinase kinase kinase 2, MEKK 2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Mitogen-activated protein kinase kinase kinase 2, MEKK 2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.01 E-value=0.0016 Score=56.63 Aligned_cols=69 Identities=22% Similarity=0.372 Sum_probs=58.2
Q ss_pred cCceEEEEecCCCChHHHHHHHHHHcCCceEEEEeCCCCCCCceeeccChhhHHHHHHHHhhcCCCCCCCeEEE
Q 037285 109 GGETRIIRIRKDISWQILRQKALEVYNQVHVIKYQLPGEDLDALVSVSCDEDLQNMMEEYNELGDREGSQRIRM 182 (1094)
Q Consensus 109 GG~triv~v~r~~~~~~l~~kl~~~~~~~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~r~R~ 182 (1094)
-||.||+-++|.+.|.+|..|+...||..+.+-|- +. .-+|.++|.+||+.-|+-.||-. ..++.||-|
T Consensus 10 ~gEkRIi~f~RPv~~~dl~~kv~~afGq~ldl~y~--n~--EL~IPl~~Q~DLDkAvellDrs~-~~ksLrilL 78 (82)
T d2nptb1 10 RGEKRILQFPRPVKLEDLRSKAKIAFGQSMDLHYT--NN--ELVIPLTTQDDLDKAVELLDRSI-HMKSLKILL 78 (82)
T ss_dssp TTEEEEEEECSSCCHHHHHHHHHHHHTSCEEEEEE--ET--TEEEECCCHHHHHHHHHHHHHCS-SCCSEEEEE
T ss_pred cCceEEEecCCCccHHHHHHHHHHHhCCeeeEEEe--cC--eEEEecccHHHHHHHHHHHccCc-cccceEEEE
Confidence 47899999999999999999999999999999998 33 46999999999999999999842 333444444
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.64 E-value=0.0016 Score=70.72 Aligned_cols=82 Identities=17% Similarity=0.047 Sum_probs=46.0
Q ss_pred EEEecccCceEEEEeeec--CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC---CCceeEEEeEeecCCCCc
Q 037285 815 QKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH---HPNVVAFYGVVQDGPGGT 889 (1094)
Q Consensus 815 ~kkLGsG~FGtVYKAk~r--Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~---HPNIVqL~Gv~~d~~~~~ 889 (1094)
.+.||.|....||+.... +..++||.-............ ....+...|..+|+.+. ...+++++.+..+ .
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~-~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~----~ 105 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWP-LTIDRARIESSALIRQGEHVPHLVPRVFYSDTE----M 105 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCC-CCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETT----T
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCC-CCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCC----C
Confidence 456899999999998763 467889965432111000000 00122335666666552 2346677765432 4
Q ss_pred eEEEeeecccch
Q 037285 890 LATVAEYMVDGS 901 (1094)
Q Consensus 890 L~IVmEYmegGS 901 (1094)
.++|||++.+..
T Consensus 106 ~~lvmE~L~~~~ 117 (392)
T d2pula1 106 AVTVMEDLSHLK 117 (392)
T ss_dssp TEEEECCCTTSE
T ss_pred CEEEEeccCCcc
Confidence 578999997644
|
| >d2bkfa1 d.15.2.2 (A:1-85) Next to BRCA1 gene 1 protein, NBR1 (KIAA0049) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Next to BRCA1 gene 1 protein, NBR1 (KIAA0049) species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.59 E-value=0.0036 Score=55.35 Aligned_cols=69 Identities=12% Similarity=0.261 Sum_probs=53.5
Q ss_pred cCceEE--EEecCCCChHHHHHHHHHHcC-CceEEEEeCCCCCCCceeeccChhhHHHHHHHHhhcCCCCCCCeEEEEEe
Q 037285 109 GGETRI--IRIRKDISWQILRQKALEVYN-QVHVIKYQLPGEDLDALVSVSCDEDLQNMMEEYNELGDREGSQRIRMFLF 185 (1094)
Q Consensus 109 GG~tri--v~v~r~~~~~~l~~kl~~~~~-~~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~r~R~FlF 185 (1094)
||+|+- |+++++.+|.+|.+++...++ ..+.|||. .|=+-.|.++||+||+.-++-+-+ ....||++++
T Consensus 12 ~~dt~RF~ls~~~~~~~~~L~~~i~~rf~l~~~~lkY~---Ddd~e~v~l~~d~dl~E~~~~a~~-----~~~~irl~v~ 83 (85)
T d2bkfa1 12 KNEIQSFLVSDPENTTWADIEAMVKVSFDLNTIQIKYL---DEENEEVSINSQGEYEEALKMAVK-----QGNQLQMQVH 83 (85)
T ss_dssp TTEEEEEEESCGGGCCHHHHHHHHHHHHTCSSEEEEEE---CTTSCEEEECSHHHHHHHHHHHHH-----TTTEEEEEEE
T ss_pred CCceEEEEecCCCCCcHHHHHHHHHHhcCcccceEEEE---cCCCCEEEEecHHHHHHHHHHHhc-----CCCEEEEEEe
Confidence 445554 456789999999999999998 67889998 666779999999999877665422 2357888776
|
| >d1uura3 d.93.1.1 (A:577-707) STAT homologue {Dictyostelium discoideum [TaxId: 44689]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: STAT homologue species: Dictyostelium discoideum [TaxId: 44689]
Probab=96.35 E-value=0.0007 Score=63.89 Aligned_cols=60 Identities=10% Similarity=0.041 Sum_probs=48.5
Q ss_pred hhccccccccccCCCChhHHHHcCC--chh---hhhhhhcCCceeEEeeeccCCCCCCccccccccccc
Q 037285 683 YFRNLAQVDFGQKDVSLIDQEHLGL--SSG---VREVREEDGRLYHFTPLTDDGAPKGRVDSQLNFGQD 746 (1094)
Q Consensus 683 ~~~~Le~~~Wy~~~IsR~~AE~ll~--a~g---VR~s~~~~G~~y~~S~l~~~ga~~g~v~shy~I~~d 746 (1094)
.+.+|++..||+|.|+|.+||.+|+ .+| ||.|..+.| .|+++.... ...++++ ||.|..+
T Consensus 2 hl~~lw~~~~~~G~isr~~ae~~L~~~~~GtFLvR~S~s~~g-~~~ls~~~~--~~~~~v~-h~~i~~~ 66 (131)
T d1uura3 2 HISTLWQEGIIYGYMGRQEVNDALQNQDPGTFIIRFSERNPG-QFGIAYIGV--EMPARIK-HYLVQPN 66 (131)
T ss_dssp THHHHHHHTSSCBSCCHHHHHHTTSSCCTTCEEEEECSSSTT-CEEEEEECS--SSSCCEE-EEECCGG
T ss_pred cchhhhhCCcEEccCCHHHHHHHHhcCCCCeEEEEecCCCCC-cEEEEEEEe--cCCCcEE-EEEEeec
Confidence 3678889999999999999999998 445 999988888 788887764 2346777 8888653
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.45 E-value=0.031 Score=59.98 Aligned_cols=76 Identities=16% Similarity=0.258 Sum_probs=45.9
Q ss_pred CCeeEEEEecccCceEEEEeeec---------CceEEEEEeecCccCCCchhHHHHHHHHHHHHHHHhhCC-CCceeEEE
Q 037285 810 EDLEEQKELGSGTFGTVYHGKWR---------GTDVAIKRIKKSCFTGRSSEQERLTVEFWKEAEILSKLH-HPNVVAFY 879 (1094)
Q Consensus 810 edYei~kkLGsG~FGtVYKAk~r---------Gt~VAVKiIkk~~~se~~~eqe~~~~eFlrEIkILkrL~-HPNIVqL~ 879 (1094)
+++++ +.|+.|-.-.+|++... ...|.+++.-.. . . .....+|..+++.+. +.-..+++
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~---~-~------~idr~~E~~i~~~ls~~gl~Pkll 111 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---E-T------ESHLVAESVIFTLLSERHLGPKLY 111 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---C-C------HHHHHHHHHHHHHHHHTTSSSCEE
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc---c-h------hhHHHHHHHHHHHHHhCCCCCeEE
Confidence 34443 56888888999998753 234666665321 1 1 123346788887775 33344777
Q ss_pred eEeecCCCCceEEEeeecccchh
Q 037285 880 GVVQDGPGGTLATVAEYMVDGSL 902 (1094)
Q Consensus 880 Gv~~d~~~~~L~IVmEYmegGSL 902 (1094)
+++.. .+|+||+++..|
T Consensus 112 ~~~~~------g~I~efi~g~~l 128 (395)
T d1nw1a_ 112 GIFSG------GRLEEYIPSRPL 128 (395)
T ss_dssp EEETT------EEEECCCCEEEC
T ss_pred EEcCC------ceEEEEeccccC
Confidence 77743 468999976544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=94.25 E-value=0.048 Score=56.99 Aligned_cols=28 Identities=18% Similarity=0.068 Sum_probs=22.8
Q ss_pred CceeccCCCCceEeccCCCCCCcEEEEecCCccc
Q 037285 936 NIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKI 969 (1094)
Q Consensus 936 GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSrl 969 (1094)
++||+|+.+.|||++ ++ ..++||+-++.
T Consensus 193 ~liHgDlh~~NvL~~----~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWR----DG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEES----SS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEe----CC--ceEEechhccc
Confidence 589999999999997 22 35899998763
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.67 E-value=0.073 Score=54.58 Aligned_cols=30 Identities=23% Similarity=0.324 Sum_probs=25.8
Q ss_pred CCceeccCCCCceEeccCCCCCCcEEEEecCCcc
Q 037285 935 KNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 968 (1094)
Q Consensus 935 ~GIIHRDLKPeNILLD~~~~e~g~VKLsDFGLSr 968 (1094)
.|+||+|+.+.||+++ .+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~----~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFL----GDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEE----TTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcc----cccceeEecccccc
Confidence 4699999999999998 55667899999875
|
| >d1bg1a3 d.93.1.1 (A:576-716) STAT3b {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: STAT3b species: Mouse (Mus musculus) [TaxId: 10090]
Probab=93.61 E-value=0.011 Score=56.67 Aligned_cols=74 Identities=12% Similarity=0.070 Sum_probs=50.8
Q ss_pred ccccccccccCCCChhHHHHcCCc--hh---hhhhh-hcCCceeEEeeeccCCCCCCcccccccccccCCCccccCCCcc
Q 037285 685 RNLAQVDFGQKDVSLIDQEHLGLS--SG---VREVR-EEDGRLYHFTPLTDDGAPKGRVDSQLNFGQDSQKTFGVDPSVS 758 (1094)
Q Consensus 685 ~~Le~~~Wy~~~IsR~~AE~ll~a--~g---VR~s~-~~~G~~y~~S~l~~~ga~~g~v~shy~I~~dsq~r~~vtp~is 758 (1094)
.+|++..||+|.|+|.+||.+|.. .| ||.|. .+.| .++++.... +... |+.|... .|...
T Consensus 2 l~lW~~gw~~G~isr~~a~~~L~~~~~GtFLvR~S~~s~~G-~~tis~~~~-----~~~~-~~~i~~~-------~p~t~ 67 (141)
T d1bg1a3 2 LALWNEGYIMGFISKERERAILSTKPPGTFLLRFSESSKEG-GVTFTWVEK-----DISG-STQIQSV-------EPYTK 67 (141)
T ss_dssp SHHHHSSCCCBCCCTTGGGTTTTTSCTTCBCEEECSSCSSC-CEEECCCCS-----SSCS-SCCCCCC-------CCBCG
T ss_pred cceecCCeEEEeCCHHHHHHHhhCCCCCeEEEEecCCccCC-CEEEEEEec-----CcCC-ceEEeec-------CCeec
Confidence 478899999999999999999985 34 99986 4467 677775543 2222 3334321 12346
Q ss_pred cccchHHHHHhhhc
Q 037285 759 ESMQFDAMMENLRT 772 (1094)
Q Consensus 759 E~~qFdsL~ElLrt 772 (1094)
+..+|.++.+.++.
T Consensus 68 ~dl~~~sL~dlI~~ 81 (141)
T d1bg1a3 68 QQLNNMSFAEIIMG 81 (141)
T ss_dssp GGGTSSCHHHHTTS
T ss_pred CccccCCHHHHHHh
Confidence 66778888888853
|
| >d1wmha_ d.15.2.2 (A:) Protein kinase C, iota type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Protein kinase C, iota type species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.44 E-value=2.8 Score=36.18 Aligned_cols=60 Identities=22% Similarity=0.320 Sum_probs=49.4
Q ss_pred cCceEEEEecCCCChHHHHHHHHHHcC----CceEEEEeCCCCCCCceeeccChhhHHHHHHHHhhc
Q 037285 109 GGETRIIRIRKDISWQILRQKALEVYN----QVHVIKYQLPGEDLDALVSVSCDEDLQNMMEEYNEL 171 (1094)
Q Consensus 109 GG~triv~v~r~~~~~~l~~kl~~~~~----~~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~ 171 (1094)
+|+--|..++.+|+|.+|...+..+|+ .++++|+= .|+=| =++|+++.+|+.-+-.|..-
T Consensus 9 ~G~i~it~~~~~it~e~l~~evr~~C~f~~~q~fT~KWi--DeEGD-PCTISSQmEL~EA~RLye~n 72 (83)
T d1wmha_ 9 RGDIMITHFEPSISFEGLCNEVRDMCSFDNEQLFTMKWI--DEEGD-PCTVSSQLELEEAFRLYELN 72 (83)
T ss_dssp TTEEEEEEECTTCCHHHHHHHHHHHTTCCTTCCCEEEEE--CTTSC-EEECCSHHHHHHHHHHHHHT
T ss_pred cCeEEEEecCCCccHHHHHHHHHHHhCCCcCCcEEEEEE--cCCCC-ceeeecHHHHHHHHHHHHcc
Confidence 344558999999999999999999997 57899986 34444 58999999999999888653
|